26797704	Deployment	C2825812
26797704	Parental	C0030551
26797704	Family	C0015576
26797704	Child	C0008059
26797704	Adjustment	C0376209
26797704	Military Families	C3850016
26797704	military service	C1550414
26797704	United States	C0041703
26797704	wartime	C1254367
26797704	deployments	C2825812
26797704	stress	C0038435
26797704	military families	C3850016
26797704	Research	C0035168
26797704	negative impact	C1513916
26797704	deployment	C2825812
26797704	well being	C0018684
26797704	service	C1550414
26797704	members	C0680022
26797704	military	C3245458
26797704	spouses	C0162409
26797704	children	C0008059
26797704	parental	C0030551
26797704	deployments	C2825812
26797704	adjustment	C0376209
26797704	young children	C0728836
26797704	families	C3850016
26797704	deployment	C2825812
26797704	deployment records	C0034869
26797704	parent	C0030551
26797704	reported	C0684224
26797704	caregiving	C1947933
26797704	military	C3245458
26797704	parents	C0030551
26797704	deployment	C2825812
26797704	adjustment	C0376209
26797704	military families	C3850016
26797704	children	C0008059
26797704	deployment	C2825812
26797704	impaired	C0221099
26797704	family functioning	C0680051
26797704	marital	C0024841
26797704	instability	C1444783
26797704	Parental	C0030551
26797704	depressive	C0011570
26797704	posttraumatic stress symptoms	C0038436
26797704	associated with	C0332281
26797704	impairments	C0221099
26797704	social	C0035820
26797704	emotional	C0849912
26797704	adjustment	C0376209
26797704	young children	C0728836
26797704	anxiety	C0003467
26797704	childhood	C0231335
26797704	adjustment	C0376209
26797704	school-age children	C2827631
26797704	parental	C0030551
26797704	sensitivity	C0312418
26797704	associated with	C0332281
26797704	social	C0035820
26797704	emotional outcomes	C0849912
26797704	childhood	C0231335
26797704	findings	C0243095
26797704	preventive	C1456501
26797704	military families	C3850016
26797704	children	C0008059
26931495	neutral	C1254372
26931495	forbidden links	C1254372
26931495	morphological	C0543482
26931495	matches	C1708943
26931495	assembly	C0441833
26931495	mutualistic	C1254366
26931495	hawkmoth	C0599456
26931495	plant	C0032098
26931495	networks	C1882071
26931495	evolutionary ecology	C0013546
26931495	co-evolutionary processes	C1522240
26931495	patterns	C0449774
26931495	interactions	C1704675
26931495	species	C1705920
26931495	community	C0009462
26931495	level	C0441889
26931495	Pollination	C1522786
26931495	flowers	C0330090
26931495	long corolla tubes	C2699452
26931495	long-tongued hawkmoths	C0599456
26931495	model	C0026336
26931495	co-evolution	C0015219
26931495	models	C0026336
26931495	association	C0439849
26931495	mouthparts' length	C1444754
26931495	corolla	C2699452
26931495	depth	C0205125
26931495	flowers	C0330090
26931495	trait	C0599883
26931495	convergence	C2700387
26931495	specialization	C0037776
26931495	community	C0009462
26931495	assessed	C1516048
26931495	hawkmoths	C0599456
26931495	pollinate plants	C0032098
26931495	floral tube	C2698828
26931495	lengths	C1444754
26931495	proboscis	C3463932
26931495	lengths	C1444754
26931495	morphological	C0543482
26931495	match	C1708943
26931495	hypothesis	C1512571
26931495	abundance	C2346714
26931495	processes	C1522240
26931495	neutral hypothesis	C1512571
26931495	ecological trait	C0599883
26931495	mismatches	C1881865
26931495	constraints	C2986806
26931495	forbidden links	C1254372
26931495	hypothesis	C1512571
26931495	processes	C1522240
26931495	structure	C0678594
26931495	hawkmoth	C0599456
26931495	plant	C0032098
26931495	mutualistic networks	C1882071
26931495	communities	C0009462
26931495	biogeographical regions	C0017446
26931495	South America	C0037713
26931495	convergence	C2700387
26931495	morphological	C0543482
26931495	traits	C0599883
26931495	communities	C0009462
26931495	distribution	C1704711
26931495	morphological	C0543482
26931495	hawkmoths	C0599456
26931495	plants	C0032098
26931495	morphological	C0543482
26931495	match	C1708943
26931495	hypothesis	C1512571
26931495	communities	C0009462
26931495	communities	C0009462
26931495	biogeographical areas	C0017446
26931495	interactions	C1704675
26931495	neutral hypothesis	C1512571
26931495	findings	C2607943
26931495	co-evolution	C0015219
26931495	evolution	C0015219
26931495	long proboscises	C3463932
26931495	flower tubes	C0330090
26931495	morphological	C0543482
26931495	traits	C0599883
26931495	forbidden links	C1254372
26931495	hypothesis	C1512571
26931495	interactions	C1704675
26931495	mutualistic partners	C0441833
26931495	role	C1705810
26931495	niche-based processes	C1522240
27061776	Nosocomial pneumonia	C0949083
27061776	methicillin-resistant Staphylococcus aureus	C1265292
27061776	treated with	C0332293
27061776	linezolid	C0663241
27061776	vancomycin	C0042313
27061776	economic analysis	C0680954
27061776	resource use	C1704738
27061776	Spanish	C0037747
27061776	perspective	C0680951
27061776	Spanish	C0037747
27061776	perspective	C0680951
27061776	study	C2603343
27061776	healthcare resource utilization	C1704738
27061776	HCRU	C1704738
27061776	costs	C0085552
27061776	treating	C1522326
27061776	nosocomial pneumonia	C0949083
27061776	NP	C0949083
27061776	methicillin-resistant Staphylococcus aureus	C1265292
27061776	MRSA	C1265292
27061776	hospitalized adults	C0701159
27061776	linezolid	C0663241
27061776	vancomycin	C0042313
27061776	renal failure	C0035078
27061776	rate	C1521828
27061776	economic outcomes	C1274040
27061776	study groups	C0681860
27061776	post hoc evaluation	C1254363
27061776	randomized	C2986910
27061776	double-blind	C0013072
27061776	multicenter phase 4 study	C0282462
27061776	Nosocomial pneumonia	C0949083
27061776	MRSA	C1265292
27061776	hospitalized adults	C0701159
27061776	modified intent to treat	C1292734
27061776	mITT	C1292734
27061776	population	C1257890
27061776	linezolid	C0663241
27061776	vancomycin	C0042313
27061776	treated	C0332293
27061776	patients	C0030705
27061776	Costs	C0085552
27061776	HCRU	C1704738
27061776	patients	C0030705
27061776	administered	C1521801
27061776	linezolid	C0663241
27061776	vancomycin	C0042313
27061776	patients	C0030705
27061776	renal failure	C0035078
27061776	HCRU	C1704738
27061776	outcomes	C1274040
27061776	costs	C0085552
27061776	costs	C0085552
27061776	linezolid	C0663241
27061776	vancomycin	C0042313
27061776	treated	C0332293
27061776	patients	C0030705
27061776	renal failure	C0035078
27061776	rate	C1521828
27061776	linezolid	C0663241
27061776	treated	C0332293
27061776	patients	C0030705
27061776	costs	C0085552
27061776	patients	C0030705
27061776	renal failure	C0035078
27061776	patients	C0030705
27061776	renal failure	C0035078
27061776	HCRU	C1704738
27061776	days	C0439228
27061776	mechanical ventilation	C0199470
27061776	days	C0439228
27061776	ICU stay	C1254367
27061776	days	C0439228
27061776	hospital stay	C3489408
27061776	days	C0439228
27061776	cost	C0085552
27061776	linezolid	C0663241
27061776	vancomycin	C0042313
27061776	treated	C0332293
27061776	patients	C0030705
27061776	costs	C0085552
27061776	patient	C0030705
27061776	day	C0439228
27061776	cohorts	C0599755
27061776	mortality	C0392762
27061776	Spanish	C0037747
27061776	perspective	C0680951
27061776	costs	C0085552
27061776	linezolid	C0663241
27061776	vancomycin	C0042313
27061776	pneumonia	C0032285
27061776	cohorts	C0599755
27061776	drug cost	C0085123
27061776	linezolid	C0663241
27061776	offset	C1711330
27061776	renal failure	C0035078
27061776	adverse events	C0877248
27131339	HERG1	C1566128
27131339	potassium channel	C0032824
27131339	expression	C1171362
27131339	potentially	C3245505
27131339	malignant disorders	C0006826
27131339	oral mucosa	C0026639
27131339	prognostic	C0220901
27131339	relevance	C2347946
27131339	oral squamous cell carcinoma	C0585362
27131339	HERG1	C1566128
27131339	potassium channel	C0032824
27131339	critical	C1511545
27131339	role	C1705810
27131339	cell proliferation	C0596290
27131339	HERG1 protein	C1566128
27131339	expression	C1171362
27131339	analyzed	C0936012
27131339	immunohistochemistry	C0021044
27131339	IHC	C0021044
27131339	patients	C0030705
27131339	oral leukoplakias	C0023532
27131339	patients	C0030705
27131339	oral squamous cell carcinomas	C0585362
27131339	OSCC	C0585362
27131339	HERG1	C1416571
27131339	mRNA	C0035696
27131339	levels	C0441889
27131339	assessed	C1516048
27131339	real-time reverse transcriptase-polymerase chain reaction	C0599161
27131339	RT-PCR	C0599161
27131339	patients	C0030705
27131339	primary	C0205225
27131339	head and neck squamous cell carcinoma	C1168401
27131339	HNSCC	C1168401
27131339	Statistically significant	C0237881
27131339	associations	C0439849
27131339	HERG1	C1566128
27131339	expression	C1171362
27131339	tobacco consumption	C0543414
27131339	disease stage	C0699749
27131339	tumor	C0027651
27131339	differentiation	C0007589
27131339	tumor recurrence	C0521158
27131339	reduced	C0392756
27131339	survival	C0038952
27131339	no	C1518422
27131339	association	C0439849
27131339	HERG1	C1566128
27131339	expression	C1171362
27131339	risk	C0035647
27131339	progression	C0178874
27131339	oral leukoplakia	C0023532
27131339	OSCC	C0585362
27131339	high	C0205250
27131339	proportion	C1709707
27131339	tumors	C0027651
27131339	increased	C0205217
27131339	HERG1	C1416571
27131339	mRNA	C0035696
27131339	levels	C0441889
27131339	compared	C1707455
27131339	normal mucosa	C0026724
27131339	nononcologic patients	C0030705
27131339	Aberrant	C0443127
27131339	HERG1	C1566128
27131339	expression	C1171362
27131339	increases	C0442805
27131339	tumorigenesis progresses	C0178874
27131339	oral hyperplasia	C1400010
27131339	OSCC	C0585362
27131339	Increased	C0205217
27131339	HERG1	C1416571
27131339	mRNA	C0035696
27131339	levels	C0441889
27131339	detected	C0442726
27131339	OSCC	C0585362
27131339	HNSCC	C1168401
27131339	subsites	C1710234
27131339	HERG1	C1566128
27131339	expression	C1171362
27131339	clinically	C0205210
27131339	relevant	C2347946
27131339	feature	C2348519
27131339	tumor progression	C0178874
27131339	potential	C3245505
27131339	poor	C2700379
27131339	prognostic	C0220901
27131339	biomarker	C0005516
27131339	OSCC	C0585362
27213687	Nationwide	C1254362
27213687	reduction	C0547047
27213687	corneal transplantations	C0010042
27213687	keratoconus	C0022578
27213687	implementation	C1708476
27213687	cross-linking	C4065848
27213687	Keratoconus	C0022578
27213687	corneal ectasia	C0155135
27213687	irregular astigmatism	C0152194
27213687	diminished vision	C0042798
27213687	corneal scarring	C0349702
27213687	patients	C0030705
27213687	keratoconus	C0022578
27213687	corneal transplant	C0010042
27213687	Corneal cross-linking	C4065848
27213687	CXL	C4065848
27213687	treatment	C0087111
27213687	corneal transplantation	C0010042
27213687	investigated	C1292732
27213687	introduction	C0579004
27213687	CXL	C4065848
27213687	corneal transplants	C0010042
27213687	performed	C0884358
27213687	annually	C0332181
27213687	Data	C1511726
27213687	transplantation procedures	C0040732
27213687	performed	C0884358
27213687	patients	C0030705
27213687	age	C0001779
27213687	years	C0439234
27213687	Dutch National Organ Transplant Registry	C0034975
27213687	corneal transplants	C0010042
27213687	performed	C0884358
27213687	introduction	C0579004
27213687	CXL	C4065848
27213687	compared	C1707455
27213687	trend analysis	C0681702
27213687	annual	C0332181
27213687	keratoplasties	C0010042
27213687	performed	C0884358
27213687	corneal transplants	C0010042
27213687	performed	C0884358
27213687	year	C0439234
27213687	introduction	C0579004
27213687	CXL	C4065848
27213687	compared	C1707455
27213687	year	C0439234
27213687	introduction	C0579004
27213687	CXL	C4065848
27213687	transplants	C0010042
27213687	Age	C0001779
27213687	gender	C0079399
27213687	visual acuity	C0042812
27213687	patient	C0030705
27213687	time periods	C1948053
27213687	Trend analysis	C0681702
27213687	decrease	C0547047
27213687	corneal transplants	C0010042
27213687	corneal transplants	C0010042
27213687	keratoconus	C0022578
27213687	nationwide	C1254362
27213687	introduction	C0579004
27213687	CXL	C4065848
27213687	reduction	C0547047
27213687	corneal cross-linking	C4065848
27213687	reduce	C0392756
27213687	corneal transplantation	C0010042
27233918	Basal	C0678121
27233918	maximal	C0205289
27233918	metabolic rates	C0870882
27233918	response	C0871261
27233918	temperature change	C0450031
27233918	avian	C0005595
27233918	species	C1705920
27233918	birds	C0005595
27233918	acclimation	C0000934
27233918	acclimatization	C0000934
27233918	temperature	C0039476
27233918	basal	C0678121
27233918	BMR	C0678121
27233918	summit	C0870882
27233918	Msum	C0870882
27233918	maximal	C0205289
27233918	MMR	C0870882
27233918	metabolic rates	C0870882
27233918	rate	C0870882
27233918	species	C1705920
27233918	phenotype	C0031437
27233918	short-term	C0443303
27233918	temperature	C0039476
27233918	variations	C0205419
27233918	aims	C1947946
27233918	pattern	C0449774
27233918	metabolic	C0311400
27233918	temperature change	C0450031
27233918	rates	C0870882
27233918	exposure to	C0332157
27233918	warm	C0563030
27233918	cold environments	C0241842
27233918	BMR	C0678121
27233918	Msum	C0870882
27233918	MMR	C0870882
27233918	rates	C0870882
27233918	thermal	C0018837
27233918	acclimation	C0000934
27233918	white-throated sparrows	C1093387
27233918	Zonotrichia albicollis	C1093387
27233918	black-capped chickadees	C0326488
27233918	Poecile atricapillus	C0326488
27233918	snow buntings	C0326923
27233918	Plectrophenax nivalis	C0326923
27233918	acclimation	C0000934
27233918	day	C0439228
27233918	days	C0439228
27233918	acclimation	C0000934
27233918	Birds	C0005595
27233918	metabolic	C0311400
27233918	phenotype	C0031437
27233918	days	C0439228
27233918	patterns	C0449774
27233918	species	C1705920
27233918	Sparrows	C1093387
27233918	metabolic	C0311400
27233918	increases	C0442805
27233918	cold	C0241842
27233918	thermoneutrality	C0680444
27233918	chickadees	C0326488
27233918	buntings	C0326923
27233918	influenced	C4054723
27233918	temperature	C0039476
27233918	patterns	C0449774
27233918	results	C0683954
27233918	BMR	C0678121
27233918	rates	C0870882
27233918	warm	C0563030
27233918	cold environments	C0241842
27233918	Msum	C0870882
27233918	MMR	C0870882
27233918	limitations	C0449295
27233918	rate	C0870882
27233918	organ size	C1450569
27233918	function	C0542341
27233918	maximal	C0205289
27233918	metabolic	C0311400
27233918	capacity	C1516240
27233918	lost	C0745777
27233918	warm environment	C0563030
27233918	gained	C1517378
27233918	cold environment	C0241842
27233918	temperature	C0039476
27233918	stochasticity	C0038347
27233918	northern latitudes	C0017446
27233918	loss	C1517945
27233918	thermogenic	C0018837
27233918	capacity	C1516240
27233918	warm	C0563030
27233918	winter	C0241737
27233918	days	C0439228
27233918	birds	C0005595
27233918	phenotype	C0031437
27233918	cold	C0241842
27233918	days	C0439228
27235824	prime	C3825344
27235824	calories	C1556156
27235824	effects of	C1704420
27235824	supraliminal priming	C3825344
27235824	food consumption	C2983605
27235824	moderating role	C1704326
27235824	gender	C0079399
27235824	eating restraint	C0451424
27235824	intentions	C0162425
27235824	action	C3266814
27235824	weight control	C0920298
27235824	research	C0035168
27235824	weight control	C0920298
27235824	conscious	C0234421
27235824	intentions	C0162425
27235824	Priming	C3825344
27235824	subconscious	C0038535
27235824	cognition	C0009240
27235824	effects of	C1704420
27235824	semantic priming	C0871332
27235824	healthy	C3898900
27235824	body image	C0005891
27235824	goal-oriented words	C0042926
27235824	food consumption	C2983605
27235824	moderating role	C1704326
27235824	restrained eating	C0451424
27235824	gender	C0079399
27235824	participants	C0679646
27235824	experiment	C0681814
27235824	sentence	C0876929
27235824	priming	C3825344
27235824	game	C0150593
27235824	kilocalories	C0439259
27235824	consumed	C0513065
27235824	ANCOVA	C0814908
27235824	priming	C3825344
27235824	gender	C0079399
27235824	restrained eating index	C0451424
27235824	self-reported	C2700446
27235824	BMI	C1305855
27235824	interaction	C1704675
27235824	priming	C3825344
27235824	gender	C0079399
27235824	priming	C3825344
27235824	restrained eating index	C0451424
27235824	effect of	C1704420
27235824	priming	C3825344
27235824	interaction	C1704675
27235824	priming	C3825344
27235824	gender	C0079399
27235824	Females	C0086287
27235824	kilocalories	C0439259
27235824	priming	C3825344
27235824	words	C0042926
27235824	healthy	C3898900
27235824	body image	C0005891
27235824	females	C0086287
27235824	prime	C3825344
27235824	body image	C0005891
27235824	prime	C3825344
27235824	food intake	C0013470
27235824	males	C0086582
27235824	restrained eaters	C0679646
27235824	priming	C3825344
27235824	females	C0086287
27235824	food intake	C0013470
27235824	restrained	C0679646
27235824	unrestrained eaters	C0679646
27235824	priming	C3825344
27235824	words	C0042926
27235824	male's	C0086582
27235824	healthy	C3898900
27235824	body image	C0005891
27235824	muscles	C0026845
27235824	food intake	C0013470
27235824	males	C0086582
27235870	Neurotrophins	C0027754
27235870	specific receptors	C0254837
27235870	oviduct tracts	C0029954
27235870	Japanese quail	C0022345
27235870	Coturnix coturnix japonica	C0022345
27235870	Neurotrophins	C0027754
27235870	NGF	C0027752
27235870	BDNF	C0107103
27235870	NT-3	C0083735
27235870	specific receptors	C0254837
27235870	TrkA	C0072482
27235870	TrkB	C0084873
27235870	TrkC	C0132300
27235870	studied	C2603343
27235870	oviduct	C0029954
27235870	egg laying	C1622979
27235870	quails	C0022345
27235870	Neurotrophins	C0027754
27235870	NTs	C0027754
27235870	development	C1527148
27235870	maintenance	C0587894
27235870	neuronal populations	C0027882
27235870	central	C3714787
27235870	peripheral nervous system	C0206417
27235870	reproductive system	C1261210
27235870	studied	C2603343
27235870	morphological	C0332437
27235870	organization	C0029237
27235870	quail	C0022345
27235870	oviduct	C0029954
27235870	infundibulum	C0227911
27235870	magnum	C0229962
27235870	isthmus	C0227909
27235870	uterus	C0042149
27235870	vagina	C0042232
27235870	analyzed	C0936012
27235870	expression	C1171362
27235870	localization	C0007613
27235870	NTs	C0027754
27235870	Trks receptors	C0254837
27235870	tracts	C0029954
27235870	western blotting	C0005863
27235870	investigated	C1292732
27235870	NTs	C0027754
27235870	Trks receptors	C0254837
27235870	expressed	C1171362
27235870	oviductal tracts	C0029954
27235870	immunohistochemistry	C0021044
27235870	distribution	C0872250
27235870	NTs	C0027754
27235870	Trks	C0254837
27235870	NGF	C0027752
27235870	BDNF	C0107103
27235870	NT3	C0083735
27235870	lining	C1254362
27235870	ductal epithelial cells	C1512085
27235870	NGF	C0027752
27235870	secretory cells	C1519221
27235870	tubular glands	C1179446
27235870	nervous fibers	C0027749
27235870	vessel wall	C0507777
27235870	TrkA	C0072482
27235870	TrkB	C0084873
27235870	lining	C1254362
27235870	ductal epithelium	C1512086
27235870	TrkA	C0072482
27235870	TrkC	C0132300
27235870	nervous fibers	C0027749
27235870	vessel wall	C0507777
27235870	oviductal tracts	C0029954
27235870	NGF	C0027752
27235870	BDNF	C0107103
27235870	TrkA	C0072482
27235870	TrkB	C0084873
27235870	cells	C0007634
27235870	lining	C1254362
27235870	ductal epithelium	C1512086
27235870	autocrine mechanism	C3825249
27235870	action	C3266814
27236097	liposomal	C0023828
27236097	formulation	C1705957
27236097	incorporation	C0243126
27236097	retention	C0333117
27236097	PNA oligomers	C0600500
27236097	Liposomal	C0023828
27236097	formulations	C1705957
27236097	phospholipids	C0031676
27236097	unsaturation degrees	C0522535
27236097	head groups	C0205245
27236097	cholesterol content have been tested	C0201950
27236097	encapsulation	C2348438
27236097	Peptide Nucleic Acid (PNA) oligomers	C0600500
27236097	best loading capability	C3714444
27236097	ER	C0456603
27236097	liposomes	C0023828
27236097	phosphatidylglycerol	C0043840
27236097	DOPG	C0043840
27236097	negatively charged	C0003075
27236097	head group	C0205245
27236097	insertion	C0441587
27236097	cholesterol	C0008377
27236097	DOPG	C0043840
27236097	liposomes	C0023828
27236097	decrease	C0547047
27236097	PNA	C0600500
27236097	loading	C1708715
27236097	cholesterol	C0008377
27236097	addition	C1524062
27236097	PNA's	C0600500
27236097	release	C3850077
27236097	fetal bovine serum	C3812213
27236097	liposomal	C0023828
27236097	formulation	C1705957
27236097	encapsulation	C2348438
27236097	release properties	C3850077
27236097	PEGylated	C0032483
27236097	DOPG	C0043840
27236097	liposomes	C0023828
27236097	cholesterol	C0008377
27236097	optimal formulation	C0524527
27236097	loading	C1708715
27236097	PNA-a210	C0600500
27236780	Histopathology	C0677043
27236780	filum terminale	C0016109
27236780	children	C0008059
27236780	without	C0332288
27236780	tethered cord syndrome	C0080218
27236780	elastic tissue	C0013762
27236780	filum	C0016109
27236780	compare	C1707455
27236780	histologically	C0205462
27236780	transected	C0332847
27236780	fila	C0016109
27236780	pediatric	C1521725
27236780	patients	C0030705
27236780	tethered cord syndrome	C0080218
27236780	TCS	C0080218
27236780	without	C0332288
27236780	low	C1548802
27236780	conus	C0149601
27236780	collagenous	C0225333
27236780	elastic tissue	C0013762
27236780	fila	C0016109
27236780	patients	C0030705
27236780	TCS	C0080218
27236780	minimal	C0547040
27236780	cautery	C0007471
27236780	filum	C0016109
27236780	section	C0700320
27236780	compared	C1707455
27236780	fila	C0016109
27236780	pediatric	C1521725
27236780	cadavers	C0006629
27236780	without	C0332288
27236780	TCS	C0080218
27236780	controls	C0009932
27236780	Sections	C1522472
27236780	fila	C0016109
27236780	stained	C0487602
27236780	H&E	C0523207
27236780	Masson trichrome	C1294297
27236780	Verhoeff von Gieson elastic stains	C1294321
27236780	Gordon and Sweet's reticulin stain	C1293950
27236780	Fila	C0016109
27236780	controls	C0009932
27236780	loose	C0205407
27236780	fibrous connective tissue	C1184823
27236780	FCT	C1184823
27236780	thin	C0205168
27236780	evenly dispersed	C1704711
27236780	elastic fibers	C0230899
27236780	EFs	C0230899
27236780	Reticulin fibers	C0035285
27236780	RFs	C0035285
27236780	blood vessel walls	C1180033
27236780	nerve	C0027740
27236780	Fat	C0015677
27236780	identified	C0205396
27236780	microscopically	C0205288
27236780	fila	C0016109
27236780	fila	C0016109
27236780	patients	C0030705
27236780	TCS	C0080218
27236780	dense FCT	C0225333
27236780	EFs	C0230899
27236780	normal	C0205307
27236780	focally	C0205234
27236780	diffusely	C0332261
27236780	decreased	C0205216
27236780	patients	C0030705
27236780	fila	C0016109
27236780	cauterized	C0007471
27236780	resection	C0728940
27236780	thick	C1280412
27236780	coiled	C1880179
27236780	EFs	C0230899
27236780	Coiling	C0444764
27236780	minimal	C0547040
27236780	cautery	C0007471
27236780	RFs	C0035285
27236780	blood vessel walls	C1180033
27236780	Fat	C0015677
27236780	identified	C0205396
27236780	patients	C0030705
27236780	Findings	C0243095
27236780	similar	C2348205
27236780	conus	C0149601
27236780	normal	C0205307
27236780	low	C0441994
27236780	fila	C0016109
27236780	patients	C0030705
27236780	TCS	C0080218
27236780	conus	C0149601
27236780	low	C0441994
27236780	abnormal	C0205161
27236780	FCT	C1184823
27236780	EFs	C0230899
27236780	decreased	C0205216
27236780	patients	C0030705
27236780	thick	C1280412
27236780	coiled	C1880179
27236780	EFs	C0230899
27236780	patients	C0030705
27236780	Coiling	C0444764
27236780	EFs	C0230899
27236780	abnormality	C1704258
27236780	patients	C0030705
27236780	result	C0808233
27236780	cautery	C0007471
27236780	artifactual	C0085089
27236780	iatrogenic	C0439669
27236780	coiling	C0444764
27237301	Clinical value	C2826293
27237301	pathologic examination	C4086729
27237301	non-neoplastic kidney	C0022646
27237301	patients	C0030705
27237301	upper urinary tract	C1278977
27237301	malignancies	C4282132
27237301	surgical resection	C0728940
27237301	care	C1947933
27237301	treatment	C0087111
27237301	upper urinary tract	C1278977
27237301	malignancies	C4282132
27237301	nephrectomy	C0027695
27237301	risk factor	C0035648
27237301	development	C1527148
27237301	chronic kidney disease	C1561643
27237301	CKD	C1561643
27237301	study	C2603343
27237301	histologic	C0205462
27237301	evaluation	C0220825
27237301	non-neoplastic kidney	C0022646
27237301	early identification	C0814435
27237301	kidney disease	C0022658
27237301	prognostic	C0220901
27237301	postoperative	C0032790
27237301	renal	C0022646
27237301	outcomes	C0085415
27237301	retrospectively analyzed	C0035363
27237301	patients	C0030705
27237301	upper urinary tract	C1278977
27237301	malignancies	C4282132
27237301	uninephrectomy	C0027695
27237301	uninephroureterectomy	C0027732
27237301	pathologic	C1521733
27237301	evaluation	C0220825
27237301	non-neoplastic kidney	C0022646
27237301	special stains	C2038188
27237301	immunofluorescence	C0079603
27237301	electron microscopic studies	C0026019
27237301	degree	C0449286
27237301	parenchymal	C0933845
27237301	changes	C0392747
27237301	patients	C0030705
27237301	kidney	C0022646
27237301	pathology	C0030664
27237301	patients	C0030705
27237301	glomerular abnormalities	C1398788
27237301	diabetic nephropathy	C0011881
27237301	vascular	C0005847
27237301	nephropathy	C0027695
27237301	reflux nephropathy	C3495566
27237301	chronic pyelonephritis	C0085697
27237301	histologic score	C0449820
27237301	patients	C0030705
27237301	Score	C0449820
27237301	patients	C0030705
27237301	Postoperative	C0032790
27237301	estimated glomerular filtration rate	C3811844
27237301	eGFR	C3811844
27237301	months	C0439231
27237301	patients	C0030705
27237301	CKD	C1561643
27237301	CKD	C1561643
27237301	nephrectomized patients	C0030705
27237301	risk factors	C0035648
27237301	CKD	C1561643
27237301	nephrectomized patients	C0030705
27237301	Cox regression analysis	C0034980
27237301	postoperative	C0032790
27237301	AKI	C2609414
27237301	preoperative	C0445204
27237301	eGFR	C3811844
27237301	histologic	C0205462
27237301	non-neoplastic kidney	C0022646
27237301	predictors	C2698872
27237301	CKD	C1561643
27237301	pathologic	C1521733
27237301	evaluation	C0220825
27237301	non-neoplastic kidney	C0022646
27237301	diagnostic	C0348026
27237301	prognostic	C0220901
27239027	Phenotypes	C0031437
27239027	Duchenne Muscular Dystrophy	C0013264
27239027	Patient	C0030705
27239027	Myoblasts	C0596995
27239027	Human	C0086418
27239027	iPSC	C2717959
27239027	Model	C0684309
27239027	Duchenne muscular dystrophy	C0013264
27239027	DMD	C0013264
27239027	genetic disease	C0019247
27239027	animal models	C0012644
27239027	DMD	C0013264
27239027	human cell	C0682523
27239027	patient	C0030705
27239027	DYSTROPHIN	C1414083
27239027	mutations	C0596611
27239027	human	C0086418
27239027	DMD	C0013264
27239027	model	C0684309
27239027	human induced pluripotent stem cells	C3658289
27239027	hiPSCs	C3658289
27239027	disease	C0012634
27239027	related	C1552599
27239027	phenotypes	C0031437
27239027	patient	C0030705
27239027	dependent	C0851827
27239027	variation	C0205419
27239027	genetic	C0314603
27239027	pharmacological	C0205464
27239027	chemical-compound	C0220806
27239027	strategy	C0035171
27239027	hiPSCs	C3658289
27239027	myoblasts	C0596995
27239027	myogenic transcriptional	C0040649
27239027	program	C3484370
27239027	striated	C0205364
27239027	contractile	C1752744
27239027	myofibers	C3179197
27239027	muscle regeneration	C1850849
27239027	in vivo	C1515655
27239027	DMD	C0013264
27239027	hiPSC	C3658289
27239027	myoblasts	C0596995
27239027	disease	C0012634
27239027	related	C1552599
27239027	phenotypes	C0031437
27239027	patient	C0030705
27239027	patient	C0030705
27239027	variability	C2827666
27239027	aberrant	C0443127
27239027	inflammation	C0021368
27239027	immune-response genes	C0086344
27239027	collagens	C0009325
27239027	BMP	C1155364
27239027	TGFβ signaling	C1155363
27239027	genetic	C0314603
27239027	correction	C1947976
27239027	pharmacological	C0205464
27239027	SMAD	C1571580
27239027	inhibition	C1519312
27239027	DMD	C0013264
27239027	hiPSC	C3658289
27239027	myoblasts	C0596995
27239027	genetically	C0314603
27239027	isogenic	C2348628
27239027	myoblasts	C0596995
27239027	multi	C0439064
27239027	nucleated	C1979936
27239027	myotubes	C0242697
27239027	human	C0086418
27239027	DMD	C0013264
27239027	model	C0684309
27239027	hiPSC	C3658289
27239027	disease modeling	C0684309
27239445	SNAI1	C4308198
27239445	promotes	C0033414
27239445	development	C1527148
27239445	HCC	C2239176
27239445	enhancement	C2349975
27239445	proliferation	C1514485
27239445	inhibition of apoptosis	C1512772
27239445	SNAI1	C4308198
27239445	zinc-finger transcription factor	C0040648
27239445	induction	C0205263
27239445	epithelial-mesenchymal transition	C1523298
27239445	EMT	C1523298
27239445	cancers	C0006826
27239445	SNAI1	C4308198
27239445	proliferation	C1514485
27239445	apoptosis	C0162638
27239445	hepatocellular carcinoma	C2239176
27239445	study	C2603343
27239445	effects	C1280500
27239445	mechanisms	C0441712
27239445	SNAI1	C4308198
27239445	proliferation	C1514485
27239445	apoptosis	C0162638
27239445	hepatocellular carcinoma	C2239176
27239445	clinical	C0205210
27239445	samples	C0370003
27239445	cell lines	C0085983
27239445	SNAI1	C4308198
27239445	expressed	C1171362
27239445	tissues	C0040300
27239445	liver cancer	C2239176
27239445	nontumor tissues	C0040300
27239445	SNAI1	C4308198
27239445	expressed	C1171362
27239445	hepatoma cell lines HepG2	C2717940
27239445	SMMC-7721	C0085983
27239445	BEL-7402	C0085983
27239445	human normal liver cell line L02	C0682523
27239445	SNAI1	C4308198
27239445	expression	C1171362
27239445	distal metastasis	C4255448
27239445	tumor capsule formation	C0027671
27239445	histological differentiation	C1511938
27239445	hepatocellular carcinoma	C2239176
27239445	HCC	C2239176
27239445	knockdown	C2350567
27239445	SNAI1	C1420267
27239445	lentiviral	C0079679
27239445	vectors	C1520007
27239445	RNAi	C1136031
27239445	SNAI	C4308198
27239445	cell proliferation	C1514485
27239445	G1 arrest	C3178834
27239445	downregulation	C0013081
27239445	cyclin D1	C0174680
27239445	cyclin A	C0079184
27239445	knockdown	C2350567
27239445	SNAI1	C1420267
27239445	promoted	C0033414
27239445	apoptosis	C0162638
27239445	expression	C1171362
27239445	Bcl-2	C4042483
27239445	SNAI1	C4308198
27239445	development	C1527148
27239445	hepatocellular carcinoma	C2239176
27239445	regulating the growth	C1160191
27239445	apoptosis	C0162638
27239445	tumor cells	C0597032
27240257	Quantitative assessment	C0034384
27240257	fluorescent proteins	C0033684
27240257	fluorescent proteins	C0033684
27240257	FPs	C0033684
27240257	genetic labeling	C1513384
27240257	molecules	C0567416
27240257	cells	C0007634
27240257	fluorescence microscopy	C0026022
27240257	Genetic manipulations	C0178659
27240257	FPs	C0033684
27240257	blue to red spectral regions	C1254362
27240257	autofluorescent	C0544711
27240257	FPs	C0033684
27240257	β-barrel structure	C0599216
27240257	rigidity	C0205556
27240257	chemical	C0220806
27240257	environment	C0014406
27240257	fluorescence	C0016315
27240257	structure	C0026383
27240257	FP	C0033684
27240257	properties	C0871161
27240257	FP	C0033684
27240257	FP	C0033684
27240257	FP	C0033684
27240257	quantitatively	C0392762
27240257	brightness	C0678578
27240257	photostability	C0243095
27240257	pH	C0020283
27240257	stability	C0205360
27240257	monomeric	C0596973
27240257	properties	C0871161
27240257	FPs	C0033684
27240257	straightforward	C1272701
27240257	comparison	C1707455
27240257	FPs	C0033684
27240257	spectral region	C1254362
27240560	Consumption of fruits and vegetables	C1271941
27240560	associated with	C0332281
27240560	risk behaviors	C0086931
27240560	adolescents	C0205653
27240560	Northeast Brazil	C0006137
27240560	prevalence	C0220900
27240560	consumption of fruits and vegetables	C1271941
27240560	association with	C0332281
27240560	low	C0205251
27240560	level	C0441889
27240560	physical activity	C0026606
27240560	exposure to	C0332157
27240560	sedentary behavior	C3824706
27240560	consumption	C2983605
27240560	soft drinks	C3489624
27240560	overweight	C0497406
27240560	obesity	C0028754
27240560	adolescents	C0205653
27240560	cross-sectional school-based study	C0010362
27240560	sample	C0370003
27240560	students	C0038492
27240560	years	C1510829
27240560	state of Sergipe	C1301808
27240560	Brazil	C0006137
27240560	outcome	C1274040
27240560	low	C0205251
27240560	consumption of fruits and vegetables	C1271941
27240560	servings/day	C0439505
27240560	Independent variables	C0870693
27240560	level	C0441889
27240560	physical activity	C0026606
27240560	sedentary behavior	C3824706
27240560	consumption	C2983605
27240560	soft drinks	C3489624
27240560	overweight	C0497406
27240560	obesity	C0028754
27240560	Global Student Health Survey questionnaire	C0034394
27240560	body mass	C3698309
27240560	height	C0005890
27240560	measurements	C0947289
27240560	chi-square test	C0008041
27240560	crude and adjusted binary logistic regression	C0206031
27240560	significance level	C0814896
27240560	prevalence	C0220900
27240560	inadequate	C0205412
27240560	consumption of fruits and vegetables	C1271941
27240560	high	C0205250
27240560	CI	C0009667
27240560	Higher	C0205250
27240560	low	C0205251
27240560	consumption of fruits and vegetables	C1271941
27240560	boys	C0870221
27240560	exposed to	C0332157
27240560	sedentary behavior	C3824706
27240560	OR	C0028873
27240560	CI	C0009667
27240560	consumed	C2983605
27240560	soft drinks	C3489624
27240560	OR	C0028873
27240560	CI	C0009667
27240560	insufficiently	C0231180
27240560	physical activity	C0026606
27240560	OR	C0028873
27240560	CI	C0009667
27240560	girls	C0870604
27240560	consumed	C2983605
27240560	soft drinks	C3489624
27240560	OR	C0028873
27240560	CI	C0009667
27240560	overweight	C0497406
27240560	obesity	C0028754
27240560	OR	C0028873
27240560	CI	C0009667
27240560	public policies	C0034033
27240560	consumption of healthy foods	C2983605
27240560	adolescents	C0205653
27242761	Cobalamin	C0086024
27242761	Protection	C1545588
27242761	Oxidative Stress	C0242606
27242761	Acidophilic	C0333931
27242761	Iron-oxidizing Bacterium	C0004611
27242761	Leptospirillum Group II CF-1	C2758310
27242761	Leptospirillum	C0995279
27242761	aerobic	C1510824
27242761	iron-oxidizing bacteria	C0004611
27242761	phylum Nitrospira	C0995591
27242761	microbial	C0599840
27242761	communities	C1253910
27242761	catalyze	C2350294
27242761	biomining	C0026175
27242761	sulfidic ores	C0567321
27242761	metal ions	C0022023
27242761	microorganisms	C0445623
27242761	metal	C0025552
27242761	environments	C0014406
27242761	concentrations	C1446561
27242761	reactive oxygen species	C0162772
27242761	ROS	C0162772
27242761	Cobalamin	C0086024
27242761	vitamin B12	C0042845
27242761	cobalt	C0009148
27242761	tetrapyrrole	C0076335
27242761	cofactor	C0178555
27242761	intramolecular rearrangement reactions	C0596965
27242761	intracellular	C0178719
27242761	antioxidant	C0003402
27242761	investigated	C1292732
27242761	effect	C1280500
27242761	exogenous	C0205228
27242761	cobalamin	C0086024
27242761	oxidative stress	C0242606
27242761	parameters	C0549193
27242761	Leptospirillum group II strain CF-1	C2758310
27242761	revealed	C0443289
27242761	external supplementation	C0681579
27242761	cobalamin	C0086024
27242761	intracellular	C0178719
27242761	ROSs	C0162772
27242761	damage	C1883709
27242761	biomolecules	C0574031
27242761	stimulates	C1948023
27242761	growth	C0018270
27242761	survival of cells	C0007620
27242761	oxidative stress	C0242606
27242761	ferric ion	C2346593
27242761	hydrogen peroxide	C0020281
27242761	chromate	C0008543
27242761	diamide	C0011953
27242761	strain CF-1	C0995279
27242761	oxidative stress	C0242606
27242761	transcriptional activation	C0162493
27242761	cbiA gene	C0017337
27242761	CbiA	C0033684
27242761	cobalamin	C0086024
27242761	biosynthetic pathway	C1721101
27242761	data	C1511726
27242761	cobalamin	C0086024
27242761	redox	C0030012
27242761	protection	C1545588
27242761	Leptospirillum strain CF-1	C0995279
27242761	microorganism	C0445623
27242761	oxidative	C0311404
27242761	environmental conditions	C0348080
27242761	mechanisms	C0441712
27242761	protective	C1545588
27242761	effect	C1280500
27242761	cobalamin	C0086024
27242761	oxidative stress	C0242606
27242761	biomining	C0026175
27242761	processes	C1522240
27242761	effective	C1704419
27244222	longitudinal study	C0023981
27244222	childcare	C0683807
27244222	services'	C0557854
27244222	obesity	C0028754
27244222	prevention policies and practices	C1254363
27244222	obesogenic	C0028754
27244222	environments	C0014406
27244222	childcare	C0683807
27244222	services	C0557854
27244222	physical activity	C0026606
27244222	nutrition-promoting practices	C1521729
27244222	Australian	C0238711
27244222	childcare	C0683807
27244222	services	C0557854
27244222	best-practice	C1254363
27244222	healthy eating	C0452415
27244222	physical activity	C0026606
27244222	practices	C1254363
27244222	socio-economic status	C0086996
27244222	locality	C1254362
27244222	randomly selected sample	C0150105
27244222	supervisors	C0403172
27244222	childcare	C0683807
27244222	services	C0557854
27244222	New South Wales	C0027975
27244222	Australia	C0004340
27244222	telephone survey	C0681820
27244222	Supervisors	C0403172
27244222	service's	C0557854
27244222	practices	C1254363
27244222	nutrition	C1521729
27244222	physical activity	C0026606
27244222	policies	C0242456
27244222	staff	C0851286
27244222	physical activity	C0026606
27244222	nutrition	C1521729
27244222	time	C0040223
27244222	movement	C0026649
27244222	skills	C0678856
27244222	outdoor play	C0032214
27244222	weekly	C0332174
27244222	screen time opportunitie	C4038978
27244222	non-sweetened beverages	C0005329
27244222	prevalence	C0220900
27244222	services	C0557854
27244222	practice	C1254363
27244222	services	C0557854
27244222	practices	C1254363
27244222	services	C0557854
27244222	practice	C1254363
27244222	locality	C1254362
27244222	socio-economic status	C0086996
27244222	Government	C0018104
27244222	investment	C3242637
27244222	obesity	C0028754
27244222	prevention programmes	C1254363
27244222	childcare	C0683807
27244222	healthy eating	C0452415
27244222	physical activity	C0026606
27244222	practices	C1254363
27244222	jurisdiction	C0680647
27244222	practices	C1254363
27244222	childcare	C0683807
27244222	services	C0557854
27247892	Isolation	C0205409
27247892	characterization	C1880022
27247892	Burkholderia sp. strain CCA53	C4130454
27247892	ligninolytic	C1156998
27247892	potential	C3245505
27247892	Microbial	C0599840
27247892	degradation	C0699900
27247892	lignin	C0023705
27247892	fermentable sugars	C0242209
27247892	effective	C1704419
27247892	utilization	C0457083
27247892	biofuel	C2717891
27247892	production	C0033268
27247892	lignocellulosic	C0064974
27247892	biomass	C0005535
27247892	study	C2603343
27247892	lignin-degrading	C1156998
27247892	bacterium	C0004611
27247892	isolated	C0205409
27247892	leaf	C0242724
27247892	soil	C0037592
27247892	Burkholderia sp.	C1264855
27247892	16S rRNA	C3537372
27247892	gene sequencing	C1294197
27247892	strain	C0456178
27247892	CCA53	C4130454
27247892	lignin-degrading	C1156998
27247892	capability	C2698977
27247892	assessed	C1516048
27247892	growth	C0018270
27247892	medium	C0010454
27247892	alkali lignin	C0023705
27247892	lignin	C0023705
27247892	aromatic monomers	C0596973
27247892	carbon	C0007009
27247892	source	C0449416
27247892	Alkali lignin	C0023705
27247892	lignin	C0023705
27247892	aromatic monomers	C0596973
27247892	growth	C0018270
27247892	strain	C0456178
27247892	effective	C1704419
27247892	utilization	C0457083
27247892	p-hydroxybenzene monomers	C0596973
27247892	findings	C0243095
27247892	Burkholderia sp. strain CCA53	C4130454
27247892	fragmentary activity	C0441655
27247892	lignin degradation	C1156998
27250823	Diagnostic	C0348026
27250823	utility	C0457083
27250823	conventional	C0205214
27250823	techniques	C0430022
27250823	endobronchial ultrasonography	C2959489
27250823	guidance	C0150600
27250823	transbronchial biopsy	C0863477
27250823	Endobronchial ultrasonography	C2959489
27250823	guide sheath	C0025080
27250823	transbronchial biopsy	C0863477
27250823	EBUS	C2959489
27250823	GS	C0025080
27250823	TBB	C0863477
27250823	diagnose	C0011900
27250823	peripheral pulmonary lesions	C0577916
27250823	PPLs	C0577916
27250823	study	C2603343
27250823	diagnostic	C0348026
27250823	utility	C0457083
27250823	conventional	C0205214
27250823	TBB	C0863477
27250823	EBUS	C2959489
27250823	GS	C0025080
27250823	TBB	C0863477
27250823	retrospective analysis	C0035363
27250823	patients	C0030705
27250823	conventional	C0205214
27250823	TBB	C0863477
27250823	EBUS	C2959489
27250823	GS	C0025080
27250823	TBB	C0863477
27250823	PPL	C0577916
27250823	multivariate analysis	C0026777
27250823	association	C0439849
27250823	clinical	C0205210
27250823	factors	C1521761
27250823	EBUS	C2959489
27250823	probe	C0182400
27250823	distance	C0012751
27250823	sample size	C0242618
27250823	area	C0205146
27250823	diagnostic yield	C0205556
27250823	patients	C0030705
27250823	diagnosed	C0011900
27250823	EBUS	C2959489
27250823	GS	C0025080
27250823	TBB	C0863477
27250823	patients	C0030705
27250823	diagnosed	C0011900
27250823	EBUS	C2959489
27250823	GS	C0025080
27250823	TBB	C0863477
27250823	diagnosed	C0011900
27250823	conventional	C0205214
27250823	TBB	C0863477
27250823	Ground glass opacity	C3827002
27250823	GGO	C3827002
27250823	significant	C0750502
27250823	factor	C1521761
27250823	diagnostic yield	C0205556
27250823	conventional	C0205214
27250823	TBB	C0863477
27250823	EBUS	C2959489
27250823	GS	C0025080
27250823	TBB	C0863477
27250823	Multivariate analysis	C0026777
27250823	receiver operator curves	C0035787
27250823	distance	C0012751
27250823	PPL	C0577916
27250823	EBUS	C2959489
27250823	probe	C0182400
27250823	utility	C0457083
27250823	conventional	C0205214
27250823	TBB	C0863477
27250823	conventional	C0205214
27250823	TBB	C0863477
27250823	EBUS	C2959489
27250823	GS	C0025080
27250823	TBB	C0863477
27250823	procedure	C0430022
27250823	diagnosis	C0011900
27250823	ground glass opacity	C3827002
27250823	PPLs	C0577916
27250823	cases	C0868928
27250823	distance	C0012751
27250823	EBUS	C2959489
27250823	probe	C0182400
27250823	lesion	C0577916
27251117	Active	C0205177
27251117	diffusion	C0012222
27251117	microtubule-based transport	C2755890
27251117	myosin	C0033684
27251117	forces	C0441722
27251117	position	C0733755
27251117	organelles	C0029219
27251117	cells	C0007634
27251117	distribution	C1704711
27251117	peroxisomes	C0752063
27251117	POs	C0752063
27251117	lipid droplets	C0230704
27251117	LDs	C0230704
27251117	role	C1705810
27251117	lipid	C0023779
27251117	reactive oxygen species	C0162772
27251117	homeostasis	C0019868
27251117	distribution	C1704711
27251117	diffusive motion	C0012222
27251117	motility	C0007608
27251117	role	C1705810
27251117	fungus	C0016832
27251117	Ustilago maydis	C0446013
27251117	POs	C0752063
27251117	LDs	C0230704
27251117	diffusive motions	C0012222
27251117	movements	C0007608
27251117	ATP	C0001480
27251117	bidirectional	C1706937
27251117	endosome	C0034850
27251117	motility	C0007608
27251117	microtubule	C0026046
27251117	associated	C0332281
27251117	membrane	C0596901
27251117	trafficking	C0599896
27251117	enhances	C2349975
27251117	diffusion	C0012222
27251117	organelles	C0029219
27251117	endosome transport	C1156042
27251117	POs	C0752063
27251117	LDs	C0230704
27251117	growing cell end	C3159038
27251117	pole-ward drift	C0007613
27251117	anterograde delivery	C0598952
27251117	secretory cargo	C0597427
27251117	cell tip	C1656978
27251117	myosin-5	C0969679
27251117	Modelling	C0870071
27251117	microtubule-based directed transport	C2755890
27251117	active	C0205177
27251117	diffusion	C0012222
27251117	distribution	C1704711
27251117	mobility	C1516353
27251117	POs	C0752063
27251117	mammalian	C0024660
27251117	COS-7 cells	C1257858
27251117	microtubules	C0026046
27251117	F-actin	C1180307
27251117	distribute	C1704711
27251117	POs	C0752063
27251117	cytoskeletal	C0010853
27251117	forces	C0441722
27251117	organelle	C0029219
27251117	positioning	C0733755
27251117	eukaryotes	C0684063
27251918	catheter ablation	C0162563
27251918	management	C0376636
27251918	atrial fibrillation	C0004238
27251918	Atrial fibrillation	C0004238
27251918	electrical activation	C1658783
27251918	pulmonary veins	C0034090
27251918	Catheter ablation	C0162563
27251918	radiofrequency	C0850292
27251918	cryothermal energy	C0010412
27251918	electrically	C0442828
27251918	isolates	C0205409
27251918	veins	C0034090
27251918	left atrium	C0225860
27251918	reducing	C0392756
27251918	burden	C2828008
27251918	atrial fibrillation	C0004238
27251918	episodes	C1254367
27251918	patient's	C0030705
27251918	symptoms	C1457887
27251918	Catheter ablation	C0162563
27251918	antiarryhthmic drugs	C0003195
27251918	patients	C0030705
27251918	medical problems	C1715372
27251918	obesity	C0028754
27251918	hypertension	C0020538
27251918	obstructive sleep apnoea	C0520679
27251918	treated	C1522326
27251918	ablation	C0547070
27251918	treatment	C0087111
27251918	potential	C3245505
27251918	cure	C1880198
27251918	patients	C0030705
27251918	symptoms	C1457887
27251918	procedural complications	C0742724
27252074	Chinese Herbal	C3146288
27252074	Mixture	C0439962
27252074	Tien-Hsien Liquid	C1528399
27252074	Augments	C0205217
27252074	Anticancer	C2986475
27252074	Immunity	C0020964
27252074	Tumor Cell	C0597032
27252074	Vaccinated	C1116171
27252074	Mice	C0025929
27252074	Chinese herbal	C3146288
27252074	mixture	C0439962
27252074	Tien-Hsien liquid	C1528399
27252074	THL	C1528399
27252074	anticancer	C2986475
27252074	dietary supplement	C0242295
27252074	years	C0439234
27252074	previous	C0205156
27252074	studies	C2603343
27252074	THL	C1528399
27252074	modulate	C0443264
27252074	immune response	C0301872
27252074	inhibit	C3463820
27252074	tumor growth	C0598934
27252074	study	C2603343
27252074	evaluated	C0220825
27252074	effect	C1280500
27252074	THL	C1528399
27252074	anticancer	C2986475
27252074	immune response	C0301872
27252074	mice	C0025929
27252074	vaccinated	C1116171
27252074	γ-ray	C0017011
27252074	irradiated	C1282930
27252074	tumor cells	C0597032
27252074	antitumor	C2986475
27252074	effect	C1280500
27252074	THL	C1528399
27252074	determined	C0521095
27252074	mice	C0025929
27252074	vaccinated	C1116171
27252074	low-tumorigenic CT-26-low colon cancer cells	C0085983
27252074	γ-ray-irradiated	C2985557
27252074	high-tumorigenic CT-26-high colon cancer cells	C0085983
27252074	number	C0237753
27252074	natural killer (NK) cells	C0022688
27252074	T lymphocytes	C0039194
27252074	spleen	C0037993
27252074	analyzed	C0936012
27252074	flow cytometry	C0016263
27252074	tumor	C0027651
27252074	killing	C0599733
27252074	activities	C0441655
27252074	NK cells	C0022688
27252074	cytotoxic T lymphocytes	C0039195
27252074	CTLs	C0039195
27252074	analyzed	C0936012
27252074	flow cytometry	C0016263
27252074	YAC-1	C0085983
27252074	CT-26-high cells	C0085983
27252074	target	C1521840
27252074	cells	C0007634
27252074	levels	C0441889
27252074	IFN-γ	C0021745
27252074	IL-2	C0021756
27252074	TNF-α	C1456820
27252074	determined by	C0521095
27252074	ELISA	C0014441
27252074	THL	C1528399
27252074	suppressed	C1260953
27252074	growth	C0018270
27252074	CT-26-high tumor	C0085983
27252074	mice	C0025929
27252074	vaccinated	C1116171
27252074	low-tumorigenic CT-26-low cells	C0085983
27252074	γ-irradiated	C2985557
27252074	CT-26-high cells	C0085983
27252074	THL	C1528399
27252074	increased	C0205217
27252074	NK cells	C0022688
27252074	CD4+ T lymphocytes	C0039215
27252074	spleen	C0037993
27252074	enhanced	C2349975
27252074	tumor	C0027651
27252074	killing	C0599733
27252074	activities	C0441655
27252074	NK cells	C0022688
27252074	CTL	C0039195
27252074	mice	C0025929
27252074	vaccinated	C1116171
27252074	γ-irradiated	C2985557
27252074	CT-26-high cells	C0085983
27252074	THL	C1528399
27252074	increased	C0205217
27252074	production	C0205245
27252074	IFN-γ	C0021745
27252074	IL-2	C0021756
27252074	TNF-α	C1456820
27252074	mice	C0025929
27252074	vaccinated	C1116171
27252074	γ-irradiated	C2985557
27252074	CT-26-high cells	C0085983
27252074	THL	C1528399
27252074	enhance	C2349975
27252074	antitumor	C2986475
27252074	immune responses	C0301872
27252074	mice	C0025929
27252074	vaccinated	C1116171
27252074	killed	C0205245
27252074	tumor cells	C0597032
27252074	results	C1274040
27252074	THL	C1528399
27252074	complementary medicine	C1148474
27252074	cancer	C0006826
27252074	patients	C0030705
27252074	previously	C0205156
27252074	treated	C1522326
27252074	killed tumor cell vaccines	C0376659
27252074	radiotherapy	C1522449
27252074	chemotherapy	C3665472
27252721	Timing	C0449243
27252721	Ring Formation	C0243056
27252721	Pinus halepensis	C1028806
27252721	Arbutus unedo	C1036425
27252721	Southern	C1710133
27252721	Italy	C0022277
27252721	Outlook	C0420834
27252721	Analysis	C0936012
27252721	Xylogenesis	C0243056
27252721	Tree-Ring	C0040811
27252721	Chronologies	C0008717
27252721	Mediterranean	C0282645
27252721	tree rings	C0040811
27252721	characterized	C1880022
27252721	intra-annual density fluctuations	C0231241
27252721	IADFs	C0231241
27252721	climate-driven	C0008946
27252721	cambial activity	C0243056
27252721	IADFs	C0231241
27252721	structural	C0678594
27252721	signals	C0010439
27252721	information	C1533716
27252721	relations	C0439849
27252721	between	C0205103
27252721	environmental	C0014406
27252721	conditions	C0348080
27252721	eco-physiological	C0243056
27252721	processes	C1522240
27252721	during	C0347984
27252721	xylogenesis	C0243056
27252721	intra-annual	C0332181
27252721	resolution	C2699488
27252721	unbiased	C1711255
27252721	synchronization	C0439580
27252721	IADF	C0231241
27252721	position	C0733755
27252721	tree	C0040811
27252721	rings	C0521164
27252721	seasonal	C1254367
27252721	fluctuations	C0231239
27252721	environmental	C0014406
27252721	conditions	C0348080
27252721	timing	C0449243
27252721	cambial activity	C0243056
27252721	wood	C0043217
27252721	formation	C1522492
27252721	species-	C0205556
27252721	site-specific	C0205556
27252721	processes	C1522240
27252721	applied	C4048755
27252721	microcoring technique	C0449851
27252721	analyze	C0936012
27252721	xylogenesis	C0243056
27252721	Pinus halepensis	C1028806
27252721	Arbutus unedo	C1036425
27252721	attempt	C1516084
27252721	study	C2603343
27252721	xylogenesis	C0243056
27252721	hardwood	C0043217
27252721	species	C1705920
27252721	frequent	C0332183
27252721	IADFs	C0231241
27252721	species	C1705920
27252721	co-occur	C1709305
27252721	site	C0205145
27252721	southern	C1710133
27252721	Italy	C0022277
27252721	characterized	C1880022
27252721	Mediterranean	C0282645
27252721	climate	C0008946
27252721	tree-ring dating	C2350279
27252721	identification	C0205396
27252721	IADFs	C0231241
27252721	performed	C0884358
27252721	traditional	C0443324
27252721	dendroecological	C0205556
27252721	analysis	C0936012
27252721	analyzed	C0936012
27252721	xylogenesis	C0243056
27252721	during	C0347984
27252721	summer	C0241301
27252721	considered	C0750591
27252721	constraint	C0443288
27252721	xylogenesis	C0243056
27252721	IADF	C0231241
27252721	formation	C1522492
27252721	different	C1705242
27252721	phases	C0205390
27252721	cell development	C0815089
27252721	current	C0521116
27252721	wood	C0043217
27252721	increment	C1705117
27252721	IADFs	C0231241
27252721	formed	C0205431
27252721	analyzed	C0936012
27252721	phases	C0205390
27252721	September	C3828193
27252721	winter	C0241737
27252721	verify	C1711411
27252721	possible	C0332149
27252721	formation	C1522492
27252721	IADFs	C0231241
27252721	fall	C0238715
27252721	cell	C3178867
27252721	production	C0243056
27252721	differentiation	C0007589
27252721	completed	C0205197
27252721	calendar year	C0456586
27252721	species	C1705920
27252721	formed	C0205431
27252721	IADFs	C0231241
27252721	earlywood	C0043217
27252721	cells	C3178867
27252721	latewood	C0043217
27252721	temporary	C0205374
27252721	growth	C2911660
27252721	restoration	C0243095
27252721	triggered by	C1444748
27252721	rain	C0034640
27252721	events	C0441471
27252721	during	C0347984
27252721	period	C1948053
27252721	summer	C0241301
27252721	drought	C0013140
27252721	calendar year	C0456586
27252721	cells	C3178867
27252721	phases	C0205390
27252721	enlargement	C0442800
27252721	secondary cell wall	C1167351
27252721	deposition	C0333562
27252721	occurred	C1709305
27252721	A. unedo	C1036425
27252721	sensitive	C0332324
27252721	P. halepensis	C1028806
27252721	IADF	C0231241
27252721	formed	C0205431
27252721	earlier	C1279919
27252721	season	C0036497
27252721	frequent	C0332183
27252721	tree-ring	C0040811
27252721	dendro-anatomical	C0205556
27252721	analysis	C0936012
27252721	tree-ring	C0040811
27252721	xylogenesis	C0243056
27252721	detect	C0442726
27252721	period	C1948053
27252721	IADF	C0231241
27252721	formation	C1522492
27252721	species	C1705920
27252721	Results	C1274040
27252721	functional	C0205245
27252721	terms	C1705313
27252721	environmental	C0014406
27252721	conditions	C0348080
27252721	triggering	C1444748
27252721	IADFs	C0231241
27252721	methodological	C0815254
27252721	terms	C1705313
27252721	applicability	C4048755
27252721	xylogenesis	C0243056
27252721	analysis	C0936012
27252721	Mediterranean	C0282645
27252721	woods	C0043217
27252721	formation	C1522492
27252721	IADFs	C0231241
27252721	uniform	C0205375
27252721	stem	C0242767
27254792	Emergence	C0205556
27254792	family medicine	C0015607
27254792	Ethiopia	C0015024
27254792	international	C1512888
27254792	collaborative	C0282116
27254792	education model	C3161035
27254792	Family Medicine	C0015607
27254792	FM	C0015607
27254792	specialty	C0037778
27254792	Ethiopia	C0015024
27254792	first seven family physicians	C1704221
27254792	graduated	C0588053
27254792	February	C3830166
27254792	residency	C0035182
27254792	programme	C0010478
27254792	Addis Ababa University	C0041740
27254792	Cooperation	C0392337
27254792	Ethiopian	C0239304
27254792	expatriate	C3842568
27254792	decision-makers	C0554244
27254792	physicians	C0031831
27254792	begin	C0439659
27254792	programme	C0010478
27254792	Intentional	C1512888
27254792	replacement	C0559956
27254792	expatriates	C3842568
27254792	Ethiopian	C0239304
27254792	family physicians	C1704221
27254792	begun	C0439659
27254792	Barriers	C0205556
27254792	lack of	C0332268
27254792	understanding	C0162340
27254792	FM	C0015607
27254792	human	C0024752
27254792	financial resources	C0516918
27254792	scaling up	C0392762
27254792	programme	C0010478
27254792	Regular	C0205272
27254792	programme	C0010478
27254792	review	C1704362
27254792	resident physician	C1320928
27254792	involvement	C0009476
27254792	FM	C0015607
27254792	training programme	C0040607
27254792	adapt	C0205556
27254792	fit	C2349186
27254792	Ethiopian	C0239304
27254792	context	C0449255
27254792	successes	C0597535
27254792	result	C1274040
27254792	support	C0037438
27254792	advocacy	C0150446
27254792	Federal Ministry of Health	C0013562
27254792	Ethiopian	C0239304
27254792	African	C0027567
27254792	international	C1512888
27254792	international primary care organisations	C0596660
27256947	Experience	C0596545
27256947	Women	C0043210
27256947	Veterans	C0042610
27256947	War	C0043027
27256947	Issues surrounding mental health	C4061796
27256947	women	C0043210
27256947	veterans	C0042610
27256947	Iraq	C0022066
27256947	Afghanistan	C0001732
27256947	wars	C0043027
27256947	phenomenological	C0871071
27256947	study	C2603343
27256947	document	C1301746
27256947	themes	C0869035
27256947	stories	C0282574
27256947	women	C0043210
27256947	veterans	C0042610
27256947	war	C0043027
27256947	Themes	C0869035
27256947	stories	C0282574
27256947	sentiments	C0683293
27256947	changed	C0392747
27256947	view of self	C0242498
27256947	permeating aggravation	C0243095
27256947	confounding broken relationships	C2371543
27256947	frequent deployments	C2321230
27256947	change in military status	C1550416
27256947	remembering	C0034770
27256947	war	C0043027
27256947	experiences	C0596545
27256947	seeking opportunity for what is possible	C0243095
27256947	Mental health issues	C4061796
27256947	themes	C0869035
27256947	story	C0282574
27256947	mental health	C0025353
27256947	veterans	C0042610
27256947	veterans	C0042610
27256947	transition of coming back	C2700061
27257353	Trajectories	C0205134
27257353	Health	C0018684
27257353	Behavioral Health Services	C0009472
27257353	Use	C0457083
27257353	Community	C0009462
27257353	Corrections	C1947976
27257353	Rural	C0240919
27257353	Adults	C0001675
27257353	trajectories	C0205134
27257353	health	C0018684
27257353	behavioral health services	C0009472
27257353	utilization	C0457083
27257353	community corrections-involved	C0009463
27257353	CCI	C0009463
27257353	adults	C0001675
27257353	demographic	C0011292
27257353	clinical	C0205210
27257353	trajectories	C0205134
27257353	latent class growth analysis	C0936012
27257353	LCGA	C0936012
27257353	services	C0009472
27257353	rural	C0240919
27257353	CCI	C0009463
27257353	adults	C0001675
27257353	medical	C0205476
27257353	mental health	C0025353
27257353	substance use	C1705534
27257353	treatment utilization	C0815187
27257353	behavior	C0004927
27257353	days	C0439228
27257353	years	C0439234
27257353	LCGA	C0936012
27257353	1.5-year	C0439234
27257353	trajectories	C0205134
27257353	demographic	C0011292
27257353	health services	C0018747
27257353	rural	C0240919
27257353	CCI	C0009463
27257353	adults	C0001675
27257353	medical services	C0199168
27257353	users	C1706077
27257353	users	C1706077
27257353	users	C1706077
27257353	mental health	C0025353
27257353	substance use	C1705534
27257353	services	C0009472
27257353	Employment	C0014003
27257353	gender	C0079399
27257353	medication usage	C0240320
27257353	depression	C0011570
27257353	severity	C0439793
27257353	membership	C0680038
27257353	services	C0009472
27257353	social workers	C0037444
27257353	community services	C0009472
27257353	providers	C0018724
27257353	health services	C0018747
27257353	CCI	C0009463
27257353	CCI	C0009463
27257353	adults	C0001675
27257353	risk	C0035647
27257353	prevention	C0199176
27257353	intervention domains	C0184661
27257613	Data set	C0150098
27257613	interactomes	C0872079
27257613	metabolic pathways	C1291081
27257613	proteins	C0033684
27257613	expressed	C1171362
27257613	brains	C0006104
27257613	Alzheimer׳s disease	C0002395
27257613	Alzheimer׳s disease	C0002395
27257613	dementia	C0497327
27257613	elderly	C0001792
27257613	frequency	C0439603
27257613	worldwide	C2700280
27257613	complex	C0439855
27257613	interactions	C1704675
27257613	genetic	C0814299
27257613	environmental factors	C0686732
27257613	molecular players	C0033684
27257613	disease	C0002395
27257613	data	C1511726
27257613	article	C1706852
27257613	protein expression	C1171362
27257613	protein	C0033684
27257613	extracts	C2828366
27257613	cortex regions of brains	C0458324
27257613	patients	C0030705
27257613	Alzheimer׳s disease	C0002395
27257613	normal brain	C0006104
27257613	identified	C0205396
27257613	iTRAQ-labeled	C2986808
27257613	polypeptides	C1305923
27257613	analyzed	C0936012
27257613	proteins	C0033684
27257613	expression level	C3244092
27257613	KEGG metabolic pathways	C3826812
27257613	mitochondrial complexes of the electron transport chain	C1325653
27257613	ATP synthase	C0949692
27257613	analyzed	C0936012
27257613	over- and sub-expressed polypeptides	C1305923
27257613	IPA software	C0037585
27257613	Core I and Biomarkers I modules	C0037589
27257613	Data	C1511726
27257613	article	C1706852
27257613	research	C0035168
27257613	article	C1706852
27257613	proteins	C0033684
27257613	expressed	C1171362
27257613	brains	C0006104
27257613	Alzheimer's disease	C0002395
27257613	iTRAQ labeling	C0022885
27257613	tandem mass spectrometry	C0599748
27257694	Emergency general surgery	C2216322
27257694	specific frailty index	C4075886
27257694	validation study	C0681836
27257694	Assessment	C0220825
27257694	operative risk	C0747003
27257694	geriatric patients	C0870602
27257694	emergency general surgery	C2216322
27257694	EGS	C2216322
27257694	Frailty	C0424594
27257694	measure	C0079809
27257694	risk assessment	C0086930
27257694	surgical cases	C1706256
27257694	study	C2603343
27257694	validate	C1519941
27257694	variable	C0439828
27257694	emergency general surgery specific frailty index	C4075415
27257694	EGSFI	C4075415
27257694	collected	C1516695
27257694	geriatric	C1704440
27257694	age > 65	C0522003
27257694	emergency general surgery	C2216322
27257694	patients	C0870602
27257694	year	C0439234
27257694	Post-operative complications	C0032787
27257694	collected	C1516695
27257694	Frailty Index	C4075886
27257694	calculated	C1443182
27257694	patients	C0030705
27257694	pre-admission	C0559269
27257694	condition	C0348080
27257694	variable	C0439828
27257694	Rockwood Frailty Index	C4075886
27257694	FI	C4075886
27257694	EGSFI	C4075415
27257694	regression model	C0034980
27257694	complications	C0032787
27257694	FI	C4075886
27257694	ROC curve analysis	C0035787
27257694	cutoff	C1442160
27257694	frail	C0871754
27257694	status	C0449438
27257694	validated	C1519941
27257694	results	C1274040
27257694	patients	C0030705
27257694	predicting	C0681842
27257694	complications	C0032787
27257694	patients	C0030705
27257694	Validation	C1519941
27257694	enrolled	C1516879
27257694	study	C2603343
27257694	Mean age	C0001779
27257694	years	C0439234
27257694	complications	C0032787
27257694	common	C0205214
27257694	complications	C0032787
27257694	pneumonia	C0032285
27257694	UTI	C0042029
27257694	wound infection	C0043241
27257694	Univariate analysis	C0683962
27257694	variables	C0439828
27257694	associated with	C0332281
27257694	complications	C0032787
27257694	EGSFI	C4075415
27257694	cutoff	C1442160
27257694	frailty score	C4075885
27257694	ROC curve analysis	C0035787
27257694	frail	C0871754
27257694	status	C0449438
27257694	patients	C0030705
27257694	frail	C0871754
27257694	non-frail	C0871754
27257694	enrolled	C1516879
27257694	validation	C1519941
27257694	cohort	C0599755
27257694	Frail	C0871754
27257694	patients	C0030705
27257694	post-operative complications	C0032787
27257694	nonfrail patients	C0870602
27257694	Frail	C0871754
27257694	status	C0449438
27257694	EGSFI	C4075415
27257694	significant predictor	C2698872
27257694	post-operative complications	C0032787
27257694	OR	C0028873
27257694	CI	C0009667
27257694	Age	C0001779
27257694	associated with	C0332281
27257694	postoperative complications	C0032787
27257694	OR	C0028873
27257694	CI	C0009667
27257694	variable	C0439828
27257694	validated	C1519941
27257694	EGSFI	C4075415
27257694	bedside tool	C4286058
27257694	frailty status	C0424594
27257694	patients	C0030705
27257694	emergency general surgery	C2216322
27257694	Frail	C0871754
27257694	status	C0449438
27257694	EGSFI	C4075415
27257694	independent predictor	C2698872
27257694	post-operative complications	C0032787
27257694	mortality	C0205848
27257694	geriatric	C1704440
27257694	emergency general surgery	C2216322
27257694	patients	C0870602
27257694	Prognostic Studies	C0242481
27257694	Investigating	C1292732
27257694	Effect	C1280500
27257694	Patient Characteristic	C1285579
27257694	Outcome of Disease	C0679250
27257822	Epidemiologic	C0014508
27257822	Characteristics	C1521970
27257822	Pertussis	C0043167
27257822	Central	C0454714
27257822	Eastern European Countries	C0015177
27257822	epidemiological survey	C0376688
27257822	annual	C0332181
27257822	incidence	C0021149
27257822	pertussis	C0043167
27257822	reported	C0700287
27257822	Central	C0454714
27257822	Eastern European countries	C0015177
27257822	pertussis	C0043167
27257822	reports	C0025102
27257822	countries	C0454664
27257822	features	C2348519
27257822	country	C0454664
27257822	annual	C0332181
27257822	incidence	C0021149
27257822	pertussis	C0043167
27257822	countries	C0454664
27257822	government institutions	C2607850
27257822	national surveillance systems	C1708333
27257822	reviewed	C1709940
27257822	changes	C0392747
27257822	pertussis	C0043167
27257822	incidence rates	C1708485
27257822	country	C0454664
27257822	differences	C1705242
27257822	similarities	C2348205
27257822	countries	C0454664
27257822	pertussis	C0043167
27257822	surveillance	C0220920
27257822	case definitions	C0679227
27257822	detection	C0442726
27257822	confirmation	C0521091
27257822	pertussis	C0043167
27257822	incidence	C0021149
27257822	number of cases	C0021149
27257822	pertussis	C0043167
27257822	year	C0439234
27257822	age group	C0027362
27257822	population	C1257890
27257822	year	C0439234
27257822	age group	C0027362
27257822	pertussis	C0043167
27257822	immunization schedule	C0020972
27257822	coverage	C1999244
27257822	whole-cell pertussis vaccines	C0031237
27257822	wP	C0031237
27257822	acellular pertussis vaccines	C0982332
27257822	aP	C0982332
27257822	heterogeneity	C0019409
27257822	reported	C0700287
27257822	annual	C0332181
27257822	incidence rates	C1708485
27257822	countries	C0454664
27257822	Reported	C0700287
27257822	pertussis	C0043167
27257822	incidence rates	C1708485
27257822	population	C1257890
27257822	highest	C1522410
27257822	rates	C1521828
27257822	reported	C0700287
27257822	Estonia	C0014908
27257822	lowest	C1708760
27257822	Hungary	C0020174
27257822	Serbia	C0036708
27257822	burden	C2828008
27257822	infants	C0021270
27257822	year	C0439234
27257822	Bulgaria	C0006368
27257822	Hungary	C0020174
27257822	Latvia	C0023128
27257822	Romania	C0035826
27257822	Serbia	C0036708
27257822	countries	C0454664
27257822	burden	C2828008
27257822	older children	C0008059
27257822	surveillance	C0220920
27257822	adults	C0001675
27257822	associated with	C0332281
27257822	wP	C0031237
27257822	aP vaccines	C0982332
27257822	reported	C0700287
27257822	pertussis	C0043167
27257822	incidence rates	C1708485
27257822	heterogeneity	C0019409
27257822	reported	C0700287
27257822	data	C1511726
27257822	factors	C1521761
27257822	surveillance	C0220920
27257822	system	C0449913
27257822	characteristics	C1521970
27257822	capabilities	C2698977
27257822	case definitions	C0679227
27257822	type	C0332307
27257822	pertussis	C0043167
27257822	confirmation tests	C0022885
27257822	public	C0678367
27257822	awareness	C1328734
27257822	disease	C0043167
27257822	differences	C1705241
27257822	magnitude	C1704240
27257822	disease	C0043167
27257822	factors	C1521761
27257822	pertussis	C0043167
27257822	detection	C0442726
27257822	confirmation	C0521091
27257822	surveillance programs	C1515095
27257822	Europe	C0015176
27257822	seroprevalence studies	C0600367
27257822	protocols	C0442711
27257822	methodologies	C0086912
27259362	Identification	C0205396
27259362	characterization	C1880022
27259362	Dichelobacter nodosus	C0314932
27259362	serogroup H	C0449555
27259362	ovine	C1123019
27259362	footrot	C0016513
27259362	India	C0021201
27259362	foot swabs	C0183753
27259362	inter digital spaces	C0230506
27259362	sheep	C0036945
27259362	footrot	C0016513
27259362	lesions	C0221198
27259362	screened	C1710031
27259362	rRNA	C0035701
27259362	Dichelobacter nodosus	C0314932
27259362	PCR	C0032520
27259362	samples	C2347026
27259362	positive	C1514241
27259362	positive	C1514241
27259362	samples	C2347026
27259362	multiplex PCR	C3179032
27259362	targeting fimA gene	C0242613
27259362	identification	C0205396
27259362	serogroups	C0449543
27259362	D. nodosus	C0314932
27259362	Serogroup H	C0449555
27259362	serogroup B	C0456771
27259362	samples	C2347026
27259362	serogroup I	C0449543
27259362	samples	C2347026
27259362	serogroup H	C0449555
27259362	identified	C0205396
27259362	Indian subcontinent	C0454693
27259362	phylogenetic analysis	C1519068
27259362	sequence	C0004793
27259362	serogroup H	C0449555
27259362	sequences	C0004793
27259362	GenBank	C0598211
27259362	serotype H1	C0449943
27265654	Conservation education	C0013652
27265654	habitat	C0871648
27265654	restoration	C0205245
27265654	endangered	C2717882
27265654	Sagalla caecilian	C2999417
27265654	Boulengerula niedeni	C2999417
27265654	Sagalla Hill	C0022558
27265654	Kenya	C0022558
27265654	Sagalla caecilian	C2999417
27265654	Boulengerula niedeni	C2999417
27265654	endangered	C2717882
27265654	amphibian	C0002668
27265654	endemic	C0681784
27265654	Sagalla Hill	C0022558
27265654	Taita Hills	C0022558
27265654	burrowing worm	C0018893
27265654	species	C1705920
27265654	soft	C0205358
27265654	soil	C0037592
27265654	high	C0205250
27265654	moisture	C0868994
27265654	organic matter	C0439861
27265654	major	C0205164
27265654	threats	C0749385
27265654	Sagalla caecilian	C2999417
27265654	soil erosion	C1254365
27265654	caused	C0678227
27265654	steep slopes	C1254362
27265654	ground	C0242744
27265654	water siphoning	C1254366
27265654	soil hardening	C1254366
27265654	exotic eucalyptus trees	C0015148
27265654	study	C2603343
27265654	better	C0332272
27265654	understanding	C0162340
27265654	local	C0205276
27265654	people's	C0027361
27265654	attitude	C0004271
27265654	species	C1705920
27265654	contribute	C1880177
27265654	continued	C0549178
27265654	conservation	C2347858
27265654	restoration	C0205245
27265654	remaining	C1527428
27265654	habitat	C0871648
27265654	study	C2603343
27265654	found	C0150312
27265654	Sagalla	C0022558
27265654	people	C0027361
27265654	aware	C0004448
27265654	species	C1705920
27265654	habits	C0018464
27265654	soils	C0037592
27265654	high	C0205250
27265654	organic matter	C0439861
27265654	found	C0150312
27265654	Sagalla	C0022558
27265654	people	C0027361
27265654	organic	C0747055
27265654	manure	C0024765
27265654	cow	C0007452
27265654	dung	C0015733
27265654	farms	C0557759
27265654	Habitat	C0871648
27265654	restoration	C0205245
27265654	planting	C0441655
27265654	indigenous	C0205276
27265654	plants	C0032098
27265654	found	C0150312
27265654	ongoing	C0549178
27265654	especially	C0205555
27265654	compounds	C1706082
27265654	public institutions	C1552744
27265654	private lands	C0681784
27265654	drought	C0013140
27265654	found	C0150312
27265654	seedlings	C0242437
27265654	development	C1527148
27265654	low	C0205251
27265654	elevation	C0702240
27265654	sites	C0205145
27265654	destruction	C1948029
27265654	livestock	C2936506
27265654	during	C0347984
27265654	dry	C0205222
27265654	season	C0036497
27265654	major	C0205164
27265654	threat	C0749385
27265654	study	C2603343
27265654	recommended	C0034866
27265654	future	C0016884
27265654	habitat	C0871648
27265654	restoration	C0205245
27265654	initiative	C0424093
27265654	include	C0332257
27265654	strong	C0442821
27265654	chain-link	C3273359
27265654	fencing	C0441655
27265654	seedlings	C0242437
27265654	livestock	C2936506
27265654	activity	C0441655
27265654	preferred	C0558295
27265654	habitats	C0871648
27265654	species	C1705920
27265654	valleys	C0563004
27265654	systematic	C0220922
27265654	planting	C0441655
27265654	keystone plant	C0032098
27265654	species	C1705920
27265654	fig trees	C0969754
27265654	Ficus	C0969754
27265654	creates	C1706214
27265654	microhabitats	C0871648
27265654	better	C0332272
27265654	general	C0205246
27265654	woodlots	C1254362
27265654	indigenous	C0205276
27265654	trees	C0040811
27266753	clinical	C0205210
27266753	economic	C0013557
27266753	burden	C2828008
27266753	significant	C0750502
27266753	bleeding	C0019080
27266753	during	C0347984
27266753	lung resection surgery	C0396565
27266753	retrospective matched cohort analysis	C2985505
27266753	real	C0205238
27266753	world	C2700280
27266753	data	C1511726
27266753	objective	C1571702
27266753	retrospective study	C0035363
27266753	quantify	C1709793
27266753	clinical	C0205210
27266753	economic	C0013557
27266753	burden	C2828008
27266753	significant	C0750502
27266753	bleeding	C0019080
27266753	lung resection surgery	C0396565
27266753	US	C0041703
27266753	study	C2603343
27266753	utilized	C1524063
27266753	data	C1511726
27266753	Premier Perspective Database(TM)	C0242356
27266753	Adult	C0001675
27266753	patients	C0030705
27266753	primary pulmonary lobectomy	C0189497
27266753	segmentectomy procedures	C0189488
27266753	categorized	C0871968
27266753	surgical approach	C0449446
27266753	VATS	C0752151
27266753	open	C4283938
27266753	primary diagnosis	C0332137
27266753	primary	C0920688
27266753	metastatic lung cancer	C0920688
27266753	non-lung cancer	C0430022
27266753	Patients	C0030705
27266753	units	C0439148
27266753	blood products	C0456388
27266753	at least	C1524031
27266753	unit	C0439148
27266753	PRBCs	C2316467
27266753	significant	C0750502
27266753	bleeding	C0019080
27266753	cohort	C0599755
27266753	units	C0439148
27266753	non-significant	C1273937
27266753	bleeding	C0019080
27266753	cohort	C0599755
27266753	blood products	C0456388
27266753	no	C1518422
27266753	bleeding	C0019080
27266753	cohort	C0599755
27266753	cohort analysis	C0086027
27266753	performed	C0884358
27266753	significant	C0750502
27266753	bleeding	C0019080
27266753	no	C1518422
27266753	bleeding	C0019080
27266753	cohort	C0599755
27266753	matching variables	C0815175
27266753	hospital	C0019994
27266753	lung cancer diagnosis	C0920688
27266753	year of surgery	C0439234
27266753	APR-DRG severity score	C0457451
27266753	procedure type	C0944777
27266753	approach	C0449446
27266753	age	C0001779
27266753	gender	C0079399
27266753	All	C0444868
27266753	patient	C0030705
27266753	cohort	C0599755
27266753	patients	C0030705
27266753	significant	C0750502
27266753	bleeding	C0019080
27266753	non-significant	C1273937
27266753	bleeding	C0019080
27266753	no	C1518422
27266753	bleeding	C0019080
27266753	Overall	C1561607
27266753	incidence	C0021149
27266753	significant	C0750502
27266753	chest	C0817096
27266753	bleeding	C0019080
27266753	Patients	C0030705
27266753	significant	C0750502
27266753	bleeding	C0019080
27266753	cohort	C0599755
27266753	non-significant	C1273937
27266753	bleeding	C0019080
27266753	cohort	C0599755
27266753	days	C0439228
27266753	days	C0439228
27266753	longer	C0205166
27266753	length of stay	C0023303
27266753	hospital	C0019994
27266753	compared	C1707455
27266753	no	C1518422
27266753	bleeding	C0019080
27266753	cohort	C0599755
27266753	Overall	C1561607
27266753	hospital costs	C0206174
27266753	significant	C0750502
27266753	bleeding	C0019080
27266753	cohort	C0599755
27266753	higher	C0205250
27266753	no	C1518422
27266753	bleeding	C0019080
27266753	cohort	C0599755
27266753	covered	C0439844
27266753	Medicare	C0018717
27266753	years of age	C1510829
27266753	greater	C1704243
27266753	severity of illness	C0521117
27266753	segmentectomy	C2987624
27266753	Hospital costs	C0206174
27266753	significant	C0750502
27266753	bleeding	C0019080
27266753	cohort	C0599755
27266753	non-significant	C1273937
27266753	bleeding	C0019080
27266753	significantly	C0750502
27266753	higher	C0205250
27266753	no	C1518422
27266753	bleeding	C0019080
27266753	cohort	C0599755
27266753	significant	C0750502
27266753	bleeding	C0019080
27266753	during	C0347984
27266753	lung resection surgery	C0396565
27266753	rare	C0522498
27266753	patients	C0030705
27266753	complication	C0009566
27266753	stay	C3489408
27266753	longer	C0205166
27266753	hospital	C0019994
27266753	cost	C0206174
27266840	Laceration	C0043246
27266840	branch of	C1253959
27266840	profunda femoris artery	C0226455
27266840	caused	C0678227
27266840	spike	C0243095
27266840	displaced	C0012727
27266840	lesser trochanter	C0223866
27266840	inter-trochanteric	C0229984
27266840	femoral fracture	C0015802
27266840	case report	C0007320
27266840	Injury	C3263722
27266840	femoral vessels	C1116455
27266840	extremely	C0205403
27266840	rare	C0522498
27266840	complication	C0009566
27266840	intertrochanteric	C0229984
27266840	femoral fractures	C0015802
27266840	cases	C0220856
27266840	reported	C0700287
27266840	vascular lesion	C1402315
27266840	involves	C1314939
27266840	superficial femoral artery	C0447106
27266840	cases	C0220856
27266840	involve	C1314939
27266840	profunda femoris artery	C0226455
27266840	report	C0684224
27266840	case	C0220856
27266840	acute bleeding	C0333276
27266840	laceration	C0043246
27266840	perforating	C0549099
27266840	branch of	C1253959
27266840	profunda femoris artery	C0226455
27266840	caused	C0678227
27266840	sharp	C1444775
27266840	fragment of	C0332255
27266840	displaced	C0012727
27266840	lesser trochanter	C0223866
27266840	intertrochanteric	C0229984
27266840	femoral fracture	C0015802
27266840	lesion	C0221198
27266840	treated	C1522326
27266840	transcatheter embolization	C0203006
27266840	arterial injury	C0340652
27266840	iatrogenic	C0439669
27266840	occurring	C1709305
27266840	intramedullary	C2732619
27266840	internal fixation	C0016642
27266840	frequently	C0332183
27266840	injury	C3263722
27266840	fracture	C0016658
27266840	caused	C0678227
27266840	sharp	C1444775
27266840	bone fragment	C3698366
27266840	damages	C1883709
27266840	profunda femoris artery	C0226455
27266840	perforating	C0549099
27266840	branches	C1253959
27266840	intertrochanteric	C0229984
27266840	femoral fractures	C0015802
27266840	avulsed	C0262386
27266840	lesser trochanter	C0223866
27266840	at risk	C1444641
27266840	femoral vessel	C1116455
27266840	injuries	C3263722
27266840	caused	C0678227
27266840	displaced	C0012727
27266840	bone	C0262950
27266840	spike	C0243095
27266840	meticulous	C0205556
27266840	clinical	C0205210
27266840	laboratory monitoring	C3165364
27266840	pre-	C0445204
27266840	post-operatively	C0032790
27266840	prevent serious complications	C0547286
27270311	perivascular	C0005847
27270311	tumor cells	C0597032
27270311	integrin αvβ3	C1138427
27270311	signaling	C1514762
27270311	migration	C1622501
27270311	endothelial cells	C0225336
27270311	secretion	C1327616
27270311	pro-angiogenic factors	C0002976
27270311	tumor cells	C0597032
27270311	stromal cells	C0162597
27270311	perivascular	C0005847
27270311	aggressive angiogenesis	C1519670
27270311	glioblastoma	C0017636
27270311	GBM	C0017636
27270311	angiogenesis	C1519670
27270311	brain	C0006104
27270311	tumor cells	C0597032
27270311	tumor cells	C0597032
27270311	cancer stem	C1956422
27270311	CSCs	C1956422
27270311	endothelial cells	C0225336
27270311	ECs	C0225336
27270311	in vitro	C1533691
27270311	binding	C0597358
27270311	integrin αvβ3	C1138427
27270311	expressed	C0597360
27270311	ECs	C0225336
27270311	RGD-peptide	C0052350
27270311	L1CAM	C0950625
27270311	expressed	C1171362
27270311	CSCs	C1956422
27270311	EC	C0225336
27270311	network formation	C0007613
27270311	migration	C1622501
27270311	fibroblast growth factor	C0016026
27270311	Activation	C1879547
27270311	αvβ3	C1138427
27270311	bone marrow tyrosine kinase on chromosome X	C1384557
27270311	BMX	C1453891
27270311	migration	C1622501
27270311	binding	C0597358
27270311	migration	C1622501
27270311	RGD-peptide	C0052350
27270311	treatment	C1522326
27270311	mice	C0025929
27270311	intracerebral	C0442111
27270311	GBM	C0017636
27270311	xenografts	C0522537
27270311	Sox2	C0300483
27270311	tumor cells	C0597032
27270311	CSCs	C1956422
27270311	ECs	C0225336
27270311	integrin αvβ3	C1138427
27270311	BMX	C1453891
27270311	p130CAS	C1451358
27270311	phosphorylation	C1158886
27270311	ECs	C0225336
27270311	vessel	C0005847
27270311	surface area	C0205146
27270311	regulation	C1327622
27270311	angiogenesis	C1519670
27270311	GBM	C0017636
27270311	therapeutic	C0302350
27270311	anti-angiogenic	C0596087
27270753	Ocimum americanum	C1483717
27270753	essential oil	C0028910
27270753	pathogens	C0450254
27270753	Aeromonas hydrophila	C0085491
27270753	Gyrodactylus sp.	C1211435
27270753	silver catfish	C1939719
27270753	Rhamdia quelen	C1194855
27270753	bactericidal activity	C1271650
27270753	MIC-test	C0427978
27270753	Ocimum americanum	C1483717
27270753	inflorescences	C2697680
27270753	essential oil	C0028910
27270753	OAEO	C0028910
27270753	Aeromonas hydrophila	C0085491
27270753	OAEO	C0028910
27270753	compound	C0205198
27270753	oil	C0028908
27270753	linalool	C0064997
27270753	inhibitors	C0243077
27270753	hemolysis	C0019054
27270753	Aer. hydrophila	C0085491
27270753	fish	C1939719
27270753	erythrocytes	C0014792
27270753	in vivo experiment	C0681829
27270753	survival	C0038952
27270753	fish	C0016163
27270753	Rhamdia quelen	C1194855
27270753	experimentally	C0681814
27270753	infected	C0439663
27270753	Aer. hydrophila	C0085491
27270753	exposed	C0332157
27270753	OAEO	C0028910
27270753	experiment	C0681814
27270753	in vitro	C0681828
27270753	in vivo	C0681829
27270753	OAEO	C0028910
27270753	inflorescences	C2697680
27270753	leaves	C0242724
27270753	parasite Gyrodactylus sp.	C1211435
27270753	OAEO	C0028910
27270753	weak	C1762617
27270753	in vitro	C0681828
27270753	Aer. hydrophila	C0085491
27270753	OAEO	C0028910
27270753	inhibited	C3463820
27270753	hemolysis	C0019054
27270753	Aer. hydrophila	C0085491
27270753	fish	C1939719
27270753	erythrocytes	C0014792
27270753	linalool	C0064997
27270753	not present	C0332197
27270753	hemolysis	C0019054
27270753	inhibition activity	C3463820
27270753	water	C0043047
27270753	OAEO	C0028910
27270753	promoted	C0033414
27270753	survival	C0038952
27270753	infected	C0439663
27270753	fish	C1939719
27270753	Aer. hydrophila	C0085491
27270753	OAEO	C0028910
27270753	effective	C1704419
27270753	Gyrodactylus sp.	C1211435
27270753	significantly reducing	C4055638
27270753	parasites	C0030498
27270753	fish	C1939719
27271770	Interleukin-1β	C0021753
27271770	Stress Granules	C1325596
27271770	Sequester	C0333312
27271770	COX-2	C0387583
27271770	mRNA	C0035696
27271770	Regulates	C1327622
27271770	Stability	C2350440
27271770	Translation	C0678935
27271770	Human	C0086418
27271770	OA	C0029408
27271770	Chondrocytes	C0225369
27271770	Enhanced	C2349975
27271770	expression	C0017262
27271770	cyclooxygenase-2	C1367485
27271770	COX-2	C1367485
27271770	mRNA	C0035696
27271770	IL-1β	C0021753
27271770	stimulated	C1292856
27271770	OA	C0029408
27271770	chondrocytes	C0225369
27271770	synthesis of protein	C0597295
27271770	delayed	C0205421
27271770	stress granules	C1325596
27271770	SGs	C1325596
27271770	ribonucleoprotein complexes	C1167298
27271770	regulate	C1327622
27271770	mRNA translation	C0678935
27271770	delayed	C0205421
27271770	translation	C0678935
27271770	COX-2	C1367485
27271770	mRNAs	C0035696
27271770	IL-1β	C0021753
27271770	stimulated	C1292856
27271770	OA	C0029408
27271770	chondrocytes	C0225369
27271770	Stimulation	C1292856
27271770	human	C0086418
27271770	chondrocytes	C0225369
27271770	IL-1β	C0021753
27271770	stress response	C0149784
27271770	genes	C0017337
27271770	phosphorylation	C1158886
27271770	eIF2α	C0013733
27271770	triggered	C1444748
27271770	assembly of SGs	C2247634
27271770	immunofluorescence staining	C0079603
27271770	SGs	C1325596
27271770	markers	C0005516
27271770	COX-2 protein	C0387583
27271770	RNA	C0035668
27271770	fluorescence in situ hybridization	C0162789
27271770	RNA	C0035668
27271770	immunoprecipitation	C0021069
27271770	COX-2	C1367485
27271770	mRNAs	C0035696
27271770	sequestered	C0333312
27271770	SGs	C1325596
27271770	IL-1β	C0021753
27271770	stimulated	C1292856
27271770	OA	C0029408
27271770	chondrocytes	C0225369
27271770	No	C1513916
27271770	increase	C0442805
27271770	COX-2	C0387583
27271770	protein expression	C1171362
27271770	persistence	C0439590
27271770	SGs	C1325596
27271770	enhanced	C2349975
27271770	expression	C1171362
27271770	COX-2 protein	C0387583
27271770	clearance	C0449297
27271770	SGs	C1325596
27271770	Inhibition	C3463820
27271770	SGs	C1325596
27271770	clearance	C0449297
27271770	blocked	C0332206
27271770	COX-2	C1367485
27271770	mRNA	C0035696
27271770	translation	C0678935
27271770	blocking	C0332206
27271770	assembly of SGs	C2247634
27271770	TIA-1	C1429678
27271770	depletion	C0333668
27271770	increased	C0205217
27271770	production	C0005572
27271770	COX-2	C0387583
27271770	PGE2	C0012472
27271770	assembly of SGs	C2247634
27271770	sequestration	C0333312
27271770	COX-2	C1367485
27271770	mRNAs	C0035696
27271770	human	C0086418
27271770	OA	C0029408
27271770	chondrocytes	C0225369
27271770	pathological conditions	C0039058
27271770	Post-transcriptional regulation	C1514248
27271770	COX-2	C1367485
27271770	mRNAs translation	C0678935
27271770	SGs	C1325596
27271770	IL-1β	C0021753
27271770	catabolic	C0311402
27271770	response	C0871261
27271770	therapeutically	C0087111
27271770	OA	C0029408
27271969	Spatio-Temporal Distribution	C1704711
27271969	Bark	C0949119
27271969	Ambrosia	C0331432
27271969	Beetles	C0009276
27271969	Brazilian	C0006137
27271969	Tropical Dry Forest	C0086312
27271969	Bark	C0949119
27271969	ambrosia	C0331432
27271969	beetles	C0009276
27271969	host plants	C0868970
27271969	tunnels	C1116506
27271969	assessed	C1516048
27271969	beetle	C0009276
27271969	community	C0009462
27271969	dynamics	C0237587
27271969	tropical dry forest	C0086312
27271969	sites	C0205145
27271969	early	C1279919
27271969	intermediate	C1254367
27271969	late	C0205087
27271969	successional stages	C1306673
27271969	resource	C0035201
27271969	availability	C0470187
27271969	seasonal variations	C0036496
27271969	guild structure	C0205556
27271969	collected	C1516695
27271969	beetles	C0009276
27271969	species	C1705920
27271969	bark	C0949119
27271969	beetle	C0009276
27271969	species	C1705920
27271969	ambrosia	C0331432
27271969	beetle	C0009276
27271969	species	C1705920
27271969	Local	C0205276
27271969	richness	C0205556
27271969	bark	C0949119
27271969	ambrosia	C0331432
27271969	beetles	C0009276
27271969	species	C1705920
27271969	Bark	C0949119
27271969	ambrosia	C0331432
27271969	composition	C1254370
27271969	successional stages	C1306673
27271969	gradient	C0812409
27271969	beta diversity	C1880371
27271969	sites	C0205145
27271969	species	C1705920
27271969	bark	C0949119
27271969	beetle	C0009276
27271969	community	C0009462
27271969	Bark	C0949119
27271969	beetle	C0009276
27271969	richness	C0205556
27271969	abundance	C2346714
27271969	intermediate stages	C1306673
27271969	availability of	C0470187
27271969	wood	C0043217
27271969	spatial mechanism	C0441712
27271969	Climate	C0008946
27271969	factors	C1521761
27271969	non-seasonal	C0205556
27271969	Ambrosia	C0331432
27271969	beetles	C0009276
27271969	successional stages	C1306673
27271969	increase	C0442805
27271969	wood	C0043217
27271969	increased	C0205217
27271969	abundance	C2346714
27271969	richness	C0205556
27271969	dry	C0036497
27271969	wet seasons	C0036497
27271969	abundance	C2346714
27271969	increased	C0205217
27271969	air	C0001861
27271969	moisture	C0868994
27271969	temperatures	C0039476
27271969	rainfall	C0034640
27271969	bark	C0949119
27271969	beetle	C0009276
27271969	species	C1705920
27271969	accumulation	C0205245
27271969	sites	C0205145
27271969	wood	C0043217
27271969	production	C0441655
27271969	fungi	C0016832
27271969	host	C0868970
27271969	air	C0001861
27271969	moisture	C0868994
27271969	conditions	C0348080
27271969	species	C1705920
27271969	accumulation	C0205245
27271969	ambrosia	C0331432
27271969	biological	C0205460
27271969	pattern	C0205556
27271969	tropical rain forests	C0086312
27271969	dry forest areas	C0086312
27272784	Detection	C1511790
27272784	Flat Aberrant Crypt Foci (Flat ACF)	C1510713
27272784	A/J Min/+ Mouse	C2986594
27272784	Flat aberrant crypt foci	C1510713
27272784	flat ACF	C1510713
27272784	mucin-depleted foci	C3828884
27272784	MDF	C3828884
27272784	preneoplastic colonic lesions	C1514395
27272784	A/J Min/+ mouse model	C2986594
27272784	colon carcinogenesis	C0699790
27272784	detection	C1511790
27272784	flat ACF	C1510713
27272784	lesions	C0221198
27272784	histological examination	C0019637
27272784	MDF	C3828884
27272784	Colons	C0009368
27272784	stained with methylene blue	C1319310
27272784	MB	C0025746
27272784	flat ACF	C1510713
27272784	detection	C1511790
27272784	restained	C0487602
27272784	high-iron diamine-alcian blue	C0062712
27272784	HID-AB	C0062712
27272784	MDF	C3828884
27272784	detection	C1511790
27272784	flat ACF	C1510713
27272784	MB staining	C1319310
27272784	fraction of	C1264633
27272784	flat ACF	C1510713
27272784	MDF	C3828884
27272784	Flat ACF	C1510713
27272784	MDF	C3828884
27272784	severe dysplasia	C0334048
27272784	lack of	C0332268
27272784	mucus	C1513729
27272784	goblet cells	C0014597
27272784	accumulation	C4055506
27272784	cytoplasmic	C0521449
27272784	β-catenin	C0105770
27272784	flat ACF	C1510713
27272784	surface	C0699040
27272784	biomarkers	C0005516
27272784	Apc	C0162832
27272784	colon carcinogenesis	C0699790
27273160	Transcriptional enhancement	C0162493
27273160	Smn	C1420257
27273160	levels	C0428479
27273160	motoneurons	C0026609
27273160	axon	C0004461
27273160	morphology	C0332437
27273160	zebrafish	C0043457
27273160	spinal muscular atrophy	C0026847
27273160	SMA	C0026847
27273160	Smn protein	C1571507
27273160	defects	C0241225
27273160	motoneurons	C0026609
27273160	Smn expression	C1171362
27273160	motoneurons	C0026609
27273160	ex vivo zebrafish culture system	C4305352
27273160	zebrafish	C0043457
27273160	GFP	C0120285
27273160	marked	C1708632
27273160	motoneurons	C0026609
27273160	Smn protein	C0428479
27273160	smn mRNA	C0035696
27273160	levels	C0392762
27273160	motoneurons	C0026609
27273160	cell	C0007634
27273160	Smn levels	C0428479
27273160	motoneurons	C0026609
27273160	transcriptional activation	C0162493
27273160	ETS family transcription factor Etv5b	C0919488
27273160	smn transcription	C0040649
27273160	motoneurons	C0026609
27273160	Smn protein	C1571507
27273160	motoneurons	C0026609
27273160	axonogenesis	C1160337
27273160	cell-autonomous manner	C0007613
27273160	findings	C0587081
27273160	motoneurons	C0026609
27273160	Smn	C1571507
27273160	evidence	C3887511
27273160	increased	C0205217
27273160	vulnerability	C0012655
27273160	SMA conditions	C0026847
27274281	Evaluation	C0220825
27274281	axitinib	C1700874
27274281	Response Evaluation Criteria in Solid Tumors	C1709926
27274281	Choi criteria	C0935549
27274281	treated	C0332154
27274281	patients	C0030705
27274281	metastatic renal cell carcinoma	C0278678
27274281	Axitinib	C1700874
27274281	tyrosine kinase inhibitor	C1268567
27274281	vascular endothelial growth factor receptors	C0148199
27274281	patients	C0030705
27274281	Canada	C0006823
27274281	Australia	C0004340
27274281	approval	C2346845
27274281	axitinib	C1700874
27274281	countries	C0454664
27274281	treatment	C0087111
27274281	clear-cell metastatic renal cell carcinoma	C2931852
27274281	mRCC	C2931852
27274281	regimen	C0040808
27274281	single-arm	C2826346
27274281	open-label study	C1709323
27274281	axitinib	C1700874
27274281	efficacy	C1707887
27274281	safety	C1705187
27274281	quality of life	C0034380
27274281	QoL	C0034380
27274281	patients	C0030705
27274281	mRCC	C2931852
27274281	disease	C0012634
27274281	progressed	C0242656
27274281	first-line regimen	C1708063
27274281	response rate	C0237629
27274281	evaluated	C0220825
27274281	Response Evaluation Criteria in Solid Tumors	C1709926
27274281	RECIST	C1709926
27274281	Choi criteria	C0935549
27274281	Progression-free survival	C0242792
27274281	overall survival	C4086681
27274281	safety	C1705187
27274281	QoL	C0034380
27274281	study	C2603343
27274281	statistics	C2717898
27274281	patients	C0030705
27274281	Canada	C0006823
27274281	Australia	C0004340
27274281	patients	C0030705
27274281	sunitinib	C1176020
27274281	therapy	C0087111
27274281	patients	C0030705
27274281	clear-cell carcinoma	C0206681
27274281	nephrectomy	C0027695
27274281	Liver	C0023884
27274281	lung	C0024109
27274281	lymph nodes	C0024204
27274281	metastases	C0027627
27274281	patient	C0030705
27274281	brain metastasis	C0220650
27274281	Median	C0876920
27274281	axitinib	C1700874
27274281	days	C0439228
27274281	range	C1514721
27274281	days	C0439228
27274281	survival	C0038952
27274281	months	C0439231
27274281	patients	C0030705
27274281	responses	C0871261
27274281	RECIST	C1709926
27274281	Choi criteria	C0935549
27274281	patients	C0030705
27274281	progressive	C0242656
27274281	disease	C0012634
27274281	RECIST	C1709926
27274281	Choi criteria	C0935549
27274281	progression	C0242656
27274281	death	C0011065
27274281	study	C2603343
27274281	patients	C0030705
27274281	study	C2603343
27274281	drug	C1254351
27274281	Fatigue	C0015672
27274281	diarrhea	C0011991
27274281	treatment	C0087111
27274281	adverse events	C0877248
27274281	mean	C0444504
27274281	European	C0015176
27274281	Quality of Life	C0034380
27274281	score	C0449820
27274281	baseline	C1442488
27274281	treatment	C0087111
27274281	patients	C0030705
27274281	definitive	C0443196
27274281	conclusions	C1707478
27274281	safety	C1705187
27274281	efficacy	C1707887
27274281	axitinib	C1700874
27274281	studies	C2603343
27274281	patients	C0030705
27274281	mRCC	C2931852
27274281	patients	C0030705
27274281	QoL	C0034380
27274281	response rate	C0237629
27274281	RECIST	C1709926
27274281	Choi criteria	C0935549
27274281	research	C0008972
27274541	Biochemical	C0205474
27274541	characteristics	C1521970
27274541	AtFAR2	C4307379
27274541	fatty acid reductase	C0060094
27274541	Arabidopsis thaliana	C0162740
27274541	fatty acyl-CoA	C0001374
27274541	ACP substrates	C0001369
27274541	fatty alcohols	C0015694
27274541	Fatty alcohols	C0015694
27274541	derivatives	C0243072
27274541	important	C3898777
27274541	deposition	C0333562
27274541	functional	C0205245
27274541	pollen wall	C1820005
27274541	Mutations	C0596611
27274541	genes	C0017337
27274541	fatty acid reductases	C0060094
27274541	FAR	C0060094
27274541	fatty alcohol	C0015694
27274541	production	C0205245
27274541	abnormal	C0205161
27274541	development	C1527148
27274541	pollen	C0032385
27274541	disrupted	C0332454
27274541	AtFAR2 (MS2) gene	C1428496
27274541	Arabidopsis thaliana	C0162740
27274541	results	C1274040
27274541	pollen	C0032385
27274541	developing	C1527148
27274541	abnormal	C0205161
27274541	exine layer	C1820006
27274541	reduced fertility	C0243095
27274541	phenotype	C0031437
27274541	AtFAR2	C4307379
27274541	targeted	C1521840
27274541	chloroplasts	C0008266
27274541	purified form	C0348078
27274541	specific	C0205369
27274541	acyl-ACP substrates	C0001369
27274541	data	C1511726
27274541	in vitro	C1533691
27274541	planta	C0032098
27274541	characterizations	C1880022
27274541	AtFAR2	C4307379
27274541	A. thaliana	C0162740
27274541	enzyme	C0014442
27274541	C16:0-ACP	C0001369
27274541	C16:0-CoA	C0030239
27274541	substrates	C0178623
27274541	C16:0-alcohol	C0055152
27274541	AtFAR2	C4307379
27274541	properties	C0205556
27274541	substrate	C0178623
27274541	specificity	C0037791
27274541	AtFAR6	C0060094
27274541	in vitro	C1533691
27274541	data	C1511726
27274541	chloroplast	C0008266
27274541	localized	C0392752
27274541	enzyme	C0014442
27274541	AtFAR2	C4307379
27274541	enzyme	C0014442
27274541	exine layer	C1820006
27274541	functionality	C0542341
27274541	AtFAR6	C0060094
27274541	functional	C0205245
27274541	redundancy	C1313915
27274541	AtFAR2	C4307379
27274791	Comparing	C1707455
27274791	Time Perception	C0040226
27274791	Morphine	C0026549
27274791	Derived	C1441547
27274791	Drugs	C0013227
27274791	Addicts	C0858354
27274791	Controls	C0009932
27274791	aim	C1947946
27274791	study	C2603343
27274791	compare	C1707455
27274791	time perception	C0040226
27274791	drug addicts	C0700285
27274791	controls	C0009932
27274791	drug addicts	C0700285
27274791	selected	C1707391
27274791	non-addict individuals	C0237401
27274791	selected	C1707391
27274791	control group	C0009932
27274791	groups	C0441833
27274791	tests	C0392366
27274791	time	C0040223
27274791	reproduction	C0035150
27274791	time estimation	C0871937
27274791	time	C0040223
27274791	discrimination	C0012632
27274791	significant	C0750502
27274791	difference	C1705242
27274791	addicts	C0858354
27274791	group	C0441833
27274791	control group	C0009932
27274791	error	C0743559
27274791	time	C0040223
27274791	reproduction	C0035150
27274791	time estimation	C0871937
27274791	addict	C0858354
27274791	group	C0441833
27274791	comparison	C1707455
27274791	control group	C0009932
27274791	lower	C2003888
27274791	reproduction	C0035150
27274791	higher	C0205250
27274791	reproduction	C0035150
27274791	error	C0743559
27274791	lower	C2003888
27274791	estimation	C0680844
27274791	higher	C0205250
27274791	estimation	C0680844
27274791	error	C0743559
27274791	time	C0040223
27274791	discrimination	C0012632
27274791	significant	C0750502
27274791	difference	C1705242
27274791	errors	C0743559
27274791	groups	C0441833
27274791	images	C1704922
27274791	drug consumption	C0678263
27274791	tools	C0336791
27274791	normal	C0205307
27274791	images	C1704922
27274791	durations	C0449238
27274791	normal	C0205307
27274791	group	C0441833
27274791	images	C1704922
27274791	drug consumption	C0678263
27274791	tools	C0336791
27274791	shorter	C1806781
27274791	period	C1948053
27274791	time	C0040223
27274791	Time perception	C0040226
27274791	different	C1705242
27274791	morphine	C0026549
27274791	derived	C1441547
27274791	drugs	C0013227
27274791	addicts	C0858354
27274791	controls	C0009932
27277750	Co-delivery	C1705822
27277750	pemetrexed	C0210657
27277750	miR-21 antisense oligonucleotide	C0079925
27277750	lipid	C0023779
27277750	polymer	C0032521
27277750	hybrid nanoparticles	C1450054
27277750	effects	C1280500
27277750	glioblastoma	C0017636
27277750	cells	C0007634
27277750	Combination therapy	C0009429
27277750	anticancer drugs	C0003392
27277750	nucleic acid	C0028606
27277750	multidrug resistance	C0242640
27277750	cancer	C0027651
27277750	apoptosis	C0162638
27277750	study	C2603343
27277750	lipid	C0023779
27277750	polymer	C0032521
27277750	hybrid nanoparticles	C1450054
27277750	LPNs	C1713964
27277750	pemetrexed	C0210657
27277750	miR-21 antisense oligonucleotide	C0079925
27277750	anti-miR-21	C0079925
27277750	treatment	C1522326
27277750	glioblastoma	C0017636
27277750	aggressive	C2945759
27277750	brain tumor	C0006118
27277750	LPNs	C1713964
27277750	particle size	C0030608
27277750	distribution	C1704711
27277750	zeta potential	C0597697
27277750	measurements	C0242485
27277750	encapsulation	C2348438
27277750	efficiency	C0013682
27277750	in vitro	C1533691
27277750	release experiments	C0681814
27277750	Morphology	C0332437
27277750	LPNs	C1713964
27277750	transmission electron microscopy	C0678118
27277750	LPNs	C1713964
27277750	hydrodynamic	C2936194
27277750	size	C0456389
27277750	sustained release	C0391871
27277750	pemetrexed	C0210657
27277750	Encapsulation	C2348438
27277750	pemetrexed	C0210657
27277750	LPNs	C1713964
27277750	cellular uptake	C0007613
27277750	confocal microscopy analysis	C0242842
27277750	co-delivery	C1705822
27277750	anti-miR-21	C0079925
27277750	accumulation	C4055506
27277750	LPNs	C1713964
27277750	nucleus	C0007610
27277750	U87MG cells	C0007634
27277750	cytotoxicity	C0596402
27277750	results	C1274040
27277750	concentration	C0678563
27277750	anti-miR-21	C0079925
27277750	LPNs	C1713964
27277750	drug delivery systems	C0085104
27277750	concentration	C0678563
27277750	anti-miR-21	C0079925
27277750	treatment	C0087111
27277750	glioblastoma	C0017636
27278134	Expert	C1522486
27278134	position paper	C0282574
27278134	prolonged	C0439590
27278134	dual antiplatelet therapy	C1096021
27278134	secondary prevention	C0679699
27278134	myocardial infarction	C0027051
27278134	protective effect	C1280500
27278134	dual antiplatelet therapy	C1096021
27278134	DAPT	C1096021
27278134	acute coronary syndrome	C0948089
27278134	duration	C0449238
27278134	debate	C0870392
27278134	studies	C2603343
27278134	prolonged	C0439590
27278134	therapy	C0087111
27278134	clinical	C0205210
27278134	benefit	C0814225
27278134	patients	C0030705
27278134	acute coronary syndrome	C0948089
27278134	position paper	C0282574
27278134	Austrian	C0337795
27278134	experts	C1522486
27278134	current	C0521116
27278134	evidence	C3887511
27278134	studies	C2603343
27278134	practical guide	C0681467
27278134	patients	C0030705
27278134	benefit	C0814225
27278134	prolonged	C0439590
27278134	DAPT	C1096021
27279861	Medulloblastoma	C0025149
27279861	molecular pathways	C1704259
27279861	histopathological	C0243140
27279861	classification	C0008902
27279861	Malignant brain tumors	C0153633
27279861	leading	C1522538
27279861	cause	C0015127
27279861	cancer	C0006826
27279861	death	C1306577
27279861	pediatric	C1521725
27279861	patients	C0030705
27279861	medulloblastoma	C0025149
27279861	treatment	C0087111
27279861	surgical resection	C0015252
27279861	recommended	C0034866
27279861	chemotherapy	C3665472
27279861	neuroaxis	C3714787
27279861	radiotherapy	C1522449
27279861	improving	C1272745
27279861	survival rate	C0038954
27279861	survivors	C0206194
27279861	treatment	C0087111
27279861	induced	C0205263
27279861	side effects	C0879626
27279861	reduce	C0392756
27279861	toxic effects	C0600688
27279861	molecular-targeted treatment	C2699893
27279861	Medulloblastoma	C0025149
27279861	research	C0035168
27279861	robust	C2986815
27279861	articles	C1706852
27279861	published	C0034037
27279861	review	C0282443
27279861	molecular	C1521991
27279861	pathophysiology	C0031847
27279861	neoplasm	C0027651
27279861	pathological	C1521733
27279861	classification	C0008902
27279861	tumor biology	C1519672
27279861	histological picture	C1301121
27280293	Spatio-Temporal History	C3494293
27280293	HIV-1 CRF35_AD	C3656358
27280293	Afghanistan	C0001732
27280293	Iran	C0022065
27280293	HIV-1 Circulating Recombinant Form 35_AD	C0019704
27280293	CRF35_AD	C3656358
27280293	epidemiological	C0014507
27280293	profile	C2003903
27280293	Afghanistan	C0001732
27280293	Iran	C0022065
27280293	clade	C0029235
27280293	Afghanistan	C0001732
27280293	Iran	C0022065
27280293	dissemination	C0332261
27280293	Bayesian phylogeographic analysis	C0242196
27280293	spatio-temporal dispersion pattern	C0332261
27280293	clade	C0029235
27280293	CRF35_AD	C3656358
27280293	gag and pol sequences	C0004793
27280293	Los Alamos	C3829256
27280293	HIV database	C0950132
27280293	sequences	C0004793
27280293	Iran	C0022065
27280293	sequences	C0004793
27280293	Afghanistan	C0001732
27280293	CRF35_AD	C3656358
27280293	pol sequence	C0004793
27280293	USA	C0041703
27280293	Bayesian Markov Chain Monte Carlo algorithm	C0002045
27280293	BEAST v1.8.1	C0037585
27280293	Bayesian stochastic search variable selection method	C0034980
27280293	Bayes factor values	C1553908
27280293	CRF35_AD	C3656358
27280293	sequences	C0004793
27280293	parental sequences	C0004793
27280293	Kenya	C0022558
27280293	Uganda	C0041573
27280293	subtype A1	C3656358
27280293	sequences	C0004793
27280293	Afghan	C0001732
27280293	refugees	C0034961
27280293	Pakistan	C0030211
27280293	phylogenies	C0031797
27280293	Afghan	C0001732
27280293	Iranian	C0022065
27280293	CRF35_AD	C3656358
27280293	sequences	C0004793
27280293	monophyletic cluster	C1704332
27280293	cluster	C1704332
27280293	cluster	C1704332
27280293	bidirectional	C1706937
27280293	dispersion	C0332261
27280293	virus	C0042776
27280293	Afghanistan	C0001732
27280293	Iran	C0022065
27280293	Afghanistan	C0001732
27280293	Iran	C0022065
27280293	epidemic	C0277548
27280293	cluster	C1704332
27280293	CRF35_AD	C3656358
27280293	sequences	C0004793
27280293	Afghan	C0001732
27280293	refugees	C0034961
27280293	living in	C0337646
27280293	Pakistan	C0030211
27280293	Afghan	C0001732
27280293	Iranian	C0022065
27280293	CRF35_AD	C3656358
27280293	CRF35_AD	C3656358
27280293	sequence	C0004793
27280293	USA	C0041703
27280293	Kenyan	C0022558
27280293	subtype A1	C3656358
27280293	sequences	C0004793
27280293	CRF35_AD	C3656358
27280293	Potential	C3245505
27280293	factors	C1521761
27280293	viral	C0042776
27280293	Afghanistan	C0001732
27280293	Iran	C0022065
27280293	mass migration	C0600210
27280293	Afghan	C0001732
27280293	refugees	C0034961
27280293	labours	C0022867
27280293	Iran	C0022065
27280293	extensive	C0205231
27280293	preventive	C1456501
27282265	Benefits	C0814225
27282265	Combination Therapy	C0009429
27282265	Esomeprazole	C0937846
27282265	Rebamipide	C0069562
27282265	Symptom	C1457887
27282265	Improvement	C2986411
27282265	Reflux Esophagitis	C0014869
27282265	International	C1512888
27282265	Multicenter Study	C1096776
27282265	investigate	C1292732
27282265	effects	C1280500
27282265	esomeprazole	C0937846
27282265	rebamipide	C0069562
27282265	combination therapy	C0009429
27282265	symptomatic	C1457887
27282265	improvement	C2986411
27282265	patients	C0030705
27282265	reflux esophagitis	C0014869
27282265	patients	C0030705
27282265	reflux esophagitis	C0014869
27282265	randomized	C0206034
27282265	treatment regimens	C0040808
27282265	esomeprazole	C0937846
27282265	rebamipide	C0069562
27282265	daily	C0332173
27282265	combination therapy	C0009429
27282265	group	C0441833
27282265	esomeprazole	C0937846
27282265	daily	C0332173
27282265	monotherapy	C0087111
27282265	group	C0441833
27282265	symptom	C1457887
27282265	questionnaire	C0034394
27282265	evaluated	C1292732
27282265	heartburn	C0018834
27282265	acid regurgitation	C0849747
27282265	upper gastrointestinal symptoms	C0857493
27282265	efficacy	C1280519
27282265	decrease	C0547047
27282265	symptom score	C3476546
27282265	decreases	C0547047
27282265	symptom score	C3476546
27282265	weeks	C0439230
27282265	combination therapy	C0009429
27282265	group	C0441833
27282265	monotherapy	C0087111
27282265	group	C0441833
27282265	reflux	C0014869
27282265	symptom	C1457887
27282265	baseline	C1442488
27282265	weeks	C0439230
27282265	treatment	C0087111
27282265	combination therapy	C0009429
27282265	group	C0441833
27282265	monotherapy	C0087111
27282265	group	C0441833
27282265	week	C0439230
27282265	treatment	C0087111
27282265	esomeprazole	C0937846
27282265	rebamipide	C0069562
27282265	combination therapy	C0009429
27282265	effective	C1704419
27282265	decreasing	C0442797
27282265	symptoms	C1457887
27282265	reflux esophagitis	C0014869
27282265	esomeprazole	C0937846
27282265	monotherapy	C0087111
27283167	Integrating	C0205195
27283167	Palliative Care	C0030231
27283167	Pediatric Oncology	C1518931
27283167	Evolving	C0332253
27283167	Paradigm	C0681797
27283167	Comprehensive	C0009586
27283167	Cancer Care	C0920687
27283167	integrating	C0205195
27283167	palliative care	C0030231
27283167	PC	C0030231
27283167	cancer treatment	C0920425
27283167	increased	C0205217
27283167	PC	C0030231
27283167	integrating	C0205195
27283167	PC	C0030231
27283167	comprehensive	C0009586
27283167	cancer centers,	C1516604
27283167	pediatric centers	C0020017
27283167	year	C0439234
27283167	establishing	C0443211
27283167	PC	C0030231
27283167	Quality of Life Service	C0008079
27283167	QoLS	C0008079
27283167	St. Jude Children's Research Hospital	C1519168
27283167	records of patients	C0025102
27283167	QoLS	C0008079
27283167	March	C3829202
27283167	December	C3830550
27283167	Variables	C1705098
27283167	year	C0439234
27283167	statistics	C1456551
27283167	diagnostic groups	C0011928
27283167	QoLS	C0008079
27283167	encounters	C1512346
27283167	goals of care	C2930505
27283167	duration of survival	C2919551
27283167	location of death	C2924451
27283167	QoLS	C0008079
27283167	patient	C0030705
27283167	encounters	C1512346
27283167	increased	C0205217
27283167	consults	C0009818
27283167	increased	C0205217
27283167	encounters	C1512346
27283167	patient	C0030705
27283167	increased	C0205217
27283167	Goal of care	C2930505
27283167	initial consultation	C2065349
27283167	comfort	C1331418
27283167	increasing	C0442808
27283167	goal of cure	C3897861
27283167	initial consult	C2065349
27283167	death	C1306577
27283167	increased	C0205217
27283167	increased	C0205217
27283167	outpatient	C0029921
27283167	location of death	C2924451
27283167	outpatient	C0029921
27283167	deaths	C1306577
27283167	increasing	C0442808
27283167	majority	C0205164
27283167	year	C0439234
27283167	Hospital-wide	C1510665
27283167	patients	C0030705
27283167	PC	C0030231
27283167	death	C1306577
27283167	increased	C0205217
27283167	approximately	C0332232
27283167	QoLS	C0008079
27283167	increase	C0205217
27283167	referrals	C0034927
27283167	encounters	C1512346
27283167	patient	C0030705
27283167	increased	C0205217
27283167	clinical services	C1704289
27283167	earlier	C1279919
27283167	consultation	C0009818
27283167	longer term	C0443252
27283167	follow-up	C1522577
27283167	increasing	C0442808
27283167	outpatient	C0029921
27283167	location of death	C2924451
27283167	universal	C0175671
27283167	PC	C0030231
27283167	end-of-life	C0039548
27283167	integration	C0205195
27283167	PC	C0030231
27283167	comprehensive	C0009586
27283167	cancer center	C1516604
27283167	care provision	C3244104
27283167	time	C0040223
27283167	model	C3161035
27283167	programs	C0679897
27285457	PROTECTIVE EFFECTS OF	C1704420
27285457	DIPEPTIDYL PEPTIDASE-4 INHIBITORS	C1827106
27285457	PROGRESSION	C0242656
27285457	DIABETIC RETINOPATHY	C0011884
27285457	PATIENTS	C0030705
27285457	TYPE 2 DIABETES	C0011860
27285457	investigate	C1292732
27285457	effects of	C1704420
27285457	dipeptidyl peptidase-4 inhibitors	C1827106
27285457	DPP4	C1827106
27285457	progression	C0242656
27285457	diabetic retinopathy	C0011884
27285457	DR	C0011884
27285457	patients	C0030705
27285457	Type 2 diabetes	C0011860
27285457	DR	C0011884
27285457	severity scale	C0392762
27285457	medical records	C0025102
27285457	patients	C0030705
27285457	Type 2 diabetes	C0011860
27285457	retrospectively	C1514923
27285457	reviewed	C1709940
27285457	Fundus photographs	C0200189
27285457	graded	C0441800
27285457	Early Treatment Diabetic Retinopathy Study methods	C3899277
27285457	associations	C0332281
27285457	baseline	C1442488
27285457	risk factors	C0035648
27285457	progression	C0242656
27285457	DR	C0011884
27285457	investigated	C1292732
27285457	patients	C0030705
27285457	treated	C1522326
27285457	DPP4 inhibitors	C1827106
27285457	treated	C1522326
27285457	hypoglycemic agents	C0020616
27285457	progression	C0242656
27285457	retinopathy	C0011884
27285457	Early Treatment Diabetic Retinopathy Study scale	C0392762
27285457	treatment	C1522326
27285457	DPP4 inhibitors	C1827106
27285457	reduced	C0392756
27285457	progression	C0242656
27285457	DR	C0011884
27285457	patients	C0030705
27285457	propensity score	C2718044
27285457	Treatment	C1522326
27285457	DPP4 inhibitors	C1827106
27285457	associated with	C0332281
27285457	lower	C2003888
27285457	risk	C0035647
27285457	DR	C0011884
27285457	progression	C0242656
27285457	Treatment	C1522326
27285457	DPP4 inhibitors	C1827106
27285457	independent	C0085862
27285457	protective factor	C1521761
27285457	progression	C0242656
27285457	DR	C0011884
27285457	improving glycemic control	C0243095
27285457	benefits	C0814225
27285457	DPP4 inhibitors	C1827106
27285457	reducing	C0392756
27285457	DR	C0011884
27285457	progression	C0242656
27285457	preliminary	C0439611
27285457	data	C1511726
27285457	evaluation	C0220825
27285457	DPP4 inhibitors	C1827106
27285457	progression	C0242656
27285457	DR	C0011884
27285457	randomized	C0034656
27285457	double-blind	C0013072
27285457	placebo-controlled trial	C0599724
27293894	Production	C0033268
27293894	Laccase	C0064566
27293894	Cochliobolus sp.	C0009206
27293894	Isolated	C0205409
27293894	Plastic	C0032167
27293894	Dumped Soils	C0037592
27293894	Ability	C0085732
27293894	Degrade	C0678637
27293894	Low Molecular Weight PVC	C0032624
27293894	man-made problems	C2963156
27293894	ever	C3887636
27293894	increasing	C0442808
27293894	plastic	C0032167
27293894	waste	C0043045
27293894	filling	C1708059
27293894	municipal solid waste	C1550151
27293894	landfill sites	C0563007
27293894	plastic	C0032167
27293894	biodegradation	C0005482
27293894	fungi	C0016832
27293894	enzymes	C0014442
27293894	plastic	C0032167
27293894	degradation	C0005482
27293894	laboratory conditions	C2826637
27293894	ability	C0085732
27293894	fungi	C0016832
27293894	degrade	C0678637
27293894	low molecular weight polyvinyl chloride	C0032624
27293894	PVC	C0032624
27293894	enzyme laccase	C0064566
27293894	isolated	C0205409
27293894	fungal	C0016832
27293894	species	C1705920
27293894	Cochliobolus sp.	C0009206
27293894	plastic	C0032167
27293894	dumped soils	C0037592
27293894	cultured	C0200954
27293894	Czapek Dox Agar slants	C0010454
27293894	effectiveness	C1280519
27293894	fungal	C0016832
27293894	species	C1705920
27293894	degradation	C0005482
27293894	low molecular weight polyvinyl chloride	C0032624
27293894	PVC	C0032624
27293894	laboratory conditions	C2826637
27293894	FTIR	C0206055
27293894	GC-MS	C0024868
27293894	SEM	C0026020
27293894	control	C1550141
27293894	Cochliobolus sp.	C0009206
27293894	PVC	C0032624
27294945	Effects of	C1704420
27294945	Cerium	C0055114
27294945	Titanium Oxide	C0145999
27294945	Nanoparticles	C1721060
27294945	Soil	C0037592
27294945	Nutrient	C0678695
27294945	Composition	C0486616
27294945	Barley	C0331554
27294945	Hordeum vulgare L	C0331554
27294945	Kernels	C0453143
27294945	implications	C0205245
27294945	metal nanoparticles	C1721060
27294945	MeNPs)	C1721060
27294945	unknown	C0439673
27294945	many	C0439064
27294945	food crops	C0242775
27294945	purpose	C1285529
27294945	study	C2603343
27294945	effects of	C1704420
27294945	cerium oxide	C0055114
27294945	nCeO₂	C0055114
27294945	titanium oxide	C0145999
27294945	nTiO₂	C0145999
27294945	nanoparticles	C1721060
27294945	soil	C0037592
27294945	nutritional parameters	C1521739
27294945	barley	C0331554
27294945	Hordeum vulgare L.	C0331554
27294945	kernels	C0453143
27294945	Mineral nutrients	C0682741
27294945	amylose	C0002732
27294945	β-glucans	C1134651
27294945	amino acid	C0002520
27294945	crude protein	C0033684
27294945	CP	C0033684
27294945	concentrations were measured	C1446561
27294945	kernels	C0453143
27294945	Whole	C0444667
27294945	flour	C0016260
27294945	ICP-AES/MS	C2930679
27294945	HPLC	C0008562
27294945	Elemental CHNS Analyzer	C1706246
27294945	Ce	C0007828
27294945	Ti	C0040302
27294945	accumulation	C4055506
27294945	MeNPs	C1721060
27294945	treatments	C1522326
27294945	control treatment	C1522326
27294945	nCeO₂	C0055114
27294945	nTiO₂	C0145999
27294945	impact	C4049986
27294945	composition	C0486616
27294945	nutritional quality	C3489446
27294945	barley	C0331554
27294945	kernels	C0453143
27294945	contrasting ways	C0205556
27294945	MeNPs	C1721060
27294945	β-glucans	C1134651
27294945	unaffected	C2986417
27294945	amylose	C0002732
27294945	amino acids	C0002520
27294945	CP	C0033684
27294945	increased	C0205217
27294945	amino acids	C0002520
27294945	lysine	C0024337
27294945	proline	C0033382
27294945	largest increase	C0442805
27294945	Potassium	C0032821
27294945	S	C0038774
27294945	negatively impacted	C4049986
27294945	MeNPs	C1721060
27294945	affected	C0392760
27294945	nCeO₂	C0055114
27294945	Zn	C0373748
27294945	Mn concentrations	C0373677
27294945	nTiO₂	C0145999
27294945	nTiO₂	C0145999
27294945	treatments	C1522326
27294945	demonstrated	C3687625
27294945	kernels	C0453143
27294945	negatively affected	C1513916
27294945	nCeO₂	C0055114
27294945	nTiO₂	C0145999
27294945	beneficial effects	C0205556
27294945	MeNPs	C1721060
27294945	negatively impact	C4049986
27294945	malt	C0024651
27294945	feed production	C4042899
27305683	Quantifying	C1709793
27305683	Contributions	C1880177
27305683	Cortical Responses Evoked	C0853990
27305683	Continuous Wrist Manipulation	C1293270
27305683	Cortical responses	C0853990
27305683	continuous stimuli	C0542478
27305683	magneto-	C0024489
27305683	electroencephalography	C0013819
27305683	EEG	C0013819
27305683	stimulated frequency	C0237630
27305683	nonlinear behavior	C0004927
27305683	analysis	C0936012
27305683	techniques	C0449851
27305683	linearity	C0205132
27305683	contributions	C1880177
27305683	cortical responses	C0853990
27305683	goal of this paper	C0018017
27305683	quantify	C1709793
27305683	contributions	C1880177
27305683	cortical response	C0853990
27305683	continuous	C0549178
27305683	sensory stimulation	C0150763
27305683	EEG	C0013819
27305683	cortical response evoked	C0853990
27305683	continuous movement of the wrist joint	C0575717
27305683	robotic manipulator	C0336537
27305683	stimulus signals	C0234402
27305683	several	C0443302
27305683	sinusoids	C0682624
27305683	periodic	C0332182
27305683	cortical response	C0853990
27305683	assess	C1516048
27305683	contributions	C1880177
27305683	Wrist dynamics	C0454465
27305683	joint angle	C0022417
27305683	torque	C0376590
27305683	linearized	C0205132
27305683	cortical response	C0853990
27305683	nonparametric linear model	C0242932
27305683	results	C0683954
27305683	evoked cortical responses	C0853990
27305683	linear	C0205132
27305683	mechanical stimulus	C0234402
27305683	cortical response	C0596450
27306679	Using	C1524063
27306679	melanopsin	C0670514
27306679	study	C2603343
27306679	G protein signaling	C1517335
27306679	cortical	C0007776
27306679	neurons	C0027882
27306679	understanding	C0162340
27306679	G protein-coupled receptors	C0682972
27306679	GPCRs	C0682972
27306679	central nervous system	C3714787
27306679	CNS	C3714787
27306679	tools	C3273359
27306679	study	C2603343
27306679	signaling	C3537152
27306679	precise temporal	C1547902
27306679	control	C2587213
27306679	overcome	C2983310
27306679	tested	C0039593
27306679	bistable	C0205360
27306679	mammalian	C0024660
27306679	opsin	C2355587
27306679	melanopsin	C0670514
27306679	G protein signaling	C1517335
27306679	CNS	C3714787
27306679	neurons	C0027882
27306679	used	C1524063
27306679	biolistic	C0376638
27306679	gene gun	C0920531
27306679	transfect melanopsin	C0670514
27306679	cortical	C0007776
27306679	pyramidal cells	C0206441
27306679	maintained	C1314677
27306679	organotypic slice culture	C0040284
27306679	Whole cell recordings	C0242624
27306679	transfected neurons	C0027882
27306679	blue light	C0303896
27306679	effectively	C1704419
27306679	activated	C1515877
27306679	transfected melanopsin	C0670514
27306679	elicit	C0449265
27306679	biphasic	C0205184
27306679	modulation	C0678672
27306679	membrane	C0596901
27306679	excitability	C0235169
27306679	associated with	C0332281
27306679	activation	C1515877
27306679	GPCRs	C0682972
27306679	coupling	C1948027
27306679	Gαq-11	C1333650
27306679	exogenous	C0205228
27306679	agonist	C2987634
27306679	concentration	C1446561
27306679	obtained	C1301820
27306679	pulses	C1947910
27306679	few	C0205388
27306679	milliseconds	C0439223
27306679	triggering	C1444748
27306679	single	C0205171
27306679	melanopsin	C0670514
27306679	activation-deactivation cycle	C1254367
27306679	resulting	C1274040
27306679	temporal control	C2587213
27306679	melanopsin	C0670514
27306679	activation	C1515877
27306679	compare	C1707455
27306679	activation	C1515877
27306679	kinetics	C0022702
27306679	electrophysiological	C2350527
27306679	response	C0871261
27306679	intracellular	C0178719
27306679	loops	C0445022
27306679	melanopsin	C0670514
27306679	5-HT2A receptor	C0289174
27306679	light-activated	C1254366
27306679	GPCR	C0682972
27306679	interacting	C1704675
27306679	5-HT2A receptor	C0289174
27306679	interacting	C1704675
27306679	proteins	C0033684
27306679	resulting	C1274040
27306679	chimera	C0162768
27306679	expressed	C0205245
27306679	weak	C1762617
27306679	activity	C0441655
27306679	validated	C1519941
27306679	potential	C3245505
27306679	usefulness	C3827682
27306679	melanopsin	C0670514
27306679	tool	C3273359
27306679	study	C2603343
27306679	G protein signaling	C1517335
27306679	CNS	C3714787
27306679	neurons	C0027882
27308854	Maternal	C0026591
27308854	vitamin D	C0042866
27308854	levels	C0441889
27308854	risk	C0035647
27308854	perinatal death	C0455986
27308854	association	C0439849
27308854	maternal	C0026591
27308854	vitamin D	C0042866
27308854	levels	C0441889
27308854	perinatal death	C0455986
27308854	retrospective	C1514923
27308854	cross-sectional study	C0010362
27308854	singleton	C1313913
27308854	births	C0005615
27308854	weeks	C0439230
27308854	perinatal death	C0455986
27308854	control group	C0009932
27308854	pregnancies	C0032961
27308854	vitamin D	C0042866
27308854	level	C0441889
27308854	weeks	C0439230
27308854	gestation	C0032961
27308854	analysis	C0936012
27308854	Maternal	C0026591
27308854	vitamin D	C0042866
27308854	levels	C0441889
27308854	normal	C0205307
27308854	deficient	C0011155
27308854	insufficient	C0231180
27308854	cohorts	C0599755
27308854	variables	C0439828
27308854	groups	C0599755
27308854	perinatal deaths	C0455986
27308854	controls	C0009932
27308854	vitamin D	C0042866
27308854	levels	C0441889
27308854	perinatal death	C0455986
27308854	cohort	C0599755
27308854	control group	C0009932
27308854	deaths	C0011065
27308854	normal	C0205307
27308854	deficient	C0011155
27308854	insufficient	C0231180
27308854	groups	C0599755
27308854	maternal	C0026591
27308854	vitamin D	C0042866
27308854	levels	C0441889
27308854	associated with	C0332281
27308854	risk	C0035647
27308854	perinatal demise	C0455986
27312354	Effect	C1280500
27312354	constitutive inactivation	C0598496
27312354	myostatin gene	C1333667
27312354	gain	C1517378
27312354	muscle strength	C0517349
27312354	postnatal growth	C0243109
27312354	murine	C0025929
27312354	models	C0599779
27312354	effect	C1280500
27312354	constitutive inactivation	C0598496
27312354	gene encoding myostatin	C1333667
27312354	gain	C1517378
27312354	muscle performance	C0517349
27312354	postnatal growth	C0243109
27312354	murine	C0025929
27312354	myostatin	C1333667
27312354	knockout (KO) models	C1171353
27312354	Lee model	C0599779
27312354	KO(Lee	C0206745
27312354	Grobet model	C0599779
27312354	KO(Grobet)	C0206745
27312354	measured	C0444706
27312354	contraction	C0026820
27312354	tibialis anterior muscle	C0242690
27312354	in situ	C0444498
27312354	Absolute maximal isometric force	C0022205
27312354	increased	C0205217
27312354	KO(Lee)	C0206745
27312354	KO(Grobet) mice	C0206745
27312354	compared	C1707455
27312354	wild-type mice	C0026809
27312354	absolute maximal power	C0517349
27312354	increased	C0205217
27312354	KO(Lee) mice	C0206745
27312354	specific	C0205369
27312354	maximal force	C0517349
27312354	relative	C0205345
27312354	maximal force	C0517349
27312354	muscle	C0026845
27312354	mass	C0577559
27312354	decreased	C0205216
27312354	male	C0086582
27312354	female	C0086287
27312354	KO mice	C0206745
27312354	except	C0332300
27312354	6-month	C0439231
27312354	female	C0086287
27312354	KO(Grobet) mice	C0206745
27312354	specific	C0205369
27312354	maximal power	C2371225
27312354	reduced	C0392756
27312354	male	C0086582
27312354	KO(Lee) mice	C0206745
27312354	Genetic inactivation	C0598496
27312354	myostatin	C1333667
27312354	increases	C0442805
27312354	maximal force	C0517349
27312354	power	C2371225
27312354	return	C0332156
27312354	reduces	C0392756
27312354	muscle	C0026845
27312354	quality	C0332306
27312354	male	C0086582
27312354	mice	C0026809
27314612	Methylation	C0376452
27314612	status	C0449438
27314612	promoter region	C0033413
27314612	human	C0086418
27314612	frizzled 9 gene	C1333589
27314612	acute myeloid leukemia	C0023465
27314612	FZD9 gene	C1333589
27314612	chromosome 7q11.23	C4267768
27314612	tumor suppressor gene	C0079427
27314612	study	C2603343
27314612	examined	C0332128
27314612	involvement	C1314939
27314612	FZD9	C1333589
27314612	promoter	C0086860
27314612	methylation	C0376452
27314612	downregulation	C0013081
27314612	FZD9	C1333589
27314612	expression	C0017262
27314612	leukemia	C0023418
27314612	cells	C0007634
27314612	expression	C0017262
27314612	FZD9 gene	C1333589
27314612	absent	C0332197
27314612	leukemic	C0023418
27314612	cell lines	C0085983
27314612	treatment	C1522326
27314612	DNA demethylating agent	C0029224
27314612	5-aza-2'-deoxycytidine	C0029224
27314612	Bisulfite sequencing analysis	C3831347
27314612	FZD9	C1333589
27314612	promoter region	C0033413
27314612	methylated	C0376452
27314612	cell lines	C0085983
27314612	FZD9 gene	C1333589
27314612	expressed	C0017262
27314612	DNA methylation	C0025723
27314612	promoter region	C0033413
27314612	inactivation	C0544461
27314612	FZD9 gene	C1333589
27314612	associated with	C0332281
27314612	leukemia	C0023418
27314612	DNA	C0012854
27314612	methylated	C0376452
27314612	peripheral blood mononuclear cells	C1321301
27314612	Methylation	C0376452
27314612	polymerase chain reaction analysis	C0032520
27314612	promoter region	C0033413
27314612	FZD9 gene	C1333589
27314612	frequently	C0332183
27314612	methylated	C0376452
27314612	primary	C0205225
27314612	relapse	C0035020
27314612	acute myeloid leukemia	C0023465
27314612	acute promyelocytic leukemia	C0023487
27314612	methylation	C0376452
27314612	B-cell	C0004561
27314612	acute lymphocytic leukemia	C0023449
27314612	study	C2603343
27314612	methylation	C0376452
27314612	profile	C1979963
27314612	FZD9 gene	C1333589
27314612	tumor-suppressor gene	C0079427
27314612	acute myeloid leukemia	C0023465
27318197	Identification	C0205396
27318197	group	C0441833
27318197	XTHs	C1175650
27318197	genes	C0017337
27318197	heavy metal	C0347988
27318197	mercury	C0025424
27318197	salinity and drought stresses	C0871732
27318197	Medicago truncatula	C0330774
27318197	Xyloglucan endotransglucosylase/hydrolases	C1175650
27318197	XTH	C1175650
27318197	enzymes	C0014442
27318197	regulating	C1327622
27318197	cell wall construction	C1156159
27318197	extension	C0231448
27318197	metabolism	C3826603
27318197	study	C0008972
27318197	XTH protein	C1175650
27318197	genes	C0017337
27318197	Medicago truncatula	C0330774
27318197	genome	C0017428
27318197	bioinformatics	C1140694
27318197	microarray	C1709016
27318197	RT-PCR	C0599161
27318197	XTH	C1175650
27318197	highly conserved domain	C1514562
27318197	XTHs	C1175650
27318197	Cys	C0010654
27318197	C terminal region	C1514562
27318197	potential	C3245505
27318197	disulfide bonds	C1511997
27318197	XTH	C1175650
27318197	protein sequences	C0002518
27318197	XTHs	C1175650
27318197	families	C1335532
27318197	family	C1335532
27318197	groups	C0441833
27318197	genomic location	C1880951
27318197	XTH genes	C0017337
27318197	M. truncatula	C0330774
27318197	chromosomes	C0008633
27318197	evolutional expansion	C0282688
27318197	genes	C0017337
27318197	localized	C0392752
27318197	gene duplications	C0017261
27318197	involvement	C1314939
27318197	XTHs	C1175650
27318197	heavy metals	C0347988
27318197	abiotic stresses	C0871732
27318197	XTH genes	C0017337
27318197	heavy metal	C0347988
27318197	Hg	C0025424
27318197	Cu	C0009968
27318197	salt and drought stresses	C0871732
27318197	MtXTH genes	C0017337
27318197	HgCl2	C0025417
27318197	salt and drought stresses	C0871732
27318197	expression	C0017262
27318197	stresses	C0871732
27318197	XTH genes	C0017337
27318197	quantitative	C0392762
27318197	RT-PCR	C0599161
27318197	qRT-PCR	C0599161
27318197	specified	C0205369
27318197	expression	C0017262
27318197	XTH gene	C0017337
27318197	Medtr4g128580	C0017337
27318197	MtXTH3	C0017337
27318197	environmental stresses	C0871732
27318197	MtXTH3	C0017337
27318197	Hg	C0025424
27318197	exposure	C0332157
27318197	results	C1274040
27318197	group	C0441833
27318197	MtXTHs	C0017337
27318197	expressed	C1171362
27318197	environmental stresses	C0871732
27318553	Vestibular disorders	C0042594
27318553	nausea	C0027497
27318553	head	C0751177
27318553	neck	C0746787
27318553	intensity-modulated radiation therapy	C1512814
27318553	relationship	C0439849
27318553	nausea	C0027497
27318553	vestibular disorders	C0042594
27318553	patients	C0030705
27318553	treated with	C0332293
27318553	intensity modulated radiation therapy	C1512814
27318553	IMRT	C1512814
27318553	head	C0751177
27318553	neck cancer	C0746787
27318553	prospective single-centre study	C0033522
27318553	enrolled	C1516879
27318553	patients	C0030705
27318553	videonystagmography	C0087111
27318553	radiation therapy	C1522449
27318553	patient	C0030705
27318553	Nausea	C0027497
27318553	baseline	C1442488
27318553	post-radiotherapy	C1522449
27318553	videonystagmography	C0087111
27318553	patients	C0030705
27318553	videonystagmography	C0087111
27318553	patients	C0030705
27318553	vestibular damage	C0235928
27318553	diagnosed	C0011900
27318553	post-radiotherapy	C1522449
27318553	irradiation	C1282930
27318553	patients	C0030705
27318553	nauseous	C0027497
27318553	dizziness	C0012833
27318553	univariate analysis	C0683962
27318553	relationship	C0439849
27318553	statistically significant	C0237881
27318553	dose	C0178602
27318553	vestibules	C0042606
27318553	vestibular disorder	C0042594
27318553	videonystagmography	C0087111
27318553	odds ratio	C0028873
27318553	OR	C0028873
27318553	no	C1513916
27318553	relationship	C0439849
27318553	vestibular disorder	C0042594
27318553	videonystagmography	C0087111
27318553	nausea	C0027497
27318553	Irradiation	C1282930
27318553	vestibular system	C0682674
27318553	IMRT	C1512814
27318553	nausea	C0027497
27318951	Youth	C0087178
27318951	Internalizing Symptoms	C1398215
27318951	Familias Unidas	C0814781
27318951	Intervention	C0683495
27318951	Variation	C1705241
27318951	Response	C0521982
27318951	Prevention programs	C0679717
27318951	parenting	C0085092
27318951	family functioning	C0680051
27318951	reduce	C0441610
27318951	poor behavioral	C1398200
27318951	adolescents	C0205653
27318951	substance use	C0237123
27318951	HIV risk	C0744979
27318951	internalizing problems	C1398215
27318951	youth	C0087178
27318951	programs	C0679717
27318951	Familias Unidas	C0814781
27318951	family-focused intervention	C0683495
27318951	substance use	C0237123
27318951	sexual risk	C1563228
27318951	Hispanic	C0086409
27318951	youth	C0087178
27318951	reductions	C0441610
27318951	internalizing symptoms	C1398215
27318951	youth	C0087178
27318951	intervention	C0683495
27318951	internalizing symptoms	C1398215
27318951	individual-level data	C0814855
27318951	Familias Unidas	C0814781
27318951	trials	C1515364
27318951	eighth grade	C2135624
27318951	students	C0038492
27318951	school population	C0242445
27318951	ninth grade	C2135625
27318951	students	C0038492
27318951	school population	C0242445
27318951	adolescents	C0205653
27318951	conduct	C0149654
27318951	aggression	C0001807
27318951	attention problems	C3843050
27318951	adolescents	C0205653
27318951	delinquency	C0522174
27318951	Causal inference growth mixture modeling	C0814921
27318951	class	C0008902
27318951	model	C3161035
27318951	classes	C0008902
27318951	youth	C0087178
27318951	low	C0205251
27318951	medium	C0439536
27318951	internalizing symptoms	C1398215
27318951	baseline	C1442488
27318951	intervention	C0683495
27318951	control	C0009932
27318951	participants	C0679646
27318951	reductions	C0441610
27318951	internalizing symptoms	C1398215
27318951	class	C0008902
27318951	youth	C0087178
27318951	high	C0205250
27318951	levels	C0441889
27318951	baseline	C1442488
27318951	internalizing symptoms	C1398215
27318951	steady	C0205361
27318951	levels	C0441889
27318951	internalizing symptoms	C1398215
27318951	exposed to	C0332157
27318951	intervention	C0683495
27318951	symptoms	C1398215
27318951	control condition	C0243148
27318951	Female gender	C0086287
27318951	low	C0205251
27318951	baseline	C1442488
27318951	levels	C0441889
27318951	parent	C0030551
27318951	adolescent	C0205653
27318951	communication	C0009452
27318951	older age	C1999167
27318951	high-risk	C0332167
27318951	class	C0008902
27318951	youth	C0087178
27318951	initial risk levels	C3166291
27318951	preventive intervention	C0683495
27318951	response	C0521982
27318951	preventive interventions	C0683495
27319985	Acute Kidney Injury	C2609414
27319985	Severity	C0439793
27319985	Long-Term	C0443252
27319985	Readmission	C0030700
27319985	Mortality	C0205848
27319985	Cardiac Surgery	C0018821
27319985	Acute kidney injury	C2609414
27319985	AKI	C2609414
27319985	complication	C0009566
27319985	cardiac surgery	C0018821
27319985	AKI	C2609414
27319985	severity	C0439793
27319985	associated with	C0332281
27319985	risk	C0035647
27319985	short-term	C0443303
27319985	long-term	C0443252
27319985	patients	C0030705
27319985	coronary artery bypass graft surgery	C0010055
27319985	Northern New England biomarker registry	C0034975
27319985	Patients	C0030705
27319985	renal failure	C0035078
27319985	died	C1306577
27319985	index admission	C0030673
27319985	Severity	C0439793
27319985	AKI	C2609414
27319985	Acute Kidney Injury Network	C0008902
27319985	AKIN	C0008902
27319985	cohort	C0009247
27319985	national Medicare	C0596896
27319985	state all-payer claims	C0282574
27319985	readmissions	C0030700
27319985	National Death Index	C3889680
27319985	survival	C0220921
27319985	Kaplan-Meier	C1720943
27319985	multivariate Cox proportional hazards modeling	C0010235
27319985	readmission	C0030700
27319985	death	C1306577
27319985	patients	C0030705
27319985	AKI	C2609414
27319985	AKIN	C0008902
27319985	readmissions	C0030700
27319985	deaths	C1306577
27319985	AKI	C2609414
27319985	patients	C0030705
27319985	risk	C0035647
27319985	readmission	C0030700
27319985	confidence interval	C0009667
27319985	CI	C0009667
27319985	patients	C0030705
27319985	risk	C0035647
27319985	CI	C0009667
27319985	patients	C0030705
27319985	no	C1513916
27319985	AKI	C2609414
27319985	patients	C0030705
27319985	AKI	C2609414
27319985	patients	C0030705
27319985	risk	C0035647
27319985	mortality	C0205848
27319985	CI	C0009667
27319985	patients	C0030705
27319985	risk	C0035647
27319985	CI	C0009667
27319985	Severity	C0439793
27319985	AKI	C2609414
27319985	AKIN	C0008902
27319985	associated with	C0332281
27319985	risk	C0035647
27319985	readmission	C0030700
27319985	mortality	C0205848
27319985	AKI	C2609414
27319985	perioperative period	C2712230
27319985	long-term	C0443252
27319985	patients	C0030705
27319985	mortality	C0205848
27319985	health care utilization	C0030672
27321338	Association	C0439849
27321338	abdominal fat	C1563742
27321338	serum	C0229671
27321338	amylase	C0002712
27321338	older	C0001792
27321338	cohort	C0599755
27321338	Baltimore	C0004716
27321338	Longitudinal Study	C0023981
27321338	Aging	C0001811
27321338	Abdominal fat	C1563742
27321338	determinant	C1521761
27321338	metabolic diseases	C0025517
27321338	older	C0001792
27321338	individuals	C0237401
27321338	Obesity	C0028754
27321338	diabetes	C0011847
27321338	associated with	C0332281
27321338	low	C0205251
27321338	serum amylase (SA) levels	C0729348
27321338	association	C0439849
27321338	SA	C0729348
27321338	metabolic disease	C0025517
27321338	investigated	C1292732
27321338	association	C0439849
27321338	low	C0205251
27321338	SA	C0729348
27321338	diabetes	C0011847
27321338	sex	C1522384
27321338	specific	C0205369
27321338	associations	C0439849
27321338	serum	C0229671
27321338	amylase	C0002712
27321338	abdominal fat	C1563742
27321338	older adults	C0001675
27321338	community-dwelling	C4045975
27321338	volunteers	C0020155
27321338	Baltimore	C0004716
27321338	Longitudinal Study	C0023981
27321338	Aging	C0001811
27321338	participants	C0679646
27321338	age	C0001779
27321338	years	C0439234
27321338	assessed	C1516048
27321338	abdominal fat	C1563742
27321338	computed tomography	C0040405
27321338	diabetes status	C1317301
27321338	American Diabetes Association	C1705019
27321338	criteria	C0243161
27321338	Linear regression analyses	C0023733
27321338	assessed	C1516048
27321338	cross-sectional associations	C0439849
27321338	abdominal fat	C1563742
27321338	SA	C0729348
27321338	logistic regression	C0206031
27321338	assessed	C1516048
27321338	odds	C0028873
27321338	diabetes	C0011847
27321338	low	C0205251
27321338	SA	C0729348
27321338	unadjusted analyses	C0936012
27321338	individuals	C0237401
27321338	lowest	C0205251
27321338	SA	C0729348
27321338	quartile	C2828255
27321338	odds	C0028873
27321338	diabetes	C0011847
27321338	CI	C0009667
27321338	quartile	C2828255
27321338	association	C0439849
27321338	significant	C0750502
27321338	visceral adipose tissue area	C1563740
27321338	VAT	C1563740
27321338	abdominal subcutaneous adipose tissue	C1563741
27321338	SAT	C1563741
27321338	BMI	C1305855
27321338	adjusted analyses	C0936012
27321338	VAT	C1563740
27321338	SAT	C1563741
27321338	significantly	C0750502
27321338	associated with	C0332281
27321338	SA	C0729348
27321338	sexes	C1522384
27321338	women	C0043210
27321338	SA	C0729348
27321338	associated with	C0332281
27321338	VAT	C1563740
27321338	SAT	C1563741
27321338	BMI	C1305855
27321338	VAT	C1563740
27321338	SAT	C1563741
27321338	BMI	C1305855
27321338	association	C0439849
27321338	SA	C0002712
27321338	diabetes	C0011847
27321338	abdominal visceral fat	C1563740
27321338	women	C0043210
27321338	SA	C0002712
27321338	associated with	C0332281
27321338	VAT	C1563740
27321338	BMI	C1305855
27321338	SAT	C1563741
27321338	mechanistic studies	C2698671
27321338	SA's	C0002712
27321338	metabolic diseases	C0025517
27321568	Efficacy	C1280519
27321568	Intravenous	C0348016
27321568	Chlorothiazide	C0008273
27321568	Refractory	C0205269
27321568	Acute Decompensated Heart Failure	C1609524
27321568	Unresponsive	C0205269
27321568	Adjunct	C1719882
27321568	Metolazone	C0025854
27321568	efficacy	C1280519
27321568	intravenous	C0348016
27321568	chlorothiazide	C0008273
27321568	patients	C0030705
27321568	acute decompensated heart failure	C1609524
27321568	ADHF	C1609524
27321568	loop diuretic	C0354100
27321568	resistant	C0332325
27321568	refractory	C0205269
27321568	metolazone	C0025854
27321568	Retrospective cohort study	C2985505
27321568	patients	C0030705
27321568	controls	C0009932
27321568	Large	C0549177
27321568	academic	C1510747
27321568	tertiary care hospital	C0337954
27321568	patients	C0030705
27321568	ADHF	C1609524
27321568	inadequate	C0205412
27321568	response	C0871261
27321568	high-dose	C0444956
27321568	loop diuretics	C0354100
27321568	dose	C0178602
27321568	oral	C0442027
27321568	metolazone	C0025854
27321568	greater	C1704243
27321568	metolazone	C0025854
27321568	index dose	C0178602
27321568	dose	C0178602
27321568	intravenous	C0348016
27321568	chlorothiazide	C0008273
27321568	chlorothiazide	C0008273
27321568	index dose	C0178602
27321568	metolazone	C0025854
27321568	inadequate	C0205412
27321568	institutional protocol	C0442711
27321568	doses	C0178602
27321568	metolazone	C0025854
27321568	administered	C0806914
27321568	dose	C0178602
27321568	chlorothiazide	C0008273
27321568	index dose	C0178602
27321568	index dose	C0178602
27321568	metolazone	C0025854
27321568	index dose	C0178602
27321568	administered	C0806914
27321568	hours	C0439227
27321568	chlorothiazide	C0008273
27321568	index dose	C0178602
27321568	Data	C1511726
27321568	diuretic	C0354100
27321568	doses	C0178602
27321568	metolazone	C0025854
27321568	chlorothiazide	C0008273
27321568	analysis	C0936012
27321568	dose	C0178602
27321568	loop diuretic	C0354100
27321568	intravenous	C0348016
27321568	furosemide	C0016860
27321568	hour	C0439227
27321568	period	C1948053
27321568	metolazone	C0025854
27321568	index dose	C0178602
27321568	stay	C3489408
27321568	days	C0439228
27321568	in-hospital mortality	C0085556
27321568	patients	C0030705
27321568	end point	C2349179
27321568	net-negative	C0205160
27321568	urine output	C0232856
27321568	hours	C0439227
27321568	index dose	C0178602
27321568	patients	C0030705
27321568	patients	C0030705
27321568	chlorothiazide	C0008273
27321568	metolazone	C0025854
27321568	doses	C0178602
27321568	hour	C0439227
27321568	urine output	C0232856
27321568	administration	C0001555
27321568	metolazone	C0025854
27321568	interquartile range	C1711350
27321568	IQR	C1711350
27321568	IQR	C1711350
27321568	administration	C0001555
27321568	chlorothiazide	C0008273
27321568	Compared	C1707455
27321568	metolazone	C0025854
27321568	chlorothiazide	C0008273
27321568	doses	C0178602
27321568	increase	C0442805
27321568	urine output	C0232856
27321568	hours	C0439227
27321568	dose	C0178602
27321568	hours	C0439227
27321568	dose	C0178602
27321568	net-negative	C0205160
27321568	urine output	C0232856
27321568	hours	C0439227
27321568	chlorothiazide	C0008273
27321568	metolazone	C0025854
27321568	dose	C0178602
27321568	chlorothiazide	C0008273
27321568	metolazone	C0025854
27321568	intravenous	C0348016
27321568	chlorothiazide	C0008273
27321568	improved	C0184511
27321568	diuresis	C0012797
27321568	patients	C0030705
27321568	ADHF	C1609524
27321568	refractory	C0205269
27321568	loop diuretic	C0354100
27321568	adjunctive	C1719882
27321568	oral	C0442027
27321568	metolazone	C0025854
27322653	Comparisons	C1707455
27322653	Safety	C0036043
27322653	Clinical	C0205210
27322653	Outcomes	C1274040
27322653	Multiple-level	C0035139
27322653	Single-level Cervical Disk Replacement	C0035139
27322653	Cervical Spondylosis	C1384641
27322653	Systematic Review	C1955832
27322653	Meta-analysis	C0282458
27322653	systematic review	C1955832
27322653	meta-analysis	C0282458
27322653	study	C2603343
27322653	evaluate	C1292732
27322653	efficacy	C1280519
27322653	safety	C0036043
27322653	multiple-level cervical disk replacement	C0035139
27322653	CDR	C0035139
27322653	single-level CDR	C0035139
27322653	treatment	C0087111
27322653	cervical spondylosis	C1384641
27322653	multiple-level CDR	C0035139
27322653	anterior	C0205094
27322653	decompression	C1829459
27322653	fusion	C1293131
27322653	cervical multiple-level spondylosis	C1384641
27322653	efficacy	C1280519
27322653	safety	C0036043
27322653	multi-level CDR	C0035139
27322653	single-level CDR	C0035139
27322653	MEDLINE	C0025141
27322653	EMBASE	C0242356
27322653	Cochrane library databases	C0242356
27322653	controlled studies	C0681867
27322653	compared	C1707455
27322653	clinical	C0205210
27322653	outcomes	C1274040
27322653	single-level	C0035139
27322653	multiple-level CDR	C0035139
27322653	treatment	C0087111
27322653	cervical spondylosis	C1384641
27322653	outcomes	C1274040
27322653	analyzed	C0936012
27322653	prevalence	C0033105
27322653	heterotopic ossification	C0029396
27322653	reoperation	C0035110
27322653	preoperative	C0445204
27322653	postoperative	C0032790
27322653	Neck Disability Index scores	C2959538
27322653	preoperative	C0445204
27322653	postoperative	C0032790
27322653	Visual Analog Scale scores	C2960751
27322653	success	C0679864
27322653	rate	C1521828
27322653	Odom grading system	C0008902
27322653	studies	C2603343
27322653	patients	C0030705
27322653	randomized controlled trials	C0206035
27322653	prospective studies	C0033522
27322653	retrospective studies	C0035363
27322653	single-level	C0035139
27322653	multiple-level	C0035139
27322653	prevalence	C0033105
27322653	heterotopic ossification	C0029396
27322653	reoperation	C0035110
27322653	rate	C1521828
27322653	Neck Disability Index score	C2959538
27322653	Visual Analog Scale score	C2960751
27322653	success	C0679864
27322653	rate	C1521828
27322653	Odom grading system	C0008902
27322653	meta-analysis	C0282458
27322653	clinical	C0205210
27322653	outcomes	C1274040
27322653	multiple-level CDR	C0035139
27322653	single-level CDR	C0035139
27322653	cervical spondylosis	C1384641
27322653	multiple-level CDR	C0035139
27322653	effective	C1704419
27322653	safe	C0036043
27322653	single-level CDR	C0035139
27322653	studies	C2603343
27322653	evaluation	C0015195
27330692	Evaluation	C0220825
27330692	Effects of	C1704420
27330692	Intravenous	C0348016
27330692	Percutaneous	C0522523
27330692	Low Level Laser Therapy	C0279027
27330692	Management	C0002766
27330692	Shoulder	C0037004
27330692	Myofascial Pain Syndrome	C0027073
27330692	Myofascial pain syndrome	C0027073
27330692	MPS	C0027073
27330692	treatment	C0087111
27330692	treatment frame	C0087111
27330692	efficient	C0442799
27330692	treatment	C0087111
27330692	modalities	C0695347
27330692	effects of	C1704420
27330692	intravenous	C0348016
27330692	laser therapy	C1955835
27330692	IVL	C1955835
27330692	percutaneous	C0522523
27330692	low level laser	C0279027
27330692	PLLL	C0279027
27330692	management	C0002766
27330692	shoulder	C0037004
27330692	MPS	C0027073
27330692	randomized controlled trial	C0206035
27330692	patients	C0030705
27330692	inclusion criteria	C1512693
27330692	control	C0009932
27330692	IVL	C1257890
27330692	PLLL	C1257890
27330692	Control group	C0009932
27330692	placebo	C1706408
27330692	low level laser	C0279027
27330692	IVL group	C1257890
27330692	IVL therapy	C1955835
27330692	PLLL group	C1257890
27330692	PLLL therapy	C0279027
27330692	patients	C0030705
27330692	better	C0332272
27330692	body posture	C1262869
27330692	body mechanics	C0598002
27330692	gentle massage	C0150347
27330692	trigger points	C0458343
27330692	stretching exercises	C0600080
27330692	affected	C0392760
27330692	muscle	C0026845
27330692	trapezius	C0224361
27330692	oral	C0442027
27330692	nortriptyline	C0028420
27330692	regimen	C0040808
27330692	pain severity	C1507013
27330692	functional disability	C0872173
27330692	quality of life	C0034380
27330692	Patients	C0030705
27330692	Numeric Rating Scale	C4050142
27330692	NRS	C4050142
27330692	Pain Disability Index	C0282574
27330692	PDI	C0282574
27330692	Short Form Health Survey	C0451286
27330692	SF-12	C1519135
27330692	Data collected	C4019276
27330692	analyzed	C0936012
27330692	analysis of variance	C0002780
27330692	ANOVA	C0002780
27330692	Mann-Whitney	C1708930
27330692	t tests	C0871472
27330692	PDI	C0282574
27330692	pain intensity	C1320357
27330692	reduced	C0392756
27330692	PLLL	C1257890
27330692	IVL groups	C1257890
27330692	control group	C0009932
27330692	PDI	C0282574
27330692	IVL group	C1257890
27330692	PLLL group	C1257890
27330692	statistically significant	C0237881
27330692	quality of life	C0034380
27330692	statistically significantly	C0237881
27330692	IVL	C1257890
27330692	PLLL groups	C1257890
27330692	control group	C0009932
27330692	IVL group	C1257890
27330692	statistically significant	C0237881
27330692	PLLL group	C1257890
27330692	No side effects	C1963761
27330692	intervention groups	C2986530
27330692	Intravenous	C0348016
27330692	laser	C1955835
27330692	PLLL therapy	C0279027
27330692	effect	C1280500
27330692	pain severity	C1507013
27330692	PDI	C0282574
27330692	quality of life	C0034380
27330692	no adverse event	C1963761
27330692	intravenous	C0348016
27330692	lasers	C1955835
27330692	PLLL therapy	C0279027
27330692	effective	C1704419
27330692	modalities	C0695347
27330692	managing	C0002766
27330692	patients	C0030705
27330692	shoulder	C0037004
27330692	MPS	C0027073
27331407	Structural	C0678594
27331407	Insights	C0233820
27331407	5-HT1A	C0379900
27331407	D4	C0114835
27331407	Selectivity	C1510827
27331407	WAY-100635	C0290799
27331407	Analogues	C0243071
27331407	Molecular Modeling	C0600115
27331407	Synthesis	C1883254
27331407	in Vitro	C1533691
27331407	Binding	C1167622
27331407	5-HT1A receptors	C0379900
27331407	therapeutic	C0302350
27331407	target	C1521840
27331407	selective	C0205556
27331407	5-HT1A	C0379900
27331407	ligands	C0023688
27331407	WAY-100635	C0290799
27331407	prototypical antagonist	C0243076
27331407	receptors	C0597357
27331407	compound	C0205198
27331407	affinity	C0683185
27331407	D4 dopamine receptors	C0114835
27331407	5-HT1A	C0379900
27331407	D4	C0114835
27331407	selectivity	C1510827
27331407	WAY-100635	C0290799
27331407	analogues	C0243071
27331407	structural	C0678594
27331407	In silico	C3489666
27331407	investigations	C1292732
27331407	interactions	C1704675
27331407	5-HT1A	C0379900
27331407	D4	C0114835
27331407	selectivity	C1510827
27331407	WAY-100635	C0290799
27331407	analogues	C0243071
27331407	hydrogen bond	C0020276
27331407	Ser 7.36	C0036720
27331407	D4 receptor	C0114835
27331407	D4	C0114835
27331407	affinity	C0683185
27331407	synthesized	C1883254
27331407	aza	C0004471
27331407	analogues	C0243071
27331407	Ser 7.36	C0036720
27331407	affinity	C0683185
27331407	aza	C0004471
27331407	analogues	C0243071
27331407	mutant	C0596988
27331407	D4 receptor S7.36A	C0114835
27331407	hydrogen bond	C0020276
27331407	Ser 5.42 residue	C0036720
27331407	D4	C0114835
27331407	binding	C1167622
27334470	Genomic analysis	C3854164
27334470	nontypeable pneumococci	C0038410
27334470	invasive pneumococcal disease	C1320214
27334470	South Africa	C0037712
27334470	capsular polysaccharide	C1979807
27334470	virulence factor	C1136170
27334470	Streptococcus pneumoniae	C0038410
27334470	target	C1521840
27334470	pneumococcal vaccines	C0358314
27334470	pathogenic	C3816499
27334470	pneumococci	C0038410
27334470	serologically nontypeable	C0449943
27334470	nontypeable pneumococci	C0038410
27334470	NTPn	C0038410
27334470	rarity	C0522498
27334470	NTPn	C0038410
27334470	characterized	C1880022
27334470	data	C1511726
27334470	organisms	C0029235
27334470	disease	C0012634
27334470	genotypically	C0017431
27334470	characterize	C1880022
27334470	NTPn	C0038410
27334470	invasive pneumococcal disease	C1320214
27334470	South Africa	C0037712
27334470	Isolates	C1764827
27334470	laboratory	C0022877
27334470	based	C1705938
27334470	surveillance	C0220920
27334470	invasive pneumococcal disease	C1320214
27334470	South Africa	C0037712
27334470	characterized	C1880022
27334470	genome analysis	C3854164
27334470	ancestral	C0439660
27334470	serotypes	C0449943
27334470	serotypes	C0449943
27334470	NTPn	C0038410
27334470	Group I	C0441833
27334470	NTPn	C0038410
27334470	multilocus sequence typing	C2936544
27334470	capsular region	C1254362
27334470	sequence analyses	C0162801
27334470	Antimicrobial resistance	C1456627
27334470	patterns	C0449774
27334470	mutations	C0026882
27334470	potentially	C3245505
27334470	nontypeability	C0449943
27334470	identified	C0205396
27334470	NTPn	C0038410
27334470	Twenty-two	C4284772
27334470	partial	C0728938
27334470	capsular genes	C0017337
27334470	Group I	C0441833
27334470	complete	C0205197
27334470	capsular deletion	C0017260
27334470	replacement	C0559956
27334470	genes	C0017337
27334470	Group II	C0441833
27334470	Seventy-nine	C3828184
27334470	percent	C0439165
27334470	NTPn	C0038410
27334470	isolates	C1764827
27334470	encapsulated	C0205223
27334470	S. pneumoniae	C0038410
27334470	serotypes	C0449943
27334470	ancestral	C0439660
27334470	serotypes	C0449943
27334470	serotypes	C0449943
27334470	13-valent pneumococcal conjugate vaccine	C3152625
27334470	mutations	C0026882
27334470	capsular region	C1254362
27334470	Group I	C0441833
27334470	NTPn	C0038410
27334470	nontypeable	C0449943
27334470	phenotype	C0031437
27334470	Nonsusceptibility	C2827756
27334470	tetracycline	C0039644
27334470	erythromycin	C0014806
27334470	NTPn	C0038410
27334470	encapsulated	C0205223
27334470	S. pneumoniae	C0038410
27334470	NTPn	C0038410
27334470	invasive pneumococcal disease	C1320214
27334470	South Africa	C0037712
27334522	Pre-hypertension	C1696708
27334522	pre-diabetes	C0362046
27334522	predicting	C0681842
27334522	cardiovascular events	C1320716
27334522	long term	C0443252
27334522	study	C2603343
27334522	pre-diabetes	C0362046
27334522	pre-hypertension	C1696708
27334522	predicting	C0681842
27334522	cardiovascular events	C1320716
27334522	population	C0032659
27334522	cross-sectional survey	C0010362
27334522	Iranian	C1553355
27334522	population	C0683971
27334522	years	C0439234
27334522	Isfahan Province	C0017446
27334522	random, multistage cluster-sampling	C2347298
27334522	cohort	C0599755
27334522	study outcome	C2985619
27334522	unstable angina	C0002965
27334522	UA	C0002965
27334522	acute	C0205178
27334522	occurrence	C2745955
27334522	myocardial infarction	C0027051
27334522	MI	C0027051
27334522	sudden cardiac death	C0085298
27334522	SCD	C0085298
27334522	brain stroke	C3844825
27334522	cardiovascular disease	C0007222
27334522	CVD	C0007222
27334522	assessment	C0220825
27334522	diabetes state	C0011849
27334522	diabetics	C0241863
27334522	pre-diabetic	C0243095
27334522	hypertension	C0020538
27334522	pre-hypertension	C1696708
27334522	pre-hypertension	C1696708
27334522	pre-diabetes	C0362046
27334522	gender	C0079399
27334522	pre-hypertension	C1696708
27334522	pre-diabetes	C0362046
27334522	occurrence	C2745955
27334522	MI	C0027051
27334522	hazard ratio	C2985465
27334522	HR	C2985465
27334522	confidence interval	C0009667
27334522	CI	C0009667
27334522	COX regression models	C3161035
27334522	pre-hypertension	C1696708
27334522	UA	C0002965
27334522	CVD	C0007222
27334522	occurrence	C2745955
27334522	HR	C2985465
27334522	CI	C0009667
27334522	HR	C2985465
27334522	CI	C0009667
27334522	pre-diabetes	C0362046
27334522	gender	C0079399
27334522	age	C0001779
27334522	data	C1511726
27334522	evidence	C3887511
27334522	pre-hypertension	C1696708
27334522	pre-diabetes	C0362046
27334522	appearance	C0700364
27334522	progression	C0242656
27334522	MI	C0027051
27334522	healthy individuals	C1708335
27334522	predicting	C0681842
27334522	pre-hypertension	C1696708
27334522	occurrence	C2745955
27334522	UA	C0002965
27334522	CVD	C0007222
27334522	pre-hypertension	C1696708
27334522	pre-diabetes	C0362046
27334522	pre-hypertension	C1696708
27334522	pre-diabetes	C0362046
27334522	predicting	C0681842
27334522	cardiovascular events	C1320716
27336997	Strategies	C0683852
27336997	Successful	C1272703
27336997	Clinical	C0205210
27336997	Teaching	C0220924
27336997	article	C1706852
27336997	roles	C1705810
27336997	adjunct clinical faculty	C0015538
27336997	preceptors	C0221457
27336997	teach	C0039401
27336997	nursing students	C0038496
27336997	new	C0205314
27336997	graduates	C0588053
27336997	apply	C4048755
27336997	knowledge	C0376554
27336997	clinical settings	C3176918
27336997	article	C1706852
27336997	teaching strategies	C0683852
27336997	learning environment	C1510556
27337390	Learned helplessness	C0018897
27337390	Insights	C0233820
27337390	neuroscience	C0027910
27337390	Learned helplessness	C0018897
27337390	failure	C0231174
27337390	escape	C0870509
27337390	shock	C0036974
27337390	induced	C0205263
27337390	aversive events	C1510994
27337390	Seligman and Maier	C0086418
27337390	theorized	C0871935
27337390	animals	C0003062
27337390	learned	C0023185
27337390	outcomes	C1274040
27337390	independent of	C0332291
27337390	responses	C0871261
27337390	learning	C0023185
27337390	escape	C0870509
27337390	learned helplessness	C0018897
27337390	well-charted biologically	C0205460
27337390	theory	C0871935
27337390	Passivity	C0679170
27337390	response	C0871261
27337390	shock	C0036974
27337390	learned	C0023185
27337390	response	C0871261
27337390	prolonged	C0439590
27337390	aversive events	C1510994
27337390	serotonergic activity	C1148560
27337390	dorsal raphe nucleus	C0175392
27337390	inhibits	C3463820
27337390	escape	C0870509
27337390	passivity	C0679170
27337390	learning	C0023185
27337390	control	C0243148
27337390	medial prefrontal cortex	C3498368
27337390	detection	C0442726
27337390	control	C0243148
27337390	automatic	C0205554
27337390	inhibition	C3463820
27337390	dorsal raphe nucleus	C0175392
27337390	animals	C0003062
27337390	learn	C0023185
27337390	control	C0243148
27337390	aversive events	C1510994
27337390	passive	C3686820
27337390	failure	C0231174
27337390	learn	C0023185
27337390	escape	C0870509
27337390	reaction	C0443286
27337390	prolonged	C0439590
27337390	aversive stimulation	C0870183
27337390	alterations	C1515926
27337390	ventromedial prefrontal cortex	C3850122
27337390	dorsal raphe	C0175392
27337390	pathway	C1705987
27337390	expectation	C0679138
27337390	control	C0243148
27337390	passivity	C0679170
27337390	compensating	C0205432
27337390	detection	C0442726
27337390	expectation	C0679138
27337390	control	C0243148
27337390	treat	C1292734
27337390	depression	C0011570
27339305	peptide	C0030956
27339305	human β thymosin	C1999611
27339305	anti-biofilm	C3548526
27339305	anti-biofilm agents	C1254351
27339305	Staphylococcus spp.	C4275190
27339305	Pseudomonas aeruginosa	C0033809
27339305	antibiotics	C0003232
27339305	biofilm	C0081786
27339305	infections	C3714514
27339305	infection	C3714514
27339305	recurrence	C2825055
27339305	chronicity	C0547045
27339305	antimicrobial peptides	C4084937
27339305	discover	C1880355
27339305	anti-infective agents	C0003204
27339305	active	C0205177
27339305	pathogens	C0450254
27339305	planktonic	C0032071
27339305	biofilm	C0081786
27339305	fragment	C1335533
27339305	human thymosin β4	C1999611
27339305	studied	C2603343
27339305	MD simulation	C2717775
27339305	conformations of the peptide	C1518960
27339305	central hydrophobic core	C0205099
27339305	peripheral	C0205100
27339305	residues	C1709915
27339305	interaction	C1704675
27339305	models	C3161035
27339305	biological membranes	C0682529
27339305	eukaryotic	C0684063
27339305	bacterial membrane	C0682529
27339305	peptide	C0030956
27339305	antimicrobial activity	C1271650
27339305	in vitro	C0681828
27339305	planktonic	C0032071
27339305	biofilm	C0081786
27339305	group	C0441833
27339305	strains	C1518614
27339305	Staphylococcus spp.	C4275190
27339305	P. aeruginosa	C0033809
27339305	strain	C1518614
27339305	human thymosin β4	C1999611
27339305	fragment	C1335533
27339305	EIEKFDKSKLK	C0002518
27339305	antibacterial activity	C1149575
27339305	staphylococcal	C0038170
27339305	strains	C1518614
27339305	Pseudomonas aeruginosa	C0033809
27339305	concentrations	C0560150
27339305	biofilm formation	C1325881
27339305	sub-inhibitory concentrations	C0600495
27339305	activity	C0441655
27339305	fragment	C1335533
27339305	biofilm formation	C1325881
27339305	conformations	C1518960
27339305	MD simulations	C2717775
27339305	interaction	C1704675
27339305	bacterial membrane	C0682529
27339305	Human thymosin β4	C1999611
27339305	fragment	C1335533
27339305	lead compound	C1254351
27339305	recombinant derivatives	C0034861
27339305	pharmaceutical	C0008003
27339893	Structural	C0678594
27339893	Basis	C1527178
27339893	Simvastatin	C0074554
27339893	Competitive Antagonism	C0013159
27339893	Complement Receptor 3	C0079785
27339893	complement system	C0009498
27339893	innate immune response	C0020969
27339893	infection	C0009450
27339893	severe complications	C3495031
27339893	inflammation	C0021368
27339893	Small molecule	C1328819
27339893	antagonists	C0243076
27339893	complement receptor 3	C0079785
27339893	CR3	C0079785
27339893	structural	C0678594
27339893	basis	C1527178
27339893	mode of action	C1524059
27339893	report	C0684224
27339893	structure	C0678594
27339893	human	C0086418
27339893	CR3	C0079785
27339893	ligand-binding I domain	C0682969
27339893	complex	C1704241
27339893	simvastatin	C0074554
27339893	Simvastatin	C0074554
27339893	targets	C1521840
27339893	metal	C0025552
27339893	ion-dependent	C0205556
27339893	adhesion site	C1254362
27339893	ligand-binding	C1517880
27339893	conformation	C0026377
27339893	CR3	C0079785
27339893	I domain	C1514562
27339893	contact with	C0332158
27339893	chelated Mg(2+) ion	C0719248
27339893	Simvastatin	C0074554
27339893	antagonizes	C0243095
27339893	I domain binding	C0682969
27339893	complement fragments	C0009498
27339893	iC3b	C0369029
27339893	C3d	C0056184
27339893	intercellular adhesion molecule-1	C0063695
27339893	virtue	C0042764
27339893	I domain's	C1514562
27339893	distribution	C0037775
27339893	binding kinetics	C0031327
27339893	ligands	C0023688
27339893	possible	C0332149
27339893	ligand binding	C1517880
27339893	kinetics	C0031327
27339893	simvastatin	C0074554
27339893	antagonism	C0013159
27339893	static	C0441463
27339893	cellular	C0178539
27339893	experiments	C0681814
27339893	simvastatin	C0074554
27339893	reduced	C0392756
27339893	adhesion	C3714578
27339893	K562 cells	C0600432
27339893	expressing	C0597360
27339893	recombinant	C1514798
27339893	CR3	C0079785
27339893	primary	C0205225
27339893	human	C0086418
27339893	monocytes	C0026473
27339893	endogenous	C0205227
27339893	expression	C0597360
27339893	receptor	C0597357
27339893	Application	C0185125
27339893	force	C0441722
27339893	adhering	C3714578
27339893	monocytes	C0026473
27339893	effects of	C1704420
27339893	simvastatin	C0074554
27339893	concentration	C1446561
27339893	drug	C1254351
27339893	reduced	C0392756
27339893	adhesion	C3714578
27339893	compared	C1707455
27339893	untreated	C0205556
27339893	cells	C0007634
27339893	ability	C0085732
27339893	simvastatin	C0074554
27339893	target	C1521840
27339893	CR3	C0079785
27339893	ligand binding	C1517880
27339893	activated	C1879547
27339893	conformation	C0026377
27339893	novel	C0205314
27339893	mechanism	C0678659
27339893	anti-inflammatory effects	C1515999
27339893	compound	C1706082
27339893	CR3	C0079785
27339893	conformation	C0026377
27339893	pro-inflammatory	C0205556
27339893	environments	C0014406
27339893	report	C0684224
27339893	designs	C0013171
27339893	CR3	C0079785
27339893	antagonists	C0243076
27339893	identifies	C0243095
27339893	druggable	C0205556
27339893	receptors	C0597357
27339893	characterization	C1880022
27339893	ligand binding	C1517880
27339893	kinetics	C0031327
27339893	presence	C3854307
27339893	antagonists	C0243076
27346336	Common	C0205214
27346336	Laboratory	C0022877
27346336	Parameters	C0449381
27346336	Differentiating	C2945687
27346336	Community-Acquired	C0694549
27346336	Healthcare-Associated Pneumonia	C1443237
27346336	correct	C2349182
27346336	diagnosis	C0011900
27346336	healthcare-associated pneumonia	C1443237
27346336	HCAP	C1443237
27346336	community-acquired pneumonia	C0694549
27346336	essential	C0205224
27346336	selection	C1707391
27346336	correct	C2349182
27346336	empirical	C1880496
27346336	antimicrobial	C1136254
27346336	broad-spectrum	C2827424
27346336	highly potent	C3245505
27346336	antimicrobial therapies	C0087111
27346336	resistant	C0332325
27346336	strains	C1518614
27346336	HCAP	C1443237
27346336	treating	C1522326
27346336	resistant	C0332325
27346336	strains	C1518614
27346336	associated with	C0332281
27346336	community	C0009462
27346336	long-term care facility	C1708733
27346336	acquired infections	C3714514
27346336	targeted	C1521840
27346336	empirical approach	C0871728
27346336	standard approach	C0205556
27346336	today	C0750526
27346336	differentiate	C2945687
27346336	medical history	C0262926
27346336	past	C1444699
27346336	days	C0439228
27346336	admission	C0184666
27346336	Measurable	C1513040
27346336	quantitative	C0392762
27346336	assessment	C0220825
27346336	assist	C1269765
27346336	decision	C0679006
27346336	measurable	C1513040
27346336	method	C0025663
27346336	differentiating	C2945687
27346336	community-acquired	C0694549
27346336	healthcare-associated pneumonias	C1443237
27346336	records	C0034869
27346336	patients	C0030705
27346336	admitted	C0184666
27346336	diagnosis	C0011900
27346336	pneumonia	C0032285
27346336	groups	C0441833
27346336	cause of their disease	C0679232
27346336	common practice	C0237607
27346336	routine	C0205547
27346336	laboratory work	C0022885
27346336	admittance	C0184666
27346336	analyzed	C0936012
27346336	logistical regression	C0206031
27346336	Student's t-test	C0871453
27346336	red blood cell distribution width	C0427460
27346336	neutrophil	C0027950
27346336	neutrophil -to- lymphocyte ratio	C0456603
27346336	lymphocyte	C0024264
27346336	routine parameters	C0449381
27346336	blood count	C0005771
27346336	assist	C1269765
27346336	differentiating	C2945687
27346336	community-acquired	C0694549
27346336	healthcare-associated pneumonias	C1443237
27346336	statistically significant parameters	C0871428
27346336	medical history	C0262926
27346336	chest radiography	C0039985
27346336	other parameters	C0449381
27346336	immediate	C0205253
27346336	clinical impression	C2973287
27346336	patient	C0030705
27346336	pneumonia	C0032285
27347792	quasi-experimental study	C0681814
27347792	reminiscence program	C0150321
27347792	autobiographical memory	C0561843
27347792	older adults	C0001792
27347792	cognitive impairment	C0338656
27347792	past memories	C0233793
27347792	reminiscence interventions	C0150321
27347792	several decades	C2981279
27347792	outcomes	C1274040
27347792	mental health	C0025353
27347792	older adults	C0001792
27347792	studies	C2603343
27347792	autobiographical memory	C0561843
27347792	recall	C0034770
27347792	older individuals	C3826770
27347792	cognitive impairment	C0338656
27347792	study	C2603343
27347792	individual	C0237401
27347792	reminiscence program	C0150321
27347792	older persons	C3826770
27347792	cognitive decline	C0234985
27347792	nursing homes	C0028688
27347792	cognition	C0009240
27347792	autobiographical memory	C0561843
27347792	mood	C0026516
27347792	behavior	C0004927
27347792	anxiety	C0003469
27347792	pre-test and post-test design	C0032919
27347792	single blinded assessment	C0220825
27347792	participants	C0679646
27347792	experimental group	C1257890
27347792	control group	C0009932
27347792	individual	C0237401
27347792	reminiscence	C0871247
27347792	sessions	C1883016
27347792	outcome measures	C0086749
27347792	examined	C0332128
27347792	cognition	C0009240
27347792	Montreal Cognitive Assessment	C3496286
27347792	Autobiographical Memory Test	C0392366
27347792	behavior	C0004927
27347792	Alzheimer Disease Assessment Subscale Non-Cog	C0450989
27347792	emotional status	C0243095
27347792	Cornell Scale for Depression	C0679604
27347792	Dementia	C0497327
27347792	Geriatric Depression Scale	C0451184
27347792	Geriatric Anxiety Inventory	C0282574
27347792	Participants	C0679646
27347792	reminiscence sessions	C1883016
27347792	outcomes	C1274040
27347792	control group	C0009932
27347792	cognition	C0009240
27347792	anxiety	C0003469
27347792	depression	C0011570
27347792	retrieved	C0034770
27347792	autobiographical events	C0441471
27347792	memories	C0025260
27347792	events	C0441471
27347792	recalling	C0034770
27347792	events	C0441471
27347792	recalled	C0034770
27347792	events	C0441471
27347792	reminiscence therapy	C0150321
27347792	recall	C0034770
27347792	autobiographical memory	C0561843
27347792	Reminiscence therapy	C0150321
27347792	cognitive function	C0392335
27347792	anxiety	C0003469
27347792	depressive symptoms	C0086132
27347792	altered behavior	C0542299
27348285	Economic Burden	C1512163
27348285	Illness	C0221423
27348285	Patients	C0030705
27348285	Severe Asthma	C0581126
27348285	Care Setting	C4034203
27348285	pharmacotherapy	C0013216
27348285	number	C0237753
27348285	patients	C0030705
27348285	severe asthma	C0581126
27348285	inadequate	C0205412
27348285	disease	C0012634
27348285	control	C0243148
27348285	Patients	C0030705
27348285	severe asthma	C0581126
27348285	experience	C0596545
27348285	exacerbations	C0349790
27348285	health care resources	C0683535
27348285	assess	C1516048
27348285	health care resource	C0683535
27348285	utilization	C0042153
27348285	costs	C0085123
27348285	patients	C0030705
27348285	persistent	C0205322
27348285	severe asthma	C0581126
27348285	experienced	C0596545
27348285	exacerbations	C0349790
27348285	patients	C0030705
27348285	persistent	C0205322
27348285	asthma	C0004096
27348285	retrospective	C1514923
27348285	analysis	C0936012
27348285	national administrative claims database	C0242356
27348285	identified	C0205396
27348285	patients	C0030705
27348285	aged	C0001779
27348285	years	C0439234
27348285	medical claim	C0586198
27348285	asthma	C0004096
27348285	diagnosis	C0011900
27348285	medical	C2136534
27348285	pharmacy coverage	C2114292
27348285	commercial	C0680536
27348285	Medicare Advantage plan	C3844556
27348285	Patients	C0030705
27348285	assigned	C1516050
27348285	cohorts	C0599755
27348285	persistent asthma	C3266628
27348285	PA	C3266628
27348285	severe asthma	C0581126
27348285	SA	C0581126
27348285	algorithm	C0002045
27348285	asthma	C0004096
27348285	health care resource	C0683535
27348285	use	C0457083
27348285	pharmacy claims	C2114292
27348285	controller medication	C0013227
27348285	SA	C0581126
27348285	patients	C0030705
27348285	meet	C1550543
27348285	PA	C3266628
27348285	criteria	C0243161
27348285	evidence	C3887511
27348285	asthma exacerbations	C0349790
27348285	Asthma	C0004096
27348285	health care resource	C0683535
27348285	utilization	C0042153
27348285	costs	C0085123
27348285	computed	C1880157
27348285	asthma	C0004096
27348285	medication	C2081612
27348285	use	C0457083
27348285	rescue	C0039798
27348285	controller therapy	C0039798
27348285	medical claims	C0586198
27348285	asthma	C0004096
27348285	diagnosis	C0011900
27348285	primary position	C0444508
27348285	Adherence	C1510802
27348285	controller therapy	C0039798
27348285	assessed	C1516048
27348285	days	C0439228
27348285	proportion of days covered	C1254367
27348285	PDC	C1254367
27348285	claim	C0586198
27348285	controller therapy	C0039798
27348285	Differences	C1705242
27348285	PA	C3266628
27348285	SA	C0581126
27348285	cohorts	C0599755
27348285	analyzed	C0936012
27348285	t-test	C0871472
27348285	continuous variables	C0439828
27348285	chi-square test	C0008041
27348285	categorical variables	C0439828
27348285	Asthma	C0004096
27348285	costs	C0085123
27348285	analyzed	C0936012
27348285	linear model	C0023732
27348285	gamma distribution	C1708185
27348285	log link	C0026348
27348285	adjusted	C0456081
27348285	patient	C0030705
27348285	demographics	C1698647
27348285	age	C0001779
27348285	gender	C0079399
27348285	region	C0017446
27348285	insurance type	C0680873
27348285	Quan-Charlson comorbidity score	C0449820
27348285	patients	C0030705
27348285	PA	C3266628
27348285	patients	C0030705
27348285	SA	C0581126
27348285	patients	C0030705
27348285	Compared	C1707455
27348285	PA	C3266628
27348285	cohort	C0599755
27348285	SA	C0581126
27348285	cohort	C0599755
27348285	older	C3826770
27348285	mean age	C0001779
27348285	years	C0439234
27348285	years	C0439234
27348285	comorbidity score	C0449820
27348285	asthma	C0004096
27348285	medications	C2081612
27348285	SA	C0581126
27348285	cohort,	C0599755
27348285	compared	C1707455
27348285	PA	C3266628
27348285	cohort	C0599755
27348285	PDC	C1254367
27348285	oral	C1272919
27348285	inhaled	C0004048
27348285	controller therapy	C0087111
27348285	SA	C0581126
27348285	cohort	C0599755
27348285	compared	C1707455
27348285	PA	C3266628
27348285	cohort	C0599755
27348285	SA	C0581126
27348285	patients	C0030705
27348285	greater mean count	C1704243
27348285	asthma	C0004096
27348285	hospitalizations	C0019993
27348285	emergency room visits	C0586082
27348285	ambulatory visits	C4035875
27348285	asthma	C0004096
27348285	costs	C0010186
27348285	SA	C0581126
27348285	PA	C3266628
27348285	cohorts	C0599755
27348285	asthma	C0004096
27348285	costs	C0010186
27348285	asthma	C0004096
27348285	medication	C2081612
27348285	costs	C0010186
27348285	Adjusted	C0456081
27348285	asthma	C0004096
27348285	costs	C0010186
27348285	cost ratio	C0392762
27348285	SA	C0581126
27348285	cohort	C0599755
27348285	adjusted	C0456081
27348285	asthma	C0004096
27348285	medication	C2081612
27348285	costs	C0010186
27348285	SA	C0581126
27348285	cohort	C0599755
27348285	Patients	C0030705
27348285	SA	C0581126
27348285	experienced	C0596545
27348285	exacerbations	C0349790
27348285	use	C0457083
27348285	controller medications	C0087111
27348285	years	C0439234
27348285	adherent	C0334154
27348285	controller therapy	C0039798
27348285	patients	C0030705
27348285	PA	C3266628
27348285	pharmacotherapy	C0013216
27348285	SA	C0581126
27348285	patients	C0030705
27348285	adjusted	C0456081
27348285	asthma	C0004096
27348285	costs	C0010186
27348285	adjusted	C0456081
27348285	asthma	C0004096
27348285	medication	C2081612
27348285	costs	C0010186
27348285	PA	C3266628
27348285	patients	C0030705
27348285	Patients	C0030705
27348285	SA	C0581126
27348285	consistently	C0332290
27348285	health care	C0086388
27348285	utilization	C0042153
27348285	Funding	C0243098
27348285	study	C2603343
27348285	GlaxoSmithKline	C1552903
27348285	GSK	C1552903
27348285	authors	C3812881
27348285	meet	C1550543
27348285	criteria	C0243161
27348285	authorship	C0004351
27348285	International Committee for Medical Journal Editors	C2699414
27348285	Albers	C0805191
27348285	Forshag	C0805191
27348285	Yancey	C0805191
27348285	employees	C0599987
27348285	GSK	C1552903
27348285	GSK	C1552903
27348285	Dalal	C0805191
27348285	Nagar	C0805191
27348285	Ortega	C0805191
27348285	employees	C0599987
27348285	GSK	C1552903
27348285	time	C0040223
27348285	research	C0035168
27348285	Chastek	C0805191
27348285	Korrer	C0805191
27348285	employees	C0599987
27348285	Optum	C0596660
27348285	consulting fees	C0015751
27348285	GSK	C1552903
27348285	research	C0035168
27348285	study	C2603343
27348285	Study concept	C0178566
27348285	design	C1707689
27348285	contributed	C1880177
27348285	Chastek	C0805191
27348285	Nagar	C0805191
27348285	Dalal	C0805191
27348285	Korrer	C0805191
27348285	data collection	C0010995
27348285	Chastek	C0805191
27348285	data interpretation	C0010998
27348285	Chastek	C0805191
27348285	Ortega	C0805191
27348285	Forshag	C0805191
27348285	Dalal	C0805191
27348285	manuscript	C0600659
27348285	Chastek	C0805191
27348285	Dalal	C0805191
27348285	revised	C3244319
27348285	Albers	C0805191
27348285	Yancy	C0805191
27348285	assisted	C1269765
27348285	authors	C3812881
27348405	Differential regulation	C1325907
27348405	spontaneous	C0205359
27348405	evoked	C1444748
27348405	inhibitory synaptic transmission	C2255939
27348405	somatosensory cortex	C0037658
27348405	retinoic acid	C0040845
27348405	Retinoic acid	C0040845
27348405	RA	C0040845
27348405	developmental	C0458003
27348405	morphogen	C1254351
27348405	novel	C0205314
27348405	synaptic	C4236609
27348405	signaling molecule	C1519315
27348405	mature	C0205286
27348405	hippocampal	C0019564
27348405	neurons	C0027882
27348405	modulate	C0678672
27348405	excitatory	C0234107
27348405	inhibitory synaptic transmission	C2255939
27348405	homeostatic	C0019868
27348405	synaptic plasticity	C0027880
27348405	RA	C0040845
27348405	modulating	C0678672
27348405	neural circuits	C0814033
27348405	outside	C0205101
27348405	hippocampus	C0019564
27348405	mode of RA's action	C1524059
27348405	synapses	C0039062
27348405	similar	C2348205
27348405	within	C0332285
27348405	hippocampal	C0019564
27348405	RA	C0040845
27348405	synaptic function	C0027793
27348405	outside	C0205101
27348405	hippocampus	C0019564
27348405	novel	C0205314
27348405	function	C0542341
27348405	all-trans retinoic acid	C0040845
27348405	inhibitory synapses	C1512777
27348405	Acute	C0205178
27348405	RA	C0040845
27348405	treatment	C1522326
27348405	increases	C0442805
27348405	spontaneous	C0205359
27348405	inhibitory synaptic transmission	C2255939
27348405	L2/3 pyramidal neurons	C0206441
27348405	somatosensory cortex	C0037658
27348405	effect	C1280500
27348405	expression	C0597360
27348405	RA's receptor	C0140279
27348405	RARα	C0140279
27348405	pre- and post-synaptically	C0027793
27348405	RA	C0040845
27348405	evoked	C1444748
27348405	inhibitory transmission	C2255939
27348405	extracellular	C0521119
27348405	activation of action potentials	C4233793
27348405	presynaptic	C0206181
27348405	interneurons	C0021792
27348405	interneurons	C0021792
27348405	pyramidal neurons	C0206441
27348405	results	C0683954
27348405	RA's	C0040845
27348405	action	C3266814
27348405	synapses	C0039062
27348405	diverse	C1880371
27348405	synaptic connection	C0027793
27348405	excitatory	C0234107
27348405	inhibitory	C2255939
27348405	circuit	C0814033
27348405	hippocampal	C0019564
27348405	cortical)	C0007776
27348405	synaptic signaling	C4236609
27348405	RA	C0040845
27348405	regulation of synaptic plasticity	C1326639
27348405	classic roles	C1705810
27348405	brain development	C1160340
27348405	retinoic acid	C0040845
27348405	RA	C0040845
27348405	regulate	C1325907
27348405	excitatory	C0234107
27348405	inhibitory transmission	C2255939
27348405	adult	C0001675
27348405	brain	C0006104
27348405	authors	C3812881
27348405	layer 2/3	C0934502
27348405	L2/3	C0934502
27348405	somatosensory cortex	C0037658
27348405	S1	C0037658
27348405	acute	C0205178
27348405	RA	C0040845
27348405	induces	C0205263
27348405	increases	C0442805
27348405	spontaneous	C0205359
27348405	action-potential	C0001272
27348405	evoked	C1444748
27348405	transmission	C0027793
27348405	retinoic acid receptor	C0140279
27348405	RARα	C0140279
27348405	presynaptic	C0206181
27348405	PV	C0030616
27348405	interneurons	C0021792
27348405	postsynaptic	C0682686
27348405	pyramidal (PN) neurons	C0206441
27348711	Utilization	C0013223
27348711	Pattern	C0449774
27348711	Drug Use	C0871719
27348711	Traditional Chinese Medicine	C0025131
27348711	Chinese	C0025123
27348711	Western Medicine	C1879848
27348711	Integrated Chinese-Western Medicine	C0025118
27348711	Treatments	C0087111
27348711	Allergic Rhinitis	C2607914
27348711	National Health Insurance Program	C1254363
27348711	Taiwan	C0039260
27348711	Patients	C0030705
27348711	Taiwan	C0039260
27348711	allergic rhinitis	C2607914
27348711	Western medicine	C1879848
27348711	treatment	C0087111
27348711	Traditional Chinese Medicine	C0025131
27348711	treatment	C0087111
27348711	integrated Chinese-Western medicine	C0025118
27348711	treatment	C0087111
27348711	pairwise comparison	C0086766
27348711	Traditional Chinese Medicine	C0025131
27348711	Western medicine	C1879848
27348711	integrated Chinese-Western medicine	C0025118
27348711	treatments	C0087111
27348711	simultaneous	C0521115
27348711	analysis	C0936012
27348711	treatments	C0087111
27348711	analyzed	C0936012
27348711	patients	C0030705
27348711	allergic rhinitis	C2607914
27348711	treatments	C0087111
27348711	demographic	C0011298
27348711	characteristic	C1521970
27348711	medical	C0205476
27348711	use	C0457083
27348711	drug use patterns	C0871719
27348711	treatments	C0087111
27348711	National Health Insurance Research Database	C0282574
27348711	data source	C0011001
27348711	patients	C0030705
27348711	diagnosed	C0011900
27348711	allergic rhinitis	C2607914
27348711	International Classification of Diseases, Ninth Revision	C2346503
27348711	Clinical Modification codes 470-478	C0282574
27348711	Chi-square test	C0008041
27348711	Tukey studentized range (honest significant difference) test	C0392366
27348711	investigate	C1292732
27348711	treatments	C0087111
27348711	Visit frequency	C0808393
27348711	allergic rhinitis	C2607914
27348711	treatment	C0087111
27348711	female	C0043210
27348711	male	C0025266
27348711	patients	C0030705
27348711	treatment	C0087111
27348711	Traditional Chinese Medicine	C0025131
27348711	Western medicine	C1879848
27348711	integrated Chinese-Western medicine	C0025118
27348711	Persons	C0027361
27348711	highest	C1522410
27348711	proportion	C1709707
27348711	visits	C1512346
27348711	allergic rhinitis	C2607914
27348711	Traditional Chinese Medicine	C0025131
27348711	treatment	C0087111
27348711	medical	C0205476
27348711	person-time	C0027361
27348711	daily	C0332173
27348711	drug cost	C0085123
27348711	person-time	C0027361
27348711	lowest	C1708760
27348711	total	C0439810
27348711	expenditure	C0015316
27348711	person-time	C0027361
27348711	Western medicine	C1879848
27348711	lowest	C1708760
27348711	daily	C0332173
27348711	drug cost	C0085123
27348711	person-time	C0027361
27348711	highest	C1522410
27348711	total	C0439810
27348711	expenditure	C0015316
27348711	person-time	C0027361
27348711	total	C0439810
27348711	expenditure	C0015316
27348711	person-time	C0027361
27348711	daily	C0332173
27348711	drug cost	C0085123
27348711	person-time	C0027361
27348711	medical	C0205476
27348711	items	C1551338
27348711	person-time	C0027361
27348711	integrated Chinese-Western medicine	C0025118
27348711	treatment	C0087111
27348711	Traditional Chinese Medicine	C0025131
27348711	Western medicine	C1879848
27348711	treatments	C0087111
27348711	patients	C0030705
27348711	allergic rhinitis	C2607914
27348711	integrated Chinese-Western medicine	C0025118
27348711	treatment	C0087111
27348711	visit frequency	C0808393
27348711	integrated Chinese-Western medicine	C0025118
27348711	highest	C1522410
27348711	multiple-composition	C0439064
27348711	medicines	C0013227
27348711	frequently	C0332183
27348711	single-composition	C0205171
27348711	medicines	C0013227
27348711	mar huang	C0390643
27348711	Ephedra sinica Stapf	C0950030
27348711	decrease	C0547047
27348711	risk of	C0035647
27348711	medications	C0013227
27354219	TLR9	C1423633
27354219	Deficiency	C0011155
27354219	Accelerated	C0521110
27354219	Renal Disease	C0022658
27354219	Myeloid Lineage	C0007634
27354219	Abnormalities	C1704258
27354219	Pristane	C0071986
27354219	Murine	C0026809
27354219	Lupus	C0012634
27354219	Systemic lupus erythematosus	C0024141
27354219	SLE)	C0024141
27354219	chronic	C0205191
27354219	life-threatening	C2826244
27354219	autoimmune disorder	C0004364
27354219	organ	C0178784
27354219	pathologies	C0030664
27354219	kidney	C0022646
27354219	destruction	C1948029
27354219	murine	C0026809
27354219	models	C0012644
27354219	SLE	C0024141
27354219	endosomal	C1820047
27354219	TLRs	C0670896
27354219	autoantibodies	C0004358
27354219	clinical	C0205210
27354219	disease	C0012634
27354219	manifestations	C0205319
27354219	TLR9	C1423633
27354219	deficient	C0011155
27354219	autoimmune	C0443146
27354219	strains	C1518614
27354219	disease	C0012634
27354219	pathology	C0030664
27354219	Injection	C1533685
27354219	BALB/c mice	C0025919
27354219	2,6,10,14-tetramethylpentadecane	C0071986
27354219	TMPD	C0071986
27354219	pristane	C0071986
27354219	SLE-like disease	C0012634
27354219	Tlr9(-/-)	C1423633
27354219	BALB/c mice	C0025919
27354219	injected i.p.	C0021493
27354219	TMPD	C0071986
27354219	autoimmunity	C0004368
27354219	TLR	C0670896
27354219	accumulation	C4055506
27354219	TLR7	C1336639
27354219	expressing	C0017262
27354219	Ly6C(hi)	C1530208
27354219	inflammatory	C0333348
27354219	monocytes	C0026473
27354219	site of injection	C2700396
27354219	upregulation	C0041904
27354219	IFN	C0021747
27354219	gene expression	C0017262
27354219	peritoneal cavity	C1704247
27354219	myeloid lineage precursors	C0007634
27354219	common myeloid progenitors	C1956319
27354219	granulocyte	C0018183
27354219	myeloid precursors	C0007634
27354219	bone marrow	C0005953
27354219	TMPD	C0071986
27354219	injected	C1533685
27354219	Tlr9(-/-)	C1423633
27354219	BALB/c mice	C0025919
27354219	autoantibody	C0004358
27354219	RNA	C0035668
27354219	neutrophil	C0027950
27354219	cytoplasmic	C0521449
27354219	Ags	C0003320
27354219	myeloperoxidase	C0027021
27354219	TMPD	C0071986
27354219	injected	C1533685
27354219	wild-type BALB/c mice	C0025919
27354219	TMP	C0071986
27354219	injected	C1533685
27354219	Tlr9(-/-)	C1423633
27354219	mice	C0026809
27354219	wild-type mice	C1520150
27354219	glomerular IgG	C0020852
27354219	deposition	C0333562
27354219	granulocytes	C0018183
27354219	glomerulonephritis	C0017658
27354219	reduced	C0392756
27354219	lifespan	C0870809
27354219	TLR7	C1336639
27354219	response	C0871261
27354219	self-antigens	C0004359
27354219	model	C0012644
27354219	autoimmunity	C0004368
27354219	BALB/c	C0025919
27354219	pristane	C0071986
27354219	model	C0012644
27354219	TLR7	C1336639
27354219	models	C0012644
27354219	SLE	C0024141
27354219	negatively	C0205160
27354219	TLR9	C1423633
27354640	Effect	C1280500
27354640	Xenotransplantation	C0520484
27354640	Site	C0205145
27354640	MicroRNA	C1101610
27354640	Expression	C0017262
27354640	Human	C0086418
27354640	Colon Cancer	C0699790
27354640	Stem Cells	C0038250
27354640	Cancer stem cells	C1956422
27354640	CSCs	C1956422
27354640	high	C0205250
27354640	tumorigenic	C0007621
27354640	ability	C0085732
27354640	patient-derived tumor xenografts	C4050317
27354640	PDXs	C4050317
27354640	PDXs	C4050317
27354640	attractive	C2346874
27354640	pre-clinical model	C1514292
27354640	gene expression	C0017262
27354640	biological behavior	C0001398
27354640	cancer cells	C0334227
27354640	tumor	C0027651
27354640	change	C0392747
27354640	establishment	C0443211
27354640	PDXs	C4050317
27354640	Human	C0086418
27354640	colon cancer	C0699790
27354640	PDX	C4050317
27354640	established	C0443211
27354640	passaged	C1709474
27354640	subcutaneously	C0443315
27354640	orthotopically	C0574893
27354640	murine	C0025929
27354640	intestine	C0021853
27354640	Histology	C0019638
27354640	flow cytometric	C0016263
27354640	profile	C1979963
27354640	surgical	C0543467
27354640	specimen	C2347026
27354640	PDX	C4050317
27354640	analyzed	C0936012
27354640	CSCs	C1956422
27354640	isolated	C0205409
27354640	tumors	C0027651
27354640	microRNA	C1101610
27354640	miRNA	C1101610
27354640	expression	C0017262
27354640	analyzed	C0936012
27354640	semi-quantitative polymerase chain reaction	C2733022
27354640	surgical	C0543467
27354640	specimens	C2347026
27354640	PDXs	C4050317
27354640	histologically	C0019638
27354640	similar	C2348205
27354640	size	C0456389
27354640	CSC	C1956422
27354640	population	C1257890
27354640	increased	C0205217
27354640	expression	C0017262
27354640	miRNA	C1101610
27354640	CSCs	C1956422
27354640	changed	C0392747
27354640	passaged	C1709474
27354640	PDXs	C4050317
27354640	Expression	C0017262
27354640	oncogenic	C0007090
27354640	miRNAs	C1101610
27354640	highly	C0205250
27354640	up-regulated	C0041904
27354640	CSCs	C1956422
27354640	orthotopically	C0574893
27354640	passaged	C1709474
27354640	PDXs	C4050317
27354640	xenotransplantation	C0520484
27354640	site	C0205145
27354640	number	C0237753
27354640	tumor	C0027651
27354640	passages	C1709474
27354640	affect	C0001721
27354640	miRNA	C1101610
27354640	expression	C0017262
27354640	human	C0086418
27354640	colon	C0009368
27354640	CSCs	C1956422
27355356	Chemosensitivity	C2347610
27355356	Cardiovascular Risk	C1113685
27355356	Ventilatory Response	C1321070
27355356	Exercise	C0015259
27355356	COPD	C0024117
27355356	COPD	C0024117
27355356	elevated	C3163633
27355356	cardiovascular risk	C1113685
27355356	potentiated	C1704419
27355356	ventilatory response	C1321070
27355356	exercise	C0015259
27355356	carotid	C0741968
27355356	chemoreceptor	C0008010
27355356	CC	C0008010
27355356	activity	C0234208
27355356	sensitivity	C0234208
27355356	sensitivity	C0234208
27355356	clinical conditions	C0683325
27355356	sympathetic	C0039044
27355356	vasoconstrictor outflow	C1456863
27355356	predictive	C0681890
27355356	mortality	C1306577
27355356	CC	C0008010
27355356	activity	C0234208
27355356	sensitivity	C0234208
27355356	functional	C0205245
27355356	significance	C0750502
27355356	not been well examined	C0332129
27355356	COPD	C0024117
27355356	CC	C0008010
27355356	activity	C0234208
27355356	sensitivity	C0234208
27355356	elevated	C3163633
27355356	COPD	C0024117
27355356	increased	C0205217
27355356	pulse wave velocity	C3494431
27355356	marker	C0005516
27355356	CV risk	C1113685
27355356	ventilatory response	C1321070
27355356	exercise	C0015259
27355356	COPD	C0024117
27355356	patients	C0030705
27355356	healthy	C3898900
27355356	controls	C0009932
27355356	examined	C0332128
27355356	Participants	C0679646
27355356	baseline	C1442488
27355356	cardiopulmonary exercise	C2959886
27355356	pulmonary function testing	C0024119
27355356	CC	C0008010
27355356	activity	C0234208
27355356	evaluated	C0220825
27355356	drop in	C0085639
27355356	ventilation	C0035203
27355356	breathing	C0035203
27355356	O2	C0030054
27355356	CC	C0008010
27355356	sensitivity	C0234208
27355356	ventilatory response to hypoxia	C0199505
27355356	pO2	C1283004
27355356	Peripheral	C0205100
27355356	arterial stiffness	C0599949
27355356	evaluated	C0220825
27355356	measurement	C0242485
27355356	pulse wave velocity	C3494431
27355356	PWV	C3494431
27355356	applanation tonometry	C0430862
27355356	breathing	C0035203
27355356	room air	C3846005
27355356	chemoreceptor	C0008010
27355356	inhibition	C3463820
27355356	breathing	C0035203
27355356	100%	C3817553
27355356	O2	C0030054
27355356	CC	C0008010
27355356	activity	C0234208
27355356	CC	C0008010
27355356	sensitivity	C0234208
27355356	PWV	C3494431
27355356	ventilatory response	C1321070
27355356	exercise	C0015259
27355356	COPD	C0024117
27355356	controls	C0009932
27355356	CC	C0008010
27355356	sensitivity	C0234208
27355356	PWV	C3494431
27355356	CC	C0008010
27355356	activity	C0234208
27355356	CC	C0008010
27355356	sensitivity	C0234208
27355356	ventilatory response	C1321070
27355356	exercise	C0015259
27355356	COPD	C0024117
27355356	CC	C0008010
27355356	breathing	C0035203
27355356	100%	C3817553
27355356	O2	C0030054
27355356	PWV	C3494431
27355356	COPD	C0024117
27355356	no effect	C1301751
27355356	controls	C0009932
27355356	CC	C0008010
27355356	activity	C0234208
27355356	sensitivity	C0234208
27355356	elevated	C3163633
27355356	COPD	C0024117
27355356	cardiovascular risk	C1113685
27355356	CC	C0008010
27355356	activity	C0234208
27355356	sensitivity	C0234208
27355356	potentiated	C1704419
27355356	ventilatory response	C1321070
27355356	exercise	C0015259
27356972	Isolation of Cells	C0007616
27356972	Specialized	C1704211
27356972	Anticancer	C0003392
27356972	Alkaloid Metabolism	C1158456
27356972	Fluorescence-Activated Cell Sorting	C0079366
27356972	Plant	C0032098
27356972	specialized	C1704211
27356972	metabolism	C0025519
27356972	complex	C0439855
27356972	cell	C0007634
27356972	specific	C0205369
27356972	compartmentation	C0007583
27356972	biosynthesis	C0005572
27356972	plant	C0032098
27356972	natural products	C1566558
27356972	manipulation	C0392747
27356972	pathways	C1705987
27356972	isolate	C0220862
27356972	characterize	C1880022
27356972	specific	C0205369
27356972	cell types	C0449475
27356972	Catharanthus roseus	C0331124
27356972	medicinal	C0013227
27356972	terpenoid indole alkaloids	C1449663
27356972	anticancer	C0003392
27356972	vinblastine	C0042670
27356972	vincristine	C0042679
27356972	biosynthetic steps	C0005572
27356972	specialized	C1704211
27356972	mesophyll cells	C2936408
27356972	idioblasts	C3178867
27356972	optical	C0029144
27356972	fluorescence	C0016315
27356972	alkaloid	C0301258
27356972	accumulating	C4055506
27356972	C. roseus	C0331124
27356972	leaf	C0242724
27356972	idioblasts	C3178867
27356972	characterized	C1880022
27356972	methodology	C3266812
27356972	isolation	C0220862
27356972	idioblast	C3178867
27356972	protoplasts	C0033731
27356972	fluorescence-activated cell sorting	C0079366
27356972	autofluorescence	C0544711
27356972	cells	C0007634
27356972	omic strategies	C0035171
27356972	identification	C0205396
27356972	candidate genes	C0017337
27356972	biosynthesis	C0005572
27356972	pathway	C1705987
27356972	regulation	C1327622
27356972	transmembrane transport	C1519624
27356972	anticancer	C0243095
27356972	alkaloids	C0301258
27356972	C. roseus	C0331124
27357217	Interaction	C1704675
27357217	Antimicrobial Peptides	C4084937
27357217	Rhesus θ-Defensin	C1450181
27357217	Porcine	C3665571
27357217	Protegrin-1	C0300260
27357217	Anionic Phospholipid Monolayers	C0031676
27357217	Langmuir isotherm	C0282574
27357217	Brewster angle microscopy	C0026018
27357217	BAM	C0026018
27357217	neutron reflectivity studies	C0242481
27357217	model	C0596899
27357217	bacterial cell membranes	C0007603
27357217	antimicrobial peptides	C4084937
27357217	Rhesus θ-defensin 1	C1450181
27357217	RTD-1	C1450181
27357217	porcine	C3665571
27357217	protegrin 1	C0300260
27357217	PG-1	C0300260
27357217	peptides	C0030956
27357217	interacted	C1704675
27357217	monolayers	C0031676
27357217	air	C0001861
27357217	water	C0043047
27357217	phosphatidylethanolamine	C1450468
27357217	phosphatidylglycerol	C0031614
27357217	approximate	C0332232
27357217	cell membranes	C0007603
27357217	Gram positive bacteria	C0018154
27357217	Langmuir film	C1561572
27357217	measurements	C0242485
27357217	peptides	C0030956
27357217	perturb	C0332453
27357217	lipid monolayers	C0031676
27357217	surface pressure	C0004180
27357217	BAM	C0026018
27357217	small domains	C1514562
27357217	lipid films	C0596899
27357217	monolayer	C0031676
27357217	surface pressure	C0004180
27357217	PG-1	C0300260
27357217	RTD-1	C1450181
27357217	interaction	C1704675
27357217	monolayer	C0031676
27357217	RTD-1	C1450181
27357217	neutron reflectivity studies	C0026336
27357217	PG-1	C0300260
27357217	RTD-1	C1450181
27357217	model	C0596899
27357217	amphiphilic	C0002671
27357217	PG-1	C0300260
27357217	embedded	C1707903
27357217	lipid film	C0596899
27357217	lipid acyl chains	C1254355
27357217	thickness	C1280412
27357217	lipid headgroup layer	C1254355
27357217	RTD-1	C1450181
27357217	lipid acyl chains	C1254355
27357217	PG-1	C0300260
27357217	thickness	C1280412
27357217	lipid headgroup layer	C1254355
27357217	peptides	C0030956
27357217	anionic lipid monolayers	C0031676
27357217	hemolytic activities	C0009542
27357217	differing propensities	C2718044
27357217	transmembrane	C1167322
27357217	pores	C1325742
27357607	Development	C0243107
27357607	chrysin	C0055661
27357607	poloxamer	C0600615
27357607	toxicity	C0040539
27357607	evaluation	C0220825
27357607	fish	C0016163
27357607	embryos	C0013935
27357607	Poloxamer	C0600615
27357607	micelles	C0025938
27357607	micelles	C0025938
27357607	safety	C0036043
27357607	efficacy	C1280519
27357607	water	C0043047
27357607	insoluble	C0205556
27357607	drugs	C0013227
27357607	Chrysin	C0055661
27357607	anticancer	C2986475
27357607	anti-inflammatory	C1515999
27357607	antioxidant	C3179302
27357607	anti-aromatase activities	C1148560
27357607	water	C0043047
27357607	insoluble	C0205556
27357607	properties	C0871161
27357607	pharmaceutical application	C0039429
27357607	chrysin	C0055661
27357607	poloxamer	C0600615
27357607	micelles	C0025938
27357607	poloxamers	C0600615
27357607	Pluronic F-68	C0032254
27357607	Pluronic F-127	C0032253
27357607	chrysin	C0055661
27357607	Pluronic F-68	C0032254
27357607	micelles	C0025938
27357607	CS-P68	C0025938
27357607	chrysin	C0055661
27357607	Pluronic F-127	C0032253
27357607	micelles	C0025938
27357607	CS-P127	C0025938
27357607	increase	C0442805
27357607	aqueous	C0599956
27357607	solubility	C0037628
27357607	chrysin	C0055661
27357607	results	C1274040
27357607	polymer	C0032521
27357607	drug	C0013227
27357607	polymer	C0032521
27357607	size	C0456389
27357607	characteristics	C1521970
27357607	micelles	C0025938
27357607	micelle system	C0025938
27357607	CS-P68	C0025938
27357607	CS-P127	C0025938
27357607	drug	C0013227
27357607	polymer	C0032521
27357607	ratios	C0456603
27357607	nanosize-range diameter	C1301886
27357607	in vivo study	C0681829
27357607	zebrafish	C0043457
27357607	eggs	C0029974
27357607	toxicity	C0040539
27357607	CS-P68	C0025938
27357607	CS-P127	C0025938
27357607	dose response	C1546996
27357607	CS-P68	C0025938
27357607	CS-P127	C0025938
27357607	drug dose	C0678766
27357607	less	C0547044
27357607	zebrafish	C0043457
27357607	embryo	C0013935
27357607	growth	C0018270
27357607	study	C2603343
27357607	enhanced	C2349975
27357607	water solubility	C0597682
27357607	chrysin	C0055661
27357607	Chrysin	C0055661
27357607	poloxamer	C0600615
27357607	micelles	C0025938
27357607	in vivo studies	C0681829
27357607	mammalian	C0024660
27357607	animals	C0003062
27357607	humans	C0086418
27357626	Adenoviral	C0001483
27357626	Delivery	C0011209
27357626	Tumor Necrosis Factor-α	C1456820
27357626	Interleukin-2	C0021756
27357626	Adoptive Cell Therapy	C0079613
27357626	Immunosuppressive	C0021081
27357626	Melanoma	C0025202
27357626	Adoptive T-cell transfer	C0376517
27357626	treatment approach	C0679624
27357626	metastatic cancer	C0027627
27357626	efficacy	C1280519
27357626	solid tumors	C0280100
27357626	toxic	C1407029
27357626	adoptive T-cell therapies	C0079613
27357626	benefit	C0814225
27357626	modalities	C0695347
27357626	full	C0443225
27357626	potential	C3245505
27357626	excessive	C0442802
27357626	toxicity	C0040539
27357626	aimed	C1947946
27357626	improve	C1272745
27357626	efficacy	C1280519
27357626	safety	C0205556
27357626	adoptive T-cell transfer	C0376517
27357626	adenoviral vectors	C1510800
27357626	delivery	C1705822
27357626	immunomodulatory	C1963758
27357626	murine	C0026809
27357626	cytokines	C0079189
27357626	B16.OVA	C0029974
27357626	melanoma tumors	C0004565
27357626	tumors	C0027651
27357626	concomitant	C0521115
27357626	T-cell receptor	C0034790
27357626	transgenic OT-I	C0025936
27357626	transgenic OT-I T-cell transfer	C0376517
27357626	adenoviruses	C0001483
27357626	cytokine	C0079189
27357626	injected	C0449894
27357626	B16.OVA	C0029974
27357626	tumors	C0027651
27357626	safety	C0205556
27357626	virus-mediated	C0042776
27357626	virus-mediated cytokine delivery	C0011209
27357626	cytokine	C0079189
27357626	Antitumor	C2986475
27357626	efficacy	C1280519
27357626	enhanced	C2349975
27357626	adenoviruses	C0001483
27357626	murine	C0026809
27357626	interleukin-2	C0021756
27357626	mIL-2	C0021756
27357626	tumor necrosis factor-α	C1456820
27357626	mTNFα	C1456820
27357626	T-cell transfer	C0376517
27357626	viruses	C0042776
27357626	improvement	C2986411
27357626	efficacy	C1280519
27357626	triple	C0205174
27357626	combination	C0205195
27357626	mIL-2	C0021756
27357626	mTNFα	C1456820
27357626	OT-I T-cells	C0039194
27357626	Mechanistic studies	C0441712
27357626	mIL-2	C0021756
27357626	important	C3898777
27357626	role	C1705810
27357626	activating	C1879547
27357626	T-cells	C0039194
27357626	tumor	C0027651
27357626	mTNFα	C0041368
27357626	chemokine	C0282554
27357626	expression	C1171362
27357626	adenovirus	C0001483
27357626	treatments	C0087111
27357626	enhanced	C2349975
27357626	tumor	C0027651
27357626	OT-I T-cells	C0039194
27357626	demonstrated	C3687625
27357626	SPECT/CT imaging	C3472245
27357626	(111)In-labeled cells	C0007634
27357626	results	C1274040
27357626	suggest	C1705535
27357626	cytokine-coding	C0079189
27357626	adenoviruses	C0001483
27357626	improving	C1272745
27357626	efficacy	C1280519
27357626	adoptive T-cell therapies	C0079613
27363786	Maternal	C1858460
27363786	Legacy	C0242538
27363786	Female	C0086287
27363786	Identity	C3826248
27363786	Offspring	C0680063
27363786	Sex Ratio	C0036893
27363786	Loggerhead Sea Turtle	C0999068
27363786	organisms	C0029235
27363786	temperature-dependent	C0039476
27363786	sex determination	C1367886
27363786	incubation environment	C0014406
27363786	offspring	C0680063
27363786	sex ratios	C0036893
27363786	global	C2348867
27363786	temperatures	C0039476
27363786	warmed	C0687712
27363786	organisms	C0029235
27363786	adjust	C2364069
27363786	climate change	C2718051
27363786	degree	C0441889
27363786	mothers	C0026591
27363786	influence	C4054723
27363786	sex ratios	C0036893
27363786	offspring	C0680063
27363786	years	C0439234
27363786	nesting data	C1511726
27363786	individual	C0237401
27363786	female	C0086287
27363786	loggerhead sea turtles	C0999068
27363786	Caretta caretta	C0999068
27363786	Bald Head Island	C0022130
27363786	North Carolina	C0028407
27363786	maternal	C1858460
27363786	identity	C3826248
27363786	nest	C1254362
27363786	sex ratio	C0036893
27363786	univariate	C0683962
27363786	multivariate predictive models	C0242481
27363786	variability	C2827666
27363786	nest	C1254362
27363786	sex ratios	C0036893
27363786	mothers	C0026591
27363786	consistency	C0332529
27363786	mothers	C0026591
27363786	spatial	C1254362
27363786	temporal	C0040223
27363786	thermal variation	C2584332
27363786	individual	C0237401
27363786	nesting preferences	C0027776
27363786	divergences	C0443204
27363786	nest	C1254362
27363786	sex ratios	C0036893
27363786	female's	C0086287
27363786	nest	C1254362
27363786	sex ratios	C0036893
27363786	environmental	C0014406
27363786	conditions	C0348080
27363786	constrained	C1707494
27363786	individuals	C0237401
27363786	mitigate	C1553901
27363786	environmental change	C4060636
27363786	loggerhead	C0999068
27363786	populations	C1257890
27363786	female-biased	C0242568
27363786	offspring	C0680063
27363786	sex ratios	C0036893
27363786	maternal behavioral	C0024919
27363786	critical	C1511545
27363786	species	C1705920
27363786	vulnerable	C0231204
27363786	extinction	C3826380
27364501	RhoA	C0643681
27364501	Activity	C1537044
27364501	Worse	C1457868
27364501	Overall Survival	C4086681
27364501	Patients	C0030705
27364501	Surgical Resection	C0015252
27364501	Lauren	C3829311
27364501	Diffuse-Type Gastric Adenocarcinoma	C0279635
27364501	RHOA	C0812234
27364501	mutations	C0596611
27364501	Lauren	C3829311
27364501	diffuse-type gastric adenocarcinoma	C0279635
27364501	GA	C0278701
27364501	intestinal-type GA	C0279633
27364501	RhoA	C0643681
27364501	activity	C1537044
27364501	prognostic	C1514474
27364501	overall survival	C4086681
27364501	OS	C4086681
27364501	patients	C0030705
27364501	GA	C0278701
27364501	Retrospective review	C0035363
27364501	GA	C0278701
27364501	patients	C0030705
27364501	curative resection	C1511562
27364501	single institution	C2607850
27364501	Tissue	C0040300
27364501	microarrays	C1709016
27364501	surgical specimens	C1254419
27364501	phosphorylated	C1519061
27364501	RhoA	C0643681
27364501	marker	C0005516
27364501	RhoA	C0643681
27364501	signaling	C2611812
27364501	OS	C4086681
27364501	Kaplan-Meier method	C2827659
27364501	multivariate analysis	C0026777
27364501	Cox proportional hazards regression modeling	C0010235
27364501	patients	C0030705
27364501	diffuse-type GA	C0279635
27364501	patients	C0030705
27364501	intestinal-type GA	C0279633
27364501	intestinal-type GA	C0279633
27364501	diffuse-type GA	C0279635
27364501	tumors	C0027651
27364501	associated with	C0332281
27364501	tumor size	C0475440
27364501	advanced tumor, node, metastasis (TNM) classification system stage	C1515169
27364501	patients	C0030705
27364501	diffuse-type GA	C0279635
27364501	RhoA	C0643681
27364501	activity	C1537044
27364501	associated with	C0332281
27364501	worse	C1457868
27364501	OS	C4086681
27364501	RhoA	C0643681
27364501	activity	C1537044
27364501	OS	C4086681
27364501	OS	C4086681
27364501	patients	C0030705
27364501	intestinal-type GA	C0279633
27364501	OS	C4086681
27364501	multivariate analysis	C0026777
27364501	diffuse-type GA	C0279635
27364501	patients	C0030705
27364501	RhoA	C0643681
27364501	activity	C1537044
27364501	prognostic factor	C1514474
27364501	OS	C4086681
27364501	hazard ratio	C2985465
27364501	confidence interval	C0009667
27364501	RhoA	C0643681
27364501	activity	C1537044
27364501	worse	C1457868
27364501	OS	C4086681
27364501	patients	C0030705
27364501	diffuse-type GA	C0279635
27364501	curative surgical resection	C1511562
27364501	genomic studies	C0887950
27364501	RhoA	C0643681
27364501	therapeutic	C0087111
27364501	target	C1521840
27364501	diffuse-type GA	C0279635
27364610	Doxifluridine	C0048808
27364610	conjugated	C0522529
27364610	2-5A	C0045143
27364610	analog	C0243071
27364610	strong	C0442821
27364610	RNase L	C0071795
27364610	activation	C0599177
27364610	ability	C2698977
27364610	tumor suppressive	C1519692
27364610	effect	C1280500
27364610	RNase L	C0071795
27364610	activated	C0599177
27364610	2',5'-oligoadenylates	C0045143
27364610	2-5A	C0045143
27364610	subnanomolar	C0392762
27364610	levels	C0441889
27364610	cleave	C0205242
27364610	single-stranded RNA	C3272452
27364610	reported	C0684224
27364610	hypothesis	C1512571
27364610	introduction	C0579004
27364610	8-methyladenosine	C0100309
27364610	terminus	C1705315
27364610	2-5A tetramer	C0092311
27364610	shifts	C0333051
27364610	2-5A	C0045143
27364610	binding site	C0005456
27364610	RNase L	C0071795
27364610	study	C2603343
27364610	synthesized	C1883254
27364610	modified	C0392747
27364610	2-5A	C0045143
27364610	analog	C0243071
27364610	8-methyladenosine	C0100309
27364610	terminus	C1705315
27364610	doxifluridine	C0048808
27364610	conjugated	C0522529
27364610	8-methyladenosine	C0100309
27364610	substituted	C1706204
27364610	2-5A	C0045143
27364610	analog	C0243071
27364610	significantly more	C4055637
27364610	effective	C1704419
27364610	activator	C1879547
27364610	RNase L	C0071795
27364610	parent	C2699423
27364610	monophophorylated	C1327237
27364610	2-5A tetramer	C0092311
27364610	tumor suppressive	C1519692
27364610	effect	C1280500
27364610	against	C0521124
27364610	human	C0086418
27364610	cervical cancer	C4048328
27364610	cells	C0007634
27366508	Video Laryngoscopy	C2363575
27366508	Advantages	C0205556
27366508	Direct Laryngoscopy	C0392823
27366508	during	C0347984
27366508	Cardiopulmonary Resuscitation	C0007203
27366508	Interruption	C1512900
27366508	chest compressions	C4032596
27366508	minimized	C0392756
27366508	negative	C0205160
27366508	effects	C1280500
27366508	survival	C0038954
27366508	randomized	C0034656
27366508	controlled	C2587213
27366508	cross-over study	C0150097
27366508	aimed	C1947946
27366508	analyze	C0936012
27366508	effectiveness	C1280519
27366508	Macintosh	C1531939
27366508	Miller	C1532566
27366508	McCoy	C0563580
27366508	McGrath laryngoscopes	C0180453
27366508	during	C0347984
27366508	chest compressions	C4032596
27366508	scope	C1710028
27366508	cardiopulmonary resuscitation	C0007203
27366508	scenario	C0683579
27366508	time	C0040223
27366508	required	C1514873
27366508	successful	C1272703
27366508	tracheal intubation	C0021932
27366508	number of attempts	C3163850
27366508	dental trauma	C1301685
27366508	severity	C0439793
27366508	need	C0027552
27366508	optimization	C2698650
27366508	manoeuvres	C0441655
27366508	recorded	C0243095
27366508	during	C0347984
27366508	cardiopulmonary resuscitation	C0007203
27366508	chest compressions	C4032596
27366508	experience	C0596545
27366508	computer games	C0870328
27366508	during	C0347984
27366508	years	C0439234
27366508	participants	C0679646
27366508	recorded	C0243095
27366508	McCoy laryngoscope	C0563580
27366508	shortest time	C0040223
27366508	successful	C1272703
27366508	tracheal intubation	C0021932
27366508	presence	C0150312
27366508	chest compressions	C4032596
27366508	During	C0347984
27366508	use	C0042153
27366508	McCoy laryngoscopes	C0563580
27366508	fewer	C0205388
27366508	tracheal intubation	C0021932
27366508	attempts	C1516084
27366508	lower incidence	C0021149
27366508	dental trauma	C1301685
27366508	lower	C2003888
27366508	visual analogue scale scores	C2960751
27366508	intubation	C0021925
27366508	recorded	C0243095
27366508	Participants	C0679646
27366508	experienced	C0596545
27366508	computer game	C0870328
27366508	players	C1257890
27366508	Macintosh	C1531939
27366508	McCoy	C0563580
27366508	McGrath	C0180453
27366508	achieved	C0432600
27366508	successful	C1272703
27366508	tracheal intubation	C0021932
27366508	significantly	C0750502
27366508	shorter time	C0040223
27366508	during	C0347984
27366508	resuscitation	C0035273
27366508	chest compressions	C4032596
27366508	Dental trauma	C1301685
27366508	incidence	C0021149
27366508	number	C0237753
27366508	tracheal intubation	C0021932
27366508	attempts	C1516084
27366508	significant	C0750502
27366508	difference	C1705242
27366508	four	C0205450
27366508	laryngoscopes	C0180453
27366508	rate	C1521828
27366508	playing	C0441655
27366508	computer games	C0870328
27366508	McGrath video laryngoscopes	C2363575
27366508	advantages	C0205556
27366508	direct laryngoscopes	C0392823
27366508	smooth	C0205556
27366508	successful	C1272703
27366508	tracheal intubation	C0021932
27366508	during	C0347984
27366508	rhythmic chest compressions	C4032596
27366508	McCoy laryngoscope	C0563580
27366508	provided	C1999230
27366508	tracheal intubation	C0021932
27366508	shorter time	C0040223
27366508	fewer	C0205388
27366508	attempts	C1516084
27366508	laryngoscope	C0180453
27366508	increase	C0442805
27366508	success rate	C1521828
27366508	resuscitation	C0035273
27371819	nurse-patient communication	C0870983
27371819	nursing students	C0038496
27371819	Effective communication skills	C0870313
27371819	pivotal factors	C1521761
27371819	positive interpersonal relationships	C0021797
27371819	nursing undergraduates	C0038496
27371819	perspectives	C0678958
27371819	communicating	C0205196
27371819	patients	C0030705
27371819	study	C2603343
27371819	nursing students'	C0038496
27371819	perspectives	C0678958
27371819	experiences	C0596545
27371819	nurse-patient communication	C0870983
27371819	clinical	C0205210
27371819	placement	C1524072
27371819	participants	C0679646
27371819	second-year undergraduates	C0682177
27371819	first-year master's students	C0682177
27371819	Interviews	C0021822
27371819	Cantonese	C0023008
27371819	Chinese	C0008120
27371819	English	C0376245
27371819	content analysis	C0681915
27371819	approach	C0449445
27371819	data	C1511726
27371819	themes	C0869035
27371819	interview data	C1511726
27371819	nurse-patient communication	C0870983
27371819	reveals	C0443289
27371819	students	C0038492
27371819	nurse-patient communication	C0870983
27371819	conversation contents	C0582166
27371819	content of the conversations	C0582166
27371819	students	C0038492
27371819	patients	C0030705
27371819	theme	C0869035
27371819	self-reflection	C0243095
27371819	nurse-patient communication	C0870983
27371819	themes	C0869035
27371819	communication pattern in different	C4061885
27371819	hospital settings	C0019994
27371819	nurse-patient communication	C0870983
27371819	students'	C0038492
27371819	communication styles	C0205556
27371819	hospitals	C0019994
27371819	encounter	C1947978
27371819	improve	C0184511
27371819	students'	C0038492
27371819	communication skills	C0870313
27371819	educators	C0259853
27371819	clinical staff	C0851286
27371819	students	C0038492
27371819	enhance	C2349975
27371819	students'	C0038492
27371819	reflective skills	C0678856
27371819	confidence	C1704726
27371819	understanding	C0162340
27371819	students'	C0038492
27371819	difficulties	C0332218
27371819	nurse-patient communication	C0870983
27371819	experience	C0596545
27371819	skills	C0678856
27371819	educators	C0259853
27371819	recommendations	C0034866
27371819	improve	C0184511
27371819	communication skills	C0870313
27371819	clinical practice	C0205897
27371819	study	C2603343
27371819	reveal	C0443289
27371819	students'	C0038492
27371819	nurse-patient communication	C0870983
27371819	skills	C0870313
27371819	improved	C0184511
27374165	hippocampal	C0019564
27374165	volume loss	C0243095
27374165	marker	C0005516
27374165	memory deficits	C0233794
27374165	repeated stress	C0038435
27374165	Exposure to	C0332157
27374165	severe	C0205082
27374165	prolonged	C0439590
27374165	stress	C0038435
27374165	detrimental effects	C0243095
27374165	hippocampus	C0019564
27374165	relatively	C0205345
27374165	little	C0700321
27374165	known	C0205309
27374165	gradual	C0439833
27374165	changes	C0392747
27374165	hippocampal structure	C0019564
27374165	behavioral	C0004927
27374165	consequences	C0686907
27374165	repeated stress	C0038435
27374165	Behavioral analyses	C1160858
27374165	chronic stress	C1510527
27374165	decline	C0547047
27374165	spatial memory	C0814087
27374165	impact	C4049986
27374165	stress	C0038435
27374165	concurrent	C0205420
27374165	volumetric measurements	C0079809
27374165	animals	C0003062
27374165	reduction	C0392756
27374165	hippocampal	C0019564
27374165	volumes	C0392762
27374165	stressed	C0038435
27374165	animals	C0003062
27374165	unstressed counterparts	C0231300
27374165	stress	C0038435
27374165	animals	C0003062
27374165	behaviorally	C0004927
27374165	worst	C1522166
27374165	affected	C1292725
27374165	chronic stress	C1510527
27374165	suffered	C0683278
27374165	early loss in hippocampal volume	C0243095
27374165	hippocampal	C0019564
27374165	volume	C0392762
27374165	stress	C0038435
27374165	induced	C0205263
27374165	memory deficits	C0233794
27374165	risk factor	C0035648
27374165	cognitive impairments	C0338656
27374165	stress-related psychiatric disorders	C0599909
27375918	Association	C0439849
27375918	C9orf72	C1428691
27375918	Repeats	C0004793
27375918	Risk	C0035647
27375918	Alzheimer's Disease	C0002395
27375918	Amyotrophic Lateral Sclerosis	C0002736
27375918	Meta-Analysis	C0920317
27375918	C9orf72	C1428691
27375918	genetic	C0314603
27375918	cause	C0015127
27375918	amyotrophic lateral sclerosis	C0002736
27375918	ALS	C0002736
27375918	frontotemporal dementia	C0338451
27375918	FTD	C0338451
27375918	Caucasian populations	C0043157
27375918	relationship	C0439849
27375918	C9orf72	C1428691
27375918	repeats	C0004793
27375918	Alzheimer's disease	C0002395
27375918	AD	C0002395
27375918	not clear	C3845108
27375918	articles	C0282420
27375918	assessing	C1516048
27375918	C9orf72	C1428691
27375918	ethnicities	C0243103
27375918	ALS	C0002736
27375918	meta-analysis	C0920317
27375918	investigate	C1292732
27375918	relationship	C0439849
27375918	C9orf72	C1428691
27375918	repeat expansions	C1257790
27375918	repeats	C0004793
27375918	intermediate	C0205103
27375918	repeat copies	C0004793
27375918	repeats	C0004793
27375918	AD	C0002395
27375918	ALS	C0002736
27375918	results	C1274040
27375918	positive	C1446409
27375918	correlations	C1707520
27375918	C9orf72	C1428691
27375918	repeat expansions	C1257790
27375918	risk	C0035647
27375918	Alzheimer's disease	C0002395
27375918	OR	C0028873
27375918	CI	C0009667
27375918	p	C1709380
27375918	intermediate	C0205103
27375918	repeat copies	C0004793
27375918	C9orf72 gene	C1428691
27375918	associated with	C0332281
27375918	risk	C0035647
27375918	disease	C0012634
27375918	C9orf72	C1428691
27375918	repeat expansions	C1257790
27375918	positively	C1446409
27375918	correlated	C1707520
27375918	risk	C0035647
27375918	familial	C1862939
27375918	sporadic ALS	C1862941
27375918	OR	C0028873
27375918	CI	C0009667
27375918	p	C1709380
27375918	OR	C0028873
27375918	CI	C0009667
27375918	p	C1709380
27375918	positive	C1446409
27375918	correlation	C1707520
27375918	gene variations	C0042333
27375918	ALS	C0002736
27375918	risk	C0035647
27375918	Caucasians	C0043157
27375918	Asians	C0078988
27375918	OR	C0028873
27375918	CI	C0009667
27375918	p	C1709380
27375918	OR	C0028873
27375918	CI	C0009667
27375918	p	C1709380
27378028	validation	C1519941
27378028	pressure	C0033095
27378028	MRI	C0336660
27378028	pain tolerance	C0162703
27378028	device	C0025080
27378028	behavioral	C0004927
27378028	emotional	C0013987
27378028	effects	C1280500
27378028	pain	C0030193
27378028	functional Magnetic Resonance Imaging	C0376335
27378028	fMRI	C0376335
27378028	MRI	C0336660
27378028	compatible	C1524057
27378028	pressure	C0033095
27378028	algometer	C0025080
27378028	elicit	C0449265
27378028	pain	C0030193
27378028	MRI	C0336660
27378028	apparatus	C0025080
27378028	incremental	C1705117
27378028	measurable	C1513040
27378028	pressure	C0033095
27378028	scanning bore	C0183115
27378028	device	C0025080
27378028	pressure	C0033095
27378028	pain	C0030193
27378028	test	C0022885
27378028	MRI	C0336660
27378028	incompatible	C1524057
27378028	algometer	C0025080
27378028	AlgoMed	C0025080
27378028	pain tolerance	C0162703
27378028	tested	C0022885
27378028	pressure	C0033095
27378028	pain	C0030193
27378028	MRI	C0336660
27378028	environment	C0014406
27378028	brain	C0006104
27378028	activation	C1879547
27378028	neural networks	C0242406
27378028	pain	C0030193
27378028	test	C0022885
27378028	pain	C0030193
27378028	scanned	C0441633
27378028	MRI scanner	C0336660
27378028	validity and reliability	C0035036
27378028	device	C0025080
27378028	pain tolerance	C0162703
27378028	device	C0025080
27378028	pain tolerance	C0162703
27378028	algometer	C0025080
27378028	device	C0025080
27378028	BOLD	C1655730
27378028	insula	C0021640
27378028	BA 13	C2326439
27378028	anterior cingulate gyrus	C0175190
27378028	BA 24	C2334367
27378028	pressure	C0033095
27378028	increased	C0205217
27378028	parametrically	C0681933
27378028	increased	C0205217
27378028	thermal	C2032530
27378028	electrical	C2032523
27378028	mechanical	C0699886
27378028	pain applications	C0521491
27378028	Behavioral	C0004927
27378028	functional	C0205245
27378028	data	C1511726
27378028	device	C0025080
27378028	administering	C1533734
27378028	pressure	C0033095
27378028	pain	C0030193
27378028	MRI	C0336660
27378028	environments	C0014406
27378028	MRI	C0336660
27378028	device	C0025080
27378028	instrument	C0348000
27378028	measure	C0242485
27378028	administer	C1621583
27378028	pressure	C0033095
27378028	pain	C0030193
27378927	Anti-Inflammatory Properties	C1515999
27378927	Menthol	C0025368
27378927	Menthone	C0065950
27378927	Schistosoma mansoni Infection	C0036330
27378927	Schistosomiasis	C0036323
27378927	parasitic disease	C0030499
27378927	species	C1705920
27378927	trematode worms	C3662558
27378927	people	C0027361
27378927	affected	C0392760
27378927	drug development	C0872152
27378927	essential	C0205224
27378927	parasite	C0030498
27378927	resistant	C1514892
27378927	Praziquantel	C0032911
27378927	drug	C0013227
27378927	infection	C3714514
27378927	study	C2603343
27378927	evaluated	C0220825
27378927	parasitological	C0205468
27378927	immunological	C0205470
27378927	histological	C0205462
27378927	parameters	C0449381
27378927	mice	C0025929
27378927	infected	C0439663
27378927	Schistosoma mansoni	C0036319
27378927	treated with	C0332293
27378927	herbal commercial medicine	C2240391
27378927	drug	C0013227
27378927	menthol	C0025368
27378927	menthone	C0065950
27378927	treatment regimen	C0040808
27378927	herbal medicine	C2240391
27378927	decreased	C0205216
27378927	S. mansoni	C0036319
27378927	eggs	C0686887
27378927	feces	C0015733
27378927	liver	C0023884
27378927	intestine	C0021853
27378927	reduced	C0392756
27378927	hepatic granulomas	C0745754
27378927	observed	C1441672
27378927	reduction	C0441610
27378927	blood eosinophilia	C0014457
27378927	decrease	C0205216
27378927	IL-4	C0021758
27378927	IL-10	C0085295
27378927	blood levels	C0005768
27378927	treatment	C0087111
27378927	schistosomiasis	C0036323
27378927	treatment	C0087111
27378927	herbal medicine	C2240391
27378927	immunomodulatory	C0205556
27378927	anti-inflammatory action	C1515999
27378927	animal model	C0599779
27378927	schistosomiasis	C0036323
27378927	contributing	C1880177
27378927	decrease	C0205216
27378927	pathological	C1521733
27378927	effects	C1280500
27378927	S. mansoni infection	C0036330
27381206	Catastrophic	C0007397
27381206	health expenditure	C0015318
27381206	comparative analysis	C0683941
27381206	empty-nest	C0870492
27381206	non-empty-nest	C1254370
27381206	households	C0020052
27381206	seniors	C0001792
27381206	Shandong, China	C0008115
27381206	aim	C1947946
27381206	study	C2603343
27381206	compare	C1707455
27381206	catastrophic	C0007397
27381206	health expenditure	C0015318
27381206	CHE	C0015318
27381206	prevalence	C0683919
27381206	determinants	C1521761
27381206	empty-nest	C0870492
27381206	non-empty-nest	C1254370
27381206	elderly	C0001792
27381206	households	C0020052
27381206	Shandong province of China	C0008115
27381206	total	C0439810
27381206	elderly	C0001792
27381206	households	C0020052
27381206	included	C0332257
27381206	analysis	C0936012
27381206	CHE	C0015318
27381206	incidence	C0021149
27381206	elderly	C0001792
27381206	households	C0020052
27381206	CHE	C0015318
27381206	incidence	C0021149
27381206	empty-nest	C0870492
27381206	singles	C1549113
27381206	empty-nest	C0870492
27381206	couples	C0010222
27381206	statistically	C0871425
27381206	higher	C0205250
27381206	non-empty-nest	C1254370
27381206	elderly	C0001792
27381206	households	C0020052
27381206	inverse association	C1708567
27381206	observed	C1441672
27381206	CHE	C0015318
27381206	incidence	C0021149
27381206	income level	C0870689
27381206	elderly	C0001792
27381206	household	C0020052
27381206	types	C0332307
27381206	Factors	C1521761
27381206	including	C0332257
27381206	household	C0020052
27381206	elderly members	C0001792
27381206	non-communicable chronic diseases	C0008679
27381206	elderly	C0001792
27381206	household members	C0015578
27381206	hospitalised	C0701159
27381206	past year	C4086728
27381206	lower	C2003888
27381206	household	C0020052
27381206	income	C0021162
27381206	significant	C0750502
27381206	risk factors	C0035648
27381206	CHE	C0015318
27381206	household	C0020052
27381206	types	C0332307
27381206	Health insurance	C0021682
27381206	status	C0449438
27381206	significant	C0750502
27381206	determinant	C1521761
27381206	CHE	C0015318
27381206	empty-nest	C0870492
27381206	singles	C1549113
27381206	non-empty-nest	C1254370
27381206	households	C0020052
27381206	CHE	C0015318
27381206	incidence	C0021149
27381206	elderly	C0001792
27381206	households	C0020052
27381206	high	C0205250
27381206	China	C0008115
27381206	Empty-nest	C0870492
27381206	households	C0020052
27381206	higher	C0205250
27381206	risk	C0035647
27381206	CHE	C0015318
27381206	non-empty-nest	C1254370
27381206	households	C0020052
27381206	findings	C0243095
27381206	suggest	C1705535
27381206	special	C0205555
27381206	insurance	C0021682
27381206	broaden	C0332464
27381206	coverage	C1551362
27381206	health services	C0018747
27381206	heighten	C0442803
27381206	reimbursement rate	C0554896
27381206	empty-nest	C0870492
27381206	elderly	C0001792
27381206	health insurance	C0021682
27381206	schemes	C1519193
27381206	Financial	C2350008
27381206	social protection	C0242457
27381206	interventions	C0262765
27381206	essential	C0205224
27381206	identifie	C0205396
27381206	at-risk	C1444641
27381206	subgroups	C1515021
27381206	elderly	C0001792
27381206	households	C0020052
27381670	agonistic autoantibodies	C0004358
27381670	type-1 angiotensin II receptor	C0529330
27381670	pathogenesis	C0699748
27381670	retinopathy	C0035309
27381670	preeclampsia	C0032914
27381670	investigate	C1292732
27381670	mechanism	C0441712
27381670	AT1-AA	C0021054
27381670	retinopathy	C0035309
27381670	preeclampsia	C0032914
27381670	positive rate	C1521828
27381670	titer	C0475208
27381670	AT1-AA	C0021054
27381670	plasma	C0032105
27381670	women	C0043210
27381670	severe preeclampsia	C0341950
27381670	pregnant women	C0033011
27381670	AT1-AA	C0021054
27381670	titer	C0475208
27381670	correlated	C1707520
27381670	retinopathy	C0035309
27381670	preeclampsia	C0032914
27381670	rat	C0034721
27381670	model	C0887965
27381670	intravenous injection	C0021494
27381670	AT1-AA	C0021054
27381670	plasma	C0032105
27381670	patient	C0030705
27381670	severe preeclampsia	C0341950
27381670	plasma	C0032105
27381670	titer	C0475208
27381670	positive rate	C1521828
27381670	AT1-AA	C0021054
27381670	women	C0043210
27381670	severe preeclampsia	C0341950
27381670	pregnant women	C0033011
27381670	antibody	C0003241
27381670	titer	C0475208
27381670	preeclampsia	C0032914
27381670	retinopathy	C0035309
27381670	correlated	C1707520
27381670	TNF-α	C1456820
27381670	VEGF	C1256770
27381670	animal experiment	C0205664
27381670	results	C1274040
27381670	modeled rats	C0034721
27381670	symptoms	C1457887
27381670	symptoms	C1457887
27381670	human	C0086418
27381670	preeclampsia	C0032914
27381670	retinopathy	C0035309
27381670	Ocular fundus	C4071854
27381670	examination	C0582103
27381670	retinal microvascular abnormalities	C0035300
27381670	hemorrhaging	C0019080
27381670	leakage	C4281748
27381670	severe preeclampsia	C0341950
27381670	Morphological changes	C1254362
27381670	edema	C0013604
27381670	thickening	C0205400
27381670	INL	C1512784
27381670	ONL	C0507777
27381670	pigment atrophy	C0243095
27381670	TNF-α	C1456820
27381670	VEGF	C1256770
27381670	vitreous humor	C0229096
27381670	retina	C0035298
27381670	model rats	C0034721
27381670	studies	C2603343
27381670	results	C1274040
27381670	abnormal expression	C0017262
27381670	AT1-AA	C0021054
27381670	damage	C1883709
27381670	retinal capillary endothelial cells	C0225336
27381670	vascular permeability	C0162337
27381670	resulting in	C0332294
27381670	retinopathy	C0035309
27382289	Characterizing	C1880022
27382289	sexual function	C0278092
27382289	patients	C0030705
27382289	generalized anxiety disorder	C0270549
27382289	pooled analysis	C0242481
27382289	vilazodone	C1530072
27382289	studies	C0002783
27382289	Vilazodone	C1530072
27382289	reduce	C0392756
27382289	core symptoms	C1457887
27382289	generalized anxiety disorder	C0270549
27382289	GAD	C0270549
27382289	randomized	C0206035
27382289	double-blind	C0013072
27382289	placebo-controlled trials	C0599724
27382289	sexual dysfunction	C0549622
27382289	SD	C0549622
27382289	GAD	C0270549
27382289	post hoc analysis	C0242481
27382289	trials	C0008976
27382289	evaluate	C0220825
27382289	effects of	C1704420
27382289	vilazodone	C1530072
27382289	sexual functioning	C0278092
27382289	GAD	C0270549
27382289	patients	C0030705
27382289	Data	C1511726
27382289	pooled	C2349200
27382289	fixed-dose trial	C0008976
27382289	vilazodone	C1530072
27382289	mg/day	C0439422
27382289	NCT01629966	C0282574
27382289	flexible-dose studies	C0242481
27382289	vilazodone	C1530072
27382289	mg/day	C0439422
27382289	NCT01766401	C0282574
27382289	NCT01844115	C0282574
27382289	adults	C0001675
27382289	GAD	C0270549
27382289	Sexual functioning	C0278092
27382289	assessed	C1516048
27382289	Changes in Sexual Functioning Questionnaire	C0034394
27382289	CSFQ	C0034394
27382289	Outcomes	C0086750
27382289	mean change from baseline to end of treatment	C0392762
27382289	EOT	C0205556
27382289	CSFQ total score	C2960025
27382289	percentage	C0439165
27382289	patients	C0030705
27382289	shifting	C0333051
27382289	SD	C0549622
27382289	baseline	C1442488
27382289	CSFQ total score	C2960025
27382289	males	C0025266
27382289	females	C0043210
27382289	normal functioning	C4296962
27382289	EOT	C0205556
27382289	Treatment-emergent adverse events	C0877248
27382289	sexual functioning	C0278092
27382289	analyzed	C0936012
27382289	total	C0439810
27382289	patients	C0030705
27382289	analyses	C0936012
27382289	SD	C0549622
27382289	baseline	C1442488
27382289	females	C0043210
27382289	placebo	C1696465
27382289	vilazodone	C1530072
27382289	males	C0025266
27382289	placebo	C1696465
27382289	vilazodone	C1530072
27382289	CSFQ total score	C2960025
27382289	improvement	C2986411
27382289	females	C0043210
27382289	placebo	C1696465
27382289	vilazodone	C1530072
27382289	males	C0025266
27382289	placebo	C1696465
27382289	vilazodone	C1530072
27382289	no statistically significant differences	C3842396
27382289	treatment	C1522326
27382289	groups	C0441833
27382289	percentage	C0439165
27382289	patients	C0030705
27382289	shifted	C0333051
27382289	SD	C0549622
27382289	baseline	C1442488
27382289	normal	C0205307
27382289	sexual functioning	C0278092
27382289	EOT	C0205556
27382289	males	C0025266
27382289	placebo	C1696465
27382289	vilazodone	C1530072
27382289	females	C0043210
27382289	placebo	C1696465
27382289	vilazodone	C1530072
27382289	no statistical testing	C3841003
27382289	erectile dysfunction	C0242350
27382289	delayed ejaculation	C0234047
27382289	vilazodone	C1530072
27382289	treated	C1522326
27382289	males	C0025266
27382289	no treatment-emergent adverse events	C1963761
27382289	sexual functioning	C0278092
27382289	occurred	C1709305
27382289	patients	C0030705
27382289	treatment	C1522326
27382289	group	C0441833
27382289	Approximately	C0332232
27382289	patients	C0030705
27382289	vilazodone	C1530072
27382289	GAD	C0270549
27382289	studies	C0002783
27382289	SD	C0549622
27382289	baseline	C1442488
27382289	Vilazodone	C1530072
27382289	placebo	C1696465
27382289	effects	C1280500
27382289	CSFQ	C0034394
27382289	outcomes	C0086750
27382289	females	C0043210
27382289	males	C0025266
27382289	limited	C0439801
27382289	adverse impact	C0879626
27382289	sexual functioning	C0278092
27382289	vilazodone	C1530072
27385165	Biogeochemical	C0205474
27385165	Controls	C0243148
27385165	Uranium	C0041928
27385165	Bioavailability	C0005508
27385165	Dissolved Phase	C1948047
27385165	Natural	C0205296
27385165	Freshwaters	C0016710
27385165	risks	C0035647
27385165	associated with	C0332281
27385165	uranium	C0041928
27385165	U	C0041928
27385165	mining	C0026175
27385165	processing	C1709694
27385165	investigated	C1292732
27385165	biogeochemical	C0205474
27385165	controls	C0243148
27385165	U	C0041928
27385165	bioavailability	C0005508
27385165	freshwater	C0016710
27385165	species	C1705920
27385165	Lymnaea stagnalis	C0323913
27385165	Gastropoda	C0324023
27385165	Bioavailability	C0005508
27385165	dissolved U(VI)	C0041928
27385165	characterized	C1880022
27385165	controlled	C2587213
27385165	laboratory	C0022877
27385165	experiments	C0681814
27385165	water	C0043047
27385165	hardness	C0018599
27385165	pH	C0020283
27385165	presence	C0150312
27385165	complexing ligands	C0023688
27385165	dissolved natural organic matter	C0567360
27385165	DOM	C0567360
27385165	Results	C0456984
27385165	dissolved U	C0041928
27385165	bioavailable	C0935763
27385165	geochemical conditions	C0017448
27385165	tested	C0039593
27385165	Uranium	C0041928
27385165	uptake	C0243144
27385165	rates	C1521828
27385165	first order kinetics	C0878685
27385165	environmental	C0014406
27385165	concentrations	C1446561
27385165	Uranium	C0041928
27385165	uptake	C0243144
27385165	rates	C1521828
27385165	L. stagnalis	C0323913
27385165	saturation	C0522534
27385165	uptake	C0243144
27385165	kinetics	C0022702
27385165	exposure	C0332157
27385165	concentrations	C1446561
27385165	suggesting	C1705535
27385165	uptake	C0243144
27385165	ion channels	C0022009
27385165	U	C0041928
27385165	uptake	C0243144
27385165	constants	C1547014
27385165	Ca	C0006675
27385165	uptake	C0243144
27385165	rates	C1521828
27385165	suggest	C1705535
27385165	U	C0041928
27385165	Ca	C0006675
27385165	membrane transporters	C0596902
27385165	U	C0041928
27385165	bioavailability	C0005508
27385165	decreases	C0442797
27385165	increasing	C0442808
27385165	pH	C0020283
27385165	increasing	C0442808
27385165	Ca	C0006675
27385165	Mg	C0024467
27385165	concentrations	C1446561
27385165	DOM	C0567360
27385165	present	C0150312
27385165	ions	C0022023
27385165	U	C0041928
27385165	uptake	C0243144
27385165	rates	C1521828
27385165	Speciation modeling	C0870071
27385165	formation	C1522492
27385165	constants	C1547014
27385165	U	C0041928
27385165	ternary complexes	C1254350
27385165	reveals	C0443289
27385165	aqueous	C0599956
27385165	concentration	C1446561
27385165	dicarbonato U	C0041928
27385165	species	C1705920
27385165	U	C0041928
27385165	bioavailability	C0005508
27385165	L. stagnalis	C0323913
27385165	free-ion activity	C0441655
27386263	Interleukin-21	C0962190
27386263	pathogenesis	C0699748
27386263	type I autoimmune hepatitis	C4303164
27386263	follicular	C1571705
27386263	helper T (Tfh) cells	C0018894
27386263	interleukin (IL)-21	C0962190
27386263	peripheral blood	C0229664
27386263	human	C0086418
27386263	murine	C0026809
27386263	models	C0012644
27386263	autoimmune hepatitis	C0241910
27386263	AIH	C0241910
27386263	IL-21	C0962190
27386263	type-I cytokine family	C0079189
27386263	immune system	C0020962
27386263	B cell activation	C1155003
27386263	plasma cell differentiation	C1817697
27386263	immunoglobulin production	C0003261
27386263	serum	C0229671
27386263	IL-21	C0962190
27386263	levels	C0441889
27386263	patients	C0030705
27386263	type I AIH	C4303164
27386263	clinical	C0205210
27386263	laboratory	C0022877
27386263	parameters	C0549193
27386263	histology	C0019638
27386263	Japanese	C1556094
27386263	patients	C0030705
27386263	liver disease	C0023895
27386263	AIH	C0241910
27386263	primary biliary cholangitis	C0008312
27386263	drug-induced liver injury	C0860207
27386263	acute hepatitis B	C0276609
27386263	chronic hepatitis C	C0524910
27386263	non-alcoholic steatohepatitis	C3241937
27386263	viral hepatitis	C0042721
27386263	healthy volunteers	C1708335
27386263	Serum	C0229671
27386263	IL-21	C0962190
27386263	levels	C0441889
27386263	enzyme-linked immunosorbent assay	C0014441
27386263	Real-time polymerase chain reaction	C1709846
27386263	mRNA	C0035696
27386263	levels	C0441889
27386263	Bcl-6	C1332399
27386263	IL-21	C1416406
27386263	CXCR5	C1332421
27386263	Tfh-related factors	C0033684
27386263	peripheral	C0205100
27386263	mononuclear cells	C0806987
27386263	diagnosis	C0011900
27386263	AIH	C0241910
27386263	male-to-female ratio	C0243095
27386263	cirrhosis	C0023890
27386263	severe	C0205082
27386263	disease	C0012634
27386263	IL-21	C0962190
27386263	levels	C0441889
27386263	increased	C0205217
27386263	serum	C0229671
27386263	patients	C0030705
27386263	AIH	C0241910
27386263	other liver diseases	C0156194
27386263	controls	C0009932
27386263	serum	C0229671
27386263	IL-21	C0962190
27386263	levels	C0441889
27386263	increased	C0205217
27386263	severe	C0205082
27386263	AIH	C0241910
27386263	Serum	C0229671
27386263	IL-21	C0962190
27386263	levels	C0441889
27386263	serum	C0229671
27386263	bilirubin levels	C0344395
27386263	grading of necroinflammatory activity	C1954433
27386263	serum albumin levels	C0728877
27386263	patients	C0030705
27386263	AIH	C0241910
27386263	patients	C0030705
27386263	biochemical	C0205474
27386263	remission	C0544452
27386263	AIH	C0241910
27386263	serum	C0229671
27386263	IL-21	C0962190
27386263	levels	C0441889
27386263	elevated	C3163633
27386263	correlated	C1707520
27386263	positively	C1514241
27386263	serum IgG levels	C2732508
27386263	Expression	C1171362
27386263	Tfh-related factors	C0033684
27386263	Bcl-6	C1448774
27386263	IL-21	C0962190
27386263	peripheral blood mononuclear cells	C1321301
27386263	patients	C0030705
27386263	AIH	C0241910
27386263	higher	C0205250
27386263	healthy volunteers	C1708335
27386263	IL-21	C0962190
27386263	pathogenesis	C0699748
27386263	AIH	C0241910
27386263	AIH	C0241910
27386263	therapy	C0039798
27388962	Resistance	C4281815
27388962	Exercise	C0015259
27388962	Pregnancy	C0032961
27388962	Outcome	C0032972
27388962	health benefits	C0086387
27388962	exercise	C0015259
27388962	traditional advice	C0150600
27388962	rest	C0035253
27388962	pregnancy	C0032961
27388962	changed	C0392747
27388962	healthy	C3898900
27388962	active	C0205177
27388962	pregnancy	C0032961
27388962	exercise	C0015259
27388962	life	C0376558
27388962	pregnant woman	C0033011
27388962	benefits	C0814225
27388962	combination	C0205195
27388962	resistance	C4281815
27388962	aerobic exercises	C0001701
27388962	studies	C2603343
27388962	resistance	C4281815
27388962	training programs	C0040607
27388962	no adverse	C0853204
27388962	outcomes	C0032972
27390504	ocular prosthesis	C0015417
27390504	rehabilitation	C0034991
27390504	child	C0008059
27390504	retinoblastoma	C0035335
27390504	maxillofacial prosthodontist	C2193570
27390504	important	C3898777
27390504	management of a patient	C1610129
27390504	anopthalmosis	C0003119
27390504	Prosthetic management	C0087111
27390504	anopthalmic defect	C0003119
27390504	ocular prosthesis	C0015417
27390504	eye	C0015392
27390504	patient's	C0030705
27390504	self-confidence	C0237529
27390504	rehabilitating	C0034992
27390504	society	C0037455
27390504	fabrication	C0087111
27390504	ocular prosthesis	C0015417
27390504	case report	C0007320
27390504	technique	C0449851
27390504	fabrication	C0087111
27390504	ocular prosthesis	C0015417
27390504	child	C0008059
27390504	lost	C0745777
27390504	eye	C0015392
27390504	enucleation	C0014392
27390504	retinoblastoma	C0035335
27390504	rehabilitation	C0034991
27390504	self-image	C2712201
27390504	child	C0008059
27390849	Pulmonary function	C0231921
27390849	health-related quality of life	C4279947
27390849	year	C0439234
27390849	follow up	C1522577
27390849	cardiac surgery	C0018821
27390849	Pulmonary function	C0231921
27390849	severely	C0205082
27390849	reduced	C0392756
27390849	early	C1279919
27390849	period	C1948053
27390849	cardiac surgery	C0018821
27390849	impairments	C0684336
27390849	months	C0439231
27390849	after surgery	C0032790
27390849	Evaluation	C0220825
27390849	pulmonary function	C0231921
27390849	lacking	C0332268
27390849	prospective study	C0033522
27390849	pulmonary function	C0231921
27390849	health-related quality of life	C4279947
27390849	investigated	C1292732
27390849	year	C0439234
27390849	cardiac surgery	C0018821
27390849	Pulmonary function	C0231921
27390849	measurements	C0242485
27390849	health-related quality of life	C4279947
27390849	SF-36	C1519136
27390849	dyspnoea	C0013404
27390849	subjective	C0439655
27390849	breathing	C0035203
27390849	coughing	C0010200
27390849	ability	C0085732
27390849	pain	C0030193
27390849	evaluated	C0220825
27390849	before	C0332152
27390849	year	C0439234
27390849	after surgery	C0032790
27390849	patients	C0030705
27390849	coronary artery bypass grafting	C0010055
27390849	valve surgery	C0543467
27390849	surgery	C0543467
27390849	year	C0439234
27390849	after surgery	C0032790
27390849	forced vital capacity	C0231958
27390849	forced expiratory volume	C0016529
27390849	decreased	C0205216
27390849	compared	C1707455
27390849	preoperative	C0445204
27390849	values	C1522609
27390849	Saturation of peripheral oxygen	C2317096
27390849	unchanged	C0442739
27390849	year	C0439234
27390849	postoperatively	C0032790
27390849	compared	C1707455
27390849	baseline	C1442488
27390849	improved	C0184511
27390849	health-related quality of life	C4279947
27390849	year	C0439234
27390849	after surgery	C0032790
27390849	improvements	C2986411
27390849	aspects	C1879746
27390849	SF-36	C1519136
27390849	Sternotomy	C0185792
27390849	pain	C0030193
27390849	low	C0205251
27390849	year	C0439234
27390849	postoperatively	C0032790
27390849	at rest	C0443144
27390849	deep breath	C1321587
27390849	coughing	C0010200
27390849	pulmonary function	C0231921
27390849	associated with	C0332281
27390849	dyspnoea	C0013404
27390849	limitations	C0449295
27390849	impaired	C0684336
27390849	subjective	C0439655
27390849	breathing	C0035203
27390849	coughing	C0010200
27390849	ability	C0085732
27390849	year	C0439234
27390849	cardiac surgery	C0018821
27390849	static	C0441463
27390849	dynamic	C0729333
27390849	lung function measurements	C0024119
27390849	decreased	C0205216
27390849	health-related quality of life	C4279947
27390849	improved	C0184511
27390849	comparison	C1707455
27390849	preoperative	C0445204
27390849	values	C1522609
27390849	Measured	C0444706
27390849	levels	C0441889
27390849	pain	C0030193
27390849	low	C0205251
27390849	saturation of peripheral oxygen	C2317096
27390849	same	C0445247
27390849	preoperatively	C0445204
27391592	Impact	C4049986
27391592	Soil	C0037592
27391592	Salinity	C0392762
27391592	Structure	C0678594
27391592	Bacterial	C0004611
27391592	Endophytic	C1265415
27391592	Community	C0009462
27391592	Identified	C0205396
27391592	Roots	C0242726
27391592	Caliph Medic	C0330774
27391592	Medicago truncatula	C0330774
27391592	forage crop	C0032098
27391592	Caliph medic	C0330774
27391592	Medicago truncatula	C0330774
27391592	model legume plant	C1514135
27391592	molecular characterization	C1880022
27391592	interaction	C1704675
27391592	rhizobia	C0004611
27391592	plants	C0032098
27391592	endophytic microbiome	C1956108
27391592	plant	C0032098
27391592	Endophytic	C1265415
27391592	bacteria	C0004611
27391592	plants	C0032098
27391592	requirements	C1514873
27391592	growth	C0597252
27391592	development	C0597252
27391592	bacteria	C0004611
27391592	mechanism	C0441712
27391592	salinity stress	C1254365
27391592	adaptation	C0392673
27391592	plants	C0032098
27391592	isolation	C0220862
27391592	utilization	C0042153
27391592	bacteria	C0004611
27391592	Caliph medic	C0330774
27391592	farming	C0557759
27391592	bacterial	C0004611
27391592	OTUs	C0008902
27391592	identified	C0205396
27391592	interior	C0205102
27391592	roots	C0242726
27391592	plant	C0032098
27391592	pyrosequencing	C2732543
27391592	small ribosomal subunit gene	C0017337
27391592	16S rDNA	C0017337
27391592	cultivation-independent approach	C0022885
27391592	differential	C0443199
27391592	abundance	C2346714
27391592	bacteria	C0004611
27391592	plants	C0032098
27391592	salinity stress	C1254365
27391592	high-quality reads	C0392762
27391592	sequencing	C1294197
27391592	libraries	C0017272
27391592	control	C0040300
27391592	salinity-treated tissues	C0040300
27391592	Statistical analysis	C0871424
27391592	abundance	C2346714
27391592	OTUs	C0008902
27391592	roots	C0242726
27391592	exposed to	C0332157
27391592	salinity stress	C1254365
27391592	Sequence analysis	C0162801
27391592	identified	C0205396
27391592	species	C1705920
27391592	growth-promoting bacteria	C0004611
27391592	marine	C0599383
27391592	salt-stressed soil-borne bacteria	C0004611
27391592	nitrogen-fixing bacterial	C4277688
27391592	isolates	C1764827
27391592	bacteria	C0004611
27391592	community	C0009462
27391592	salinity stress	C1254365
27391592	Caliph medic	C0330774
27391592	association	C0439849
27391592	endophytes	C1265415
27391592	salt stress conditions	C1254365
27391592	model plant	C1514135
27391592	evidence	C3887511
27391592	growth promoting activity	C0441655
27391592	group	C0441833
27391592	endophytic	C1265415
27391592	bacteria	C0004611
27391592	isolated	C0205409
27391592	plant roots	C0242726
27391592	cultivation-dependent approach	C0022885
27391592	isolates	C1764827
27391592	ACC-deaminase	C0044278
27391592	ammonia	C0002607
27391592	IAA	C0936060
27391592	solubilize	C0205245
27391592	Zn+2	C0043481
27391592	PO4-3	C1601799
27391592	data	C1511726
27391592	occurrence	C2745955
27391592	cultivation-independent techniques	C0022885
27391592	bacteria	C0004611
27391592	endophytic	C1265415
27391592	bacteria	C0004611
27391592	Caliph medic	C0330774
27391592	normal	C0205307
27391592	saline	C0036082
27391592	conditions	C0348080
27392220	Cancer Stem Cells	C1956422
27392220	CML	C0023473
27392220	Transcriptional	C0040649
27392220	Therapy	C0087111
27392220	Leukemia	C0023418
27392220	stem cells	C1956422
27392220	LSCs	C1956422
27392220	therapies	C0087111
27392220	chronic myeloid leukemia	C0023473
27392220	CML	C0023473
27392220	molecular network	C1148560
27392220	critical	C0231242
27392220	CML	C0023473
27392220	LSC	C1956422
27392220	survival	C0007620
27392220	transcriptional regulators	C0040648
27392220	p53	C0079419
27392220	c-Myc	C0314684
27392220	eradication	C2248542
27393222	Crocetin	C0056501
27393222	improves	C0184511
27393222	quality	C0332306
27393222	in vitro	C1533691
27393222	produced	C0205245
27393222	bovine	C3667982
27393222	embryos	C0013935
27393222	blastocyst development	C1326531
27393222	cryotolerance	C1704410
27393222	apoptosis	C0162638
27393222	assess	C0184514
27393222	effect	C1280500
27393222	supplementation	C0087111
27393222	bovine	C3667982
27393222	culture medium	C0010454
27393222	natural antioxidant	C0003402
27393222	crocetin	C0056501
27393222	in vitro	C1533691
27393222	blastocyst development	C1326531
27393222	quality	C0332306
27393222	evaluated	C0220825
27393222	cryotolerance	C1704410
27393222	apoptosis index	C0918012
27393222	total cells number	C0007584
27393222	allocation	C1706778
27393222	Abattoir	C0000715
27393222	oocytes	C0029045
27393222	matured	C0205286
27393222	fertilized	C0232904
27393222	in vitro	C1533691
27393222	standard procedure	C1710183
27393222	hours	C0439227
27393222	IVF	C0015915
27393222	presumptive	C3640893
27393222	zygotes	C0043544
27393222	cultured	C0430400
27393222	synthetic oviduct	C0029954
27393222	fluid medium	C1705217
27393222	crocetin	C0056501
27393222	humidified air	C0508271
27393222	CO2	C0007012
27393222	O2	C0030054
27393222	N2	C0028158
27393222	Day	C0439228
27393222	embryo yields	C0392762
27393222	assessed	C1516048
27393222	blastocysts	C1281743
27393222	Cryotop method	C0025663
27393222	ethylene glycol	C0015083
27393222	DMSO	C0012403
27393222	sucrose	C0038636
27393222	blastocysts	C1281743
27393222	Day	C0439228
27393222	absence	C0332197
27393222	control	C0009932
27393222	presence	C0150312
27393222	crocetin	C0056501
27393222	terminal deoxynucleotidyl transferase-mediated dUTP nick end labelling	C1515232
27393222	differential staining	C0487602
27393222	evaluate	C0220825
27393222	apoptotic rate	C1521828
27393222	allocation	C1706778
27393222	cells	C0007634
27393222	inner cell mass	C1283994
27393222	ICM	C1283994
27393222	trophectoderm	C0041178
27393222	TE	C0041178
27393222	lineages	C1881379
27393222	Embryo development	C0013936
27393222	crocetin group	C0441833
27393222	control	C0009932
27393222	total	C0439810
27393222	embryo	C0013935
27393222	output	C4263297
27393222	grade 1	C1275673
27393222	2	C1275673
27393222	blastocysts	C1281743
27393222	percentage	C1549488
27393222	fast-developing embryos	C0013936
27393222	increased	C0205217
27393222	crocetin group	C0441833
27393222	control	C0009932
27393222	enrichment of culture medium	C3503937
27393222	crocetin	C0056501
27393222	improved	C0184511
27393222	embryo	C0013935
27393222	cryotolerance	C1704410
27393222	control	C0009932
27393222	hatching	C0598016
27393222	rates	C1521828
27393222	hours	C0439227
27393222	postwarming culture	C0010454
27393222	crocetin	C0056501
27393222	decreased	C0205216
27393222	percentage	C1549488
27393222	apoptotic	C1516044
27393222	cells	C0007634
27393222	blastocysts	C1281743
27393222	control	C0009932
27393222	ICM	C1283994
27393222	TE	C0041178
27393222	total	C0439810
27393222	total	C0439810
27393222	cells	C0007634
27393222	crocetin	C0056501
27393222	control	C0009932
27393222	enrichment of bovine culture medium	C3503937
27393222	crocetin	C0056501
27393222	increased	C0205217
27393222	blastocyst yield	C0392762
27393222	quality	C0332306
27393222	improved	C0184511
27393222	chronology	C0008717
27393222	embryo development	C0013936
27393222	increased	C0205217
27393222	resistance	C4281815
27393222	cryopreservation	C0519951
27393222	reduced incidence	C0021149
27393222	apoptosis	C0162638
27401811	Matrix solid-phase dispersion	C0022885
27401811	liquid chromatography-tandem mass spectrometry	C4049918
27401811	determination	C1148554
27401811	paraben	C0030398
27401811	preservatives	C0033086
27401811	mollusks	C0026391
27401811	method for the extraction	C0449341
27401811	determination	C1148554
27401811	parabens	C0030398
27401811	esters	C0014898
27401811	4-hydroxybenzoic acid	C0048323
27401811	preservatives	C0033086
27401811	personal care products	C4288402
27401811	pharmaceuticals	C1254351
27401811	chlorinated derivatives	C0020247
27401811	mono-	C0066415
27401811	di-chloro methyl paraben	C0066415
27401811	mollusk	C0026391
27401811	samples	C2347026
27401811	matrix solid-phase dispersion	C0022885
27401811	MSPD	C0022885
27401811	liquid chromatography-tandem mass spectrometry	C4049918
27401811	MSPD parameters	C2825207
27401811	solvent	C0037638
27401811	solid support	C1254353
27401811	clean-up sorbent	C1254353
27401811	optimized	C2698650
27401811	parabens	C0030398
27401811	investigated	C1292732
27401811	precleaning	C1947930
27401811	sorbents	C1254353
27401811	freeze-dried	C0016698
27401811	mollusk	C0026391
27401811	dispersed	C0332624
27401811	silica	C0037098
27401811	packed	C2828395
27401811	cartridge	C1553461
27401811	C18	C0029224
27401811	clean-up sorbent	C1254353
27401811	cartridge	C1553461
27401811	acetonitrile	C0050456
27401811	evaporated	C0596539
27401811	reconstituted	C0441655
27401811	methanol	C0001963
27401811	analysis	C0936012
27401811	validation	C1519941
27401811	recoveries	C0237820
27401811	analytes	C0443354
27401811	precision	C1706245
27401811	limits of detection	C2718050
27401811	quantification	C0392762
27401811	LOD	C2718050
27401811	LOQ	C1519941
27401811	dry weight	C1439839
27401811	levels	C0441889
27401811	methodology	C0969625
27401811	mussel	C0026871
27401811	clam	C0008894
27401811	cockle	C0453050
27401811	samples	C2347026
27401811	Methyl paraben	C0066415
27401811	LOQ	C0392762
27401811	samples	C2347026
27401811	clam	C0008894
27401811	sample	C2347026
27401811	concentrations	C1446561
27401811	dry weight	C1439839
27401811	Ethyl paraben	C0059788
27401811	LOQ	C0392762
27401811	mussel	C0026871
27401811	cockle	C0453050
27401811	samples	C2347026
27401811	concentration level	C1446561
27401811	n-Propyl paraben	C0072238
27401811	LOQ	C0392762
27401811	mussel	C0026871
27401811	sample	C2347026
27402799	reconstructive	C0524865
27402799	overlapping stent	C0038257
27402799	LEO+	C0038257
27402799	SILK	C0025080
27402799	treatment	C0087111
27402799	intracranial	C0524466
27402799	circumferential	C0205113
27402799	fusiform aneurysms	C0333099
27402799	posterior	C1254362
27402799	circulation	C0005775
27402799	Intracranial	C0524466
27402799	circumferential	C0205113
27402799	fusiform aneurysms	C0333099
27402799	posterior	C1254362
27402799	circulation	C0005775
27402799	arterial branches	C0003842
27402799	perforating	C0549099
27402799	vessels	C0005847
27402799	vessels	C0005847
27402799	difficult	C0332218
27402799	treat	C1522326
27402799	endovascular	C0524425
27402799	reconstruction technique	C0524865
27402799	telescoping self-expandable stent	C4042807
27402799	LEO+	C0038257
27402799	flow-diverter device	C0025080
27402799	SILK	C0025080
27402799	different	C1705242
27402799	surgical times	C3494201
27402799	patients	C0030705
27402799	circumferential	C0205113
27402799	fusiform aneurysm	C0333099
27402799	aneurysm	C0002940
27402799	posterior cerebral artery	C0149576
27402799	diagnosed	C0011900
27402799	headache	C0018681
27402799	partially	C0728938
27402799	thrombosed aneurysm	C1265766
27402799	lower	C1548802
27402799	basilar artery	C0004811
27402799	diagnosed	C0011900
27402799	ischemia	C0022116
27402799	brain stem	C0006121
27402799	Endovascular	C0524425
27402799	treatment	C0524865
27402799	vascular	C0005847
27402799	reconstruction technique	C0524865
27402799	different	C1705242
27402799	surgical times	C3494201
27402799	overlapping; a telescoped self-expandable stent	C2937236
27402799	LEO+	C0038257
27402799	flow-diverter device	C0025080
27402799	SILK	C0025080
27402799	Angiographic	C0002978
27402799	control	C0243148
27402799	months	C0439231
27402799	arterial patency	C1508228
27402799	flow	C0806140
27402799	maintenance	C0024501
27402799	arterial branches	C0003842
27402799	perforating	C0549099
27402799	vessels	C0005847
27402799	thrombosis	C0040053
27402799	aneurysm	C0002940
27402799	combined	C0205195
27402799	different	C1705242
27402799	surgical times	C3494201
27402799	self-expandable stent	C4042807
27402799	flow-diverter device	C0025080
27402799	successful	C1272703
27402799	patients	C0030705
27402799	complications	C0009566
27402799	procedure	C2700391
27402799	long-term	C0443252
27402799	follow-up	C1522577
27402799	arterial	C0003842
27402799	vascular	C0005847
27402799	reconstruction	C0524865
27402799	maintenance	C0024501
27402799	cerebral perfusion	C3162005
27402799	complete	C0205197
27402799	aneurysm	C0002940
27402799	occlusion	C0441597
27402799	month	C0439231
27402799	angiographic	C0002978
27402799	follow-up	C1522577
27402799	aneurysm recanalization	C3854508
27402799	intra-stent stenosis	C1261287
27402799	Circumferential	C0205113
27402799	fusiform aneurysm	C0333099
27402799	posterior	C1254362
27402799	circulation	C0005775
27402799	arterial branches	C0003842
27402799	perforating	C0549099
27402799	vessels	C0005847
27402799	brain stem	C0006121
27402799	treated	C1522326
27402799	arterial	C0003842
27402799	reconstruction technique	C0524865
27402799	different	C1705242
27402799	surgical times	C3494201
27402799	self-expandable stent	C4042807
27402799	LEO+	C0038257
27402799	flow-diverter device	C0025080
27402799	SILK	C0025080
27402799	minimizing	C0392756
27402799	risk	C0035647
27402799	complications	C0009566
27402799	failure	C0231175
27402799	endovascular	C0524425
27402799	technique	C0524865
27402799	potential	C3245505
27402799	arterial reconstruction	C2937236
27402799	thrombosis	C0040053
27402799	aneurysmatic sac	C0002940
27402799	flow	C0806140
27402799	maintenance	C0024501
27402799	eloquent arteries	C0003842
27402799	cerebral aneurysm	C0917996
27403678	Polysaccharide	C0032595
27403678	Specific	C0205369
27403678	Memory B Cells	C0682638
27403678	Protection	C1545588
27403678	Experimental	C1517586
27403678	Human	C0086418
27403678	Pneumococcal	C0038410
27403678	Carriage	C0853960
27403678	previously	C0205156
27403678	experimental	C1517586
27403678	pneumococcal	C0038410
27403678	carriage	C0853960
27403678	enhances	C2349975
27403678	immunity	C0020964
27403678	protects	C1545588
27403678	healthy	C3898900
27403678	adults	C0001675
27403678	against	C0521124
27403678	carriage	C0853960
27403678	reacquisition	C1706701
27403678	rechallenge	C2347900
27403678	homologous	C0301883
27403678	strain	C1518614
27403678	naturally	C0205296
27403678	acquired	C0439661
27403678	pneumococcal protein	C0004627
27403678	polysaccharide	C0032595
27403678	PS	C0032595
27403678	specific	C0205369
27403678	immunity	C0020964
27403678	protection	C1545588
27403678	against	C0521124
27403678	carriage	C0853960
27403678	acquisition	C1706701
27403678	heterologous challenge	C3658217
27403678	healthy volunteers	C1708335
27403678	naturally	C0205296
27403678	colonized	C1947989
27403678	pneumococcus	C0038410
27403678	clearance	C0449297
27403678	natural	C0205296
27403678	carriage	C0853960
27403678	episode	C0332189
27403678	heterologous	C0301884
27403678	6B strain	C1688613
27403678	cohort	C0599755
27403678	volunteers	C1708335
27403678	6BPS	C0032595
27403678	specific	C0205369
27403678	PspA	C0071312
27403678	specific	C0205369
27403678	PspC	C2000489
27403678	specific	C0205369
27403678	IgG	C0020852
27403678	IgA	C0020835
27403678	plasma	C0032112
27403678	memory B-cell populations	C0682638
27403678	before	C0332152
27403678	after	C0687676
27403678	experimental	C1517586
27403678	pneumococcal	C0038410
27403678	inoculation	C2987620
27403678	Heterologous challenge	C3658217
27403678	6B	C1688613
27403678	carriage	C0853960
27403678	volunteers	C1708335
27403678	previous	C0205156
27403678	natural	C0205296
27403678	pneumococcal	C0038410
27403678	carriage	C0853960
27403678	Protection	C1545588
27403678	carriage	C0853960
27403678	associated with	C0332281
27403678	high	C0205250
27403678	circulating	C0175630
27403678	6BPS	C0032595
27403678	IgG	C0020852
27403678	secreting	C1327616
27403678	memory B cells	C0682638
27403678	baseline	C1442488
27403678	associations	C0439849
27403678	protection	C1545588
27403678	carriage	C0853960
27403678	baseline	C1442488
27403678	levels	C0441889
27403678	6BPS	C0032595
27403678	IgG	C0020852
27403678	serum	C0229671
27403678	nasal wash	C0206289
27403678	PspA	C0071312
27403678	specific	C0205369
27403678	PspC	C2000489
27403678	specific	C0205369
27403678	memory B cells	C0682638
27403678	plasma cells	C0032112
27403678	volunteers	C1708335
27403678	not develop	C0243095
27403678	carriage	C0853960
27403678	circulating	C0175630
27403678	6BPS	C0032595
27403678	memory B cells	C0682638
27403678	decreased	C0205216
27403678	6BPS	C0032595
27403678	plasma cells	C0032112
27403678	increased	C0205217
27403678	postinoculation	C0231291
27403678	naturally	C0205296
27403678	acquired	C0439661
27403678	PS	C0032595
27403678	specific	C0205369
27403678	memory B cells	C0682638
27403678	not levels	C0243095
27403678	circulating	C0175630
27403678	IgG	C0020852
27403678	pneumococcal	C0038410
27403678	exposure	C0332157
27403678	associated with	C0332281
27403678	protection	C1545588
27403678	against	C0521124
27403678	carriage	C0853960
27403678	acquisition	C1706701
27405692	Hounsfield unit	C1552985
27405692	recovery	C0237820
27405692	clinical	C0205210
27405692	cone beam CT	C1956110
27405692	images	C1551337
27405692	thorax	C0817096
27405692	image guided radiation therapy	C3179062
27405692	comprehensive	C1880156
27405692	artefact	C0085089
27405692	correction	C1947976
27405692	method	C0025663
27405692	clinical	C0205210
27405692	cone beam CT	C1956110
27405692	CBCT	C1956110
27405692	images	C1551337
27405692	image guided radiation therapy	C3179062
27405692	IGRT	C3179062
27405692	method	C0025663
27405692	reduce	C0392756
27405692	artefacts	C0085089
27405692	recover	C0237820
27405692	CT	C0040405
27405692	Hounsfield units	C1552985
27405692	HU	C1552985
27405692	reconstructed	C0020912
27405692	CBCT	C1956110
27405692	images	C1551337
27405692	lung cancer	C0242379
27405692	patients	C0030705
27405692	Projection image	C1551337
27405692	artefact	C0085089
27405692	corrections	C1947976
27405692	image lag	C0085089
27405692	detector scatter	C0085089
27405692	body scatter	C0085089
27405692	beam hardening	C2828112
27405692	CBCT	C1956110
27405692	images	C1551337
27405692	lung cancer	C0242379
27405692	patients	C0030705
27405692	Image quality	C0806487
27405692	evaluated	C0220825
27405692	visual	C0234621
27405692	appearance	C0700364
27405692	reconstructed	C0020912
27405692	images	C1551337
27405692	HU	C1552985
27405692	CT	C0040405
27405692	images	C1551337
27405692	total volume	C0449468
27405692	HU	C1552985
27405692	error	C0743559
27405692	Artefacts	C0085089
27405692	reduced	C0392756
27405692	CT	C0040405
27405692	HUs	C1552985
27405692	recovered	C0237820
27405692	artefact	C0085089
27405692	corrected	C0205202
27405692	CBCT	C1956110
27405692	images	C1551337
27405692	Visual inspection	C3669138
27405692	confirms	C0750484
27405692	artefacts	C0085089
27405692	suppressed	C1260953
27405692	method	C0025663
27405692	HU	C1552985
27405692	root mean square	C2347976
27405692	difference	C1705241
27405692	reconstructed	C0020912
27405692	CBCTs	C1956110
27405692	reference	C1706462
27405692	CT	C0040405
27405692	images	C1551337
27405692	reduced	C0392756
27405692	artefact	C0085089
27405692	corrections	C1947976
27405692	compared	C1707455
27405692	standard	C1442989
27405692	clinical	C0205210
27405692	CBCT	C1956110
27405692	reconstruction	C0020912
27405692	artefact	C0085089
27405692	correction	C1947976
27405692	method	C0025663
27405692	clinical	C0205210
27405692	CBCT	C1956110
27405692	images	C1551337
27405692	IGRT	C3179062
27405692	HU	C1552985
27405692	values	C1522609
27405692	recovered	C0237820
27405692	corrected	C0205202
27405692	CBCT	C1956110
27405692	images	C1551337
27405692	method	C0025663
27405692	post processing	C0449935
27405692	clinical	C0205210
27405692	projection images	C1551337
27405692	patient	C0030705
27405692	specific	C0205369
27405692	optimisation	C2698650
27405692	tool	C0037589
27405692	image	C1551337
27405692	quality	C0332306
27405692	improvement	C2986411
27405692	large	C0549177
27405692	numbers	C0237753
27405692	CBCT	C1956110
27405692	images	C1551337
27407027	Risk Factors	C0035648
27407027	Infection	C3714514
27407027	Knee Arthroscopy	C1304878
27407027	Analysis	C0936012
27407027	Cases	C0868928
27407027	United States	C0041703
27407027	Databases	C0242356
27407027	identify	C0205396
27407027	quantify	C1709793
27407027	patient-	C0035648
27407027	procedure-related risk factors	C0035648
27407027	post-arthroscopic	C1254367
27407027	knee infections	C1400580
27407027	dataset	C0150098
27407027	administrative health care database	C0242356
27407027	years	C0439234
27407027	insurers	C0021675
27407027	Medicare	C0018717
27407027	random sample	C0150105
27407027	knee arthroscopies	C1304878
27407027	performed	C0884358
27407027	patients	C0030705
27407027	aged	C0001779
27407027	years	C0439234
27407027	Current Procedural Terminology (CPT) codes	C1136322
27407027	CPT code	C1136322
27407027	high-	C1292781
27407027	low-complexity procedure	C1292781
27407027	incisions	C0184898
27407027	operative time	C3494201
27407027	infections	C3714514
27407027	CPT code	C1136322
27407027	incision	C0184898
27407027	drainage	C0013103
27407027	days	C0439228
27407027	surgery	C0038895
27407027	Superficial infections	C3714514
27407027	International Classification of Diseases, Ninth Revision infection codes	C2346503
27407027	record	C0034869
27407027	incision	C0184898
27407027	drainage	C0013103
27407027	Patients	C0030705
27407027	age	C0001779
27407027	sex	C1522384
27407027	body mass index	C1305855
27407027	tobacco use	C0543414
27407027	presence	C3854307
27407027	diabetes	C0011847
27407027	Charlson Comorbidity Index	C1516737
27407027	patients	C0030705
27407027	arthroscopic knee procedures	C1304878
27407027	postoperative infections	C0392618
27407027	Superficial infections	C3714514
27407027	Tobacco use	C0543414
27407027	morbid obesity	C0028756
27407027	risk factors	C0035648
27407027	deep	C3714514
27407027	superficial infections	C3714514
27407027	relative risk	C0242492
27407027	infection rates	C3714514
27407027	patients	C0030705
27407027	high-complexity arthroscopies	C1304878
27407027	men	C0025266
27407027	obese	C0028754
27407027	patients	C0030705
27407027	diabetic	C0011847
27407027	patients	C0030705
27407027	younger	C0332239
27407027	patients	C0030705
27407027	relative risk	C0242492
27407027	Charlson Comorbidity Index	C1516737
27407027	associated with	C0332281
27407027	superficial	C3714514
27407027	total infections	C3714514
27407027	Post-arthroscopic	C1254367
27407027	knee infections	C1400580
27407027	morbidly obese	C0028756
27407027	patients	C0030705
27407027	tobacco users	C3853727
27407027	patients	C0030705
27407027	complex procedures	C1292781
27407027	men	C0025266
27407027	obese patients	C0030705
27407027	diabetic patients	C0030705
27407027	young patients	C0030705
27407027	patients	C0030705
27407027	comorbidity	C0009488
27407027	population	C0032659
27407027	preoperative counseling	C0920638
27407027	aid surgeons	C0582175
27407027	patient selection	C0242802
27407027	infection prevention	C0547605
27407027	individuals	C0237401
27407027	inherent risk	C0035647
27407027	cross-sectional study	C0010362
27412368	Association	C0439849
27412368	prenatal	C0678804
27412368	exposure to	C0332157
27412368	tetrachloroethylene	C0039637
27412368	PCE	C0039637
27412368	polycystic ovary syndrome	C0032460
27412368	reproductive disorders	C1659749
27412368	cape cod	C0017446
27412368	health study	C0008972
27412368	retrospective cohort study	C0035363
27412368	Tetrachloroethylene	C0039637
27412368	PCE	C0039637
27412368	organic	C0747055
27412368	lipophilic	C0598631
27412368	solvent	C0037638
27412368	neuroendocrine	C0027912
27412368	toxicity	C0040539
27412368	objective	C0018017
27412368	study	C2603343
27412368	association	C0439849
27412368	prenatal	C0678804
27412368	early childhood	C0599196
27412368	exposure to	C0332157
27412368	PCE	C0039637
27412368	contaminated	C0205279
27412368	drinking water	C0599638
27412368	development	C0243107
27412368	adult-onset	C1853562
27412368	Polycystic Ovary Syndrome	C0032460
27412368	PCOS	C0032460
27412368	endometriosis	C0014175
27412368	difficulty conceiving	C0013418
27412368	miscarriage	C0000786
27412368	exposed	C0332157
27412368	unexposed	C2349018
27412368	female	C0086287
27412368	participants	C0679646
27412368	completed	C0205197
27412368	questionnaires	C0034394
27412368	demographic	C0011292
27412368	lifestyle	C0023676
27412368	characteristics	C1521970
27412368	reproductive disorders	C1659749
27412368	Residential locations	C0442506
27412368	prenatal	C0678804
27412368	period	C1948053
27412368	age	C0001779
27412368	estimate	C0750572
27412368	PCE	C0039637
27412368	exposure	C0332157
27412368	water modeling software	C0037585
27412368	exposure to	C0332157
27412368	PCE	C0039637
27412368	adjusted risk ratio	C0242492
27412368	PCOS	C0032460
27412368	CI	C0009667
27412368	statistically significan	C0237881
27412368	associations	C0439849
27412368	observed	C1441672
27412368	increasing	C0442808
27412368	levels	C0441889
27412368	exposure	C0332157
27412368	PCOS	C0032460
27412368	reproductive disorders	C1659749
27412368	associations	C0439849
27412368	found	C0150312
27412368	adult	C0001675
27412368	women	C0043210
27412368	exposure to	C0332157
27412368	PCE	C0039637
27412368	contaminated	C0205279
27412368	drinking water	C0599638
27412368	adult-onset	C1853562
27412368	reproductive disorders	C1659749
27412452	Host plant	C0032098
27412452	sexual attractiveness	C0029235
27412452	female	C0086287
27412452	white-spotted longicorn beetle	C0009276
27412452	Anoplophora malasiaca	C1229576
27412452	Anoplophora malasiaca	C1229576
27412452	Coleoptera	C0009276
27412452	Cerambycidae	C1005233
27412452	landscape	C0870781
27412452	crop	C0242775
27412452	trees	C0040811
27412452	Japan	C0022341
27412452	precopulatory	C0205556
27412452	responses	C0871261
27412452	A. malasiaca	C1229576
27412452	populations	C1257890
27412452	mandarin orange	C0884217
27412452	willow	C0995181
27412452	blueberry trees	C0950036
27412452	males	C0086582
27412452	host plant	C0032098
27412452	population	C1257890
27412452	females	C0086287
27412452	willow	C0995181
27412452	blueberry	C0950036
27412452	populations	C0032659
27412452	males	C0086582
27412452	blueberry	C0950036
27412452	willow	C0995181
27412452	populations	C1257890
27412452	females	C0086287
27412452	mandarin orange	C0884217
27412452	population	C0032659
27412452	antennae	C2936203
27412452	female	C0086287
27412452	populations	C1257890
27412452	sex pheromones	C0036863
27412452	elytra	C0229962
27412452	females	C0086287
27412452	mandarin orange	C0884217
27412452	population	C0032659
27412452	chemicals	C0220806
27412452	males	C0086582
27412452	populations	C0032659
27412452	β-Elemene	C1101268
27412452	mandarin orange	C0884217
27412452	females	C0086287
27412452	rejection	C1548437
27412452	response	C0871261
27412452	willow	C0995181
27412452	males	C0086582
27412452	female	C0086287
27412452	repellent	C0544309
27412452	males	C0086582
27412452	host plant	C0032098
27412452	populations	C0032659
27412452	host plant	C0032098
27412452	female's	C0086287
27412452	sexual attractiveness	C0029235
27412759	Molecular	C1521991
27412759	detection	C1511790
27412759	infection	C3714514
27412759	homogeneity	C1881065
27412759	impact	C4049986
27412759	miltefosine	C0068006
27412759	treatment	C1522326
27412759	Syrian golden hamster	C0018561
27412759	Leishmania donovani	C0023273
27412759	L. infantum	C0023272
27412759	visceral leishmaniasis	C0023290
27412759	Control	C2587213
27412759	visceral leishmaniasis	C0023290
27412759	Leishmania infantum	C0023272
27412759	Leishmania donovani	C0023273
27412759	chemotherapy	C3665472
27412759	compromised	C2945640
27412759	antileishmanial compounds	C0304339
27412759	evaluation	C0220825
27412759	novel	C0205314
27412759	drugs	C1254351
27412759	Syrian golden hamster	C0018561
27412759	clinically	C0205210
27412759	relevant	C2347946
27412759	laboratory model	C0086272
27412759	study	C2603343
27412759	molecular parasite detection assays	C1294355
27412759	targeting	C1521840
27412759	cathepsin-like cysteine protease B	C0699919
27412759	CPB	C0699919
27412759	DNA	C0012854
27412759	rRNA	C0035701
27412759	absolute	C0205344
27412759	amastigote	C0686878
27412759	quantification	C1709793
27412759	target	C1521840
27412759	organs	C0178784
27412759	liver	C0023884
27412759	spleen	C0037993
27412759	quantitative PCR	C1709846
27412759	(qPCR) techniques	C1709846
27412759	correlation	C1707520
27412759	microscopic reading	C0369671
27412759	Giemsa-stained	C0523205
27412759	tissue	C0040300
27412759	smears	C1272593
27412759	multiple	C0439064
27412759	single	C0205171
27412759	tissue pieces	C0040300
27412759	detection	C0442726
27412759	methods	C0025663
27412759	homogeneity	C1881065
27412759	infection	C3714514
27412759	liver	C0023884
27412759	spleen	C0037993
27412759	robustness	C2986815
27412759	whole organ burdens	C0005884
27412759	small	C0700321
27412759	single	C0205171
27412759	tissue piece	C0040300
27412759	Comparison	C1707455
27412759	pre	C3539075
27412759	post-treatment	C2709088
27412759	burdens	C2828008
27412759	infected	C0439663
27412759	hamsters	C0018561
27412759	detection	C0442726
27412759	methods	C0025663
27412759	revealed	C0443289
27412759	parasite	C0030498
27412759	reduction	C0392756
27412759	spleen	C0037993
27412759	compared	C1707455
27412759	liver	C0023884
27412759	organ	C0178784
27412759	dependent	C0851827
27412759	clearance	C0449297
27412759	efficacy	C1280519
27412759	miltefosine	C0068006
27412759	conclusion	C1707478
27412759	study	C2603343
27412759	hamster	C0018561
27412759	high	C0205250
27412759	homogeneity	C1881065
27412759	infection	C3714514
27412759	liver	C0023884
27412759	spleen	C0037993
27412759	molecular	C1521991
27412759	detection	C1511790
27412759	methods	C0025663
27412759	assessment	C0220825
27412759	low	C0205251
27412759	post-treatment	C2709088
27412759	tissue	C0040300
27412759	burdens	C2828008
27415391	Approximate	C0332232
27415391	Bayesian computation	C1553908
27415391	estimating	C0750572
27415391	number concentrations	C1446561
27415391	monodisperse	C0205556
27415391	nanoparticles	C1450054
27415391	suspension	C1382107
27415391	optical microscopy	C0026018
27415391	present	C0449450
27415391	approximate	C0332232
27415391	Bayesian computation	C1553908
27415391	scheme	C1519193
27415391	estimating	C0750572
27415391	number concentrations	C1446561
27415391	monodisperse	C0205556
27415391	diffusing	C0012222
27415391	nanoparticles	C1450054
27415391	suspension	C1382107
27415391	optical particle tracking microscopy	C0026018
27415391	method	C0449851
27415391	based	C1705938
27415391	probability distribution	C3826440
27415391	time	C0040223
27415391	spent	C0680968
27415391	particle	C0597177
27415391	inside	C0205102
27415391	detection	C1511790
27415391	region	C0205147
27415391	method	C0449851
27415391	suspensions	C1382107
27415391	well-controlled	C3853142
27415391	reference	C1706462
27415391	particles	C0597177
27415391	usefulness	C3827682
27415391	application	C4048755
27415391	gene therapy	C0017296
27415391	applying	C4048755
27415391	method	C0449851
27415391	estimate	C0750572
27415391	number concentrations	C1446561
27415391	plasmid	C0032136
27415391	DNA molecules	C0012854
27415391	average number	C1510992
27415391	DNA molecules	C0012854
27415391	complexed	C1704241
27415391	liposomal	C0023828
27415391	drug delivery	C0085104
27415391	particles	C0597177
27417076	Gestational age	C0017504
27417076	stillbirth	C0595939
27417076	risk	C0035647
27417076	Indigenous	C1512704
27417076	non	C1518422
27417076	Indigenous	C1512704
27417076	women	C0043210
27417076	Queensland	C0034391
27417076	Australia	C0004340
27417076	population based study	C1709599
27417076	Australia	C0004340
27417076	stillbirth	C0595939
27417076	rates	C1521828
27417076	Aboriginal	C0935542
27417076	Torres Strait Islander	C1257890
27417076	Indigenous Australian	C3826690
27417076	non	C1518422
27417076	Indigenous	C1512704
27417076	women	C0043210
27417076	Diabetes	C0011847
27417076	hypertension	C0020538
27417076	antepartum haemorrhage	C0269608
27417076	small-for-gestational age	C0235991
27417076	SGA	C0235991
27417076	identified	C0205396
27417076	important	C3898777
27417076	rates	C1521828
27417076	Indigenous	C1512704
27417076	women	C0043210
27417076	study	C2603343
27417076	gestational age	C0017504
27417076	risk	C0035647
27417076	stillbirth	C0595939
27417076	associated with	C0332281
27417076	conditions	C0348080
27417076	Indigenous	C1512704
27417076	non	C1518422
27417076	Indigenous	C1512704
27417076	women	C0043210
27417076	Retrospective	C1514923
27417076	population-based study	C1709599
27417076	singleton	C1313913
27417076	births	C0005608
27417076	weeks	C0439230
27417076	gestation	C0032961
27417076	grams	C0439208
27417076	birthweight	C0005612
27417076	Queensland	C0034391
27417076	July	C3829447
27417076	December	C3830550
27417076	data	C1511726
27417076	Queensland	C0034391
27417076	Perinatal	C0178795
27417076	Data Collection	C0010995
27417076	routinely-maintained database	C0242356
27417076	data	C1511726
27417076	births	C0005608
27417076	Queensland	C0034391
27417076	Multivariate logistic regression	C0206031
27417076	adjusted odds ratios	C0028873
27417076	aOR	C0028873
27417076	confidence intervals	C0009667
27417076	maternal	C1858460
27417076	demographic	C0011292
27417076	pregnancy factors	C3533185
27417076	births	C0005608
27417076	analysed	C0936012
27417076	Indigenous	C1512704
27417076	women	C0043210
27417076	non	C1518422
27417076	Indigenous	C1512704
27417076	women	C0043210
27417076	Stillbirth	C0595939
27417076	rates	C1521828
27417076	CI	C0009667
27417076	CI	C0009667
27417076	births	C0005608
27417076	Indigenous	C1512704
27417076	non	C1518422
27417076	Indigenous	C1512704
27417076	women	C0043210
27417076	gestational	C0439671
27417076	age groups	C0027362
27417076	antepartum haemorrhage	C0269608
27417076	SGA	C0235991
27417076	pre-existing diabetes	C2114054
27417076	pre-existing hypertension	C2114056
27417076	associated with	C0332281
27417076	increased	C0205217
27417076	risk	C0035647
27417076	stillbirth	C0595939
27417076	pre-eclampsia	C0032914
27417076	eclampsia	C0013537
27417076	risk	C0035647
27417076	stillbirth	C0595939
27417076	gestational diabetes	C0085207
27417076	study	C2603343
27417076	gestational age	C0017504
27417076	stillbirth	C0595939
27417076	risk	C0035647
27417076	Indigenous	C1512704
27417076	non	C1518422
27417076	Indigenous	C1512704
27417076	women	C0043210
27417076	risk	C0035647
27417076	term gestations	C0032961
27417076	appropriate	C1548787
27417076	responsive	C0205342
27417076	healthcare	C0086388
27417076	stillbirth	C0595939
27417076	risk	C0035647
27417076	Indigenous	C1512704
27417076	women	C0043210
27417211	Defining	C0509805
27417211	Describing	C0678257
27417211	Categorizing	C0871968
27417211	Public Health Infrastructure	C0699943
27417211	Priorities	C0439607
27417211	Tropical Cyclone	C0337000
27417211	Flood	C0016248
27417211	Storm	C1254365
27417211	Tornado	C0040476
27417211	Tsunami-Related Disasters	C0027485
27417211	study	C2603343
27417211	literature review	C0282441
27417211	databases	C0242356
27417211	define	C0509805
27417211	describe	C0678257
27417211	categorize	C0871968
27417211	public health infrastructure	C0699943
27417211	PHI	C0699943
27417211	priorities	C0439607
27417211	tropical cyclone	C0337000
27417211	flood	C0016248
27417211	storm	C1254365
27417211	tornado	C0040476
27417211	tsunami-related disasters	C0027485
27417211	publication databases	C0993637
27417211	define	C0509805
27417211	describe	C0678257
27417211	categorize	C0871968
27417211	PHI	C0699943
27417211	discuss	C2584313
27417211	tropical cyclone	C0337000
27417211	flood	C0016248
27417211	storm	C1254365
27417211	tornado	C0040476
27417211	tsunami-related disasters	C0027485
27417211	impact	C4049986
27417211	PHI	C0699943
27417211	data	C1511726
27417211	aggregation	C0332621
27417211	articles	C1706852
27417211	data	C1511726
27417211	grouped	C1522242
27417211	PHI	C0699943
27417211	themes	C0869035
27417211	prioritized	C0439607
27417211	articles	C1706852
27417211	PHI	C0699943
27417211	categorized	C0871968
27417211	themes	C0869035
27417211	descriptors	C0282354
27417211	priority	C0439607
27417211	PHI	C0699943
27417211	workforce	C0024752
27417211	water	C0599638
27417211	sanitation	C0036172
27417211	equipment	C0014672
27417211	communication	C0009452
27417211	physical structure	C0556997
27417211	power	C0032865
27417211	governance	C0220842
27417211	prevention	C2700409
27417211	supplies	C1561604
27417211	service	C0557854
27417211	transport	C1317949
27417211	surveillance	C0220920
27417211	review	C0282443
27417211	workforce	C0024752
27417211	thematic areas	C0869035
27417211	PHI	C0699943
27417211	disasters	C0027485
27417211	workforce	C0024752
27417211	health services	C0018747
27417211	post-disaster	C1254367
27417211	PHI	C0699943
27417211	PHI	C0699943
27417211	priorities	C0439607
27417211	disaster	C0027485
27418256	Fragment	C1335533
27418256	Discovery	C1880355
27418256	5-Arylisatin	C0022115
27418256	Inhibitors	C1513016
27418256	Matrix Metalloproteinases 2	C0172537
27418256	13	C0255672
27418256	Matrix metalloproteinases	C0623362
27418256	MMPs	C0623362
27418256	pathologies	C0699748
27418256	MMP-2	C0172537
27418256	MMP-13	C0255672
27418256	cancer progression	C1947901
27418256	study	C2603343
27418256	structure-based screening	C1710032
27418256	metalloproteinase	C0623362
27418256	fragments	C1335533
27418256	computational model	C0009609
27418256	fragment	C1335533
27418256	set	C1705195
27418256	EDASA Scientific compound library	C0282574
27418256	fragments	C1335533
27418256	biological assay	C0005507
27418256	validate	C1519941
27418256	model	C0009609
27418256	scaffolds	C1179132
27418256	activity	C0441655
27418256	assay	C0005507
27418256	isatin-based compounds	C0022115
27418256	fragments	C1335533
27418256	design	C1707689
27418256	MMP inhibitors	C1513016
27418256	micromolar activity	C0441655
27418256	chemical synthesis	C0007987
27418256	flexible	C0443220
27418256	creative access	C0444454
27418256	analogues	C0002776
27427129	Incidence	C0021149
27427129	environmental	C0686732
27427129	genetic factors	C0814299
27427129	congenital cataract	C0009691
27427129	Children	C0008059
27427129	Lahore	C0681784
27427129	incidence	C0021149
27427129	environmental	C0686732
27427129	genetic factors	C0814299
27427129	congenital cataract	C0009691
27427129	infants	C0021270
27427129	descriptive study	C0008972
27427129	Layton Rahmatullah Benevolent Trust	C1708333
27427129	Lahore	C0681784
27427129	Pakistan	C0030211
27427129	children	C0008059
27427129	years	C1510829
27427129	age	C0001779
27427129	rubella syndrome	C0748452
27427129	herpes simplex	C0019348
27427129	birth trauma	C2145877
27427129	trisomy 21	C3537167
27427129	Nance-Horan syndrome	C0796085
27427129	Lowe's syndrome	C0028860
27427129	cases	C0021149
27427129	patients	C0030705
27427129	diagnosed	C0011900
27427129	congenital cataract	C0009691
27427129	aged	C0001779
27427129	years	C1510829
27427129	years	C1510829
27427129	years	C1510829
27427129	Bilateral congenital cataract	C3277059
27427129	patients	C0030705
27427129	unilateral congenital cataract	C3640028
27427129	Environmental factors	C0686732
27427129	cases	C0021149
27427129	genetic factors	C0814299
27427129	Congenital cataract	C0009691
27427129	predominated	C0332251
27427129	boys	C0870221
27427129	girls	C0870604
27427129	diagnosis	C0011900
27427129	therapy	C0087111
27427129	technology	C0039421
27427129	long-term	C0443252
27427129	permanent	C0205355
27427129	care	C1947933
27428958	Transcriptome	C3178810
27428958	Metabolome	C2350399
27428958	Analyses	C0936012
27428958	Glucosinolates	C0017767
27428958	Broccoli Cultivars	C0330498
27428958	Jasmonate	C1176128
27428958	Treatment	C1522326
27428958	Induction	C0205263
27428958	Glucosinolate	C0017767
27428958	Defense	C1880266
27428958	Trichoplusia ni	C0998450
27428958	Hübner	C0805191
27428958	Lepidopteran	C0023338
27428958	larvae	C0023047
27428958	growth	C0018270
27428958	influenced	C4054723
27428958	host	C1167395
27428958	plant	C0032098
27428958	glucosinolate	C0017767
27428958	GS	C0017767
27428958	concentrations	C1446561
27428958	influenced	C4054723
27428958	phytohormone	C0032082
27428958	jasmonate	C1176128
27428958	JA	C1176128
27428958	insect	C0021585
27428958	resistance	C4281815
27428958	biomarkers	C0017393
27428958	lepidopteran	C0023338
27428958	pests	C0869004
27428958	transcriptome	C3178810
27428958	metabolome	C2350399
27428958	analyses	C0936012
27428958	JA	C1176128
27428958	treatments	C1522326
27428958	broccoli cultivars	C0330498
27428958	Green Magic	C0330498
27428958	VI-158	C0330498
27428958	induced	C0205263
27428958	indole GSs	C0017767
27428958	neoglucobrassicin	C2975109
27428958	glucobrassicin	C0061370
27428958	test	C0039593
27428958	inducible	C0205263
27428958	GSs	C0017767
27428958	growth	C0018270
27428958	cabbage looper	C0684063
27428958	Trichoplusia ni	C0998450
27428958	cabbage looper larvae	C0023047
27428958	plants	C0032098
27428958	JA	C1176128
27428958	treatments	C1522326
27428958	days	C0439228
27428958	treatment	C1522326
27428958	days	C0439228
27428958	feeding	C2987508
27428958	weight	C0043100
27428958	larvae	C0023047
27428958	survival rate	C0038954
27428958	decrease	C0547047
27428958	increasing	C0442805
27428958	JA	C1176128
27428958	concentrations	C1446561
27428958	broccoli cultivars	C0330498
27428958	JA	C1176128
27428958	inducible	C0205263
27428958	GSs	C0017767
27428958	measured	C0444706
27428958	high performance liquid chromatography	C0008562
27428958	Neoglucobrassicin	C2975109
27428958	Green Magic	C0330498
27428958	glucobrassicin	C0061370
27428958	VI-158	C0330498
27428958	leaves	C0242724
27428958	increased	C0205217
27428958	dose-dependent	C1512045
27428958	glucosinolates	C0017767
27428958	hydrolysis	C0020291
27428958	products	C1514468
27428958	inverse	C0439850
27428958	correlations	C1707520
27428958	larval	C0023047
27428958	weight	C0043100
27428958	survival	C0038952
27428958	days	C0439228
27428958	treatment	C1522326
27428958	positively	C1446409
27428958	correlated	C1707520
27428958	days	C0439228
27428958	pupation	C1326578
27428958	JA	C1176128
27428958	inducible	C0205263
27428958	glucosinolates	C0017767
27428958	influence	C4054723
27428958	growth	C0018270
27428958	survival	C0038952
27428958	cabbage looper larvae	C0023047
27428958	Transcriptome profiling	C0752248
27428958	changes	C0392747
27428958	glucosinolate	C0017767
27428958	hydrolysis	C0020291
27428958	product	C1514468
27428958	concentrations	C1446561
27428958	JA	C1176128
27428958	treatments	C1522326
27428958	genes	C0017337
27428958	GS	C0017767
27428958	metabolism	C0025519
27428958	differentiate	C2945687
27428958	broccoli cultivars	C0330498
27428958	pattern	C0449774
27428958	transcriptional	C0040649
27428958	response	C0871261
27428958	JA	C1176128
27428958	treatments	C1522326
27428958	change	C0392747
27428958	indole GS	C0017767
27428958	concentrations	C1446561
27428958	transcripts	C1519595
27428958	transcription factor	C0040648
27428958	MYB122	C0040648
27428958	biosynthesis	C0005572
27428958	genes	C0017337
27428958	CYP79B2	C0017337
27428958	UGT74B1	C0017337
27428958	SUR1	C1412082
27428958	SOT16	C0017337
27428958	SOT17	C0017337
27428958	SOT18	C0017337
27428958	indole glucosinolate	C1254350
27428958	modification	C3840684
27428958	gene	C0017337
27428958	IGMT1	C0017337
27428958	glucosinolate	C0017767
27428958	hydrolysis	C0020291
27428958	TGG1	C0017337
27428958	TGG2	C0017337
27428958	ESM1	C1414460
27428958	increased	C0205217
27428958	Green Magic	C0330498
27428958	UGT74B1	C0017337
27428958	MYB122	C0017337
27428958	increased	C0205217
27428958	VI-158	C0330498
27428958	metabolite	C0870883
27428958	transcript	C1519595
27428958	biomarker	C0017393
27428958	transcriptome profiling	C0752248
27428958	identify	C0205396
27428958	genes	C0017337
27428958	formation	C1522492
27428958	indole GS	C0017767
27428958	hydrolysis	C0020291
27428958	products	C1514468
27428958	metabolite	C0870883
27428958	transcript	C1519595
27428958	biomarkers	C0017393
27428958	effective	C1704419
27428958	marker	C0017393
27428958	assisted	C1269765
27428958	breeding	C0006159
27428958	resistance	C4281815
27428958	lepidopteran	C0023338
27428958	pests	C0869004
27428958	broccoli	C0330498
27428958	Brassica vegetables	C0453113
27429935	clinical prognosis	C1317293
27429935	implants	C0021102
27429935	super-erupted	C3839493
27429935	dentition	C0011443
27429935	teeth	C0040426
27429935	missing	C0080233
27429935	super-eruption of teeth	C3839493
27429935	opposing arch	C1254362
27429935	area	C0205146
27429935	occlusal plane	C0524544
27429935	missing teeth	C0080233
27429935	implants	C0021102
27429935	oral surgeon	C0260272
27429935	super-erupted teeth	C0040426
27429935	treated	C1522326
27429935	normalize	C1882115
27429935	occlusal plane	C0524544
27429935	study	C0008972
27429935	evaluated	C0220825
27429935	clinical prognosis	C1317293
27429935	dentition	C0011443
27429935	implant placement	C0021107
27429935	prosthetic treatment	C0204076
27429935	completed	C0205197
27429935	occlusal plane	C0524544
27429935	super-erupted teeth	C0040426
27429935	opposing arch	C1254362
27429935	treatment	C1522326
27429935	super-erupted teeth	C0040426
27429935	patients	C0030705
27429935	males	C0086582
27429935	females	C0086287
27429935	treated	C1522326
27429935	implants	C0021102
27429935	prosthetics	C0175649
27429935	super-erupted	C3839493
27429935	dentition	C0011443
27429935	Seoul	C3850150
27429935	National University Bundang Hospital	C0019994
27429935	implants	C0021102
27429935	crestal bone loss	C0002382
27429935	survival rates	C0038954
27429935	surgical	C0274311
27429935	prosthetic complications	C0274320
27429935	months	C0439231
27429935	prosthetic loading	C0204076
27429935	case	C1706256
27429935	cover screw	C0021102
27429935	implant surgery	C0543467
27429935	crestal bone loss	C0002382
27429935	implants	C0021102
27429935	survived	C3179277
27429935	survival rate	C0038954
27429935	prosthetic complication	C0274320
27429935	case	C1706256
27429935	clinical results	C0456984
27429935	prosthetic complications	C0274320
27429935	crestal bone loss	C0002382
27429935	implant	C0021102
27429935	survival rates	C0038954
27429935	implants	C0021102
27429935	super-erupted opposing tooth	C0040426
27430662	Evaluation	C0034375
27430662	Mathisen's technique	C0449851
27430662	ureteral reimplantation	C0401287
27430662	children	C0008059
27430662	primary	C0205225
27430662	vesicoureteral reflux	C0042580
27430662	cross-trigonal ureteral reimplantation (Cohen)	C0401296
27430662	technique	C0449851
27430662	children	C0008059
27430662	non-physiological transfer	C0025361
27430662	ureteral orifices	C0447577
27430662	endoscopic ureteral operations	C0401343
27430662	later	C0205087
27430662	life	C0376558
27430662	described	C1552738
27430662	alternative	C1523987
27430662	method	C0449851
27430662	ureteral reimplantation	C0401287
27430662	lateralization	C0542341
27430662	neohiatus	C1254362
27430662	orthotopic	C0574893
27430662	course	C0750729
27430662	submucosal ureter	C0227684
27430662	evaluated	C1516048
27430662	success	C0679864
27430662	complication	C2362589
27430662	rates	C1521828
27430662	techniques	C0449851
27430662	applied	C4048755
27430662	sequentially	C1519249
27430662	departments	C1704729
27430662	consecutive	C1707491
27430662	patients	C0030705
27430662	ureters	C2348561
27430662	males	C0025266
27430662	females	C0043210
27430662	Mathisen reimplantation	C0401287
27430662	compared	C1707455
27430662	consecutive	C1707491
27430662	patients	C0030705
27430662	ureters	C2348561
27430662	males	C0025266
27430662	females	C0043210
27430662	Cohen reimplantation	C0401296
27430662	Inclusion	C1512693
27430662	criteria	C0243161
27430662	primary	C0205225
27430662	vesicoureteral reflux	C0042580
27430662	VUR	C0042580
27430662	previous	C0205156
27430662	intervention	C0184661
27430662	Reflux	C0042580
27430662	grades	C1511980
27430662	ureters	C2348561
27430662	VUR ≥ III	C3274338
27430662	ureters	C2348561
27430662	VUR ≥ III	C3274338
27430662	complicating	C1522701
27430662	factors	C1521761
27430662	ureteroceles	C0041960
27430662	megaureters	C0521620
27430662	posterior urethral valves	C0238506
27430662	groups	C0441833
27430662	comparable	C1707455
27430662	Cohen's reimplantation	C0401296
27430662	immediate	C0205253
27430662	complications	C0009566
27430662	intervention	C0184661
27430662	during	C0347984
27430662	follow-up	C1522577
27430662	mean	C0444504
27430662	months	C0439231
27430662	patients	C0030705
27430662	suffered	C0683278
27430662	febrile urinary tract infections	C3875265
27430662	UTIs	C3875265
27430662	diagnosed	C0011900
27430662	persisting	C0549178
27430662	VUR	C0042580
27430662	Persistent	C0549178
27430662	hydronephroses	C0020295
27430662	SFU	C0020295
27430662	patients	C0030705
27430662	reimplantation	C0401287
27430662	Mathisen's technique	C0449851
27430662	patients	C0030705
27430662	suffered	C0683278
27430662	significant	C0750502
27430662	intravesical bleeding	C1390213
27430662	follow-up	C1522577
27430662	mean	C0444504
27430662	months	C0439231
27430662	patients	C0030705
27430662	suffered	C0683278
27430662	febrile UTIs	C3875265
27430662	patients	C0030705
27430662	diagnosed	C0011900
27430662	persisting	C0549178
27430662	VUR	C0042580
27430662	mean	C0444504
27430662	follow-up	C1522577
27430662	months	C0439231
27430662	patients	C0030705
27430662	persistent	C0549178
27430662	VUR	C0042580
27430662	high-grade	C0205556
27430662	VUR	C0042580
27430662	compared	C1707455
27430662	whole group	C0441833
27430662	patients	C0030705
27430662	persistent	C0549178
27430662	hydronephroses	C0020295
27430662	SFU	C0020295
27430662	Mathisen's technique	C0449851
27430662	ureteral reimplantation	C0401287
27430662	significantly	C0750502
27430662	patients	C0030705
27430662	ureterorenal units	C1519795
27430662	lower	C0441994
27430662	success	C0679864
27430662	rate	C1521828
27430662	patients	C0030705
27430662	ureterorenal units	C1519795
27430662	comparison	C1707455
27430662	Cohen's technique	C0449851
27430662	patients	C0030705
27430662	ureterorenal units	C1519795
27430662	intervention	C0184661
27430662	obstruction	C0028778
27430662	persistent	C0549178
27430662	hydronephrosis	C0020295
27430662	Cohen group	C0441833
27430662	orthotopic	C0574893
27430662	ureteral orifice	C0447577
27430662	bladder neck	C0227716
27430662	Mathisen's reimplantation	C0401287
27430662	cross-trigonal ureteral reimplantation	C0401296
27430662	reliable	C3858758
27430662	VUR	C0042580
27430662	correction	C1947976
27430662	patient selection	C0242802
27430662	technique	C0449851
27430662	prove essential	C0205224
27430662	difficulties	C0332218
27430662	ectopic	C0574895
27430662	ureteral orifices	C0447577
27430662	Cohen technique	C0449851
27430662	long-term	C0443252
27430662	follow-up	C1522577
27430662	concept	C0178566
27430662	anatomic	C0220784
27430662	orthotopic	C0574893
27430662	ureteral reimplantation	C0401287
27430662	technique	C0449851
27432486	use of	C1524063
27432486	neonatal	C2939425
27432486	extracorporeal life support	C0015357
27432486	pediatric	C1521725
27432486	cardiac intensive care unit	C0587446
27432486	evaluate	C0220825
27432486	extracorporeal life support system	C0015357
27432486	ECLS	C0015357
27432486	neonates	C0021289
27432486	pediatric	C1521725
27432486	cardiac intensive care unit	C0587446
27432486	neonates	C0021289
27432486	ECLS	C0015357
27432486	evaluated	C0220825
27432486	median	C0876920
27432486	age	C0001779
27432486	days	C0439228
27432486	range	C1514721
27432486	days	C0439228
27432486	median	C0876920
27432486	body weight	C0005910
27432486	range	C1514721
27432486	Venoarterial	C0450124
27432486	ECLS	C0015357
27432486	performed	C0884358
27432486	Ascendan aorta	C0003956
27432486	right atrial	C0225844
27432486	cannulation	C0917707
27432486	patients	C0030705
27432486	neck	C0027530
27432486	cannulation	C0917707
27432486	patients	C0030705
27432486	performed	C0884358
27432486	ECLS	C0015357
27432486	E-CPR	C0007203
27432486	patients	C0030705
27432486	inability to wean	C0243095
27432486	cardiopulmonary bypass	C0007202
27432486	CPB	C0007202
27432486	patients	C0030705
27432486	respiratory insufficiency	C0035229
27432486	hypoxia	C0242184
27432486	patients	C0030705
27432486	low cardiac output	C0600177
27432486	LCOS	C0600177
27432486	patients	C0030705
27432486	Median	C0876920
27432486	duration	C0449238
27432486	ECLS	C0015357
27432486	days	C0439228
27432486	range	C1514721
27432486	Hemorrhagic	C0333275
27432486	complications	C0009566
27432486	renal complications	C1408259
27432486	pulmonary complications	C0281169
27432486	infectious	C0009450
27432486	complications	C0009566
27432486	neurologic complications	C0235029
27432486	mechanical complications	C0009566
27432486	patients	C0030705
27432486	Weaning	C0043084
27432486	successful	C1272703
27432486	patients	C0030705
27432486	patients	C0030705
27432486	successfully	C1272703
27432486	discharged	C0030685
27432486	ECLS	C0015357
27432486	important	C3898777
27432486	treatment option	C0683525
27432486	performed	C0884358
27432486	successfully	C1272703
27432486	centers	C0475309
27432486	world	C2700280
27432486	maintain	C0024501
27432486	life support	C0521300
27432486	patients	C0030705
27432486	unresponsive to medical treatment	C0205269
27432486	utilization	C0042153
27432486	modality	C0695347
27432486	newborns	C0021289
27432486	congenital heart disease	C0152021
27435204	Medicare	C0018717
27435204	claims	C3242446
27435204	indicators	C1522602
27435204	healthcare	C0086388
27435204	utilization	C0042153
27435204	differences	C1705242
27435204	hospitalization	C0019993
27435204	ischemic stroke	C0948008
27435204	Race	C0034510
27435204	gender	C0079399
27435204	caregiving	C1947933
27435204	effects	C1280500
27435204	Background	C1706907
27435204	Differences	C1705242
27435204	healthcare	C0086388
27435204	utilization	C0042153
27435204	stroke	C0948008
27435204	race	C0034510
27435204	gender	C0079399
27435204	differences	C1705242
27435204	stroke	C0948008
27435204	factors	C1521761
27435204	reduce	C0392756
27435204	post	C0687676
27435204	acute stroke	C0751956
27435204	care costs	C0086600
27435204	systematic	C0220922
27435204	differences	C1705242
27435204	Medicare	C0018717
27435204	claims	C3242446
27435204	healthcare	C0086388
27435204	utilization	C0042153
27435204	hospitalization	C0019993
27435204	ischemic stroke	C0948008
27435204	US	C0041703
27435204	population	C1257890
27435204	sample	C0681850
27435204	Claims	C3242446
27435204	examined	C0332128
27435204	six-month	C0439231
27435204	period	C1948053
27435204	hospitalization	C0019993
27435204	ischemic stroke	C0948008
27435204	survivors	C0206194
27435204	years	C0439234
27435204	older	C0001792
27435204	REasons	C0392360
27435204	Geographic	C1171306
27435204	Racial Differences	C0682075
27435204	Stroke	C0948008
27435204	REGARDS	C0948008
27435204	Statistical analyses	C0871424
27435204	examined	C0332128
27435204	differences	C1705242
27435204	post	C0687676
27435204	acute healthcare	C0679878
27435204	utilization	C0042153
27435204	pre	C0332152
27435204	stroke	C0948008
27435204	utilization	C0042153
27435204	function	C0542341
27435204	race	C0034510
27435204	African-American	C0085756
27435204	White	C0007457
27435204	gender	C0079399
27435204	age	C0001779
27435204	stroke belt	C0681784
27435204	residence	C0237096
27435204	income	C0021162
27435204	Medicaid dual-eligibility	C3494385
27435204	Charlson comorbidity index	C3714916
27435204	person	C0027361
27435204	lived	C2982691
27435204	available	C0470187
27435204	caregiver	C0085537
27435204	women	C0043210
27435204	men	C0025266
27435204	receive	C1514756
27435204	home health care	C3845073
27435204	emergency department services	C0374899
27435204	post	C0687676
27435204	acute care	C0679878
27435204	period	C1948053
27435204	effects	C1280500
27435204	maintained	C1314677
27435204	further	C1517331
27435204	adjustment	C0456081
27435204	acute stroke	C0751956
27435204	severity	C0439793
27435204	African-Americans	C0085756
27435204	home health care	C3845073
27435204	visits	C1512346
27435204	Whites	C0007457
27435204	patients	C0030705
27435204	received	C1709850
27435204	home health care	C3845073
27435204	co-residing	C2982691
27435204	caregiver	C0085537
27435204	associated with	C0332281
27435204	reduced	C0392756
27435204	acute hospitalization	C0019993
27435204	length of stay	C0023303
27435204	post	C0687676
27435204	acute emergency department	C0586082
27435204	primary care physician visits	C3251682
27435204	Underutilization of healthcare	C4042758
27435204	stroke	C0948008
27435204	long-term	C0443252
27435204	stroke	C0948008
27435204	women	C0043210
27435204	African-Americans	C0085756
27435204	epidemiologically	C0014508
27435204	sample	C0681850
27435204	Caregiver	C0085537
27435204	availability	C0470187
27435204	contribute	C1880177
27435204	reduced	C0392756
27435204	formal care	C1947933
27435204	cost	C0010186
27435204	post	C0687676
27435204	acute	C0679878
27435204	period	C1948053
27436068	dynamic global vegetation models	C3161035
27436068	seasonality	C0683922
27436068	carbon fluxes	C2936196
27436068	Amazon basin	C0017446
27436068	data	C1511726
27436068	model	C3161035
27436068	intercomparison	C0683958
27436068	forest	C0086312
27436068	response	C0871261
27436068	long-term	C0443252
27436068	climate change	C2718051
27436068	dynamic global vegetation models	C3161035
27436068	DGVMs	C3161035
27436068	ecosystem	C0162358
27436068	response	C0871261
27436068	short-term	C0443303
27436068	variations	C0036496
27436068	environmental drivers	C0014406
27436068	seasonal patterns	C0683922
27436068	dataset	C0150098
27436068	forests	C0086312
27436068	Brasil flux network	C0242356
27436068	dry-season	C0036497
27436068	intensities	C0522510
27436068	lengths	C1444754
27436068	models	C3161035
27436068	IBIS	C3161035
27436068	ED2	C3161035
27436068	JULES	C3161035
27436068	CLM3.5	C3161035
27436068	seasonality	C0683922
27436068	carbon exchanges	C2936196
27436068	Amazonian	C0017446
27436068	tropical forests	C0086312
27436068	DGVMs	C3161035
27436068	gross primary productivity	C0033269
27436068	GPP	C0033269
27436068	photosynthetic capacity	C1516240
27436068	Pc	C1516240
27436068	fluxes	C2348693
27436068	Models	C3161035
27436068	dry-season	C0036497
27436068	declines	C0547047
27436068	GPP	C0033269
27436068	equatorial Amazon	C0017446
27436068	Manaus K34	C0017446
27436068	Santarem K67	C0017446
27436068	Caxiuanã CAX	C0017446
27436068	GPP	C0033269
27436068	Model	C3161035
27436068	dry-season	C0036497
27436068	GPP	C0033269
27436068	reductions	C0392756
27436068	environmental	C0014406
27436068	factor	C1521761
27436068	soil water stress	C0038435
27436068	photosynthetic infrastructure	C0031764
27436068	Pc	C1516240
27436068	dry-season	C0036497
27436068	GPP	C0033269
27436068	biological	C0205460
27436068	leaf	C0242724
27436068	abscission	C1177284
27436068	Pc	C1516240
27436068	environmental	C0014406
27436068	radiation	C0851346
27436068	models	C3161035
27436068	net ecosystem exchange	C0392762
27436068	NEE	C0392762
27436068	respiration	C0035203
27436068	Re	C0035203
27436068	southern Amazon	C0017446
27436068	forest	C0086312
27436068	dry-season	C0036497
27436068	declines	C0547047
27436068	GPP	C0033269
27436068	Re	C0035203
27436068	DGVMs	C3161035
27436068	simulations	C0679083
27436068	models	C3161035
27436068	photosynthesis	C0031764
27436068	southern Amazonia	C0017446
27436068	biophysical processes	C1511162
27436068	light-harvesting	C1158303
27436068	adaptations	C0001398
27436068	leaf area index	C0918012
27436068	LAI	C0918012
27436068	leaf	C0242724
27436068	assimilation	C3714634
27436068	rate	C1521828
27436068	leaf demography	C0011298
27436068	leaf	C0242724
27436068	wood	C0032098
27436068	equatorial Amazon	C0017446
27436068	carbon flux	C2936196
27436068	model	C3161035
27436068	flux	C2348693
27436068	seasonality	C0683922
27436068	tropical forests	C0086312
27436068	biophysical mechanisms	C1148560
27436068	model developments	C0920595
27436635	Blood Pressure	C0005823
27436635	All-Cause Mortality	C0007465
27436635	Level	C0441889
27436635	Cognitive Function	C0392335
27436635	Elderly	C0001792
27436635	Results	C0683954
27436635	Population-Based Study	C1709599
27436635	Rural Greece	C0018226
27436635	study	C1709599
27436635	aimed	C1947946
27436635	investigate	C1292732
27436635	effect	C1280500
27436635	blood pressure	C0005823
27436635	BP	C0005823
27436635	mortality	C1306577
27436635	levels	C0441889
27436635	cognitive function	C0392335
27436635	associations	C0439849
27436635	brachial	C0445456
27436635	systolic BP	C0871470
27436635	diastolic BP	C0428883
27436635	mean arterial pressure	C0428886
27436635	MAP	C0428886
27436635	pulse pressure	C0949236
27436635	all-cause mortality	C0007465
27436635	prospectively explored	C0243095
27436635	follow-up	C1522577
27436635	years	C0439234
27436635	community-dwelling	C4045975
27436635	individuals	C0237401
27436635	≥60 years	C4062292
27436635	adjusted Cox models	C0010234
27436635	stratified	C0205363
27436635	cognitive impairment	C0338656
27436635	Mini-Mental State Examination	C0451306
27436635	MMSE	C0451306
27436635	No association	C0205556
27436635	brachial	C0445456
27436635	BP	C0005823
27436635	variables	C0439828
27436635	mortality	C1306577
27436635	total	C0439810
27436635	sample	C0370003
27436635	quartiles analysis	C0871424
27436635	MAP	C0428886
27436635	highest quartile	C2828255
27436635	compared	C1707455
27436635	second	C0205436
27436635	associated with	C0332281
27436635	mortality	C1306577
27436635	hazard ratio	C2985465
27436635	confidence intervals	C0009667
27436635	cognitively impaired	C0338656
27436635	individuals	C0237401
27436635	fractional-polynomials approach	C0242481
27436635	BP	C0005823
27436635	confirmed	C0750484
27436635	finding	C0243095
27436635	further	C1517331
27436635	solely	C0205171
27436635	MMSE	C0451306
27436635	subcohort	C0009247
27436635	U-shaped trends	C0040833
27436635	MAP	C0428886
27436635	systolic BP	C0871470
27436635	increased	C0205217
27436635	mortality risk	C0035647
27436635	extremely	C0205403
27436635	low or high values	C0205556
27436635	pattern	C0449774
27436635	evident	C3887511
27436635	patients	C0030705
27436635	MMSE	C0451306
27436635	Elderly	C0001792
27436635	individuals	C0237401
27436635	cognitive impairment	C0338656
27436635	more	C0205172
27436635	susceptible	C0231204
27436635	detrimental effects	C0879626
27436635	low	C0205251
27436635	elevated	C3163633
27436635	MAP	C0428886
27436635	systolic BP	C0871470
27437203	Hypovitaminosis D	C0042870
27437203	Cardiometabolic Risk	C0035647
27437203	Women	C0043210
27437203	PCOS	C0032460
27437203	Women	C0043210
27437203	Polycystic Ovary Syndrome	C0032460
27437203	PCOS	C0032460
27437203	metabolic disturbances	C0746556
27437203	insulin resistance	C0021655
27437203	hypertension	C0020538
27437203	atherogenic dyslipidemia	C0242339
27437203	Accumulating	C4055506
27437203	Vitamin D deficiency	C0042870
27437203	PCOS	C0032460
27437203	associated with	C0332281
27437203	metabolic	C0025517
27437203	endocrinal dysfunctions	C1397856
27437203	PCOS	C0032460
27437203	women	C0043210
27437203	PCOS	C0032460
27437203	risk	C0035647
27437203	cardiovascular disease	C0007222
27437203	study	C2603343
27437203	Vitamin D	C0042866
27437203	metabolic	C0025517
27437203	endocrinal dysregulations	C1397856
27437203	women	C0043210
27437203	PCOS	C0032460
27437203	early identification	C0814435
27437203	prevention	C0679698
27437203	symptomatic	C0231220
27437203	cardiac disease	C0018799
27437203	women	C0043210
27437203	PCOS	C0032460
27437203	Rotterdam criteria	C0679228
27437203	healthy control	C2986479
27437203	PCOS	C0032460
27437203	Vitamin D	C0042866
27437203	cardiometabolic risk factors	C0035648
27437203	fasting plasma glucose	C1318375
27437203	insulin resistance	C0021655
27437203	dyslipidemia	C0242339
27437203	hs-CRP	C0742906
27437203	endocrinal	C0521425
27437203	parameters	C0549193
27437203	hyperandrogenism	C0206081
27437203	correlation studies	C0010101
27437203	Vitamin D	C0042866
27437203	cardiometabolic risk factor	C0035648
27437203	PCOS	C0032460
27437203	statistically analysed	C0871424
27437203	SPSS software version 16	C0037585
27437203	unpaired student's t-test	C1710574
27437203	Pearson's correlation coefficient	C0871052
27437203	Vitamin D	C0042866
27437203	healthy controls	C2986479
27437203	Hyperinsulinemia	C0020459
27437203	insulin resistance	C0021655
27437203	dyslipidemia	C0242339
27437203	study	C2603343
27437203	Vitamin D	C0042866
27437203	insulin	C0021641
27437203	Homeostatic Model of Assessment- Insulin Resistance Index	C3639411
27437203	HOMA-IR	C3639411
27437203	Hypovitaminosis D	C0042870
27437203	PCOS	C0032460
27437203	metabolic	C0025517
27437203	hormonal disorders	C3263685
27437203	PCOS	C0032460
27437203	impaired fasting glucose	C1272092
27437203	IR	C0021655
27437203	dyslipidemia	C0242339
27437203	Cardio vascular risks	C0035647
27437203	PCOS	C0032460
27437203	observational studies	C3658316
27437203	randomized control trials	C0206035
27437203	hypothesis	C1512571
27438380	Family	C0015576
27438380	close	C1821461
27438380	friends	C0079382
27438380	closer	C1821461
27438380	social support	C0037438
27438380	resilience	C0683253
27438380	older	C0001792
27438380	spousal	C0162409
27438380	dementia	C0497327
27438380	carers	C1305660
27438380	Spousal	C0162409
27438380	dementia	C0497327
27438380	carers	C1305660
27438380	support	C0037438
27438380	needs	C0027552
27438380	disengage	C0205556
27438380	existing	C2987476
27438380	social networks	C0150775
27438380	time	C0040223
27438380	caring	C0150499
27438380	disease progresses	C0242656
27438380	support	C0037438
27438380	resources	C0035201
27438380	resilience	C0683253
27438380	carers	C1305660
27438380	relationship	C0439849
27438380	complex	C0439855
27438380	relationship type	C2826982
27438380	social support	C0037438
27438380	resilience	C0683253
27438380	availability	C0470187
27438380	function	C0542341
27438380	perceived functional aspects	C0205245
27438380	support	C0037438
27438380	older	C0001792
27438380	spousal	C0162409
27438380	dementia	C0497327
27438380	carers	C1305660
27438380	in-depth qualitative interviews	C0021822
27438380	spousal	C0162409
27438380	carers	C1305660
27438380	carer	C1305660
27438380	support groups	C0036606
27438380	North West England	C0014282
27438380	Family	C0015576
27438380	friends	C0079382
27438380	functions	C0542341
27438380	resilient	C0679646
27438380	non-resilient participants	C0679646
27438380	Family support	C0150232
27438380	perceived	C0030971
27438380	created	C1706214
27438380	feelings	C1527305
27438380	over-dependence	C0205556
27438380	Participants	C0679646
27438380	resist involvement	C1314939
27438380	grandchildren	C0337548
27438380	narrow and low-level support functions	C0037438
27438380	Friend	C0079382
27438380	support	C0037438
27438380	perceived	C0030971
27438380	helpful	C3898897
27438380	circumstances	C0851364
27438380	Neighbours	C1553702
27438380	crisis management	C0262762
27438380	perceptions	C0030971
27438380	moderate	C0205081
27438380	effect	C1280500
27438380	support	C0037438
27438380	resilience	C0683253
27438380	Family	C0150232
27438380	friend	C0079382
27438380	support	C0037438
27438380	sufficient	C0205410
27438380	resilience	C0683253
27438380	Support functions	C0037438
27438380	resilience	C0683253
27438380	perceived	C0030971
27438380	need	C0027552
27438380	Implications	C0243095
27438380	findings	C2607943
27440782	Measure Up Pressure Down: Provider Toolkit	C0205787
27440782	Improve	C2986411
27440782	Hypertension	C0020538
27440782	Control	C1753303
27440782	Hypertension	C0020538
27440782	risk factors	C0035648
27440782	heart disease	C0018799
27440782	stroke	C0038454
27440782	kidney failure	C0035078
27440782	diabetes complications	C0342257
27440782	Americans	C0596070
27440782	adults	C0001675
27440782	high blood pressure	C0020538
27440782	cost	C0087112
27440782	associated with	C0332281
27440782	treating	C0087111
27440782	condition	C0020538
27440782	Measure Up Pressure Down: Provider Toolkit	C0205787
27440782	Improve	C2986411
27440782	Hypertension	C0020538
27440782	Control	C1753303
27440782	resource	C0018741
27440782	developed	C1527148
27440782	American Medical Group Foundation	C1708333
27440782	partnership	C1711206
27440782	American Medical Group Association	C1708333
27440782	goal	C0018017
27440782	toolkit	C1301746
27440782	health care practitioners	C1709627
27440782	work	C0043227
27440782	together	C1883357
27440782	team	C0871489
27440782	control	C1753303
27440782	rate	C1521828
27440782	high blood pressure	C0020538
27440782	patient population	C0030705
27440782	toolkit	C1301746
27440782	health educators	C1136362
27440782	clinic administrators	C0019949
27440782	physicians	C0031831
27440782	students	C0038492
27440782	clinic staff	C0851286
27440782	resource	C0018741
27440782	developing	C1527148
27440782	infrastructure	C1512763
27440782	treat	C0087111
27440782	individuals	C0027361
27440782	high blood pressure	C0020538
27440782	chronic conditions.	C0008679
27441638	Potentiation	C0279023
27441638	LPS	C0023810
27441638	Induced	C0007994
27441638	Apoptotic Cell Death	C0162638
27441638	Human Hepatoma HepG2 Cells	C2717940
27441638	Aspirin	C0004057
27441638	ROS	C0162772
27441638	Mitochondrial Dysfunction	C4021734
27441638	Protection	C1545588
27441638	N-Acetyl Cysteine	C0001047
27441638	Cytotoxicity	C0596402
27441638	inflammation	C0021368
27441638	associated	C0243082
27441638	toxic	C1407029
27441638	responses	C0871261
27441638	observed	C1441672
27441638	induced	C0205263
27441638	bacterial	C0521009
27441638	lipopolysaccharides	C0023810
27441638	LPS	C0023810
27441638	in vitro	C1533691
27441638	in vivo	C1515655
27441638	nonsteroidal anti-inflammatory drugs	C0003211
27441638	NSAIDs	C0003211
27441638	aspirin	C0004057
27441638	reported	C0700287
27441638	inflammation	C0021368
27441638	associated diseases	C0243083
27441638	cancer	C0006826
27441638	diabetes	C0011847
27441638	cardiovascular disorders	C0007222
27441638	molecular	C1521991
27441638	mechanisms	C0441712
27441638	studies	C0008972
27441638	aspirin	C0004057
27441638	treated	C0332293
27441638	HepG2 cells	C2717940
27441638	cell cycle arrest	C1155873
27441638	induction	C0205263
27441638	apoptosis	C0162638
27441638	associated with	C0332281
27441638	mitochondrial dysfunction	C4021734
27441638	study	C0008972
27441638	HepG2 cells	C2717940
27441638	treated with	C0332293
27441638	LPS	C0023810
27441638	combination	C0205195
27441638	aspirin	C0004057
27441638	induces	C0205263
27441638	subcellular	C0729605
27441638	toxic responses	C3549372
27441638	increase	C0442805
27441638	reactive oxygen species	C0162772
27441638	ROS	C0162772
27441638	oxidative stress	C0242606
27441638	mitochondrial respiratory dysfunction	C4021734
27441638	apoptosis	C0162638
27441638	LPS	C0023810
27441638	Aspirin	C0004057
27441638	induced	C0205263
27441638	toxicity	C0600688
27441638	attenuated	C0599946
27441638	pre-treatment	C2709094
27441638	cells	C0007634
27441638	N-acetyl cysteine	C0001047
27441638	NAC	C0001047
27441638	oxidative stress	C0242606
27441638	glutathione	C0017817
27441638	dependent	C0851827
27441638	redox-homeostasis	C1156287
27441638	mitochondria	C0026237
27441638	compared	C1707455
27441638	extra	C1254362
27441638	mitochondrial	C0026237
27441638	cellular compartments	C1166607
27441638	Pre-treatment	C2709094
27441638	HepG2 cells	C2717940
27441638	NAC	C0001047
27441638	protection	C1545588
27441638	redox homeostasis	C1156287
27441638	mitochondrial dysfunction	C4021734
27441638	results	C0683954
27441638	altered	C0392747
27441638	redox metabolism	C1156287
27441638	oxidative stress	C0242606
27441638	mitochondrial	C0026237
27441638	function	C0542341
27441638	HepG2 cells	C2717940
27441638	LPS	C0023810
27441638	aspirin	C0004057
27441638	induced	C0205263
27441638	cytotoxicity	C0596402
27441638	results	C0683954
27441638	pharmacological	C0205464
27441638	toxicological	C0205472
27441638	therapeutic properties	C0039798
27441638	NSAIDs	C0003211
27441638	cancer cells	C0334227
27441638	exposed	C0332157
27441638	bacterial endotoxins	C0014264
27442784	Placental	C0032043
27442784	Pathologic	C0205469
27442784	Associations	C0439849
27442784	Morbidly Adherent Placenta	C0405107
27442784	Pathogenesis	C0699748
27442784	pathology	C0205469
27442784	morbidly adherent placenta	C0405107
27442784	MAP	C0405107
27442784	placental	C0032043
27442784	pathology	C0205469
27442784	implantation site	C0230992
27442784	pathology	C0205469
27442784	associated with	C0332281
27442784	MAP	C0405107
27442784	single	C0205171
27442784	institution	C2607850
27442784	retrospective case-control study	C0035363
27442784	placentas	C0032043
27442784	patients	C0030705
27442784	delivered	C0566687
27442784	MAP	C0405107
27442784	cases	C1706256
27442784	clinical	C0205210
27442784	intervention	C1273869
27442784	delivery	C0011209
27442784	spontaneous	C0205359
27442784	placental delivery	C0404381
27442784	manual extraction	C0391874
27442784	placenta	C0032043
27442784	Controls	C0009932
27442784	patients	C0030705
27442784	placentas	C0032043
27442784	examination	C0582103
27442784	history	C0032967
27442784	maternal	C0026591
27442784	malignancy	C0006826
27442784	no	C1513916
27442784	clinical	C0205210
27442784	suspicion	C0750491
27442784	accreta	C0032044
27442784	Placental	C0032043
27442784	pathologic findings	C1317598
27442784	maternal vascular underperfusion	C0012634
27442784	MVU	C0012634
27442784	acute inflammation	C0333361
27442784	chronic inflammation	C0021376
27442784	fetal	C0015965
27442784	vascular obstruction	C1096458
27442784	hemorrhage	C0019080
27442784	bivariable and multivariable analyses	C0814907
27442784	categories	C0683312
27442784	pathologic	C0205469
27442784	changes	C0392747
27442784	MAP	C0405107
27442784	placentas	C0032043
27442784	control	C0009932
27442784	placentas	C0032043
27442784	chronic basal inflammation	C0021376
27442784	changes	C0392747
27442784	MVU	C0012634
27442784	retromembranous	C0019080
27442784	intervillous hemorrhage	C0269801
27442784	multivariable analyses	C0026777
27442784	confounders	C0009673
27442784	chronic basal villitis	C1300128
27442784	aOR	C0028873
27442784	plasma cell deciduitis	C3899627
27442784	aOR	C0028873
27442784	increased syncytial knots	C3898771
27442784	aOR	C0028873
27442784	aOR	C0028873
27442784	increased perivillous fibrin	C0243095
27442784	aOR	C0028873
27442784	subchorionic	C0087086
27442784	intervillous thrombi	C3898711
27442784	aOR	C0028873
27442784	associated with	C0332281
27442784	MAP	C0405107
27442784	MAP	C0405107
27442784	associated with	C0332281
27442784	intraparenchymal placental hemorrhage	C0542014
27442784	villous	C1519984
27442784	changes	C0392747
27442784	MVU	C0012634
27442784	lymphoplasmacytic infiltrate	C1334467
27442784	implantation site	C0230992
27442784	basal chronic inflammatory infiltrate	C1333036
27442784	MAP	C0405107
27443504	copper	C0009968
27443504	responsive	C0205342
27443504	self	C0036588
27443504	cleaving	C0205242
27443504	DNAzyme	C0540193
27443504	immobilizing	C0205245
27443504	Cu(2+)	C0009968
27443504	responsive	C0205342
27443504	self	C0036588
27443504	cleaving	C0205242
27443504	DNAzyme	C0540193
27443504	PET	C0032485
27443504	conical multinanochannels	C0005479
27443504	control	C2587213
27443504	ion transport	C0162585
27443504	regulating	C1327622
27443504	surface	C0205148
27443504	charge	C1706211
27443504	density	C0178587
27443504	channels	C0005479
27445856	High-Intensity Intermittent Training	C4277545
27445856	Positively	C1446409
27445856	Affects	C1280500
27445856	Aerobic	C0001701
27445856	Anaerobic Performance	C3841233
27445856	Judo	C0079650
27445856	Athletes	C0238703
27445856	Exercise Mode	C0015259
27445856	effects	C1280500
27445856	high-intensity intermittent training	C4277545
27445856	HIIT	C4277545
27445856	lower	C1268088
27445856	upper-body	C1268087
27445856	graded exercise	C0015259
27445856	high-intensity intermittent exercise	C4277545
27445856	HIIE	C4277545
27445856	performance	C1882330
27445856	physiological	C0205463
27445856	muscle damage	C0410158
27445856	markers responses	C0243095
27445856	judo	C0079650
27445856	athletes	C0238703
27445856	subjects	C0080105
27445856	randomly allocated	C0034656
27445856	control group	C0009932
27445856	HIIT	C4277545
27445856	groups	C0441833
27445856	tested pre- and post	C0032919
27445856	lower-body	C1268088
27445856	cycle-ergometer	C2107077
27445856	cycle-ergometer	C2107077
27445856	uchi-komi	C0449851
27445856	judo technique entrance	C0449851
27445856	HIIT	C4277545
27445856	upper-body	C1268087
27445856	group	C0441833
27445856	increase	C0442805
27445856	maximal aerobic power	C2371107
27445856	upper-body	C1268087
27445856	exercise test	C0429687
27445856	lower-body	C1268088
27445856	group	C0441833
27445856	increased	C0442805
27445856	power	C2371107
27445856	onset blood lactate	C3824990
27445856	upper-body	C1268087
27445856	exercise test	C0429687
27445856	uchi-komi group	C0441833
27445856	increased	C0442805
27445856	upper	C1268087
27445856	lower-body	C1268088
27445856	lower-body	C1268088
27445856	increased	C0442805
27445856	lower-body	C1268088
27445856	HIIE	C4277545
27445856	decrease	C0547047
27445856	delta blood lactate	C3824990
27445856	uchi-komi training	C0559197
27445856	group	C0441833
27445856	upper-body	C1268087
27445856	training	C0220931
27445856	group	C0441833
27445856	Training	C0220931
27445856	testosterone-cortisol	C4035023
27445856	ratio	C0456603
27445856	increased	C0442805
27445856	lower-body	C1268088
27445856	HIIE	C4277545
27445856	lower-body	C1268088
27445856	uchi-komi (61.4%) training	C0559197
27445856	groups	C0441833
27445856	short-duration	C0439593
27445856	HIIT	C4277545
27445856	regular judo training	C0220931
27445856	increase	C0442805
27445856	upper-body	C1268087
27445856	aerobic power	C2371107
27445856	lower	C1268088
27445856	upper-body	C1268087
27445856	HIIE	C4277545
27445856	performance	C1882330
27445997	Microbiomes	C1956108
27445997	Muricea californica	C1093383
27445997	M. fruticosa	C1011258
27445997	Comparative Analyses	C0683941
27445997	Eastern Pacific	C0030168
27445997	Octocorals	C0997913
27445997	Octocorals	C0997913
27445997	understudied	C2603343
27445997	microbial	C0599840
27445997	diversity	C1880371
27445997	scleractinian	C0997908
27445997	reef-building coral microbiomes	C1956108
27445997	examined	C0332128
27445997	threats	C0749385
27445997	climate change	C2718051
27445997	Muricea californica	C1093383
27445997	Muricea fruticosa	C1011258
27445997	co-occurring species	C1705920
27445997	gorgonian octocoral	C0997913
27445997	abundantly found	C0150312
27445997	kelp	C0036500
27445997	forests	C0086312
27445997	southern California	C0006754
27445997	excellent basis	C1527178
27445997	octocoral	C0997913
27445997	microbiomes	C1956108
27445997	host	C1167395
27445997	specific	C0205369
27445997	Illumina MiSeq amplicon sequencing	C2348563
27445997	replicate samples	C1609629
27445997	microbiomes	C1956108
27445997	multiple colonies	C0439158
27445997	species	C1705920
27445997	Muricea	C1093383
27445997	measure	C0079809
27445997	inter-	C1947989
27445997	intra-colony	C1947989
27445997	microbiome	C1956108
27445997	variabilities	C2827666
27445997	microbiomes	C1956108
27445997	sea water	C0036499
27445997	zoanthids	C0684063
27445997	benthic invertebrate	C0021948
27445997	analysis	C0936012
27445997	bacterial taxa	C0682467
27445997	associate with	C0332281
27445997	octocorals	C0997913
27445997	first report	C0684224
27445997	microbiomes	C1956108
27445997	species	C1705920
27445997	Muricea	C1093383
27445997	microbiomes	C1956108
27445997	isolated	C0205409
27445997	sample type	C2347029
27445997	distinct	C1705242
27445997	octocoral	C0997913
27445997	species	C1705920
27445997	type	C0332307
27445997	predicting	C0681842
27445997	composition	C0486616
27445997	Muricea	C1093383
27445997	microbiome	C1956108
27445997	Bacterial taxa	C0682467
27445997	compositional differences	C1705241
27445997	distinct	C1705242
27445997	strains	C1518614
27445997	Mycoplasma	C0026934
27445997	associated with	C0332281
27445997	M. californica	C1093383
27445997	M. fruticosa	C1011258
27445997	abundance	C2346714
27445997	Spirochaetes	C1222582
27445997	observed	C1441672
27445997	M. californica	C1093383
27445997	greater	C1704243
27445997	diversity	C1880371
27445997	γ-Proteobacteria	C0751988
27445997	associated with	C0332281
27445997	M. fruticosa	C1011258
27445997	bacterial taxa	C0682467
27445997	differences	C1705241
27445997	presence	C0150312
27445997	photosymbiont-containing invertebrate	C0021948
27445997	microbiomes	C1956108
27447713	2,8-Dihydroxyadenine	C0045643
27447713	Nephropathy	C0022658
27447713	Cause	C0015127
27447713	End-Stage Renal Disease	C0022661
27447713	Renal Transplant	C0022671
27447713	Adenine phosphoribosyltransferase	C0001414
27447713	Adenine phosphoribosyltransferase deficiency	C0268120
27447713	autosomal recessive disorder	C3899988
27447713	uric acid	C0041980
27447713	metabolism	C0025519
27447713	formation	C1522492
27447713	excretion	C0221102
27447713	2,8-dihydroxyadenine	C0045643
27447713	urine	C0042036
27447713	solubility	C0037628
27447713	2,8-dihydroxyadenine	C0045643
27447713	precipitation	C0032931
27447713	formation	C1522492
27447713	urinary crystals	C0151579
27447713	renal stones	C0022650
27447713	Patients	C0030705
27447713	disorder	C0012634
27447713	recurrent nephrolithiasis	C1737262
27447713	nephropathy secondary	C4288763
27447713	crystal	C1533132
27447713	precipitation	C0032931
27447713	renal parenchyma	C0227628
27447713	disease	C0012634
27447713	underdiagnosed	C0243095
27447713	recur	C0034897
27447713	renal transplant	C0022671
27447713	causing	C0015127
27447713	graft failure	C1262018
27447713	clinical	C0205210
27447713	manifestations	C0205319
27447713	chemical	C0243178
27447713	radiologic features	C1948139
27447713	uric acid	C0041980
27447713	uric acid stones	C0006736
27447713	lack of awareness	C0589402
27447713	clinicians	C0871685
27447713	causes	C0015127
27447713	underdiagnoses	C0243095
27447713	treatable	C1522326
27447713	disease	C0012634
27447713	Allopurinol	C0002144
27447713	xanthine dehydrogenase	C0043316
27447713	inhibitor	C0014432
27447713	treatment	C0039798
27447713	fluid intake	C0429791
27447713	dietary modifications	C0086153
27447713	adenine phosphoribosyl transferase	C0001414
27447713	adenine phosphoribosyl transferase deficiency	C0268120
27447713	urolithiasis	C0451641
27447713	children	C0008059
27447713	patients	C0030705
27447713	recurrent urolithiasis	C0750009
27447713	patients	C0030705
27447713	urolithiasis	C0451641
27447713	associated with	C0332281
27447713	renal failure	C0035078
27447713	cause	C0015127
27447713	patients	C0030705
27447713	end-stage renal disease	C0022661
27447713	renal transplant recipients	C0376387
27447713	female patient	C0150905
27447713	late diagnosis	C2718037
27447713	2,8-dihydroxyadenine	C0045643
27447713	nephropathy	C0022658
27447713	end-stage renal disease	C0022661
27447713	native	C0302891
27447713	nephrectomy	C0027695
27447713	renal transplant	C0022671
27447713	prevented	C1456501
27447713	recurrence	C2825055
27447713	graft	C0022671
27449022	Social capital	C1510639
27449022	healthy	C3898900
27449022	ageing	C0001811
27449022	Indonesia	C0021247
27449022	large	C0549177
27449022	international	C1512888
27449022	literature	C0023866
27449022	positive	C1446409
27449022	association	C0439849
27449022	social capital	C1510639
27449022	measures	C0079809
27449022	physical	C0517226
27449022	mental health	C0025353
27449022	research	C0035168
27449022	links	C0439849
27449022	social capital	C1510639
27449022	healthy	C3898900
27449022	ageing	C0001811
27449022	developing country	C0011750
27449022	environment	C0014406
27449022	universal social security coverage	C0037435
27449022	absent	C0332197
27449022	health infrastructure	C0018684
27449022	poor	C0542537
27449022	test	C0039593
27449022	model	C3161035
27449022	linkages	C0332280
27449022	social capital	C1510639
27449022	health outcomes	C1550208
27449022	older adults	C0001792
27449022	Indonesia	C0021247
27449022	data	C1511726
27449022	Indonesian Family Life Survey-East	C0038951
27449022	IFLS-East	C0038951
27449022	multivariate regression analysis	C0034980
27449022	social capital	C1510639
27449022	role	C1705810
27449022	mitigating	C0205556
27449022	poor health	C0683321
27449022	older	C0001792
27449022	individuals	C0237401
27449022	aged	C0001779
27449022	years	C0439234
27449022	Indonesia	C0021247
27449022	vulnerable provinces	C1514578
27449022	test	C0039593
27449022	robustness	C2986815
27449022	social capital	C1510639
27449022	variables	C0439828
27449022	health	C0018684
27449022	measures	C0079809
27449022	self-assessed	C1516048
27449022	health	C0018684
27449022	Activities of Daily Living	C0001288
27449022	ADL	C0001288
27449022	measures	C0079809
27449022	chronic illness	C0008679
27449022	mental health	C0025353
27449022	measures	C0079809
27449022	demographic	C0011298
27449022	groups	C0441833
27449022	controlling	C2587213
27449022	array	C1510941
27449022	socio-economic	C0086996
27449022	demographic	C0011298
27449022	geographic	C1517526
27449022	characteristics	C1521970
27449022	findings	C0243095
27449022	access	C0444454
27449022	social capital	C1510639
27449022	measures	C0079809
27449022	neighbourhood	C1553702
27449022	trust	C0237935
27449022	community participation	C0009476
27449022	associated with	C0332281
27449022	higher	C0205250
27449022	degree	C0449286
27449022	physical mobility	C0871081
27449022	independence	C0085862
27449022	mental well-being	C0025353
27449022	older	C0001792
27449022	individuals	C0237401
27449022	influence	C4054723
27449022	chronic illnesses	C0008679
27449022	results	C1274040
27449022	consistent	C0332290
27449022	estimate	C0750572
27449022	samples	C0681850
27449022	gender	C0079399
27449022	rural	C0240919
27449022	urban	C2700386
27449022	residence	C0237096
27449022	age	C0001779
27449022	categories	C0683312
27449022	policy	C0242456
27449022	results	C1274040
27449022	social capital	C1510639
27449022	measures	C1879489
27449022	moderating	C1881878
27449022	influence	C4054723
27449022	poor health	C0683321
27449022	Activities of Daily Living	C0001288
27449508	Modulation	C0443264
27449508	Interleukins	C0021764
27449508	Sepsis	C0036690
27449508	Associated	C0332281
27449508	Clotting Disorders	C0005779
27449508	Hemostatic Derangement	C0005779
27449508	Interleukins	C0021764
27449508	central	C0205099
27449508	role	C1705810
27449508	immune system	C0020962
27449508	involved	C1314939
27449508	immunological	C0021053
27449508	inflammatory	C1290884
27449508	infectious disease	C0009450
27449508	states	C1442792
27449508	sepsis syndrome	C0036690
27449508	Levels	C0441889
27449508	interleukins	C0021764
27449508	correlate	C1707520
27449508	overall survival	C4086681
27449508	directly	C1947931
27449508	indirectly	C0439852
27449508	affect	C0001721
27449508	regulators	C0005525
27449508	coagulation	C0005778
27449508	fibrinolysis	C0016017
27449508	hemostasis	C0019116
27449508	thrombosis	C0040053
27449508	hypothesis	C1512571
27449508	sepsis-associated coagulopathies	C0005779
27449508	SACs	C0005779
27449508	interleukins	C0021764
27449508	upregulated	C0041904
27449508	hemostatic imbalance	C0005779
27449508	thrombogenic mediators	C0574031
27449508	profiled	C2003903
27449508	levels	C0441889
27449508	interleukins	C0021764
27449508	IL-1α	C0600251
27449508	IL-1β	C0021753
27449508	IL-2	C0021756
27449508	IL-4	C0021758
27449508	IL-6	C0021760
27449508	IL-8	C0079633
27449508	IL-10	C0085295
27449508	in addition to	C0332287
27449508	d-dimer	C0060323
27449508	DD	C0060323
27449508	patients	C0030705
27449508	SAC	C0005779
27449508	normal	C0205307
27449508	donors	C0005795
27449508	observed	C1441672
27449508	highest	C1522410
27449508	increase	C0442805
27449508	interleukins	C0021764
27449508	IL-6	C0021760
27449508	322-fold	C1880833
27449508	IL-8	C0079633
27449508	48-fold	C1880833
27449508	IL-10	C0085295
27449508	72-fold	C1880833
27449508	DD	C0060323
27449508	18-fold	C1880833
27449508	suggests	C1705535
27449508	interleukins	C0021764
27449508	IL-6	C0021760
27449508	IL-10	C0085295
27449508	association with	C0332281
27449508	coagulopathy	C0005779
27449508	fibrinolytic dysregulation	C0543673
27449508	sepsis	C0036690
27449508	considered	C0750591
27449508	candidates	C0021764
27449508	potential	C3245505
27449508	therapeutic	C0302350
27449508	targets	C1521840
27449508	SAC	C0005779
27450737	Thymosin β4	C0076616
27450737	Development	C1527148
27450737	Repair	C0043240
27450737	Engineering	C0205245
27450737	Cardiovascular System	C0007226
27450737	cardiovascular disease	C0007222
27450737	clinical trials	C0008976
27450737	test	C0039593
27450737	therapies	C0087111
27450737	treating	C1522326
27450737	heart	C0018787
27450737	myocardial infarction	C0027051
27450737	MI	C0027051
27450737	heart failure	C0018801
27450737	doctors	C0031831
27450737	patients	C0030705
27450737	repair the heart	C0189919
27450737	ventricular contractility	C1258017
27450737	systemic disease	C0442893
27450737	vascular disorders	C0042373
27450737	stroke	C0038454
27450737	peptides	C0030956
27450737	thymosin β4	C0076616
27450737	Tβ4	C0076616
27450737	cardiovascular	C3887460
27450737	niche	C0333343
27450737	fetal development	C4246208
27450737	injuries	C0018805
27450737	MI	C0027051
27450737	neovasculogenesis	C0027671
27450737	paracrine signals	C0525011
27450737	endogenous	C0205227
27450737	endogenous stem cell	C4084729
27450737	wound repair	C0043240
27450737	research	C0035168
27450737	in vivo	C1515655
27450737	administration	C1533734
27450737	Tβ4	C0076616
27450737	injections	C1533685
27450737	coatings	C0304222
27450737	implants	C0021102
27450737	cell differentiation	C0007589
27450737	Tβ4	C0076616
27450737	administration	C1533734
27450737	angiogenesis	C0302600
27450737	wound healing	C0043240
27450737	heart	C0018787
27450737	MI	C0027051
27450737	brain	C0006104
27450737	stroke	C0038454
27450737	adult stem cells	C1171322
27450737	cardiac	C0018787
27450737	lineage	C0282637
27450737	implantation	C0021107
27450737	heart	C0018787
27450737	contractility	C1258017
27450737	survival	C0220921
27450737	clinical trials	C0008976
27450737	in vivo	C1515655
27450737	effect	C1280500
27450737	therapies	C0087111
27450737	human	C0086418
27450737	patients	C0030705
27450737	goal	C0018017
27450737	people	C0027361
27450737	cardiovascular disease	C0007222
27451448	Yersinia ruckeri	C1257868
27451448	Isolates	C3494793
27451448	Recovered from	C0521108
27451448	Diseased	C0012634
27451448	Atlantic Salmon	C0327949
27451448	Salmo salar	C0327949
27451448	Scotland	C0036453
27451448	Rainbow Trout	C0036108
27451448	Oncorhynchus mykiss	C0036108
27451448	Represent	C1882932
27451448	Subpopulations	C1257890
27451448	Yersinia ruckeri	C1257868
27451448	etiological agent	C1314792
27451448	enteric redmouth	C0275759
27451448	ERM	C0275759
27451448	disease	C0012634
27451448	salmonids	C0036129
27451448	Enteric redmouth disease	C0275759
27451448	associated with	C0332281
27451448	rainbow trout	C0036108
27451448	Oncorhynchus mykiss	C0036108
27451448	Walbaum	C0036108
27451448	incidence	C0021149
27451448	Atlantic salmon	C0327949
27451448	Salmo salar	C0327949
27451448	increasing	C0442808
27451448	Yersinia ruckeri	C1257868
27451448	isolates	C3494793
27451448	recovered from	C0521108
27451448	diseased	C0012634
27451448	Atlantic salmon	C0327949
27451448	poorly characterized	C1880022
27451448	relationship	C0439849
27451448	isolates	C3494793
27451448	associated with	C0332281
27451448	species	C1705920
27451448	Phenotypic	C0031437
27451448	Y. ruckeri	C1257868
27451448	isolates	C3494793
27451448	infected	C0439663
27451448	Atlantic salmon	C0327949
27451448	Scotland	C0036453
27451448	isolates	C3494793
27451448	infected	C0439663
27451448	rainbow trout	C0036108
27451448	characterized	C1880022
27451448	Biotyping	C0441707
27451448	serotyping	C0036759
27451448	comparison	C1707455
27451448	outer membrane	C1167331
27451448	protein profiles	C3463810
27451448	Y. ruckeri	C1257868
27451448	clones	C1522642
27451448	associated with	C0332281
27451448	Atlantic salmon	C0327949
27451448	associated with	C0332281
27451448	rainbow trout	C0036108
27451448	Atlantic salmon	C0327949
27451448	clones	C1522642
27451448	rainbow trout	C0036108
27451448	findings	C0243095
27451448	subpopulations	C1257890
27451448	Y. ruckeri	C1257868
27451448	associated with	C0332281
27451448	species	C1705920
27451448	O serotype	C0449549
27451448	56 biotype 1	C0449562
27451448	Atlantic salmon	C0327949
27451448	isolates	C3494793
27451448	serotype	C0449943
27451448	increased prevalence	C1512456
27451448	Rainbow trout	C0036108
27451448	isolates	C3494793
27451448	represented	C1882932
27451448	biotype 2	C0449562
27451448	serotype O1	C0449549
27451448	ERM	C0275759
27451448	species	C1705920
27451448	United Kingdom	C0041700
27451448	biotype 2	C0449562
27451448	serotype O8	C0449549
27451448	isolates	C3494793
27451448	rainbow trout	C0036108
27451448	vaccines	C0042210
27451448	serotypes O1 and O8	C0449549
27451448	rainbow trout	C0036108
27451448	Atlantic salmon	C0327949
27451448	Scotland	C0036453
27451448	Vaccination	C0042196
27451448	Atlantic salmon	C0327949
27451448	bacterial	C0004611
27451448	Yersinia ruckeri	C1257868
27451448	increasing	C0442808
27451448	incidence	C0021149
27451448	vaccine	C0042210
27451448	salmon	C0036110
27451448	vaccines	C0042210
27451448	rainbow trout	C0036108
27451448	serotypes	C0449943
27451448	species	C1705920
27451448	serotypes	C0449943
27451448	infection	C3714514
27451448	Atlantic salmon	C0327949
27451448	strains	C0327949
27451448	relationships	C0439849
27451448	recovered from	C0521108
27451448	rainbow trout	C0036108
27451448	Y. ruckeri	C1257868
27451448	isolates	C3494793
27451448	recovered from	C0521108
27451448	diseased	C0012634
27451448	Atlantic salmon	C0327949
27451448	Scotland	C0036453
27451448	rainbow trout	C0036108
27451448	isolates	C3494793
27451448	species	C1705920
27451448	represent	C1882932
27451448	subpopulations	C1257890
27451448	O serotype	C0449549
27451448	significant	C0750502
27451448	proportion	C1709707
27451448	disease	C0012634
27451448	Atlantic salmon	C0327949
27451448	findings	C0243095
27451448	development of improved vaccines	C0597634
27451448	Y. ruckeri	C1257868
27452524	CD84	C0666283
27452524	CLL	C0023434
27452524	microenvironment	C3494179
27452524	interactions	C0007582
27452524	Chronic lymphocytic leukemia	C0023434
27452524	CLL	C0023434
27452524	malignant disease	C0442867
27452524	mature lymphocytes	C1513026
27452524	Signals	C1710082
27452524	CLL	C0023434
27452524	microenvironment	C3494179
27452524	promote	C0033414
27452524	progression of the disease	C0242656
27452524	induce	C0205263
27452524	drug resistance	C0013203
27452524	phenomenon	C1882365
27452524	dependent	C0851827
27452524	malignant B cells	C0079731
27452524	stromal cells	C1518246
27452524	CD84	C0666283
27452524	signaling lymphocyte activation molecule family	C4277631
27452524	immunoreceptors	C0597357
27452524	self-associates	C1819957
27452524	orthogonal homophilic dimer	C0596448
27452524	CD84	C0666283
27452524	CLL	C0023434
27452524	cells	C0007634
27452524	microenvironment	C3494179
27452524	promoting	C0033414
27452524	cell survival	C0007620
27452524	in vitro	C1533691
27452524	results	C1274040
27452524	CD84 expressed	C1171362
27452524	CLL	C0023434
27452524	cells	C0007634
27452524	interact	C1704675
27452524	CD84 expressed	C1171362
27452524	cells	C0007634
27452524	microenvironment	C3494179
27452524	inducing	C0205263
27452524	cell survival	C0007620
27452524	Blocking	C0332206
27452524	CD84	C0666283
27452524	in vitro	C1533691
27452524	in vivo	C1515655
27452524	disrupt	C0332454
27452524	interaction	C1704675
27452524	CLL	C0023434
27452524	cells	C0007634
27452524	microenvironment	C3494179
27452524	resulting in	C0332294
27452524	induced	C0205263
27452524	cell death	C0007587
27452524	findings	C0243095
27452524	novel	C0205314
27452524	therapeutic	C0302350
27452524	blockade	C3540676
27452524	CD84	C0666283
27452524	dependent	C0851827
27452524	survival	C0007620
27452524	pathway	C1704259
27453213	Aurantimonas endophytica sp. nov.	C1207105
27453213	endophytic bacterium	C1265415
27453213	roots	C0242726
27453213	Anabasis elatior (C. A. Mey.) Schischk	C3012678
27453213	orange-coloured	C1313858
27453213	aerobic	C1510824
27453213	motile	C1979933
27453213	short-rods bacterial strain	C0004611
27453213	EGI 6500337T	C0004611
27453213	root	C0242726
27453213	halophyte	C2350261
27453213	Anabasis elatior (C. A. Mey.) Schischk	C3012678
27453213	Urumqi	C0017446
27453213	Xinjiang province	C0017446
27453213	north-west China	C0008115
27453213	Growth	C0018270
27453213	pH	C0020283
27453213	pH	C0020283
27453213	NaCl	C0037494
27453213	Phylogenetic tree	C1519069
27453213	16S rRNA	C3537372
27453213	gene sequences	C0162327
27453213	strain EGI 6500337T	C0004611
27453213	genera Aurantimonas	C1207105
27453213	Aureimonas	C1894985
27453213	family Aurantimonadaceae	C1494877
27453213	16S rRNA	C3537372
27453213	gene sequence	C0162327
27453213	strain EGI 6500337T	C0004611
27453213	Aurantimonas coralicida DSM 14790T	C1207106
27453213	Aurantimonas manganoxydans DSM 21871T	C2783928
27453213	Strain EGI 6500337T	C0004611
27453213	Q-10	C0034435
27453213	isoprenoid quinone	C0034435
27453213	fatty acids	C0015684
27453213	C18:1 7c	C2599892
27453213	C19:0 8c cyclo	C0015684
27453213	lipid profile	C0023779
27453213	strain EGI 6500337T	C0004611
27453213	diphosphatidylglycerol	C0023779
27453213	phosphatidylglycerol	C0031619
27453213	phosphatidylcholine	C1959616
27453213	phosphatidylethanolamine	C0031618
27453213	genus Aurantimonas	C1207105
27453213	DNA	C0012854
27453213	G+C content	C1135899
27453213	strain EGI 6500337T	C0004611
27453213	DNA	C0012854
27453213	DNA	C0012854
27453213	strain EGI 6500337T	C0004611
27453213	Aurantimonas coralicida DSM 14790T	C1207106
27453213	phylogenetic analysis	C1519068
27453213	chemotaxonomic data	C1511726
27453213	phenotypic characteristics	C0031437
27453213	strain EGI 6500337T	C0004611
27453213	genus Aurantimonas	C1207105
27453213	Aurantimonas endophytica sp. nov.	C1207105
27453213	strain	C0004611
27453213	EGI 6500337T	C0004611
27453213	KCTC 52296T	C0004611
27453213	CPCC 100904T	C0004611
27453830	Assessment	C0220825
27453830	classification	C0008902
27453830	protocol deviations	C1705236
27453830	Deviations	C1705236
27453830	trial protocol	C2599718
27453830	clinical trials	C0008976
27453830	classified	C0008902
27453830	deviations	C1705236
27453830	violations	C1709750
27453830	impact	C4049986
27453830	trial	C0008976
27453830	deviations	C1705236
27453830	classified	C0008902
27453830	grades from 1 to 5	C0008902
27453830	deviation	C1705236
27453830	Grade 1	C0687695
27453830	no	C1513916
27453830	impact	C4049986
27453830	subjects'	C2349001
27453830	well-being	C0424578
27453830	quality of data	C0242483
27453830	deviation	C1705236
27453830	Grade 5	C0441804
27453830	death	C1306577
27453830	subject	C2349001
27453830	classification	C0008902
27453830	deviations	C1705236
27453830	deviations	C1705236
27453830	Grades 1 and 2	C0008902
27453830	Grades 3 and 4	C0008902
27453830	deviations	C1705236
27453830	death of the subject	C3897054
27453830	classification	C0008902
27453830	trial	C0008976
27453830	managers	C0335141
27453830	occurrence	C2745955
27453830	deviations	C1705236
27453830	impact	C4049986
27454401	Fabrication	C1254366
27454401	modelling	C0870071
27454401	fractal	C0205148
27454401	biomimetic	C0205148
27454401	micro	C0205148
27454401	nano-topographical surfaces	C0205148
27454401	Natural	C0205296
27454401	surface topographies	C0459111
27454401	hierarchical features	C2348519
27454401	micro	C1254372
27454401	nanoscale	C1254372
27454401	modern	C1254367
27454401	tissue engineering	C0596171
27454401	biomaterial	C0005479
27454401	design	C1707689
27454401	limitations	C0449295
27454401	cell's microenvironment	C3179020
27454401	human body	C0242821
27454401	fractal topographical cues	C0005898
27454401	cell	C0007634
27454401	behaviour	C0004927
27454401	recreating	C0205245
27454401	biomimetic	C0870781
27454401	fractal topographies	C0870781
27454401	in vitro	C1533691
27454401	trivial process	C1522240
27454401	fabrication methods	C1254366
27454401	fail	C0231175
27454401	control	C0243148
27454401	spatial resolution	C1254362
27454401	features	C2348519
27454401	different	C1705242
27454401	lengths	C1444754
27454401	scales	C0183110
27454401	biomimetic properties	C0871161
27454401	method	C0025663
27454401	accurately	C0443131
27454401	reproducing	C0205245
27454401	micro	C0870781
27454401	nanoscale topography	C0870781
27454401	human	C0086418
27454401	biological tissue	C0457457
27454401	synthetic polymer	C0440257
27454401	fabrication process	C1254366
27454401	biological tissue	C0457457
27454401	surface	C0205148
27454401	characterised	C1880022
27454401	atomic force microscopy	C0242849
27454401	AFM	C0242849
27454401	spatial	C1254362
27454401	data	C1511726
27454401	grayscale 'digital photomask'	C2827989
27454401	maskless grayscale optical lithography	C0599199
27454401	modified deep reactive ion etching	C1254366
27454401	replica molding	C1254366
27454401	accurately	C0443131
27454401	fractal topography	C0870781
27454401	acellular dermal matrix	C3494272
27454401	ADM	C3494272
27454401	polydimethylsiloxane	C0137758
27454401	PDMS	C0137758
27454401	Characterisation	C1880022
27454401	AFM	C0242849
27454401	different	C1705242
27454401	length	C1444754
27454401	scales	C0183110
27454401	nano	C0870781
27454401	micro-topographical	C0870781
27454401	features	C2348519
27454401	fractal dimension	C0439534
27454401	native	C0302891
27454401	ADM	C3494272
27454401	reproduced	C0205245
27454401	PDMS	C0137758
27454401	fractal topography	C0870781
27454401	biological surfaces	C0205148
27454401	synthetic materials	C0440251
27454401	novel	C0205314
27454401	fabrication process	C1254366
27454401	medical device	C0025080
27454401	biocompatibility	C0596177
27454401	performance	C1882330
27457339	Investigating	C1292732
27457339	Effects of	C1704420
27457339	Acidic pH	C0020283
27457339	Proliferation	C0596290
27457339	Invasion	C2699153
27457339	Drug	C1254351
27457339	Induced	C0205263
27457339	Apoptosis	C0162638
27457339	Lymphoblastic Leukemia	C0023448
27457339	extracellular	C0015352
27457339	pH	C0020283
27457339	tumors	C0027651
27457339	tumor progression	C0178874
27457339	normal	C0205307
27457339	tissues	C0040300
27457339	study	C2603343
27457339	investigate	C1292732
27457339	effects of	C1704420
27457339	extracellular	C0015352
27457339	acidic pH	C0020283
27457339	proliferation	C0596290
27457339	invasion	C2699153
27457339	drug	C1254351
27457339	induced	C0205263
27457339	apoptosis	C0162638
27457339	acute lymphoblastic cells	C0883208
27457339	cells	C0883208
27457339	different	C1705242
27457339	pH	C0020283
27457339	pH	C0020283
27457339	pH	C0020283
27457339	days	C0439228
27457339	Cell proliferation	C0596290
27457339	assessed	C1516048
27457339	MTT assay	C2986858
27457339	cell invasion	C2699153
27457339	invasion assay	C0022885
27457339	gene expression analysis	C1880945
27457339	MMP-9	C0165519
27457339	Drug	C1254351
27457339	induced	C0205263
27457339	apoptosis	C0162638
27457339	exposure to	C0332157
27457339	doxorubicin	C0013089
27457339	annexin V	C0059249
27457339	PI	C0033470
27457339	staining	C0487602
27457339	gene expression analysis	C1880945
27457339	BAX pro-apoptotic protein	C0219474
27457339	growth	C0007595
27457339	invasion	C2699153
27457339	leukemic	C0023418
27457339	cells	C0007634
27457339	pH	C0020283
27457339	cells	C0007634
27457339	pH	C0020283
27457339	resistant	C0332325
27457339	apoptosis	C0162638
27457339	doxorubicin	C0013089
27457339	acidic pH	C0020283
27457339	increases	C0442805
27457339	proliferation	C0596290
27457339	invasion	C2699153
27457339	reduces	C0392756
27457339	drug	C1254351
27457339	induced	C0205263
27457339	apoptosis	C0162638
27457339	acute lymphoblastic leukemia	C0023449
27457339	Extracellular	C0015352
27457339	acidity	C0020283
27457339	leukemic	C0023418
27457339	cells	C0007634
27457339	manipulation	C0205245
27457339	extracellular liquid	C0015349
27457339	therapeutic strategy	C0087111
27457339	leukemia	C0023418
27457339	acute lymphoblastic leukemia	C0023449
27459898	Gold	C0018026
27459898	Nanosponge	C0441126
27459898	Multistimuli-Responsive Drug Vehicles	C0042444
27459898	Targeted	C1521840
27459898	Chemo-Photothermal Therapy	C0087111
27459898	Gold	C0018026
27459898	nanosponge	C0441126
27459898	multistimuli-responsive drug vehicles	C0042444
27459898	chemo-photothermal therapy	C0087111
27459898	drug	C1254351
27459898	delivery	C1705822
27459898	release	C0391871
27459898	nonspecific	C0750540
27459898	systemic	C0205373
27459898	spread	C0332261
27459898	drugs	C0013227
27459898	enhancing	C2349975
27459898	therapeutic efficiency	C2348767
27459898	acute	C0205178
27459898	side effects	C0041755
27462099	Hemodynamic	C0019010
27462099	transient cognitive impairment	C0338656
27462099	transient ischemic attack	C0007787
27462099	minor stroke	C0038454
27462099	transcranial Doppler study	C0554756
27462099	Transient cognitive impairment	C0338656
27462099	TCI	C0338656
27462099	Mini Mental State Evaluation	C0451306
27462099	score	C0449820
27462099	transient ischemic attack	C0007787
27462099	minor stroke	C0038454
27462099	identify	C0205396
27462099	patients	C0030705
27462099	risk	C0035647
27462099	dementia	C0497327
27462099	aimed	C1947946
27462099	replicate	C1883725
27462099	TCI	C0338656
27462099	Montreal Cognitive Assessment	C3496286
27462099	MoCA	C3496286
27462099	compare	C1707455
27462099	persistent Mild Cognitive Impairment	C1270972
27462099	PMCI	C1270972
27462099	global	C2348867
27462099	cerebral	C0228174
27462099	hemodynamic	C0019010
27462099	changes	C0392747
27462099	transient	C0205374
27462099	impairment	C0221099
27462099	patients	C0030705
27462099	transient ischemic attack	C0007787
27462099	minor stroke	C0038454
27462099	assessed	C1516048
27462099	MoCA	C3496286
27462099	transcranial Doppler ultrasound	C0206077
27462099	acutely	C0205178
27462099	compared	C1707455
27462099	patients	C0030705
27462099	TCI	C0338656
27462099	baseline	C1442488
27462099	MoCA	C3496286
27462099	points	C1552961
27462099	increase	C0442805
27462099	PMCI	C1270972
27462099	MoCA	C3496286
27462099	points	C1552961
27462099	increase	C0442805
27462099	no cognitive impairment	C4230628
27462099	NCI	C4230628
27462099	MoCA	C3496286
27462099	patients	C0030705
27462099	PMCI	C1270972
27462099	TCI	C0338656
27462099	NCI	C4230628
27462099	baseline	C1442488
27462099	TCI	C0338656
27462099	patients	C0030705
27462099	higher systolic blood pressure	C0277884
27462099	lower	C0205251
27462099	cerebral blood flow velocities	C0005798
27462099	end-diastolic velocity	C0439830
27462099	mean flow velocity	C4287833
27462099	NCI	C4230628
27462099	clinical	C0205210
27462099	hemodynamic	C0019010
27462099	profiles	C1979963
27462099	PMCI	C1270972
27462099	Systolic BP fell	C0277885
27462099	baseline	C1442488
27462099	mean	C0444504
27462099	reduction	C0441610
27462099	end-diastolic velocity	C0439830
27462099	mean flow velocity	C4287833
27462099	increased	C0442805
27462099	mean	C0444504
27462099	increase	C0442805
27462099	changes	C0392747
27462099	not differ	C3842396
27462099	patients	C0030705
27462099	TCI	C0338656
27462099	PMCI	C1270972
27462099	NCI	C4230628
27462099	TCI	C0338656
27462099	detectable	C3830527
27462099	MoCA	C3496286
27462099	transient ischemic attack	C0007787
27462099	minor stroke	C0038454
27462099	clinical	C0205210
27462099	hemodynamic	C0019010
27462099	profile	C1979963
27462099	PMCI	C1270972
27462099	TCI	C0338656
27462099	not appear	C0332197
27462099	exaggerated	C0442801
27462099	acute	C0205178
27462099	reversible	C0205343
27462099	global	C2348867
27462099	hemodynamic	C0019010
27462099	changes	C0392747
27463942	Apixaban	C1831808
27463942	Twice	C1948050
27463942	Daily	C0332173
27463942	Clinical	C0205210
27463942	Outcomes	C1274040
27463942	Patients	C0030705
27463942	Atrial Fibrillation	C0004238
27463942	Advanced	C0205179
27463942	Age	C0001779
27463942	Low	C0205251
27463942	Body Weight	C0005910
27463942	High	C0205250
27463942	Creatinine	C0010294
27463942	Secondary Analysis	C0683944
27463942	Randomized Clinical Trial	C0206034
27463942	Apixaban	C1831808
27463942	Reduction	C0392756
27463942	Stroke	C0038454
27463942	Thromboembolic Complications	C0040038
27463942	Atrial Fibrillation	C0004238
27463942	ARISTOTLE	C0008976
27463942	trial	C0008976
27463942	dose	C0178602
27463942	apixaban	C1831808
27463942	twice	C1948050
27463942	daily	C0332173
27463942	patients	C0030705
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	years	C0439234
27463942	weight	C0005910
27463942	creatinine level	C0428279
27463942	level	C0441889
27463942	reduced	C0392756
27463942	dose	C0178602
27463942	apixaban	C1831808
27463942	twice	C1948050
27463942	daily	C0332173
27463942	patients	C0030705
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	twice	C1948050
27463942	daily	C0332173
27463942	dose	C0178602
27463942	apixaban	C1831808
27463942	frequency	C0439603
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	effects of	C1704420
27463942	twice	C1948050
27463942	daily	C0332173
27463942	dose	C0178602
27463942	apixaban	C1831808
27463942	stroke	C0038454
27463942	systemic embolism	C0149876
27463942	bleeding	C0019080
27463942	patients	C0030705
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	patients	C0030705
27463942	ARISTOTLE trial	C0008976
27463942	analysis	C0936012
27463942	stroke	C0038454
27463942	systemic embolism	C0149876
27463942	bleeding	C0019080
27463942	hazard ratios	C2985465
27463942	HRs	C2985465
27463942	CIs	C0009667
27463942	evaluated	C0220825
27463942	Interactions	C1704675
27463942	effects of	C1704420
27463942	apixaban	C1831808
27463942	warfarin	C0043031
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	assessed	C1516048
27463942	patient	C0030705
27463942	ARISTOTLE trial	C0008976
27463942	follow-up	C1522577
27463942	Data	C1511726
27463942	Analysis	C0936012
27463942	bleeding	C0019080
27463942	study	C2603343
27463942	drug treatment	C0013216
27463942	Analysis	C0936012
27463942	stroke	C0038454
27463942	systemic embolism	C0149876
27463942	intention	C1283828
27463942	treat	C1522326
27463942	patients	C0030705
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	twice	C1948050
27463942	daily	C0332173
27463942	dose	C0178602
27463942	apixaban	C1831808
27463942	warfarin	C0043031
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	patients	C0030705
27463942	stroke	C0038454
27463942	systemic embolism	C0149876
27463942	HR	C2985465
27463942	CI	C0009667
27463942	bleeding	C0019080
27463942	HR	C2985465
27463942	CI	C0009667
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	benefit	C0814225
27463942	twice	C1948050
27463942	daily	C0332173
27463942	dose	C0178602
27463942	apixaban	C1831808
27463942	warfarin	C0043031
27463942	stroke	C0038454
27463942	systemic embolism	C0149876
27463942	patients	C0030705
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	HR	C2985465
27463942	CI	C0009667
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	HR	C2985465
27463942	CI	C0009667
27463942	benefit	C0814225
27463942	twice	C1948050
27463942	daily	C0332173
27463942	dose	C0178602
27463942	apixaban	C1831808
27463942	warfarin	C0043031
27463942	bleeding	C0019080
27463942	patients	C0030705
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	HR	C2985465
27463942	CI	C0009667
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	HR	C2985465
27463942	CI	C0009667
27463942	dose	C0178602
27463942	reduction	C0392756
27463942	age	C0001779
27463942	body weight	C0005910
27463942	creatinine level	C0428279
27463942	level	C0441889
27463942	creatinine	C0010294
27463942	clearance	C1382187
27463942	Patients	C0030705
27463942	atrial fibrillation	C0004238
27463942	age	C0001779
27463942	body weight	C0005910
27463942	renal dysfunction	C3279454
27463942	risk	C0035647
27463942	stroke	C0038454
27463942	systemic embolism	C0149876
27463942	bleeding	C0019080
27463942	benefits	C0814225
27463942	twice	C1948050
27463942	daily	C0332173
27463942	dose	C0178602
27463942	apixaban	C1831808
27463942	warfarin	C0043031
27463942	patients	C0030705
27463942	twice	C1948050
27463942	daily	C0332173
27463942	dose	C0178602
27463942	apixaban	C1831808
27463942	patients	C0030705
27463942	dose	C0178602
27463942	reduction	C0392756
27465464	Transition	C2700061
27465464	Hospital	C0019994
27465464	Home	C0442519
27465464	Preterm Infants	C4048294
27465464	Families	C0015576
27465464	day	C0439228
27465464	discharge	C0030685
27465464	neonatal intensive care unit	C0021709
27465464	NICU	C0021709
27465464	parents	C0030551
27465464	newborn infants	C0021289
27465464	joy	C0018592
27465464	happiness	C0018592
27465464	home	C0442519
27465464	feeling	C1527305
27465464	parents	C0030551
27465464	scheduled routines	C0205547
27465464	hospital	C0019994
27465464	monitor alarms	C2091666
27465464	clinical rounds	C1456356
27465464	numerous	C0439064
27465464	tests	C0022885
27465464	happens	C1709305
27465464	little patients	C0030705
27465464	families	C0015576
27465464	leave	C1706081
27465464	NICU	C0021709
27465464	happens	C1709305
27465464	leaving	C1706081
27465464	hospital	C0019994
27465464	life	C0376558
27465464	perceived	C0030971
27465464	normal	C0205307
27465464	article	C0282420
27465464	summary	C1706244
27465464	research	C0035168
27465464	vulnerable population	C0949366
27465464	high-risk	C0332167
27465464	preterm infants	C4048294
27465464	families	C0015576
27465464	postdischarge	C0586003
27465464	evidence	C3887511
27465464	transition	C2700061
27465464	home	C0442519
27465464	hospital discharge	C0586003
27465464	phenomenon	C1882365
27465464	families	C0015576
27465464	experience	C0596545
27465464	challenging	C0205556
27465464	attention	C1283164
27465464	clinicians	C0871685
27465464	researchers	C0687734
27465464	effective	C1704419
27465464	efficient	C0442799
27465464	high-quality care	C0034379
27466053	Visual Analytics	C0042825
27466053	Pattern Discovery	C1518918
27466053	Home Care	C0994454
27466053	Clinical Relevance	C2347946
27466053	Quality Improvement	C2936612
27466053	Visualization	C0175631
27466053	cognitive load of information	C0870301
27466053	interpret	C1285553
27466053	assess large amounts of data	C0184514
27466053	home health data	C3878819
27466053	visual analysis techniques	C3536884
27466053	clinically salient	C0449440
27466053	associations	C0750490
27466053	patient characteristics	C0815172
27466053	problem-oriented health outcomes	C1550208
27466053	older adult home health patients	C1443513
27466053	home health service	C0184605
27466053	Knowledge	C0376554
27466053	Behavior	C0004927
27466053	Status ratings	C0681889
27466053	discharge	C0030685
27466053	admission	C0030673
27466053	discharge	C0030685
27466053	Omaha System	C1140113
27466053	dataset	C0150098
27466053	patient data	C2707520
27466053	home health agencies	C0019859
27466053	SPSS Visualization Designer v1.0	C0037589
27466053	visually analyze patterns	C0042825
27466053	heat maps	C1609081
27466053	histograms	C2348974
27466053	Visualizations	C0175631
27466053	clinical salience	C2826293
27466053	tested	C0039593
27466053	correlation analysis	C0010101
27466053	patients	C0030705
27466053	female	C0086287
27466053	visualizations	C0175631
27466053	meaningful patterns	C1609081
27466053	bivariate associations	C0681927
27466053	associations	C0750490
27466053	associations	C0750490
27466053	Charlson co-morbidity index	C3714916
27466053	urinary	C1524119
27466053	diagnoses and problems	C0338067
27466053	visual analysis	C0042825
27466053	association	C0750490
27466053	home health episode	C0085554
27466053	Charlson co-morbidity index	C3714916
27466053	behavior or status outcomes	C0243095
27466053	patients	C0030705
27466053	impaired urinary function	C0871563
27466053	visual analysis	C0042825
27466053	subgroups	C1515021
27466053	older home health patient population	C2361270
27466053	data patterns	C1609081
27466053	clinicians	C0871685
27466053	patient improvement	C3858649
27466053	home health interventions	C1553498
27466053	patient outcomes	C0030698
27466300	Transforming Growth Factor Beta 1	C1704256
27466300	TGF-β1	C1704256
27466300	Thyroid Cancer	C0007115
27466300	Patients	C0030705
27466300	Peripheral Blood	C0229664
27466300	Transforming growth factor beta	C0040690
27466300	TGF-β	C0040690
27466300	pathophysiological	C0031847
27466300	conditions	C0348080
27466300	cancer	C0006826
27466300	level	C0441889
27466300	TGF-β	C0040690
27466300	patients	C0030705
27466300	differentiated thyroid cancer	C1337013
27466300	DTC	C1337013
27466300	examined	C0332128
27466300	study	C2603343
27466300	TGF-β	C0040690
27466300	concentration	C1446561
27466300	serum samples	C1550100
27466300	PHA	C0031858
27466300	stimulated	C0038337
27466300	whole blood	C0370231
27466300	culture	C0200949
27466300	in vitro	C1533691
27466300	analyze	C0936012
27466300	TGF-β1	C1704256
27466300	levels	C0441889
27466300	leukocyte	C0023516
27466300	lymphocyte	C0024264
27466300	platelets	C0005821
27466300	counts	C0007584
27466300	histological	C0205462
27466300	thyroid cancer	C0007115
27466300	stage of disease	C0699749
27466300	TGF-β1	C1704256
27466300	DTC	C1337013
27466300	patients	C0030705
27466300	healthy	C3898900
27466300	controls	C0009932
27466300	duoSet ELISA Development kit	C0812225
27466300	human TGF-β1	C0080222
27466300	concentration	C1446561
27466300	TGF-β1	C1704256
27466300	serum samples	C1550100
27466300	groups	C1257890
27466300	platelet	C0005821
27466300	counts	C0007584
27466300	statistically significant	C0237881
27466300	serum concentrations	C0683149
27466300	TGF-β1	C1704256
27466300	DTC	C1337013
27466300	patients	C0030705
27466300	control subjects	C0009932
27466300	PHA	C0031858
27466300	stimulated	C0038337
27466300	whole blood	C0370231
27466300	cultures	C0200949
27466300	DTC	C1337013
27466300	patients	C0030705
27466300	TGF-β1	C1704256
27466300	controls	C0009932
27466300	studies	C2603343
27466300	significance	C0750502
27466300	in vitro	C1533691
27466300	findings	C0243095
27466374	P-glycoprotein	C0242643
27466374	traffics	C0205245
27466374	nucleus	C0007610
27466374	plasma membrane	C0007603
27466374	rat brain	C1882598
27466374	endothelium	C0014257
27466374	inflammatory pain	C0234251
27466374	P-glycoprotein	C0242643
27466374	PgP	C0242643
27466374	drug	C1254351
27466374	efflux pump	C3824504
27466374	blood-brain barrier	C0005854
27466374	endothelial cells	C0225336
27466374	clinical	C0205210
27466374	obstacle	C0679881
27466374	central nervous system	C3714787
27466374	drug delivery	C0087111
27466374	Identifying	C1254363
27466374	PgP	C0242643
27466374	regulatory pathways	C1514829
27466374	central nervous system	C3714787
27466374	drug delivery	C0087111
27466374	PgP activity	C1753353
27466374	increases	C0442805
27466374	rat brain	C1882598
27466374	microvessels	C2350570
27466374	concomitant	C0521115
27466374	decreased	C0205216
27466374	central nervous system	C3714787
27466374	drug delivery	C0087111
27466374	acute	C0205178
27466374	peripheral	C0205100
27466374	inflammatory pain	C0234251
27466374	PgP	C0242643
27466374	traffics	C0205245
27466374	luminal	C0524462
27466374	plasma membrane	C0007603
27466374	microvessel	C2350570
27466374	endothelial cells	C0225336
27466374	intracellular	C0178719
27466374	stores	C1698986
27466374	peripheral	C0205100
27466374	inflammatory pain	C0234251
27466374	immunofluorescence microscopy	C0079604
27466374	detected	C0442726
27466374	PgP	C0242643
27466374	endothelial cell	C0225336
27466374	nuclei	C0007610
27466374	luminal	C0524462
27466374	plasma membrane	C0007603
27466374	control animals	C1511501
27466374	peripheral	C0205100
27466374	inflammatory pain	C0234251
27466374	luminal	C0524462
27466374	PgP	C0242643
27466374	staining	C0487602
27466374	increased	C0205217
27466374	staining	C0487602
27466374	nucleus	C0007610
27466374	decreased	C0205216
27466374	Biochemical analysis	C3495389
27466374	nuclear	C0007610
27466374	PgP	C0242643
27466374	content	C0456205
27466374	visual observations	C0199219
27466374	Peripheral	C0205100
27466374	inflammatory pain	C0234251
27466374	increased	C0205217
27466374	endothelial cell	C0225336
27466374	luminal	C0524462
27466374	staining	C0487602
27466374	polymerase 1 and transcript release factor	C1419128
27466374	cavin1	C1419128
27466374	serum deprivation response protein	C1419916
27466374	cavin2	C1419916
27466374	caveolar scaffold proteins	C0033684
27466374	caveolin1	C0033684
27466374	protein kinase C delta binding protein	C1418917
27466374	cavin3	C1418917
27466374	location	C0450429
27466374	data	C1511726
27466374	PgP	C0242643
27466374	traffics	C0205245
27466374	stores	C1698986
27466374	nucleus	C0007610
27466374	endothelial cell	C0225336
27466374	luminal membrane	C0597895
27466374	peripheral	C0205100
27466374	inflammatory pain	C0234251
27466374	observation	C0302523
27466374	peripheral	C0205100
27466374	inflammatory pain	C0234251
27466374	inhibits	C3463820
27466374	central nervous system	C3714787
27466374	drug	C1254351
27466374	uptake	C0243144
27466374	novel	C0205314
27466374	regulatory mechanism	C0243095
27466374	PgP activity	C1753353
27466374	rat brain	C1882598
27469396	Functional	C0205245
27469396	Impairment	C0221099
27469396	Children	C0008059
27469396	Externalizing Behavior Disorders	C0004930
27469396	Psychometric	C0033920
27469396	Properties	C0871161
27469396	Weiss Functional Impairment Rating Scale-Parent Report	C0282574
27469396	German	C0017480
27469396	Clinical Sample	C0370003
27469396	psychometric	C0033920
27469396	properties	C0871161
27469396	German	C0017480
27469396	Weiss Functional Impairment Rating Scale-Parent Report	C0282574
27469396	WFIRS-P	C0282574
27469396	clinical sample	C0370003
27469396	children	C0008059
27469396	years	C0439234
27469396	externalizing behavior disorders	C0004930
27469396	Data	C1511726
27469396	collected	C1516698
27469396	clinical trials	C0008976
27469396	Factorial validity	C0871742
27469396	reliability	C2347947
27469396	divergent validity	C0392762
27469396	symptoms	C1457887
27469396	ADHD	C1263846
27469396	oppositional defiant disorder	C0029121
27469396	ODD	C0029121
27469396	assessed	C1516048
27469396	Confirmatory factor analyses	C0870334
27469396	revealed	C0443289
27469396	bifactor model	C3161035
27469396	consistent with	C0332290
27469396	theoretical assumption	C0871935
27469396	general construct	C2827421
27469396	impairment	C0221099
27469396	additional	C1524062
27469396	specific factors	C1521761
27469396	satisfactory	C0205410
27469396	data fit	C1511726
27469396	Model	C3161035
27469396	reliability	C2347947
27469396	estimates	C0750572
27469396	general construct	C2827421
27469396	specific factors	C1521761
27469396	variance	C1711260
27469396	consistencies	C0332529
27469396	correlations	C1707520
27469396	Correlations	C1707520
27469396	WFIRS-P Scales	C0282574
27469396	ADHD	C1263846
27469396	ODD	C0029121
27469396	symptoms	C1457887
27469396	low	C0205251
27469396	moderate	C0205081
27469396	results	C1274040
27469396	factorial validity	C0871742
27469396	reliability	C2347947
27469396	divergent validity	C0392762
27469396	WFIRS-P	C0282574
27469581	Canadians	C1257890
27469581	Americans	C0596070
27469581	learn	C0023185
27469581	health care systems	C0018696
27469581	papers	C0282420
27469581	comparing	C1707455
27469581	Canadian	C1257890
27469581	US	C0041703
27469581	healthcare systems	C0018696
27469581	health policy	C0018735
27469581	experts	C0009817
27469581	recommended	C0034866
27469581	Americans	C0596070
27469581	implement	C1708476
27469581	single-payer system	C0282487
27469581	healthcare expenditures	C0015318
27469581	paper	C0282420
27469581	country	C0454664
27469581	significant	C0750502
27469581	philosophic	C2986477
27469581	structural	C0678594
27469581	change	C0392747
27469581	healthcare system	C0018696
27469581	learned	C0023185
27469581	breakthrough	C0444503
27469581	model	C0006823
27469581	Canada	C0006823
27469581	Western Europe	C0043129
27469581	USA	C0041703
27469581	implement	C1708476
27469581	universal	C0175671
27469581	health insurance	C0021682
27469581	Americans	C0596070
27469581	uninsured	C0087134
27469581	minimal	C0547040
27469581	coverage	C1551362
27469581	medical expenditures	C0015318
27469581	USA	C0041703
27469581	smart cards	C1519382
27469581	evaluate eligibility	C0013893
27469581	process	C1522240
27469581	health insurance claims	C3824919
27469581	resulting in	C0332294
27469581	estimated	C0750572
27469581	reduction	C0392756
27469581	US	C0041703
27469581	health expenditures	C0015318
27469581	effecting	C1280500
27469581	access	C0018748
27469581	quality of care	C0034379
27469581	result	C1274040
27469581	loss	C1517945
27469581	white-collar jobs	C0028811
27469581	hospitals	C0019994
27469581	physician offices	C0031834
27469581	insurance companies	C1549448
27469581	long-term	C0443252
27469581	economic	C0013557
27469581	gain	C1517378
27469581	Canada	C0006823
27469581	functions	C0542341
27469581	multi-payer	C2348942
27469581	reimbursement system	C0035002
27469581	federal	C0015737
27469581	provincial	C1514578
27469581	tax	C0039371
27469581	supported	C1521721
27469581	plan	C0679909
27469581	provinces	C1514578
27469581	universal coverage	C0376640
27469581	hospital	C0019994
27469581	physician services	C0587569
27469581	residents	C2347958
27469581	employer-paid	C3824871
27469581	health insurance	C0021682
27469581	benefits	C0814225
27469581	effective	C1280519
27469581	reimburse	C0205432
27469581	pharmaceuticals	C0031321
27469581	dental	C0011365
27469581	healthcare services	C0018747
27469581	USA	C0041703
27469581	Western European countries	C0043129
27469581	implementing	C1708476
27469581	upper-income	C0871944
27469581	Canadians	C1257890
27469581	federal	C0015737
27469581	provincial	C1514578
27469581	plan	C0679909
27469581	private	C0679727
27469581	insurance coverage	C0376629
27469581	hospital	C0019994
27469581	physician	C0587569
27469581	pharmaceutical	C0031321
27469581	dental	C0011365
27469581	healthcare services	C0018747
27469581	revenues	C0681042
27469581	private sector	C0033176
27469581	eliminate	C1883720
27469581	specialists	C1611835
27469581	medical staffs	C0025106
27469581	prompt	C0871157
27469581	admissions	C0184666
27469581	elective cases	C0745036
27469581	private	C0033173
27469581	wings of hospitals	C0019994
27469581	increase	C0205217
27469581	funding	C0243098
27469581	currently	C0521116
27469581	undercapitalized	C0243095
27469581	system	C0449913
27469581	enhance	C2349975
27469581	sluggish	C3842079
27469581	operations	C3241922
27469581	competition	C0013550
27469581	two-tier approach	C0025663
27469581	USA	C0041703
27469581	Canada	C0006823
27469581	private insurance	C3845555
27469581	legal	C1301860
27469581	recommended	C0034866
27469581	western European countries	C0043129
27469581	percentagea	C0439165
27469581	Canada	C0006823
27469581	public	C0678367
27469581	funding	C0243098
27469581	health expenditures	C0015318
27469581	attempts	C1516084
27469581	implement	C1708476
27469581	result	C1274040
27469581	political	C0032379
27469581	rancor	C0542301
27469581	Canadians	C1257890
27469581	effective	C1280519
27469581	efficient	C0442799
27469581	delivery of care	C0011211
27469581	long-term	C0443252
27469581	fiscal	C0681005
27469581	agree	C3641827
27469581	privatization	C0033180
27469581	healthcare system	C0018696
27469581	Americans	C0596070
27469581	smart card	C1519382
27469581	insurance eligibility	C0680867
27469581	controls	C2587213
27469581	pharmaceuticals	C1254351
27471363	Optimal	C2698651
27471363	Duration	C0449238
27471363	Coronary Ligation	C0396819
27471363	Reperfusion	C0027054
27471363	Reperfusion Injury	C0035126
27471363	Study	C2603343
27471363	Rat	C0034721
27471363	Model	C0026339
27471363	Reperfusion injury	C0035126
27471363	RI	C0035126
27471363	important	C3898777
27471363	impact	C4049986
27471363	clinical	C0205210
27471363	prognosis	C3854082
27471363	patients	C0030705
27471363	acute myocardial injury	C0746730
27471363	coronary	C1522318
27471363	blood flow	C0232338
27471363	reestablished	C0443211
27471363	studies	C2603343
27471363	investigated	C1292732
27471363	timeframe	C0332168
27471363	coronary occlusion	C0151814
27471363	reperfusion	C0027054
27471363	effects	C1280500
27471363	RI	C0035126
27471363	rats	C0034721
27471363	groups	C0441833
27471363	coronary ligation	C0396819
27471363	period	C1948053
27471363	group	C0441833
27471363	subgroups	C0441833
27471363	different	C1705242
27471363	reperfusion	C0027054
27471363	periods	C1948053
27471363	baseline	C1442488
27471363	subgroup	C0441833
27471363	animals	C0003062
27471363	protocols	C0542547
27471363	designed	C1707689
27471363	ligation	C0023690
27471363	reperfusion	C0027054
27471363	periods	C1948053
27471363	Evans blue	C0015205
27471363	2,3,5-triphenyltetrazolium chloride	C0146883
27471363	different	C1705242
27471363	myocardial injury	C0746730
27471363	areas	C0205146
27471363	area	C0205146
27471363	at risk	C1444641
27471363	AAR	C0205146
27471363	myocardial necrosis	C1442837
27471363	differences	C1705242
27471363	ratios	C0456603
27471363	necrotic	C0027540
27471363	area	C0205146
27471363	AAR	C0205146
27471363	subgroup	C0441833
27471363	baseline	C1442488
27471363	averaged	C1510992
27471363	calculate	C1441506
27471363	overall	C1561607
27471363	value	C1522609
27471363	heart	C0018787
27471363	RI	C0035126
27471363	percentages	C0439165
27471363	significant	C0750502
27471363	differences	C1705242
27471363	different	C1705242
27471363	time points	C2348792
27471363	reperfusion	C0027054
27471363	different	C1705242
27471363	time points	C2348792
27471363	ligation	C0023690
27471363	effects	C1280500
27471363	different	C1705242
27471363	time courses	C0449247
27471363	RI	C0035126
27471363	group	C0441833
27471363	highest	C1522410
27471363	RI	C0035126
27471363	difference	C1705242
27471363	baseline	C1442488
27471363	group	C0441833
27471363	Maximal	C0205289
27471363	RI	C0035126
27471363	timeframe	C0332168
27471363	animal model	C0026339
27471363	result	C1274040
27471363	assess	C1516048
27471363	benefits	C0814225
27471363	RI therapies	C0035124
27471363	experimental rat model	C0012644
27473209	Derivation	C1441547
27473209	Predictive	C0681890
27473209	Score	C0449820
27473209	Hemorrhagic	C0019080
27473209	Progression	C0449258
27473209	Cerebral Contusions	C0750971
27473209	Moderate	C3508473
27473209	Severe Traumatic Brain Injury	C3508474
27473209	traumatic brain injury	C0876926
27473209	TBI	C0876926
27473209	hemorrhagic	C0019080
27473209	progression	C0449258
27473209	contusions	C0009938
27473209	HPCs	C0009938
27473209	frequently	C0332183
27473209	established	C0443211
27473209	predictive	C0681890
27473209	score	C0449820
27473209	high-risk	C0332167
27473209	patients	C0030705
27473209	HPC	C0009938
27473209	Consecutive	C1707491
27473209	patients	C0030705
27473209	hospitalized	C0701159
27473209	moderate	C3508473
27473209	severe TBI	C3508474
27473209	primary outcome	C3274433
27473209	HPC	C0009938
27473209	increase	C0442805
27473209	contusion	C0009938
27473209	volume	C0449468
27473209	absolute	C0205344
27473209	increase	C0442805
27473209	serial imaging	C0203640
27473209	Logistic regression models	C0023965
27473209	created	C1706214
27473209	risk factors	C0035648
27473209	HPC	C0009938
27473209	HPC	C0009938
27473209	Score	C0449820
27473209	derived	C1441547
27473209	final model	C3161035
27473209	patients	C0030705
27473209	patients	C0030705
27473209	HPC	C0009938
27473209	univariate analyses	C0683962
27473209	HPC	C0009938
27473209	associated with	C0332281
27473209	older age	C0001779
27473209	higher initial blood pressure	C0436789
27473209	antiplatelet medications	C0085826
27473209	anticoagulants	C0003280
27473209	subarachnoid hemorrhage	C0038525
27473209	SAH	C0038525
27473209	subdural hematoma	C0018946
27473209	SDH	C0018946
27473209	skull fracture	C0037304
27473209	frontal	C0016732
27473209	contusion	C0009938
27473209	larger	C0549177
27473209	contusion	C0009938
27473209	volume	C0449468
27473209	shorter interval	C1272706
27473209	injury	C0178314
27473209	initial CT	C0040405
27473209	final model	C3161035
27473209	SAH	C0038525
27473209	OR	C0028873
27473209	CI	C0009667
27473209	SDH	C0018946
27473209	OR	C0028873
27473209	CI	C0009667
27473209	skull fracture	C0037304
27473209	OR	C0028873
27473209	CI	C0009667
27473209	associated with	C0332281
27473209	HPC	C0009938
27473209	factors	C1521761
27473209	HPC	C0009938
27473209	Score	C0449820
27473209	derived	C1441547
27473209	SAH	C0038525
27473209	SDH	C0018946
27473209	skull fracture	C0037304
27473209	score	C0449820
27473209	receiver operating curve	C0035787
27473209	Patients	C0030705
27473209	score	C0449820
27473209	incidence	C0021149
27473209	HPC	C0009938
27473209	patients	C0030705
27473209	score	C0449820
27473209	incidence	C0021149
27473209	HPC	C0009938
27473209	HPC	C0009938
27473209	Score	C0449820
27473209	risk	C0035647
27473209	stratification	C1514984
27473209	HPC	C0009938
27473209	patients	C0030705
27473209	moderate	C3508473
27473209	severe TBI	C3508474
27473877	Expressing	C0565975
27473877	sexuality	C0036915
27473877	nursing homes	C0028688
27473877	experience	C0683573
27473877	older women	C0043210
27473877	qualitative study	C0949415
27473877	nursing homes	C0028688
27473877	barriers	C4045969
27473877	expression	C0565975
27473877	sexuality	C0036915
27473877	exist	C2987476
27473877	lack of privacy	C2712041
27473877	attitudes	C0004271
27473877	staff	C0028698
27473877	family	C0015576
27473877	sexual partner	C0036911
27473877	physical limitations	C0243095
27473877	study	C0949415
27473877	lived experience	C0683573
27473877	sexuality	C0036915
27473877	elderly Spanish women	C3161473
27473877	nursing homes	C0028688
27473877	qualitative phenomenological approach	C0949415
27473877	Data	C1511726
27473877	collected	C0010995
27473877	month period	C0439231
27473877	sampling	C0870078
27473877	Spanish residents	C2347958
27473877	nursing homes	C0028688
27473877	Madrid	C0017446
27473877	Data	C1511726
27473877	unstructured and semi-structured interviews	C0021822
27473877	data	C1511726
27473877	analyzed	C0936012
27473877	thematic analysis	C0242481
27473877	female	C0086287
27473877	residents	C2347958
27473877	themes	C0869035
27473877	data	C1511726
27473877	expressing	C0565975
27473877	sexuality	C0036915
27473877	sexuality	C0036915
27473877	duty	C0028702
27473877	vows	C1254367
27473877	Female	C0086287
27473877	residents	C2347958
27473877	manage	C0184516
27473877	sexuality	C0036915
27473877	Nursing Homes	C0028688
27473877	expression	C0565975
27473877	sexuality	C0036915
27473877	older female	C0086287
27473877	nursing home	C0028688
27473877	residents	C2347958
27474557	Xylan-based	C0062221
27474557	temperature	C0039476
27474557	pH	C0020283
27474557	sensitive	C0332324
27474557	hydrogels	C0600484
27474557	drug controlled release	C1707506
27474557	Xylan-based	C0062221
27474557	temperature	C0039476
27474557	pH	C0020283
27474557	sensitive	C0332324
27474557	hydrogels	C0600484
27474557	crosslinking copolymerization	C1880180
27474557	xylan	C0062221
27474557	N-isopropylacrylamide	C0083668
27474557	NIPAm	C0083668
27474557	acrylic acid	C1321887
27474557	AA	C1321887
27474557	N,Ń-methylenebis-acrylamide	C0067314
27474557	MBA	C0067314
27474557	cross-linker	C0034760
27474557	2,2-dimethoxy-2-phenylacetophenone	C1121773
27474557	photoinitiator	C0029224
27474557	ultraviolet irradiation	C0041625
27474557	influence	C4054723
27474557	NIPAm	C0083668
27474557	AA	C1321887
27474557	MBA	C0067314
27474557	xylan-based	C0062221
27474557	hydrogels	C0600484
27474557	morphology	C0332437
27474557	interactions	C1704675
27474557	hydrogels	C0600484
27474557	characterized	C1880022
27474557	SEM	C0026020
27474557	FTIR	C0206055
27474557	lower critical solution temperature	C0039476
27474557	LCST	C0039476
27474557	hydrogels	C0600484
27474557	investigated	C1292732
27474557	DSC	C0006780
27474557	results	C0683954
27474557	LCST	C0039476
27474557	hydrogels	C0600484
27474557	AA	C1321887
27474557	drug	C0013227
27474557	encapsulation	C2348438
27474557	efficiency	C0013682
27474557	hydrogels	C0600484
27474557	cumulative	C1511559
27474557	release	C3850077
27474557	rate	C1521828
27474557	acetylsalicylic acid	C0004057
27474557	intestinal	C0021853
27474557	gastric fluid	C2828094
27474557	Xylan-based	C0062221
27474557	hydrogels	C0600484
27474557	biocompatible	C1524057
27474557	NIH3T3 cell	C0007600
27474557	MTT assay	C2986858
27474557	drug carriers	C0013161
27474557	intestinal	C0021853
27474557	targeted	C1521840
27474557	oral drug delivery	C0001563
27474570	Isolation	C0220862
27474570	prebiotic	C2717875
27474570	activity	C0205177
27474570	water-soluble	C0492715
27474570	polysaccharides	C0032594
27474570	fractions	C1264633
27474570	bamboo shoots	C4040751
27474570	Phyllostachys praecox	C1639319
27474570	water-soluble	C0492715
27474570	polysaccharides	C0032594
27474570	bamboo shoots	C4040751
27474570	Phyllostachys praecox	C1639319
27474570	WBP	C0032594
27474570	isolated	C0205409
27474570	characterizations	C0243175
27474570	prebiotic	C2717875
27474570	activities	C0205177
27474570	investigated	C1292732
27474570	yield	C0392762
27474570	WBP	C0032594
27474570	hot-water	C0337023
27474570	extraction	C0684295
27474570	fractions	C1264633
27474570	WBP-1	C0032594
27474570	WBP-2	C0032594
27474570	molecular weight	C0026385
27474570	chromatography	C0008550
27474570	polysaccharides	C0032594
27474570	fractions	C1264633
27474570	heteropolysaccharides-protein complexes	C1704241
27474570	amino acids	C0002520
27474570	protein	C0033684
27474570	rhamnose	C0035417
27474570	arabinose	C0003682
27474570	xylose	C0043375
27474570	mannose	C0024742
27474570	glucose	C0017725
27474570	galactose	C0016945
27474570	molar ratios	C2825550
27474570	polysaccharide	C0032594
27474570	α-	C0006999
27474570	β-glycosidic linkages	C0006999
27474570	sugar	C0007004
27474570	FTIR	C0206055
27474570	NMR spectra	C0877853
27474570	WBP-1	C0032594
27474570	WBP-2	C0032594
27474570	Bifidobacterium adolescentis	C0314972
27474570	Bifidobacterium bifidum	C0314974
27474570	production	C0205245
27474570	organic acids	C0369760
27474570	polysaccharides	C0032594
27474570	potential	C3245505
27474570	prebiotic	C2717875
27474570	properties	C0871161
27478234	nutraceutical	C0243095
27478234	antinutritional properties	C0243095
27478234	barnyard	C1075468
27478234	finger millet	C0026145
27478234	varieties	C1254372
27478234	Himalayan region	C0681784
27478234	varieties	C1254372
27478234	barnyard	C1075468
27478234	Echinochloa frumentacea	C1075468
27478234	finger	C0997163
27478234	Eleusine coracana	C0997163
27478234	northwestern Himalaya	C0681784
27478234	investigated	C1292732
27478234	nutraceutical	C0243095
27478234	antinutritional properties	C0243095
27478234	Barnyard millet	C0026145
27478234	amount	C1265611
27478234	crude fiber	C2348013
27478234	total dietary fiber	C0012173
27478234	tryptophan	C0041249
27478234	content	C0456205
27478234	total carotenoids	C0007271
27478234	α-tocopherol	C0969677
27478234	finger millet	C0026145
27478234	finger millet	C0026145
27478234	amount	C1265611
27478234	methionine	C0025646
27478234	ascorbic acid	C0003968
27478234	barnyard millet	C0026145
27478234	secondary metabolites	C0870883
27478234	biological functions	C3714634
27478234	barnyard millet	C0026145
27478234	amount	C1265611
27478234	polyphenols	C0071649
27478234	tannins	C0039294
27478234	ortho-dihydroxy phenol	C0029224
27478234	content	C0456205
27478234	finger millet	C0026145
27478234	antinutitional compounds	C0029224
27478234	barnyard millet	C0026145
27478234	phytic acid	C0031855
27478234	content	C0456205
27478234	finger millet	C0026145
27478234	no significant difference	C3842396
27478234	trypsin inhibition activity	C1148560
27478234	barnyard millet	C0026145
27478234	finger millet	C0026145
27478234	varieties	C1254372
27478234	Barnyard millet	C0026145
27478234	acid phosphatase	C0001109
27478234	α-galactosidase	C0016955
27478234	α-amylase inhibitor activity	C1152556
27478234	finger millet	C0026145
27478234	Finger millet seeds	C0026145
27478234	calcium	C0006675
27478234	content	C0456205
27478234	amount	C1265611
27478234	manganese	C0024706
27478234	content	C0456205
27478234	barnyard millet seeds	C0026145
27478234	barnyard millet	C0026145
27478234	varieties	C1254372
27478234	finger millet	C0026145
27478234	varieties	C1254372
27481922	Polymorphisms	C0752046
27481922	Inflammatory	C0333348
27481922	Mediator Genes	C0017337
27481922	Risk	C0035647
27481922	Preeclampsia	C0032914
27481922	Taiyuan	C0681784
27481922	China	C0008115
27481922	Excessive	C0442802
27481922	maternal	C1858460
27481922	inflammatory response	C1155266
27481922	pathogenesis	C0699748
27481922	preeclampsia	C0032914
27481922	epidemiologic studies	C0002783
27481922	investigated	C1292732
27481922	associations	C0439849
27481922	genetic variations	C0042333
27481922	inflammatory	C0333348
27481922	mediator genes	C0017337
27481922	preeclampsia	C0032914
27481922	risk	C0035647
27481922	studies	C0002783
27481922	single-nucleotide polymorphisms	C0752046
27481922	IL-1A	C1708430
27481922	IL-1B	C1334112
27481922	IL-1R1	C0391754
27481922	IL-2RA	C1101536
27481922	IL-5RA	C1704269
27481922	IL-6	C1334122
27481922	IL-6R	C0063717
27481922	TNFSF11	C1367028
27481922	TNFRSF11A	C1420805
27481922	IL-28RA	C1425622
27481922	IRAK4	C1334137
27481922	KIT genes	C1416655
27481922	risk	C0035647
27481922	preeclampsia	C0032914
27481922	clinical	C0205210
27481922	subtypes	C0449560
27481922	nested case-control study	C0027775
27481922	preeclampsia	C0032914
27481922	cases	C1706256
27481922	controls	C0009932
27481922	IL-1R1	C0391754
27481922	IL-5RA	C1704269
27481922	IL-6R	C0063717
27481922	TNFSF11	C1367028
27481922	associated with	C0332281
27481922	risk	C0035647
27481922	preeclampsia	C0032914
27481922	significant	C0750502
27481922	associations	C0439849
27481922	preeclampsia	C0032914
27481922	overall	C1561607
27481922	late-onset	C4025592
27481922	preeclampsia	C0032914
27481922	severe	C0205082
27481922	preeclampsia	C0032914
27481922	IL-6R	C0063717
27481922	rs2229238	C0282574
27481922	TNFSF11	C1367028
27481922	rs9525643	C0282574
27481922	polymorphisms	C0752046
27481922	associated with	C0332281
27481922	risk	C0035647
27481922	preeclampsia	C0032914
27481922	TNFSF11	C1367028
27481922	rs2200287	C0282574
27481922	rs2148072	C0282574
27481922	polymorphisms	C0752046
27481922	associated with	C0332281
27481922	risk	C0035647
27481922	preeclampsia	C0032914
27481922	study	C2603343
27481922	evidence	C3887511
27481922	genetic variations	C0042333
27481922	inflammatory	C0333348
27481922	mediator genes	C0017337
27481922	IL-1R1	C0391754
27481922	IL-6R	C0063717
27481922	TNFSF11	C1367028
27481922	IL-5RA	C1704269
27481922	associated with	C0332281
27481922	preeclampsia	C0032914
27481922	risk	C0035647
27481922	risk	C0035647
27481922	preeclampsia	C0032914
27481922	subtypes	C0449560
27484091	school	C0036375
27484091	bonding	C0237497
27484091	African American	C0085756
27484091	adolescents	C0205653
27484091	low-income communities	C0024045
27484091	latent class analysis	C0242481
27484091	Positive	C1446409
27484091	school	C0036375
27484091	bonding	C0237497
27484091	significant	C0750502
27484091	precursor	C1709634
27484091	students	C0038492
27484091	school	C0036375
27484091	success	C0597535
27484091	African American	C0085756
27484091	youth	C0087178
27484091	lower	C0205251
27484091	school	C0036375
27484091	success	C0597535
27484091	White counterparts	C1257890
27484091	study	C2603343
27484091	correlates	C1707520
27484091	school	C0036375
27484091	bonding	C0237497
27484091	African American	C0085756
27484091	youth	C0087178
27484091	recruited	C2949735
27484091	community settings	C0009462
27484091	Chicago	C0008044
27484091	Major	C0205164
27484091	findings	C0243095
27484091	negative peer norms	C1513916
27484091	exposure to	C0332157
27484091	community violence	C4061413
27484091	poor	C2700379
27484091	mental health	C0025353
27484091	negatively	C0205160
27484091	correlated	C1707520
27484091	school	C0036375
27484091	bonding	C0237497
27484091	parental monitoring	C0814580
27484091	positive self-regard	C1821524
27484091	future	C0016884
27484091	orientation	C0029266
27484091	correlated	C1707520
27484091	higher	C0205250
27484091	school	C0036375
27484091	motivation	C0026605
27484091	Students	C0038492
27484091	classified	C0008902
27484091	high	C0205250
27484091	moderate	C0205081
27484091	school	C0036375
27484091	bonding	C0237497
27484091	live	C2982691
27484091	parents	C0030551
27484091	experience	C0596545
27484091	higher	C0205250
27484091	levels	C0441889
27484091	parental monitoring	C0814580
27484091	exhibit positive self-regard	C1821524
27484091	findings	C0243095
27487593	DEPRESSION	C0011570
27487593	ANXIETY	C0003469
27487593	STRESS	C0038443
27487593	ASSOCIATED	C0332281
27487593	FACTORS	C1521761
27487593	CORPS MEMBERS	C0680022
27487593	KEBBI STATE	C0681784
27487593	Depression	C0011570
27487593	anxiety	C0003469
27487593	stress	C0038443
27487593	health problems	C1446377
27487593	associated with	C0332281
27487593	negative	C1513916
27487593	health	C0018684
27487593	consequences	C0686907
27487593	national youth service	C1561598
27487593	characterized	C1880022
27487593	experiences	C0596545
27487593	life style	C0023676
27487593	adjustments	C0376209
27487593	corps member	C0680022
27487593	psychological factors	C0033898
27487593	corps members	C0680022
27487593	study	C2603343
27487593	prevalence	C0683921
27487593	depression	C0011570
27487593	anxiety	C0003469
27487593	stress	C0038443
27487593	associated	C0332281
27487593	factors	C1521761
27487593	corps members	C0680022
27487593	Kebbi state	C0681784
27487593	cross-sectional study	C0010362
27487593	corps members	C0680022
27487593	local government areas	C0681785
27487593	state	C1301808
27487593	local government areas	C0681785
27487593	participants	C0679646
27487593	simple random sampling	C0681878
27487593	Data	C1511726
27487593	May	C3812381
27487593	June	C3829443
27487593	self-administered questionnaire	C0034394
27487593	Data analysis	C0010992
27487593	chi-square test	C0008041
27487593	relationship	C0439849
27487593	categorical variables	C0439828
27487593	multivariate logistic regression	C0206031
27487593	factors	C1521761
27487593	depression	C0011570
27487593	anxiety	C0003469
27487593	stress	C0038443
27487593	response rate	C0237629
27487593	respondents	C0282122
27487593	males	C0086582
27487593	single	C0037179
27487593	years	C1510829
27487593	age	C0001779
27487593	prevalences	C0033105
27487593	depression	C0011570
27487593	anxiety	C0003469
27487593	stress	C0038443
27487593	respondents	C0282122
27487593	factors	C1521761
27487593	depression	C0011570
27487593	North central	C0017446
27487593	OR	C0028873
27487593	CI	C0009667
27487593	South-south	C0017446
27487593	perception	C0030971
27487593	earning	C0680989
27487593	income	C0021162
27487593	OR	C0028873
27487593	CI	C0009667
27487593	CI	C0009667
27487593	anxiety	C0003469
27487593	male gender	C0086582
27487593	OR	C0028873
27487593	CI	C0009667
27487593	North central	C0017446
27487593	risk factors	C0035648
27487593	OR	C0028873
27487593	CI	C0009667
27487593	years	C1510829
27487593	age	C0001779
27487593	risk factor	C0035648
27487593	stress	C0038443
27487593	OR	C0028873
27487593	CI	C0009667
27487593	schooled	C0013658
27487593	towns	C1555315
27487593	residence	C0237096
27487593	stressed	C0564404
27487593	OR	C0028873
27487593	CI	C0009667
27487593	factors	C1521761
27487593	significant association	C0439849
27487593	outcome variables	C0439828
27487593	multivariate analysis	C0026777
27487593	conclusion	C1707478
27487593	prevalences	C0033105
27487593	depression	C0011570
27487593	anxiety	C0003469
27487593	stress	C0038443
27487593	high	C0205250
27487593	corps members	C0680022
27487593	Kebbi state	C0681784
27487593	study	C2603343
27487593	national level	C0681788
27487593	problem	C0033213
27489015	Trans-oral	C0442366
27489015	fine needle aspiration cytology	C2236896
27489015	cervical (C1 and C2) vertebral	C0223098
27489015	lesions	C0221198
27489015	diagnostic approach	C0430022
27489015	Fine needle aspiration (FNA) cytology	C2236896
27489015	non-invasive	C0205303
27489015	diagnosing	C0011900
27489015	superficial	C1336528
27489015	deep-seated neoplastic	C0027651
27489015	non-neoplastic lesions	C0221198
27489015	diagnostic utility	C0348026
27489015	trans-oral	C0442366
27489015	FNA	C2236896
27489015	cervical (C1 and C2) vertebral	C0223098
27489015	paravertebral	C0446501
27489015	lesions	C0221198
27489015	FNA	C2236896
27489015	cervical vertebral	C0223098
27489015	paravertebral	C0446501
27489015	lesions	C0221198
27489015	trans-oral route	C0442366
27489015	image-guidance	C1254363
27489015	cytology	C0010819
27489015	department	C1704729
27489015	PGIMER	C0035172
27489015	Chandigarh	C0681784
27489015	diagnosis	C0011900
27489015	diagnosis	C0011900
27489015	granulomatous inflammation	C0553697
27489015	tuberculosis	C0041296
27489015	Trans-oral	C0442366
27489015	FNA	C2236896
27489015	outpatient procedure	C1299353
27489015	C1 and C2 vertebral	C0223098
27489015	paravertebral	C0446501
27489015	lesions	C0221198
27489015	clinically	C0683325
27489015	radiologically	C0039431
27489015	early diagnosis	C0596473
27489015	management of these patients	C1610129
27491687	Neonatal infections	C0854706
27491687	Case definition	C1704788
27491687	guidelines	C0162791
27491687	data collection	C0010995
27491687	analysis	C0936012
27491687	presentation	C0449450
27491687	immunisation	C0020971
27491687	safety data	C1511726
27491687	Maternal	C1858460
27491687	vaccination	C0042196
27491687	research	C0035168
27491687	definitions	C1704788
27491687	safety standards	C2828392
27491687	GAIA group	C1522486
27491687	Brighton Collaboration	C1522486
27491687	definitions	C1704788
27491687	maternal	C1858460
27491687	vaccine	C0042210
27491687	research	C0035168
27491687	study	C2603343
27491687	definitions	C1704788
27491687	neonatal infections	C0854706
27491687	neonatal infections	C0854706
27491687	GAIA	C1522486
27491687	working group	C1883562
27491687	literature	C0023866
27491687	review	C0565989
27491687	Medline	C0025141
27491687	EMBASE	C0242356
27491687	Cochrane collaboration	C1882071
27491687	definitions	C1704788
27491687	neonatal	C1882071
27491687	public health networks	C1882071
27491687	criteria	C0243161
27491687	derived	C1441547
27491687	consensus process	C0376298
27491687	definitions	C1704788
27491687	neonatal	C0021289
27491687	blood stream infections	C2316160
27491687	BSI	C2316160
27491687	meningitis	C0025289
27491687	lower respiratory tract infections	C0149725
27491687	LRTI	C0149725
27491687	definition	C1704788
27491687	definitions	C1704788
27491687	data collection	C0010995
27491687	analysis	C0936012
27491687	presentation	C0449450
27491687	harmonized	C0150103
27491687	Brighton Collaboration	C1522486
27491687	GAIA	C1522486
27491687	format	C1301627
27491687	international standards	C2828392
27491687	study	C2603343
27491687	reporting	C0011000
27491778	Beneficial	C0814225
27491778	effects	C1280500
27491778	dark chocolate	C3853217
27491778	exercise	C0015259
27491778	capacity	C1516240
27491778	sedentary	C0205254
27491778	subjects	C2349001
27491778	mechanisms	C0441712
27491778	double blind	C0013072
27491778	randomized	C0034656
27491778	placebo controlled	C1706408
27491778	trial	C0008976
27491778	heart failure	C0018801
27491778	patients	C0030705
27491778	consumption	C1947907
27491778	(-)-epicatechin	C1881340
27491778	(-)-Epi	C1881340
27491778	cocoa	C0009209
27491778	skeletal muscle	C0242692
27491778	SkM	C0242692
27491778	mitochondrial	C0026237
27491778	structure	C0678594
27491778	decrease	C0547047
27491778	biomarkers	C0005516
27491778	oxidative stress	C0242606
27491778	effects	C1280500
27491778	exercise	C0015259
27491778	capacity	C1516240
27491778	mechanisms	C0441712
27491778	normal	C0205307
27491778	sedentary	C0205254
27491778	subjects	C2349001
27491778	normal	C0205307
27491778	sedentary	C0205254
27491778	subjects	C2349001
27491778	years old	C0001675
27491778	randomized	C0034656
27491778	placebo	C0032042
27491778	dark chocolate	C3853217
27491778	DC	C3853217
27491778	groups	C0441833
27491778	consumed	C2983605
27491778	months	C0439231
27491778	Subjects	C2349001
27491778	treatment	C0087111
27491778	bicycle ergometry	C0857787
27491778	assess	C0184514
27491778	VO2 max	C0429693
27491778	work	C0043227
27491778	SkM biopsy	C2315740
27491778	assess	C0184514
27491778	mitochondrial	C0026237
27491778	density	C0178587
27491778	function	C0542341
27491778	oxidative stress	C0242606
27491778	blood sampling	C0005834
27491778	assess	C0184514
27491778	metabolic	C0311400
27491778	endpoints	C2349179
27491778	subjects	C2349001
27491778	trial	C0008976
27491778	DC	C3853217
27491778	VO2 max	C0429693
27491778	increased	C0442805
27491778	increase	C0442805
27491778	work	C0043227
27491778	watts	C0439261
27491778	placebo	C0032042
27491778	DC	C3853217
27491778	increases	C0442805
27491778	HDL	C0023821
27491778	decreased	C0205216
27491778	triglycerides	C0041004
27491778	DC	C3853217
27491778	SkM	C0242692
27491778	significant	C0750502
27491778	increases	C0442805
27491778	protein	C0033684
27491778	LKB1	C1431123
27491778	AMPK	C2350345
27491778	PGC1α	C1452082
27491778	active	C0205177
27491778	phosphorylated	C0031715
27491778	AMPK	C2350345
27491778	LKB1	C1431123
27491778	citrate synthase activity	C2258114
27491778	mitochondrial	C0026237
27491778	density	C0178587
27491778	DC	C3853217
27491778	significant	C0750502
27491778	increases	C0442805
27491778	SkM	C0242692
27491778	glutathione	C0017817
27491778	decreases	C0547047
27491778	protein carbonylation	C1563721
27491778	work	C0043227
27491778	VO2 max	C0429693
27491778	DC	C3853217
27491778	activation	C1879547
27491778	SkM	C0242692
27491778	mitochondria	C0026237
27491778	efficiency	C0013682
27491778	clinical studies	C0008972
27491778	observations	C0302523
27494020	Reduction	C0392756
27494020	Hospital-Wide	C0019994
27494020	Clinical Laboratory Specimen Identification	C0200344
27494020	Errors	C0743559
27494020	Process Interventions	C0814452
27494020	Year	C0439234
27494020	Retrospective Observational Study	C0035363
27494020	Accurate	C0443131
27494020	patient identification	C1269815
27494020	specimen labeling	C1254363
27494020	crucial steps	C1254372
27494020	prevention	C1706420
27494020	medical errors	C0376531
27494020	improving	C1272745
27494020	patient safety	C1113679
27494020	patient specimen	C1292459
27494020	identification	C0205396
27494020	errors	C0743559
27494020	occurred	C1709305
27494020	outpatient department	C1547116
27494020	OPD	C1547116
27494020	emergency department	C0562508
27494020	ED	C0562508
27494020	inpatient department	C1547116
27494020	IPD	C1547116
27494020	bed	C0004916
27494020	academic medical center	C0000872
27494020	Taiwan	C0039260
27494020	documented	C1301725
27494020	analyzed	C1254363
27494020	reduce	C0392756
27494020	errors	C0743559
27494020	series	C0205549
27494020	strategies	C0679716
27494020	restrictive specimen acceptance policy	C0680575
27494020	ED	C0562508
27494020	IPD	C1547116
27494020	computer-assisted	C2362103
27494020	barcode	C0004738
27494020	positive patient identification system	C0009612
27494020	ED	C0562508
27494020	IPD	C1547116
27494020	automated	C0205554
27494020	sample labeling	C1254363
27494020	combined	C0205195
27494020	electronic identification systems	C3687093
27494020	introduced	C1292748
27494020	OPD	C1547116
27494020	specimens	C1550655
27494020	collected	C1516698
27494020	identified	C0243095
27494020	patient identification	C1269815
27494020	errors	C0743559
27494020	errors	C0743559
27494020	specimens	C1550655
27494020	collected	C1516698
27494020	interventions	C1273869
27494020	relative	C0205345
27494020	reduction	C0392756
27494020	total number	C4288115
27494020	rate	C1521828
27494020	institutional identification	C1254363
27494020	errors	C0743559
27494020	ED	C0562508
27494020	IPD	C1547116
27494020	OPD	C1547116
27494020	year	C0439234
27494020	period	C1948053
27494020	errors	C0743559
27494020	before	C0332152
27494020	interventions	C1273869
27494020	after	C0687676
27494020	interventions	C1273869
27494020	relative	C0205345
27494020	reductions	C0392756
27494020	Accurate	C0443131
27494020	patient identification	C1269815
27494020	patient safety	C1113679
27494020	health	C0018684
27494020	settings	C1318139
27494020	data collected	C4019276
27494020	study	C2603343
27494020	restrictive specimen acceptance policy	C0680575
27494020	computer-generated	C0022885
27494020	positive identification systems	C0009612
27494020	reduce	C0392756
27494020	patient identification	C1269815
27494020	errors	C0743559
27494908	Management	C0376636
27494908	skin and soft-tissue infections	C0852000
27494908	teaching hospital	C0020027
27494908	severity-of-illness tool	C0449851
27494908	Skin and soft-tissue infections	C0852000
27494908	SSTIs	C0852000
27494908	diverse	C1880371
27494908	range	C1514721
27494908	infections	C3714514
27494908	severity	C0439793
27494908	Clinical Resource Efficiency Support Team (CREST) scoring system	C0162791
27494908	stratifies	C0008902
27494908	patients	C0030705
27494908	classes	C0008902
27494908	severe	C0205082
27494908	severe	C0205082
27494908	Standardized Early Warning Score	C2919819
27494908	SEWS	C2919819
27494908	objective	C2985627
27494908	study	C2603343
27494908	CREST	C0162791
27494908	hospitalized patients	C0870668
27494908	SSTIs	C0852000
27494908	disease severity	C0521117
27494908	evaluate	C0220825
27494908	antibiotic	C0003232
27494908	retrospective	C0035363
27494908	hypothesis	C1512571
27494908	evaluation	C0220825
27494908	hospitalized patients	C0870668
27494908	SSTIs	C0852000
27494908	admitted	C0184666
27494908	CREST	C0162791
27494908	empirical	C1880496
27494908	antimicrobial	C1136254
27494908	categorized	C0871968
27494908	over-treatment	C4046039
27494908	under-treatment	C0087111
27494908	patients	C0030705
27494908	inclusion criteria	C1512693
27494908	patients	C0030705
27494908	classified	C0008902
27494908	CREST	C0162791
27494908	class I	C1550329
27494908	class I	C1550329
27494908	Over-treatment	C4046039
27494908	severe	C0205082
27494908	classes	C0008902
27494908	class I	C1550329
27494908	class II	C1550329
27494908	percent	C0439165
27494908	class I	C1550329
27494908	over-treated	C4046039
27494908	intravenous	C1522726
27494908	antibiotic	C0003232
27494908	oral therapy	C0559681
27494908	broad-spectrum antibiotics	C0003232
27494908	class II	C1550329
27494908	over-treated	C4046039
27494908	broad-spectrum antibiotics	C0003232
27494908	clinical failure	C3640841
27494908	patients	C0030705
27494908	response	C0521982
27494908	class II	C1550329
27494908	class III	C1550329
27494908	class IV	C1550329
27494908	Retrospective	C1514923
27494908	application	C0185125
27494908	CREST	C0162791
27494908	management	C0376636
27494908	SSTIs	C0852000
27494908	CREST	C0162791
27494908	severe	C0205082
27494908	SSTIs	C0852000
27494908	treated	C0087111
27494908	outpatient	C0029921
27495798	Breakthrough	C0444503
27495798	viridans streptococcal bacteremia	C0152965
27495798	allogeneic hematopoietic stem cell transplant	C4255274
27495798	recipients	C0376387
27495798	receiving	C1514756
27495798	levofloxacin	C0282386
27495798	prophylaxis	C0199176
27495798	Japanese	C0022341
27495798	hospital	C0019994
27495798	Breakthrough	C0444503
27495798	viridans streptococcal bacteremia	C0152965
27495798	VSB	C0152965
27495798	patients	C0030705
27495798	hematological malignancy	C0376545
27495798	receiving	C1514756
27495798	levofloxacin	C0282386
27495798	prophylaxis	C0199176
27495798	major	C0205164
27495798	blood stream infection	C0004610
27495798	BSI	C0004610
27495798	occurring	C1709305
27495798	during	C0347984
27495798	febrile neutropenia	C0746883
27495798	clinical data	C1516606
27495798	focused	C1285542
27495798	VSB	C0152965
27495798	allogeneic hematopoietic stem cell transplant	C4255274
27495798	allo-HSCT	C4255274
27495798	recipients	C0376387
27495798	lacking	C0332268
27495798	medical records	C0025102
27495798	allo-HSCT	C4255274
27495798	recipients	C0376387
27495798	received	C1514756
27495798	oral	C1527415
27495798	levofloxacin	C0282386
27495798	prophylaxis	C0199176
27495798	Toranomon Hospital	C0019994
27495798	reviewed	C1709940
27495798	evaluate	C0220825
27495798	breakthrough	C0444503
27495798	VSB	C0152965
27495798	viridans streptococcal	C1140704
27495798	VGS	C1140704
27495798	species	C1705920
27495798	identified	C0205396
27495798	using	C1524063
27495798	sodA gene	C0017337
27495798	sequencing	C1294197
27495798	assessed	C1516048
27495798	drug susceptibility	C1326871
27495798	allo-HSCT	C4255274
27495798	recipients	C0376387
27495798	levofloxacin	C0282386
27495798	prophylaxis	C0199176
27495798	breakthrough	C0444503
27495798	VSB	C0152965
27495798	recipients	C0376387
27495798	VSB	C0152965
27495798	treated	C1522326
27495798	cefepime	C0055003
27495798	based	C1527178
27495798	piperacillin/tazobactam	C0250480
27495798	based	C1527178
27495798	regimen	C0040808
27495798	susceptibility	C1326871
27495798	rates	C1521828
27495798	VGS	C1140704
27495798	strains	C1518614
27495798	levofloxacin	C0282386
27495798	cefepime	C0055003
27495798	piperacillin/tazobactam	C0250480
27495798	meropenem	C0066005
27495798	vancomycin	C0042313
27495798	MIC50	C0427978
27495798	minimum inhibitory concentration	C0427978
27495798	MIC90	C0427978
27495798	ceftazidim	C0007559
27495798	higher	C0205250
27495798	MIC90	C0427978
27495798	anti-pseudomonal beta-lactams	C1254351
27495798	APBLs	C1254351
27495798	VGS	C1140704
27495798	strain	C1518614
27495798	penicillin	C0220892
27495798	MIC	C0427978
27495798	Etest	C3850116
27495798	no	C1518422
27495798	cases	C0868928
27495798	acute respiratory distress syndrome	C1848829
27495798	ARDS	C1848829
27495798	associated with	C0332281
27495798	VSB	C0152965
27495798	rate	C1521828
27495798	viridans group streptococcal shock syndrome	C0152965
27495798	high	C0205250
27495798	30-day	C0439228
27495798	mortality rate	C0205848
27495798	VSB	C0152965
27495798	group	C0681860
27495798	not	C1518422
27495798	differ	C1705242
27495798	significantly	C0750502
27495798	BSI	C0004610
27495798	without	C0332288
27495798	VSB	C0152965
27495798	group	C0681860
27495798	non	C1518422
27495798	BSI	C0004610
27495798	group	C0681860
27495798	VSB	C0152965
27495798	not	C1518422
27495798	risk factor	C0035648
27495798	mortality	C0205848
27495798	60 days	C0439228
27495798	following	C0332282
27495798	allo-HSCT	C4255274
27495798	APBL	C1254351
27495798	increased	C0205217
27495798	anti-VGS activity	C0243095
27495798	APBL-VA	C0243095
27495798	monotherapy	C0087111
27495798	optimal	C2698651
27495798	treating	C1522326
27495798	VGS	C1140704
27495798	strains	C1518614
27495798	anti-gram-positive agent	C1254351
27495798	APBL-VA	C0243095
27495798	treating	C1522326
27495798	VSB	C0152965
27495798	local	C0205276
27495798	factors	C1521761
27495798	susceptibility	C1326871
27495798	results	C1274040
27495798	breakthrough	C0444503
27495798	VSB	C0152965
27495798	not	C1518422
27495798	major	C0205164
27495798	cause of death	C0007465
27495798	allo-HSCT	C4255274
27495798	beta-lactam	C0282215
27495798	non-susceptible VGS	C1140704
27495798	ARDS	C1848829
27495798	rare	C0522498
27497497	splenorrhaphy	C1261005
27497497	hemodynamically unstable	C0948268
27497497	child	C0008059
27497497	splenorrhaphy	C1261005
27497497	splenectomy	C0037995
27497497	postsplenectomy	C3854596
27497497	sepsis	C0243026
27497497	splenorrhaphy	C1261005
27497497	familiarity	C0600269
27497497	procedure	C0087111
27497497	splenectomies	C0037995
27497497	splenorrhaphies	C1261005
27497497	trauma	C3714660
27497497	pediatric surgeon	C0586905
27497497	perform	C0884358
27497497	career	C0178534
27497497	Pediatric Health Information System (PHIS) Database	C0242356
27497497	patients	C0030705
27497497	years	C0439234
27497497	International Classification of Diseases 9th Edition	C2346503
27497497	diagnosis code	C1550350
27497497	splenic injury	C0160405
27497497	Age	C0001779
27497497	gender	C0079399
27497497	grade	C0441800
27497497	splenic injury	C0160405
27497497	operations	C0543467
27497497	performed	C0884358
27497497	extracted	C1516695
27497497	pediatric surgeons	C0586905
27497497	hospital	C0019994
27497497	children	C0008059
27497497	identified	C0205396
27497497	splenectomy	C0037995
27497497	splenorrhaphy	C1261005
27497497	surgeon	C0582175
27497497	performed	C0884358
27497497	splenectomies	C0037995
27497497	splenorrhaphies	C1261005
27497497	trauma	C3714660
27497497	rates	C1521828
27497497	constant	C1948059
27497497	surgeon	C0582175
27497497	perform	C0884358
27497497	splenectomies	C0037995
27497497	splenorrhaphies	C1261005
27497497	trauma	C3714660
27497497	year	C0439234
27497497	surgical career	C0178534
27497497	Nonoperative management	C0161969
27497497	experience level	C0870520
27497497	pediatric surgeons	C0586905
27497497	perform	C0884358
27497497	splenectomy	C0037995
27497497	splenorrhaphy	C1261005
27498399	Vestibular	C0042606
27498399	inter-stimulus interval	C0870743
27498399	effects	C1280500
27498399	sound evoked potentials	C0015215
27498399	central	C0205099
27498399	origin	C0439659
27498399	presence	C0150312
27498399	vestibular	C0042606
27498399	contributions	C1880177
27498399	auditory evoked potentials	C0015215
27498399	AEPs	C0015215
27498399	vestibular	C0042606
27498399	threshold	C0004312
27498399	vestibular evoked myogenic potentials	C2936453
27498399	VEMPs	C2936453
27498399	deflection	C0012727
27498399	labeled	C1708632
27498399	prior	C0332152
27498399	long	C0205166
27498399	latency	C0242465
27498399	AEPs	C0015215
27498399	report	C0700287
27498399	results	C2825142
27498399	experiment	C0681814
27498399	effect of	C1704420
27498399	inter-stimulus interval	C0870743
27498399	ISI	C0870743
27498399	regularity	C0449581
27498399	potentials	C0015214
27498399	above	C1282910
27498399	below	C0542339
27498399	VEMP	C2936453
27498399	threshold	C0004312
27498399	healthy	C3898900
27498399	right-handed	C0344333
27498399	subjects	C2349001
27498399	evoked potentials	C0015214
27498399	sound stimulation	C0001164
27498399	above	C1282910
27498399	below	C0542339
27498399	vestibular	C0042606
27498399	threshold	C0004312
27498399	stimulus	C0234402
27498399	rates	C1521828
27498399	ISIs	C0870743
27498399	intervals	C0870743
27498399	presented	C0449450
27498399	regular	C0205272
27498399	irregular	C0205271
27498399	ANOVA	C0002780
27498399	global field power	C0392762
27498399	GFP	C0392762
27498399	intensity	C0237686
27498399	ISI	C0870743
27498399	regularity	C0449581
27498399	significant	C0750502
27498399	ANOVA	C0002780
27498399	effects of	C1704420
27498399	intensity	C0237686
27498399	effects	C1280500
27498399	interactions	C1704675
27498399	additional	C1524062
27498399	effects of	C1704420
27498399	ISI	C0870743
27498399	intensity	C0237686
27498399	evidence of	C0332120
27498399	non	C1518422
27498399	linear	C0205132
27498399	interactions	C1704675
27498399	ISI	C0870743
27498399	intensity	C0237686
27498399	source analysis	C0936012
27498399	consistent with	C0332290
27498399	prior	C0332152
27498399	above	C1282910
27498399	vestibular	C0042606
27498399	threshold	C0004312
27498399	in addition to	C0332287
27498399	bilateral	C0238767
27498399	superior	C1282910
27498399	temporal cortex	C0039485
27498399	ocular	C0015392
27498399	cerebellar	C0007765
27498399	cingulate	C0228272
27498399	sources	C0449416
27498399	statistical analysis	C0871424
27498399	source	C0449416
27498399	currents	C1705970
27498399	interactions	C1704675
27498399	intensity	C0237686
27498399	ISI	C0870743
27498399	sensitivity	C0036667
27498399	vestibular	C0042606
27498399	sources	C0449416
27498399	specific	C0205369
27498399	vestibular	C0042606
27498399	preference	C0558295
27498399	stimulus	C0234402
27498399	rates	C1521828
27498399	associated with	C0332281
27498399	locomotion	C0023946
27498399	rates	C1521828
27498399	ISIs	C0870743
27498399	saccular	C0205137
27498399	afferents	C0205115
27498399	increased	C0205217
27498399	gain	C1517378
27498399	reflexes	C0034929
27498399	sensitive	C0332324
27500198	Systematic Review	C1955832
27500198	Diagnostic	C0348026
27500198	Prognostic Value	C1514475
27500198	Urinary	C1524119
27500198	Protein	C0033684
27500198	Biomarkers	C0005516
27500198	Urothelial Bladder Cancer	C0751571
27500198	cystoscopy	C0010702
27500198	gold-standard	C0150110
27500198	detecting	C0442726
27500198	tumours	C0027651
27500198	urinary bladder	C0005682
27500198	bladder tumours	C0005695
27500198	recur	C0034897
27500198	progress	C0242656
27500198	patients	C0030705
27500198	cystoscopies	C0010702
27500198	long-term	C0443252
27500198	surveillance	C0733511
27500198	procedure	C0184661
27500198	patient	C0030705
27500198	healthcare providers	C0018724
27500198	identification	C0205396
27500198	validation	C1519941
27500198	bladder tumour	C0005695
27500198	molecular markers	C0005516
27500198	urine	C0042036
27500198	tumour	C0027651
27500198	detection	C0442726
27500198	reliance	C0599403
27500198	cystoscopy	C0010702
27500198	biomarkers	C0005516
27500198	Proteins	C0033684
27500198	studied class of biomolecule	C0681852
27500198	researchers	C0035173
27500198	urinary	C1524119
27500198	biomarkers	C0005516
27500198	comprehensive systematic review	C1955832
27500198	literature	C0023866
27500198	database	C0242356
27500198	proteins	C0033684
27500198	investigated	C0220825
27500198	proteins	C0033684
27500198	sensitivity and specificity	C0036668
27500198	bladder cancer	C0005695
27500198	detection	C0442726
27500198	investigation	C0220825
27500198	investigation	C0220825
27500198	investigated	C0220825
27500198	prognostic markers	C1514475
27500198	biomarkers	C0005516
27500198	rigorous validation	C0681836
27500198	preventing	C1292733
27500198	proteins	C0033684
27500198	disease	C0012634
27500198	biomarker	C0005516
27500198	large-scale efforts	C0814860
27500198	validation	C0681836
27500262	Qualitative Study	C0949415
27500262	Decision-Making	C0011109
27500262	Hopes	C0392347
27500262	Realities	C0871222
27500262	Adults	C0001675
27500262	Type 1 Diabetes	C0011854
27500262	Islet Cell Transplantation	C0079646
27500262	individuals	C0237401
27500262	type 1 diabetes	C0011854
27500262	pancreatic islet transplantation	C0079646
27500262	IT	C0079646
27500262	hypoglycemia	C0020615
27500262	optimizes glycemia	C3267174
27500262	systemic immunosuppression	C0021079
27500262	candidates	C1257890
27500262	recipients	C0376387
27500262	transplantation	C0040732
27500262	waiting list	C0586018
27500262	recipients	C0376387
27500262	posttransplant	C1254367
27500262	qualitative	C0205556
27500262	research design	C0035171
27500262	interviews	C0683518
27500262	adults	C0001675
27500262	pretransplant	C1254367
27500262	posttransplant	C1254367
27500262	UK	C0041700
27500262	centers	C0475309
27500262	Canadian	C0006823
27500262	center	C0475309
27500262	Interviews	C0683518
27500262	audio-recorded	C2316646
27500262	inductive thematic analysis	C0936012
27500262	Interviewees	C0489844
27500262	years	C0439234
27500262	duration	C0449238
27500262	diabetes	C0011847
27500262	years	C0439234
27500262	women	C0043210
27500262	expectations	C0679138
27500262	hopes	C0392347
27500262	realities	C0871222
27500262	decision-making	C0011109
27500262	hospital stay	C3489408
27500262	follow-up	C1522577
27500262	hypoglycemic episodes	C0745153
27500262	reduced	C0392756
27500262	insulin	C0021641
27500262	complications	C0009566
27500262	psychological well-being	C0424578
27500262	interviewees	C0489844
27500262	decision-making	C0011109
27500262	clinicians	C0871685
27500262	family	C0015576
27500262	stressful	C0231297
27500262	immunosuppressant	C0021081
27500262	side effects	C0879626
27500262	severe	C0205082
27500262	interviewees	C0489844
27500262	no	C1513916
27500262	regrets	C0080101
27500262	Posttransplant	C1254367
27500262	interviewees	C0489844
27500262	confidence	C0237529
27500262	freedom from hypoglycemia	C0243095
27500262	glycemic control	C3267174
27500262	insulin	C0021641
27500262	transplant	C0040732
27500262	hopes	C0392347
27500262	insulin-free	C0243095
27500262	interviews	C0683518
27500262	IT	C0079646
27500262	IT	C0079646
27500262	candidates	C1257890
27500809	nanocomposite	C0205199
27500809	bone	C0262950
27500809	strength	C0237897
27500809	damage	C1883709
27500809	resistance	C4281815
27500809	human bone	C0277764
27500809	amorphous	C1979848
27500809	mineral	C0026162
27500809	precursor	C1709634
27500809	formation	C1522492
27500809	nanocrystalline	C1721058
27500809	apatite	C0003522
27500809	amorphous	C1979848
27500809	mineral	C0026162
27500809	transmission electron microscopy	C0678118
27500809	amorphous	C1979848
27500809	calcium phosphate	C0006711
27500809	regions	C0005898
27500809	disordered phase	C1254362
27500809	trabecular bone	C0222660
27500809	Nanomechanical experiments	C0681814
27500809	cylindrical	C0946010
27500809	samples	C0370003
27500809	diameters	C1301886
27500809	bone's	C0262950
27500809	ordered	C1254362
27500809	disordered phases	C1254362
27500809	transition	C2700061
27500809	plastic	C0678558
27500809	deformation	C0575133
27500809	brittle	C3810845
27500809	failure	C0016658
27500809	strength	C0237897
27500809	smaller	C0547044
27500809	samples	C0370003
27500809	transition	C2700061
27500809	failure	C0231174
27500809	mechanism	C0441712
27500809	suppression	C1260953
27500809	extrafibrillar	C0225328
27500809	shearing	C0205013
27500809	samples	C0370003
27500809	smaller	C0547044
27500809	stronger	C0442821
27500809	size effect	C0814843
27500809	sample-size	C0242618
27500809	scaling	C1947916
27500809	findings	C0243095
27500809	multi-scale nature	C0349590
27500809	bone	C0262950
27500809	biomineralization	C0006660
27500809	process	C1522240
27501910	Assessing	C1516048
27501910	physiological	C0205463
27501910	relevance	C2347946
27501910	architectures	C0678594
27501910	p7 protein	C0257097
27501910	hepatitis C virus	C0220847
27501910	environments	C0014406
27501910	viroporin	C3820740
27501910	p7	C0257097
27501910	hepatitis C virus	C0220847
27501910	multimeric channels	C0022009
27501910	ion transport	C0162585
27501910	endoplasmic reticulum membrane	C0230770
27501910	subject	C1706203
27501910	studies	C2603343
27501910	molecular assembly	C0872376
27501910	ion channel	C0022009
27501910	structural	C0678594
27501910	characteristics	C1521970
27501910	p7	C0257097
27501910	monomer	C0596973
27501910	Structural	C0678594
27501910	investigation	C1292732
27501910	p7	C0257097
27501910	detergent	C0011740
27501910	environments	C0014406
27501910	analyze	C0936012
27501910	molecular dynamics simulations	C2717775
27501910	structure	C0678594
27501910	p7	C0257097
27501910	monomer	C0596973
27501910	sequence	C0002518
27501910	conformation	C0026377
27501910	environment	C0014406
27501910	conductance	C0678840
27501910	models	C0026339
27501910	hexameric	C1254350
27501910	p7	C0257097
27501910	ion channel	C0022009
27501910	ion translocation	C0162585
27501910	lipid bilayer	C0023768
27501910	models	C0026339
27501910	cations	C0007447
27501910	position	C1550045
27501910	orientation	C1704322
27501910	acidic or basic residues	C1709915
27501910	ion	C0022023
27501910	selectivity	C1707391
27501910	conductance	C0678840
27501910	channel	C0022009
27501910	packing	C1148560
27501910	monomers	C0596973
27501910	channel	C0022009
27501910	collapse	C0332521
27501910	pore	C1325742
27501910	ion translocation	C0162585
27501910	physiological	C0205463
27501910	relevance	C2347946
27501910	p7	C0257097
27501910	ion channel	C0022009
27501910	models	C0026339
27501910	multimeric structures	C0678594
27501910	environments	C0014406
27502941	genome	C0017428
27502941	DNA-binding	C1148673
27502941	profile	C1979963
27502941	BarR	C0033684
27502941	β-alanine	C0000392
27502941	responsive	C0205342
27502941	transcription factor	C0040648
27502941	archaeon	C0003732
27502941	Sulfolobus acidocaldarius	C0085459
27502941	Leucine-responsive Regulatory Protein	C0125575
27502941	Lrp	C0125575
27502941	family	C1335532
27502941	family	C1335532
27502941	regulatory transcription factors	C0040648
27502941	prokaryotes	C0686817
27502941	BarR	C0033684
27502941	Lrp	C0125575
27502941	transcription factor	C0040648
27502941	archaeon	C0003732
27502941	Sulfolobus acidocaldarius	C0085459
27502941	activates	C1879547
27502941	expression	C0017262
27502941	β-alanine aminotransferase gene	C0017337
27502941	β-alanine degradation	C1156738
27502941	Lrp	C0125575
27502941	transcription factors	C0040648
27502941	BarR	C0033684
27502941	not responsive	C0237284
27502941	α-amino acids	C0311462
27502941	β-alanine	C0000392
27502941	β-alanine aminotransferase gene	C0017337
27502941	BarR	C0033684
27502941	β-alanine	C0000392
27502941	precursor	C0014436
27502941	coenzyme A	C0009226
27502941	metabolite	C0870883
27502941	aim	C1947946
27502941	study	C2603343
27502941	DNA-binding	C1148673
27502941	characteristics	C1521970
27502941	BarR	C0033684
27502941	regulon	C0206522
27502941	local	C0205276
27502941	genome	C0017428
27502941	genome-wide binding profile	C2986505
27502941	BarR	C0033684
27502941	chromatin immunoprecipation	C1328856
27502941	high-throughput sequencing	C2936621
27502941	ChIP-seq	C2936621
27502941	genomic	C0017428
27502941	binding	C1167622
27502941	loci	C1708726
27502941	binding regions	C3158196
27502941	BarR protein	C0033684
27502941	in vitro	C1533691
27502941	electrophoretic mobility shift assays	C0949632
27502941	conserved	C0009802
27502941	semi-palindromic	C2350254
27502941	binding motif	C1514535
27502941	genomic sites	C0017428
27502941	intergenic regions	C0887859
27502941	promoter	C0086860
27502941	qRT-PCR analysis	C2733022
27502941	operon	C0029073
27502941	activation	C0599177
27502941	BarR	C0033684
27502941	glutamine synthase operon	C0029073
27502941	Lrp	C0125575
27502941	transcription factors	C0040648
27502941	BarR	C0033684
27502941	ChIP-seq profile	C3463810
27502941	β-alanine aminotransferase promoter region	C0033413
27502941	combination	C0205195
27502941	binding motif	C1514535
27502941	operator structure	C0086734
27502941	complicated	C0231242
27502941	multiple (major and auxiliary) operators	C0086734
27502941	BarR	C0033684
27502941	limited	C0439801
27502941	regulon	C0206522
27502941	glutamine synthase genes	C0017337
27502941	β-alanine aminotransferase	C0017337
27502941	Regulation	C1327622
27502941	glutamine synthase	C0017801
27502941	β-alanine	C1156837
27502941	α-amino acid metabolism	C3547146
27502941	S. acidocaldarius	C0085459
27502941	BarR	C0033684
27502941	regulon	C0206522
27502941	Lrp	C0125575
27502941	regulators	C1704735
27503472	GH32 family	C0017976
27503472	activity	C0243102
27503472	topological	C0026377
27503472	protein contact networks	C3178902
27503472	Protein Contact Networks methodology	C3178902
27503472	border region	C1254362
27503472	domains to substrate binding	C0682969
27503472	Glycoside hydrolases	C0017976
27503472	GH	C0017976
27503472	enzymes	C0014442
27503472	hydrolyze	C0020291
27503472	glycosidic bond	C0813982
27503472	carbohydrates	C0007004
27503472	carbohydrate	C0007004
27503472	non-carbohydrate moiety	C1254350
27503472	enzymes	C0014442
27503472	biological processes	C3714634
27503472	plants	C0032098
27503472	GH32 family	C0017976
27503472	enzymes	C0014442
27503472	sequence	C0002518
27503472	structure	C0596527
27503472	substrate	C0178623
27503472	preferences	C0558295
27503472	kinetic properties	C0220865
27503472	Structural	C1510464
27503472	topological	C0026377
27503472	proteins	C0033684
27503472	GH32 family	C0017976
27503472	Protein Contact network	C3178902
27503472	PCN	C3178902
27503472	3D structures	C0026377
27503472	contact networks	C3178902
27503472	amino-acid residues	C0002518
27503472	PCN	C3178902
27503472	functional	C0205245
27503472	domains	C1514562
27503472	structural	C1510464
27503472	GH32 enzymes	C0017976
27503472	allosteric	C0002146
27503472	activation	C0014429
27503472	binding of the border (cleft) region	C1517880
27503472	domains	C1514562
27503472	allosteric	C0002146
27503472	enzymatic activity	C0243102
27503472	GH32 family	C0017976
27503472	biochemical studies	C0430027
27503472	topological signature	C0026377
27503472	affinity	C1510827
27503472	enzymes	C0017976
27503472	substrates	C0178623
27503979	Grasping	C0220843
27503979	Moon	C0079853
27503979	Enhancing	C2349975
27503979	Access	C0444454
27503979	Careers	C0178534
27503979	Health Professions	C0018722
27503979	former	C0750523
27503979	HHS	C0041711
27503979	secretary	C0341647
27503979	reflects	C0558058
27503979	minorities	C0026192
27503979	doctors	C0031831
27503979	health professionals	C1704312
27504100	Multivariate	C0026777
27504100	Imaging	C0011923
27504100	Genetics Study	C2827447
27504100	MRI	C0024485
27504100	Gray Matter	C0018220
27504100	Volume	C0449468
27504100	SNPs	C0752046
27504100	Biological	C0205460
27504100	Pathways	C1705987
27504100	Correlated	C1707520
27504100	Brain	C0006104
27504100	Structural	C0678594
27504100	Differences	C1705241
27504100	Attention Deficit Hyperactivity Disorder	C1263846
27504100	Attention deficit hyperactivity disorder	C1263846
27504100	ADHD	C1263846
27504100	prevalent	C0220900
27504100	neurodevelopmental disorder	C1535926
27504100	affecting	C0392760
27504100	children	C0008059
27504100	adolescents	C0205653
27504100	adults	C0001675
27504100	etiology	C1314792
27504100	result	C1274040
27504100	diverse	C1880371
27504100	pathophysiologies	C0277785
27504100	affect	C0392760
27504100	structure	C0678594
27504100	function	C0542341
27504100	specific	C0205369
27504100	brain circuits	C0682723
27504100	neurobiological abnormalities	C0027765
27504100	ADHD	C1263846
27504100	reduced	C0392756
27504100	fronto-striatal-cerebellar gray matter	C3850014
27504100	GM	C0018220
27504100	volume	C0449468
27504100	genetic	C0314603
27504100	correlates	C1707520
27504100	unknown	C0439673
27504100	study	C2603343
27504100	T1-weighted MR images of brain structure	C2454640
27504100	adolescents	C0205653
27504100	ADHD	C1263846
27504100	diagnosed	C0011900
27504100	multivariate parallel independent component analysis	C0026777
27504100	Para-ICA	C0026777
27504100	technique	C0449851
27504100	imaging	C0011923
27504100	genetic	C0314603
27504100	relationships	C0439849
27504100	regional	C0205147
27504100	GM	C0018220
27504100	volume	C0449468
27504100	single nucleotide polymorphism	C0752046
27504100	data	C1511726
27504100	Para-ICA analyses	C0026777
27504100	genetic data	C0872179
27504100	MR	C0024485
27504100	data	C1511726
27504100	iterative cross-validation	C0681935
27504100	stability	C0205360
27504100	ICA	C0026777
27504100	solutions	C2699488
27504100	partial correlation analyses	C0678931
27504100	controlling	C2239193
27504100	age	C0001779
27504100	sex	C1522384
27504100	ethnicity	C0243103
27504100	genotype-phenotype	C0678920
27504100	component	C1705248
27504100	pairs	C1709450
27504100	ADHD	C1263846
27504100	non-ADHD	C0243095
27504100	groups	C0441833
27504100	Bonferroni correction	C2347434
27504100	multiple	C0439064
27504100	comparisons	C1707455
27504100	brain	C0006104
27504100	phenotype	C0031437
27504100	component	C1705248
27504100	structures	C0678594
27504100	abnormally low	C1299352
27504100	volume	C0449468
27504100	ADHD	C1263846
27504100	studies	C2603343
27504100	associated with	C0332281
27504100	ADHD	C1263846
27504100	symptom severity	C1319166
27504100	performance	C1882330
27504100	cognitive tests	C0392366
27504100	patients	C0030705
27504100	diagnosed	C0011900
27504100	disorder	C0012634
27504100	Pathway analysis	C0868995
27504100	genotype	C0017431
27504100	component	C1705248
27504100	biological	C0205460
27504100	pathways	C1705987
27504100	structural	C0678594
27504100	abnormalities	C1704258
27504100	ADHD	C1263846
27504100	pathways	C1705987
27504100	dopaminergic neurotransmission	C0234101
27504100	neurodevelopment	C0599855
27504100	hypothesized	C1512571
27504100	abnormal	C0205161
27504100	ADHD	C1263846
27504100	pathways	C1705987
27504100	glutamatergic	C1523698
27504100	GABA-eric physiological systems	C0234105
27504100	ADHD	C1263846
27504100	sleep abnormalities	C0037317
27504422	Clinicopathological	C0282421
27504422	Immunohistochemical	C1441616
27504422	Verruciform Xanthoma	C3872816
27504422	Lower Gingiva	C0227123
27504422	Case Report	C0085973
27504422	Verruciform xanthoma	C3872816
27504422	VX	C3872816
27504422	benign lesion	C0086692
27504422	oral mucosa	C0026639
27504422	slow-growing	C4086857
27504422	asymptomatic	C0231221
27504422	lesion	C0086692
27504422	gingival margin	C1184544
27504422	masticatory	C0005654
27504422	mucosa	C0026724
27504422	hard palate	C0226901
27504422	tongue	C0040408
27504422	buccal mucosa	C1578559
27504422	floor of the mouth	C0026638
27504422	alveolar mucosa	C4239924
27504422	soft palate	C0030219
27504422	junction	C0205144
27504422	hard	C0226901
27504422	soft palate	C0030219
27504422	lesion	C0086692
27504422	skin	C1123023
27504422	genital organs	C0017420
27504422	Clinically	C0205210
27504422	VX	C3872816
27504422	sessile	C1335952
27504422	pedunculated appearance	C1335371
27504422	papule	C0332563
27504422	single plaque	C2221189
27504422	verrucous	C0206706
27504422	papillomatous	C0030354
27504422	mucosal	C0026724
27504422	growth	C1621966
27504422	colour	C0009393
27504422	white	C0220938
27504422	pink	C0332585
27504422	grey	C1269776
27504422	yellow	C0221205
27504422	thickness	C1280412
27504422	epidermis	C0014520
27504422	clinical	C0205210
27504422	findings	C0243095
27504422	VX	C3872816
27504422	verrucous carcinoma	C0206706
27504422	benign tumours	C0086692
27504422	squamous papilloma	C0205874
27504422	verruca vulgaris	C0043037
27504422	mucosal fibroma	C0016045
27504422	clinical	C0205210
27504422	histopathological	C0243140
27504422	examinations	C0031809
27504422	accurate differential diagnosis	C0011906
27504422	Histologically	C0205462
27504422	VX	C3872816
27504422	parakeratosis	C0030436
27504422	rete ridges	C1516920
27504422	accumulation	C4055506
27504422	foam cells	C0016390
27504422	xanthoma cells	C1520164
27504422	clinicopathological	C0282421
27504422	immunohistochemical	C1441616
27504422	findings	C0243095
27504422	VX	C3872816
27504422	lower gingiva	C0227123
27504422	male patient	C0150904
27507301	MicroRNA 101b	C2825314
27507301	Downregulated	C0013081
27507301	Prefrontal Cortex	C0162783
27507301	Genetic Model	C0026343
27507301	Depression	C0011581
27507301	Targets	C1521840
27507301	Glutamate Transporter	C0061467
27507301	SLC1A1	C1529079
27507301	EAAT3	C1529079
27507301	in Vitro	C1533691
27507301	MicroRNAs	C1101610
27507301	miRNAs	C1101610
27507301	small	C0700321
27507301	regulatory	C1704735
27507301	molecules	C0567416
27507301	translational repression	C1519619
27507301	base pairing with target mRNAs	C2263416
27507301	Cumulative	C1511559
27507301	evidence	C3887511
27507301	changes	C0392747
27507301	miRNA	C2825314
27507301	expression	C0017262
27507301	pathophysiology	C0031847
27507301	treatment	C0087111
27507301	neuropsychiatric disorders	C2015799
27507301	major depressive disorder	C1269683
27507301	MDD	C1269683
27507301	miRNA	C2825314
27507301	expression	C0017262
27507301	assay	C0005507
27507301	simultaneously	C0521115
27507301	miRNAs	C2825314
27507301	profile	C1979963
27507301	prefrontal cortex	C0162783
27507301	PFC	C0162783
27507301	genetic rat model	C0026343
27507301	MDD	C1269683
27507301	Flinders Sensitive Line	C0026343
27507301	FSL	C0026343
27507301	controls	C0009932
27507301	Flinders Resistant Line	C0026343
27507301	FRL	C0026343
27507301	Gene expression	C0017262
27507301	data	C1511726
27507301	PFC	C0162783
27507301	FSL	C0026343
27507301	FRL	C0026343
27507301	animals	C0003062
27507301	mRNA	C0035696
27507301	target	C1521840
27507301	selection	C1707391
27507301	Luciferase reporter assays	C0005507
27507301	verify	C1711411
27507301	miRNA	C2825314
27507301	targets	C1521840
27507301	in vitro	C1533691
27507301	identified	C0205396
27507301	miRNAs	C2825314
27507301	downregulated	C0013081
27507301	PFC	C0162783
27507301	FSL model	C0026343
27507301	compared	C1707455
27507301	controls	C0009932
27507301	identified	C0205396
27507301	miRNAs	C2825314
27507301	miR-101b	C2825314
27507301	conserved	C2347858
27507301	rat	C0086893
27507301	human	C0086418
27507301	downregulated	C0013081
27507301	PFC	C0162783
27507301	depressed	C1579931
27507301	suicide	C0038661
27507301	subjects	C0681850
27507301	combination	C0205195
27507301	in silico	C3489666
27507301	in vitro	C1533691
27507301	analyses	C0936012
27507301	miR-101b	C2825314
27507301	targets	C1521840
27507301	neuronal	C0027882
27507301	glutamate transporter	C0061467
27507301	SLC1A1	C1529079
27507301	EAAC1	C1529079
27507301	EAAT3	C1529079
27507301	mRNA	C0035696
27507301	protein levels	C0428479
27507301	SLC1A1	C1529079
27507301	upregulated	C0041904
27507301	PFC	C0162783
27507301	FSL model	C0026343
27507301	miRNAs	C2825314
27507301	associated with	C0332281
27507301	depression-like states	C0344315
27507301	preclinical study	C1709631
27507301	replicated	C0205173
27507301	human	C0086418
27507301	association	C0439849
27507301	miR-101	C2825314
27507301	depression	C0011581
27507301	targets	C1521840
27507301	miR-101b	C2825314
27507301	glutamate transporter	C0061467
27507301	preclinical	C1709630
27507301	data	C1511726
27507301	hypothesis	C1512571
27507301	glutamatergic	C0242899
27507301	dysregulation	C0243095
27507301	etiology	C1314792
27507301	depression	C0011581
27507385	Practical Guide	C0181090
27507385	Forensic Nursing	C1721027
27507385	Incorporating	C0332257
27507385	forensic	C1721027
27507385	principles	C1882460
27507385	nursing practice	C0028687
27507385	Amar Angela F	C0086418
27507385	Sekula L Kathleen	C0086418
27507385	Practical Guide	C0181090
27507385	Forensic Nursing	C1721027
27507385	forensic	C1721027
27507385	principles	C1882460
27507385	nursing practice	C0028687
27507385	George Bernard Shaw	C0086418
27507385	Britons	C0337925
27507385	Americans	C0596070
27507385	divided	C0332849
27507385	common language	C0023008
27507385	fascinating publication	C0034036
27507385	roles and responsibilities	C3890565
27507385	forensic nurses	C0028661
27507385	US	C0041703
27508301	Incidence	C0021149
27508301	Diabetes Mellitus	C0011849
27508301	Obesity	C0028754
27508301	Overlap	C1948020
27508301	Comorbidities	C0009488
27508301	HIV+	C0019699
27508301	Hispanics	C0086409
27508301	Initiating	C1704686
27508301	Antiretroviral Therapy	C1963724
27508301	Cardiovascular disease	C0007222
27508301	CVD	C0007222
27508301	health	C0018684
27508301	threat	C0749385
27508301	HIV+	C0019699
27508301	patients	C0030705
27508301	antiretroviral therapy	C1963724
27508301	ART	C1963724
27508301	cardiometabolic	C0025517
27508301	comorbidities	C0009488
27508301	predictors of risk	C0035648
27508301	Data	C1511726
27508301	incidence	C0021149
27508301	metabolic	C0311400
27508301	comorbidities	C0009488
27508301	HIV+	C0019699
27508301	individuals	C0237401
27508301	initiating	C1704686
27508301	ART	C1963724
27508301	low	C0870823
27508301	middle income	C0870890
27508301	countries	C0454664
27508301	LMICs	C0454664
27508301	particularly	C0205556
27508301	Hispanics	C0086409
27508301	examined	C0332128
27508301	incidence	C0021149
27508301	diabetes	C0011847
27508301	obesity	C0028754
27508301	prospective cohort	C0599755
27508301	initiating	C1704686
27508301	ART	C1963724
27508301	Dominican Republic	C0013014
27508301	Participants	C0679646
27508301	years	C0439234
27508301	initiating	C1704686
27508301	ART	C1963724
27508301	days	C0439228
27508301	study	C2603343
27508301	enrollment	C1516879
27508301	examined	C0332128
27508301	incidence	C0021149
27508301	impaired fasting glucose	C1272092
27508301	IFG	C1272092
27508301	diabetes mellitus	C0011849
27508301	DM	C0011849
27508301	overweight, and obesity	C1561826
27508301	Fasting plasma glucose	C0583513
27508301	FPG	C0583513
27508301	IFG	C1272092
27508301	FPG	C0583513
27508301	diagnosis	C1704656
27508301	medical record	C0025102
27508301	hypoglycemic medication	C0020616
27508301	DM	C0011849
27508301	Overweight and obesity	C1561826
27508301	BMI	C1305855
27508301	Dyslipidemia	C0242339
27508301	total cholesterol	C0543421
27508301	use of	C1524063
27508301	lipid-lowering medication	C0003367
27508301	Framingham risk equation	C3176199
27508301	used	C1273517
27508301	determine	C0521095
27508301	ten-year	C0439234
27508301	CVD	C0007222
27508301	risk	C0086930
27508301	end of observation	C0302523
27508301	initiating	C1704686
27508301	ART	C1963724
27508301	DM	C0011849
27508301	IFG	C1272092
27508301	baseline	C1442488
27508301	DM	C0011849
27508301	person	C0027361
27508301	years	C0439234
27508301	follow up	C1522577
27508301	PYFU	C1522577
27508301	IFG	C1272092
27508301	PYFU	C1522577
27508301	baseline	C1442488
27508301	obese	C0028754
27508301	overweight	C0497406
27508301	obese	C0028754
27508301	PYFU	C1522577
27508301	overweight	C0497406
27508301	PYFU	C1522577
27508301	Median	C2939193
27508301	observation	C0700325
27508301	periods	C1948053
27508301	diabetes	C0011847
27508301	obesity	C0028754
27508301	analyses	C0936012
27508301	months	C0439231
27508301	months	C0439231
27508301	Increased	C0205217
27508301	CVD	C0007222
27508301	risk	C0086930
27508301	10-year Framingham risk score	C4086295
27508301	present	C0150312
27508301	cohort	C0599755
27508301	cohort	C0599755
27508301	cardiometabolic comorbidity	C0009488
27508301	Hispanic	C0086409
27508301	cohort	C0599755
27508301	LMIC	C0454664
27508301	incidences	C0021149
27508301	IFG	C1272092
27508301	DM	C0011849
27508301	overweight	C0497406
27508301	obesity	C0028754
27508301	similar	C2348205
27508301	higher than	C0205250
27508301	found	C0150312
27508301	high income	C0948433
27508301	countries	C0454664
27508301	cardiometabolic disorders	C0025517
27508301	affected	C0392760
27508301	initiating	C1704686
27508301	ART	C1963724
27508301	Care models	C0596657
27508301	cardiovascular risk	C0850624
27508301	reduction	C0441610
27508301	HIV	C0019693
27508301	treatment programs	C0679841
27508301	needed	C0027552
27508301	prevent	C1292733
27508301	CVD	C0007222
27508301	associated	C0332281
27508301	mortality	C0205848
27508301	vulnerable population	C0949366
27508328	Laparoscopic Approach	C0031150
27508328	Thermoablation Microwave	C3854551
27508328	Treatment	C0087111
27508328	Hepatocellular Carcinoma	C2239176
27508328	Experience	C0596545
27508328	surgical therapy	C0543467
27508328	hepatocellular carcinoma	C2239176
27508328	HCC	C2239176
27508328	liver transplantation	C0023911
27508328	LT	C0023911
27508328	hepatic resection	C0400440
27508328	small	C0700321
27508328	percentage	C0439165
27508328	patients	C0030705
27508328	procedures	C2700391
27508328	Microwave thermal ablation	C3854551
27508328	MWTA	C3854551
27508328	effective	C1280519
27508328	alternative	C1523987
27508328	treatment	C0087111
27508328	HCC	C2239176
27508328	complicates	C0231242
27508328	cirrhotic liver disease	C0023890
27508328	final	C3853528
27508328	procedure	C2700391
27508328	downstaging	C0430022
27508328	patients	C0030705
27508328	LT	C0023911
27508328	combination	C0205195
27508328	resective	C0015252
27508328	surgery	C0543467
27508328	oncological	C0027651
27508328	radicality	C0439807
27508328	retrospective study	C0035363
27508328	evaluate	C0220825
27508328	experience	C0596545
27508328	laparoscopic approach	C0031150
27508328	MWTA	C3854551
27508328	cohort	C0599755
27508328	consecutive	C1707491
27508328	patients	C0030705
27508328	MWTA	C3854551
27508328	laparoscopic approach	C0031150
27508328	demographic data	C0011289
27508328	Barcelona clinic liver cancer stage	C3899974
27508328	severity	C0439793
27508328	cirrhotic liver disease	C0023890
27508328	size	C0456389
27508328	ablated	C0547070
27508328	lesion	C0221198
27508328	duration	C0449238
27508328	procedure	C2700391
27508328	complications	C0231242
27508328	days	C0439228
27508328	surgery	C0543467
27508328	MWTA	C3854551
27508328	hepatic	C0205054
27508328	parenchymal	C4277702
27508328	insertions	C0441587
27508328	mean	C0444504
27508328	patient	C0030705
27508328	mean	C0444504
27508328	duration	C0449238
27508328	surgery	C0543467
27508328	minutes	C0439232
27508328	blood loss	C3163616
27508328	procedures	C2700391
27508328	necrosis	C0027540
27508328	CT scan	C0040405
27508328	patients	C0030705
27508328	mean	C0444504
27508328	hospital stay	C3489408
27508328	days	C0439228
27508328	complications	C0231242
27508328	postablation	C1292448
27508328	syndrome	C0039082
27508328	peritoneal fluid	C0003964
27508328	transient	C0205374
27508328	jaundice	C0022354
27508328	patients	C0030705
27508328	no mortality	C0243095
27508328	Laparoscopic	C0031150
27508328	MWTA	C3854551
27508328	effective	C1280519
27508328	treatment	C0087111
27508328	unresectable	C1519810
27508328	HCC	C2239176
27508328	percutaneous	C0522523
27508328	procedure	C2700391
27510571	Structured	C0678594
27510571	Instruction	C1442085
27510571	Modified	C0392747
27510571	Storybooks	C0814818
27510571	Teach	C0039401
27510571	Morphosyntax	C0023741
27510571	Vocabulary	C0042926
27510571	Preschoolers	C0008100
27510571	Deaf	C3824904
27510571	Hard of Hearing	C0525064
27510571	Children	C0008059
27510571	deaf	C3824904
27510571	hard of hearing	C0525064
27510571	D	C3824904
27510571	HH	C0525064
27510571	at risk	C1444641
27510571	diminished	C0205216
27510571	morphosyntactical	C0023741
27510571	vocabulary	C0042926
27510571	development	C1527148
27510571	effects of	C1704420
27510571	repeated	C0205341
27510571	reading	C0034754
27510571	combined	C0205195
27510571	structured	C0678594
27510571	instruction	C1442085
27510571	Targets	C1521840
27510571	morphosyntactical form	C0023741
27510571	vocabulary words	C0042926
27510571	Participants	C0679646
27510571	preschoolers	C0008100
27510571	D	C3824904
27510571	HH	C0525064
27510571	receiving	C1514756
27510571	instruction	C1442085
27510571	oral	C0442027
27510571	Data	C1511726
27510571	multiple	C0439064
27510571	baseline design	C0282121
27510571	children	C0008059
27510571	acquired	C1706701
27510571	targeted	C1521840
27510571	skills	C0678856
27510571	generalization	C0237635
27510571	skills	C0678856
27510571	untrained	C0243095
27510571	context	C0449255
27510571	Implications	C0205556
27510571	teaching	C0039401
27510571	young	C0332239
27510571	children	C0008059
27510571	D	C3824904
27510571	HH	C0525064
27510571	using	C1524063
27510571	repeated	C0205341
27510571	storybook	C0814818
27510571	reading	C0034754
27510784	Application	C0185125
27510784	BRAF V600E	C3250916
27510784	mutation	C0026882
27510784	specific	C0205369
27510784	immunohistochemistry	C0021044
27510784	diagnosis	C0011900
27510784	gastrointestinal stromal tumors	C0238198
27510784	evaluate	C0220825
27510784	BRAF V600E	C3250916
27510784	allele	C0002085
27510784	specific	C0205369
27510784	antibody	C0003241
27510784	diagnosis	C0011900
27510784	gastrointestinal stromal tumors	C0238198
27510784	GISTs	C0238198
27510784	BRAF V600E	C3250916
27510784	mutation	C0026882
27510784	specific	C0205369
27510784	immunohistochemistry	C0021044
27510784	BRAF	C0812241
27510784	sequencing	C1561491
27510784	consecutive	C1707491
27510784	GISTs	C0238198
27510784	cases	C0868928
27510784	KIT	C1511353
27510784	PDGFRA mutations	C1518782
27510784	cases	C0868928
27510784	KIT	C1416655
27510784	PDGFRA wild	C1705319
27510784	GISTs	C0238198
27510784	GISTs	C0238198
27510784	men	C0025266
27510784	women	C0043210
27510784	mean	C2347634
27510784	age	C0001779
27510784	tumors	C0027651
27510784	stomach	C0038351
27510784	cases	C0868928
27510784	small bowel	C0021852
27510784	cases	C0868928
27510784	peritoneal cavity	C1704247
27510784	case	C0868928
27510784	Strong	C0442821
27510784	diffuse	C0205219
27510784	cytoplasmic	C0521449
27510784	BRAF	C1259929
27510784	staining	C1704680
27510784	noted	C4288581
27510784	cases	C0868928
27510784	cases	C0868928
27510784	weak	C1762617
27510784	staining	C1704680
27510784	cases	C0868928
27510784	no	C0332197
27510784	staining	C1704680
27510784	cases	C0868928
27510784	strong	C0442821
27510784	BRAF	C1259929
27510784	immunostain	C0038128
27510784	confirmed	C0521093
27510784	BRAF mutations	C1511021
27510784	cases	C0868928
27510784	stomach	C0038351
27510784	case	C0868928
27510784	small intestine	C0021852
27510784	tumors	C0027651
27510784	spindle cell	C0682540
27510784	morphology	C0332437
27510784	case	C0868928
27510784	progressive disease	C1335499
27510784	No	C0332197
27510784	BRAF mutations	C1511021
27510784	detected	C0442726
27510784	cases	C0868928
27510784	weak	C1762617
27510784	negative	C0205160
27510784	BRAF	C1259929
27510784	immunostain	C0038128
27510784	BRAF V600E	C3250916
27510784	mutation	C0026882
27510784	specific	C0205369
27510784	immunohistochemistry	C0021044
27510784	highly sensitive	C0439822
27510784	specific	C0205369
27510784	marker	C0005516
27510784	detecting	C0442726
27510784	BRAF-mutated	C1511021
27510784	GISTs	C0238198
27511525	pegylated liposomal etoposide nanoparticles	C0015133
27511525	breast cancer cell lines	C1512505
27511525	efficacy of	C1280519
27511525	pegylated liposomal etoposide nanoparticles	C0015133
27511525	T-47D	C3897399
27511525	MCF-7 breast cancer cell lines	C0596890
27511525	Pegylated liposomal etoposide NPs	C0015133
27511525	reverse phase evaporation method	C0596539
27511525	size	C0456389
27511525	size distribution	C0037775
27511525	zeta potential	C0597697
27511525	NPs	C0015133
27511525	Zetasizer instrument	C0348000
27511525	cytotoxicity	C0596402
27511525	NPs	C0015133
27511525	methyl thiazol tetrazolium assay	C2986858
27511525	release pattern of the drug from the vesicles	C0360812
27511525	dialysis method	C3483167
27511525	Drug loading	C0678767
27511525	encapsulation efficiency	C2348438
27511525	EE	C2348438
27511525	mean size	C0456389
27511525	size distribution	C0037775
27511525	zeta potential	C0597697
27511525	pegylated liposomal etoposide NPs	C0015133
27511525	Drug loading	C0678767
27511525	EE	C2348438
27511525	etoposide release in the formulation	C1707824
27511525	cytotoxicity effect	C0596402
27511525	etoposide NPs	C0015133
27511525	T-47D	C3897399
27511525	MCF-7 cell lines of breast cancer	C0596890
27511525	antitumor activity	C2986475
27511525	free drug	C0678752
27511525	Liposome-based NPs	C0015133
27511525	drug delivery system	C0085104
27511629	Bindex(®) ultrasound device	C1875843
27511629	reliability	C2347947
27511629	cortical bone	C0222652
27511629	thickness	C1280412
27511629	measures	C0079809
27511629	relationship	C0439849
27511629	regional	C0205147
27511629	bone mineral density	C0005938
27511629	Bindex(®) quantitative ultrasound (QUS) device	C1875843
27511629	study	C2603343
27511629	analyzed	C0936012
27511629	relative	C0205345
27511629	absolute	C0205344
27511629	intra- and inter-session reliability	C2347947
27511629	relationship	C0439849
27511629	data	C1511726
27511629	Bindex(®)-QUS	C1875843
27511629	bone mineral density	C0005938
27511629	BMD	C0005938
27511629	measured	C0444706
27511629	dual-energy x-ray absorptiometry	C1510486
27511629	skeletal sites	C1282387
27511629	young	C0080105
27511629	healthy subjects	C1708335
27511629	age	C0001779
27511629	years	C1510829
27511629	Bindex(®)-QUS	C1875843
27511629	calculates	C1441506
27511629	density index	C0005938
27511629	thickness	C1280412
27511629	cortical bone	C0222652
27511629	measured	C0444706
27511629	distal radius	C0588207
27511629	distal	C0588200
27511629	proximal tibia	C0588198
27511629	data	C1511726
27511629	relative	C0205345
27511629	absolute	C0205344
27511629	intra-	C2347947
27511629	ICC	C0392762
27511629	CV	C0681921
27511629	inter-session reliability	C2347947
27511629	ICC	C0392762
27511629	CV	C0681921
27511629	density index	C0005938
27511629	highest	C1522410
27511629	positive	C1446409
27511629	correlations	C1707520
27511629	cortical	C0222652
27511629	thickness	C1280412
27511629	BMD	C0005938
27511629	distal radius	C0588207
27511629	distal tibia	C0588200
27511629	data	C1511726
27511629	Bindex(®)-QUS	C1875843
27511629	parameters	C0449381
27511629	measurement	C0242485
27511629	sessions	C1883017
27511629	measurements	C0242485
27511629	BMD	C0005938
27511629	specific	C0205369
27511629	skeletal sites	C1282387
27511629	Bindex(®)-QUS	C1875843
27511629	measurement	C0242485
27511629	skeletal adaptations	C2248552
27514242	Botulinum Toxin	C0006055
27514242	Refractory Pain	C0030200
27514242	Symptoms	C1457887
27514242	Parkinsonism	C0242422
27514242	Parkinson's disease	C0030567
27514242	PD	C0030567
27514242	parkinsonian syndromes	C0242422
27514242	chronic	C0205191
27514242	progressive	C0205329
27514242	neurodegenerative diseases	C0524851
27514242	disease	C0012634
27514242	motor	C0426980
27514242	non-motor symptoms	C1457887
27514242	burden	C2828008
27514242	symptom	C1457887
27514242	relief	C0564405
27514242	quality of life	C0034380
27514242	improvement	C2986411
27514242	goal	C0018017
27514242	treatment	C0087111
27514242	Botulinum toxins	C0006055
27514242	BTX	C0006055
27514242	effective	C1704419
27514242	treatment	C0087111
27514242	modality	C0695347
27514242	neurological conditions	C0027765
27514242	potential	C3245505
27514242	usefulness	C3827682
27514242	BTX	C0006055
27514242	population	C1257890
27514242	performed	C0884358
27514242	retrospective	C1514923
27514242	chart review	C0541653
27514242	patients	C0030705
27514242	clinical diagnosis	C0332140
27514242	idiopathic PD	C0865475
27514242	atypical parkinsonism	C4302185
27514242	treatment	C0039798
27514242	BTX injections	C1321035
27514242	center	C1708333
27514242	symptoms	C1457887
27514242	Response	C0871261
27514242	BTX	C0006055
27514242	assessed	C1516048
27514242	subjective Clinical Global Impression	C3639708
27514242	Records	C0034869
27514242	patients	C0030705
27514242	reviewed	C1709940
27514242	idiopathic PD	C0865475
27514242	diagnosis	C0011900
27514242	patients	C0030705
27514242	indication	C3146298
27514242	BTX	C0006055
27514242	treatment	C0087111
27514242	pain	C0030193
27514242	indications	C3146298
27514242	treatment	C0087111
27514242	functional impairment	C4062321
27514242	resulting	C0678226
27514242	dystonia	C0013421
27514242	sialorrhea	C0037036
27514242	freezing of gait	C0860515
27514242	camptocormia	C0264162
27514242	pain	C0030193
27514242	indication	C3146298
27514242	patients	C0030705
27514242	PD	C0030567
27514242	reported	C0700287
27514242	benefits	C0814225
27514242	BTX injections	C1321035
27514242	benefit	C0814225
27514242	maintained	C1314677
27514242	last recorded visit	C1512346
27514242	difference	C1705242
27514242	outcome	C1274040
27514242	compared	C1707455
27514242	injection	C0021485
27514242	results	C1274040
27514242	patients	C0030705
27514242	atypical parkinsonism	C4302185
27514242	results	C1274040
27514242	efficacy	C1280519
27514242	different	C1705242
27514242	uses	C0457083
27514242	BTX	C0006055
27514242	symptomatic	C0231220
27514242	treatment	C1522326
27514242	patients	C0030705
27514242	parkinsonism	C0242422
27514242	advanced	C0205179
27514242	stages	C1306673
27514242	disease	C0012634
27514242	suggest	C1705535
27514242	BTX	C0006055
27514242	treatment	C0087111
27514242	role	C1705810
27514242	treatment	C1522326
27514242	pain	C0030193
27514242	population	C1257890
27516217	Chronic exposure to	C0743284
27516217	haloperidol	C0018546
27516217	olanzapine	C0171023
27516217	shape changes	C1562006
27516217	rat	C0034693
27516217	hippocampus	C0019564
27516217	grey-matter	C0018220
27516217	volume loss	C0205245
27516217	brain abnormalities	C4021085
27516217	schizophrenia	C0036341
27516217	SCZ	C0036341
27516217	volume and shape deformation	C1562006
27516217	hippocampus	C0019564
27516217	chronic antipsychotic medication	C0040615
27516217	exposure	C0743284
27516217	chronic exposure	C0743284
27516217	relevant doses	C0178602
27516217	haloperidol	C0018546
27516217	HAL	C0018546
27516217	olanzapine	C0171023
27516217	OLZ	C0171023
27516217	rat	C0034693
27516217	hippocampal	C3496509
27516217	volume and shape	C0243095
27516217	ex vivo	C2348480
27516217	structural MRI	C0024485
27516217	brain retained inside the cranium	C0037303
27516217	distortions	C0332482
27516217	dissection	C0012737
27516217	tensor-based morphometry	C0200760
27516217	TBM	C0200760
27516217	elastic surface-based shape deformation analysis	C0936012
27516217	hippocampus	C0019564
27516217	post-mortem	C0004398
27516217	brain tissue	C0459385
27516217	Chronic exposure	C0743284
27516217	HAL	C0018546
27516217	OLZ	C0171023
27516217	hippocampus	C0019564
27516217	exploratory thresholds	C0430009
27516217	post-mortem	C0004398
27516217	shape deformation analysis	C0936012
27516217	HAL	C0018546
27516217	OLZ	C0171023
27516217	exposure	C0743284
27516217	divergent shape deformations	C1562006
27516217	rat	C0034693
27516217	hippocampus	C0019564
27516217	dorsal hippocampus	C0019564
27516217	HAL	C0018546
27516217	exposure	C0743284
27516217	inward shape deformation	C1562006
27516217	OLZ	C0171023
27516217	exposure	C0743284
27516217	outward shape deformation	C1562006
27516217	outward shape deformations	C1562006
27516217	drugs	C0013227
27516217	ventral hippocampus	C0019564
27516217	hippocampal	C0019564
27516217	shape changes	C1562006
27516217	Chronic exposure	C0743284
27516217	HAL	C0018546
27516217	OLZ	C0171023
27516217	rat	C0034693
27516217	hippocampal shape	C0175202
27516254	Shear	C1254365
27516254	extensional properties	C1254365
27516254	kefiran	C0628688
27516254	Kefiran	C0628688
27516254	neutral polysaccharide	C0032594
27516254	glucose	C0017725
27516254	galactose	C0016945
27516254	Lactobacillus kefiranofaciens	C0317649
27516254	kefir grains	C4280055
27516254	health promoting properties	C1254365
27516254	shear	C1254365
27516254	extensional properties	C1254365
27516254	different	C1705242
27516254	kefiran	C0628688
27516254	aqueous dispersions	C0439861
27516254	assessed	C1516048
27516254	compared	C1707455
27516254	neutral gums	C0029224
27516254	food	C0016452
27516254	cosmetic	C0010164
27516254	pharmaceutics industries	C0013185
27516254	methylcellulose	C0025729
27516254	locust bean gum	C3190255
27516254	guar gum	C0061996
27516254	Kefiran	C0628688
27516254	shear flow characteristics	C1254365
27516254	neutral gums	C0029224
27516254	lower	C0205251
27516254	viscosities	C0042784
27516254	concentration	C0392762
27516254	gum	C0029224
27516254	system	C0449913
27516254	correlation	C1707520
27516254	dynamic and steady shear properties	C1254365
27516254	master curve	C0205134
27516254	apparent	C0750489
27516254	complex	C0439855
27516254	viscosities	C0042784
27516254	extensional properties	C1254365
27516254	gums	C0029224
27516254	capillary break-up rheometer	C0699733
27516254	kefiran	C0628688
27516254	solutions	C0037633
27516254	extensional properties	C1254365
27516254	behaviour	C1521970
27516254	Newtonian	C0205556
27516791	Air	C0001861
27516791	tamponade	C0332459
27516791	heart	C0018787
27516791	Pneumopericardium	C0032319
27516791	rare disease	C0678236
27516791	presence	C0150312
27516791	air	C0001861
27516791	gas	C0017110
27516791	pericardial sac	C0031050
27516791	etiological factors	C1521761
27516791	chest trauma	C0039980
27516791	barotrauma	C0004760
27516791	air	C0001861
27516791	fistulas	C0016169
27516791	pericardium	C0031050
27516791	surrounding	C1282914
27516791	structures	C0678594
27516791	secondary gas production	C0205245
27516791	microorganisms	C0445623
27516791	pericardial sac	C0031050
27516791	iatrogenic	C0439669
27516791	factors	C1521761
27516791	spontaneous	C0205359
27516791	pneumopericardium	C0032319
27516791	considered	C0750591
27516791	harmless	C0205556
27516791	temporary	C0205374
27516791	state	C1442792
27516791	review of	C0699752
27516791	clinical cases	C1706256
27516791	presence	C0150312
27516791	air	C0001861
27516791	pericardium	C0031050
27516791	cardiac tamponade	C0007177
27516791	life-threatening	C2826244
27516791	hemodynamic	C0019010
27516791	disturbances	C2699787
27516791	present	C0150312
27516791	year-old	C1510829
27516791	patient	C0030705
27516791	chronic	C0205191
27516791	bronchopericardial	C1186133
27516791	fistula	C0016169
27516791	cardiac arrest	C0018790
27516791	air	C0001861
27516791	tamponade	C0332459
27516791	heart	C0018787
27517885	Complete	C0205197
27517885	Chloroplast Genome	C1955992
27517885	Sequence	C0314659
27517885	Medicinal Plant	C0032100
27517885	Swertia mussotii	C1624947
27517885	PacBio RS II Platform	C1609455
27517885	Swertia mussotii	C1624947
27517885	medicinal plant	C0032100
27517885	great	C0549177
27517885	economic	C0392762
27517885	medicinal value	C1254351
27517885	Qinghai Tibetan Plateau	C0681784
27517885	complete	C0205197
27517885	chloroplast (cp) genome	C1955992
27517885	S. mussotii	C1624947
27517885	size	C3178847
27517885	pair	C1709450
27517885	inverted repeat (IR) regions	C2350250
27517885	separate	C0443299
27517885	large single-copy (LSC) region	C0314659
27517885	small single-copy (SSC) region	C0314659
27517885	S. mussotii	C1624947
27517885	cp genome	C1955992
27517885	encodes	C2700640
27517885	protein-coding genes	C3839127
27517885	transfer RNA	C0035711
27517885	tRNA	C0035711
27517885	genes	C0017337
27517885	ribosomal RNA (rRNA) genes	C0035899
27517885	GC content	C1135899
27517885	S. mussotii	C1624947
27517885	cp genes	C1955992
27517885	genomes	C0017428
27517885	Gentianales	C1080874
27517885	species	C1705920
27517885	analysis	C0936012
27517885	repeat structure	C0314659
27517885	repeats	C0314659
27517885	palindromic repeats	C2350254
27517885	detected	C0442726
27517885	S. mussotii	C1624947
27517885	cp genome	C1955992
27517885	SSRs	C1519302
27517885	S. mussotii	C1624947
27517885	cp genome	C1955992
27517885	majority	C0205164
27517885	mononucleotides	C0028630
27517885	Gentianales	C1080874
27517885	species	C1705920
27517885	entire	C0439751
27517885	cp genome	C1955992
27517885	comparison study	C1579762
27517885	S. mussotii	C1624947
27517885	species	C1705920
27517885	Gentianaceae	C0950077
27517885	complete	C0205197
27517885	cp genome	C1955992
27517885	sequence	C0314659
27517885	intragenic	C0017337
27517885	information	C1533716
27517885	cp	C0008266
27517885	genetic engineering	C0017387
27517885	medicinal plant	C0032100
27519886	Meta-Analysis	C0920317
27519886	Experiments	C0681814
27519886	Evaluating	C1261322
27519886	Effects of	C1704420
27519886	Rapamycin	C0072980
27519886	Life Span	C0870809
27519886	Laboratory Mouse	C0025929
27519886	Rapamycin	C0072980
27519886	effects	C1280500
27519886	aging	C0001811
27519886	mice	C0025929
27519886	applied	C4048755
27519886	healthy	C3898900
27519886	aging	C0001811
27519886	humans	C0086418
27519886	study	C2603343
27519886	analyzed	C0936012
27519886	raw	C1709843
27519886	data	C1511726
27519886	survival studies	C0038953
27519886	rapamycin	C0072980
27519886	control	C1550141
27519886	treated	C1522326
27519886	mice	C0025929
27519886	goals	C0018017
27519886	estimating	C0750572
27519886	summary	C1706244
27519886	statistics	C0600673
27519886	identifying	C0205396
27519886	factors	C1521761
27519886	associated with	C0332281
27519886	effect size	C0814843
27519886	heterogeneity	C0019409
27519886	Meta-analysis	C0920317
27519886	demonstrated	C0443289
27519886	significant	C0750502
27519886	heterogeneity	C0019409
27519886	studies	C0947630
27519886	hazard ratio	C2985465
27519886	(HR)	C2985465
27519886	estimates	C0750572
27519886	ranging	C1514721
27519886	confidence interval	C0009667
27519886	[CI]	C0009667
27519886	CI	C0009667
27519886	Sex	C1522384
27519886	major	C0205164
27519886	factor	C1521761
27519886	accounting	C0586014
27519886	effect size	C0814843
27519886	variation	C0205419
27519886	mortality	C0205848
27519886	decreased	C0205216
27519886	more	C0205172
27519886	females	C0086287
27519886	HR	C2985465
27519886	CI	C0009667
27519886	compared	C1707455
27519886	males	C0086582
27519886	HR	C2985465
27519886	CI	C0009667
27519886	Rapamycin	C0072980
27519886	effects	C1280500
27519886	genotype	C0017431
27519886	dependent	C1701901
27519886	stronger	C0442821
27519886	survivorship	C0038955
27519886	increases	C0442805
27519886	hybrid	C0020205
27519886	mice	C0025929
27519886	CI	C0009667
27519886	relative	C0205345
27519886	pure	C0599804
27519886	inbred strains	C0025927
27519886	CI	C0009667
27519886	Number	C0237753
27519886	needed	C1514873
27519886	treat	C1522326
27519886	applied	C4048755
27519886	effect size	C0814843
27519886	metric	C0025867
27519886	identified	C0205396
27519886	senescence	C0231337
27519886	age	C0001779
27519886	peak	C0444505
27519886	treatment	C0039798
27519886	benefit	C0814225
27519886	results	C1274040
27519886	provide	C1999230
27519886	synthesis	C1883254
27519886	existing	C2987476
27519886	data	C1511726
27519886	support	C1521721
27519886	translation	C3494164
27519886	findings	C0243095
27519886	mouse	C0025929
27519886	primate species	C0033147
27519886	rapamycin's	C0072980
27519886	effect	C1280500
27519886	survival	C0038952
27519886	depends	C1701901
27519886	sex	C1522384
27519886	genotype	C0017431
27519886	factors	C1521761
27519886	treatment	C0039798
27519886	response	C0871261
27521864	Transfusion medicine	C1273858
27521864	medical education	C0013631
27521864	analysis	C0936012
27521864	curricular grids	C0681363
27521864	Brazil	C0006137
27521864	review	C1552617
27521864	current literature	C0023866
27521864	Blood transfusions	C0005841
27521864	medical procedures	C0199171
27521864	world	C2700280
27521864	education	C0013621
27521864	transfusion medicine	C1273858
27521864	vital	C0442732
27521864	medical care	C0496675
27521864	promote	C0033414
27521864	practice	C0033284
27521864	blood	C0005767
27521864	doctors	C0031831
27521864	investigate	C1292732
27521864	teaching	C0039401
27521864	transfusion medicine	C1273858
27521864	medical schools	C0036378
27521864	Brazil	C0006137
27521864	websites	C2349146
27521864	Brazilian	C1257890
27521864	medical schools	C0036378
27521864	operation	C3241922
27521864	curricula	C0010478
27521864	medical courses	C0013652
27521864	investigated	C1292732
27521864	transfusion medicine discipline	C1273858
27521864	analyzed	C0936012
27521864	description of content	C0678257
27521864	transfusion medicine	C1273858
27521864	disciplines	C1518533
27521864	medical school	C0036378
27521864	information	C1533716
27521864	curriculum	C0010478
27521864	medical schools	C0036378
27521864	published	C0034037
27521864	curriculum	C0010478
27521864	disciplines of transfusion medicine	C1273858
27521864	hematology	C0018943
27521864	discipline of transfusion medicine	C1273858
27521864	curricular grid	C0681363
27521864	Education	C0013621
27521864	transfusion medicine	C1273858
27521864	fundamental importance	C3898777
27521864	safe and efficient transfusion practices	C1879316
27521864	Deficiencies	C0011155
27521864	medical	C0205476
27521864	knowledge	C0376554
27521864	deficiency	C0011155
27521864	teaching	C0039401
27521864	basics	C1527178
27521864	prospective studies	C0033522
27521864	assess	C0184514
27521864	knowledge	C0376554
27521864	transfusion medicine	C1273858
27521864	Brazilian	C1257890
27521864	medical schools	C0036378
27521864	importance	C3898777
27521864	training	C0220931
27521864	transfusion medicine	C1273858
27521864	medical students	C0038495
27524031	Advanced	C0205179
27524031	interlocking systems	C0025080
27524031	improve	C0184511
27524031	heavy	C0439539
27524031	load-bearing	C1318107
27524031	characteristics	C1521970
27524031	flexible	C0443220
27524031	intramedullary nailing	C0021885
27524031	Flexible	C0443220
27524031	intramedullary nailing	C0021885
27524031	FIN	C0021885
27524031	minimally invasive	C0282624
27524031	widespread	C0205391
27524031	standard	C1442989
27524031	method	C0087111
27524031	osteosynthesis	C0016643
27524031	pediatric	C1521725
27524031	long bone fractures	C0240231
27524031	unstable fractures	C0559876
27524031	lower extremity	C0023216
27524031	interlocking systems	C0025080
27524031	axial	C0205131
27524031	shortening	C0441636
27524031	subsequent	C0332282
27524031	perforation	C1881710
27524031	nail	C0441224
27524031	insertion site	C0449682
27524031	study	C0008972
27524031	screw	C0005975
27524031	interlocking systems	C0025080
27524031	FINs	C0021885
27524031	Hofer TwinPlug	C0038932
27524031	titanium	C0040302
27524031	interlocking screws	C0441273
27524031	Hofer FixPlug	C0038932
27524031	titanium	C0040302
27524031	interlocking screw	C0441273
27524031	Hofer Plug	C0038932
27524031	titanium	C0040302
27524031	interlocking screw	C0441273
27524031	Hofer Plug	C0038932
27524031	titanium	C0040302
27524031	interlocking screw	C0441273
27524031	comparison	C1707455
27524031	stainless steel	C0038126
27524031	nails	C0441224
27524031	screw	C0005975
27524031	experimentally investigated	C1292732
27524031	cadaveric	C0006629
27524031	lamb	C1123019
27524031	tibiae	C0588199
27524031	load	C1708715
27524031	characteristics	C1521970
27524031	failure	C0014678
27524031	modes	C1513371
27524031	heavy	C0439539
27524031	loading	C1708715
27524031	specimens	C0370003
27524031	sequential	C1705294
27524031	axial	C0205131
27524031	cyclic	C1511572
27524031	loading	C1708715
27524031	cycles	C1511572
27524031	stepwise increase	C0442805
27524031	load	C1708715
27524031	amplitude	C2346753
27524031	failure	C0014678
27524031	Migration	C1881827
27524031	locking screws	C0441273
27524031	internal	C0205102
27524031	damage	C0010957
27524031	bone tissue	C0391978
27524031	micro-computed tomography (CT) imaging	C0729619
27524031	Ender nails	C0441224
27524031	failed	C0231175
27524031	average	C1510992
27524031	peak	C0444505
27524031	load	C1708715
27524031	TwinPlugs	C0038932
27524031	FixPlugs	C0038932
27524031	Plugs	C0038932
27524031	Plugs	C0038932
27524031	TwinPlugs	C0038932
27524031	FixPlugs	C0038932
27524031	Plugs	C0038932
27524031	failed	C0231175
27524031	loading	C1708715
27524031	cycles	C1511572
27524031	Ender nails	C0441224
27524031	Plugs	C0038932
27524031	abrupt	C1276802
27524031	failure	C0014678
27524031	prior	C0332152
27524031	indication	C3146298
27524031	axial	C0205131
27524031	stability	C0205360
27524031	FIN	C0021885
27524031	improved	C0184511
27524031	screw	C0005975
27524031	plugs	C0038932
27524031	simultaneously	C0521115
27524031	eye-locked system	C1704459
27524031	Ender nails	C0441224
27524031	biomechanical	C3658372
27524031	results	C0683954
27524031	plug	C0038932
27524031	interlocking systems	C0025080
27524031	screws	C0005975
27524031	conventional	C0439858
27524031	Ender nails	C0441224
27524031	plugs	C0038932
27524031	screws	C0005975
27524875	Surgical	C0543467
27524875	Guidance	C1959633
27524875	Multiplexed Molecular Imaging	C1537028
27524875	Tissues	C0040300
27524875	Labeled	C1522485
27524875	SERS	C1720804
27524875	Nanoparticles	C1450054
27524875	imaging	C0011923
27524875	cell-surface receptors	C0034800
27524875	biomarkers)	C0005516
27524875	presence	C0150312
27524875	cancer	C0006826
27524875	sensitivity	C0332324
27524875	specificity	C1511884
27524875	heterogeneities	C0019409
27524875	expression of protein	C1171362
27524875	biomarkers	C0041366
27524875	tumors	C0027651
27524875	molecular imaging	C1537028
27524875	technologies	C0752188
27524875	multiplexed panel	C1254353
27524875	cancer biomarkers	C0041366
27524875	surface-enhanced Raman-scattering	C1720804
27524875	SERS	C1720804
27524875	nanoparticles	C1450054
27524875	NPs	C1450054
27524875	sensitive	C0332324
27524875	multiplexed biomarker	C1254353
27524875	detection	C1511790
27524875	review	C0282443
27524875	tumor	C0027651
27524875	imaging	C0011923
27524875	SERS	C1720804
27524875	NPs	C1450054
27524875	structure	C0678594
27524875	optical properties	C1254365
27524875	SERS	C1720804
27524875	NPs	C1450054
27524875	imaging	C0011923
27524875	administration	C1621583
27524875	NPs	C1450054
27524875	tissue	C0040300
27524875	topical	C0332237
27524875	systemic	C0205373
27524875	optical configuration	C0678647
27524875	imaging	C0011923
27524875	Raman imaging systems	C1257898
27524875	spectral demultiplexing methods	C1537028
27524875	quantifying	C1709793
27524875	NP	C1450054
27524875	concentrations	C1446561
27524875	disambiguation	C2346729
27524875	specific	C0205369
27524875	nonspecific	C0750540
27524875	ratiometric imaging	C0011923
27524875	targeted	C1521840
27524875	untargeted	C1550141
27524875	control	C1550141
27524875	NP	C1450054
27526315	Expression	C0017262
27526315	methylation	C0376452
27526315	posttraumatic stress disorder	C0038436
27526315	resilience	C0683253
27526315	evidence	C3887511
27526315	role	C1705810
27526315	odorant receptors	C0164313
27526315	Post-traumatic stress disorder	C0038436
27526315	PTSD	C0038436
27526315	potentially	C3245505
27526315	disabling disorder	C0596452
27526315	people	C0027361
27526315	exposed to	C0332157
27526315	severe	C0205082
27526315	trauma	C3714660
27526315	Twin studies	C1096782
27526315	genetic	C0314603
27526315	factors	C1521761
27526315	variance	C1711260
27526315	PTSD	C0038436
27526315	specific	C0205369
27526315	role	C1705810
27526315	genetic	C0314603
27526315	factors	C1521761
27526315	pathogenesis	C0699748
27526315	PTSD	C0038436
27526315	genome-wide	C2350277
27526315	gene expression	C0017262
27526315	DNA methylation	C0376452
27526315	profiles	C0237801
27526315	participants	C0679646
27526315	PTSD	C0038436
27526315	participants	C0679646
27526315	resilient	C0683253
27526315	severity	C0392364
27526315	trauma	C3714660
27526315	exposure	C0332157
27526315	genes	C0017337
27526315	differentially	C0443199
27526315	expressed	C0017262
27526315	adjusted	C0456081
27526315	fold-change	C1880833
27526315	upregulated	C0041904
27526315	PTSD	C0038436
27526315	odorant/olfactory receptor	C0164313
27526315	genes	C0017337
27526315	up-regulated	C0041904
27526315	PTSD	C0038436
27526315	genes	C0017337
27526315	immune activation	C1155000
27526315	Gamma-Aminobutyric Acid A (GABAA) receptor	C0206518
27526315	vitamin D synthesis	C1157731
27526315	adjusted	C0456081
27526315	significance	C0750502
27526315	DNA methylation	C0376452
27526315	increased	C0205217
27526315	gene expression	C0017262
27526315	important	C3898777
27526315	role	C1705810
27526315	PTSD	C0038436
27526315	expression	C0017262
27526315	consequence of	C0686907
27526315	DNA methylation	C0376452
27526315	role	C1705810
27526315	odorant receptor	C0164313
27526315	expression	C0597360
27526315	independent	C0332291
27526315	replication	C0598312
27532629	Absorption Characteristics	C0220777
27532629	Vertebrate	C0042567
27532629	Non	C1518422
27532629	Visual	C0234621
27532629	Opsin, Opn3	C0967413
27532629	animals	C0003062
27532629	possess	C3154893
27532629	multiple	C0439064
27532629	opsins	C2355587
27532629	sense	C0042789
27532629	light	C0023693
27532629	visual	C0234621
27532629	non	C1518422
27532629	visual functions	C0042789
27532629	spectral	C1883073
27532629	characteristics	C1521970
27532629	non	C1518422
27532629	visual	C0234621
27532629	opsins	C2355587
27532629	vertebrate	C0042567
27532629	Opn3s	C0967413
27532629	distributed	C1704711
27532629	vertebrates	C0042567
27532629	successfully	C1272703
27532629	expressed	C1171362
27532629	zebrafish	C0043457
27532629	Opn3	C2355587
27532629	mammalian	C0024660
27532629	cultured cells	C0007635
27532629	measured	C0444706
27532629	absorption spectrum spectroscopically	C0037812
27532629	incubated	C1439852
27532629	11-cis retinal	C0085717
27532629	zebrafish	C0043457
27532629	Opn3	C2355587
27532629	blue-sensitive photopigment	C0035323
27532629	absorption	C0234682
27532629	maximum	C0806909
27532629	Opn3	C0967413
27532629	converts	C0439836
27532629	all-trans retinal-bearing	C0035331
27532629	photoproduct	C1550506
27532629	absorption spectrum	C0037812
27532629	similar	C2348205
27532629	dark state	C0010985
27532629	brief	C1879313
27532629	blue-light	C0303896
27532629	irradiation	C1282930
27532629	photoproduct	C1550506
27532629	blue-shift	C0449819
27532629	in position	C1550045
27532629	isosbestic point	C0449819
27532629	irradiation	C1282930
27532629	cAMP	C0001455
27532629	dependent	C3244310
27532629	luciferase	C0024075
27532629	reporter	C1522485
27532629	assay	C1510438
27532629	investigate	C1292732
27532629	light	C0023693
27532629	dependent	C3244310
27532629	cAMP	C0001455
27532629	responses	C1657589
27532629	cultured cells	C0007635
27532629	expressing	C1171362
27532629	zebrafish	C0043457
27532629	pufferfish	C0936076
27532629	anole	C0327220
27532629	chicken	C0008051
27532629	Opn3	C2355587
27532629	wild type	C1883559
27532629	opsins	C2355587
27532629	responses	C1657589
27532629	cells	C0007634
27532629	expressing	C1171362
27532629	chimera	C0008109
27532629	mutants	C1564139
27532629	WT Opn3s	C0967413
27532629	third intracellular	C0178719
27532629	loops	C0002518
27532629	replaced	C0559956
27532629	third intracellular	C0178719
27532629	loop	C0002518
27532629	Gs-coupled	C0289372
27532629	jellyfish	C0022381
27532629	opsin	C2355587
27532629	displayed	C0870432
27532629	light	C0023693
27532629	dependent	C3244310
27532629	changes	C0443172
27532629	cAMP	C0001455
27532629	Opn3	C0967413
27532629	activating	C0599177
27532629	G protein(s)	C0086376
27532629	light	C0023693
27532629	dependent	C3244310
27532629	assay	C1510438
27532629	measure	C0079809
27532629	relative	C0205345
27532629	wavelength	C0449819
27532629	dependent	C3244310
27532629	response	C0871261
27532629	cells	C0007634
27532629	expressing	C1171362
27532629	Opn3	C0967413
27532629	chimeras	C0008109
27532629	multiple	C0439064
27532629	quantally	C0034385
27532629	matched	C1708943
27532629	stimuli	C0234402
27532629	inferred	C3245504
27532629	spectral sensitivity	C0871405
27532629	curve	C0205134
27532629	zebrafish	C0043457
27532629	Opn3	C2355587
27532629	accurately	C0443131
27532629	matched	C1708943
27532629	measured	C0444706
27532629	absorption spectrum	C0037812
27532629	spectral sensitivity	C0871405
27532629	curve	C0205134
27532629	mouse	C0026809
27532629	anole	C0327220
27532629	Opn3	C2355587
27532629	zebrafish	C0043457
27532629	Opn3	C2355587
27532629	chicken	C0008051
27532629	pufferfish	C0936076
27532629	Opn3-JiL3	C1564139
27532629	chimeras	C0008109
27532629	blue-sensitive pigments	C0381986
27532629	vertebrate	C0042567
27532629	Opn3s	C0967413
27532629	blue-sensitive G protein-coupled pigments	C0289372
27532629	cAMP	C0001455
27532629	dependent	C3244310
27532629	luciferase	C0024075
27532629	reporter	C1522485
27532629	assay	C1510438
27532629	chimeric	C0008109
27532629	opsins	C2355587
27532629	third intracellular	C0178719
27532629	loop	C0002518
27532629	jellyfish	C0022381
27532629	opsin	C2355587
27532629	estimating	C0750572
27532629	absorption spectra	C0037812
27532629	opsins	C2355587
27532629	signaling cascades	C2611812
27532629	absorption spectra	C0037812
27532629	difficult	C0332218
27532798	Effectiveness	C1280519
27532798	offloading	C2922211
27532798	methods	C0087111
27532798	preventing	C0679698
27532798	primary	C0205225
27532798	diabetic foot ulcers	C1456868
27532798	adults	C0001675
27532798	diabetes	C0011847
27532798	systematic review	C1955832
27532798	incidence	C0021149
27532798	foot ulceration	C0085119
27532798	diabetes	C0011847
27532798	increasing	C0442808
27532798	foot care	C0150240
27532798	professionals	C0679924
27532798	offloading	C2922211
27532798	management strategies	C1254363
27532798	excess	C1979886
27532798	pressure	C4284008
27532798	prevent	C0679698
27532798	diabetic foot ulcers	C1456868
27532798	DFUs	C1456868
27532798	measures	C0079809
27532798	padding	C0455069
27532798	insoles	C0493044
27532798	orthotic devices	C0029365
27532798	footwear	C0336894
27532798	evidence	C3887511
27532798	effectiveness	C1280519
27532798	offloading	C2922211
27532798	preventing	C0679698
27532798	primary	C0205225
27532798	ulceration	C0085119
27532798	diabetes	C0011847
27532798	evidence	C3887511
27532798	methods	C0087111
27532798	offloading	C2922211
27532798	prevent	C0679698
27532798	development	C1527148
27532798	reduce	C0392756
27532798	risk	C0035647
27532798	primary	C0205225
27532798	foot ulceration	C0085119
27532798	adults	C0001675
27532798	diabetes	C0011847
27532798	question	C0681799
27532798	addressed	C0376649
27532798	review	C0282443
27532798	effectiveness	C1280519
27532798	methods	C0087111
27532798	offloading	C2922211
27532798	preventing	C0679698
27532798	primary	C0205225
27532798	DFUs	C1456868
27532798	adults	C0001675
27532798	diabetes	C0011847
27532798	Adults	C0001675
27532798	years	C0439234
27532798	diabetes mellitus	C0011849
27532798	age	C0001779
27532798	gender	C0079399
27532798	ethnicity	C0243103
27532798	duration	C0449238
27532798	type	C0332307
27532798	diabetes	C0011847
27532798	history	C1287400
27532798	DFUs	C1456868
27532798	clinical setting	C3176918
27532798	Interventions	C0184661
27532798	methods	C0087111
27532798	offloading	C2922211
27532798	Studies	C2603343
27532798	interventions	C0184661
27532798	usual	C3538928
27532798	practice	C0087111
27532798	prevention	C0679698
27532798	DFUs	C1456868
27532798	excluded	C1554077
27532798	primary	C0205225
27532798	outcome	C1274040
27532798	primary	C0205225
27532798	foot ulceration	C0085119
27532798	secondary	C0205436
27532798	outcome	C1274040
27532798	plantar	C0230463
27532798	pressure	C4284008
27532798	review	C0282443
27532798	quantitative	C0392762
27532798	study designs	C0035171
27532798	literature	C0023866
27532798	databases	C0242356
27532798	studies	C2603343
27532798	English	C0376245
27532798	JBI-MAStARI extraction tool	C0037589
27532798	data	C1511726
27532798	Results	C1274040
27532798	summarized	C1553398
27532798	narrative	C0815257
27532798	tables	C1706074
27532798	studies	C2603343
27532798	effectiveness	C1280519
27532798	offloading	C2922211
27532798	interventions	C0184661
27532798	inclusion criteria	C1512693
27532798	evidence	C3887511
27532798	footwear	C0336894
27532798	prototype shoe plus polyurethane	C0036988
27532798	cork insole	C3873740
27532798	prevent	C0679698
27532798	skin	C1123023
27532798	orthotic devices	C0029365
27532798	reduction	C0392756
27532798	grade	C0205082
27532798	number	C0237753
27532798	calluses	C0457978
27532798	shoe plus	C0036988
27532798	insole	C3873740
27532798	plantar	C0230463
27532798	pressure	C4284008
27532798	risk	C0035647
27532798	skin ulceration	C0085119
27532798	evidence	C3887511
27532798	population	C1257890
27532798	adults	C0001675
27532798	diabetes	C0011847
27532798	history	C1287400
27532798	DFU	C1456868
27532798	footwear	C0336894
27532798	orthotic devices	C0029365
27532798	plantar	C0230463
27532798	pressure	C4284008
27532798	prevent	C0679698
27532798	primary	C0205225
27532798	DFU	C1456868
27532798	evidence	C3887511
27532798	effectiveness	C1280519
27532798	offloading	C2922211
27534567	Punch	C0004930
27534567	injury	C0043251
27534567	self-harm	C0424366
27534567	young people	C0087178
27534567	Punch	C0004930
27534567	injuries	C0043251
27534567	form	C0348078
27534567	self-harm	C0424366
27534567	characterised	C1880022
27534567	intentional	C1283828
27534567	act of striking	C0441655
27534567	object	C0347997
27534567	closed	C0587267
27534567	fist	C0336667
27534567	aimed	C1947946
27534567	characteristics	C1521970
27534567	trends	C1521798
27534567	young people	C0087178
27534567	presenting	C0449450
27534567	injuries	C0043251
27534567	sustained	C0443318
27534567	punch	C0004930
27534567	mechanism	C0441712
27534567	comprehensive	C1880156
27534567	retrospective review	C0035363
27534567	medical records	C0025102
27534567	completed	C0205197
27534567	young people	C0087178
27534567	aged	C0001779
27534567	years	C0439234
27534567	presenting	C0449450
27534567	Central London Emergency Department	C1708333
27534567	12-month period	C4082117
27534567	subset of the total group	C1515021
27534567	identified	C0205396
27534567	punch	C0004930
27534567	injury	C0043251
27534567	subgroup	C1515021
27534567	punch	C0004930
27534567	injury	C0043251
27534567	presentations	C0449450
27534567	identified	C0205396
27534567	subgroup	C1515021
27534567	male	C0086582
27534567	female	C0086287
27534567	ratio	C0456603
27534567	presentations	C0449450
27534567	associated with	C0332281
27534567	fracture	C0016658
27534567	patients	C0030705
27534567	re-presented	C0449450
27534567	punch	C0004930
27534567	injury	C0043251
27534567	victim of violence	C2711168
27534567	psychiatric	C0205487
27534567	presentation	C0449450
27534567	conclusion	C1707478
27534567	male preponderance	C0243095
27534567	observed	C1441672
27534567	frequent	C0332183
27534567	re-presentations	C0449450
27534567	high-risk	C0332167
27534567	circumstances	C0868928
27534567	screening	C1710032
27534567	mental health	C0025353
27534567	social	C0728831
27534567	substance misuse	C4061432
27534567	identified	C0205396
27534567	research	C0035168
27534567	needed	C0027552
27534567	targeted	C1521840
27534567	effective	C1704419
27534567	interventions	C1273869
27534567	group	C0087178
27537689	Delayed	C0205421
27537689	Recognition	C1285650
27537689	Deterioration	C0563273
27537689	Patients	C0030705
27537689	General Wards	C0043030
27537689	Human	C0086418
27537689	Monitoring	C1283169
27537689	Failures	C0231175
27537689	Root Cause Analysis	C3179036
27537689	ICU Admissions	C0583239
27537689	ICU admission	C0583239
27537689	inpatient	C0021562
27537689	serious adverse event	C1519255
27537689	SAE	C1519255
27537689	root causes	C3179036
27537689	ICU-admissions	C0583239
27537689	healthcare worker	C0018724
27537689	organisational	C0220885
27537689	technical	C0402239
27537689	disease	C0012634
27537689	patient	C0030705
27537689	ICU admissions	C0583239
27537689	general wards	C0043030
27537689	Root-Cause Analysis Tool	C3179036
27537689	PRISMA-medical	C0199168
27537689	Track and Trigger System (MEWS)	C0681689
27537689	hospital	C0019994
27537689	protocol	C0008971
27537689	Track and Trigger system	C0681689
27537689	deterioration	C0563273
27537689	general hospital wards	C0043030
27537689	patients	C0030705
27537689	ICU	C0021708
27537689	Retrospective observational study	C1518527
27537689	patients	C0030705
27537689	admitted	C0184666
27537689	Intensive Care Unit	C0021708
27537689	general nursing ward	C0204637
27537689	PRISMA-analysis	C0936012
27537689	root causes	C3179036
27537689	ICU admissions	C0583239
27537689	protocol	C0008971
27537689	early warning score system	C2919393
27537689	root causes	C3179036
27537689	root causes	C3179036
27537689	healthcare worker	C0018724
27537689	failures	C0231175
27537689	monitoring	C1283169
27537689	patient	C0030705
27537689	disease	C0012634
27537689	patient	C0030705
27537689	organisational	C0220885
27537689	root causes	C3179036
27537689	patients	C0030705
27537689	vital parameters	C0549193
27537689	doctor	C0031831
27537689	vital parameter	C0549193
27537689	ICU admission	C0583239
27537689	MEWS	C0681689
27537689	documented	C1301725
27537689	in-depth analysis	C0936012
27537689	ICU admissions	C0583239
27537689	general ward	C0043030
27537689	healthcare worker	C0018724
27537689	root causes	C3179036
27537689	monitoring	C1283169
27537689	failures	C0231175
27537689	clinically deteriorating	C0563273
27537689	patients	C0030705
27537689	ICU admissions	C0583239
27537689	monitoring	C1283169
27537689	patients	C0030705
27539962	phosphodiesterase 10A inhibitor	C0031638
27539962	non-human primates	C0237798
27539962	therapeutic approach	C0039798
27539962	schizophrenia	C0036341
27539962	side effect profile	C0879626
27539962	Schizophrenia	C0036341
27539962	symptoms	C1457887
27539962	associated with	C0332281
27539962	alterations in basal ganglia-cortical networks	C0004782
27539962	cyclic nucleotides	C0028631
27539962	cAMP	C0001455
27539962	cGMP	C0018338
27539962	signaling pathways	C0037080
27539962	Phosphodiesterase 10A (PDE10A) inhibitors	C0031638
27539962	therapeutic agents	C1611640
27539962	schizophrenia	C0036341
27539962	regulation of cAMP	C2613288
27539962	cGMP	C2612051
27539962	striatum	C0010097
27539962	PDE10A	C1447737
27539962	signaling mechanisms	C0037080
27539962	striatal-cortical network	C0682726
27539962	cognitive function	C0392335
27539962	non-human primates	C0237798
27539962	NHPs	C0237798
27539962	PDE10A inhibitor	C0031638
27539962	FRM-6308	C0031638
27539962	high potency	C1656349
27539962	human recombinant PDE10A	C1447737
27539962	in vitro	C0681828
27539962	behavioral effects	C0243095
27539962	FRM-6308	C0031638
27539962	dose range	C0178602
27539962	rhesus monkeys	C0024400
27539962	standardized motor disability scale	C4228195
27539962	primates	C0033147
27539962	motor tasks	C0556033
27539962	drug effects on the nervous system" (DENS) scale	C0678802
27539962	neuronal	C0521390
27539962	metabolic effects	C2945675
27539962	FRM-6308	C0031638
27539962	[(18)F]-fluorodeoxyglucose PET imaging	C2315783
27539962	FRM-6308	C0031638
27539962	motor system	C0682711
27539962	s.c. doses	C0021499
27539962	NHPs	C0237798
27539962	FDG	C0046056
27539962	SUV	C2348529
27539962	striatum	C0010097
27539962	cortical	C1181303
27539962	Higher doses	C0444956
27539962	sedation	C0235195
27539962	occasional involuntary movements	C0427086
27539962	tolerance after repeated exposures	C0743284
27539962	FRM-6308	C0031638
27539962	adequate pharmacological profile	C1320678
27539962	clinical trials	C0008976
27539962	antipsychotic efficacy	C3179403
27539962	PDE10A	C1447737
27539962	inhibition	C3463820
27539962	treatment	C1522326
27539962	schizophrenia	C0036341
27539962	patients	C0030705
27541815	Agglomeration	C1704332
27541815	Luminescent	C1450275
27541815	Porous	C1881977
27541815	Silicon	C0037107
27541815	Nanoparticles	C1450054
27541815	Colloidal Solutions	C0009361
27541815	prepared	C4082130
27541815	colloidal solutions	C0009361
27541815	clusters	C1704332
27541815	porous	C1881977
27541815	silicon	C0037107
27541815	nanoparticles	C1450054
27541815	methanol	C0001963
27541815	water	C0043047
27541815	phosphate-buffered saline	C0036082
27541815	PBS	C0036082
27541815	size	C0456389
27541815	nanoclusters	C1704332
27541815	highly	C0205250
27541815	porous	C1881977
27541815	"cauliflower"-like structure	C0678594
27541815	porous	C1881977
27541815	silicon	C0037107
27541815	nanoparticles	C1450054
27541815	interconnected	C0449379
27541815	nanocrystals	C1721058
27541815	size	C0456389
27541815	strong	C0442821
27541815	visible	C0205379
27541815	luminescence	C1450275
27541815	orange	C1313858
27541815	red	C1260956
27541815	spectral	C2827424
27541815	region	C0205147
27541815	Hydrophilic behaviour	C0475370
27541815	good	C0205170
27541815	solubility	C0037628
27541815	nanoclusters	C1704332
27541815	water	C0043047
27541815	water	C0043047
27541815	based	C1705938
27541815	solutions	C0037633
27541815	obtained	C1301820
27541815	hydrogen peroxide	C0020281
27541815	etching	C2350458
27541815	solution	C0037633
27541815	preparation	C1521827
27541815	after-bath	C1549544
27541815	hydrogen peroxide	C0020281
27541815	simple	C0205352
27541815	filtration	C0016107
27541815	solutions	C0037633
27541815	syringe filters	C0180875
27541815	extracted	C0849355
27541815	smaller	C0700321
27541815	nanoclusters	C1704332
27541815	sizes	C0456389
27541815	approx	C0332232
27541815	nanoclusters	C1704332
27541815	water	C0043047
27541815	PBS solution	C0036082
27541815	pH neutral	C1882074
27541815	prone	C0231204
27541815	agglomeration	C1704332
27541815	confirmed	C0750484
27541815	zeta potential	C0597697
27541815	measurements	C0242485
27541815	samples	C0370003
27541815	ambient conditions	C1879688
27541815	several	C0443302
27541815	typical	C3538928
27541815	nanocluster	C1704332
27541815	size	C0456389
27541815	increased	C0205217
27541815	approx	C0332232
27541815	stable	C0205360
27541815	freshly	C0443224
27541815	filtered	C1704449
27541815	aged	C2362314
27541815	samples	C0370003
27541815	agglomerated	C1704332
27541815	porous	C1881977
27541815	silicon	C0037107
27541815	nanoparticles	C1450054
27541815	porous	C1881977
27541815	silicon	C0037107
27541815	water	C0043047
27541815	PBS solutions	C0036082
27541815	biological	C0205460
27541815	studies	C2603343
27541815	luminescent	C1450275
27541815	markers	C0005516
27541815	living cells	C0007634
27542694	Development	C1527148
27542694	liquid chromatography-tandem mass spectrometry	C4049918
27542694	method	C0449851
27542694	quantitative analysis	C0681919
27542694	trace	C0442822
27542694	d-amino acids	C0002520
27542694	d-Amino acids	C0002520
27542694	recently	C0332185
27542694	attention	C0004268
27542694	research fields	C0242481
27542694	including	C0332257
27542694	medical	C0205476
27542694	clinical	C0205210
27542694	food industry	C0524863
27542694	important	C3898777
27542694	biological functions	C3714634
27542694	l-amino acid	C0002520
27542694	chiral	C3539649
27542694	amino acid	C0002520
27542694	separation	C1441514
27542694	techniques	C0449851
27542694	require	C1514873
27542694	complicated	C0231242
27542694	derivatization	C0596319
27542694	procedures	C0025664
27542694	desirable	C0205556
27542694	chromatographic	C0205556
27542694	detectability	C0442726
27542694	aim	C1947946
27542694	research	C0035168
27542694	develop	C1527148
27542694	highly sensitive	C0439822
27542694	analytical method	C0178476
27542694	enantioseparation	C1441514
27542694	chiral	C3539649
27542694	amino acids	C0002520
27542694	derivatization	C0596319
27542694	process	C1522240
27542694	liquid chromatography-tandem mass spectrometry	C4049918
27542694	LC-MS/MS	C4049918
27542694	optimizing	C2698650
27542694	MS/MS	C2123592
27542694	parameters	C0549193
27542694	established	C0443211
27542694	quantification	C1709793
27542694	method	C0449851
27542694	simultaneous	C0521115
27542694	analysis	C0936012
27542694	d-amino acids	C0002520
27542694	high sensitivity	C2346484
27542694	reproducibility	C1514863
27542694	applied	C4048755
27542694	method	C0449851
27542694	food sample	C0444315
27542694	vinegar	C0148405
27542694	validation	C1519941
27542694	quantified	C1709793
27542694	trace levels	C0442822
27542694	d-amino acids	C0002520
27542694	samples	C0370003
27542694	results	C0456984
27542694	applicability	C1706839
27542694	feasibility	C0205556
27542694	LC-MS/MS	C4049918
27542694	method	C0449851
27542694	novel	C0205314
27542694	effective	C1704419
27542694	d-amino acid	C0002520
27542694	measurement	C0242485
27542694	biological samples	C2347026
27542782	Multi-center Evaluation of the Accuracy of the Contrast MEdium INduced Pd/Pa RaTiO	C0282574
27542782	FFR	C1299469
27542782	MEMENTO	C0282574
27542782	FFR	C1299469
27542782	Study	C2603343
27542782	Adenosine	C0001443
27542782	administration	C1533734
27542782	maximal	C0205289
27542782	hyperaemia	C0020452
27542782	fractional flow reserve	C1299469
27542782	FFR	C1299469
27542782	assessment	C0220825
27542782	accuracy	C0443131
27542782	Pd	C1254360
27542782	Pa	C0456180
27542782	ratio	C0456603
27542782	submaximal	C0205556
27542782	hyperaemia	C0020452
27542782	non-ionic contrast medium	C1875544
27542782	contrast FFR	C1299469
27542782	cFFR	C1299469
27542782	FFR	C1299469
27542782	resting	C0679218
27542782	Pd	C1254360
27542782	Pa	C0456180
27542782	collaborative	C0681804
27542782	patients	C0030705
27542782	hospitals	C0019994
27542782	four	C0205450
27542782	European countries	C0681784
27542782	Italy	C0022277
27542782	Spain	C0037747
27542782	France	C0016674
27542782	Portugal	C0032729
27542782	Resting	C0679218
27542782	Pd	C1254360
27542782	Pa	C0456180
27542782	cFFR	C1299469
27542782	FFR	C1299469
27542782	coronary stenoses	C0242231
27542782	functionally	C0205245
27542782	pressure wires	C0025080
27542782	cFFR	C1299469
27542782	intracoronary injection	C1554869
27542782	contrast medium	C0009924
27542782	FFR	C1299469
27542782	administration	C1533734
27542782	adenosine	C0001443
27542782	Resting	C0679218
27542782	Pd	C1254360
27542782	Pa	C0456180
27542782	cFFR	C1299469
27542782	higher	C0205250
27542782	FFR	C1299469
27542782	correlation	C1707520
27542782	Bland-Altman analysis	C0282574
27542782	cFFR	C1299469
27542782	FFR	C1299469
27542782	CI	C0009667
27542782	ROC curve	C0035787
27542782	analysis	C0936012
27542782	accuracy	C0443131
27542782	cFFR	C1299469
27542782	FFR	C1299469
27542782	CI	C0009667
27542782	resting	C0679218
27542782	Pd	C1254360
27542782	Pa	C0456180
27542782	CI	C0009667
27542782	cFFR	C1299469
27542782	FFR	C1299469
27542782	hybrid approach	C0282574
27542782	lower	C0205251
27542782	lesions	C0221198
27542782	adenosine	C0001443
27542782	resting	C0679218
27542782	Pd	C1254360
27542782	Pa	C0456180
27542782	FFR	C1299469
27542782	hybrid approach	C0282574
27542782	cFFR	C1299469
27542782	accurate	C0443131
27542782	functional	C0205245
27542782	coronary stenosis	C0242231
27542782	adenosine	C0001443
27542782	FFR	C1299469
27542782	stenoses	C1261287
27542782	time	C0040223
27542782	costs	C0010186
27542789	Transfemoral aortic valve implantation	C0021107
27542789	repositionable Lotus valve	C0184252
27542789	treatment	C0087111
27542789	patients	C0030705
27542789	symptomatic	C0231220
27542789	severe	C0205082
27542789	aortic stenosis	C0003507
27542789	results	C1274040
27542789	single-centre experience	C0237607
27542789	study	C2603343
27542789	evaluate	C0220825
27542789	day	C0439228
27542789	results	C1274040
27542789	repositionable Lotus valve	C0184252
27542789	patients	C0030705
27542789	transfemoral aortic valve implantation	C0021107
27542789	single-centre experience	C0237607
27542789	patients	C0030705
27542789	severe	C0205082
27542789	symptomatic	C0231220
27542789	aortic stenosis	C0003507
27542789	NCT02162069	C3274381
27542789	procedures	C2700391
27542789	general anaesthesia	C0002915
27542789	transfemoral approach	C0087111
27542789	Patients	C0030705
27542789	days	C0439228
27542789	Patients	C0030705
27542789	received	C1514756
27542789	Lotus device	C0184252
27542789	Mean oversizing	C0392762
27542789	annulus	C2262860
27542789	left ventricular outflow tract	C4284103
27542789	LVOT	C4284103
27542789	groups	C0441833
27542789	no residual	C0746917
27542789	moderate	C0205081
27542789	severe	C0205082
27542789	aortic regurgitation	C0003504
27542789	rate of mild aortic regurgitation	C0392762
27542789	aortic regurgitation	C0003504
27542789	valve	C0003501
27542789	embolisation	C0190360
27542789	second	C0205436
27542789	valve	C0003501
27542789	no conversion	C0243095
27542789	surgery	C0543467
27542789	pacemaker implantation	C0189842
27542789	complete	C0151517
27542789	third degree	C0151517
27542789	type II (Mobitz) second degree atrioventricular block	C0155700
27542789	patients	C0030705
27542789	implanted devices	C0948629
27542789	days	C0439228
27542789	rates	C1521828
27542789	all-cause mortalit	C0205848
27542789	stroke	C0038454
27542789	low	C0205251
27542789	patients	C0030705
27542789	severe	C0205082
27542789	aortic stenosis	C0003507
27542789	transfemoral TAVI	C3509486
27542789	repositionable Lotus valve	C0184252
27542789	associated with	C0332281
27542789	high	C0205250
27542789	rate	C1521828
27542789	device	C0025080
27542789	success	C0679864
27542789	moderate	C0205081
27542789	severe	C0205082
27542789	residual	C1609982
27542789	aortic regurgitation	C0003504
27542789	low	C0205251
27542789	rates	C1521828
27542789	major	C0205164
27542789	vascular complications	C1393529
27542789	mortality	C0205848
27542789	days	C0439228
27542814	Comparison	C1707455
27542814	Measured	C0444706
27542814	Concentration	C0457929
27542814	3H	C0041119
27542814	Kalpakkam Environment	C0681784
27542814	Predicted Atmospheric Dispersion Model	C0026336
27542814	field	C3539073
27542814	measurements	C0242485
27542814	3H	C0041119
27542814	HTO	C0077315
27542814	air	C0935443
27542814	moisture	C0868994
27542814	Madras Atomic Power Station	C0562516
27542814	compared	C1707455
27542814	atmospheric dispersion modeling	C0026336
27542814	Air 3H samples	C1546536
27542814	collected	C1516695
27542814	sectors	C1708237
27542814	site	C0205145
27542814	boundary	C2828371
27542814	operating	C3241922
27542814	reactors	C0028591
27542814	period	C1948053
27542814	y	C0439234
27542814	compared	C1707455
27542814	Gaussian Plume model	C0026336
27542814	predictions	C0681842
27542814	measured	C0444706
27542814	value	C1522609
27542814	slight	C2937276
27542814	variation	C0205419
27542814	observed	C1441672
27542814	methods	C0025663
27542814	uncertainty	C0087130
27542814	measurement	C0242485
27542814	air	C0001861
27542814	3H	C0041119
27542814	concentration	C0457929
27542814	measurement	C0242485
27542814	site-specific	C0449604
27542814	meteorological parameters	C0025594
27542814	radiation dose	C4019308
27542814	imparted	C0332289
27542814	members of public	C0678367
27542814	levels	C0441889
27542814	observed	C1441672
27542814	station	C0562516
27542814	technical specification limit	C0439801
27542814	3H	C0041119
27543814	aureocin A70	C1101398
27543814	promising agent	C0450442
27543814	food biopreservation	C0016484
27543814	Aureocin A70	C1101398
27543814	bacteriocin	C0004641
27543814	inhibits the growth	C2249823
27543814	Gram-positive bacteria	C0018154
27543814	Listeria monocytogenes	C0023861
27543814	strains	C1518614
27543814	food	C0016452
27543814	food safety	C1456535
27543814	Aureocin A70	C1101398
27543814	bactericidal	C0004635
27543814	lytic	C0439680
27543814	listerial	C0023861
27543814	strains	C1518614
27543814	antibacterial activity	C0441655
27543814	aureocin A70	C1101398
27543814	UHT-treated	C3179136
27543814	skimmed milk	C0349375
27543814	inoculated	C1439852
27543814	food	C0016452
27543814	L. monocytogenes L12 strain	C0023861
27543814	storage	C1698986
27543814	Aureocin A70	C1101398
27543814	reduction	C0301630
27543814	listerial	C0023861
27543814	viable cell counts	C0007584
27543814	incubation	C1439852
27543814	Aureocin A70	C1101398
27543814	toxic	C1407029
27543814	Vero	C0042542
27543814	L-929 cell lines	C0007634
27543814	hemolytic activity	C0302110
27543814	sheep	C0036945
27543814	red blood cells	C0014792
27543814	Aureocin A70	C1101398
27543814	Aureocin A70	C1101398
27543814	susceptibility	C1547045
27543814	simulated	C1948023
27543814	gastric juice	C0017133
27543814	bile salts	C0005404
27543814	gastrointestinal conditions	C4061136
27543814	entrapment	C2825784
27543814	aureocin A70	C1101398
27543814	alginate	C0102137
27543814	gelatin matrix	C1533434
27543814	bacteriocin	C0004641
27543814	low-density polyethylene plastic	C0752344
27543814	aureocin A70	C1101398
27543814	bioactive	C3714412
27543814	packaging	C2828395
27543814	control the growth	C2249823
27543814	bacteria	C0004611
27543814	aureocin A70	C1101398
27543814	promising alternative	C0450442
27543814	food applications	C0016484
27544926	Folate	C0178638
27544926	conjugated	C0522529
27544926	gene	C0017337
27544926	carrying	C0872177
27544926	microbubbles	C1258018
27544926	focused ultrasound	C1517281
27544926	concurrent	C0205420
27544926	blood-brain barrier	C0005854
27544926	opening	C1254362
27544926	local	C0205276
27544926	gene delivery	C0872177
27544926	Previous	C0205156
27544926	studies	C2603343
27544926	circulating	C0175630
27544926	DNA	C0012854
27544926	encapsulated	C0205223
27544926	microbubbles	C1258018
27544926	MBs	C1258018
27544926	combined	C0205195
27544926	focused ultrasound	C1517281
27544926	FUS	C1517281
27544926	used	C1524063
27544926	local	C0205276
27544926	blood-brain barrier	C0005854
27544926	BBB	C0005854
27544926	opening	C1254362
27544926	gene delivery	C0872177
27544926	studies	C2603343
27544926	focused	C1285542
27544926	increase	C0442805
27544926	efficiency	C0013682
27544926	gene delivery	C0872177
27544926	brain tumors	C0006118
27544926	released	C0391871
27544926	gene	C0017337
27544926	penetrating	C0205321
27544926	BBB	C0005854
27544926	use of	C1524063
27544926	folate	C0178638
27544926	cationic MBs	C1258018
27544926	FCMBs	C1258018
27544926	combined	C0205195
27544926	FUS	C1517281
27544926	trigger	C1444748
27544926	BBB	C0005854
27544926	FCMBs	C1258018
27544926	nanometer	C0439202
27544926	sized	C0456389
27544926	vesicles	C1622418
27544926	transported	C0005528
27544926	brain	C0006104
27544926	parenchyma	C0933845
27544926	FCMBs	C1258018
27544926	aggregate	C0205418
27544926	tumor cells	C0597032
27544926	overexpressed	C1514559
27544926	folate receptor	C2955669
27544926	enhancing	C2349975
27544926	gene delivery	C0872177
27544926	folate	C2955669
27544926	stimulated	C1948023
27544926	endocytosis	C0014139
27544926	results	C1274040
27544926	confirmed	C0521093
27544926	FCMBs	C1258018
27544926	carry	C0872177
27544926	DNA	C0012854
27544926	surface	C0205148
27544926	MB	C1258018
27544926	shell	C1948022
27544926	good	C0205170
27544926	targeting	C1521840
27544926	ability	C1516240
27544926	C6 glioma cells	C0007634
27544926	FUS	C1517281
27544926	parameters	C0549193
27544926	FCMBs	C1258018
27544926	enhanced	C2349975
27544926	gene delivery	C0872177
27544926	confirmed by	C0521093
27544926	cell	C0007634
27544926	experiments	C0681814
27544926	center frequency	C1705502
27544926	acoustic pressure	C4284008
27544926	pulse	C1947910
27544926	repetition	C0205341
27544926	frequency	C1705502
27544926	cycle	C1511572
27544926	number	C0237753
27544926	exposure	C0332157
27544926	time	C0040223
27544926	FCMBs	C1258018
27544926	concentration	C1446561
27544926	In vivo	C1515655
27544926	data	C1511726
27544926	indicated	C1444656
27544926	FCMBs	C1258018
27544926	better	C0332272
27544926	gene	C0017337
27544926	transfection	C0314641
27544926	efficiency	C0013682
27544926	MBs	C1258018
27544926	without	C0332288
27544926	folate	C2955669
27544926	conjugation	C1160466
27544926	traditional	C0443324
27544926	approach	C0449445
27544926	directly	C1947931
27544926	injecting	C1533685
27544926	gene	C0017337
27544926	study	C2603343
27544926	novel	C0205314
27544926	development	C1527148
27544926	multifunctional	C0205245
27544926	MBs	C1258018
27544926	FUS	C1517281
27544926	triggered	C1444748
27544926	gene delivery	C0872177
27544926	therapy	C0087111
27550416	Modulation	C0443264
27550416	IL-6	C0021760
27550416	induced	C0205263
27550416	RANKL	C0666364
27550416	expression	C1171362
27550416	arthritic	C0003864
27550416	synovium	C0039099
27550416	transcription factor SOX5	C2350546
27550416	Receptor activator of nuclear factor κB ligand	C0666364
27550416	RANKL	C0666364
27550416	critically	C1511545
27550416	bone erosion	C0587240
27550416	rheumatoid arthritis	C0003873
27550416	RA	C0003873
27550416	previously	C0205156
27550416	younger age	C0001779
27550416	RA	C0003873
27550416	RANKL	C0666364
27550416	SNP	C0752046
27550416	elevated	C3163633
27550416	binding	C1145667
27550416	transcription factor SOX5	C2350546
27550416	study	C2603343
27550416	regulation	C1157519
27550416	SOX5	C2350546
27550416	RANKL	C0666364
27550416	expression	C1171362
27550416	RA	C0003873
27550416	synovial	C0039099
27550416	fibroblasts	C0016030
27550416	SF	C0016030
27550416	development	C1527148
27550416	bone erosion	C0587240
27550416	collagen-induced arthritis	C0971858
27550416	CIA	C0971858
27550416	mouse	C0026809
27550416	data	C0150098
27550416	indicated	C1444656
27550416	SOX5	C2350546
27550416	synovium	C0039099
27550416	synovial fluid	C0039097
27550416	RA	C0003873
27550416	compared	C1707455
27550416	osteoarthritis	C0029408
27550416	patients	C0030705
27550416	Pro-inflammatory	C0333348
27550416	cytokines	C0079189
27550416	upregulated	C0041904
27550416	SOX5	C2350546
27550416	RANKL	C0666364
27550416	expression	C1171362
27550416	RA	C0003873
27550416	SF	C0016030
27550416	fibroblast cell line	C0682524
27550416	MH7A	C0007634
27550416	Overexpression	C1514559
27550416	SOX5	C2350546
27550416	resulted	C1274040
27550416	significantly increased	C0205217
27550416	RANKL	C0666364
27550416	knockdown	C2350567
27550416	SOX5	C1420328
27550416	resulted	C1274040
27550416	diminished	C0205216
27550416	IL-6	C0021760
27550416	RANKL	C0666364
27550416	upregulation	C0041904
27550416	MH7A cells	C0007634
27550416	Chromatin immunoprecipitation	C1328856
27550416	ChIP	C1328856
27550416	approximately	C0332232
27550416	RANKL-specific DNA	C0012854
27550416	anti-SOX5 immunoprecipitate	C0301871
27550416	IL-6	C0021760
27550416	treated	C1522326
27550416	MH7A cells	C0007634
27550416	compared	C1707455
27550416	untreated cells	C0243095
27550416	silencing	C0598496
27550416	SOX5 gene	C1420328
27550416	significantly diminished	C0205216
27550416	RANKL	C0666364
27550416	positive	C1514241
27550416	cells	C0007634
27550416	bone erosion	C0587240
27550416	CIA	C0971858
27550416	mice	C0026809
27550416	findings	C0243095
27550416	suggest	C1705535
27550416	SOX5	C2350546
27550416	regulator	C1704735
27550416	IL-6	C0021760
27550416	induced	C0205263
27550416	RANKL	C0666364
27550416	expression	C1171362
27550416	RA	C0003873
27550416	SF	C0016030
27553051	Intracameral	C1636767
27553051	cefuroxime	C0007562
27553051	prevention	C0679698
27553051	postoperative endophthalmitis	C1282227
27553051	experience	C0596545
27553051	Hong Kong	C0019907
27553051	study	C2603343
27553051	effect	C1280500
27553051	introducing	C0579004
27553051	intracameral	C1636767
27553051	cefuroxime	C0007562
27553051	compounded	C0013164
27553051	hospital pharmacy	C0260123
27553051	postoperative endophthalmitis	C1282227
27553051	tertiary eye centre	C0596660
27553051	Hong Kong	C0019907
27553051	cataract surgeries	C2939459
27553051	routine	C0205547
27553051	use	C0457083
27553051	intracameral	C1636767
27553051	cefuroxime	C0007562
27553051	cataract surgery	C2939459
27553051	cefuroxime	C0007562
27553051	aliquots	C1510844
27553051	hospital pharmacy	C0260123
27553051	aseptic	C0232920
27553051	aseptic compounding	C0013164
27553051	rates	C1521828
27553051	postoperative endophthalmitis	C1282227
27553051	Group	C0681860
27553051	no	C0332197
27553051	intracameral	C1636767
27553051	cefuroxime	C0007562
27553051	Group	C0681860
27553051	intracameral	C1636767
27553051	cefuroxime	C0007562
27553051	eyes	C0015392
27553051	Group	C0681860
27553051	Group	C0681860
27553051	postoperative endophthalmitis	C1282227
27553051	Group	C0681860
27553051	endophthalmitis	C0014236
27553051	Group	C0681860
27553051	rate	C1521828
27553051	reduction	C0392756
27553051	statistically significant	C0237881
27553051	endophthalmitis	C0014236
27553051	positive culture	C0159125
27553051	Organisms	C0029235
27553051	Group G Streptococcus	C0318162
27553051	Group B Streptococcus	C0038402
27553051	Staphylococcus aureus	C0038172
27553051	Serratia marcescens	C0036766
27553051	coagulase-negative Staphylococcus	C0445625
27553051	Antibiotic susceptibility	C0427965
27553051	testing results	C0456984
27553051	organisms	C0029235
27553051	susceptible	C0231204
27553051	penicillin group	C0030842
27553051	No adverse events	C2699517
27553051	use	C0457083
27553051	intracameral	C1636767
27553051	cefuroxime	C0007562
27553051	use	C0457083
27553051	intracameral	C1636767
27553051	cefuroxime	C0007562
27553051	reduce	C0547047
27553051	rate	C1521828
27553051	postoperative endophthalmitis	C1282227
27553051	tertiary centre	C0596660
27553051	Hong Kong	C0019907
27553051	use	C0457083
27553051	aseptic	C0232920
27553051	aseptic compounding	C0013164
27553051	cefuroxime	C0007562
27553051	aliquots	C1510844
27553051	hospital pharmacy	C0260123
27554917	assessment	C1261322
27554917	treatment	C0087111
27554917	internationally	C1512888
27554917	adopted children	C0337541
27554917	anorectal malformation	C3495676
27554917	ARM	C3495676
27554917	internationally	C1512888
27554917	adopted children	C0337541
27554917	congenital birth defects	C0000768
27554917	colorectal	C0555952
27554917	diagnoses	C0430022
27554917	children	C0008059
27554917	anorectal malformation	C3495676
27554917	ARM	C3495676
27554917	reoperation	C0035110
27554917	Knowledge	C0518904
27554917	complications	C0009566
27554917	ARM	C3495676
27554917	surgery	C0543467
27554917	treatment	C0087111
27554917	algorithms	C0002045
27554917	patients	C0030705
27554917	past medical	C0455458
27554917	surgical history	C0744961
27554917	adopted	C0425382
27554917	population	C1257890
27554917	investigations	C1261322
27554917	indications	C3146298
27554917	rate	C1521828
27554917	reoperation	C0035110
27554917	adopted children	C0337541
27554917	ARM	C3495676
27554917	patients	C0030705
27554917	males	C0086582
27554917	reoperative surgery	C0035110
27554917	anus	C0003461
27554917	outside	C0205101
27554917	sphincter	C1409894
27554917	males	C0086582
27554917	females	C0086287
27554917	Anal stricture	C0266229
27554917	rectal prolapse	C0034888
27554917	retained	C0333118
27554917	vaginal septum	C0431649
27554917	strictured	C1261287
27554917	vaginal introitus	C0458952
27554917	reoperative surgery	C0035110
27554917	rate	C1521828
27554917	internationally	C1512888
27554917	adopted child	C0337541
27554917	ARM	C3495676
27554917	children	C0008059
27554917	complications	C0009566
27554917	repair	C1705181
27554917	surgical care	C0520254
27554917	children	C0008059
27558793	fluorescent	C0016315
27558793	gold	C0018026
27558793	nanoclusters	C1721060
27558793	food proteins	C0012177
27558793	detection	C1511790
27558793	food	C0016452
27558793	contaminants	C2827365
27558793	bioactive nutrients	C3714412
27558793	nanotechnology	C0872323
27558793	food	C0016452
27558793	Ultra-small gold nanoclusters	C1721060
27558793	Au NCs	C1721060
27558793	nanomaterials	C1450053
27558793	Au NCs	C1721060
27558793	food proteins	C0012177
27558793	environmentally friendly preparation	C2350565
27558793	fluorescence	C0016315
27558793	photo-stability	C0205556
27558793	biocompatibility	C0596177
27558793	protein-Au hybrids	C1721059
27558793	nano-bio-food interface	C1708333
27558793	single metal atoms	C0567415
27558793	plasmonic	C2603343
27558793	metal nanoparticles	C1721060
27558793	hybrid system	C1881073
27558793	biomacromolecule	C1179809
27558793	inorganic	C1881215
27558793	ions	C0022023
27558793	synthesis	C1883254
27558793	optical properties	C0871161
27558793	Au NCs	C1721060
27558793	food proteins	C0012177
27558793	detection	C1511790
27558793	food	C0016452
27558793	contaminants	C2827365
27558793	bioactive nutrients	C3714412
27558793	food proteins	C0012177
27558793	gold nanoclusters	C1721060
27558793	synthesis	C1883254
27562025	Sub-lethal effects	C3151529
27562025	dietary	C0012155
27562025	neonicotinoid insecticide	C1997222
27562025	exposure	C0332157
27562025	honey bee queen	C0323351
27562025	fecundity	C0015895
27562025	colony	C1947989
27562025	development	C0243107
27562025	factors	C1521761
27562025	negatively	C0205160
27562025	honey bee	C0323351
27562025	Apis mellifera L.	C0323351
27562025	health	C0018684
27562025	pervasive	C0205391
27562025	systemic	C0205373
27562025	neonicotinoid insecticides	C1997222
27562025	consumption	C1947907
27562025	contaminated	C0205279
27562025	nectar	C2717960
27562025	pollen	C0032385
27562025	treated	C1522326
27562025	plants	C0032098
27562025	neonicotinoids	C1997222
27562025	foraging	C2752984
27562025	learning	C0023185
27562025	memory	C0025260
27562025	worker bees	C0004923
27562025	neonicotinoids	C1997222
27562025	queen bees	C0004923
27562025	trophallaxis	C0237876
27562025	food	C0016452
27562025	sharing	C0237876
27562025	assess	C0184514
27562025	queen	C0004923
27562025	productivity	C0033269
27562025	small	C0700321
27562025	colonies	C1947989
27562025	sizes	C0456389
27562025	bees	C0004923
27562025	fed	C2987508
27562025	imidacloprid	C0218499
27562025	syrup	C0458173
27562025	weeks	C0439230
27562025	adverse effects	C0879626
27562025	imidacloprid	C0218499
27562025	queens	C0004923
27562025	egg-laying	C1622979
27562025	locomotor activity	C0023946
27562025	worker bees	C0004923
27562025	foraging	C2752984
27562025	hygienic	C0020405
27562025	activities	C0441655
27562025	colony	C1947989
27562025	development	C0678723
27562025	brood	C0004923
27562025	pollen	C0032385
27562025	treated	C1522326
27562025	colonies	C1947989
27562025	less	C0547044
27562025	colony	C1947989
27562025	size	C0456389
27562025	increased	C0205217
27562025	larger	C1704243
27562025	colony	C1947989
27562025	populations	C1257890
27562025	pesticide exposure	C2220281
27562025	study	C2603343
27562025	adverse effects	C0879626
27562025	imidacloprid	C0218499
27562025	queen bee	C0004923
27562025	fecundity	C0015895
27562025	behavior	C0004927
27562025	improves	C1272747
27562025	understanding	C0162340
27562025	neonicotinoids	C1997222
27562025	impair	C0221099
27562025	colony	C1947989
27562025	functioning	C0205245
27562025	data	C1511726
27562025	risk-mitigation efforts	C4296788
27562025	reducing	C0392756
27562025	neonicotinoid	C1997222
27562025	exposure	C0332157
27562025	early spring	C0241232
27562025	colonies	C1947989
27562025	smallest	C0700321
27562025	queens	C0004923
27562025	vulnerable	C0231204
27562025	exposure	C0332157
27562951	Therapeutic applications	C0039798
27562951	CRISPR	C3658200
27562951	RNA-guided	C0082774
27562951	genome editing	C4279981
27562951	programmable nuclease	C0597094
27562951	genome editing	C4279981
27562951	technologies	C0039421
27562951	targeted	C1521840
27562951	gene	C0017337
27562951	disruption	C0332453
27562951	correction	C1720855
27562951	in vitro	C1533691
27562951	in vivo	C1515655
27562951	genome editing	C4279981
27562951	target	C1521840
27562951	genomic sites	C1880951
27562951	gene function	C0314627
27562951	animals	C0003062
27562951	plants	C0032098
27562951	programmable nucleases	C0597094
27562951	type II clustered regularly interspaced short palindromic repeats	C3658200
27562951	CRISPR	C3658200
27562951	CRISPR-associated nuclease 9 (Cas9) system	C3658355
27562951	research	C0035168
27562951	medicine	C0025118
27562951	biotechnology	C0005574
27562951	CRISPR-Cas9	C3658355
27562951	gene editing	C4279981
27562951	therapeutic purposes	C0039798
27562951	patient	C0030705
27562951	stem cells	C0038250
27562951	animal models	C0599779
27562951	therapeutic approaches	C0039798
27562951	delivery methods	C0565867
27562951	biomedical	C1879848
27562951	applications	C0039798
27562951	therapeutic applications	C0039798
27562951	CRISPR-Cas9 system	C3658355
27563235	Design	C1707689
27563235	characteristics	C1521970
27563235	cytotoxic	C1511636
27563235	fibroblast growth factor 1	C0079349
27563235	conjugate	C1254351
27563235	fibroblast growth factor receptor	C0060369
27563235	targeted cancer therapy	C3854476
27563235	Fibroblast growth factor receptors	C0060369
27563235	FGFRs	C0060369
27563235	cancer therapy	C0920425
27563235	targets	C1521840
27563235	overexpressed	C1514559
27563235	multiple	C0439064
27563235	tumors	C0027651
27563235	breast	C1458155
27563235	prostate	C0033578
27563235	bladder	C0005695
27563235	lung cancer	C0242379
27563235	natural ligand	C1749457
27563235	FGFR	C0060369
27563235	engineered variant	C0034861
27563235	fibroblast growth factor 1	C0079349
27563235	FGF1V	C0079349
27563235	conjugated	C0522529
27563235	potent cytotoxic drug	C0304497
27563235	monomethyl auristatin E	C1565020
27563235	MMAE	C1565020
27563235	targeting agent	C0599894
27563235	cancer cells	C0334227
27563235	overexpressing	C1514559
27563235	FGFRs	C0060369
27563235	antibodies	C0003241
27563235	antibody-drug conjugates	C2346828
27563235	FGF1V-valine-citrulline-MMAE conjugate	C1254351
27563235	stability profile	C1327386
27563235	bound	C1167622
27563235	FGFRs	C0060369
27563235	cell surface	C0699040
27563235	specifically	C0205369
27563235	efficiently	C0442799
27563235	released	C1283071
27563235	drug (MMAE)	C1565020
27563235	cleavage	C0597304
27563235	lysosomal protease cathepsin B	C0699919
27563235	conjugate	C1254351
27563235	prominent	C0205402
27563235	cytotoxic effect	C0596402
27563235	cell lines	C0334227
27563235	expressing	C0597360
27563235	FGFR	C0060369
27563235	FGF1V-vcMMAE	C1254351
27563235	cytotoxic	C1511636
27563235	concentrations	C1446561
27563235	lower	C2003888
27563235	MMAE	C1565020
27563235	FGFR	C0060369
27563235	cells	C0334227
27563235	lacking	C0332268
27563235	FGFR	C0060369
27563235	did not show	C1513916
27563235	increased	C0205217
27563235	mortality	C0007587
27565311	morphology	C0332437
27565311	surface hydroxyl	C0700307
27565311	toxicity	C0600688
27565311	BiOCl	C0053787
27565311	human	C0086418
27565311	HaCaT cells	C0022567
27565311	bismuth oxychloride	C0053787
27565311	nanomaterials	C1881976
27565311	BiOCls	C0053787
27565311	pollutant	C0599786
27565311	removal	C1883720
27565311	Residues	C0599786
27565311	environmental remediations	C3853059
27565311	hazardous materials	C0018626
27565311	human	C0086418
27565311	health risks	C0086930
27565311	BiOCls	C0053787
27565311	study	C2603343
27565311	physicochemical properties	C0871161
27565311	cytotoxicity	C0596402
27565311	BiOCls	C0053787
27565311	human	C0086418
27565311	skin	C1123023
27565311	cell line	C0007634
27565311	HaCaT	C0022567
27565311	morphology	C0332437
27565311	surface hydroxyl	C0700307
27565311	toxicity	C0600688
27565311	BiOCls	C0053787
27565311	Microsphere-shaped	C0332479
27565311	BiOCl	C0053787
27565311	toxicity	C0600688
27565311	nanosheet-shaped	C0332479
27565311	BiOCl	C0053787
27565311	weaker particle-membrane interactions	C0007613
27565311	surface hydroxyl	C0700307
27565311	microsphere-shaped	C0332479
27565311	BiOCl	C0053787
27565311	toxicity	C0600688
27565311	interaction	C0007613
27565311	cell membrane	C0007603
27565311	microsphere-shaped	C0332479
27565311	BiOCl	C0053787
27565311	surface hydroxyl	C0700307
27565311	nanosheet-shaped	C0332479
27565311	BiOCl	C0053787
27565311	cell membrane	C0007603
27565311	damage	C0599732
27565311	PI	C0033470
27565311	PI uptake	C0005507
27565311	LDH	C0022917
27565311	LDH release	C0005507
27565311	mechanism	C0007613
27565311	"chemical" mechanism	C1623221
27565311	oxidative stress paradigm	C0681797
27565311	ROS	C0162772
27565311	GSH	C0017817
27565311	physical	C0205485
27565311	damage	C0599732
27565311	cell membrane	C0007603
27565311	physical	C1623221
27565311	"chemical" response	C1623221
27565311	cell death	C0007587
27565311	experiments	C0681814
27565311	MMP	C1720920
27565311	cell cycle arrest	C1155873
27565311	apoptosis	C0162638
27565311	necrosis	C0027540
27565311	toxicological aspects	C0040539
27565311	BiOCls	C0053787
27565311	Data	C1511726
27565311	rational design	C1707689
27565311	BiOCls	C0053787
27565311	unintended consequences	C0205556
27565311	application potentials	C3245505
27566296	Reduced	C0392756
27566296	haemodynamic coupling	C4042905
27566296	exercise	C0015259
27566296	associated with	C0332281
27566296	vascular stiffening	C3178781
27566296	pulmonary arterial hypertension	C2973725
27566296	Inadequate	C0205412
27566296	right ventricular	C0225883
27566296	RV	C0225883
27566296	pulmonary arterial	C0034052
27566296	PA	C0034052
27566296	functional	C0205245
27566296	responses	C0205245
27566296	exercise	C0015259
27566296	pulmonary arterial hypertension	C2973725
27566296	PAH	C2973725
27566296	study	C2603343
27566296	invasive	C0683468
27566296	catheterisation	C0007430
27566296	echocardiography	C0013516
27566296	assess	C1516048
27566296	RV	C0225883
27566296	RV function	C0080311
27566296	ventricular	C0018827
27566296	vascular	C0005847
27566296	coupling	C1254358
27566296	subjects	C0080105
27566296	PAH	C2973725
27566296	subjects	C0080105
27566296	PAH	C2973725
27566296	right heart	C0225808
27566296	catheterisation	C0007430
27566296	Doppler echocardiography	C0013520
27566296	rest	C0035253
27566296	incremental	C1705117
27566296	exercise	C0015259
27566296	cardiac MRI	C0412692
27566296	rest	C0035253
27566296	Measurements	C0242485
27566296	rest	C0035253
27566296	haemodynamics	C0019010
27566296	RV function	C0080311
27566296	coupling efficiency	C0013682
27566296	η	C0013682
27566296	Measurements	C0242485
27566296	incremental	C1705117
27566296	exercise	C0015259
27566296	pulmonary vascular resistance	C0456261
27566296	Z0	C0456261
27566296	characteristic impedance	C0007185
27566296	ZC	C0007185
27566296	measure	C0242485
27566296	proximal	C0205107
27566296	PA	C0034052
27566296	stiffness	C0599949
27566296	proximal	C0205107
27566296	distal	C0205108
27566296	patients	C0030705
27566296	PAH	C2973725
27566296	proximal	C0205107
27566296	PAs	C0034052
27566296	significantly	C0750502
27566296	stiffer	C0205400
27566296	maximum	C0806909
27566296	exercise	C0015259
27566296	ZC	C0007185
27566296	rest	C0035253
27566296	decreased	C0205216
27566296	rest	C0035253
27566296	Z0	C0456261
27566296	exercise	C0015259
27566296	resistance-compliance (RC) time	C0392762
27566296	decreased	C0205216
27566296	exercise	C0015259
27566296	rest	C0035253
27566296	patients	C0030705
27566296	resting	C0035253
27566296	coupling efficiency	C0013682
27566296	η	C0013682
27566296	stiffer	C0205400
27566296	proximal	C0205107
27566296	PAs	C0034052
27566296	rest	C0035253
27566296	maximum	C0806909
27566296	exercise	C0015259
27566296	level	C0441889
27566296	reduction	C0392756
27566296	maximum	C0806909
27566296	exercise	C0015259
27566296	PAH	C2973725
27566296	exercise	C0015259
27566296	proximal	C0205107
27566296	distal	C0205108
27566296	PA	C0034052
27566296	stiffening	C0599949
27566296	Z0	C0456261
27566296	decreased	C0205216
27566296	RC time	C0392762
27566296	exercise	C0015259
27566296	Stiff PAs	C0034052
27566296	rest	C0035253
27566296	haemodynamic coupling	C4042905
27566296	reduced	C0392756
27566296	pulmonary vascular	C0459963
27566296	contributes	C1880177
27566296	maximum	C0806909
27566296	exercise	C0015259
27566296	level	C0441889
27566564	Altered pH gradient	C1138565
27566564	plasma membrane	C0007603
27566564	osteosarcoma	C0029463
27566564	cells	C0007634
27566564	mechanism	C0441712
27566564	drug resistance	C0013203
27566564	therapy	C0087111
27566564	osteosarcoma	C0029463
27566564	OS	C0029463
27566564	primary bone malignancy	C4282132
27566564	combination of surgery and chemotherapy	C0920442
27566564	Multidrug resistance	C0242640
27566564	P-glycoprotein	C0242643
27566564	P-gp	C0242643
27566564	overexpression	C1514559
27566564	treatment failure	C0162643
27566564	progression	C0242656
27566564	OS	C0029463
27566564	mechanisms	C0441712
27566564	acidic extracellular pH	C0020283
27566564	pHe	C0020283
27566564	sarcomas	C1261473
27566564	doxorubicin	C0013089
27566564	DXR	C0013089
27566564	cytotoxicity	C0596402
27566564	reduced	C0392756
27566564	P-gp	C0376623
27566564	OS	C0029463
27566564	cells cultured	C0007635
27566564	pHe	C0020283
27566564	Short-time	C0443303
27566564	exposure to	C0332157
27566564	pHe	C0020283
27566564	significantly increased	C1707919
27566564	acidity	C0368606
27566564	lysosomes	C0024369
27566564	combination	C0205195
27566564	DXR	C0013089
27566564	omeprazole	C0028978
27566564	proton pump inhibitor	C0358591
27566564	lysosomal acidity	C1156062
27566564	significantly enhanced	C1707919
27566564	DXR	C0013089
27566564	cytotoxicity	C0596402
27566564	OS	C0029463
27566564	xenografts	C0522537
27566564	combination treatment	C0013218
27566564	DXR	C0013089
27566564	omeprazole	C0028978
27566564	significantly reduced	C3890174
27566564	tumor volume	C0475276
27566564	body weight loss	C1262477
27566564	impaired toxicity	C0013221
27566564	DXR	C0013089
27566564	pHe	C0020283
27566564	increased	C0205217
27566564	autophagy	C0004391
27566564	lysosomal acidification	C1156062
27566564	SNARF	C0084578
27566564	staining	C0487602
27566564	reversal	C0443290
27566564	pH gradient	C1138565
27566564	plasma membrane	C0007603
27566564	ΔpHcm	C1138565
27566564	reduced	C0392756
27566564	DXR	C0013089
27566564	intracellular	C0178719
27566564	accumulation	C4055506
27566564	reversal	C0443290
27566564	ΔpHcm	C1138565
27566564	OS	C0029463
27566564	cells	C0007634
27566564	resistance	C4281815
27566564	DXR	C0013089
27566564	cisplatin	C0008838
27566564	methotrexate	C0025677
27566564	vincristine	C0042679
27566564	OS	C0029463
27566564	cells	C0007634
27566564	short-term	C0443303
27566564	acidosis	C0001122
27566564	resistance	C4281815
27566564	chemotherapeutic drugs	C0003392
27566564	reversal	C0443290
27566564	ΔpHcm	C1138565
27566564	buffer	C0006353
27566564	therapies	C0087111
27566564	regimens	C2945654
27566564	proton pump inhibitors	C0358591
27566564	combination	C0205195
27566564	concentrations	C1446561
27566564	anticancer agents	C0003392
27566564	novel	C0205314
27566564	overcome	C2983310
27566564	drug resistance	C0013203
27566854	Boston Keratoprosthesis Type 1	C1261333
27566854	Randomized Controlled Trial	C0206035
27566854	Fresh	C0443224
27566854	Frozen	C1548793
27566854	Corneal Donor Carriers	C0030705
27566854	Long-Term	C0443252
27566854	Follow-up	C1522577
27566854	compare	C1707455
27566854	long-term	C0443252
27566854	clinical outcomes	C1274040
27566854	fresh	C0443224
27566854	frozen	C1548793
27566854	corneal graft carriers	C0030705
27566854	Boston Keratoprosthesis type 1	C1261333
27566854	B-KPro	C1261333
27566854	nonblinded	C2986424
27566854	randomized controlled trial.	C0206035
27566854	participants	C0679646
27566854	initial	C0205265
27566854	study protocol	C2348563
27566854	months	C0439231
27566854	extension	C0231448
27566854	phase	C0205390
27566854	follow-up visits	C0589121
27566854	months	C0439231
27566854	patients	C0030705
27566854	B-KPro surgery	C0176217
27566854	experienced surgeon	C0582175
27566854	Hospitalier de l'Université de Montréal	C0020028
27566854	allograft carrier	C0348047
27566854	Patients	C0030705
27566854	excluded	C2828389
27566854	previously	C0205156
27566854	B-KPro	C1261333
27566854	implantation	C0021107
27566854	Participants	C0679646
27566854	randomized	C3815594
27566854	receive	C1514756
27566854	B-KPro	C1261333
27566854	frozen	C1548793
27566854	fresh	C0443224
27566854	corneal graft carrier	C0348047
27566854	tissue	C0040300
27566854	availability	C0470187
27566854	day	C0439228
27566854	surgery	C0543467
27566854	eye bank	C0015394
27566854	outcome measure	C0086749
27566854	device retention	C0243095
27566854	months	C0439231
27566854	surgical feasibility	C0243095
27566854	visual acuity	C0042812
27566854	VA	C0042812
27566854	complications	C0009566
27566854	eyes	C0015392
27566854	patients	C0030705
27566854	initial	C0205265
27566854	study protocol	C2348563
27566854	eyes	C0015392
27566854	randomized	C0034656
27566854	fresh	C0443224
27566854	frozen	C1548793
27566854	carrier grafts	C0348047
27566854	eyes	C0015392
27566854	months	C0439231
27566854	follow-up	C1522577
27566854	extension	C0231448
27566854	eyes	C0015392
27566854	frozen	C1548793
27566854	eyes	C0015392
27566854	fresh	C0443224
27566854	carrier graft	C0348047
27566854	no differences	C3842396
27566854	baseline	C1442488
27566854	characteristics	C1521970
27566854	patients	C0030705
27566854	extension	C0231448
27566854	phase	C0205390
27566854	months	C0439231
27566854	VA	C0042812
27566854	fresh group	C0441833
27566854	improved	C0184511
27566854	baseline	C1442488
27566854	frozen group	C0441833
27566854	improved	C0184511
27566854	baseline	C1442488
27566854	Device retention	C0243095
27566854	months	C0439231
27566854	months	C0439231
27566854	differences	C1705242
27566854	rate	C1521828
27566854	complications	C0009566
27566854	groups	C0441833
27566854	Fresh	C0443224
27566854	frozen	C1548793
27566854	corneal donors	C0524358
27566854	clinical outcomes	C1274040
27566854	carriers	C0348047
27566854	B-KPro	C1261333
27566854	differences	C1705242
27566854	device retention	C0243095
27566854	visual rehabilitation	C0243095
27566854	rates	C1521828
27566854	complications	C0009566
27566854	months	C0439231
27567148	Impact	C4049986
27567148	Educational Intervention	C0281163
27567148	Improve	C0184511
27567148	Antibiotic	C0003232
27567148	Prescribing	C2239117
27567148	Nurse Practitioners	C0028657
27567148	Pediatric	C0008059
27567148	Urgent Care Center	C1710587
27567148	pediatric visits	C1444717
27567148	antibiotic	C0003232
27567148	prescription	C0033080
27567148	educational sessions	C1276369
27567148	reduce	C0392756
27567148	inappropriate	C1548788
27567148	antibiotic	C0003232
27567148	use	C0457083
27567148	Intervention study	C1096775
27567148	evaluating	C0220825
27567148	antibiotic	C0003232
27567148	prescribing	C2239117
27567148	educational sessions	C1276369
27567148	urinary tract infection	C0042029
27567148	skin	C0037278
27567148	soft tissue infection	C0149778
27567148	pharyngitis	C0031350
27567148	upper respiratory tract infection	C0041912
27567148	acute otitis media	C0271429
27567148	acute bacterial sinusitis	C0275556
27567148	nurse practitioners	C0028657
27567148	urgent care centers	C1710587
27567148	enrolled	C1516879
27567148	study	C2603343
27567148	rate	C1521828
27567148	inappropriate	C1548788
27567148	antibiotic	C0003232
27567148	use	C0457083
27567148	intervention	C0184661
27567148	decrease	C0547047
27567148	inappropriate	C1548788
27567148	antibiotic	C0003232
27567148	prescribing	C2239117
27567148	educational session	C1276369
27567148	inappropriate	C1548788
27567148	antibiotic	C0003232
27567148	prescribing	C2239117
27567148	wrong dosage	C3845820
27567148	not indicated	C1444655
27567148	Educational sessions	C1276369
27567148	improvement	C2986411
27567148	inappropriate	C1548788
27567148	antibiotic	C0003232
27567148	use	C0457083
27567148	stewardship	C1554086
27567148	interventions	C0184661
27567148	reduce	C0392756
27567148	antibiotic	C0003232
27567148	use	C0457083
27568284	Zika Virus	C0318793
27568284	Disrupts	C0332454
27568284	Phospho-TBK1	C1449326
27568284	Localization	C1159772
27568284	Mitosis	C0026255
27568284	Human	C0086418
27568284	Neuroepithelial	C1518280
27568284	Stem Cells	C0038250
27568284	Radial Glia	C3661481
27568284	mechanisms	C0441712
27568284	Zika virus	C0318793
27568284	ZIKV	C0318793
27568284	microcephaly	C0025958
27568284	neurodevelopment	C0599855
27568284	defects	C1457869
27568284	poorly	C0205169
27568284	understood	C0162340
27568284	derivation	C1441547
27568284	characterization	C1880022
27568284	single-cell RNA-seq	C0162327
27568284	neocortical	C0175173
27568284	spinal cord	C0037925
27568284	neuroepithelial	C1518280
27568284	stem (NES) cells	C0038250
27568284	early	C1279919
27568284	human	C0086418
27568284	neurodevelopment	C0599855
27568284	ZIKV	C0318793
27568284	neuropathogenesis	C1518296
27568284	human	C0086418
27568284	NES cells	C0038250
27568284	organotypic	C0205556
27568284	fetal	C0015965
27568284	brain	C0006104
27568284	slices	C1519355
27568284	ZIKV	C0318793
27568284	infected	C0439663
27568284	micrencephalic	C0025958
27568284	brain	C0006104
27568284	ZIKV	C0318793
27568284	infects	C0439663
27568284	neocortical	C0175173
27568284	spinal	C0037925
27568284	NES cells	C0038250
27568284	fetal	C0015965
27568284	radial glial cells	C3661481
27568284	RGCs	C3661481
27568284	disrupted	C0332454
27568284	mitoses	C0026255
27568284	supernumerary	C1883702
27568284	centrosomes	C0242608
27568284	structural	C0678594
27568284	disorganization	C4061689
27568284	cell death	C0007587
27568284	ZIKV infection	C0276289
27568284	NES cells	C0038250
27568284	RGCs	C3661481
27568284	centrosomal	C0242608
27568284	depletion	C0333668
27568284	mitochondrial	C0026237
27568284	sequestration	C0443301
27568284	phospho-TBK1	C1449326
27568284	mitosis	C0026255
27568284	nucleoside analogs	C1579410
27568284	inhibit	C3463820
27568284	ZIKV	C0318793
27568284	replication	C0042774
27568284	NES cells	C0038250
27568284	ZIKV	C0318793
27568284	induced	C0205263
27568284	pTBK1	C1449326
27568284	relocalization	C0007613
27568284	cell death	C0007587
27568284	established	C0443211
27568284	model system	C3161035
27568284	human	C0086418
27568284	neural stem cells	C1113654
27568284	cellular	C0007634
27568284	molecular	C1521991
27568284	mechanisms	C0441712
27568284	neurodevelopmental	C0599855
27568284	defects	C1457869
27568284	associated with	C0332281
27568284	ZIKV infection	C0276289
27568284	potential	C3245505
27568284	treatment	C0087111
27569088	Prevalence	C0033105
27569088	HPV	C0021344
27569088	genotypes	C0017431
27569088	cervical adenocarcinoma	C0279672
27569088	study	C2603343
27569088	Greek	C0337806
27569088	women	C0043210
27569088	study	C2603343
27569088	prevalence	C0033105
27569088	human papillomavirus	C0021344
27569088	HPV	C0021344
27569088	genotypes	C0017431
27569088	cervical adenocarcinomas	C0279672
27569088	Greek	C0337806
27569088	women	C0043210
27569088	study group	C0681860
27569088	adenocarcinoma	C0001418
27569088	cases	C1706256
27569088	in situ	C0007099
27569088	invasive	C1334274
27569088	HPV DNA	C3872595
27569088	amplified	C0683230
27569088	polymerase chain reaction	C0032520
27569088	PCR	C0032520
27569088	HPV	C0021344
27569088	genotypes	C0017431
27569088	identified	C0205396
27569088	reverse hybridization	C0221902
27569088	high prevalence	C0033105
27569088	HPV infection	C0343641
27569088	in situ	C0007099
27569088	invasive (94.83%) adenocarcinomas	C1334274
27569088	cancers	C0006826
27569088	unusual morphology	C0332437
27569088	HPV 16	C0999806
27569088	commonest	C0205214
27569088	strain	C1518614
27569088	HPV 18	C0999807
27569088	cases	C1706256
27569088	HPV 52 positive	C3641016
27569088	co-infection	C0275524
27569088	HPV 16	C0999806
27569088	18	C0999807
27569088	strains	C1518614
27569088	exception	C1705847
27569088	HPV 66	C3641020
27569088	co-infections	C0275524
27569088	age difference	C0699810
27569088	HPV	C0021344
27569088	strain	C1518614
27569088	positivity	C1446409
27569088	HPV DNA	C3872595
27569088	large majority	C0680220
27569088	cervical adenocarcinomas	C0279672
27569088	studies	C0008972
27569088	HPV 52	C3641016
27569088	commonly	C0205214
27569088	encountered	C0422301
27569088	strain	C1518614
27569088	HPV 16	C0999806
27569088	HPV 18	C0999807
27569088	help	C1269765
27569088	decision making	C0011109
27569088	vaccination	C0042196
27569088	policy	C0242456
27569088	prevention	C2700409
27569088	HPV infection	C0343641
27569088	Greece	C0018226
27570111	Glucose metabolism	C0596620
27570111	weighted imaging	C0011923
27570111	chemical exchange-sensitive MRI	C0024485
27570111	2-deoxyglucose	C4049845
27570111	2DG	C4049845
27570111	brain	C0006104
27570111	Sensitivity	C1511883
27570111	biological	C0205460
27570111	sources	C0449416
27570111	Recent proof-of-principle studies	C2603343
27570111	uptake	C0243144
27570111	metabolism	C0025519
27570111	2-deoxy-D-glucose	C4049845
27570111	2DG	C4049845
27570111	chemical exchange-sensitive spin-lock (CESL) MRI approach	C0024485
27570111	dynamic	C0729333
27570111	in vivo	C1515655
27570111	CESL MRI	C0024485
27570111	healthy	C3898900
27570111	rat	C0086893
27570111	brains	C0006104
27570111	intravenous injection	C0021494
27570111	2DG	C4049845
27570111	2DG	C4049845
27570111	doses	C0178602
27570111	2DG	C4049845
27570111	CESL	C0024485
27570111	signals	C1710082
27570111	increased	C0205217
27570111	injection	C1533685
27570111	dose	C0178602
27570111	2DG	C4049845
27570111	transport	C0005528
27570111	metabolism	C0025519
27570111	2DG	C4049845
27570111	CESL	C0024485
27570111	2DG	C4049845
27570111	higher	C0205250
27570111	isoflurane	C0022180
27570111	level	C0441889
27570111	reduces	C0392756
27570111	glucose metabolism	C0596620
27570111	increases	C0442805
27570111	blood flow	C0232338
27570111	2DG	C4049845
27570111	CESL	C0024485
27570111	measured	C0444706
27570111	isoflurane	C0022180
27570111	2DG	C4049845
27570111	CESL	C0024485
27570111	signal	C1710082
27570111	reduced	C0392756
27570111	higher	C0205250
27570111	isoflurane	C0022180
27570111	2DG	C4049845
27570111	phosphorylation	C0031715
27570111	intracellular space	C0682581
27570111	regional heterogeneities	C0086833
27570111	glucose metabolism	C0596620
27570111	2DG	C4049845
27570111	CESL	C0024485
27570111	higher	C0205250
27570111	cortex	C0007776
27570111	corpus callosum	C0010090
27570111	CESL MRI	C0024485
27570111	injection	C1533685
27570111	non-transportable mannitol	C0024730
27570111	2DG	C4049845
27570111	CESL	C0024485
27570111	decreased	C0205216
27570111	increased	C0205217
27570111	spin-lock pulse power	C3854080
27570111	2DG	C4049845
27570111	CESL	C0024485
27570111	chemical	C0220806
27570111	exchange	C4019011
27570111	processes	C1522240
27570111	extravascular space	C1254362
27570111	2DG	C4049845
27570111	CESL MRI	C0024485
27570111	signals	C1710082
27570111	glucose transport	C0178666
27570111	metabolism	C0596620
27570111	biomarker	C0005516
27570111	metabolic	C0311400
27570111	studies	C2603343
27570111	normal	C0006104
27570111	diseased	C0012634
27570111	brains	C0006104
27570362	Parental	C0030551
27570362	perceptions	C0030971
27570362	children´s agency	C0237463
27570362	Parental warmth	C0814578
27570362	school achievement	C0700132
27570362	adjustment	C0376209
27570362	study	C2603343
27570362	Swedish	C1710263
27570362	mothers'	C0026591
27570362	fathers'	C0015671
27570362	warmth	C0814578
27570362	children	C0008059
27570362	children´s agency	C0237463
27570362	agency	C0237463
27570362	children's	C0008059
27570362	school achievement	C0700132
27570362	Swedish	C1710263
27570362	children's	C0008059
27570362	mothers	C0026591
27570362	fathers	C0015671
27570362	interviewed	C0021822
27570362	time points	C1442880
27570362	children	C0008059
27570362	years	C0439234
27570362	warmth	C0814578
27570362	children	C0008059
27570362	children's agency	C0237463
27570362	children's	C0008059
27570362	school achievement	C0700132
27570362	Parental warmth	C0814578
27570362	Time	C0040223
27570362	correlated	C1707520
27570362	child agency	C0237463
27570362	Time	C0040223
27570362	correlated	C1707520
27570362	child	C0008059
27570362	academic achievement	C0700132
27570362	Time	C0040223
27570362	girls	C0870604
27570362	boys	C0870221
27570362	study	C2603343
27570362	Swedish	C1710263
27570362	parents' warmth	C0814578
27570362	perceptions	C0030971
27570362	children's agency	C0237463
27570362	child	C0008059
27570362	problems	C0033213
27570362	academic achievement	C0700132
27570362	findings	C0243095
27570362	year	C0439234
27570362	longitudinal study	C0023981
27570362	boys	C0870221
27570362	girls	C0870604
27570362	child agency	C0237463
27570362	parental warmth	C0814578
27570362	children's	C0008059
27570362	adjustment	C0376209
27571215	Vasopressin	C0042413
27571215	regulates the growth	C0596286
27571215	biliary epithelium	C3686472
27571215	polycystic liver disease	C0158683
27571215	neurohypophysial hormone	C0032017
27571215	arginine vasopressin	C0003779
27571215	AVP	C0003779
27571215	receptor	C0597357
27571215	V1a	C0284725
27571215	V1b	C0284726
27571215	V2	C0162829
27571215	liver	C0023884
27571215	AVP	C0003779
27571215	involved	C1314939
27571215	ureogenesis	C0597619
27571215	glycogenolysis	C0596624
27571215	neoglucogenesis	C0598530
27571215	regeneration	C0034963
27571215	presence	C0150312
27571215	AVP	C0003779
27571215	biliary epithelium	C3686472
27571215	Cholangiocytes	C3686472
27571215	target cells	C0221284
27571215	animal models	C0012644
27571215	cholestasis	C0008370
27571215	bile duct	C0005400
27571215	ligation	C0023690
27571215	BDL	C0023690
27571215	human	C0086418
27571215	pathologies	C0030664
27571215	polycystic liver disease	C0158683
27571215	characterized	C1880022
27571215	presence	C0150312
27571215	cysts	C0010709
27571215	biliary epithelium	C3686472
27571215	In vivo	C1515655
27571215	liver	C0023884
27571215	fragments	C0486805
27571215	BDL	C0023690
27571215	mice	C0025929
27571215	rats	C0034721
27571215	liver samples	C0586689
27571215	ADPKD	C0085413
27571215	patients	C0030705
27571215	intrahepatic	C1512948
27571215	bile duct	C0005400
27571215	mass	C0577559
27571215	immunohistochemistry	C0021044
27571215	cytokeratin-19	C0010803
27571215	expression	C0597360
27571215	V1a	C0284725
27571215	V1b	C0284726
27571215	V2	C0162829
27571215	immunohistochemistry	C0021044
27571215	immunofluorescence	C0079603
27571215	real-time PCR	C1709846
27571215	In vitro	C1533691
27571215	mouse	C0025929
27571215	cholangiocytes	C3686472
27571215	H69	C0007634
27571215	non-malignant	C1518371
27571215	human	C0086418
27571215	cholangiocytes	C3686472
27571215	LCDE	C0007634
27571215	human	C0086418
27571215	cholangiocytes	C3686472
27571215	cystic epithelium	C0259770
27571215	stimulated	C0038337
27571215	vasopressin	C0042413
27571215	presence	C0150312
27571215	AVP antagonists	C1719946
27571215	OPC-31260	C0171458
27571215	Tolvaptan	C1176308
27571215	cellular growth	C0007595
27571215	MTT assay	C0201596
27571215	cAMP	C0001455
27571215	Cholangiocytes	C3686472
27571215	V2 receptor	C0162829
27571215	upregulated	C0041904
27571215	BDL	C0023690
27571215	ADPKD	C0085413
27571215	liver samples	C0586689
27571215	Administration	C1533734
27571215	AVP	C0003779
27571215	increased	C0205217
27571215	proliferation	C0596290
27571215	cAMP	C0001455
27571215	cholangiocytes	C3686472
27571215	LCDE cells	C0007634
27571215	no effect	C1301751
27571215	proliferation	C0596290
27571215	mouse	C0025929
27571215	cholangiocytes	C3686472
27571215	H69 cells	C0007634
27571215	Increases	C0442805
27571215	blocked	C0332206
27571215	preincubation	C1441618
27571215	AVP antagonists	C1719946
27571215	results	C1274040
27571215	AVP	C0003779
27571215	receptors	C0597357
27571215	modulation	C0544633
27571215	proliferation rate	C0812425
27571215	biliary epithelium	C3686472
27571223	Central Corneal Thickness	C1720164
27571223	Reproducibility	C0035149
27571223	Instruments	C1518597
27571223	assess	C0184514
27571223	ultrasonic	C1875843
27571223	US	C1875843
27571223	optical instruments	C1518597
27571223	measurement	C0242485
27571223	central corneal thickness	C1720164
27571223	CCT	C1720164
27571223	evaluate	C0220825
27571223	intra- and inter-operator reproducibility	C0035149
27571223	cross-sectional study	C0010362
27571223	CCT	C1720164
27571223	healthy	C3898900
27571223	eyes	C0015392
27571223	spectral-domain optical coherence tomography (SD-OCT) devices	C3876157
27571223	one time-domain OCT	C4052697
27571223	Scheimpflug camera	C0179543
27571223	US-based instrument	C1875843
27571223	Inter- and intra-operator reproducibility	C1514863
27571223	evaluated	C0220825
27571223	intraclass correlation coefficient	C0010100
27571223	ICC	C0010100
27571223	coefficient of variation	C0681921
27571223	CV	C0681921
27571223	Bland-Altman test	C0870616
27571223	analysis	C0936012
27571223	Instrument	C0348000
27571223	instrument	C0348000
27571223	reproducibility	C0035149
27571223	ANOVA	C0002780
27571223	tested	C0039593
27571223	devices	C0025080
27571223	systemic	C0205373
27571223	bias	C0242568
27571223	random	C0439605
27571223	error	C0743559
27571223	structural equation model	C0681947
27571223	CCT	C1720164
27571223	instruments	C0348000
27571223	instrument	C0348000
27571223	instrument	C0348000
27571223	correlation test	C1707521
27571223	high	C0205250
27571223	values	C0042295
27571223	investigated	C1292732
27571223	devices	C0025080
27571223	correlation coefficient	C0010100
27571223	range	C1514721
27571223	p values	C1709380
27571223	Topcon-Spectral OCT/SLO Opko	C1518597
27571223	Cirrus HD-OCT Zeiss-RS-3000 Nidek	C1518597
27571223	SS-1000 CASIA	C1518597
27571223	Spectral OCT/SLO Opko	C1518597
27571223	ICC	C0010100
27571223	CV	C0681921
27571223	inter- and intra-operator reproducibility	C1514863
27571223	optic	C0029144
27571223	devices	C0025080
27571223	US	C1875843
27571223	device	C0025080
27571223	Bland-Altman	C0870616
27571223	analysis	C0936012
27571223	biases	C0242568
27571223	intra- and inter-operator reproducibility	C1514863
27571223	scale	C0349674
27571223	bias	C0242568
27571223	instruments	C0348000
27571223	interfere with	C0521102
27571223	CCT	C1720164
27571223	monitoring	C1283169
27571223	optimal	C2698651
27571223	monitoring	C1283169
27571223	device	C0025080
27571883	Predictors	C2698872
27571883	neurologic	C0006110
27571883	nonneurologic death	C1306577
27571883	patients	C0030705
27571883	brain metastasis	C0220650
27571883	treated	C1522326
27571883	upfront stereotactic radiosurgery	C0085203
27571883	whole-brain radiation therapy	C1520143
27571883	study	C2603343
27571883	factors	C1521761
27571883	predictive	C0681890
27571883	neurologic death	C0006110
27571883	patients	C0030705
27571883	brain metastasis	C0220650
27571883	treated	C1522326
27571883	upfront stereotactic radiosurgery	C0085203
27571883	SRS	C0085203
27571883	whole brain radiation therapy	C1520143
27571883	WBRT	C1520143
27571883	competing risk	C0035647
27571883	nonneurologic death	C1306577
27571883	retrospective	C1514923
27571883	single-institution	C2607850
27571883	analysis	C0936012
27571883	patients	C0030705
27571883	brain metastasis	C0220650
27571883	treated	C1522326
27571883	SRS	C0085203
27571883	WBRT	C1520143
27571883	Competing risks analysis	C0814767
27571883	hazard ratios	C2985465
27571883	HRs	C2985465
27571883	neurologic	C0006110
27571883	nonneurologic death	C1306577
27571883	predictor	C2698872
27571883	patients	C0030705
27571883	treated	C1522326
27571883	upfront SRS	C0085203
27571883	neurologic death	C0006110
27571883	nonneurologic death	C1306577
27571883	Multivariate competing risks analysis	C0026777
27571883	increased	C0205217
27571883	hazard	C2985465
27571883	neurologic death	C0006110
27571883	diagnosis-specific graded prognostic assessment	C0282574
27571883	DS-GPA	C0282574
27571883	melanoma	C0025202
27571883	histology	C0344441
27571883	increased	C0205217
27571883	brain metastases	C0220650
27571883	decreased	C0205216
27571883	hazard	C2985465
27571883	SRS	C0085203
27571883	dose	C0178602
27571883	Targeted agents	C1254351
27571883	decreased	C0205216
27571883	HR	C2985465
27571883	neurologic death	C0006110
27571883	years	C0439234
27571883	increased	C0205217
27571883	hazard	C2985465
27571883	nonneurologic death	C1306577
27571883	age	C0001779
27571883	nonmelanoma histology	C0344441
27571883	extracranial disease	C0012634
27571883	progressive	C0205329
27571883	systemic disease	C0442893
27571883	Melanoma	C0025202
27571883	DS-GPA	C0282574
27571883	number	C0237753
27571883	brain metastases	C0220650
27571883	SRS	C0085203
27571883	dose	C0178602
27571883	predictive	C0681890
27571883	neurologic death	C0006110
27571883	age	C0001779
27571883	nonmelanoma histology	C0344441
27571883	systemic disease	C0442893
27571883	predictive	C0681890
27571883	nonneurologic death	C1306577
27571883	Targeted agents	C1254351
27571883	delay	C0205421
27571883	neurologic death	C0006110
27572131	Pharmacological Actions	C0007992
27572131	Glucagon-Like Peptide-1	C0061355
27572131	Gastric Inhibitory Polypeptide	C0017132
27572131	Glucagon	C0017687
27572131	Glucagon family	C0017687
27572131	peptide hormones	C0597192
27572131	brain-gut peptides	C0030956
27572131	pleiotropic actions	C2936488
27572131	interactions	C0596610
27572131	unique members of class B1	C0008902
27572131	G protein-coupled receptors	C0682972
27572131	GPCRs	C0682972
27572131	regulators	C1704735
27572131	hormonal	C0458083
27572131	homeostasis	C0019868
27572131	drug targets	C0085104
27572131	metabolic disorders	C0025517
27572131	type-2 diabetes mellitus	C0011860
27572131	T2DM	C0011860
27572131	obesity	C0028754
27572131	dysregulations of the nervous systems	C0027765
27572131	migraine	C0149931
27572131	anxiety	C0003469
27572131	depression	C0011570
27572131	neurodegeneration	C0027746
27572131	psychiatric disorders	C0004936
27572131	cardiovascular diseases	C0007222
27572131	overview	C0814812
27572131	pharmacological actions	C0007992
27572131	therapeutic advances	C0087111
27572131	glucagon-like peptide-1	C0061355
27572131	GLP-1	C0061355
27572131	gastric inhibitory polypeptide	C0017132
27572131	GIP	C0017132
27572131	glucagon	C0017687
27573109	Endemic	C1254362
27573109	hydrothermal vent	C3178903
27573109	species	C1705920
27573109	identified	C0205396
27573109	ocean	C1547972
27573109	seed bank	C4042839
27573109	Hydrothermal vent	C3178903
27573109	systems	C0449913
27573109	microbial	C0599840
27573109	communities	C0009462
27573109	several	C0443302
27573109	microorganisms	C0445623
27573109	considered	C0750591
27573109	endemic	C1254362
27573109	habitat	C0871648
27573109	unclear	C3845108
27573109	organisms	C0029235
27573109	colonize	C4289767
27573109	geographically	C0017446
27573109	distant	C0443203
27573109	hydrothermal	C0205556
27573109	environments	C0014406
27573109	16S rRNA	C3537372
27573109	gene sequences	C0162326
27573109	compare	C1707455
27573109	bacterial	C0521009
27573109	communities	C0009462
27573109	Atlantic	C0004167
27573109	hydrothermal vent	C3178903
27573109	samples	C2347026
27573109	available	C0470187
27573109	global	C2348867
27573109	ocean	C1547972
27573109	samples	C0370003
27573109	Analysing	C0936012
27573109	sequences	C0162326
27573109	obtained	C1301820
27573109	16S rRNA	C3537372
27573109	genes	C0017337
27573109	genera	C1708235
27573109	ocean waters	C1547972
27573109	contained	C0332256
27573109	vent	C0043187
27573109	suggests	C1705535
27573109	previously	C0205156
27573109	observed	C1441672
27573109	vent	C0043187
27573109	exclusiveness	C0243095
27573109	cases	C0868928
27573109	probably	C0750492
27573109	artefact	C0243095
27573109	lower	C2003888
27573109	sequencing	C1294197
27573109	depth	C0205556
27573109	findings	C0243095
27573109	role	C1704326
27573109	ocean	C1547972
27573109	seed bank	C4042839
27573109	predicament	C0243095
27573109	species	C1705920
27573109	expected	C1517001
27573109	endemic	C1254362
27573109	vent	C0043187
27573109	systems	C0449913
27573109	able	C1299581
27573109	colonize	C4289767
27573109	geographically	C0017446
27573109	distant	C0443203
27573109	hydrothermal	C0205556
27573109	habitats	C0871648
27573109	contribute	C1880177
27573109	understanding	C0162340
27573702	Cerebral toxoplasmosis	C0085315
27573702	patients	C0030705
27573702	acquired immune deficiency syndrome	C0001175
27573702	neurological emergency department	C0562508
27573702	tertiary hospital	C0337954
27573702	Cerebral toxoplasmosis	C0085315
27573702	cause	C0015127
27573702	space	C1883067
27573702	brain lesion	C0221505
27573702	patients	C0030705
27573702	HIV/AIDS	C0497169
27573702	Brazil	C0006137
27573702	post-HAART era	C0681698
27573702	high	C0205250
27573702	rates	C1521828
27573702	morbidity	C0026538
27573702	mortality	C0205848
27573702	study	C2603343
27573702	case series	C0150093
27573702	patients	C0030705
27573702	diagnosed	C0011900
27573702	cerebral toxoplasmosis	C0085315
27573702	clinical	C0205210
27573702	features	C1521970
27573702	brain imaging	C0203860
27573702	cerebrospinal fluid	C0007806
27573702	aspects	C1879746
27573702	analyzed	C0936012
27573702	Cerebral toxoplasmosis	C0085315
27573702	diagnosis	C0011900
27573702	infection	C3714514
27573702	human immunodeficiency virus	C0019682
27573702	HIV	C0019682
27573702	patients	C0030705
27573702	HIV seropositive	C0019699
27573702	time	C0040223
27573702	diagnosis	C0011900
27573702	cerebral toxoplasmosis	C0085315
27573702	reported	C0700287
27573702	antiretroviral therapy	C1963724
27573702	receiving	C1514756
27573702	primary	C0205225
27573702	prophylaxis	C0199176
27573702	toxoplasmosis	C0085315
27573702	Headache	C0018681
27573702	strength deficit	C1457887
27573702	fever	C0015967
27573702	signs and symptoms	C0037088
27573702	study	C2603343
27573702	patients	C0030705
27573702	changes	C0392747
27573702	consistent with	C0332290
27573702	toxoplasmosis	C0085315
27573702	CT	C0040405
27573702	MRI	C0024485
27573702	CSF samples	C1292530
27573702	positive	C1446409
27573702	indirect haemagglutination test	C0022885
27573702	reaction	C0443286
27573702	Toxoplasma gondii IgG	C0370074
27573702	ELISA	C0014441
27573702	positive	C1446409
27573702	direct haemagglutination test	C0022885
27573702	patients	C0030705
27573702	first-line treatment	C1708063
27573702	toxoplasmosis	C0085315
27573702	Cerebral toxoplasmosis	C0085315
27573702	relevant	C2347946
27573702	neurological disease	C0027765
27573702	individuals	C0237401
27573702	AIDS	C0001175
27573702	admitted	C0184666
27573702	neurology	C0027855
27573702	emergency departments	C0562508
27573702	Early diagnosis	C0596473
27573702	initiation	C1704686
27573702	empiric treatment	C0749647
27573702	antiretroviral therapy	C1963724
27573702	prognosis	C0033325
27575455	Maf1	C1825934
27575455	regulation	C1327622
27575455	yeast	C0043393
27575455	RNA polymerase III	C0035680
27575455	correlated	C1707520
27575455	CCA addition at the 3' end of tRNA	C1158763
27575455	tRNA precursors	C0041133
27575455	eukaryotic cells	C0015161
27575455	tRNA synthesis	C1622985
27575455	negatively	C0205160
27575455	regulated	C1327622
27575455	protein Maf1	C0536951
27575455	yeast	C0043393
27575455	humans	C0086418
27575455	Maf1	C1825934
27575455	yeast	C0043393
27575455	Saccharomyces cerevisiae	C0036025
27575455	repression	C0920533
27575455	trna transcription	C1158829
27575455	cells	C0007634
27575455	medium	C0010454
27575455	glucose	C0017725
27575455	medium	C0010454
27575455	glycerol	C0017861
27575455	non-fermentable	C0015852
27575455	carbon	C0007009
27575455	source	C0449416
27575455	strain	C1518614
27575455	deleted	C2069771
27575455	gene	C0017337
27575455	encoding	C2700640
27575455	Maf1	C1825934
27575455	maf1Δ	C1825934
27575455	viable	C0443348
27575455	tRNA precursors	C0041133
27575455	study	C2603343
27575455	tRNA precursors	C0041133
27575455	analysed	C0936012
27575455	RNA-Seq	C0917793
27575455	Northern hybridization	C0599862
27575455	wild type	C1883559
27575455	strain	C1518614
27575455	maf1Δ	C1825934
27575455	mutant	C0678941
27575455	glucose	C0017725
27575455	medium	C0010454
27575455	repressive conditions	C0348080
27575455	negative	C0205160
27575455	effect	C1280500
27575455	maf1Δ	C1825934
27575455	mutant	C0678941
27575455	addition of the auxiliary CCA nucleotides to the 3' end of pre-tRNAs	C1158763
27575455	cells	C0007634
27575455	growth	C0018270
27575455	conditions	C0348080
27575455	effect	C1280500
27575455	reduced	C0392756
27575455	overexpression	C1514559
27575455	yeast	C0043393
27575455	CCA1 gene	C1413163
27575455	encoding	C2700640
27575455	ATP(CTP):tRNA nucleotidyltransferase	C0077328
27575455	CCA sequence	C0004793
27575455	export	C0699789
27575455	tRNA precursors	C0041133
27575455	nucleus	C0007610
27575455	tRNA charging	C1327001
27575455	amino acids	C0002520
27575455	Data	C1511726
27575455	CCA-addition to intron -containing end-processed tRNA precursors	C1158763
27575455	intron	C0021920
27575455	limiting step	C1261552
27575455	tRNA maturation	C1158762
27575455	Maf1	C1825934
27575455	RNA polymerase III	C0035680
27575455	Pol III	C0035680
27575455	repression	C0920533
27575455	correlation	C1707520
27575455	CCA	C0004793
27575455	synthesis	C1157592
27575455	Pol III	C0035680
27575455	regulation	C1327622
27575455	Maf1	C1825934
27575455	coordination	C0700114
27575455	tRNA transcription	C1158829
27575455	processing	C1158762
27575455	regulation of translation	C1157519
27575503	Pre-existing	C2347662
27575503	renal	C0022646
27575503	lesions	C0221198
27575503	renal	C0022646
27575503	trauma	C3714660
27575503	diagnosis	C1704656
27575503	accountability	C0078889
27575503	cases	C1706256
27575503	Pre-existing	C2347662
27575503	renal	C0022646
27575503	lesions	C0221198
27575503	PERL	C0221198
27575503	patho-physiology	C0031847
27575503	trauma	C3714660
27575503	radiographic imaging	C0457276
27575503	influence	C4054723
27575503	therapeutic	C0087111
27575503	aims	C1947946
27575503	study	C2603343
27575503	PERL	C0221198
27575503	blunt	C1997138
27575503	renal	C0022646
27575503	trauma	C3714660
27575503	conservative management	C0459914
27575503	partial permanent disability	C2080701
27575503	PPD	C2080701
27575503	medical records	C0025102
27575503	patients	C0030705
27575503	PERL	C0221198
27575503	blunt	C1997138
27575503	renal	C0022646
27575503	trauma	C3714660
27575503	patient	C0030705
27575503	pre-existing	C2347662
27575503	renal	C0022646
27575503	clinical	C0205210
27575503	symptoms	C1457887
27575503	CT scan	C0040405
27575503	study	C2603343
27575503	findings	C0243095
27575503	injuries	C3263723
27575503	therapeutic	C0087111
27575503	accountability	C0078889
27575503	PPD	C2080701
27575503	men	C0025266
27575503	women	C0043210
27575503	mean	C0444504
27575503	age	C0001779
27575503	years	C0439234
27575503	years	C0439234
27575503	Renal	C0022646
27575503	trauma	C3714660
27575503	traffic accident	C0000932
27575503	patients	C0030705
27575503	Renal	C0022646
27575503	severity	C0439793
27575503	trauma	C3714660
27575503	trauma	C3714660
27575503	trauma	C3714660
27575503	abdominal organs	C0446633
27575503	patients	C0030705
27575503	Urinary stones	C0042018
27575503	patients	C0030705
27575503	pelvi-ureteric junction obstruction	C0521619
27575503	horseshoe kidny	C0221353
27575503	ectopic kidney	C0238207
27575503	urinary tract carcinoma	C2007041
27575503	nephrectomy	C0027695
27575503	cases	C1706256
27575503	hemodynamic instability	C0948268
27575503	Ureteral stenting	C0183518
27575503	cases	C1706256
27575503	patients	C0030705
27575503	operated	C0543467
27575503	renal	C0022646
27575503	pathology	C0919386
27575503	conservative treatment	C0459914
27575503	cases	C1706256
27575503	PPD	C2080701
27575503	renal	C0022646
27575503	trauma	C3714660
27575503	cases	C1706256
27575503	PERL	C0221198
27575503	renal	C0022646
27575503	trauma	C3714660
27575503	cases	C1706256
27575503	patient's	C0030705
27575503	findings	C0243095
27575503	therapeutic	C0087111
27575503	PERL	C0221198
27575503	severity	C0439793
27575503	damage	C1883709
27575503	hemo-dynamically stable	C0578150
27575503	patient	C0030705
27575503	Accountability	C0078889
27575503	PPD	C2080701
27575503	PERL	C0221198
27575503	renal injuries	C0160420
27575503	severity	C0439793
27576084	Polymeric	C0032521
27576084	Nanostructure	C1450053
27576084	Multifunctional Components	C1705248
27576084	Tumor	C0027651
27576084	Targeted Delivery	C0920677
27576084	Antiangiogenic	C3179230
27576084	Gene	C0017337
27576084	Tumor Growth	C0598934
27576084	Suppression	C2700409
27576084	Nucleic acid-based	C0028606
27576084	therapy	C0087111
27576084	revolutionary methodology	C3266812
27576084	treatment	C1522326
27576084	diseases	C0012634
27576084	protein	C0033684
27576084	dysfunction	C3887504
27576084	lack of	C0332268
27576084	systemically	C0205373
27576084	applicable	C1706839
27576084	synthetic delivery systems	C0920677
27576084	local applications	C1393254
27576084	DNA-based	C0012854
27576084	therapy	C0087111
27576084	poor bioavailability	C0005508
27576084	systemic administrations	C0678812
27576084	multiple	C0439064
27576084	chemistry-based strategies	C3178923
27576084	manufacture	C0870840
27576084	gene delivery formulations	C0920677
27576084	improved	C0184511
27576084	tolerability	C4053931
27576084	DNA	C0012854
27576084	enzymatic	C1511131
27576084	degradation	C0314674
27576084	biological	C0205460
27576084	milieu	C0014406
27576084	prolonged retention	C1753315
27576084	distinctive multilayered	C0205556
27576084	functional	C0205245
27576084	architecture	C1254362
27576084	plasmid DNA	C0032136
27576084	pDNA	C0032136
27576084	electrostatically complexed	C2348396
27576084	cationic	C0007447
27576084	poly(lysine)	C0032426
27576084	polyplex	C0032521
27576084	interior	C0205102
27576084	pDNA	C0032136
27576084	reservoir	C1254362
27576084	cross-linked	C0178576
27576084	redox	C0030012
27576084	responsive	C0205342
27576084	disulfide	C0012771
27576084	cross-linking	C0332220
27576084	occurrence	C2745955
27576084	polyplex	C0032521
27576084	disassembly	C1707798
27576084	exchange reaction	C1148560
27576084	biological	C0205460
27576084	charged components	C0022023
27576084	pDNA	C0032136
27576084	reservoir	C1254362
27576084	sequential	C1705294
27576084	thermoresponsive	C0205245
27576084	poly(N-isopropylacrylamide)	C0071490
27576084	palisade	C1704513
27576084	intermediate barrier	C1704513
27576084	biocompatible	C0005479
27576084	hydrophilic	C0475370
27576084	poly(ethylene glycol)	C0032483
27576084	PEG	C0032483
27576084	shell	C1948022
27576084	accessibility	C0814423
27576084	biological	C0205460
27576084	species	C1705920
27576084	nuclease	C0597094
27576084	degradation	C0243125
27576084	pDNA	C0032136
27576084	investigations	C0220825
27576084	strategies	C0679199
27576084	blood	C0005767
27576084	retention	C0268000
27576084	method	C0025663
27576084	therapy	C0087111
27576084	ligand cyclic (Arg-Gly-Asp) peptide	C1685100
27576084	PEG	C0032483
27576084	tumor	C0027651
27576084	targeted	C1521840
27576084	delivery	C1524066
27576084	gene expression	C0017262
27576084	antiangiogenic	C3179230
27576084	gene	C0017337
27576084	targeted	C1521840
27576084	tumor cells	C0597032
27576084	exerting	C0015264
27576084	antiangiogenesis	C3179230
27576084	tumors	C0027651
27576084	abrogation	C2746065
27576084	tumor growth	C0598934
27576084	potential	C3245505
27576084	gene delivery system	C0920677
27576084	treatment	C1522326
27576084	intractable	C0205269
27576084	diseases	C0012634
27578508	Evaluation	C0220825
27578508	VIDAS Anti-HCV Assay	C0005507
27578508	Detection	C1511790
27578508	Hepatitis C Virus Infection	C4288963
27578508	Anti-hepatitis C virus antibody	C0166049
27578508	anti-HCV	C0166049
27578508	assays	C0005507
27578508	screening	C1710032
27578508	HCV	C0220847
27578508	HCV -infected persons	C0027361
27578508	VIDAS Anti-HCV Assay	C0005507
27578508	France	C0016674
27578508	enzyme-linked fluorescence test	C0022885
27578508	principle	C0178566
27578508	Korea	C0022771
27578508	clinical	C0205210
27578508	performance	C1882330
27578508	VIDAS assay	C0005507
27578508	HCV-positive	C1112419
27578508	HCV-negative	C1619717
27578508	blood samples	C0178913
27578508	Architect anti-HCV	C0005507
27578508	Abbott Laboratories	C1552881
27578508	USA	C0041703
27578508	COBAS TaqMan HCV real-time PCR	C1709846
27578508	Roche Diagnostics	C3828314
27578508	USA	C0041703
27578508	Procleix Ultrio Plus Assay	C0005507
27578508	USA	C0041703
27578508	Human Serum Bank	C0597886
27578508	HSB	C0597886
27578508	VIDAS	C1553144
27578508	discrepant results	C1290905
27578508	recombinant immunoblot assay	C2987205
27578508	RIBA	C2987205
27578508	agreement rates	C1521828
27578508	HCV-positive	C1112419
27578508	HCV-negative	C1619717
27578508	samples	C0178913
27578508	VIDAS assay	C0005507
27578508	HSB	C0597886
27578508	confidence interval	C0009667
27578508	CI	C0009667
27578508	CI	C0009667
27578508	discrepant	C1290905
27578508	samples	C0178913
27578508	positive	C1446409
27578508	Core 2+	C0019166
27578508	NS3-2 2+	C0021054
27578508	samples	C0178913
27578508	negative	C0205160
27578508	NS4 2+	C0021054
27578508	RIBA	C2987205
27578508	correlation	C1707520
27578508	titers	C0475208
27578508	VIDAS	C1553144
27578508	Architect assays	C0005507
27578508	VIDAS anti-HCV assay	C0005507
27578508	VIDAS	C1553144
27578508	automated immunoassay platform	C0020980
27578508	laboratories	C0022877
27578508	Architect anti-HCV	C0005507
27578508	COBAS PCR assays	C1709846
27578508	HCV infection	C4288963
27578508	Weakly test-positive (ambiguous)	C0456984
27578508	samples	C0178913
27578508	anti-HCV	C0166049
27578508	RIBA	C2987205
27578508	HCV RNA assay	C1272251
27581456	Reassembly of Excitable Domains	C1254358
27581456	CNS	C3714787
27581456	Axon Regeneration	C1621980
27581456	Action potential initiation	C4236548
27581456	propagation	C4236672
27581456	myelinated axons	C0682682
27581456	ion channel clustering	C1660767
27581456	axon initial segments	C1179989
27581456	(AIS	C1179989
27581456	nodes of Ranvier	C0034667
27581456	Disruption	C0332453
27581456	injury	C3263723
27581456	impairs	C1883709
27581456	nervous system function	C0027767
27581456	injured	C0332664
27581456	CNS	C3714787
27581456	axons	C0004461
27581456	refractory	C0034954
27581456	regeneration	C1621980
27581456	robust	C2986815
27581456	long-distance	C0012751
27581456	regeneration	C1621980
27581456	remyelination	C0334220
27581456	reestablishment	C1254358
27581456	AIS	C1179989
27581456	nodes of Ranvier	C0034667
27581456	unknown	C0439673
27581456	mouse	C0025929
27581456	optic nerve	C0029130
27581456	crush	C0332679
27581456	model	C0012644
27581456	CNS	C3714787
27581456	traumatic injury	C3263723
27581456	analysis	C0936012
27581456	AIS	C1179989
27581456	node	C0034667
27581456	disruption	C0332453
27581456	nerve crush	C0161479
27581456	disruption	C0332453
27581456	AIS	C1179989
27581456	loss	C1517945
27581456	nodes	C0034667
27581456	crush	C0332679
27581456	loss	C1517945
27581456	nodes	C0034667
27581456	injury	C3263723
27581456	Genetic deletion	C0017260
27581456	tumor suppressor phosphatase and tensin homolog	C0694888
27581456	Pten	C0694888
27581456	retinal ganglion cells	C0035316
27581456	RGCs	C0035316
27581456	stimulation	C0007613
27581456	RGCs	C0035316
27581456	inflammation	C0021368
27581456	cAMP	C0001455
27581456	regeneration	C1621980
27581456	treatmen	C3161471
27581456	reestablishment	C1254358
27581456	RGC	C0035316
27581456	AIS	C1179989
27581456	remyelination	C0334220
27581456	reassembly	C1254358
27581456	nodes	C0034667
27581456	regions proximal	C0205107
27581456	within	C0332285
27581456	distal	C0205108
27581456	crush	C0332679
27581456	site	C1515974
27581456	Remyelination	C0334220
27581456	near the retina	C0459620
27581456	progressed	C1272688
27581456	distally	C0205108
27581456	electron microscopy	C0026019
27581456	axons	C0004461
27581456	grew	C0007595
27581456	rapidly	C0456962
27581456	remyelination	C0334220
27581456	nodal ion channel clustering	C1660767
27581456	slower	C0439834
27581456	genetic deletion	C0017260
27581456	ankyrinG	C1384562
27581456	RGCs	C0035316
27581456	block	C0332206
27581456	AIS	C1179989
27581456	reassembly	C1254358
27581456	axon regeneration	C1621980
27581456	neuronal polarity	C0085304
27581456	not required	C0243095
27581456	axon regeneration	C1621980
27581456	regenerating	C1621980
27581456	CNS	C3714787
27581456	axons	C0004461
27581456	remyelinated	C0334220
27581456	reassemble	C1254358
27581456	AIS	C1179989
27581456	nodes of Ranvier	C0034667
27581456	regenerated	C1621980
27581456	CNS	C3714787
27581456	axons	C0004461
27581456	capacity	C1516240
27581456	remyelinate	C0334220
27581456	reassemble	C1254358
27581456	axon initial segments	C1179989
27581456	nodes of Ranvier	C0034667
27581456	rapid	C0456962
27581456	efficient	C0442799
27581456	action potential propagation	C4236672
27588139	Clinicopathological	C0030667
27588139	kinesin family member 18A	C1610793
27588139	expression	C1171362
27588139	invasive breast cancer	C0853879
27588139	kinesin	C0085139
27588139	motor proteins	C1720835
27588139	targets	C1521840
27588139	cancer therapy	C0920425
27588139	Kinesins	C0085139
27588139	microtubule	C0026042
27588139	motor proteins	C1720835
27588139	diverse functions	C0542341
27588139	cell	C0007634
27588139	transport	C0005528
27588139	vesicles	C1622418
27588139	organelles	C0029219
27588139	chromosomes	C0008633
27588139	protein complexes	C1180347
27588139	movement of microtubules	C1156033
27588139	expression	C1171362
27588139	kinesin family member 18A	C1610793
27588139	KIF18A	C1610793
27588139	member of kinesin superfamily	C0085139
27588139	investigated	C1292732
27588139	breast cancer	C0006142
27588139	immunohistochemistry	C0021044
27588139	breast cancer	C0006142
27588139	KIF18A	C1610793
27588139	expression level	C3244092
27588139	associated with	C0332281
27588139	lymph node metastasis	C0686619
27588139	patients	C0030705
27588139	KIF18A	C1610793
27588139	expression	C1171362
27588139	survival	C0038952
27588139	patients	C0030705
27588139	KIF18A	C1610793
27588139	expression	C1171362
27588139	disease-free survival	C0242793
27588139	Multivariate analysis	C0026777
27588139	venous invasion	C1710625
27588139	hazard ratio	C2985465
27588139	confidence interval	C0009667
27588139	KIF18A	C1610793
27588139	expression	C1171362
27588139	hazard ratio	C2985465
27588139	confidence interval	C0009667
27588139	predictive factors	C0683956
27588139	lymph node metastasis	C0686619
27588139	KIF18A	C1610793
27588139	predictive	C0683956
27588139	marker	C0005516
27588139	lymph node metastasis	C0686619
27588139	breast cancer	C0006142
27588139	curative adjuvant	C3846124
27588139	treatment	C0087111
27589009	inflammatory chronic disease	C1290886
27589009	influences	C4054723
27589009	infliximab	C0666743
27589009	pharmacokinetics	C0031328
27589009	Infliximab	C0666743
27589009	anti-tumor necrosis factor	C1562242
27589009	monoclonal antibody	C0003250
27589009	chronic inflammatory diseases	C1290886
27589009	rheumatoid arthritis	C0003873
27589009	RA	C0003873
27589009	psoriatic arthritis	C0003872
27589009	PsA	C0003872
27589009	ankylosing spondylitis	C0038013
27589009	AS	C0038013
27589009	Crohn's disease	C0010346
27589009	CD	C0010346
27589009	ulcerative colitis	C0009324
27589009	UC	C0009324
27589009	Infliximab	C0666743
27589009	pharmacokinetics	C0031328
27589009	patients	C0030705
27589009	influence	C4054723
27589009	underlying disease	C0012634
27589009	assessed	C1516048
27589009	influence	C4054723
27589009	cohort	C0599755
27589009	patients monitored	C0030695
27589009	assay	C1510438
27589009	Infliximab	C0666743
27589009	concentrations	C1446561
27589009	determined	C0521095
27589009	samples collected	C0200345
27589009	treatment	C1522326
27589009	initiation	C1704686
27589009	patients	C0030705
27589009	treated	C1522326
27589009	RA	C0003873
27589009	PsA	C0003872
27589009	AS	C0038013
27589009	CD	C0010346
27589009	UC	C0009324
27589009	Infliximab	C0666743
27589009	pharmacokinetics	C0031328
27589009	analyzed	C0936012
27589009	population	C1257890
27589009	elimination	C2735304
27589009	rate constant	C2986811
27589009	AS	C0038013
27589009	patients	C0030705
27589009	volume of distribution	C0683148
27589009	V	C0683148
27589009	elimination	C2735304
27589009	clearance	C0449297
27589009	CL	C0449297
27589009	CD	C0010346
27589009	UC	C0009324
27589009	patients	C0030705
27589009	AS	C0038013
27589009	CL	C0449297
27589009	AS	C0038013
27589009	RA	C0003873
27589009	patients	C0030705
27589009	CL	C0449297
27589009	AS	C0038013
27589009	patients	C0030705
27589009	Simulations	C0679083
27589009	methotrexate	C0025677
27589009	dosing	C0178602
27589009	regimen	C0040808
27589009	RA	C0003873
27589009	patients	C0030705
27589009	target	C1521840
27589009	concentration	C1446561
27589009	target	C1521840
27589009	concentrations	C1446561
27589009	approximately	C0332232
27589009	RA	C0003873
27589009	patients	C0030705
27589009	cotreated	C1522326
27589009	methotrexate	C0025677
27589009	CD	C0010346
27589009	UC	C0009324
27589009	patients	C0030705
27589009	dosing	C0178602
27589009	regimens	C0040808
27589009	development	C1527148
27589009	dosing	C0178602
27589009	optimization	C2698650
27589009	concentration measurements	C1446561
27590021	International	C1512888
27590021	validation	C1519941
27590021	urinary	C1610733
27590021	biomarker	C0005516
27590021	panel	C0022885
27590021	active	C0205177
27590021	lupus nephritis	C0024143
27590021	children	C0008059
27590021	markers	C0005516
27590021	juvenile-onset systemic lupus erythematosus	C1274834
27590021	JSLE	C1274834
27590021	disease activity	C4065474
27590021	lupus nephritis	C0024143
27590021	LN	C0024143
27590021	novel	C0205314
27590021	urine	C0042036
27590021	biomarkers	C0005516
27590021	detecting	C1511790
27590021	LN	C0024143
27590021	flares	C1517205
27590021	biomarker	C0005516
27590021	panels	C0022885
27590021	diagnostic accuracy	C0598285
27590021	aim	C1947946
27590021	study	C2603343
27590021	assess	C1516048
27590021	biomarker	C0005516
27590021	panel	C0022885
27590021	active	C0205177
27590021	LN	C0024143
27590021	international	C1512888
27590021	JSLE	C1274834
27590021	cohorts	C0599755
27590021	urinary	C1610733
27590021	biomarkers	C0005516
27590021	vascular cell adhesion molecule-1	C0078056
27590021	VCAM-1	C0078056
27590021	monocyte chemoattractant protein 1	C0128897
27590021	MCP-1	C0128897
27590021	lipocalin-like prostaglandin D synthase	C0072296
27590021	LPGDS	C0072296
27590021	transferrin	C0040679
27590021	TF	C0040679
27590021	ceruloplasmin	C0007841
27590021	alpha-1-acid glycoprotein	C0029297
27590021	AGP	C0029297
27590021	neutrophil gelatinase-associated lipocalin	C0215955
27590021	NGAL	C0215955
27590021	quantified	C0392762
27590021	cross-sectional study	C0010362
27590021	participants	C0679646
27590021	UK	C0041700
27590021	JSLE	C1274834
27590021	Cohort Study	C0009247
27590021	Cohort 1	C0599755
27590021	Einstein Lupus	C1708333
27590021	Cohort	C0599755
27590021	Cohort 2	C0599755
27590021	Binary	C1706942
27590021	logistic regression modelling	C0206031
27590021	receiver operating characteristic	C0034772
27590021	curve analysis	C0392762
27590021	area under the curve	C0376690
27590021	AUC	C0376690
27590021	assess	C1516048
27590021	combinations	C0205195
27590021	biomarkers	C0005516
27590021	diagnostic accuracy	C0598285
27590021	JSLE	C1274834
27590021	patients	C0030705
27590021	cohorts	C0599755
27590021	active	C0205177
27590021	LN	C0024143
27590021	LN	C0024143
27590021	Urinary	C1610733
27590021	AGP	C0029297
27590021	ceruloplasmin	C0007841
27590021	VCAM-1	C0078056
27590021	MCP-1	C0128897
27590021	LPGDS	C0072296
27590021	levels	C0441889
27590021	significantly higher	C4055637
27590021	patients	C0030705
27590021	active	C0205177
27590021	LN	C0024143
27590021	non	C1518422
27590021	LN	C0024143
27590021	patients	C0030705
27590021	cohorts	C0599755
27590021	Urinary	C1610733
27590021	TF	C0040679
27590021	patient	C0030705
27590021	Cohort 2	C0599755
27590021	Cohort 1	C0599755
27590021	optimal	C2698651
27590021	biomarker	C0005516
27590021	panel	C0022885
27590021	AGP	C0029297
27590021	ceruloplasmin	C0007841
27590021	LPGDS	C0072296
27590021	TF	C0040679
27590021	AUC	C0376690
27590021	active	C0205177
27590021	LN	C0024143
27590021	Cohort 2	C0599755
27590021	markers	C0005516
27590021	optimal	C2698651
27590021	urine	C0042036
27590021	biomarker	C0005516
27590021	panel	C0022885
27590021	AUC	C0376690
27590021	international	C1512888
27590021	JSLE	C1274834
27590021	cohorts	C0599755
27590021	urinary	C1610733
27590021	AGP	C0029297
27590021	ceruloplasmin	C0007841
27590021	LPGDS	C0072296
27590021	TF	C0040679
27590021	active	C0205177
27590021	LN	C0024143
27590021	children	C0008059
27593389	interleukin 18 (IL-18) receptor	C0666963
27593389	immunoreactive	C0020962
27593389	neurons	C0027882
27593389	retrosplenial cortex	C4085586
27593389	IL18	C1334109
27593389	knockout mice	C0206745
27593389	Interleukin 18	C0383327
27593389	IL-18	C0383327
27593389	inflammatory	C0333348
27593389	immune response	C0301872
27593389	immune response	C0301872
27593389	lymphocytes	C0024264
27593389	Delay in learning or memory	C1254367
27593389	IL-18	C1334109
27593389	knockout mouse	C0206745
27593389	IL-18	C0383327
27593389	immunoreactive	C0020962
27593389	neurons	C0027882
27593389	retrosplenial cortex	C4085586
27593389	RSC	C4085586
27593389	subiculum	C2950582
27593389	neurons	C0027882
27593389	IL-18 receptor	C0666963
27593389	ultrastructure	C0041623
27593389	IL-18 receptor	C0666963
27593389	immunoreactive	C0020962
27593389	neurons	C0027882
27593389	RSC	C4085586
27593389	IL-18 receptor	C0666963
27593389	immunoreactive	C0020962
27593389	neurons	C0027882
27593389	IL-18	C1334109
27593389	knockout mouse	C0206745
27593389	IL-18 receptor	C0666963
27593389	immunoreactive	C0020962
27593389	neurons	C0027882
27593389	layer V of the granular RSC	C3498609
27593389	neurons	C0027882
27593389	oval nucleus	C0007610
27593389	cytoplasm	C0010834
27593389	free ribosomes	C0035553
27593389	endoplasmic reticulum	C0014239
27593389	mitochondria	C0026237
27593389	Nissl bodies	C0028117
27593389	axosomatic terminals	C1180004
27593389	IL-18 receptor	C0666963
27593389	immunoreactive	C0020962
27593389	neurons	C0027882
27593389	RSC	C4085586
27593389	IL-18	C1334109
27593389	knockout mouse	C0206745
27593389	small electron-dense	C0596488
27593389	neurons	C0027882
27593389	layer V	C3498609
27593389	nucleus	C0007610
27593389	cytoplasm	C0010834
27593389	electron-dense	C0596488
27593389	mitochondria	C0026237
27593389	rough endoplasmic reticulum	C0230779
27593389	swollen	C0038999
27593389	IL-18 receptor	C0666963
27593389	immunoreactive	C0020962
27593389	neurons	C0027882
27593389	degenerating	C2673328
27593389	degeneration	C0027746
27593389	IL18-receptor	C0666963
27593389	immunoreactive	C0020962
27593389	neurons	C0027882
27593389	RSC	C4085586
27593389	abnormal behaviors	C0233514
27593389	IL-18	C1334109
27593389	knockout mice	C0206745
27593461	genetic	C0314603
27593461	variability	C2827666
27593461	water	C0043047
27593461	use	C0457083
27593461	efficiency	C0013682
27593461	inter	C1548610
27593461	intra cultivar	C0032098
27593461	genetic diversity	C0042333
27593461	grapevines	C0330100
27593461	Genetic	C0314603
27593461	improvement	C2986411
27593461	crop	C0242775
27593461	Water	C0043047
27593461	Use	C0457083
27593461	Efficiency	C0013682
27593461	WUE	C0013682
27593461	goal	C1571704
27593461	increasing	C0442808
27593461	water	C0043047
27593461	scarcity	C0231179
27593461	sustainable	C0443318
27593461	agriculture	C0001829
27593461	grapevines	C0330100
27593461	subject	C1706203
27593461	relevant	C2347946
27593461	distribution	C1704711
27593461	semi-arid	C0011673
27593461	areas	C0205146
27593461	cultivars	C0032098
27593461	difficult	C0332218
27593461	introduce	C1292748
27593461	viticulture	C0681558
27593461	consumer	C1707496
27593461	appreciation	C2346843
27593461	wine	C0043188
27593461	taste	C1547046
27593461	Clones	C1522642
27593461	cultivars	C0032098
27593461	accepted	C1272684
27593461	intra-cultivar	C0032098
27593461	genetic	C0314603
27593461	variability	C2827666
27593461	WUE	C0013682
27593461	compares	C1707455
27593461	field	C0001829
27593461	variability	C2827666
27593461	water	C0043047
27593461	use	C0457083
27593461	efficiency	C0013682
27593461	WUEi	C0013682
27593461	collection	C1516698
27593461	cultivars	C0032098
27593461	contrast	C1979874
27593461	collection	C1516698
27593461	clones	C1522642
27593461	Tempranillo cultivar	C0032098
27593461	results	C1274040
27593461	clonal	C1704387
27593461	variability	C2827666
27593461	WUEi	C0013682
27593461	around	C0750503
27593461	inter-cultivar	C0032098
27593461	assessment	C1516048
27593461	clonal	C1704387
27593461	selection	C1707391
27593461	WUE	C0013682
27593461	WUEi	C0013682
27593461	data	C1511726
27593461	stem	C0242767
27593461	water	C0043047
27593461	potential	C3245505
27593461	stomatal conductance	C1326524
27593461	possible	C0332149
27593461	identify	C0205396
27593461	cultivars	C0032098
27593461	clones	C1522642
27593461	confidence intervals	C0009667
27593461	linear regression	C0023733
27593461	significantly higher	C4055637
27593461	lower	C4055638
27593461	WUEi	C0013682
27593461	values	C1522609
27593461	results	C1274040
27593461	contribute	C1880177
27593461	genetic	C0314603
27593461	improvement	C2986411
27593461	grapevine	C0330100
27593461	WUE	C0013682
27596934	isolating	C0220862
27596934	primary	C0205225
27596934	hepatocytes	C0227525
27596934	mini pigs	C0039011
27596934	porcine	C0039005
27596934	hepatocyte	C0227525
27596934	isolation	C0220862
27596934	development	C1527148
27596934	bioartificial liver devices	C0336562
27596934	hepatocyte transplantation	C1998344
27596934	Serva collagenase NB grades	C0162745
27596934	collagenases	C0162745
27596934	tissue	C0040300
27596934	isolation	C0220862
27596934	N-acetylcysteine	C0001047
27596934	NAC	C0001047
27596934	viability	C0443348
27596934	human	C0086418
27596934	hepatocytes	C0227525
27596934	effectiveness	C1280519
27596934	collagenases	C0162745
27596934	effect of	C1704420
27596934	NAC	C0001047
27596934	hepatocyte	C0227525
27596934	isolation	C0220862
27596934	porcine	C0039005
27596934	liver tissue	C0736268
27596934	Porcine	C0039005
27596934	hepatocytes	C0227525
27596934	isolated	C0220862
27596934	perfusion method	C0031001
27596934	mini pigs	C0039011
27596934	Serva NB 4	C0162745
27596934	group	C0441833
27596934	Serva NB 8	C0162745
27596934	group	C0441833
27596934	NB 8	C0162745
27596934	NAC	C0001047
27596934	group	C0441833
27596934	Viability	C0443348
27596934	hepatocytes	C0227525
27596934	spheroids formation	C1844596
27596934	rocker culture	C0430400
27596934	serum-free medium	C0085414
27596934	Metabolic function	C0025519
27596934	gene expression	C0017262
27596934	albumin	C0001924
27596934	urea	C0041942
27596934	synthesis	C0220781
27596934	hepatocyte	C0227525
27596934	isolation	C0220862
27596934	Cells	C0007634
27596934	NB 8	C0162745
27596934	NAC	C0001047
27596934	group	C0441833
27596934	viability	C0443348
27596934	NB 8	C0162745
27596934	group	C0441833
27596934	NB 4	C0162745
27596934	group	C0441833
27596934	cell	C0007634
27596934	cells	C0007634
27596934	NB 8	C0162745
27596934	NAC	C0001047
27596934	group	C0441833
27596934	cells	C0007634
27596934	NB 8	C0162745
27596934	group	C0441833
27596934	cells	C0007634
27596934	NB 4	C0162745
27596934	group	C0441833
27596934	secretion	C0036536
27596934	albumin	C0001924
27596934	NB 8	C0162745
27596934	NAC	C0001047
27596934	group	C0441833
27596934	NB 8	C0162745
27596934	group	C0441833
27596934	NB 4	C0162745
27596934	group	C0441833
27596934	injury	C0178314
27596934	hepatocytes	C0227525
27596934	NB 8	C0162745
27596934	NAC	C0001047
27596934	group	C0441833
27596934	means ± SD	C0444504
27596934	collagenase Serva NB 8	C0162745
27596934	NAC	C0001047
27596934	porcine	C0039005
27596934	hepatocyte	C0227525
27596934	isolation	C0220862
27596934	viable cells	C1441322
27598472	Endothermal venous ablation	C2242647
27598472	saphenous vein	C0036186
27598472	patients	C0030705
27598472	anticoagulation therapy	C0003281
27598472	study	C2603343
27598472	risks	C0035647
27598472	bleeding	C0019080
27598472	deep venous thrombosis	C0149871
27598472	DVT	C0149871
27598472	endovenous heat induced thrombosis	C0042487
27598472	EHIT	C0042487
27598472	failure	C0231174
27598472	ablation	C0547070
27598472	patients	C0030705
27598472	ablation	C0547070
27598472	oral anticoagulation	C0003281
27598472	compared	C1707455
27598472	patients	C0030705
27598472	group A	C0441835
27598472	endovenous ablation	C2242647
27598472	saphenous veins	C0036186
27598472	oral anticoagulation	C0003281
27598472	patients	C0030705
27598472	group B	C0441836
27598472	endovenous ablation	C2242647
27598472	time period	C1948053
27598472	anticoagulation	C0003281
27598472	demographic data	C0392762
27598472	history of	C0332119
27598472	DVT	C0149871
27598472	Clinical	C0205210
27598472	Etiologic	C0205556
27598472	Anatomic	C0220784
27598472	Pathologic	C1521733
27598472	CEAP	C0205556
27598472	classification	C0008902
27598472	VCSS	C0392762
27598472	Venous Clinical Severity Score	C0392762
27598472	indications	C3146298
27598472	anticoagulation	C0003281
27598472	anticoagulants	C0003280
27598472	bleeding	C0019080
27598472	DVT	C0149871
27598472	EHIT	C0042487
27598472	failure	C0231174
27598472	ablation	C0547070
27598472	Patients	C0030705
27598472	group A	C0441835
27598472	older	C3826770
27598472	men	C0025266
27598472	DVT	C0149871
27598472	PE	C0034065
27598472	CEAP	C0205556
27598472	VCSS	C0392762
27598472	group B	C0441836
27598472	anticoagulation	C0003281
27598472	warfarin	C0043031
27598472	direct oral inhibitors	C1254351
27598472	DOIs	C1254351
27598472	rate	C1521828
27598472	failure	C0231174
27598472	ablation	C0547070
27598472	days	C0439228
27598472	Group A	C0441835
27598472	Group B	C0441836
27598472	one month	C4082115
27598472	EHIT	C0042487
27598472	cases	C0868928
27598472	group A	C0441835
27598472	days	C0439228
27598472	group B	C0441836
27598472	1 month	C4082115
27598472	DVT	C0149871
27598472	SVT	C0039240
27598472	hematoma	C0018944
27598472	wound infection	C0043241
27598472	rates	C1521828
27598472	groups	C0441833
27598472	Ablation	C0547070
27598472	saphenous veins	C0036186
27598472	patients	C0030705
27598472	oral anticoagulation	C0003281
27598472	risk	C0035647
27598472	bleeding	C0019080
27598472	hematoma	C0018944
27598472	incidence	C0021149
27598472	EHIT	C0042487
27598472	incidence	C0021149
27598472	failure	C0231174
27598472	ablation	C0547070
27599756	Variation analysis	C0242481
27599756	PRIM1 gene	C1335259
27599756	Chinese	C0152035
27599756	patients	C0030705
27599756	primary ovarian insufficiency	C0085215
27599756	genetic susceptibility	C0314657
27599756	primary ovarian insufficiency	C0085215
27599756	POI	C0085215
27599756	natural	C0856856
27599756	early menopause	C0025322
27599756	delivered	C1705822
27599756	genetic mechanisms	C0017399
27599756	POI	C0085215
27599756	PRIM1	C1335259
27599756	DNA replication	C0598312
27599756	synthesizing	C1883254
27599756	RNA primers	C0073429
27599756	Okazaki fragments	C0069390
27599756	associated with	C0332281
27599756	age	C0001779
27599756	natural menopause	C0856856
27599756	early menopause	C0025322
27599756	POI	C0085215
27599756	European	C0239307
27599756	women	C0043210
27599756	study	C2603343
27599756	investigate	C1292732
27599756	mutations	C0026882
27599756	PRIM1	C1335259
27599756	POI	C0085215
27599756	Chinese	C0152035
27599756	women	C0043210
27599756	exons	C0015295
27599756	exon-intron boundaries	C0028606
27599756	PRIM1 gene	C1335259
27599756	sequenced	C1294197
27599756	Han Chinese	C0814942
27599756	women	C0043210
27599756	POI	C0085215
27599756	mutations	C0026882
27599756	identified	C0205396
27599756	perturbations	C0332453
27599756	PRIM1 gene	C1335259
27599756	POI	C0085215
27599756	Chinese	C0152035
27599756	women	C0043210
27602302	Selection	C1707391
27602302	marker gene	C0017337
27602302	reference library	C0023621
27602302	wetland	C1721088
27602302	plants	C0032098
27602302	metabarcoding	C2936547
27602302	analyze	C0936012
27602302	diet	C0012155
27602302	wintering	C0241737
27602302	herbivorous	C0562691
27602302	waterbirds	C0005595
27602302	Food	C0016452
27602302	availability	C0470187
27602302	diet	C0012155
27602302	selection	C1707391
27602302	factors	C1521761
27602302	influencing	C4054723
27602302	abundance	C2346714
27602302	distribution	C1704711
27602302	wild	C0445392
27602302	waterbirds	C0005595
27602302	changes	C0392747
27602302	waterbird	C0005595
27602302	population	C0032659
27602302	feed on	C3853577
27602302	analyzing	C0936012
27602302	diet	C0012155
27602302	difficult	C0332218
27602302	inefficient	C0231185
27602302	methods	C0025664
27602302	microhistologic observation	C0019637
27602302	diet	C0012155
27602302	greater white-fronted goose Anser albifrons	C1015285
27602302	bean goose Anser fabalis	C1015285
27602302	obligate herbivores	C0562691
27602302	wintering	C0241737
27602302	China	C0008115
27602302	Middle	C0017446
27602302	Lower Yangtze River floodplain	C0017446
27602302	selected	C1707391
27602302	suitable	C3900053
27602302	marker gene	C0017337
27602302	wetland	C1721088
27602302	plants	C0032098
27602302	geese	C0017225
27602302	wintering period	C0241737
27602302	candidate genes	C0017337
27602302	rbcL	C0017337
27602302	rpoC1	C0017337
27602302	rpoB	C0017337
27602302	matK	C1334485
27602302	trnH-psbA	C2936548
27602302	trnL	C1421162
27602302	UAA	C1956149
27602302	atpF-atpH	C2936548
27602302	psbK-psbI	C2936548
27602302	selection	C1707391
27602302	analysis	C0936012
27602302	representative	C1882932
27602302	sequences	C0162326
27602302	NCBI	C1705803
27602302	comparison	C1707455
27602302	amplification	C0017256
27602302	efficiency	C0013682
27602302	plant	C0032098
27602302	samples	C0370003
27602302	wintering area	C0017446
27602302	trnL gene	C1421162
27602302	c/h primers	C0206416
27602302	local	C0205276
27602302	plant	C0032098
27602302	reference library	C0023621
27602302	constructed	C2827421
27602302	gene	C0017337
27602302	DNA metabarcoding	C2936547
27602302	discovered	C1880355
27602302	food items	C0016452
27602302	feces	C0015733
27602302	birds	C0005595
27602302	dietary	C0012155
27602302	sequences	C0162326
27602302	specie	C1705920
27602302	level	C0441889
27602302	greater white-fronted goose	C1015285
27602302	sequences	C0162326
27602302	Poaceae spp.	C0018210
27602302	Carex spp	C1000671
27602302	sequences	C0162326
27602302	bean goose	C1064115
27602302	Carex spp	C1000671
27602302	samples	C0370003
27602302	microhistology	C0019637
27602302	consistent	C0332290
27602302	food composition	C0459115
27602302	metabarcoding	C2936547
27602302	results	C1274040
27602302	greater white-fronted goose	C1015285
27602302	Poaceae	C0018210
27602302	bean goose	C1064115
27602302	taxa	C1515221
27602302	discovered	C1880355
27602302	microhistologic analysis	C0019637
27602302	taxa	C1515221
27602302	matched	C1708943
27602302	methods	C0025664
27602302	DNA metabarcoding	C2936547
27602302	taxonomically	C0008903
27602302	detailed information	C1533716
27602302	Discrepancies	C1290905
27602302	biased	C0242568
27602302	PCR	C0032520
27602302	amplification	C0017256
27602302	metabarcoding	C2936547
27602302	discriminating	C2987623
27602302	power	C3854080
27602302	marker genes	C0017337
27602302	monocots	C0331451
27602302	biases	C0242568
27602302	microhistologic analysis	C0019637
27602302	diet	C0012155
27602302	differences	C1705242
27602302	geese	C0017225
27602302	species	C1705920
27602302	ecological	C0162358
27602302	significance	C0750502
27602302	study	C2603343
27602302	DNA metabarcoding	C2936547
27602302	perspectives	C0683498
27602302	studies	C2603343
27602302	herbivorous	C0562691
27602302	waterbird	C0005595
27602302	diets	C0012155
27602302	inter-specific interactions	C1704675
27602302	investigate	C1292732
27602302	interactions	C1704675
27602302	herbivores	C0562691
27602302	plants	C0032098
27602302	microhistologic analysis	C0019637
27602302	metabarcoding methods	C2936547
27602302	information	C1533716
27602763	Expressions	C1171362
27602763	CD8	C0085358
27602763	TILs	C0079722
27602763	PD-L1	C0965245
27602763	Foxp3	C1504797
27602763	TILs	C0079722
27602763	stage I NSCLC	C0278504
27602763	adjuvant chemotherapy	C0085533
27602763	decisions	C0679006
27602763	adjuvant chemotherapy	C0085533
27602763	recommended	C0034866
27602763	patients	C0030705
27602763	high risk	C0332167
27602763	stage I non-small cell lung cancer	C0278504
27602763	NSCLC	C0007131
27602763	identifying	C0205396
27602763	high risk	C0332167
27602763	patients	C0030705
27602763	study	C2603343
27602763	aims	C1947946
27602763	identify	C0205396
27602763	patient	C0030705
27602763	cohorts	C0599755
27602763	adjuvant chemotherapy	C0085533
27602763	tumor	C0027651
27602763	micro-immune	C0439662
27602763	environment	C0014406
27602763	CD8	C0085358
27602763	TILs	C0079722
27602763	significantly associated with	C0332281
27602763	disease-free survival	C0242793
27602763	DFS	C0242793
27602763	overall survial	C4086681
27602763	OS	C4086681
27602763	Patients	C0030705
27602763	high risk factors	C1830377
27602763	DFS	C0242793
27602763	compared	C1707455
27602763	patients	C0030705
27602763	high	C0205250
27602763	CD8	C0085358
27602763	TILs	C0079722
27602763	DFS	C0242793
27602763	patients	C0030705
27602763	low	C0205251
27602763	CD8	C0085358
27602763	TILs	C0079722
27602763	risk factors	C1830377
27602763	no correlation	C0243095
27602763	PD-L1	C0965245
27602763	expressions	C1171362
27602763	survival	C0220921
27602763	PD-L1	C0965245
27602763	highly	C0205250
27602763	expressed	C1171362
27602763	men	C0025266
27602763	squamous	C1182670
27602763	well differentiated	C0205615
27602763	carcinoma	C0278504
27602763	Foxp3	C1504797
27602763	TILs	C0079722
27602763	low	C0205251
27602763	Foxp3	C1504797
27602763	high	C0205250
27602763	CD8	C0085358
27602763	TILs	C0079722
27602763	associated with	C0332281
27602763	prolonged	C0439590
27602763	DFS	C0242793
27602763	patients	C0030705
27602763	surgically resected	C1521996
27602763	stage I NSCLC	C0278504
27602763	included	C0332257
27602763	immunohistochemistry	C0021044
27602763	CD8	C0085358
27602763	tumor infiltrating lymphocytes	C0079722
27602763	TILs	C0079722
27602763	programmed death ligand-1	C0965245
27602763	PD-L1	C0965245
27602763	forkhead box P3	C1504797
27602763	Foxp3	C1504797
27602763	TILs	C0079722
27602763	CD8	C0085358
27602763	TILs	C0079722
27602763	effective	C1704419
27602763	Patients	C0030705
27602763	surgically resected	C1521996
27602763	stage I NSCLC	C0278504
27602763	CD8	C0085358
27602763	TILs	C0079722
27602763	adjuvant chemotherapy	C0085533
27602763	high risk	C0332167
27604681	twins discordant	C2609166
27604681	affective disorders	C0001723
27604681	anterior callosal	C0226208
27604681	white matter	C0682708
27604681	microstructure	C0678594
27604681	neurobiological	C0027817
27604681	mechanisms	C0441712
27604681	risk	C0035647
27604681	affective disorders	C0001723
27604681	group of individuals	C0027361
27604681	family history	C0241889
27604681	major depressive	C1269683
27604681	MDD	C1269683
27604681	bipolar disorder	C0005586
27604681	BD	C0005586
27604681	white matter	C0682708
27604681	fiber tracts	C3499212
27604681	cingulum bundle	C0228272
27604681	uncinate fasciculus	C0228271
27604681	anterior limb of the internal capsule	C0152342
27604681	corpus callosum	C0010090
27604681	brain regions	C1273723
27604681	affective disorders	C0001723
27604681	mono	C0041432
27604681	dizygotic twins	C0041429
27604681	co-twin	C0041427
27604681	diagnosed	C0011900
27604681	MDD	C1269683
27604681	BD	C0005586
27604681	high-risk	C1257890
27604681	healthy	C3898900
27604681	twins	C0872326
27604681	co-twin	C0041427
27604681	no familial history of	C0332123
27604681	affective disorders	C0001723
27604681	diffusion tensor imaging study	C1537007
27604681	high-risk group	C1257890
27604681	fractional anisotropy	C2348041
27604681	FA	C2348041
27604681	water	C0043047
27604681	diffusion	C0012222
27604681	directionality	C1707761
27604681	radial	C0442038
27604681	diffusivity	C3899378
27604681	anterior region of corpus callosum	C0152325
27604681	low-risk group	C1257890
27604681	abnormality	C1704258
27604681	zygosity	C1710709
27604681	depressive disorder	C0011581
27604681	co-twin	C0041427
27604681	anterior callosal fiber	C0010090
27604681	FA	C2348041
27604681	high-risk group	C1257890
27604681	interhemispheric communication	C0870728
27604681	left	C0228194
27604681	right frontal regions	C0228193
27604681	mood regulation	C2370884
27604681	anterior callosal	C0010090
27604681	FA	C2348041
27604681	vulnerability	C0679109
27604681	marker	C0005516
27604681	affective disorders	C0001723
27604681	individuals	C0237401
27604681	familial risk	C0035647
27605910	Study of Aversive	C0004415
27605910	Instrumental Learning	C0009651
27605910	Strains	C1518614
27605910	Performance	C1882330
27605910	Neuroendocrine	C0027912
27605910	Immunologic Systems	C0020962
27605910	avoidance	C0870186
27605910	response	C0871261
27605910	pathological	C1521733
27605910	anxiety	C0003467
27605910	normal daily functions	C0542341
27605910	performance	C1882330
27605910	active avoidance	C0871637
27605910	AA	C0871637
27605910	rat strains	C1514734
27605910	Sprague-Dawley	C2699239
27605910	SD	C2699239
27605910	Wistar	C2700262
27605910	performers	C1550480
27605910	evaluated	C0220825
27605910	anxiety	C0003467
27605910	traits	C0599883
27605910	elevated plus maze	C0870866
27605910	EPM	C0870866
27605910	corticosterone levels	C0857657
27605910	motor activity	C0234130
27605910	open field test	C0022885
27605910	plasma levels	C0022885
27605910	Interleukin-6	C0021760
27605910	IL-6	C0021760
27605910	Interleukin-1Beta	C0021753
27605910	IL-1beta	C0021753
27605910	Nerve Growth Factor Beta	C0027753
27605910	NGF-beta	C0027753
27605910	Tumor Necrosis Factor-Alpha	C0041368
27605910	TNF-alpha	C0041368
27605910	cytokine-induced neutrophil chemoattractant 1	C0378112
27605910	CINC-1	C0378112
27605910	performers	C1550480
27605910	immunologic system	C0020962
27605910	aversive learning	C0004415
27605910	Behavioral criteria	C2986890
27605910	subpopulations	C1257890
27605910	SD	C0034715
27605910	Wistar rats	C0034716
27605910	behavioral scores	C2986890
27605910	AA	C0871637
27605910	test	C0392366
27605910	animals	C0003062
27605910	tested	C0392366
27605910	anxiety	C0003467
27605910	behavior	C0004927
27605910	EPM	C0870866
27605910	motor activity	C0234130
27605910	open-field test	C0022885
27605910	Plasma corticosterone levels	C0857657
27605910	measured	C0444706
27605910	avoidance	C0870186
27605910	test	C0392366
27605910	Cytokine levels	C2699541
27605910	IL-6	C0021760
27605910	IL-1beta	C0021753
27605910	NGF-beta	C0027753
27605910	TNF-alpha	C0041368
27605910	CINC-1	C0378112
27605910	measured	C0444706
27605910	plasma	C0032105
27605910	Wistar rats	C0034716
27605910	Wistar rats	C0034716
27605910	SD rats	C0034715
27605910	performance	C1882330
27605910	associated with	C0332281
27605910	anxiety	C0003467
27605910	behavior	C0004927
27605910	EPM	C0870866
27605910	performers	C1550480
27605910	levels of corticosterone	C0857657
27605910	control animals	C1511501
27605910	corticosterone levels	C0857657
27605910	hypocortisolism	C0001403
27605910	performance	C1882330
27605910	CINC-1	C0378112
27605910	levels	C0441889
27605910	performers	C1550480
27605910	immunologic system	C0020962
27605910	activation	C1879547
27605910	learning deficits	C0851265
27605910	complex	C0439855
27605910	interactions	C1704675
27605910	neuroimmune	C0682644
27605910	consequences	C0686907
27605910	performance	C1882330
27609696	Costing	C0220812
27609696	healthy' food baskets	C0453857
27609696	Australia	C0004340
27609696	systematic review	C1955832
27609696	food	C0016452
27609696	price	C0080045
27609696	affordability	C0814630
27609696	monitoring tools	C0282574
27609696	protocols	C0442711
27609696	methods	C0025663
27609696	systematic review	C1955832
27609696	similarities	C2348205
27609696	differences	C1705242
27609696	metrics	C0025867
27609696	results	C1274040
27609696	recently	C0332185
27609696	currently	C0521116
27609696	tools	C0282574
27609696	protocols	C0442711
27609696	methods	C0025663
27609696	monitoring	C1283169
27609696	Australian	C0004340
27609696	healthy food	C0453857
27609696	prices	C0080045
27609696	affordability	C0814630
27609696	Electronic databases	C0242356
27609696	peer-reviewed literature	C0023866
27609696	online grey literature	C0023866
27609696	systematically	C0220922
27609696	searched	C1706202
27609696	PRISMA	C0242481
27609696	articles	C1706852
27609696	reports	C0684224
27609696	healthy food	C0453857
27609696	diet price assessment tools	C0282574
27609696	protocols	C0442711
27609696	methods	C0025663
27609696	results	C1274040
27609696	retail pricing	C0080045
27609696	National	C0681784
27609696	state	C1301808
27609696	regional	C0205147
27609696	local areas	C0017446
27609696	Australia	C0004340
27609696	Assessment tools	C0282574
27609696	protocols	C0442711
27609696	methods	C0025663
27609696	measure	C0079809
27609696	price	C0080045
27609696	'healthy' foods	C0453857
27609696	diets	C0012155
27609696	identified	C0205396
27609696	surveys	C0038951
27609696	healthy' food	C0453857
27609696	pricing	C0080045
27609696	food pricing tools	C0282574
27609696	multiple areas	C4266465
27609696	time periods	C1948053
27609696	minor	C0205165
27609696	food pricing tools	C0282574
27609696	single survey area	C0445260
27609696	time period	C1948053
27609696	Analysis	C0936012
27609696	methodological	C3266812
27609696	differences	C1705242
27609696	included	C0332257
27609696	foods	C0016452
27609696	reference households	C0020052
27609696	availability	C0470187
27609696	quality measures	C3242457
27609696	household income	C0557163
27609696	sources	C0449416
27609696	store	C0680165
27609696	sampling methods	C0449370
27609696	data collection	C0010995
27609696	protocols	C0442711
27609696	analysis methods	C3900047
27609696	results	C1274040
27609696	Healthy' food	C0453857
27609696	price	C0080045
27609696	assessment	C1516048
27609696	methods	C0025663
27609696	Australia	C0004340
27609696	lack	C0332268
27609696	comparability	C1707455
27609696	metrics	C0025867
27609696	healthy' diet	C0012155
27609696	recommended	C0034866
27609696	Australian Dietary Guidelines	C3658297
27609696	Assessment	C1516048
27609696	price	C0080045
27609696	price differential	C1549478
27609696	affordability	C0814630
27609696	healthy	C0452415
27609696	recommended	C0034866
27609696	current	C0521116
27609696	(unhealthy) diets	C3805118
27609696	provide	C1999230
27609696	robust	C2986815
27609696	data	C1511726
27609696	health and fiscal policy	C0681005
27609696	Australia	C0004340
27609696	INFORMAS	C0282574
27609696	optimal	C2698651
27609696	potential	C3245505
27609696	development	C1527148
27609696	methods	C0025663
27610122	Consecutive	C1707491
27610122	Endovascular Treatment	C2936204
27610122	Ruptured	C0443294
27610122	Small	C0700321
27610122	Anterior Communicating Artery Aneurysms	C0740386
27610122	Small	C0700321
27610122	aneurysms	C0740386
27610122	anterior communicating artery	C0149562
27610122	anatomy	C0700276
27610122	endovascular technologies	C2936204
27610122	coil embolization	C0189713
27610122	small	C0700321
27610122	aneurysm	C0740386
27610122	treatment	C1522326
27610122	safety	C0036043
27610122	efficacy	C1280519
27610122	small	C0700321
27610122	anterior communicating artery aneurysms	C0740386
27610122	long-term clinical	C0085415
27610122	radiographic outcomes	C0085415
27610122	consecutive	C1707491
27610122	patients	C0030705
27610122	ruptured	C0443294
27610122	small	C0700321
27610122	anterior communicating artery aneurysms	C0740386
27610122	endovascular coil embolization techniques	C0189713
27610122	neuroendovascular database	C0242356
27610122	small	C0700321
27610122	ruptured	C0443294
27610122	anterior communicating artery aneurysms	C0740386
27610122	patients	C0030705
27610122	ruptured	C0443294
27610122	small	C0700321
27610122	anterior communicating artery aneurysms	C0740386
27610122	consecutively	C1707491
27610122	coil embolization	C0189713
27610122	diameter	C1301886
27610122	aneurysm occlusion	C0189724
27610122	aneurysms	C0740386
27610122	aneurysm occlusion	C0189724
27610122	aneurysms	C0740386
27610122	Intraoperative	C0456904
27610122	perforation	C0549099
27610122	patients	C0030705
27610122	clinical worsening	C1546960
27610122	external ventricular drain	C0844106
27610122	thromboembolic event	C0040038
27610122	patient	C0030705
27610122	clinical worsening	C1546960
27610122	radiologic infarct	C0021308
27610122	follow-up	C1522577
27610122	months	C0439231
27610122	follow-up	C1522577
27610122	months	C0439231
27610122	consecutive	C1707491
27610122	endovascular treatments	C2936204
27610122	ruptured	C0443294
27610122	small	C0700321
27610122	anterior communicating artery aneurysms	C0740386
27610122	coil embolization	C0189713
27610122	small	C0700321
27610122	aneurysms	C0740386
27610122	location	C0450429
27610122	complications	C0009566
27610122	recanalization	C0034771
27613669	Factors	C1521761
27613669	affecting	C0392760
27613669	formation	C1522492
27613669	nitrogenous disinfection	C0012683
27613669	by-products	C0684298
27613669	chlorination	C2728946
27613669	aspartic acid	C0004015
27613669	drinking water	C0599638
27613669	formation	C1522492
27613669	nitrogenous disinfection	C0012683
27613669	by-products	C0684298
27613669	N-DBPs	C0684298
27613669	chlorination	C2728946
27613669	aspartic acid	C0004015
27613669	Asp	C0004015
27613669	investigated	C1292732
27613669	dichloroacetonitrile	C0057843
27613669	DCAN	C0057843
27613669	N-DBPs	C0684298
27613669	dichloroacetamide	C0045293
27613669	DCAcAm	C0045293
27613669	chloropicrin	C0055437
27613669	TCNM	C0055437
27613669	chlorination	C2728946
27613669	Asp	C0004015
27613669	formation	C1522492
27613669	DCAN	C0057843
27613669	DCAcAm	C0045293
27613669	TCNM	C0055437
27613669	increasing	C0442808
27613669	decreasing	C0442797
27613669	chlorination	C2728946
27613669	Asp	C0004015
27613669	increasing	C0442808
27613669	contact time	C1254367
27613669	dosage	C0178602
27613669	chlorine	C0008209
27613669	formation	C1522492
27613669	DCAN	C0057843
27613669	DCAcAm	C0045293
27613669	TCNM	C0055437
27613669	yields	C0392762
27613669	DCAN	C0057843
27613669	DCAcAm	C0045293
27613669	Cl2	C0008209
27613669	Asp	C0004015
27613669	molar ratio	C2825550
27613669	yield	C0392762
27613669	TCNM	C0055437
27613669	increased	C0205217
27613669	increasing	C0442808
27613669	Cl2	C0008209
27613669	Asp	C0004015
27613669	molar ratio	C2825550
27613669	TCNM	C0055437
27613669	ratio	C2825550
27613669	Cyanogen chloride	C0056659
27613669	CNCl	C0056659
27613669	Cl2	C0008209
27613669	Asp	C0004015
27613669	molar ratio	C2825550
27613669	N-DBPs	C0684298
27613669	formation	C1522492
27613669	pH	C0020283
27613669	DCAN	C0057843
27613669	formation	C1522492
27613669	increased	C0205217
27613669	increasing	C0442808
27613669	pH	C0020283
27613669	decreased	C0205216
27613669	increasing	C0442808
27613669	pH	C0020283
27613669	DCAcAm	C0045293
27613669	TCNM	C0055437
27613669	increased	C0205217
27613669	increasing	C0442808
27613669	pH	C0020283
27613669	decreased	C0205216
27613669	temperatures	C0039476
27613669	reduced	C0392756
27613669	formation	C1522492
27613669	DCAN	C0057843
27613669	DCAcAm	C0045293
27613669	increased	C0205217
27613669	TCNM	C0055437
27613669	formation	C1522492
27613669	DCAN	C0057843
27613669	DCAcAm	C0045293
27613669	formation	C1522492
27613669	decreased	C0205216
27613669	stable	C0205360
27613669	TCNM	C0055437
27613669	formation	C1522492
27613669	increased	C0205217
27613669	increasing	C0442808
27613669	chlorine	C0008209
27613669	contact time	C1254367
27613669	chloramination	C1254366
27613669	N-nitrosodimethylamine	C0012431
27613669	NDMA	C0012431
27613669	chloramination	C1254366
27613669	Asp	C0004015
27613669	increased	C0205217
27613669	prolonged	C0439590
27613669	chloramination	C1254366
27613669	contact time	C1254367
27613669	bromide ions	C3848571
27613669	enhanced	C2349975
27613669	yields	C0392762
27613669	haloacetonitriles	C0001004
27613669	N-DBPs	C0684298
27613669	brominated species	C0029224
27614145	Midodrine	C0026078
27614145	tolvaptan	C1176308
27614145	patients	C0030705
27614145	cirrhosis	C0023890
27614145	refractory	C3532188
27614145	recurrent ascites	C0741243
27614145	randomised	C0034656
27614145	pilot study	C0031928
27614145	Splanchnic arterial vasodilatation	C1372887
27614145	sodium	C0020488
27614145	water retention	C0542203
27614145	cirrhotic ascites	C0401037
27614145	Midodrine	C0026078
27614145	tolvaptan	C1176308
27614145	patients	C0030705
27614145	combination	C0013218
27614145	midodrine	C0026078
27614145	tolvaptan	C1176308
27614145	ascites	C0401037
27614145	evaluate	C0220825
27614145	safety	C0036043
27614145	efficacy	C1280519
27614145	midodrine	C0026078
27614145	tolvaptan	C1176308
27614145	combination	C0013218
27614145	refractory	C3532188
27614145	recurrent ascites	C0741243
27614145	cirrhotics	C0023890
27614145	cirrhotic	C0439686
27614145	patients	C0030705
27614145	refractory	C3532188
27614145	recurrent ascites	C0741243
27614145	randomised	C0034656
27614145	midodrine	C0026078
27614145	tolvaptan	C1176308
27614145	medical therapy	C0418981
27614145	SMT	C0418981
27614145	SMT	C0418981
27614145	significant increase in urinary volume	C1287298
27614145	urinary sodium	C3671887
27614145	months	C0439231
27614145	groups	C1257890
27614145	SMT	C0418981
27614145	worsening	C0332271
27614145	renal	C0232805
27614145	hepatic function	C0232741
27614145	group	C1257890
27614145	deterioration	C0868945
27614145	model for end-stage liver disease	C3826979
27614145	MELD	C3826979
27614145	Midodrine	C0026078
27614145	combination	C0013218
27614145	midodrine	C0026078
27614145	tolvaptan	C1176308
27614145	tolvaptan	C1176308
27614145	SMT	C0418981
27614145	ascites	C0401037
27614145	months	C0439231
27614145	combination therapy	C0013218
27614145	midodrine	C0026078
27614145	ascites	C0401037
27614145	month	C0439231
27614145	morbidity	C0026538
27614145	mortality	C0205848
27614145	groups	C1257890
27614145	SMT	C0418981
27614145	pilot study	C0031928
27614145	midodrine	C0026078
27614145	combination	C0013218
27614145	tolvaptan	C1176308
27614145	ascites	C0401037
27614145	renal	C1565489
27614145	hepatic dysfunction	C0086565
27614145	combination therapy	C0013218
27614145	ascites	C0401037
27614145	midodrine	C0026078
27614145	tolvaptan	C1176308
27618138	Acute Complicated Sinusitis	C0149512
27618138	Years	C0439234
27618138	Experience	C0596545
27618138	University Hospital	C0020028
27618138	West Indies	C0043122
27618138	Complicated sinusitis	C0149512
27618138	rare	C0678236
27618138	patient	C0030705
27618138	unfavourable outcome	C1274040
27618138	data	C1511726
27618138	condition	C0012634
27618138	Caribbean	C0043122
27618138	study	C2603343
27618138	clinical characteristics	C0683325
27618138	treatment outcomes	C0085415
27618138	patients	C0030705
27618138	admitted	C0184666
27618138	condition	C0012634
27618138	retrospective	C1514923
27618138	chart review	C0553620
27618138	patients	C0030705
27618138	admitted	C0184666
27618138	University Hospital of the West Indies	C0020028
27618138	UHWI	C0020028
27618138	complicated sinusitis	C0149512
27618138	data	C1511726
27618138	analysed	C0936012
27618138	SPSS statistics 22 software	C0600673
27618138	patients	C0030705
27618138	males	C0086582
27618138	females	C0086287
27618138	mean	C0444504
27618138	SD	C0871420
27618138	age	C0001779
27618138	years	C1510829
27618138	orbital	C0029180
27618138	complications	C0009566
27618138	intracranial	C0524466
27618138	complications	C0009566
27618138	common	C0205214
27618138	organisms	C0029235
27618138	isolated	C0205409
27618138	streptococcus	C0038402
27618138	common	C0205214
27618138	sensitivity	C0237865
27618138	amoxicillin	C0002645
27618138	clavulinic acid	C0055860
27618138	patients	C0030705
27618138	external	C0205101
27618138	surgical approach	C0449446
27618138	mean	C0444504
27618138	SD	C0871420
27618138	hospital stay	C3489408
27618138	days	C0439228
27618138	patients	C0030705
27618138	endoscopic approach	C0442418
27618138	mean	C0444504
27618138	SD	C0871420
27618138	hospital stay	C3489408
27618138	days	C0439228
27618138	no	C0205160
27618138	statistical difference	C1705241
27618138	mean	C0444504
27618138	hospital stay	C3489408
27618138	groups	C0441833
27618138	mean	C0444504
27618138	duration	C0449238
27618138	hospital stay	C3489408
27618138	treated medically	C0237726
27618138	days	C0439228
27618138	days	C0439228
27618138	surgical	C0449446
27618138	group	C0441833
27618138	mean	C0444504
27618138	difference	C1705241
27618138	days	C0439228
27618138	Acute complicated sinusitis	C0149512
27618138	commonly	C0205214
27618138	adolescent males	C0001589
27618138	common	C0205214
27618138	complication	C0009566
27618138	orbital	C0029180
27618138	Surgical treatment	C0543467
27618138	patients	C0030705
27618138	fail	C0231175
27618138	medical	C0205476
27618138	management	C1273870
27618138	endoscopic approach	C0442418
27619227	proteomic analysis	C0022885
27619227	alterations	C1515926
27619227	development	C0597252
27619227	photosynthesis	C0031764
27619227	proteins	C0033684
27619227	diploid	C0012568
27619227	triploid	C3536727
27619227	rice	C1140671
27619227	Polyploidy	C0032578
27619227	influences	C4054723
27619227	rice	C1140671
27619227	Oryza sativa L.	C1140671
27619227	morphology	C0332437
27619227	physiology	C0031843
27619227	rice	C1140671
27619227	domestication	C0175819
27619227	agricultural traits	C0599883
27619227	Diploid	C0012568
27619227	DP	C0012568
27619227	triploid	C3536727
27619227	TP	C3536727
27619227	rice	C1140671
27619227	differences	C1705242
27619227	morphological	C0332437
27619227	parameters	C0449381
27619227	plant	C0032098
27619227	height	C0489786
27619227	leaf	C0242724
27619227	length	C1444754
27619227	leaf	C0242724
27619227	width	C0487742
27619227	physiological	C0205463
27619227	index	C0918012
27619227	chlorophyll	C0008260
27619227	content	C0456205
27619227	mechanisms	C0441712
27619227	morphological	C0332437
27619227	differences	C1705242
27619227	proteomic	C0033684
27619227	changes	C0392747
27619227	DP	C0012568
27619227	TP	C3536727
27619227	tandem mass tags (TMT) mass spectrometry (MS)	C2123592
27619227	MS	C0037813
27619227	changes	C0392747
27619227	protein expression	C1171362
27619227	DP	C0012568
27619227	TP	C3536727
27619227	photosynthesis	C0031764
27619227	metabolic pathways	C1291081
27619227	associated with	C0332281
27619227	proteomic alteration	C1514563
27619227	DP	C0012568
27619227	TP	C3536727
27619227	biological process	C3714634
27619227	pathway enrichment analysis	C0022885
27619227	abundance	C2346714
27619227	chloroplast proteins	C3178938
27619227	pathways	C1704259
27619227	identified	C0205396
27619227	TP	C3536727
27619227	Quantitative real-time PCR analysis	C3179034
27619227	chloroplast proteins	C3178938
27619227	ATPF	C0033684
27619227	PSAA	C0033684
27619227	PSAB	C0084235
27619227	PSBB	C0033684
27619227	RBL	C0033684
27619227	TP	C3536727
27619227	abundance	C2346714
27619227	DP	C0012568
27619227	study	C2603343
27619227	morphology	C0332437
27619227	physiology	C0031843
27619227	proteomic profiling	C1327760
27619227	alteration	C1515926
27619227	DP	C0012568
27619227	TP	C3536727
27619227	molecular mechanisms	C3537153
27619227	ATPF	C0033684
27619227	PSAA	C0033684
27619227	PSAB	C0084235
27619227	PSBB	C0033684
27619227	RBL	C0033684
27619227	expression	C1171362
27619227	changes	C0392747
27619227	TP	C3536727
27619227	development	C0597252
27619227	growth	C0597252
27619227	rice	C1140671
27619227	photosynthesis	C0031764
27619227	metabolic pathways	C1291081
27621870	Correlation	C1707520
27621870	cardiopulmonary exercise testing	C2959886
27621870	parameters	C0549193
27621870	quality of life	C0034380
27621870	stable	C0677946
27621870	COPD	C0024117
27621870	patients	C0030705
27621870	relationships	C0439849
27621870	Cardio-pulmonary exercise testing	C2959886
27621870	CPET	C2959886
27621870	parameters	C0549193
27621870	patients	C0030705
27621870	daily symptoms	C0436354
27621870	activities	C0871707
27621870	disease	C0012634
27621870	social	C0162468
27621870	emotional impact	C1514593
27621870	correlation	C1707520
27621870	COPD	C0024117
27621870	daily symptoms	C0436354
27621870	quality of life	C0034380
27621870	St. George's Respiratory Questionnaire	C0451500
27621870	SGRQ	C0451500
27621870	COPD	C0024117
27621870	severity index	C4053940
27621870	BODE-index	C4053940
27621870	CPET	C2959886
27621870	parameters	C0549193
27621870	Symptom	C1457887
27621870	CPET	C2959886
27621870	consecutive	C1707491
27621870	COPD	C0024117
27621870	GOLD I-III	C0699749
27621870	exacerbation	C0740304
27621870	phase	C0205390
27621870	SGRQ	C0451500
27621870	patient	C0030705
27621870	SGRQ-score	C3472502
27621870	correlated	C1707520
27621870	negatively	C0205160
27621870	FEV1	C0849974
27621870	predicted	C0681842
27621870	maximal work-rate	C0744679
27621870	%WR-max	C0744679
27621870	V'O2	C0429627
27621870	WR	C0018810
27621870	breathing reserve	C0392762
27621870	did not correlate	C0243095
27621870	Peak-V'O2	C0429693
27621870	leg fatigue was the main cause for stopping the test	C2036296
27621870	Peak-V'O2	C0429693
27621870	%WR-max	C0744679
27621870	HR-Reserve	C0392762
27621870	Breathing reserve	C0392762
27621870	significant	C0237881
27621870	correlation	C1707520
27621870	BODE-index	C4053940
27621870	∆VO2	C0429627
27621870	∆WR	C0018810
27621870	breathing-reserve	C0392762
27621870	relationships	C0439849
27621870	CPET	C2959886
27621870	parameter	C0549193
27621870	daily	C0332173
27621870	subjective complaints	C2936631
27621870	COPD	C0024117
27621870	CPET	C2959886
27621870	because of leg fatigue	C2036296
27621870	earlier stages	C2363430
27621870	COPD	C0024117
27621870	negative	C0205160
27621870	correlation	C1707520
27621870	∆VO2	C0429627
27621870	∆WR	C0018810
27621870	BODE-index	C4053940
27621870	COPD	C0024117
27621870	progression	C0242656
27621870	negative past history	C3699386
27621870	comorbidities	C0009488
27621870	cardiac	C0262402
27621870	musculoskeletal problems	C0026859
27621953	Intrapartum	C0456337
27621953	Cervical Laceration	C0007851
27621953	Pregnancy Outcomes	C0032972
27621953	objective	C0018017
27621953	study	C2603343
27621953	pregnancy outcomes	C0032972
27621953	cervical insufficiency	C1401059
27621953	preterm birth	C0151526
27621953	pregnancy	C0032961
27621953	following	C0332282
27621953	intrapartum	C0456337
27621953	cervical laceration	C0007851
27621953	cohort	C0599755
27621953	women	C0043210
27621953	consecutive	C1707491
27621953	singleton pregnancies	C0341899
27621953	weeks	C0439230
27621953	gestation	C0032961
27621953	tertiary health care system	C0018696
27621953	Cervical laceration	C0007851
27621953	cases	C1706256
27621953	identified	C0205396
27621953	ICD9 codes	C1550213
27621953	included	C0332257
27621953	suture repair	C0087111
27621953	required	C1514873
27621953	study	C2603343
27621953	women	C0043210
27621953	confirmed	C0750484
27621953	cervical laceration	C0007851
27621953	delivery	C0005615
27621953	lacerations	C0043246
27621953	vaginal delivery	C1541822
27621953	(VD)	C1541822
27621953	cesarean delivery	C0007876
27621953	(CD)	C0007876
27621953	median	C0876920
27621953	gestational age	C0017504
27621953	delivery	C0005615
27621953	weeks	C0439230
27621953	median	C0876920
27621953	birth weight	C0005612
27621953	differ	C1705242
27621953	VD	C1541822
27621953	CD	C0007876
27621953	pregnancy	C0032961
27621953	women	C0043210
27621953	prophylactic	C0445202
27621953	cerclage	C0195681
27621953	carried	C0206243
27621953	term	C0233324
27621953	delivered	C0151526
27621953	weeks	C0439230
27621953	total	C0439810
27621953	women	C0043210
27621953	delivered	C0151526
27621953	pregnancy	C0032961
27621953	weeks	C0439230
27621953	prior	C0332152
27621953	term	C0233324
27621953	VD	C1541822
27621953	prior	C0332152
27621953	weeks	C0439230
27621953	VD	C1541822
27621953	case	C1706256
27621953	recurrent	C2945760
27621953	cervical laceration	C0007851
27621953	occurring	C1709305
27621953	setting	C0868928
27621953	vaginal deliveries	C1541822
27621953	Obstetric	C0205484
27621953	cervical lacerations	C0007851
27621953	uncommon	C0522498
27621953	Complications	C0009566
27621953	following	C0332282
27621953	pregnancy	C0032961
27621953	low	C0205251
27621953	lack	C0332268
27621953	prophylactic	C0445202
27621953	cerclage	C0195681
27623760	Wnt Pathway	C1520113
27623760	Activator	C3659232
27623760	Induces Apoptosis	C1326205
27623760	Cell Death	C0007587
27623760	Mouse Monocytic Leukemia	C1521831
27623760	Cells	C0007634
27623760	Wnt agonist,	C3659232
27623760	2-amino-4-[3,4-(methylenedioxy)benzylamino]-6-(3-methoxyphenyl) pyrimidine	C3659232
27623760	cell-permeable	C0007605
27623760	pyrimidine compound	C3659232
27623760	Wnt	C0753137
27623760	leukemic mouse cell lines	C1517806
27623760	RAW 264.7	C4042840
27623760	J774.1	C1517806
27623760	Wnt agonist	C3659232
27623760	Wnt agonist	C3659232
27623760	cell death	C0007587
27623760	Wnt agonist	C3659232
27623760	inhibition	C3463820
27623760	GSK-3β	C0244988
27623760	activity	C0243102
27623760	induced	C0205263
27623760	β-catenin accumulation	C1511110
27623760	nucleus	C0007610
27623760	Wnt agonist	C3659232
27623760	caspase-independent cell death	C3820502
27623760	cell death ER stress signaling	C2610698
27623760	Wnt agonist	C3659232
27623760	induced apoptotic cell death	C1326205
27623760	RAW 264.7 cells	C4042840
27625333	Extracorporeal membrane oxygenation	C0015357
27625333	outcomes	C1274040
27625333	children	C0008059
27625333	hemophagocytic lymphohistiocytosis	C0024291
27625333	Pediatric	C1521725
27625333	patients	C0030705
27625333	hemophagocytic lymphohistiocytosis	C0024291
27625333	HLH	C0024291
27625333	refractory	C0205269
27625333	respiratory	C1145670
27625333	cardiac failure	C0018801
27625333	consideration	C0518609
27625333	extracorporeal membrane oxygenation	C0015357
27625333	ECMO	C0015357
27625333	support	C0183683
27625333	purposes	C1285529
27625333	study	C0008972
27625333	use	C0457083
27625333	outcomes	C0085415
27625333	ECMO	C0015357
27625333	pediatric	C1521725
27625333	HLH	C0024291
27625333	patients	C0030705
27625333	identify	C0205396
27625333	risk factors	C0035648
27625333	hospital mortality	C0085556
27625333	compare	C1707455
27625333	ECMO	C0015357
27625333	use	C0457083
27625333	outcomes	C0085415
27625333	ECMO	C0015357
27625333	population	C1257890
27625333	Pediatric	C1521725
27625333	patients	C0030705
27625333	years	C1510829
27625333	diagnosis	C0011900
27625333	HLH	C0024291
27625333	Extracorporeal Life Support Organization	C3161508
27625333	ELSO	C3161508
27625333	Registry	C0034975
27625333	included	C0332257
27625333	data	C1511726
27625333	children	C0008059
27625333	HLH	C0024291
27625333	ELSO	C3161508
27625333	registry	C0034975
27625333	included	C0332257
27625333	study	C0008972
27625333	cases	C1706256
27625333	occurred	C1709305
27625333	last	C0205156
27625333	decade	C2981279
27625333	HLH	C0024291
27625333	patients	C0030705
27625333	respiratory	C1145670
27625333	indication	C3146298
27625333	ECMO	C0015357
27625333	cardiac	C0018801
27625333	indication	C3146298
27625333	E	C0442087
27625333	CPR	C0007203
27625333	cardiac failure	C0018801
27625333	respiratory	C1145670
27625333	ECMO	C0015357
27625333	patients	C0030705
27625333	VA ECMO	C3863606
27625333	Compared	C1707455
27625333	pediatric	C1521725
27625333	patients	C0030705
27625333	ELSO	C3161508
27625333	registry	C0034975
27625333	study period	C0489652
27625333	HLH	C0024291
27625333	patients	C0030705
27625333	hospital survival	C0220921
27625333	HLH	C0024291
27625333	p	C1709380
27625333	pediatric	C1521725
27625333	HLH	C0024291
27625333	patients	C0030705
27625333	ECMO	C0015357
27625333	risk factors	C0035648
27625333	mortality	C0178686
27625333	identified	C0205396
27625333	development	C1527148
27625333	hemorrhagic	C0333275
27625333	complication	C0009566
27625333	ECMO	C0015357
27625333	associated with	C0332281
27625333	decreased	C0547047
27625333	mortality	C0178686
27625333	p	C1709380
27625333	Comparing	C1707455
27625333	HLH	C0024291
27625333	patients	C0030705
27625333	respiratory failure	C1145670
27625333	patients	C0030705
27625333	immune compromised conditions	C4284394
27625333	survival rate	C0038954
27625333	HLH	C0024291
27625333	immune compromised	C4284394
27625333	p	C1709380
27625333	HLH	C0024291
27625333	uncommon	C0522498
27625333	indication	C3146298
27625333	ECMO	C0015357
27625333	patients	C0030705
27625333	increased	C0205217
27625333	mortality	C0178686
27625333	compared	C1707455
27625333	pediatric	C1521725
27625333	ECMO	C0015357
27625333	population	C1257890
27625333	data	C1511726
27625333	decision-making	C0011109
27625333	ECMO	C0015357
27625333	pediatric	C1521725
27625333	HLH	C0024291
27625333	patients	C0030705
27625705	Gut microbiome	C2985398
27625705	alterations	C1515926
27625705	patients	C0030705
27625705	stage 4	C0205585
27625705	hepatitis C	C0019196
27625705	Hepatitis C virus	C0220847
27625705	HCV	C0220847
27625705	liver diseases	C0023895
27625705	cirrhosis	C0023890
27625705	cancer	C0006826
27625705	worldwide	C0043236
27625705	HCV	C0220847
27625705	epidemiology	C0002783
27625705	pathophysiology	C0277785
27625705	therapy	C0039798
27625705	reciprocal interactions	C0596935
27625705	HCV infection	C4288963
27625705	HCV	C0220847
27625705	chronic liver diseases	C0341439
27625705	human	C0086418
27625705	gut microbiome	C2985398
27625705	Egypt	C0013715
27625705	world's	C2700280
27625705	highest prevalence	C1512456
27625705	HCV infections	C4288963
27625705	study	C2603343
27625705	gut microbial community	C2985398
27625705	composition	C0486616
27625705	Egyptian	C0337801
27625705	HCV	C0220847
27625705	patients	C0030705
27625705	patients	C0030705
27625705	liver	C0023884
27625705	state	C1442792
27625705	stool samples	C1550661
27625705	stage 4	C0205585
27625705	HCV	C0220847
27625705	patients	C0030705
27625705	healthy individuals	C1708335
27625705	high-throughput	C0872186
27625705	16S rRNA gene sequencing	C1294197
27625705	Illumina MiSeq	C0348000
27625705	alpha-diversity	C0282469
27625705	healthy persons'	C1708335
27625705	gut microbiomes	C2985398
27625705	higher	C0205250
27625705	HCV	C0220847
27625705	patients	C0030705
27625705	phylum Bacteroidetes	C0995456
27625705	HCV	C0220847
27625705	patients	C0030705
27625705	healthy individuals	C1708335
27625705	higher	C0205250
27625705	abundance	C2346714
27625705	Firmicutes	C1254144
27625705	Proteobacteria	C0751985
27625705	Actinobacteria	C0600148
27625705	Genus	C1708235
27625705	analysis	C0936012
27625705	abundance	C2346714
27625705	Prevotella	C0242946
27625705	Faecalibacterium	C1229075
27625705	higher	C0205250
27625705	HCV	C0220847
27625705	patients	C0030705
27625705	Ruminococcus	C0318074
27625705	Clostridium	C0009054
27625705	healthy group	C0441833
27625705	higher	C0205250
27625705	abundance	C2346714
27625705	Bacteroidetes	C0995456
27625705	HCV	C0220847
27625705	patients	C0030705
27625705	Prevotella	C0242946
27625705	overabundance	C2346714
27625705	probiotic genus	C0525033
27625705	Bifidobacterium	C0005380
27625705	microbiotas	C2985398
27625705	healthy individuals	C1708335
27625705	study	C2603343
27625705	phyla	C1709533
27625705	genera	C1708235
27625705	stage 4	C0205585
27625705	HCV	C0220847
27625705	patients	C0030705
27625705	healthy individuals	C1708335
27625705	microbiome	C1956108
27625705	chronic hepatitis C	C0524910
27625705	bacterial translocation	C0282583
27625705	liver's	C0023884
27625705	impaired role	C0231410
27625705	digestion	C0012238
27625705	protein synthesis	C0597295
27625705	microbiome	C1956108
27625705	composition	C0486616
27625705	capabilities	C2698977
27625705	patients	C0030705
27625705	biomarker	C0005516
27625705	Prevotella	C0242946
27625705	Faecalibacterium	C1229075
27625705	Bifidobacterium	C0005380
27626099	Peptide	C0030956
27626099	Interference	C0042730
27626099	PB2	C0753209
27626099	eIF4G1	C1505487
27626099	Interaction	C0872079
27626099	Inhibits	C3463820
27626099	Influenza A Viruses	C0029347
27626099	Replication	C0042774
27626099	in Vitro	C0681828
27626099	in Vivo	C0681829
27626099	Influenza viruses	C0029341
27626099	obligate parasites	C0562628
27626099	hijack the host cellular system	C1154502
27626099	influenza virus PB2	C1611366
27626099	host eukaryotic translation initiation factor 4-γ 1	C1505487
27626099	eIF4G1	C1505487
27626099	viral mRNA translation	C1154505
27626099	peptide	C0030956
27626099	interference	C0042730
27626099	PB2	C0753209
27626099	eIF4G1	C1505487
27626099	interaction	C0872079
27626099	inhibited	C3463820
27626099	virus replication	C0042774
27626099	in vitro	C0681828
27626099	in vivo	C0681829
27626099	intranasal administration	C0001560
27626099	peptide	C0030956
27626099	protection	C1545588
27626099	lethal	C3151529
27626099	challenges	C0805586
27626099	influenza A viruses	C0029347
27626099	BALB/c mice	C0025919
27626099	H1N1	C1615607
27626099	H5N1	C1613950
27626099	H7N9 influenza virus subtypes	C3658219
27626099	Mapping	C0949728
27626099	PB2 protein	C0753209
27626099	eIF4G1	C1505487
27626099	binding sites	C0005456
27626099	PB2 cap	C0753209
27626099	binding domain	C1149343
27626099	Virtual docking analysis	C3494274
27626099	inhibitory	C3463820
27626099	peptide	C0030956
27626099	associated with	C0332281
27626099	amino acid residues	C0002520
27626099	PB2	C0753209
27626099	cap-binding activity	C0201711
27626099	PB2	C0753209
27626099	eIF4G1	C1505487
27626099	interactive site	C0005456
27626099	druggable	C1254351
27626099	influenza	C0021400
27626099	therapeutics	C0087111
27626498	DRG1	C1414151
27626498	oncogene	C0029016
27626498	lung adenocarcinoma	C0152013
27626498	promotes	C0033414
27626498	tumor progression	C0178874
27626498	spindle checkpoint signaling	C3156402
27626498	regulation	C1327622
27626498	GTP binding protein 1	C1430718
27626498	DRG1	C0905573
27626498	DRG family	C1335532
27626498	regulating cell growth	C0596286
27626498	molecular basis	C1853126
27626498	DRG1	C0905573
27626498	cell proliferation regulation	C1156235
27626498	DRG1	C0905573
27626498	tumor progression	C0178874
27626498	DRG1	C0905573
27626498	lung adenocarcinomas	C0152013
27626498	expressed	C1171362
27626498	lung	C0024109
27626498	tissues	C0040300
27626498	DRG1	C1414151
27626498	knockdown	C2350567
27626498	growth inhibition	C2244509
27626498	tumor cells	C0597032
27626498	cells	C0007634
27626498	M phase	C0007591
27626498	Overexpression	C1171362
27626498	DRG1	C0905573
27626498	chromosome	C0008633
27626498	missegregation	C0314627
27626498	tumorigenesis	C0007621
27626498	ectopic	C1512167
27626498	DRG1	C1414151
27626498	taxol	C0678133
27626498	induced	C0205263
27626498	apoptosis	C0162638
27626498	lung adenocarcinoma	C0152013
27626498	cells	C0007634
27626498	Mechanistic	C0598002
27626498	analyses	C0936012
27626498	DRG1	C0905573
27626498	localizes	C0392752
27626498	mitotic spindles	C0026258
27626498	dividing cells	C0230517
27626498	binds	C1167622
27626498	spindle checkpoint signaling	C3156402
27626498	proteins	C1335962
27626498	in vivo	C1515655
27626498	studies	C2603343
27626498	DRG1	C1414151
27626498	tumorigenesis	C0007621
27626498	mechanism	C0441712
27626498	DRG1	C1414151
27626498	taxol	C0678133
27627778	Gelsolin	C0061187
27627778	Onychophora	C1001576
27627778	Tardigrada	C1010027
27627778	variability	C2827666
27627778	Ecdysozoa	C3578917
27627778	Rearrangements	C0596965
27627778	filamentous actin network	C1180307
27627778	range	C1514721
27627778	actin binding proteins	C0001239
27627778	gelsolin proteins	C0061187
27627778	actin filaments	C0025979
27627778	fast growing	C4086299
27627778	nucleate	C1155976
27627778	actin assembly	C2610250
27627778	calcium	C0006675
27627778	dependent	C0851827
27627778	gelsolin	C0061187
27627778	onychophoran	C1001576
27627778	Peripatoides novaezealandiae	C1083155
27627778	eutardigrade	C1010027
27627778	Hypsibius dujardini	C1465325
27627778	cDNA	C0006556
27627778	P. novaezealandiae	C1083155
27627778	obtained	C1301820
27627778	coding sequence	C0079941
27627778	open reading frame	C0079941
27627778	bp	C0600436
27627778	encodes	C2700640
27627778	protein	C0033684
27627778	amino acids	C0002520
27627778	calculated	C1441506
27627778	molecular mass	C3152252
27627778	sequence	C0002518
27627778	comprised	C2700400
27627778	segments	C0441635
27627778	analysis	C0936012
27627778	data	C1511726
27627778	TardiBase	C0242356
27627778	reveals	C0443289
27627778	gelsolin	C0061187
27627778	eutardigrade	C1010027
27627778	Hypsibius dujardini	C1465325
27627778	segments	C0441635
27627778	coding sequence	C0079941
27627778	bp	C0600436
27627778	amino acids	C0002520
27627778	calculated	C1441506
27627778	molecular mass	C3152252
27627778	Peripatoides	C1014425
27627778	Hypsibius	C1481832
27627778	gelsolin	C0061187
27627778	revealed	C0443289
27627778	conserved	C0009802
27627778	binding motifs	C1956035
27627778	G-actin	C0016890
27627778	F-actin	C1180307
27627778	phosphatidylinositol 4,5-bisphosphate	C0070798
27627778	PIP2	C0070798
27627778	type-1	C0005456
27627778	type-2	C0005456
27627778	Ca(2+)	C0596235
27627778	binding sites	C0005456
27627778	result	C1274040
27627778	binding	C1167622
27627778	calcium ions	C0596235
27627778	gelsolin proteins	C0061187
27627778	lack	C0332268
27627778	C-terminal	C1514562
27627778	latch-helix	C1704821
27627778	rapid	C0456962
27627778	activation	C1879547
27627778	Ca(2+) range	C0201925
27627778	gelsolin	C0061187
27627778	segments	C0441635
27627778	present	C0150312
27627778	ancestor	C0870134
27627778	ecdysozoan	C3578917
27627778	Panarthropoda	C1039396
27627778	Onychophora	C1001576
27627778	Tardigrada	C1010027
27627778	Arthropoda	C0003903
27627778	primarily	C0205225
27627778	gelsolin	C0061187
27627778	studied	C2603343
27627778	Chordata	C0920312
27627778	reveals	C0443289
27627778	segments	C0441635
27627778	Mapping	C0030944
27627778	molecular data	C0026382
27627778	well-established	C0443211
27627778	phylogeny	C0031797
27627778	revealed	C0443289
27627778	gelsolin	C0061187
27627778	segments	C0441635
27627778	correlate	C1707520
27627778	phylogenetic	C0031797
27627778	lineage	C1881379
27627778	functional	C0205245
27627778	alter	C0392747
27627778	kinetics	C0022702
27627778	actin polymerization	C1155982
27628042	MiR-424-5p	C1537908
27628042	participates	C0679823
27628042	esophageal squamous cell carcinoma	C0279626
27628042	invasion	C0027626
27628042	metastasis	C0027627
27628042	SMAD7	C1334470
27628042	pathway	C0037080
27628042	EMT	C1523298
27628042	ESCC	C0279626
27628042	life-threatening	C2826244
27628042	disease	C0012634
27628042	invasion	C0027626
27628042	metastasis	C0027627
27628042	early stage	C2363430
27628042	detect	C0442726
27628042	molecular	C1521991
27628042	mechanisms	C0441712
27628042	invasion	C0027626
27628042	metastasis	C0027627
27628042	ESCC	C0279626
27628042	evidence	C3887511
27628042	deregulation	C1880287
27628042	miR-424-5p	C1537908
27628042	role	C1705810
27628042	cancers	C0006826
27628042	role	C1705810
27628042	functional	C0205245
27628042	mechanism	C0441712
27628042	ESCC	C0279626
27628042	seldom	C0522498
27628042	expression levels	C3244092
27628042	miR-424-5p	C1537908
27628042	detected	C0442726
27628042	ESCC	C0279626
27628042	tissues	C0040300
27628042	cell lines	C0085983
27628042	real-time PCR methods	C1709846
27628042	invasion	C0027626
27628042	metastasis	C0027627
27628042	proliferation	C0596290
27628042	ESCC	C0279626
27628042	cell lines	C0085983
27628042	transfected	C0314641
27628042	miR-424-5p	C1537908
27628042	analyzed	C0936012
27628042	transwell invasion assay	C1510438
27628042	wound healing assay	C1510438
27628042	cell proliferation assay	C3899698
27628042	target gene	C0017337
27628042	miR-424-5p	C1537908
27628042	verified	C1711411
27628042	luciferase activity assay	C1510438
27628042	role	C1705810
27628042	miR-424-5p	C1537908
27628042	EMT	C1523298
27628042	investigated	C1292732
27628042	real-time PCR	C1709846
27628042	western blot assay	C0949466
27628042	expression levels	C3244092
27628042	miR-424-5p	C1537908
27628042	decreased	C0205216
27628042	ESCC	C0279626
27628042	tissues	C0040300
27628042	cell lines	C0085983
27628042	expression levels	C3244092
27628042	miR-424-5p	C1537908
27628042	lymph node	C0024204
27628042	metastasis	C0027627
27628042	ESCC	C0279626
27628042	tissues	C0040300
27628042	miR-424-5p	C1537908
27628042	EC-1 cells	C0597032
27628042	miR-424-5p	C1537908
27628042	decrease	C0547047
27628042	invasion	C0027626
27628042	metastasis	C0027627
27628042	proliferation	C0596290
27628042	EC-1 cells	C0597032
27628042	role	C1705810
27628042	inhibition	C3463820
27628042	invasion	C0027626
27628042	metastasis	C0027627
27628042	ESCC	C0279626
27628042	cells	C0597032
27628042	tissues	C0040300
27628042	SMAD7	C1334470
27628042	target gene	C0017337
27628042	miR-424-5p	C1537908
27628042	luciferase activity assay	C1510438
27628042	miR-424-5p	C1537908
27628042	negatively	C0205160
27628042	regulate	C0017263
27628042	SMAD7	C1334470
27628042	expression	C0017262
27628042	EMT	C1523298
27628042	SMAD7	C1334470
27628042	overexpression	C0017262
27628042	SMAD7	C1334470
27628042	enhance	C2349975
27628042	miR-424-5p	C1537908
27628042	anti-EMT	C0243095
27628042	function	C0542341
27628042	results	C1274040
27628042	miR-424-5p	C1537908
27628042	SMAD7	C1334470
27628042	pathway	C0037080
27628042	ESCC	C0279626
27628042	invasion	C0027626
27628042	metastasis	C0027627
27628042	up-regulation	C0041904
27628042	miR-424-5p	C1537908
27628042	preventing	C1292733
27628042	tumor invasion	C1269955
27628042	metastasis	C0027627
27628933	Double-Network Hydrogel	C0063083
27628933	Tunable	C0205556
27628933	Mechanical Performance	C1882330
27628933	Biocompatibility	C0596177
27628933	Fabrication	C3494260
27628933	Stem Cells	C0038250
27628933	Encapsulated Fibers	C0225326
27628933	3D Assemble	C1254362
27628933	Fabrication	C3494260
27628933	cell	C0038250
27628933	encapsulated fibers	C0225326
27628933	contribute	C1880177
27628933	tissue engineering	C0596171
27628933	regenerative medicine	C1257974
27628933	existing	C2347662
27628933	methods	C0449851
27628933	unavoidability	C0205556
27628933	cell damaging	C0599732
27628933	conditions	C0348080
27628933	sophisticated equipment	C0681588
27628933	unavailability	C0686905
27628933	materials	C0520510
27628933	mechanical	C0443254
27628933	biological	C0205460
27628933	expectations	C0679138
27628933	work	C0043227
27628933	simple	C0205352
27628933	method	C0449851
27628933	proposed	C1553874
27628933	prepare	C1521827
27628933	cell	C0038250
27628933	encapsulated fibers	C0225326
27628933	tunable	C0205556
27628933	mechanical strength	C0039526
27628933	stretching behavior	C0871161
27628933	diameter	C1301886
27628933	microstructure	C1254350
27628933	hydrogel	C0063083
27628933	fibers	C0225326
27628933	optimal	C2698651
27628933	combination	C0205195
27628933	alginate	C0102137
27628933	poly(N-iso-propylacrylamide)-poly(ethylene glycol)	C0005479
27628933	double-network hydrogel	C0063083
27628933	stiffness	C0427008
27628933	flexibility	C0242808
27628933	create	C1706214
27628933	variety	C2346866
27628933	three dimensional structures	C0026377
27628933	parallel helical	C1254362
27628933	different	C1705242
27628933	knots without crack	C1254362
27628933	hydrogel	C0063083
27628933	fibers	C0225326
27628933	better	C0332272
27628933	compatibility	C0596177
27628933	indicated	C1444656
27628933	viability	C0443348
27628933	proliferation	C1514485
27628933	expression	C0205245
27628933	pluripotency	C1514185
27628933	markers	C0005516
27628933	embryonic stem cells	C0596508
27628933	encapsulated	C0205223
27628933	4-day	C3840892
27628933	culture	C0430400
27628933	double-network hydrogel	C0063083
27628933	possesses	C0850310
27628933	specific	C0205369
27628933	quick	C0456962
27628933	responses	C0871261
27628933	alginate lyase	C0051154
27628933	EDTA	C0013618
27628933	environmental temperature	C2983601
27628933	degradation	C0243125
27628933	fibers	C0225326
27628933	fibrous assemblies	C1254362
27628933	cells	C0038250
27628933	encapsulated	C0205223
27628933	subsequent	C0332282
27628933	assay	C1510438
27628933	treatment	C0087111
27629246	Synchronous	C0439580
27629246	vitellogenin	C0042896
27629246	expression	C1171362
27629246	sexual maturation	C0036887
27629246	migration	C1533574
27629246	negatively	C0205160
27629246	correlated	C1707520
27629246	juvenile hormone	C0022439
27629246	levels	C0441889
27629246	Mythimna separata	C1477488
27629246	migration	C1533574
27629246	pests	C0869004
27629246	different	C1705242
27629246	seasonal	C0036497
27629246	habitats	C0871648
27629246	lead	C1522538
27629246	crop	C0242775
27629246	damage	C1883709
27629246	Reproductive	C0035150
27629246	immaturity	C0205252
27629246	migratory process	C1533574
27629246	oogenesis	C0029047
27629246	flight syndrome	C0039082
27629246	mechanism	C0441712
27629246	reproductive development	C0597375
27629246	migration	C1533574
27629246	migration	C1533574
27629246	unpredictably	C0562453
27629246	vitellogenin gene	C0017337
27629246	MsVg	C0017337
27629246	key	C1706198
27629246	regulatory enzyme genes	C0017362
27629246	MsJhamt	C0017337
27629246	MsJheh	C0017337
27629246	MsJhe	C0017337
27629246	juvenile hormone	C0022439
27629246	JH	C0022439
27629246	synthesis	C1883254
27629246	degradation	C0314674
27629246	identified	C0205396
27629246	characterized	C1880022
27629246	Mythimna separata	C1477488
27629246	relative expression	C0017262
27629246	MsVg	C0017337
27629246	response	C0871261
27629246	seasonal	C0036497
27629246	changes	C0392747
27629246	correlated	C1707520
27629246	stages	C1306673
27629246	ovarian development	C1160267
27629246	low levels	C0441889
27629246	JH	C0022439
27629246	titer	C0475208
27629246	not differ	C3842396
27629246	male	C0086582
27629246	moths	C0026593
27629246	increased	C0205217
27629246	female adults	C0043210
27629246	migratory season	C1533574
27629246	consistent with	C0332290
27629246	changes	C0392747
27629246	mRNA	C0035696
27629246	levels	C0441889
27629246	MsJhamt	C0017337
27629246	MsJheh	C0017337
27629246	MsJhe	C0017337
27629246	JH	C0022439
27629246	titer	C0475208
27629246	negatively	C0205160
27629246	seasonal	C0036497
27629246	levels	C0441889
27629246	vitellogenin	C0042896
27629246	mRNA	C0035696
27629246	transcripts	C1519595
27629246	ovarian development	C1160267
27629246	migrating	C1533574
27629246	M. separata	C1477488
27629246	synchrony	C0439580
27629246	MsVg expression	C0017262
27629246	sexual maturation	C0036887
27629246	potential	C3245505
27629246	MsVg	C0017337
27629246	transcript	C1519595
27629246	levels	C0441889
27629246	index	C0918012
27629246	adult	C0001675
27629246	reproductive	C0035150
27629246	status	C0449438
27629246	level	C0441889
27629246	JH	C0022439
27629246	sexual maturity	C0036887
27629246	correlated	C1707520
27629246	JH	C0022439
27629246	regulating	C1327622
27629246	MsVg expression	C0017262
27629246	reproduction	C0035150
27629246	seasonal	C0036497
27629246	northern and southern migration	C1533574
27629246	migration	C1533574
27631656	Functional Result	C1274040
27631656	Cochlear Implantation	C0302559
27631656	Children	C0008059
27631656	Adults	C0001675
27631656	Single-sided Deafness	C0521785
27631656	Patients	C0030705
27631656	single-sided deafness	C0521785
27631656	SSD	C0521785
27631656	reduced	C0392756
27631656	binaural hearing	C0596169
27631656	sound localization	C0037710
27631656	speech	C0037817
27631656	noise discrimination	C0234747
27631656	Cochlear implantation	C0302559
27631656	patients	C0030705
27631656	SSD	C0521785
27631656	alternative	C1523987
27631656	hearing devices	C0018768
27631656	contralateral	C0441988
27631656	signal	C1710082
27631656	Application	C0185125
27631656	children	C0008059
27631656	retrospectively	C0035363
27631656	children	C0008059
27631656	adults	C0001675
27631656	SSD	C0521785
27631656	treated with	C0332293
27631656	cochlear implantation	C0302559
27631656	outcome	C1274040
27631656	adult	C0001675
27631656	patients	C0030705
27631656	control group	C0009932
27631656	patients	C0030705
27631656	bilateral profound hearing loss	C0018775
27631656	cochlear implant	C0009199
27631656	mean	C3533236
27631656	speech recognition	C0597498
27631656	score	C0449820
27631656	monosyllabic	C0282574
27631656	monosyllabic words	C0042926
27631656	adults	C0001675
27631656	multisyllabic	C0282574
27631656	cochlear implant	C0009199
27631656	CI	C0009199
27631656	improved hearing	C0429200
27631656	noise	C0028263
27631656	SSD	C0521785
27631656	patients	C0030705
27631656	improvement	C2986411
27631656	speech reception threshold	C0234742
27631656	Sound localization	C0037710
27631656	angle detection error	C0282574
27631656	improved	C2986411
27631656	CI	C0009199
27631656	word recognition	C0871615
27631656	score	C0449820
27631656	monosyllabic	C0282574
27631656	monosyllabic words	C0042926
27631656	logarithm	C2986775
27631656	duration of deafness	C0449238
27631656	deafness	C0011053
27631656	improvement	C2986411
27631656	speech reception threshold	C0234742
27631656	RMS angle detection error	C0282574
27631656	CI	C0009199
27631656	SSD	C0521785
27631656	patients	C0030705
27631656	CI	C0009199
27631656	hearing	C0018767
27631656	situations	C0348080
27631656	Patients	C0030705
27631656	SSD	C0521785
27631656	improve	C1272747
27631656	cochlear implantation	C0302559
27632714	CHOROIDAL VASCULARITY INDEX	C0392762
27632714	Optical Coherence Tomography	C0920367
27632714	Parameter	C0549193
27632714	Patients	C0030705
27632714	Exudative Age-Related Macular Degeneration	C0271084
27632714	choroidal	C0008520
27632714	structural	C0678594
27632714	exudative age-related macular degeneration	C0271084
27632714	AMD	C0242383
27632714	choroidal vascularity index	C0392762
27632714	computed	C1880157
27632714	spectral domain optical coherence tomography	C0920367
27632714	depth imaging	C0011923
27632714	case series	C0150093
27632714	consecutive	C1707491
27632714	patients	C0030705
27632714	unilateral	C0205092
27632714	exudative AMD	C0271084
27632714	Choroidal	C0008520
27632714	images	C0011923
27632714	luminal	C0524462
27632714	area	C0205146
27632714	Choroidal vascularity index	C0392762
27632714	ratio	C0456603
27632714	luminal	C0524462
27632714	area	C0205146
27632714	area	C0205146
27632714	Mean	C0444504
27632714	choroidal vascularity index	C0392762
27632714	mean	C0444504
27632714	choroidal thickness	C0392762
27632714	study	C2603343
27632714	eyes	C0015392
27632714	patient	C0030705
27632714	AMD	C0242383
27632714	Student's t-test	C0871453
27632714	significantly lower	C4055638
27632714	choroidal vascularity index	C0392762
27632714	eyes	C0015392
27632714	exudative AMD	C0271084
27632714	Luminal area	C0524462
27632714	decreased	C0205216
27632714	eyes	C0015392
27632714	exudative AMD	C0271084
27632714	no significant difference	C3842396
27632714	area	C0205146
27632714	study	C2603343
27632714	eyes	C0015392
27632714	Eyes	C0015392
27632714	exudative AMD	C0271084
27632714	reduced	C0392756
27632714	choroidal vascularity index	C0392762
27632714	differences	C1705242
27632714	eyes	C0015392
27632714	Choroidal vascularity index	C0392762
27632714	potential	C3245505
27632714	noninvasive tool	C0243095
27632714	studying	C2603343
27632714	structural	C0678594
27632714	choroid	C0008520
27632714	choroidal disease	C0008521
27632714	exudative AMD	C0271084
27632886	Comparison	C1707455
27632886	Esophageal	C2316724
27632886	Rectal	C0489749
27632886	Gastrointestinal	C0809794
27632886	Temperatures	C0039476
27632886	Passive Rest	C0035253
27632886	Exercise	C0015259
27632886	Heat	C0018837
27632886	Influence	C4054723
27632886	Hydration	C1321013
27632886	esophageal	C2316724
27632886	rectal	C0489749
27632886	gastrointestinal	C0809794
27632886	temperatures	C0039476
27632886	TES	C2316724
27632886	TRE	C0489749
27632886	TGI	C0039476
27632886	exercise-induced	C0239313
27632886	hyperthermia	C0015967
27632886	hydration states	C1321013
27632886	study	C0008972
27632886	TES	C2316724
27632886	TRE	C0489749
27632886	TGI	C0039476
27632886	passive rest	C0035253
27632886	exercise-induced	C0239313
27632886	hyperthermia	C0015967
27632886	hydration states	C1321013
27632886	euhydrated	C0231162
27632886	EU	C0231162
27632886	hypohydrated	C0011175
27632886	HY	C0011175
27632886	Randomized-crossover design	C0242817
27632886	Controlled	C2239193
27632886	laboratory setting	C0022877
27632886	recreationally	C0034872
27632886	active	C0205177
27632886	male	C0086582
27632886	participants	C0679646
27632886	SD	C0871420
27632886	age	C0001779
27632886	height	C0489786
27632886	body mass	C0005910
27632886	body fat	C0344335
27632886	Participants	C0679646
27632886	trials	C0008976
27632886	EU	C0231162
27632886	HY	C0011175
27632886	bout	C0741605
27632886	treadmill exercise	C2712999
27632886	ranging	C1514721
27632886	grade	C0441800
27632886	minute	C0439232
27632886	jog	C0022400
27632886	ranging	C1514721
27632886	hot environment	C0241922
27632886	ambient temperature	C0428692
27632886	relative humidity	C0428696
27632886	wet bulb globe temperature	C0242485
27632886	passive rest	C0035253
27632886	Root mean squared difference	C2347976
27632886	RMSD	C2347976
27632886	variance	C1711260
27632886	temperature readings	C0005903
27632886	time points	C0439547
27632886	TRE	C0489749
27632886	TGI	C0039476
27632886	TRE	C0489749
27632886	TES	C2316724
27632886	TGI	C0039476
27632886	TES	C2316724
27632886	EU	C0231162
27632886	HY	C0011175
27632886	RMSD	C2347976
27632886	three-way repeated measures ANOVA	C0002780
27632886	analysis	C0936012
27632886	effects	C1280500
27632886	Tukey's HSD	C0237913
27632886	RMSD values	C2347976
27632886	device	C0025080
27632886	comparisons	C1707455
27632886	significantly	C0237881
27632886	EU	C0231162
27632886	TRE	C0489749
27632886	TGI	C0039476
27632886	TRE	C0489749
27632886	TES	C2316724
27632886	TGI	C0039476
27632886	TES	C2316724
27632886	HY	C0011175
27632886	TRE	C0489749
27632886	TGI	C0039476
27632886	TRE	C0489749
27632886	TES	C2316724
27632886	TGI	C0039476
27632886	TES	C2316724
27632886	minute	C0439232
27632886	bout	C0741605
27632886	passive rest	C0035253
27632886	TRE	C0489749
27632886	TGI	C0039476
27632886	TES	C2316724
27632886	EU	C0231162
27632886	HY	C0011175
27632886	trials	C0008976
27632886	passive rest	C0035253
27632886	exercise	C0015259
27632886	heat	C0018837
27632886	TRE	C0489749
27632886	TGI	C0039476
27632886	body temperature	C0005903
27632886	euhydration	C0231162
27632886	hypohydrated	C0011175
27632886	exercise	C0015259
27632886	clinical significance	C2826293
27633771	Annexin A1	C0103403
27633771	Aβ1-42	C0169424
27633771	blood-brain barrier disruption	C1831732
27633771	inhibition	C0021469
27633771	RhoA-ROCK signaling pathway	C0037080
27633771	blood-brain barrier	C0005854
27633771	BBB	C0005854
27633771	brain capillary	C4242462
27633771	endothelial cells	C0225336
27633771	homeostasis	C0019868
27633771	brain	C0006104
27633771	blood	C0005767
27633771	parenchyma	C0933845
27633771	central nervous system	C1269563
27633771	CNS	C1269563
27633771	disruption of the BBB	C1831732
27633771	neurodegenerative diseases	C0524851
27633771	Alzheimer's disease	C0002395
27633771	AD	C0002395
27633771	Annexin A1	C0103403
27633771	ANXA1	C0103403
27633771	anti-inflammatory messenger	C0169911
27633771	expressed	C1171362
27633771	brain endothelial cells	C0225336
27633771	BBB	C0005854
27633771	mechanism	C0678659
27633771	BBB	C0005854
27633771	AD	C0002395
27633771	β-Amyloid 1-42	C0169424
27633771	Aβ42	C0169424
27633771	BBB disruption	C1831732
27633771	human recombinant ANXA1	C0034861
27633771	hrANXA1	C0034861
27633771	murine	C0591833
27633771	brain endothelial cell line bEnd.3.	C0225336
27633771	ANXA1	C0103403
27633771	bEnd.3 cells	C0225336
27633771	capillaries	C0006901
27633771	5XFAD mice	C1514798
27633771	human serum	C0229671
27633771	patients	C0030705
27633771	AD	C0002395
27633771	mechanism	C0678659
27633771	ANXA1	C0103403
27633771	BBB	C0005854
27633771	AD	C0002395
27633771	RhoA-ROCK signaling pathway	C0037080
27633771	Aβ42	C0169424
27633771	bEnd.3 cells	C0225336
27633771	capillaries	C0006901
27633771	5XFAD mice	C1514798
27633771	RhoA	C0643681
27633771	activated	C0599177
27633771	RhoA inhibitors	C1999216
27633771	Aβ42	C0169424
27633771	BBB disruption	C1831732
27633771	overexpressed	C1171362
27633771	RhoA-GTP	C0084340
27633771	RhoA	C0643681
27633771	ANXA1	C0103403
27633771	pericytes	C0598800
27633771	cocultured	C0282547
27633771	bEnd.3 cells	C0225336
27633771	Aβ42	C0169424
27633771	RhoA activation	C0599177
27633771	bEnd.3 cells	C0225336
27633771	inhibited	C0311403
27633771	secretion	C0036536
27633771	ANXA1	C0103403
27633771	pericytes	C0598800
27633771	ANXA1	C0103403
27633771	Aβ42	C0169424
27633771	BBB disruption	C1831732
27633771	inhibition	C0021469
27633771	RhoA-ROCK signaling pathway	C0037080
27633771	ANXA1	C0103403
27633771	therapeutic reagent	C1611640
27633771	breakdown of the BBB	C1831732
27633771	AD	C0002395
27634799	Association	C0439849
27634799	kidney disease	C0022658
27634799	obstructive sleep apnea	C0520679
27634799	population study	C0681876
27634799	men	C0025266
27634799	determine	C1148554
27634799	relationship	C0439849
27634799	obstructive sleep apnea	C0520679
27634799	OSA	C0520679
27634799	chronic kidney disease	C1561643
27634799	CKD	C1561643
27634799	population studies	C0681876
27634799	association	C0439849
27634799	sparse	C0521114
27634799	conflicting	C0855281
27634799	confined	C0443288
27634799	studies	C2603343
27634799	administrative	C3845829
27634799	data	C1511726
27634799	Cross-sectional analysis	C0010362
27634799	participants	C0679646
27634799	Men Androgens Inflammation Lifestyle Environment and Stress (MAILES) study	C0009247
27634799	aged	C0001779
27634799	Renal	C0022646
27634799	data	C1511726
27634799	men	C0025266
27634799	prior	C0332152
27634799	OSA	C0520679
27634799	diagnosis	C0011900
27634799	in-home	C0442519
27634799	polysomnography	C0162701
27634799	Embletta X100	C0182339
27634799	CKD	C1561643
27634799	estimated glomerular filtration rate	C3811844
27634799	eGFR	C3811844
27634799	eGFR	C3811844
27634799	albuminuria	C0001925
27634799	albumin creatinine ratio	C1655929
27634799	CKD	C1561643
27634799	Stage	C1306673
27634799	Stage	C1306673
27634799	predominantly	C0332251
27634799	mild severity	C1513302
27634799	significant	C0750502
27634799	association	C0439849
27634799	OSA	C0520679
27634799	odds ratio	C0028873
27634799	OR	C0028873
27634799	confidence interval	C0009667
27634799	CI	C0009667
27634799	severe	C0205082
27634799	OSA	C0520679
27634799	OR	C0028873
27634799	respiratory	C0521346
27634799	arousal	C0233972
27634799	index	C0918012
27634799	OR	C0028873
27634799	measures	C0079809
27634799	hypoxemia	C0700292
27634799	adjustment	C0456081
27634799	age	C0001779
27634799	hypertension	C0020538
27634799	diabetes	C0011847
27634799	smoking	C0037369
27634799	obesity	C0028754
27634799	NSAID	C3536840
27634799	use	C0457083
27634799	association	C0439849
27634799	CKD	C1561643
27634799	daytime sleepiness	C0541854
27634799	men	C0025266
27634799	CKD	C1561643
27634799	OSA	C0520679
27634799	not significantly	C1273937
27634799	more	C0205172
27634799	likely	C0033204
27634799	report	C0700287
27634799	symptoms	C1457887
27634799	sleepiness	C0013144
27634799	snoring	C0037384
27634799	apneas	C0003578
27634799	identified	C0205396
27634799	STOP OSA screening questionnaire	C1134635
27634799	men	C0025266
27634799	OSA	C0520679
27634799	Predominantly	C0332251
27634799	mild	C2945599
27634799	CKD	C1561643
27634799	associated with	C0332281
27634799	severe	C0205082
27634799	OSA	C0520679
27634799	arousals	C0003808
27634799	population studies	C0681876
27634799	examining	C0332128
27634799	longitudinal	C0205127
27634799	relationship	C0439849
27634799	CKD	C1561643
27634799	OSA	C0520679
27634799	warranted	C0205245
27634799	methods	C0025663
27634799	needed	C0027552
27634799	identify	C0020792
27634799	OSA	C0520679
27634799	CKD	C1561643
27634799	few	C0205388
27634799	symptoms	C1457887
27634880	vitronectin	C0055023
27634880	migration-enhancing factor	C0574031
27634880	cancer cells	C0597032
27634880	chaperoned	C0243041
27634880	fibrinogen	C0016006
27634880	metastasis	C4255448
27634880	cancer cells	C0597032
27634880	fibrinogen	C0016006
27634880	lymphatics	C0024235
27634880	body cavities	C0333343
27634880	Diluted	C1948037
27634880	plasma	C0032105
27634880	migration	C1622501
27634880	malignant cell lines	C0334227
27634880	pro-metastatic factors	C1521761
27634880	factor(s)	C1521761
27634880	diluted	C1948037
27634880	plasma	C0032105
27634880	phenomenon	C1882365
27634880	heat	C0018837
27634880	inactivation	C0544461
27634880	dialysis	C0011945
27634880	proteinase K	C0059256
27634880	treatment	C1522326
27634880	molecular size filtration studies	C0016107
27634880	pro-migratory activity	C0441655
27634880	diluted	C1948037
27634880	plasma	C0032105
27634880	protein	C0033684
27634880	GαI protein-coupled receptors	C0682972
27634880	p42/44 MAPK	C0752312
27634880	AKT signaling	C1623484
27634880	cells	C0007634
27634880	pro-migratory activity	C0441655
27634880	plasma	C0032105
27634880	plasma concentrations	C0683150
27634880	serum	C0229671
27634880	fibrinogen	C0016006
27634880	chaperone	C0243041
27634880	protein(s)	C0033684
27634880	pro-migratory protein(s)	C0033684
27634880	diluted	C1948037
27634880	plasma	C0032105
27634880	fibrinogen	C0016006
27634880	serum	C0229671
27634880	gel filtration	C0008559
27634880	hydrophobic interaction chromatography	C0008550
27634880	mass spectrometry analysis	C0037813
27634880	protein	C0033684
27634880	in vitro	C1533691
27634880	experiments	C0681814
27634880	pro-migratory factor	C0574031
27634880	chaperoned	C0243041
27634880	fibrinogen	C0016006
27634880	vitronectin	C0055023
27634880	fibrinogen	C0016006
27634880	mechanism	C0678659
27634880	metastasis	C4255448
27634880	cancer cells	C0597032
27634880	lymphatics	C0024235
27634880	body cavities	C0333343
27634880	concentration	C1264643
27634880	fibrinogen	C0016006
27634880	vitronectin	C0055023
27634880	migration	C1622501
27634880	tumor cells	C0597032
27636378	Development	C1527148
27636378	initial	C0205265
27636378	validation	C1519941
27636378	Respirator	C3824912
27636378	Comfort	C1331418
27636378	Wearing Experience	C0596545
27636378	Function	C0542341
27636378	Instrument	C0348000
27636378	R-COMFI	C0348000
27636378	Filtering face-piece respirators	C3824912
27636378	FFRs	C3824912
27636378	protect	C1545588
27636378	health care personnel	C0018724
27636378	airborne particles	C1510837
27636378	clinical studies	C0008972
27636378	FFR	C3824912
27636378	adherence	C1510802
27636378	low	C0205251
27636378	part	C0449719
27636378	discomfort	C2364135
27636378	intolerance	C0231199
27636378	objective	C0018017
27636378	study	C0681814
27636378	initially	C0205265
27636378	evaluate	C1516048
27636378	psychometric properties	C0871161
27636378	instrument	C0348000
27636378	designed	C0014677
27636378	measure	C0079809
27636378	comfort	C1331418
27636378	tolerability	C4053931
27636378	FFRs	C3824912
27636378	Instrument	C0348000
27636378	literature reviews	C0282441
27636378	focus groups	C0016400
27636378	several	C0443302
27636378	iterations	C1854293
27636378	ranking	C0699794
27636378	experts	C0009817
27636378	Psychometric evaluation	C0033920
27636378	instrument	C0348000
27636378	Rasch partial credit model	C3161035
27636378	PCM	C3161035
27636378	analysis	C0936012
27636378	Pivot anchoring	C0282574
27636378	threshold	C0449864
27636378	difficulty	C0332218
27636378	analyses	C0936012
27636378	point	C1552961
27636378	participants	C0679646
27636378	possessing	C3154893
27636378	trait	C0599883
27636378	trait	C0599883
27636378	final	C3853528
27636378	instrument	C0348000
27636378	completed	C0205197
27636378	health care personnel	C0018724
27636378	Veterans	C0042610
27636378	Health Administration facilities	C2936317
27636378	data	C1511726
27636378	analyzed	C0936012
27636378	Rasch PCM	C3161035
27636378	removed	C0849355
27636378	violated the assumption of independence	C0205556
27636378	mis-fitting	C0205556
27636378	not relevant	C2347946
27636378	Category	C0683312
27636378	function	C0542341
27636378	analysis	C0936012
27636378	categories	C0683312
27636378	progressed	C1272688
27636378	monotonically	C0205556
27636378	Principal components analysis	C0429865
27636378	existence	C1547035
27636378	subscales	C0392762
27636378	Discomfort	C2364135
27636378	Wearing Experience	C0596545
27636378	Function	C0542341
27636378	Final	C3853528
27636378	reliability	C2347947
27636378	analyses	C0936012
27636378	scale	C0392762
27636378	moderate	C0205081
27636378	high person reliability	C2347947
27636378	reliability	C2347947
27636378	instrument	C0348000
27636378	contained	C0332256
27636378	knowledge	C0162340
27636378	instrument	C0348000
27636378	evidence	C3887511
27636378	reliability and validity	C0035036
27636378	assess	C1516048
27636378	discomfort	C2364135
27636378	tolerance	C1704410
27636378	FFRs	C3824912
27636378	health care personnel	C0018724
27636378	published	C0034037
27636378	psychometrically sound measure	C0079809
27636378	comfort	C1331418
27636378	tolerability	C4053931
27636378	FFRs	C3824912
27636378	Respirator	C3824912
27636378	Comfort	C1331418
27636378	Wearing Experience	C0596545
27636378	Function	C0542341
27636378	Instrument	C0348000
27636378	R-COMFI	C0348000
27636378	significance	C0750502
27636378	instrument	C0348000
27636378	respirators	C3824912
27636378	adherence	C1510802
27636378	practice	C0032893
27636378	R-COMFI	C0348000
27636378	within	C0332285
27636378	VA healthcare system	C0018696
27636378	psychometrically sound instrument	C0348000
27636378	evaluate	C1516048
27636378	comfort	C1331418
27636378	tolerability	C4053931
27636378	respirators	C3824912
27636378	developmental	C0458003
27638250	Kidney transplant recipients	C4304779
27638250	nonrenal solid organ transplantation	C0029216
27638250	alloreactivity	C0301873
27638250	risk	C0035647
27638250	infection	C3714514
27638250	kidney transplant recipients	C4304779
27638250	KTRs	C4304779
27638250	nonrenal solid organ transplantation	C0029216
27638250	SOT	C0029216
27638250	patient	C0030705
27638250	allograft	C0040739
27638250	outcomes	C0085415
27638250	infections	C3714514
27638250	alloreactivity	C0301873
27638250	studied	C2603343
27638250	KTRs	C4304779
27638250	nonrenal SOT	C0029216
27638250	KTRs	C4304779
27638250	KTRs	C4304779
27638250	Samples	C0504082
27638250	pretransplantation	C1254367
27638250	post-transplantation	C1254367
27638250	Alloreactive	C0301873
27638250	CMV-specific	C0010825
27638250	T cells	C0039194
27638250	interferon-γ ELISPOT assay	C0920508
27638250	Patient	C0030705
27638250	survival	C0038952
27638250	KTRs	C4304779
27638250	SOT	C0029216
27638250	KTRs	C4304779
27638250	death	C0011065
27638250	allograft	C0040739
27638250	survival	C0038952
27638250	KTRs	C4304779
27638250	SOT	C0029216
27638250	KTRs	C4304779
27638250	KTRs	C4304779
27638250	SOT	C0029216
27638250	5-year	C0439234
27638250	death	C0011065
27638250	allograft	C0040739
27638250	survival	C0038952
27638250	KTRs	C4304779
27638250	KTRs	C4304779
27638250	SOT	C0029216
27638250	panel-reactive antibodies	C1141951
27638250	frequencies	C0439603
27638250	alloreactive	C0301873
27638250	T cells	C0039194
27638250	acute rejections	C3273245
27638250	KTRs	C4304779
27638250	KTRs	C4304779
27638250	SOT	C0029216
27638250	incidences	C0021149
27638250	EBV viremia	C1701919
27638250	PTLD	C0432487
27638250	sepsis	C0243026
27638250	death	C0011065
27638250	sepsis	C0243026
27638250	CMV-specific	C0010825
27638250	cellular immunity	C0020966
27638250	associated with	C0332281
27638250	CMV	C0010825
27638250	replication	C0042774
27638250	KTRs	C4304779
27638250	patient	C0030705
27638250	allograft	C0040739
27638250	outcomes	C0085415
27638250	KTRs	C4304779
27638250	SOT	C0029216
27638250	KTRs	C4304779
27638250	alloreactivity	C0301873
27638250	allograft	C0040739
27638250	outcomes	C0085415
27638250	KTRs	C4304779
27638250	SOT	C0029216
27638250	infectious complications	C0940933
27638250	overimmunosuppression	C4048329
27639061	Improved	C0184511
27639061	protocol	C0442711
27639061	isolation	C0220862
27639061	follicular dendritic cells	C0242245
27639061	Follicular dendritic cells	C0242245
27639061	FDCs	C0242245
27639061	lymphoid organs	C0502330
27639061	role	C1705810
27639061	humoral immune response	C1155229
27639061	isolation	C0204727
27639061	FDCs	C0242245
27639061	difficult	C0332218
27639061	small	C0700321
27639061	population size	C0032683
27639061	fragility	C0302113
27639061	mechanical	C0038442
27639061	chemical stresses	C1254365
27639061	genetic	C0314603
27639061	biochemical	C0205474
27639061	characteristics	C1521970
27639061	FDCs	C0242245
27639061	unclear	C3845108
27639061	FDCs	C0242245
27639061	ICAM-1(+)	C0063695
27639061	cells	C0007634
27639061	CD45	C0054961
27639061	(-)	C0205160
27639061	non-hematopoietic cell fraction	C0805525
27639061	mouse spleen	C1519474
27639061	cell separation	C0007616
27639061	combination	C0205195
27639061	enzymes	C0014442
27639061	new	C0205314
27639061	combination	C0205195
27639061	enzymes	C0014442
27639061	FDCs	C0242245
27639061	CD45	C0054961
27639061	(-)	C0205160
27639061	ICAM-1(+)	C0063695
27639061	CD21	C0056184
27639061	35(+)	C0009552
27639061	cell fraction	C0805525
27639061	CD45	C0054961
27639061	(-)	C0205160
27639061	ICAM-1(+)	C0063695
27639061	CD21	C0056184
27639061	35(+)	C0009552
27639061	cells	C0007634
27639061	mouse spleen	C1519474
27639061	antigen	C0003320
27639061	in vivo	C1515655
27639061	days	C0439228
27639061	CD45	C0054961
27639061	(-)	C0205160
27639061	ICAM-1(+)	C0063695
27639061	CD21	C0056184
27639061	35(+)	C0009552
27639061	cells	C0007634
27639061	isolated	C0205409
27639061	spleen of mice	C1519474
27639061	cognate antigen	C0003320
27639061	enhanced	C2349975
27639061	survival	C0007620
27639061	proliferation	C1514485
27639061	antigen-specific B cells	C0007634
27639061	in vitro	C1533691
27639061	improved	C0184511
27639061	protocol	C0442711
27639061	isolation	C0220862
27639061	FDCs	C0242245
27639061	analysis	C0936012
27639061	FDCs	C0242245
27639061	in vitro	C1533691
27639061	in vivo	C1515655
27643784	Dental	C0226984
27643784	enamel defects	C2750331
27643784	German	C1556085
27643784	medieval	C0242321
27643784	early-modern-age	C0242818
27643784	populations	C1257890
27643784	Aim	C1947946
27643784	study	C2603343
27643784	investigate	C1292732
27643784	frequency	C0439603
27643784	type	C0332307
27643784	developmental defects of enamel	C2750331
27643784	DDE	C2750331
27643784	medieval	C0242321
27643784	early-modern-age	C0242818
27643784	population	C1257890
27643784	Thuringia, Germany	C0017480
27643784	skeletons	C0816871
27643784	subdivided	C0332849
27643784	single	C0205171
27643784	burials	C0006407
27643784	individuals	C0237401
27643784	buried	C0006407
27643784	groups	C0441833
27643784	examined	C0332128
27643784	DDE	C2750331
27643784	classified	C0008902
27643784	teeth	C0040426
27643784	DDE	C2750331
27643784	index	C0918012
27643784	Molar-incisor-hypomineralisation	C2350038
27643784	MIH	C2350038
27643784	type	C0332307
27643784	DDE	C2750331
27643784	recorded	C0034869
27643784	European Academy of Paediatric Dentistry	C0000877
27643784	EAPD	C0000877
27643784	criteria	C0243161
27643784	DDE	C2750331
27643784	individuals	C0237401
27643784	single	C0205171
27643784	burials	C0006407
27643784	group	C0441833
27643784	burials	C0006407
27643784	Hypoplastic	C0543481
27643784	pits	C1860853
27643784	frequent	C0332183
27643784	defect	C1457869
27643784	primary teeth	C3266841
27643784	linear enamel hypoplasia	C0011351
27643784	LEH	C0011351
27643784	permanent teeth	C1720362
27643784	individuals	C0237401
27643784	hypomineralised	C0085511
27643784	permanent tooth	C0348070
27643784	MIH	C2350038
27643784	permanent molar	C0026367
27643784	permanent incisors	C3161464
27643784	Second primary molars	C0227108
27643784	affected	C0392760
27643784	children	C0008059
27643784	juveniles	C3146221
27643784	individual	C0237401
27643784	affected	C0392760
27643784	molars	C0026367
27643784	incisors	C0021156
27643784	combination	C0205195
27643784	Endogenous	C0205227
27643784	factors	C1521761
27643784	nutritional deficiencies	C0162429
27643784	health problems	C1398682
27643784	early	C1279919
27643784	childhood	C0231335
27643784	aetiological	C1314792
27643784	reasons	C0392360
27643784	DDE	C2750331
27643784	MIH	C2350038
27643784	frequency	C0439603
27643784	DDE	C2750331
27643784	MIH	C2350038
27643784	masked	C0150108
27643784	extended	C0231449
27643784	carious lesions	C0011334
27643784	dental wear	C2717979
27643784	ante-mortem	C0243095
27643784	tooth loss	C0080233
27644674	Breast Cancer	C0006142
27644674	Detection Rate	C0392762
27644674	Incidence	C0021149
27644674	Prevalence	C0220900
27644674	Interval	C1272706
27644674	Cancer	C0006826
27644674	Mammography Screening	C0203028
27644674	Times	C0040223
27644674	Thai	C0337910
27644674	Women	C0043210
27644674	guideline	C0162791
27644674	American Cancer Society	C0002455
27644674	mammography	C0024671
27644674	MMG	C0024671
27644674	women	C0043210
27644674	Thailand	C0039725
27644674	opportunistic mammography screening	C0422389
27644674	limited	C0439801
27644674	data	C1511726
27644674	incidence	C0021149
27644674	breast cancer	C0006142
27644674	study	C0008972
27644674	estimate	C0750572
27644674	breast cancer	C0006142
27644674	detection	C1516193
27644674	incident	C1551358
27644674	prevalence rates	C0220900
27644674	Thai	C0337910
27644674	women	C0043210
27644674	opportunistic mammography screening	C0422389
27644674	women	C0043210
27644674	years	C0439234
27644674	procedure	C0220908
27644674	detection rate	C0392762
27644674	observation	C0302523
27644674	number	C0237753
27644674	women	C0043210
27644674	positive findings	C0586815
27644674	total number	C4288115
27644674	women	C0043210
27644674	screened	C0199230
27644674	incidence rate	C1708485
27644674	calculated	C0444686
27644674	MMG	C0024671
27644674	detected	C0442726
27644674	MMG	C0024671
27644674	women	C0043210
27644674	MMGs	C0024671
27644674	person	C0027361
27644674	duration	C0449238
27644674	interval	C1272706
27644674	years	C0439234
27644674	breast cancer	C0006142
27644674	detected	C0442726
27644674	women	C0043210
27644674	detection rate	C0392762
27644674	persons	C0027361
27644674	prevalence rate	C0220900
27644674	breast cancer	C0006142
27644674	person	C0027361
27644674	incidence	C0021149
27644674	detected	C0442726
27644674	person	C0027361
27644674	interval	C1272706
27644674	women	C0043210
27644674	detected	C0442726
27644674	MMG	C0024671
27644674	women	C0043210
27644674	Opportunistic mammography screening	C0422389
27644674	Thailand	C0039725
27644674	detected	C0442726
27644674	breast cancer	C0006142
27644674	women	C0043210
27644674	cancer detection	C1516193
27644674	interval	C1272706
27644674	screening mammogram	C0203028
27644855	groundwater	C0596631
27644855	vulnerability	C0332157
27644855	Daule aquifer	C3178977
27644855	Ecuador	C0013593
27644855	susceptibility index method	C0871511
27644855	Guayas region	C0017446
27644855	Ecuador	C0013593
27644855	national crops	C0242775
27644855	agricultural activities	C0001829
27644855	groundwater	C0596631
27644855	nitrate	C0699857
27644855	contamination	C2349974
27644855	fertiliser	C0015919
27644855	water	C0043047
27644855	needs	C0027552
27644855	susceptibility index assessment method	C0871511
27644855	agricultural activities	C0001829
27644855	groundwater	C0596631
27644855	quality	C0332306
27644855	aquifer	C3178977
27644855	Guayas	C0017446
27644855	river basin	C0205146
27644855	Ecuador	C0013593
27644855	DRASTIC method	C0871511
27644855	land use	C0814835
27644855	areas	C0205146
27644855	highly	C0205250
27644855	vulnerable	C0332157
27644855	contamination	C2349974
27644855	irrigation	C2936278
27644855	perimeters	C1295726
27644855	paddy fields	C0562975
27644855	alluvial deposits	C0055863
27644855	moderately	C0205081
27644855	vulnerable	C0332157
27644855	low	C0205251
27644855	vulnerability	C0332157
27644855	areas	C0205146
27644855	aquatic environments	C0563034
27644855	forests	C0086312
27644855	semi-natural zones	C1710706
27644855	water bodies	C2584335
27644855	Daule aquifer	C3178977
27644855	vulnerability	C0332157
27644855	wide	C0332464
27644855	flat topography	C0870781
27644855	aquifer	C3178977
27644855	high risk of contamination	C4060526
27644855	nitrates	C0699857
27644855	good	C0205170
27644855	agricultural practices	C0001829
27644855	monitoring network to control	C0243095
27644855	nitrates	C0699857
27644855	concentrations	C1446561
27644855	groundwater	C0596631
27644855	quality	C0332306
27644855	drinking	C0599638
27644855	purposes	C1285529
27645367	Heterogeneous	C0019409
27645367	depression	C0011570
27645367	trajectories	C1254367
27645367	multiple sclerosis	C0026769
27645367	patients	C0030705
27645367	Trajectories	C1254367
27645367	depression	C0011570
27645367	heterogeneous	C0019409
27645367	Multiple Sclerosis	C0026769
27645367	MS	C0026769
27645367	patients	C0030705
27645367	trajectories	C1254367
27645367	clinicians	C0871685
27645367	progression	C0449258
27645367	depression	C0011570
27645367	MS	C0026769
27645367	patients	C0030705
27645367	Latent class growth analysis	C0681947
27645367	LCGA	C0681947
27645367	MS	C0026769
27645367	patients	C0030705
27645367	electronic health records (EHR) data base	C2362543
27645367	subgroups	C1257890
27645367	MS	C0026769
27645367	patients	C0030705
27645367	depression screening	C0740218
27645367	PHQ-9	C1718207
27645367	Latent	C0205275
27645367	trajectory	C1254367
27645367	group	C1257890
27645367	baseline	C1442488
27645367	clinical characteristics	C0683325
27645367	subgroups	C1257890
27645367	high	C0205250
27645367	participants	C0679646
27645367	moderate	C0205081
27645367	low	C0205251
27645367	variable	C0439828
27645367	depression level	C1319226
27645367	trajectories	C1254367
27645367	subpopulation	C1257890
27645367	trajectories	C1254367
27645367	high	C0205250
27645367	moderate	C0205081
27645367	low	C0205251
27645367	MS	C0026769
27645367	disability	C0231170
27645367	baseline	C1442488
27645367	trajectory	C1254367
27645367	moderate	C0205081
27645367	depression	C0011570
27645367	threshold	C0449864
27645367	LCGA	C0681947
27645367	MS	C0026769
27645367	patients	C0030705
27645367	template	C1705542
27645367	EHR data base	C2362543
27645367	heterogeneous	C0019409
27645367	depression screening	C0740218
27645367	trajectories	C1254367
27645367	Clinicians	C0871685
27645367	information	C1533716
27645367	monitor patients	C0030695
27645367	high	C0205250
27645367	unstable	C0443343
27645367	depression levels	C1319226
27646139	PLA2 gene	C0017337
27646139	humoral immune responses	C1155229
27646139	Bactrocera dorsalis (Hendel)	C1001509
27646139	phospholipase A2 (PLA2) gene	C0017337
27646139	encodes	C2700640
27646139	enzyme	C0014442
27646139	catalyzes	C0205245
27646139	hydrolysis	C0020291
27646139	phospholipids	C0031676
27646139	PLs	C0031676
27646139	sn-2 position	C0733755
27646139	role	C1704326
27646139	humoral immune responses	C1155229
27646139	study	C2603343
27646139	investigated	C1292732
27646139	expression profile	C1956267
27646139	PLA2	C0017337
27646139	different	C1705242
27646139	tissues	C0040300
27646139	developmental stages	C0870411
27646139	Bactrocera dorsalis (Hendel)	C1001509
27646139	transcriptional	C0040649
27646139	level	C0441889
27646139	PLA2	C0017337
27646139	high	C0205250
27646139	egg	C1254358
27646139	mature stage	C1326793
27646139	testis	C0039597
27646139	tissue	C0040300
27646139	Bacterial infection	C0004623
27646139	expression	C0017262
27646139	PLA2	C0017337
27646139	up-regulation	C0041904
27646139	fat body	C0015665
27646139	Silencing	C0598496
27646139	PLA2	C0017337
27646139	influenced	C4054723
27646139	expression	C0017262
27646139	immune-related genes	C0017337
27646139	MyD88	C1417530
27646139	defensin	C0057256
27646139	Toll pathway	C1155478
27646139	relish	C0033684
27646139	diptericin	C0033684
27646139	Imd pathway	C2753278
27646139	expression	C0017262
27646139	MyD88	C1417530
27646139	defensin	C0057256
27646139	down-regulated	C0013081
27646139	ds-PLA2	C0017337
27646139	group	C0441833
27646139	ds-egfp	C1258415
27646139	group	C0441833
27646139	B. dorsalis	C1001509
27646139	infected	C0439663
27646139	L. monocytogenes	C0023861
27646139	S. aureus	C0038172
27646139	PLA2	C0017337
27646139	activation	C0017255
27646139	Toll pathway	C1155478
27646139	infection	C3714514
27646139	L. monocytogenes	C0023861
27646139	E. coli	C0014834
27646139	activate	C1515877
27646139	Imd pathway	C2753278
27646139	increase	C0442805
27646139	mRNA	C0035696
27646139	levels	C0441889
27646139	relish	C0033684
27646139	diptericin	C0033684
27646139	ds-PLA2	C0017337
27646139	group	C0441833
27646139	increases	C0442805
27646139	ds-egfp	C1258415
27646139	group	C0441833
27646139	Imd pathway	C2753278
27646139	repressed	C0205245
27646139	silencing	C0598496
27646139	PLA2	C0017337
27646139	development	C1527148
27646139	lipid droplets	C0230704
27646139	fat body	C0015665
27646139	cells	C0007634
27646139	influenced	C4054723
27646139	silencing	C0598496
27646139	PLA2	C0017337
27646139	PLA2	C0017337
27646139	function	C0542341
27646139	fat body	C0015665
27646139	tissue	C0040300
27646139	PLA2	C0017337
27646139	PLA2 gene	C0017337
27646139	humoral immune responses	C1155229
27646139	reducing	C0392756
27646139	lipid storage	C1159705
27646139	fat body	C0015665
27646139	cells	C0007634
27646139	B. dorsalis	C1001509
27648744	Gambling disorders	C0030662
27648744	gambling	C0016995
27648744	psychiatric	C0205487
27648744	comorbidity	C0009488
27648744	Thai general population	C0337910
27648744	National Mental Health Survey	C3481515
27648744	prevalence	C0033105
27648744	problem	C0850474
27648744	pathological gambling	C0030662
27648744	gender	C0079399
27648744	age-group	C0027362
27648744	gambling types	C0016995
27648744	comorbidities	C0009488
27648744	psychiatric disorders	C0004936
27648744	Thai general population	C0337910
27648744	participants	C0679646
27648744	Thailand's	C0039725
27648744	National Mental Health Survey	C3481515
27648744	multistage stratified cluster survey	C0038951
27648744	Composite International Diagnostic Interview	C0451085
27648744	Diagnoses	C0011900
27648744	problem	C0850474
27648744	pathological gambling	C0030662
27648744	psychiatric disorders	C0004936
27648744	DSM-IV-TR criteria	C0220952
27648744	criteria	C0243161
27648744	gamblers	C0858352
27648744	lifetime	C4071830
27648744	single year loss	C1517945
27648744	USD	C0562019
27648744	gambling	C0016995
27648744	lifetime	C4071830
27648744	prevalence rates	C0033105
27648744	pathological	C0030662
27648744	problem gambling	C0850474
27648744	confidence interval	C0009667
27648744	CI	C0009667
27648744	CI	C0009667
27648744	gambling	C0016995
27648744	playing lotteries	C0018464
27648744	standard error	C1710181
27648744	SE	C1710181
27648744	prevalence	C0033105
27648744	females	C0086287
27648744	older age groups	C0001792
27648744	psychiatric disorders	C0004936
27648744	pathological gamblers	C0030662
27648744	alcohol abuse	C0085762
27648744	nicotine dependence	C0028043
27648744	drug use disorder	C0013222
27648744	Pathological gambling	C0030662
27648744	major depressive episodes	C0024517
27648744	drug dependence	C1510472
27648744	intermittent explosive disorder	C0021776
27648744	pathological gambling	C0030662
27648744	major depressive episode	C0024517
27648744	adjusted odds ratio	C0028873
27648744	AOR	C0028873
27648744	CI	C0009667
27648744	recognition	C0524637
27648744	gambling disorders	C0030662
27648744	public health	C3244304
27648744	Thailand	C0039725
27648744	culturally	C0220814
27648744	preventive	C1456501
27648744	pathological gamblers	C0030662
27648744	substance use disorders	C0038586
27648744	major depression	C1269683
27649458	Synovial sarcoma	C0039101
27649458	hypopharynx	C0020629
27649458	pediatric	C1521725
27649458	patient	C0030705
27649458	Case report	C0085973
27649458	Synovial sarcoma	C0039101
27649458	SS	C0039101
27649458	soft tissue	C0225317
27649458	sarcoma	C1261473
27649458	head and neck sarcomas	C1827431
27649458	SS	C0039101
27649458	Head	C0018670
27649458	Neck	C0027530
27649458	pediatric	C1521725
27649458	population	C1257890
27649458	SS	C0039101
27649458	rare	C0522498
27649458	head & neck malignancy	C1827431
27649458	boy	C0870221
27649458	diagnosed	C0011900
27649458	SS	C0039101
27649458	hypopharynx	C0020629
27649458	treated by	C0332293
27649458	surgical excision	C0728940
27649458	post operative	C0241311
27649458	radio	C1522449
27649458	chemotherapy	C3665472
27649458	anatomical location	C0923870
27649458	functional	C0205245
27649458	challenges	C0805586
27649458	swallowing	C0011167
27649458	phonation	C0031577
27649458	respiration	C0035203
27649458	pediatric	C1521725
27649458	population	C1257890
27649458	Pre-operative	C0445204
27649458	post-operative	C0241311
27649458	histopathological	C0243140
27649458	diagnosis	C0011900
27649458	SS	C0039101
27649458	Optimal	C2698651
27649458	treatment	C0087111
27649458	Head	C0018670
27649458	Neck	C0027530
27649458	SS	C0039101
27649458	functional	C0205245
27649458	oncologic	C0205478
27649458	aspects	C1879746
27649458	SS	C0039101
27649458	rare	C0522498
27649458	head & neck malignancy	C1827431
27649458	pediatric	C1521725
27649458	population	C1257890
27649458	multifaceted	C0205291
27649458	challenges	C0805586
27649458	post-operative	C0241311
27649458	histopathological	C0243140
27649458	diagnosis	C0011900
27649458	optimal	C2698651
27649458	modality	C0695347
27649458	treatment	C0087111
27649458	Clinical judgment	C0237512
27649458	pediatric	C1521725
27649458	population	C1257890
27649458	tumor free margins	C0332648
27649458	organ preservation	C0029209
27649458	head	C0018670
27649458	neck	C0027530
27649458	region	C0005898
27649982	Ocular hypotensive	C0028841
27649982	effect	C1280500
27649982	EP3	C1449580
27649982	FP	C0662784
27649982	agonist	C2987634
27649982	ONO-9054	C4277062
27649982	Xalatan	C0593887
27649982	day	C0439228
27649982	double-masked	C0013072
27649982	randomised	C0439605
27649982	study	C2603343
27649982	ONO-9054	C4277062
27649982	reduction	C0392756
27649982	intraocular pressure	C0021888
27649982	IOP	C0021888
27649982	patients	C0030705
27649982	ocular hypertension	C0028841
27649982	OHT	C0028841
27649982	open-angle glaucoma	C0017612
27649982	OAG	C0017612
27649982	study	C2603343
27649982	EP3	C1449580
27649982	FP	C0662784
27649982	agonist	C2987634
27649982	ONO-9054	C4277062
27649982	FP	C0662784
27649982	agonist	C2987634
27649982	Xalatan	C0593887
27649982	Adults	C0001675
27649982	OAG	C0017612
27649982	OHT	C0028841
27649982	IOP	C0021888
27649982	ONO-9054	C4277062
27649982	Xalatan	C0593887
27649982	daily	C0332173
27649982	days	C0439228
27649982	Day	C0439228
27649982	IOP	C0021888
27649982	ONO-9054	C4277062
27649982	Xalatan	C0593887
27649982	IOPs	C0021888
27649982	decrease	C0547047
27649982	IOP	C0021888
27649982	ONO-9054	C4277062
27649982	day	C0439228
27649982	IOP	C0021888
27649982	reduction	C0392756
27649982	ONO-9054	C4277062
27649982	Xalatan	C0593887
27649982	post hoc analyses	C0936012
27649982	IOPs	C0021888
27649982	day	C0439228
27649982	ONO-9054	C4277062
27649982	Xalatan	C0593887
27649982	IOP	C0021888
27649982	ONO-9054	C4277062
27649982	Xalatan	C0593887
27649982	post hoc analysis	C0936012
27649982	ONO-9054	C4277062
27649982	IOP	C0021888
27649982	IOPs	C0021888
27649982	Xalatan	C0593887
27649982	ONO-9054	C4277062
27649982	IOP	C0021888
27649982	Xalatan	C0593887
27650531	Whole-body strength training	C0872279
27650531	Huber Motion Lab	C0014672
27650531	traditional strength training	C0872279
27650531	cardiac rehabilitation	C0700431
27650531	randomized controlled study	C0681867
27650531	Isometric strengthening	C0022206
27650531	patients	C0030705
27650531	coronary heart disease	C0010068
27650531	CHD	C0010068
27650531	potential side effects	C0879626
27650531	lack	C0332268
27650531	appropriate	C1548787
27650531	reliable	C3858758
27650531	devices	C0699733
27650531	modes	C1513371
27650531	resistance training	C0872279
27650531	mode	C1513371
27650531	Huber Motion Lab	C0014672
27650531	HML	C0014672
27650531	traditional strength training	C0872279
27650531	TST	C0872279
27650531	CHD	C0010068
27650531	patients	C0030705
27650531	cardiac rehabilitation	C0700431
27650531	patients	C0030705
27650531	HML	C0014672
27650531	TST	C0872279
27650531	Patients	C0030705
27650531	blinded	C0150108
27650531	evaluation	C0220825
27650531	rehabilitation program	C0034991
27650531	testing for cardiopulmonary exercise	C2959886
27650531	maximal isometric voluntary contraction	C0430022
27650531	endothelial	C0014257
27650531	function	C1254358
27650531	body composition	C0005885
27650531	weeks	C0439230
27650531	training	C0220931
27650531	groups	C0441833
27650531	body composition	C0005885
27650531	anthropometric	C0003188
27650531	characteristics	C1521970
27650531	endothelial	C0014257
27650531	function	C1254358
27650531	HML	C0014672
27650531	peak	C0444505
27650531	power output	C0445194
27650531	maximal	C0205289
27650531	heart rate	C0018810
27650531	gain	C1517378
27650531	force	C0441722
27650531	measured	C0444706
27650531	greater	C1704243
27650531	training	C0015259
27650531	protocols	C2348563
27650531	CHD	C0010068
27650531	patients	C0030705
27650531	training protocol	C2348563
27650531	isometric contractions	C0022205
27650531	passive	C3686820
27650531	recovery	C2004454
27650531	HML	C0014672
27650531	rehabilitation programs	C0034991
27650531	patients	C0030705
27650531	CHD	C0010068
27650531	functional outcomes	C0205556
27653173	Percutaneous coronary intervention	C1532338
27653173	heart surgery	C0018821
27653173	learning	C0023185
27653173	needs of patients	C0686904
27653173	Jordan	C0022418
27653173	prioritize	C0549179
27653173	perceived	C0030971
27653173	learning	C0023185
27653173	needs of patients	C0686904
27653173	percutaneous coronary intervention	C1532338
27653173	open-heart surgery	C0189745
27653173	learning	C0023185
27653173	post-cardiac intervention	C0184661
27653173	patients	C0030705
27653173	health education programmes	C0679897
27653173	patient	C0030705
27653173	central care	C1279810
27653173	design	C1707689
27653173	convenience	C3831015
27653173	sample	C1257890
27653173	patients	C0030705
27653173	percutaneous coronary intervention	C1532338
27653173	patients	C0030705
27653173	open-heart surgery	C0189745
27653173	patients	C0030705
27653173	Participants	C0679646
27653173	Patient	C0030705
27653173	Learning Needs Scale	C0282574
27653173	Data	C1511726
27653173	Patients	C0030705
27653173	groups	C0441833
27653173	health and recovery related information	C0846605
27653173	learning need	C0023185
27653173	topics	C1555712
27653173	priority	C0549179
27653173	learning	C0023185
27653173	patient groups	C0030705
27653173	information	C1533716
27653173	wound care	C0886052
27653173	priority	C0549179
27653173	learning	C0023185
27653173	topic	C1555712
27653173	physical activity	C0026606
27653173	learning	C0023185
27653173	needs	C0027552
27653173	groups	C0441833
27653173	educational secondary prevention programmes	C0679717
27653173	patients	C0030705
27653173	headings	C0038545
27653173	needs	C0027552
27653173	cardiac	C0018787
27653173	interventional procedure	C0184661
27653173	wound care	C0886052
27653173	medications	C2081612
27653173	learning	C0023185
27653173	needs	C0027552
27653173	patients	C0030705
27653173	health policy	C0018735
27653173	decision makers	C0242170
27653173	topics	C1555712
27653173	time	C0040223
27653173	hospital discharge	C0586003
27653173	policy	C0018735
27653173	patients	C0030705
27653173	learning	C0023185
27653173	needs	C0027552
27653173	establishment	C0442594
27653173	managerial support	C0037438
27653173	patients	C0030705
27653173	learning	C0023185
27653173	needs	C0027552
27653173	discharge	C0586003
27653173	health services	C0018747
27653173	support	C0037438
27653173	patients	C0030705
27653173	hospital discharge	C0586003
27653173	Secondary prevention programmes	C0679717
27653173	health education	C0018701
27653173	topics	C1555712
27653173	patients	C0030705
27653173	priority	C0549179
27653173	patients' needs	C0686904
27653173	patients	C0030705
27653173	information	C1533716
27653173	needs	C0027552
27653173	learning	C0023185
27653173	environment	C0014406
27653173	patients	C0030705
27653173	families	C0015576
27653736	Complications	C0009566
27653736	Events	C0441471
27653736	Hepatectomy	C0019144
27653736	Living-Related Liver Donation	C1318453
27653736	Italian	C0022277
27653736	Single Center	C0475309
27653736	Report	C0684224
27653736	Cases	C0868928
27653736	healthy	C3898900
27653736	individuals	C0237401
27653736	liver living donors	C0348050
27653736	complications	C0009566
27653736	surgery	C0543467
27653736	complications	C0009566
27653736	living donor	C0348050
27653736	management	C1273870
27653736	safety	C0036043
27653736	retrospective study	C0035363
27653736	database	C0242356
27653736	analysis	C0936012
27653736	perioperative	C1518988
27653736	medium-term	C1254367
27653736	long-term	C0443252
27653736	complications	C0009566
27653736	events	C0441471
27653736	single center	C0475309
27653736	liver resections	C0019144
27653736	adult	C0001675
27653736	adult	C0001675
27653736	living-donor	C0348050
27653736	liver transplantation	C0023911
27653736	living donors	C0348050
27653736	surgery	C0543467
27653736	No	C1513916
27653736	living donor	C0348050
27653736	mortality	C0178686
27653736	patients	C0030705
27653736	complication	C0009566
27653736	patients	C0030705
27653736	mild	C2945599
27653736	long-term	C0443252
27653736	dysfunction	C3887504
27653736	hepatectomies	C0019144
27653736	events	C0441471
27653736	strategy	C0679199
27653736	assessment	C0220825
27653736	living donor	C0348050
27653736	complications	C0009566
27653736	selection	C1707391
27653736	center	C0475309
27653736	patient outcome	C1547647
27653736	reports	C0684224
27658531	Tooth wear	C2717979
27658531	quantify	C1709793
27658531	intra-specific	C0205369
27658531	variations	C0205419
27658531	diet	C0012155
27658531	chewing	C0024888
27658531	movements	C0026649
27658531	mammals	C0024660
27658531	tooth	C0040426
27658531	function	C0542341
27658531	efficiency	C0013682
27658531	mechanical	C0376706
27658531	properties	C0871161
27658531	food	C0016452
27658531	chewing	C0024888
27658531	dynamics	C0729333
27658531	aspects	C1879746
27658531	studied	C2603343
27658531	intra-specific	C0205369
27658531	3D	C0450363
27658531	dental	C1550246
27658531	surface	C0205148
27658531	texture	C0449582
27658531	analysis	C0936012
27658531	sample	C2347026
27658531	field voles	C0042947
27658531	Microtus agrestis	C1002449
27658531	Finnish Lapland	C0016132
27658531	seasons	C0036497
27658531	localities	C2828208
27658531	test	C0039593
27658531	inter-population	C1257890
27658531	variations	C0205419
27658531	intra-individual	C1257890
27658531	variation	C0205419
27658531	chewing	C0024888
27658531	dynamics	C0729333
27658531	analysing	C0936012
27658531	facets	C0205148
27658531	second upper molars	C4082818
27658531	results	C0683954
27658531	localities	C2828208
27658531	environments	C0014406
27658531	voles	C0042947
27658531	feed	C2987508
27658531	texture	C0449582
27658531	data	C1511726
27658531	diets	C0012155
27658531	variable	C0439828
27658531	concentrations	C1446561
27658531	abrasives	C0450125
27658531	textures	C0449582
27658531	buccal facets	C1540415
27658531	isotropic	C1882365
27658531	direction	C0449738
27658531	deviates	C0012727
27658531	mesial	C1708982
27658531	chewing	C0024888
27658531	direction	C0449738
27658531	lingual	C0040408
27658531	facets	C0205148
27658531	interpret	C1285553
27658531	results	C0683954
27658531	food	C0016452
27658531	chewing	C0024888
27658531	movements	C0026649
27658531	food particles	C0311119
27658531	lingual	C0040408
27658531	molars	C0026367
27658531	dental microwear	C2717979
27658531	analysis	C0936012
27658531	fossils	C0016614
27658531	homologous	C0301883
27658531	facets	C0205148
27658531	molar	C0026367
27658531	functional unit	C0205245
27659310	Human cathelicidin LL-37	C3891304
27659310	antibiofilm effect	C0243095
27659310	EGCG	C0059438
27659310	Streptococcus mutans	C0038409
27659310	Streptococcus mutans	C0038409
27659310	biofilms	C0081786
27659310	resistance	C4281815
27659310	mechanism	C0441712
27659310	antimicrobial agents	C1136254
27659310	human	C0086418
27659310	oral cavity	C0226896
27659310	human cathelicidin LL-37	C3891304
27659310	inhibitory effects	C1280500
27659310	biofilm formation	C1325881
27659310	S. mutans	C0038409
27659310	interaction	C1704675
27659310	lipoteichoic acid	C0065067
27659310	LTA	C0065067
27659310	antibacterial	C0243095
27659310	biofilm	C0081786
27659310	dispersal abilities	C0332624
27659310	(-)-Epigallocatechin gallate	C0059438
27659310	EGCG	C0059438
27659310	tea	C0039400
27659310	catechins	C0007404
27659310	anti-infective potential	C0243095
27659310	inhibit the growth	C2249823
27659310	microorganisms	C0445623
27659310	biofilm formation	C1325881
27659310	evaluated	C0220825
27659310	LL-37	C3891304
27659310	EGCG	C0059438
27659310	antibiofilm effect	C0243095
27659310	EGCG	C0059438
27659310	S. mutans	C0038409
27659310	biofilm formation	C1325881
27659310	S. mutans	C0038409
27659310	strains	C1518614
27659310	children's	C0008059
27659310	saliva	C0036087
27659310	tested	C0039593
27659310	biofilm formation	C1325881
27659310	assay	C0005507
27659310	antibiofilm effect	C0243095
27659310	EGCG	C0059438
27659310	LL-37	C3891304
27659310	analyzed	C0936012
27659310	biofilm	C0081786
27659310	eradication	C2700409
27659310	concentration	C1446561
27659310	assay	C0005507
27659310	emission-scanning electron microscopy	C0026020
27659310	interaction	C1704675
27659310	EGCG	C0059438
27659310	LL-37	C3891304
27659310	LTA	C0065067
27659310	S. mutans	C0038409
27659310	quartz crystal microbalance analysis	C2936414
27659310	EGCG	C0059438
27659310	planktonic	C0032071
27659310	S. mutans	C0038409
27659310	biofilm formation	C1325881
27659310	bacteria cells	C0004611
27659310	biofilms	C0081786
27659310	concentration	C1446561
27659310	EGCG	C0059438
27659310	LTA	C0065067
27659310	LL-37	C3891304
27659310	bactericidal activity	C0544570
27659310	EGCG	C0059438
27659310	biofilm formation	C1325881
27659310	biofilms	C0081786
27659310	quantitative	C0392762
27659310	crystal violet	C0017440
27659310	staining	C0487602
27659310	emission-scanning electron microscopy	C0026020
27659310	quartz crystal microbalance analysis	C2936414
27659310	LL-37	C3891304
27659310	interacted	C1704675
27659310	EGCG	C0059438
27659310	binding	C1167622
27659310	EGCG	C0059438
27659310	LTA	C0065067
27659310	S. mutans	C0038409
27659310	LL-37	C3891304
27659310	antibiofilm effect	C0243095
27659310	EGCG	C0059438
27659310	S. mutans	C0038409
27659310	dental treatment	C0011331
27659310	LL-37	C3891304
27659310	antibiofilm compound	C1254351
27660855	Discovery	C1880355
27660855	Orally	C0226896
27660855	Efficacious	C1704419
27660855	Phosphoinositide-3-Kinase delta	C1450115
27660855	Inhibitors	C0014432
27660855	Improved	C0184511
27660855	Metabolic	C0311400
27660855	Stability	C0205360
27660855	Aberrant signaling	C3537152
27660855	phosphoinositide-3-kinase delta	C1450115
27660855	PI3K-delta	C1450115
27660855	pathologies	C0677042
27660855	hematological malignancies	C0376545
27660855	rheumatoid arthritis	C0003873
27660855	discovery	C1880355
27660855	optimization	C2698650
27660855	in vivo	C1515655
27660855	evaluation	C0220825
27660855	pyridine-containing	C0576798
27660855	PI3K-delta	C1450115
27660855	inhibitors	C0014432
27660855	discovery	C1880355
27660855	35	C1254351
27660855	inhibitor	C0014432
27660855	PI3K-delta	C1450115
27660855	pharmacokinetic profile	C0031328
27660855	efficacious	C1704419
27660855	rodent model	C1519106
27660855	rheumatoid arthritis	C0003873
27665258	Mobile phone	C1136360
27665258	use	C0457083
27665258	behavioural problems	C0233514
27665258	concentration	C0086045
27665258	capacity	C1516240
27665258	adolescents	C0205653
27665258	prospective study	C0033522
27665258	study	C2603343
27665258	investigate	C1292732
27665258	exposure to	C0332157
27665258	radiofrequency electromagnetic fields	C0013835
27665258	RF-EMF	C0013835
27665258	mobile phones	C1136360
27665258	wireless communication devices	C3825042
27665258	behavioural problems	C0233514
27665258	concentration	C0086045
27665258	capacity	C1516240
27665258	adolescents	C0205653
27665258	HERMES	C0681814
27665258	Health	C0018684
27665258	Effects	C1280500
27665258	Related	C0439849
27665258	Mobile phonE	C1136360
27665258	adolescentS	C0205653
27665258	sample	C0681850
27665258	Swiss	C0241315
27665258	adolescents	C0205653
27665258	aged	C0001779
27665258	years	C0439234
27665258	Behavioural problems	C0233514
27665258	assessed	C1516048
27665258	Strengths and Difficulties Questionnaire	C3472494
27665258	SDQ	C3472494
27665258	concentration	C0086045
27665258	capacity	C1516240
27665258	adolescents	C0205653
27665258	measured	C0444706
27665258	standardized computerized cognitive test	C0237892
27665258	FAKT	C0282574
27665258	Cross-sectional	C0010362
27665258	longitudinal	C0023981
27665258	1year	C0439234
27665258	follow-up	C0589120
27665258	analyses	C0936012
27665258	performed	C0884358
27665258	investigate	C1292732
27665258	associations	C0439849
27665258	behavioural problems	C0233514
27665258	concentration	C0086045
27665258	capacity	C1516240
27665258	different	C1705242
27665258	exposure	C0332157
27665258	measures	C0079809
27665258	self-reported	C2700446
27665258	operator	C0335223
27665258	wireless communication device	C3825042
27665258	cumulative	C1511559
27665258	RF-EMF	C0013835
27665258	brain	C0006104
27665258	whole body	C0444584
27665258	measured	C0444706
27665258	RF-EMF	C0013835
27665258	exposure	C0332157
27665258	cross-sectional analyses	C0010362
27665258	behavioural problems	C0233514
27665258	associated with	C0332281
27665258	self-reported	C0684224
27665258	wireless device	C0699733
27665258	use	C0457083
27665258	measures	C0079809
27665258	operator	C0335223
27665258	mobile phone	C1136360
27665258	use	C0457083
27665258	measures	C0079809
27665258	concentration	C0086045
27665258	capacity	C1516240
27665258	associated with	C0332281
27665258	self-reported	C2700446
27665258	operator	C0335223
27665258	exposures	C0332157
27665258	longitudinal analyses	C0023981
27665258	absence	C0332197
27665258	associations	C0439849
27665258	lack	C0332268
27665258	consistent	C0332290
27665258	exposure	C0332157
27665258	patterns	C0449774
27665258	longitudinal analyses	C0023981
27665258	behavioural problems	C0233514
27665258	concentration	C0086045
27665258	capacity	C1516240
27665258	affected	C0392760
27665258	wireless communication devices	C3825042
27665258	RF-EMF	C0013835
27665258	exposure	C0332157
27665258	Information	C1533716
27665258	bias	C0242568
27665258	explanations	C0681841
27665258	cross-sectional findings	C0010362
27665545	Twisting method	C0449851
27665545	reducing	C0392756
27665545	friction	C0162691
27665545	insertion	C0021107
27665545	sheath	C1299426
27665545	introducer	C0179695
27665545	sheathless guiding catheter	C0221799
27665545	sheathless system	C0449913
27665545	inserts	C0441587
27665545	catheter	C0179724
27665545	directly	C1947931
27665545	artery	C0003842
27665545	reduce	C0392756
27665545	puncture	C1881711
27665545	site	C0230992
27665545	complications	C0274317
27665545	2-Fr reduction	C0332519
27665545	outer diameter	C4086674
27665545	gap	C3887622
27665545	dilator	C0180431
27665545	guiding catheter	C0221799
27665545	sheathless system	C0449913
27665545	larger	C0549177
27665545	gap	C3887622
27665545	dilator	C0180431
27665545	sheath	C1299426
27665545	introducer system	C0179695
27665545	insertion	C0021107
27665545	resistance	C1880315
27665545	twisting method	C0449851
27665545	rapid	C0456962
27665545	alternating	C0332270
27665545	rotation	C0035868
27665545	device	C0025080
27665545	insertion	C0021107
27665545	insertion	C0021107
27665545	reduce	C0392756
27665545	insertion	C0021107
27665545	resistance	C1880315
27665545	effective	C1704419
27665545	sheathless system	C0449913
27665545	larger	C0549177
27665545	gap	C3887622
27665545	effect of	C1704420
27665545	size	C0456389
27665545	reduction	C0332519
27665545	sheathless system	C0449913
27665545	effect of	C1704420
27665545	insertion	C0021107
27665545	resistance	C1880315
27665545	reduction	C0392756
27665545	twisting method	C0449851
27665545	insertion	C0021107
27665545	simulator	C0183309
27665545	compared	C1707455
27665545	insertion	C0021107
27665545	resistance	C1880315
27665545	5-Fr sheath	C1299426
27665545	introducer	C0179695
27665545	5-Fr sheathless system	C0449913
27665545	twisting method	C0449851
27665545	insertion	C0021107
27665545	simulator	C0183309
27665545	sheath	C1299426
27665545	introducer	C0179695
27665545	sheathless system	C0449913
27665545	mock	C0562577
27665545	artery	C0003842
27665545	5-mm urethane	C2721056
27665545	1-mm rubber sheet	C0183069
27665545	electrical motor	C1705994
27665545	twisting	C0449851
27665545	motion	C0026597
27665545	crank shaft	C1705197
27665545	Insertion	C0021107
27665545	resistance	C1880315
27665545	penetration	C0205321
27665545	measured	C0444706
27665545	tension meter	C1706378
27665545	insertion	C0021107
27665545	resistance	C1880315
27665545	5-Fr sheathless system	C0449913
27665545	5-Fr sheath	C1299426
27665545	introducer	C0179695
27665545	resistance	C1880315
27665545	reduced	C0392756
27665545	twisting	C0449851
27665545	sheathed	C0179724
27665545	sheathless catheters	C0179724
27665545	conclusion	C1707478
27665545	benefits	C0814225
27665545	twisting	C0449851
27665545	insertion	C0021107
27665545	sheathless guiding catheter	C0221799
27665545	reduction	C0392756
27665545	puncture	C1881711
27665545	site	C0230992
27665545	complications	C0274317
27665550	Unconventional	C2700116
27665550	Protein Secretion	C1159339
27665550	Plants	C0032098
27665550	Unconventional	C2700116
27665550	protein secretion	C1159339
27665550	UPS	C1159339
27665550	describes	C1552738
27665550	secretion pathways	C1159342
27665550	several	C0443302
27665550	canonical	C0870245
27665550	secretion	C0036536
27665550	plasma membrane	C0007603
27665550	involve	C1314939
27665550	secretion	C0036536
27665550	proteins	C0033684
27665550	alternatives	C1523987
27665550	conventional	C3538928
27665550	secretion	C0036536
27665550	primarily	C0205225
27665550	observed	C1441672
27665550	studied	C0008972
27665550	yeast	C0043393
27665550	animal cells	C0007634
27665550	sessile	C0205348
27665550	plants	C0032098
27665550	unique	C1710548
27665550	adapt to adverse conditions	C0001400
27665550	environmental challenges	C0557737
27665550	attention	C0004268
27665550	unconventional	C2700116
27665550	secretion pathways	C1159342
27665550	plant cells	C3178867
27665550	proteins	C0033684
27665550	identified	C0205396
27665550	proteomic studies	C0872252
27665550	UPS	C1159339
27665550	pathways	C1705987
27665550	plants	C0032098
27665550	induction	C0205263
27665550	UPS	C1159339
27665550	pathways	C1705987
27665550	correlated	C1707520
27665550	pathogenesis	C0699748
27665550	stress responses	C2350025
27665550	UPS	C1159339
27665550	comprehensively	C1880156
27665550	organizing	C1300196
27665550	proteins	C0033684
27665550	apoplast	C1325756
27665550	UPS	C1159339
27665550	establishment	C0443211
27665550	collection	C1516698
27665550	plant proteins	C0032089
27665550	UPS	C1159339
27665550	pathways	C1705987
27665550	endomembrane	C1167315
27665550	trafficking	C0599896
27665550	several	C0443302
27665550	novel	C0205314
27665550	enabling	C1171285
27665550	technologies	C0039421
27665550	vesicle	C1622418
27665550	proteomics	C0872252
27665550	chemical	C0220806
27665550	genomics	C0887950
27665550	potential	C3245505
27665550	dissecting	C0205239
27665550	secretion pathways	C1159342
27665550	providing	C1999230
27665550	information	C1533716
27665550	induce	C0205263
27669010	Neospora caninum	C0242906
27669010	Axis Deer	C0999597
27669010	Axis axis	C0325211
27669010	Fallow Deer	C0325214
27669010	Dama dama	C0325214
27669010	Northern	C1709269
27669010	Mexico	C0025885
27669010	Serum samples	C1550100
27669010	axis deer	C0999597
27669010	Axis axis	C0325211
27669010	fallow deer	C0325214
27669010	Dama dama	C0325214
27669010	enzyme-linked immunosorbent assay	C0014441
27669010	Neospora caninum antibodies	C0807090
27669010	axis	C0325211
27669010	fallow deer	C0325214
27669010	positive	C1514241
27669010	N. caninum antibodies	C0807090
27670138	ABBA study	C2603343
27670138	bulimia nervosa	C2267227
27670138	binge eating disorder	C0596170
27670138	randomised controlled trial	C0206035
27670138	symptoms	C1457887
27670138	bulimia nervosa	C2267227
27670138	BN	C2267227
27670138	binge eating disorder	C0596170
27670138	BED	C0596170
27670138	recurrent episodes of binge eating	C1843777
27670138	negative psychological	C1306597
27670138	physical consequences	C1446390
27670138	BN/BED	C0013473
27670138	patients	C0030705
27670138	tendencies towards food	C0003618
27670138	cognitive bias	C0237494
27670138	information processing	C0700301
27670138	Cognitive bias modification	C3162263
27670138	CBM	C3162263
27670138	biases	C0242568
27670138	treating	C0087111
27670138	mental disorders	C0004936
27670138	alcohol addiction	C0001973
27670138	alcohol cues	C0679056
27670138	relapse	C0035020
27670138	rates	C1521828
27670138	CBM	C3162263
27670138	bias modification	C1554963
27670138	data	C1511726
27670138	proof-of-concept study	C2603343
27670138	people	C0027361
27670138	food craving	C0872380
27670138	CBM	C1554963
27670138	treatment approach	C0679624
27670138	BN/BED	C0013473
27670138	BN/BED	C0013473
27670138	addictive disorders	C0085281
27670138	rationale	C2699007
27670138	bias modification	C1554963
27670138	sham training	C3897046
27670138	bias modification	C1554963
27670138	binge-eating episodes	C1843777
27670138	BN/BED	C0013473
27670138	patients	C0030705
27670138	pre-treatment	C2709094
27670138	CBM	C3162263
27670138	global	C2348867
27670138	eating disorder psychopathology	C0556019
27670138	trait	C0599883
27670138	cue-elicited food craving	C0872380
27670138	food intake	C0013470
27670138	attentional bias	C4277667
27670138	visual food cues	C0010439
27670138	Treatment acceptance	C3468361
27670138	attrition rates	C0814623
27670138	responses	C1706817
27670138	double-blind	C0013072
27670138	randomised	C0034656
27670138	placebo-controlled	C0599724
27670138	parallel-group superiority trial	C0680731
27670138	BN/BED	C0013473
27670138	patients	C0030705
27670138	bias towards food	C0242568
27670138	implicit learning paradigm	C0681797
27670138	Patients	C0030705
27670138	sham	C3897046
27670138	similar task	C3540678
27670138	food cues	C0010439
27670138	bias	C0242568
27670138	public registration	C3897463
27670138	randomisation	C0034656
27670138	central study office	C1522486
27670138	standardisation of the treatments	C0038136
27670138	blinding of assessors	C0150108
27670138	randomised controlled trial	C0206035
27670138	bias modification	C1554963
27670138	clinical BN/BED sample	C0008976
27670138	bias modification	C1554963
27670138	BN/BED	C0013473
27670138	treatment	C0087111
27677517	Protein	C0033684
27677517	Design	C1707689
27677517	Nanostructural Engineering	C0033629
27677517	Remarks	C0282411
27677517	chapter	C0005990
27677517	conclusions	C1830648
27677517	book	C0006002
27677517	research	C0035168
27677517	field	C0683945
27677517	protein	C0033684
27677517	design	C1707689
27677517	nanostructural engineering	C0033629
27677517	research field	C0683945
27677517	multidisciplinary	C0205556
27677517	research efforts	C0035168
27677517	design	C1707689
27677517	synthetic protein	C0597552
27677517	nanostructures	C1450053
27677517	functional	C0205245
27677517	materials	C0520510
27677517	progress	C1272688
27677517	chapters	C0005990
27677517	book	C0006002
27677517	examples	C1707959
27677517	advances	C3854260
27677517	use of	C1524063
27677517	proteins	C0033684
27677517	peptides	C0030956
27677517	building blocks	C1254372
27677517	fabrication	C1254366
27677517	architectures	C1254372
27677517	functional	C0205245
27677517	nanostructures	C1450053
27677517	assemblies	C1706853
27677517	materials	C0520510
27677517	strategies	C0025664
27677517	prepare	C1521827
27677517	functional	C0205245
27677517	protein	C0033684
27677517	nanostructures	C1450053
27677517	nanostructured materials	C1450053
27677517	devices	C0699733
27677517	aspects	C1879746
27677517	research	C0035168
27677517	community	C0009462
27677517	developments	C0035170
27677842	Synthesis	C1883254
27677842	characterization	C1880022
27677842	drug	C1254351
27677842	loading	C1708715
27677842	property	C0871161
27677842	Monomethoxy-Poly(ethylene glycol)-Poly(ε-caprolactone)-Poly(D,L-lactide) (MPEG-PCLA) copolymers	C0032521
27677842	Amphiphilic block copolymers	C0032521
27677842	drug delivery systems	C0085104
27677842	monomethoxy-poly (ethylene glycol)-poly (ε-caprolactone-co-D,L-lactide) (MPEG-PCLA) copolymers	C0032521
27677842	composition	C0243176
27677842	poly (ε-caprolactone)	C0137734
27677842	PCL	C0137734
27677842	poly (D,L-lactide)	C0071444
27677842	PDLLA	C0071444
27677842	ring-opening copolymerization	C1880180
27677842	ε-CL	C0908527
27677842	D,L-LA	C0293984
27677842	MPEG	C0066763
27677842	stannous octoate	C0963887
27677842	structure	C0678594
27677842	molecular weight	C0026385
27677842	characterized	C1880022
27677842	nuclear magnetic resonance	C0028580
27677842	NMR	C0028580
27677842	gel permeation chromatography	C0008559
27677842	GPC	C0008559
27677842	crystallinity	C0444626
27677842	hydrophilicity	C0475370
27677842	thermal	C0018837
27677842	stability	C0205360
27677842	hydrolytic	C0020291
27677842	degradation behavior	C0243125
27677842	amphiphilic MPEG-PCLA copolymers	C0032521
27677842	properties	C0871161
27677842	composition	C0243176
27677842	PCLA	C1744269
27677842	clinical applications	C0683325
27677842	drug	C1254351
27677842	loading	C1708715
27677842	properties	C0871161
27677842	Docetaxel	C0246415
27677842	DTX	C0246415
27677842	MPEG-PCLA	C0032521
27677842	micelles	C0025938
27677842	high	C0205250
27677842	loading	C1708715
27677842	capacity	C1516240
27677842	encapsulation	C2348438
27677842	efficiency	C0013682
27677842	lyophilized	C0205556
27677842	DTX	C0246415
27677842	MPEG-PCLA	C0032521
27677842	micelles	C0025938
27677842	MPEG-PCL	C0032521
27677842	micelles	C0025938
27677842	re-dissolved	C0205245
27677842	normal saline	C0445115
27677842	DTX	C0246415
27677842	MPEG-PCLA	C0032521
27677842	micelles	C0025938
27677842	enhanced	C2349975
27677842	antitumor	C2986475
27677842	activity	C0441655
27677842	DTX	C0246415
27677842	DTX	C0246415
27677842	micelles	C0025938
27677842	slower	C0439834
27677842	sustained	C0443318
27677842	release	C1283071
27677842	behavior	C0871161
27677842	in vitro	C1533691
27677842	higher	C0205250
27677842	DTX	C0246415
27677842	concentration	C1264643
27677842	retention time	C0392762
27677842	in vivo	C1515655
27677842	MPEG-PCLA copolymer	C0032521
27677842	ratio	C0456603
27677842	PCL	C0137734
27677842	PDLLA	C0071444
27677842	drug delivery carrier	C0013161
27677842	DTX	C0246415
27678317	Thyroid cancer	C0007115
27678317	burden	C1516167
27678317	Central	C0007674
27678317	South America	C0037713
27678317	Incidence	C0021149
27678317	thyroid cancer	C0007115
27678317	TC	C0007115
27678317	rapidly	C0456962
27678317	increasing	C0442808
27678317	worldwide	C0043236
27678317	TC	C0007115
27678317	burden	C1516167
27678317	Central	C0007674
27678317	South America	C0037713
27678317	CSA	C0002454
27678317	geographic patterns	C0442527
27678317	trends	C0040833
27678317	TC	C0007115
27678317	sex	C0079399
27678317	CSA	C0002454
27678317	regional	C0683928
27678317	national-level	C0681788
27678317	incidence	C1708485
27678317	data	C1511726
27678317	population-based cancer registries	C1514227
27678317	countries	C0454664
27678317	cancer deaths	C1516192
27678317	WHO	C0043237
27678317	mortality	C0205848
27678317	database	C0242356
27678317	countries	C0454664
27678317	world	C2700280
27678317	age-standardized incidence rates	C1706747
27678317	ASRs	C1706747
27678317	age-standardized mortality rates	C1706748
27678317	ASMRs	C1706748
27678317	person	C0027361
27678317	years	C0439234
27678317	ASRs	C1706747
27678317	histological subtype	C0449574
27678317	estimated the annual percentage change	C0023732
27678317	EAPC	C0023732
27678317	time trends	C0040833
27678317	CSA	C0002454
27678317	countries	C0454664
27678317	TC	C0007115
27678317	incidence	C1708485
27678317	mortality rates	C0205848
27678317	highest	C1522410
27678317	TC	C0007115
27678317	ASRs	C1706747
27678317	females	C0086287
27678317	males	C0086582
27678317	Ecuador	C0013593
27678317	Brazil	C0006137
27678317	Costa Rica	C0010182
27678317	Colombia	C3245499
27678317	highest	C1522410
27678317	ASMRs	C1706748
27678317	Ecuador	C0013593
27678317	Colombia	C3245499
27678317	Mexico	C0025885
27678317	Peru	C0031238
27678317	Panama	C0030266
27678317	females	C0086287
27678317	males	C0086582
27678317	Papillary TC	C0238463
27678317	diagnosed	C0011900
27678317	histological subtype	C0449574
27678317	incidence pattern	C1708485
27678317	TC	C0007115
27678317	Argentinean	C0238689
27678317	Brazilian	C0238815
27678317	Chilean	C0239045
27678317	Costa Rican	C0239127
27678317	females	C0086287
27678317	TC	C0007115
27678317	incidence	C1708485
27678317	increased	C0205217
27678317	annually	C0332181
27678317	papillary TC	C0238463
27678317	increased	C0205217
27678317	annually	C0332181
27678317	mortality	C0205848
27678317	stable	C0205360
27678317	males	C0086582
27678317	trends	C0040833
27678317	TC	C0007115
27678317	stable	C0205360
27678317	TC	C0007115
27678317	occurred	C1709305
27678317	frequently	C0332183
27678317	females	C0086287
27678317	males	C0086582
27678317	overall	C1561607
27678317	high	C0205250
27678317	incidence	C1708485
27678317	low	C0205251
27678317	mortality	C0205848
27678317	TC	C0007115
27678317	suggest	C1705535
27678317	subclinical disease	C0277544
27678317	improved	C0332272
27678317	detection methods	C0449335
27679696	Histopathological	C0243140
27679696	Evaluation	C0220825
27679696	Effectiveness	C1280519
27679696	Glycyrrhizic Acid	C0061751
27679696	Radioprotector	C1318473
27679696	Development	C1527148
27679696	Radiation-Induced Lung Fibrosis	C0340126
27679696	Radiotherapy	C1522449
27679696	thorax	C0817096
27679696	lung inflammation	C0032285
27679696	fibrosis	C0034069
27679696	aim	C1947946
27679696	study	C2603343
27679696	investigate	C1292732
27679696	glycyrrhizic acid	C0061751
27679696	GLA	C0061751
27679696	development	C1527148
27679696	lung fibrosis	C0034069
27679696	irradiated	C1522449
27679696	animals	C0003062
27679696	Wistar rats	C0034716
27679696	groups	C0441833
27679696	Group A	C0441833
27679696	rats	C0034693
27679696	thoracic irradiation	C2169121
27679696	Rats	C0034693
27679696	group B	C0441833
27679696	GLA	C0061751
27679696	irradiation	C1522449
27679696	Group C	C0441833
27679696	GLA	C0061751
27679696	irradiation	C1522449
27679696	Group D	C0441833
27679696	GLA	C0061751
27679696	irradiation	C1522449
27679696	GLA	C0061751
27679696	administered	C1521801
27679696	dose	C0178602
27679696	body weight	C0005910
27679696	intraperitoneal injection	C0021493
27679696	thoracic irradiation	C2169121
27679696	Radiation therapy	C1522449
27679696	Cobalt-60	C0303395
27679696	animals	C0003062
27679696	thoracic irradiation	C2169121
27679696	lungs	C0024109
27679696	dissected	C0205239
27679696	histopathological	C0243140
27679696	evaluation	C0220825
27679696	Histopathologically	C0243140
27679696	decrease	C0547047
27679696	thickening	C0205400
27679696	alveolar	C0225695
27679696	bronchial wall	C1180039
27679696	fibrous bands	C0334163
27679696	collagen	C0009325
27679696	animals	C0003062
27679696	group B	C0441833
27679696	animals	C0003062
27679696	group A	C0441833
27679696	experimental study	C0681814
27679696	administration	C0001555
27679696	GLA	C0061751
27679696	thoracic irradiation	C2169121
27679696	protective agent	C0033613
27679696	radiation-induced fibrosis	C0340126
27679696	animals	C0003062
27679696	model	C0012644
27682280	Avulsions	C0262386
27682280	Triceps Brachii	C0559502
27682280	injuries	C3263722
27682280	surgical treatment	C0543467
27682280	study	C2603343
27682280	clinical presentations	C2708283
27682280	intra -operative	C0456904
27682280	findings	C0243095
27682280	treatments	C0087111
27682280	outcome	C1274040
27682280	treatment	C0087111
27682280	injuries	C3263722
27682280	patients	C0030705
27682280	avulsion	C0262386
27682280	distal end	C0205108
27682280	triceps brachii (TB) tendon	C0448542
27682280	patients	C0030705
27682280	rupture	C3203359
27682280	avulsion	C0262386
27682280	distal end	C0205108
27682280	TB tendon	C0448542
27682280	medical records	C0025102
27682280	imaging files	C0242193
27682280	clinical	C0205210
27682280	outcomes	C1274040
27682280	follow up visit	C0589121
27682280	clinical	C0205210
27682280	outcomes	C1274040
27682280	Mayo Elbow Score	C0282574
27682280	follow-up visit	C0589121
27682280	patients	C0030705
27682280	male	C0086582
27682280	injury	C3263722
27682280	left hand	C0230371
27682280	hand	C0018563
27682280	age	C0001779
27682280	years	C0439234
27682280	bony	C0443157
27682280	fleck	C0009938
27682280	elbow	C0013769
27682280	lateral radiograph	C0202571
27682280	patients	C0030705
27682280	injuries	C3263722
27682280	intra-articular	C0442108
27682280	fractures	C0016658
27682280	medial collateral ligament rupture	C0840716
27682280	V-Y plasty	C0087111
27682280	distal	C0205108
27682280	TB	C0559502
27682280	patients	C0030705
27682280	surgery	C0543467
27682280	TB tendon	C0448542
27682280	rupture	C3203359
27682280	diagnosis	C1704656
27682280	upper -extremity trauma	C0749817
27682280	injuries	C3263722
27683416	Prolyl-4-hydroxylase 2	C1451071
27683416	3	C2002278
27683416	murine	C0591833
27683416	erythropoietin	C0014822
27683416	brain	C0006104
27683416	pericytes	C0598800
27683416	response	C1704632
27683416	systemic	C0205373
27683416	hypoxia	C0242184
27683416	increased	C0205217
27683416	production of red blood cells	C0014819
27683416	hypoxia-inducible factor	C0215848
27683416	HIF	C0215848
27683416	induction	C0205263
27683416	erythropoietin	C0014822
27683416	EPO	C0014822
27683416	EPO	C0014822
27683416	glycoprotein hormone	C0312438
27683416	normal erythropoiesis	C0014819
27683416	peritubular	C0456918
27683416	renal interstitial fibroblast-like cells	C1514842
27683416	cellular markers	C0005516
27683416	neuronal cells	C0027882
27683416	pericytes	C0598800
27683416	investigate	C1292732
27683416	EPO	C0014822
27683416	functional	C0205245
27683416	feature	C2348519
27683416	pericytes	C0598800
27683416	gene targeting	C0242613
27683416	von Hippel-Lindau	C0019562
27683416	prolyl-4-hydroxylase domain (PHD)/HIF	C3658213
27683416	cell	C0007634
27683416	expressing	C1171362
27683416	neural glial antigen 2	C1311695
27683416	molecular marker	C0005516
27683416	pericytes	C0598800
27683416	multiple organs	C0178784
27683416	pericytes	C0598800
27683416	brain	C0006104
27683416	EPO	C0014822
27683416	mice	C0026809
27683416	genetic	C0314603
27683416	HIF	C0215848
27683416	activation	C1879547
27683416	systemic	C0205373
27683416	hypoxia	C0242184
27683416	induction	C0205263
27683416	Epo	C0014822
27683416	high-resolution	C1719039
27683416	in situ hybridization	C0162788
27683416	brain	C0006104
27683416	pericytes	C0598800
27683416	cellular source	C0007634
27683416	Epo	C0014822
27683416	hypoxic	C0242184
27683416	brain	C0006104
27683416	Epo	C0014822
27683416	expressing	C1171362
27683416	cells	C0007634
27683416	Epo	C0014822
27683416	transcription	C0040649
27683416	brain	C0006104
27683416	pericytes	C0598800
27683416	HIF-2	C0215848
27683416	PHD2	C1451071
27683416	PHD3	C2002278
27683416	oxygen	C0030054
27683416	2-oxoglutarate	C1291208
27683416	prolyl-4-hydroxylases	C3658213
27683416	HIF	C0215848
27683416	activity	C0243102
27683416	experimental	C1517586
27683416	evidence	C3887511
27683416	pericytes	C0598800
27683416	brain	C0006104
27683416	oxygen sensors	C0183211
27683416	hypoxia	C0242184
27683416	EPO	C0014822
27683416	findings	C2607943
27683416	EPO	C0014822
27683416	functional	C0205245
27683416	feature	C2348519
27683416	pericytes	C0598800
27683416	brain	C0006104
27683416	kidney	C0022646
27686752	Patient Satisfaction	C0030702
27686752	Pharmacist	C0031323
27686752	Collaborative	C0282116
27686752	Follow-Up Care	C3899107
27686752	Ambulatory	C1561561
27686752	Rheumatology Clinic	C3812871
27686752	Patient satisfaction	C0030702
27686752	pharmacist	C0031323
27686752	intervention	C0184661
27686752	general outpatient clinics	C0029916
27686752	nurse-led care	C0086584
27686752	rheumatology clinics	C3812871
27686752	patient satisfaction	C0030702
27686752	care	C0017313
27686752	pharmacist	C0031323
27686752	physician	C0031831
27686752	collaborative model	C0596657
27686752	traditional physician model	C0596657
27686752	rheumatology clinic	C3812871
27686752	cross-sectional survey	C0010362
27686752	inflammatory arthritis	C0003864
27686752	patients	C0030705
27686752	follow-up visit	C0589121
27686752	Edmonton	C0681784
27686752	Alberta	C0681784
27686752	Canada	C0006823
27686752	ten-week period	C2347804
27686752	Patient satisfaction	C0030702
27686752	Leeds Satisfaction Questionnaire	C4039173
27686752	Likert scale	C0451267
27686752	six dimensions	C0454192
27686752	satisfaction	C0030702
27686752	collaborative care	C0086388
27686752	traditional physician models	C0596657
27686752	patients	C0030705
27686752	questionnaire	C1879301
27686752	collaborative care	C0086388
27686752	traditional physician model	C0596657
27686752	respondents	C0282122
27686752	female	C0086287
27686752	mean score for satisfaction	C0451370
27686752	six dimensions	C0454192
27686752	collaborative care group	C1273804
27686752	traditional physician group	C0031831
27686752	Patient satisfaction	C0030702
27686752	collaborative care group	C1273804
27686752	No difference	C3842396
27686752	participants	C0679646
27686752	pharmacist	C0031323
27686752	collaborative care model	C0596657
27686752	high expectations	C0679138
27686752	care of patients	C0030677
27686752	inflammatory arthritis	C0003864
27686752	pharmacists	C0031323
27686752	collaborative care	C0086388
27686752	care for patients	C0030677
27686752	rheumatology clinics	C3812871
27690050	Ontology	C1518584
27690050	High	C0205250
27690050	Level	C0441889
27690050	Context	C0449255
27690050	Inference	C0679201
27690050	Human Behavior	C3826173
27690050	Identification	C0205396
27690050	progress	C1280477
27690050	automatic	C0205554
27690050	identification	C0205396
27690050	individual	C0237401
27690050	primitives	C3645627
27690050	human behavior	C3826173
27690050	activities	C0026606
27690050	locations	C0450429
27690050	complex	C0439855
27690050	nature	C1262865
27690050	human behavior	C3826173
27690050	contextual	C0449255
27690050	information	C1533716
27690050	ontology	C1518584
27690050	method	C0025663
27690050	low	C0205251
27690050	level	C0441889
27690050	primitives	C3645627
27690050	behavior	C0004927
27690050	activity	C0026606
27690050	locations	C0450429
27690050	emotions	C0013987
27690050	unprecedented	C0439673
27690050	date	C0011008
27690050	high	C0205250
27690050	level	C0441889
27690050	context	C0449255
27690050	information	C1533716
27690050	contributes	C1880177
27690050	ontology	C1518584
27690050	low	C0205251
27690050	level	C0441889
27690050	high	C0205250
27690050	level	C0441889
27690050	context	C0449255
27690050	information	C1533716
27690050	relationships	C0439849
27690050	framework	C1709697
27690050	ontology	C1518584
27690050	models	C3161035
27690050	high	C0205250
27690050	level	C0441889
27690050	contexts	C0449255
27690050	event	C0441471
27690050	erroneously	C0205556
27690050	detected	C0442726
27690050	low	C0205251
27690050	evel	C0441889
27690050	context	C0449255
27690050	inference	C0679201
27690050	relevant	C2347946
27690050	set	C0036849
27690050	users	C1706077
27690050	instances	C1550608
27690050	scenarios	C0683579
27690050	users	C1706077
27692572	Characterization	C1880022
27692572	exposure	C0014412
27692572	epidemiological studies	C0002783
27692572	air pollution	C0001873
27692572	biodegradable	C0205556
27692572	wastes	C0043045
27692572	Misclassification	C0008902
27692572	comparison	C1707455
27692572	exposure	C0014412
27692572	assessment	C0220825
27692572	strategies	C0035171
27692572	exposure	C0014412
27692572	environmental	C0014406
27692572	epidemiologists	C1516908
27692572	misclassification	C0008902
27692572	exposures	C0014412
27692572	population	C1257890
27692572	epidemiological studies	C0002783
27692572	air pollution	C0001873
27692572	biodegradable	C0205556
27692572	wastes	C0043045
27692572	objective	C2985627
27692572	study	C2603343
27692572	investigate	C1292732
27692572	exposure	C0014412
27692572	air pollution	C0001873
27692572	biodegradable	C0205556
27692572	wastes	C0043045
27692572	analyzing	C0936012
27692572	misclassification	C0008902
27692572	exposure	C0014412
27692572	surrogates	C1551364
27692572	differentia	C0443199
27692572	misclassification	C0008902
27692572	effects	C1280500
27692572	misclassification	C0008902
27692572	health	C0018684
27692572	effect	C1280500
27692572	estimates	C0750572
27692572	interpretation	C1285553
27692572	epidemiological	C0002783
27692572	results	C0683954
27692572	exposure	C0014412
27692572	health outcomes	C1550208
27692572	cross validation	C0681935
27692572	exposure	C0014412
27692572	assessment	C0220825
27692572	studied	C2603343
27692572	ammonia	C0002607
27692572	concentrations	C1446561
27692572	residence	C0237096
27692572	Metric I	C0025867
27692572	distance	C0012751
27692572	source	C0449416
27692572	Metric II	C0025867
27692572	sources	C0449416
27692572	distances	C0012751
27692572	residence	C0237096
27692572	Metric IIIa	C0025867
27692572	b	C0025867
27692572	location	C0450429
27692572	region	C0017446
27692572	Metric IV	C0025867
27692572	Exposure-response models	C3161035
27692572	Metric I	C0025867
27692572	goodness-of-fit	C0870608
27692572	IV	C0025867
27692572	III	C0025867
27692572	II	C0025867
27692572	Metric I	C0025867
27692572	Metric IV	C0025867
27692572	results	C0683954
27692572	exposure	C0014412
27692572	misclassification	C0008902
27692572	analysis	C0936012
27692572	interpretation	C1285553
27692572	health	C0018684
27692572	effect	C1280500
27692572	estimates	C0750572
27692572	Metric IIIb	C0025867
27692572	IIIa	C0025867
27692572	II	C0025867
27692572	study	C2603343
27692572	NH3	C0002607
27692572	concentrations	C1446561
27692572	estimations	C0750572
27692572	exposure	C0014412
27692572	surrogates	C1551364
27692572	surrogates	C1551364
27692572	distance	C0012751
27692572	source	C0449416
27692572	populations	C1257890
27692572	studies	C2603343
27692696	De Ritis Ratio (AST/ALT)	C0364051
27692696	Significant Prognostic Factor	C1514474
27692696	Patients	C0030705
27692696	Upper Tract Urothelial Cancer	C0751571
27692696	Treated	C1522326
27692696	Surgery	C0038895
27692696	investigated	C1292732
27692696	clinical prognostic value	C0220901
27692696	preoperative	C0445204
27692696	De Ritis ratio (aspartate aminotransferase [AST]/alanine aminotransferase [ALT])	C0364051
27692696	postsurgical	C0231287
27692696	survival	C0038952
27692696	outcomes	C1274040
27692696	patients	C0030705
27692696	upper tract urothelial cancer	C0751571
27692696	UTUC	C0751571
27692696	retrospectively analyzed	C0035363
27692696	data	C1511726
27692696	patients	C0030705
27692696	radical nephrouretectomy	C0027732
27692696	UTUC	C0751571
27692696	Multivariate regression	C0681923
27692696	tests	C0392366
27692696	possible associations	C0439849
27692696	adverse pathologic events	C0030660
27692696	AST/ALT	C0364051
27692696	postoperative	C0032790
27692696	progression	C0449258
27692696	survival	C0038952
27692696	tested	C0039593
27692696	Kaplan-Meier analyses	C1720943
27692696	Cox proportional hazards models	C0010235
27692696	receiver operator characteristic curve	C0034772
27692696	AST/ALT	C0364051
27692696	cancer-specific mortality	C1516192
27692696	patients	C0030705
27692696	AST/ALT	C0364051
27692696	AST/ALT	C0364051
27692696	patients	C0030705
27692696	AST/ALT	C0364051
27692696	Kaplan-Meier analyses	C1720943
27692696	AST/ALT	C0364051
27692696	progression-free survival	C0242792
27692696	PFS	C0242792
27692696	cancer-specific survival	C0038954
27692696	CSS	C0038954
27692696	overall survival	C4086681
27692696	AST/ALT	C0364051
27692696	associated with	C0332281
27692696	T stage	C0475455
27692696	hazard ratio	C2985465
27692696	HR	C2985465
27692696	confidence interval	C0009667
27692696	CI	C0009667
27692696	higher cellular grade	C0441800
27692696	HR	C2985465
27692696	CI	C0009667
27692696	multivariate regression	C0681923
27692696	tests	C0392366
27692696	multivariate Cox analyses	C0026777
27692696	AST/ALT	C0364051
27692696	independent predictor	C2698872
27692696	PFS	C0242792
27692696	HR	C2985465
27692696	CI	C0009667
27692696	CSS	C0038954
27692696	HR	C2985465
27692696	overall survival	C4086681
27692696	HR	C2985465
27692696	CI	C0009667
27692696	preoperative	C0445204
27692696	AST/ALT	C0364051
27692696	significant predictor	C2698872
27692696	worse	C1457868
27692696	postoperative	C0032790
27692696	survival	C0038952
27692696	patients	C0030705
27692696	surgically treated	C0543467
27692696	UTUC	C0751571
27692696	prospective studies	C0033522
27692696	prognostic value	C0220901
27692696	preoperative	C0445204
27692696	AST/ALT	C0364051
27693948	Molecular simulation	C2717775
27693948	study	C2603343
27693948	concentration	C1446561
27693948	effects of	C1704420
27693948	rofecoxib	C0762662
27693948	POPC	C0044576
27693948	bilayer	C0023768
27693948	interactions	C0687133
27693948	rofecoxib	C0762662
27693948	POPC	C0044576
27693948	(1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine)	C0044576
27693948	bilayer	C0023768
27693948	studied	C2603343
27693948	using	C1524063
27693948	all-atom molecular dynamics simulation	C2717775
27693948	method	C0025663
27693948	POPC	C0044576
27693948	bilayer	C0023768
27693948	systems	C0449913
27693948	different	C1705242
27693948	number	C0237753
27693948	rofecoxib	C0762662
27693948	molecules	C0567416
27693948	constructed	C0205431
27693948	simulate	C1883725
27693948	different	C1705242
27693948	drug	C1254351
27693948	concentration	C1446561
27693948	free energy	C0678591
27693948	rofecoxib	C0762662
27693948	passing	C2828360
27693948	pure	C0205556
27693948	POPC	C0044576
27693948	bilayer	C0023768
27693948	minima	C1524031
27693948	high	C0205250
27693948	concentration	C1446561
27693948	model	C0026344
27693948	minimum	C1524031
27693948	free energy	C0678591
27693948	bilayer	C0023768
27693948	center	C0205099
27693948	energy change	C0678592
27693948	bulk water	C3663211
27693948	POPC	C0044576
27693948	bilayer	C0023768
27693948	increases	C0442805
27693948	central	C0205099
27693948	barrier	C0028778
27693948	cross	C2828360
27693948	hydrophobic core	C1254355
27693948	bilayer	C0023768
27693948	slightly	C0750482
27693948	decreases	C0547047
27693948	suggesting	C1705535
27693948	increasing	C0442808
27693948	drug	C1254351
27693948	concentration	C1446561
27693948	favorable	C0278250
27693948	rofecoxib	C0762662
27693948	partition	C1534709
27693948	bilayer	C0023768
27693948	pass	C2828360
27693948	bialyer	C0023768
27693948	center	C0205099
27693948	Energy	C1442080
27693948	analysis	C0936012
27693948	stabilization	C0205360
27693948	selected	C1707391
27693948	rofecoxib	C0762662
27693948	pre-inserted	C1883719
27693948	rofecoxib	C0762662
27693948	molecule	C0567416
27693948	van der Waals interaction	C2346563
27693948	energy	C1442080
27693948	predicted	C0681842
27693948	permeability	C0031164
27693948	rofecoxib	C0762662
27693948	high	C0205250
27693948	concentration	C1446561
27693948	model	C0026344
27693948	weakens	C1762617
27693948	compared	C1707455
27693948	low	C0205251
27693948	concentration	C1446561
27693948	model	C0026344
27694392	Short-term Variability	C2827666
27694392	Vitamin D	C0042866
27694392	Biomarkers	C0005516
27694392	Quantifying	C1709793
27694392	variability	C2827666
27694392	biomarkers	C0005516
27694392	important	C3898777
27694392	variability	C2827666
27694392	misclassification	C0008902
27694392	individuals	C0237401
27694392	variability	C2827666
27694392	important	C3898777
27694392	markers	C0005516
27694392	vitamin D metabolism	C1159433
27694392	repeatability study	C2603343
27694392	Atherosclerosis	C0004153
27694392	Risk	C0035647
27694392	Communities study participants	C1997894
27694392	female	C0086287
27694392	black	C0005680
27694392	age	C0001779
27694392	Fasting	C1976106
27694392	serum	C0229671
27694392	weeks	C0439230
27694392	Vitamin D binding protein	C0042872
27694392	VDBP	C0042872
27694392	25-hydroxyvitamin D	C0535968
27694392	25(OH)D	C0535968
27694392	measured	C0444706
27694392	LC-MS	C0872318
27694392	fibroblast growth factor	C0016026
27694392	FGF23	C0016026
27694392	parathyroid hormone	C0030520
27694392	PTH	C0030520
27694392	enzyme-linked immunoassay	C0086231
27694392	calcium	C0006675
27694392	phosphorus	C0031705
27694392	Roche Cobas 6000	C0022885
27694392	Free	C1996904
27694392	bioavailable	C0935763
27694392	25(OH)D	C0535968
27694392	calculated	C1441506
27694392	calculated	C1441506
27694392	within-person CV	C0681921
27694392	CVW	C0681921
27694392	intraclass correlation coefficient	C1707429
27694392	ICC	C1707429
27694392	Spearman rank correlation coefficient	C0242929
27694392	r	C0242929
27694392	percent	C0439165
27694392	reclassified	C0205542
27694392	CVW	C0681921
27694392	lowest	C1708760
27694392	calcium	C0006675
27694392	albumin	C0001924
27694392	25(OH)D	C0535968
27694392	VDBP	C0042872
27694392	phosphorus	C0031705
27694392	intermediate	C1550465
27694392	free	C1996904
27694392	25(OH)D	C0535968
27694392	bioavailable	C0935763
27694392	25(OH)D	C0535968
27694392	highest	C1522410
27694392	PTH	C0030520
27694392	FGF23	C0016026
27694392	Reclassification	C0008902
27694392	highest	C1522410
27694392	PTH	C0030520
27694392	VDBP	C0042872
27694392	phosphorus	C0031705
27694392	ICC	C1707429
27694392	r	C0242929
27694392	highest	C1522410
27694392	25(OH)D	C0535968
27694392	free	C1996904
27694392	25(OH)D	C0535968
27694392	bioavailable	C0935763
27694392	25(OH)D	C0535968
27694392	PTH	C0030520
27694392	lower	C0205251
27694392	approximately	C0332232
27694392	biomarkers	C0005516
27694392	week	C0439230
27694392	short-term variability	C2827666
27694392	assessed	C1516048
27694392	CVW	C0681921
27694392	quite low	C0205251
27694392	VDBP	C0042872
27694392	calcium	C0006675
27694392	phosphorus	C0031705
27694392	fairly high	C0205250
27694392	FGF23	C0016026
27694392	PTH	C0030520
27694392	multiple measurements	C0242485
27694392	FGF23	C0016026
27694392	PTH	C0030520
27694392	minimize	C1524031
27694392	misclassification	C0008902
27694392	results	C1274040
27694392	insight	C0233820
27694392	potential	C3245505
27694392	misclassification	C0008902
27694392	vitamin D	C0042866
27694392	markers	C0005516
27694392	research	C0035168
27694392	clinical settings	C4086198
27695327	Fabrication	C1522240
27695327	gelatin methacrylate	C0029224
27695327	nanohydroxyapatite	C0020326
27695327	microgel	C0017243
27695327	arrays	C1510941
27695327	periodontal tissue regeneration	C1448477
27695327	Periodontitis	C0031099
27695327	chronic infectious disease	C0151317
27695327	major cause	C1333617
27695327	tooth loss	C0080233
27695327	oral health	C0029162
27695327	issues	C0033213
27695327	world	C2700280
27695327	Periodontal tissue regeneration	C1448477
27695327	ultimate goal	C0018017
27695327	dentists	C0011441
27695327	researchers	C0035173
27695327	fabrication	C1522240
27695327	methods	C0025663
27695327	focused	C1285542
27695327	top-down tissue engineering	C0596171
27695327	strategy	C0679199
27695327	drawbacks	C0205556
27695327	remain	C0243095
27695327	low throughput	C0205556
27695327	diffusion	C0012222
27695327	properties	C0871161
27695327	resulting	C0332294
27695327	large sample size	C0242618
27695327	Gelatin methacrylate	C0029224
27695327	GelMA	C0029224
27695327	photocrosslinkable	C0178576
27695327	biocompatible	C0005479
27695327	hydrogel	C0063083
27695327	capacities	C1516240
27695327	enabling	C1171285
27695327	cell encapsulation	C3831155
27695327	regeneration of functional tissues	C1623047
27695327	novel	C0205314
27695327	method	C0449851
27695327	fabricate	C1522240
27695327	GelMA	C0029224
27695327	nanohydroxylapatite	C0020326
27695327	nHA	C0020326
27695327	microgel	C0017243
27695327	arrays	C1510941
27695327	photocrosslinkable	C0178576
27695327	strategy	C0679199
27695327	viability	C0007620
27695327	proliferation	C0596290
27695327	osteogenic differentiation	C1159974
27695327	in vivo	C1515655
27695327	osteogenesis	C0029433
27695327	human	C0086418
27695327	periodontal ligament	C0031093
27695327	stem cells	C0038250
27695327	hPDLSCs	C0038250
27695327	encapsulated	C0205223
27695327	microgels	C0017243
27695327	evaluated	C0220825
27695327	results	C1274040
27695327	suggested	C1705535
27695327	microgels	C0017243
27695327	provide	C1999230
27695327	potential	C3245505
27695327	periodontal tissue repair and regeneration	C1448477
27695327	Microgel	C0017243
27695327	arrays	C1510941
27695327	fabricated	C1522240
27695327	blending	C0678946
27695327	different	C1705242
27695327	weight ratios	C2919747
27695327	GelMA	C0029224
27695327	nHA	C0020326
27695327	hPDLSCs	C0038250
27695327	encapsulated	C0205223
27695327	GelMA	C0029224
27695327	nHA	C0020326
27695327	microgels	C0017243
27695327	ratios	C0456603
27695327	systematic	C0220922
27695327	evaluation	C0220825
27695327	cell viability	C0007620
27695327	proliferation	C0596290
27695327	osteogenic differentiation	C1159974
27695327	In vivo	C1515655
27695327	osteogenesis	C0029433
27695327	nude mice	C0025932
27695327	GelMA	C0029224
27695327	nHA	C0020326
27695327	microgels	C0017243
27695327	appropriate	C1548787
27695327	microarchitecture	C0205556
27695327	mechanical strength	C0808080
27695327	surface	C0205148
27695327	roughness	C0205556
27695327	cell adhesion	C0007577
27695327	proliferation	C0596290
27695327	GelMA	C0029224
27695327	nHA	C0020326
27695327	microgels	C0017243
27695327	enhanced	C2349975
27695327	osteogenic differentiation	C1159974
27695327	hPDLSCs	C0038250
27695327	elevating	C3163633
27695327	expression levels	C3244092
27695327	osteogenic biomarker	C0005516
27695327	genes	C0017337
27695327	ALP	C0017337
27695327	BSP	C1415840
27695327	OCN	C1412791
27695327	RUNX2	C1419771
27695327	In vivo	C1515655
27695327	ectopic	C0574895
27695327	transplantation	C0040732
27695327	results	C1274040
27695327	GelMA	C0029224
27695327	nHA	C0020326
27695327	microgels	C0017243
27695327	increased	C0205217
27695327	mineralized tissue	C0040300
27695327	formation	C1522492
27695327	abundant	C2346714
27695327	vascularization	C0042382
27695327	compared	C1707455
27695327	GelMA group	C0029224
27695327	GelMA	C0029224
27695327	nHA	C0020326
27695327	microgels	C0017243
27695327	hPDLSCs	C0038250
27695327	viability	C0007620
27695327	proliferation	C0596290
27695327	osteogenic differentiation	C1159974
27695327	in vitro	C1533691
27695327	further	C1517331
27695327	promoted	C0033414
27695327	new	C0205314
27695327	bone formation	C0029433
27695327	in vivo	C1515655
27695327	GelMA	C0029224
27695327	nHA	C0020326
27695327	microgels	C0017243
27695327	provide	C1999230
27695327	potential	C3245505
27695327	periodontal tissue regeneration	C1448477
27698544	Esomeprazole	C0937846
27698544	rabeprazole	C0378482
27698544	triple	C0205174
27698544	therapy	C0087111
27698544	Helicobacter pylori	C0079488
27698544	regardless	C3641650
27698544	clarithromycin	C0055856
27698544	susceptibility	C1264642
27698544	CYP2C19	C1332828
27698544	genotypes	C0017431
27698544	study	C2603343
27698544	assess	C1516048
27698544	efficacy	C1280519
27698544	esomeprazole	C0937846
27698544	triple	C0205174
27698544	therapy	C0087111
27698544	compared	C1707455
27698544	rabeprazole	C0378482
27698544	triple	C0205174
27698544	therapy	C0087111
27698544	CYP2C19	C1332828
27698544	genotype	C0017431
27698544	clarithromycin	C0055856
27698544	susceptibility	C1264642
27698544	status	C0449438
27698544	eradication therapy of Helicobacter pylori	C0559761
27698544	H. pylori	C0079488
27698544	Japan	C0022341
27698544	H. pylori	C0079488
27698544	infected patients	C0030705
27698544	randomly	C0439605
27698544	allocated	C1706778
27698544	patients	C0030705
27698544	EAC group	C0030705
27698544	esomeprazole	C0937846
27698544	clarithromycin	C0055856
27698544	amoxicillin	C0002645
27698544	week	C0439230
27698544	drugs	C0013227
27698544	given	C1947971
27698544	twice daily	C0585361
27698544	RAC group	C0030705
27698544	rabeprazole	C0378482
27698544	clarithromycin	C0055856
27698544	amoxicillin	C0002645
27698544	week	C0439230
27698544	drugs	C0013227
27698544	given	C1947971
27698544	twice daily	C0585361
27698544	H. pylori	C0079488
27698544	eradication rate	C1521828
27698544	PP analyses	C0936012
27698544	CI	C0009667
27698544	EAC group	C0030705
27698544	CI	C0009667
27698544	RAC group	C0030705
27698544	differences	C1705242
27698544	eradication rates	C1521828
27698544	clarithromycin	C0055856
27698544	clarithromycin -resistant	C0860039
27698544	sensitive	C0332324
27698544	strains	C0004611
27698544	CI	C0009667
27698544	CI	C0009667
27698544	EAC group	C0030705
27698544	CI	C0009667
27698544	CI	C0009667
27698544	RAC group	C0030705
27698544	eradication rate	C1521828
27698544	clarithromycin	C0055856
27698544	sensitive	C0332324
27698544	strains	C0004611
27698544	higher	C0205250
27698544	resistant strains	C0860039
27698544	both	C1706086
27698544	groups	C0441833
27698544	EAC	C0030705
27698544	RAC	C0030705
27698544	therapies	C0087111
27698544	efficacy	C1280519
27698544	regardless	C3641650
27698544	CYP2C19	C1332828
27698544	genotype	C0017431
27698544	clarithromycin	C0055856
27698544	susceptibility	C1264642
27698544	status	C0449438
27698544	Japan	C0022341
27698942	Early	C1279919
27698942	Response Monitoring	C1822578
27698942	Cancer	C0006826
27698942	Antiangiogenesis Therapy	C0281318
27698942	Noninvasive	C2986496
27698942	PET Molecular Imaging	C0032743
27698942	Multifactorial	C1837655
27698942	Bioparameters	C0549193
27698942	Antiangiogenesis therapy	C0281318
27698942	AAT	C0281318
27698942	survival	C0038952
27698942	patients	C0030705
27698942	clinical settings	C3176918
27698942	early	C1279919
27698942	therapeutic effects	C1527144
27698942	cancer	C0006826
27698942	AAT	C0281318
27698942	early	C1279919
27698942	response monitoring	C1822578
27698942	AAT	C0281318
27698942	efficacy	C2348767
27698942	anti-angiogenic drug	C0596087
27698942	sunitinib	C1176020
27698942	U87MG tumors	C0027651
27698942	noninvasive	C2986496
27698942	positron emission computed tomography (PET) molecular imaging	C1699633
27698942	multifactorial	C1837655
27698942	bioparameters	C0549193
27698942	U87MG tumor	C0027651
27698942	mice	C0025929
27698942	intragastric	C0442113
27698942	injections	C0021485
27698942	sunitinib	C1176020
27698942	vehicle	C0042444
27698942	Longitudinal	C0205127
27698942	MicroPET/CT scans	C1699633
27698942	(18)F-FDG	C0046056
27698942	(18)F-FMISO,	C3661419
27698942	(18)F-ML-10	C2700345
27698942	(18)F-Alfatide II	C3852643
27698942	metabolism	C0025519
27698942	hypoxia	C0242184
27698942	apoptosis	C0162638
27698942	angiogenesis	C1519670
27698942	therapy	C0087111
27698942	Tumor tissues	C0475358
27698942	mice	C0025929
27698942	immunohistochemical	C1441616
27698942	IHC	C1441616
27698942	biomarkers	C0041365
27698942	Glut-1	C1527589
27698942	CA-IX	C2351139
27698942	TUNEL	C0872284
27698942	ανβ3	C1138427
27698942	CD31	C0081939
27698942	PET imaging	C1699633
27698942	tumor sizes	C0475440
27698942	mouse	C0025929
27698942	weights	C0005910
27698942	tumor	C0027651
27698942	uptake	C0243144
27698942	tumor	C0027651
27698942	muscle	C0026845
27698942	T	C0027651
27698942	M	C0026845
27698942	tumor growth	C0598934
27698942	ratios	C0456603
27698942	TGR	C0456603
27698942	statistical analyses	C0871424
27698942	Sunitinib	C1176020
27698942	U87MG tumor growth	C0598934
27698942	tumor size	C0475440
27698942	sunitinib	C1176020
27698942	treatment	C1533734
27698942	control group	C0009932
27698942	uptakes	C0243144
27698942	(18)F-FMISO	C3661419
27698942	hypoxia	C0242184
27698942	(18)F-ML-10	C2700345
27698942	apoptosis	C0162638
27698942	(18)F-Alfatide II	C3852643
27698942	angiogenesis	C1519670
27698942	tumor	C0027651
27698942	lesions	C0221198
27698942	early	C1279919
27698942	early stage	C2363430
27698942	sunitinib	C1176020
27698942	treatment	C1533734
27698942	uptake	C0243144
27698942	(18)F-FDG	C0046056
27698942	glucose metabolism	C0596620
27698942	late stage	C1279941
27698942	PET imaging	C1699633
27698942	ex vivo	C2348480
27698942	IHC	C1441616
27698942	biomarkers	C0041365
27698942	PET imaging	C1699633
27698942	(18)F-Alfatide II	C3852643
27698942	(18)F-FMISO	C3661419
27698942	TGR	C0456603
27698942	(18)F-FDG	C0046056
27698942	(18)F-ML-10	C2700345
27698942	TGR	C0456603
27698942	tumor	C0027651
27698942	uptake	C0243144
27698942	PET	C1699633
27698942	MVD	C3272839
27698942	TGR	C0456603
27698942	(18)F-Alfatide II	C3852643
27698942	PET	C1699633
27698942	early	C1279919
27698942	response	C1822578
27698942	therapeutic efficacy	C2348767
27698942	anti-angiogenic drug	C0596087
27698942	sunitinib	C1176020
27698942	U87MG tumors	C0027651
27698942	early	C1279919
27698942	response monitoring	C1822578
27698942	efficacy	C2348767
27698942	cancer	C0006826
27698942	AAT	C0281318
27698942	noninvasive	C2986496
27698942	PET molecular imaging	C0032743
27698942	multifactorial	C1837655
27698942	bioparameters	C0549193
27698942	angiogenesis	C1519670
27698942	imaging	C0011923
27698942	(18)F-Alfatide II	C3852643
27698942	RGD	C0052350
27704589	research priorities	C0376368
27704589	nurses	C0028661
27704589	children's	C0008059
27704589	hospital	C0019994
27704589	United Kingdom	C0041700
27704589	study	C2603343
27704589	research priority	C0376368
27704589	efficiency	C0013682
27704589	impact	C4049986
27704589	research activity	C0079816
27704589	nurses	C0028661
27704589	children's	C0008059
27704589	healthcare institution	C1274109
27704589	clinical staff	C0025106
27704589	coherent	C4068804
27704589	transparent	C0205556
27704589	consensus	C0376298
27704589	nurse-led research agenda	C0681798
27704589	research topics	C0681795
27704589	nurses	C0028661
27704589	modified nominal group technique	C0035177
27704589	consensus method	C0025663
27704589	participants	C0679646
27704589	nurses	C0028661
27704589	clinical areas	C1547541
27704589	ranked	C0699794
27704589	priorities	C0376368
27704589	divisional heads	C0018676
27704589	nursing	C0028677
27704589	staff	C0025106
27704589	clinical areas	C1547541
27704589	divisional priorities	C0376368
27704589	Nursing Research Working Group	C0027363
27704589	divisions' priorities	C0376368
27704589	voted	C0042978
27704589	research priorities	C0376368
27704589	organization	C1274109
27704589	research topics	C0681795
27704589	ranking	C0699794
27704589	priorities	C0376368
27704589	Divisional level	C2919030
27704589	organizational priorities	C0376368
27704589	patient	C0030705
27704589	hospital system	C0019994
27704589	play	C0032214
27704589	staff wellbeing	C0018684
27704589	patient care	C0017313
27704589	productivity	C0033269
27704589	team work	C0043227
27704589	service	C0557854
27704589	supporting parents	C0030551
27704589	parent	C0030551
27704589	priorities	C0376368
27704589	clinical teams	C0086390
27704589	patient-specific nurse-led research agenda	C0681798
27704589	Organizational priorities	C0376368
27704589	management structures	C3273539
27704589	subgroup	C0027363
27704589	Nursing Research Working Group	C0027363
27704589	priorities	C0376368
27704589	nurse-led research activity	C0079816
27704589	inquiry	C2987583
27705854	Accurate	C0443131
27705854	Lungs	C0024109
27705854	Segmentation	C0700381
27705854	CT	C0040405
27705854	Chest	C0817096
27705854	Images	C1704254
27705854	Adaptive Appearance-Guided Shape Modeling	C0870071
27705854	accurately	C0443131
27705854	segment	C0700381
27705854	pathological	C1521733
27705854	healthy	C3898900
27705854	lungs	C0024109
27705854	reliable	C0205423
27705854	computer-aided disease diagnostics	C0011905
27705854	stack	C3272897
27705854	chest	C0817096
27705854	CT	C0040405
27705854	scans	C0441633
27705854	modeled	C0870071
27705854	spatially inhomogeneous	C1254362
27705854	joint 3D Markov-Gibbs random field	C0205556
27705854	MGRF	C0205556
27705854	voxel-wise	C2700259
27705854	lung	C0024109
27705854	chest	C0817096
27705854	CT	C0040405
27705854	image	C1704254
27705854	signals	C1710082
27705854	intensities	C0871362
27705854	proposed	C1553874
27705854	MGRF	C0205556
27705854	integrates	C1705422
27705854	visual	C0234621
27705854	appearance	C0700364
27705854	sub-models	C0026336
27705854	lung	C0024109
27705854	submodel	C0026336
27705854	appearance	C0700364
27705854	submodel	C0026336
27705854	original	C0205313
27705854	CT	C0040405
27705854	image	C1704254
27705854	Gaussian scale space (GSS) filtered version	C0205556
27705854	signal	C1710082
27705854	empirical	C1880496
27705854	marginal	C1947914
27705854	probability distribution	C3826440
27705854	signals	C1710082
27705854	linear combination of discrete Gaussians	C0205556
27705854	LCDG	C0205556
27705854	positive dominant and multiple sign-alternate subordinate DGs	C0205556
27705854	LCDGs	C0205556
27705854	lungs	C0024109
27705854	chest	C0817096
27705854	tissues	C0040300
27705854	appearance	C0700364
27705854	submodel	C0026336
27705854	quantifies	C1709793
27705854	conditional	C1701901
27705854	pairwise	C0392762
27705854	intensity	C0871362
27705854	dependencies	C3669743
27705854	original	C0205313
27705854	GSS-filtered	C0205556
27705854	images	C1704254
27705854	submodel	C0026336
27705854	training data	C1511726
27705854	segmentation	C0700381
27705854	lung	C0024109
27705854	chest	C0817096
27705854	appearances	C0700364
27705854	accuracy	C0443131
27705854	proposed	C1553874
27705854	segmentation	C0700381
27705854	quantitatively	C0392762
27705854	assessed	C1516048
27705854	databases	C0242356
27705854	ISBI VESSEL12 challenge	C0242356
27705854	MICCAI LOLA11 challenge	C0242356
27705854	database	C0242356
27705854	CT	C0040405
27705854	images	C1704254
27705854	lung	C0024109
27705854	pathologies	C0205469
27705854	scanners	C0183115
27705854	protocols	C0040808
27705854	Quantitative	C0392762
27705854	assessment	C1516048
27705854	Dice similarity coefficients	C0392762
27705854	95-percentile bidirectional Hausdorff distances	C0392762
27705854	percentage volume differences	C0392762
27705854	accuracy	C0443131
27705854	model	C0026336
27705854	database	C0242356
27705854	VESSEL12 database	C0242356
27705854	accuracy	C0443131
27705854	accuracy	C0443131
27705854	approach	C3266812
27705854	verified	C1711411
27705854	blind	C1561605
27705854	evaluation	C0015196
27705854	LOLA11	C0242356
27705854	competition	C3687609
27705854	average	C1510992
27705854	segmentation	C0700381
27705854	state-of-the-art	C0205314
27705854	techniques	C0449851
27705854	compared	C1707455
27706190	Influence	C4054723
27706190	Different	C1705242
27706190	Levels	C1306673
27706190	Lipoic Acid Synthase	C1424272
27706190	Gene Expression	C0017262
27706190	Diabetic Nephropathy	C0011881
27706190	Oxidative stress	C0242606
27706190	pathogenesis	C0699748
27706190	diabetic nephropathy	C0011881
27706190	DN	C0011881
27706190	outcomes	C1274040
27706190	clinical trials	C0008976
27706190	role	C1705810
27706190	antioxidants	C0003402
27706190	kidney	C0022646
27706190	during	C0347984
27706190	development	C1527148
27706190	diabetic nephropathy	C0011881
27706190	generated	C3146294
27706190	novel	C0205314
27706190	genetic antioxidant mouse model	C2986594
27706190	over- or under-expression	C0017262
27706190	lipoic acid synthase gene	C1424272
27706190	Lias	C1424272
27706190	models	C2986594
27706190	mated	C1260875
27706190	Ins2Akita/+ mice	C0025929
27706190	type I diabetic	C0836995
27706190	mouse model	C2986594
27706190	compare	C1707455
27706190	major	C0205164
27706190	pathologic changes	C4086730
27706190	oxidative stress	C0242606
27706190	status	C0449438
27706190	mice	C0025929
27706190	results	C1274040
27706190	Ins2Akita/+ mice	C0025929
27706190	under-expressed	C0017262
27706190	Lias gene	C1424272
27706190	higher	C0205250
27706190	oxidative stress	C0242606
27706190	more	C0205172
27706190	severe	C0205082
27706190	DN	C0011881
27706190	features	C2348519
27706190	albuminuria	C0001925
27706190	glomerular basement membrane thickening	C0445347
27706190	mesangial matrix expansion	C3553722
27706190	Ins2Akita/+ mice	C0025929
27706190	highly	C0205250
27706190	expressed	C0017262
27706190	Lias gene	C1424272
27706190	display	C0870432
27706190	lower	C0205251
27706190	oxidative stress	C0242606
27706190	less	C0547044
27706190	DN	C0011881
27706190	pathologic changes	C4086730
27706190	study	C2603343
27706190	demonstrates	C3687625
27706190	endogenous	C0205227
27706190	antioxidant	C0003402
27706190	capacity	C1516240
27706190	effective strategy for prevention	C0679723
27706190	treatment	C1522326
27706190	DN	C0011881
27706588	Assessment	C1516048
27706588	genetic	C0314603
27706588	relationship	C0439849
27706588	Rhododendron	C0330429
27706588	cultivars	C1883525
27706588	amplified fragment length polymorphism	C1955927
27706588	inter-simple sequence repeat	C0684192
27706588	markers	C0012872
27706588	Genetic	C0314603
27706588	relationships	C0439849
27706588	Rhododendron	C0330429
27706588	cultivars	C1883525
27706588	China	C0008115
27706588	assessed	C1516048
27706588	inter-simple sequence repeat	C0684192
27706588	ISSR	C0684192
27706588	amplified fragment length polymorphism	C1955927
27706588	AFLP	C1955927
27706588	markers	C0012872
27706588	ISSR	C0684192
27706588	primers	C0206416
27706588	polymorphic	C1882417
27706588	AFLP	C1955927
27706588	primer pairs	C0206416
27706588	polymorphism	C1882417
27706588	polymorphic	C1882417
27706588	products	C1514468
27706588	cluster analysis	C0009085
27706588	similarities	C2348205
27706588	results	C1274040
27706588	ISSR	C0684192
27706588	AFLP	C1955927
27706588	cultivars	C1883525
27706588	clustered	C0332227
27706588	branches	C1254370
27706588	branch	C1254370
27706588	cultivars	C1883525
27706588	cultivars	C1883525
27706588	groups	C0441833
27706588	branch	C1254370
27706588	cluster	C1704332
27706588	results	C1274040
27706588	genetic	C0314603
27706588	relationships	C0439849
27706588	cultivars	C1883525
27706588	related	C0439849
27706588	morphological	C0543482
27706588	characteristics	C1521970
27706588	flowering	C1820370
27706588	phase	C0205390
27706588	results	C1274040
27706588	study	C2603343
27706588	classification	C0008902
27706588	Rhododendron	C0330429
27706588	cultivars	C1883525
27706588	flowering	C1820370
27706588	phase	C0205390
27706588	cluster	C1704332
27706588	results	C1274040
27706588	select	C1707391
27706588	breeding	C0006159
27707812	Spontaneous activity	C0443158
27707812	correlated	C1707520
27707812	coding	C2700640
27707812	density	C0178587
27707812	primary auditory cortex	C2954070
27707812	Sensory neurons	C0027883
27707812	sensory modalities	C0234402
27707812	processing	C1709694
27707812	spontaneous firing rates	C1254359
27707812	SFRs	C1254359
27707812	sensory stimuli	C0683107
27707812	functional	C0205245
27707812	significance	C0750502
27707812	spontaneous activity	C0443158
27707812	studies	C2603343
27707812	auditory system	C0587901
27707812	spontaneous activity	C0443158
27707812	correlated	C1707520
27707812	physiological	C0205463
27707812	anatomic	C0220784
27707812	neurons	C0027882
27707812	SFRs	C1254359
27707812	encoding	C2700640
27707812	auditory stimuli	C0178490
27707812	SFRs	C1254359
27707812	tinnitus	C0040264
27707812	auditory areas	C0004302
27707812	ototoxic	C1407041
27707812	substances	C0439861
27707812	noise	C0028263
27707812	trauma	C3714660
27707812	study	C2603343
27707812	recorded single-unit activity	C1537057
27707812	primary auditory cortex	C2954070
27707812	marmoset	C0006764
27707812	monkeys	C0026447
27707812	wide-band random-spectrum stimuli	C0234402
27707812	white Gaussian noise	C3161035
27707812	WGN	C3161035
27707812	divergences	C0443204
27707812	stimulus	C0234402
27707812	encoding	C2700640
27707812	spontaneous activity	C0443158
27707812	activation	C1879547
27707812	suppression	C1260953
27707812	wide-band stimuli	C0234402
27707812	response	C0871261
27707812	WGN	C3161035
27707812	response latencies	C0242465
27707812	WGN	C3161035
27707812	correlated	C1707520
27707812	activation	C1879547
27707812	response	C0871261
27707812	stimulus	C0234402
27707812	spontaneous spiking	C0443158
27707812	stimulus	C0234402
27707812	processing	C1709694
27707812	primary auditory cortex	C2954070
27707812	malfunction	C0231174
27707812	tinnitus	C0040264
27708057	Systematic mapping	C0079435
27708057	functional	C0205245
27708057	enhancer	C0014290
27708057	promoter	C2350877
27708057	connections	C0205245
27708057	CRISPR	C3658200
27708057	CRISPR interference	C0200924
27708057	Gene expression	C0017262
27708057	mammals	C0024660
27708057	regulated	C0017263
27708057	noncoding elements	C0021920
27708057	physiology	C0031843
27708057	disease	C0012634
27708057	functions	C0542341
27708057	target genes	C0017337
27708057	noncoding elements	C0021920
27708057	unknown	C0439673
27708057	high-throughput approach	C0872047
27708057	clustered regularly interspaced short palindromic repeats	C3658200
27708057	clustered regularly interspaced short palindromic repeats (CRISPR) interference	C0200924
27708057	CRISPR	C3658200
27708057	CRISPRi	C0200924
27708057	regulatory elements	C0021920
27708057	target genes	C0017337
27708057	assess	C0184514
27708057	megabase	C1533164
27708057	sequence	C0004793
27708057	transcription factors	C0040648
27708057	MYC	C1137610
27708057	GATA1	C1530719
27708057	distal	C0205108
27708057	enhancers	C0014290
27708057	control	C0243148
27708057	gene expression	C0017262
27708057	cellular proliferation	C0596290
27708057	Quantitative	C0392762
27708057	features	C2348519
27708057	chromatin	C0008546
27708057	state	C1442792
27708057	chromosome	C0008633
27708057	conformation	C1299941
27708057	enhancers	C0014290
27708057	MYC	C1137610
27708057	elements	C0004793
27708057	strategy	C0449851
27708057	enhancer	C0014290
27708057	promoter	C2350877
27708057	connectivity	C0205245
27708057	CRISPRi	C0200924
27708057	approach	C1292724
27708057	dissect	C0205239
27708057	transcriptional networks	C1720950
27708057	interpret	C1285553
27708057	contributions	C1880177
27708057	noncoding genetic variation	C0042333
27708057	human	C0086418
27708057	disease	C0012634
27710899	Proliferation	C0596290
27710899	effects of	C1704420
27710899	gastrodin	C0061139
27710899	RSC96 Schwann cells	C0036387
27710899	regulating	C1327622
27710899	ERK1	C0082529
27710899	2	C0170168
27710899	PI3K	C0044602
27710899	signaling pathways	C0037080
27710899	proliferation	C0596290
27710899	migration	C1622501
27710899	Schwann cells	C0036387
27710899	SCs	C0036387
27710899	process	C1522240
27710899	peripheral nerve repair	C0196777
27710899	promotion	C0033414
27710899	growth	C0007595
27710899	SCs	C0036387
27710899	cell based therapy	C3658313
27710899	Gastrodin	C0061139
27710899	GAS	C0061139
27710899	Chinese traditional	C0025124
27710899	herbal medicine	C2240391
27710899	Gastrodia elata Blume	C1040858
27710899	reported	C0700287
27710899	associated with	C0332281
27710899	neuroprotective properties	C0598958
27710899	GAS	C0061139
27710899	activated	C1879547
27710899	MAPK	C0752312
27710899	PI3K	C0044602
27710899	signaling pathways	C0037080
27710899	growth	C0007595
27710899	nerve cells	C0027882
27710899	reported	C0700287
27710899	hypothesis	C1512571
27710899	GAS	C0061139
27710899	SCs	C0036387
27710899	growth	C0007595
27710899	effect of	C1704420
27710899	GAS	C0061139
27710899	rat	C0034693
27710899	RSC96 Schwann cells	C0036387
27710899	SCs	C0036387
27710899	mechanism	C0441712
27710899	concentration	C1446561
27710899	GAS	C0061139
27710899	treatment	C0087111
27710899	RSC96 SCs	C0036387
27710899	cell proliferation	C0596290
27710899	gene expression	C0017262
27710899	neurotrophic factors	C0027754
27710899	Regulation of	C1327622
27710899	MAPK	C0752312
27710899	PI3K	C0044602
27710899	signaling pathways	C0037080
27710899	phosphorylation	C1158886
27710899	ERK1	C0082529
27710899	2	C0170168
27710899	Akt	C0164786
27710899	GAS	C0061139
27710899	promote	C0033414
27710899	proliferation	C0596290
27710899	RSC96 SCs	C0036387
27710899	dose	C0178602
27710899	time	C0040223
27710899	concentration	C1446561
27710899	Exploration	C1280903
27710899	mechanism	C0441712
27710899	GAS	C0061139
27710899	SCs	C0036387
27710899	metabolism	C1524026
27710899	inhibiting	C3463820
27710899	ERK1	C0082529
27710899	2	C0170168
27710899	phosphorylation	C1158886
27710899	activating	C1879547
27710899	Akt	C0164786
27710899	phosphorylation	C1158886
27710899	RSC96 SCs	C0036387
27710899	treatment	C0087111
27710899	peripheral nerve injuries	C0262593
27713074	influenza A virus (H7N9)	C3658219
27713074	anti-neuraminidase	C0243095
27713074	monoclonal antibody	C0003250
27713074	prophylactic and therapeutic activity	C0199176
27713074	in vivo	C1515655
27713074	Zoonotic	C0043528
27713074	A(H7N9) avian influenza viruses	C3658219
27713074	China	C0008115
27713074	threat	C0749385
27713074	human	C0086418
27713074	public health	C0699943
27713074	infected	C0439663
27713074	individuals	C0237401
27713074	mortality rate	C0205848
27713074	Treatment options	C0683525
27713074	infected	C0439663
27713074	A(H7N9)	C3658219
27713074	neuraminidase (NA) inhibitors	C1443650
27713074	influenza viruses	C0029341
27713074	A(H7N9)	C3658219
27713074	resistant	C0332325
27713074	drugs	C0013227
27713074	monoclonal antibodies	C0003250
27713074	strategy	C0679199
27713074	influenza virus	C0029341
27713074	infection	C3714514
27713074	murine	C0026809
27713074	monoclonal antibody	C0003250
27713074	3c10-3	C3849272
27713074	NA	C1545516
27713074	A(H7N9)	C3658219
27713074	prophylactic	C0445202
27713074	systemic administration	C0678812
27713074	3c10-3	C3849272
27713074	wild-type	C1883559
27713074	A/Anhui/1/2013	C0029347
27713074	H7N9	C3658219
27713074	infection	C3714514
27713074	treatment	C0087111
27713074	systemic	C0205373
27713074	dose	C0178602
27713074	3c10-3	C3849272
27713074	A(H7N9)	C3658219
27713074	dose	C0178602
27713074	time	C0040223
27713074	dependent	C3244310
27713074	protection	C1545588
27713074	mice	C0026809
27713074	therapeutic	C0302350
27713074	potential	C3245505
27713074	3c10-3	C3849272
27713074	Epitope mapping	C0242831
27713074	3c10-3	C3849272
27713074	binds	C1167622
27713074	enzyme	C0014442
27713074	active site	C0205681
27713074	NA	C1545516
27713074	functional	C0205245
27713074	3c10-3	C3849272
27713074	enzyme activity	C0243102
27713074	NA	C1545516
27713074	spread	C0332261
27713074	virus	C0042776
27713074	cultured cells	C0007635
27713074	Affinity	C1510827
27713074	analysis	C0936012
27713074	3c10-3	C3849272
27713074	binds	C1167622
27713074	recombinant	C0034861
27713074	NA	C1545516
27713074	wild-type	C1883559
27713074	A/Anhui/1/2013	C0029347
27713074	variant	C0205419
27713074	NA	C1545516
27713074	mutation	C0026882
27713074	NAI	C1443650
27713074	resistance	C4281815
27713074	3c10-3	C3849272
27713074	potential	C3245505
27713074	therapeutic	C0302350
27713074	A(H7N9)	C3658219
27713074	infections	C3714514
27713074	alternative	C1523987
27713074	combination	C0205195
27713074	NA	C1545516
27713074	antiviral inhibitors	C0003451
27714497	Mechanisms	C0441712
27714497	ear	C0013443
27714497	trauma	C3714660
27714497	reconstructive	C0524865
27714497	techniques	C0449851
27714497	consecutive	C1707491
27714497	patients	C0030705
27714497	Acquired	C0439661
27714497	auricular	C1549094
27714497	deformities	C0302142
27714497	diminish	C0205216
27714497	facial esthetics	C0871976
27714497	psychological distress	C0815107
27714497	injuries	C3263723
27714497	applied reconstructive	C0524865
27714497	techniques	C0449851
27714497	academic hospital	C0000872
27714497	Netherlands	C0027778
27714497	retrospective	C1514923
27714497	chart review	C0553620
27714497	patients	C0030705
27714497	auricular	C1549094
27714497	reconstruction	C0524865
27714497	acquired deformity	C0221430
27714497	Data	C1511726
27714497	gender	C0079399
27714497	affected side	C3166323
27714497	cause of injury	C0552510
27714497	anatomical region	C0005898
27714497	surgeries	C0543467
27714497	cartilage	C0007301
27714497	skin cover used	C3874019
27714497	analyzed	C0936012
27714497	patients	C0030705
27714497	Acquired	C0439661
27714497	auricular	C1549094
27714497	deformities	C0302142
27714497	bite injuries	C0005658
27714497	traffic accidents	C0000932
27714497	burns	C0006434
27714497	post-otoplasty	C0868838
27714497	complications	C0009566
27714497	upper third of the auricle	C0502136
27714497	injured	C0332664
27714497	entire auricle	C0013453
27714497	cases	C0868928
27714497	reconstruction	C0524865
27714497	costal cartilage	C0222787
27714497	cutaneous cover	C0221912
27714497	postauricular skin flap	C0395655
27714497	cases	C0868928
27714497	study	C2603343
27714497	treatment	C0039798
27714497	acquired	C0439661
27714497	auricular	C1549094
27714497	deformities	C0302142
27714497	results	C1274040
27714497	studies	C2603343
27714497	literature	C0023866
27714497	Bite wounds	C0561546
27714497	acquired	C0439661
27714497	auricular	C1549094
27714497	injuries	C3263723
27714497	upper third	C0502136
27714497	reconstructions	C0524865
27714497	costal cartilage	C0222787
27714497	postauricular flap	C0440884
27714497	deformity	C0302142
27714730	Anatomic	C0220784
27714730	assessment	C0220825
27714730	left main bifurcation	C1254362
27714730	dynamic bifurcation angles	C1254362
27714730	computed tomography angiography	C1536105
27714730	left main coronary artery	C1261082
27714730	LMCA	C1261082
27714730	anatomy	C0700276
27714730	diagnosis	C1704338
27714730	therapeutic	C0087111
27714730	investigate	C1292732
27714730	LMCA	C1261082
27714730	anatomy	C0700276
27714730	128-multisliced coronary computed-tomography-angiography	C1536105
27714730	CCTA	C1536105
27714730	patients	C0030705
27714730	LMCA	C1261082
27714730	CCTA	C1536105
27714730	studies	C0008972
27714730	study	C2603343
27714730	Anatomical features	C0700276
27714730	LMCA	C1261082
27714730	cross-sectional areas	C0552389
27714730	LMCA	C1261082
27714730	ostial	C0444567
27714730	LMCA	C1261082
27714730	distal	C0205108
27714730	LAD ostial	C3898617
27714730	LCX	C0815994
27714730	ostial	C0444567
27714730	LMCA	C1261082
27714730	bifurcation angles	C1254362
27714730	BA	C1254362
27714730	LMCA	C1261082
27714730	LCX	C0815994
27714730	BA	C1254362
27714730	LMCA	C1261082
27714730	LAD	C3898617
27714730	BA	C1254362
27714730	LAD	C3898617
27714730	LCX	C0815994
27714730	BA	C1254362
27714730	end-diastole	C1562146
27714730	end-systole	C1563001
27714730	age	C0001779
27714730	males	C0086582
27714730	RCA	C0226042
27714730	dominant	C1527180
27714730	patients	C0030705
27714730	LMCA	C1261082
27714730	length	C1444754
27714730	LMCA	C1261082
27714730	ostial	C0444567
27714730	LMCA	C1261082
27714730	distal	C0205108
27714730	LAD ostial	C3898617
27714730	LCX	C0815994
27714730	ostial	C0444567
27714730	areas	C0205146
27714730	LMCA	C1261082
27714730	ostial	C0444567
27714730	distal	C0205108
27714730	area	C0205146
27714730	LMCA	C1261082
27714730	distal	C0205108
27714730	LAD ostial	C3898617
27714730	area	C0205146
27714730	LMCA	C1261082
27714730	distal	C0205108
27714730	LCX	C0815994
27714730	ostial	C0444567
27714730	area ratios	C1442066
27714730	patients	C0030705
27714730	patients	C0030705
27714730	Systolic motion	C0026597
27714730	LMCA	C1261082
27714730	BAs	C1254362
27714730	systolic motion	C0026597
27714730	LMCA	C1261082
27714730	LAD	C3898617
27714730	patients	C0030705
27714730	LAD	C3898617
27714730	LCX	C0815994
27714730	patients	C0030705
27714730	Patients	C0030705
27714730	LAD	C3898617
27714730	LCX	C0815994
27714730	BA	C1254362
27714730	LMCA	C1261082
27714730	LAD ostial	C3898617
27714730	area	C0205146
27714730	LCX	C0815994
27714730	ostial	C0444567
27714730	area	C0205146
27714730	diastolic-to-systolic range	C1514721
27714730	DSR	C1514721
27714730	LAD	C3898617
27714730	LCX	C0815994
27714730	BA	C1254362
27714730	patients	C0030705
27714730	LAD	C3898617
27714730	LCX	C0815994
27714730	BA	C1254362
27714730	LMCA	C1261082
27714730	T-shaped distal	C0205108
27714730	BA	C1254362
27714730	LMCA	C1261082
27714730	LAD ostial	C3898617
27714730	area	C0205146
27714730	LCX	C0815994
27714730	ostial	C0444567
27714730	area	C0205146
27714730	DSR	C1514721
27714730	distal	C0205108
27714730	BA	C1254362
27714730	patients	C0030705
27714730	Y-shaped distal	C0205108
27714730	BA	C1254362
27714730	findings	C0243095
27714730	LMCA	C1261082
27714730	bifurcation stenting	C2348535
27714730	stents	C0038257
27714730	LMCA	C1261082
27716187	three	C0205449
27716187	perspective study	C2603343
27716187	home	C0442519
27716187	nursing home residents	C0682287
27716187	residents	C0682287
27716187	care professionals	C0018724
27716187	relatives	C0080103
27716187	home	C0442519
27716187	nursing home residents	C0682287
27716187	multifactorial	C1837655
27716187	phenomenon	C1882365
27716187	important	C3898777
27716187	quality	C0332306
27716187	living	C0376558
27716187	purpose	C1285529
27716187	study	C2603343
27716187	investigate	C1292732
27716187	factors	C1521761
27716187	influencing	C4054723
27716187	home	C0442519
27716187	older adults	C3826770
27716187	residing	C2982691
27716187	nursing home	C0028688
27716187	residents	C0682287
27716187	relatives	C0080103
27716187	care professionals	C0018724
27716187	participants	C0679646
27716187	residents	C0682287
27716187	relatives	C0080103
27716187	care professionals	C0018724
27716187	nursing homes	C0028688
27716187	Netherlands	C0027778
27716187	qualitative study	C0949415
27716187	subsequent	C0332282
27716187	interviews	C0021822
27716187	focus groups	C0016400
27716187	data	C1511726
27716187	open ended coding	C2827655
27716187	axial coding	C0205556
27716187	selective coding	C0205556
27716187	home	C0442519
27716187	nursing home residents	C0682287
27716187	influenced	C4054723
27716187	factors	C1521761
27716187	building	C1999269
27716187	interior design	C0021751
27716187	eating	C0392339
27716187	drinking	C0013124
27716187	autonomy	C0085862
27716187	control	C2587213
27716187	involvement	C1314939
27716187	relatives	C0080103
27716187	activities	C0441655
27716187	quality of care	C0034379
27716187	Residents	C0682287
27716187	relatives	C0080103
27716187	importance	C3898777
27716187	nature	C0349590
27716187	outdoors	C1709359
27716187	coping strategies	C0009967
27716187	Relatives	C0080103
27716187	care professionals	C0018724
27716187	organization	C0029246
27716187	facilitation	C0262752
27716187	care	C1947933
27716187	residents	C0682287
27716187	home	C0442519
27716187	nursing home residents	C0682287
27716187	influenced	C4054723
27716187	multitude	C0439064
27716187	factors	C1521761
27716187	psychology	C1524060
27716187	residents	C0682287
27716187	social and built environmental contexts	C0037414
27716187	holistic	C0683249
27716187	factors	C1521761
27716187	influence	C4054723
27716187	home	C0442519
27716187	residents	C0682287
27716187	optimize	C2698650
27716187	home	C0442519
27716187	study	C0949415
27716187	nursing home	C0028688
27716187	nature	C0349590
27716187	residence	C0237096
27716187	place	C0442504
27716187	people	C0027361
27716187	numerous	C0439064
27716352	one health	C4277525
27716352	national health policies	C0027458
27716352	developing countries	C0011750
27716352	India's	C0021201
27716352	Globally	C2348867
27716352	threat	C0749385
27716352	infectious diseases	C0009450
27716352	emerging infectious diseases	C0872315
27716352	originating	C0439659
27716352	human	C0086418
27716352	animal	C0003062
27716352	environment	C0014406
27716352	interface	C1704675
27716352	health systems	C1456613
27716352	pathogen	C0450254
27716352	emergence	C0872315
27716352	Asia	C0003980
27716352	Africa	C0001737
27716352	Latin America	C0023122
27716352	policy frameworks	C0242456
27716352	threat	C0749385
27716352	urgent	C0439609
27716352	Emergence of diseases	C0872315
27716352	avian influenza	C0016627
27716352	Ebola virus disease	C0282687
27716352	threatened	C0749385
27716352	social	C0728831
27716352	disruption	C0332453
27716352	established	C0443211
27716352	intersectoral coordination/collaboration	C4277663
27716352	events	C0441471
27716352	initiation	C1704686
27716352	establishing	C0443211
27716352	institutionalised	C0562359
27716352	collaborative frameworks	C0282116
27716352	India	C0021201
27716352	One Health approach	C4277525
27716352	disease prevention and control	C0085557
27716352	gains	C1517378
27716352	influenza	C0021400
27716352	control	C2239193
27716352	infectious diseases	C0009450
27716352	Intersectoral coordination	C4277663
27716352	reactive	C0205332
27716352	threats	C0749385
27716352	systemic	C0205373
27716352	failure	C0231175
27716352	sustain	C0443318
27716352	coordinated	C0700114
27716352	response	C0443286
27716352	draft	C1547277
27716352	National Health Policy	C0027458
27716352	failed	C0231175
27716352	establish	C0443211
27716352	intersectoral coordination	C4277663
27716352	disease control approaches	C0085557
27716352	linkages	C0332280
27716352	human	C0086418
27716352	health	C0018684
27716352	animal	C0003062
27716352	health	C0018684
27716352	husbandry	C0003052
27716352	agriculture	C0001829
27716352	environmental	C0014406
27716352	sectors	C1708237
27716352	duplicative	C0205173
27716352	weak response systems	C0243095
27716352	absence	C0332197
27716352	health impact assessment	C3494320
27716352	development	C1527148
27716352	agenda	C0681473
27716352	policies	C0242456
27716352	negative	C0205160
27716352	effects	C1280500
27716352	health	C0018684
27716352	wellbeing of man	C3813622
27716352	animal	C0003062
27716352	environment	C0014406
27716352	Lack of attention	C1398138
27716352	capacity	C1516240
27716352	critical	C1511545
27716352	sectors	C1708237
27716352	raised	C0442818
27716352	challenges	C0805586
27716352	deploying	C2825812
27716352	mitigation	C1553901
27716352	strategies	C0679199
27716352	developing countries	C0011750
27716352	India	C0021201
27716352	portion	C0449719
27716352	world's	C2700280
27716352	poorest	C0542537
27716352	livestock farmers	C0335415
27716352	absence	C0332197
27716352	policy	C0242456
27716352	discourse	C0009452
27716352	One Health approach	C4277525
27716352	development	C1527148
27716352	health policies	C0018735
27716352	hurdle	C0009566
27716352	eliminating	C1883720
27716352	poverty	C0032854
27716352	poverty	C0032854
27716352	related	C0439849
27716352	diseases	C0012634
27716352	adoption	C0332162
27716352	One Health approaches	C4277525
27716352	health	C0018684
27716352	sectoral	C0439741
27716352	policies	C0242456
27716352	critical	C1511545
27716352	policy	C0242456
27716352	India	C0021201
27716352	developing countries	C0011750
27716352	establish	C0443211
27716352	preparedness	C1318963
27716352	plans	C0032074
27716352	encourage	C1511253
27716352	policy environment	C0282166
27716352	assessment	C0220825
27716352	mitigation	C1553901
27716352	downstream	C0522506
27716352	impacts	C4049986
27716352	agenda	C0681473
27716352	incorporated	C0243126
27717972	Assessment	C0220825
27717972	demographic	C0011292
27717972	pathoanatomic risk factors	C0035648
27717972	recurrent	C2945760
27717972	patellofemoral	C0447801
27717972	instability	C0022410
27717972	WARPS/STAID classification	C0008902
27717972	clinical	C0205210
27717972	assessment	C0220825
27717972	features	C2348519
27717972	anatomic	C0220784
27717972	characteristics	C1521970
27717972	subsets	C1515021
27717972	patients	C0030705
27717972	patellofemoral instability	C0427262
27717972	population	C0030705
27717972	purpose of this study	C0681832
27717972	demographics	C1698647
27717972	prevalence	C0220900
27717972	risky	C1444641
27717972	pathoanatomies	C1384516
27717972	patients	C0030705
27717972	WARPS	C0008902
27717972	STAID	C0008902
27717972	recurrent	C2945760
27717972	patellofemoral	C0447801
27717972	instability	C0022410
27717972	WARPS/STAID classification	C0008902
27717972	Banff Patella Instability Instrument	C0282574
27717972	BPII	C0282574
27717972	Marx activity scale	C0282574
27717972	Patellar	C0030647
27717972	Instability Severity Score	C0021504
27717972	ISS	C0021504
27717972	patients	C0030705
27717972	recurrent	C2945760
27717972	patellofemoral	C0447801
27717972	instability	C0022410
27717972	WARPS	C0008902
27717972	STAID subtype	C0008902
27717972	patients	C0030705
27717972	assessed	C1516048
27717972	Clinical data	C1516606
27717972	assessment	C0220825
27717972	demographic	C0011292
27717972	risk factors	C0035648
27717972	sex	C0079399
27717972	BMI	C1305855
27717972	bilaterality	C0238767
27717972	symptoms	C1457887
27717972	affected	C0449642
27717972	limb side	C0015385
27717972	age	C0001779
27717972	dislocation	C0856775
27717972	pathoanatomic risk factors	C0035648
27717972	TT-TG distance	C0012751
27717972	patella	C0030647
27717972	height	C1317145
27717972	grade	C0441800
27717972	trochlear dysplasia	C4274287
27717972	Beighton score	C4273179
27717972	rotational abnormalities	C1704258
27717972	tibia	C0040184
27717972	femur	C0015811
27717972	Patients	C0030705
27717972	BPII	C0282574
27717972	Marx activity scale	C0282574
27717972	ISS	C0021504
27717972	calculated	C1443182
27717972	clinical assessment data	C1516606
27717972	Patients	C0030705
27717972	WARPS	C0008902
27717972	STAID subtypes	C0008902
27717972	comparative analysis	C0683941
27717972	t test	C0871472
27717972	demographics	C1698647
27717972	pathoanatomic risk factors	C0035648
27717972	groups	C0681860
27717972	Convergent validity	C1510594
27717972	Pearson r correlation coefficient	C0871052
27717972	WARPS/STAID	C0457451
27717972	ISS scores	C0021504
27717972	Demographic risk factors	C0011292
27717972	associated with	C0332281
27717972	WARPS subtype	C0008902
27717972	female sex	C0086287
27717972	age	C0001779
27717972	dislocation	C0856775
27717972	bilaterality	C0238767
27717972	Pathoanatomic risk factors	C0035648
27717972	associated with	C0332281
27717972	WARPS subtype	C0008902
27717972	trochlear dysplasia	C4274287
27717972	TT-TG distance	C0012751
27717972	ligamentous laxity	C0158359
27717972	rotational abnormalities	C1704258
27717972	t test	C0871472
27717972	ISS	C0021504
27717972	WARPS subtype	C0008902
27717972	STAID subtype	C0008902
27717972	relationship	C0439849
27717972	WARPS/STAID	C0457451
27717972	ISS scores	C0021504
27717972	Pearson r correlation coefficient	C0871052
27717972	relationship	C0439849
27717972	study	C0008972
27717972	statistically significant	C0237881
27717972	evidence	C3887511
27717972	demographics	C1698647
27717972	pathoanatomies	C1384516
27717972	WARPS	C0008902
27717972	STAID	C0008902
27717972	patellofemoral	C0447801
27717972	instability	C0022410
27717972	subtypes	C0449560
27717972	quality-of-life	C0034380
27717972	activity level	C0683317
27717972	subtypes	C0449560
27717972	WARPS/STAID score	C0457451
27717972	convergent validity	C1510594
27717972	ISS	C0021504
27717972	divergent validity	C2349101
27717972	BPII score	C0282574
27717972	Marx activity scale	C0282574
27717972	study	C0008972
27717972	WARPS/STAID classification	C0008902
27717972	ISS	C0021504
27717972	patients	C0030705
27717972	recurrent	C2945760
27717972	patellofemoral	C0447801
27717972	instability	C0022410
27718023	Expression	C1171362
27718023	caspase 3	C0291573
27718023	ovarian follicle	C0018120
27718023	cells	C0007634
27718023	lizard	C0023916
27718023	Podarcis sicula	C1025381
27718023	caspase 3	C0291573
27718023	previtellogenesis	C0042895
27718023	ovarian	C0205065
27718023	follicular epithelium	C0040300
27718023	lizard	C0023916
27718023	Podarcis sicula	C1025381
27718023	localization	C0475264
27718023	caspase 3	C0291573
27718023	enzyme assay	C2717977
27718023	Western blotting	C0005863
27718023	immunocytochemistry	C0242349
27718023	fragment	C1708096
27718023	caspase 3	C1413132
27718023	cloned	C0598888
27718023	species	C1705920
27718023	sequenced	C1561491
27718023	in situ hybridization	C0162788
27718023	localize	C0392752
27718023	messengers	C0815028
27718023	phylogenetic survey	C1519068
27718023	homology	C2697616
27718023	reptilian	C0035161
27718023	caspases	C0010656
27718023	follicle	C1571705
27718023	cells	C0007634
27718023	expressed	C1171362
27718023	caspase	C0010656
27718023	mRNA	C0035696
27718023	caspase 3	C0291573
27718023	transcribed	C0040649
27718023	stem phase	C0205390
27718023	translated	C0597295
27718023	cell differentiation	C0007589
27718023	proform protein	C0033684
27718023	differentiated (nurse) stage	C0205615
27718023	activated	C0599177
27718023	previtellogenesis	C0042895
27718023	degeneration of cells	C0333467
27718023	protein sequence	C0002518
27718023	reptilian	C0035161
27718023	caspases 3	C0291573
27718023	epithelial cells	C0014597
27718023	ovarian follicle	C0018120
27718023	caspase 3	C0291573
27718023	nurse stage	C0205615
27718023	apoptosis	C0162638
27720129	Increased	C0205217
27720129	acute	C0205178
27720129	mortality	C0205848
27720129	chemoradiotherapy	C0436307
27720129	locally advanced head and neck cancer	C0278996
27720129	patients	C0030705
27720129	years	C1510829
27720129	Concurrent chemoradiotherapy	C3178775
27720129	CRT	C3178775
27720129	standard of care	C2936643
27720129	sites	C0205145
27720129	locally advanced head and neck squamous cell carcinomas	C1168401
27720129	LAHNC	C1168401
27720129	meta-analysis	C0920317
27720129	chemotherapy	C3665472
27720129	survival	C0220921
27720129	patients	C0030705
27720129	years	C1510829
27720129	elderly	C0001792
27720129	patients	C0030705
27720129	treated	C1522326
27720129	CRT	C3178775
27720129	increased	C0205217
27720129	toxicity	C0600688
27720129	improvements	C2986411
27720129	survival	C0220921
27720129	single-institution	C2607850
27720129	IRB-approved	C2346499
27720129	retrospective study	C0035363
27720129	patients	C0030705
27720129	treated	C1522326
27720129	CRT	C3178775
27720129	LAHNC	C1168401
27720129	Multivariate models	C0026348
27720129	death	C1306577
27720129	months	C0439231
27720129	death	C1306577
27720129	time	C0040223
27720129	logistic regression	C0206031
27720129	Cox modeling	C0870071
27720129	Patients	C0030705
27720129	years	C1510829
27720129	treated	C1522326
27720129	concurrent	C0205420
27720129	cisplatin	C0008838
27720129	weeks	C0439230
27720129	weekly	C0439230
27720129	carboplatin	C0079083
27720129	patients	C0030705
27720129	years	C1510829
27720129	Patients	C0030705
27720129	years	C1510829
27720129	increased	C0205217
27720129	toxicity	C0600688
27720129	treatment	C0087111
27720129	hospitalizations	C0019993
27720129	PEG removal	C0087111
27720129	follow-up	C1522577
27720129	death	C1306577
27720129	proportion	C1709707
27720129	patients	C0030705
27720129	years	C1510829
27720129	months	C0439231
27720129	CRT	C3178775
27720129	Patients	C0030705
27720129	increased	C0205217
27720129	risk	C0035647
27720129	death	C1306577
27720129	months	C0439231
27720129	CRT	C3178775
27720129	odds ratio	C0028873
27720129	CI	C0009667
27720129	survival	C0220921
27720129	time	C0040223
27720129	hazard ratio	C2985465
27720129	CI	C0009667
27720129	Patients	C0030705
27720129	years	C1510829
27720129	treated	C1522326
27720129	toxic	C1407029
27720129	chemotherapy	C3665472
27720129	rates	C1521828
27720129	hospitalization	C0019993
27720129	treatment	C0087111
27720129	increased	C0205217
27720129	rates	C1521828
27720129	acute	C0205178
27720129	mortality	C0205848
27720129	CRT	C3178775
27720129	efficacy	C1280519
27720129	chemoradiotherapy	C0436307
27720129	elderly	C0001792
27720129	patients	C0030705
27720129	prospective setting	C0205556
27733749	Food security	C3178753
27733749	nutritional status	C0392209
27733749	children	C0008059
27733749	foster care	C0599759
27733749	nutritional status	C0392209
27733749	foster children	C0337544
27733749	quality	C0332306
27733749	daily menus	C0016452
27733749	group homes	C0018257
27733749	Food Security	C3178753
27733749	organizations	C1561598
27733749	study	C2603343
27733749	children	C0008059
27733749	group homes	C0018257
27733749	group A	C0681860
27733749	children	C0008059
27733749	general population	C0683971
27733749	group B	C0681860
27733749	nutritional status	C0392209
27733749	BMI percentiles	C2227318
27733749	Mean	C0444504
27733749	percentiles	C1264641
27733749	groups	C0681860
27733749	statistical analysis	C0871424
27733749	nutritional	C0392209
27733749	caloric daily distributions	C2164132
27733749	organization	C1561598
27733749	recall method	C0025663
27733749	questionnaire	C0034394
27733749	Food Security	C3178753
27733749	analysis	C0936012
27733749	mean	C0444504
27733749	BMI	C1305855
27733749	age	C0001779
27733749	percentiles	C1264641
27733749	differences	C3842396
27733749	group A	C0681860
27733749	group B	C0681860
27733749	average	C1510992
27733749	daily	C0332173
27733749	nutrient	C0392209
27733749	calorie distribution	C0392209
27733749	group homes	C0018257
27733749	nearly optimal	C0243095
27733749	excess	C1979886
27733749	proteins	C0453858
27733749	deficiency	C0011155
27733749	PUFAs	C0032615
27733749	low intake	C0231353
27733749	iron	C0518043
27733749	calcium	C0489458
27733749	organizations	C1561598
27733749	High Food Security	C3178753
27733749	Nutritional conditions	C0392209
27733749	foster children	C0337544
27733749	children	C0008059
27733749	general population	C0683971
27733749	Foster care	C0599759
27733749	necessary conditions	C0337645
27733749	growth	C0018270
27734729	Incontinence	C0021167
27734729	dermatitis	C0011603
27734729	reducing	C0392756
27734729	adverse events	C0879626
27734729	Incontinence	C0021167
27734729	dermatitis	C0011603
27734729	IAD	C0011603
27734729	problem	C0033213
27734729	patients	C0030705
27734729	faecal	C0015732
27734729	urinary incontinence	C0042024
27734729	Urine	C0042036
27734729	skin	C1123023
27734729	flora	C0314761
27734729	permeability	C0031164
27734729	stratum corneum	C0221921
27734729	faecal	C0015733
27734729	enzymes	C0014442
27734729	skin	C1123023
27734729	skin damage	C0849640
27734729	Faecal	C0015733
27734729	bacteria	C0004611
27734729	penetrate	C0205321
27734729	skin	C1123023
27734729	risk	C0035647
27734729	secondary infection	C0442886
27734729	IAD	C0011603
27734729	prevented	C0199176
27734729	healed	C0205249
27734729	appropriate	C1548787
27734729	skin cleansing	C0455082
27734729	skin protection	C1543231
27734729	appropriate	C1548787
27734729	containment devices	C0181299
27734729	HARTMANN incontinence pads	C0085099
27734729	fluids	C0302908
27734729	IAD	C0011603
27734729	skin's	C1123023
27734729	acidic pH	C0020283
27734729	acidic pH	C0020283
27734729	skin	C1123023
27734729	barrier function	C2246986
27734729	infection	C3714514
27734729	acidic pH	C0020283
27734729	skin	C1123023
27734729	damage	C1883709
27740919	Feasibility	C0015730
27740919	transition	C2700061
27740919	intervention	C0184661
27740919	aimed	C1947946
27740919	adolescents	C0205653
27740919	chronic illness	C0008679
27740919	International	C1512888
27740919	guidelines	C0162791
27740919	transition	C2700061
27740919	programmes	C0043113
27740919	adolescents	C0205653
27740919	chronic illness	C0008679
27740919	inadequate	C0205412
27740919	transition	C2700061
27740919	poor disease control	C0421179
27740919	risk	C0035647
27740919	lacking	C0332268
27740919	outpatient follow-up	C0589125
27740919	investigate	C1292732
27740919	feasibility	C0015730
27740919	transition	C2700061
27740919	intervention	C0184661
27740919	aimed	C1947946
27740919	adolescents	C0205653
27740919	chronic illness	C0008679
27740919	focusing	C0589098
27740919	declines	C1136454
27740919	drop-outs	C0030686
27740919	no-shows	C4042858
27740919	advantages	C1254370
27740919	disadvantages	C1254370
27740919	participating	C0679823
27740919	adolescents	C0205653
27740919	juvenile idiopathic arthritis	C3495559
27740919	JIA	C3495559
27740919	participate	C0679823
27740919	randomised controlled trial	C0206035
27740919	RCT	C0206035
27740919	transition	C2700061
27740919	intervention	C0184661
27740919	Reasons	C0392360
27740919	decline	C1136454
27740919	drop-outs	C0030686
27740919	calculated	C0444686
27740919	Adolescents	C0205653
27740919	experiences	C0596545
27740919	advantages	C1254370
27740919	disadvantages	C1254370
27740919	participating	C0679823
27740919	reasons	C0392360
27740919	no-shows	C4042858
27740919	investigated	C1292732
27740919	focus groups	C0016400
27740919	telephone interviews	C0021823
27740919	analysed	C0936012
27740919	thematic	C0949415
27740919	analysis	C0936012
27740919	patients	C0030705
27740919	declined to participate	C1136454
27740919	intervention	C0184661
27740919	dropped out	C0030686
27740919	intervention	C0184661
27740919	Unspecified	C0205370
27740919	declines	C1136454
27740919	practical issues	C0033213
27740919	common	C0205214
27740919	reason	C0392360
27740919	decline	C1136454
27740919	do not wish to continue	C0004927
27740919	common	C0205214
27740919	reason	C0392360
27740919	drop-out	C0030686
27740919	Reasons	C0392360
27740919	no-shows	C4042858
27740919	forgetting	C0598853
27740919	Advantages	C1254370
27740919	participating	C0679823
27740919	participating	C0679823
27740919	without	C0332288
27740919	parents	C0030551
27740919	trust	C0237935
27740919	confidentiality	C0009669
27740919	agenda	C0681473
27740919	responsiveness	C0205342
27740919	Disadvantages	C1254370
27740919	unclear	C3845108
27740919	aim	C1947946
27740919	study	C2603343
27740919	JIA	C3495559
27740919	conversations	C0871703
27740919	transport	C0040802
27740919	issues	C0033213
27740919	adolescents	C0205653
27740919	difficulties	C1299586
27740919	understanding	C0162340
27740919	aim	C1947946
27740919	intervention	C0184661
27740919	participants	C0205653
27740919	conversations	C0871703
27740919	trust	C0237935
27740919	confidentiality	C0009669
27740919	communication	C0009452
27740919	adolescents	C0205653
27740919	programmes	C0043113
27740919	preferences	C0558295
27740919	cooperation	C0392337
27740919	parents	C0030551
27740919	health care providers	C0018724
27743356	High-Throughput Analysis	C0872186
27743356	IgG N-Glycome	C0208205
27743356	UPLC	C0008565
27743356	FLR	C0180919
27743356	biological	C0205460
27743356	clinical	C0205210
27743356	relevance	C2347946
27743356	glycosylation	C0017982
27743356	apparent	C0750489
27743356	large scale studies	C2603343
27743356	glycome	C2348869
27743356	Glycans	C0032594
27743356	immunoglobulin G	C0020852
27743356	IgG	C0020852
27743356	essential	C0205224
27743356	function	C0031843
27743356	IgG	C0020852
27743356	glycosylation	C0017982
27743356	change	C0392747
27743356	processes	C1522240
27743356	IgG	C0020852
27743356	glycoproteins	C0017968
27743356	approaches	C0449445
27743356	liquid chromatography	C0008565
27743356	capillary gel electrophoresis	C0596607
27743356	mass spectrometry	C0037813
27743356	study	C2603343
27743356	IgG	C0020852
27743356	glycosylation	C0017982
27743356	Generation	C3146294
27743356	high-quality	C0205556
27743356	glycomics	C1512223
27743356	data	C1511726
27743356	high-throughput	C0872047
27743356	reproducible	C0035149
27743356	robust	C2986815
27743356	sample preparation	C3824791
27743356	accurate	C0443131
27743356	quantitative analysis	C0681919
27743356	chapter	C1552857
27743356	protocol	C2348563
27743356	high-throughput	C0872047
27743356	IgG N-glycan	C0208205
27743356	release	C1283071
27743356	fluorescent labeling	C0022885
27743356	cleanup	C0243114
27743356	analysis	C0936012
27743356	fluorescently labeled	C1708632
27743356	IgG N-glycans	C0208205
27743356	hydrophilic interaction liquid chromatography	C0008565
27743356	HILIC	C0008565
27743356	ultra performance liquid chromatography	C0008565
27743356	UPLC	C0008565
27743356	fluorescence	C0016315
27743356	FLR	C0180919
27743356	detection	C1511790
27744219	Biomimetic	C1136386
27744219	whitlockite	C0078483
27744219	inorganic	C1881215
27744219	nanoparticles	C1450054
27744219	in situ	C0444498
27744219	remodeling	C0085268
27744219	bone regeneration	C0005972
27744219	Bone remodeling	C0085268
27744219	complex	C0439855
27744219	signaling pathway	C0037080
27744219	osteoblasts	C0029418
27744219	osteoclasts	C0029431
27744219	mechanisms	C0441712
27744219	homeostasis	C0019868
27744219	growth	C0007595
27744219	differentiation	C0007589
27744219	signaling pathways	C0037080
27744219	cells	C0007634
27744219	bone	C0262950
27744219	extracellular matrices	C0015350
27744219	bone remodeling	C0085268
27744219	ionic	C0022023
27744219	concentration	C1446561
27744219	elucidated	C2986669
27744219	synthetic	C1883254
27744219	whitlockite	C0078483
27744219	WH: Ca18Mg2(HPO4)2(PO4)12)	C0078483
27744219	nanoparticles	C1450054
27744219	recapitulate	C0205341
27744219	bone regeneration	C0005972
27744219	stimulating	C1948023
27744219	osteogenic differentiation	C0007589
27744219	prohibiting	C1292733
27744219	osteoclastic	C0029431
27744219	activity	C0441655
27744219	transforming	C0040682
27744219	hydroxyapatite	C0020326
27744219	HAP	C0020326
27744219	neo bone tissues	C0391978
27744219	PO4(3-)	C1601799
27744219	Mg(2+)	C2346927
27744219	physiological	C0205463
27744219	conditions	C0348080
27744219	structural analysis	C0242481
27744219	phase	C0205390
27744219	transformation	C0040682
27744219	WH	C0078483
27744219	HAP	C0020326
27744219	factor	C1521761
27744219	bone regeneration	C0005972
27744219	denser	C0439794
27744219	hierarchical	C0699032
27744219	neo-bone	C0262950
27744219	structure	C0678594
27744219	findings	C0243095
27744219	living	C0376558
27744219	bone	C0262950
27744219	minerals	C0026162
27744219	actively	C0205177
27744219	communicate	C0007582
27744219	induce	C0205263
27744219	self-healing	C1254358
27744219	bone	C0262950
27744219	minerals	C0026162
27744219	passive	C3686820
27744219	cellular	C0007634
27744219	mineralization	C1254358
27745773	inactivation	C0544461
27745773	dentin	C0011429
27745773	proteases	C1947941
27745773	crosslinkers	C0010360
27745773	reversible	C0205343
27745773	Inactivation	C0544461
27745773	dentin	C0011429
27745773	proteases	C1947941
27745773	crosslinkers	C0010360
27745773	suggested	C1705535
27745773	prevent	C2700409
27745773	degradation	C0314674
27745773	dentin	C0011429
27745773	collagen	C0009325
27745773	hybrid	C0598148
27745773	layer	C1254362
27745773	not known	C0439673
27745773	inhibition	C3463820
27745773	reversible	C0205343
27745773	aim	C1947946
27745773	study	C2603343
27745773	evaluate	C0441655
27745773	inactivation	C0544461
27745773	effect	C1280500
27745773	crosslinkers	C0010360
27745773	dentin	C0011429
27745773	protease	C1947941
27745773	activity	C0243102
27745773	period	C1948053
27745773	Demineralized dentin beams	C0296481
27745773	treated with	C1522326
27745773	glutaraldehyde	C0017814
27745773	GA1	C0017814
27745773	glutaraldehyde	C0017814
27745773	GA5	C0017814
27745773	grape seed extract	C0772454
27745773	GS1	C0772454
27745773	grape seed extract	C0772454
27745773	GS5	C0772454
27745773	sumac berry extract	C4047315
27745773	S	C4047315
27745773	20μM curcumin	C0010467
27745773	CR20	C0010467
27745773	curcumin	C0010467
27745773	CR200	C0010467
27745773	Untreated	C0243095
27745773	beams	C0296481
27745773	control	C0009932
27745773	beams	C0296481
27745773	incubated	C1439852
27745773	incubation media	C0358514
27745773	analyze	C0936012
27745773	solubilized	C1948047
27745773	telopeptide	C0030956
27745773	ICTP	C1101784
27745773	CTX	C1173299
27745773	fragments	C0030935
27745773	indicators	C1522602
27745773	MMP	C0623362
27745773	cathepsin K	C0284930
27745773	degradation	C0314674
27745773	incubation	C1439852
27745773	relative	C0205345
27745773	MMP	C0623362
27745773	activity	C1148560
27745773	dentin beams	C0296481
27745773	generic	C1705810
27745773	MMP	C0623362
27745773	assay	C2717977
27745773	Data	C1511726
27745773	analyzed	C0936012
27745773	repeated-measures	C0871881
27745773	ANOVA	C0002780
27745773	treated	C1522326
27745773	groups	C0441833
27745773	significant	C0750502
27745773	decrease	C0547047
27745773	CTX	C1173299
27745773	dentin	C0011429
27745773	ICTP	C1101784
27745773	dentin	C0011429
27745773	fragments	C0030935
27745773	incubation	C1439852
27745773	compared	C1707455
27745773	control	C0009932
27745773	dentin	C0011429
27745773	GA5	C0017814
27745773	GS5	C0772454
27745773	CR200	C0010467
27745773	maintained	C1314677
27745773	inhibitory	C3463820
27745773	effect	C1280500
27745773	incubation	C1439852
27745773	results	C1254595
27745773	dry mass loss	C1254366
27745773	relative	C0205345
27745773	MMP	C0623362
27745773	activity	C1148560
27745773	results	C0683954
27745773	study	C2603343
27745773	long-term effect	C0023983
27745773	crosslinker	C0010360
27745773	dose dependent	C1512045
27752082	Inhibition	C0021469
27752082	STEP61	C3883719
27752082	ameliorates	C0205556
27752082	deficits	C2987487
27752082	mouse	C0025929
27752082	hiPSC	C3658289
27752082	schizophrenia	C0036341
27752082	models	C0012644
27752082	brain	C0006104
27752082	specific	C0205369
27752082	tyrosine phosphatase	C0085536
27752082	STEP	C3883719
27752082	STriatal-Enriched protein tyrosine Phosphatase	C3883719
27752082	regulator	C1704735
27752082	synaptic function	C0027793
27752082	STEP	C3883719
27752082	synaptic	C0039062
27752082	strengthening	C0205556
27752082	increasing	C0205217
27752082	N-methyl D-aspartate glutamate receptor	C0080093
27752082	NMDAR	C0080093
27752082	internalization	C0599281
27752082	dephosphorylation	C3160734
27752082	GluN2B	C1741283
27752082	inactivation	C0314679
27752082	kinases	C0031727
27752082	extracellular signal-regulated kinase 1	C0082529
27752082	2	C0170168
27752082	Fyn	C1530914
27752082	STEP61	C3883719
27752082	elevated	C3163633
27752082	cortex	C1176472
27752082	Nrg1(+/-)	C1367656
27752082	knockout	C1522225
27752082	mouse model	C2986594
27752082	schizophrenia	C0036341
27752082	SZ	C0036341
27752082	Genetic	C0314603
27752082	reduction	C0441610
27752082	pharmacological	C0205464
27752082	inhibition	C3463820
27752082	STEP	C3883719
27752082	prevents	C1292733
27752082	NMDARs	C0080093
27752082	synaptic membranes	C0039063
27752082	behavioral deficits	C0004930
27752082	Nrg1(+/-)	C1367656
27752082	mice	C0025929
27752082	STEP61 protein	C3883719
27752082	increased	C0205217
27752082	cortical	C1176472
27752082	lysates	C1881488
27752082	central nervous system	C3714787
27752082	specific	C0205369
27752082	ErbB2	C0069515
27752082	4	C0214098
27752082	mouse model	C2986594
27752082	SZ	C0036341
27752082	human induced pluripotent stem cell	C3658289
27752082	hiPSC	C3658289
27752082	forebrain	C0085140
27752082	neurons	C0027882
27752082	Ngn2	C1422204
27752082	induced	C0205263
27752082	excitatory neurons	C0027882
27752082	independent	C0332291
27752082	SZ	C0036341
27752082	patient	C0030705
27752082	cohorts	C0599755
27752082	selected	C1707391
27752082	SZ	C0036341
27752082	models	C0012644
27752082	increased	C0205217
27752082	STEP61	C3883719
27752082	protein levels	C0542493
27752082	reduced	C0392756
27752082	ubiquitination	C1519751
27752082	degradation	C0597297
27752082	convergent	C0205556
27752082	findings	C0243095
27752082	mouse	C0025929
27752082	hiPSC	C3658289
27752082	SZ	C0036341
27752082	models	C0012644
27752082	provide	C1999230
27752082	evidence	C3887511
27752082	STEP61	C3883719
27752082	dysfunction	C3887504
27752082	SZ	C0036341
27752744	Incident	C1551358
27752744	fracture	C0016658
27752744	associated with	C0332281
27752744	increased	C0205217
27752744	risk	C0035647
27752744	mortality	C0205848
27752744	frailty	C0424594
27752744	status	C0449438
27752744	elderly	C0001792
27752744	Japanese	C1556094
27752744	men	C0025266
27752744	Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Cohort Study	C0009247
27752744	Frail	C0871754
27752744	elderly	C0001792
27752744	individuals	C0237401
27752744	elevated	C3163633
27752744	risks	C0035647
27752744	fracture	C0016658
27752744	mortality	C0205848
27752744	incident	C1551358
27752744	fractures	C0016658
27752744	associated with	C0332281
27752744	increased	C0205217
27752744	risk	C0035647
27752744	death	C1306577
27752744	pre-fracture	C0016658
27752744	frailty	C0424594
27752744	status	C0449438
27752744	physical performance tests	C0679543
27752744	laboratory tests	C0022885
27752744	geriatric	C1704440
27752744	diseases	C0012634
27752744	community-dwelling	C4045975
27752744	elderly	C0001792
27752744	Japanese	C1556094
27752744	men	C0025266
27752744	fractures	C0016658
27752744	increase	C0442805
27752744	risk	C0035647
27752744	mortality	C0205848
27752744	frailty	C0424594
27752744	complicate	C0231242
27752744	association	C0439849
27752744	false-positive result	C1112254
27752744	evaluated	C0220825
27752744	association	C0439849
27752744	pre-fracture	C0016658
27752744	levels	C0441889
27752744	frailty	C0424594
27752744	examined	C0332128
27752744	community-dwelling	C4045975
27752744	ambulatory	C0439841
27752744	men	C0025266
27752744	aged	C0001779
27752744	years	C1510829
27752744	baseline	C1442488
27752744	Fujiwara-kyo Osteoporosis Risk in Men Study	C0009247
27752744	frailty	C0424594
27752744	status	C0449438
27752744	activities of daily living	C0001288
27752744	ADL	C0001288
27752744	physical performance tests	C0679543
27752744	grip strength	C0429271
27752744	one-foot standing balance with eyes open	C0516711
27752744	timed 10-m walk	C2315460
27752744	laboratory sera tests	C0022885
27752744	sera	C0229671
27752744	Participants	C0679646
27752744	years	C0439234
27752744	incident	C1551358
27752744	clinical	C0205210
27752744	fractures	C0016658
27752744	death	C1306577
27752744	Effects of	C1704420
27752744	incident	C1551358
27752744	fracture	C0016658
27752744	death	C1306577
27752744	Cox proportional hazards model	C0033489
27752744	fracture	C0016658
27752744	follow-up	C1522577
27752744	time-dependent predictor	C2698872
27752744	frailty status indices	C4075886
27752744	covariates	C0205556
27752744	identified	C0205396
27752744	fractures	C0016658
27752744	men	C0025266
27752744	deaths	C1306577
27752744	follow-up	C1522577
27752744	period	C1948053
27752744	median	C2939193
27752744	follow-up	C1522577
27752744	years	C0439234
27752744	Participants	C0679646
27752744	incident	C1551358
27752744	fractures	C0016658
27752744	not have significantly worse	C0243095
27752744	frailty	C0424594
27752744	statuses	C0449438
27752744	significantly	C0750502
27752744	higher	C0205250
27752744	cumulative	C1511559
27752744	mortality rate	C0205848
27752744	fractures	C0016658
27752744	Age-adjusted	C4300468
27752744	hazard ratio	C2985465
27752744	HR	C2985465
27752744	death	C1306577
27752744	incident	C1551358
27752744	fracture	C0016658
27752744	confidence interval	C0009667
27752744	physical performance	C2607857
27752744	decreased	C0205216
27752744	significant	C0750502
27752744	HR	C2985465
27752744	no significant change	C0442739
27752744	laboratory test results	C1254360
27752744	Exclusion	C2828389
27752744	deaths	C1306577
27752744	months	C0439231
27752744	follow-up	C1522577
27752744	not alter	C0243095
27752744	results	C0456984
27752744	Incident	C1551358
27752744	clinical	C0205210
27752744	fracture	C0016658
27752744	associated with	C0332281
27752744	elevated	C3163633
27752744	risk	C0035647
27752744	death	C1306577
27752744	independently	C1299583
27752744	pre-fracture	C0016658
27752744	levels	C0441889
27752744	frailty	C0424594
27752744	community-dwelling	C4045975
27752744	elderly	C0001792
27752744	men	C0025266
27754397	Total Energy Expenditure	C0429629
27754397	Obese	C0028754
27754397	Kuwaiti Primary School	C0036375
27754397	Children	C0008059
27754397	Assessed	C1516048
27754397	Doubly-Labeled Water Technique	C0449851
27754397	pilot study	C0031928
27754397	assess	C1516048
27754397	total energy expenditure	C0429629
27754397	TEE	C0429629
27754397	obese	C0028754
27754397	years	C0439234
27754397	Kuwaiti	C1257890
27754397	children	C0008059
27754397	girls	C0870604
27754397	boys	C0870221
27754397	Total body water	C0429632
27754397	TBW	C0429632
27754397	TEE	C0429629
27754397	assessed	C1516048
27754397	doubly-labeled water technique	C0449851
27754397	TBW	C0429632
27754397	intercept	C3146232
27754397	elimination rate	C0231360
27754397	deuterium	C0011744
27754397	TEE	C0429629
27754397	difference	C1705241
27754397	elimination rates	C0231360
27754397	(18)O	C0030061
27754397	deuterium	C0011744
27754397	TBW	C0429632
27754397	estimate	C0750572
27754397	fat-free mass	C0424679
27754397	FFM	C0424679
27754397	hydration	C0596317
27754397	factors	C1521761
27754397	ages	C0001779
27754397	gender	C0079399
27754397	Fat mass	C3656665
27754397	FM	C3656665
27754397	calculated	C1441506
27754397	difference	C1705241
27754397	body weight	C0005910
27754397	FFM	C0424679
27754397	Body weight	C0005910
27754397	statistically different	C1705241
27754397	TBW	C0429632
27754397	significantly higher	C0205250
27754397	boys	C0870221
27754397	girls	C0870604
27754397	girls	C0870604
27754397	significantly higher	C0205250
27754397	estimated	C0750572
27754397	FM	C3656665
27754397	TEE	C0429629
27754397	significantly higher	C0205250
27754397	boys	C0870221
27754397	girls	C0870604
27754397	Estimated	C0750572
27754397	physical activity level	C3694575
27754397	PAL	C3694575
27754397	significantly higher	C0205250
27754397	boys	C0870221
27754397	results	C1274040
27754397	dataset	C0150098
27754397	TEE	C0429629
27754397	years	C0439234
27754397	obese	C0028754
27754397	Kuwaiti	C1257890
27754397	children	C0008059
27754397	gender differences	C0036866
27754397	school based interventions	C0679800
27754397	childhood obesity	C2362324
27755168	Mesenchymal stromal cells	C3178844
27755168	clinical	C0205210
27755168	kidney transplantation	C0022671
27755168	tolerant	C0231198
27755168	Progress	C1280477
27755168	improvement	C2986411
27755168	short-term	C0443303
27755168	long-term	C0443252
27755168	outcomes	C0085415
27755168	kidney transplantation	C0022671
27755168	plateau	C2964353
27755168	consequences of	C0686907
27755168	efficient	C0442799
27755168	nonspecific	C0750540
27755168	immunosuppressive drugs	C0021081
27755168	cell therapy	C0302189
27755168	mesenchymal stromal cells	C3178844
27755168	alternative	C1523987
27755168	strategy	C0679716
27755168	therapy	C0087111
27755168	therapies	C0087111
27755168	controlled	C2587213
27755168	tapering	C0441640
27755168	immunosuppressive medication	C0021081
27755168	ambition	C0870128
27755168	generating	C3146294
27755168	donor	C0013018
27755168	immune regulation	C1327458
27755168	tolerance	C0020963
27755168	alloimmunity	C0598604
27755168	direct	C0439851
27755168	indirect	C0439852
27755168	semi-direct	C0205556
27755168	alloantigen	C0002131
27755168	donor	C0013018
27755168	immune regulation	C1327458
27755168	mechanisms	C0441712
27755168	mesenchymal stromal cells	C3178844
27755168	alloimmunity	C0598604
27755168	interaction	C0007582
27755168	antigen presenting cells	C0003315
27755168	dendritic cells	C0011306
27755168	critical	C1511545
27755168	importance	C3898777
27755168	current	C0521116
27755168	status	C0449438
27755168	clinical trials	C0008976
27755168	mesenchymal stromal cells	C3178844
27755168	kidney transplantation	C0022671
27755168	therapeutic strategies	C0087111
27755168	contribute	C1880177
27755168	control	C0243148
27755168	alloreactivity	C0598604
27755168	organ transplantation	C0029216
27760552	Facilitating factors	C1521761
27760552	barriers	C4045969
27760552	malaria	C0024530
27760552	research	C0035168
27760552	utilization	C0042153
27760552	policy development	C0242440
27760552	Malawi	C0024548
27760552	Research	C0035168
27760552	determinants	C1521761
27760552	health	C0018684
27760552	providing	C1999230
27760552	evidence	C3887511
27760552	policy development	C0242440
27760552	successful	C1272703
27760552	Utilization	C0042153
27760552	research	C0035168
27760552	intricate	C0439855
27760552	process	C1522240
27760552	contextual factors	C0683580
27760552	enhancing	C2349975
27760552	factors	C1521761
27760552	barriers	C4045969
27760552	research	C0035168
27760552	utilization	C0042153
27760552	malaria	C0024530
27760552	policy development	C0242440
27760552	Malawi	C0024548
27760552	Qualitative	C0205556
27760552	research	C0035168
27760552	interviews	C0021822
27760552	informants	C0870704
27760552	malaria	C0024530
27760552	researchers	C0035173
27760552	policy makers	C0242170
27760552	programme	C0683739
27760552	managers	C0335141
27760552	key stakeholders	C1257890
27760552	Purposive sampling	C0681880
27760552	snowballing techniques	C2348215
27760552	identifying	C0205396
27760552	informants	C0870704
27760552	Interview	C0021822
27760552	transcripts	C0034869
27760552	entered	C1521975
27760552	QSR Nvivo 11 software	C0037585
27760552	analysis	C0936012
27760552	Respondents	C0282122
27760552	identified	C0205396
27760552	global	C2348867
27760552	efforts	C0441655
27760552	knowledge translation	C3494164
27760552	local	C0205276
27760552	political will	C0032380
27760552	conducive	C3898897
27760552	research	C0035168
27760552	utilization	C0042153
27760552	factors	C1521761
27760552	availability of	C0470187
27760552	research	C0035168
27760552	availability of	C0470187
27760552	local	C0205276
27760552	researchers	C0035173
27760552	stakeholders	C1257890
27760552	supporting	C1521721
27760552	knowledge translation	C3494164
27760552	barriers	C4045969
27760552	lack	C0332268
27760552	researcher	C0035173
27760552	public	C0678367
27760552	engagement	C2937292
27760552	politics	C0032379
27760552	researchers'	C0035173
27760552	lack	C0332268
27760552	communication skills	C0870313
27760552	lack	C0332268
27760552	research	C0035168
27760552	collaborations	C0282116
27760552	funder driven research	C0681805
27760552	unknown	C0439673
27760552	World Health Organization	C0043237
27760552	policy	C0242456
27760552	lack	C0332268
27760552	malaria	C0024530
27760552	research	C0035168
27760552	repository	C3847505
27760552	identified	C0205396
27760552	facilitating factors	C1521761
27760552	malaria	C0024530
27760552	research	C0035168
27760552	utilization	C0042153
27760552	policy development	C0242440
27760552	Malawi	C0024548
27760552	factors	C1521761
27760552	systematically	C0220922
27760552	coordinated	C0700114
27760552	identified	C0205396
27760552	barriers	C4045969
27760552	improve	C0184511
27760552	malaria	C0024530
27760552	research	C0035168
27760552	utilization	C0042153
27760552	policy development	C0242440
27760552	Malaria	C0024530
27760552	research	C0035168
27760552	implementation	C1708476
27760552	evidence-based	C3887511
27760552	reduce	C0392756
27760552	malaria	C0024530
27760552	burden	C2828008
27760552	paradigm shift	C0681797
27760552	malaria	C0024530
27760552	control	C2587213
27760552	elimination	C1948029
27760552	Malawi	C0024548
27760700	Altered	C0392747
27760700	interregional	C0005898
27760700	correlations	C1707520
27760700	serotonin transporter	C0170657
27760700	availability	C0470187
27760700	cerebral glucose	C1988487
27760700	glucose metabolism	C0596620
27760700	schizophrenia	C0036341
27760700	high-resolution PET	C0032743
27760700	[(11)C]DASB	C1570551
27760700	[(18)F]FDG	C0046056
27760700	interregional	C0005898
27760700	correlations	C1707520
27760700	serotonin transporter	C0170657
27760700	SERT	C0170657
27760700	availability	C0470187
27760700	glucose metabolism	C0596620
27760700	7-Tesla magnetic resonance imaging	C0024485
27760700	MRI	C0024485
27760700	high-resolution positron emission tomography	C0032743
27760700	PET	C0032743
27760700	(11)C-3-amino-4-(2-dimethylaminomethylphenylthio)benzonitrile	C1570551
27760700	[(11)C]DASB	C1570551
27760700	[(18)F]fluorodeoxyglucose	C0046056
27760700	[(18)F]FDG	C0046056
27760700	antipsychotic-free patients	C0030705
27760700	schizophrenia	C0036341
27760700	disrupted	C0332454
27760700	functional connectivity	C1707489
27760700	schizophrenia	C0036341
27760700	patients	C0030705
27760700	schizophrenia	C0036341
27760700	healthy controls	C2986479
27760700	high-resolution PET	C0032743
27760700	MRI	C0024485
27760700	binding potential	C2986841
27760700	BPND	C2986841
27760700	[(11)C]DASB	C1570551
27760700	standardized uptake value ratio	C3897504
27760700	SUVR	C3897504
27760700	[(18)F]FDG	C0046056
27760700	SERT	C0170657
27760700	availability	C0470187
27760700	region of interest	C0807727
27760700	ROI	C0807727
27760700	analyses	C0936012
27760700	region	C1273723
27760700	anterior	C0205094
27760700	hippocampus	C0019564
27760700	SERT	C0170657
27760700	availability	C0470187
27760700	patients	C0030705
27760700	schizophrenia	C0036341
27760700	controls	C0009932
27760700	ROI	C0807727
27760700	voxel	C2700259
27760700	analyses	C0936012
27760700	[(18)F]FDG	C0046056
27760700	SUVR values	C3897504
27760700	patients	C0030705
27760700	controls	C0009932
27760700	right superior frontal gyrus	C2338731
27760700	medial part	C0442056
27760700	left superior frontal gyrus	C2334005
27760700	interregional	C0005898
27760700	correlations	C1707520
27760700	[(11)C]DASB	C1570551
27760700	BPND	C2986841
27760700	[(18)F]FDG	C0046056
27760700	SUVR	C3897504
27760700	positive	C1514241
27760700	correlations	C1707520
27760700	brain regions	C1273723
27760700	control subjects	C0009932
27760700	patients	C0030705
27760700	schizophrenia	C0036341
27760700	patients	C0030705
27760700	control subjects	C0009932
27760700	correlations	C1707520
27760700	SERT	C0170657
27760700	availability	C0470187
27760700	parietal	C0030560
27760700	temporal cortices	C0039485
27760700	glucose metabolism	C0596620
27760700	posterior cingulate cortex	C0175191
27760700	abnormal	C0205161
27760700	functional connectivity	C1707489
27760700	higher-order cortical regions	C0458324
27760700	schizophrenia	C0036341
27760700	role	C1705810
27760700	posterior cingulate gyrus	C0175191
27760700	circuitry	C0260041
27760700	pathophysiology	C0031847
27760700	schizophrenia	C0036341
27761922	Urticarial	C0042109
27761922	exanthema	C0015230
27761922	hepatitis B	C0019163
27761922	pregnant woman	C0033011
27761922	polymorphic eruption	C0031736
27761922	pregnancy	C0032961
27761922	Hepatitis B virus (HBV) infection in pregnant women	C3854623
27761922	western countries	C0017446
27761922	cutaneous	C0221912
27761922	manifestation of	C1280464
27761922	HBV infection	C0019163
27761922	dermatosis	C0037274
27761922	pregnancy	C0032961
27761922	woman	C0043210
27761922	pregnancy	C0032961
27761922	pruritic rash	C0033771
27761922	erythematous plaques	C0332477
27761922	purple centre	C0243095
27761922	Serology testing	C0036743
27761922	acute HBV infection	C0019163
27761922	biopsy	C0005558
27761922	superficial	C0205124
27761922	interstitial perivascular inflammatory infiltrate	C3810076
27761922	lymphocytes	C0024264
27761922	eosinophils	C0014467
27761922	diagnosis	C0011900
27761922	exanthema	C0015230
27761922	acute hepatitis B infection	C0019163
27761922	patient	C0030705
27761922	delivered	C0559563
27761922	clinically healthy boy	C0686744
27761922	first dose	C0178602
27761922	HBV vaccine	C0474232
27761922	intravenous specific immunoglobulin	C0085297
27761922	second dose	C0178602
27761922	infected	C0439663
27761922	HBV	C0019169
27761922	HBV	C0019163
27761922	exanthema	C0015230
27761922	pregnant woman	C0033011
27761922	newborn	C0021289
27761922	vertical transmission	C0242648
27761922	cirrhosis	C1623038
27761922	hepatocellular carcinoma	C2239176
27764829	Mutant Prevention Concentration	C1273380
27764829	Mutant Selection Window	C0001555
27764829	Topical Antimicrobial Agents	C1136255
27764829	Propionibacterium acnes	C0033477
27764829	mutant prevention concentration	C1273380
27764829	MPC	C1273380
27764829	mutant selection window	C0001555
27764829	MSW	C0001555
27764829	antimicrobial agents	C1136254
27764829	pathogenic	C0450254
27764829	bacteria	C0004611
27764829	antimicrobial	C1136254
27764829	therapies	C0087111
27764829	MPCs	C1273380
27764829	topical antimicrobial agents	C1136255
27764829	Propionibacterium acnes	C0033477
27764829	Staphylococcus aureus	C0038172
27764829	skin infections	C0162627
27764829	MSWs	C0001555
27764829	MPCs	C1273380
27764829	nadifloxacin	C0286402
27764829	clindamycin	C0008947
27764829	clindamycin	C0008947
27764829	MPC	C1273380
27764829	lowest	C1708760
27764829	P. acnes	C0033477
27764829	nadifloxacin	C0286402
27764829	MPC	C1273380
27764829	lowest	C1708760
27764829	S. aureus	C0038172
27764829	Calculations	C1956058
27764829	minimum inhibitory concentrations	C1304747
27764829	MPCs	C1273380
27764829	clindamycin	C0008947
27764829	lowest	C1708760
27764829	MSW	C0001555
27764829	P. acnes	C0033477
27764829	S. aureus	C0038172
27764829	Nadifloxacin	C0286402
27764829	MSWs	C0001555
27764829	higher	C0205250
27764829	P. acnes	C0033477
27764829	S. aureus	C0038172
27764829	P. acnes	C0033477
27764829	resistance	C0013203
27764829	fluoroquinolones	C0949665
27764829	S. aureus	C0038172
27764829	topical application	C0683174
27764829	clindamycin	C0008947
27764829	resistant	C0013203
27764829	P. acnes	C0033477
27764829	S. aureus	C0038172
27765805	colectomy	C0009274
27765805	colon perforation	C0347646
27765805	kayexalate	C0124498
27765805	administration	C1533734
27765805	literature review	C0282441
27765805	rare	C0522498
27765805	complication	C0009566
27765805	Kayexalate	C0124498
27765805	ion exchange resin	C0022014
27765805	treat	C0087111
27765805	patients	C0030705
27765805	hyperkalemia	C0020461
27765805	Bowel ulceration	C0009324
27765805	necrosis	C0027540
27765805	rare	C0522498
27765805	complication	C0009566
27765805	kayexalate	C0124498
27765805	administration	C1533734
27765805	concomitant	C0521115
27765805	administration	C1533734
27765805	sorbitol	C0037688
27765805	damage	C1883709
27765805	bowel	C0021853
27765805	kayexalate	C0124498
27765805	administration	C1533734
27765805	bowel necrosis	C2243080
27765805	sorbitol	C0037688
27765805	critically ill	C0010340
27765805	patient	C0030705
27765805	colectomy	C0009274
27765805	colonic necrosis	C3671268
27765805	oral	C0442027
27765805	kayexalate	C0124498
27765805	administration	C1533734
27765805	pathologic process	C0030660
27765805	review the literature	C0282441
27765805	progression	C0242656
27766178	Total	C0439810
27766178	Arsenic	C0003818
27766178	Cadmium	C0006632
27766178	Lead	C0023175
27766178	Determination	C1148554
27766178	Brazilian Rice	C0035567
27766178	Samples	C0370003
27766178	ICP-MS	C1553183
27766178	study	C2603343
27766178	investigating	C1292732
27766178	method	C0025663
27766178	rice	C0035567
27766178	sample	C0370003
27766178	preparation	C1521827
27766178	validating	C1519941
27766178	applying	C0205245
27766178	method	C0025663
27766178	monitoring	C0205245
27766178	concentration	C1446561
27766178	total	C0439810
27766178	arsenic	C0003818
27766178	cadmium	C0006632
27766178	lead	C0023175
27766178	rice	C0035567
27766178	Inductively Coupled Plasma Mass Spectrometry	C1553183
27766178	ICP-MS	C1553183
27766178	rice	C0035567
27766178	sample	C0370003
27766178	preparation	C1521827
27766178	procedures	C2700391
27766178	analytical method	C0178476
27766178	validated	C1519941
27766178	measuring	C0242485
27766178	parameters	C0449381
27766178	limit of detection	C2718050
27766178	LOD	C2718050
27766178	limit of quantification	C1709793
27766178	LOQ	C1709793
27766178	linearity	C0392762
27766178	relative bias	C0242568
27766178	repeatability	C0205556
27766178	sample	C0370003
27766178	preparation	C1521827
27766178	recoveries	C0683340
27766178	spiked samples	C0370003
27766178	acceptable range	C1514721
27766178	muffle furnace	C1708110
27766178	heating block	C0181153
27766178	hot plate	C0182315
27766178	microwave	C0336756
27766178	Validation	C1519941
27766178	parameters	C0449381
27766178	method	C0025663
27766178	total	C0439810
27766178	arsenic	C0003818
27766178	cadmium	C0006632
27766178	lead	C0023175
27766178	method	C0025663
27766178	analyzing	C0936012
27766178	rice	C0035567
27766178	samples	C0370003
27766178	polished	C0035567
27766178	brown	C0452710
27766178	parboiled	C0035567
27766178	Brazilian population	C0032659
27766178	total	C0439810
27766178	arsenic	C0003818
27766178	cadmium	C0006632
27766178	lead	C0023175
27766178	contents	C0456205
27766178	legislative	C2937257
27766178	values	C0042295
27766178	total	C0439810
27766178	arsenic	C0003818
27766178	brown rice	C0452710
27766178	sample	C0370003
27766178	study	C2603343
27766178	monitoring	C0205245
27766178	programs	C3484370
27766178	study	C2603343
27766178	type	C0332307
27766178	cereal	C0007757
27766178	Public Health	C3244304
27768063	Safety Precautions	C0150755
27768063	Operating Procedures	C3889288
27768063	BSL-4	C1443939
27768063	Laboratory	C0022877
27768063	Biosafety Level 4	C1443939
27768063	Suit Laboratory	C0022877
27768063	Suite Entry and Exit Procedures	C0442711
27768063	Biosafety level 4	C1443939
27768063	BSL-4	C1443939
27768063	suit laboratories	C0022877
27768063	designed	C1707689
27768063	study	C2603343
27768063	high-consequence pathogens	C0450254
27768063	infection	C3714514
27768063	prophylaxes	C0199176
27768063	treatment	C0087111
27768063	laboratories	C0022877
27768063	custom-designed	C1707689
27768063	airtight doors	C0557698
27768063	supply	C1561604
27768063	exhaust airflow systems	C3273359
27768063	negative-pressure environment	C1961760
27768063	positive-pressure ("space") suits	C0376610
27768063	laboratory	C0022877
27768063	specialists	C0035173
27768063	pathogenic agents	C0450254
27768063	training	C0220931
27768063	safety protocols	C0677563
27768063	standard operating procedures	C3889288
27768063	Researchers	C0035173
27768063	majority	C0205164
27768063	work	C0043227
27768063	BSL-2	C1443937
27768063	laboratories	C0022877
27768063	BSL-4	C1443939
27768063	suit laboratories	C0022877
27768063	high-consequence pathogen	C0450254
27768063	Collaborators	C2827395
27768063	scientists	C0402112
27768063	BSL-4	C1443939
27768063	projects	C0700032
27768063	challenges	C0033213
27768063	associated with	C0332281
27768063	BSL-4	C1443939
27768063	research	C0035168
27768063	experimental	C1517586
27768063	technical	C0449851
27768063	limitations	C0449295
27768063	BSL-4	C1443939
27768063	laboratory	C0022877
27768063	space	C1883067
27768063	increased	C0205217
27768063	duration	C0449238
27768063	experiments	C0681814
27768063	entering	C0205245
27768063	exiting	C0205245
27768063	BSL-4	C1443939
27768063	suit laboratories	C0022877
27768063	complex	C0439855
27768063	time-consuming	C3827829
27768063	compared	C1707455
27768063	BSL-2	C1443937
27768063	BSL-3	C1443938
27768063	laboratories	C0022877
27768063	article	C1706852
27768063	address	C0376649
27768063	biosafety	C0036043
27768063	concerns	C2699424
27768063	entrance and exit procedures	C0442711
27768063	BSL-4	C1443939
27768063	laboratory	C0022877
27768063	NIH	C0027468
27768063	NIAID	C1513895
27768063	Integrated Research Facility	C0598009
27768063	procedures	C0442711
27768063	BSL-4	C1443939
27768063	laboratory	C0022877
27768063	positive-pressure suits	C0376610
27768063	laboratory	C0022877
27768063	air pressure	C0001876
27768063	resistant	C0332325
27768063	doors	C0557698
27768063	air-supply hoses	C0181222
27768063	moving	C0560560
27768063	exiting	C0205245
27768063	BSL-4	C1443939
27768063	suit laboratories	C0022877
27768063	chemical	C0220806
27768063	shower	C0541748
27768063	removing	C1883720
27768063	storing	C1698986
27768063	positive-pressure suits	C0376610
27768522	Masters Athletes	C0682271
27768522	Successful Aging	C0001811
27768522	Global population	C1257890
27768522	aging	C0001811
27768522	raised academic interest	C0243095
27768522	successful aging	C0001811
27768522	public policy	C0034033
27768522	consensus	C0376298
27768522	successful aging	C0001811
27768522	successful aging	C0001811
27768522	late-life process of change	C0233441
27768522	high physical	C0516981
27768522	psychological	C0233398
27768522	cognitive	C0392335
27768522	social functioning	C0037395
27768522	Masters athletes	C0682271
27768522	systematically train	C2673163
27768522	compete in	C0679932
27768522	organized forms of team	C0871489
27768522	individual sport	C0681652
27768522	older adults	C0001792
27768522	Masters athletes	C0682271
27768522	successful aging	C0001811
27768522	aging status	C0518170
27768522	comprehensive	C1880156
27768522	multidimensional	C2347299
27768522	successful aging	C0001811
27768522	successful aging literature	C0023866
27768522	successful aging	C0001811
27768522	literature	C0023866
27768522	masters athletes	C0682271
27768522	successful aging	C0001811
27768522	experimental research	C0681814
27768814	mutualism	C0599514
27768814	plant parasitic nematode	C0321773
27768814	Bursaphelenchus xylophilus	C0997987
27768814	bacterium	C0004611
27768814	Serratia quinivorans BXF1	C0445754
27768814	plant-growth	C0597252
27768814	pine	C0330186
27768814	endophyte	C1265415
27768814	antagonistic	C0243076
27768814	effects	C1280500
27768814	study	C2603343
27768814	Serratia quinivorans BXF1	C0445754
27768814	bacterium	C0004611
27768814	Bursaphelenchus xylophilus	C0997987
27768814	plant parasitic nematode	C0321773
27768814	pine	C0330186
27768814	wilt disease	C0032080
27768814	strain BXF1	C0445754
27768814	pine	C0330186
27768814	wilt disease	C0032080
27768814	strain BXF1	C0445754
27768814	in vitro	C1533691
27768814	nematode	C1704319
27768814	reproduction	C0035150
27768814	bacteria	C0004611
27768814	nematode	C1704319
27768814	chitinase gene (Bxcht-1)	C0017337
27768814	expression	C0017262
27768814	bacterial	C0004611
27768814	chitinase	C0008145
27768814	nematode	C1704319
27768814	reproduction	C0035150
27768814	strain BXF1	C0445754
27768814	colonize	C4289767
27768814	nematode	C1704319
27768814	cuticle	C0596796
27768814	nematode	C1704319
27768814	xenobiotic	C0043335
27768814	stress	C0449430
27768814	strain BXF1	C0445754
27768814	tomato	C0032098
27768814	pine	C0330186
27768814	plant-growth	C0597252
27768814	colonize	C4289767
27768814	plant-growth	C0597252
27768814	endophyte	C1265415
27768814	strain BXF1	C0445754
27768814	wilting symptoms	C1457887
27768814	pine	C0330186
27768814	shoot	C2700376
27768814	artificial incisions	C3496294
27768814	bacterium	C0004611
27768814	antagonistic	C0243076
27768814	activities	C0441655
27768814	fungi	C0016832
27768814	bacteria	C0004611
27768814	Pinus pinaster	C1028819
27768814	B. xylophilus	C0997987
27768814	symbiotic community	C0562641
27768814	pine	C0330186
27768814	wilt disease	C0032080
27768814	symptoms	C1457887
27768814	bacteria	C0004611
27768814	BXF1	C0445754
27768814	plant-growth	C0597252
27768814	antagonistic	C0243076
27768814	effects	C1280500
27768814	B. xylophilus	C0997987
27768814	bacterial	C0004611
27768814	endophytic community	C1265415
27768814	host	C1167395
27768814	pine	C0330186
27771865	Habitual physical activity	C0815170
27771865	associated with	C0332281
27771865	anthropometric	C0815129
27771865	androgenic	C0002844
27771865	profile	C1979963
27771865	PCOS	C0032460
27771865	cross-sectional study	C0010362
27771865	effect	C1280500
27771865	habitual physical activity	C0815170
27771865	PA	C0026606
27771865	metabolic	C3853758
27771865	hormonal profiles	C3495938
27771865	women	C0043210
27771865	polycystic ovary syndrome	C0032460
27771865	Anthropometric	C0815129
27771865	metabolic	C0696138
27771865	hormonal assessment	C0430022
27771865	habitual PA	C0815170
27771865	digital pedometer	C2709220
27771865	women	C0043210
27771865	PCOS	C0032460
27771865	body mass index	C1305855
27771865	BMI	C1305855
27771865	controls	C0009932
27771865	PA	C0026606
27771865	number of steps	C1651669
27771865	sedentary	C0205254
27771865	BMI	C1305855
27771865	women	C0043210
27771865	PCOS	C0032460
27771865	women	C0043210
27771865	waist circumference	C0455829
27771865	WC	C0455829
27771865	lipid accumulation product	C3658347
27771865	LAP	C3658347
27771865	sedentary	C0205254
27771865	PCOS	C0032460
27771865	women	C0043210
27771865	control group	C0009932
27771865	women	C0043210
27771865	WC	C0455829
27771865	insulin	C0021641
27771865	LAP	C3658347
27771865	sedentary controls	C0009932
27771865	PCOS	C0032460
27771865	androgen	C0002844
27771865	sedentary women	C0043210
27771865	control group	C0009932
27771865	free androgen index	C1261412
27771865	FAI	C1261412
27771865	sedentary women	C0043210
27771865	Homeostasis model assessment	C1829779
27771865	insulin resistance	C0021655
27771865	predictors	C2698872
27771865	FAI	C1261412
27771865	associated with	C0332281
27771865	FAI	C1261412
27771865	Habitual PA	C0815170
27771865	associated with	C0332281
27771865	anthropometric	C0815129
27771865	androgenic	C0002844
27771865	profile	C1979963
27771865	PCOS	C0032460
27772674	Geolocalization	C0017446
27772674	Influenza	C0021400
27772674	Outbreak	C0012652
27772674	Acute Care	C0679878
27772674	Population	C1257890
27772674	Layered-Surveillance	C0220920
27772674	Approach	C0449445
27772674	layered-surveillance	C0220920
27772674	approach	C0449445
27772674	localize	C0392752
27772674	influenza	C0021400
27772674	clusters	C0012641
27772674	acute care	C0679878
27772674	population	C1257890
27772674	system	C0449913
27772674	syndromic	C0039082
27772674	surveillance screen	C1444548
27772674	rapid polymerase chain reaction testing	C1658604
27772674	second	C0205436
27772674	geolocalization	C0017446
27772674	cluster analysis	C0009085
27772674	patients	C0030705
27772674	identified	C0205396
27772674	clusters	C0012641
27772674	at-risk populations	C0242444
27772674	high-yield	C0392762
27772674	targets	C1521840
27772674	preventive medical interventions	C3836383
27772674	prospective observational surveillance study	C0033522
27772674	Patients	C0030705
27772674	screened	C0220908
27772674	clinical decision guideline	C0282451
27772674	sensitivity	C0036667
27772674	specificity	C0037791
27772674	influenza	C0021400
27772674	Patients	C0030705
27772674	points	C1552961
27772674	signs and symptoms	C0037088
27772674	past	C1444637
27772674	days	C0439228
27772674	cough	C0010200
27772674	headache	C0018681
27772674	subjective fever	C0743979
27772674	documented fever	C0015967
27772674	triage	C0040861
27772674	temperature	C0039476
27772674	Patients	C0030705
27772674	scoring	C0449820
27772674	indicated	C1444656
27772674	influenza	C0021400
27772674	testing	C0039593
27772674	Patients	C0030705
27772674	tested	C0039593
27772674	Xpert Flu	C1510438
27772674	Cepheid	C0683757
27772674	Sunnyvale	C0017446
27772674	CA	C0006754
27772674	rapid polymerase chain reaction test	C1658604
27772674	Positive	C1446409
27772674	results	C1274040
27772674	mapped	C3858752
27772674	ArcGIS	C0815319
27772674	ESRI	C0683757
27772674	Redlands	C0017446
27772674	CA	C0006754
27772674	analyzed	C0936012
27772674	kernel density estimation	C4279908
27772674	heat maps	C0024779
27772674	patients	C0030705
27772674	tested	C0039593
27772674	Xpert Flu	C1510438
27772674	retrievable	C0205556
27772674	addresses	C1442065
27772674	Phoenix metro area	C0815251
27772674	tested	C0039593
27772674	positive for influenza A	C2748182
27772674	tested	C0039593
27772674	positive for influenza B	C2748175
27772674	influenza A virus	C0029347
27772674	clear cluster	C1704332
27772674	pattern	C0449774
27772674	patient	C0030705
27772674	population	C1257890
27772674	densest cluster	C1704332
27772674	located	C0450429
27772674	square-mile	C1552923
27772674	region	C0017446
27772674	southeast	C1711190
27772674	hospital	C0019994
27772674	layered-surveillance	C0220920
27772674	approach	C0449445
27772674	effective	C1704419
27772674	localizing	C0392752
27772674	cluster	C1704332
27772674	influenza A	C2062441
27772674	outbreak	C0012652
27772674	region	C0017446
27772674	house	C2003847
27772674	high-yield	C0392762
27772674	target	C1521840
27772674	population	C1257890
27772674	public health intervention	C0699943
27772674	collaborative	C0282116
27772674	hospital	C0019994
27772674	Maricopa County	C3829199
27772674	Department of Public Health	C3897811
27772674	perform	C0884358
27772674	community	C0009462
27772674	vaccination	C0042196
27772674	events	C0441471
27772674	influenza	C0021400
27772674	season	C0036497
27772674	reduce	C0392756
27772674	burden	C2828008
27772674	disease	C0012634
27772674	patient	C0030705
27772674	population	C1257890
27772674	system	C0449913
27772674	future	C0016884
27772674	investigations	C0220825
27772674	at-risk populations	C0242444
27773678	Heart rate	C0018810
27773678	variability	C2827666
27773678	Pre-deployment	C1254367
27773678	predictor	C2698872
27773678	post-deployment	C1254367
27773678	PTSD	C0038436
27773678	symptoms	C1457887
27773678	Heart rate	C0018810
27773678	variability	C2827666
27773678	autonomic nervous system	C0004388
27773678	activity	C0441655
27773678	study	C2603343
27773678	pre-deployment	C1254367
27773678	HRV	C2350828
27773678	post-deployment	C1254367
27773678	post-traumatic stress disorder	C0038436
27773678	PTSD	C0038436
27773678	symptoms	C1457887
27773678	Army National Guard soldiers	C0524647
27773678	Warriors Achieving Resilience (WAR) study	C2603343
27773678	outcome	C1274040
27773678	PTSD	C0038436
27773678	symptom	C1457887
27773678	severity	C0392364
27773678	PTSD	C0038436
27773678	Checklist	C0451524
27773678	Military	C3245458
27773678	version	C0333052
27773678	PCL	C0451524
27773678	baseline	C1442488
27773678	month	C0439231
27773678	post-deployment	C1254367
27773678	Heart rate	C0018810
27773678	variability	C2827666
27773678	predictor	C2698872
27773678	variables	C0439828
27773678	high frequency power	C3854080
27773678	HF	C3854080
27773678	standard deviation	C0871420
27773678	cardiac inter-beat	C0425583
27773678	interval	C1272706
27773678	SDNN	C1272706
27773678	linear mixed models	C3161035
27773678	pre-deployment	C1254367
27773678	PCL	C0451524
27773678	ln(HF) interaction	C0237688
27773678	Pre-deployment	C1254367
27773678	SDNN	C1272706
27773678	predictor	C2698872
27773678	post-deployment	C1254367
27773678	PCL	C0451524
27773678	Covariates	C0439828
27773678	age	C0001779
27773678	pre-deployment	C1254367
27773678	PCL	C0451524
27773678	race	C0034510
27773678	ethnicity	C0015031
27773678	marital status	C0024819
27773678	tobacco use	C0543414
27773678	childhood abuse	C0008060
27773678	pre-deployment	C1254367
27773678	traumatic brain injury	C0876926
27773678	combat zone	C1710706
27773678	deployment	C2825812
27773678	Pre-deployment	C1254367
27773678	heart rate	C0018810
27773678	variability	C2827666
27773678	post-deployment	C1254367
27773678	PTSD	C0038436
27773678	symptoms	C1457887
27773678	pre-deployment	C1254367
27773678	PCL	C0451524
27773678	scores	C0449820
27775720	neuronal	C0027882
27775720	PI(3,4,5)P3	C0765553
27775720	program	C3484370
27775720	oligodendrocyte	C0028944
27775720	precursor	C1709634
27775720	recruitment	C2949735
27775720	myelination	C0596991
27775720	molecular trigger	C1148560
27775720	CNS	C3714787
27775720	myelination	C0596991
27775720	unknown	C0439673
27775720	targeting	C1521840
27775720	Pten	C1530899
27775720	cerebellar granule cells	C0007634
27775720	activating	C1879547
27775720	AKT1	C0285558
27775720	mTOR	C0293060
27775720	pathway	C0086982
27775720	increased	C0205217
27775720	normally	C0205307
27775720	unmyelinated axons	C1179986
27775720	expression	C1171362
27775720	numerous	C0439064
27775720	genes	C0017337
27775720	encoding	C2700640
27775720	regulatory proteins	C0815047
27775720	expansion	C0007595
27775720	genetically wild-type	C1883559
27775720	oligodendrocyte	C0028944
27775720	progenitor cells	C0038250
27775720	oligodendrocyte	C0028944
27775720	differentiation	C0007589
27775720	de novo	C1515568
27775720	myelination	C0596991
27775720	parallel fibers	C3546707
27775720	neuronal	C0027882
27775720	program	C3484370
27775720	phosphoinositide	C0031621
27775720	PI(3,4,5)P3	C0765553
27775720	trigger	C1148560
27775720	steps	C1261552
27775720	myelination	C0596991
27777102	microglial	C0206116
27777102	response	C0871261
27777102	biodiesel exhaust	C0012151
27777102	healthy	C3898900
27777102	hypertensive	C0020538
27777102	rats	C0034721
27777102	evidence	C3887511
27777102	suggests	C1705535
27777102	deleterious	C0001688
27777102	role	C1705810
27777102	urban	C0442529
27777102	air pollution	C0001873
27777102	central nervous system (CNS) diseases	C0007682
27777102	neurodevelopmental disorders	C1535926
27777102	Microglia	C0206116
27777102	innate	C0020969
27777102	immune cells	C0312740
27777102	sentinels	C0950580
27777102	brain	C0006104
27777102	common	C0205214
27777102	source	C0449426
27777102	neuroinflammation	C0683396
27777102	air pollution	C0001873
27777102	induced	C0205263
27777102	CNS effects	C0007682
27777102	renewable energy	C3178762
27777102	soy-based biofuel	C2717891
27777102	increasing	C0442808
27777102	public	C0027361
27777102	interest	C0543488
27777102	little	C0700321
27777102	information	C1533716
27777102	soy biofuel	C2717891
27777102	affect	C1280500
27777102	brain	C0006104
27777102	people	C0027361
27777102	preexisting disease conditions	C0521987
27777102	male	C0086582
27777102	spontaneously hypertensive rats	C0034705
27777102	SHR	C0034705
27777102	normotensive	C2712122
27777102	Wistar Kyoto (WKY) rats	C0034709
27777102	exposed to	C0332157
27777102	100% Soy-based Biodiesel Exhaust	C0012151
27777102	100SBDE	C0012151
27777102	inhalation	C0004048
27777102	day	C0439228
27777102	weeks	C0439230
27777102	days	C0439228
27777102	week	C0439230
27777102	Ionized calcium-binding adapter molecule-1	C1455000
27777102	IBA-1	C1455000
27777102	staining	C0487602
27777102	microglia	C0206116
27777102	substantia nigra	C0038590
27777102	revealed	C0443289
27777102	significant	C0750502
27777102	changes	C0392747
27777102	morphology	C0332437
27777102	100SBDE	C0012151
27777102	exposure	C0332157
27777102	rats	C0034721
27777102	both	C1706086
27777102	genotypes	C0017431
27777102	SHR	C0034705
27777102	less	C0439092
27777102	sensitive	C0332324
27777102	Aconitase activity	C4234382
27777102	inhibited	C0311403
27777102	frontal cortex	C0016733
27777102	cerebellum	C0007765
27777102	WKY rats	C0034709
27777102	exposed to	C0332157
27777102	100SBDE	C0012151
27777102	No	C1518422
27777102	consistent	C0332529
27777102	changes	C0392747
27777102	occurred	C2745955
27777102	pro-inflammatory	C0333348
27777102	cytokine	C0079189
27777102	expression	C1171362
27777102	nitrated protein	C0033684
27777102	arginase1	C0003763
27777102	expression	C1171362
27777102	brain regions	C1273723
27777102	rat strain	C0034721
27777102	exposed to	C0332157
27777102	100SBDE	C0012151
27777102	IBA-1	C1455000
27777102	mRNA expression	C1515670
27777102	not	C1518422
27777102	modified	C0392747
27777102	CX3CR1	C1870161
27777102	mRNA expression	C1515670
27777102	lower	C0205251
27777102	striatum	C0010097
27777102	100SBDE	C0012151
27777102	exposed rats	C0034721
27777102	regardless	C3641650
27777102	genotype	C0017431
27777102	suggesting	C1705535
27777102	downregulation	C0013081
27777102	fractalkine receptor	C0663627
27777102	microglia	C0206116
27777102	brain region	C1273723
27777102	data	C1511726
27777102	indicate	C0392360
27777102	microglia	C0206116
27777102	detecting	C0442726
27777102	responding	C0871261
27777102	100SBDE	C0012151
27777102	exposure	C0332157
27777102	changes	C0392747
27777102	morphology	C0332437
27777102	reduced	C0392756
27777102	expression	C1171362
27777102	CX3CR1	C1870161
27777102	regardless	C3641650
27777102	genetic background	C4042916
27777102	activation	C0678666
27777102	response	C0871261
27777102	atypical	C0205182
27777102	traditional	C0443324
27777102	inflammatory markers	C0005516
27777102	M1	C0024432
27777102	M2	C4086555
27777102	activation	C0678666
27777102	brain	C0006104
27777558	Pre-Activation Negativity	C0243095
27777558	PrAN	C0243095
27777558	Brain	C0006104
27777558	Potentials	C3245505
27777558	Unfolding Words	C0025361
27777558	event-related potential	C0282171
27777558	ERP	C0282171
27777558	effect	C1280500
27777558	pre-activation negativity	C0243095
27777558	PrAN	C0243095
27777558	index	C0918012
27777558	degree of pre-activation	C0392762
27777558	word	C1705313
27777558	internal	C0205102
27777558	morphemes	C0870914
27777558	speech	C0037817
27777558	processing	C1709694
27777558	lexical competition	C1882365
27777558	measures	C0079809
27777558	word-initial speech fragments	C0037829
27777558	WIFs	C0037829
27777558	statistical analyses	C0871424
27777558	ERP	C0282171
27777558	data	C1511726
27777558	experiments	C0681814
27777558	PrAN	C0243095
27777558	lexical competition	C1882365
27777558	degree	C0449286
27777558	predictive	C0681890
27777558	certainty	C0205423
27777558	negativity	C0205160
27777558	larger	C0549177
27777558	fewer	C0205388
27777558	lexical	C1705313
27777558	competitors	C1257890
27777603	Angiotensin-converting enzyme insertion/deletion polymorphism	C4015787
27777603	association with	C0332281
27777603	obesity	C0028754
27777603	disorders	C0012634
27777603	Egyptian	C0337801
27777603	females	C0086287
27777603	case-control observational study	C1518527
27777603	WHO	C0043237
27777603	report	C0684224
27777603	obesity	C0028754
27777603	cause of death	C0007465
27777603	worldwide	C1254367
27777603	prevalence	C0220900
27777603	Egyptian	C0337801
27777603	female	C0043210
27777603	obesity	C0028754
27777603	obesity	C0028754
27777603	influenced	C4054723
27777603	genetics	C0314603
27777603	adipose tissue	C0001527
27777603	renin-angiotensin system	C0035096
27777603	over-activated	C0205245
27777603	obesity	C0028754
27777603	effect of	C1704420
27777603	angiotensin-converting enzyme (ACE) insertion/deletion (I/D) polymorphism	C4015787
27777603	obesity	C0028754
27777603	disorders	C0012634
27777603	populations	C1257890
27777603	effect	C1280500
27777603	ACE activity	C2258685
27777603	objective	C0018017
27777603	study	C2603343
27777603	association	C0439849
27777603	ACE I/D polymorphism	C4015787
27777603	obesity	C0028754
27777603	disorders	C0012634
27777603	hypertension	C0020538
27777603	insulin resistance	C0021655
27777603	metabolic syndrome	C0524620
27777603	Egyptian	C0337801
27777603	females	C0086287
27777603	Eighty	C3816958
27777603	female	C0043210
27777603	volunteers	C0020155
27777603	blood pressure	C3826646
27777603	body measurements	C0203910
27777603	recorded	C0205245
27777603	fasting	C0015663
27777603	blood sample	C0178913
27777603	quantitation	C1709793
27777603	glucose	C0017725
27777603	lipid profile	C0430044
27777603	insulin,	C0021641
27777603	leptin	C0299583
27777603	identification	C0205396
27777603	ACE I/D polymorphs	C4015787
27777603	Subjects	C0080105
27777603	hypertension	C0020538
27777603	obesity states	C4060989
27777603	Comparisons	C1707455
27777603	continuous	C0549178
27777603	parameters	C0449381
27777603	independent	C0085862
27777603	sample t-test	C1709321
27777603	groups	C0441833
27777603	frequencies	C0017270
27777603	ACE	C1452534
27777603	genotypes	C0017431
27777603	alleles	C0002085
27777603	association	C0439849
27777603	gene polymorphism	C0678951
27777603	metabolic	C0311400
27777603	parameters	C0449381
27777603	assessed	C1516048
27777603	chi-square	C0008041
27777603	Fisher's exact test	C1708064
27777603	Genotype	C0017431
27777603	frequencies	C0017270
27777603	Hardy-Weinberg equilibrium	C1547026
27777603	groups	C0441833
27777603	Genotype	C0017431
27777603	distribution	C1704711
27777603	controls	C0009932
27777603	cases	C1706256
27777603	disorders	C0012634
27777603	DD carriers	C0007294
27777603	higher	C0205250
27777603	parameters	C0449381
27777603	blood pressure	C0005823
27777603	lipid profile	C0430044
27777603	insulin resistance	C0021655
27777603	diastolic blood pressure	C0428883
27777603	significant	C0750502
27777603	I-carriers	C0007294
27777603	susceptible	C0231204
27777603	hypertension	C0020538
27777603	DD carriers	C0007294
27777603	normal	C0205307
27777603	waist/hip ratio	C0205682
27777603	OR	C0028873
27777603	CI	C0009667
27777603	normal	C0205307
27777603	conicity index	C1254595
27777603	OR	C0028873
27777603	CI	C0009667
27777603	DD genotype carriers	C0007294
27777603	significant	C0750502
27777603	association	C0439849
27777603	insulin resistance	C0021655
27777603	high body mass index	C0231254
27777603	OR	C0028873
27777603	CI	C0009667
27777603	waist circumference	C0455829
27777603	OR	C0028873
27777603	CI	C0009667
27777603	waist/height ratio	C1821269
27777603	OR	C0028873
27777603	CI	C0009667
27777603	variations	C0042333
27777603	percentages	C0439165
27777603	DD	C0007294
27777603	I-carriers	C0007294
27777603	effect of	C1704420
27777603	ACE I/D	C4015787
27777603	association	C0439849
27777603	sample	C0370003
27777603	Egyptian	C0337801
27777603	females	C0086287
27777603	ACE I/D polymorphism	C4015787
27777603	not significantly	C1273937
27777603	associated with	C0332281
27777603	obesity	C0028754
27777603	disorders	C0012634
27777603	I allele	C0002085
27777603	hypertension	C0020538
27777603	subjects	C0080105
27777603	normal	C0205307
27777603	waist/hip ratio	C0205682
27777603	conicity index	C1254595
27777603	DD genotype carriers	C0007294
27781291	Expressed	C0017262
27781291	microRNA	C1101610
27781291	associated with	C0332281
27781291	high	C0205250
27781291	rate	C1521828
27781291	egg production	C0029965
27781291	chicken	C0008051
27781291	ovarian follicles	C0018120
27781291	MicroRNA	C1101610
27781291	miRNA	C1101610
27781291	noncoding RNA	C0887909
27781291	nucleotides	C0028630
27781291	length	C1444754
27781291	function	C0542341
27781291	post-transcriptionally regulate	C1514248
27781291	gene expression	C0017262
27781291	organisms	C0029235
27781291	Tissue	C0040300
27781291	miRNA	C1101610
27781291	expression	C0017262
27781291	studies	C2603343
27781291	functions	C0542341
27781291	miRNAs	C1101610
27781291	miRNAs	C1101610
27781291	chicken	C0008051
27781291	ovarian tissue	C1518744
27781291	days	C0439228
27781291	age	C0001779
27781291	miRNA	C1101610
27781291	analysis	C0936012
27781291	ovarian tissues	C1518744
27781291	chickens	C0008051
27781291	low	C0205251
27781291	high	C0205250
27781291	rates	C1521828
27781291	egg production	C0029965
27781291	high-throughput sequencing	C2936623
27781291	low	C0205251
27781291	rate	C1521828
27781291	egg production	C0029965
27781291	chickens	C0008051
27781291	high	C0205250
27781291	rate	C1521828
27781291	egg production	C0029965
27781291	chickens	C0008051
27781291	expressed	C0017262
27781291	miRNAs	C1101610
27781291	miRNAs	C1101610
27781291	miRNAs	C1101610
27781291	pathways	C0037080
27781291	reproduction	C0035150
27781291	regulation	C0017263
27781291	steroid hormone biosynthesis	C0597517
27781291	dopaminergic synapse	C0039062
27781291	expression	C0017262
27781291	regulated	C0017263
27781291	miRNAs	C1101610
27781291	quantitative real-time polymerase chain reaction	C3179034
27781291	RT-qPCR	C3179034
27781291	miRNAs	C1101610
27781291	gga-miR-34b	C1537746
27781291	gga-miR-34c	C1537747
27781291	gga-miR-216b	C2239687
27781291	regulate	C0017263
27781291	proliferation	C0596290
27781291	cell cycle	C0007586
27781291	apoptosis	C0162638
27781291	metastasis	C4255448
27781291	expressed	C0017262
27781291	ovaries	C0029939
27781291	chickens	C0008051
27781291	high	C0205250
27781291	rates	C1521828
27781291	egg production	C0029965
27781291	miRNAs	C1101610
27781291	ovary	C0029939
27781291	development	C0242290
27781291	reproductive management	C0035150
27781291	chicken	C0008051
27781291	up-regulated	C0041904
27781291	miRNA	C1101610
27781291	gga-miR-200a-3p	C1537838
27781291	reproduction	C0035150
27781291	regulation	C0017263
27781291	pathways	C0037080
27781291	miRNA	C1101610
27781291	reproductive management	C0035150
27781291	chicken	C0008051
27784277	Air pollution	C0001873
27784277	neighbourhood	C1254362
27784277	maternal	C1858460
27784277	level	C0441889
27784277	factors	C1521761
27784277	modify	C3242344
27784277	effect	C1280500
27784277	smoking	C0037369
27784277	birth weight	C0005612
27784277	multilevel analysis	C0814909
27784277	British Columbia	C0006193
27784277	Canada	C0006823
27784277	Maternal	C1858460
27784277	smoking	C0037369
27784277	pregnancy	C0032961
27784277	negatively	C0205160
27784277	impacts	C4049986
27784277	fetal growth	C0743925
27784277	effect	C1280500
27784277	homogenous	C0439713
27784277	population	C0032659
27784277	relationship	C0439849
27784277	cigarette use	C0694535
27784277	fetal growth	C0743925
27784277	modified	C3840684
27784277	social	C0037414
27784277	physical environment	C0557720
27784277	Birth records	C0005609
27784277	BC Perinatal Database Registry	C0242356
27784277	Maternal	C1858460
27784277	smoking status	C1519386
27784277	self-reported	C0681906
27784277	number	C0449788
27784277	cigarettes	C0677453
27784277	smoked	C0037369
27784277	per day	C0439505
27784277	first prenatal care visit	C1504204
27784277	Census	C0007663
27784277	dissemination	C0205221
27784277	areas	C0017446
27784277	DAs	C0017446
27784277	neighbourhood	C1254362
27784277	level	C0441889
27784277	units	C0439148
27784277	individual	C0237401
27784277	births	C0005615
27784277	residential postal codes	C1552677
27784277	assign	C1516050
27784277	exposure to	C0332157
27784277	particulate	C1510837
27784277	air pollution	C0001873
27784277	neighbourhood	C1254362
27784277	level	C0441889
27784277	attributes	C0449234
27784277	socioeconomic status	C0086996
27784277	SES	C0086996
27784277	proportion	C1709707
27784277	post-secondary education	C0683860
27784277	immigrant	C0282163
27784277	density	C0178587
27784277	living	C0023913
27784277	rural place	C0178837
27784277	Random	C0439605
27784277	coefficient	C1707429
27784277	models	C3161035
27784277	cigarettes	C0677453
27784277	/day	C0439505
27784277	modeled	C3161035
27784277	random	C0439605
27784277	slope	C0807955
27784277	estimate	C0750572
27784277	DA	C0017446
27784277	variability	C2827666
27784277	test	C0039593
27784277	cross-level	C0441889
27784277	interactions	C1704675
27784277	neighbourhood	C1254362
27784277	level	C0441889
27784277	variables	C0439828
27784277	continuous	C0549178
27784277	birth weight	C0005612
27784277	significant	C0750502
27784277	negative	C0205160
27784277	association	C0439849
27784277	maternal	C1858460
27784277	smoking	C0037369
27784277	birth weight	C0005612
27784277	significant	C0750502
27784277	DA	C0017446
27784277	intercept	C3146232
27784277	variability	C2827666
27784277	birth weight	C0005612
27784277	DA	C0017446
27784277	slope	C0807955
27784277	variability	C2827666
27784277	maternal	C1858460
27784277	smoking	C0037369
27784277	birth weight	C0005612
27784277	inclusion	C1512693
27784277	DA	C0017446
27784277	level	C0441889
27784277	variables	C0439828
27784277	cross-level	C0441889
27784277	interactions	C1704675
27784277	High	C0205250
27784277	DA	C0017446
27784277	level	C0441889
27784277	SES	C0086996
27784277	strong	C0442821
27784277	positive	C1446409
27784277	association	C0439849
27784277	birth weight	C0005612
27784277	effect	C1280500
27784277	moderated	C1881878
27784277	increased	C0442805
27784277	cigarettes	C0677453
27784277	/day	C0439505
27784277	heavy smokers	C0459847
27784277	largest	C0443228
27784277	increases	C0442805
27784277	birth weight	C0005612
27784277	rising	C0442805
27784277	neighbourhood	C1254362
27784277	education levels	C1553770
27784277	Increased	C0442805
27784277	levels	C0441889
27784277	PM2.5	C1510837
27784277	immigrant	C0282163
27784277	density	C0178587
27784277	negatively	C0205160
27784277	associated with	C0332281
27784277	birth weight	C0005612
27784277	positive	C1446409
27784277	interactions	C1704675
27784277	increased	C0442805
27784277	levels	C0441889
27784277	smoking	C0037369
27784277	maternal age	C0024915
27784277	suspected	C0750491
27784277	drug	C0242510
27784277	alcohol use	C0001948
27784277	negative	C0205160
27784277	interactions	C1704675
27784277	increased	C0442805
27784277	levels	C0441889
27784277	maternal	C1858460
27784277	smoking	C0037369
27784277	Maternal	C1858460
27784277	smoking	C0037369
27784277	negative	C0205160
27784277	dose-response association	C0678790
27784277	birth weight	C0005612
27784277	highly	C0205250
27784277	variable	C0439828
27784277	neighbourhood	C1254362
27784277	evidence	C3887511
27784277	effect	C1280500
27784277	modification	C3840684
27784277	neighbourhood	C1254362
27784277	level	C0441889
27784277	factors	C1521761
27784277	results	C1274040
27784277	suggest	C1705535
27784277	individual	C0237401
27784277	behaviours	C0004927
27784277	limited	C0439801
27784277	success	C0597535
27784277	improving	C1272745
27784277	outcomes	C1274040
27784277	without	C0332288
27784277	contextual	C0237482
27784277	influences	C4054723
27784277	neighbourhood	C1254362
27784277	level	C0441889
27784277	studies	C2603343
27784277	corroborate	C1456348
27784277	findings	C0243095
27784277	understand	C0162340
27784277	neighbourhood	C1254362
27784277	level	C0441889
27784277	attributes	C0449234
27784277	interact	C1704675
27784277	smoking	C0037369
27784277	affect	C0001721
27784277	birth outcomes	C1286282
27786590	Individual	C0237401
27786590	Leg Muscle	C0224456
27786590	Contributions	C1880177
27786590	Walking	C0080331
27786590	Effects	C1280500
27786590	Age	C0001779
27786590	Walking Speed	C2009910
27786590	study	C2603343
27786590	examined	C0332128
27786590	contributions	C1880177
27786590	individual	C0237401
27786590	muscles	C0026845
27786590	cost of transport	C0220812
27786590	COT	C0220812
27786590	walking speeds	C2009910
27786590	healthy young	C0238598
27786590	elderly subjects	C0001792
27786590	participants	C0679646
27786590	young aged	C0238598
27786590	old aged	C1999167
27786590	COT	C0220812
27786590	mean oxygen consumption	C0030055
27786590	steady state walking	C0080331
27786590	Electromyography	C0013839
27786590	signals	C1710082
27786590	leg muscles	C0224456
27786590	cumulative activity required to traverse a unit of distance	C0001288
27786590	CMAPD	C0001288
27786590	muscle	C0026845
27786590	speed	C0678536
27786590	old group	C1999167
27786590	CMAPD	C0001288
27786590	correlated	C1707520
27786590	COT	C0220812
27786590	optimal speed	C0678536
27786590	muscles	C0026845
27786590	Soleus	C0242694
27786590	CMAPD	C0001288
27786590	speed	C0678536
27786590	young group	C0238598
27786590	aging	C0001811
27786590	Greater energy cost	C0220812
27786590	walking	C0080331
27786590	older	C0001792
27786590	individuals	C0237401
27786590	energy cost	C0220812
27786590	lower limb muscles	C2362789
27790487	Glycated Hemoglobin	C0017853
27790487	HbA1c	C0017853
27790487	Correlation	C1707520
27790487	Severity	C0439793
27790487	Coronary Artery Disease	C0010054
27790487	Non-diabetic	C0241863
27790487	Patients	C0030705
27790487	Hospital based	C0019994
27790487	Study	C2603343
27790487	North-Eastern India	C0017446
27790487	Glycated Hemoglobin (HbA1c) levels	C1261236
27790487	predictive	C0681890
27790487	cardiovascular disease	C0007222
27790487	mortality	C0178686
27790487	patients	C0030705
27790487	diabetes mellitus	C0011849
27790487	HbA1c	C0017853
27790487	Coronary Artery Disease	C0010054
27790487	CAD	C0010054
27790487	non-diabetics	C0241863
27790487	inconsistent	C0442809
27790487	evaluate	C0220825
27790487	correlation	C1707520
27790487	HbA1c level	C1261236
27790487	severity	C0439793
27790487	CAD	C0010054
27790487	non-diabetic patients	C0030705
27790487	SYNTAX score	C0449820
27790487	cohort	C0599755
27790487	CAD	C0010054
27790487	angiography	C0002971
27790487	Gauhati Medical College	C1708333
27790487	Guwahati, Assam	C0017446
27790487	India	C0021201
27790487	tertiary care hospital	C0337954
27790487	North-Eastern India	C0017446
27790487	data	C1511726
27790487	non-diabetic patients	C0030705
27790487	CAD	C0010054
27790487	angiography	C0002971
27790487	Patients	C0030705
27790487	groups	C0441833
27790487	interquartiles	C2828255
27790487	HbA1c levels	C1261236
27790487	Severity	C0439793
27790487	CAD	C0010054
27790487	assessed	C1516048
27790487	SYNTAX score	C0449820
27790487	number of coronary vessels diseased	C3275120
27790487	quartiles	C2828255
27790487	HbA1c	C0017853
27790487	SYNTAX score	C0449820
27790487	diseased vessels	C3275120
27790487	patients	C0030705
27790487	study	C2603343
27790487	age	C0001779
27790487	males	C0086582
27790487	hypertensives	C0857121
27790487	smokers	C0337664
27790487	dyslipidemic	C0243095
27790487	CAD	C0010054
27790487	severity	C0439793
27790487	SYNTAX score	C0449820
27790487	vessels	C0005847
27790487	quartiles	C2828255
27790487	p-values	C1709380
27790487	Increase	C0442805
27790487	HbA1c level	C1261236
27790487	correlated	C1707520
27790487	disease severity	C0521117
27790487	SYNTAX score	C0449820
27790487	increase	C0442805
27790487	diseased vessels	C3275120
27790487	p-value	C1709380
27790487	HbA1c level	C1261236
27790487	increases	C0442805
27790487	Age	C0001779
27790487	gender	C0079399
27790487	hypertension	C0020538
27790487	dyslipidemia	C0242339
27790487	quartiles	C2828255
27790487	smoking	C0037369
27790487	predictor	C2698872
27790487	severity	C0439793
27790487	CAD	C0010054
27790487	SYNTAX score	C0449820
27790487	clinical study	C0008972
27790487	correlation	C1707520
27790487	HbA1c	C0017853
27790487	severity	C0439793
27790487	CAD	C0010054
27790487	SYNTAX score	C0449820
27790487	vessels	C0005847
27790487	non- diabetes	C0243095
27792780	Relation	C0439849
27792780	Face	C0870537
27792780	Object Recognition	C0599621
27792780	Developmental Prosopagnosia	C0751842
27792780	Dissociation	C0086168
27792780	Systematic	C0220922
27792780	Association	C0439849
27792780	debate	C0870392
27792780	face recognition	C0870537
27792780	object recognition	C0599621
27792780	separate	C0443299
27792780	domains	C1880389
27792780	Clarification	C2986669
27792780	issue	C0033213
27792780	important	C3898777
27792780	theoretical	C0871935
27792780	implications	C0205556
27792780	face recognition	C0870537
27792780	example	C1707959
27792780	domain	C1880389
27792780	specificity	C0037791
27792780	mind	C0695534
27792780	brain	C0006104
27792780	important	C3898777
27792780	source	C0449416
27792780	input	C1708517
27792780	debate	C0870392
27792780	individuals	C0027361
27792780	developmental prosopagnosia	C0751842
27792780	suggesting	C1705535
27792780	face recognition	C0870537
27792780	selectively impaired	C0221099
27792780	selectivity	C0205556
27792780	hypothesis	C1512571
27792780	test	C0039593
27792780	performance	C1882330
27792780	individuals	C0027361
27792780	developmental prosopagnosia	C0751842
27792780	visual object processing	C0589087
27792780	involving	C1314939
27792780	regular	C0205272
27792780	degraded	C1457868
27792780	drawings	C0013113
27792780	individuals	C0027361
27792780	dissociation	C0086168
27792780	face	C0870537
27792780	object recognition	C0599621
27792780	group	C0681860
27792780	significantly	C0750502
27792780	affected	C0392760
27792780	degradation	C1457868
27792780	objects	C0347997
27792780	control	C0009932
27792780	participants	C0679646
27792780	positive	C1446409
27792780	correlations	C1707520
27792780	severity	C0439793
27792780	face recognition	C0870537
27792780	impairment	C0221099
27792780	degree	C0449286
27792780	impaired	C0221099
27792780	performance	C1882330
27792780	degraded	C1457868
27792780	objects	C0347997
27792780	face	C0870537
27792780	object	C0599621
27792780	deficits	C2987487
27792780	related	C0439849
27792780	coincidental	C0205420
27792780	evidence	C3887511
27792780	literature	C0023866
27792780	developmental prosopagnosia	C0751842
27792780	domain	C1880389
27792780	specific	C0205369
27792780	face recognition	C0870537
27794081	Reduced Chest	C0577943
27794081	Abdominal Wall	C0836916
27794081	Mobility	C0449580
27794081	Relationship	C0439849
27794081	Lung Function	C0035245
27794081	Respiratory	C0521346
27794081	Muscle Strength	C0517349
27794081	Exercise Tolerance	C0162521
27794081	Subjects	C0681850
27794081	COPD	C0024117
27794081	air-flow	C0231999
27794081	limitation	C0449295
27794081	patients	C0030705
27794081	COPD	C0024117
27794081	reduction	C0392756
27794081	vital capacity	C0042834
27794081	respiratory	C0521346
27794081	muscle strength	C0517349
27794081	exercise capacity	C0162521
27794081	chest	C0817096
27794081	abdominal wall	C0836916
27794081	mobility	C0449580
27794081	unknown	C0439673
27794081	prevalence	C0033106
27794081	patients	C0030705
27794081	COPD	C0024117
27794081	reduced chest	C0577943
27794081	abdominal wall	C0836916
27794081	mobility	C0449580
27794081	investigate	C1292732
27794081	effect	C1280500
27794081	reduced chest	C0577943
27794081	abdominal wall	C0836916
27794081	mobility	C0449580
27794081	pulmonary function	C0035245
27794081	respiratory	C0521346
27794081	muscle strength	C0517349
27794081	exercise capacity	C0162521
27794081	elderly	C0001792
27794081	male	C0086582
27794081	subjects	C0681850
27794081	COPD	C0024117
27794081	chest	C0817096
27794081	abdominal wall	C0836916
27794081	mobility	C0449580
27794081	FVC	C3714541
27794081	FEV1	C0849974
27794081	FEV1/FVC	C3815113
27794081	maximal inspiratory pressure	C4083126
27794081	PImax	C4083126
27794081	maximal expiratory pressure	C4082175
27794081	PEmax	C4082175
27794081	6-min walk distance	C0430515
27794081	6MWD	C0430515
27794081	assessed	C1516048
27794081	Chest	C0205076
27794081	abdominal wall	C0836916
27794081	mobility	C0449580
27794081	measured	C0444706
27794081	breathing	C0004048
27794081	movement scale	C0022885
27794081	regions	C0005898
27794081	upper chest	C0446469
27794081	lower chest	C0446470
27794081	abdomen	C0000726
27794081	Reduced mobility	C0700572
27794081	value	C1522609
27794081	lower	C2003888
27794081	lower limit of the normal scale	C1518030
27794081	unpaired t test	C1710574
27794081	Mann-Whitney test	C1708930
27794081	multiple regression analysis	C0681923
27794081	performed	C0884358
27794081	percentages	C0439165
27794081	subjects	C0681850
27794081	reduced mobility	C0700572
27794081	upper chest	C0446469
27794081	lower chest	C0446470
27794081	abdomen	C0000726
27794081	subjects	C0681850
27794081	reduced mobility	C0700572
27794081	significantly low	C4055638
27794081	FVC	C3714541
27794081	FEV1	C0849974
27794081	6MWD	C0430515
27794081	region	C0005898
27794081	significantly low	C4055638
27794081	FEV1/FVC	C3815113
27794081	PImax	C4083126
27794081	PEmax	C4082175
27794081	abdominal region	C1720043
27794081	compared	C1707455
27794081	mobility	C0449580
27794081	FVC	C3714541
27794081	6MWD	C0430515
27794081	associated with	C0332281
27794081	scale values	C0042295
27794081	region	C0005898
27794081	abdominal	C0000726
27794081	scale value	C0042295
27794081	subjects	C0681850
27794081	COPD	C0024117
27794081	reduced chest	C0577943
27794081	abdominal wall	C0836916
27794081	mobility	C0449580
27794081	associated with	C0332281
27794081	FVC	C3714541
27794081	abdominal wall	C0836916
27794081	mobility	C0449580
27794081	compared	C1707455
27794081	chest wall	C0205076
27794081	mobility	C0449580
27794081	associated with	C0332281
27794081	6MWD	C0430515
27794108	FGF21	C3887831
27794108	biomarker	C0005516
27794108	mitochondrial translation	C2245743
27794108	mtDNA	C0012929
27794108	maintenance	C0024501
27794108	disorders	C0012634
27794108	mitochondrial myopathy	C0162670
27794108	serum	C0229671
27794108	biomarkers	C0005516
27794108	diagnostic use	C0011933
27794108	analyzed	C0936012
27794108	serum	C0229671
27794108	FGF21	C3887831
27794108	S-FGF21	C3887831
27794108	GDF15	C1431343
27794108	patients	C0030705
27794108	mitochondrial diseases	C0751651
27794108	nonmitochondrial disorders	C0012634
27794108	partially	C0728938
27794108	overlapping	C1948020
27794108	mitochondrial disorder	C0751651
27794108	phenotypes	C0031437
27794108	meta-analysis	C0920317
27794108	S-FGF21	C3887831
27794108	mitochondrial disease	C0751651
27794108	analyzed	C0936012
27794108	S-Fgf21	C3887831
27794108	skeletal muscle	C0242692
27794108	Fgf21	C3887831
27794108	expression	C0017262
27794108	mouse	C0025929
27794108	models	C0599779
27794108	different	C1705242
27794108	muscle	C0026845
27794108	manifesting	C0205319
27794108	mitochondrial dysfunctions	C4021734
27794108	S-FGF21	C3887831
27794108	increases	C0442805
27794108	primary	C0205225
27794108	mitochondrial myopathy	C0162670
27794108	patients	C0030705
27794108	mitochondrial translation	C2245743
27794108	defects	C0000768
27794108	mitochondrial DNA (mtDNA) deletions	C4313882
27794108	controls	C0009932
27794108	mice	C0025929
27794108	mtDNA deletions	C4313882
27794108	patients	C0030705
27794108	mice	C0025929
27794108	structural respiratory chain subunit or assembly factor defects	C0000768
27794108	low	C0205251
27794108	induction	C0205263
27794108	human	C0086418
27794108	mice	C0025929
27794108	not significant	C1273937
27794108	Overall	C1561607
27794108	specificities	C0037791
27794108	FGF21	C3887831
27794108	GDF15	C1431343
27794108	patients	C0030705
27794108	mitochondrial myopathy	C0162670
27794108	sensitivities	C1511883
27794108	GDF15	C1431343
27794108	increased	C0205217
27794108	nonmitochondrial conditions	C0348080
27794108	S-FGF21	C3887831
27794108	specific	C0205369
27794108	biomarker	C0005516
27794108	muscle	C0026845
27794108	manifesting	C0205319
27794108	defects	C0000768
27794108	mitochondrial translation	C2245743
27794108	mitochondrial	C0026237
27794108	transfer-RNA	C0035711
27794108	mutations	C0026882
27794108	primary	C0205225
27794108	secondary	C0175668
27794108	mtDNA deletions	C4313882
27794108	causes	C0015127
27794108	mitochondrial disease	C0751651
27794108	normal	C0205307
27794108	S-FGF21	C3887831
27794108	not	C1513916
27794108	exclude	C0332196
27794108	structural respiratory chain complex or assembly factor defects	C0000768
27794108	diagnostics	C0430022
27794108	study	C2603343
27794108	Class III	C0441887
27794108	evidence	C3887511
27794108	elevated	C3163633
27794108	S-FGF21	C3887831
27794108	patients	C0030705
27794108	mitochondrial myopathies	C0162670
27794108	patients	C0030705
27794108	conditions	C0348080
27794108	FGF21	C3887831
27794108	GDF15	C1431343
27794108	mitochondrial myopathy	C0162670
27794108	myopathies	C0026848
27794490	effects of	C1704420
27794490	captopril	C0006938
27794490	lipopolysaccharide	C0023810
27794490	induced	C0205263
27794490	learning	C0023186
27794490	memory impairments	C0233794
27794490	brain	C0006104
27794490	cytokine	C0079189
27794490	levels	C0441889
27794490	oxidative	C0311404
27794490	damage	C0010957
27794490	rats	C0034721
27794490	Renin-angiotensin system	C0035096
27794490	inflammation	C0021368
27794490	learning	C0023185
27794490	memory	C0025260
27794490	effects of	C1704420
27794490	captopril	C0006938
27794490	lipopolysaccharide	C0023810
27794490	LPS	C0023810
27794490	induced	C0205263
27794490	learning	C0023186
27794490	memory impairments	C0233794
27794490	hippocampal	C0019564
27794490	cytokine	C0079189
27794490	levels	C0441889
27794490	brain tissues	C0459385
27794490	oxidative	C0311404
27794490	damage	C0010957
27794490	investigated	C1292732
27794490	rats	C0034721
27794490	saline	C0036082
27794490	Control	C0009932
27794490	LPS	C0023810
27794490	captopril	C0006938
27794490	LPS	C0023810
27794490	treatment	C0087111
27794490	days	C0439228
27794490	behavioral experiments	C0683444
27794490	behavioral tests	C0683444
27794490	LPS	C0023810
27794490	injection	C1533685
27794490	behavioral experiment	C0683444
27794490	Administration	C1533734
27794490	LPS	C0023810
27794490	prolonged	C0439590
27794490	latency	C0205275
27794490	Morris water maze (MWM) test	C0683444
27794490	latency	C0205275
27794490	dark compartment	C3649443
27794490	passive avoidance	C0871047
27794490	PA	C0871047
27794490	test	C0683444
27794490	Pretreatment	C3539076
27794490	doses	C0178602
27794490	captopril	C0006938
27794490	improved	C1272745
27794490	performances	C1882330
27794490	rats	C0034721
27794490	MWM	C0683444
27794490	prolonged	C0439590
27794490	latency	C0205275
27794490	dark	C3649443
27794490	PA	C0871047
27794490	test	C0683444
27794490	LPS	C0023810
27794490	increased	C0205217
27794490	IL-6	C0021760
27794490	TNF-α	C1456820
27794490	malondialdehyde	C0024643
27794490	MDA	C0024643
27794490	nitric oxide	C0028128
27794490	NO	C0028128
27794490	metabolites	C0870883
27794490	hippocampal	C0019564
27794490	tissues	C0459385
27794490	prevented	C0199176
27794490	captopril	C0006938
27794490	thiol	C0574031
27794490	superoxide dismutase	C0038838
27794490	SOD	C0038838
27794490	catalase	C0007367
27794490	CAT	C0007367
27794490	hippocampus	C0019564
27794490	LPS	C0023810
27794490	group	C0441833
27794490	control	C0009932
27794490	enhanced	C2349975
27794490	aniamls	C0003062
27794490	pretreated	C3539076
27794490	captopril	C0006938
27794490	captopril	C0006938
27794490	improved	C1272745
27794490	LPS	C0023810
27794490	induced	C0205263
27794490	learning	C0023186
27794490	memory impairments	C0233794
27794490	rats	C0034721
27794490	attenuating	C0599946
27794490	hippocampal	C0019564
27794490	cytokine	C0079189
27794490	levels	C0441889
27794490	improving	C1272745
27794490	brain tissues	C0459385
27794490	oxidative	C0311404
27794490	damage	C0010957
27794490	criteria	C0243161
27795701	Targeted therapy	C2985566
27795701	gastric cancer	C0024623
27795701	Gastric cancer	C0024623
27795701	cancer	C0006826
27795701	Surgery	C0543467
27795701	multimodal therapy	C0009429
27795701	curative therapy	C1273390
27795701	targeted therapy	C2985566
27795701	years	C0439234
27795701	implication	C1314939
27795701	HER2	C0242957
27795701	angiogenesis	C0302600
27795701	targeted therapies	C2985566
27795701	treatment	C0087111
27795701	gastric cancer	C0024623
27795701	resistance	C4281815
27795701	monoclonal antibodies	C0003250
27795701	comprehensive	C1880156
27795701	comparative	C1579762
27795701	literature	C0023866
27795701	research	C0035168
27795701	evaluate	C0220825
27795701	HER2	C0242957
27795701	angiogenesis	C0302600
27795701	targeted therapy	C2985566
27795701	gastric cancer	C0024623
27795701	trastuzumab	C0728747
27795701	ramucirumab	C2742502
27795701	agents	C0003392
27795701	therapy	C0087111
27795701	patients	C0030705
27795701	gastric cancer	C0024623
27795701	targeted therapies	C2985566
27795701	gastric cancer	C0024623
27795701	resistance	C4281815
27795701	targeted therapy	C2985566
27795701	second-line treatment	C1710038
27795701	chemotherapy	C3665472
27795701	results	C0808233
27795701	first-line treatment	C1708063
27795701	therapeutic agents	C1611640
27795701	combinations	C0013162
27795701	first-line treatment	C1708063
27795701	gastric cancer	C0024623
27795701	clinical trials	C0008976
27795726	Serum C-Reactive Protein	C1277266
27795726	Children	C0008059
27795726	Liver Disease	C0023895
27795726	Ascites	C0003962
27795726	diagnosis	C1704656
27795726	peritonitis	C0031154
27795726	complication	C0009566
27795726	cirrhosis	C0023890
27795726	study	C2603343
27795726	serum C-reactive protein levels	C1277266
27795726	diagnostic factor	C1511876
27795726	spontaneous bacterial peritonitis	C0275551
27795726	SBP	C0275551
27795726	child patients	C0030705
27795726	liver disease	C0023895
27795726	study	C2603343
27795726	children	C0008059
27795726	diagnosed	C1704656
27795726	liver disease	C0023895
27795726	ascites	C0003962
27795726	admission	C0184666
27795726	Nemazee Teaching Hospital	C0020027
27795726	Shiraz	C0017446
27795726	Iran	C0022065
27795726	examined	C0332128
27795726	Patients	C0030705
27795726	spontaneous bacterial peritonitis	C0275551
27795726	sterile ascetic fluid groups	C0682554
27795726	PMN count	C0948762
27795726	ascetic fluids	C0682554
27795726	Routine laboratory tests	C0022885
27795726	C-reactive protein (CRP) levels	C1277266
27795726	patients	C0030705
27795726	Accuracy	C0443131
27795726	sensitivity, and specificity	C0036668
27795726	CRP	C1277266
27795726	diagnosis	C1704656
27795726	SBP	C0275551
27795726	cirrhotic	C1623038
27795726	patients	C0030705
27795726	patients	C0030705
27795726	SBP	C0275551
27795726	male	C0025266
27795726	mean age	C0001779
27795726	years	C0439234
27795726	patients	C0030705
27795726	SBP	C0275551
27795726	male	C0025266
27795726	mean age	C0001779
27795726	years	C0439234
27795726	Cell counts	C0007584
27795726	protein levels	C0428479
27795726	albumin levels	C0428519
27795726	lactate dehydrogenize (LDH) levels	C0428346
27795726	ascetic fluid	C0682554
27795726	serum samples	C1550100
27795726	SBP	C0275551
27795726	SBP	C0275551
27795726	CRP	C1277266
27795726	SBP	C0275551
27795726	SBP	C0275551
27795726	sensitivity and specificity	C0036668
27795726	CRP	C1277266
27795726	diagnosis	C1704656
27795726	SBP	C0275551
27795726	PMN count	C0948762
27795726	cultured ascites	C0003962
27795726	CRP	C1277266
27795726	SBP	C0275551
27795726	PMN count	C0948762
27795726	cultured ascites	C0003962
27795726	study	C2603343
27795726	CRP	C1277266
27795726	sensitivity and specificity	C0036668
27795726	diagnosis	C1704656
27795726	SBP	C0275551
27795726	cirrhotic	C1623038
27795726	children	C0008059
27796364	bacterial	C0521009
27796364	plant	C0032098
27796364	ferredoxin	C0015858
27796364	receptor	C0597357
27796364	FusA	C0059038
27796364	Iron	C0302583
27796364	nutrient	C0678695
27796364	bacterial infection	C0004623
27796364	host	C1167395
27796364	pathogen	C0450254
27796364	Gram-negative bacteria	C0018150
27796364	TonB	C1437205
27796364	outer membrane	C1167331
27796364	receptors	C0597357
27796364	iron	C0302583
27796364	infection	C3714514
27796364	receptors	C0597357
27796364	iron	C0302583
27796364	iron-scavenging siderophores	C0142281
27796364	direct interaction	C1704675
27796364	extraction	C0185115
27796364	host	C1167395
27796364	proteins	C0033684
27796364	Characterization	C1880022
27796364	receptors	C0597357
27796364	pathogenesis	C0699748
27796364	virulence	C0042765
27796364	TonB	C1437205
27796364	receptors	C0597357
27796364	discovery	C1880355
27796364	FusA	C0059038
27796364	TonB	C1437205
27796364	receptor	C0597357
27796364	phytopathogenic Pectobacterium spp.	C0030745
27796364	iron	C0302583
27796364	plant	C0032098
27796364	ferredoxin	C0015858
27796364	crystal structure	C0444626
27796364	FusA	C0059038
27796364	binding	C1167622
27796364	ferredoxin	C0015858
27796364	extracellular loops	C0243092
27796364	extensive	C0205231
27796364	interactions	C1704675
27796364	ferredoxin	C0015858
27796364	function	C0542341
27796364	FusA	C0059038
27796364	homologues	C0162774
27796364	clinically important	C3898777
27796364	pathogens	C0450254
27796364	iron-containing proteins	C0033684
27796364	iron	C0302583
27796364	source	C0449416
27796364	bacterial	C0521009
27796364	pathogens	C0450254
27798289	Antigen	C0003320
27798289	Masking	C0005520
27798289	Fixation	C0085254
27798289	Embedding	C1707903
27798289	Dissected	C0205239
27798289	Antigen	C0003320
27798289	masking	C0005520
27798289	processed	C1522240
27798289	tissue	C0040300
27798289	multiple	C0439064
27798289	factors	C1521761
27798289	dissect	C0205239
27798289	antigenicity	C3714634
27798289	step	C1261552
27798289	processing	C1709694
27798289	frozen sections	C0016741
27798289	proxies	C0600420
27798289	whole tissue	C0040300
27798289	antigen	C0003320
27798289	masking	C0005520
27798289	fixation	C0085254
27798289	times	C0040223
27798289	room temperature	C2348236
27798289	antigens	C0003320
27798289	fixation	C0085254
27798289	times	C0040223
27798289	detection	C0442726
27798289	antigen	C0003320
27798289	retrieval	C1514918
27798289	AR	C1514918
27798289	Ki-67	C0208804
27798289	bcl-2	C1317122
27798289	ER	C1545287
27798289	transfer	C0205245
27798289	graded alcohol	C0001975
27798289	series	C0205549
27798289	staining effect	C1704680
27798289	treating	C1522326
27798289	sections	C0016741
27798289	detergents	C0011740
27798289	polymeric	C0032521
27798289	immunohistochemical	C1441616
27798289	detection	C0442726
27798289	system	C0449913
27798289	tissue	C0040300
27798289	structures	C0678594
27798289	masking	C0005520
27798289	clearing agent	C4055226
27798289	paraffin	C0030415
27798289	embedding	C1707903
27798289	step	C1261552
27798289	non-freezable	C0205556
27798289	water	C0043047
27798289	removal	C1883720
27798289	AR	C1514918
27798289	masking	C0005520
27798289	fixation	C0085254
27798289	time	C0040223
27798289	paraffin	C0030415
27798289	embedding	C1707903
27798289	AR	C1514918
27798289	destroys	C1948029
27798289	epitopes	C0003316
27798289	routine	C0205547
27798289	processing	C1709694
27798289	Processed	C1522240
27798289	frozen sections	C0016741
27798289	investigate	C1292732
27798289	fixation	C0085254
27798289	processing	C1709694
27798289	requirements	C1514873
27798289	antigens	C0003320
27798289	routine	C0205547
27798289	specimens	C0370003
27798823	Synthesis	C1883254
27798823	1,2-Dioxetanes	C0212353
27798823	Thermochemiluminescent Labels	C1522485
27798823	Ultrasensitive Bioassays	C0005507
27798823	Rational Prediction	C0681842
27798823	Olefin	C0002068
27798823	Photooxygenation	C1254366
27798823	Outcome	C1274040
27798823	Chemometric Approach	C0022885
27798823	thermochemiluminescent (TCL) molecules	C0567416
27798823	bioanalytical assays	C0005507
27798823	design	C1707689
27798823	synthesis	C1883254
27798823	library	C0023621
27798823	olefins	C0002068
27798823	photooxygenation	C1254366
27798823	1,2-dioxetane-based	C0212353
27798823	TCL labels	C1522485
27798823	optimized properties	C0871161
27798823	Fluorine	C0016330
27798823	acridan	C0283001
27798823	1,2-dioxetanes	C0212353
27798823	3- and/or 6-position	C1254362
27798823	2,7-difluorinated acridan dioxetane	C0029224
27798823	fluorescence quantum yield	C0392762
27798823	unsubstituted dioxetane	C0029224
27798823	synthesized	C1883254
27798823	olefins	C0002068
27798823	singlet oxygen addition	C1254366
27798823	rationale	C2699007
27798823	photooxygenation	C1254366
27798823	TCL dioxetanes	C0029224
27798823	chemometric approach	C0022885
27798823	principal component analysis	C0936012
27798823	linear discriminant analysis	C0936012
27798823	structural	C0678594
27798823	electronic molecular descriptors	C0282354
27798823	DFT optimizations	C2698650
27798823	olefins	C0002068
27798823	approach	C0449445
27798823	steric and electronic parameters	C0549193
27798823	dioxetane	C0029224
27798823	formation	C1522492
27798823	revealed	C0443289
27799048	Prostate external beam radiotherapy	C2367589
27799048	combined	C0205195
27799048	high-dose-rate brachytherapy	C0454270
27799048	dose	C0178602
27799048	volume	C0449468
27799048	parameters	C0449381
27799048	deformably-registered plans	C0002045
27799048	correlate	C1707520
27799048	late	C0205087
27799048	gastrointestinal complications	C0161819
27799048	Derivation	C1441547
27799048	dose	C0178602
27799048	volume	C0449468
27799048	correlated	C1707520
27799048	toxicity	C0040539
27799048	multi-modal treatments	C0087111
27799048	difficult	C0332218
27799048	voxel-by-voxel dose accumulation	C0022885
27799048	data	C1511726
27799048	single	C0205171
27799048	institution	C0018704
27799048	cohort	C0599755
27799048	long	C0205166
27799048	follow-up	C1522577
27799048	investigation	C1292732
27799048	rectal	C0205052
27799048	dose	C0178602
27799048	volume	C0449468
27799048	effects	C1280500
27799048	gastrointestinal toxicities	C1142499
27799048	phase	C0205390
27799048	combined	C0205195
27799048	external beam radiotherapy	C2367589
27799048	EBRT	C2367589
27799048	high-dose-rate (HDR) brachytherapy	C0454270
27799048	prostate treatment	C0194790
27799048	patients	C0030705
27799048	EBRT	C2367589
27799048	fractions	C1264633
27799048	Gy	C0556636
27799048	HDR	C0454270
27799048	TG43 algorithm	C0002045
27799048	fractions	C1264633
27799048	Gy	C0556636
27799048	Results	C0683954
27799048	Late Effects of Normal Tissues - Subjective, Objective, Management and Analytic toxicity assessments	C0450973
27799048	median	C0876920
27799048	follow-up	C1522577
27799048	months	C0439231
27799048	HDR	C0454270
27799048	CT	C0040405
27799048	EBRT	C2367589
27799048	CT	C0040405
27799048	Doses	C0178602
27799048	corrected	C0205202
27799048	dose fractionation	C0524811
27799048	Rectum	C0034896
27799048	dose-volume histogram	C3827011
27799048	DVH	C3827011
27799048	parameters	C0449381
27799048	calculated	C1441506
27799048	Distribution-adding	C0025663
27799048	parameters	C0449381
27799048	calculated	C1441506
27799048	EBRT	C2367589
27799048	dose	C0178602
27799048	distribution	C1704711
27799048	HDR	C0454270
27799048	dose	C0178602
27799048	distribution	C1704711
27799048	Parameter-adding	C0025663
27799048	EBRT	C2367589
27799048	DVH	C3827011
27799048	parameters	C0449381
27799048	added	C1524062
27799048	HDR	C0454270
27799048	DVH	C3827011
27799048	parameters	C0449381
27799048	Logistic regressions	C0206031
27799048	Mann-Whitney U-tests	C0242927
27799048	correlate	C1707520
27799048	parameters	C0449381
27799048	late	C0205087
27799048	peak	C0444505
27799048	toxicity	C0040539
27799048	dichotomised	C0332849
27799048	grade	C0441800
27799048	Gy	C0556636
27799048	dose	C0178602
27799048	regions	C0205147
27799048	distribution-adding	C0025663
27799048	significantly	C0750502
27799048	correlated	C1707520
27799048	rectal bleeding	C0267596
27799048	urgency	C0085606
27799048	tenesmus	C0232726
27799048	stool frequency	C0426642
27799048	Additionally	C1524062
27799048	urgency	C0085606
27799048	tenesmus	C0232726
27799048	anorectal pain	C0581362
27799048	associated with	C0332281
27799048	Gy	C0556636
27799048	Gy	C0556636
27799048	dose	C0178602
27799048	regions	C0205147
27799048	distribution-adding	C0025663
27799048	Parameter-adding	C0025663
27799048	low	C0205251
27799048	mid	C0444598
27799048	dose	C0178602
27799048	region	C0205147
27799048	significantly	C0750502
27799048	correlated	C1707520
27799048	stool frequency	C0426642
27799048	proctitis	C0033246
27799048	study	C0681814
27799048	confirms	C0750484
27799048	significant	C0750502
27799048	dose-histogram	C3827011
27799048	effects	C1280500
27799048	gastrointestinal toxicities	C1142499
27799048	including	C0332257
27799048	deformable registration	C0002045
27799048	combine	C0205195
27799048	phases	C0205390
27799048	EBRT	C2367589
27799048	HDR	C0454270
27799048	prostate cancer	C0376358
27799048	treatment	C0087111
27799048	findings	C0243095
27799048	distribution-adding	C0025663
27799048	cases	C0868928
27799048	consistent with	C0332290
27799048	parameter-adding	C0025663
27799048	mid	C0444598
27799048	high	C0205250
27799048	dose	C0178602
27799048	range	C1514721
27799048	near	C1706276
27799048	maximum	C0806909
27799048	doses	C0178602
27799048	important	C3898777
27799048	rectal bleeding	C0267596
27799048	distribution-adding	C0025663
27799048	mid	C0444598
27799048	high	C0205250
27799048	dose	C0178602
27799048	range	C1514721
27799048	important	C3898777
27799048	stool frequency	C0426642
27799048	urgency	C0085606
27799048	tenesmus	C0232726
27799048	additional	C1524062
27799048	studies	C2603343
27799048	variety	C2346866
27799048	institutions	C1272753
27799048	variety	C2346866
27799048	dose accumulation methods	C0022885
27799048	inter-fraction motion management	C1254363
27799763	Prescription	C1521941
27799763	opioids	C0242402
27799763	breathlessness	C0013404
27799763	end-stage	C0205088
27799763	COPD	C0024117
27799763	population-based study	C1709599
27799763	Low-dose	C0445550
27799763	opioids	C0242402
27799763	relieve	C1301676
27799763	breathlessness	C0013404
27799763	late-stage	C1279941
27799763	COPD	C0024117
27799763	fear	C0015726
27799763	complications	C0009566
27799763	symptom control	C1274136
27799763	study	C2603343
27799763	period	C1948053
27799763	indications	C3146298
27799763	opioids	C0242402
27799763	prescribed	C0278329
27799763	people	C0027361
27799763	end-stage	C0205088
27799763	COPD	C0024117
27799763	study	C2603343
27799763	longitudinal	C0023981
27799763	population-based study	C1709599
27799763	patients	C0030705
27799763	long-term oxygen therapy	C0418996
27799763	LTOT	C0418996
27799763	COPD	C0024117
27799763	Sweden	C0038995
27799763	dispensed	C1880359
27799763	opioid	C0242402
27799763	prescriptions	C1521941
27799763	national Prescribed Drugs Register	C0282574
27799763	days	C0439228
27799763	LTOT	C0418996
27799763	LTOT	C0418996
27799763	withdrawal	C2349954
27799763	death	C0011065
27799763	study end	C2983670
27799763	dispensed quantity	C0805077
27799763	date of dispensing	C0243095
27799763	indications	C3146298
27799763	pain	C0030193
27799763	breathlessness	C0013404
27799763	COPD	C0024117
27799763	patients	C0030705
27799763	women	C0043210
27799763	follow-up	C1522577
27799763	interquartile range	C1711350
27799763	years	C0439234
27799763	patients	C0030705
27799763	dispensed	C1880359
27799763	opioid	C0242402
27799763	prescription	C0033080
27799763	prescriptions	C0033080
27799763	prescribed	C0278329
27799763	opioids	C0242402
27799763	tramadol	C0040610
27799763	oxycodone	C0030049
27799763	morphine	C0026549
27799763	codeine	C0009214
27799763	dispensed quantity	C0805077
27799763	interquartile range	C1711350
27799763	daily doses	C2348070
27799763	prescription	C0033080
27799763	sample	C0370003
27799763	indication	C3146298
27799763	pain	C0030193
27799763	breathlessness	C0013404
27799763	opioids	C0242402
27799763	relief	C1301676
27799763	breathlessness	C0013404
27799763	study	C2603343
27799763	opioids	C0242402
27799763	prescribed	C0278329
27799763	relieve	C1301676
27799763	breathlessness	C0013404
27799763	oxygen-dependent	C1655730
27799763	COPD	C0024117
27799763	symptom control	C1274136
27799763	study	C2603343
27799763	baseline	C1442488
27799763	morphine	C0026549
27802488	In Vivo	C1515655
27802488	3-Dimensional	C0450363
27802488	Strain Mapping	C1283195
27802488	Confirms	C0521093
27802488	Large	C0549177
27802488	Optic Nerve Head	C0029127
27802488	Deformations	C0302142
27802488	Following	C0332282
27802488	Horizontal Eye Movements	C0015413
27802488	measure	C0079809
27802488	lamina cribrosa	C0229114
27802488	LC	C0229114
27802488	strains	C0302142
27802488	deformations	C0302142
27802488	following	C0332282
27802488	abduction	C0231456
27802488	adduction	C0231457
27802488	healthy subjects	C1708335
27802488	compare	C1707455
27802488	resulting	C1274040
27802488	relatively	C0205345
27802488	high	C0205250
27802488	acute	C0205178
27802488	intraocular pressure	C0021888
27802488	IOP	C0021888
27802488	elevation	C0702240
27802488	total	C0439810
27802488	eyes	C0015392
27802488	healthy subjects	C1708335
27802488	included	C2700399
27802488	eyes	C0015392
27802488	peripapillary atrophy	C1719838
27802488	PPA	C1719838
27802488	each	C1457900
27802488	subject	C0681850
27802488	optic nerve heads	C0029127
27802488	ONHs	C0029127
27802488	imaged	C1704922
27802488	optical coherence tomography	C0920367
27802488	OCT	C0920367
27802488	baseline	C1442488
27802488	twice	C1948050
27802488	different	C1705242
27802488	gaze	C0590323
27802488	positions	C0733755
27802488	adduction	C0231457
27802488	abduction	C0231456
27802488	following	C0332282
27802488	acute	C0205178
27802488	IOP	C0021888
27802488	elevation	C0702240
27802488	approximately	C0332232
27802488	Hg	C0025424
27802488	baseline	C1442488
27802488	ophthalmodynamometry	C0029085
27802488	Strains	C0302142
27802488	LC	C0229114
27802488	loading scenarios	C0683579
27802488	mapped	C3858752
27802488	three-dimensional	C0450363
27802488	tracking	C0546881
27802488	algorithm	C0002045
27802488	eyes	C0015392
27802488	LC	C0229114
27802488	strains	C0302142
27802488	induced	C0205263
27802488	adduction	C0231457
27802488	abduction	C0231456
27802488	significantly higher	C4055637
27802488	control	C0009932
27802488	strains	C0302142
27802488	measured	C0444706
27802488	repeated	C0205341
27802488	baseline	C1442488
27802488	acquisitions	C1706701
27802488	Strains	C0302142
27802488	LC	C0229114
27802488	adduction	C0231457
27802488	average	C1510992
27802488	higher	C0205250
27802488	abduction	C0231456
27802488	difference	C1705242
27802488	statistically significant	C0237881
27802488	Strains	C0302142
27802488	LC	C0229114
27802488	induced	C0205263
27802488	IOP	C0021888
27802488	elevations	C0702240
27802488	average	C1510992
27802488	Hg	C0025424
27802488	significantly higher	C4055637
27802488	control	C0009932
27802488	strains	C0302142
27802488	Gaze	C0590323
27802488	induced	C0205263
27802488	LC	C0229114
27802488	strains	C0302142
27802488	PPA	C1719838
27802488	group	C0030705
27802488	average	C1510992
27802488	larger	C0549177
27802488	non-PPA group	C0030705
27802488	relationship	C0439849
27802488	statistically significant	C0237881
27802488	results	C0683954
27802488	confirm	C1456348
27802488	horizontal eye movements	C0015413
27802488	generate	C0205556
27802488	significant	C0750502
27802488	ONH	C0029127
27802488	strains	C0302142
27802488	consistent with	C0332290
27802488	previous	C0205156
27802488	estimations	C0680844
27802488	finite element analysis	C0600552
27802488	Further studies	C2603343
27802488	possible	C0332149
27802488	ONH	C0029127
27802488	strains	C0302142
27802488	induced	C0205263
27802488	eye movements	C0015413
27802488	axonal loss	C1832338
27802488	optic neuropathies	C0029132
27804215	Simultaneously	C0521115
27804215	Targeting	C1521840
27804215	Myofibroblast Contractility	C4235370
27804215	Extracellular Matrix	C0015350
27804215	Cross-Linking	C0332220
27804215	Therapeutic Concept	C0302350
27804215	Airway	C0458827
27804215	Fibrosis	C0016059
27804215	Fibrosis	C0016059
27804215	solid organ transplantation	C0029216
27804215	irreversible	C0205355
27804215	process	C1522240
27804215	major	C0205164
27804215	graft dysfunction	C1167870
27804215	death	C0011065
27804215	limited	C0439801
27804215	therapies	C0087111
27804215	remodeling	C0678692
27804215	characterized	C1880022
27804215	aberrant	C0443127
27804215	accumulation	C4055506
27804215	contractile myofibroblasts	C0225360
27804215	deposit	C0333562
27804215	excessive	C0442802
27804215	extracellular matrix	C0015350
27804215	ECM	C0015350
27804215	increase	C0442805
27804215	tissue stiffness	C2017125
27804215	Studies	C2603343
27804215	stiff	C0427008
27804215	ECM	C0015350
27804215	promotes	C0033414
27804215	fibroblast	C0016030
27804215	myofibroblast	C0225360
27804215	differentiation	C0007589
27804215	stimulating	C1879547
27804215	ECM	C0015350
27804215	production	C1883254
27804215	positive feedback loop	C0678664
27804215	perpetuates	C0205556
27804215	fibrosis	C0016059
27804215	hypothesized	C1512571
27804215	simultaneously	C0521115
27804215	targeting	C1521840
27804215	myofibroblast contractility	C4235370
27804215	relaxin	C0035031
27804215	ECM	C0015350
27804215	stiffness	C0427008
27804215	lysyl oxidase	C0024375
27804215	inhibitors	C0014432
27804215	feedback loop	C0678663
27804215	reversing	C1555029
27804215	established	C0443211
27804215	fibrosis	C0016059
27804215	test	C0039593
27804215	orthotopic tracheal transplantation	C0040732
27804215	OTT	C0040732
27804215	mouse model	C2986594
27804215	robust	C2986815
27804215	fibrotic	C0334129
27804215	airway	C0458827
27804215	remodeling	C0678692
27804215	Mice	C0025929
27804215	established	C0443211
27804215	fibrosis	C0016059
27804215	treated	C1522326
27804215	saline	C0036082
27804215	mono-	C0520016
27804215	combination therapies	C0013218
27804215	monotherapies	C0520016
27804215	no effect	C1301751
27804215	combining these agents	C0013162
27804215	decreased	C0205216
27804215	collagen	C0009325
27804215	deposition	C0333562
27804215	promoted	C0033414
27804215	re-epithelialization	C0334221
27804215	remodeled airways	C2717792
27804215	Relaxin	C0035031
27804215	inhibited	C0311403
27804215	myofibroblast	C0225360
27804215	differentiation	C0007589
27804215	contraction	C1140999
27804215	matrix	C0015350
27804215	stiffness	C0427008
27804215	dependent	C3244310
27804215	prostaglandin E2	C3813211
27804215	PGE2	C3813211
27804215	effect	C1280500
27804215	combination therapy	C0013218
27804215	PGE2 receptor	C0034835
27804215	knockout	C0206745
27804215	PGE2	C3813211
27804215	inhibited	C0311403
27804215	OTT	C0040732
27804215	mice	C0025929
27804215	study	C2603343
27804215	revealed	C0443289
27804215	synergistic	C2986495
27804215	roles	C1705810
27804215	cellular contractility	C1140999
27804215	tissue stiffness	C2017125
27804215	maintenance	C0024501
27804215	fibrotic	C0334129
27804215	tissue	C0040300
27804215	therapeutic	C0302350
27804215	principle	C0678989
27804215	fibrosis	C0016059
27804311	Systemic matrix metalloproteinase-8	C1721358
27804311	response	C3714634
27804311	chronic tonsillitis	C0149517
27804311	development	C1527148
27804311	diseases	C0012634
27804311	coronary heart disease	C0010068
27804311	low-grade	C1282907
27804311	systemic	C0205373
27804311	inflammation	C0021368
27804311	Data	C1511726
27804311	potential	C3245505
27804311	long-term	C0443252
27804311	health	C0018684
27804311	effects	C1280500
27804311	chronic tonsillitis	C0149517
27804311	inflammatory	C0021368
27804311	conditions	C0348080
27804311	systemic matrix metalloproteinase	C1721358
27804311	(MMP)-8	C1721358
27804311	response	C3714634
27804311	head and neck cancer	C0278996
27804311	high	C0205250
27804311	plasma	C0032105
27804311	level	C0441889
27804311	tissue inhibitor of metalloproteinase	C0145947
27804311	(TIMP)-1	C0145947
27804311	predicts	C0681842
27804311	poor prognosis	C0278252
27804311	S-MMP-8	C1721358
27804311	immunofluorometric assay	C0016350
27804311	S-TIMP-1	C0145947
27804311	immunosorbent assay	C1532280
27804311	consecutive	C1707491
27804311	patients	C0030705
27804311	tonsillectomy	C0040423
27804311	benign tonsillar disease	C0153936
27804311	control	C0009932
27804311	patients	C0030705
27804311	tonsillar squamous cell carcinoma	C0280317
27804311	Tonsillar	C0040421
27804311	human papillomavirus	C0021344
27804311	HPV	C0021344
27804311	PCR	C0032520
27804311	patients	C0030705
27804311	benign tonsillar disease	C0153936
27804311	chronic tonsillitis	C0149517
27804311	hypertrophy	C0020564
27804311	associated with	C0332281
27804311	systemic MMP-8	C1721358
27804311	response	C3714634
27804311	patients	C0030705
27804311	benign tonsillar disease	C0153936
27804311	patients	C0030705
27804311	tonsillar squamous cell carcinoma	C0280317
27804311	significantly higher	C4055637
27804311	concentrations	C1446561
27804311	S-MMP-8	C1721358
27804311	S-TIMP-1	C0145947
27804311	S-MMP-8	C1721358
27804311	S-TIMP-1	C0145947
27804311	tonsillar	C0040421
27804311	HPV	C0021344
27804311	positivity	C1514241
27805500	Addressing	C0376649
27805500	holistic health	C0019844
27805500	work	C0043227
27805500	empowerment	C0679959
27805500	through	C0332273
27805500	body-mind-spirit intervention program	C0679897
27805500	helping	C0018896
27805500	professionals	C0679924
27805500	continuous	C0549178
27805500	education	C0013621
27805500	pilot study	C0031928
27805500	effectiveness	C1280519
27805500	body-mind-spirit (BMS) intervention program	C0679897
27805500	improving	C1272745
27805500	holistic well-being	C0019844
27805500	work	C0043227
27805500	empowerment	C0679959
27805500	helping	C0018896
27805500	professionals	C0679924
27805500	continuous	C0549178
27805500	education	C0013621
27805500	helping	C0018896
27805500	professionals	C0679924
27805500	postgraduate study	C0597274
27805500	participants	C0679646
27805500	attended	C1456498
27805500	BMS intervention program	C0679897
27805500	holistic approach	C0683249
27805500	health	C0018684
27805500	well-being	C0018684
27805500	levels	C0441889
27805500	physical distress	C0231303
27805500	daily functioning	C0037395
27805500	affect	C0001721
27805500	spirituality	C0237104
27805500	psychologica	C0205486
27805500	empowerment	C0679959
27805500	work	C0043227
27805500	intervention	C1273869
27805500	Participants	C0679646
27805500	levels	C0441889
27805500	negative affect	C0243095
27805500	physical distress	C0231303
27805500	spiritually disoriented	C0243095
27805500	intervention	C1273869
27805500	Enhanced	C2349975
27805500	levels	C0441889
27805500	daily functioning	C0037395
27805500	positive affect	C0018592
27805500	spiritual resilience	C0683811
27805500	tranquility	C0522165
27805500	participants	C0679646
27805500	empowered	C0562342
27805500	work	C0043227
27805500	work	C0043227
27805500	BMS intervention program	C0679897
27805500	positive	C0243095
27805500	measurable	C1513040
27805500	effec	C1280500
27805500	participants	C0679646
27805500	holistic well-being	C0019844
27805500	empowerment	C0679959
27805500	work	C0043227
27805500	Educators	C0259853
27805500	fields	C2346620
27805500	holistic	C0019844
27805500	practices	C0032893
27805500	curriculum	C0010478
27805500	practitioners	C1709627
27805500	professionals	C0679924
27805500	clients	C0008942
27805500	patients	C0030705
27805887	Successful Restoration	C0399059
27805887	Mutilated	C0332811
27805887	Primary Incisors	C0021156
27805887	Zirconia	C3503915
27805887	Crowns	C3853546
27805887	Two Year	C0439234
27805887	Results	C1274040
27805887	manuscript	C0600659
27805887	reliable technique	C0449851
27805887	restoring	C0399059
27805887	mutilated	C0332811
27805887	primary anterior teeth	C0021156
27805887	glass ionomer post	C0017597
27805887	zirconia	C3503915
27805887	crowns	C3853546
27805887	long-term	C0443252
27805887	esthetic	C0010163
27805887	restoration	C0399059
27805887	primary anterior teeth	C0021156
27805887	Children	C0008059
27805887	years	C0439234
27805887	decayed	C0011334
27805887	upper primary incisors	C0021156
27805887	Fuji IX	C0671561
27805887	intracanal space	C0282543
27805887	depth	C0205125
27805887	core	C0444669
27805887	supragingivally	C0086959
27805887	Crown preparations	C0399013
27805887	cores	C0444669
27805887	Zirconia	C3503915
27805887	crowns	C3853546
27805887	Nusmile	C0947322
27805887	Houston Texas	C3812709
27805887	USA	C0041703
27805887	fitted	C3714578
27805887	cemented	C0011343
27805887	cores	C0444669
27805887	patients	C0030705
27805887	recalled	C1707680
27805887	regular intervals	C1272706
27805887	children	C0008059
27805887	restorations	C0399059
27805887	study	C2603343
27805887	overall survival	C4086681
27805887	restorations	C0399059
27805887	months	C0439231
27805887	months	C0439231
27805887	Kaplan-Meier survival analysis	C0038953
27805887	median survival time	C2986586
27805887	mean survival time	C0086595
27805887	months	C0439231
27805887	clinical technique	C0376583
27805887	reliable	C3858758
27805887	restoration	C0399059
27805887	decayed	C0011334
27805887	primary incisors	C0021156
27805887	zirconia	C3503915
27805887	crowns	C3853546
27805887	technique	C0449851
27805887	superior esthetic	C0004898
27805887	restorations	C0399059
27805887	gingival response	C0541981
27805887	months	C0439231
27806385	Reimbursement	C3242446
27806385	Knee Surgery	C0187769
27806385	Medicare Access and Children's Health Insurance Program Reauthorization Act of 2015	C4277549
27806385	Health care cost	C0085552
27806385	nation's	C1555720
27806385	gross domestic product	C2936646
27806385	economic burdens	C1512163
27806385	physicians	C0031831
27806385	patients	C0030705
27806385	total joint replacement	C0185317
27806385	procedures	C0184661
27806385	health care environment	C0565997
27806385	knee surgeons	C0334891
27806385	health care reforms	C0206597
27806385	Medicare Access and Children's Health Insurance Program Reauthorization Act	C4277549
27806385	value-based payment reform	C0206597
27806385	knee surgeons	C0334891
27806385	contextual framework	C1254370
27806385	health care legislation	C0018719
27806385	health policy	C0018735
27806385	comprehensive	C1880156
27806385	summary	C1706244
27806385	Merit-Based Incentive Payment Systems	C0282574
27806385	Alternative Payment Models reimbursement models	C0282574
27806641	Empty	C1880497
27806641	Capsids	C0006933
27806641	Macrophage	C0024432
27806641	Inhibition	C3463820
27806641	Depletion	C0333668
27806641	Increase	C0442805
27806641	rAAV	C1520007
27806641	Transgene	C0282641
27806641	Expression	C0017262
27806641	Joints	C0022417
27806641	Healthy	C3898900
27806641	Arthritic	C0003864
27806641	Mice	C0025929
27806641	Gene therapy	C0017296
27806641	potential	C3245505
27806641	treat	C0087111
27806641	rheumatic diseases	C0035435
27806641	presence	C0150312
27806641	macrophages	C0024432
27806641	joint	C0022417
27806641	adeno-associated viral	C0001417
27806641	vector	C1520007
27806641	gene delivery	C1524066
27806641	arthritic	C0003864
27806641	healthy	C3898900
27806641	mice	C0025929
27806641	administration of agents	C2348003
27806641	influence	C4054723
27806641	macrophage	C0024432
27806641	activity	C0441655
27806641	number	C0237753
27806641	addition	C1883712
27806641	empty	C1880497
27806641	decoy capsids	C0006933
27806641	improve	C0184511
27806641	efficacy	C1280519
27806641	recombinant	C1514798
27806641	adeno-associated viral	C0001417
27806641	vector	C1520007
27806641	transgene	C0282641
27806641	expression	C0017262
27806641	joint	C0022417
27806641	Pretreatment	C3539076
27806641	triamcinolone	C0040864
27806641	clodronate	C0162357
27806641	liposomes	C0023828
27806641	improved	C0184511
27806641	luciferase	C0024075
27806641	expression	C0017262
27806641	period	C1948053
27806641	weeks	C0439230
27806641	Similar	C2348205
27806641	results	C0683954
27806641	empty	C1880497
27806641	decoy capsids	C0006933
27806641	added	C1524062
27806641	full	C0443225
27806641	genome	C0017428
27806641	capsids	C0006933
27806641	ratio	C0456603
27806641	study	C0008972
27806641	assess	C1516048
27806641	duration	C0449238
27806641	expression	C0017262
27806641	investigate	C1292732
27806641	combination	C0205195
27806641	approaches	C1292724
27806641	observed	C1441672
27806641	synergistic	C2986495
27806641	enhancement	C2349975
27806641	gene expression	C0017262
27806641	sustained	C0443318
27806641	weeks	C0439230
27806641	enhancement	C2349975
27806641	gene expression	C0017262
27806641	route of administration	C0013153
27806641	triamcinolone	C0040864
27806641	intra-articular	C0442108
27806641	intramuscular	C0442117
27806641	healthy	C3898900
27806641	mice	C0025929
27806641	combination	C0205195
27806641	improved	C0184511
27806641	expression	C0017262
27806641	transgene	C0282641
27806641	serotype	C0449943
27806641	data	C1511726
27806641	gene therapy	C0017296
27806641	joint	C0022417
27806641	tissues	C0040300
27806641	abundance	C2346714
27806641	macrophages	C0024432
27807162	Inhibitory	C3463820
27807162	Septum	C0814033
27807162	Lateral Hypothalamus	C0020654
27807162	Circuit	C0814033
27807162	Suppresses	C1260953
27807162	Feeding	C0015745
27807162	Feeding behavior	C0015745
27807162	orchestrated	C1300196
27807162	neural circuits	C0814033
27807162	hypothalamus	C0020663
27807162	hindbrain	C0035507
27807162	relative	C0205345
27807162	influence	C4054723
27807162	cognitive	C1516691
27807162	emotional	C0013987
27807162	brain circuits	C0682723
27807162	feeding	C0015745
27807162	circuitry	C0260041
27807162	hypothalamus	C0020663
27807162	hindbrain	C0035507
27807162	unclear	C3845108
27807162	using	C1524063
27807162	cell-type	C0449475
27807162	genetic methods	C0017395
27807162	circuit mapping	C0006117
27807162	behavior	C0004927
27807162	assays	C0005507
27807162	neural circuits	C0814033
27807162	septal nucleus	C0175232
27807162	lateral hypothalamus	C0020654
27807162	LH	C0020654
27807162	neural regulation	C0598959
27807162	food intake	C0013470
27807162	mice	C0025929
27807162	chemogenetic	C0205245
27807162	optogenetic	C0205245
27807162	activation	C1879547
27807162	septal	C0442004
27807162	vesicular GABA transporter	C1453453
27807162	vGAT	C1453453
27807162	containing	C0332256
27807162	neurons	C0027882
27807162	LH	C0020654
27807162	reduced	C0392756
27807162	food intake	C0013470
27807162	mice	C0025929
27807162	chemogenetic	C0205245
27807162	inhibition	C3463820
27807162	septal	C0442004
27807162	vGAT	C1453453
27807162	neurons	C0027882
27807162	increased	C0205217
27807162	food intake	C0013470
27807162	investigated	C1292732
27807162	unknown	C0439673
27807162	neural circuit	C0814033
27807162	originating	C0439659
27807162	septal	C0442004
27807162	vGAT	C1453453
27807162	neurons	C0027882
27807162	subset	C1515021
27807162	vGAT	C1453453
27807162	neurons	C0027882
27807162	LH	C0020654
27807162	area	C0205146
27807162	involved	C1314939
27807162	homeostatic	C0019868
27807162	hedonic	C3714634
27807162	control	C0243148
27807162	energy states	C0516979
27807162	data	C1511726
27807162	reveal	C0443289
27807162	inhibitory	C3463820
27807162	septohypothalamic	C0005898
27807162	feeding circuit	C0814033
27807162	therapeutic	C0302350
27807162	target	C1521840
27807162	treatment	C1522326
27807162	eating disorders	C0013473
27807162	anorexia nervosa	C0003125
27807162	septum	C0814033
27807162	hypothalamus	C0020663
27807162	control	C0243148
27807162	food intake	C0013470
27807162	negatively	C0205160
27807162	brain regions	C1273723
27807162	control	C0243148
27807162	feeding	C0015745
27807162	emotion	C0013987
27807162	related	C1552599
27807162	behaviors	C0004927
27807162	findings	C0243095
27807162	reveal	C0443289
27807162	unknown	C0439673
27807162	neural circuitry	C0260041
27807162	emotional aspects	C0243152
27807162	food intake	C0013470
27807162	provide	C1999230
27807162	insights	C0233820
27807162	development	C1527148
27807162	therapeutic	C0302350
27807162	targets	C1521840
27807162	treatment	C1522326
27807162	eating disorders	C0013473
27807796	Human	C0086418
27807796	Umbilical Cord Blood	C0162371
27807796	Derived	C1550535
27807796	Neural Stem Cell Line	C0007600
27807796	Screening	C0220908
27807796	Model	C0026339
27807796	Toxicity	C0600688
27807796	aim	C1947946
27807796	investigate	C1292732
27807796	human	C0086418
27807796	neural stem cell	C1113654
27807796	NSC	C1113654
27807796	line	C0007600
27807796	derived	C1550535
27807796	human	C0086418
27807796	umbilical cord blood	C0162371
27807796	hUCB	C0162371
27807796	toxicity	C0600688
27807796	study	C2603343
27807796	Toxicity	C0600688
27807796	neurotoxic	C0260049
27807796	environmental	C0014406
27807796	xenobiotics	C0043335
27807796	methyl mercury chloride	C0066402
27807796	CH3HgCl	C0066402
27807796	lead acetate	C0064711
27807796	CH3COOPb	C0064711
27807796	chlorpyrifos	C0013328
27807796	CP	C0013328
27807796	non-neurotoxic	C0243095
27807796	insecticide	C0021576
27807796	dichlorvos	C0012087
27807796	non-neurotoxic	C0243095
27807796	drugs	C1254351
27807796	theophylline	C0039771
27807796	acetaminophen	C0000970
27807796	assessed	C1516048
27807796	differentiation	C2945687
27807796	neuronal	C0521390
27807796	glial cell lines	C0027836
27807796	derived	C1550535
27807796	hUCB	C0162371
27807796	observed	C1441672
27807796	CH3HgCl	C0066402
27807796	toxic	C1407029
27807796	human	C0086418
27807796	NSCs	C0007600
27807796	comparison	C1707455
27807796	CH3COOPb	C0064711
27807796	CP	C0013328
27807796	minimum inhibitory concentration (MIC) value	C1304747
27807796	NSCs	C0007600
27807796	staining process	C0487602
27807796	acridine orange	C0001185
27807796	ethidium bromide	C0019873
27807796	AO	C0001185
27807796	EB	C0019873
27807796	staining	C0487602
27807796	3-(4,5-dimethylthiazol-2-yl)2,5-diphenyl tetrazolium bromide	C0094912
27807796	MTT	C0094912
27807796	assay	C1510438
27807796	Hoechst staining	C1441607
27807796	CH3HgCl	C0066402
27807796	CP	C0013328
27807796	CH3COOPb	C0064711
27807796	CH3HgCl	C0066402
27807796	LC25	C0392762
27807796	value	C0042295
27807796	staining method	C0487602
27807796	CP	C0013328
27807796	LC25	C0392762
27807796	value	C0042295
27807796	CH3COOPb	C0064711
27807796	LC25	C0392762
27807796	values	C0042295
27807796	LC50	C1443965
27807796	values	C0042295
27807796	ranged	C1514721
27807796	CH3HgCl	C0066402
27807796	CP	C0013328
27807796	CH3COOPb	C0064711
27807796	Theophylline	C0039771
27807796	acetaminophen	C0000970
27807796	dichlorvos	C0012087
27807796	impact	C4049986
27807796	viability	C0443348
27807796	NSCs	C0007600
27807796	hUCB	C0162371
27807796	NSC	C0007600
27807796	model	C0026339
27807796	toxicity	C0600688
27807796	study	C2603343
27809747	MiR 221	C1537859
27809747	222	C1537860
27809747	tamoxifen	C0039286
27809747	resistance	C0013203
27809747	Breast cancer	C0007104
27809747	cancer	C0006826
27809747	women	C0043210
27809747	early detection	C0596473
27809747	treatment	C0087111
27809747	mortality rate	C0205848
27809747	lung cancer	C0242379
27809747	breast carcinomas	C0678222
27809747	ER+	C1971473
27809747	antiestrogens	C0014930
27809747	tamoxifen	C0039286
27809747	tamoxifen	C0039286
27809747	patients	C0030705
27809747	patients	C0030705
27809747	respond poorly	C1320680
27809747	therapy	C0087111
27809747	recurrence	C0034897
27809747	tamoxifen	C0039286
27809747	resistance	C0013203
27809747	Drug resistance	C0013203
27809747	clinical	C0205210
27809747	successful treatment	C0521982
27809747	breast cancer	C0007104
27809747	unsuccessful treatments	C0438286
27809747	acquired	C0439661
27809747	resistance	C0013203
27809747	MultiDrug Resistance	C0242640
27809747	(MDR)	C0242640
27809747	MicroRNAs	C1101610
27809747	noncoding RNAs	C0887909
27809747	gene expression	C0017262
27809747	miRNAs	C1101610
27809747	cancer	C0006826
27809747	therapeutic targets	C1513403
27809747	biomarkers	C0005516
27809747	miRNA	C1101610
27809747	deregulation	C1880287
27809747	breast cancer	C0007104
27809747	reports	C0684224
27809747	miRNAs	C1101610
27809747	studies	C2603343
27809747	miRNAs	C1101610
27809747	antiestrogen therapy	C0854638
27809747	tamoxifen	C0039286
27809747	molecules	C0567416
27809747	drug resistance	C0013203
27809747	RNA molecules	C0035668
27809747	miRNAs	C1101610
27809747	breast cancer	C0007104
27809747	pathogenesis	C0699748
27809747	cancer	C0006826
27809747	drug resistance	C0013203
27809747	mechanisms	C0441712
27809747	oncomirs	C1101610
27809747	miR 221	C1537859
27809747	222	C1537860
27809747	cell cycle deregulation	C1516331
27809747	breast cancer	C0007104
27809747	oncomiRs	C1101610
27809747	resistance	C0013203
27809747	tamoxifen	C0039286
27809747	emphasized	C3898777
27812000	Ultra-low activities	C0441655
27812000	radioisotope	C0034595
27812000	permission	C0521104
27812000	tracking	C0546881
27812000	drosophilid fly	C0013138
27812000	natural habitat	C0557745
27812000	species	C1705920
27812000	ecology	C0013546
27812000	movement	C0026649
27812000	time	C0040223
27812000	space	C1883067
27812000	biology	C0005532
27812000	conservation	C2347858
27812000	tools	C0336791
27812000	tracking	C0546881
27812000	animals	C0003062
27812000	millimetre-sized insects	C0021585
27812000	tracking	C0546881
27812000	labelling procedures	C0022261
27812000	ultra-low	C0441655
27812000	permission	C0521104
27812000	exempt activities	C0441655
27812000	metastable isomer	C0022203
27812000	radionuclide	C0034595
27812000	Technetium-99	C0303612
27812000	labelling	C0022261
27812000	field detection	C0243095
27812000	mountain	C0442533
27812000	fly	C1704307
27812000	Drosophila nigrosparsa	C3766101
27812000	activity	C0441655
27812000	label	C0022261
27812000	flies	C0012578
27812000	detect single individuals	C0243095
27812000	radiation protection	C0034533
27812000	monitors	C0034532
27812000	methodology	C3266812
27812000	small-sized	C0748864
27812000	low-mobility	C0243095
27812000	animals	C0003062
27812000	light	C0023693
27812000	weather	C0043085
27812000	conditions	C0348080
27812000	visual contact	C0243095
27812000	target	C1521840
27812000	organism	C0029235
27813390	Injury surveillance	C0681625
27813390	female	C0086287
27813390	adult	C0001675
27813390	Zumba	C1254363
27813390	dancers	C0335079
27813390	patterns	C0449774
27813390	injury	C0043251
27813390	injury	C0043251
27813390	incidence rates	C1708485
27813390	associated	C0332281
27813390	Zumba	C1254363
27813390	Zumba	C1254363
27813390	dancers	C0335079
27813390	web-based	C0282111
27813390	survey	C0038951
27813390	demographic	C0011292
27813390	background	C1706907
27813390	yr	C0439234
27813390	retrospective	C1514923
27813390	injury	C0043251
27813390	history	C0019665
27813390	questions	C1522634
27813390	Inclusion	C1512693
27813390	criteria	C0243161
27813390	respondents	C0282122
27813390	aged	C0001779
27813390	yr	C0439234
27813390	group	C1257890
27813390	classes	C0456387
27813390	Zumba	C1254363
27813390	registered instructor	C0556993
27813390	class	C0456387
27813390	participant	C0679646
27813390	Binomial logistic regression analysis	C0681925
27813390	odds	C0028873
27813390	injury	C0043251
27813390	Zumba	C1254363
27813390	Mann-Whitney tests	C1708930
27813390	groups	C1257890
27813390	survey	C0038951
27813390	response rate	C1521828
27813390	respondents	C0282122
27813390	female	C0086287
27813390	registered instructors	C0556993
27813390	class	C0456387
27813390	participants	C0679646
27813390	sustained	C0443318
27813390	injury	C0043251
27813390	Zumba	C1254363
27813390	year	C0439234
27813390	odds	C0028873
27813390	injury	C0043251
27813390	CI	C0009667
27813390	greater	C1704243
27813390	registered instructors	C0556993
27813390	class	C0456387
27813390	participants	C0679646
27813390	Zumba	C1254363
27813390	dancers	C0335079
27813390	CI	C0009667
27813390	greater	C1704243
27813390	odds	C0028873
27813390	injury	C0043251
27813390	h	C0439227
27813390	Zumba	C1254363
27813390	moderate to vigorous physical activity	C0015259
27813390	MVPA	C0015259
27813390	week	C0439230
27813390	injury	C0043251
27813390	incidence rate	C1708485
27813390	registered instructors	C0556993
27813390	class	C0456387
27813390	participants	C0679646
27813390	CI	C0009667
27813390	CI	C0009667
27813390	injuries	C0043251
27813390	h	C0439227
27813390	exposure	C0205556
27813390	Zumba	C1254363
27813390	low risk	C3538919
27813390	injury	C0043251
27813390	registered instructors	C0556993
27813390	increased risk	C1444641
27813390	injury	C0043251
27813390	MVPA	C0015259
27813390	participated	C0679823
27813390	weekly	C0332174
27818328	Clinical	C0205210
27818328	Features	C2348519
27818328	Smokers	C0337664
27818328	Radiological	C0807679
27818328	Emphysema	C0034067
27818328	Airway	C0458827
27818328	Limitation	C0449295
27818328	clinical characteristics	C0683325
27818328	patients	C0030705
27818328	emphysema	C0034067
27818328	airway	C0458827
27818328	limitations	C0449295
27818328	unknown	C0439673
27818328	goal	C0018017
27818328	study	C2603343
27818328	compare	C1707455
27818328	clinical	C0205210
27818328	features	C2348519
27818328	current	C3241966
27818328	former smokers	C0337671
27818328	airflow	C0231999
27818328	limitation	C0449295
27818328	radiologic	C0807679
27818328	emphysema	C0034067
27818328	chest CT scans	C0202823
27818328	control group	C0009932
27818328	current	C3241966
27818328	ex-smokers	C0337671
27818328	emphysema	C0034067
27818328	Subjects	C0681850
27818328	anthropometric characteristics	C2459906
27818328	provided	C1999230
27818328	medical history	C0262926
27818328	low-dose	C0445550
27818328	chest CT scanning	C0202823
27818328	parameters	C0449381
27818328	pulmonary function tests	C0024119
27818328	diffusion capacity for carbon monoxide	C1516251
27818328	Dlco	C1516251
27818328	Medical Research Council dyspnea score	C4288768
27818328	COPD assessment test	C4284282
27818328	CAT	C4284282
27818328	6-min walk test	C0430515
27818328	6MWT	C0430515
27818328	comparison	C1707455
27818328	CT	C0040405
27818328	confirmed	C0750484
27818328	emphysema	C0034067
27818328	subjects	C0681850
27818328	emphysema	C0034067
27818328	group	C2348561
27818328	comparisons	C1707455
27818328	revealed	C0443289
27818328	proportion	C1709707
27818328	patients	C0030705
27818328	emphysema	C0034067
27818328	low-dose	C0445550
27818328	chest CT scanning	C0202823
27818328	abnormal Dlco	C4073173
27818328	value	C1522609
27818328	decrease	C0547047
27818328	percentage	C0439165
27818328	oxygen saturation	C0369768
27818328	6MWT	C0430515
27818328	altered	C0392747
27818328	quality of life	C0034380
27818328	CAT	C4284282
27818328	score	C0449820
27818328	analysis	C0936012
27818328	CAT questionnaire	C4284282
27818328	revealed	C0443289
27818328	patients	C0030705
27818328	emphysema	C0034067
27818328	score	C0449820
27818328	chest tightness	C0232292
27818328	limitation	C0449295
27818328	activities	C0441655
27818328	home	C0442519
27818328	compared	C1707455
27818328	no emphysema	C0243095
27818328	exacerbations	C4086268
27818328	year	C0439234
27818328	significant	C0750502
27818328	proportion	C1709707
27818328	smokers	C0337664
27818328	emphysema	C0034067
27818328	low-dose	C0445550
27818328	chest CT scanning	C0202823
27818328	airway	C0458827
27818328	limitation	C0449295
27818328	alterations	C1515926
27818328	quality of life	C0034380
27818328	exacerbations	C4086268
27818328	Dlco	C1516251
27818328	values	C1522609
27818328	oxygen saturation	C0369768
27818328	6MWT test	C0430515
27819344	Anti-tumor activity	C1516031
27819344	SL4	C4278992
27819344	breast cancer cells	C1512505
27819344	induction	C0205263
27819344	G2/M arrest	C1517345
27819344	modulation	C0678672
27819344	MAPK	C0752312
27819344	p21	C0288472
27819344	signaling pathway	C0037083
27819344	SL4	C4278992
27819344	chalcone	C0007935
27819344	compound	C1706082
27819344	retard	C0521111
27819344	tumor invasion	C1269955
27819344	angiogenesis	C1519670
27819344	suppressing	C1260953
27819344	HIF1	C0215848
27819344	activity	C0441655
27819344	induce	C0205263
27819344	apoptosis	C0162638
27819344	promoting	C0033414
27819344	ROS	C0162772
27819344	release	C1283071
27819344	report	C0684224
27819344	SL4	C4278992
27819344	inhibit	C3463820
27819344	proliferation	C0596290
27819344	different	C1705242
27819344	types	C0332307
27819344	breast cancer cell	C1512505
27819344	in vitro	C1533691
27819344	in vivo	C1515655
27819344	inducing	C0205263
27819344	G2/M cell cycle arrest	C1517345
27819344	results	C0683954
27819344	SL4	C4278992
27819344	exhibited	C0870432
27819344	strong	C0442821
27819344	anti-proliferative	C0003392
27819344	activity	C0441655
27819344	human	C0086418
27819344	breast cancer	C0678222
27819344	cell lines	C0085983
27819344	IC50 values	C0600495
27819344	lower	C2003888
27819344	studies	C2603343
27819344	indicated	C1444656
27819344	SL4	C4278992
27819344	induced	C0205263
27819344	G2/M arrest	C1517345
27819344	cell lines	C0085983
27819344	Mechanistically	C0598002
27819344	SL4	C4278992
27819344	reduces	C0392756
27819344	expression	C0017262
27819344	cyclin A2	C0297674
27819344	cdc25C	C0213045
27819344	decreases	C0547047
27819344	activity	C1537044
27819344	cdc2	C0080054
27819344	cyclin B1	C0385333
27819344	complex	C1704241
27819344	SL4	C4278992
27819344	treatment	C1533734
27819344	resulted in	C0332294
27819344	increase	C0442805
27819344	p21	C0249197
27819344	mRNA	C0035696
27819344	protein	C0033684
27819344	levels	C0441889
27819344	activation	C2259058
27819344	MAPK signaling pathways	C1518102
27819344	TGF-β pathway	C1155363
27819344	SP600125	C0968383
27819344	PD98059	C0298346
27819344	inhibitors	C0243077
27819344	JNK kinase	C0291988
27819344	ERK kinase	C0600388
27819344	significantly	C0750502
27819344	blocked	C0332206
27819344	SL4	C4278992
27819344	induced	C0205263
27819344	G2/M phase arrest	C1517345
27819344	upregulation	C0041904
27819344	p21	C0288472
27819344	SL4	C4278992
27819344	suppressed	C1260953
27819344	growth	C0007595
27819344	established	C0443211
27819344	breast tumors	C1458155
27819344	nude mice	C0025932
27819344	upregulation	C0041904
27819344	p21	C0288472
27819344	downregulation	C0013081
27819344	cdc25C	C0213045
27819344	displayed	C0870432
27819344	safety	C0036043
27819344	profile	C2003903
27819344	findings	C0243095
27819344	demonstrate	C0443211
27819344	potential	C3245505
27819344	value	C1264628
27819344	SL4	C4278992
27819344	multi-target anti-tumor drug candidate	C0003392
27820857	Identification	C0205396
27820857	In-Chain-Functionalized Compounds	C1706082
27820857	Methyl-Branched Alkanes	C0002065
27820857	Cuticular	C2699479
27820857	Waxes	C0043076
27820857	Triticum aestivum cv. Bethlehem	C1123020
27820857	cuticular	C2699479
27820857	waxes	C0043076
27820857	flag leaf	C0242724
27820857	blades	C2700402
27820857	peduncles	C2698753
27820857	Triticum aestivum cv. Bethlehem	C1123020
27820857	investigated	C1292732
27820857	novel	C0205314
27820857	wax compounds	C0043076
27820857	wax compound	C0043076
27820857	classes	C1705943
27820857	detected	C0442726
27820857	structures	C0220807
27820857	gas chromatography-mass spectrometry	C0024868
27820857	derivatives	C0243072
27820857	series of homologs	C0205549
27820857	differing	C1705242
27820857	two methylene units	C1254350
27820857	homologous series	C0205549
27820857	homologs with single methylene unit	C1254350
27820857	waxes	C0043076
27820857	flag leaf	C0242724
27820857	blades	C2700402
27820857	secondary alcohols	C0682927
27820857	predominantly	C1542147
27820857	C27	C0682927
27820857	C33	C0682927
27820857	primary	C0017951
27820857	secondary diols	C0017951
27820857	predominantly	C1542147
27820857	C28	C0017951
27820857	esters of primary	C0014898
27820857	secondary diols	C0014898
27820857	predominantly	C1542147
27820857	C50	C0014898
27820857	C28 diol	C0017945
27820857	C22 acid	C0369760
27820857	secondary hydroxyl group positions	C1254350
27820857	7-	C0014898
27820857	8-hydroxy-2-alkanol esters	C0014898
27820857	predominantly	C1542147
27820857	C35	C0014898
27820857	7-	C0014898
27820857	8-oxo-2-alkanol esters	C0014898
27820857	predominantly	C1542147
27820857	C35	C0014898
27820857	4-alkylbutan-4-olides	C0022947
27820857	predominantly	C1542147
27820857	C28	C0022947
27820857	flag leaf	C0242724
27820857	peduncle	C2698753
27820857	wax	C0043076
27820857	series	C0205549
27820857	even	C1254350
27820857	odd-numbered alkane homologs	C1254350
27820857	leaf	C0242724
27820857	peduncle	C2698753
27820857	waxes	C0043076
27820857	internal methyl branch	C1254350
27820857	C-11	C0029224
27820857	C-13 of homologs with even total carbon number	C0029224
27820857	C-12 of odd-numbered homologs	C0029224
27820857	Biosynthetic pathways	C1721101
27820857	compounds	C0205198
27820857	structural	C0220807
27820857	features	C2348519
27820857	chain length	C0596310
27820857	profiles	C2003903
27820857	wheat	C1510495
27820857	wax compound	C0043076
27821359	Pupillary response	C4067879
27821359	abnormalities	C1704258
27821359	depressive disorders	C0011581
27821359	Depressive disorders	C0011581
27821359	lack	C0332268
27821359	objective	C1571702
27821359	physiological	C0205463
27821359	measurements	C0242485
27821359	characterize	C1880022
27821359	affected population	C4285581
27821359	study	C0008972
27821359	relevant	C2347946
27821359	mechanisms	C0441712
27821359	melanopsin	C0670514
27821359	mediated	C0870868
27821359	light signaling pathway	C0037080
27821359	seasonal variation	C0036496
27821359	measured	C0444706
27821359	pupillometry	C0260180
27821359	prospectively studied	C0033522
27821359	melanopsin	C0670514
27821359	mediated	C0870868
27821359	pupillary constriction	C3537108
27821359	participants	C0030705
27821359	major depressive disorder	C1269683
27821359	MDD	C1269683
27821359	control	C0009932
27821359	summer and winter solstices	C1254367
27821359	melanopsin	C0670514
27821359	mediated response	C0870868
27821359	measured	C0444706
27821359	pupil's sustained constriction	C0728710
27821359	high intensity	C0683109
27821359	blue light	C0303896
27821359	stimulus	C0234402
27821359	attenuated	C0599946
27821359	MDD	C1269683
27821359	controls	C0009932
27821359	p	C1709380
27821359	participants	C0030705
27821359	MDD	C1269683
27821359	significantly	C0750502
27821359	reduced	C0392756
27821359	transient	C0205374
27821359	pupillary response	C4067879
27821359	low intensity	C0683108
27821359	red	C0563227
27821359	p	C1709380
27821359	blue light	C0303896
27821359	p	C1709380
27821359	high intensity	C0683109
27821359	red	C0563227
27821359	blue light	C0303896
27821359	pupillary constriction	C3537108
27821359	response	C4067879
27821359	high intensity	C0683109
27821359	blue light	C0303896
27821359	increasing	C0442808
27821359	daylight	C0023693
27821359	hours	C0439227
27821359	p	C1709380
27821359	objectively	C1571702
27821359	measured	C0444706
27821359	estimated	C0750572
27821359	light exposure	C1689916
27821359	Melanopsin	C0670514
27821359	mediated	C0870868
27821359	impairments	C0221099
27821359	pupil response	C4067879
27821359	biological marker	C0005516
27821359	vulnerability	C1821973
27821359	depression	C0011570
27821359	low light	C0683108
27821359	conditions	C0348080
27821359	Assessment	C0220825
27821359	responses	C0871261
27821359	light	C0023693
27821359	stimuli	C0234402
27821359	response	C0871261
27821359	low intensity light	C0683108
27821359	study	C0008972
27821359	neurobiology	C0027817
27821359	MDD	C1269683
27821359	mood disorders	C0525045
27821419	Long Noncoding RNAs	C2982391
27821419	Cardiovascular Pathology	C0741949
27821419	Diagnosis	C1704656
27821419	Therapy	C0087111
27821419	mammalian	C0024660
27821419	genomes	C0017428
27821419	encode	C2700640
27821419	transcripts	C1519595
27821419	translated into proteins	C1519614
27821419	purpose	C1285529
27821419	majority	C0205164
27821419	noncoding ribonucleic acids	C0887909
27821419	(RNAs)	C0887909
27821419	paradoxical	C0205310
27821419	growing	C0442808
27821419	evidence	C3887511
27821419	demonstrates	C3687625
27821419	long noncoding RNAs	C2982391
27821419	dynamically	C0729333
27821419	expressed	C0017262
27821419	different	C1705242
27821419	cell types	C0007634
27821419	diseases	C0012634
27821419	developmental stages	C0870411
27821419	execute	C1705848
27821419	wide variety	C2346866
27821419	regulatory roles	C1704735
27821419	virtually	C0205556
27821419	step	C1261552
27821419	gene expression	C0017262
27821419	translation	C1519614
27821419	long noncoding RNAs	C2982391
27821419	influence	C4054723
27821419	gene expression	C0017262
27821419	epigenetic modulations	C1516924
27821419	regulating	C0017263
27821419	alternative splicing	C0002345
27821419	molecular sponges	C0205556
27821419	abundance	C2346714
27821419	long noncoding RNAs	C2982391
27821419	cardiovascular system	C0007226
27821419	complex	C0439855
27821419	regulatory network	C1720950
27821419	governing	C2239193
27821419	physiology	C1254359
27821419	pathology	C0030660
27821419	heart	C0018787
27821419	multifaceted	C0205291
27821419	functions	C0542341
27821419	long noncoding RNAs	C2982391
27821419	current literature	C0023866
27821419	cardiac development	C2263229
27821419	disease	C0012634
27821419	Furthermore	C1517331
27821419	enormous	C0205231
27821419	long noncoding RNAs	C2982391
27821419	potentially	C3245505
27821419	avenues	C1254362
27821419	diagnosis	C1704656
27821419	prevention	C0199176
27821419	heart failure	C0018801
27821419	futuristic prospects	C1552610
27821419	long noncoding RNAs	C2982391
27821419	biomarkers	C0005516
27821419	therapeutic	C0302350
27821419	targets	C0028622
27821419	treatment	C0087111
27821419	cardiovascular disorders	C0007222
27822189	Flexible	C0443220
27822189	Coordination	C0700114
27822189	Stationary	C0439835
27822189	Mobile	C0231435
27822189	Conversations	C0871703
27822189	Gaze	C0553544
27822189	Resource Allocation	C0086914
27822189	Multiple Joint Activities	C0026606
27822189	Gaze	C0553544
27822189	coordinating	C0700114
27822189	face-to-face	C1553514
27822189	social interactions	C0037420
27822189	gaze	C0553544
27822189	social interactions	C0037420
27822189	co-occur	C1709305
27822189	joint activities	C0026606
27822189	investigated	C1292732
27822189	walking	C0080331
27822189	talking	C0234856
27822189	assessed	C1516048
27822189	gaze	C0553544
27822189	allocated	C1706778
27822189	targets	C0039309
27822189	mobile	C0231435
27822189	conversations	C0871703
27822189	allocation	C1706778
27822189	gaze	C0553544
27822189	targets	C0039309
27822189	affects	C0001721
27822189	conversational	C0871703
27822189	coordination	C0700114
27822189	reduced	C0392756
27822189	availability of	C0470187
27822189	gaze	C0553544
27822189	conversational	C0871703
27822189	coordination	C0700114
27822189	affects	C0001721
27822189	conversational	C0871703
27822189	performance	C0597198
27822189	content	C0456205
27822189	experimental study	C0681814
27822189	videotaped	C0042654
27822189	conditions	C0449910
27822189	mobility	C0425245
27822189	standing still	C0231472
27822189	talking	C0234856
27822189	walking along a straight-line itinerary	C0522230
27822189	talking	C0234856
27822189	walking	C0080331
27822189	complex itinerary	C0439855
27822189	walking	C0080331
27822189	complex itinerary	C0439855
27822189	no conversational	C0243095
27822189	task	C3540678
27822189	Gaze	C0553544
27822189	partners	C0026767
27822189	substantially reduced	C0392756
27822189	mobile	C0231435
27822189	conversations	C0871703
27822189	gaze	C0553544
27822189	coordinate	C0700114
27822189	conversation	C0871703
27822189	displays	C0870432
27822189	mutual	C1709100
27822189	orientation	C1704322
27822189	conversational	C0871703
27822189	performance	C0597198
27822189	content	C0456205
27822189	different	C1705242
27822189	stationary	C0439835
27822189	mobile	C0231435
27822189	conditions	C0449910
27822189	Results	C0456984
27822189	phenomena	C1882365
27822189	joint activities	C0026606
27823893	Sepsis	C0243026
27823893	Clinical Criteria	C1516637
27823893	Emergency Department	C0562508
27823893	Patients	C0030705
27823893	Admitted	C0184666
27823893	Intensive Care Unit	C0021708
27823893	External Validation Study	C0681836
27823893	Quick Sequential Organ Failure Assessment	C3494459
27823893	Quick Sequential Organ Failure Assessment	C3494459
27823893	qSOFA	C3494459
27823893	prognostic score	C0449821
27823893	patients	C0030705
27823893	sepsis	C0243026
27823893	aim	C1947946
27823893	area under the receiver operating curve	C0035787
27823893	AUROC	C0035787
27823893	sensitivity	C0036667
27823893	specificity	C0037791
27823893	likelihood ratios	C0150102
27823893	qSOFA	C3494459
27823893	systemic inflammation response syndrome	C0242966
27823893	SIRS	C0242966
27823893	in-hospital mortality	C0085556
27823893	emergency department	C0562508
27823893	ED	C0562508
27823893	patients	C0030705
27823893	suspected infection	C3714514
27823893	admitted	C0184666
27823893	intensive care units	C0021708
27823893	ICUs	C0021708
27823893	retrospective cohort chart review study	C2985505
27823893	ED	C0562508
27823893	patients	C0030705
27823893	admitted	C0184666
27823893	ICU	C0021708
27823893	suspected infection	C3714514
27823893	August	C3831448
27823893	February	C3830166
27823893	patients	C0030705
27823893	body fluid cultures sampled	C1292527
27823893	ED	C0562508
27823893	antibiotic administration	C0199779
27823893	antibiotics administered	C0199779
27823893	ED	C0562508
27823893	Trained chart abstractors	C1522486
27823893	study	C2603343
27823893	double-entered data	C1511726
27823893	patient's	C0030705
27823893	electronic medical record	C2362543
27823893	demographic characteristics	C0683970
27823893	vital signs	C0518766
27823893	laboratory study results	C0681827
27823893	physical examination	C0031809
27823893	findings	C0243095
27823893	in-hospital mortality	C0085556
27823893	AUROC	C0035787
27823893	sensitivity	C0036667
27823893	specificity	C0037791
27823893	likelihood ratios	C0150102
27823893	qSOFA	C3494459
27823893	SIRS	C0242966
27823893	in-hospital mortality	C0085556
27823893	patients	C0030705
27823893	admitted	C0184666
27823893	ICU	C0021708
27823893	presumed sepsis	C0243026
27823893	died during hospitalization	C3260027
27823893	AUROC	C0035787
27823893	confidence interval	C0009667
27823893	CI	C0009667
27823893	SIRS	C0242966
27823893	CI	C0009667
27823893	qSOFA	C3494459
27823893	qSOFA	C3494459
27823893	in-hospital mortality	C0085556
27823893	sensitivity	C0036667
27823893	specificity	C0037791
27823893	positive likelihood ratio	C0150102
27823893	negative likelihood ratio	C0150102
27823893	ED	C0562508
27823893	patients	C0030705
27823893	admitted	C0184666
27823893	ICU	C0021708
27823893	SIRS	C0242966
27823893	qSOFA	C3494459
27823893	prognostic value	C0449821
27823893	in-hospital mortality	C0085556
27823893	prognostic values	C0449821
27823893	Sepsis-3 guidelines	C0282451
27823893	ICU	C0021708
27823893	encounters	C3889614
27823981	Repetitive transcranial magnetic stimulation	C0872259
27823981	cognitive function	C0392335
27823981	Alzheimer's disease	C0002395
27823981	patients	C0030705
27823981	Repetitive transcranial magnetic stimulation	C0872259
27823981	rTMS	C0872259
27823981	intervention	C0184661
27823981	neurological disorders	C0027765
27823981	prospective	C0033522
27823981	randomized	C0034656
27823981	double-blind	C0013072
27823981	placebo-controlled trial	C1706408
27823981	investigates	C1292732
27823981	rTMS	C0872259
27823981	cases	C0868928
27823981	Alzheimer's disease	C0002395
27823981	AD	C0002395
27823981	participants	C0679646
27823981	mild	C2945599
27823981	moderate	C0205081
27823981	groups	C1257890
27823981	Neuropsychological tests	C0027902
27823981	AD Assessment Scale	C0450989
27823981	cognitive subscale	C0282574
27823981	ADAS	C0450989
27823981	cog	C0282574
27823981	Mini-Mental State Examination	C0451306
27823981	MMSE	C0451306
27823981	Montreal Cognitive Assessment	C3496286
27823981	MoCA	C3496286
27823981	World Health Organization University of California-Los Angeles, Auditory Verbal Learning Test	C0589055
27823981	WHO-UCLA AVLT	C0589055
27823981	weeks	C0439230
27823981	intervention	C0184661
27823981	data	C1511726
27823981	AD	C0002395
27823981	patients	C0030705
27823981	interaction effect	C0548930
27823981	ADAS	C0450989
27823981	cog	C0282574
27823981	MMSE	C0451306
27823981	WHO-UCLA AVLT	C0589055
27823981	score	C0449820
27823981	rTMS	C0872259
27823981	group	C1257890
27823981	compared	C1707455
27823981	baselines	C1442488
27823981	weeks	C0439230
27823981	treatment	C0087111
27823981	MoCA	C3496286
27823981	scores	C0449820
27823981	ameliorated	C0184511
27823981	mild	C2945599
27823981	AD	C0002395
27823981	patients	C0030705
27823981	rTMS	C0872259
27823981	subgroup analysis	C0936012
27823981	rTMS	C0872259
27823981	memory	C0025260
27823981	language	C0023008
27823981	mild	C2945599
27823981	AD	C0002395
27823981	patients	C0030705
27823981	moderate	C0205081
27823981	AD	C0002395
27823981	patients	C0030705
27823981	findings	C0243095
27823981	repetitive transcranial magnetic stimulation	C0872259
27823981	cognitive function	C0392335
27823981	memory	C0025260
27823981	language	C0023008
27823981	level	C0441889
27823981	AD	C0002395
27823981	patients	C0030705
27823981	mild	C2945599
27823981	stage	C0205390
27823981	AD	C0002395
27823981	rTMS	C0872259
27823981	adjuvant therapy	C0677850
27823981	cholinesterase inhibitors	C0008425
27823981	mild	C2945599
27823981	stage	C0205390
27823981	AD	C0002395
27823981	patients	C0030705
27824066	Novel	C0205314
27824066	Insulin/Glucose	C1719133
27824066	Model	C3161035
27824066	Mixed-Meal Test	C0202098
27824066	Patients	C0030705
27824066	Type 1 Diabetes	C0011854
27824066	Insulin Pump	C1140609
27824066	Therapy	C0087111
27824066	Current	C0521116
27824066	closed-loop insulin delivery methods	C0181334
27824066	glucose-insulin (G/I) system	C1719133
27824066	mostly	C0750554
27824066	complex	C0439855
27824066	studies	C0008972
27824066	employing	C0557351
27824066	glucose tracer technology	C0726401
27824066	tested	C0039593
27824066	performance	C1882330
27824066	minimal model	C3161035
27824066	GLUKINSLOOP 2.0	C3161035
27824066	G/I system	C1719133
27824066	characterize	C1880022
27824066	glucose and insulin	C1719133
27824066	dynamics	C3826426
27824066	multiple	C0439064
27824066	mixed meal tests	C0202098
27824066	MMT	C0202098
27824066	different	C1705242
27824066	sizes	C0456389
27824066	patients	C0030705
27824066	type 1 diabetes	C0011854
27824066	T1D	C0011854
27824066	insulin pump	C1140609
27824066	therapy	C0087111
27824066	continuous subcutaneous insulin infusion	C0393124
27824066	CSII	C0393124
27824066	GLUKINSLOOP 2.0	C3161035
27824066	identified	C0205396
27824066	G/I system	C1719133
27824066	provided	C1999230
27824066	G/I	C1719133
27824066	time-courses	C0449247
27824066	acceptable	C1879533
27824066	reproducibility	C1514863
27824066	G/I system	C1719133
27824066	parameters	C0449381
27824066	repeated	C0205341
27824066	studies	C0008972
27824066	identical	C0205280
27824066	double-sized	C0392762
27824066	MMTs	C0202098
27824066	model	C3161035
27824066	provide	C1999230
27824066	description	C0678257
27824066	G/I system	C1719133
27824066	T1D	C0011854
27824066	patients	C0030705
27824066	CSII	C0393124
27824066	applied	C4048755
27824066	"virtual" patients	C1553497
27824066	results	C0456984
27824066	relevant	C2347946
27824066	improving	C1272745
27824066	closed-loop	C0443183
27824066	CSII	C0393124
27824925	Impact	C4049986
27824925	White Matter Hyperintensities	C2938912
27824925	Cognition	C0009240
27824925	Memory Clinic	C0442592
27824925	Patients	C0030705
27824925	Small Vessel Disease	C2733158
27824925	impact	C4049986
27824925	small vessel disease	C2733158
27824925	SVD	C2733158
27824925	cognition	C0009240
27824925	focus	C0205234
27824925	white matter hyperintensity	C2938912
27824925	WMH	C2938912
27824925	volume	C0449468
27824925	extent	C0439792
27824925	WMH	C2938912
27824925	location	C1515974
27824925	relates	C0439849
27824925	cognitive performance	C0392335
27824925	received	C1514756
27824925	less	C0439092
27824925	attention	C0004268
27824925	functionally	C0205245
27824925	important	C3898777
27824925	relation	C0439849
27824925	WMH	C2938912
27824925	location	C1515974
27824925	cognition	C0009240
27824925	memory clinic	C0442592
27824925	cohort	C0599755
27824925	patients	C0030705
27824925	sporadic	C0205422
27824925	SVD	C2733158
27824925	patients	C0030705
27824925	SVD	C2733158
27824925	memory clinics	C0442592
27824925	Assumption-free region of interest-based analyses	C0936012
27824925	based	C1527178
27824925	white matter	C0682708
27824925	tracts	C1185740
27824925	voxel	C2700259
27824925	wise	C1527178
27824925	analyses	C0936012
27824925	used	C1524063
27824925	association	C0439849
27824925	WMH	C2938912
27824925	location	C1515974
27824925	executive functioning	C0935584
27824925	visuomotor speed	C0025361
27824925	memory	C0025260
27824925	Region of interest-based analyses	C0936012
27824925	WMHs	C2938912
27824925	located	C1515974
27824925	within	C0332285
27824925	anterior thalamic radiation	C2338170
27824925	forceps minor	C0152325
27824925	inversely	C0439850
27824925	associated with	C0332281
27824925	executive functioning	C0935584
27824925	visuomotor speed	C0025361
27824925	independent of	C0332291
27824925	total	C0439810
27824925	WMH	C2938912
27824925	volume	C0449468
27824925	Memory	C0025260
27824925	associated with	C0332281
27824925	WMH	C2938912
27824925	volume	C0449468
27824925	forceps minor	C0152325
27824925	independent of	C0332291
27824925	total	C0439810
27824925	WMH	C2938912
27824925	volume	C0449468
27824925	independent assumption-free voxel-wise analysis	C0936012
27824925	identified	C0205396
27824925	voxels	C2700259
27824925	same	C0445247
27824925	tracts	C1185740
27824925	Region of interest-based analyses	C0936012
27824925	WMH	C2938912
27824925	volume	C0449468
27824925	within	C0332285
27824925	anterior thalamic radiation	C2338170
27824925	variance	C1711260
27824925	executive functioning	C0935584
27824925	compared	C1707455
27824925	total	C0439810
27824925	WMH	C2938912
27824925	volume	C0449468
27824925	WMH	C2938912
27824925	volume	C0449468
27824925	within	C0332285
27824925	forceps minor	C0152325
27824925	variance	C1711260
27824925	visuomotor speed	C0025361
27824925	variance	C1711260
27824925	memory	C0025260
27824925	compared	C1707455
27824925	total	C0439810
27824925	WMH	C2938912
27824925	volume	C0449468
27824925	findings	C0243095
27824925	identify	C0205396
27824925	anterior thalamic radiation	C2338170
27824925	forceps minor	C0152325
27824925	white matter	C0682708
27824925	tracts	C1185740
27824925	WMHs	C2938912
27824925	associated with	C0332281
27824925	cognitive impairment	C0338656
27824925	memory clinic	C0442592
27824925	patients	C0030705
27824925	SVD	C2733158
27824925	WMH	C2938912
27824925	volumes	C0449468
27824925	tracts	C1185740
27824925	variance	C1711260
27824925	cognition	C0009240
27824925	total	C0439810
27824925	WMH	C2938912
27824925	importance	C3898777
27824925	lesion location	C2184261
27824925	functional	C0205245
27824925	consequences of	C0686907
27824925	WMHs	C2938912
27825443	Natural	C0205296
27825443	competence	C0086035
27825443	transformation	C0040683
27825443	molecular biologists	C0260017
27825443	artificial	C2004457
27825443	transformation of bacteria	C0040683
27825443	context	C0449255
27825443	laboratory	C0022877
27825443	cloning	C0009015
27825443	experiments	C0681814
27825443	natural	C0205296
27825443	competence	C0086035
27825443	transformation	C0040683
27825443	specific	C0205369
27825443	physiological	C0205463
27825443	state	C1442792
27825443	prokaryotes	C0686817
27825443	genetic material	C0440471
27825443	surroundings	C1282914
27825443	absorbed	C0205245
27825443	DNA	C0012854
27825443	recombined	C0205195
27825443	organism's	C0029235
27825443	genome	C0017428
27825443	natural	C0205296
27825443	transformation	C0040683
27825443	consequence	C0686907
27825443	natural	C0205296
27825443	competence	C0086035
27825443	transformation	C0040683
27825443	primary	C0205225
27825443	mode	C1513371
27825443	horizontal gene transfer	C0887912
27825443	HGT	C0887912
27825443	prokaryotes	C0686817
27825443	conjugation	C0009757
27825443	direct	C1947931
27825443	cell	C0007634
27825443	cell	C0007634
27825443	transfer	C3244299
27825443	DNA	C0012854
27825443	specialized	C1704211
27825443	conjugal pilus	C0242435
27825443	phage	C0004651
27825443	transduction	C0040667
27825443	DNA	C0012854
27825443	transfer	C3244299
27825443	viruses	C0042776
27825443	HGT	C0887912
27825443	bacterial	C0521009
27825443	evolution	C0015219
27825443	past	C1444637
27825443	research	C0035168
27825443	HGT	C0887912
27825443	natural	C0205296
27825443	competence	C0086035
27825443	transformation	C0040683
27825443	contributes	C1880177
27825443	pathogens	C0450254
27825443	spread	C0332261
27825443	virulence factors	C1136170
27825443	natural	C0205296
27825443	competence	C0086035
27825443	transformation	C0040683
27825443	investigating	C1292732
27825443	exchange	C1749881
27825443	pathogenic	C3816499
27825443	traits	C0599883
27825443	pneumococci	C0038410
27825443	increase	C0442805
27825443	abundance	C2346714
27825443	spread	C0332261
27825443	multidrug-resistant microbes	C4076168
27825443	research	C0035168
27825443	HGT	C0887912
27826087	Three-dimensional constructive interference in steady-state (3D-CISS) sequences	C1275506
27826087	Phase-contrast MRI	C0024485
27826087	arrested hydrocephalus	C0270718
27826087	three-dimensional constructive interference in steady-state (3D-CISS) sequences	C1275506
27826087	phase-contrast magnetic resonance imaging	C0024485
27826087	PC-MRI	C0024485
27826087	patients	C0030705
27826087	arrested hydrocephalus	C0270718
27826087	Prospective study	C0033522
27826087	patients	C0030705
27826087	arrested hydrocephalus	C0270718
27826087	patients	C0030705
27826087	PC-MRI	C0024485
27826087	3D-CISS	C1275506
27826087	assessment	C0220825
27826087	aqueduct	C0228168
27826087	Axial	C0205131
27826087	through-plane	C1254362
27826087	sagittal	C0205129
27826087	in-plane	C1254362
27826087	PC-MRI	C0024485
27826087	sagittal	C0205129
27826087	3D-CISS	C1275506
27826087	assess	C0184514
27826087	cerebral aqueduct	C0007769
27826087	spontaneous	C0205359
27826087	third ventriculostomy	C0844213
27826087	Aqueductal	C0228168
27826087	patency	C0175566
27826087	graded	C0441800
27826087	3D-CISS	C1275506
27826087	PC-MRI	C0024485
27826087	Quantitative analysis	C0200767
27826087	aqueduct	C0228168
27826087	PC-MRI	C0024485
27826087	obstruction	C0028778
27826087	aqueductal	C0228168
27826087	obstruction	C0028778
27826087	ventricular obstruction	C0042512
27826087	ventricular obstruction	C0042512
27826087	arrest	C0237477
27826087	hydrocephalus	C0020255
27826087	spontaneous	C0205359
27826087	third ventriculostomy	C0844213
27826087	endoscopic third ventriculostomy	C0844212
27826087	ventriculo-peritoneal shunt	C3874496
27826087	detected	C0442726
27826087	patients	C0030705
27826087	positive	C1446409
27826087	correlation	C1707520
27826087	moderate	C0205081
27826087	agreement	C0680240
27826087	grading	C0441800
27826087	PC-MRI	C0024485
27826087	3D-CISS sequences	C1275506
27826087	mean peak systolic velocity	C0392762
27826087	CSF	C0007806
27826087	stroke volume	C0038455
27826087	mean flow	C0392762
27826087	3D-CISS	C1275506
27826087	PC-MRI	C0024485
27826087	non-invasive	C0205303
27826087	diagnosis	C0011900
27826087	cause	C0015127
27826087	arrested hydrocephalus	C0270718
27828958	Historical	C0681698
27828958	Environment	C0014406
27828958	Modern Population Genetics	C0017404
27828958	Biogeography	C2936603
27828958	Island	C0022130
27828958	Endemic	C0243130
27828958	Lizard	C0023916
27828958	Xantusia riversiana reticulata	C0999100
27828958	restricted distribution	C1704711
27828958	isolation	C0205409
27828958	island	C0022130
27828958	endemics	C0243130
27828958	genetic	C0042333
27828958	phenotypic	C0031437
27828958	diversity	C1880371
27828958	conservation	C2347858
27828958	management	C3273539
27828958	agencies	C0237463
27828958	isolated	C0205409
27828958	species	C1705920
27828958	sensitive	C0332324
27828958	life history	C0598779
27828958	traits	C0599883
27828958	high risk	C0332167
27828958	adverse effects	C0879626
27828958	genetic drift	C0917892
27828958	habitat	C0871648
27828958	degradation	C0243125
27828958	non-native wildlife	C0003070
27828958	study	C2603343
27828958	population	C1257890
27828958	genetic diversity	C0042333
27828958	structure	C0678594
27828958	stability	C0205360
27828958	island giant	C0023916
27828958	Xantusia riversiana	C0999100
27828958	Island Night Lizard	C0023916
27828958	San Clemente Island	C0022130
27828958	California	C0006754
27828958	removal	C1883720
27828958	feral goats	C1510458
27828958	DNA	C0012854
27828958	microsatellites	C1519302
27828958	population	C1257890
27828958	genetically	C0314603
27828958	robust	C2986815
27828958	historical	C0681698
27828958	grazing	C3178952
27828958	population sizes	C0032683
27828958	genetic diversity	C0042333
27828958	sampling	C0870078
27828958	locations	C0017446
27828958	habitat	C0871648
27828958	degree of degradation	C0205556
27828958	site-specific	C0449604
27828958	patterns	C0449774
27828958	genetic variation	C0042333
27828958	genetic diversity	C0042333
27828958	mainland congeners	C0035161
27828958	management	C3273539
27828958	island	C0022130
27828958	endemic	C0243130
27828958	high	C0205250
27828958	low	C0205251
27828958	elevation areas	C0702240
27828958	repositories	C3847505
27828958	genetic diversity	C0042333
27828958	case study	C0085973
27828958	low-dispersal	C1254365
27828958	coastal	C0557760
27828958	organisms	C0029235
27828958	future	C0016884
27828958	climate change	C2718051
27829026	Rhesus	C0024400
27829026	Cytomegalovirus Infection	C0010823
27829026	Cynomolgus Macaques	C0024399
27829026	Cytomegaloviruses	C0010825
27829026	CMV	C0010825
27829026	co-evolution	C0015219
27829026	adaptation	C0392673
27829026	host	C1167395
27829026	species	C1705920
27829026	infection	C3714514
27829026	primates	C0033147
27829026	genome	C0017428
27829026	phylogenetic analysis	C1519068
27829026	CMV	C0010825
27829026	isolates	C1764827
27829026	nonhuman primate	C0237798
27829026	species	C1705920
27829026	Indian-origin	C0425361
27829026	rhesus macaques	C0024400
27829026	RM	C0024400
27829026	Mauritian	C0024944
27829026	cynomolgus macaques	C0024399
27829026	MCM	C0024399
27829026	lineage	C1881379
27829026	species of origin	C0449420
27829026	MCM	C0024399
27829026	CMV	C0010825
27829026	isolates	C1764827
27829026	genetic diversity	C0042333
27829026	primate	C0033147
27829026	host	C1167395
27829026	ability	C0085732
27829026	Rhesus	C0024400
27829026	CMV	C0010825
27829026	RhCMV	C0010825
27829026	laboratory strain	C0007635
27829026	replicate	C1883725
27829026	MCM	C0024399
27829026	fibroblasts	C0016030
27829026	inhibit antigen presentation	C2250749
27829026	MCM	C0024399
27829026	T cells	C0039194
27829026	in vitro	C1533691
27829026	RhCMV	C0010825
27829026	infect	C3714514
27829026	MCM	C0024399
27829026	in vivo	C1515655
27829026	host	C1167395
27829026	CD8+ T	C0242629
27829026	NK cells	C0022688
27829026	RhCMV	C0010825
27829026	clone	C1522642
27829026	genetically	C0314603
27829026	repaired	C1705181
27829026	express	C0017262
27829026	homologues	C1334043
27829026	HCMV	C0010825
27829026	anti-apoptosis	C1512772
27829026	gene UL36	C0210337
27829026	epithelial cell tropism	C4277517
27829026	genes UL128	C2605215
27829026	UL130	C1608605
27829026	infected	C3714514
27829026	MCM	C1257890
27829026	induction	C0017391
27829026	transgene	C0282641
27829026	T cells	C0039194
27829026	virus shedding	C0162633
27829026	Recombinant variants	C0034861
27829026	RhCMV	C0010825
27829026	expression	C0017262
27829026	UL36	C0210337
27829026	UL128	C2605215
27829026	UL130	C1608605
27829026	MCM	C1257890
27829026	infection	C3714514
27829026	species	C1705920
27829026	restriction	C0443288
27829026	hosts	C1167395
27829026	cell tropism	C4277517
27829026	apoptosis	C0162638
27829026	determinants	C1521761
27829026	CMV	C0010825
27829026	transmission	C1160716
27829026	primate	C0033147
27829026	species	C1705920
27829026	macaque	C0024398
27829026	model	C3161035
27829026	human	C0086418
27829026	CMV	C0010825
27829026	infection	C3714514
27829026	immunology	C0152036
27829026	MCM	C1257890
27829026	nonhuman primate	C0237798
27829026	species	C1705920
27829026	host	C1167395
27829026	immunogenetics	C0021005
27829875	Mildly	C2945599
27829875	raised	C0442818
27829875	tricuspid regurgitant velocity	C2059632
27829875	pregnant women	C0033011
27829875	sickle cell disease	C0002895
27829875	associated with	C0332281
27829875	poor	C0542537
27829875	obstetric	C0205484
27829875	outcome	C1274040
27829875	observational cross-sectional study	C0010362
27829875	Pulmonary hypertension	C0020542
27829875	associated with	C0332281
27829875	mortality	C0024923
27829875	pregnancy	C0032961
27829875	patients	C0030705
27829875	sickle cell disease	C0002895
27829875	pulmonary hypertension	C0020542
27829875	Tricuspid regurgitant velocity	C2059632
27829875	echocardiography	C0013516
27829875	screening	C1710032
27829875	pulmonary hypertension	C0020542
27829875	non-pregnant	C0232973
27829875	population	C1257890
27829875	pilot study	C0031928
27829875	non-invasive	C0205303
27829875	screening test	C0871311
27829875	pulmonary hypertension	C0020542
27829875	pregnancy	C0032961
27829875	tricuspid regurgitant velocity	C2059632
27829875	associated with	C0332281
27829875	poor	C0542537
27829875	outcomes	C1274040
27829875	cross-sectional study	C0010362
27829875	tertiary referral centre	C0587437
27829875	multidisciplinary clinic	C0242933
27829875	pregnant women	C0033011
27829875	sickle cell disease	C0002895
27829875	Women	C0043210
27829875	sickle cell disease	C0002895
27829875	pulmonary hypertension	C0020542
27829875	singleton	C1313913
27829875	pregnancies	C0032961
27829875	echocardiography	C0013516
27829875	tricuspid regurgitant velocity	C2059632
27829875	pregnancy	C0032961
27829875	pregnancies	C0032961
27829875	tricuspid regurgitant velocity	C2059632
27829875	no significant	C1273937
27829875	characteristics	C1521970
27829875	sickle cell	C0221283
27829875	complications	C0009566
27829875	medical	C0205476
27829875	co-morbidities	C0026538
27829875	women	C0043210
27829875	tricuspid regurgitant velocity	C2059632
27829875	obstetric	C0205484
27829875	perinatal	C0178795
27829875	outcomes	C1274040
27829875	tricuspid regurgitant velocity	C2059632
27831503	randomized trial	C0206034
27831503	TLR-2	C0754728
27831503	agonist	C2987634
27831503	CADI-05	C2703083
27831503	targeting	C1521840
27831503	desmocollin-3	C1453561
27831503	advanced	C0205179
27831503	non-small-cell lung cancer	C0007131
27831503	Randomized controlled trial	C0206035
27831503	evaluate	C0220825
27831503	synergy	C0013215
27831503	taxane	C0215136
27831503	platinum	C0032207
27831503	chemotherapy	C3665472
27831503	CADI-05	C2703083
27831503	Toll like receptor-2	C0754728
27831503	agonist	C2987634
27831503	targeting	C1521840
27831503	desmocollin-3	C1453561
27831503	first-line therapy	C1708063
27831503	advanced	C0205179
27831503	non-small-cell lung cancer	C0007131
27831503	NSCLC	C0007131
27831503	Patients	C0030705
27831503	advanced	C0205179
27831503	NSCLC	C0007131
27831503	randomized	C3815594
27831503	cisplatin-paclitaxel	C0280455
27831503	chemotherapy	C3665472
27831503	group	C0441833
27831503	cisplatin-paclitaxel	C0280455
27831503	CADI-05	C2703083
27831503	chemoimmunotherapy	C2986423
27831503	group	C0441833
27831503	CADI-05	C2703083
27831503	administered	C1621583
27831503	week	C0439230
27831503	chemotherapy	C3665472
27831503	days	C0439228
27831503	cycle	C1302181
27831503	month	C0439231
27831503	months	C0439231
27831503	disease progression	C0242656
27831503	Overall survival	C4086681
27831503	log-rank test	C0392366
27831503	Computed tomography	C0040405
27831503	baseline	C1442488
27831503	cycles	C1302181
27831503	cycles	C1302181
27831503	Response rate	C0237629
27831503	evaluated	C0220825
27831503	Response Evaluation Criteria in Solid Tumors	C1709926
27831503	criteria	C0243161
27831503	independent radiologist	C0260194
27831503	intention-to-treat analysis	C2718028
27831503	survival	C0038952
27831503	benefit	C0814225
27831503	groups	C0441833
27831503	days	C0439228
27831503	hazard ratio	C2985465
27831503	confidence interval	C0009667
27831503	subgroup analysis	C0936012
27831503	improvement	C2986411
27831503	median survival	C2986586
27831503	days	C0439228
27831503	squamous NSCC	C0027671
27831503	chemoimmunotherapy	C2986423
27831503	hazard ratio	C2985465
27831503	patients	C0030705
27831503	cycles	C1302181
27831503	chemotherapy	C3665472
27831503	improved	C2986411
27831503	median	C0444504
27831503	overall survival	C4086681
27831503	days	C0439228
27831503	days	C0439228
27831503	hazard ratio	C2985465
27831503	chemoimmunotherapy	C2986423
27831503	group	C0441833
27831503	chemotherapy	C3665472
27831503	group	C0441833
27831503	associated with	C0332281
27831503	improved	C2986411
27831503	survival	C0038952
27831503	year	C0439234
27831503	chemoimmunotherapy	C2986423
27831503	group	C0441833
27831503	Systemic adverse events	C0877248
27831503	identical	C0205280
27831503	group	C0441833
27831503	survival	C0038952
27831503	benefit	C0814225
27831503	addition	C1883712
27831503	CADI-05	C2703083
27831503	combination	C0205195
27831503	cisplatin-paclitaxel	C0280455
27831503	patients	C0030705
27831503	advanced	C0205179
27831503	NSCLC	C0007131
27831503	squamous cell subset	C0221910
27831503	survival	C0038952
27831992	Sex Life	C0376558
27831992	Impact	C4049986
27831992	Operative	C0038895
27831992	Intervention	C0184661
27831992	Sex Life-related Pain	C0030193
27831992	Degenerative	C0011164
27831992	Spinal	C0037949
27831992	Analysis	C0936012
27831992	SPORT Study	C2603343
27831992	study	C2603343
27831992	therapeutic retrospective cohort study	C2985505
27831992	study	C2603343
27831992	sexual function	C0278092
27831992	patients	C0030705
27831992	spinal stenosis	C0037944
27831992	SPS	C0037944
27831992	degenerative spondylolisthesis	C0264184
27831992	DS	C0264184
27831992	impact	C4049986
27831992	operative	C0038895
27831992	sexual function	C0278092
27831992	patients	C0030705
27831992	nonoperative	C0039798
27831992	operative	C0038895
27831992	treatment	C0039798
27831992	patients	C0030705
27831992	SPS	C0037944
27831992	DS	C0264184
27831992	sexual function	C0278092
27831992	Demographic	C0011298
27831992	treatment	C0039798
27831992	follow-up	C1522577
27831992	data	C1511726
27831992	patients	C0030705
27831992	SPORT study	C2603343
27831992	patients	C0030705
27831992	sexual life relevant	C0441833
27831992	SLR	C0441833
27831992	sexual life not relevant (NR) group	C0441833
27831992	Univariate	C0683962
27831992	multivariate analysis	C0026777
27831992	patient	C0030705
27831992	characteristics	C1521970
27831992	NR	C0441833
27831992	SLR group	C0441833
27831992	Operative	C0038895
27831992	treatment	C0039798
27831992	groups	C0441833
27831992	nonoperative	C0039798
27831992	group	C0441833
27831992	impact	C4049986
27831992	surgery	C0543467
27831992	sexual function	C0278092
27831992	patients	C0030705
27831992	sex life	C0441833
27831992	patients	C0030705
27831992	NR group	C0441833
27831992	patients	C0030705
27831992	SLR group	C0441833
27831992	Patients	C0030705
27831992	older	C0001792
27831992	female	C0086287
27831992	unmarried	C0037179
27831992	stenotic levels	C0441889
27831992	central stenosis	C0476189
27831992	NR group	C0441833
27831992	patients	C0030705
27831992	analysis	C0936012
27831992	operative	C0038895
27831992	nonoperative	C0039798
27831992	treatment	C0039798
27831992	follow-up	C1522577
27831992	operative	C0038895
27831992	groups	C0441833
27831992	percentage	C0439165
27831992	patients	C0030705
27831992	pain	C0030193
27831992	sex life	C0441833
27831992	nonoperative	C0039798
27831992	group	C0441833
27831992	nonoperative	C0039798
27831992	years	C0439234
27831992	follow-up	C1522577
27831992	Sex life	C0376558
27831992	patients	C0030705
27831992	DS	C0264184
27831992	SPS	C0037944
27831992	operative	C0038895
27831992	treatment	C0039798
27831992	improved	C0184511
27831992	sex life-related pain	C0030193
27835851	Functional analyses	C0936012
27835851	OcRhS1	C0033684
27835851	OcUER1	C0033684
27835851	UDP-L-rhamnose	C0609108
27835851	biosynthesis	C0005572
27835851	Ornithogalum caudatum	C0331605
27835851	UDP-L-rhamnose	C0609108
27835851	UDP-Rha	C0609108
27835851	sugar donor	C1254351
27835851	synthesis	C0005572
27835851	rhamnose	C0035417
27835851	compounds	C1706082
27835851	plants	C0331605
27835851	enzymes	C0014442
27835851	encoding	C2700640
27835851	genes	C0017337
27835851	UDP-Rha	C0609108
27835851	biosynthesis	C0005572
27835851	plants	C0331605
27835851	genes	C0017337
27835851	encoding	C2700640
27835851	rhamnose synthase	C0014442
27835851	RhS	C0014442
27835851	bi-functional	C0443560
27835851	UDP-4-keto-6-deoxy-D-glucose	C0014442
27835851	UDP-4K6DG	C0014442
27835851	3, 5-epimerase/UDP-4-keto-L-rhamnose	C0014442
27835851	UDP-4KR	C0014442
27835851	4-keto-reductase	C0014442
27835851	UER	C0014442
27835851	Ornithogalum caudatum	C0331605
27835851	RNA	C0035668
27835851	Seq data	C0026382
27835851	OcRhS1 gene	C0017337
27835851	ORF	C0079941
27835851	open reading frame	C0079941
27835851	encoding	C2700640
27835851	tri-functional RhS enzyme	C1750262
27835851	In vitro	C1533691
27835851	enzymatic assays	C2717977
27835851	revealed	C0443289
27835851	OcRhS1	C0033684
27835851	UDP-D-glucose	C0077887
27835851	UDP-Glc	C0077887
27835851	UDP-Rha	C0609108
27835851	consecutive	C1707491
27835851	reactions	C0443286
27835851	Biochemical	C0205474
27835851	evidences	C0332120
27835851	recombinant OcRhS1	C0034861
27835851	temperature range	C0457171
27835851	Km	C1706312
27835851	value	C1522609
27835851	OcRhS1	C0033684
27835851	UDP-Glc	C0077887
27835851	OcRhS1	C0033684
27835851	multi-domain protein	C2326433
27835851	cofactor-binding motifs	C1323251
27835851	cofactors	C1323251
27835851	OcRhS1	C0033684
27835851	research	C0035168
27835851	N-terminal portion of OcRhS1	C0033684
27835851	OcRhS1-N	C0033684
27835851	metabolize	C0205245
27835851	UDP-Glc	C0077887
27835851	UDP-4K6DG	C1254348
27835851	OcUER1	C0017337
27835851	ORF	C0079941
27835851	encoding	C2700640
27835851	polypeptide	C1305923
27835851	aa	C0002520
27835851	OcUER1	C0033684
27835851	carboxy-terminal domain of OcRhS1	C0033684
27835851	OcRhS1-C	C0033684
27835851	UDP-4K6DG	C1254348
27835851	UDP-Rha	C0609108
27835851	UDP-Glc	C0077887
27835851	bio-transformed	C0220798
27835851	UDP-Rha	C0609108
27835851	OcRhS1-N	C0033684
27835851	OcUER1	C0033684
27835851	biochemical assay	C0005507
27835851	expression profiles	C3463810
27835851	OcRhS1	C0033684
27835851	OcUER1	C0033684
27835851	revealed	C0443289
27835851	biosynthesis	C0005572
27835851	rhamnose	C0035417
27835851	polysaccharides	C0032594
27835851	O. caudatum	C0331605
27837017	antibody	C0003241
27837017	acquisition	C1706701
27837017	merozoite	C0444659
27837017	antigens	C0003320
27837017	malaria	C0024530
27837017	immunity	C0020964
27837017	surveillance	C0733511
27837017	Antibodies	C0003241
27837017	acquired human immunity	C0678209
27837017	Plasmodium falciparum (Pf) malaria	C0024535
27837017	merozoites	C0444659
27837017	blood	C0005767
27837017	replication	C0007590
27837017	disease	C0024530
27837017	Merozoites	C0444659
27837017	antigens	C0003320
27837017	immune system	C0020962
27837017	antibodies	C0003241
27837017	responses	C1314973
27837017	antigens	C0003320
27837017	acquired	C0439661
27837017	boosted	C1511253
27837017	acquisition	C1706701
27837017	antibodies	C0003241
27837017	antigens	C0003320
27837017	infection	C3714514
27837017	acquisition	C1706701
27837017	immunity	C0020964
27837017	responses	C1314973
27837017	merozoite	C0444659
27837017	antigens	C0003320
27837017	children	C0008059
27837017	adults	C0001675
27837017	age	C0001779
27837017	malaria	C0024530
27837017	antibodies	C0003241
27837017	age	C0001779
27837017	infection	C3714514
27837017	responses	C1314973
27837017	age	C0001779
27837017	infection	C3714514
27837017	antibody	C0003241
27837017	acquisition	C1706701
27837017	antigens	C0003320
27837017	antigen	C0003320
27837017	malaria	C0024530
27837017	hypothesis	C1512571
27837017	Antigen	C0003320
27837017	responses	C1314973
27837017	response	C1314973
27837017	antibodies	C0003241
27837017	acquired	C0439661
27837017	childhood	C0231335
27837017	late response	C0205087
27837017	response	C1314973
27837017	antigen	C0003320
27837017	responses	C1314973
27837017	infection	C3714514
27837017	responses	C1314973
27837017	acquisition	C1706701
27837017	human	C0086418
27837017	immunity	C0020964
27837017	malaria	C0024530
27837017	malaria vaccines	C0206255
27837017	merozoite	C0444659
27837017	antigens	C0003320
27837017	antigens	C0003320
27837017	malaria	C0024530
27837017	surveillance	C0733511
27837093	Variety	C2346866
27837093	DNA Replication Activity	C0598312
27837093	Cyanobacteria	C1047211
27837093	Correlates	C0871083
27837093	Respiration Activity	C0035203
27837093	Dark	C0010986
27837093	Cyanobacteria	C1047211
27837093	light	C0023693
27837093	cell growth	C0007595
27837093	cellular	C0007634
27837093	energy	C1442080
27837093	photosynthesis	C0031764
27837093	Synechococcus elongatus PCC 7942	C1003877
27837093	cyanobacteria	C1047211
27837093	DNA replication	C0598312
27837093	photosynthetic electron transport	C0013846
27837093	critical signal	C1710082
27837093	regulatory	C1327622
27837093	mechanism	C0441712
27837093	DNA replication	C0598312
27837093	conservation	C2347858
27837093	regulatory mechanism	C0441712
27837093	investigated	C1292732
27837093	cyanobacteria	C1047211
27837093	regulatory	C1327622
27837093	signal	C1710082
27837093	light	C0023693
27837093	regulation	C1327622
27837093	DNA replication	C0598312
27837093	light	C0023693
27837093	dark	C0010986
27837093	model	C0026336
27837093	cyanobacteria	C1047211
27837093	S. elongatus PCC 7942	C1003877
27837093	Synechocystis sp. PCC 6803	C0995541
27837093	Anabaena sp. PCC 7120	C1047885
27837093	DNA replication activity	C0598312
27837093	Synechocystis	C0995541
27837093	Anabaena	C1047885
27837093	retained	C0333118
27837093	cells	C0007634
27837093	transferred to	C4049693
27837093	dark	C0010986
27837093	decreased	C0205216
27837093	S. elongatus	C1003877
27837093	Glycogen metabolism	C0599784
27837093	respiration	C0035203
27837093	Synechocystis	C0995541
27837093	Anabaena	C1047885
27837093	S. elongatus	C1003877
27837093	dark	C0010986
27837093	DNA replication activity	C0598312
27837093	Synechocystis	C0995541
27837093	Anabaena	C1047885
27837093	reduced	C0205216
27837093	S. elongatus	C1003877
27837093	inhibition	C3463820
27837093	respiratory	C0521346
27837093	electron transport	C0013846
27837093	dark	C0010986
27837093	disparity	C1290905
27837093	DNA replication	C0598312
27837093	dark	C0010986
27837093	cyanobacteria	C1047211
27837093	difference	C1705242
27837093	activity	C0205177
27837093	respiratory	C0521346
27837093	electron transport	C0013846
27838149	Radiosensitization	C0279024
27838149	non-small-cell lung cancer	C0007131
27838149	cells	C0334227
27838149	xenografts	C0520484
27838149	interactive effects	C1704675
27838149	pemetrexed	C0210657
27838149	methoxyamine	C0066156
27838149	anti-folate	C1254351
27838149	pemetrexed	C0210657
27838149	radiosensitizer	C0034541
27838149	pre-clinical models	C1514292
27838149	pemetrexed	C0210657
27838149	effective	C1704419
27838149	base-excision-repair	C1158530
27838149	inhibitor	C1999216
27838149	methoxyamine	C0066156
27838149	tested	C0039593
27838149	methoxyamine	C0066156
27838149	enhances	C2349975
27838149	pemetrexed	C0210657
27838149	radiosensitization	C0279024
27838149	lung adenocarcinoma	C0152013
27838149	xenografts	C0520484
27838149	A549	C4277577
27838149	H1299 cells	C0334227
27838149	cell cycle	C0007586
27838149	distribution	C1704711
27838149	flow cytometry	C0016263
27838149	radiosensitization	C0279024
27838149	clonogenic assay	C0041372
27838149	DNA repair	C0012899
27838149	neutral comet assay	C0751980
27838149	repair protein	C1159338
27838149	activation	C0599177
27838149	H460 cells	C0334227
27838149	Xenografts	C0520484
27838149	nude mice	C0025932
27838149	received drug	C0332154
27838149	radiation	C0851346
27838149	tumor growth	C0598934
27838149	caliper	C0175720
27838149	in vivo	C0681829
27838149	toxicity	C0600688
27838149	animal weight	C0005910
27838149	Exposure to	C0332157
27838149	pemetrexed	C0210657
27838149	methoxyamine	C0066156
27838149	H1299	C0334227
27838149	H460	C0334227
27838149	A549	C4277577
27838149	irradiation	C1282930
27838149	accumulation	C4055506
27838149	cells	C0334227
27838149	radiosensitive G1/S border	C1254362
27838149	dose	C0178602
27838149	enhancement	C2349975
27838149	factors	C1521761
27838149	inactivation	C0544461
27838149	dose	C0178602
27838149	Radiosensitization	C0279024
27838149	DNA double-strand-break rejoining	C3155842
27838149	DNA-PKcs	C0212694
27838149	tumor-growth	C0598934
27838149	rate	C0449249
27838149	tumor-growth	C0598934
27838149	delay	C0205421
27838149	methoxyamine	C0066156
27838149	pemetrexed	C0210657
27838149	pre-irradiation	C1282930
27838149	mice	C0025932
27838149	treatment	C1522326
27838149	methoxyamine	C0066156
27838149	pemetrexed	C0210657
27838149	patients	C0030705
27838149	non-squamous non-small-cell lung cancer	C2585890
27842269	language	C0023008
27842269	social interaction	C0037420
27842269	Communication	C0009452
27842269	chronic	C0205191
27842269	non-fluent aphasia	C0349390
27842269	Clinical research	C0008972
27842269	massed practice	C0870850
27842269	rehabilitation	C0034991
27842269	chronic	C0205191
27842269	post-stroke	C1254367
27842269	aphasia	C0003537
27842269	massed practice	C0870850
27842269	progress	C1280477
27842269	speech-language therapy	C0037831
27842269	neuroscience	C0027910
27842269	language	C0023008
27842269	communication	C0009452
27842269	social interaction	C0037420
27842269	synergistic effects	C1280500
27842269	left perisylvian eloquent areas	C3495412
27842269	communicative	C0009452
27842269	language function	C0233732
27842269	outcome	C1274040
27842269	intensive aphasia therapy	C0087111
27842269	individuals	C0237401
27842269	left-hemisphere lesions	C2026233
27842269	chronic	C0205191
27842269	non-fluent aphasia	C0349390
27842269	training	C0220931
27842269	counterbalanced order	C1705176
27842269	Intensive Language-Action Therapy	C0023017
27842269	ILAT	C0023017
27842269	Constraint-Induced Aphasia Therapy	C0087111
27842269	verbal utterances	C2202690
27842269	communication	C0009452
27842269	social interaction	C0037420
27842269	Naming Therapy	C0037585
27842269	speech production per se	C0037827
27842269	training	C0220931
27842269	duration	C0449238
27842269	days	C0439228
27842269	therapy	C0087111
27842269	materials	C0520510
27842269	number of utterances	C0243095
27842269	treatment groups	C0087111
27842269	aphasia	C0003537
27842269	test battery	C0204458
27842269	language	C0023008
27842269	performance	C0597198
27842269	ILAT	C0023017
27842269	method	C0025663
27842269	Naming Therapy	C0037585
27842269	language	C0023008
27842269	treatment	C0087111
27842269	training	C0220931
27842269	massed practice	C0870850
27842269	chronic	C0205191
27842269	post-stroke	C1254367
27842269	aphasia	C0003537
27842269	language	C0023008
27842269	communication	C0009452
27842269	social interaction	C0037420
27842269	intensive aphasia therapy	C0087111
27844448	miR-27b	C1537730
27844448	inhibits	C3463820
27844448	gastric cancer	C0699791
27844448	metastasis	C0027627
27844448	targeting	C1521840
27844448	NR2F2	C1506576
27844448	Increasing	C0442808
27844448	attention	C0004268
27844448	down-regulation	C0013081
27844448	miRNAs	C1101610
27844448	cancer process	C0007097
27844448	Nuclear receptor subfamily 2	C1506576
27844448	NR2F2	C1506576
27844448	COUP-TFII	C1506576
27844448	involved	C1314939
27844448	development	C1527148
27844448	types	C0332307
27844448	cancers	C0007097
27844448	role	C1705810
27844448	gastric cancer	C0699791
27844448	experiment	C0681814
27844448	oncomine	C0242356
27844448	Kaplan-meier database	C0242356
27844448	revealed	C0443289
27844448	NR2F2	C1506576
27844448	up-regulated	C0041904
27844448	gastric cancer	C0699791
27844448	high	C0205250
27844448	NR2F2	C1506576
27844448	expression	C1171362
27844448	contributed	C1880177
27844448	poor	C0542537
27844448	survival	C0038954
27844448	MicroRNA-27b	C1537730
27844448	targeted	C1521840
27844448	down-regulated	C0013081
27844448	NR2F2	C1506576
27844448	human	C0086418
27844448	gastric cancer	C0699791
27844448	tissues	C0040300
27844448	cells	C1518174
27844448	ectopic expression	C1512167
27844448	miR-27b	C1537730
27844448	inhibited	C0311403
27844448	gastric cancer	C0699791
27844448	cell proliferation	C0596290
27844448	tumor growth	C0598934
27844448	in vitro	C1533691
27844448	in vivo	C1515655
27844448	Assays	C0005507
27844448	suggested	C1705535
27844448	overexpression	C0017262
27844448	miR-27b	C1537730
27844448	promote	C0033414
27844448	MGC-803 cells	C0007634
27844448	migration	C1622501
27844448	invasion	C2699153
27844448	retard	C0521111
27844448	metastasis	C0027627
27844448	liver	C0023884
27844448	down-regulation	C0013081
27844448	miR-27b	C1537730
27844448	GES-1 cells	C0007634
27844448	proliferation	C0596290
27844448	metastasis	C0027627
27844448	in vitro	C1533691
27844448	findings	C0243095
27844448	reveal	C0443289
27844448	miR-27b	C1537730
27844448	tumor suppressor	C0079427
27844448	gastric cancer	C0699791
27844448	biomarker	C0005516
27844448	improving	C1272745
27844448	patients	C0030705
27844448	survival	C0038954
27845744	Promoting	C0033414
27845744	Healthy	C3898900
27845744	Growth	C0018270
27845744	Feeding	C2987508
27845744	Obesity	C0028754
27845744	Need	C0027552
27845744	Evidence	C3887511
27845744	Infant	C0021270
27845744	Nutritional Supplement	C0242295
27845744	Developmental Origins of Health and Disease	C0282574
27845744	DOHaD	C0282574
27845744	growth	C0018270
27845744	infancy	C0231330
27845744	childhood	C0231335
27845744	lifespan	C0870809
27845744	health	C0018684
27845744	Evidence of	C0332120
27845744	long-term	C0443252
27845744	health	C0018684
27845744	risks	C0035647
27845744	small	C0700321
27845744	neonates	C0021289
27845744	grow	C0870861
27845744	rapidly	C0456962
27845744	interventions	C1273869
27845744	healthy	C3898900
27845744	growth	C0018270
27845744	weight gain	C0043094
27845744	healthy	C3898900
27845744	growth	C0018270
27845744	essential	C0205224
27845744	infant	C0021270
27845744	young	C0332239
27845744	child	C0008059
27845744	feeding	C2987508
27845744	industries	C0021267
27845744	Liquid	C0302908
27845744	nutritional supplements	C0242295
27845744	formulated	C0016497
27845744	undernourished	C0162429
27845744	children	C0008059
27845744	increasingly	C0442808
27845744	marketed	C0683746
27845744	consumed	C2983605
27845744	children	C0008059
27845744	Clarifying	C2986669
27845744	promoting	C0033414
27845744	healthy	C3898900
27845744	growth	C0018270
27845744	important	C3898777
27845744	Evidence	C3887511
27845744	social	C0728831
27845744	beliefs	C0004951
27845744	cultural	C0220814
27845744	practices	C0237607
27845744	supplementary feeding	C0038847
27845744	specific	C0205369
27845744	concerns	C2699424
27845744	long-term	C0443252
27845744	health	C0018684
27845744	consequences of	C0686907
27845744	associated	C0332281
27845744	altered	C0392747
27845744	feeding	C2987508
27845744	culture	C0220814
27845744	reduced	C0392756
27845744	dietary	C0012155
27845744	variety	C2346866
27845744	weight gain	C0043094
27845744	Reassessing	C1516048
27845744	evidence for	C0332120
27845744	relevance	C2347946
27845744	dietary supplements'	C0242295
27845744	promoting	C0033414
27845744	healthy	C3898900
27845744	growth	C0018270
27845744	healthy	C3898900
27845744	children	C0008059
27845744	needed	C0027552
27845744	global	C2348867
27845744	obesity	C0028754
27845744	opportunity	C0683937
27845744	intervention approaches	C0184661
27845744	small	C0700321
27845744	children	C0008059
27845744	rapid	C0456962
27845744	growth	C0018270
27845744	risk	C0035647
27845744	chronic disease	C0008679
27845744	Scientific	C0036397
27845744	health care	C0086388
27845744	partnerships	C1711206
27845744	needed	C0027552
27845744	governmental	C0680773
27845744	populations	C1257890
27845744	overconsumption	C0441655
27845744	important	C3898777
27845854	On-Site	C0205145
27845854	Fertility Preservation Services	C1171194
27845854	Adolescents	C0205653
27845854	Young Adults	C0238598
27845854	Comprehensive Cancer Center	C1708333
27845854	Adolescents	C0205653
27845854	young adults	C0238598
27845854	AYAs	C0027362
27845854	cancer treatments	C0920425
27845854	impair fertility	C0021359
27845854	counseling	C0010210
27845854	risk of infertility	C1171162
27845854	fertility preservation	C1171194
27845854	FP	C1171194
27845854	treatment	C0087111
27845854	survivorship	C0038955
27845854	objective	C0018017
27845854	AYA	C0027362
27845854	patient	C0030705
27845854	population	C1257890
27845854	on-site fertility consultation service	C0009818
27845854	comprehensive cancer center	C1708333
27845854	factors	C1521761
27845854	patients	C0030705
27845854	FP treatment	C3839343
27845854	retrospective chart review	C0035363
27845854	AYA	C0027362
27845854	women	C0043210
27845854	consultation	C0009818
27845854	MD Anderson Fertility Preservation and Family Building Service	C0018747
27845854	service	C0557854
27845854	Records	C0025102
27845854	AYA	C0027362
27845854	patients	C0030705
27845854	reviewed	C1709940
27845854	age	C0001779
27845854	ethnicity	C0015031
27845854	cancer type	C0872066
27845854	gravidity	C0600457
27845854	parity	C0030563
27845854	survivorship	C0038955
27845854	status	C0449438
27845854	FP treatment	C3839343
27845854	Patients	C0030705
27845854	Caucasian	C0043157
27845854	Hispanic	C0086409
27845854	African American	C0085756
27845854	women	C0043210
27845854	FP	C1171194
27845854	cancer treatment	C0920425
27845854	options	C1518601
27845854	family building	C0009861
27845854	survivorship	C0038955
27845854	cancer types	C0872066
27845854	hematologic	C0376545
27845854	breast	C0678222
27845854	gynecologic	C0699889
27845854	Patients	C0030705
27845854	on-site fertility consultation service	C0009818
27845854	ethnically	C0243103
27845854	diverse	C1880371
27845854	fertility counseling	C1689849
27845854	treatment	C0087111
27845854	survivorship	C0038955
27845854	pre- and postcancer treatment	C0920425
27845854	referral	C0034927
27845854	group	C0441833
27845854	ethnically	C0243103
27845854	diverse	C1880371
27845854	Caucasian	C0043157
27845854	women	C0043210
27845854	FP treatment	C3839343
27845854	women	C0043210
27845854	ethnicities	C0243103
27847549	Results	C1274040
27847549	Multicenter	C1096776
27847549	Randomized	C0034656
27847549	Controlled Trial	C0936233
27847549	Hydrogen Peroxide	C0020281
27847549	Kit	C0812225
27847549	Benzoyl Peroxide	C0005088
27847549	Kit	C0812225
27847549	Mild-to-moderate	C1299392
27847549	Acne	C0702166
27847549	evaluate	C0220825
27847549	efficacy	C1280519
27847549	tolerability	C3274448
27847549	hydrogen peroxide	C0020281
27847549	regimen	C0040808
27847549	benzoyl peroxide	C0005088
27847549	regimen	C0040808
27847549	mild-to-moderate	C1299392
27847549	acne	C0702166
27847549	Methods	C0025663
27847549	week	C0439230
27847549	multicenter study	C1096776
27847549	patients	C0030705
27847549	randomized	C0034656
27847549	hydrogen peroxide	C0020281
27847549	benzoyl peroxide	C0005088
27847549	regimen	C0040808
27847549	primary outcome measure	C3274433
27847549	clinical response	C4055223
27847549	assessed	C1516048
27847549	Global Acne Grading System	C1273712
27847549	GAGS	C1273712
27847549	baseline	C1442488
27847549	weeks	C0439230
27847549	weeks	C0439230
27847549	Week	C0439230
27847549	patient	C0030705
27847549	self-satisfaction questionnaire	C0034394
27847549	administered	C1521801
27847549	Investigators	C0035173
27847549	queried	C1522634
27847549	assessment	C0220825
27847549	tolerability	C3274448
27847549	cosmetic	C0010164
27847549	acceptability	C0814633
27847549	Tolerability	C3274448
27847549	measured	C0444706
27847549	visit	C1512346
27847549	treatment regimens	C0040808
27847549	associated with	C0332281
27847549	improvement	C2986411
27847549	GAGS score	C0449820
27847549	Week	C0439230
27847549	compared	C1707455
27847549	baseline	C1442488
27847549	GAGS score	C0449820
27847549	regimens	C0040808
27847549	period	C1948053
27847549	No significant adverse events	C1963761
27847549	reported	C0700287
27847549	observed	C1441672
27847549	treatment arm	C1522541
27847549	patients	C0030705
27847549	investigators	C0035173
27847549	regimens	C0040808
27847549	effective	C1704419
27847549	cosmetically	C0010164
27847549	acceptable	C0814633
27847549	hydrogen peroxide	C0020281
27847549	regimen	C0040808
27847549	comparable	C1707455
27847549	efficacy	C1280519
27847549	safety	C0036043
27847549	cosmetic	C0010164
27847549	acceptability	C0814633
27847549	benzoyl peroxide	C0005088
27847549	regimen	C0040808
27847549	treatment	C0087111
27847549	mild-to-moderate	C1299392
27847549	acne	C0702166
27847822	Multisensory Integration	C0679019
27847822	Virtual Hand Illusion	C0020903
27847822	Active Movement	C0231481
27847822	sense of	C0025361
27847822	sense of immersion	C0243095
27847822	virtual reality	C0871582
27847822	Perceptual illusions	C2052872
27847822	perceived	C0030971
27847822	virtual body	C0871582
27847822	multisensory	C2585668
27847822	virtual reality	C0871582
27847822	Rubber Hand	C0025080
27847822	Virtual Hand Illusions	C0020903
27847822	visual	C0556861
27847822	tactile stimulation	C0152054
27847822	multisensory integration	C0679019
27847822	Virtual Hand Illusion	C0020903
27847822	active movement	C0231481
27847822	virtual xylophone playing	C0871582
27847822	synchronous	C0439580
27847822	visual	C0556861
27847822	tactile	C0152054
27847822	auditory stimulation	C0001164
27847822	sensory stimulations	C0150763
27847822	multisensory integration	C0679019
27847822	active movement	C0231481
27847822	sense of	C0025361
27847822	immersion in virtual reality	C0871582
27847836	Obstructive	C0549186
27847836	Acute Pancreatitis	C0001339
27847836	PEG Tube	C2985542
27847836	Migration	C0549474
27847836	Percutaneous gastrostomy	C0176751
27847836	method	C0449851
27847836	enteral nutrition	C0014327
27847836	patients	C0030705
27847836	incapable	C1550518
27847836	oral intake	C0518037
27847836	oral intake	C0518037
27847836	insufficient	C0231180
27847836	metabolic	C0311400
27847836	needs	C0027552
27847836	total parenteral nutrition	C0030548
27847836	enteral feeding	C0086225
27847836	gut	C0699819
27847836	mucosal	C0026724
27847836	integrity	C1947912
27847836	risk	C0035647
27847836	bacterial translocation	C0282583
27847836	gastrointestinal tract	C0017189
27847836	Complications	C0009566
27847836	bleeding	C0019080
27847836	aspiration	C0700198
27847836	internal organ injury	C0332675
27847836	perforation	C0151664
27847836	periostomal leaks	C0341600
27847836	tube dislodgement	C1608950
27847836	occlusion	C0028778
27847836	Acute pancreatitis	C0001339
27847836	percutaneous gastrostomy tube	C2985542
27847836	migration	C0549474
27847836	patient	C0030705
27847836	acute	C0205178
27847836	obstructive	C0549186
27847836	pancreatitis	C0030305
27847836	percutaneous gastrostomy tube	C2985542
27847836	migration	C0549474
27848238	Tractable	C0205556
27848238	Method	C0025663
27848238	Measuring	C0444706
27848238	Nanomaterial	C1450053
27848238	Risk	C0035647
27848238	Bayesian Networks	C3161035
27848238	banding	C0185014
27848238	evaluation	C1550157
27848238	potential	C3245505
27848238	human	C0086418
27848238	health risks	C0679809
27848238	exposure to	C0332157
27848238	nanomaterials	C1450053
27848238	NMs	C1450053
27848238	implementation	C1708476
27848238	data	C1511726
27848238	toxicological	C4042799
27848238	measurements	C0242485
27848238	risk	C0035647
27848238	NMs	C1450053
27848238	physicochemical	C2350461
27848238	data	C1511726
27848238	concentration	C1446561
27848238	exposure route	C0683172
27848238	Bayesian networks	C3161035
27848238	tool	C0449851
27848238	NM	C1450053
27848238	risk	C0035647
27848238	tool	C0449851
27848238	tractable	C0205556
27848238	accessible	C0205556
27848238	scalable	C0392762
27848238	data	C1511726
27848238	quality	C0332306
27848238	data sets	C0150098
27848238	data sets	C0150098
27848238	data	C1511726
27848238	values	C1522609
27848238	probability distribution	C3826440
27848238	tool	C0449851
27848238	quality	C0332306
27848238	data	C1511726
27848238	risk	C0035647
27848238	measurement	C0242485
27848238	NMs	C1450053
27848238	risk	C0035647
27848238	potential	C3245505
27848238	carbon nanotubes	C1138408
27848238	silver	C0037125
27848238	titanium dioxide	C0076733
27848238	non-experts	C0027361
27848238	risk	C0035647
27848238	NMs	C1450053
27848238	NM	C1450053
27848238	risk	C0035647
27848238	evaluated	C1550157
27848238	tractable	C0205556
27848238	quantitative	C0392762
27848238	risk	C0035647
27849409	Gender	C0079399
27849409	Direction	C0449738
27849409	Effect	C1280500
27849409	Alcohol Problems	C0549393
27849409	Internalizing Symptoms	C0871786
27849409	Longitudinal Sample	C0023981
27849409	College Students	C0682177
27849409	Alcohol problems	C0549393
27849409	internalizing symptoms	C0871786
27849409	associated	C0332281
27849409	relate	C0439849
27849409	unclear	C3845108
27849409	study	C2603343
27849409	limitations	C0449295
27849409	literature	C0023866
27849409	comorbidity	C0009488
27849409	alcohol problems	C0549393
27849409	internalizing symptoms	C0871786
27849409	investigating	C1292732
27849409	direction	C0449738
27849409	effect	C1280500
27849409	phenotypes	C0031437
27849409	gender differences	C0036866
27849409	college students	C0682177
27849409	data	C1511726
27849409	longitudinal study	C0023981
27849409	college students	C0682177
27849409	United States	C0041703
27849409	questionnaire-based	C0034394
27849409	data	C1511726
27849409	years	C0439234
27849409	college	C0557806
27849409	Cross-lagged models	C2348012
27849409	direction	C0449738
27849409	effect	C1280500
27849409	internalizing symptoms	C0871786
27849409	alcohol problems	C0549393
27849409	effects	C1280500
27849409	gender	C0079399
27849409	investigated	C1292732
27849409	multigroup modeling	C0392762
27849409	significant	C0750502
27849409	correlations	C1707520
27849409	alcohol problems	C0549393
27849409	internalizing symptoms	C0871786
27849409	direction	C0449738
27849409	effect	C1280500
27849409	alcohol problems	C0549393
27849409	internalizing symptoms	C0871786
27849409	genders	C0079399
27849409	relationship	C0439849
27849409	age	C0001779
27849409	males	C0086582
27849409	alcohol problems	C0549393
27849409	predicted	C0681842
27849409	internalizing symptoms	C0871786
27849409	internalizing symptoms	C0871786
27849409	alcohol problems	C0549393
27849409	females	C0086287
27849409	relationship	C0439849
27849409	alcohol problems	C0549393
27849409	internalizing symptoms	C0871786
27849409	relationship	C0439849
27849409	alcohol problems	C0549393
27849409	internalizing symptoms	C0871786
27849409	complex	C0439855
27849409	genders	C0079399
27849409	males	C0086582
27849409	phenotypes	C0031437
27849409	predictive	C0681890
27849409	females	C0086287
27849409	relationship	C0439849
27849409	alcohol problems	C0549393
27849409	study	C2603343
27849409	population-based sample	C1709598
27849409	relationships	C0439849
27849409	alcohol problems	C0549393
27849409	internalizing symptoms	C0871786
27849409	individuals	C0027361
27849409	clinically diagnosed	C0332140
27849409	mental health	C0025353
27849409	substance use problems	C0740858
27853757	Real-time	C1550177
27853757	monitoring	C1283169
27853757	vesicle	C1622418
27853757	pH	C0020283
27853757	endocytic	C0014139
27853757	pathway	C1704259
27853757	EGF	C0242275
27853757	conjugated two-photon probe	C2347609
27853757	ratiometric two-photon probe	C2347609
27853757	BHS3	C2347609
27853757	EGF	C0242275
27853757	pH	C0020283
27853757	sensitive	C0332324
27853757	epidermal growth factor	C0242275
27853757	EGF	C0242275
27853757	real-time	C1550177
27853757	monitoring	C1283169
27853757	quantitative	C0392762
27853757	analysis	C0936012
27853757	acidic luminal	C0524461
27853757	pH	C0020283
27853757	values	C0042295
27853757	endocytic	C0014139
27853757	pathway activity	C1704259
27853757	Two-photon microscopy imaging	C1537066
27853757	BHS3	C2347609
27853757	EGF	C0242275
27853757	quantitative	C0392762
27853757	analysis	C0936012
27853757	pH	C0020283
27853757	distributions	C1704711
27853757	vesicles	C1622418
27853757	dynamics	C3826426
27853757	receptor-mediated endocytosis	C0597361
27853757	real-time	C1550177
27856018	Body burden	C0005884
27856018	heavy metals	C0347988
27856018	HIV	C0744979
27856018	high risk population	C0870646
27856018	USA	C0041703
27856018	HIV	C0744979
27856018	high risk population	C0870646
27856018	threat	C0749385
27856018	HIV infection	C0019693
27856018	higher	C0205250
27856018	chance	C0237506
27856018	exposure to environmental contaminants	C0522741
27856018	studies	C2603343
27856018	examined	C0332129
27856018	body burden	C0005884
27856018	environmental pollutants	C0014417
27856018	heavy metals	C0347988
27856018	HIV	C0744979
27856018	high risk populations	C0870646
27856018	study	C2603343
27856018	adults aged	C0001675
27856018	high risk of	C0332167
27856018	HIV infection	C0019693
27856018	higher	C0205250
27856018	blood levels of heavy metals	C0495719
27856018	compared	C1707455
27856018	low risk	C3538919
27856018	HIV infection	C0019693
27856018	United States	C0041703
27856018	National Health and Nutrition Examination Survey	C0376344
27856018	NHANES	C0376344
27856018	compare	C1707455
27856018	exposures to	C0332157
27856018	heavy metals	C0347988
27856018	cadmium	C0006632
27856018	lead	C0023175
27856018	mercury	C0025424
27856018	HIV	C0744979
27856018	risk status	C1319831
27856018	results	C1274040
27856018	people	C0027361
27856018	high risk of	C0332167
27856018	HIV	C0744979
27856018	higher	C0205250
27856018	blood concentrations	C0427728
27856018	heavy metals	C0347988
27856018	compared	C1707455
27856018	lower	C0205251
27856018	HIV risks	C0744979
27856018	multivariate linear regression	C0023733
27856018	models	C0026336
27856018	HIV risk	C0744979
27856018	associated with	C0332281
27856018	increased	C0205217
27856018	blood cadmium	C0855870
27856018	lead	C0853362
27856018	total mercury	C0202414
27856018	adjusting	C0456081
27856018	age	C0001779
27856018	sex	C0079399
27856018	race	C0034510
27856018	education	C0683842
27856018	poverty	C0032854
27856018	income	C0021162
27856018	ratio	C0456603
27856018	study	C2603343
27856018	people	C0027361
27856018	high risk of	C0332167
27856018	HIV	C0744979
27856018	higher	C0205250
27856018	body burden	C0005884
27856018	heavy metals	C0347988
27856018	cadmium	C0006632
27856018	lead	C0023175
27856018	mercury	C0025424
27856018	compared	C1707455
27856018	low risk	C3538919
27856018	HIV	C0744979
27856018	longitudinal study	C0023981
27856018	more	C0205172
27856018	pollutants	C0599786
27856018	warranted	C1552821
27856018	potential	C3245505
27856018	health	C0018684
27856018	effects	C1280500
27856018	elevated	C3163633
27856018	pollutants	C0599786
27856018	HIV-infected	C0019693
27856018	HIV	C0744979
27856018	high-risk populations	C0870646
27857155	Fluorescence-	C0079366
27857155	magnetic-activated cell sorting	C0599662
27857155	strategies	C0449851
27857155	separate	C0443299
27857155	spermatozoa	C0037868
27857155	plural	C0439064
27857155	contributors	C1257890
27857155	biological mixtures	C2347026
27857155	human identification	C0242954
27857155	method	C0449851
27857155	distinguish	C0443299
27857155	sperm cells	C0037868
27857155	men	C0025266
27857155	multi-suspect	C0750491
27857155	sexual assault	C0237236
27857155	cases	C0868928
27857155	MACS	C0599662
27857155	FACS	C0079366
27857155	isolate	C0220862
27857155	single	C0205171
27857155	donor	C0013018
27857155	sperm cells	C0037868
27857155	forensic mixture samples	C0370003
27857155	female	C0043210
27857155	vaginal	C0042232
27857155	epithelial cells	C0014597
27857155	sperm cells	C0037868
27857155	multiple	C0439064
27857155	contributors	C1257890
27857155	Sperms	C0037868
27857155	vaginal swab	C0444207
27857155	isolated	C0205409
27857155	MACS	C0599662
27857155	FITC	C0085216
27857155	A kinase anchor protein 3	C1309095
27857155	AKAP3	C1309095
27857155	antibody	C0003241
27857155	target individual	C0237401
27857155	sperm cells	C0037868
27857155	donors	C0013018
27857155	separated	C0443299
27857155	FACS	C0079366
27857155	FITC	C0085216
27857155	blood group A/B antigen	C0302043
27857155	antibody	C0003241
27857155	procedure	C2700391
27857155	tested	C0039593
27857155	mock	C0562577
27857155	multi-suspect	C0750491
27857155	sexual assault	C0237236
27857155	samples	C0370003
27857155	practical casework	C0179660
27857155	sample	C0370003
27857155	complete	C0205197
27857155	single	C0205171
27857155	donor	C0013018
27857155	STR profiles	C1519302
27857155	sperm	C0037868
27857155	epithelial cell	C0014597
27857155	sperm	C0037868
27857155	mixtures	C0439962
27857155	contributors	C1257890
27857155	sperm	C0037868
27857155	epithelial cells	C0014597
27857155	sperm cells	C0037868
27857155	mixtures	C0439962
27857155	sensitivity	C0036667
27857155	target cells	C2939170
27857155	detected	C0442726
27857155	cell number	C0007584
27857155	blood types	C1383165
27857155	individuals	C0237401
27857155	procedure	C2700391
27857155	forensic DNA analysis	C0200898
27857155	multi-suspect	C0750491
27857155	sexual assault	C0237236
27857155	cases	C0868928
27857155	use of	C1524063
27857155	FACS	C0079366
27857155	MACS	C0599662
27857155	sperm	C0037868
27857155	AKAP3	C1309095
27857155	antigen	C0003320
27857155	human	C0086418
27857155	blood type antigen	C0701817
27857815	Iron Stain	C0918182
27857815	Assessing	C1516048
27857815	Intracranial Hemorrhage	C0151699
27857815	timing	C0449243
27857815	red blood cells	C0014792
27857815	organization	C1300196
27857815	hemorrhage	C0019080
27857815	significance	C0237881
27857815	catabolism	C0699900
27857815	heme	C0018966
27857815	processing	C1709694
27857815	iron	C0302583
27857815	application	C4048755
27857815	assigning	C1516050
27857815	attempting	C1516084
27857815	assign	C1516050
27857815	time course	C0449247
27857815	traumatic	C3714660
27857815	events	C0441471
27857815	contusions	C0009938
27857815	hemorrhages	C0019080
27857815	Attempts	C1516084
27857815	date contusions	C0009938
27857815	unsuccessful	C1272705
27857815	macroscopic observation	C1551402
27857815	microscopic observations	C0369671
27857815	data	C1511726
27857815	anatomically	C0220784
27857815	imprecise	C0205408
27857815	function	C0542341
27857815	time	C0040223
27857815	Intracranial lesions	C0581296
27857815	significance	C0237881
27857815	timing	C0449243
27857815	organizing	C1300196
27857815	hemorrhage	C0019080
27857815	acute	C0205178
27857815	life-threatening	C2826244
27857815	nature	C0349590
27857815	hemorrhages	C0019080
27857815	medicolegal investigation	C0420141
27857815	potential	C3245505
27857815	crimes	C0010325
27857815	Prussian Blue reaction	C0033779
27857815	iron	C0302583
27857815	histochemical	C0019635
27857815	reaction	C0443286
27857815	years	C0439234
27857815	diagnostic test	C0086143
27857815	chronicity	C0547045
27857815	study	C2603343
27857815	examined	C0332128
27857815	Prussian Blue iron stain	C0060234
27857815	living patients	C0030705
27857815	intracranial hemorrhages	C0151699
27857815	symptom onset	C4086878
27857815	presence	C0150312
27857815	Prussian Blue	C0060234
27857815	reactivity	C0678596
27857815	correlated	C1707520
27857815	chronicity	C0547045
27857815	found	C0243095
27857815	cases	C0868928
27857815	intracranial hemorrhage	C0151699
27857815	cases	C0868928
27857815	focal iron	C0302583
27857815	reactivity	C0678596
27857815	duration	C0449238
27857815	symptom onset	C4086878
27857815	surgery	C0543467
27857815	cases	C0868928
27857815	ranged	C1514721
27857815	hours	C0439227
27857815	days	C0439228
27857815	cases	C0868928
27857815	no iron reactivity	C0243095
27857815	duration	C0449238
27857815	symptom onset	C4086878
27857815	surgery	C0543467
27857815	hours	C0439227
27857815	days	C0439228
27857815	Prussian Blue reaction	C0033779
27857815	unreliable	C0749770
27857815	indicator	C0021212
27857815	timing	C0449243
27857815	intracranial hemorrhage	C0151699
27857815	Prussian blue reaction	C0033779
27857815	independent indicator	C0021212
27857815	chronicity	C0547045
27857815	valid	C2349099
27857815	indicated	C1444656
27857815	iron staining	C1522279
27857815	timing	C0449243
27857815	pre-existing	C2347662
27857815	lesions	C0221198
27857815	brain lesions	C0221505
27857815	Prussian blue reaction	C0033779
27857815	clinical	C0205210
27857815	timing	C0449243
27857815	neurologic decline	C4314692
27857815	clinical data	C1516606
27857815	accurate	C0443131
27857815	susceptible	C0231204
27857815	false positive results	C0205557
27860542	Successful	C1272703
27860542	Fetal Tele-Echo	C0412564
27860542	Small Regional Hospital	C0019994
27860542	Prenatal diagnosis	C0033053
27860542	complex	C0439855
27860542	congenital heart disease	C0152021
27860542	CHD	C0152021
27860542	improve	C0184511
27860542	newborn	C2239178
27860542	outcomes	C1274040
27860542	prenatal diagnosis	C0033053
27860542	access	C0444454
27860542	fetal echocardiography	C0412564
27860542	United States	C0041703
27860542	clinical fetal tele-echo	C0412564
27860542	King's Daughters Medical Center	C0565990
27860542	KDMC	C0565990
27860542	Ashland	C3811365
27860542	KY	C0022557
27860542	eastern Kentucky	C0022557
27860542	congenital heart surgeon	C0334892
27860542	study	C2603343
27860542	fetal tele-echo	C0412564
27860542	local sonographers	C1954848
27860542	small regional hospital	C0019994
27860542	accurately	C0443131
27860542	efficiently	C0442799
27860542	fetuses	C0015965
27860542	complex	C0439855
27860542	CHD	C0152021
27860542	Medical records	C0025102
27860542	reviewed	C1709940
27860542	mother-infant pairs	C0596977
27860542	fetal tele-echoes	C0412564
27860542	performed	C0884358
27860542	KDMC	C0565990
27860542	interpreted	C1285553
27860542	University of Louisville pediatric cardiology	C0020028
27860542	Findings	C0243095
27860542	fetal tele-echo	C0412564
27860542	newborn	C0021289
27860542	newborn	C0021289
27860542	echo	C0013516
27860542	clinical course	C0449259
27860542	Correct	C2349182
27860542	no difference	C3842396
27860542	fetal tele-echo	C0412564
27860542	newborn	C0021289
27860542	echo	C0013516
27860542	fetal tele-echo	C0412564
27860542	newborn	C0021289
27860542	Major Difference	C1705241
27860542	affected	C0392760
27860542	newborn	C0021289
27860542	newborn	C2239178
27860542	clinical course	C0449259
27860542	Minor Difference	C1705241
27860542	clinical course	C0449259
27860542	mother-infant pairs	C0596977
27860542	analyzed	C0936012
27860542	Fetal tele-echoes	C0412564
27860542	Correct	C2349182
27860542	Correct	C2349182
27860542	Major Differences	C1705241
27860542	Minor Differences	C1705241
27860542	complex	C0439855
27860542	CHD	C0152021
27860542	fetal tele-echo	C0412564
27860542	sensitivity	C0332324
27860542	specificity	C0037791
27860542	fetal echocardiograms	C0278336
27860542	mother-infant pair	C0596977
27860542	Fetal tele-echocardiography	C0412564
27860542	performed	C0884358
27860542	local sonographers	C1954848
27860542	small regional hospital	C0019994
27860542	accurately	C0443131
27860542	efficiently	C0442799
27860542	fetuses	C0015965
27860542	complex	C0439855
27860542	CHD	C0152021
27861731	Identification	C0205396
27861731	mineral	C0026162
27861731	binding	C1145667
27861731	peptides	C0030956
27861731	discriminate	C0205235
27861731	chalcopyrite	C0605435
27861731	enargite	C0026162
27861731	separation	C0443299
27861731	minerals	C0026162
27861731	subsequent	C0332282
27861731	extraction	C0684295
27861731	metals	C0025552
27861731	imperative	C3898777
27861731	increasing	C0442808
27861731	mineralogical	C0026162
27861731	complexity	C0439855
27861731	ore deposits	C0026162
27861731	difficult	C0332218
27861731	impossible	C0243095
27861731	separate	C0443299
27861731	slurries	C1883043
27861731	solutions	C0037633
27861731	containing	C0332256
27861731	minerals	C0026162
27861731	metals	C0025552
27861731	Low	C0205251
27861731	recovery	C0237820
27861731	metal	C0026162
27861731	typical	C3538928
27861731	complex	C0439855
27861731	deposits	C0026162
27861731	significant	C0750502
27861731	losses	C1517945
27861731	tailings	C0021265
27861731	In addition	C0332287
27861731	minerals	C0026162
27861731	impurities	C2827365
27861731	toxic	C1407029
27861731	difficult	C0332218
27861731	costly	C0220812
27861731	control	C2587213
27861731	processing	C1709694
27861731	concentrate	C4283884
27861731	mineral	C0026162
27861731	product	C1514468
27861731	example	C1707959
27861731	complex	C0439855
27861731	significant	C0750502
27861731	economic	C0013557
27861731	environmental	C0014406
27861731	costs	C0010186
27861731	associated with	C0332281
27861731	diluting	C1948037
27861731	processing	C1709694
27861731	copper	C0009968
27861731	concentrates	C4283884
27861731	containing	C0332256
27861731	arsenic	C0003818
27861731	mineral enargite	C0026162
27861731	Cu3 AsS4	C0026162
27861731	production	C0033268
27861731	pure	C1882508
27861731	copper	C0009968
27861731	separation	C0443299
27861731	problems	C0033213
27861731	phage display	C1519025
27861731	identify	C0205396
27861731	peptides	C0030956
27861731	selective	C0205556
27861731	recognition	C0205396
27861731	enargite	C0026162
27861731	arsenic	C0003818
27861731	free	C0332296
27861731	copper sulfide	C0389357
27861731	chalcopyrite	C0605435
27861731	random	C0439605
27861731	peptide phage display libraries	C0751719
27861731	identification	C0205396
27861731	enargite	C0026162
27861731	selective	C0205556
27861731	peptide	C0030956
27861731	sequence MHKPTVHIKGPT	C0002518
27861731	chalcopyrite	C0605435
27861731	selective	C0205556
27861731	peptide	C0030956
27861731	sequence RKKKCKGNCCYTPQ	C0002518
27861731	Mineral	C0026162
27861731	binding	C1145667
27861731	selectivity	C0205556
27861731	binding	C1145667
27861731	studies	C2603343
27861731	zeta potential	C0597697
27861731	determination	C1148554
27861731	immunochemistry	C0020986
27861731	Peptides	C0030956
27861731	ability	C1299581
27861731	discriminate	C0205235
27861731	enargite	C0026162
27861731	chalcopyrite	C0605435
27861731	option	C1518601
27861731	separation	C0443299
27861731	arsenic	C0003818
27861731	containing	C0332256
27861731	contaminants	C2827365
27861731	copper	C0009968
27861731	concentrates	C4283884
27861731	major	C0205164
27861731	advance	C3854260
27861731	replacement	C0559956
27861731	reduction	C0392756
27861731	toxic	C1407029
27861731	collectors	C1516698
27861731	reducing	C0392756
27861731	level	C0441889
27861731	arsenic	C0003818
27861731	bearing	C0206243
27861731	minerals	C0026162
27861731	early	C1279919
27861731	stages	C1306673
27861731	mineral	C0026162
27861731	processing	C1709694
27861771	High-density lipoprotein	C0023821
27861771	sphingosine-1-phosphate	C0074992
27861771	heterozygous familial hypercholesterolaemia	C0342882
27861771	Patients	C0030705
27861771	heterozygous familial hypercholesterolaemia	C0342882
27861771	FH	C0342882
27861771	suffer	C0751408
27861771	high plasma cholesterol	C0858226
27861771	environment	C0014406
27861771	oxidative stress	C0242606
27861771	high-density lipoprotein	C0023821
27861771	HDL	C0023821
27861771	sphingosine-1-phosphate	C0074992
27861771	S1P	C0074992
27861771	HDL	C0023821
27861771	S1P	C0074992
27861771	HDL	C0023821
27861771	protection against oxidative stress	C3823580
27861771	statin treatment	C1314135
27861771	case-control study	C0007328
27861771	HDL	C0023821
27861771	isolated	C0205409
27861771	FH	C0342882
27861771	patients	C0030705
27861771	statin treatment	C1314135
27861771	healthy controls	C2986479
27861771	HDL	C0023821
27861771	S1P	C0074992
27861771	HDL	C0023821
27861771	protect	C1545588
27861771	cardiomyocytes	C0225828
27861771	oxidative stress	C0242606
27861771	in vitro	C0681828
27861771	HDL	C0023821
27861771	S1P	C0074992
27861771	cell protection	C0524828
27861771	HDL-cholesterol	C0023822
27861771	apolipoprotein AI	C0085201
27861771	HDL	C0023821
27861771	cell protection	C0524828
27861771	HDL	C0023821
27861771	S1P	C0074992
27861771	HDL	C0023821
27861771	FH	C0342882
27861771	patients	C0030705
27861771	apolipoprotein AI	C0085201
27861771	apolipoprotein M	C1438565
27861771	FH	C0342882
27861771	patients	C0030705
27861771	Statin treatment	C1314135
27861771	FH	C0342882
27861771	environment	C0014406
27861771	HDL	C0023821
27861771	S1P	C0074992
27861771	HDL	C0023821
27861771	S1P	C0074992
27861771	cell protection	C0524828
27861771	Statin treatment	C1314135
27861771	HDL	C0023821
27863736	Moberg Picking-Up Test	C1293918
27863736	patients	C0030705
27863736	hand osteoarthritis	C0263746
27863736	Clinical measurement	C0947289
27863736	Moberg Pick-up Test	C1293918
27863736	MPUT	C1293918
27863736	functional performance	C3853978
27863736	patients	C0030705
27863736	hand	C0018563
27863736	inflammatory disease	C1290884
27863736	MPUT	C1293918
27863736	hand osteoarthritis	C0263746
27863736	OA	C0263746
27863736	functional performance	C3853978
27863736	MPUT	C1293918
27863736	hand OA	C0263746
27863736	patients	C0030705
27863736	healthy controls	C2986479
27863736	hand OA	C0263746
27863736	patients	C0030705
27863736	controls	C0009932
27863736	MPUT	C1293918
27863736	AUSCAN	C3891717
27863736	Cochin questionnaires	C0034394
27863736	grip	C0518032
27863736	pinch strength	C1720876
27863736	pain	C0030193
27863736	visual analog scale	C0042815
27863736	Likert scale	C0451267
27863736	MPUT	C1293918
27863736	MPUT	C1293918
27863736	evaluation	C1261322
27863736	OA	C0263746
27863736	statistically significant	C0237881
27863736	control group	C0009932
27863736	OA	C0263746
27863736	more	C0205172
27863736	time	C0040223
27863736	test	C0392366
27863736	grip	C0518032
27863736	pinch strength measurements	C1720876
27863736	control group	C0009932
27863736	OA	C0263746
27863736	difficulty	C0332218
27863736	control group	C0009932
27863736	test	C0392366
27863736	MPUT	C1293918
27863736	test	C0392366
27863736	functional performance	C3853978
27863736	hand OA	C0263746
27867770	Soymilk	C3825658
27867770	residue	C1709915
27867770	okara	C0960549
27867770	natural	C0205296
27867770	immobilization carrier	C0205556
27867770	Lactobacillus plantarum	C0317608
27867770	cells	C0007634
27867770	enhances	C2349975
27867770	soymilk	C3825658
27867770	fermentation	C0015852
27867770	glucosidic isoflavone	C0022179
27867770	bioconversion	C0439836
27867770	cell survival	C0007620
27867770	simulated gastric	C1704242
27867770	intestinal	C0021853
27867770	conditions	C0348080
27867770	Cell immobilization	C0282542
27867770	alternative	C1523987
27867770	microencapsulation	C0025974
27867770	cells	C0007634
27867770	liquid	C0302908
27867770	medium	C1705217
27867770	artificial	C2004457
27867770	immobilization carriers	C0205556
27867770	safety	C0036043
27867770	risk	C0035647
27867770	Okara	C0960549
27867770	food-grade	C0016452
27867770	byproduct	C0439861
27867770	soymilk	C3825658
27867770	production	C0033268
27867770	prebiotics	C2717875
27867770	Lactobacilli	C0317608
27867770	health	C0018684
27867770	enhancing	C2349975
27867770	effects	C1280500
27867770	host	C1167395
27867770	study	C2603343
27867770	okara	C0960549
27867770	L. plantarum 70810 cells	C0007634
27867770	okara-immobilized	C0960549
27867770	L. plantarum 70810 cells	C0007634
27867770	IL	C0007634
27867770	soymilk	C3825658
27867770	fermentation	C0015852
27867770	glucosidic isoflavone	C0022179
27867770	bioconversion	C0439836
27867770	cell	C0007634
27867770	resistance	C4281815
27867770	simulated gastric	C1704242
27867770	intestinal	C0021853
27867770	stresses	C0449430
27867770	Scanning electron microscopy	C0026020
27867770	SEM	C0026020
27867770	cells	C0007634
27867770	adherence	C1510802
27867770	surface	C0205148
27867770	okara	C0960549
27867770	Lactic acid	C0064582
27867770	acetic acid	C0000983
27867770	isoflavone	C0022179
27867770	analyses	C0936012
27867770	fermented	C1827145
27867770	soymilk	C3825658
27867770	performed	C0884358
27867770	HPLC with UV detection	C0201764
27867770	Viability	C0443348
27867770	immobilized	C0282542
27867770	free L. plantarum 70810 cells	C0007634
27867770	FL	C0007634
27867770	soymilk	C3825658
27867770	fermentation	C0015852
27867770	changes	C0392747
27867770	pH	C1304686
27867770	titrable acidity	C0368606
27867770	viscosity	C0042784
27867770	measured	C0444706
27867770	conventional methods	C0025663
27867770	in vitro	C1533691
27867770	testing	C0039593
27867770	gastrointestinal	C0521362
27867770	resistance	C4281815
27867770	fermented	C1827145
27867770	soymilk	C3825658
27867770	inoculated	C2987620
27867770	FL	C0007634
27867770	IL	C0007634
27867770	aliquot	C1510844
27867770	incubated	C1439852
27867770	acidic MRS broth	C1705217
27867770	gastric	C1704242
27867770	pancreatic juices	C0030296
27867770	bile salts	C0005404
27867770	simulated gastric	C1704242
27867770	intestinal	C0021853
27867770	stresses	C0449430
27867770	plate count of colony forming units	C0201253
27867770	MRS agar	C1720273
27867770	SEM	C0026020
27867770	lactobacilli	C0317608
27867770	cells	C0007634
27867770	attached	C3714578
27867770	surface	C0205148
27867770	okara	C0960549
27867770	Compared	C1707455
27867770	FL	C0007634
27867770	IL	C0007634
27867770	higher	C0205250
27867770	specific	C0205369
27867770	growth rate	C0449249
27867770	shorter	C1806781
27867770	lag phase	C0205390
27867770	growth	C0018270
27867770	lactic	C0064582
27867770	acetic acids	C0000983
27867770	faster	C0456962
27867770	decrease	C0547047
27867770	pH	C1304686
27867770	increase	C0442805
27867770	titrable acidity	C0368606
27867770	higher	C0205250
27867770	soymilk	C3825658
27867770	viscosity	C0042784
27867770	IL	C0007634
27867770	soymilk	C3825658
27867770	daizein	C0022179
27867770	genistein	C0061202
27867770	compared	C1707455
27867770	control	C1550141
27867770	Compared	C1707455
27867770	FL	C0007634
27867770	IL	C0007634
27867770	simulatedgastric	C1704242
27867770	intestinal	C0021853
27867770	stresses	C0449430
27867770	in vitro	C1533691
27867770	low pH	C0728725
27867770	low pH plus	C0728725
27867770	pepsin	C0014442
27867770	pancreatin	C0030304
27867770	bile salt	C0005404
27867770	results	C1274040
27867770	okara	C0960549
27867770	immobilization carrier	C0205556
27867770	enhance	C2349975
27867770	growth	C0018270
27867770	glucosidic isoflavone	C0022179
27867770	bioconversion	C0439836
27867770	activities	C0441655
27867770	L. plantarum	C0317608
27867770	soymilk	C3825658
27867770	improve	C0184511
27867770	cell survivability	C0007620
27867770	simulated gastric	C1704242
27867770	intestinal	C0021853
27867770	conditions	C0348080
27871600	visual stylet (Discopo)-guided	C0543467
27871600	laryngeal mask airway placement	C0396618
27871600	conventional blind technique	C0442775
27871600	randomized	C0034656
27871600	laryngeal mask airway (LMA) insertion	C0396618
27871600	fiberoptic view	C0449911
27871600	LMA	C0162645
27871600	placement	C1524072
27871600	Discopo visual stylet-guided insertion	C0543467
27871600	conventional blind technique	C0442775
27871600	randomized	C0034656
27871600	controlled study	C0681867
27871600	Operating room	C0029064
27871600	university hospital	C0020028
27871600	adult	C0001675
27871600	patients	C0030705
27871600	elective surgery	C0206058
27871600	LMA	C0162645
27871600	general anesthesia	C0002915
27871600	Patients	C0030705
27871600	randomly	C0034656
27871600	groups	C0681860
27871600	GLMA group	C0681860
27871600	visual stylet-guided technique	C0543467
27871600	BLMA group	C0681860
27871600	blind technique	C0442775
27871600	placement	C1524072
27871600	LMA	C0162645
27871600	clinical test	C3173977
27871600	fiberoptic	C1708050
27871600	assessment	C0220825
27871600	Unblinded data	C1511726
27871600	insertion	C0021107
27871600	success rate	C1521828
27871600	LMA	C0162645
27871600	position	C1550045
27871600	fiberoptic view	C0449911
27871600	LMA	C0162645
27871600	anatomical position	C0277809
27871600	hemodynamic responses	C4042806
27871600	adverse	C0001688
27871600	insertion	C0021107
27871600	responses	C0871261
27871600	bucking	C0852885
27871600	breathholding	C0235744
27871600	laryngospasm	C0920061
27871600	Blinded data	C1511726
27871600	postoperative	C0032790
27871600	airway morbidity	C1301933
27871600	blood staining	C0005835
27871600	LMA	C0162645
27871600	sore throat	C0242429
27871600	hoarseness	C0019825
27871600	Insertion	C0021107
27871600	GLMA	C0681860
27871600	BLMA group	C0681860
27871600	GLMA	C0681860
27871600	BLMA	C0681860
27871600	patients	C0030705
27871600	BLMA group	C0681860
27871600	reinsertion	C0021107
27871600	GLMA group	C0681860
27871600	fiberoptic view	C0449911
27871600	GLMA group	C0681860
27871600	groups	C0681860
27871600	hemodynamic stress responses	C0149784
27871600	incidences	C0021149
27871600	adverse	C0001688
27871600	insertion	C0021107
27871600	postoperative	C0032790
27871600	airway morbidity	C1301933
27871600	LMA	C0162645
27871600	insertion	C0021107
27871600	Discopo visual stylet	C0543467
27871600	success rate	C1521828
27871600	accuracy rate	C0443131
27871600	LMA	C0162645
27871600	placement	C1524072
27871600	hemodynamic stress response	C0149784
27871600	incidences	C0021149
27871600	adverse events	C0877248
27871881	Targeting	C1521840
27871881	brain	C0006104
27871881	peripheral plasticity	C0027880
27871881	lipidome	C0023779
27871881	acute	C0205178
27871881	kainic acid	C0022471
27871881	induced	C0205263
27871881	epileptic seizures	C0014544
27871881	mice	C0025929
27871881	quantitative mass spectrometry	C3525763
27871881	Epilepsy	C0014544
27871881	chronic neurological disorder	C1290882
27871881	manifested	C0205319
27871881	types	C0332307
27871881	human	C0086418
27871881	population	C1257890
27871881	molecular mechanisms	C1148560
27871881	epileptogenesis	C0014544
27871881	pharmacoresistance	C2712961
27871881	epilepsy	C0014544
27871881	patients	C0030705
27871881	medical	C0205476
27871881	care	C0086388
27871881	evidence	C3887511
27871881	lipid	C0023779
27871881	signalling pathways	C0037080
27871881	epileptogenesis	C0014544
27871881	lipid	C0023779
27871881	signals	C0037080
27871881	potential	C3245505
27871881	biomarkers	C0005516
27871881	epileptic disorder	C0014544
27871881	potential	C3245505
27871881	therapeutic agents	C1611640
27871881	targets	C1521840
27871881	lipidomic	C0023779
27871881	strategy	C0035171
27871881	lipid	C0023779
27871881	brain regions	C1273723
27871881	periphery tissues	C0040300
27871881	plasma	C0032105
27871881	specific	C0205369
27871881	acute	C0205178
27871881	epileptic seizures	C0014544
27871881	mice	C0025929
27871881	seizure	C0014544
27871881	induction	C0205263
27871881	systemic	C3494163
27871881	kainic acid	C0022471
27871881	injection	C3494163
27871881	compared	C1707455
27871881	vehicle controls	C0009932
27871881	levels	C0441889
27871881	phospholipids	C0031676
27871881	sphingomyelins	C0037906
27871881	endocannabinoids	C1172779
27871881	anandamide	C0211726
27871881	AEA	C0211726
27871881	2-arachidonoyl glycerol	C0299477
27871881	2-AG	C0299477
27871881	endocannabinoid	C1172779
27871881	compounds	C1706082
27871881	oleoylethanolamide	C1454896
27871881	OEA	C1454896
27871881	palmitoylethanolamide	C0069964
27871881	PEA	C0069964
27871881	arachidonic acid	C0003695
27871881	AA	C0003695
27871881	eicosanoids	C0013725
27871881	fatty acyl	C0574031
27871881	lipidome	C0023779
27871881	pulverized	C3494163
27871881	tissues	C0459385
27871881	brain regions	C1273723
27871881	kainic acid	C0022471
27871881	induced	C0205263
27871881	epileptic seizure	C0014544
27871881	models	C0026336
27871881	vehicle controls	C0009932
27871881	hypothalamus	C0020663
27871881	hippocampus	C0019564
27871881	thalamus	C0039729
27871881	striatum	C0010097
27871881	cerebellum	C0007765
27871881	cerebral cortex	C0007776
27871881	peripheral	C0205100
27871881	organs	C0178784
27871881	heart	C0018787
27871881	lungs	C0024109
27871881	plasma	C0032105
27871881	lipid	C0023779
27871881	acute	C0205178
27871881	epileptic seizures	C0014544
27871881	compared	C1707455
27871881	non-seizure controls	C0009932
27871881	brain region	C1273723
27871881	periphery tissue	C0040300
27871881	specific	C0205369
27871881	specific	C0205369
27871881	plasma	C0032105
27871881	lipid	C0023779
27871881	marker candidates	C0005516
27871881	research studies	C0681814
27871881	drug discovery	C0920472
27871881	response monitoring	C0085421
27872609	Panitumumab	C0879427
27872609	Encephalopathy	C0085584
27872609	Intra-arterial	C1561451
27872609	Application	C0185125
27872609	Dislocated Central Venous Access Device	C0025080
27872609	Acute	C0205178
27872609	central nervous system	C3714787
27872609	CNS	C3714787
27872609	toxicity	C3160947
27872609	immune	C0439662
27872609	side effects	C0879626
27872609	monoclonal antibodies	C0003250
27872609	cancer therapy	C0920425
27872609	patient	C0030705
27872609	acute-onset encephalopathy	C4014441
27872609	coma	C0009421
27872609	administration	C1621583
27872609	panitumumab	C0879427
27872609	treatment	C0087111
27872609	metastatic colorectal cancer	C0948380
27872609	Echocardiography	C0013516
27872609	drug	C0013227
27872609	left cardiac ventricle	C0225897
27872609	dislocated central venous line	C0025080
27872609	Diffusion-weighted magnetic resonance imaging	C0598801
27872609	cortical hyperintensities	C3149362
27872609	frontal lobes	C0016733
27872609	neurological condition	C0027765
27872609	days	C0439228
27872609	patient	C0030705
27872609	died	C0011065
27872609	weeks	C0439230
27872609	administration	C1621583
27872609	antibody	C0003241
27872609	intra-arterial route	C1561451
27872609	condition	C0012634
27872609	Toxic encephalopathy	C0149504
27872609	hitherto	C0205156
27872609	complication	C0009566
27872609	panitumumab	C0879427
27872609	treatment	C0087111
27872609	patients	C0030705
27872609	CNS	C3714787
27872609	symptoms	C1457887
27872609	therapy	C0087111
27874309	Abundance	C2346714
27874309	Characterization	C1880022
27874309	Microsatellites	C1519302
27874309	Cattle	C0007452
27874309	Y Chromosome	C0043381
27874309	Microsatellites	C1519302
27874309	simple sequence repeats	C1519302
27874309	SSRs	C1519302
27874309	organisms	C0029235
27874309	genomic organization	C1517495
27874309	function	C0314627
27874309	characterize	C1880022
27874309	abundance	C2346714
27874309	SSRs	C1519302
27874309	base-pairs	C0600436
27874309	bp	C0600436
27874309	cattle	C0007452
27874309	Y chromsome	C0043381
27874309	frequency	C0439603
27874309	density	C0178587
27874309	SSRs	C1519302
27874309	Y chromosome	C0043381
27874309	sequence	C0162326
27874309	examined	C0332128
27874309	SSRs	C1519302
27874309	length	C1444754
27874309	cattle	C0007452
27874309	Y chromosome	C0043381
27874309	sequence	C0162326
27874309	SSRs	C1519302
27874309	length	C0162326
27874309	bp	C0600436
27874309	frequency	C0439603
27874309	density	C0178587
27874309	bp	C0600436
27874309	SSRs	C1519302
27874309	cattle	C0007452
27874309	Y chromosome	C0043381
27874309	Mononucleotide repeats	C0028630
27874309	length	C0162326
27874309	bp	C0600436
27874309	SSRs	C1519302
27874309	di-	C0282524
27874309	tetra-	C0028630
27874309	tri-	C0028630
27874309	penta-	C0028630
27874309	hexa-nucleotide repeats	C0028630
27874309	SSRs	C1519302
27874309	dinucleotides	C0028630
27874309	A	C0001407
27874309	AC	C0004793
27874309	AT	C0004793
27874309	AAC	C0004793
27874309	AGC	C0004793
27874309	GTTT	C0004793
27874309	CTTT	C0004793
27874309	ATTT	C0004793
27874309	AACTG	C0004793
27874309	Y chromosome	C0043381
27874309	study	C2603343
27874309	cattle	C0007452
27874309	Y chromosome	C0043381
27874309	DNA	C0012854
27874309	polymorphic	C1882417
27874309	cattle	C0007452
27874309	Y-chromosome	C0043381
27874309	SSRs	C1519302
27875058	Antenatal	C2828394
27875058	Stressful Life Events	C0038444
27875058	Postpartum	C0086839
27875058	Depressive Symptoms	C0086132
27875058	United States	C0041703
27875058	Women's	C0043210
27875058	Socioeconomic Status	C0086996
27875058	Indices	C0918012
27875058	State Level	C1711201
27875058	women	C0043210
27875058	suffer	C0683278
27875058	postpartum depression	C0221074
27875058	PPD	C0221074
27875058	predictors	C2698872
27875058	antenatal	C2828394
27875058	stressful life event	C0038444
27875058	SLE	C0038444
27875058	experiences	C0237609
27875058	association	C0439849
27875058	women's	C0043210
27875058	state-level	C1711201
27875058	socioeconomic status	C0086996
27875058	SES	C0086996
27875058	PPD	C0221074
27875058	study	C0681814
27875058	association	C0439849
27875058	antenatal	C2828394
27875058	SLE	C0038444
27875058	PPD	C0221074
27875058	symptoms	C1457887
27875058	moderated	C1881878
27875058	women's	C0043210
27875058	state-level	C1711201
27875058	SES	C0086996
27875058	Data	C1511726
27875058	Pregnancy Risk Assessment Monitoring System	C0038951
27875058	PRAMS	C0038951
27875058	State-level	C1711201
27875058	women's	C0043210
27875058	employment	C0014003
27875058	earnings	C0680989
27875058	social	C0728831
27875058	economic	C0013557
27875058	autonomy	C0085862
27875058	indices	C0918012
27875058	indicators	C0021212
27875058	Institute of Women's Policy Research	C1561598
27875058	IWPR	C1561598
27875058	Multilevel multivariable logistic regression analyses	C0681925
27875058	women	C0043210
27875058	valid	C2349099
27875058	responses	C0871261
27875058	PPD	C0221074
27875058	symptoms	C1457887
27875058	prevalence	C0220900
27875058	Illinois	C0020898
27875058	Arkansas	C0003790
27875058	Women	C0043210
27875058	stressor	C0597530
27875058	categories	C0683312
27875058	partner	C3887537
27875058	related	C0445223
27875058	traumatic	C0332663
27875058	emotional	C0849912
27875058	financial	C0376243
27875058	odds	C0028873
27875058	adjusted odds ratio	C0028873
27875058	aOR	C0028873
27875058	confidence interval	C0009667
27875058	CI	C0009667
27875058	PPD	C0221074
27875058	symptoms	C1457887
27875058	odds	C0028873
27875058	PPD	C0221074
27875058	symptoms	C1457887
27875058	decreased	C0205216
27875058	increase	C0442805
27875058	state-level	C1711201
27875058	social	C0728831
27875058	economic	C0013557
27875058	autonomy	C0085862
27875058	index	C0918012
27875058	aOR	C0028873
27875058	CI	C0009667
27875058	cross-level interaction	C0205556
27875058	stressor	C0597530
27875058	categories	C0683312
27875058	state-level	C1711201
27875058	index	C0918012
27875058	Screening	C1305399
27875058	antenatal	C2828394
27875058	SLEs	C0038444
27875058	women	C0043210
27875058	at risk	C1444641
27875058	PPD	C0221074
27875058	symptoms	C1457887
27875058	odds	C0028873
27875058	PPD	C0221074
27875058	symptoms	C1457887
27875058	decreased	C0205216
27875058	increasing	C0442805
27875058	state-level	C1711201
27875058	social	C0728831
27875058	economic	C0013557
27875058	autonomy	C0085862
27875058	women	C0043210
27875058	states	C1301808
27875058	indices	C0918012
27875058	more vulnerable	C0231204
27875058	antenatal	C2828394
27875058	stressors	C0597530
27875058	policy implications	C0814846
27875058	SES	C0086996
27875058	women	C0043210
27875058	states	C1301808
27876369	Multi-component model	C0026339
27876369	intramural hematoma	C0333200
27876369	multi-component model	C0026339
27876369	studying	C2603343
27876369	interaction	C1704675
27876369	blood flow	C0232338
27876369	deforming	C1562006
27876369	aortic wall	C0507851
27876369	intramural hematoma	C0333200
27876369	IMH	C0333200
27876369	aortic wall	C0507851
27876369	simulated	C0679083
27876369	composite structure submodel	C0026339
27876369	material properties	C0205556
27876369	wall layers	C0934502
27876369	IMH	C0333200
27876369	poroelasticity submodel	C0026339
27876369	pressure	C0001876
27876369	hematoma	C0018944
27876369	deformation	C1562006
27876369	submodel	C0026339
27876369	hematoma	C0018944
27876369	aortic submodel	C0026339
27876369	submodel	C0026339
27876369	pulsatile blood flow	C0034106
27876369	Model simulations	C0679083
27876369	investigate	C1292732
27876369	hematoma	C0018944
27876369	permeability	C0031164
27876369	patients	C0030705
27876369	age	C0001779
27876369	hematoma	C0018944
27876369	wall stress	C0038435
27876369	clinical data	C1516606
27876369	simulations	C0679083
27876369	hematoma	C0018944
27876369	permeability	C0031164
27876369	wall stress	C0038435
27876369	blood coagulation	C0005778
27876369	hematoma	C0018944
27876369	mechanical stability	C0243095
27876369	experimental	C1517586
27876369	observations	C0302523
27876369	coagulation	C0005778
27876369	beneficial effect	C1280500
27876369	patient	C0030705
27876369	IMH	C0333200
27877221	Impact of	C4049986
27877221	Diabetes	C0011847
27877221	Risk	C0035647
27877221	Prostate Cancer	C0376358
27877221	Development	C1527148
27877221	Body Mass Index	C1305855
27877221	Cohort Study	C0009247
27877221	obesity	C0028754
27877221	prostate cancer	C0376358
27877221	without	C0332288
27877221	diabetic	C0011847
27877221	patients	C0030705
27877221	data	C1511726
27877221	Korean population	C1556095
27877221	National Health Insurance System	C0027452
27877221	NHIS	C0027452
27877221	participants	C0679646
27877221	health examinations	C0260135
27877221	men ≥40 years old	C0025266
27877221	without	C0332288
27877221	prostate cancer	C0376358
27877221	Multivariate adjusted	C0026777
27877221	Cox regression analysis	C0010235
27877221	hazard ratio	C2985465
27877221	HR	C2985465
27877221	confidence interval	C0009667
27877221	CI	C0009667
27877221	prostate cancer	C0376358
27877221	body mass index	C1305855
27877221	BMI	C1305855
27877221	without	C0332288
27877221	diabetes	C0011847
27877221	HR	C2985465
27877221	prostate cancer	C0376358
27877221	diabetes	C0011847
27877221	stratified	C0205363
27877221	BMI	C1305855
27877221	age	C0001779
27877221	multivariable-adjusted models	C0026777
27877221	population	C1257890
27877221	without	C0332288
27877221	diabetes	C0011847
27877221	HR	C2985465
27877221	prostate cancer	C0376358
27877221	significantly increased	C0205217
27877221	BMI	C1305855
27877221	model adjusted for age and multiple variables	C0026777
27877221	HR	C2985465
27877221	population	C1257890
27877221	diabetes	C0011847
27877221	HR	C2985465
27877221	prostate cancer	C0376358
27877221	significantly increased	C0205217
27877221	BMI	C1305855
27877221	multivariable-adjusted model	C0026777
27877221	marked decrease	C0547047
27877221	HR	C2985465
27877221	population	C1257890
27877221	BMI	C1305855
27877221	BMI	C1305855
27877221	population	C1257890
27877221	population	C1257890
27877221	obesity	C0028754
27877221	development	C1527148
27877221	prostate cancer	C0376358
27877221	risk increases	C0332167
27877221	BMI	C1305855
27877221	diabetes	C0011847
27882066	Bioinformatic	C1140694
27882066	Analysis	C0936012
27882066	Codon	C0009221
27882066	Usage	C0457083
27882066	Phylogenetic Relationships	C1519069
27882066	Genotypes	C0017431
27882066	Hepatitis C Virus	C0220847
27882066	hepatitis C virus	C0220847
27882066	HCV	C0220847
27882066	genotypes	C0017431
27882066	study	C2603343
27882066	phylogenetically investigate	C1519068
27882066	genotypes	C0017431
27882066	HCV	C0220847
27882066	amino acid	C0002520
27882066	codon	C0009221
27882066	usage	C0457083
27882066	structure of the virus	C2717802
27882066	treatment regimes	C0418956
27882066	codon	C0009221
27882066	usage	C0457083
27882066	genotypes	C0017431
27882066	HCV	C0220847
27882066	nucleotide sequence	C0004793
27882066	investigated	C1292732
27882066	website Gene Infinity	C2349146
27882066	phylogenetic analysis	C1519068
27882066	evolutionary relationship	C0205556
27882066	HCV	C0220847
27882066	genotypes	C0017431
27882066	analyzed	C0936012
27882066	MEGA 7 software	C0037585
27882066	genotypes	C0017431
27882066	HCV	C0220847
27882066	groups	C0441833
27882066	codon	C0009221
27882066	usage	C0457083
27882066	properties	C0871161
27882066	group	C0441833
27882066	genotypes 1 and 5	C0017431
27882066	group	C0441833
27882066	genotypes 2 and 6	C0017431
27882066	similarity	C2348205
27882066	codon	C0009221
27882066	usage	C0457083
27882066	similarity	C2348205
27882066	codon	C0009221
27882066	usage	C0457083
27882066	phylogenetic analysis	C1519068
27882066	resemblance	C0205556
27882066	correlation	C1707520
27882066	genotypes 1 and 4	C0017431
27882066	HCV	C0220847
27882066	GC	C0028630
27882066	guanine	C0018321
27882066	guanine - cytosine	C0028630
27882066	cytosine	C0010843
27882066	genome structure	C0017428
27882066	codons	C0009221
27882066	translation	C0678935
27882066	Genotypes 1 and 4	C0017431
27882066	similarity	C2348205
27882066	genome sequences	C1254364
27882066	proteins	C0033684
27882066	codons	C0009221
27882066	gene expression	C0017262
27882066	studies	C2603343
27882066	approach	C0449445
27882066	treatment	C1522326
27882066	genotypes	C0017431
27882066	codon	C0009221
27882066	usage	C0457083
27882066	properties	C0871161
27884163	Chronic	C0205191
27884163	adiponectin deficiency	C2675518
27884163	Alzheimer's disease	C0002395
27884163	cognitive impairments	C0338656
27884163	pathologies	C0030664
27884163	AMPK	C2350345
27884163	cerebral	C0006104
27884163	insulin resistance	C0021655
27884163	aged	C0001779
27884163	mice	C0026809
27884163	Insulin resistance	C0021655
27884163	pathogenesis	C0699748
27884163	type 2 diabetes mellitus	C0011860
27884163	T2DM	C0011860
27884163	patients	C0030705
27884163	risk	C0035647
27884163	Alzheimer's disease	C0002395
27884163	AD	C0002395
27884163	insulin resistance	C0021655
27884163	pathogenesis	C0699748
27884163	GSK3β	C0244989
27884163	activation	C0014429
27884163	intra-	C0175996
27884163	extracellular	C0521119
27884163	amyloid-beta	C3484390
27884163	Aβ	C3484390
27884163	Adiponectin	C0389071
27884163	APN	C0389071
27884163	adipokine	C1955907
27884163	anti-inflammatory effects	C1515999
27884163	APN	C0389071
27884163	insulin resistance	C0021655
27884163	T2DM	C0011860
27884163	APN	C0389071
27884163	AD	C0002395
27884163	study	C2603343
27884163	adiponectin deficiency	C2675518
27884163	adiponectin deficiency	C2675518
27884163	cerebral	C0006104
27884163	insulin resistance	C0021655
27884163	cognitive decline	C0338656
27884163	Alzheimer's-like pathology	C0699748
27884163	mice	C0026809
27884163	study	C2603343
27884163	adiponectin	C0389071
27884163	cognitive functions	C0392335
27884163	adiponectin-knockout	C1522225
27884163	(APN-KO) mice	C0206745
27884163	chronic	C0205191
27884163	APN deficiency	C2675518
27884163	CNS	C3714787
27884163	Behavioral tests	C0683444
27884163	study	C2603343
27884163	cognitions	C0009240
27884163	male	C0086582
27884163	APN-KO mice	C0206745
27884163	Brains	C0006104
27884163	tissue	C0040300
27884163	lysates	C1881488
27884163	study	C2603343
27884163	molecular changes	C1148560
27884163	brain	C0006104
27884163	APN-KO mice	C0206745
27884163	SH-SY5Y neuroblastoma cell line	C0007600
27884163	study	C2603343
27884163	molecular mechanism	C3537153
27884163	APN	C0389071
27884163	insulin treatment	C0745343
27884163	Aged	C0001779
27884163	APN	C0389071
27884163	mice	C0026809
27884163	spatial memory	C0814087
27884163	learning	C0023185
27884163	impairments	C0684336
27884163	fear-conditioned	C1510535
27884163	memory deficit	C0233794
27884163	anxiety	C0003467
27884163	mice	C0026809
27884163	AD	C0002395
27884163	pathologies	C0699748
27884163	cerebral	C0006104
27884163	Aβ42	C0169424
27884163	Aβ	C3484390
27884163	hyperphosphorylated Tau proteins	C0085401
27884163	microgliosis	C3686874
27884163	astrogliosis	C0017639
27884163	cerebral	C0006104
27884163	IL-1β	C0021753
27884163	TNFα	C1456820
27884163	neuronal apoptosis	C1660771
27884163	synaptic	C0229984
27884163	proteins levels	C0428479
27884163	APN deficiency	C2675518
27884163	neuronal	C0521390
27884163	brain	C0006104
27884163	AD	C0002395
27884163	pathologies	C1521733
27884163	APN	C0389071
27884163	KO mice	C0206745
27884163	AMPK	C2350345
27884163	phosphorylation	C0031715
27884163	insulin signaling	C1512804
27884163	Akt	C0014442
27884163	GSK3β	C0244989
27884163	activation	C0014429
27884163	hippocampus	C0019564
27884163	frontal cortex	C0016733
27884163	Aged	C0001779
27884163	APN	C0389071
27884163	mice	C0026809
27884163	hippocampal	C0019564
27884163	insulin resistance	C0021655
27884163	pAkt	C0014442
27884163	insulin injection	C0199782
27884163	APN	C0389071
27884163	treatment	C0087111
27884163	SH-SY5Y cells	C0815000
27884163	insulin resistance	C0021655
27884163	overexpressing	C1171362
27884163	Aβ	C3484390
27884163	pAkt	C0014442
27884163	AdipoR1	C1259440
27884163	insulin treatment	C0745343
27884163	blocked	C0028778
27884163	compound C	C1706082
27884163	APN	C0389071
27884163	neuronal	C0521390
27884163	insulin sensitivity	C0920563
27884163	AMPK	C2350345
27884163	chronic	C0205191
27884163	APN deficiency	C2675518
27884163	AMPK	C2350345
27884163	AD-like pathogenesis	C0699748
27884163	aged	C0001779
27884163	mice	C0026809
27884163	cognitive impairments	C0338656
27884163	psychiatric symptoms	C0233401
27884960	inorganic phosphate	C0031603
27884960	sag	C1511741
27884960	unfused	C0205257
27884960	tetanic contractions	C0026820
27884960	skeletal muscle	C0242692
27884960	hypothesis	C1512571
27884960	cytosolic	C1383501
27884960	inorganic phosphate	C0031603
27884960	Pi	C0031603
27884960	contraction	C0026820
27884960	induced	C0205263
27884960	reductions	C0301630
27884960	twitch	C0231530
27884960	duration	C0449238
27884960	impair	C0221099
27884960	force	C0441722
27884960	decline	C1511741
27884960	sag	C1511741
27884960	unfused	C0205257
27884960	tetanic contractions	C0026820
27884960	fast-twitch muscle	C0242873
27884960	five-state model	C0026336
27884960	crossbridge cycling	C2265877
27884960	simulate	C0205173
27884960	twitch	C0231530
27884960	unfused	C0205257
27884960	tetanic contractions	C0026820
27884960	Pi	C0031603
27884960	concentration	C1446561
27884960	Pi	C0031603
27884960	increased	C0205217
27884960	twitch	C0231530
27884960	duration	C0449238
27884960	decreased	C0205216
27884960	progressive	C0205329
27884960	reductions	C0441610
27884960	sensitivity	C0332324
27884960	Pi	C0031603
27884960	Pi	C0031603
27884960	increased	C0205217
27884960	unfused	C0205257
27884960	simulated	C0679083
27884960	Pi	C0031603
27884960	sag	C1511741
27884960	pronounced	C4288581
27884960	initial	C0205265
27884960	Pi	C0031603
27884960	low	C0205251
27884960	magnitude	C1704240
27884960	Pi	C0031603
27884960	increase	C0205217
27884960	large	C0549177
27884960	Fast-twitch	C0231530
27884960	extensor digitorum longus (EDL) muscles	C0224464
27884960	sag-prone	C0205245
27884960	Pi	C0031603
27884960	slow-twitch	C0231530
27884960	soleus muscles	C0242694
27884960	sag	C1511741
27884960	resistant	C1514892
27884960	Pi	C0031603
27884960	isolated	C0205409
27884960	female	C0086287
27884960	C57BL/6 mice	C1521751
27884960	Muscles	C0026845
27884960	incubated	C1439852
27884960	solutions	C0037633
27884960	glucose	C0017725
27884960	pyruvate	C0244104
27884960	typical	C3538928
27884960	low	C0205251
27884960	Pi	C0031603
27884960	environments	C0014406
27884960	Twitch	C0231530
27884960	duration	C0449238
27884960	pyruvate	C0244104
27884960	glucose	C0017725
27884960	muscles	C0026845
27884960	Stimuli	C0234402
27884960	applied	C4048755
27884960	intervals	C1272706
27884960	peak	C0444505
27884960	twitch	C0231530
27884960	tension	C1442730
27884960	sag	C1511741
27884960	glucose	C0017725
27884960	pyruvate	C0244104
27884960	EDL	C0224464
27884960	pyruvate	C0244104
27884960	glucose	C0017725
27884960	glucose	C0017725
27884960	pyruvate	C0244104
27884960	soleus	C0242694
27884960	pyruvate	C0244104
27884960	glucose	C0017725
27884960	Pi	C0031603
27884960	crossbridge cycling	C2265877
27884960	tenable mechanism	C0441712
27884960	sag	C1511741
27884960	low basal	C1389277
27884960	Pi	C0031603
27884960	fast-twitch	C0231530
27884960	slow-twitch muscle	C0231530
27884960	explanation	C0681841
27884960	fiber-type	C0242697
27884960	sag	C1511741
27885308	Pancreatic Cancer	C0235974
27885308	Survival Analysis	C0038953
27885308	Study	C2603343
27885308	Oklahoma	C0028914
27885308	Pancreatic cancer	C0235974
27885308	deadly cancers	C0006826
27885308	Risk factors	C0035648
27885308	associated with	C0332281
27885308	disease	C0012634
27885308	age	C0001779
27885308	race	C0034510
27885308	sex	C0079399
27885308	smoking status	C1519386
27885308	diabetes status	C1317301
27885308	prospective analysis	C0033522
27885308	risk factors	C0035648
27885308	length of survival	C0023980
27885308	pancreatic cancer patients	C1516213
27885308	Oklahoma	C0028914
27885308	Kaplan-Meier survival curves	C1720944
27885308	created	C1706214
27885308	log-rank test	C0039593
27885308	difference	C1705242
27885308	survival time	C2919552
27885308	Cox proportional hazard regression models	C0033489
27885308	strength of association	C0205556
27885308	estimated	C0750572
27885308	hazard ratios	C2985465
27885308	median survival time	C2986586
27885308	cohort	C0599755
27885308	months	C0439231
27885308	Significant	C0750502
27885308	risk factors	C0035648
27885308	reduced	C0392756
27885308	survival times	C2919552
27885308	age	C0001779
27885308	stage at diagnosis	C1514952
27885308	year of diagnosis	C3173168
27885308	Results	C0456984
27885308	research findings	C0243095
27885308	noteworthy improvements	C2986411
27885308	survival times	C2919552
27885308	pancreatic cancer patients	C1516213
27885308	Oklahoma	C0028914
27885308	Length of survival	C0023980
27885308	study period	C2347804
27885308	significantly	C0750502
27885308	associated with	C0332281
27885308	risk factors	C0035648
27885308	age	C0001779
27885308	stage of diagnosis	C1514952
27887661	Biochemical	C0205474
27887661	proteomic	C0872252
27887661	analyses	C0936012
27887661	physiological response	C0542478
27887661	housing	C0020057
27887661	gilts	C0039005
27887661	potential	C3245505
27887661	stress	C0449430
27887661	markers	C0005516
27887661	objective	C1571702
27887661	assessment	C0220825
27887661	animal	C0003062
27887661	stress	C0449430
27887661	laboratory	C0022877
27887661	biomarkers	C0005516
27887661	serum	C0229671
27887661	composition	C0486616
27887661	gilts	C0039005
27887661	housing	C0020057
27887661	stalls	C0020057
27887661	animal	C0003062
27887661	discomfort	C2364135
27887661	Blood	C0005767
27887661	saliva samples	C0438730
27887661	housing	C0020057
27887661	Biochemical	C0205474
27887661	analyses	C0936012
27887661	adaptive	C0231193
27887661	lipid	C0023779
27887661	protein metabolism	C0597299
27887661	housing	C0020057
27887661	cortisol	C0020268
27887661	muscular	C0026845
27887661	markers	C0005516
27887661	variability	C2827666
27887661	animals	C0003062
27887661	2D-DIGE	C2936240
27887661	iTRAQ	C0282574
27887661	proteomic	C0872252
27887661	approaches	C0039152
27887661	serum protein	C0036825
27887661	composition	C0486616
27887661	housing	C0020057
27887661	gilts	C0039005
27887661	techniques	C0449851
27887661	alterations	C1515926
27887661	homeostatic mechanisms	C1561987
27887661	innate immune	C0020969
27887661	redox	C0030012
27887661	acute phase proteins	C0001347
27887661	haptoglobin	C0018595
27887661	apolipoprotein A-I	C0085201
27887661	antioxidant	C0003402
27887661	peroxiredoxin 2	C1137156
27887661	2D-DIGE	C2936240
27887661	proteins	C0033684
27887661	innate immune system	C0020969
27887661	lactotransferrin	C0022942
27887661	protegrin 3	C0300261
27887661	galectin 1	C0252527
27887661	iTRAQ	C0282574
27887661	oxidative stress	C0242606
27887661	enzymes	C0014442
27887661	peroxiredoxin 2	C1137156
27887661	glutathione peroxidase 3	C1436542
27887661	Proteomics	C0872252
27887661	decrease	C0392756
27887661	apolipoproteins	C0003591
27887661	intracellular	C0178719
27887661	proteins	C0033684
27887661	serum	C0229671
27887661	physical injury	C1328749
27887661	tissues	C0040300
27887661	Housing	C0020057
27887661	gilts	C0039005
27887661	stalls	C0020057
27887661	lipid	C0023779
27887661	protein catabolism	C0597297
27887661	oxidative stress	C0242606
27887661	innate immune system	C0020969
27887661	tissue damage	C0010957
27887661	stress assessment	C4076401
27887661	gilts	C0039005
27887661	score	C0449820
27887661	lipid	C0023779
27887661	metabolites	C0870883
27887661	innate immunity	C0020969
27887661	oxidative stress	C0242606
27887661	markers	C0005516
27887661	intracellular	C0178719
27887661	proteins	C0033684
27887778	Cultivation	C1511556
27887778	microalgae	C2936330
27887778	species	C1705920
27887778	effluent	C1550144
27887778	anaerobic digester	C3856828
27887778	biodiesel	C2717894
27887778	production	C0033268
27887778	study	C2603343
27887778	investigated	C1292732
27887778	effluent	C1550144
27887778	anaerobic digestion (AD) system	C3856828
27887778	used	C1524063
27887778	nutrients	C0678695
27887778	source	C0449416
27887778	microalgae	C2936330
27887778	cultivation	C1511556
27887778	effluent	C1550144
27887778	treated	C1522326
27887778	Nitrogen	C0028158
27887778	phosphorus	C0031705
27887778	AD	C3856828
27887778	AD	C3856828
27887778	effluent	C1550144
27887778	microalgal	C2936330
27887778	growth	C0018270
27887778	removal	C0849355
27887778	efficiency	C0013682
27887778	different	C1705242
27887778	algal	C0002028
27887778	species	C1705920
27887778	tested	C0039593
27887778	Micractinium inermum	C2669599
27887778	stood out	C0205245
27887778	highest	C1522410
27887778	biomass	C0005535
27887778	FAME	C0029224
27887778	productivity	C0392762
27887778	dry	C0205222
27887778	cell	C0007634
27887778	weight	C0005910
27887778	FAME	C0029224
27887778	contents	C0456205
27887778	concentrations	C1446561
27887778	nutrients	C0678695
27887778	decreased	C0205216
27887778	over	C0347984
27887778	time	C0040223
27887778	FAME	C0029224
27887778	contents	C0456205
27887778	increased	C0205217
27887778	quality	C0332306
27887778	well	C0205170
27887778	several	C0443302
27887778	biodiesel	C2717894
27887778	quality	C0332306
27887778	standards	C1442989
27887778	study	C2603343
27887778	AD	C3856828
27887778	effluent	C1550144
27887778	cheap	C0392762
27887778	nutrient	C0678695
27887778	rich	C0699759
27887778	medium	C0439536
27887778	microalgae	C2936330
27887778	cultivation	C1511556
27887778	equally	C0205163
27887778	importantly	C3898777
27887778	microalgae	C2936330
27887778	treatment	C1522326
27887778	option	C1518601
27889529	Antiviral activities	C0243095
27889529	antimalarials	C0003374
27889529	against	C0521124
27889529	dengue virus type 2	C0318759
27889529	Zika virus	C0318793
27889529	previous	C0205156
27889529	study,	C2603343
27889529	antimalarial compounds	C0003374
27889529	amodiaquine	C0002641
27889529	AQ	C0002641
27889529	derivatives	C0243072
27889529	potent	C1704419
27889529	anti-dengue viral (DENV) activity	C0243095
27889529	stable	C0205360
27889529	DENV2	C0318759
27889529	Renilla luciferase	C1450145
27889529	reporter	C0206414
27889529	replicon	C0035142
27889529	expressing	C0017262
27889529	BHK-21 cells	C0007634
27889529	infectivity	C0030657
27889529	plaque	C0032102
27889529	qRT-PCR assays	C1514628
27889529	study	C2603343
27889529	performed	C0884358
27889529	molecular modeling	C0600115
27889529	compounds	C1254351
27889529	stereo-electronic properties	C0205556
27889529	optimal	C2698651
27889529	antiviral activity	C0243095
27889529	similarity	C2348205
27889529	stereo-electronic profiles	C0205556
27889529	electrostatic potential profiles	C0596484
27889529	compounds	C1254351
27889529	in silico screening	C0178605
27889529	compounds	C1254351
27889529	literature	C0023866
27889529	identified	C0205396
27889529	additional	C1524062
27889529	compounds	C1254351
27889529	Quinacrine	C0034403
27889529	QC	C0034403
27889529	Mefloquine	C0025153
27889529	MQ	C0025153
27889529	GSK369796	C3884469
27889529	antiviral activities	C0243095
27889529	three compounds	C1254351
27889529	high	C0205250
27889529	anti-DENV activity	C0243095
27889529	DENV2	C0318759
27889529	replicon	C0035142
27889529	expressing	C0017262
27889529	cells	C0007634
27889529	EC50 values	C0392762
27889529	QC	C0034403
27889529	MQ	C0025153
27889529	GSK369796	C3884469
27889529	infectivity assays	C0032102
27889529	revealed	C0443289
27889529	EC50 values	C0392762
27889529	QC	C0034403
27889529	MQ	C0025153
27889529	GSK369796	C3884469
27889529	mode of action	C1524059
27889529	compounds	C1254351
27889529	through	C0332273
27889529	inhibition	C3463820
27889529	autophagy	C0004391
27889529	affecting	C0392760
27889529	DENV2	C0318759
27889529	replication	C0042774
27889529	compounds	C1254351
27889529	antiviral activity	C0243095
27889529	against	C0521124
27889529	Zika virus	C0318793
27889529	ZIKV	C0318793
27889529	EC50 values	C0392762
27889529	QC	C0034403
27889529	MQ	C0025153
27889529	GSK369796	C3884469
27892236	babies	C0021270
27892236	fetal alcohol spectrum disorder	C2985290
27892236	pathway	C1705987
27892236	Alcohol	C0001967
27892236	consumed	C0001948
27892236	pregnancy	C0032961
27892236	nation's	C0683734
27892236	preventable	C2700409
27892236	cause	C0015127
27892236	developmental disabilities	C0008073
27892236	birth defects	C0220810
27892236	babies	C0021270
27892236	born	C0005615
27892236	alcohol-related damage	C3146244
27892236	World Health Organization	C0043237
27892236	Fetal alcohol spectrum disorders	C2985290
27892236	FASDs	C2985290
27892236	autism	C0004352
27892236	diagnosed	C0011900
27892857	Genotyping	C1285573
27892857	German	C1556085
27892857	Austrian	C0337795
27892857	Taylorella equigenitalis	C0318205
27892857	isolates	C1764827
27892857	repetitive extragenic palindromic (REP) PCR	C0032520
27892857	pulsed-field gel electrophoresis	C0085117
27892857	PFGE	C0085117
27892857	total	C0439810
27892857	Taylorella (T.) equigenitalis	C0318205
27892857	T. asinigenitalis	C1036797
27892857	field	C1521738
27892857	isolates	C1764827
27892857	collected	C1516698
27892857	available	C0470187
27892857	genotyping	C1285573
27892857	REP- (repetitive extragenic palindromic) PCR	C0032520
27892857	PFGE	C0085117
27892857	pulsed-field gel electrophoresis	C0085117
27892857	study	C2603343
27892857	T. equigenitalis	C0318205
27892857	field	C1521738
27892857	isolates	C1764827
27892857	breeds	C0006159
27892857	German horses	C0019944
27892857	revealed	C0443289
27892857	spectrum	C2827424
27892857	REP	C0004793
27892857	rep-E1-E4	C0017431
27892857	rep-E3a	C0017431
27892857	PFGE	C0085117
27892857	TE-A1-A9	C0017431
27892857	TE-B1-B3	C0017431
27892857	TE-C	C0017431
27892857	TE-E1	C0017431
27892857	TE-E2	C0017431
27892857	genotypes	C0017431
27892857	T. equigenitalis	C0318205
27892857	field	C1521738
27892857	isolates	C1764827
27892857	obtained	C1301820
27892857	Austrian Lipizzaner horses	C0324170
27892857	differentiated	C0205556
27892857	REP	C0004793
27892857	rep-E1	C0017431
27892857	rep-E3a	C0017431
27892857	rep-E4	C0017431
27892857	PFGE	C0085117
27892857	genotypes	C0017431
27892857	TE-A2	C0017431
27892857	TE-A5	C0017431
27892857	TE-D	C0017431
27892857	isolated	C0205409
27892857	Austrian Trotters	C0019944
27892857	REP	C0004793
27892857	PFGE	C0085117
27892857	genotype	C0017431
27892857	rep-E2/TE-A1	C0017431
27892857	T. equigenitalis	C0318205
27892857	isolate	C1764827
27892857	recovered from	C0521108
27892857	Holsteiner stallion	C0019944
27892857	living	C0376558
27892857	South Africa	C0037712
27892857	revealed	C0443289
27892857	REP	C0004793
27892857	PFGE	C0085117
27892857	genotype	C0017431
27892857	rep-E1/TE-A5	C0017431
27892857	exclusively	C1548966
27892857	present	C0150312
27892857	majority	C0680220
27892857	Austrian Lipizzaner horses	C0324170
27892857	study	C2603343
27892857	strain	C1518614
27892857	study	C2603343
27892857	revealed	C0443289
27892857	genotype	C0017431
27892857	REP	C0004793
27892857	PFGE	C0085117
27892857	rep-E1/TE-F	C0017431
27892857	strains	C1518614
27892857	T. asinigenitalis	C1036797
27892857	strain	C1518614
27892857	separated	C0443299
27892857	REP	C0004793
27892857	rep-A1-A3	C0017431
27892857	PFGE	C0085117
27892857	genotypes	C0017431
27892857	TA-A1	C0017431
27892857	TA-A2	C0017431
27892857	TA-A3	C0017431
27892857	TA-B	C0017431
27892857	TA-C	C0017431
27892857	TA-D	C0017431
27892857	Overall,	C1561607
27892857	generated	C3146294
27892857	REP	C0004793
27892857	PFGE	C0085117
27892857	genotypes	C0017431
27892857	good	C0205170
27892857	correlation	C1707520
27892857	REP-PCR	C0032520
27892857	suitable method	C0871511
27892857	molecular epidemiological screening	C1294203
27892857	T. equigenitalis	C0318205
27892857	T. asinigenitalis	C1036797
27892857	isolates	C1764827
27892857	differentiated	C0205556
27892857	detail	C1522508
27892857	genotyping	C1285573
27892857	PFGE	C0085117
27896225	Urokinase	C0042071
27896225	Urokinase Receptor	C0071216
27896225	Mast Cells	C0024880
27896225	Effects	C1280500
27896225	Functional	C0205245
27896225	Interaction	C1704675
27896225	fMLF Receptors	C0597357
27896225	Mast cell	C0024880
27896225	basophils	C0004827
27896225	express	C0597360
27896225	high affinity receptor	C0597357
27896225	IgE	C0020846
27896225	FcɛRI	C0020846
27896225	primary effector cells	C0312740
27896225	allergic disorders	C0020517
27896225	urokinase	C0042071
27896225	uPA	C0042071
27896225	plasminogen activation system	C1622667
27896225	physiological	C0031845
27896225	pathological events	C0030660
27896225	cell migration	C1622501
27896225	tissue remodelling	C1254358
27896225	inflammation	C0021368
27896225	wound healing	C0043240
27896225	angiogenesis	C0302600
27896225	metastasis	C4255448
27896225	uPA	C0042071
27896225	serine protease	C2717971
27896225	uPAR	C0071216
27896225	high affinity glycosyl-phosphatidyl-inositol (GPI)-anchored	C0119748
27896225	receptor	C0597357
27896225	uPAR	C0071216
27896225	uPA	C0042071
27896225	activity	C0243102
27896225	cell surface	C0699040
27896225	activates intracellular signaling	C3822614
27896225	interactions	C1704675
27896225	integrins	C0021701
27896225	receptor tyrosine kinases	C0206364
27896225	G-protein-coupled family	C0872043
27896225	fMLF chemotaxis receptors	C0597357
27896225	FPRs	C0597357
27896225	investigated	C1292732
27896225	expression	C1171362
27896225	uPA	C0042071
27896225	uPAR	C0071216
27896225	functional	C0205245
27896225	interaction	C1704675
27896225	FPRs	C0597357
27896225	human	C0086418
27896225	mast cells	C0024880
27896225	MCs	C0024880
27896225	basophils	C0004827
27896225	MCs	C0024880
27896225	uPA	C0042071
27896225	chemotaxis	C0008018
27896225	MCs	C0024880
27896225	uPAR	C0071216
27896225	DII-DIII-uPAR	C0071216
27896225	SRSRY sequence	C0002518
27896225	FPRs	C0597357
27896225	cell chemotaxis	C2610454
27896225	MCs	C0024880
27896225	mRNAs	C0035696
27896225	FPRs	C0597357
27896225	uPA	C0042071
27896225	soluble peptide	C0030956
27896225	uPAR84-95	C0071216
27896225	SRSRY chemotactic sequence	C0002518
27896225	uPAR	C0071216
27896225	FPRs	C0597357
27896225	MCs	C0024880
27896225	chemotaxis	C0008018
27896225	uPA	C0042071
27896225	chemoattractant	C0008013
27896225	MCs	C0024880
27896225	exposure	C0332157
27896225	chemotactic	C0008018
27896225	epitope	C0003316
27896225	uPAR	C0071216
27896225	endogenous	C0205227
27896225	ligand	C0023688
27896225	FPRs	C0597357
27896225	mechanism	C0441712
27896225	VEGF-A	C0078058
27896225	secretion	C0036536
27896225	human	C0086418
27896225	MCs	C0024880
27896225	induced	C0205263
27896225	uPA	C0042071
27896225	uPAR84-95	C0071216
27896225	stimulation.	C1148560
27898362	Psychogenic non-epileptic seizure	C1142430
27898362	patients	C0030705
27898362	intellectual disability	C3714756
27898362	choice	C1707391
27898362	therapeutic intervention	C0808232
27898362	studies	C2603343
27898362	treatments	C0087111
27898362	psychogenic non-epileptic seizure	C1142430
27898362	PNES	C1142430
27898362	neglecting	C0243095
27898362	subgroup	C1515021
27898362	patients	C0030705
27898362	intellectual disability	C3714756
27898362	ID	C3714756
27898362	present	C0521116
27898362	study	C2603343
27898362	attempted	C1516084
27898362	demonstrate	C0205319
27898362	effects	C1704420
27898362	preferred	C0558295
27898362	therapeutic intervention	C0808232
27898362	PNES	C1142430
27898362	patients	C0030705
27898362	ID	C3714756
27898362	treated	C1522326
27898362	Japanese municipal center	C1708333
27898362	short	C1806781
27898362	referral chain	C0034927
27898362	examined	C0332128
27898362	PNES	C1142430
27898362	patients	C0030705
27898362	ID	C3714756
27898362	ID	C3714756
27898362	group	C0441833
27898362	PNES	C1142430
27898362	patients	C0030705
27898362	ID	C3714756
27898362	non-ID	C0243095
27898362	group	C0441833
27898362	retrospectively	C1514923
27898362	case charts	C3842891
27898362	In addition to	C0332287
27898362	examining	C0332128
27898362	demographic	C0011298
27898362	clinical data	C1516606
27898362	effects of	C1704420
27898362	different	C1705242
27898362	therapeutic intervention	C0808232
27898362	examined	C0332128
27898362	function	C0542341
27898362	decrease	C0547047
27898362	disappearance	C2746065
27898362	PNES	C1142430
27898362	ID	C3714756
27898362	group	C0441833
27898362	Age	C0001779
27898362	visit	C1512346
27898362	PNES	C1142430
27898362	onset	C0332162
27898362	younger	C0332239
27898362	ID	C3714756
27898362	non-ID	C0243095
27898362	group	C0441833
27898362	PNES	C1142430
27898362	ratio	C0456603
27898362	visit	C1512346
27898362	higher	C0205250
27898362	non-ID	C0243095
27898362	group	C0441833
27898362	group	C0441833
27898362	chi square	C1552646
27898362	Psychosis	C0033975
27898362	ID	C3714756
27898362	group	C0441833
27898362	chi square	C1552646
27898362	cognitive therapy	C0009244
27898362	pharmaco-therapeutic	C0013216
27898362	similarly	C2348205
27898362	distributed	C1704711
27898362	groups	C0441833
27898362	environmental	C0014406
27898362	adjustment	C0456081
27898362	introduced	C1292748
27898362	ID	C3714756
27898362	group	C0441833
27898362	compared	C1707455
27898362	non-ID	C0243095
27898362	group	C0441833
27898362	chi square	C1552646
27898362	Brief	C1879313
27898362	weekly	C0332174
27898362	visit service	C1512346
27898362	utilized	C0042153
27898362	patients	C0030705
27898362	ID	C3714756
27898362	ID	C3714756
27898362	chi square	C1552646
27898362	Optimal	C2698651
27898362	treatment	C0087111
27898362	patient	C0030705
27898362	subgroup	C1515021
27898362	subject	C1706203
27898362	future	C0016884
27898362	prospective studies	C0033522
27900080	Effect of	C1704420
27900080	immunomodulatory regimen	C1963758
27900080	cancer prevention	C0281206
27900080	case report	C0085973
27900080	present	C0150312
27900080	case study	C0085973
27900080	immunomodulatory regimen	C1963758
27900080	cancer prevention	C0281206
27900080	reported	C0700287
27900080	patient	C0030705
27900080	abnormally high	C1299351
27900080	level	C0441889
27900080	tumor markers	C0041365
27900080	carbohydrate antigen-724	C0248054
27900080	CA724	C0248054
27900080	CA19-9	C0006613
27900080	carcinoembryonic antigen	C0007082
27900080	CEA	C0007082
27900080	without	C0332288
27900080	detectable	C3830527
27900080	tumor	C0027651
27900080	treated with	C0332293
27900080	immunomodulatory therapy	C1963758
27900080	infusion	C0574032
27900080	cytokine-induced autologous killer cells	C2348032
27900080	CIKs	C2348032
27900080	request	C1272683
27900080	patient	C0030705
27900080	therapy	C0087111
27900080	tumor markers	C0041365
27900080	rapidly	C0456962
27900080	decreased	C0205216
27900080	normal reference level	C0086715
27900080	slight	C2937276
27900080	fluctuations	C0231241
27900080	narrow	C0333164
27900080	range	C1514721
27900080	frequently	C0332183
27900080	patient	C0030705
27900080	monitored	C0150369
27900080	months	C0439231
27900080	present	C0150312
27900080	day	C0439228
27900080	no abnormality	C3809765
27900080	observed	C1441672
27900080	results	C0808233
27900080	therapy	C0087111
27900080	novel	C0205314
27900080	effective	C1704419
27900080	reliable	C0205556
27900080	cancer prevention	C0281206
27900080	regimen	C0087111
27900080	prevention of malignancies	C0281206
27900080	treatment	C0087111
27900080	major	C0205164
27900080	cancer	C0006826
27900080	prophylactic regimen	C0199176
27900080	patients	C0030705
27900080	high risk of	C0332167
27900080	cancer	C0006826
27900133	relationships	C0439849
27900133	rugby	C0035945
27900133	players'	C0679646
27900133	tackle	C0018578
27900133	training	C0220931
27900133	attitudes	C0004271
27900133	behaviour	C0004927
27900133	match tackle attitudes	C0004271
27900133	behaviour	C0004927
27900133	tackle	C0018578
27900133	rugby	C0035945
27900133	technical	C0205556
27900133	physical	C0205485
27900133	contest	C0040595
27900133	players	C0679646
27900133	player's	C0679646
27900133	tolerate	C0680282
27900133	contest	C0040595
27900133	tackle	C0018578
27900133	prerequisite	C0679209
27900133	safe	C0814103
27900133	participation	C0679823
27900133	success	C0597535
27900133	rugby	C0035945
27900133	relationship	C0439849
27900133	tackle training	C0220931
27900133	tackling	C0018578
27900133	matches	C0150593
27900133	rugby union	C0035945
27900133	investigated	C1292732
27900133	relationships	C0439849
27900133	players'	C0679646
27900133	training attitudes	C0004271
27900133	behaviour	C0004927
27900133	match attitudes	C0004271
27900133	behaviour	C0004927
27900133	tackling	C0018578
27900133	rugby union	C0035945
27900133	questionnaire	C0034394
27900133	assess	C0184514
27900133	attitude	C0004271
27900133	behaviours	C0004927
27900133	frequency	C1561548
27900133	quantity	C1265611
27900133	junior	C1708595
27900133	players	C0679646
27900133	5-point Likert Scale	C0451267
27900133	Questionnaires	C0034394
27900133	players	C0679646
27900133	schools	C0036375
27900133	tournament	C0040595
27900133	schools	C0036375
27900133	analysis	C0936012
27900133	Associations	C0004083
27900133	training attitudes	C0004271
27900133	behaviours	C0004927
27900133	tested	C0039593
27900133	χ(2) test, Cramer's V and τ-b	C0392366
27900133	technique	C0449851
27900133	prevent	C2700409
27900133	injuries	C0004161
27900133	training	C0220931
27900133	players	C0679646
27900133	moderate	C0205081
27900133	ball	C1706910
27900133	moderate	C0205081
27900133	moderate	C0205081
27900133	match play	C0150593
27900133	technique	C0449851
27900133	improve	C0184511
27900133	performance	C1882330
27900133	training	C0220931
27900133	players	C0679646
27900133	ball	C1706910
27900133	moderate	C0205081
27900133	preventing	C2700409
27900133	ball	C1706910
27900133	retaining	C0333118
27900133	position	C0733755
27900133	moderate	C0205081
27900133	match play	C0150593
27900133	study	C2603343
27900133	relationships	C0439849
27900133	players	C0679646
27900133	training attitudes	C0004271
27900133	behaviour	C0004927
27900133	match attitudes	C0004271
27900133	behaviour	C0004927
27900133	tackling	C0018578
27900133	rugby union	C0035945
27900133	tackle	C0018578
27900133	training	C0220931
27900133	prevent	C2700409
27900133	injury	C0004161
27900133	technique	C0449851
27900133	prevent	C2700409
27900133	injuries	C0004161
27900133	associated with	C0332281
27900133	behaviours	C0004927
27900133	reduce	C0392756
27900133	risk of injury	C0582456
27900133	matches	C0150593
27903991	Role	C1705810
27903991	Oxidative Stress	C0242606
27903991	Inflammatory	C0333348
27903991	Factors	C1521761
27903991	Diabetic Kidney Disease	C0011881
27903991	Diabetic nephropathy	C0011881
27903991	DN	C0011881
27903991	serious	C0205404
27903991	complication	C0009566
27903991	diabetes mellitus	C0011849
27903991	prevalence	C0033106
27903991	increasing	C0442808
27903991	developed countries	C0282613
27903991	Diabetic nephropathy	C0011881
27903991	common	C0205214
27903991	single	C0205171
27903991	end-stage renal disease	C0022661
27903991	worldwide	C2700280
27903991	Oxidative stress	C0242606
27903991	inflammation	C0021368
27903991	factors	C1521761
27903991	hypothesized	C1512571
27903991	play a role	C1705810
27903991	development	C1527148
27903991	late	C0205087
27903991	diabetes complications	C0342257
27903991	Chronic hyperglycemia	C0342300
27903991	increases	C0442805
27903991	oxidative stress	C0242606
27903991	significantly modifies	C0392747
27903991	structure	C0678594
27903991	function	C0031843
27903991	proteins	C0033684
27903991	lipids	C0023779
27903991	induces	C0205263
27903991	glycoxidation	C0260088
27903991	peroxidation	C0178796
27903991	hyperglycemia	C0020456
27903991	auto-oxidation	C0311405
27903991	glucose	C0017725
27903991	glycation	C0598528
27903991	proteins	C0033684
27903991	activation	C1879547
27903991	polyol mechanism	C0441712
27903991	Overproduction	C0033268
27903991	intracellular	C0178719
27903991	reactive oxygen species	C0162772
27903991	contributes	C1880177
27903991	several	C0443302
27903991	microvascular	C0443258
27903991	macrovascular	C0205245
27903991	complications	C0009566
27903991	DN	C0011881
27903991	reactive oxygen species	C0162772
27903991	modulates	C0443264
27903991	signaling cascade	C2611812
27903991	immune factors	C0021054
27903991	increase	C0442805
27903991	reactive oxygen species	C0162772
27903991	increase	C0442805
27903991	production	C0033268
27903991	inflammatory	C0333348
27903991	cytokines	C0079189
27903991	increase	C0442805
27903991	inflammatory	C0333348
27903991	cytokines	C0079189
27903991	stimulate	C1948023
27903991	production	C0033268
27903991	free radicals	C0016693
27903991	studies	C0681814
27903991	kidney inflammation	C0027697
27903991	serious	C0205404
27903991	promoting	C0033414
27903991	development	C1527148
27903991	progression	C0449258
27903991	DN	C0011881
27903991	Inflammatory	C0333348
27903991	factors	C1521761
27903991	activated	C1879547
27903991	metabolic	C0311400
27903991	biochemical	C0205474
27903991	hemodynamic	C0019010
27903991	exist	C2987476
27903991	diabetic kidney	C0011881
27903991	review	C0282443
27903991	oxidative stress	C0242606
27903991	inflammatory	C0333348
27903991	factors	C1521761
27903991	DN	C0011881
27903991	role	C1705810
27903991	immune	C0007634
27903991	inflammatory cells	C0440752
27903991	inflammatory	C0333348
27903991	cytokines	C0079189
27903991	stress oxidative	C0242606
27903991	factors	C1521761
27908503	Cobalt-60 Machines	C0025080
27908503	Medical Linear Accelerators	C0023730
27908503	Competing Technologies	C0039421
27908503	External Beam Radiotherapy	C1517033
27908503	Medical linear accelerators	C0023730
27908503	linacs	C0023730
27908503	cobalt-60 machines	C0025080
27908503	technologies	C0039421
27908503	external beam radiotherapy	C1517033
27908503	comparison	C1707455
27908503	technologies	C0039421
27908503	infrastructure	C1514880
27908503	maintenance	C0024501
27908503	dosimetry	C0034603
27908503	shielding	C0243095
27908503	requirements	C1514873
27908503	staffing	C0087023
27908503	costs	C0010186
27908503	security	C1519222
27908503	patient	C0030705
27908503	throughput	C2986816
27908503	clinical use	C0042153
27908503	Infrastructure	C1514880
27908503	maintenance	C0024501
27908503	demanding	C0699784
27908503	linacs	C0023730
27908503	complex electric componentry	C3273359
27908503	dosimetry	C0034603
27908503	higher	C0205250
27908503	beam energy	C1442080
27908503	modulated	C0443264
27908503	dose rate	C1512044
27908503	smaller	C0547044
27908503	focal spot size	C2348694
27908503	easier	C0332219
27908503	create	C1706214
27908503	optimised	C2698650
27908503	treatment	C0087111
27908503	linac	C0023730
27908503	dose	C0178602
27908503	coverage	C1999244
27908503	tumour	C0027651
27908503	healthy organs	C0178784
27908503	risk	C0035647
27908503	shielding	C0243095
27908503	requirements	C1514873
27908503	concrete bunker	C3273359
27908503	cobalt-60 machines	C0025080
27908503	linacs	C0023730
27908503	shielding	C0243095
27908503	protection	C1545588
27908503	neutrons	C0027946
27908503	linacs	C0023730
27908503	Staffing levels	C3845726
27908503	higher	C0205250
27908503	linacs	C0023730
27908503	staff training	C0681113
27908503	linacs	C0023730
27908503	Life cycle costs	C0220812
27908503	higher	C0205250
27908503	linacs	C0023730
27908503	multi-energy linacs	C0023730
27908503	Security	C1519222
27908503	complex	C0439855
27908503	cobalt-60 machines	C0025080
27908503	high	C0205250
27908503	activity	C0441655
27908503	radioactive source	C0182598
27908503	Patient	C0030705
27908503	throughput	C2986816
27908503	affected	C0392760
27908503	source	C0449416
27908503	decay	C2700592
27908503	cobalt-60 machines	C0025080
27908503	poor	C0542537
27908503	maintenance	C0024501
27908503	breakdowns	C0014678
27908503	affect	C0392760
27908503	patient	C0030705
27908503	throughput	C2986816
27908503	linacs	C0023730
27908503	clinical use	C0042153
27908503	complex	C0439855
27908503	treatment	C0087111
27908503	techniques	C0449851
27908503	easier	C0332219
27908503	linacs	C0023730
27908503	availability of	C0470187
27908503	electron beams	C0013840
27908503	high	C0205250
27908503	energy	C1442080
27908503	linacs	C0023730
27908503	treatments	C0087111
27908503	cobalt-60 machines	C0025080
27908503	linacs	C0023730
27908503	radiotherapy	C1522449
27908503	low-	C1331016
27908503	middle-income	C0870890
27908503	countries	C0454664
27908503	radiotherapy department	C0587444
27908503	combination	C0205195
27908503	technologies	C0039421
27908503	orthovoltage X-ray units	C1704729
27908503	option	C1518601
27908503	Local	C0205276
27908503	needs	C0027552
27908503	conditions	C0348080
27908503	resources	C0035201
27908503	decision	C0679006
27908503	technology	C0039421
27908503	characteristics	C1521970
27908503	teletherapy	C0419095
27908503	goal	C0018017
27908503	sustainability	C0205245
27908503	radiotherapy service	C0587559
27908503	lifetime	C4071830
27908503	equipment	C0014672
27908539	Design	C1707689
27908539	synthesis	C1883254
27908539	molecular docking	C3494274
27908539	anti-Proteus mirabilis	C0279516
27908539	urease	C0041945
27908539	inhibition	C1524081
27908539	fluoroquinolone carboxylic acid derivatives	C1254351
27908539	hydroxamic acid	C0020314
27908539	hydrazide	C0682951
27908539	amide derivatives	C0002482
27908539	ciprofloxacin	C0008809
27908539	analogues	C0243071
27908539	levofloxacin	C0282386
27908539	spectroscopic techniques	C0449851
27908539	compounds	C1254351
27908539	activity	C2248397
27908539	urease	C0041945
27908539	bacteria	C0004611
27908539	Proteus mirabilis	C0033701
27908539	urease	C0041945
27908539	inhibitory activity	C2248397
27908539	indophenol method	C1318795
27908539	tested	C0392366
27908539	compounds	C1254351
27908539	activity	C2248397
27908539	acetohydroxamic acid	C0050451
27908539	AHA	C0050451
27908539	ciprofloxacin hydrazide derivative 3a	C1254351
27908539	levofloxacin hydroxamic acid 7	C1254351
27908539	activity	C2248397
27908539	IC50	C0600495
27908539	Molecular docking study	C3494274
27908539	binding ability	C1167622
27908539	tested	C0392366
27908539	compounds	C1254351
27908539	active site	C0205681
27908539	urease	C0041945
27909143	Interobserver	C0870736
27909143	Intraobserver	C0870992
27909143	Reliability	C2347947
27909143	Clinical Assessments	C3845884
27909143	Knee Osteoarthritis	C0409959
27909143	Clinical examination	C1456356
27909143	knee	C0022742
27909143	measurement error	C0681899
27909143	interobserver	C0870736
27909143	intraobserver	C0870992
27909143	reliability	C2347947
27909143	patients	C0030705
27909143	knee osteoarthritis	C0409959
27909143	OA	C0409959
27909143	subjects	C0681850
27909143	symptomatic	C0231220
27909143	knee OA	C0409959
27909143	participants	C0679646
27909143	open-label clinical trial	C1709323
27909143	intraarticular steroid therapy	C0585373
27909143	standardization	C0038136
27909143	clinical test procedures	C0022885
27909143	clinicians	C0871685
27909143	assessed	C0220825
27909143	subjects	C0681850
27909143	visit	C1512346
27909143	clinician	C0871685
27909143	assessed	C0220825
27909143	subjects	C0681850
27909143	interval period	C1272706
27909143	steroid	C0149783
27909143	intervention	C0184661
27909143	Clinical examination	C1456356
27909143	included	C0332257
27909143	assessment	C0220825
27909143	bony enlargement	C0221610
27909143	crepitus	C0277964
27909143	quadriceps wasting	C0555751
27909143	knee effusion	C0343166
27909143	joint-line	C0446569
27909143	anserine	C0224834
27909143	tenderness	C0240094
27909143	knee range of movement	C0576094
27909143	ROM	C0576094
27909143	Intraclass correlation coefficients	C0392762
27909143	ICC	C0392762
27909143	estimated kappa	C0392762
27909143	κ	C0392762
27909143	weighted kappa	C0392762
27909143	κω	C0392762
27909143	Bland-Altman plots	C0392762
27909143	interobserver	C0870736
27909143	intraobserver	C0870992
27909143	levels	C0441889
27909143	agreement	C0680240
27909143	Landis and Koch criteria	C0871425
27909143	interobserver κ scores	C0237855
27909143	moderate	C0205081
27909143	patellofemoral joint	C0447801
27909143	κ	C0392762
27909143	anserine	C0224834
27909143	tenderness	C0240094
27909143	κ	C0392762
27909143	good	C0205170
27909143	bony enlargement	C0221610
27909143	κ	C0392762
27909143	quadriceps wasting	C0555751
27909143	κ	C0392762
27909143	crepitus	C0277964
27909143	κ	C0392762
27909143	medial	C0205098
27909143	tibiofemoral joint	C0447795
27909143	tenderness	C0240094
27909143	κ	C0392762
27909143	effusion	C0343166
27909143	ballottement	C0231756
27909143	κ	C0392762
27909143	bulge sign	C3696902
27909143	κω	C0392762
27909143	excellent	C1548784
27909143	lateral	C0205093
27909143	tibiofemoral joint	C0447795
27909143	tenderness	C0240094
27909143	κ	C0392762
27909143	flexion	C0231452
27909143	ICC	C0392762
27909143	extension	C0231448
27909143	ICC	C0392762
27909143	ROM	C0576094
27909143	Intraobserver κ scores	C0237855
27909143	moderate	C0205081
27909143	lateral	C0205093
27909143	tibiofemoral joint	C0447795
27909143	tenderness	C0234233
27909143	κ	C0392762
27909143	κ	C0392762
27909143	effusion	C0343166
27909143	ballottement test	C0231756
27909143	κ	C0392762
27909143	patellofemoral joint	C0447801
27909143	κ	C0392762
27909143	medial	C0205098
27909143	tibiofemoral joint	C0447795
27909143	κ	C0392762
27909143	anserine	C0224834
27909143	tenderness	C0234233
27909143	κ	C0392762
27909143	excellent	C1548784
27909143	effusion	C0343166
27909143	bulge sign	C3696902
27909143	κω	C0392762
27909143	bony enlargement	C0221610
27909143	κ	C0392762
27909143	quadriceps wasting	C0555751
27909143	κ	C0392762
27909143	flexion	C0231452
27909143	ICC	C0392762
27909143	extension	C0231448
27909143	ICC	C0392762
27909143	ROM	C0576094
27909143	individuals	C0237401
27909143	symptomatic	C0231220
27909143	knee OA	C0409959
27909143	reliability	C2347947
27909143	clinical examination	C1456356
27909143	knee	C0022742
27909143	clinical signs	C3540840
27909143	knee OA	C0409959
27913319	benefits	C0814225
27913319	targeted	C1521840
27913319	drug delivery	C0085104
27913319	nanocarriers	C1450053
27913319	partico/pharmacokinetic framework	C0031328
27913319	in vivo	C1515655
27913319	kinetic framework	C0031328
27913319	analyze	C0936012
27913319	quantitative	C0392762
27913319	nanocarriers	C1450053
27913319	deliver drugs	C0085104
27913319	anticancer agents	C0003392
27913319	compared	C1707455
27913319	administering	C1533734
27913319	drugs	C0013227
27913319	framework	C0178566
27913319	levels	C0441889
27913319	kinetics	C0031327
27913319	particokinetics	C0022702
27913319	associated with	C0332281
27913319	deposition	C0333562
27913319	nanocarriers	C1450053
27913319	tissues	C0040300
27913319	associated with	C0332281
27913319	drug effect	C0728866
27913319	toxicity	C0600688
27913319	residence	C0237096
27913319	tissues	C0040300
27913319	elimination	C0683141
27913319	nanocarriers	C1450053
27913319	body	C0242821
27913319	release pattern	C0231360
27913319	free drug	C0678752
27913319	nanocarriers	C1450053
27913319	pharmacokinetics	C0031327
27913319	free drug	C0678752
27913319	deposition	C0333562
27913319	elimination processes	C0683141
27913319	target	C1521840
27913319	toxicity	C0600688
27913319	associated	C0439849
27913319	tissues	C0040300
27913319	total body clearance	C0087101
27913319	drug targeting index	C1637833
27913319	DTI	C1637833
27913319	quantitate	C0392762
27913319	nanocarrier	C1450053
27913319	drug delivery	C0085104
27913319	effects	C1280500
27913319	deposition	C0333562
27913319	nanoparticles	C1450054
27913319	target	C1521840
27913319	tissues	C0040300
27913319	tissues	C0040300
27913319	associated with	C0332281
27913319	drug toxicity	C0013221
27913319	compared	C1707455
27913319	drug	C0013227
27913319	administered	C1533734
27913319	methods	C0025663
27913319	calculating	C1441506
27913319	DTI	C1637833
27913319	particokinetic	C0022702
27913319	pharmacokinetic	C0031328
27913319	drug release rate	C1521828
27913319	result	C1274040
27913319	developing	C0872152
27913319	nanocarrier	C1450053
27913319	formulations	C1705957
27913319	populations	C1257890
27913319	individuals	C0237401
27914462	Recombinant	C1514798
27914462	MHC Tetramers	C0024518
27914462	Isolation	C0204727
27914462	Virus	C0042776
27914462	Specific	C0205369
27914462	CD8(+) Cells	C0242629
27914462	Healthy Donors	C3898902
27914462	Potential	C3245505
27914462	Cell Therapy	C0302189
27914462	Posttransplant Cytomegalovirus Infection	C0010823
27914462	Patients	C0030705
27914462	allogeneic	C1515895
27914462	hematopoietic stem cell transplantation	C0472699
27914462	cytomegalovirus reactivation	C1142560
27914462	T-cell immunity	C1817907
27914462	acute inflammatory reaction	C0333361
27914462	damage of internal organs	C0332675
27914462	Transfusion	C0086573
27914462	virus-specific	C0205369
27914462	donor T-lymphocytes	C0039194
27914462	highly toxic	C1407029
27914462	ineffective	C3242229
27914462	antiviral therapy	C0280274
27914462	Potentially	C3245505
27914462	cell therapy	C0302189
27914462	transfusion	C0086573
27914462	cytotoxic T-lymphocytes	C0039195
27914462	specific	C0205369
27914462	viral antigens	C0003342
27914462	isolation	C0204727
27914462	donor's blood circulation	C0005775
27914462	in vitro expansion	C1533691
27914462	Specific	C0205369
27914462	T-cells	C0039194
27914462	potentially	C3245505
27914462	alloreactive lymphocytes	C0024264
27914462	recombinant	C1514798
27914462	major histocompatibility complex	C0024518
27914462	MHC	C0024518
27914462	multimers	C1979934
27914462	synthetic viral peptides	C0597551
27914462	transfusion	C0086573
27914462	virus	C0042776
27914462	specific	C0205369
27914462	T-cells	C0039194
27914462	patients	C0030705
27914462	in vitro expansion	C1533691
27914462	cells	C0007634
27914462	hematopoietic	C0229601
27914462	stem cell donors	C3898902
27914462	transplant recipients	C0376387
27914462	National Research Center for Hematology	C1708333
27914462	HLA-A*02 allele	C0555908
27914462	Russian	C0337816
27914462	donors	C3898902
27914462	immune response	C0301872
27914462	cytomegalovirus	C0010825
27914462	CMV	C0010825
27914462	recombinant	C1514798
27914462	HLA-A*02	C0555908
27914462	multimers	C1979934
27914462	immunodominant	C0205556
27914462	cytomegalovirus peptide	C0030956
27914462	NLV	C0030956
27914462	healthy donors	C3898902
27914462	T-cell immunity	C1817907
27914462	antigen	C0003320
27914462	transplantation	C0040732
27914462	patients	C0030705
27914462	specific	C0205369
27914462	T-lymphocytes	C0039194
27914462	donor cells	C0007634
27914462	immune phenotype	C0031437
27914462	memory cells	C0682639
27914462	activated	C2259058
27914462	proliferate	C0596290
27914462	specific	C0205369
27914462	antigen	C0003320
27914462	Donor lymphocytes	C1395724
27914462	enriched	C0681540
27914462	purity	C1882508
27914462	magnetic separation	C0599662
27914462	recombinant	C1514798
27914462	MHC	C0024518
27914462	multimers	C1979934
27914462	activated	C0678666
27914462	cocultivation	C0282547
27914462	antigen	C0003320
27914462	cells	C0007634
27914462	HLA	C0019721
27914462	incompatible donors	C0013018
27914462	specific	C0205369
27914462	antigen	C0003320
27914462	study	C2603343
27914462	immune response	C0301872
27914462	CMV	C0010825
27914462	healthy donors	C3898902
27914462	HLA-A*02 allele	C0555908
27914462	Russian population	C1257890
27914462	virus-specific	C0205369
27914462	cells	C0007634
27914462	HLA-A*02-NLV	C0555908
27914462	multimers	C1979934
27914462	transfusion	C1879316
27914462	cells	C0007634
27914462	patients	C0030705
27914462	CMV	C0010825
27914462	allogeneic	C1515895
27914462	immune response	C0301872
27914587	Outcomes	C0085415
27914587	chest wall resections	C0087111
27914587	pediatric	C1521725
27914587	sarcoma	C1261473
27914587	patients	C0030705
27914587	Chest wall tumors	C1290309
27914587	pediatric	C1521725
27914587	patients	C0030705
27914587	study	C2603343
27914587	outcomes	C0085415
27914587	pediatric	C1521725
27914587	patients	C0030705
27914587	chest wall resections	C0087111
27914587	sarcomas	C1261473
27914587	retrospective review	C0035363
27914587	patients	C0030705
27914587	chest wall resections	C0087111
27914587	sarcoma	C1261473
27914587	University of Texas MD Anderson Cancer Center	C1519805
27914587	patients	C0030705
27914587	Ewing's sarcoma	C0553580
27914587	osteosarcoma	C0029463
27914587	sarcomas	C1261473
27914587	synovial sarcoma	C0039101
27914587	chondrosarcoma	C0008479
27914587	rhabdomyosarcoma	C0035412
27914587	Gore-Tex	C0018088
27914587	Marlex™ mesh	C0005479
27914587	methyl methacrylate sandwich	C0005479
27914587	patients	C0030705
27914587	children	C0008059
27914587	not require reconstruction	C3840851
27914587	patients	C0030705
27914587	normal	C0205307
27914587	activity	C0441655
27914587	occasional discomfort	C0231218
27914587	pain impairing function	C0684336
27914587	medication	C0013227
27914587	physical therapy	C0949766
27914587	impairment	C0684336
27914587	surgery	C0038894
27914587	children	C0008059
27914587	scoliosis	C0036439
27914587	patients	C0030705
27914587	posterior	C0205095
27914587	rib tumors	C1290243
27914587	Median overall survival	C4086681
27914587	entire cohort	C0599755
27914587	months	C0439231
27914587	Histology	C0019638
27914587	location	C0450429
27914587	tumor	C0027651
27914587	ribs	C0035561
27914587	surgical margins	C0229985
27914587	significantly associated with	C0332281
27914587	overall survival	C4086681
27914587	Tumors	C0027651
27914587	posterior	C0205095
27914587	ribs	C0035561
27914587	death	C0011065
27914587	Scoliosis	C0036439
27914587	posterior	C0205095
27914587	rib resections	C0185827
27914587	Histology	C0019638
27914587	location	C0450429
27914587	tumor	C0027651
27914587	surgical margins	C0229985
27914587	survival	C0038952
27914587	Treatment Study	C3161471
27914987	Tetrabromobisphenol A	C0076220
27914987	activates	C1879547
27914987	hepatic	C0023884
27914987	interferon pathway	C1512834
27914987	rats	C0034721
27914987	Tetrabromobisphenol A	C0076220
27914987	TBBPA	C0076220
27914987	flame retardant	C0016198
27914987	printed circuit boards	C1707396
27914987	paper	C0030351
27914987	textiles	C0039717
27914987	two-year	C0439234
27914987	study	C2603343
27914987	TBBPA	C0076220
27914987	uterine tumors	C0042138
27914987	female	C0086287
27914987	Wistar-Han rats	C2700261
27914987	liver	C0023903
27914987	colon tumors	C0009375
27914987	B6C3F1 mice	C2698297
27914987	gene	C0017337
27914987	pathway	C1704259
27914987	cancer	C0027651
27914987	female	C0086287
27914987	Wistar Han rats	C2700261
27914987	TBBPA	C0076220
27914987	oral gavage	C2698653
27914987	corn oil	C0010029
27914987	week	C0439230
27914987	weeks	C0439230
27914987	TBBPA	C0076220
27914987	exposure	C0332157
27914987	body weights	C0005910
27914987	liver	C0577053
27914987	uterus lesions	C0567079
27914987	liver	C0736253
27914987	uterine organ	C0736936
27914987	weights	C0043100
27914987	controls	C0009932
27914987	dose	C0178602
27914987	animals	C0003062
27914987	analyzed	C0936012
27914987	Analysis	C0936012
27914987	hepatic	C0023884
27914987	uterine	C0042149
27914987	transcriptomes	C3178810
27914987	TBBPA	C0076220
27914987	liver	C0023884
27914987	transcripts	C1519595
27914987	genes	C0017337
27914987	expressed	C0017262
27914987	controls	C0009932
27914987	Pathway analysis	C0868995
27914987	activation	C1879547
27914987	interferon	C0021747
27914987	IFN	C0021747
27914987	metabolic networks	C1706062
27914987	TBBPA	C0076220
27914987	uterus	C0042149
27914987	Activation	C1879547
27914987	interferon pathway	C1512834
27914987	liver	C0023884
27914987	13-weeks	C0439230
27914987	TBBPA	C0076220
27914987	exposure	C0332157
27914987	TBBPA	C0076220
27914987	exposure	C0332157
27914987	immunomodulatory	C1963758
27914987	changes	C0392747
27914987	carcinogenic processes	C0596263
27916672	Famous faces	C0870537
27916672	voices	C0920674
27916672	Differential	C1705242
27916672	profiles	C0449774
27916672	early	C1279919
27916672	right	C0228232
27916672	left	C0228233
27916672	semantic dementia	C0338462
27916672	Alzheimer's disease	C0002395
27916672	Famous face	C0870537
27916672	voice recognition	C0920674
27916672	impaired	C0221099
27916672	semantic dementia	C0338462
27916672	SD	C0338462
27916672	Alzheimer's Disease	C0002395
27916672	AD	C0002395
27916672	severely	C0205082
27916672	AD	C0002395
27916672	perceptual	C0030971
27916672	impairment	C0221099
27916672	face	C0870537
27916672	voice	C0920674
27916672	processing	C0025361
27916672	performance	C1882330
27916672	complex	C0439855
27916672	semantic	C0036612
27916672	tasks	C0441655
27916672	SD	C0338462
27916672	face	C0870537
27916672	voice recognition	C0920674
27916672	disorders	C0012634
27916672	prevalence	C0220900
27916672	atrophy	C0333641
27916672	right temporal lobe	C0228232
27916672	RTL	C0228232
27916672	study	C2603343
27916672	investigate	C1292732
27916672	famous faces	C0870537
27916672	voices recognition	C0920674
27916672	SD	C0338462
27916672	AD	C0002395
27916672	diseases	C0012634
27916672	differential	C1705242
27916672	pattern	C0449774
27916672	impairment	C0221099
27916672	disruption	C0332453
27916672	cognitive	C0009240
27916672	mechanisms	C0441712
27916672	face	C0870537
27916672	voice recognition	C0920674
27916672	disorders	C0012634
27916672	patients	C0030705
27916672	atrophy	C0333641
27916672	RTL	C0228232
27916672	potential	C3245505
27916672	influence	C4054723
27916672	primary	C0205225
27916672	perceptual	C0030971
27916672	problems	C0033213
27916672	face	C0870537
27916672	voice recognition	C0920674
27916672	patients	C0030705
27916672	early	C1279919
27916672	SD	C0338462
27916672	AD	C0002395
27916672	administered	C1521801
27916672	tests	C2081632
27916672	face	C0870537
27916672	voice	C0920674
27916672	perception	C0030971
27916672	SD	C0338462
27916672	prevalence	C0220900
27916672	right	C0228232
27916672	prevalence	C0220900
27916672	left temporal	C0228233
27916672	atrophy	C0333641
27916672	patients	C0030705
27916672	visual	C0234621
27916672	auditory	C0439825
27916672	perceptual	C0030971
27916672	impairment	C0221099
27916672	administered	C1521801
27916672	experimental	C1517586
27916672	battery	C1555716
27916672	famous face	C0870537
27916672	voice recognition	C0920674
27916672	naming	C0392366
27916672	SD	C0338462
27916672	patients	C0030705
27916672	cerebral	C0006104
27916672	PET imaging	C0032743
27916672	right	C0228232
27916672	left	C0228233
27916672	SD	C0338462
27916672	modality	C0695347
27916672	decrease	C0547047
27916672	FDG uptake	C0046056
27916672	right	C0228232
27916672	left temporal lobe	C0228233
27916672	Correlation	C1707520
27916672	PET imaging	C0032743
27916672	famous face	C0870537
27916672	voice recognition	C0920674
27916672	Results	C1274040
27916672	differential	C1705242
27916672	performance	C1882330
27916672	profile	C0449774
27916672	diseases	C0012634
27916672	AD	C0002395
27916672	patients	C0030705
27916672	impaired	C0221099
27916672	naming tests	C0392366
27916672	recognition	C0524637
27916672	SD	C0338462
27916672	patients	C0030705
27916672	impaired	C0221099
27916672	naming	C0392366
27916672	recognition of famous faces	C0870537
27916672	voices	C0920674
27916672	face	C0870537
27916672	voice recognition	C0920674
27916672	disorders	C0012634
27916672	SD	C0338462
27916672	patients	C0030705
27916672	RTL	C0228232
27916672	atrophy	C0333641
27916672	conceptual	C1254372
27916672	impairment	C0221099
27916672	Pyramids and Palm Trees test	C0451399
27916672	verbal	C0439824
27916672	modality	C0695347
27916672	SD	C0338462
27916672	patients	C0030705
27916672	PET	C0032743
27916672	correlation	C1707520
27916672	FDG uptake	C0046056
27916672	face-to-name	C1708943
27916672	voice-to-name matching	C1708943
27916672	data	C1511726
27916672	right	C0228232
27916672	left temporal lobe	C0228233
27916672	data	C1511726
27916672	hypothesis	C1512571
27916672	cognitive	C0009240
27916672	impairment	C0221099
27916672	face	C0870537
27916672	voice recognition	C0920674
27916672	dementias	C0338462
27916672	pattern	C0449774
27916672	impairment	C0221099
27916672	SD	C0338462
27916672	semantic	C0036612
27916672	representations	C1882932
27916672	semantic	C0036612
27916672	control	C2587213
27916672	impaired	C0221099
27916672	naming	C0392366
27916672	preserved recognition	C0524637
27916672	AD	C0002395
27916672	correlation	C1707520
27916672	face	C0870537
27916672	voice recognition	C0920674
27916672	disorders	C0012634
27916672	RTL	C0228232
27916672	damage	C0178314
27916672	hypothesis	C1512571
27916672	RTL	C0228232
27916672	person	C0027361
27916672	knowledge	C0376554
27916672	non-verbal representations	C0681317
27917468	Dry skin	C0151908
27917468	related	C0439849
27917468	recovery rate	C1521828
27917468	skin temperature	C0037294
27917468	cold	C0009264
27917468	stress	C0449430
27917468	blood flow	C0232338
27917468	Cutaneous	C0221912
27917468	blood flow	C0232338
27917468	important	C3898777
27917468	thermoregulation	C0232416
27917468	oxygen supply	C0429622
27917468	nutritional support	C0242739
27917468	maintain	C0024501
27917468	skin	C1123023
27917468	evidence	C3887511
27917468	blood flow	C0232338
27917468	skin physiology	C0037289
27917468	surveys	C0038951
27917468	healthy volunteers	C1708335
27917468	relationship	C0439849
27917468	dry skin	C0151908
27917468	cutaneous	C0221912
27917468	vascular function	C0232337
27917468	stratum corneum	C0221921
27917468	transepidermal water loss	C0232421
27917468	visual dryness score	C1512080
27917468	investigated	C1292732
27917468	dry skin	C0151908
27917468	parameters	C0449381
27917468	Cutaneous	C0221912
27917468	blood flow	C0232338
27917468	resting state	C0679218
27917468	recovery rate	C1521828
27917468	RR	C1521828
27917468	skin temperature	C0037294
27917468	hand	C0018563
27917468	cold-stress test	C0022885
27917468	responsiveness	C0205342
27917468	facial skin	C0222084
27917468	blood flow	C0232338
27917468	local cooling	C0419138
27917468	examined	C0332128
27917468	indices	C0918012
27917468	cutaneous	C0221912
27917468	vascular functions	C0232337
27917468	relationships	C0439849
27917468	dry skin	C0151908
27917468	parameters	C0449381
27917468	cutaneous	C0221912
27917468	vascular functions	C0232337
27917468	assessed	C1516048
27917468	RR	C1521828
27917468	correlated	C1707520
27917468	visual dryness score	C1512080
27917468	skin	C1123023
27917468	leg	C1140621
27917468	correlated	C1707520
27917468	stratum corneum	C0221921
27917468	correlation	C1707520
27917468	resting state	C0679218
27917468	blood flow	C0232338
27917468	dry skin	C0151908
27917468	parameters	C0449381
27917468	observed	C1441672
27917468	face	C0015450
27917468	body	C0242821
27917468	deterioration	C0868945
27917468	skin dryness	C0151908
27917468	summer	C0241301
27917468	winter	C0241737
27917468	significant	C0750502
27917468	RR	C1521828
27917468	RR	C1521828
27917468	correlated	C1707520
27917468	responsiveness	C0205342
27917468	facial skin	C0222084
27917468	blood flow	C0232338
27917468	local cooling	C0419138
27917468	indicating	C1444656
27917468	RR	C1521828
27917468	dry skin	C0151908
27917468	RR	C1521828
27917468	blood flow	C0232338
27917468	resting state	C0679218
27917468	dry skin	C0151908
27917468	homeostasis	C0019868
27917468	seasonal	C0036496
27917468	environmental changes	C4060636
27919226	Molar loss	C0080233
27919226	powder diet	C0301569
27919226	memory deficit	C0233794
27919226	mRNA expression	C1515670
27919226	brain-derived neurotrophic factor	C0107103
27919226	hippocampus	C0019564
27919226	adult	C0001675
27919226	mice	C0025929
27919226	tooth loss	C0080233
27919226	risk factor	C0035648
27919226	Alzheimer's disease	C0002395
27919226	soft diet	C0301569
27919226	feeding	C2987508
27919226	memory impairment	C0233794
27919226	brain-derived neurotrophic factor	C0107103
27919226	BDNF	C0107103
27919226	associated with	C0332281
27919226	tooth loss	C0080233
27919226	soft diet	C0301569
27919226	animal model	C0599779
27919226	BDNF	C1332408
27919226	expression	C0017262
27919226	patients	C0030705
27919226	Alzheimer's disease	C0002395
27919226	effect of	C1704420
27919226	tooth loss	C0080233
27919226	soft diet	C0301569
27919226	brain function	C0678908
27919226	effect of	C1704420
27919226	molar loss	C0080233
27919226	powder diet	C0301569
27919226	memory ability	C0025260
27919226	expression	C0017262
27919226	BDNF mRNA	C1332408
27919226	hippocampus	C0019564
27919226	adult	C0001675
27919226	C57BL/6J mice	C0025929
27919226	C57BL/6J mice	C0025929
27919226	randomly	C0034656
27919226	upper molar teeth	C0927248
27919226	Solid diet	C0012155
27919226	feeding	C2987508
27919226	Extracted	C0040440
27919226	upper molar teeth	C0927248
27919226	Solid diet	C0012155
27919226	feeding	C2987508
27919226	upper molar teeth	C0927248
27919226	Powder diet	C0301569
27919226	feeding	C2987508
27919226	upper molar teeth	C0927248
27919226	Powder diet	C0301569
27919226	feeding	C2987508
27919226	analyze	C0936012
27919226	memory ability	C0025260
27919226	passive avoidance	C0871047
27919226	BDNF-related mRNA	C1332408
27919226	hippocampus	C0019564
27919226	analyzed	C0936012
27919226	real-time polymerase chain reaction	C1709846
27919226	RT-PCR	C1709846
27919226	memory test	C0022885
27919226	brains	C0006104
27919226	analyze	C0936012
27919226	no differences	C3842396
27919226	memory function	C0025260
27919226	BDNF mRNA	C1332408
27919226	memory impairment	C0233794
27919226	BDNF mRNA	C1332408
27919226	powder diet	C0301569
27919226	no effect	C1301751
27919226	memory function	C0025260
27919226	BDNF mRNA	C1332408
27919226	effect of	C1704420
27919226	molar loss	C0080233
27919226	powder diet	C0301569
27919226	memory function	C0025260
27919226	BDNF mRNA	C1332408
27919226	molar loss	C0080233
27919226	long-term effect	C0023983
27919226	memory ability	C0025260
27919226	powder diet	C0301569
27920607	species	C1705920
27920607	Fiorianteon Olmi	C0684063
27920607	Hymenoptera	C0020415
27920607	Dryinidae	C1191214
27920607	Afrotropical region	C0017446
27920607	Fiorianteon sulcatumsp	C0684063
27920607	Fianarantsoa Province	C0017446
27920607	Madagascar	C0024443
27920607	species	C1705920
27920607	Fiorianteon	C0684063
27920607	Afrotropical region	C0017446
27920607	genus	C1708235
27920607	Fiorianteon	C0684063
27920607	genus	C1708235
27920607	Conganteon	C0684063
27920607	distal	C0205108
27920607	stigmal vein	C0042449
27920607	long	C0205166
27920607	shorter	C0424641
27920607	proximal	C0205107
27920607	stigmal vein	C0042449
27920607	proximal	C0205107
27920607	vein	C0042449
27920607	Conganteon	C0684063
27920947	The Daniel K. Inouye College of Pharmacy Scripts	C0871893
27920947	Poha Berry	C0016767
27920947	Physalis peruviana	C0331245
27920947	Potential	C3245505
27920947	Anti-inflammatory	C1515999
27920947	Cancer Prevention	C0281206
27920947	Activities	C0441655
27920947	The Daniel K. Inouye College of Pharmacy	C0036381
27920947	historic event	C0441471
27920947	Spring	C0241232
27920947	graduated	C0588053
27920947	students	C0038492
27920947	Pacific region	C0017446
27920947	PhD	C1512022
27920947	pharmaceutical sciences	C0031336
27920947	University of Hawai'i	C0041740
27920947	Hilo	C0017446
27920947	college	C0036381
27920947	PhD	C1512022
27920947	programs	C3484370
27920947	disciplines	C1518533
27920947	Cancer Biology	C1516164
27920947	Medicinal Chemistry	C0008003
27920947	Pharmaceutics	C4277728
27920947	Pharmacognosy	C0031326
27920947	Pharmacology	C0031330
27920947	Pharmacognosy	C0031326
27920947	dissertations	C0376645
27920947	plant-derived	C0032098
27920947	natural products	C1566558
27920947	potential	C3245505
27920947	anti-inflammatory	C1515999
27920947	cancer	C0006826
27920947	chemopreventive	C3273128
27920947	activities	C0441655
27920947	Physalis peruviana	C0331245
27920947	Pp	C0331245
27920947	South America	C0037713
27920947	naturalized	C0205296
27920947	Island of Hawai'i	C0017446
27920947	edible	C0032099
27920947	fruits	C0016767
27920947	cape gooseberry	C0331245
27920947	poha	C0331245
27920947	Hawai'i	C0017446
27920947	withanolides	C1955897
27920947	physaperuvin G	C1254351
27920947	physaperuvins I-J	C1254351
27920947	withanolides	C1955897
27920947	4β-hydroxywithanolide E	C1254351
27920947	withaperuvin C	C1254351
27920947	physalactone	C1254351
27920947	coagulin	C1254351
27920947	isolated	C0205409
27920947	aerial parts	C1136056
27920947	P. peruviana	C0331245
27920947	compounds	C1706082
27920947	phyperunolide F	C1254351
27920947	withanolide S	C1254351
27920947	isolated	C0205409
27920947	poha berry fruits	C0016767
27920947	structures	C0678594
27920947	absolute stereochemistry	C2350023
27920947	poha	C0331245
27920947	spectroscopy methods	C2984732
27920947	Nuclear Magnetic Resonance (NMR) spectroscopy	C0877853
27920947	X-ray diffraction	C0043301
27920947	mass spectrometry	C0037813
27920947	analyses	C0936012
27920947	isolated	C0205409
27920947	poha	C0331245
27920947	compounds	C1706082
27920947	aerial parts	C1136056
27920947	fruits	C0016767
27920947	anti-inflammatory activity	C1515999
27920947	lipopolysaccharide	C0023810
27920947	LPS	C0023810
27920947	murine	C0026809
27920947	macrophage RAW 264.7 cells	C4042840
27920947	tumor necrosis factor alpha	C0041368
27920947	TNF-α	C0041368
27920947	nuclear factor-kappa B	C0079904
27920947	NF-κB	C0079904
27920947	human embryonic kidney cells 293	C2936239
27920947	isolated	C0205409
27920947	natural compounds	C1566558
27920947	activity	C0205177
27920947	assays	C0005507
27920947	models	C3161035
27920947	colon cancer	C0007102
27920947	4β-hydroxywithanolide E	C1254351
27920947	4HWE	C1254351
27920947	inhibited	C0311403
27920947	growth	C0018270
27920947	colon cancer	C0007102
27920947	monolayer	C0007585
27920947	spheroid	C0282501
27920947	cultures	C0007585
27920947	compound	C1706082
27920947	induced	C0205263
27920947	cell cycle arrest	C1155873
27920947	low concentrations	C1446561
27920947	apoptosis	C0162638
27920947	higher concentrations	C1446561
27920947	data	C1511726
27920947	ingestion	C0232478
27920947	poha berries	C0016767
27920947	colon cancer	C0007102
27920947	poha	C0016452
27920947	isolates compounds	C1706082
27920947	growth inhibitory effects	C1512280
27920947	U251MG glioblastoma	C0017636
27920947	MDA-MB-231 breast cancer cells	C3898556
27920947	signal transducer and activation of transcription 3 (STAT3)	C0253050
27920947	NIH-3T3 mouse fibroblasts	C1257739
27920947	provisional patents	C0030650
27920947	University of Hawai'i Office of Technology Transfer and Economic Development	C0041740
27922526	Air Pollutant	C0001869
27922526	Exposure	C0332157
27922526	Delivery	C0011209
27922526	Placental Abruption	C0000832
27922526	Japan	C0022341
27922526	Placental abruption	C0000832
27922526	emergency obstetric complication	C0178292
27922526	etiology	C1314792
27922526	abruption	C0000832
27922526	acute	C0205178
27922526	stimuli	C0234402
27922526	ischemia	C0022116
27922526	inflammation	C0021368
27922526	associated with	C0332281
27922526	rupture of the decidual artery	C0155760
27922526	placental separation	C0233170
27922526	Ischemia	C0022116
27922526	inflammation	C0021368
27922526	acute	C0205178
27922526	biologic	C0205460
27922526	effects	C1280500
27922526	air pollution	C0001873
27922526	case-crossover design	C4288565
27922526	hypothesis	C1512571
27922526	short-term	C0443303
27922526	increase	C0442805
27922526	exposure	C0332157
27922526	air pollutants	C0001869
27922526	potential	C3245505
27922526	trigger	C0032930
27922526	placental abruption	C0000832
27922526	data	C1511726
27922526	western Japan	C0017446
27922526	Kyushu-Okinawa Districts	C0017446
27922526	Japan Perinatal Registry Network database	C0242356
27922526	singleton	C1313913
27922526	pregnant women	C0033011
27922526	placental abruption	C0000832
27922526	daily	C0332173
27922526	concentrations	C1265611
27922526	air pollutants	C0001869
27922526	nitrogen dioxide	C0028160
27922526	NO2	C0028160
27922526	suspended particulate matter	C1510837
27922526	ozone	C0030106
27922526	sulfur dioxide	C0038777
27922526	SO2	C0038777
27922526	monitoring station	C1883167
27922526	delivery	C0011209
27922526	hospital	C0019994
27922526	woman	C0043210
27922526	information	C1533716
27922526	onset day	C0449244
27922526	abruption	C0000832
27922526	case	C0868928
27922526	day	C0439228
27922526	day	C0439228
27922526	delivery	C0011209
27922526	Exposure	C0332157
27922526	NO2	C0028160
27922526	associated with	C0332281
27922526	placental abruption	C0000832
27922526	temperature	C0039476
27922526	odds ratio	C0028873
27922526	increase	C0442805
27922526	confidence interval	C0009667
27922526	association	C0439849
27922526	participants	C0679646
27922526	delivered	C0011209
27922526	emergency cesarean	C0558380
27922526	delivered	C0011209
27922526	35 weeks of gestation	C0233042
27922526	no association	C1513916
27922526	suspended particulate matter	C1510837
27922526	ozone	C0030106
27922526	SO2	C0038777
27922526	association	C0439849
27922526	NO2	C0028160
27922526	exposure	C0332157
27922526	days	C0439228
27922526	day	C0439228
27922526	delivery	C0011209
27922526	placental abruption	C0000832
27922526	pregnant Japanese women	C0033011
27922994	Infusion Therapy	C4316303
27922994	Standards	C0034925
27922994	Practice	C0237607
27922994	Infusion Nurses Society	C1708333
27922994	publishes	C0034037
27922994	evidence-based practice	C1510541
27922994	standards	C0034925
27922994	article	C1706852
27922994	process	C1522240
27922994	used	C1524063
27922994	standards	C0034925
27922994	development	C1527148
27922994	format	C1301627
27922994	standards	C0034925
27922994	provides	C1999230
27922994	summary	C1706244
27922994	selected	C1707391
27922994	standards	C0034925
27922994	applied	C4048755
27922994	home care	C0019855
27922994	Standards	C0034925
27922994	important	C3898777
27922994	document	C1301746
27922994	available	C0470187
27922994	every	C1948061
27922994	home care	C0019855
27922994	organization	C1708333
27922994	provides	C1999230
27922994	home infusion therapy	C0242945
27924297	Datasets	C0150098
27924297	validation	C1519941
27924297	in vivo	C1515655
27924297	siRNA	C1099354
27924297	silencing	C0598496
27924297	CD40	C1539081
27924297	detection	C1511790
27924297	markers	C0017393
27924297	atherosclerosis	C0003850
27924297	progression	C0242656
27924297	ApoE	C1412481
27924297	deficient	C0011155
27924297	mice	C0025929
27924297	Data	C1511726
27924297	Data	C1511726
27924297	in vivo	C1515655
27924297	silencing	C0598496
27924297	CD40	C1539081
27924297	progression	C0242656
27924297	experimental	C0681814
27924297	atherogenesis	C1563937
27924297	NFκB	C0079904
27924297	miR-125b	C2352284
27924297	potential	C3245505
27924297	mediators	C1363844
27924297	pathogenesis	C0699748
27924297	atherosclerosis	C0003850
27924297	M. Hueso	C1547383
27924297	L. De Ramon	C1547383
27924297	E. Navarro	C1547383
27924297	E. Ripoll	C1547383
27924297	J.M. Cruzado	C1547383
27924297	J.M. Grinyo	C1547383
27924297	J. Torras	C1547383
27924297	validation	C1519941
27924297	silencing	C0598496
27924297	CD40	C1539081
27924297	expression	C0017262
27924297	siRNA	C1099354
27924297	ApoE(-/-)	C1412481
27924297	mouse	C0025929
27924297	aortas	C0003483
27924297	splenic	C0037993
27924297	lymphocytic subpopulations	C0079720
27924297	infiltration	C0332448
27924297	aortic intima	C0226009
27924297	F4/80(+)	C0007634
27924297	galectin-3(+) macrophages	C0024432
27924297	NF-κB(+) cells	C0007634
27924297	Gene Ontology	C1138831
27924297	TLDA analysis	C0936012
27924297	detection	C1511790
27924297	potential	C3245505
27924297	mediators	C1363844
27924297	atherosclerosis	C0003850
27924297	progression	C0242656
27924297	genes	C0017337
27924297	expression	C0017262
27924297	increased	C0205217
27924297	atherosclerosis	C0003850
27924297	progression	C0242656
27924297	downregulated	C0013081
27924297	CD40	C1539081
27924297	silencing	C0598496
27927071	Investigation	C1552578
27927071	evaluation	C0220825
27927071	criteria	C0243161
27927071	backwashing	C1522240
27927071	effects	C1280500
27927071	pilot-scale	C0031928
27927071	BAF	C0180861
27927071	treating	C1522326
27927071	petrochemical	C0220806
27927071	wastewater	C3494254
27927071	Parameters	C0549193
27927071	evaluation	C0220825
27927071	criteria	C0243161
27927071	air	C0001861
27927071	water	C0043047
27927071	backwashing	C1522240
27927071	effect	C1280500
27927071	pilot-scale	C0031928
27927071	biological aerated filter	C0180861
27927071	BAF	C0180861
27927071	treating	C1522326
27927071	petrochemical	C0220806
27927071	wastewater	C3494254
27927071	investigated	C1292732
27927071	parameters	C0549193
27927071	suspended	C1705537
27927071	solids	C0302909
27927071	SS	C0302909
27927071	specific oxygen uptake rate	C0429627
27927071	SOUR	C0429627
27927071	backwashing	C1522240
27927071	effluent	C1546612
27927071	recovery	C0237820
27927071	BAF	C0180861
27927071	backwashing	C1522240
27927071	removal	C1883720
27927071	biomass	C0005535
27927071	bioactivity	C0205556
27927071	attached	C3714578
27927071	filter	C0180861
27927071	media	C1705217
27927071	backwashing	C1522240
27927071	Results	C1274040
27927071	weight	C0043100
27927071	total	C0439810
27927071	sludge	C0282346
27927071	backwashing	C1522240
27927071	effluent	C1546612
27927071	increased	C0205217
27927071	increase	C0442805
27927071	water	C0043047
27927071	backwashing	C1522240
27927071	intensity	C0522510
27927071	total	C0439810
27927071	SOUR	C0429627
27927071	backwashing	C1522240
27927071	effluent	C1546612
27927071	notably	C4288581
27927071	increase	C0442805
27927071	air	C0001861
27927071	backwashing	C1522240
27927071	intensity	C0522510
27927071	optimal	C2698651
27927071	backwashing	C1522240
27927071	intensity	C0522510
27927071	air	C0001861
27927071	water	C0043047
27927071	obtained	C1301820
27927071	BAF	C0180861
27927071	backwashed	C1522240
27927071	BAF	C0180861
27927071	recovered	C0521108
27927071	high	C0205250
27927071	average	C1510992
27927071	removal	C1883720
27927071	chemical oxygen demand	C2936287
27927071	COD	C2936287
27927071	ammonia nitrogen	C0368666
27927071	High	C0205250
27927071	amount	C1265611
27927071	biomass	C0005535
27927071	removal	C1883720
27927071	low	C0205251
27927071	level	C0441889
27927071	bioactivity	C0205556
27927071	removal	C1883720
27927071	attached	C3714578
27927071	filter	C0180861
27927071	media	C1705217
27927071	Concentrations	C1446561
27927071	benzene	C0005036
27927071	toluene	C0040383
27927071	ethylbenzene	C0059792
27927071	(o-, m-, p-) xylenes	C0043368
27927071	BTEX	C0029224
27927071	phenol	C0070570
27927071	backwashed	C1522240
27927071	sludge	C0282346
27927071	analyzed	C0936012
27927071	backwashing	C1522240
27927071	essential	C0205224
27927071	remove	C1883720
27927071	aromatic compounds	C1510940
27927071	adsorbed	C0001674
27927071	microorganisms	C0445623
27928742	Implementation	C1708476
27928742	infrared	C0260249
27928742	Raman	C0037815
27928742	modalities	C0695347
27928742	glycosaminoglycan	C0017973
27928742	characterization	C0243175
27928742	complex	C0439855
27928742	systems	C0449913
27928742	Glycosaminoglycans	C0017973
27928742	GAGs	C0017973
27928742	natural	C0205296
27928742	linear	C0205132
27928742	negatively charged	C0003075
27928742	heteropolysaccharides	C0032594
27928742	incident	C1551358
27928742	mammalian	C0024660
27928742	tissue	C0040300
27928742	disaccharide	C0012611
27928742	units	C0439148
27928742	sulfated	C1954876
27928742	non-sulfated monosaccharides	C0026492
27928742	tissue	C0040300
27928742	types	C0332307
27928742	GAGs	C0017973
27928742	structural	C0678594
27928742	heterogeneity	C0019409
27928742	position	C0733755
27928742	degree	C0449286
27928742	sulfation	C0597538
27928742	disaccharide	C0012611
27928742	units	C0439148
27928742	composition	C0205556
27928742	heparin	C0019134
27928742	heparan sulfate	C0019143
27928742	chondroitine sulfate	C0008466
27928742	dermatan sulfate	C0011602
27928742	keratan sulfate	C0022563
27928742	hyaluronic acid	C0020196
27928742	covalently linked	C1511539
27928742	core	C0444669
27928742	protein	C0033684
27928742	proteoglycans	C0033692
27928742	free	C1996904
27928742	chains	C1524075
27928742	hyaluronan	C0813622
27928742	GAGs	C0017973
27928742	cell	C0007634
27928742	properties	C0871161
27928742	functions	C0007613
27928742	direct	C0439851
27928742	interaction	C1704675
27928742	cell receptors	C0034800
27928742	sequestration	C0443301
27928742	growth factors	C0018284
27928742	evidences of	C0332120
27928742	divert	C0743226
27928742	biological	C0205460
27928742	roles	C1705810
27928742	GAGs	C0017973
27928742	characterization	C0243175
27928742	cell	C0007634
27928742	tissue	C0040300
27928742	levels	C0441889
27928742	non-invasive	C0205303
27928742	techniques	C0449851
27928742	investigate	C1292732
27928742	qualitatively	C0205556
27928742	quantitatively	C0392762
27928742	GAGs	C0017973
27928742	in vitro	C1533691
27928742	diagnostic	C0348026
27928742	biomarkers	C0005516
27928742	therapeutic	C0302350
27928742	targets	C0085104
27928742	human	C0086418
27928742	diseases	C0012634
27928742	cancer	C0006826
27928742	Infrared	C0260249
27928742	Raman microspectroscopies	C0037815
27928742	imaging	C0079595
27928742	sensitive	C0332324
27928742	classify	C0008902
27928742	GAG	C0017973
27928742	types	C0332307
27928742	subtypes	C0449560
27928742	molecular structures	C0678594
27928742	Spectroscopic	C0037812
27928742	markers	C0206015
27928742	GAG	C0017973
27928742	molecules	C0567416
27928742	identified	C0205396
27928742	investigations	C1261322
27928742	GAG	C0017973
27928742	infrared	C0260249
27928742	Raman	C0037815
27928742	GAG	C0017973
27928742	complex	C0439855
27928742	biological	C0205460
27928742	systems	C0449913
27928742	cells	C0007634
27928742	implementation	C1708476
27928742	vibrational spectroscopy techniques	C0022885
27928742	GAG	C0017973
27928742	analysis	C0002778
27928742	GAG	C0017973
27928742	infrared	C0260249
27928742	Raman	C0037815
27928742	conditioned media	C0162518
27928742	live cells	C0007634
27932568	Targeting	C1521840
27932568	HIF2	C1436532
27932568	Clear Cell Renal Cell Carcinoma	C0279702
27932568	von Hippel-Lindau tumor-suppressor protein	C1566585
27932568	pVHL	C1566585
27932568	signature "truncal" event	C0243095
27932568	clear cell renal cell carcinoma	C0279702
27932568	kidney cancer	C1378703
27932568	pVHL	C1566585
27932568	ubiquitin ligase	C0077678
27932568	targets	C1521840
27932568	α subunit	C0599220
27932568	hypoxia-inducible factor (HIF) transcription factor	C1528322
27932568	destruction	C1948029
27932568	Preclinical	C1709630
27932568	studies	C0008972
27932568	deregulation	C1514542
27932568	HIF	C1528322
27932568	HIF2	C1436532
27932568	pVHL	C1566585
27932568	renal carcinogenesis	C1378703
27932568	HIF2α	C0538487
27932568	undruggable	C0205556
27932568	Rick Bruick	C0805191
27932568	Kevin Gardner	C0805191
27932568	University of Texas Southwestern	C0041740
27932568	small molecule	C1328819
27932568	HIF2α antagonists	C0243076
27932568	PT2385	C3896783
27932568	PT2399	C0243076
27932568	Peloton Therapeutics	C0815266
27932568	block	C0332206
27932568	dimerization	C1323327
27932568	HIF2α	C0538487
27932568	protein ARNT1	C1506870
27932568	inhibit clear cell renal cell carcinoma growth	C1512773
27932568	preclinical models	C1514292
27932568	PT2385	C3896783
27932568	clinic	C0442592
27932568	such compounds	C1254351
27932568	clustered regularly interspaced short palindromic repeat	C3658200
27932568	CRISPR	C3658200
27932568	gene editing approaches	C4277689
27932568	unappreciated heterogeneity	C0019409
27932568	clear cell renal carcinomas	C0279702
27932568	patient	C0030705
27932568	xenografts	C0520484
27932568	HIF2	C1436532
27932568	predictive biomarkers	C0041366
27932568	optimize	C2698650
27932568	such agents	C1254351
27932568	clinic	C0442592
27935120	Prevalence	C0683921
27935120	high-risk	C0332167
27935120	human papillomavirus infection	C0343641
27935120	women	C0086287
27935120	Shaanxi	C0008115
27935120	province	C1514578
27935120	China	C0008115
27935120	hospital	C0019994
27935120	investigation	C0220825
27935120	investigate	C1292732
27935120	characteristics	C1521970
27935120	female	C0086287
27935120	high-risk human papillomavirus (HR-HPV) infection	C0343641
27935120	Shaanxi	C0008115
27935120	province	C1514578
27935120	China	C0008115
27935120	women	C0086287
27935120	HPV	C0021344
27935120	genotyping test	C2368152
27935120	cytology	C0010818
27935120	cervix biopsy	C0195314
27935120	women	C0086287
27935120	women	C0086287
27935120	HPV infection	C0343641
27935120	rate	C1521828
27935120	HR-HPV	C0021344
27935120	HR-HPV	C0021344
27935120	genotypes	C0017431
27935120	HPV-16	C0999806
27935120	HPV-58	C3641018
27935120	HPV-52	C3641016
27935120	HPV-18	C0999807
27935120	HPV-31	C2936597
27935120	prevalence	C0683921
27935120	HR-HPV	C0021344
27935120	women	C0086287
27935120	carcinogenic	C0007090
27935120	genotypes	C0017431
27935120	HPV-16	C0999806
27935120	HPV-18	C0999807
27935120	HPV-58	C3641018
27935120	HPV-52	C3641016
27935120	HPV-31	C2936597
27935120	HPV-16	C0999806
27935120	HPV-18	C0999807
27935120	cervical cancer	C0007847
27935120	infection	C3714514
27935120	HR-HPVs	C0021344
27935120	not	C0205160
27935120	risk factor	C0035648
27935120	cervical lesions	C0235656
27935120	HPV infection	C0343641
27935120	women	C0086287
27935120	Shaanxi	C0008115
27935120	province	C1514578
27935120	Women	C0086287
27935120	high-risk group	C0684030
27935120	HR-HPV infection	C0343641
27935120	cervical cancer	C0007847
27935120	HPV-16	C0999806
27935120	HPV-18	C0999807
27935120	carcinogenic	C0007090
27935120	genotypes	C0017431
27935120	region	C0017446
27935944	Novel	C0205314
27935944	Lost	C0745777
27935944	Forests	C0086312
27935944	Upper Midwestern United States	C0026081
27935944	New	C0205314
27935944	Estimates	C0750572
27935944	Settlement-Era	C1254367
27935944	Stem	C0242767
27935944	Density	C0178587
27935944	Biomass	C0005535
27935944	EuroAmerican	C0683983
27935944	land-use	C0814835
27935944	legacies	C0242538
27935944	transformed	C0443172
27935944	forest structure	C0086312
27935944	United States	C0041703
27935944	US	C0041703
27935944	More	C0205172
27935944	accurate	C0443131
27935944	reconstructions	C1706853
27935944	historical states	C0175169
27935944	critical	C1511545
27935944	processes	C1522240
27935944	governing	C0243148
27935944	past	C1444637
27935944	current	C0521116
27935944	future	C0016884
27935944	forest	C0086312
27935944	dynamics	C3826426
27935944	reconstructions	C1706853
27935944	pre-settlement	C1254367
27935944	forest	C0086312
27935944	upper Midwestern US	C0026081
27935944	Minnesota	C0026183
27935944	Wisconsin	C0043193
27935944	Michigan	C1548669
27935944	Century Public Land Survey System	C0038951
27935944	PLSS	C0038951
27935944	estimates	C0750572
27935944	relative	C0205345
27935944	above-ground	C1282910
27935944	biomass	C0005535
27935944	stem	C0242767
27935944	density	C0178587
27935944	basal area	C0205112
27935944	tree	C0040811
27935944	types	C0332307
27935944	mapping	C1283195
27935944	robust	C2986815
27935944	past	C1444637
27935944	efforts	C1516084
27935944	correction factors	C3166265
27935944	sampling design	C0815259
27935944	azimuthal censoring	C0205556
27935944	biases	C0242568
27935944	tree	C0040811
27935944	selection	C1707391
27935944	pre-settlement	C1254367
27935944	modern	C1254367
27935944	forests	C0086312
27935944	US	C0041703
27935944	Forest	C0086312
27935944	Service	C0557854
27935944	Forest Inventory and Analysis (FIA) data	C0242356
27935944	prevalence	C0220900
27935944	lost	C0745777
27935944	forests	C0086312
27935944	pre-settlement	C1254367
27935944	forests	C0086312
27935944	no	C1518422
27935944	current	C0521116
27935944	analog	C0205556
27935944	novel	C0205314
27935944	forests	C0086312
27935944	modern	C1254367
27935944	forests	C0086312
27935944	no	C1518422
27935944	past	C1444637
27935944	analogs	C0205556
27935944	pre-settlement	C1254367
27935944	modern	C1254367
27935944	forests	C0086312
27935944	land-use	C0814835
27935944	impacts	C4049986
27935944	ecological responses	C0237534
27935944	Modern	C1254367
27935944	forests	C0086312
27935944	homogeneous	C1881065
27935944	ecotonal	C0812409
27935944	gradients	C0812409
27935944	diffuse	C0205219
27935944	in the past	C1444637
27935944	Novel	C0205314
27935944	forest	C0086312
27935944	assemblages	C1516698
27935944	FIA	C0242356
27935944	pre-settlement	C1254367
27935944	forests	C0086312
27935944	no longer	C0243095
27935944	exist	C2987476
27935944	modern	C1254367
27935944	context	C0449255
27935944	Lost	C0745777
27935944	forests	C0086312
27935944	tamarack	C0884985
27935944	forests	C0086312
27935944	northeastern	C1709272
27935944	Minnesota	C0026183
27935944	hemlock	C0242872
27935944	cedar	C0949849
27935944	forests	C0086312
27935944	north-central Wisconsin	C0043193
27935944	Upper Peninsula of Michigan	C0025939
27935944	elm	C0330531
27935944	oak	C0330302
27935944	basswood	C1024812
27935944	ironwood	C0330803
27935944	forests	C0086312
27935944	forest	C0086312
27935944	prairie boundary	C0442534
27935944	south central Minnesota	C0026183
27935944	eastern	C1707877
27935944	Wisconsin	C0043193
27935944	Novel	C0205314
27935944	FIA	C0242356
27935944	forest	C0086312
27935944	assemblages	C1516698
27935944	region	C0017446
27935944	novelty	C2700116
27935944	strong	C0442821
27935944	relationship	C0439849
27935944	spatial distance	C0012751
27935944	remnant	C1527428
27935944	forests	C0086312
27935944	upper Midwest	C0026081
27935944	novelty	C2700116
27935944	predicted	C0681842
27935944	remnants	C1527428
27935944	historical	C0019659
27935944	forest type	C0086312
27935944	spatial	C1883067
27935944	relationships	C0439849
27935944	remnant	C1527428
27935944	novel	C0205314
27935944	forests	C0086312
27935944	shifts	C0333051
27935944	ecotone structure	C1254362
27935944	loss	C1517945
27935944	historic	C0019659
27935944	forest types	C0086312
27935944	significant	C0750502
27935944	land	C0557668
27935944	managers	C0335141
27935944	landscape	C0870781
27935944	priority	C0549179
27935944	novelty	C2700116
27935944	ecological	C0162358
27935944	change	C0392747
27935944	potential	C3245505
27935944	modern	C1254367
27935944	spatial distributions	C0037775
27935944	species	C0032098
27935944	communities	C1253910
27935944	relationship	C0439849
27935944	geophysical	C2717748
27935944	climatic attributes	C2350607
27935944	potential	C3245505
27935944	changing	C0392747
27935944	climate	C0008946
27935944	signal	C1710082
27935944	human	C0086418
27935944	settlement	C0036852
27935944	modern	C1254367
27935944	forests	C0086312
27935944	broad	C0332464
27935944	homogenize	C0205375
27935944	modern	C1254367
27935944	forests	C0086312
27935944	relative	C0205345
27935944	historic	C0019659
27935944	significant	C0750502
27935944	future	C0016884
27935944	management	C1273870
27936362	Prevalence	C0220900
27936362	Self-Reported	C0681906
27936362	Prescription Drug	C0304227
27936362	Use	C0457083
27936362	National	C0681788
27936362	Sample	C0370003
27936362	U.S	C0041703
27936362	Drivers	C0684312
27936362	Drug	C1254351
27936362	driving	C0004379
27936362	increasing	C0442808
27936362	concern	C2699424
27936362	illegal drugs	C0086190
27936362	evidence	C3887511
27936362	prescribed medications	C3166216
27936362	impair driving ability	C0877256
27936362	determine	C1148554
27936362	self-reported	C0681906
27936362	prevalence	C0220900
27936362	prescription drug	C0304227
27936362	use	C0457083
27936362	medical	C0205476
27936362	nonmedical	C0243095
27936362	use	C0457083
27936362	nationally	C0681788
27936362	representative	C1882932
27936362	sample	C0370003
27936362	drivers	C0684312
27936362	driver	C0684312
27936362	characteristics	C1521970
27936362	National Roadside Survey	C0242481
27936362	drivers	C0684312
27936362	randomly	C0439605
27936362	complete	C0205197
27936362	survey	C0681817
27936362	prescription drug	C0304227
27936362	use	C0457083
27936362	drivers	C0684312
27936362	prescription drug	C0304227
27936362	past	C1444637
27936362	days	C0439228
27936362	common drug class	C1254351
27936362	sedatives	C0036557
27936362	antidepressants	C0003289
27936362	narcotics	C0027415
27936362	stimulants	C0304402
27936362	Drivers	C0684312
27936362	prescription drug	C0304227
27936362	use	C0457083
27936362	female	C0086287
27936362	older	C1518563
27936362	non-Hispanic White	C3843227
27936362	disability	C0231170
27936362	drivers	C0684312
27936362	medication	C0013227
27936362	use	C0457083
27936362	drug	C1254351
27936362	prescribed	C0278329
27936362	use	C0457083
27936362	prescription	C1521941
27936362	significantly higher	C4055637
27936362	males	C0086582
27936362	Black/African American	C0085756
27936362	Hispanic	C0086409
27936362	drivers	C0684312
27936362	older	C1518563
27936362	drivers	C0684312
27936362	prescription	C1521941
27936362	prescribed	C0278329
27936362	narcotics	C0027415
27936362	sedatives	C0036557
27936362	stimulants	C0304402
27936362	antidepressants	C0003289
27936362	findings	C2607943
27936362	drivers	C0684312
27936362	potentially impairing	C0221099
27936362	prescription drugs	C0304227
27936362	medically	C0205476
27936362	nonmedically	C0243095
27936362	targeting	C1521840
27936362	interventions	C1273869
27936362	impaired driving	C0877256
27936362	medications	C4284232
27938482	Repetitive	C2945760
27938482	Prolonged	C0439590
27938482	Omega-3 Fatty Acid	C0015689
27938482	Treatment	C0087111
27938482	After	C0687676
27938482	Traumatic Brain Injury	C0876926
27938482	Enhances	C2349975
27938482	Long-Term	C0443252
27938482	Tissue	C0040300
27938482	Restoration	C0087111
27938482	Cognitive Recovery	C0009244
27938482	Traumatic brain injury	C0876926
27938482	TBI	C0876926
27938482	disabling clinical conditions	C4061999
27938482	lead	C1522538
27938482	neurocognitive disorders	C4041080
27938482	survivors	C0206194
27938482	group	C1705429
27938482	others	C1257890
27938482	reported	C0684224
27938482	prophylactic enrichment	C0199176
27938482	dietary	C2699635
27938482	omega-3 polyunsaturated fatty acids	C0015689
27938482	n-3 PUFAs	C0015689
27938482	ameliorate	C0332303
27938482	cognitive deficits	C0009241
27938482	after	C0687676
27938482	TBI	C0876926
27938482	unclear	C3845108
27938482	clinically	C0443178
27938482	relevant	C2347946
27938482	therapeutic regimen	C1276413
27938482	n-3 PUFAs	C0015689
27938482	administered	C1521801
27938482	after	C0687676
27938482	TBI	C0876926
27938482	improvement	C2986411
27938482	long-term	C0443252
27938482	cognitive recovery	C0009244
27938482	study	C2603343
27938482	decline	C1511741
27938482	cognitive function	C0009241
27938482	main	C1542147
27938482	outcome	C1274040
27938482	after	C0687676
27938482	TBI	C0876926
27938482	investigate	C1292732
27938482	therapeutic efficacy	C2348767
27938482	post	C0687676
27938482	TBI	C0876926
27938482	n-3 PUFA	C0015689
27938482	treatment	C0087111
27938482	mechanisms	C0441712
27938482	Mice	C0025929
27938482	sham operation	C0141287
27938482	controlled	C2587213
27938482	cortical	C0007776
27938482	impact	C4049986
27938482	random assignment	C0814868
27938482	receive	C1514756
27938482	four	C0205450
27938482	treatments	C0087111
27938482	vehicle	C0042444
27938482	control	C2587213
27938482	daily	C0332173
27938482	intraperitoneal injections	C0021493
27938482	n-3 PUFAs	C0015689
27938482	weeks	C0439230
27938482	beginning	C0439659
27938482	h	C0439227
27938482	after	C0687676
27938482	TBI	C0876926
27938482	fish oil dietary	C0556145
27938482	supplementation	C0242297
27938482	study	C2603343
27938482	beginning	C0439659
27938482	day	C0439228
27938482	after	C0687676
27938482	TBI	C0876926
27938482	combination	C0205195
27938482	treatments	C0087111
27938482	chronic	C0205191
27938482	brain tissue	C0459385
27938482	loss	C1517945
27938482	endogenous	C0205227
27938482	brain repair processes	C0161849
27938482	neurogenesis	C0814002
27938482	angiogenesis	C0302600
27938482	oligodendrogenesis	C3714634
27938482	days	C0439228
27938482	after	C0687676
27938482	TBI	C0876926
27938482	results	C1274040
27938482	revealed	C0443289
27938482	cognitive deficits	C0009241
27938482	massive	C0522501
27938482	tissue	C0459385
27938482	loss	C1517945
27938482	TBI	C0876926
27938482	mice	C0025929
27938482	receiving	C1514756
27938482	post-TBI	C0876926
27938482	n-3 PUFA	C0015689
27938482	treatments	C0087111
27938482	combined	C0205195
27938482	treatment	C0087111
27938482	fish oil dietary	C0556145
27938482	supplement	C0242295
27938482	n-3 PUFA	C0015689
27938482	injections	C1272883
27938482	demonstrated	C3687625
27938482	reproducible beneficial effect	C0683156
27938482	cognitive deficits	C0009241
27938482	reducing	C0392756
27938482	gross	C0439806
27938482	tissue	C0459385
27938482	loss	C1517945
27938482	treatment	C0087111
27938482	promoted	C0033414
27938482	post-TBI	C0876926
27938482	restorative processes	C0541662
27938482	brain	C0006104
27938482	including	C0332257
27938482	immature neurons	C0027882
27938482	microvessels	C2350570
27938482	oligodendrocytes	C0028944
27938482	correlated	C1707520
27938482	improved	C0184511
27938482	cognitive recovery	C1274040
27938482	results	C1274040
27938482	indicated	C1444656
27938482	repetitive	C2945760
27938482	prolonged	C0439590
27938482	n-3 PUFA	C0015689
27938482	treatments	C0087111
27938482	after	C0687676
27938482	TBI	C0876926
27938482	enhancing	C2349975
27938482	brain	C0006104
27938482	remodeling	C0678692
27938482	potential	C3245505
27938482	therapy	C0087111
27938482	TBI	C0876926
27938482	victims	C0680681
27938482	clinic	C0442592
27939139	Influence	C4054723
27939139	yeast	C0043393
27939139	lactic acid bacterium	C1210581
27939139	constituent	C0729650
27939139	profile	C1979963
27939139	soy sauce	C0453374
27939139	during	C0347984
27939139	fermentation	C0015852
27939139	Soy sauce	C0453374
27939139	Japanese	C0022341
27939139	traditional	C0443324
27939139	seasoning	C0349383
27939139	composed	C0392762
27939139	various	C0443302
27939139	constituents	C0729650
27939139	produced	C0033268
27939139	microbes	C0445623
27939139	during	C0347984
27939139	long-term	C0443252
27939139	fermentation process	C0015852
27939139	Due to	C0678226
27939139	complexity	C0205245
27939139	process	C1522240
27939139	investigation	C0242481
27939139	constituent	C0729650
27939139	profile	C1979963
27939139	during	C0347984
27939139	fermentation	C0015852
27939139	difficult	C0243095
27939139	Metabolomics	C1328813
27939139	comprehensive	C1880156
27939139	study	C2603343
27939139	low	C0205251
27939139	molecular weight	C0026385
27939139	compounds	C0205198
27939139	biological	C0205460
27939139	samples	C0370003
27939139	understanding	C0162340
27939139	constituent	C0729650
27939139	contribution	C1880177
27939139	food flavor	C0596585
27939139	characteristics	C1521970
27939139	metabolomics	C1328813
27939139	suitable	C3900053
27939139	analysis	C0936012
27939139	soy sauce	C0453374
27939139	fermentation	C0015852
27939139	studies	C2603343
27939139	soy sauce	C0453374
27939139	fermentation	C0015852
27939139	using	C1524063
27939139	metabolomics	C1328813
27939139	approach	C0449445
27939139	reported	C0684224
27939139	investigated	C1292732
27939139	changes	C0392747
27939139	low	C0205251
27939139	molecular weight	C0026385
27939139	hydrophilic	C0392762
27939139	volatile compounds	C0443769
27939139	soy sauce	C0453374
27939139	gas chromatography/mass spectrometry	C0024868
27939139	GC/MS	C0024868
27939139	based	C1527178
27939139	non-targeted	C0205245
27939139	metabolic profiling	C1328813
27939139	data	C1511726
27939139	analyzed	C0936012
27939139	statistical analysis	C0871424
27939139	influences	C4054723
27939139	yeast	C0043393
27939139	lactic acid bacterium	C1210581
27939139	constituent	C0729650
27939139	profile	C1979963
27939139	results	C1274040
27939139	suggested	C1705535
27939139	novel	C0205314
27939139	finding	C0243095
27939139	lactic acid bacterium	C1210581
27939139	affected	C0392760
27939139	production	C0033268
27939139	several	C0443302
27939139	constituents	C0729650
27939139	cyclotene	C0056829
27939139	furfural	C0016849
27939139	furfuryl alcohol	C0060863
27939139	methional	C0066117
27939139	soy sauce	C0453374
27939139	fermentation process	C0015852
27941491	Low	C0205251
27941491	intensity	C0522510
27941491	sprint training	C0454374
27941491	blood flow restriction	C0220931
27941491	investigated	C1292732
27941491	effects of	C1704420
27941491	practical blood flow restriction	C0220931
27941491	pBFR	C0220931
27941491	leg muscles	C0224456
27941491	sprint training	C0454374
27941491	time	C0040223
27941491	well-trained sport students	C0038492
27941491	Participants	C0679646
27941491	sprints	C0035953
27941491	sprinting speed	C0678536
27941491	twice a week	C0556985
27941491	weeks	C0439230
27941491	IG	C2986530
27941491	pBFR	C0220931
27941491	CG	C0009932
27941491	time	C0040223
27941491	decreased	C0205216
27941491	IG	C2986530
27941491	CG	C0009932
27941491	muscle	C0026845
27941491	thickness	C1280412
27941491	rectus femoris	C0584894
27941491	increased	C0205217
27941491	IG	C2986530
27941491	group	C0441833
27941491	time	C0040223
27941491	interactions	C1704675
27941491	muscle	C0026845
27941491	thickness	C1280412
27941491	biceps femoris	C0224449
27941491	biceps brachii	C0559499
27941491	maximal isometric force	C0392762
27941491	leg press	C4054656
27941491	not change	C0442739
27941491	group	C0441833
27941491	rate of force development	C0392762
27941491	IG	C2986530
27941491	Growth hormone	C0037663
27941491	testosterone	C0039601
27941491	insulin-like growth factor 1	C0021665
27941491	cortisol	C0020268
27941491	concentrations	C0392762
27941491	not significantly differ	C0243095
27941491	groups	C0441833
27941491	measurement	C0242485
27941491	time point	C2348792
27941491	sprints	C0035953
27941491	training	C0220931
27941491	session	C1883016
27941491	muscle damage	C0410158
27941491	marker	C0005516
27941491	h-FABP	C1312696
27941491	increased	C0205217
27941491	CG	C0009932
27941491	IG	C2986530
27941491	pBFR	C0220931
27941491	time	C0040223
27941491	low	C0205251
27941491	intensity	C0522510
27941491	sprint interval training	C0454374
27941491	benefits	C0814225
27941491	training	C0220931
27941491	pBFR	C0220931
27941491	decreased	C0205216
27941491	level	C0441889
27941491	muscle damage	C0410158
27941491	increase	C0442805
27941491	rectus femoris muscle	C0584894
27941491	thickness	C1280412
27941491	higher	C0205250
27941491	rate of force development	C0392762
27941491	tested	C0039593
27941491	hormones	C0019932
27941491	beneficial effects	C1280500
27941576	Sedation	C0344106
27941576	Patients	C0030705
27941576	Disorders of Consciousness	C0009792
27941576	Neuroimaging	C0679575
27941576	Resting State Functional Brain Connectivity	C4288291
27941576	head movement	C0376591
27941576	resting state functional magnetic resonance imaging	C4288291
27941576	post-coma	C0151294
27941576	patients	C0030705
27941576	disorders of consciousness	C0009792
27941576	DOC	C0009792
27941576	sedated	C0344106
27941576	propofol	C0033487
27941576	sedation	C0344106
27941576	brain connectivity patterns	C0449774
27941576	damaged brain	C0270611
27941576	differential diagnosis	C0011906
27941576	study	C2603343
27941576	assess	C0184514
27941576	resting state functional magnetic resonance imaging	C4288291
27941576	scanning	C0441633
27941576	patients	C0030705
27941576	diagnostic	C0348026
27941576	research	C0035168
27941576	purposes	C1285529
27941576	resting state connectivity	C1707489
27941576	bilateral	C0238767
27941576	external control	C0680371
27941576	auditory	C0439825
27941576	sensorimotor	C0237434
27941576	visual	C0234621
27941576	resting state networks	C1882071
27941576	connectivity	C1707489
27941576	thalamus	C0039729
27941576	healthy	C3898900
27941576	unsedated	C0243095
27941576	controls	C0009932
27941576	unsedated	C0243095
27941576	patients	C0030705
27941576	DOC	C0009792
27941576	patients	C0030705
27941576	DOC	C0009792
27941576	sedated	C0344106
27941576	propofol	C0033487
27941576	DOC	C0009792
27941576	age at onset	C0206132
27941576	etiology	C1314792
27941576	time spent	C0243095
27941576	DOC	C0009792
27941576	diagnosis	C0011900
27941576	standardized behavioral assessment scores	C0449820
27941576	movement	C0026649
27941576	intensities	C0522510
27941576	structural brain injury	C0270611
27941576	T1-based voxel-based morphometry	C0200760
27941576	DOC	C0009792
27941576	associated with	C0332281
27941576	resting state network connectivity	C1707489
27941576	visual	C0234621
27941576	network	C1882071
27941576	Thalamic	C0039729
27941576	connectivity	C1707489
27941576	reduced	C0392756
27941576	Propofol	C0033487
27941576	administration	C1533734
27941576	patients	C0030705
27941576	associated with	C0332281
27941576	decreases	C0547047
27941576	thalamic	C0039729
27941576	insular	C0021640
27941576	connectivity	C1707489
27941576	findings	C2607943
27941576	connectivity	C1707489
27941576	decreases	C0547047
27941576	associated with	C0332281
27941576	propofol	C0033487
27941576	sedation	C0344106
27941576	thalamus	C0039729
27941576	insula	C0021640
27941576	DOC	C0009792
27941576	structural brain injury	C0270611
27941576	thalamus	C0039729
27941576	brain arousal	C0003808
27941576	disruption	C0332453
27941576	diminished	C0205216
27941576	movement	C0026649
27941576	patients	C0030705
27941576	research	C0035168
27941576	research question	C0681799
27942049	Potassium depletion	C1971021
27942049	stimulates	C1948023
27942049	Na-Cl cotransporter	C0074782
27942049	phosphorylation	C0031715
27942049	inactivation	C0544461
27942049	ubiquitin ligase	C0077678
27942049	Kelch-like 3	C4042100
27942049	Kelch-like 3	C4042100
27942049	KLHL3	C4042100
27942049	component	C1179435
27942049	E3 ubiquitin ligase complex	C0077678
27942049	regulates	C1327622
27942049	blood pressure	C0005823
27942049	targeting	C1521840
27942049	With-No-Lysine (WNK) kinases	C0031727
27942049	degradation	C0243125
27942049	Mutations	C0026882
27942049	KLHL3	C4042100
27942049	increased renal salt reabsorption	C3278017
27942049	impaired	C0221099
27942049	K(+)	C0032821
27942049	secretion	C0036536
27942049	hypertension	C0020538
27942049	hyperkalemia	C0020461
27942049	clinical studies	C0008972
27942049	dietary K(+)	C0162800
27942049	intake	C1512806
27942049	affects	C0392760
27942049	blood pressure	C0005823
27942049	mechanisms	C0441712
27942049	obscure	C3845108
27942049	KLHL3	C4042100
27942049	ubiquitin ligase	C0077678
27942049	complex	C1180347
27942049	K(+)	C0032821
27942049	activation	C0599177
27942049	Na-Cl cotransporter	C0074782
27942049	NCC	C0074782
27942049	kidney	C0022646
27942049	distal convoluted tubules	C0022676
27942049	mice	C0025929
27942049	eating	C0013470
27942049	low-K(+) diet	C0948941
27942049	KLHL3	C4042100
27942049	phosphorylation	C0031715
27942049	S433	C1254362
27942049	(KLHL3(S433-P))	C4042100
27942049	modification	C3840684
27942049	impairs	C0221099
27942049	WNK	C0031727
27942049	binding	C1145667
27942049	KLHL3	C4042100
27942049	levels	C0441889
27942049	accumulation	C4055506
27942049	target	C1521840
27942049	substrate	C3891814
27942049	WNK4	C1452813
27942049	activation	C0599177
27942049	downstream	C0522506
27942049	kinases SPAK	C1436950
27942049	STE20	C4307920
27942049	SPS1	C1436950
27942049	proline-alanine-rich protein kinase	C1312482
27942049	OSR1	C1438448
27942049	oxidative stress-responsive 1	C1438448
27942049	NCC	C0074782
27942049	phosphorylation	C0031715
27942049	accumulation	C4055506
27942049	plasma membrane	C0007603
27942049	phosphorylation	C0031715
27942049	S433	C1254362
27942049	levels	C0441889
27942049	active	C0205177
27942049	protein kinase C	C0033634
27942049	protein kinase A	C0010531
27942049	phosphorylates	C0031715
27942049	S433	C1254362
27942049	HEK cells	C2936239
27942049	expressing	C1171362
27942049	KLHL3	C4042100
27942049	WNK4	C1452813
27942049	activation	C0599177
27942049	protein kinase C	C0033634
27942049	phorbol 12-myristate 13-acetate	C0039654
27942049	induces	C0205263
27942049	KLHL3(S433-P)	C4042100
27942049	WNK4	C1452813
27942049	levels	C0441889
27942049	ubiquitination	C1519751
27942049	data	C1511726
27942049	role	C1705810
27942049	KLHL3	C4042100
27942049	K(+)	C0032821
27942049	induction	C0205263
27942049	NCC	C0074782
27942049	physiologic adaptation	C0001400
27942049	distal	C0205108
27942049	electrogenic	C0232633
27942049	Na(+) reabsorption	C2610987
27942049	preventing	C1292733
27942049	renal	C0022646
27942049	K(+)	C0032821
27942049	loss	C1517945
27942049	promoting	C0033414
27942049	blood pressure	C0005823
27942150	relationship	C0439849
27942150	thoracic	C0817096
27942150	configuration	C0277809
27942150	changes	C0392747
27942150	volumes	C0449468
27942150	hemithoraces	C0934569
27942150	upright sitting	C1280451
27942150	patients	C0030705
27942150	respiratory disease	C0035204
27942150	asymmetrical movement of the thorax	C1821161
27942150	study	C2603343
27942150	investigate	C1292732
27942150	relationship	C0439849
27942150	thoracic	C0817096
27942150	configuration	C0277809
27942150	changes	C0392747
27942150	thoracic volume	C0231961
27942150	sedentary	C0205254
27942150	healthy	C3898900
27942150	men	C0025266
27942150	upright sitting	C1280451
27942150	reflective markers	C0008963
27942150	anterior	C0205094
27942150	posterior	C0205095
27942150	aspects	C1879746
27942150	trunk	C0460005
27942150	thoracic volume	C0231961
27942150	quiet	C0439654
27942150	volitional	C0042950
27942150	deep breathing	C1328799
27942150	three-dimensional motion analyzer	C0025080
27942150	difference	C1705241
27942150	volume	C0449468
27942150	upper	C1282910
27942150	lower	C0441994
27942150	hemithoraces	C0934569
27942150	measured	C0444706
27942150	calculation	C1441506
27942150	thoracic volume	C0231961
27942150	imaginary hexahedra	C2348964
27942150	upper	C1282910
27942150	lower	C0441994
27942150	thorax	C0817096
27942150	reflective markers	C0008963
27942150	anterior	C0205094
27942150	posterior	C0205095
27942150	aspects	C1879746
27942150	thorax	C0817096
27942150	hexahedron	C2348964
27942150	imaginary triangular pyramids	C1254362
27942150	calculate	C1441506
27942150	positional	C0240795
27942150	vectors	C0442335
27942150	volume	C0449468
27942150	hexahedra	C2348964
27942150	triangular pyramids	C1254362
27942150	calculated	C1441506
27942150	thoracic volumes	C0231961
27942150	findings	C2607943
27942150	left	C0205091
27942150	upper	C1282910
27942150	right	C0205090
27942150	lower	C0441994
27942150	hemithorax	C0934569
27942150	larger	C0549177
27942150	thoracic volumes	C0231961
27942150	conclusion	C1707478
27942150	left	C0205091
27942150	upper	C1282910
27942150	right	C0205090
27942150	lower	C0441994
27942150	hemithoraces	C0934569
27942150	expand	C0205229
27942150	sides	C0441987
27942150	characteristics	C1521970
27942150	thoracic	C0817096
27942150	excursion	C0232086
27942150	quiet	C0439654
27942150	volitional	C0042950
27942150	deep breathing	C1328799
27942150	value	C0332320
27942150	assessment	C0220825
27942150	instruction	C1442085
27942150	breathing techniques	C4040465
27942150	patients	C0030705
27951480	Development	C1527148
27951480	four-item Letter and Shape Drawing test	C0260168
27951480	LSD-4	C0260168
27951480	bedside test	C0282662
27951480	visuospatial function	C2370887
27951480	Conventional	C0439858
27951480	bedside tests	C0282662
27951480	visuospatial function	C2370887
27951480	Clock Drawing	C0260168
27951480	CDT	C0260168
27951480	Intersecting Pentagons	C0260168
27951480	IPT	C0260168
27951480	lack	C0332268
27951480	consistency	C0332529
27951480	interpretation	C0456377
27951480	compared	C1707455
27951480	performance	C1882330
27951480	visuospatial ability	C0814069
27951480	LSD	C0260168
27951480	IPT	C0260168
27951480	CDT	C0260168
27951480	MMSE	C0451306
27951480	acute	C0205178
27951480	elderly	C0001792
27951480	medical	C0205476
27951480	inpatients	C0021562
27951480	mean	C0444504
27951480	age	C0001779
27951480	range	C1514721
27951480	females	C0086287
27951480	scored	C0449820
27951480	MMSE	C0451306
27951480	mild	C2945599
27951480	score	C0449820
27951480	severe	C0205082
27951480	score	C0449820
27951480	impairment	C0221099
27951480	scored	C0449820
27951480	CDT	C0260168
27951480	IPT	C0260168
27951480	scored	C0449820
27951480	CDT	C0260168
27951480	IPT	C0260168
27951480	agreed	C3641827
27951480	classification	C0008902
27951480	patients	C0030705
27951480	strong	C0442821
27951480	MMSE	C0451306
27951480	categories	C0683312
27951480	Correlation	C1707520
27951480	LSD	C0260168
27951480	visuospatial tests	C0260168
27951480	high	C0205250
27951480	four-item version	C0333052
27951480	LSD	C0260168
27951480	items	C1551338
27951480	high	C0205250
27951480	correlation	C1707520
27951480	LSD-15	C0260168
27951480	strong	C0442821
27951480	association with	C0332281
27951480	MMSE	C0451306
27951480	categories	C0683312
27951480	LSD-4	C0260168
27951480	easily	C0332219
27951480	interpreted	C1285553
27951480	bedside test	C0282662
27951480	visuospatial function	C2370887
27951480	high	C0205250
27951480	coverage	C1999244
27951480	elderly	C0001792
27951480	patients	C0030705
27951480	neurocognitive impairment	C0338656
27951480	conventional	C0439858
27951480	visuospatial ability	C0814069
27951480	identify	C0205396
27951480	significant	C0750502
27951480	cognitive impairment	C0338656
27956431	Salvage Therapy	C0085405
27956431	Ceftolozane-Tazobactam	C3656593
27956431	Multidrug-Resistant Pseudomonas aeruginosa	C4039743
27956431	Infections	C0854135
27956431	Infections	C0854135
27956431	multidrug-resistant Pseudomonas aeruginosa	C4039743
27956431	MDRPA	C4039743
27956431	therapeutic management	C0086388
27956431	patients	C0030705
27956431	MDRPA	C4039743
27956431	infection	C0854135
27956431	pneumonia	C0032285
27956431	salvage therapy	C0085405
27956431	ceftolozane-tazobactam	C3656593
27956431	empirical treatment	C1299597
27956431	suboptimal	C2984009
27956431	treatment	C0087111
27956431	patients	C0030705
27956431	septic shock	C0036983
27956431	patients	C0030705
27956431	died	C0011065
27956431	follow-up	C1522577
27956431	Microbiological	C0025951
27956431	cure	C1880198
27956431	patients	C0030705
27960292	Ankaflavin	C1568221
27960292	Monascin	C1871155
27960292	Induce	C0205263
27960292	Apoptosis	C0162638
27960292	Activated	C1879547
27960292	Hepatic Stellate Cells	C2340138
27960292	Suppression	C0678671
27960292	Akt	C0164786
27960292	NF-κB	C0079904
27960292	p38	C1451465
27960292	Signaling Pathway	C0037080
27960292	increased	C0205217
27960292	proliferation	C0596290
27960292	activated	C1879547
27960292	hepatic stellate cells	C2340138
27960292	HSCs	C2340138
27960292	associated with	C0332281
27960292	hepatic fibrosis	C0239946
27960292	excessive	C0442802
27960292	extracellular matrix	C0015350
27960292	ECM	C0015350
27960292	protein	C0033684
27960292	inhibitory	C3463820
27960292	effects of	C1704420
27960292	Monascus purpureus	C0997449
27960292	metabolites	C0870883
27960292	ankaflavin	C1568221
27960292	monascin	C1871155
27960292	Akt	C0164786
27960292	nuclear factor (NF)-κB	C0079904
27960292	p38 mitogen-activated protein kinase	C1120843
27960292	MAPK	C1120843
27960292	signaling pathways	C0037080
27960292	HSC-T6	C0682523
27960292	activated hepatic stellate cell line	C0682523
27960292	Ankaflavin	C1568221
27960292	monascin	C1871155
27960292	induced	C0205263
27960292	apoptosis	C0162638
27960292	significantly	C0750502
27960292	inhibited	C0311403
27960292	cell growth	C0007595
27960292	cell viabilities	C0007620
27960292	control cells	C0007634
27960292	Apoptosis	C0162638
27960292	G1 phase arrest	C3178834
27960292	G1 phase	C0079395
27960292	percentages	C0439165
27960292	control cells	C0007634
27960292	correlated	C1707520
27960292	increased	C0205217
27960292	p53	C0080055
27960292	p21	C0288472
27960292	levels	C0428479
27960292	caspase 3 activity	C1150132
27960292	decreased	C0205216
27960292	cyclin D1	C0174680
27960292	Bcl-2-family protein	C3269083
27960292	levels	C0428479
27960292	apoptotic	C1516044
27960292	effects of	C1704420
27960292	ankaflavin	C1568221
27960292	monascin	C1871155
27960292	HSC-T6	C0682523
27960292	specific	C0205369
27960292	potential	C3245505
27960292	treating	C1522326
27960292	liver fibrosis	C0239946
27965132	Low-Volume	C3494217
27965132	High-Volume Centers	C3494218
27965132	Management of Fournier's Gangrene	C0376636
27965132	Fournier's Gangrene	C0238419
27965132	Washington State	C0043038
27965132	Fournier's gangrene	C0238419
27965132	FG	C0238419
27965132	life-threatening infection	C1859430
27965132	affecting	C0392760
27965132	perineum	C0031066
27965132	genitals	C0017420
27965132	Complex	C0439855
27965132	patient management	C1610129
27965132	tertiary centers	C0587437
27965132	hospital transfer	C2065834
27965132	patterns	C0449774
27965132	morbidity	C0026538
27965132	patients	C0030705
27965132	FG	C0238419
27965132	Washington State	C0043038
27965132	Washington State	C0043038
27965132	Comprehensive	C1880156
27965132	Abstract Reporting	C0000857
27965132	hospital discharges	C0541652
27965132	Washington	C0043038
27965132	patients	C0030705
27965132	FG	C0238419
27965132	diagnosis and treatment codes	C0282574
27965132	stratified	C0205363
27965132	low-volume centers	C3494217
27965132	LVCs	C3494217
27965132	high-volume centers	C3494218
27965132	HVCs	C3494218
27965132	transfer status	C0586512
27965132	debridements	C0011079
27965132	septic shock	C0036983
27965132	acute renal failure	C0022660
27965132	acute respiratory failure	C0264490
27965132	length of hospitalization	C3694481
27965132	death	C1306577
27965132	FG	C0238419
27965132	patients	C0030705
27965132	HVC	C3494218
27965132	treated	C1522326
27965132	FG	C0238419
27965132	patients	C0030705
27965132	Overall mortality	C0205848
27965132	patients	C0030705
27965132	treated	C1522326
27965132	LVCs	C3494217
27965132	patients	C0030705
27965132	treated	C1522326
27965132	HVC	C3494218
27965132	LVC	C3494217
27965132	High-volume center	C3494218
27965132	patients	C0030705
27965132	comorbidities	C0009488
27965132	mortality	C0205848
27965132	septic shock	C0036983
27965132	respiratory failure	C1145670
27965132	LVC	C3494217
27965132	patients	C0030705
27965132	HVC	C3494218
27965132	transferred patients	C0030704
27965132	immediate	C0205253
27965132	delayed	C0205421
27965132	associated with	C0332281
27965132	debridements	C0011079
27965132	septic shock	C0036983
27965132	acute renal failure	C0022660
27965132	Patients	C0030705
27965132	treated	C1522326
27965132	HVC	C3494218
27965132	acutely ill	C2051411
27965132	mortality	C0205848
27965132	patients	C0030705
27965132	treated	C1522326
27965132	LVCs	C3494217
27965132	acuity patients	C3494263
27965132	Immediate	C0205253
27965132	delayed	C0205421
27965132	FG	C0238419
27965132	health outcomes	C1550208
27965132	disease	C0012634
27965132	acuity of patients	C3494263
27965132	transfer status	C0586512
27965450	Pneumocystis carinii	C0032276
27965450	Inositol Transporter 1	C0596902
27965450	Fungi	C0016832
27965450	genus Pneumocystis	C0597258
27965450	lungs	C0024109
27965450	mammals	C0024660
27965450	fatal	C1302234
27965450	pneumonia	C0339961
27965450	PCP	C1535939
27965450	Pneumocystis pneumonia	C1535939
27965450	hosts	C1167395
27965450	immune systems	C0020962
27965450	in vitro	C1533691
27965450	culture system	C0430400
27965450	species	C1705920
27965450	Pneumocystis	C0597258
27965450	fungi	C0016832
27965450	discovery	C1880355
27965450	therapies	C0087111
27965450	Pneumocystis carinii	C0032276
27965450	Pneumocystis murina	C1499624
27965450	Pneumocystis jirovecii	C0320385
27965450	enzymes	C0014442
27965450	myo-inositol biosynthesis	C1156341
27965450	genes with homologies	C1334043
27965450	fungal	C0016832
27965450	myo-inositol	C0021547
27965450	transporters	C0596902
27965450	myo-inositol	C0021547
27965450	eukaryotic	C0015161
27965450	viability	C0007620
27965450	transporter	C0596902
27965450	ITR1	C0596902
27965450	functionally	C0205245
27965450	structurally	C0678594
27965450	P. carinii	C0032276
27965450	structure	C1510464
27965450	P. carinii	C0032276
27965450	ITR1	C0596902
27965450	PcITR1	C0596902
27965450	transmembrane	C1167322
27965450	alpha-helices	C0162805
27965450	intracellular	C0178719
27965450	C	C1707271
27965450	N termini	C1706793
27965450	inositol	C0021547
27965450	transporters	C0596902
27965450	myo-inositol transport	C1159756
27965450	P. carinii	C0032276
27965450	transport system	C0005528
27965450	sugars	C0242209
27965450	inositol	C0021547
27965450	stereoisomers	C0376211
27965450	competitive	C0005458
27965450	inhibitors	C0243077
27965450	Glucose transport	C0178666
27965450	transport	C0005528
27965450	myo-inositol transport	C1159756
27965450	mammalian	C0024660
27965450	transporters	C0596902
27965450	sodium dependent	C1523889
27965450	cytochalasin B	C0010737
27965450	resistant	C0332325
27965450	Inositol transport	C1159756
27965450	fungi	C0016832
27965450	attractive	C2346874
27965450	drug	C1254351
27965450	target	C1521840
27965450	fungi	C0016832
27965450	transport	C0005528
27965450	mammalian	C0024660
27965450	fungal	C0016832
27965450	transporters	C0596902
27965450	host	C1167395
27965450	transport	C0005528
27965450	critical	C1511545
27965450	nutrient	C0678695
27965450	low	C0205251
27965450	toxicity	C0600688
27965450	potential	C3245505
27965450	inhibitors	C0243077
27965450	fungal	C0016832
27965450	transporter	C0596902
27965450	myo-Inositol	C0021547
27965450	sugarlike	C0242209
27965450	nutrient	C0678695
27965450	essential	C0205224
27965450	life	C0376558
27965450	organisms	C0029235
27965450	Humans	C0086418
27965450	microbes	C0445623
27965450	enzymes	C0014442
27965450	environment	C0014406
27965450	transport process	C1519628
27965450	cellular	C0007634
27965450	constituents	C0729650
27965450	genomes	C0085239
27965450	pathogenic fungi	C3826297
27965450	genus Pneumocystis	C0597258
27965450	pneumonia	C0339961
27965450	causing	C0678227
27965450	parasites	C0030498
27965450	myo-inositol	C0021547
27965450	enzymes	C0014442
27965450	inositol	C0021547
27965450	transporters	C0596902
27965450	sugar	C0242209
27965450	lungs	C0024109
27965450	fungi	C0016832
27965450	transport	C0005528
27965450	myo-inositol	C0021547
27965450	fungus	C0016832
27965450	transporter	C0596902
27965450	myo-inositol	C0021547
27965450	transport	C0005528
27965450	molecules	C0567416
27965450	transport	C0005528
27965450	mammalian cells	C1512977
27965450	mammals	C0024660
27965450	transport	C0005528
27965450	myo-inositol	C0021547
27965450	Pneumocystis fungi	C0597258
27965450	transport	C0005528
27965450	potential	C3245505
27965450	drug	C1254351
27965450	target	C1521840
27976878	Worldwide	C0332464
27976878	Occurrence	C2745955
27976878	Mycotoxins	C0026955
27976878	Cereals	C0007757
27976878	Cereal	C0007757
27976878	Derived	C1441547
27976878	Food Products	C0681562
27976878	Public	C0678367
27976878	Health	C0018684
27976878	Perspectives	C1254370
27976878	Cereal grains	C0007757
27976878	processed	C1522240
27976878	food products	C0681562
27976878	contaminated	C0205279
27976878	mycotoxins	C0026955
27976878	five	C0205451
27976878	major	C0205164
27976878	mycotoxins	C0026955
27976878	aflatoxins	C0001734
27976878	ochratoxins	C0028816
27976878	fumonisins	C0304082
27976878	deoxynivalenol	C0057445
27976878	zearalenone	C0043454
27976878	public	C0678367
27976878	health	C0018684
27976878	concern	C2699424
27976878	cause	C0015127
27976878	adverse effects	C0879626
27976878	humans	C0086418
27976878	airborne	C3242389
27976878	soilborne	C0205245
27976878	nature	C0449783
27976878	mycotoxigenic fungi	C0016832
27976878	worldwide	C0332464
27976878	occurrence	C2745955
27976878	mycotoxins	C0026955
27976878	basis	C1527178
27976878	global	C2348867
27976878	occurrence	C2745955
27976878	data	C1511726
27976878	reported	C0700287
27976878	incidences	C0021149
27976878	maximum	C0806909
27976878	levels	C0441889
27976878	raw	C1709843
27976878	cereal grains	C0007757
27976878	aflatoxins	C0001734
27976878	ochratoxin A	C0069299
27976878	fumonisins	C0304082
27976878	deoxynivalenol	C0057445
27976878	zearalenone	C0043454
27976878	concentrations	C1446561
27976878	mycotoxins	C0026955
27976878	lower	C0205251
27976878	processed	C1522240
27976878	food products	C0681562
27976878	incidences	C0021149
27976878	mycotoxins	C0026955
27976878	due to	C0678226
27976878	varying	C0392747
27976878	stability	C0205360
27976878	during	C0347984
27976878	processing	C0016487
27976878	distribution	C1704711
27976878	mycotoxins	C0026955
27976878	mycotoxin	C0026955
27976878	produced	C0678227
27976878	single	C0205171
27976878	several	C0443302
27976878	fungal	C0016832
27976878	species	C1705920
27976878	various	C0439064
27976878	combinations	C0205195
27976878	sample	C0444315
27976878	food	C0016452
27976878	studies	C2603343
27976878	reported	C0700287
27976878	additive	C0442796
27976878	synergistic	C2986495
27976878	effects	C1280500
27976878	suggesting	C1705535
27976878	mixtures	C0439962
27976878	significant	C0750502
27976878	threat	C0749385
27976878	public	C0678367
27976878	health	C0018684
27976878	infants	C0021270
27976878	young children	C0728836
27976878	information	C1533716
27976878	mycotoxins	C0026955
27976878	interactive	C1704675
27976878	toxicity	C0600688
27976878	summarized	C0242482
27979320	Seventh Cervical Spinous Process	C0223178
27979320	Multivariate Model	C0026348
27979320	Palpation	C0030247
27979320	Personal Information	C2983694
27979320	multivariate prediction model	C0026348
27979320	palpation	C0030247
27979320	personal information	C2983694
27979320	seventh cervical spinous process	C0223178
27979320	C7SP	C0223178
27979320	single-blinded, cross-sectional study	C0010362
27979320	primary to tertiary health care center	C1552443
27979320	model development	C0920595
27979320	temporal validation	C1519941
27979320	participants	C0679646
27979320	model development	C0920595
27979320	time-split validation stages	C0681916
27979320	C7SP	C0223178
27979320	thorax-rib static method	C0030247
27979320	TRSM	C0030247
27979320	Participants	C0679646
27979320	chest radiography	C0039985
27979320	inner	C0205102
27979320	body structure	C0460148
27979320	TRSM	C0030247
27979320	radio-opaque markers	C0181741
27979320	skin	C1123023
27979320	Age	C0001779
27979320	sex	C0079399
27979320	height	C0489786
27979320	body mass	C0518010
27979320	body mass index	C1305855
27979320	vertex-marker distanc	C0012751
27979320	DV-M	C0012751
27979320	distance	C0012751
27979320	C7SP	C0223178
27979320	vertex	C0230003
27979320	DV-C7	C0012751
27979320	Multivariate linear regression modeling	C0034980
27979320	histogram of residues	C0870616
27979320	receiver operating characteristic curves	C0035787
27979320	confusion tables	C1706074
27979320	multivariate linear prediction model	C0026348
27979320	DV-C7	C0012751
27979320	DV-C7	C0012751
27979320	Receiver operating characteristic curves	C0035787
27979320	DV-C7	C0012751
27979320	confidence interval	C0009667
27979320	DV-M	C0012751
27979320	confidence interval	C0009667
27979320	sensitivity	C0036667
27979320	specificity	C0037791
27979320	sensitivity	C0036667
27979320	specificity	C0037791
27979320	C7SP	C0223178
27979320	DV-C7	C0012751
27979320	TRSM	C0030247
27979320	C7SP	C0223178
27979320	multivariate model	C0026348
27979320	palpation	C0030247
27979320	personal information	C2983694
27983510	Comparison	C1707455
27983510	Leishmania	C1095819
27983510	typing	C0430416
27983510	results	C0456984
27983510	obtained	C1301820
27983510	European	C0015176
27983510	clinical laboratories	C1551301
27983510	Leishmaniasis	C0023281
27983510	endemic	C0544083
27983510	southern Europe	C0037724
27983510	European	C0015176
27983510	countries	C0454664
27983510	cases	C0021149
27983510	diagnosed	C0011900
27983510	travellers	C0335278
27983510	affected areas	C1879646
27983510	within	C0332285
27983510	continent	C0454690
27983510	Prompt	C0205556
27983510	accurate	C0443131
27983510	diagnosis	C0011900
27983510	clinical practice	C2986419
27983510	Europe	C0015176
27983510	Different	C1705242
27983510	methods	C0025663
27983510	exist	C2987476
27983510	identification	C0205396
27983510	infecting	C0439663
27983510	Leishmania	C1095819
27983510	species	C1705920
27983510	clinical laboratories	C1551301
27983510	European	C0015176
27983510	countries	C0454664
27983510	Israel	C0022271
27983510	Turkey	C0041400
27983510	study	C2603343
27983510	genotyping	C1285573
27983510	performance	C1882330
27983510	DNA	C0012854
27983510	promastigote cultures	C0684063
27983510	species	C1705920
27983510	analysed	C0936012
27983510	blindly	C0205556
27983510	routinely	C0205547
27983510	typing	C0430416
27983510	method	C0025663
27983510	different	C1705242
27983510	molecular targets	C1513403
27983510	analysed	C0936012
27983510	PCR-based	C0032520
27983510	methods	C0025663
27983510	Different	C1705242
27983510	levels	C0441889
27983510	identification	C0205396
27983510	achieved	C0432600
27983510	Leishmania	C1095819
27983510	subgenus	C1883697
27983510	species	C1705920
27983510	species	C1705920
27983510	reported	C0684224
27983510	overall	C1561607
27983510	error	C0743559
27983510	rate	C1521828
27983510	strains	C1518614
27983510	wrong	C3827420
27983510	species	C1705920
27983510	reasons	C0392360
27983510	incorrect	C3827420
27983510	typing	C0430416
27983510	identified	C0205396
27983510	study	C2603343
27983510	considerable	C0205556
27983510	improvement	C2986411
27983510	standardisation	C0038136
27983510	Leishmania	C1095819
27983510	typing	C0430416
27983510	validated	C1519941
27983510	standard operating procedures	C1710183
27983510	recommended	C0034866
27983510	testing	C0039593
27983510	interpretation	C0459471
27983510	reporting	C0700287
27983510	guidelines	C0162791
27983510	internal	C0205102
27983510	transcribed	C0205556
27983510	spacer 1	C0887858
27983510	rDNA	C0012931
27983510	array	C0600597
27983510	restricted	C0443288
27983510	Old World	C0205556
27983510	samples	C2347026
27983510	heat-shock protein 70 gene	C1415755
27983510	mini-exon	C0026163
27983510	applied	C4048755
27983510	globally	C2348867
27983636	Scoparone	C0074191
27983636	LPS	C0023810
27983636	Simulated	C0205245
27983636	Inflammatory Response	C1155266
27983636	Suppressing	C1260953
27983636	IRF3	C1510506
27983636	ERK	C0600388
27983636	BV-2 Microglial Cells	C0206116
27983636	Microglia	C0206116
27983636	activation	C1326120
27983636	inflammatory	C0333348
27983636	cytokines	C0079189
27983636	neurological diseases	C2359473
27983636	Parkinson's	C0030567
27983636	Alzheimer's	C0002395
27983636	other	C0205394
27983636	brain diseases	C0006111
27983636	microglial cells	C0206116
27983636	natural	C0205296
27983636	bioactive compounds	C0574031
27983636	increasingly	C0442805
27983636	important	C3898777
27983636	brain therapy	C0872120
27983636	beneficial effect	C0683156
27983636	lower	C0205251
27983636	toxicity	C0040539
27983636	Scoparone	C0074191
27983636	6,7-dimethoxycoumarin	C0074191
27983636	bioactive compound	C0574031
27983636	found	C0150312
27983636	plant parts	C2698828
27983636	shell	C1948022
27983636	chestnut	C0349771
27983636	Castanea crenata	C1047769
27983636	lipopolysaccharide	C0023810
27983636	LPS	C0023810
27983636	activated	C1515877
27983636	BV-2 microglia cells	C0206116
27983636	results	C1274040
27983636	indicated	C1444656
27983636	scoparone	C0074191
27983636	suppresses	C1260953
27983636	LPS	C0023810
27983636	stimulated	C0205245
27983636	increase	C0442805
27983636	neuroinflammatory responses	C1155266
27983636	inhibited	C0311403
27983636	pro-inflammatory	C0333348
27983636	cytokine	C0079189
27983636	BV-2 microglial cells	C0206116
27983636	mechanistic study	C0441712
27983636	scoparone	C0074191
27983636	inhibited	C0311403
27983636	LPS	C0023810
27983636	stimulated	C0205245
27983636	activation	C1326120
27983636	regulation	C1327622
27983636	IRF-3	C1510506
27983636	regulation	C1327622
27983636	ERK	C0600388
27983636	phosphorylation	C0031715
27983636	BV-2 microglial cells	C0206116
27983636	blocked	C0332206
27983636	data	C1511726
27983636	suggest	C1705535
27983636	scoparone	C0074191
27983636	anti-neuroinflammatory effects	C1515999
27983636	LPS	C0023810
27983636	activated	C1515877
27983636	BV-2 microglial cells	C0206116
27983636	used	C1524063
27983636	development	C1527148
27983636	novel	C0205314
27983636	drugs	C0013227
27983636	prevention	C1456501
27983636	treatment	C1522326
27983636	neuroinflammatory diseases	C2359473
27987038	genome editing	C4279981
27987038	differentiated	C0205615
27987038	renal	C0022646
27987038	epithelial cells	C0014597
27987038	genome editing technologies	C4279981
27987038	manipulation of genomes	C0178659
27987038	targeted introduction	C4279981
27987038	alteration	C4279981
27987038	removal of genomic sequences	C4279981
27987038	methods	C0025663
27987038	non-differentiated	C0449475
27987038	haploid	C1257912
27987038	cell types	C0449475
27987038	Genome editing	C4279981
27987038	well-differentiated	C0205615
27987038	renal	C0022646
27987038	epithelial cells	C0014597
27987038	technological issues	C0033213
27987038	optimal	C2698651
27987038	design	C1707689
27987038	efficient	C0442799
27987038	expression of multiple genome editing constructs	C4279981
27987038	attainable	C0205556
27987038	mutation rates	C3178846
27987038	screening strategies	C0282574
27987038	workflow	C1710679
27987038	rapid	C0456962
27987038	generation of targeted heterozygous and homozygous genomic sequence alterations	C4279981
27987038	renal	C0022646
27987038	cells	C0007634
27987038	transcription activator-like effector nucleases	C4277678
27987038	TALENs	C4277678
27987038	clustered regularly interspaced short palindromic repeat (CRISPR) system	C3658200
27987038	protocols	C0442711
27987038	generating	C3146294
27987038	novel	C0205314
27987038	cellular models	C0026336
27987038	studying	C2603343
27987038	autosomal dominant polycystic kidney disease	C0085413
27987038	ADPKD	C0085413
27987038	cell culture-validated genetic modifications	C4277689
27987038	mouse embryonic stem cells	C4042879
27987038	mESCs	C4042879
27987038	generation	C3146294
27987038	mouse	C0025929
27987038	models	C0599779
27987038	procedure	C2700391
27987038	genome editing	C4279981
27987038	cell type	C0449475
27987038	study	C2603343
27987038	physiological	C0031845
27987038	pathophysiological functions	C0030660
27987038	engineered genotypes	C1516876
27988278	Right Ventricular	C0225883
27988278	Response	C0871261
27988278	During	C0347984
27988278	Exercise	C0015259
27988278	Patients	C0030705
27988278	Chronic Obstructive Pulmonary Disease	C0024117
27988278	Right ventricular	C0225883
27988278	RV	C0225883
27988278	pump function	C0080311
27988278	essential	C0205224
27988278	clinical	C0205210
27988278	prognostic	C0220901
27988278	importance	C3898777
27988278	variety	C2346866
27988278	heart	C0018799
27988278	lung diseases	C0024115
27988278	evaluation	C0220825
27988278	RV	C0225883
27988278	performance	C1882330
27988278	rest	C0035253
27988278	clinical setting	C3176918
27988278	assessment	C0220825
27988278	during	C0347984
27988278	exercise	C0015259
27988278	additional	C1524062
27988278	benefit	C0814225
27988278	aim	C1947946
27988278	evaluated	C0220825
27988278	exercise	C0015259
27988278	induced	C0205263
27988278	pulmonary arterial systolic pressure	C1168444
27988278	PASP	C1168444
27988278	increase	C0442805
27988278	during	C0347984
27988278	exercise	C0015259
27988278	patients	C0030705
27988278	severe	C0392364
27988278	chronic obstructive pulmonary disease	C0024117
27988278	COPD	C0024117
27988278	RV	C0225883
27988278	contractile reserve	C0392762
27988278	Cardiopulmonary exercise testing	C2959886
27988278	CPET	C2959886
27988278	synchronic echocardiography	C0013516
27988278	performed	C0884358
27988278	patients	C0030705
27988278	Patients	C0030705
27988278	classified	C0008902
27988278	groups	C0441833
27988278	exercise	C0015259
27988278	induced	C0205263
27988278	PASP	C1168444
27988278	increase	C0442805
27988278	High	C0205250
27988278	PSAP	C1168444
27988278	Low	C0205251
27988278	PSAP	C1168444
27988278	during	C0347984
27988278	maximal	C0205289
27988278	exercise	C0015259
27988278	Patients	C0030705
27988278	followed	C0332282
27988278	years	C0439234
27988278	patients	C0030705
27988278	low	C0205251
27988278	PSAP	C1168444
27988278	high	C0205250
27988278	PSAP	C1168444
27988278	not significant	C1273937
27988278	clinical	C0205210
27988278	functional	C0205245
27988278	differences	C1705241
27988278	Low	C0205251
27988278	PSAP	C1168444
27988278	associated with	C0332281
27988278	significantly lower	C4055638
27988278	peak	C0444505
27988278	VO2	C0429627
27988278	mean	C0444504
27988278	SD	C0871420
27988278	predicted	C0681842
27988278	compared	C1707455
27988278	high	C0205250
27988278	PSAP	C1168444
27988278	response	C0871261
27988278	peak	C0444505
27988278	VO2	C0429627
27988278	predicted	C0681842
27988278	Factors	C1521761
27988278	associated with	C0332281
27988278	mortality	C0178686
27988278	age	C0001779
27988278	exercise	C0015259
27988278	induced	C0205263
27988278	PASP	C1168444
27988278	patients	C0030705
27988278	during	C0347984
27988278	years	C0439234
27988278	follow-up	C1522577
27988278	low	C0205251
27988278	PSAP	C1168444
27988278	group	C0441833
27988278	high	C0205250
27988278	PSAP	C1168444
27988278	group	C0441833
27988278	Cardiopulmonary exercise testing	C2959886
27988278	synchronic echocardiography	C0013516
27988278	assessment	C0220825
27988278	RV	C0225883
27988278	contractile reserve	C0392762
27988278	severe	C0392364
27988278	COPD	C0024117
27988278	patients	C0030705
27988278	Exercise	C0015259
27988278	induced	C0205263
27988278	PSAP	C1168444
27988278	prognostic factor	C1514474
27988278	patients	C0030705
27989992	Adverse outcomes	C1274040
27989992	older adults	C0001792
27989992	attending	C1999232
27989992	emergency departments	C0562508
27989992	systematic review	C1955832
27989992	meta-analysis	C0920317
27989992	Identification of Seniors At Risk (ISAR) screening tool	C0282574
27989992	older adults	C0001792
27989992	frequent	C0332183
27989992	emergency services	C0013961
27989992	high	C0205250
27989992	rates	C1521828
27989992	adverse outcomes	C1274040
27989992	emergency care	C1527398
27989992	systematic review	C1955832
27989992	meta-analysis	C0920317
27989992	Identification of Seniors At Risk (ISAR) screening tool	C0282574
27989992	predictive value	C1514307
27989992	adults	C0001675
27989992	years	C0439234
27989992	risk	C0035647
27989992	functional decline	C4304688
27989992	emergency department (ED) readmission	C0583237
27989992	emergency	C0013956
27989992	hospitalisation	C0019993
27989992	death	C1306577
27989992	days	C0439228
27989992	ED visit	C0586082
27989992	hospitalisation	C0019993
27989992	systematic	C0220922
27989992	literature	C0023866
27989992	search	C1706202
27989992	PubMed	C1138432
27989992	EMBASE	C0282574
27989992	CINAHL	C0282574
27989992	EBSCO	C0282574
27989992	Cochrane Library	C0282574
27989992	validation	C1519941
27989992	impact	C4049986
27989992	analysis	C0936012
27989992	ISAR tool	C0282574
27989992	pre-specified	C2826245
27989992	ISAR	C0282574
27989992	score	C0449820
27989992	score	C0449820
27989992	patients	C0030705
27989992	high risk of	C0332167
27989992	adverse outcomes	C1274040
27989992	bivariate random effects model	C3161035
27989992	pooled	C2349200
27989992	estimates	C0750572
27989992	sensitivity and specificity	C0036668
27989992	Statistical heterogeneity	C0019409
27989992	methodological quality	C0815254
27989992	validated criteria	C0243161
27989992	validation studies	C0681836
27989992	included	C0332257
27989992	pooled	C2349200
27989992	sensitivity	C0036667
27989992	ISAR	C0282574
27989992	ED	C0562508
27989992	return	C0332156
27989992	emergency	C0013956
27989992	hospitalisation	C0019993
27989992	mortality	C0205848
27989992	months	C0439231
27989992	confidence interval	C0009667
27989992	CI	C0009667
27989992	CI	C0009667
27989992	CI	C0009667
27989992	pooled	C2349200
27989992	specificity	C0037791
27989992	CI	C0009667
27989992	CI	C0009667
27989992	CI	C0009667
27989992	values	C0042295
27989992	days	C0439228
27989992	heterogeneous	C0019409
27989992	impact	C4049986
27989992	analysis	C0936012
27989992	examined	C0332128
27989992	clinical	C0205210
27989992	implementation	C1708476
27989992	ISAR	C0282574
27989992	mixed findings	C2607943
27989992	patient	C0030705
27989992	process	C1522240
27989992	outcomes	C1274040
27989992	ISAR	C0282574
27989992	predictive	C0681890
27989992	accuracy	C0443131
27989992	decision-making	C0011109
27989992	adjunct	C1719882
27989992	older adults	C0001792
27989992	discharged	C0030685
27991947	Ecohydrological modeling	C0870071
27991947	environmental	C0014406
27991947	flow	C0806140
27991947	regime	C0243148
27991947	Formoso River	C0337050
27991947	Minas Gerais State	C0006137
27991947	Brazil	C0006137
27991947	paper	C1706852
27991947	determining	C0521095
27991947	environmental	C0014406
27991947	flow	C0806140
27991947	1 km	C0439198
27991947	stretch	C0012751
27991947	Formoso River	C0337050
27991947	MG	C0006137
27991947	River2D model	C0870071
27991947	ecohydrological modeling	C0870071
27991947	following	C0332282
27991947	information	C1533716
27991947	bathymetry	C0392762
27991947	physical	C0205485
27991947	hydraulic	C0205245
27991947	features	C2348519
27991947	Habitat	C0871648
27991947	Suitability Index	C3900053
27991947	species	C1705920
27991947	Hypostomus auroguttatus	C3128443
27991947	River2D	C0870071
27991947	Weighted	C0439751
27991947	Usable	C3827682
27991947	Areas	C0205146
27991947	determined	C0521095
27991947	average	C1510992
27991947	long-term	C0443252
27991947	streamflows	C0442540
27991947	percentage	C0439165
27991947	streamflows	C0442540
27991947	later	C0205087
27991947	construction	C1881534
27991947	optimization	C2698650
27991947	matrices	C1704640
27991947	maximize	C0806909
27991947	habitat	C0871648
27991947	area	C0205146
27991947	throughout	C0332273
27991947	year	C0439234
27991947	H. auroguttatus	C3128443
27991947	Juvenile	C3146221
27991947	higher	C0205250
27991947	values	C0042295
27991947	Weighted	C0439751
27991947	Usable	C3827682
27991947	Area	C0205146
27991947	associated with	C0332281
27991947	percentage	C0439165
27991947	average	C1510992
27991947	long-term	C0443252
27991947	streamflows	C0442540
27991947	October	C3828732
27991947	September	C3828193
27991947	H. auroguttatus	C3128443
27991947	Adult	C0001675
27991947	highest	C1522410
27991947	value	C0042295
27991947	Weighted	C0439751
27991947	Usable	C3827682
27991947	Usable	C3827682
27991947	Area	C0205146
27991947	associated with	C0332281
27991947	percentage	C0439165
27991947	average	C1510992
27991947	long-term	C0443252
27991947	streamflow	C0442540
27991947	September	C3828193
27991947	environmental	C0014406
27991947	flows	C0806140
27991947	found	C0150312
27991947	stretch	C0012751
27991947	Formoso River	C0337050
27991947	varied	C0392747
27991947	over	C0347984
27991947	year	C0439234
27991947	lowest	C1708760
27991947	environmental	C0014406
27991947	flow	C0806140
27991947	observed	C1441672
27991947	December	C3830550
27991947	highest	C1522410
27991947	observed	C1441672
27991947	May	C3812381
27991947	paper	C1706852
27991947	importance	C3898777
27991947	ecohydrological studies	C0870071
27991947	forming	C1522492
27991947	basis	C1527178
27991947	water resources	C3494255
27991947	management	C0243148
27991947	actions	C3266814
27992983	Risk factors	C0035648
27992983	hepatitis C virus infection	C4288963
27992983	Colombian	C1553372
27992983	Caribbean coast	C0206155
27992983	case-control study	C0007328
27992983	million	C1881839
27992983	people	C0027361
27992983	infected	C0439663
27992983	hepatitis C virus	C0220847
27992983	Latin America	C0023122
27992983	less than	C0439092
27992983	antiviral treatment	C2363964
27992983	Studies	C2603343
27992983	Colombia	C3245499
27992983	attempted	C1516084
27992983	prevalence	C0033106
27992983	disease	C0012634
27992983	risk	C0035647
27992983	groups	C1257890
27992983	preventing	C1292733
27992983	identification	C0205396
27992983	factors	C1521761
27992983	potentially	C3245505
27992983	infection	C3714514
27992983	identify	C0205396
27992983	risk factors	C0035648
27992983	chronic hepatitis C	C0524910
27992983	Colombian	C1553372
27992983	Caribbean coast	C0206155
27992983	case-control study	C0007328
27992983	health care provider	C0018724
27992983	age	C0001779
27992983	years	C0439234
27992983	primary care level	C0033137
27992983	gastroenterology	C0017163
27992983	hepatology	C0086403
27992983	outpatient services	C0086751
27992983	patients	C0030705
27992983	positive	C1446409
27992983	ELISA	C0014441
27992983	confirmatory	C0814857
27992983	viral load test	C1656394
27992983	multivariate logistic regression analysis	C0681925
27992983	identified	C0205396
27992983	independent predictors	C2698872
27992983	infection	C3714514
27992983	Blood transfusion	C0005841
27992983	OR	C0028873
27992983	CI	C0009667
27992983	history of hospitalization	C0551576
27992983	OR	C0028873
27992983	CI	C0009667
27992983	identified	C0205396
27992983	independent predictors	C2698872
27992983	infection	C3714514
27992983	reproducibility of these results	C0035149
27992983	cost-effectiveness	C0010181
27992983	studies	C2603343
27992983	recommending	C0034866
27992983	use	C0457083
27992983	design	C1707689
27992983	new screening strategies	C2348164
27993519	G protein-coupled receptor ligands	C1149462
27993519	analysis	C0936012
27993519	emergence	C0750573
27993519	groups	C0441833
27993519	compounds	C1706082
27993519	over time	C0040223
27993519	Exponential	C1552645
27993519	growth	C2911660
27993519	number	C0237753
27993519	compounds	C1706082
27993519	experimentally	C1517586
27993519	verified	C1711411
27993519	activity	C0441655
27993519	target	C1521840
27993519	emergence	C0750573
27993519	databases	C0242356
27993519	data	C1511726
27993519	biological	C0205460
27993519	activity	C0441655
27993519	study	C2603343
27993519	ligands	C0023688
27993519	family A of the G Protein-Coupled Receptors	C0682972
27993519	collected	C1516695
27993519	ChEMBL database	C0242356
27993519	examined	C0332128
27993519	serotonin receptors	C0034838
27993519	Sets	C1705195
27993519	compounds	C1706082
27993519	examined	C0332128
27993519	appearance	C0700364
27993519	over time	C0040223
27993519	mapped	C1283195
27993519	chemical space	C1254350
27993519	drugs	C1254351
27993519	DrugBank	C4255544
27993519	emergence	C0750573
27993519	structurally new clusters of compounds	C1254350
27993519	indicated	C1444656
27993519	analysis	C0936012
27993519	obtained	C1301820
27993519	visualizations	C1704922
27993519	prepared	C4082130
27993519	available	C0470187
27993519	online	C0683828
27993519	http://chem.gmum.net/vischem	C0282574
27993519	investigation	C1517586
27993519	chemical structures	C0220807
27993519	referring	C0205543
27993519	data points	C3176122
27993519	figures	C0683878
27993519	changes	C0392747
27993519	compounds	C1706082
27993519	datasets	C0150098
27993519	over time	C0040223
27995352	Diabetes	C0011847
27995352	breast cancer	C0678222
27995352	mortality	C0026565
27995352	Black women	C0043210
27995352	Breast cancer	C0678222
27995352	mortality	C0026565
27995352	Black women	C0043210
27995352	White women	C0043210
27995352	prevalence	C0220900
27995352	type 2 diabetes mellitus	C0011860
27995352	data	C1511726
27995352	diabetes	C0011847
27995352	affects	C1280500
27995352	breast cancer	C0678222
27995352	mortality	C0026565
27995352	population	C1257890
27995352	lacking	C0332268
27995352	investigated	C1292732
27995352	diabetes	C0011847
27995352	breast cancer	C0678222
27995352	diagnosis	C0011900
27995352	breast cancer	C0678222
27995352	mortality	C0026565
27995352	Black Women's	C0043210
27995352	Health	C0086388
27995352	Study	C2603343
27995352	prospective cohort study	C1709709
27995352	Black women	C0043210
27995352	invasive	C0205281
27995352	breast cancer	C0678222
27995352	diagnosed	C0011900
27995352	followed by	C0332283
27995352	questionnaires	C0034394
27995352	National Death Index	C3889680
27995352	Multivariable Cox regression analysis	C0034980
27995352	hazard ratios	C2985465
27995352	HRs	C2985465
27995352	diabetes	C0011847
27995352	breast cancer	C0678222
27995352	mortality	C0026565
27995352	mortality	C0026565
27995352	age	C0001779
27995352	stage	C1300072
27995352	treatment modality	C3527083
27995352	estrogen receptor	C0034804
27995352	ER	C0034804
27995352	status	C0449438
27995352	body mass index	C1305855
27995352	deaths	C1306577
27995352	follow-up	C1522577
27995352	breast cancer	C0678222
27995352	Breast cancer	C0678222
27995352	mortality	C0026565
27995352	significantly increased	C4055637
27995352	women	C0043210
27995352	diagnosed	C0011900
27995352	diabetes	C0011847
27995352	breast cancer	C0678222
27995352	occurrence	C2745955
27995352	HR	C2985465
27995352	elevations	C0702240
27995352	observed	C1441672
27995352	ER+	C1719706
27995352	ER-	C1719707
27995352	breast cancer	C0678222
27995352	mortality	C0026565
27995352	diabetics	C0241863
27995352	HRs	C2985465
27995352	overall	C1561607
27995352	diabetes	C0011847
27995352	relative	C0205345
27995352	non-diabetics	C0241863
27995352	results	C0456984
27995352	present	C0150312
27995352	evidence	C3887511
27995352	positive	C1446409
27995352	type 2 diabetes	C0011860
27995352	breast cancer	C0678222
27995352	mortality	C0026565
27995352	Black women	C0043210
27995352	prevalence	C0220900
27995352	earlier onset	C1833334
27995352	type 2 diabetes	C0011860
27995352	Black women	C0043210
27995352	diabetes	C0011847
27995352	contributes	C1880177
27995352	racial	C0034510
27995352	disparities	C1171307
27995352	breast cancer	C0678222
27995352	mortality	C0026565
27998307	Neuro-Behcet disease	C0858762
27998307	presenting	C0449450
27998307	cerebellar hemorrhagic	C0149854
27998307	lesion	C0221198
27998307	case report	C0085973
27998307	review of the literature	C0282441
27998307	Behcet's disease	C0004943
27998307	heterogeneous	C1858576
27998307	multisystem	C0559758
27998307	inflammatory disorder	C1290884
27998307	unknown etiology	C0743626
27998307	oral	C0149745
27998307	genital ulcerations	C0151281
27998307	conjunction	C2699427
27998307	uveitis	C0042164
27998307	described	C1552738
27998307	Turkish	C0549217
27998307	dermatologist	C0259831
27998307	associated symptoms	C0521989
27998307	cardiovascular	C0007226
27998307	central nervous	C3714787
27998307	pulmonary	C0884309
27998307	gastrointestinal systems	C0012240
27998307	identified	C0205396
27998307	Behcet's disease	C0004943
27998307	neurological involvement	C0027765
27998307	neuro-Behcet's disease	C0858762
27998307	Patients	C0030705
27998307	neuro-Behcet's disease	C0858762
27998307	symptoms	C1457887
27998307	most	C0205393
27998307	commonly	C0205214
27998307	brainstem	C0006121
27998307	diencephalic	C0012144
27998307	regions	C0205147
27998307	report	C0684224
27998307	unusual	C2700116
27998307	case	C0868928
27998307	neuro-Behcet's disease	C0858762
27998307	patient	C0030705
27998307	presented	C0449450
27998307	cerebellar hemorrhage	C0149854
27998307	39-year-old	C0001675
27998307	Asian	C0078988
27998307	woman	C0043210
27998307	admitted	C0809949
27998307	hospital	C0019994
27998307	complaints	C0277786
27998307	sudden	C1276802
27998307	speech difficulty	C0233715
27998307	manifested	C0205319
27998307	same	C0445247
27998307	morning	C0332170
27998307	dizziness	C0012833
27998307	mild	C2945599
27998307	vomiting	C0042963
27998307	over	C0347984
27998307	previous	C0205156
27998307	days	C0439228
27998307	Magnetic resonance images	C3890166
27998307	revealed	C0443289
27998307	hemorrhagic	C0149854
27998307	lesions	C0221198
27998307	right hemisphere of the cerebellum	C2335345
27998307	Risk factors	C0035648
27998307	result	C1274040
27998307	cerebellar hemorrhage	C0149854
27998307	high blood pressure	C0020538
27998307	bleeding diathesis	C1458140
27998307	ruled out	C1410834
27998307	subsequent	C0332282
27998307	brain	C0006104
27998307	angiograms	C0002978
27998307	normal	C0205307
27998307	findings	C0243095
27998307	suggest	C1705535
27998307	patient's	C0030705
27998307	cerebellar hemorrhage	C0149854
27998307	due to	C0678226
27998307	intracranial	C0524466
27998307	vasculitis	C0042384
27998307	rare	C0522498
27998307	complication	C0009566
27998307	neuro-Behcet's disease	C0858762
27999011	Intrinsic	C0205102
27999011	rifamycin	C0035609
27999011	resistance	C0949285
27999011	Mycobacterium abscessus	C0445910
27999011	ADP-ribosyltransferase	C0085748
27999011	MAB_0591	C0017337
27999011	Rifampicin	C0035608
27999011	TB drug	C0013227
27999011	rifamycin group	C0035609
27999011	activity	C0599112
27999011	pathogen	C0450254
27999011	Mycobacterium abscessus	C0445910
27999011	bacterial resistance	C0151521
27999011	rifampicin	C0035608
27999011	polymorphisms	C0032529
27999011	gene rpoB	C0017337
27999011	enzymes	C0014442
27999011	rifampicin	C0035608
27999011	aim	C1947946
27999011	MAB_0591	C0017337
27999011	arrMab	C0017337
27999011	rifampicin	C0035608
27999011	ADP-ribosyltransferase	C0085748
27999011	Arr_Mab	C0085748
27999011	rifampicin	C0035608
27999011	resistance	C0949285
27999011	M. abscessus	C0445910
27999011	Recombinant	C1514798
27999011	Escherichia coli	C0014834
27999011	Mycobacterium tuberculosis	C0026926
27999011	strains	C1518614
27999011	expressing	C0017262
27999011	MAB_0591	C0017337
27999011	M. abscessus	C0445910
27999011	deletion mutant	C1511760
27999011	deficient	C0011155
27999011	MAB_0591	C0017337
27999011	MIC assays	C1510438
27999011	susceptibility	C1264642
27999011	rifampicin	C0035608
27999011	C25 carbamate	C0006948
27999011	rifamycin derivatives	C0035609
27999011	Heterologous	C0439860
27999011	expression	C0017262
27999011	MAB_0591	C0017337
27999011	rifampicin	C0035608
27999011	resistance	C0949285
27999011	E. coli	C0014834
27999011	M. tuberculosis	C0026926
27999011	Rifamycin	C0035609
27999011	MIC values	C1304747
27999011	M. abscessus	C0445910
27999011	ΔarrMab mutant	C0678941
27999011	compared	C1707455
27999011	M. abscessus ATCC 19977	C0445910
27999011	parental type strain	C1518614
27999011	rifamycin	C0035609
27999011	WT	C1883559
27999011	phenotype	C0031437
27999011	complementation	C0178654
27999011	M. abscessus	C0445910
27999011	ΔarrMab mutant	C0678941
27999011	arrMab	C0085748
27999011	MIC data	C1304747
27999011	C25	C0006948
27999011	modification	C3840684
27999011	rifamycin	C0035609
27999011	activity	C0599112
27999011	WT	C1883559
27999011	M. abscessus	C0445910
27999011	MIC studies	C0681814
27999011	M. abscessus	C0445910
27999011	ΔarrMab mutant	C0678941
27999011	C25	C0006948
27999011	rifamycins	C0035609
27999011	modification	C3840684
27999011	Arr_Mab	C0085748
27999011	Arr_Mab	C0085748
27999011	rifamycin	C0035609
27999011	resistance	C0949285
27999011	M. abscessus	C0445910
27999011	Arr_Mab	C0085748
27999011	rifamycin	C0035609
27999011	resistance	C0949285
27999011	M. abscessus	C0445910
27999011	C25 carbamate	C0006948
27999011	modification	C3840684
28002691	Silorane-based Resin Composites	C3489777
28002691	Review	C0282443
28002691	article	C1706852
28002691	review	C0282443
28002691	research	C0035168
28002691	silorane-based resin composites	C3489777
28002691	SBRC	C3489777
28002691	polymerization	C0314672
28002691	shrinkage	C0332513
28002691	contraction stresses	C0038442
28002691	methacrylate-based resin composites	C0009570
28002691	MRBC	C0009570
28002691	physical	C0597237
28002691	mechanical properties	C2350455
28002691	bond strength	C0678599
28002691	marginal adaptation	C0242981
28002691	cusp deflection	C2350455
28002691	clinical significance	C2826293
28002691	material	C0520510
28002691	SBRC	C3489777
28002691	tooth structure	C0040426
28002691	direct restorative material	C3503982
28002691	English	C0376245
28002691	peer-reviewed dental literature	C0282441
28002691	PubMed	C1138432
28002691	MEDLINE	C0025141
28002691	databases	C0242356
28002691	low	C0205251
28002691	shrinkage	C0332513
28002691	silorane composites	C3489777
28002691	articles	C1706852
28002691	objectives	C0018017
28003168	Endoscopic	C0014245
28003168	endonasal	C0225425
28003168	surgery	C0543467
28003168	remission	C0544452
28003168	Cushing's Disease	C0010481
28003168	ectopic	C0574895
28003168	intracavernous	C1512919
28003168	macroadenoma	C0344453
28003168	case report	C0085973
28003168	literature review	C0282441
28003168	surgical resection	C0015252
28003168	ACTH-secreting pituitary adenoma	C1306214
28003168	gold standard	C0150110
28003168	treatment	C0087111
28003168	Cushing's Disease	C0010481
28003168	Ectopic	C0574895
28003168	location	C0450429
28003168	adenomas	C0001430
28003168	rare	C0522498
28003168	diagnosis	C0011900
28003168	surgical	C0543467
28003168	success	C0597535
28003168	ectopic	C0574895
28003168	intracavernous	C1512919
28003168	ACTH-secreting macroadenoma	C1306214
28003168	endoscopic	C0014245
28003168	endonasal	C0225425
28003168	surgery	C0543467
28003168	EES	C0396138
28003168	female	C0086287
28003168	Cushing syndrome	C0010481
28003168	Increased	C0205217
28003168	ACTH	C0001655
28003168	serum cortisol	C0729349
28003168	free urine cortisol	C1985941
28003168	levels	C0441889
28003168	pituitary MRI	C0412679
28003168	pituitary tumor	C0032019
28003168	parasellar lesion	C0221198
28003168	cavernous sinus	C0007473
28003168	CS	C0007473
28003168	Inferior petrosal sinus sampling	C0206084
28003168	central	C0205099
28003168	peripheral	C0205100
28003168	ACTH	C0001655
28003168	patient	C0030705
28003168	EES	C0396138
28003168	No tumor	C0243095
28003168	sella	C0036609
28003168	CS	C0007473
28003168	tumor	C0027651
28003168	lateral	C0205093
28003168	carotid artery	C0007272
28003168	no	C1513916
28003168	complications	C0009566
28003168	EES	C0396138
28003168	Pathology	C0030664
28003168	diagnosis	C0011900
28003168	ACTH-secreting adenoma	C1306214
28003168	postoperative	C0032790
28003168	serum cortisol	C0729349
28003168	levels	C0441889
28003168	Postoperative	C0032790
28003168	MRI	C0024485
28003168	tumor resection	C0015252
28003168	follow-up	C1522577
28003168	patient	C0030705
28003168	clinical	C0205210
28003168	biochemical	C0205474
28003168	remission	C0544452
28003168	Cushing's Disease	C0010481
28003168	ectopic	C0574895
28003168	intracavernous	C1512919
28003168	ACTH-secreting adenomas	C1306214
28003168	microadenomas	C0346306
28003168	ectopic	C0574895
28003168	ACTH-secreting macroadenoma	C1306214
28003168	CS	C0007473
28003168	surgical	C0543467
28003168	EES	C0396138
28003168	resection	C0015252
28003168	ectopic	C0574895
28003168	intracavernous	C1512919
28003168	adenomas	C0001430
28003168	exploration	C1280903
28003168	CS	C0007473
28003168	no	C1513916
28003168	surgical	C0543467
28003168	complications	C0009566
28005403	Randomized Controlled Trial	C0206035
28005403	Habit Reversal Training	C0004933
28005403	Treatment	C0087111
28005403	Hair Pulling	C0040953
28005403	Youth	C0087178
28005403	study	C2603343
28005403	evaluated	C0220825
28005403	treatment	C0087111
28005403	efficacy	C1280519
28005403	habit reversal training	C0004933
28005403	HRT	C0004933
28005403	treatment as usual	C2347177
28005403	TAU	C2347177
28005403	children	C0008059
28005403	adolescents	C0205653
28005403	aged	C0001779
28005403	years	C0439234
28005403	diagnosis	C1704656
28005403	trichotillomania	C0040953
28005403	TTM	C0040953
28005403	assessment	C0220825
28005403	interviews	C0021822
28005403	rating scales	C0681889
28005403	Participants	C0679646
28005403	female	C0086287
28005403	diagnostic criteria	C0679228
28005403	TTM	C0040953
28005403	randomized	C0034656
28005403	weekly	C0332174
28005403	HRT	C0004933
28005403	therapists	C0871525
28005403	weeks	C0439230
28005403	TAU	C2347177
28005403	week	C0439230
28005403	HRT	C0004933
28005403	TAU	C2347177
28005403	week	C0439230
28005403	patients	C0030705
28005403	posttreatment assessment	C0237623
28005403	month	C0439231
28005403	follow-up	C1522577
28005403	assessments	C0220825
28005403	assessments	C0220825
28005403	rater	C2697672
28005403	blinded	C0150108
28005403	treatment	C0087111
28005403	condition	C0348080
28005403	analysis of variance	C0002780
28005403	significant	C0750502
28005403	National Institute of Mental Health	C0027466
28005403	Trichotillomania Severity Scale Total Score	C0457451
28005403	mean score	C3533236
28005403	baseline	C1442488
28005403	posttreatment	C0237623
28005403	HRT	C0004933
28005403	group	C1257890
28005403	TAU	C2347177
28005403	group	C1257890
28005403	The Massachusetts General Hospital-Hair Pulling Scale Total Score	C0457451
28005403	baseline	C1442488
28005403	posttreatment	C0237623
28005403	HRT	C0004933
28005403	group	C1257890
28005403	TAU	C2347177
28005403	group	C1257890
28005403	Clinical Global Impressions-Improvement	C3639708
28005403	participants	C0679646
28005403	treatment	C0087111
28005403	responders	C0282122
28005403	HRT	C0004933
28005403	group	C1257890
28005403	TAU	C2347177
28005403	group	C1257890
28005403	month	C0439231
28005403	follow-up	C1522577
28005403	treatment	C0087111
28005403	responders	C0282122
28005403	assessment	C0220825
28005403	improvement	C2986411
28005403	month	C0439231
28005403	follow-up	C1522577
28005403	improvement	C2986411
28005403	HRT	C0004933
28005403	treatment	C0087111
28005403	TTM	C0040953
28005403	youth	C0087178
28005775	Fully	C0443225
28005775	Endoscope	C0014243
28005775	Controlled	C2587213
28005775	Clipping	C0189711
28005775	Bilateral Middle Cerebral Artery Aneurysm	C0740385
28005775	Unilateral Supraorbital Keyhole Approach	C0087111
28005775	Clipping	C0189711
28005775	bilateral middle cerebral artery (bMCA) aneurysms	C0740385
28005775	unilateral approach	C0087111
28005775	single-stage operation	C0543467
28005775	surgical management	C1515089
28005775	patients	C0030705
28005775	bMCA aneurysms	C0740385
28005775	endoscope	C0014243
28005775	controlled	C2587213
28005775	techniques	C0449851
28005775	patient	C0030705
28005775	bMCA aneurysms	C0740385
28005775	aneurysms clipping	C0189711
28005775	unilateral supraorbital keyhole approach	C0087111
28005775	endoscope	C0014243
28005775	controlled	C2587213
28005775	microneurosurgery	C0524850
28005775	patient	C0030705
28005775	postoperative course	C0032790
28005775	without	C0332288
28005775	neurologic	C0205494
28005775	impairment	C0684336
28005775	complication	C0009566
28005775	adaptation	C1706477
28005775	endoscope	C0014243
28005775	controlled	C2587213
28005775	clipping	C0189711
28005775	bMCA aneurysms	C0740385
28005775	unilateral supraorbital keyhole approach	C0087111
28007859	Novel	C0205314
28007859	Observations	C0302523
28007859	Heteroresistant	C1514892
28007859	Vancomycin-Intermediate	C0042313
28007859	Methicillin-Resistant Staphylococcus aureus Strains	C1265292
28007859	South India	C0021201
28007859	genome sequences	C2348746
28007859	heteroresistant	C1514892
28007859	vancomycin-intermediate Staphylococcus aureus (hVISA) strains	C1318880
28007859	bloodstream infection	C2316160
28007859	strains	C1518614
28007859	mutations	C0026882
28007859	vraSR	C0017337
28007859	graSR	C0017337
28007859	walKR	C0017337
28007859	tcaRAB	C0017337
28007859	mutated	C0026882
28007859	genes	C0017337
28007859	hVISA	C1318880
28007859	phenotypes	C0031437
28008561	Endpoints	C2349179
28008561	screening	C0199230
28008561	thyroid cancer	C0549473
28008561	Republic of Korea	C0022773
28008561	thyroid	C0040132
28008561	specialists	C1611835
28008561	perspectives	C0030971
28008561	Cancer screening	C0199230
28008561	reducing	C0392756
28008561	deaths	C1306577
28008561	cancer	C0006826
28008561	Thyroid-specific cancer	C0549473
28008561	mortality	C0681679
28008561	endpoint	C2349179
28008561	estimates	C0750572
28008561	screening	C1710032
28008561	effect	C1280500
28008561	Numerous	C0439064
28008561	observations	C1964257
28008561	accumulated	C4055506
28008561	thyroid cancer	C0549473
28008561	mortality	C0681679
28008561	endpoint	C2349179
28008561	difficult	C0332218
28008561	population heterogeneity	C0086833
28008561	provision	C1283218
28008561	randomization	C0034656
28008561	requirement	C1514873
28008561	cohorts	C0599755
28008561	long follow-up	C1517942
28008561	excellent	C1961136
28008561	prognosis of the cancer	C1516221
28008561	important	C3898777
28008561	thyroid cancer	C0549473
28008561	screening	C0199230
28008561	efficacy	C1280519
28008561	Recommendations	C0034866
28008561	thyroid cancer	C0549473
28008561	screening	C0199230
28008561	effectiveness	C1280519
28008561	significant reduction	C0392756
28008561	cancer	C0549473
28008561	mortality	C0681679
28008561	endpoint	C2349179
28008561	endpoints	C2349179
28008561	reductions in mortality	C0282251
28008561	endpoint	C2349179
28008561	endpoint	C2349179
28008561	endpoints	C2349179
28008561	thyroid cancer	C0549473
28008561	incidence	C0021149
28008561	proportion	C1709707
28008561	early-stage	C2363430
28008561	tumors	C0027651
28008561	detected	C0442726
28008561	treatable stage	C1300072
28008561	identification	C0205396
28008561	small tumors	C0475277
28008561	decrease in the number of people	C0509797
28008561	metastatic disease	C0027627
28008561	increased	C0205217
28008561	surgery	C0543467
28008561	minimally invasive approaches	C2711297
28008561	lifelong	C4274169
28008561	thyroid replacement therapy	C2242640
28008561	consistent	C0332290
28008561	follow-up	C1522577
28008561	low-dose	C0445550
28008561	RAI administration	C0203778
28008561	risk factor assessments	C2983699
28008561	case findings	C1444481
28008561	continuous	C0549178
28008561	Korean	C1556095
28008561	Korean guidelines	C0162791
28008561	thyroid cancer	C0549473
28008561	national-level	C0681788
28008561	screening	C0220908
28008561	multidisciplinary thyroid experts	C0729737
28008561	evidence is insufficient	C3858734
28008561	benefits	C0814225
28008561	thyroid cancer	C0549473
28008561	screening	C0199230
28008561	research	C0035168
28008561	complete	C0205197
28008561	analysis	C0936012
28008561	endpoints	C2349179
28008561	screening	C0220908
28008561	participants	C0679646
28008561	information	C1533716
28008561	to make decisions	C0679006
28008561	thyroid cancer	C0549473
28008561	identified	C0205396
28009049	Zebrafish	C0043457
28009049	adult pigment stem cells	C1171322
28009049	multipotent	C1136335
28009049	form pigment cells	C0440745
28009049	progressive	C0205329
28009049	fate restriction process	C1160037
28009049	Clonal analysis	C0796368
28009049	identifies	C0205396
28009049	pigment cell types	C0440745
28009049	Skin pigment	C1269684
28009049	pattern formation	C1160421
28009049	paradigmatic	C0679667
28009049	pattern formation	C1160421
28009049	zebrafish	C0043457
28009049	adult	C0596090
28009049	body stripes	C0229962
28009049	generated	C1706214
28009049	coordinated	C0700114
28009049	rearrangement	C0007613
28009049	three	C0205449
28009049	pigment cell-types	C0440745
28009049	black	C0439541
28009049	melanocytes	C0025201
28009049	shiny	C0205556
28009049	iridophores	C0007634
28009049	yellow	C0221205
28009049	xanthophores	C0007634
28009049	stem cell origin	C0038250
28009049	melanocytes	C0025201
28009049	iridophores	C0007634
28009049	potency	C3245505
28009049	stem cells	C0038250
28009049	remained	C1527428
28009049	unclear	C3845108
28009049	Xanthophores	C0007634
28009049	predominantly	C1542147
28009049	proliferation	C0596290
28009049	embryonic	C0013935
28009049	xanthophores	C0007634
28009049	data	C1511726
28009049	three	C0205449
28009049	cell-types	C0007634
28009049	derive	C1441547
28009049	stem cells	C0038250
28009049	cells	C0007634
28009049	generate	C1706214
28009049	peripheral	C0205100
28009049	neural cell-types	C1113654
28009049	clonal	C1522642
28009049	compositions	C0205556
28009049	progressive	C0205329
28009049	fate restriction model	C1160037
28009049	generating	C1706214
28009049	individual	C1705242
28009049	cell-types	C0007634
28009049	numbers	C0237753
28009049	adult pigment stem cells	C1171322
28009049	associated with	C0332281
28009049	dorsal root ganglia	C0017070
28009049	remain	C0243095
28009049	low	C0205251
28009049	progenitor	C0038250
28009049	numbers	C0237753
28009049	increase	C0442805
28009049	during	C0347984
28009049	larval development	C1160209
28009049	metamorphosis	C0277806
28009049	partially	C0728938
28009049	restricted	C0443288
28009049	progenitors	C0038250
28009049	spinal nerves	C0037941
28010062	Covalent Modulators	C1254351
28010062	Vacuolar ATPase	C0379099
28010062	vacuolar H(+) ATPase	C0379099
28010062	V-ATPase	C0379099
28010062	complex	C1704241
28010062	machine	C0449913
28010062	regulates	C1327622
28010062	cellular processes	C0007613
28010062	controlling	C2587213
28010062	acidity	C0920750
28010062	intracellular	C0178719
28010062	compartments	C2349967
28010062	eukaryotes	C0684063
28010062	small-molecule	C1328819
28010062	modulators	C1254351
28010062	V-ATPase	C0379099
28010062	restricted	C0443288
28010062	targeting	C0599894
28010062	membranous	C0205287
28010062	subunit	C1711351
28010062	V-ATPase	C0379099
28010062	understood	C0162340
28010062	mechanisms	C0441712
28010062	Small molecules	C1328819
28010062	novel	C0205314
28010062	defined	C0442825
28010062	mechanisms	C0441712
28010062	inhibition	C1148560
28010062	needed	C0027552
28010062	functionally	C0205245
28010062	characterize	C1880022
28010062	V-ATPase	C0379099
28010062	therapeutic	C0302350
28010062	relevance	C2347946
28010062	V-ATPase	C0379099
28010062	human	C0086418
28010062	diseases	C0012634
28010062	electrophilic	C0205556
28010062	quinazolines	C0034407
28010062	covalently modify	C3158388
28010062	soluble	C1948047
28010062	catalytic subunit	C0600499
28010062	V-ATPase	C0379099
28010062	high	C0205250
28010062	potency	C3854080
28010062	proteomic selectivity	C0205556
28010062	revealed	C0443289
28010062	fluorescence imaging	C0430876
28010062	chemical proteomic activity-based profiling	C1327760
28010062	site	C0205145
28010062	modification	C0392747
28010062	mapped	C1283195
28010062	cysteine	C0010654
28010062	residue	C1709915
28010062	located in	C0332285
28010062	region	C1514562
28010062	V-ATPase	C0379099
28010062	subunit A	C0599220
28010062	thought	C0039869
28010062	regulate	C1327622
28010062	dissociation	C0301643
28010062	V-ATPase	C0379099
28010062	V-ATPase inhibitor	C0014432
28010062	3-bromopyruvate	C0054130
28010062	targets	C1521840
28010062	same	C0445247
28010062	cysteine	C0010654
28010062	residue	C1709915
28010062	electrophilic	C0205556
28010062	quinazolines	C0034407
28010062	modulate	C0443264
28010062	function	C0542341
28010062	V-ATPase	C0379099
28010062	cells	C0007634
28010062	well-defined	C0442825
28010062	mechanism	C0441712
28010062	action	C3266814
28010062	high	C0205250
28010062	proteomic specificity	C0037791
28010062	quinazolines	C0034407
28010062	powerful	C3854080
28010062	set	C1705195
28010062	chemical probes	C2347609
28010062	investigate	C1292732
28010062	physiological	C0205463
28010062	pathological	C1521733
28010062	roles	C1705810
28010062	V-ATPase	C0379099
28011044	Association	C0439849
28011044	Metabolic	C0311400
28011044	Tumor Volumes	C0475276
28011044	Radiation Treatment	C3871222
28011044	Glioblastoma Multiforme	C1621958
28011044	investigation	C0220825
28011044	associations	C0439849
28011044	imaging	C0011923
28011044	clinical target volumes	C0454198
28011044	CTVs	C0454198
28011044	metabolic	C0311400
28011044	tumor volumes	C0475276
28011044	MTVs	C0475276
28011044	features	C1521970
28011044	information	C1533716
28011044	CTVs	C0454198
28011044	volumes	C0475276
28011044	High-throughput extraction	C0872047
28011044	imaging	C0011923
28011044	metabolomic	C1328813
28011044	quantitative	C0392762
28011044	features	C1521970
28011044	magnetic resonance imaging	C0024485
28011044	MRI	C0024485
28011044	magnetic resonance spectroscopic imaging	C1522706
28011044	glioblastoma multiforme	C1621958
28011044	GBM	C1621958
28011044	patient	C0030705
28011044	radiation therapy	C3871222
28011044	GBM	C1621958
28011044	relevant	C2347946
28011044	metabolic	C0311400
28011044	tumor volumes	C0475276
28011044	MTVs	C0475276
28011044	aberrant	C0443127
28011044	levels	C0441889
28011044	N-acetyl aspartate	C0067684
28011044	NAA	C0067684
28011044	choline	C0008405
28011044	Cho	C0008405
28011044	clinical target volumes	C0454198
28011044	CTVs	C0454198
28011044	radiation therapy	C3871222
28011044	contrast-enhanced T1-weighted	C1707501
28011044	CE-T1w	C1707501
28011044	T2-weighted (T2w)/fluid-attenuated inversion recovery MRI	C3897397
28011044	Necrotic portions	C1334928
28011044	enhancing lesion	C3830314
28011044	edema	C0013604
28011044	CE-T1w	C1704254
28011044	T2w images	C1704254
28011044	GBM	C1621958
28011044	patients	C0030705
28011044	Clinical target volumes	C0454198
28011044	MTVs	C0475276
28011044	NAA	C0067684
28011044	MTVNAA	C0475276
28011044	Cho	C0008405
28011044	MTVCho	C0475276
28011044	Imaging	C0011923
28011044	metabolic features	C1864620
28011044	size	C0456389
28011044	shape	C0332479
28011044	signal intensities	C0871362
28011044	volumes	C0449468
28011044	Tumors	C0027651
28011044	semantic	C0036612
28011044	imaging traits	C2346469
28011044	neuroradiologist	C2985415
28011044	features	C1521970
28011044	investigated	C1292732
28011044	redundancy	C1313915
28011044	Two-way correlations	C1707520
28011044	imaging	C1704254
28011044	CTVs	C0454198
28011044	MTVs	C0475276
28011044	heatmaps	C2697572
28011044	Associations	C0439849
28011044	MTVNAA	C0475276
28011044	MTVCho	C0475276
28011044	imaging features	C2346469
28011044	Spearman correlation	C1710141
28011044	imaging features	C2346469
28011044	patient	C0030705
28011044	Half	C2825407
28011044	imaging traits	C2346469
28011044	replaced	C0559956
28011044	continuous variables	C0439828
28011044	features	C2346469
28011044	CTVs	C0454198
28011044	MTVs	C0475276
28011044	semantic	C0036612
28011044	imaging traits	C2346469
28011044	replaced	C0559956
28011044	continuous variables	C0439828
28011044	correlations	C1707520
28011044	imaging measures	C2346469
28011044	CTVs	C0454198
28011044	MTVNAA	C0475276
28011044	CTVs	C0454198
28011044	MTVCho	C0475276
28011044	MRI	C0024485
28011044	magnetic resonance spectroscopic imaging	C1522706
28011044	features	C1521970
28011044	CTVs	C0454198
28011044	MTVs	C0475276
28011044	MTV	C0475276
28011044	NAA	C0067684
28011044	associated with	C0332281
28011044	MRI	C0024485
28011044	volumes	C0449468
28011044	imaging features	C2346469
28011044	MTVCho	C0475276
28011044	Cho	C0008405
28011044	additional information	C1546922
28011044	imaging	C0011923
28011408	Measurement	C0242485
28011408	fidgeting	C0424235
28011408	patients	C0030705
28011408	anorexia nervosa	C0003125
28011408	shoe	C0036988
28011408	monitor	C0596972
28011408	seated	C4042775
28011408	non-exercise physical activity	C0026606
28011408	patients	C0030705
28011408	anorexia nervosa	C0003125
28011408	AN	C0003125
28011408	healthy controls	C2986479
28011408	HCs	C2986479
28011408	associations	C0439849
28011408	physical activity	C0026606
28011408	eating disorder	C0013473
28011408	pathology	C0677042
28011408	levels	C0441889
28011408	anxiety	C0003467
28011408	depression	C0011570
28011408	inpatients	C0021562
28011408	AN	C0003125
28011408	HCs	C2986479
28011408	shoe	C0036988
28011408	accelerometer	C0178951
28011408	SmartShoe	C0178951
28011408	time points	C1552717
28011408	while eating lunch	C2362314
28011408	filling out questionnaires	C2362314
28011408	watching television for 1h	C2362314
28011408	tasks	C3540678
28011408	patients	C0030705
28011408	AN	C0003125
28011408	more active	C0205177
28011408	HCs	C2986479
28011408	greater degree	C0449286
28011408	restless	C3887611
28011408	fidgeting	C0424235
28011408	behavior	C0004927
28011408	Degree	C0449286
28011408	physical activity	C0026606
28011408	positively correlated	C1514241
28011408	eating disorder	C0013473
28011408	psychopathology	C0033927
28011408	AN	C0003125
28011408	positive association	C1514241
28011408	physical activity	C0026606
28011408	levels	C0441889
28011408	depression	C0011570
28011408	anxiety	C0003467
28011408	individuals	C0237401
28011408	AN	C0003125
28011408	physical activity	C0026606
28011408	not	C1513916
28011408	correlated	C1707520
28011408	BMI	C1305855
28011408	duration of illness	C3176590
28011408	number of days	C3640790
28011408	hospital admission	C0184666
28011408	minimally invasive	C2711297
28011408	shoe	C0036988
28011408	monitor	C0596972
28011408	patients	C0030705
28011408	AN	C0003125
28011408	greater degree	C0449286
28011408	fidgeting	C0424235
28011408	HCs	C2986479
28011408	seated	C4042775
28011408	tasks	C3540678
28011408	activity	C0026606
28011408	measures	C0079809
28011408	pathology	C0677042
28011408	Non-exercise physical activity	C0026606
28011408	fidgeting	C0424235
28011408	clinical	C0205210
28011408	patient population	C0030705
28013377	Hospital clowning	C0018704
28013377	paediatrician's	C0237433
28013377	view	C0030971
28013377	study	C0681814
28013377	investigates	C1292732
28013377	current	C0521116
28013377	hospital clowns	C0335094
28013377	perspective	C0030971
28013377	paediatricians	C0237433
28013377	paediatric residents	C0259967
28013377	total	C0439810
28013377	attending paediatricians	C0237433
28013377	paediatric residents	C0259967
28013377	participated	C0679823
28013377	focus group sessions	C1883017
28013377	Data	C1511726
28013377	analysed	C0936012
28013377	Atlas.ti 5.0	C0037585
28013377	general	C0205246
28013377	physicians	C0031831
28013377	reported	C0684224
28013377	positive	C1446409
28013377	experiences	C0596545
28013377	interaction	C0037420
28013377	hospital clowns	C0335094
28013377	paediatric patients	C0030705
28013377	ward	C1305702
28013377	Physicians	C0031831
28013377	interested	C0543488
28013377	research	C0035168
28013377	children's perception	C3825851
28013377	hospital clowns	C0335094
28013377	research	C0035168
28013377	clinical efficacy	C3850123
28013377	hospital clowning	C0018704
28013377	No direct	C0205556
28013377	collaboration	C0282116
28013377	physicians	C0031831
28013377	hospital clowns	C0335094
28013377	reported	C0684224
28013377	physicians	C0031831
28013377	proposed	C1553874
28013377	conditions	C0348080
28013377	streamline	C0442799
28013377	encounters	C1947978
28013377	hospital clowns	C0335094
28013377	clear communication	C0009452
28013377	prior	C0332152
28013377	hospital clown	C0335094
28013377	visits	C1512346
28013377	condition	C0348080
28013377	visits	C0545082
28013377	impede	C0332454
28013377	medical interventions	C0184661
28013377	Overall	C1561607
28013377	paediatricians	C0237433
28013377	paediatric residents	C0259967
28013377	view	C0030971
28013377	positive	C1446409
28013377	impact	C4049986
28013377	paediatric patients	C0030705
28013377	important	C3898777
28013377	aspect	C1879746
28013377	hospital clown	C0335094
28013377	visits	C1512346
28013377	clinical efficacy	C3850123
28013377	hospital clowning	C0018704
28013377	hospital clowns	C0335094
28013377	worldwide	C2700280
28013377	article	C1706852
28013377	recommendations	C0034866
28013377	encounters	C1947978
28013377	paediatricians	C0237433
28013377	paediatric residents	C0259967
28013377	maintain	C0024501
28013377	optimal	C2698651
28013377	health care	C0086388
28013377	Previous	C0205156
28013377	studies	C0681814
28013377	clinically significant	C0750502
28013377	pain	C0030193
28013377	anxiety	C0003467
28013377	reducing effect	C1280500
28013377	hospital clowning	C0018704
28013377	paediatric patients	C0030705
28013377	admitted to hospitals	C0184666
28013377	undergoing	C0205556
28013377	invasive	C0205281
28013377	medical procedures	C0199171
28013377	paediatricians	C0237433
28013377	positive	C1446409
28013377	ideas	C1254370
28013377	hospital clowns	C0335094
28013377	personal prejudices	C0033023
28013377	novel	C0205314
28013377	study	C0681814
28013377	insight	C0233820
28013377	day-to-day	C1254367
28013377	interaction	C0037420
28013377	paediatricians	C0237433
28013377	hospital clowns	C0335094
28013377	ward	C1305702
28013377	study	C0681814
28013377	recommendations	C0034866
28013377	clinical practice	C0282451
28013377	encounters	C1947978
28013377	physicians	C0031831
28013377	hospital clowns	C0335094
28013377	hospital clown	C0335094
28013377	visits	C1512346
28019021	Multiparametric estimation	C1513748
28019021	brain hemodynamics	C4042806
28019021	MR fingerprinting ASL	C3891302
28019021	Assessment	C0220825
28019021	brain hemodynamics	C4042806
28019021	exogenous	C0205228
28019021	contrast agents	C0009924
28019021	increasing	C0442808
28019021	importance	C3898777
28019021	clinical applications	C0869019
28019021	MR perfusion technique	C4287652
28019021	noncontrast	C2825493
28019021	multiparametric estimation	C1513748
28019021	hemodynamic	C0019010
28019021	markers	C2745888
28019021	arterial spin labeling	C3891302
28019021	ASL	C3891302
28019021	MR fingerprinting	C0024485
28019021	MRF	C0024485
28019021	referred	C0205543
28019021	MRF-ASL	C3891302
28019021	information	C1533716
28019021	MRF sequence	C0024485
28019021	hemodynamic	C0019010
28019021	parameters	C0449381
28019021	estimated	C0750572
28019021	concomitantly	C0521115
28019021	Feasibility demonstration	C0015730
28019021	flip angle	C2348681
28019021	optimization	C2698650
28019021	comparison	C1707455
28019021	Look-Locker ASL	C3891302
28019021	reproducibility test	C1514863
28019021	sensitivity	C0332324
28019021	hypercapnia challenge	C0020440
28019021	clinical application	C0869019
28019021	intracranial steno-occlusive process	C0394264
28019021	Moyamoya disease	C0026654
28019021	performed	C0884358
28019021	technique	C0449851
28019021	Magnetic resonance fingerprinting ASL	C3891302
28019021	provided	C1999230
28019021	parameters	C0449381
28019021	B1+	C0392762
28019021	tissue	C0459385
28019021	T1	C2697938
28019021	cerebral blood flow	C0428714
28019021	CBF	C0428714
28019021	tissue	C0040300
28019021	bolus arrival time	C0243095
28019021	BAT	C0243095
28019021	arterial	C0003842
28019021	BAT	C0243095
28019021	blood volume	C0005850
28019021	blood travel time	C0919393
28019021	Coefficients	C1707429
28019021	variation	C0205419
28019021	estimated	C0750572
28019021	parameters	C0449381
28019021	Hypercapnia	C0020440
28019021	increase	C0442805
28019021	CBF	C0428714
28019021	decrease	C0547047
28019021	BAT	C0243095
28019021	tissue	C0040300
28019021	vessels	C0005847
28019021	Patients	C0030705
28019021	Moyamoya disease	C0026654
28019021	diminished	C0205216
28019021	CBF	C0428714
28019021	lengthened	C0392744
28019021	BAT	C0243095
28019021	could not be detected	C0442737
28019021	regular	C0205272
28019021	ASL	C3891302
28019021	Magnetic resonance fingerprinting ASL	C3891302
28019021	technique	C0449851
28019021	noncontrast	C2825493
28019021	multiparametric	C1513748
28019021	perfusion assessment	C4038600
28019021	International Society for Magnetic Resonance in Medicine	C0018720
28019706	Acute	C0205178
28019706	sensitivity	C0332324
28019706	vernal pool fairy shrimp	C2661017
28019706	Branchinecta lynchi	C2661017
28019706	Anostraca	C0998204
28019706	Branchinectidae	C1007142
28019706	surrogate	C4053457
28019706	species	C1705920
28019706	chemicals	C0220806
28019706	Vernal pool fairy shrimp	C2661017
28019706	Branchinecta lynchi	C2661017
28019706	Branchiopoda	C0596222
28019706	Anostraca	C0998204
28019706	fairy shrimp	C0998204
28019706	species	C1705920
28019706	threatened	C2717883
28019706	endangered	C2717882
28019706	data	C1511726
28019706	sensitivity	C0332324
28019706	Branchinecta	C1007143
28019706	spp.	C1705920
28019706	toxic effects	C0600688
28019706	contaminants	C2827365
28019706	adequately protected	C1031756
28019706	water quality	C0597680
28019706	criteria	C0243161
28019706	acute (24-h) lethality/immobilization tests	C0022885
28019706	species	C1705920
28019706	fairy shrimp	C0998204
28019706	B. lynchi	C2661017
28019706	Branchinecta lindahli	C1187775
28019706	Thamnocephalus platyurus	C1041123
28019706	chemicals	C0220806
28019706	toxic action	C1256754
28019706	ammonia	C0002607
28019706	potassium	C0032821
28019706	chloride	C0008203
28019706	sulfate	C0038720
28019706	chromium(VI)	C0008574
28019706	copper	C0009968
28019706	nickel	C0028013
28019706	zinc	C0043481
28019706	alachlor	C0051051
28019706	metolachlor	C0066468
28019706	chemicals	C0220806
28019706	h	C0439227
28019706	tests	C0022885
28019706	branchiopods	C0596222
28019706	cladocerans	C0446344
28019706	Daphnia magna	C1081963
28019706	Ceriodaphnia dubia	C1089376
28019706	amphipod	C0598804
28019706	Hyalella azteca	C1676520
28019706	h	C0439227
28019706	tests	C0022885
28019706	snails	C0037378
28019706	Physa gyrina	C0323946
28019706	Lymnaea stagnalis	C0323913
28019706	effect concentrations	C1446561
28019706	EC50s	C1446561
28019706	B. lynchi	C2661017
28019706	correlated	C1707520
28019706	EC50s	C1446561
28019706	fairy shrimp	C0998204
28019706	species	C1705920
28019706	T. platyurus	C1041123
28019706	chemicals	C0220806
28019706	Comparison	C1707455
28019706	EC50s	C1446561
28019706	fairy shrimp	C0998204
28019706	EC50s	C1446561
28019706	invertebrate taxa	C0021948
28019706	toxicity	C0600688
28019706	data	C1511726
28019706	fairy shrimp	C0998204
28019706	sensitive	C0332324
28019706	potassium	C0032821
28019706	trace metals	C0723796
28019706	compared	C1707455
28019706	invertebrate taxa	C0021948
28019706	cladocerans	C0446344
28019706	amphipods	C0598804
28019706	mussels	C0026871
28019706	toxicant	C0599787
28019706	sensitivity	C0332324
28019706	Interspecies correlation estimation models	C3161035
28019706	toxicity	C0600688
28019706	fairy shrimp	C0998204
28019706	surrogate	C4053457
28019706	species	C1705920
28019706	models	C3161035
28019706	cladocerans	C0446344
28019706	freshwater mussels	C0026871
28019706	surrogates	C4053457
28019706	sensitivity	C0332324
28019706	fairy shrimp	C0998204
28019706	contaminants	C2827365
28019706	studies	C2603343
28019706	fairy shrimp	C0998204
28019706	sensitive	C0332324
28019706	toxicants	C0599787
28019706	fairy shrimp	C0998204
28019706	genus Branchinecta	C1007143
28019706	sensitive	C0332324
28019706	fairy shrimp taxa	C0998204
28024592	Bi-layered constructs	C0005479
28024592	poly(glycerol-sebacate)	C1173093
28024592	β-tricalcium phosphate	C0106141
28024592	bone-soft tissue	C0541689
28024592	interface applications	C0205245
28024592	study	C2603343
28024592	protocol	C2348563
28024592	preparation	C1521827
28024592	bi-layered	C0205556
28024592	poly(glycerol-sebacate)	C1173093
28024592	PGS	C1173093
28024592	β-tricalcium phosphate	C0106141
28024592	β-TCP	C0106141
28024592	construct	C0005479
28024592	investigate	C1292732
28024592	bone-soft tissue	C0541689
28024592	engineering	C0596171
28024592	applications	C0205245
28024592	layered structure	C0678594
28024592	distributing	C1704711
28024592	ceramic	C0007742
28024592	particles	C0597177
28024592	prepolymer	C0597177
28024592	synthesized	C1883254
28024592	microwave reactor	C0336756
28024592	cross-linking	C0178576
28024592	construct	C0005479
28024592	vacuum	C0042221
28024592	vacuum	C0042221
28024592	stage	C1306673
28024592	separation	C0678621
28024592	cross-linked	C0178576
28024592	elastomer	C0013766
28024592	top	C1704458
28024592	ceramic	C0007742
28024592	bottom	C1511276
28024592	phases	C0205390
28024592	β-TCP	C0106141
28024592	particles	C0597177
28024592	elastomer matrix	C0013766
28024592	polymerization	C0314672
28024592	increase	C0442805
28024592	compression strength	C0376507
28024592	Tensile strength	C0039526
28024592	Young's modulus	C2350289
28024592	elongation at break	C0392762
28024592	PGS	C1173093
28024592	PGS	C1173093
28024592	β-TCP	C0106141
28024592	bi-layered constructs	C0005479
28024592	Morphology	C0678594
28024592	Scanning Electron Microscopy	C0026020
28024592	SEM	C0026020
28024592	micro-computed tomography	C2350281
28024592	μ-CT	C2350281
28024592	Tomography	C2350281
28024592	data	C1511726
28024592	open porosity	C0080037
28024592	construct	C0005479
28024592	ceramic phase	C0205390
28024592	elastomer	C0013766
28024592	side	C0441987
28024592	pore	C1254362
28024592	Homogeneous	C1881065
28024592	β-TCP	C0106141
28024592	distribution	C1704711
28024592	elastomeric structure	C0678594
28024592	Cell culture studies	C0681854
28024592	biocompatibility	C0596177
28024592	elastomer	C0013766
28024592	side	C0441987
28024592	bone	C0391978
28024592	side	C0441987
28024592	cell attachment	C0887869
28024592	investigate	C1292732
28024592	osteogenic	C0391978
28024592	properties	C0871161
28024592	construct	C0005479
28024592	BMP-2	C0527443
28024592	TGF-β1	C1704256
28024592	PGS	C1173093
28024592	β-TCP	C0106141
28024592	bi-layered constructs	C0005479
28024592	mechanical	C0205556
28024592	biological	C0205460
28024592	properties	C0871161
28024592	bone-soft tissue	C0541689
28024592	interface applications	C0205245
28024592	soft tissue	C0225317
28024592	penetration	C0205321
28024592	problem	C0033213
28024987	Effects of	C1704420
28024987	high-intensity training	C4277545
28024987	cardiovascular risk factors	C0850624
28024987	premenopausal	C0279752
28024987	postmenopausal	C0232970
28024987	women	C0043210
28024987	Menopause	C0025320
28024987	associated with	C0332281
28024987	increased	C0205217
28024987	cardiovascular disease	C0007222
28024987	factors	C1521761
28024987	loss	C1517945
28024987	estrogen	C0014939
28024987	hormonal milieu	C0019932
28024987	factors	C1521761
28024987	contribute	C1880177
28024987	deterioration	C0868945
28024987	cardiometabolic health	C0596675
28024987	postmenopausal	C0232970
28024987	women	C0043210
28024987	menopausal	C0025320
28024987	transition	C2700061
28024987	associated with	C0332281
28024987	increased	C0205217
28024987	age	C0001779
28024987	fat mass	C3656665
28024987	indications	C3146298
28024987	reduced	C0392756
28024987	cardiometabolic	C0596675
28024987	adaptations	C0392673
28024987	exercise	C0015259
28024987	postmenopausal	C0232970
28024987	women	C0043210
28024987	adverse	C0877248
28024987	health profile	C0018759
28024987	evaluate	C0220825
28024987	risk factors	C0035648
28024987	type 2 diabetes	C0011860
28024987	cardiovascular disease	C0007222
28024987	late	C0205087
28024987	premenopausal	C0279752
28024987	early	C1279919
28024987	postmenopausal	C0232970
28024987	women	C0043210
28024987	age	C0001779
28024987	body composition	C0005885
28024987	investigate	C1292732
28024987	high-intensity training	C4277545
28024987	high-intensity aerobic training	C4277545
28024987	intervention	C0184661
28024987	healthy	C3898900
28024987	nonobese	C0243095
28024987	late	C0205087
28024987	premenopausal	C0279752
28024987	early	C1279919
28024987	postmenopausal	C0232970
28024987	women	C0043210
28024987	anthropometrics	C2598145
28024987	body composition	C0005885
28024987	blood pressure	C0005823
28024987	lipid profile	C0850354
28024987	glucose tolerance	C0178665
28024987	maximal oxygen consumption	C0030055
28024987	baseline	C1442488
28024987	intervention	C0184661
28024987	baseline	C1442488
28024987	groups	C1257890
28024987	anthropometrics	C2598145
28024987	body composition	C0005885
28024987	age	C0001779
28024987	confidence limits	C0237530
28024987	menstrual period	C0025344
28024987	postmenopausal	C0232970
28024987	women	C0043210
28024987	confidecnce limits	C0237530
28024987	Hormonal levels	C1287355
28024987	estrogen	C0014939
28024987	follicle stimulation hormone	C0016774
28024987	luteinizing hormone	C0023607
28024987	menopausal status	C1513126
28024987	baseline	C1442488
28024987	postmenopausal	C0232970
28024987	women	C0043210
28024987	total cholesterol	C0543421
28024987	low-density lipoprotein-cholesterol	C0023824
28024987	high-density lipoprotein-cholesterol	C0023822
28024987	premenopausal	C0279752
28024987	women	C0043210
28024987	intervention	C0184661
28024987	reduced	C0392756
28024987	body weight	C0005910
28024987	waist circumference	C0455829
28024987	improved	C0184511
28024987	body composition	C0005885
28024987	increasing	C0442808
28024987	lean body mass	C0424678
28024987	decreasing	C0442797
28024987	fat mass	C3656665
28024987	groups	C1257890
28024987	lower diastolic blood pressure	C0277890
28024987	resting heart rate	C1821417
28024987	total cholesterol	C0543421
28024987	low-density lipoprotein-cholesterol	C0023824
28024987	total cholesterol	C0543421
28024987	high-density lipoprotein-cholesterol	C0023822
28024987	improved	C0184511
28024987	plasma insulin concentration	C1276042
28024987	oral glucose tolerance test	C0029161
28024987	groups	C1257890
28024987	Cardiovascular risk factors	C0850624
28024987	late	C0205087
28024987	premenopausal	C0279752
28024987	early	C1279919
28024987	postmenopausal	C0232970
28024987	women	C0043210
28024987	age	C0001779
28024987	body composition	C0005885
28024987	postmenopausal	C0232970
28024987	women	C0043210
28024987	high-	C0392885
28024987	low-density lipoprotein-cholesterol levels	C0202117
28024987	intervention	C0184661
28024987	high-intensity aerobic training	C4277545
28024987	risk factors	C0035648
28024987	type 2 .diabetes	C0011860
28024987	cardiovascular disease	C0007222
28024987	late	C0205087
28024987	premenopausal	C0279752
28024987	early	C1279919
28024987	postmenopausal	C0232970
28024987	women	C0043210
28025023	Correlation	C1707520
28025023	preoperative	C0445204
28025023	physical signs	C0311392
28025023	functional	C0205245
28025023	outcomes	C1274040
28025023	laminoplasty	C1535956
28025023	ossification of the posterior longitudinal ligament	C0206366
28025023	Ossification of the posterior longitudinal ligament	C0206366
28025023	OPLL	C0206366
28025023	myelopathy	C0005956
28025023	often	C0332183
28025023	managed	C0184516
28025023	surgically	C0543467
28025023	Knowledge	C0162340
28025023	predictors	C2698872
28025023	surgical	C0543467
28025023	outcomes	C0085415
28025023	provide	C1999230
28025023	decision support	C3242450
28025023	surgeons	C0582175
28025023	aims	C1947946
28025023	study	C0681814
28025023	investigate	C1292732
28025023	relationships	C0439849
28025023	preoperative	C0445204
28025023	physical signs	C0311392
28025023	postoperative	C0032790
28025023	functional	C0205245
28025023	outcomes	C1274040
28025023	patients	C0030705
28025023	OPLL	C0206366
28025023	clarify	C2986669
28025023	physical signs	C0311392
28025023	predict	C0681842
28025023	functional	C0205245
28025023	outcomes	C1274040
28025023	patients	C0030705
28025023	OPLL	C0206366
28025023	cervical laminoplasty	C2026796
28025023	included	C0332257
28025023	study	C0681814
28025023	physical signs	C0311392
28025023	hyperreflexia	C0151889
28025023	Babinski sign	C0034935
28025023	sensory disturbance	C0152027
28025023	grip strength	C0429271
28025023	10-s grip and release test	C0683443
28025023	bladder dysfunction	C0232841
28025023	factors	C1521761
28025023	age	C0001779
28025023	duration of symptoms	C0436359
28025023	minor trauma	C0555305
28025023	preoperative	C0445204
28025023	Japanese Orthopaedic Association (JOA) score	C0449820
28025023	investigated	C1292732
28025023	potential	C3245505
28025023	predictive	C0681890
28025023	prognostic factors	C1514474
28025023	univariate	C0683962
28025023	multivariate analyses	C0026777
28025023	mean	C0444504
28025023	recovery rate	C1521828
28025023	JOA score	C0449820
28025023	neurological	C0205494
28025023	recovery rate	C1521828
28025023	negatively	C0205160
28025023	associated with	C0332281
28025023	age	C0001779
28025023	duration of symptoms	C0436359
28025023	Babinski sign	C0034935
28025023	positively	C1446409
28025023	correlated	C1707520
28025023	grip strength	C0429271
28025023	Multiple logistic regression analyses	C0034980
28025023	revealed	C0443289
28025023	age	C0001779
28025023	Odds ratio	C0028873
28025023	CI	C0009667
28025023	Babinski sign	C0034935
28025023	Odds ratio	C0028873
28025023	CI	C0009667
28025023	factors	C1521761
28025023	associated with	C0332281
28025023	functional	C0205245
28025023	outcomes	C1274040
28025023	Satisfactory	C0205410
28025023	functional	C0205245
28025023	outcomes	C1274040
28025023	expected	C1517001
28025023	patients	C0030705
28025023	young	C0332239
28025023	Babinski sign	C0034935
28025023	Babinski sign	C0034935
28025023	useful	C3827682
28025023	indicator	C1522602
28025023	window of opportunity	C0205556
28025023	achieving	C0205556
28025023	satisfactory	C0205410
28025023	functional	C0205245
28025023	outcomes	C1274040
28025224	Bacteria	C0004611
28025224	Hoverflies	C1005241
28025224	Diptera	C0012578
28025224	Syrphidae	C1005241
28025224	Tree Hollows	C0927234
28025224	Iberian Mediterranean Forest	C0086312
28025224	Saproxylic insect communities	C0021585
28025224	inhabiting	C0337646
28025224	tree hollows	C0927234
28025224	Mediterranean forests	C0086312
28025224	physical characteristics	C1521970
28025224	interactions	C1704675
28025224	community member species	C1705920
28025224	organisms	C0029235
28025224	interrelationships	C0439849
28025224	relationships	C0439849
28025224	saproxylic insects	C0021585
28025224	microbiota	C3887843
28025224	microhabitats	C0871648
28025224	tree hollows	C0927234
28025224	Quercus rotundifolia Lamark	C3457247
28025224	hold water	C0205245
28025224	dead leaves	C0242724
28025224	abundant microbial populations	C0599840
28025224	larvae	C0023047
28025224	Mallota dusmeti	C3900907
28025224	Diptera	C0012578
28025224	Syrphidae	C1005241
28025224	vulnerable species	C1705920
28025224	IUCN category	C0683312
28025224	Marcos-García	C0027361
28025224	Quinto	C0027361
28025224	microbiota	C3887843
28025224	living inside	C0337646
28025224	gut	C0699819
28025224	larvae	C0023047
28025224	M. dusmeti	C3900907
28025224	microbiota	C3887843
28025224	hollow	C0332484
28025224	larvae	C0023047
28025224	develop	C0243107
28025224	Bacteria	C0004611
28025224	amplification and partial sequencing	C1441475
28025224	V1-V3 regions	C0598666
28025224	nucleotide sequence	C0004793
28025224	16S rRNA genes	C3537372
28025224	species of bacteria	C0004611
28025224	living in	C0337646
28025224	tree hollows	C0927234
28025224	species	C1705920
28025224	in the gut	C0699819
28025224	M. dusmeti	C3900907
28025224	larvae	C0023047
28025224	Bacillus cereus	C0004590
28025224	Bacillus toyonensis	C3715367
28025224	Lysinibacillus sphaericus	C0314884
28025224	filter-feeding mechanism characteristic	C0243095
28025224	M. dusmeti	C3900907
28025224	larvae	C0023047
28025224	ingestion	C0232478
28025224	bacteria	C0004611
28026207	Impact sports	C0038039
28026207	bone fractures	C0016658
28026207	adolescents	C0205653
28026207	study	C2603343
28026207	investigate	C1292732
28026207	effects of	C1704420
28026207	different	C1705242
28026207	sports	C0038039
28026207	stress fractures	C0016664
28026207	adolescents	C0205653
28026207	month	C0439231
28026207	follow-up	C1522577
28026207	period	C1948053
28026207	sample	C1257890
28026207	adolescents	C0205653
28026207	groups	C1257890
28026207	impact sports	C0038039
28026207	swimming	C0039003
28026207	non-sports	C0038039
28026207	occurrence	C2745955
28026207	stress fracture	C0016664
28026207	participants	C0679646
28026207	coaches	C0876909
28026207	confounders	C0009673
28026207	age	C0001779
28026207	sex	C1522384
28026207	resistance training	C0872279
28026207	body composition	C0005885
28026207	variables	C0439828
28026207	age	C0001779
28026207	peak	C0444505
28026207	height velocity	C0439830
28026207	adolescents	C0205653
28026207	fractures	C0016658
28026207	month	C0439231
28026207	period	C1948053
28026207	Bone mineral density	C0005938
28026207	values	C0042295
28026207	adolescents	C0205653
28026207	impact sports	C0038039
28026207	P-value	C1709380
28026207	confounders	C0009673
28026207	risk	C0035647
28026207	stress fracture	C0016664
28026207	adolescents	C0205653
28026207	impact sports	C0038039
28026207	non-active adolescents	C0205653
28026207	hazard ratio	C2985465
28026207	HR	C2985465
28026207	confidence interval	C0009667
28026207	CI	C0009667
28026207	swimming	C0039003
28026207	practice	C0032893
28026207	risk	C0035647
28026207	fracture	C0016658
28026207	HR	C2985465
28026207	CI	C0009667
28026207	findings	C0243095
28026207	study	C2603343
28026207	sports	C0038039
28026207	participation	C0679823
28026207	adolescents	C0205653
28026207	reduction	C0392756
28026207	stress fracture	C0016664
28026207	risk	C0035647
28026207	impact sports	C0038039
28026207	results	C1274040
28026207	relevant	C2347946
28026207	adolescents	C0205653
28026207	peak	C0444505
28026207	bone mass	C0005938
28026207	increased	C0205217
28026207	risk	C0035647
28026207	fractures	C0016658
28027163	Business	C0680840
28027163	Health Physics	C0018725
28027163	Jobs	C0028811
28027163	Changing Market	C0024825
28027163	health physics	C0018725
28027163	profession	C0028811
28027163	radioactive materials	C0182598
28027163	commonplace	C0205214
28027163	technological advancements	C0681519
28027163	industrial complex	C0439855
28027163	World War II	C0681710
28027163	radiation safety	C3825766
28027163	unprecedented scale	C0349674
28027163	protective measures against radiation	C3494257
28027163	laboratories	C0022877
28027163	health physicists	C0334722
28027163	protecting people	C0034533
28027163	environment	C0242228
28027163	medical	C0199168
28027163	research	C0035168
28027163	industrial	C0021267
28027163	use of radioactive materials	C4060843
28027163	radiation-generating devices	C2094479
28027163	prevalent today	C0205391
28027163	Radiation doses	C4019308
28027163	airline flights	C0001881
28027163	medical procedures	C0199171
28027163	Radiation	C0851346
28027163	integral to numerous applications	C0205245
28027163	medicine	C0025118
28027163	dentistry	C0011438
28027163	manufacturing	C0682029
28027163	scientific research	C0683933
28027163	nuclear electric power generation	C0242446
28027163	oil and gas exploration	C3179122
28027163	routine	C0205547
28027163	scripted	C0871893
28027163	higher doses	C4019308
28027163	health effects	C4060919
28027163	understood and avoided	C0205245
28027163	Instruments for the detection and measurement of radiation	C3873809
28027163	health physics	C0018725
28027163	exposures to radiation	C0015333
28027163	radioactive materials	C0182598
28027163	effectively managed	C0024679
28027163	rapid rate	C1521828
28027163	creation	C1706214
28027163	jobs	C0028811
28027163	opportunities in the profession	C1516834
28027163	recommendations	C0034866
28027163	disappearing specialties	C1273796
28032366	Permanence	C0547050
28032366	Defended	C0680227
28032366	donation	C0282366
28032366	circulatory-respiratory determination of death	C0079221
28032366	DCDD	C0079221
28032366	dead	C0011065
28032366	donor	C0029206
28032366	rule	C0870077
28032366	requires	C0027552
28032366	donor	C0029206
28032366	dead	C0011065
28032366	before	C0332152
28032366	organ procurement	C0029210
28032366	relevant limb	C2347946
28032366	Uniform Determination of Death Act 1981 (USA)	C1947938
28032366	person	C0027361
28032366	dead	C0011065
28032366	cessation	C1880019
28032366	circulatory-respiratory function	C0542341
28032366	irreversible	C0243095
28032366	Critics	C0335034
28032366	current	C0521116
28032366	practice	C0237607
28032366	DCDD	C0079221
28032366	argued	C0680226
28032366	donor	C0029206
28032366	dead	C0011065
28032366	time	C0040223
28032366	organs	C0178784
28032366	procured	C0029210
28032366	procurement of organs	C0029210
28032366	donors	C0029206
28032366	dead	C0011065
28032366	donor	C0029206
28032366	rule	C0870077
28032366	offer	C1444648
28032366	new	C0205314
28032366	argument	C0680226
28032366	defence	C0680227
28032366	current	C0521116
28032366	DCDD	C0079221
28032366	practice	C0237607
28032366	interpretation	C0459471
28032366	requirement	C1514873
28032366	irreversibility	C0243095
28032366	permanence	C0547050
28033725	Untypeable	C0205370
28033725	hepatitis C virus	C0220847
28033725	subtypes	C0449560
28033725	Pakistan	C0030211
28033725	Diagnostically	C0348026
28033725	untypeable	C0205370
28033725	subtypes	C0449560
28033725	hepatitis C virus	C0220847
28033725	HCV	C0220847
28033725	subtypes	C0449560
28033725	Pakistan	C0030211
28033725	study	C2603343
28033725	chronically infected	C0151317
28033725	HCV	C0220847
28033725	patients	C0030705
28033725	viremia	C0042749
28033725	HCV	C0220847
28033725	genotyping	C2368152
28033725	samples	C2347026
28033725	typeable	C0205309
28033725	diagnostically	C0348026
28033725	untypeable	C0205370
28033725	conclusion	C1707478
28033725	untypeable	C0205370
28033725	HCV	C0220847
28033725	subtypes	C0449560
28033725	type	C0332307
28033725	specific	C0205369
28033725	genotyping	C2368152
28033725	assay	C0005507
28033725	primers	C0206416
28033725	rare	C0522498
28033725	subtypes	C0449560
28033725	minimize	C0392756
28033725	untypeable	C0205370
28033725	HCV	C0220847
28033725	subtypes	C0449560
28036301	ITPR3 gene	C1416519
28036301	haplotype	C0018591
28036301	cervical squamous cell carcinoma	C0279671
28036301	risk	C0035647
28036301	Taiwanese	C1556096
28036301	women	C0043210
28036301	Host immunogenetic	C0021005
28036301	human papillomavirus (HPV) infection	C0343641
28036301	cervical cancer development	C1516170
28036301	Inositol 1,4,5-triphosphate receptor type 3	C1416519
28036301	ITPR3	C1416519
28036301	immune activation	C1155000
28036301	cancer	C0006826
28036301	pathogenesis	C0699748
28036301	ITPR3	C1416519
28036301	genetic polymorphisms	C0032529
28036301	risk of cervical cancer	C0596244
28036301	Taiwanese	C1556096
28036301	women	C0043210
28036301	ITPR3	C1416519
28036301	rs3748079 A/G	C0752046
28036301	rs2229634 C/T polymorphisms	C0752046
28036301	genotyped	C0017431
28036301	hospital-based study	C2603343
28036301	women	C0043210
28036301	cervical squamous cell carcinoma	C0279671
28036301	CSCC	C0279671
28036301	healthy control	C2986479
28036301	women	C0043210
28036301	genotypes	C0017431
28036301	HPV	C0021344
28036301	CSCC	C0279671
28036301	ITPR3	C1416519
28036301	variants	C0678941
28036301	CSCC	C0279671
28036301	HPV-16 positive	C4288937
28036301	CSCC	C0279671
28036301	haplotype AT	C0018591
28036301	CSCC	C0279671
28036301	OR	C0028873
28036301	CI	C0009667
28036301	OR	C0028873
28036301	CSCC	C0279671
28036301	patients infected	C0030705
28036301	HPV-16	C0999806
28036301	OR	C0028873
28036301	CI	C0009667
28036301	linkage disequilibrium analysis	C1517888
28036301	ITPR3	C1416519
28036301	association	C2717881
28036301	CSCC	C0279671
28036301	HLA-DRB1	C1415576
28036301	alleles	C0002085
28036301	AT haplotype	C0018591
28036301	ITPR3 gene	C1416519
28036301	potential marker	C0017393
28036301	genetic susceptibility	C0314657
28036301	CSCC	C0279671
28039284	categories	C0683312
28039284	actionability	C0441655
28039284	secondary	C0175668
28039284	findings	C0243095
28039284	next-generation sequencing	C0162801
28039284	Next-generation sequencing	C0162801
28039284	clinical practice	C0205897
28039284	diagnosis	C0011900
28039284	Mendelian diseases	C1285355
28039284	secondary	C0175668
28039284	findings	C0243095
28039284	technique	C0449851
28039284	informing patients	C0588446
28039284	secondary	C0175668
28039284	findings	C0243095
28039284	patients	C0030705
28039284	research	C0035168
28039284	implementation	C1708476
28039284	actionability	C0441655
28039284	disclosure	C0012625
28039284	secondary	C0175668
28039284	findings	C0243095
28039284	interpretation	C0459471
28039284	professionals	C0679924
28039284	actionability	C0441655
28039284	medical	C0205476
28039284	actions	C3266814
28039284	patient	C0030705
28039284	health-related actions	C0237121
28039284	life-plan decisions	C0679006
28039284	actionability	C0441655
28039284	mutation	C0026882
28039284	gene	C0017337
28039284	patients	C0030705
28039284	secondary	C0175668
28039284	findings	C0243095
28039284	physician	C0031831
28039284	impression	C1998467
28039284	patients	C0030705
28039284	variants	C0678941
28039284	clinical significance	C2826293
28039284	genes	C0017337
28039284	autonomy	C0085862
28039284	conclusions	C1707478
28039284	information	C1533716
28039304	Allergen	C0002092
28039304	Valency	C0392762
28039304	Dose	C0178602
28039304	FcεRI	C0162825
28039304	Occupancy	C2827063
28039304	Thresholds	C0449864
28039304	Secretory Responses	C1327439
28039304	Pen a 1	C0531911
28039304	Design	C1707689
28039304	Hypoallergens	C0002092
28039304	Ag	C0037125
28039304	crosslinking	C0178576
28039304	IgE	C0020846
28039304	FcεRI	C0162825
28039304	complexes	C0003313
28039304	mast cells	C0024880
28039304	basophils	C0004827
28039304	allergic response	C1527304
28039304	self-reported	C0681906
28039304	shrimp allergy	C1628514
28039304	shrimp-specific IgE	C1270759
28039304	serum	C0229671
28039304	basophil	C0004827
28039304	secretory	C1327616
28039304	responses	C0003261
28039304	rPen a 1	C2924509
28039304	shrimp	C0037017
28039304	tropomyosin	C0041197
28039304	FcεRI	C0162825
28039304	allergen-specific IgE	C0443736
28039304	dose	C0178602
28039304	valency	C0392762
28039304	Pen a 1	C0531911
28039304	clustered regularly interspaced palindromic repeat-based gene editing	C4277689
28039304	FcεRIα	C0162825
28039304	Pen a 1	C0531911
28039304	specific IgE	C0443736
28039304	shrimp	C0037017
28039304	positive	C1514241
28039304	plasma	C0032105
28039304	Pen a 1	C0531911
28039304	specific IgE	C0443736
28039304	Pen a 1	C0531911
28039304	dose	C0178602
28039304	response for secretion	C3155125
28039304	Pen a 1	C0531911
28039304	doses	C0178602
28039304	Mathematical modeling	C0876936
28039304	receptor aggregation	C0034780
28039304	kinetics	C0022702
28039304	FcεRI	C0162825
28039304	IgE	C0020846
28039304	allergen	C0002092
28039304	dose	C0178602
28039304	gE	C1270759
28039304	FcεRI	C0162825
28039304	complexes	C0003313
28039304	specific IgE	C1270759
28039304	Pen a 1	C0531911
28039304	IgE	C1270759
28039304	epitope	C0003316
28039304	valency	C0392762
28039304	FcεRI	C0162825
28039304	pepsin	C0030909
28039304	Pen a 1	C0531911
28039304	proteolysis	C0597304
28039304	gastric	C1704242
28039304	digestion	C0012238
28039304	secretory responses	C1327439
28039304	Recombinant fragments	C0599286
28039304	tropomyosin	C0041197
28039304	dimerization	C1323329
28039304	capacity	C1516240
28039304	Pen a 1	C0531911
28039304	IgE	C1270759
28039304	FcεRI	C0162825
28039304	complexes	C0003313
28039304	hypoallergens	C0002092
28039304	immunotherapy	C0021083
28043654	Selected	C1707391
28043654	flavonoid compounds	C0596577
28043654	inhibitors	C0243077
28043654	protein kinase	C0108555
28043654	CK2α	C1173607
28043654	CK2α'	C1449828
28043654	catalytic subunits	C0600499
28043654	CK2	C0108555
28043654	CK2	C0108555
28043654	protein kinase	C0108555
28043654	cell functions	C0007613
28043654	years	C0439234
28043654	target	C1521840
28043654	cancer research	C1516225
28043654	flavonoid compounds	C0596577
28043654	tested	C0039593
28043654	inhibitors	C0243077
28043654	protein kinase	C0108555
28043654	CK2	C0108555
28043654	substances	C0439861
28043654	highly	C0205250
28043654	active against	C3858674
28043654	catalytic subunits	C0600499
28043654	IC50	C0600495
28043654	values	C0042295
28043654	CK2α'	C1449828
28043654	inhibitor	C0243077
28043654	identified	C0205396
28043654	chrysoeriol	C0602970
28043654	IC50	C0600495
28043654	values	C0042295
28043654	CK2α	C1173607
28043654	CK2α'	C1449828
28044140	Fibrinogen	C0016006
28044140	Marker	C0005516
28044140	Diabetic Foot Ulcer	C1456868
28044140	Severity	C0392364
28044140	examine	C0220825
28044140	fibrinogen levels	C1318051
28044140	biomarker	C0005516
28044140	assessing	C0220825
28044140	disease severity	C0521117
28044140	monitoring	C1283169
28044140	disease progression	C0242656
28044140	patients	C0030705
28044140	diabetic foot ulcer	C1456868
28044140	DFU	C1456868
28044140	retrospective study	C0035363
28044140	utility	C0457083
28044140	fibrinogen	C0016006
28044140	disease severity	C0521117
28044140	patients	C0030705
28044140	DFU	C1456868
28044140	admitted	C0809949
28044140	hospital	C0019994
28044140	January	C3829466
28044140	January	C3829466
28044140	patients	C0030705
28044140	DFU	C1456868
28044140	study group	C0681860
28044140	gender	C0079399
28044140	people	C0030705
28044140	diabetes	C0011849
28044140	DFU	C1456868
28044140	control group	C0009932
28044140	DFU	C1456868
28044140	severity	C0392364
28044140	Patients	C0030705
28044140	DFU	C1456868
28044140	subgroups	C1515021
28044140	fibrinogen values	C1318051
28044140	significantly higher	C4055637
28044140	patients	C0030705
28044140	DFU	C1456868
28044140	grade	C0441800
28044140	DFU	C1456868
28044140	grades	C0441800
28044140	ROC statistic	C0034772
28044140	cut-off value	C1522609
28044140	amputation	C0002688
28044140	sensitivity	C0036667
28044140	specificity	C0037791
28044140	positive predictive value	C1514243
28044140	PPV	C1514243
28044140	negative predictive value	C1513918
28044140	Fibrinogen values	C1318051
28044140	CRP levels	C0428528
28044140	neutrophil	C0200633
28044140	WBC count	C0023508
28044140	Fibrinogen levels	C1318051
28044140	assessing	C0220825
28044140	disease severity	C0521117
28044140	monitoring	C1283169
28044140	disease progression	C0242656
28044140	patients	C0030705
28044140	DFU	C1456868
28046142	Nitrogen utilization	C1158469
28046142	efficiency	C0013682
28046142	prediction	C0681842
28046142	nitrogen	C0028158
28046142	excretion	C0221102
28046142	sheep	C0036945
28046142	offered	C1444648
28046142	fresh perennial ryegrass	C0331558
28046142	Nitrogen	C0028158
28046142	excretion	C0221102
28046142	sheep	C0036945
28046142	production systems	C0557759
28046142	nitrate	C0699857
28046142	ammonia	C0002607
28046142	nitrous oxide	C0028215
28046142	groundwater	C0596631
28046142	pollution	C0392355
28046142	global warming	C0206217
28046142	study	C2603343
28046142	identify	C0205396
28046142	key parameters	C1706198
28046142	N utilization	C1158469
28046142	efficiency	C0013682
28046142	prediction	C0681842
28046142	equations	C0552449
28046142	manure	C0024765
28046142	N	C0028158
28046142	feces	C0015733
28046142	N	C0028158
28046142	urine	C0042036
28046142	N	C0028158
28046142	outputs	C1709366
28046142	sheep	C0036945
28046142	Data	C1511726
28046142	sheep	C0036945
28046142	offered	C1444648
28046142	fresh perennial ryegrass	C0331558
28046142	sole diet	C0012155
28046142	metabolism	C0025519
28046142	experiments	C0681814
28046142	data	C1511726
28046142	non-grass-only diets	C0012155
28046142	not used	C0445107
28046142	Sheep	C0036945
28046142	breeds	C1704650
28046142	Highlander	C0027361
28046142	Texel	C1297013
28046142	Scottish Blackface	C0324108
28046142	Swaledale	C1296242
28046142	age	C0001779
28046142	mo	C0439231
28046142	Herbage	C0242775
28046142	harvested	C1522240
28046142	daily	C0332173
28046142	swards	C2700402
28046142	harvest	C1522240
28046142	dates	C0011008
28046142	offering	C1444648
28046142	variation	C0205419
28046142	range	C1514721
28046142	offered	C1444648
28046142	farm situations	C0557759
28046142	study	C2603343
28046142	experimental	C1517586
28046142	sward	C2700402
28046142	harvested	C1522240
28046142	residual height	C0489786
28046142	grow	C0018270
28046142	wk	C0439230
28046142	target	C1521840
28046142	sward	C2700402
28046142	height	C0489786
28046142	range	C1514721
28046142	depending	C3244310
28046142	time of year	C0556970
28046142	Sheep	C0036945
28046142	housed	C0557759
28046142	d	C0439228
28046142	transferred to	C4049693
28046142	metabolism	C0025519
28046142	d	C0439228
28046142	feed	C3853577
28046142	intake	C1512806
28046142	feces	C0015733
28046142	urine	C0042036
28046142	outputs	C1709366
28046142	Data	C1511726
28046142	analyzed	C0936012
28046142	linear mixed model procedure	C0023732
28046142	prediction	C0681842
28046142	equations	C0552449
28046142	feces	C0015733
28046142	urine	C0042036
28046142	manure	C0024765
28046142	N	C0028158
28046142	outputs	C1709366
28046142	N intake	C0556048
28046142	herbage	C0242775
28046142	chemical composition	C0243176
28046142	digestibility	C1522240
28046142	effects of	C1704420
28046142	sex	C0079399
28046142	breed	C1704650
28046142	periods	C1948053
28046142	removed	C0849355
28046142	Nitrogen	C0028158
28046142	intake	C1512806
28046142	best	C1522427
28046142	single predictor	C2698872
28046142	N	C0028158
28046142	output	C1709366
28046142	feces	C0015733
28046142	urine	C0042036
28046142	manure	C0024765
28046142	prediction	C0681842
28046142	manure	C0024765
28046142	N	C0028158
28046142	output	C1709366
28046142	greater	C1704243
28046142	feces	C0015733
28046142	N	C0028158
28046142	urine	C0042036
28046142	N	C0028158
28046142	Animal	C0003062
28046142	BW	C0005910
28046142	herbage	C0242775
28046142	DM	C0439861
28046142	ether extract	C0457929
28046142	NDF	C0012173
28046142	ADF	C0012173
28046142	water soluble carbohydrate	C0201929
28046142	N	C0028158
28046142	digestibility	C1522240
28046142	predict	C0681842
28046142	N	C0028158
28046142	outputs	C1709366
28046142	N	C0028158
28046142	intake	C1512806
28046142	not be available	C0686905
28046142	commercial practice	C0009433
28046142	prediction	C0681842
28046142	equations	C0552449
28046142	N utilizatio	C1158469
28046142	efficiency	C0013682
28046142	increasing	C0442808
28046142	feeding	C2987508
28046142	level	C0441889
28046142	ME	C1442080
28046142	concentration	C1446561
28046142	reducing	C0392756
28046142	N concentration	C0456228
28046142	improve	C0184511
28046142	N utilization	C1158469
28046142	efficiency	C0013682
28046142	N	C0028158
28046142	excretion	C0221102
28046142	feces	C0015733
28046142	rather than	C3897775
28046142	urine	C0042036
28046142	equations	C0552449
28046142	study	C2603343
28046142	approach	C0449445
28046142	sheep	C0036945
28046142	producers	C1709696
28046142	quantify	C1709793
28046142	N	C0028158
28046142	excretion	C0221102
28046142	production	C0033268
28046142	mitigation strategies	C0035171
28046142	reduce	C0392756
28046142	environmental impact	C0282165
28046142	sheep	C0036945
28046142	production systems	C0557759
28049415	Improving	C1272745
28049415	protein complex	C1180347
28049415	prediction	C0681842
28049415	reconstructing	C0282574
28049415	high-confidence	C1704725
28049415	protein-protein interaction network	C3178902
28049415	Escherichia coli	C0014834
28049415	physical interaction	C1704675
28049415	data sources	C0011001
28049415	protein-protein physical interaction	C0872079
28049415	PPI	C0872079
28049415	datasets	C0150098
28049415	Escherichia coli	C0014834
28049415	methodology	C3266812
28049415	integrate	C1705422
28049415	datasets	C0150098
28049415	modules	C1709061
28049415	biological process	C3714634
28049415	protein complexes	C1180347
28049415	Naïve Bayesian formula	C0489829
28049415	integrate	C1705422
28049415	PPI	C0872079
28049415	datasets	C0150098
28049415	weighted	C0043100
28049415	PPI network	C3178902
28049415	weights	C0043100
28049415	network	C1882071
28049415	methodology	C3266812
28049415	integrate	C1705422
28049415	physical PPI	C0872079
28049415	datasets	C0150098
28049415	weighted	C0043100
28049415	PPI network	C3178902
28049415	detected	C0442726
28049415	modules	C1709061
28049415	PPI network	C3178902
28049415	functional	C0205245
28049415	modules	C1709061
28049415	co-expression	C0185117
28049415	modules	C1709061
28049415	functional	C0205245
28049415	modules	C1709061
28049415	functional	C0205245
28049415	modules	C1709061
28049415	detected	C0442726
28049415	Gene Ontology	C1138831
28049415	terms	C1254370
28049415	dataset	C0150098
28049415	integrating	C1705422
28049415	methodology	C3266812
28049415	physical PPI	C0872079
28049415	datasets	C0150098
28049415	orthologous	C1709346
28049415	high-confidence	C1704725
28049415	interactions	C1704675
28049415	organism	C0029235
28049415	AP-MS	C0037813
28049415	PPI	C0872079
28049415	datasets	C0150098
28049415	gained high weights	C0043094
28049415	integrated	C1705422
28049415	networks	C1882071
28049415	weights	C0043100
28049415	AP-MS	C0037813
28049415	PPI	C0872079
28049415	dataset	C0150098
28049415	datasets	C0150098
28049415	public databases	C0242356
28049415	detected	C0442726
28049415	modules	C1709061
28049415	hub protein(s)	C3179452
28049415	protein	C0033684
28049415	modules	C1709061
28049415	detected	C0442726
28049415	functionally	C0205245
28049415	relevant	C2347946
28049415	construct	C2827421
28049415	protein complexes	C1180347
28049415	high confidence	C1704725
28049415	protein complex	C1180347
28049415	prediction	C0681842
28049415	functional	C0205245
28049415	literature	C0023866
28053186	AAV9	C1564874
28053186	NPC1	C1417776
28053186	significantly	C0750502
28053186	ameliorates	C0243095
28053186	Purkinje cell	C0034143
28053186	death	C0007587
28053186	behavioral abnormalities	C0233514
28053186	mouse	C0025929
28053186	NPC disease	C0220756
28053186	Niemann-Pick type C (NPC) disease	C0220756
28053186	fatal	C1302234
28053186	inherited	C0439660
28053186	neurodegenerative disorder	C0524851
28053186	loss-of-function	C0243095
28053186	mutations	C0026882
28053186	NPC1	C1417776
28053186	NPC2 gene	C1422736
28053186	treat	C1292734
28053186	NPC disease	C0220756
28053186	adeno-associated virus	C1564874
28053186	AAV	C1564874
28053186	serotype 9	C0449943
28053186	AAV9	C1564874
28053186	functional	C0205245
28053186	NPC1 gene	C1417776
28053186	systemically	C0205373
28053186	NPC1(-/-)	C1417776
28053186	mice	C0206745
28053186	postnatal day 4	C0419611
28053186	single	C0205171
28053186	AAV9-NPC1 injection	C0021485
28053186	robust	C2986815
28053186	NPC1	C1417776
28053186	expression	C0017262
28053186	tissues	C0040300
28053186	brain	C0006104
28053186	heart	C0018787
28053186	lung	C0024109
28053186	AAV9-mediated	C0086597
28053186	NPC1 delivery	C1524066
28053186	significantly	C0750502
28053186	promoted	C0033414
28053186	Purkinje cell	C0034143
28053186	survival	C0038952
28053186	locomotor activity	C0023946
28053186	coordination	C0237543
28053186	increased	C0205217
28053186	lifespan	C1254367
28053186	NPC1(-/-)	C1417776
28053186	mice	C0206745
28053186	AAV-based gene therapy	C0860404
28053186	treat	C1292734
28053186	NPC disease	C0220756
28055142	Executive functions	C0935584
28055142	deficits	C2987487
28055142	impair	C0221099
28055142	extinction	C0015347
28055142	generalization	C0017324
28055142	fear	C0015726
28055142	movement-related pain	C0240386
28055142	Generalization	C0017324
28055142	fear	C0015726
28055142	movement-related pain	C0240386
28055142	movements	C0026649
28055142	fear responses	C1327613
28055142	movements	C0026649
28055142	associated with	C0332281
28055142	pain	C0030193
28055142	peak-shift effect	C1280500
28055142	phenomenon	C1882365
28055142	movements	C0026649
28055142	elicit	C0449265
28055142	fear responses	C1327613
28055142	pain-provoking	C1960719
28055142	movement	C0026649
28055142	CS+	C0234404
28055142	CS+	C0234404
28055142	variance	C1711260
28055142	generalize	C0017324
28055142	extinction learning	C0237613
28055142	movements	C0026649
28055142	pain	C0030193
28055142	variance	C1711260
28055142	associated with	C0332281
28055142	executive function capacity	C0935584
28055142	individuals	C0237401
28055142	inhibit fear responses	C3894332
28055142	examined	C0332128
28055142	executive function capacity	C0935584
28055142	generalization	C0017324
28055142	extinction	C0015347
28055142	generalization	C0017324
28055142	peak-shift	C0333051
28055142	conditioned fear	C1510535
28055142	movement-related pain	C0240386
28055142	expectancy	C0679138
28055142	Healthy participants	C1708335
28055142	proprioceptive	C2370956
28055142	fear conditioning task	C0009647
28055142	Executive function tests	C0935584
28055142	updating	C1519814
28055142	inhibition	C0021467
28055142	extinction	C0015347
28055142	fear	C0015726
28055142	movement-related pain	C0240386
28055142	pain	C0030193
28055142	expectancy	C0679138
28055142	generalization	C0017324
28055142	Low inhibitory capacity	C0021467
28055142	associated with	C0332281
28055142	extinction	C0015347
28055142	generalized fear	C0015726
28055142	movement-related pain	C0240386
28055142	pain	C0030193
28055142	expectancy	C0679138
28055142	area-shift	C0333051
28055142	peak-shift effect	C1280500
28055142	peak	C0444505
28055142	conditioned fear response	C1327613
28055142	stimulus	C0234402
28055142	Participants	C0679646
28055142	inhibitory capacity	C0021467
28055142	fear responses	C1327613
28055142	generalized fear	C0015726
28055142	time	C0040223
28055142	findings	C0243095
28055142	treatments	C1522326
28055142	Low inhibitory capacity	C0021467
28055142	associated with	C0332281
28055142	generalization	C0017324
28055142	extinction	C0015347
28055142	fear	C0015726
28055142	generalization	C0017324
28055142	Fear	C0015726
28055142	elicited by	C0449265
28055142	movement	C0026649
28055142	CS+/-	C0234404
28055142	CS+	C0234404
28055142	stimulus	C0234402
28055142	pain-onset	C1507009
28055920	Robust	C2986815
28055920	DLPP	C0392762
28055920	Nongreedy ℓ₁$-Norm Minimization	C0205556
28055920	Maximization	C0205556
28055920	discriminant locality preserving projection based on L1-norm	C0392762
28055920	DLPP-L1	C0392762
28055920	robust	C2986815
28055920	subspace learning	C0023185
28055920	image	C1704922
28055920	classification	C0008902
28055920	projection	C0348018
28055920	vectors	C0442335
28055920	greedy strategy	C0035171
28055920	projection	C0348018
28055920	vectors	C0442335
28055920	maximizing	C0205556
28055920	objective	C1571702
28055920	function	C0542341
28055920	solution	C1706817
28055920	trace ratio optimization algorithm	C0002045
28055920	objective	C1571702
28055920	function	C0542341
28055920	dimensionality reduction	C0282574
28055920	recognition	C0237818
28055920	accuracy	C0443131
28055920	nongreedy algorithm	C0002045
28055920	trace ratio formula	C0489829
28055920	DLPP-L1	C0392762
28055920	convergence	C2700387
28055920	databases	C0242356
28055920	algorithm	C0002045
28056024	Double-Blind	C0013072
28056024	Randomized Controlled Trial	C0206035
28056024	Maternal Postpartum	C0157460
28056024	Deworming	C0199859
28056024	Infant	C0021270
28056024	Weight Gain	C0043094
28056024	Peruvian	C1553375
28056024	Nutritional interventions	C0086153
28056024	critical	C1511545
28056024	growth and development period	C1397007
28056024	age	C0001779
28056024	health	C0018684
28056024	trajectories	C0750729
28056024	life course	C1510618
28056024	evidence	C3887511
28056024	interventions	C0808232
28056024	maternal health	C0024921
28056024	days	C0439228
28056024	life	C0376558
28056024	mothers	C0026591
28056024	children	C0680063
28056024	intervention	C0808232
28056024	deworming	C0199859
28056024	maternal postpartum care	C0545491
28056024	areas	C0205146
28056024	soil	C0037592
28056024	transmitted	C0332289
28056024	helminth	C0018893
28056024	STH	C0018893
28056024	infections	C0018889
28056024	endemic	C0277550
28056024	February	C3830166
28056024	August	C3831448
28056024	mother	C0026591
28056024	infant	C0021270
28056024	trial	C0008976
28056024	assessing	C0220825
28056024	effectiveness	C1280519
28056024	maternal postpartum	C0157460
28056024	deworming	C0199859
28056024	infant	C0021270
28056024	maternal health	C0024921
28056024	outcomes	C0085415
28056024	Following	C0332282
28056024	delivery	C0005615
28056024	mothers	C0026591
28056024	dose	C0178602
28056024	albendazole	C0001911
28056024	placebo	C1696465
28056024	Participants	C0679646
28056024	followed-up	C1522577
28056024	1	C4082115
28056024	6 months	C4082120
28056024	postpartum	C0086839
28056024	no statistically significant	C1273937
28056024	difference	C1705241
28056024	weight gain	C0043094
28056024	infants	C0021270
28056024	experimental	C0237950
28056024	control groups	C0009932
28056024	mean difference	C0392762
28056024	CI	C0009667
28056024	6 months	C4082120
28056024	age	C0001779
28056024	deworming	C0199859
28056024	no effect	C1301751
28056024	infant morbidity	C0848889
28056024	indicators	C0018761
28056024	ad hoc analyses	C0026348
28056024	mothers	C0026591
28056024	positive	C1514241
28056024	STHs	C0018893
28056024	baseline	C1442488
28056024	infants	C0021270
28056024	mothers	C0026591
28056024	length	C0005890
28056024	gain	C1517378
28056024	mean difference	C0392762
28056024	CI	C0009667
28056024	length-for-age z-score	C0449820
28056024	mean difference	C0392762
28056024	CI	C0009667
28056024	6 months	C4082120
28056024	age	C0001779
28056024	study population	C2348561
28056024	STH-infected	C0018889
28056024	uninfected	C3898900
28056024	mothers	C0026591
28056024	maternal postpartum	C0157460
28056024	deworming	C0199859
28056024	insufficient	C0231180
28056024	infant	C0021270
28056024	growth	C0018270
28056024	morbidity	C0848889
28056024	indicators	C0018761
28056024	6 months	C4082120
28056024	postpartum	C0086839
28056024	STH-infected	C0018889
28056024	mothers	C0026591
28056024	infant	C0021270
28056024	length-for-age	C0517420
28056024	maternal postpartum	C0157460
28056024	deworming	C0199859
28056024	study populations	C2348561
28056024	prevalences	C0033105
28056024	intensities	C4049786
28056024	STH infections	C0018889
28056024	whipworm	C0040954
28056024	hookworm infections	C0019911
28056024	public health concern	C0034024
28056376	preliminary	C0439611
28056376	comparative study	C1579762
28056376	classical	C0443177
28056376	interventional radiological approaches	C0034602
28056376	multi-phase	C0205390
28056376	post-mortem CT	C3697228
28056376	angiography	C0002978
28056376	Multi-phase	C0205390
28056376	post-mortem computed tomography angiography	C1536105
28056376	MPMCTA	C1536105
28056376	new	C0205314
28056376	diagnostic tool	C0430022
28056376	forensic pathology	C1450224
28056376	technique	C0449851
28056376	direct visualization	C3846514
28056376	vascular	C1402315
28056376	solid organ	C0440790
28056376	lesions	C0221198
28056376	invasiveness	C1301757
28056376	procedure	C2700391
28056376	surgical denudation	C0243095
28056376	inguinal	C0018246
28056376	cervical	C0205064
28056376	insertion	C0021107
28056376	surgical cannulas	C0520453
28056376	relatives	C0080103
28056376	refusing	C1705116
28056376	scientific autopsies	C0004398
28056376	hypothesis	C1512571
28056376	minimally-invasive procedure	C2711297
28056376	interventional radiological techniques	C0344093
28056376	MPMCTA	C1536105
28056376	replacement	C0559956
28056376	surgical cannulas	C0520453
28056376	radiological catheters	C0085590
28056376	improve	C0184511
28056376	approval	C0205540
28056376	rate	C1521828
28056376	scientific autopsies	C0004398
28056376	families	C0015576
28056376	aim	C1947946
28056376	study	C2603343
28056376	feasibility	C0015730
28056376	minimally-invasive	C2711297
28056376	MPMCTA	C1536105
28056376	compare	C1707455
28056376	performance	C1882330
28056376	current	C0521116
28056376	reference-standard	C0034925
28056376	consecutively	C1707491
28056376	corpses	C0006629
28056376	groups	C0441833
28056376	contrast	C1979874
28056376	enhancement	C2349975
28056376	radiological catheters	C0085590
28056376	surgical cannulas	C0520453
28056376	Corpses	C0006629
28056376	data	C1511726
28056376	quality	C0332306
28056376	imaging procedure	C0011923
28056376	compared	C1707455
28056376	global vascular	C0005847
28056376	opacification	C0449584
28056376	cerebral venous opacification	C0449584
28056376	lower limbs	C0023216
28056376	opacification	C0449584
28056376	arterial	C0221464
28056376	venous	C0348013
28056376	minimally-invasive approach	C2711297
28056376	scientific autopsies	C0004398
28056376	radiological catheter	C0085590
28056376	Vascular	C0005847
28056376	opacification	C0449584
28056376	optimal	C2698651
28056376	effective	C1704419
28056376	control reference group	C0009932
28056376	surgical cannula	C0520453
28056376	incision	C0184898
28056376	associated with	C0332281
28056376	non-occlusive aspects	C0205556
28056892	Correlations	C1707520
28056892	physical activity	C0026606
28056892	neurocognitive domain functions	C0392335
28056892	patients	C0030705
28056892	schizophrenia	C0036341
28056892	cross-sectional study	C0010362
28056892	Neurocognitive dysfunction	C4041080
28056892	symptom	C1457887
28056892	schizophrenia	C0036341
28056892	treatment	C0087111
28056892	correlation	C1707520
28056892	physical activity	C0026606
28056892	neurocognitive function	C0392335
28056892	healthy individuals	C0237401
28056892	correlation	C1707520
28056892	patients	C0030705
28056892	schizophrenia	C0036341
28056892	relationship	C0439849
28056892	inpatients	C0021562
28056892	outpatients	C0029921
28056892	study	C2603343
28056892	examine	C0582103
28056892	correlations	C1707520
28056892	physical activity	C0026606
28056892	neurocognitive domains	C0392335
28056892	inpatients	C0021562
28056892	outpatients	C0029921
28056892	schizophrenia	C0036341
28056892	suggestions	C1705535
28056892	study	C2603343
28056892	patients	C0030705
28056892	schizophrenia	C0036341
28056892	examined	C0582103
28056892	inpatients	C0021562
28056892	outpatients	C0029921
28056892	years	C0439234
28056892	age	C0001779
28056892	symptoms	C1457887
28056892	assessed	C1516048
28056892	Positive	C1446409
28056892	Negative	C0205160
28056892	Symptom Scale	C0429688
28056892	neurocognitive functions	C0392335
28056892	Cognitrax	C0871696
28056892	neurocognitive index	C0872227
28056892	NCI	C0872227
28056892	scores	C0449820
28056892	participants	C0679646
28056892	HJA-750C accelerometer	C0178951
28056892	one week	C4082116
28056892	measure	C0079809
28056892	physical activity	C0026606
28056892	durations	C0449238
28056892	Partial correlation analyses	C0010101
28056892	exercise	C0015259
28056892	cognitive	C0009240
28056892	parameters	C0449381
28056892	outpatient	C0029921
28056892	higher	C0205250
28056892	physical activity	C0026606
28056892	Motor	C1513492
28056892	Psychomotor	C0033923
28056892	Speeds	C0678536
28056892	outpatients	C0029921
28056892	higher	C0205250
28056892	physical activity	C0026606
28056892	associated with	C0332281
28056892	lower	C0205251
28056892	NCI	C0872227
28056892	Attention	C0004268
28056892	score	C0449820
28056892	Memory	C0025260
28056892	scores	C0449820
28056892	inpatients	C0021562
28056892	higher	C0205250
28056892	physical activity	C0026606
28056892	associated with	C0332281
28056892	neurocognitive functions	C0392335
28056892	outpatients	C0029921
28056892	inpatients	C0021562
28056892	schizophrenia	C0036341
28056892	higher	C0205250
28056892	physical activity	C0026606
28056892	associated with	C0332281
28056892	cognitive domains	C0392335
28056892	study	C2603343
28056892	examining	C0582103
28056892	relationship	C0439849
28056892	physical activity	C0026606
28056892	neurocognitive function	C0392335
28056892	inpatients	C0021562
28056892	outpatients	C0029921
28056892	relationship	C0439849
28056892	inpatients	C0021562
28056892	outpatients	C0029921
28057994	completely	C0205197
28057994	calcified	C0175895
28057994	prostate	C0033572
28057994	Prostatic calcification	C1868729
28057994	prostatic calculus	C0149525
28057994	formation	C1522492
28057994	adult	C0001675
28057994	population	C1257890
28057994	chronic prostatitis	C0085696
28057994	prostatic calcification	C1868729
28057994	gland	C0033572
28057994	rare	C0522498
28057994	presenting	C0449450
28057994	case	C0868928
28057994	glandular prostate	C0033572
28057994	converted	C0392747
28057994	stone	C0006736
28058375	rare	C0522498
28058375	cause	C0015127
28058375	gastric obstruction	C0149700
28058375	Lighters	C0336770
28058375	swallowing	C0011167
28058375	majority	C0205164
28058375	swallowed foreign bodies	C0520753
28058375	thrown	C0849355
28058375	spontaneously	C0205359
28058375	without	C0332288
28058375	causing	C0678227
28058375	complications	C0009566
28058375	digestive system	C0012240
28058375	Multiple	C0439064
28058375	number	C0237753
28058375	foreign bodies	C0016542
28058375	swallowed	C0011167
28058375	psychiatric patients	C0748064
28058375	delay diagnosis	C2718036
28058375	increase	C0442805
28058375	complication	C0009566
28058375	rate	C1521828
28058375	Long	C0205166
28058375	hard	C0018599
28058375	objects	C0016542
28058375	pylorus	C0034196
28058375	cause	C0015127
28058375	obstruction	C0028778
28058375	ulceration	C3887532
28058375	bleeding	C0019080
28058375	perforation	C0549099
28058375	Endoscopy	C0014245
28058375	used	C1524063
28058375	effective	C1704419
28058375	method	C0449851
28058375	cases	C0868928
28058375	exploratory laparatomy	C0085704
28058375	performed	C0884358
28058375	unsuccessful	C1272705
28058375	endoscopic	C0442418
28058375	foreign object	C0016542
28058375	removal	C0015252
28058375	schizophrenic	C0036341
28058375	patient	C0030705
28058375	gastric outlet obstruction	C0162651
28058375	due to	C0678226
28058375	multiple	C0439064
28058375	cigarette lighter	C0336770
28058375	swallowing	C0011167
28058375	lighters	C0336770
28058375	removed	C0849355
28058375	stomach	C0038351
28058375	through	C0332273
28058375	gastrotomy	C0192401
28058375	lighter	C0336770
28058375	removed	C0849355
28058375	descending colon	C0227389
28058375	milking	C0185115
28058375	through	C0332273
28058375	anus	C0003461
28058375	difficulties	C0033213
28058375	psychiatric patients	C0748064
28058375	surgery	C0543467
28058375	due to	C0678226
28058375	intake	C1512806
28058375	foreign bodies	C0016542
28058593	Ceftaroline fosamil	C2001525
28058593	community-acquired pneumonia	C0694549
28058593	skin	C1123023
28058593	skin structure infections	C3714514
28058593	systematic review	C1955832
28058593	Ceftaroline	C2001525
28058593	administered	C1621583
28058593	cephalosporin	C3536856
28058593	in vitro	C1533691
28058593	expanded	C0205229
28058593	activity	C1321418
28058593	compared	C1707455
28058593	cephalosporins	C3536856
28058593	data	C1511726
28058593	therapy	C0087111
28058593	Review	C1955832
28058593	compare	C1707455
28058593	efficacy	C1280519
28058593	safety	C0036043
28058593	ceftaroline	C2001525
28058593	antibiotic	C0003232
28058593	regimens	C0040808
28058593	community-acquired pneumonia	C0694549
28058593	CAP	C0694549
28058593	complicated skin and skin structure infections	C3714514
28058593	cSSSIs	C3714514
28058593	databases	C0242356
28058593	MEDLINE	C0025141
28058593	EBSCO	C0242356
28058593	Embase	C0242356
28058593	Manual review of references was completed	C3259354
28058593	experts	C1522486
28058593	unpublished data	C0887929
28058593	Randomized controlled trials	C0206035
28058593	ceftaroline	C2001525
28058593	CAP	C0694549
28058593	cSSSI	C3714514
28058593	populations	C1257890
28058593	Outcomes	C1274040
28058593	clinical cure	C3640840
28058593	mortality	C0205848
28058593	adverse events	C0877248
28058593	serious adverse events	C1519255
28058593	discontinuation	C4288399
28058593	adverse events	C0877248
28058593	Meta-analysis	C0282458
28058593	outcomes	C1274040
28058593	subgroup	C1515021
28058593	analyses	C0936012
28058593	gram positive infections	C0085426
28058593	CAP	C0694549
28058593	infections	C3714514
28058593	methicillin-resistant Staphylococcus aureus	C1265292
28058593	cSSSIs	C3714514
28058593	Risk	C0035647
28058593	bias	C0242568
28058593	studies	C2603343
28058593	trials	C0681815
28058593	risk	C0035647
28058593	bias	C0242568
28058593	CAP	C0694549
28058593	ceftaroline	C2001525
28058593	efficacious	C1280519
28058593	clinical cure	C3640840
28058593	ceftriaxone	C0007561
28058593	risk ratio	C0242492
28058593	RR	C0242492
28058593	confidence interval	C0009667
28058593	CI	C0009667
28058593	cSSSIs	C3714514
28058593	clinical cure	C3640840
28058593	ceftaroline	C2001525
28058593	vancomycin	C0042313
28058593	aztreonam	C0004521
28058593	RR	C0242492
28058593	CI	C0009667
28058593	mortality	C0205848
28058593	serious adverse events	C1519255
28058593	discontinuation	C4288399
28058593	adverse events	C0877248
28058593	adverse events	C0877248
28058593	Ceftaroline	C2001525
28058593	therapeutic alternative	C0949216
28058593	patients	C0030705
28058593	CAP	C0694549
28058593	cSSSIs	C3714514
28058593	risks	C0035647
28058593	bias	C0242568
28058593	poor external validity	C2924039
28058593	first-line agent	C0003232
28062192	effects of	C1704420
28062192	glucose	C0017725
28062192	insulin	C0021641
28062192	GLP-1	C0061355
28062192	GIP	C0017132
28062192	bulbospinal	C0005898
28062192	neurons	C0027882
28062192	rostral ventrolateral medulla	C2328883
28062192	neonatal	C0021289
28062192	wistar rats	C0034716
28062192	patients	C0030705
28062192	diabetes mellitus	C0011849
28062192	DM	C0011849
28062192	hypertension	C0020538
28062192	mechanisms	C0441712
28062192	correlation	C1707520
28062192	bulbospinal	C0005898
28062192	neurons	C0027882
28062192	rostral ventrolateral medulla	C2328883
28062192	RVLM	C2328883
28062192	affected	C0392760
28062192	levels	C0441889
28062192	glucose	C0017725
28062192	insulin	C0021641
28062192	incretins	C1562292
28062192	glucagon like peptide-1	C0061355
28062192	GLP-1	C0061355
28062192	glucose-dependent insulinotropic peptide	C0017132
28062192	GIP	C0017132
28062192	patients	C0030705
28062192	DM	C0011849
28062192	investigate	C1292732
28062192	RVLM	C2328883
28062192	neurons	C0027882
28062192	activated	C1879547
28062192	glucose	C0017725
28062192	insulin	C0021641
28062192	GLP-1	C0061355
28062192	GIP	C0017132
28062192	changes	C0392747
28062192	membrane potentials	C0025251
28062192	bulbospinal	C0005898
28062192	RVLM	C2328883
28062192	neurons	C0027882
28062192	whole-cell	C0007634
28062192	patch-clamp technique	C0242625
28062192	superfusion	C1254366
28062192	levels	C0441889
28062192	glucose	C0017725
28062192	hormones	C0019932
28062192	neonatal	C0021289
28062192	Wistar rats	C0034716
28062192	brainstem	C0006121
28062192	spinal cord	C0037925
28062192	preparation	C1521827
28062192	experiments	C0681814
28062192	low	C0205251
28062192	level	C0441889
28062192	glucose	C0017725
28062192	bulbospinal	C0005898
28062192	RVLM	C2328883
28062192	neurons	C0027882
28062192	insulin	C0021641
28062192	superfusion	C1254366
28062192	RVLM	C2328883
28062192	neurons	C0027882
28062192	depolarized	C0234081
28062192	GLP-1	C0061355
28062192	GIP	C0017132
28062192	superfusion	C1254366
28062192	RVLM	C2328883
28062192	neurons	C0027882
28062192	hyperpolarized	C0522208
28062192	histological examinations	C0019637
28062192	transporters for glucose	C0017742
28062192	receptors	C0597357
28062192	insulin	C0021641
28062192	GLP-1	C0061355
28062192	GIP	C0017132
28062192	RVLM	C2328883
28062192	neurons	C0027882
28062192	Low	C0205251
28062192	level	C0441889
28062192	glucose	C0017725
28062192	depolarized	C0234081
28062192	RVLM	C2328883
28062192	neurons	C0027882
28062192	presence	C3854307
28062192	glucose transporter 3	C0119484
28062192	GLUT3	C0119484
28062192	insulin	C0021641
28062192	depolarized	C0234081
28062192	GLP-1	C0061355
28062192	hyperpolarized	C0522208
28062192	GIP	C0017132
28062192	hyperpolarized	C0522208
28062192	RVLM	C2328883
28062192	neurons	C0027882
28062192	specific	C0205369
28062192	receptor	C0597357
28062192	low	C0205251
28062192	level	C0441889
28062192	glucose	C0017725
28062192	stimulates	C1948023
28062192	bulbospinal	C0005898
28062192	RVLM	C2328883
28062192	neurons	C0027882
28062192	specific	C0205369
28062192	transporters	C0017742
28062192	neurons	C0027882
28062192	inducing	C0205263
28062192	hypertension	C0020538
28062192	increase	C0442805
28062192	insulin	C0021641
28062192	reduction	C0392756
28062192	incretins	C1562292
28062192	activate	C1879547
28062192	sympathetic nervous system	C0039044
28062192	induce	C0205263
28062192	hypertension	C0020538
28062192	activating	C1879547
28062192	RVLM	C2328883
28062192	neurons	C0027882
28062192	receptors	C0597357
28063273	Mechanisms	C0441712
28063273	compensation	C0001549
28063273	gait	C0016928
28063273	patients	C0030705
28063273	drop foot	C0085684
28063273	Drop foot	C0085684
28063273	syndrome	C0039082
28063273	multiple	C0439064
28063273	interactions	C1704675
28063273	joints	C0022417
28063273	muscles	C0026845
28063273	Abnormalities	C1704258
28063273	movement patterns	C0427096
28063273	motion capture techniques	C0752188
28063273	compensation	C0001549
28063273	mechanisms	C0441712
28063273	mechanisms	C0441712
28063273	compensatory	C0231186
28063273	mechanisms	C0441712
28063273	patients	C0030705
28063273	drop foot	C0085684
28063273	study	C0008972
28063273	patients	C0030705
28063273	computerized	C0009609
28063273	gait analysis system	C3874714
28063273	healthy subjects	C1708335
28063273	falling	C0427122
28063273	intervals	C1272706
28063273	percentage	C0439165
28063273	differences	C1705241
28063273	groups	C1257890
28063273	study	C0008972
28063273	kinematic parameters	C0600169
28063273	control group	C0009932
28063273	patient group	C0030705
28063273	kinetic parameters	C0022702
28063273	falling	C0427122
28063273	interval	C1272706
28063273	interval	C1272706
28063273	spatiotemporal parameters	C3494293
28063273	interval	C1272706
28063273	kinematic	C0600169
28063273	kinetic	C0022702
28063273	spatiotemporal parameters	C3494293
28063273	gait pattern	C0016928
28063273	groups	C1257890
28063273	motor deficits	C0521654
28063273	compensatory	C0231186
28063273	mechanisms	C0441712
28063273	drop foot	C0085684
28063273	patients	C0030705
28063273	kinematic	C0600169
28063273	kinetic	C0022702
28063273	gait	C0016928
28063273	compensation	C0001549
28063273	change	C0392747
28063273	movement	C0026649
28063273	ankle joint	C0003087
28063305	Inhibitory	C3463820
28063305	effects of	C1704420
28063305	Lactobacillus rhamnosus	C0317597
28063305	Lactobacillus casei	C0022940
28063305	Candida	C0006837
28063305	biofilm	C0081786
28063305	denture surface	C0457711
28063305	Candida albicans	C0006837
28063305	biofilm	C0081786
28063305	associated with	C0332281
28063305	denture-related stomatitis	C0038364
28063305	oral candidiasis	C0006849
28063305	elderly	C0001792
28063305	Probiotics	C0525033
28063305	bacteria	C0004611
28063305	antibacterial activity	C0243095
28063305	pathogenic bacteria	C0004611
28063305	investigate	C1292732
28063305	antifungal activity	C0243095
28063305	probiotics	C0525033
28063305	C. albicans	C0006837
28063305	inhibitory	C3463820
28063305	effects of	C1704420
28063305	probiotics	C0525033
28063305	Candida	C0006837
28063305	biofilm	C0081786
28063305	denture surface	C0457711
28063305	spent culture media	C0010454
28063305	probiotics	C0525033
28063305	antifungal efficacy	C1280519
28063305	C. albicans	C0006837
28063305	Candida	C0006837
28063305	biofilm	C0081786
28063305	denture base resin	C3503992
28063305	treated	C1522326
28063305	Lactobacillus rhamnosus	C0317597
28063305	Lactobacillus casei	C0022940
28063305	biofilm	C0081786
28063305	L. rhamnosus	C0317597
28063305	L. casei	C0022940
28063305	treated	C1522326
28063305	C. albicans	C0006837
28063305	Colony-forming units	C0553561
28063305	C. albicans	C0006837
28063305	denture surface	C0457711
28063305	spreading	C0332261
28063305	agar	C0001771
28063305	plate	C0180454
28063305	denture base resin	C3503992
28063305	treated	C1522326
28063305	spent culture media	C0010454
28063305	days	C0439228
28063305	denture surface	C0457711
28063305	roughness	C0243095
28063305	atomic force microscope	C0242849
28063305	L. rhamnosus	C0317597
28063305	L. casei	C0022940
28063305	antifungal activity	C0243095
28063305	probiotics	C0525033
28063305	spent culture medium	C0010454
28063305	L. rhamnosus	C0317597
28063305	L. casei	C0022940
28063305	antifungal activity	C0243095
28063305	blastoconidia	C0521050
28063305	biofilm	C0081786
28063305	C. albicans	C0006837
28063305	L. rhamnosus	C0317597
28063305	L. casei	C0022940
28063305	antifungal activity	C0243095
28063305	Candida	C0006837
28063305	biofilm	C0081786
28063305	biofilm	C0081786
28063305	L. rhamnosus	C0317597
28063305	L. casei	C0022940
28063305	inhibited	C3463820
28063305	formation	C1522492
28063305	Candida	C0006837
28063305	biofilm	C0081786
28063305	denture surface	C0457711
28063305	probiotics	C0525033
28063305	surface roughness	C0243095
28063305	denture base resin	C3503992
28063305	L. rhamnosus	C0317597
28063305	L. casei	C0022940
28063305	probiotics	C0525033
28063305	prevention	C2700409
28063305	treatment	C0039798
28063305	denture-related stomatitis	C0038364
28063657	Persistent Organic Pollutants	C0001869
28063657	POPs	C0001869
28063657	atmosphere	C0004178
28063657	Chilean	C0239045
28063657	cities	C0008848
28063657	passive	C3686820
28063657	air samplers	C0178984
28063657	study	C2603343
28063657	passive	C3686820
28063657	air samplers	C0178984
28063657	polyurethane foam	C0071696
28063657	PUF	C0071696
28063657	disks	C0180459
28063657	deployed	C2825812
28063657	cities	C0008848
28063657	Chile	C0008107
28063657	Santiago	C0017446
28063657	STG	C0017446
28063657	sampling sites	C0449705
28063657	Concepciόn	C0017446
28063657	CON	C0017446
28063657	Temuco	C0017446
28063657	TEM	C0017446
28063657	Polychlorinated biphenyls	C0032447
28063657	PCBs	C0032447
28063657	indicator	C1522602
28063657	congeners	C0678518
28063657	chlorinated pesticides	C0360424
28063657	hexachlorocyclohexanes	C0005038
28063657	HCHs	C0005038
28063657	dichlorodiphenyl trichloroethanes	C0011041
28063657	DDTs	C0011041
28063657	flame retardants	C0016198
28063657	polybrominated diphenyl ethers	C2350562
28063657	PBDEs	C2350562
28063657	determined by	C0521095
28063657	gas chromatography coupled mass spectrometry	C0024868
28063657	GC/MS	C0024868
28063657	sampling	C0870078
28063657	rate	C1521828
28063657	R	C1521828
28063657	urban sites	C0178876
28063657	estimate	C0750572
28063657	atmospheric	C0004178
28063657	concentrations	C1446561
28063657	individual	C1457900
28063657	compounds	C0205198
28063657	PCB	C0032447
28063657	concentrations	C1446561
28063657	air	C0001861
28063657	ranged	C1514721
28063657	TEM	C0017446
28063657	STG	C0017446
28063657	CON	C0017446
28063657	Higher molecular weight	C1979900
28063657	PCBs	C0032447
28063657	PCB	C0032447
28063657	detected	C0442726
28063657	industrial sites	C0442611
28063657	Concepción	C0017446
28063657	HCHs	C0005038
28063657	prevalence	C0683919
28063657	γ-HCH	C0005038
28063657	sites	C0205145
28063657	indicative	C1522602
28063657	inputs	C1708517
28063657	lindane	C0005038
28063657	limited	C0439801
28063657	technical	C1553014
28063657	HCHs	C0005038
28063657	Chile	C0008107
28063657	DDTs	C0011041
28063657	detected	C0442726
28063657	prevalence	C0683919
28063657	p,p'-DDE	C0011038
28063657	accounting	C0680857
28063657	DDTs	C0011041
28063657	PBDE	C2350562
28063657	concentrations	C1446561
28063657	air	C0001861
28063657	ranged	C1514721
28063657	STG	C0017446
28063657	CON	C0017446
28063657	TEM	C0017446
28063657	similar	C2348205
28063657	reported	C0684224
28063657	urban areas	C0178876
28063657	globally	C2348867
28063657	pattern	C0449774
28063657	PBDEs	C2350562
28063657	cities	C0008848
28063657	PBDE	C2350562
28063657	dominant	C1527180
28063657	sites	C0205145
28063657	results	C0683954
28063657	assessments	C0220825
28063657	air	C0001861
28063657	concentrations	C1446561
28063657	POPs	C0001869
28063657	urban areas	C0178876
28063657	country	C0454664
28063657	data	C1511726
28063657	support	C1521721
28063657	Chilean	C0239045
28063657	commitments	C0870312
28063657	signatory	C4288222
28063657	Stockholm Convention	C0242359
28063657	POPs	C0001869
28063657	reporting	C0011000
28063657	member	C2698041
28063657	country	C0454664
28063657	Group of Latin America and Caribbean Countries (GRULAC) region	C0017446
28067693	Intraoperative	C0456904
28067693	ketamine	C0022614
28067693	reduces	C0392756
28067693	immediate	C0205253
28067693	postoperative	C0032790
28067693	opioid	C0002772
28067693	consumption	C1512806
28067693	spinal fusion surgery	C0919636
28067693	chronic pain	C0150055
28067693	patients	C0030705
28067693	opioid	C0002772
28067693	dependency	C0851827
28067693	randomized	C0034656
28067693	blinded trial	C2347038
28067693	Perioperative	C1518988
28067693	handling	C1832073
28067693	surgical patients	C0871463
28067693	opioid	C0002772
28067693	dependency	C0851827
28067693	important	C3898777
28067693	clinical	C0205210
28067693	problem	C0033213
28067693	Animal studies	C0683949
28067693	ketamine	C0022614
28067693	attenuates	C0599946
28067693	central sensitization	C2938905
28067693	hyperalgesia	C0020429
28067693	reduces	C0392756
28067693	postoperative	C0032790
28067693	opioid	C0002772
28067693	opioid tolerance	C0240601
28067693	hypothesized	C1512571
28067693	intraoperative	C0456904
28067693	ketamine	C0022614
28067693	reduce	C0392756
28067693	immediate	C0205253
28067693	postoperative	C0032790
28067693	opioid	C0002772
28067693	consumption	C1512806
28067693	placebo	C1696465
28067693	chronic pain	C0150055
28067693	patients	C0030705
28067693	opioid	C0002772
28067693	dependency	C0851827
28067693	lumbar spinal fusion surgery	C0186045
28067693	Primary outcome	C3274433
28067693	morphine	C0026549
28067693	consumption	C1512806
28067693	0 to 24 hours	C0439585
28067693	postoperatively	C0032790
28067693	Secondary outcomes	C3274440
28067693	acute pain at rest	C0234253
28067693	mobilization	C0185112
28067693	2 to 24 hours	C0439585
28067693	postoperatively	C0032790
28067693	visual analogue scale	C3536884
28067693	adverse events	C0877248
28067693	persistent	C0205322
28067693	pain	C0030193
28067693	postoperatively	C0032790
28067693	patients	C0030705
28067693	randomly assigned	C0034656
28067693	intraoperative	C0456904
28067693	S-ketamine	C2825616
28067693	bolus 0.5 mg/kg and infusion	C1511237
28067693	placebo	C1696465
28067693	Postoperatively	C0032790
28067693	patients	C0030705
28067693	opioids	C0002772
28067693	paracetamol	C0000970
28067693	patient-controlled analgesia	C0078944
28067693	morphine	C0026549
28067693	final analyses	C3899115
28067693	patients	C0030705
28067693	Patient-controlled analgesia	C0078944
28067693	morphine	C0026549
28067693	consumption	C1512806
28067693	postoperatively	C0032790
28067693	significantly	C0750502
28067693	reduced	C0392756
28067693	ketamine	C0022614
28067693	placebo	C1696465
28067693	mean	C0444504
28067693	difference	C1705242
28067693	confidence interval	C0009667
28067693	Sedation	C0235195
28067693	significantly	C0750502
28067693	reduced	C0392756
28067693	ketamine	C0022614
28067693	postoperatively	C0032790
28067693	no significant differences	C3842396
28067693	acute pain	C0184567
28067693	nausea	C0027497
28067693	vomiting	C0042963
28067693	hallucinations	C0018524
28067693	nightmares	C0028084
28067693	Back pain	C0004604
28067693	postoperatively	C0032790
28067693	preoperative	C0445204
28067693	pain	C0030193
28067693	significantly	C0750502
28067693	improved	C0184511
28067693	ketamine	C0022614
28067693	placebo	C1696465
28067693	intraoperative	C0456904
28067693	ketamine	C0022614
28067693	significantly	C0750502
28067693	reduced	C0392756
28067693	morphine	C0026549
28067693	consumption	C1512806
28067693	0 to 24 hours	C0439585
28067693	lumbar fusion surgery	C0186045
28067693	opioid	C0002772
28067693	dependent	C0851827
28067693	patients	C0030705
28067693	trend	C1521798
28067693	persistent	C0205322
28067693	pain	C0030193
28067693	postoperatively	C0032790
28067693	further	C1517331
28067693	investigation	C1292732
28068639	Effects of	C1704420
28068639	argan oil	C2975054
28068639	mitochondrial function	C0007613
28068639	antioxidant system	C0460002
28068639	activity	C0243102
28068639	NADPH	C0027303
28068639	generating	C3146294
28068639	enzymes	C0014442
28068639	acrylamide	C0050587
28068639	treated	C0332293
28068639	rat	C0034715
28068639	brain	C0006104
28068639	Argan oil	C2975054
28068639	AO	C2975054
28068639	compounds	C1706082
28068639	polyphenols	C0071649
28068639	tocopherols	C0087096
28068639	antioxidants	C0003402
28068639	Acrylamide	C0050587
28068639	ACR	C0050587
28068639	classified	C0008902
28068639	neurotoxic agent	C0260049
28068639	animals	C0003062
28068639	humans	C0086418
28068639	Mitochondrial	C0026237
28068639	oxidative stress	C0242606
28068639	dysfunction	C4021734
28068639	probable	C0033204
28068639	molecular mechanisms	C0678659
28068639	neurodegenerative diseases	C0524851
28068639	Female	C0086287
28068639	Sprague Dawley rats	C0034715
28068639	exposed to	C0332157
28068639	ACR	C0050587
28068639	AO	C2975054
28068639	activities	C0441655
28068639	cytosolic	C1820051
28068639	enzymes	C0014442
28068639	xanthine oxidase	C0043317
28068639	XO	C0043317
28068639	glucose 6-phosphate dehydrogenase	C0017757
28068639	G6PDH	C0017757
28068639	glutathione-S-transferase	C0017837
28068639	GST	C0017837
28068639	mitochondrial	C0026237
28068639	oxidative stress	C0242606
28068639	oxidative phosphorylation	C0030013
28068639	OXPHOS	C0030013
28068639	tricarboxylic acid cycle	C0008858
28068639	TCA	C0008858
28068639	enzymes	C0014442
28068639	mitochondrial	C0026237
28068639	metabolic function	C0025519
28068639	adenosine triphosphate	C0001480
28068639	ATP	C0001480
28068639	level	C0441889
28068639	acetylcholinesterase (AChE) activity	C1149827
28068639	assessed	C1516048
28068639	rat	C0034715
28068639	brain	C0006104
28068639	Cytosolic	C1820051
28068639	mitochondrial	C0026237
28068639	antioxidant enzymes	C0014442
28068639	significantly	C0750502
28068639	diminished	C0205216
28068639	brains	C0006104
28068639	rats	C0034715
28068639	treated with	C0332293
28068639	ACR	C0050587
28068639	compared	C1707455
28068639	control	C0009932
28068639	ACR	C0050587
28068639	treatment	C0087111
28068639	resulted	C1274040
28068639	significant	C0750502
28068639	reduction	C0392756
28068639	brain	C0006104
28068639	ATP	C0001480
28068639	level	C0441889
28068639	mitochondrial	C0026237
28068639	metabolic function	C0025519
28068639	OXPHOS	C0030013
28068639	TCA	C0008858
28068639	enzymes	C0014442
28068639	Administration	C1533734
28068639	AO	C2975054
28068639	cytosolic	C1820051
28068639	mitochondrial	C0026237
28068639	oxidative stress	C0242606
28068639	normalizing	C1882115
28068639	nicotinamide adenine dinucleotide phosphate	C0027303
28068639	NADPH	C0027303
28068639	generating	C3146294
28068639	enzymes	C0014442
28068639	improved	C0184511
28068639	mitochondrial function	C0007613
28068639	enhancing	C2349975
28068639	nicotinamide adenine dinucleotide	C0027270
28068639	NADH	C0027270
28068639	generated	C3146294
28068639	enzymes activities	C0243102
28068639	ATP	C0001480
28068639	level	C0441889
28068639	mitochondria	C0026237
28068639	reason	C0392360
28068639	AO's	C2975054
28068639	beneficial effects	C0683156
28068639	study	C2603343
28068639	synergistic effects	C0683168
28068639	different	C1705242
28068639	bioactive compounds	C3714412
28068639	effective	C1704419
28068639	mitochondria	C0026237
28068639	Modulation	C0443264
28068639	brain	C0006104
28068639	mitochondrial functions	C0007613
28068639	antioxidant systems	C0460002
28068639	AO	C2975054
28068639	development	C1527148
28068639	mitochondria	C0026237
28068639	targeted	C0599894
28068639	antioxidants	C0003402
28068639	future	C0016884
28070811	Encaged	C0337189
28070811	Chironomus riparius	C1677085
28070811	larvae	C0023047
28070811	assessment	C1516048
28070811	trace metal	C0723796
28070811	bioavailability	C0470187
28070811	transfer	C1705822
28070811	landfill leachate	C1720817
28070811	collection	C1516698
28070811	pond	C0337048
28070811	Household	C0001288
28070811	wastes	C0018627
28070811	constitute	C0729650
28070811	vector	C0205556
28070811	environmental contamination	C0014419
28070811	buried	C1254362
28070811	degradation	C0243125
28070811	leachates	C1720817
28070811	containing	C0332256
28070811	significant	C0750502
28070811	trace metal	C0723796
28070811	TM	C0723796
28070811	concentrations	C1446561
28070811	constitute	C0729650
28070811	risk	C0035647
28070811	biota	C1253910
28070811	objectives	C0018017
28070811	study	C2603343
28070811	assess	C1516048
28070811	bioavailability	C0470187
28070811	transfer	C1705822
28070811	potential	C3245505
28070811	TMs	C0723796
28070811	present	C0150312
28070811	water	C0043047
28070811	sediments	C0282590
28070811	reservoir	C0442537
28070811	receiving	C1514756
28070811	landfill leachates	C1720817
28070811	active	C0205177
28070811	biomonitoring	C0005517
28070811	exposing	C0443289
28070811	laboratory organisms	C1517710
28070811	cages	C0337189
28070811	deployed	C2825812
28070811	in the field	C3539073
28070811	Aquatic insects	C0596121
28070811	Chironomus riparius	C1677085
28070811	larvae	C0023047
28070811	represent	C1882932
28070811	organisms	C0029235
28070811	trophic	C0596583
28070811	functioning	C0542341
28070811	aquatic ecosystems	C0563034
28070811	results	C0683954
28070811	water	C0043047
28070811	suspended	C1553403
28070811	particles	C0597177
28070811	sediments	C0282590
28070811	significant	C0750502
28070811	contaminated	C0205279
28070811	TMs	C0723796
28070811	As	C0003818
28070811	Cd	C0006632
28070811	Cu	C0009968
28070811	Ni	C0028013
28070811	Pb	C0023175
28070811	Zn	C0043481
28070811	contribution	C1880177
28070811	transfer	C1705822
28070811	TMs	C0723796
28070811	specific	C0205369
28070811	element	C0013879
28070811	considered	C0750591
28070811	Cd	C0006632
28070811	sediments	C0282590
28070811	Pb	C0023175
28070811	suspended	C1553403
28070811	particles	C0597177
28070811	sediments	C0282590
28070811	TMs	C0723796
28070811	investigated	C1292732
28070811	fractionation	C0016640
28070811	insoluble	C0205556
28070811	cytosolic	C1820051
28070811	fraction	C1264633
28070811	revealed	C0443289
28070811	detoxification	C0150543
28070811	strategies	C0679199
28070811	preventing	C1292733
28070811	induction	C0205263
28070811	deleterious effects	C0879626
28070811	individual	C0237401
28070811	scale	C1522412
28070811	accumulation	C4055506
28070811	TMs	C0723796
28070811	C. riparius	C1677085
28070811	larvae	C0023047
28070811	tissues	C0040300
28070811	represent	C1882932
28070811	significant	C0750502
28070811	potentially	C3245505
28070811	transferable	C1705822
28070811	higher	C0205250
28070811	trophic	C0596583
28070811	levels	C0441889
28072457	Binge-Like	C0556346
28072457	Ethanol Exposure	C0814017
28072457	Adolescence	C0001578
28072457	Febrile	C0015967
28072457	Response	C0871261
28072457	Rats	C0034721
28072457	Ethanol (EtOH) exposure	C0814017
28072457	phases	C0205390
28072457	life	C0376558
28072457	risk of infections	C0582147
28072457	alterations	C1515926
28072457	central nervous system	C3714787
28072457	binge-like	C0556346
28072457	EtOH exposure	C0814017
28072457	adolescent	C0001578
28072457	rats	C0034721
28072457	febrile	C0015967
28072457	response	C0871261
28072457	lipopolysaccharide	C0023810
28072457	LPS	C0023810
28072457	interleukin-1β	C0021753
28072457	IL-1β	C0021753
28072457	rats	C0034721
28072457	exposed to EtOH	C0814017
28072457	postnatal days	C0443281
28072457	binge-like	C0556346
28072457	Fever	C0015967
28072457	LPS	C0023810
28072457	intraperitoneally	C0442120
28072457	postnatal days	C0443281
28072457	IL-β	C0021753
28072457	postnatal day	C0443281
28072457	Hematological	C0018943
28072457	peritoneal macrophages	C0206190
28072457	plasma	C0032105
28072457	cerebrospinal	C0007807
28072457	IL-1β	C0021753
28072457	levels	C0441889
28072457	postnatal day	C0443281
28072457	EtOH exposure	C0814017
28072457	adolescence	C0001578
28072457	normal body temperature	C0231262
28072457	febrile	C0015967
28072457	response	C0871261
28072457	LPS	C0023810
28072457	postnatal	C0443281
28072457	febrile	C0015967
28072457	response	C0871261
28072457	postnatal day	C0443281
28072457	EtOH-exposed	C0814017
28072457	animals	C0034721
28072457	febrile	C0015967
28072457	response	C0871261
28072457	intracerebroventricular	C0595818
28072457	IL-1β	C0021753
28072457	animals	C0034721
28072457	binge-like	C0556346
28072457	EtOH exposure	C0814017
28072457	adolescence	C0001578
28072457	Acute oral treatment	C1527415
28072457	EtOH	C0001962
28072457	LPS	C0023810
28072457	administration	C1533734
28072457	febrile	C0015967
28072457	response	C0871261
28072457	LPS	C0023810
28072457	Binge-like	C0556346
28072457	EtOH exposure	C0814017
28072457	adolescence	C0001578
28072457	hematological	C0018943
28072457	viability	C0007620
28072457	peritoneal macrophages	C0206190
28072457	Binge-like	C0556346
28072457	EtOH exposure	C0814017
28072457	plasma	C0032105
28072457	IL-1β	C0021753
28072457	levels	C0441889
28072457	cerebrospinal fluid	C0007806
28072457	levels	C0441889
28072457	cytokine	C0079189
28072457	binge-like	C0556346
28072457	EtOH exposure	C0814017
28072457	adolescence	C0001578
28072457	central nervous system	C3714787
28072457	febrile	C0015967
28072457	response	C0871261
28072457	cessation	C1880019
28072457	EtOH exposure	C0814017
28072457	LPS	C0023810
28072457	IL-1β	C0021753
28072668	Genital	C2945680
28072668	Extragenital Gonorrhea	C0018081
28072668	Chlamydia	C0008149
28072668	Children	C0008059
28072668	Adolescents	C0205653
28072668	Evaluated	C0220825
28072668	Sexual Abuse	C0282350
28072668	study	C2603343
28072668	nucleic acid amplification test	C0200932
28072668	detecting	C1511790
28072668	genital	C1993250
28072668	extragenital Neisseria gonorrhoeae	C1993250
28072668	NG	C1993250
28072668	Chlamydia trachomatis	C0008151
28072668	CT	C0008151
28072668	children	C0008059
28072668	adolescents	C0205653
28072668	assessed	C0184514
28072668	sexual abuse	C0282350
28072668	assault	C0237236
28072668	children	C0008059
28072668	aged	C0001779
28072668	years	C0439234
28072668	evaluated	C0220825
28072668	sexual victimization	C0376695
28072668	emergency department	C0562508
28072668	outpatient settings	C0013966
28072668	Data	C1511726
28072668	age	C0001779
28072668	sex	C0079399
28072668	sexual contact	C2229923
28072668	anogenital	C4071900
28072668	findings	C0243095
28072668	previous	C0205156
28072668	sexual contact	C2229923
28072668	toxicology results	C2348811
28072668	sites	C0205145
28072668	tested	C0022885
28072668	NG	C1993250
28072668	CT	C0008151
28072668	patients	C0030705
28072668	tested	C0022885
28072668	tested	C0022885
28072668	site	C0205145
28072668	infected	C0439663
28072668	site	C0205145
28072668	Chlamydia trachomatis	C0008151
28072668	patients	C0030705
28072668	NG	C1993250
28072668	bivariate analysis	C0681927
28072668	associated with	C0332281
28072668	female sex	C0086287
28072668	age	C0001779
28072668	years	C0439234
28072668	previous	C0205156
28072668	sexual contact	C2229923
28072668	healed	C0205249
28072668	genital injury	C0560637
28072668	drug/alcohol intoxication	C4061089
28072668	examination	C0582103
28072668	hours	C0439227
28072668	sexual contact	C2229923
28072668	patients	C0030705
28072668	positive	C1514241
28072668	anal	C0003461
28072668	tests	C0022885
28072668	positive	C1514241
28072668	oral	C0442027
28072668	tests	C0022885
28072668	patients	C0030705
28072668	positive	C1514241
28072668	extragenital tests	C0022885
28072668	positive	C1514241
28072668	tests	C0022885
28072668	anogenital	C4071900
28072668	injury	C0178314
28072668	positive	C1514241
28072668	anal	C0003461
28072668	oral	C0442027
28072668	test	C0022885
28072668	genitals	C0017420
28072668	site	C0205145
28072668	Positive	C1514241
28072668	tests	C0022885
28072668	NG	C1993250
28072668	CT	C0008151
28072668	patients	C0030705
28072668	evaluated	C0220825
28072668	sexual victimization	C0376695
28072668	infection	C3714514
28072668	sexual contact	C2229923
28072668	contiguous spread	C0332261
28072668	infection	C3714514
28072668	infected assailant secretions	C0036537
28072668	patient	C0030705
28072668	symptoms	C1457887
28072668	sexual contact	C2229923
28072668	NG	C0948747
28072668	CT infections	C0518948
28072668	patients	C0030705
28072668	evaluated	C0220825
28072668	sexual victimization	C0376695
28074357	Longitudinal	C0205127
28074357	Effects of	C1704420
28074357	Parenting	C0679001
28074357	Adaptive Behavior	C0085880
28074357	Children	C0008059
28074357	Fragile X Syndrome	C0016667
28074357	studies	C2603343
28074357	declines	C0392756
28074357	adaptive behavior	C0085880
28074357	children	C0008059
28074357	fragile X syndrome	C0016667
28074357	FXS	C0016667
28074357	middle	C1254367
28074357	childhood	C0231335
28074357	examined	C0332128
28074357	effects of	C1704420
28074357	maternal	C0026591
28074357	responsivity	C2371924
28074357	adaptive behavior	C0085880
28074357	children	C0008059
28074357	FXS	C0016667
28074357	homes	C0442513
28074357	middle	C1254367
28074357	childhood	C0231335
28074357	analyses	C0936012
28074357	sustained	C0443318
28074357	maternal	C0026591
28074357	responsivity	C2371924
28074357	significant	C0750502
28074357	positive impact	C4049986
28074357	trajectories	C1254362
28074357	communication	C0009452
28074357	adaptive behavior	C0085880
28074357	domains	C1516778
28074357	middle	C1254367
28074357	childhood	C0231335
28074357	effects	C1280500
28074357	significant	C0750502
28074357	controlling	C2239193
28074357	autism symptoms	C4314700
28074357	developmental level	C0008071
28074357	children	C0008059
28074357	declines	C0392756
28074357	adaptive behavior	C0085880
28074357	middle	C1254367
28074357	childhood	C0231335
28074357	sustained	C0443318
28074357	high levels	C0441889
28074357	maternal	C0026591
28074357	responsivity	C2371924
28074357	minimized	C1524031
28074357	decline	C0392756
28074357	observed	C1441672
28074357	communication	C0009452
28074357	socialization	C0037447
28074357	daily living domains	C0683251
28076405	Development	C1527148
28076405	Validation	C1519941
28076405	Method	C0022885
28076405	Diagnosis	C0011900
28076405	Avian	C0005595
28076405	Botulism	C0006057
28076405	Liver	C0023884
28076405	matrix	C1706515
28076405	laboratory	C0022885
28076405	confirmation of	C0521091
28076405	avian	C0005595
28076405	botulism	C0006057
28076405	real-time PCR	C1709846
28076405	developed	C1527148
28076405	optimized	C2698650
28076405	validated	C1519941
28076405	analytical	C0936012
28076405	steps	C1261552
28076405	preceding	C0332152
28076405	PCR	C0032520
28076405	detection	C0442726
28076405	Clostridium botulinum group III	C4303900
28076405	avian	C0005595
28076405	liver	C0023884
28076405	pre	C0332152
28076405	PCR	C0032520
28076405	steps	C1261552
28076405	enrichment	C0010454
28076405	incubation	C1439852
28076405	liver	C0023884
28076405	37°C	C1545716
28076405	h	C0439227
28076405	anaerobic chamber	C0179876
28076405	DNA extraction	C3839098
28076405	enzymatic digestion	C0523169
28076405	DNA purification	C0872148
28076405	sample	C2347026
28076405	storage	C1698986
28076405	analysis	C0936012
28076405	effect	C1280500
28076405	detection	C0442726
28076405	group III C. botulinum strains	C4304189
28076405	results	C1274040
28076405	storage	C1698986
28076405	temperatures	C0039476
28076405	Short-term	C0443303
28076405	storage	C1698986
28076405	h	C0439227
28076405	decrease	C0547047
28076405	sensitivity	C0332324
28076405	h	C0439227
28076405	storage	C1698986
28076405	temperature	C0039476
28076405	Analysis	C0936012
28076405	livers	C0023884
28076405	pooling	C2349200
28076405	samples	C2347026
28076405	enrichment culturing	C0040284
28076405	Pooling	C2349200
28076405	DNA extraction	C3839098
28076405	livers	C0023884
28076405	enrichment medium	C0010454
28076405	Pulsifier® blender	C0492537
28076405	Surrey	C0454877
28076405	UK	C0041700
28076405	paddle blender	C0492537
28076405	Spiked liver	C0023884
28076405	samples	C2347026
28076405	detection	C0442726
28076405	spores	C0038028
28076405	liver	C0023884
28076405	types C	C4304189
28076405	D	C4304187
28076405	spores	C0038028
28076405	type E	C4303900
28076405	method	C0022885
28076405	developed	C1527148
28076405	analysis	C0936012
28076405	samples	C2347026
28076405	outbreaks	C0021149
28076405	specificity	C0037791
28076405	sensitivity	C0332324
28076405	compared	C1707455
28076405	PCR	C0032520
28076405	methods	C0022885
28076405	mosaic type C	C4304189
28076405	D	C4304187
28076405	neurotoxin	C0027934
28076405	samples	C2347026
28076405	wild	C0325328
28076405	domestic birds	C0324556
28077898	Quality Improvement	C2936612
28077898	Liver	C0023884
28077898	Ultrasound	C0041618
28077898	Images	C1704922
28077898	Fuzzy	C0162586
28077898	Techniques	C0025663
28077898	Liver	C0023884
28077898	ultrasound	C0041618
28077898	images	C1704922
28077898	diagnose	C0011900
28077898	diffuse liver diseases	C0023895
28077898	fatty liver	C0015695
28077898	low	C0205251
28077898	quality	C0332306
28077898	images	C1704922
28077898	analyze	C0936012
28077898	diagnose	C0011900
28077898	diseases	C0012634
28077898	study	C2603343
28077898	contrast	C1979874
28077898	quality	C0332306
28077898	liver	C0023884
28077898	ultrasound	C0041618
28077898	images	C1704922
28077898	study	C2603343
28077898	image	C1704922
28077898	contrast	C1979874
28077898	enhancement algorithms	C0002045
28077898	fuzzy logic	C0162586
28077898	liver	C0023884
28077898	ultrasound	C0041618
28077898	images	C1704922
28077898	kidney	C0022646
28077898	Matlab2013b	C0037585
28077898	image	C1704922
28077898	contrast	C1979874
28077898	quality	C0332306
28077898	fuzzy	C0162586
28077898	definition	C1704788
28077898	image	C1704922
28077898	contrast	C1979874
28077898	improvement	C2986411
28077898	algorithms	C0002045
28077898	fuzzy	C0162586
28077898	intensification operator	C0181273
28077898	contrast	C1979874
28077898	improvement	C2986411
28077898	algorithms	C0002045
28077898	fuzzy	C0162586
28077898	image	C1704922
28077898	histogram hyperbolization	C0025663
28077898	contrast	C1979874
28077898	improvement	C2986411
28077898	algorithms	C0002045
28077898	fuzzy	C0162586
28077898	IF-THEN rules	C0870077
28077898	measurement	C0242485
28077898	Mean Squared Error	C0743559
28077898	Peak	C0444505
28077898	Signal to Noise Ratio	C2986823
28077898	images	C1704922
28077898	fuzzy	C0162586
28077898	methods	C0025663
28077898	results	C1274040
28077898	implementation	C1708476
28077898	compared	C1707455
28077898	histogram equalization method	C0025663
28077898	improvement	C2986411
28077898	contrast	C1979874
28077898	visual quality	C0422976
28077898	images	C1704922
28077898	improvement	C2986411
28077898	liver	C0023884
28077898	segmentation algorithms	C0002045
28077898	images	C1704922
28077898	Comparison	C1707455
28077898	algorithms	C0002045
28077898	fuzzy logic	C0162586
28077898	image	C1704922
28077898	contrast	C1979874
28077898	compared	C1707455
28077898	image processing	C0178706
28077898	algorithms	C0002045
28077898	contrast	C1979874
28077898	improvement	C2986411
28077898	fuzzy	C0162586
28077898	intensification operator	C0181273
28077898	algorithm	C0002045
28077898	method	C0025663
28077898	studies	C2603343
28077898	ultrasound	C0041618
28077898	images	C1704922
28077898	quality improvement	C2936612
28077898	image processing	C0178706
28077898	analysis	C0936012
28077898	applications	C4048755
28078640	Development	C1527148
28078640	pediatric quality of life inventory	C2698752
28078640	neurofibromatosis type 1	C0027831
28078640	module	C3542953
28078640	items	C0871509
28078640	children	C0008059
28078640	adolescents	C0205653
28078640	young adults	C0238598
28078640	qualitative methods	C0681940
28078640	Health-related quality of life	C4279947
28078640	HRQOL	C4279947
28078640	important	C3898777
28078640	measures	C0079809
28078640	evaluating	C0220825
28078640	effectiveness	C1280519
28078640	clinical treatments	C1516635
28078640	disease	C0012634
28078640	specific	C0205369
28078640	outcome measure	C0086749
28078640	assess	C0184514
28078640	HRQOL	C4279947
28078640	children	C0008059
28078640	adolescents	C0205653
28078640	young adults	C0238598
28078640	Neurofibromatosis Type 1	C0027831
28078640	NF1	C0027831
28078640	study	C2603343
28078640	items	C0871509
28078640	content validity	C1510592
28078640	Pediatric Quality of Life Inventory™	C2698752
28078640	PedsQL™	C2698752
28078640	NF1	C0027831
28078640	Module	C3542953
28078640	children	C0008059
28078640	adolescents	C0205653
28078640	young adults	C0238598
28078640	iterative	C1854293
28078640	process	C1522240
28078640	multiphase qualitative methods	C0681940
28078640	literature review	C0282441
28078640	survey	C0038951
28078640	expert opinions	C0600219
28078640	semi-structured interviews	C0021822
28078640	cognitive	C1516691
28078640	interviews	C0021822
28078640	pilot testing	C0031928
28078640	domains	C1880389
28078640	qualitative methods	C0681940
28078640	content	C0456205
28078640	items	C0871509
28078640	domains	C1880389
28078640	skin	C1123023
28078640	pain	C0030193
28078640	pain	C0030193
28078640	impact	C4049986
28078640	pain management	C0002766
28078640	cognitive functioning	C0392335
28078640	speech	C0037817
28078640	fine motor	C0678857
28078640	balance	C0205415
28078640	vision	C0042789
28078640	perceived	C0030971
28078640	physical appearance	C0750731
28078640	communication	C0009452
28078640	worry	C0233481
28078640	treatment	C0087111
28078640	medicines	C0013227
28078640	gastrointestinal symptoms	C0426576
28078640	limited	C0439801
28078640	participants	C0679646
28078640	single	C0205171
28078640	site	C0205145
28078640	Qualitative methods	C0681940
28078640	content validity	C1510592
28078640	PedsQL™	C2698752
28078640	NF1	C0027831
28078640	Module	C3542953
28078640	children	C0008059
28078640	adolescents	C0205653
28078640	young adults	C0238598
28078640	PedsQL™	C2698752
28078640	NF1	C0027831
28078640	Module	C3542953
28078640	national multisite field testing	C0039593
28078640	psychometric	C0033920
28078640	validation	C1519941
28078640	instrument	C0038951
28078640	development	C1527148
28079476	Mimiviruses	C1671055
28079476	Human	C0086418
28079476	Interferon	C3652465
28079476	System	C0020962
28079476	Viral Evasion	C1154492
28079476	Classical	C0443177
28079476	Antiviral Activities	C1155328
28079476	Inhibition	C3463820
28079476	Interferon-β	C0015980
28079476	Regulated	C1327622
28079476	Immunomodulatory	C1963758
28079476	Pathway	C1705987
28079476	review	C0282443
28079476	role	C1705810
28079476	mimiviruses	C1671055
28079476	potential	C3245505
28079476	human	C0086418
28079476	pathogens	C0450254
28079476	clinical	C0205210
28079476	evolutionary	C0015219
28079476	evidence	C3887511
28079476	propose	C1553874
28079476	antiviral	C1155328
28079476	immunomodulatory	C0005525
28079476	pathway	C1705987
28079476	controlled	C2587213
28079476	interferon-β	C0015980
28079476	IFN-β	C0015980
28079476	immune-responsive gene 1	C3253749
28079476	IRG1	C3253749
28079476	itaconic acid	C0064110
28079476	product	C1514468
28079476	Acanthamoeba polyphaga Mimivirus	C1644952
28079476	APMV	C1644952
28079476	isolated	C0205409
28079476	amoebae	C0002642
28079476	hospital	C0019994
28079476	investigating	C1292732
28079476	pneumonia	C0032285
28079476	outbreak	C0012652
28079476	Mimivirus	C1671055
28079476	ubiquity	C0205556
28079476	role	C1705810
28079476	protist	C0597305
28079476	pathogens	C0450254
28079476	putative	C0205124
28079476	status	C1442792
28079476	human	C0086418
28079476	pathogen	C0450254
28079476	gaining	C1517378
28079476	strength	C0808080
28079476	evidence	C3887511
28079476	study	C2603343
28079476	APMV	C1644952
28079476	human	C0086418
28079476	cells	C0007634
28079476	interaction	C1752856
28079476	virus	C1671055
28079476	evade	C1654934
28079476	IFN	C0021747
28079476	system	C0020962
28079476	inhibiting	C3463820
28079476	regulation	C0017263
28079476	interferon	C3652465
28079476	genes	C0017337
28079476	virus	C1671055
28079476	humans	C0086418
28079476	host-pathogen interactions	C1752856
28079476	virus	C1671055
28079476	capable	C2698977
28079476	IFN-α2	C2937361
28079476	IFN-β	C0015980
28079476	treated	C1522326
28079476	cells	C0007634
28079476	exclusive	C1548966
28079476	IFN-β	C0015980
28079476	antiviral	C1155328
28079476	pathway	C1705987
28079476	hypothesis	C1512571
28079476	based	C1705938
28079476	preliminary data	C1548161
28079476	published articles	C1706852
28079476	IFN-β	C0015980
28079476	preferentially	C0558295
28079476	upregulates	C0041904
28079476	IRG1 in human	C3253749
28079476	macrophagic cells	C0024432
28079476	itaconic acid	C0064110
28079476	metabolite	C0870883
28079476	metabolism	C0025519
28079476	antiviral activity	C1155328
28079476	inactivating	C0544461
28079476	virus	C1671055
28079476	immunomodulatory	C1963758
28079476	pathway	C1705987
28079476	relevant	C2347946
28079476	APMV	C1644952
28079476	infections	C3714514
28079476	infectious diseases	C0009450
28080032	Heteroprotein	C0033684
28080032	Complex	C1704241
28080032	Bovine Lactoferrin	C1440867
28080032	Pea Protein	C3535674
28080032	Isolate	C1875400
28080032	Associative	C0205556
28080032	electrostatic interactions	C0683119
28080032	oppositely	C0205556
28080032	charged	C1706211
28080032	globular proteins	C0178663
28080032	lactoferrin	C0022942
28080032	LF	C0022942
28080032	pea protein	C3535674
28080032	isolate	C1875400
28080032	PPI	C3535674
28080032	mixture	C0439962
28080032	vicilin	C0078228
28080032	legumin	C0064738
28080032	convicilin	C0056265
28080032	studied	C2603343
28080032	specific	C0205369
28080032	PPI	C3535674
28080032	LF	C0022942
28080032	molar ratio	C2825550
28080032	room temperature	C1822393
28080032	Structural	C0678594
28080032	aspects	C1879746
28080032	electrostatic	C0376534
28080032	complexes	C1704241
28080032	different	C1705242
28080032	length	C1444754
28080032	scales	C0449286
28080032	investigated	C1292732
28080032	function	C0542341
28080032	pH	C0020283
28080032	different	C1705242
28080032	complementary techniques	C0449851
28080032	dynamic light scattering	C1882368
28080032	small-angle X-ray scattering	C1537058
28080032	SAXS	C1660735
28080032	turbidity measurements	C2700094
28080032	atomic force microscopy	C0242849
28080032	AFM	C0242849
28080032	techniques	C0449851
28080032	results	C0456984
28080032	consistently	C0332290
28080032	displayed	C0870432
28080032	complexation	C1704241
28080032	LF	C0022942
28080032	PPI	C3535674
28080032	occur	C1709305
28080032	optimum	C2698651
28080032	narrow	C0333164
28080032	range	C1514721
28080032	pH	C0020283
28080032	viscous	C0311419
28080032	liquid	C1304698
28080032	phase	C0205390
28080032	complex	C1704241
28080032	coacervate	C0302908
28080032	obtained	C1301820
28080032	centrifugation	C0007703
28080032	turbid	C0311420
28080032	LF	C0022942
28080032	PPI	C3535674
28080032	mixture	C0439962
28080032	maximum	C0806909
28080032	turbidity	C0301633
28080032	ζ-potential	C0597697
28080032	observed	C1441672
28080032	pH	C0020283
28080032	SAXS	C1660735
28080032	data	C1511726
28080032	coacervates	C0302908
28080032	densely	C0439794
28080032	assembled	C1706853
28080032	roughly	C0205556
28080032	spherical	C0332501
28080032	size	C0456389
28080032	distribution	C0037775
28080032	maximum	C0806909
28080032	extension	C0231448
28080032	pH	C0020283
28080032	AFM	C0242849
28080032	image analysis	C0200765
28080032	size	C0456389
28080032	distributions	C0037775
28080032	containing	C0332256
28080032	frequent	C0332183
28080032	cluster	C1704332
28080032	sizes	C0456389
28080032	spherical	C0332501
28080032	elliptical shapes	C1947977
28080032	frequent	C0332183
28080032	chainlike	C0205556
28080032	structures	C0678594
28080032	frequently	C0332183
28080032	observed	C1441672
28080032	complexes	C1704241
28080032	LF	C0022942
28080032	PPI	C3535674
28080032	coacervation	C1882365
28080032	frequent	C0332183
28080032	chain-like aggregates	C0205418
28080032	PPI	C3535674
28080032	PPI	C3535674
28080032	complexes	C1704241
28084862	Visual	C0234621
28084862	outcome	C1274040
28084862	endocrine function	C0678896
28084862	tumor	C0027651
28084862	control	C2587213
28084862	fractionated stereotactic radiation therapy	C4289264
28084862	craniopharyngiomas in adults	C0278875
28084862	prospective cohort	C1709709
28084862	study	C2603343
28084862	examine	C0582103
28084862	visual	C0234621
28084862	outcome	C1274040
28084862	endocrine function	C0678896
28084862	tumor	C0027651
28084862	control	C2587213
28084862	prospective cohort	C1709709
28084862	craniopharyngioma	C0010276
28084862	patients	C0030705
28084862	treated with	C0332293
28084862	fractionated stereotactic radiation therapy	C4289264
28084862	FSRT	C4289264
28084862	adult	C0001675
28084862	patients	C0030705
28084862	craniopharyngiomas	C0010276
28084862	eligible	C1548635
28084862	analysis	C0936012
28084862	treated with	C0332293
28084862	linear accelerator-based	C0221878
28084862	FSRT	C4289264
28084862	cases	C1706256
28084862	diagnosis	C1704656
28084862	histological	C0205462
28084862	analysis	C0936012
28084862	prescription	C0033080
28084862	dose	C0178602
28084862	tumor	C0027651
28084862	Gy	C0556636
28084862	median	C0876920
28084862	range	C1514721
28084862	Gy	C0556636
28084862	fraction	C1264633
28084862	radiation dose	C4019308
28084862	optic nerves	C0029130
28084862	chiasm	C0029126
28084862	Gy	C0556636
28084862	median	C0876920
28084862	range	C1514721
28084862	cohort	C0599755
28084862	ophthalmological	C0200149
28084862	endocrine evaluations	C2960670
28084862	magnetic resonance imaging	C0024485
28084862	MRI	C0024485
28084862	scans	C0441633
28084862	Median	C0876920
28084862	follow-up	C1522577
28084862	years	C0439234
28084862	range	C1514721
28084862	years	C0439234
28084862	range	C1514721
28084862	years	C0439234
28084862	range	C1514721
28084862	visual	C0234621
28084862	outcome	C1274040
28084862	endocrine function	C0678896
28084862	tumor	C0027651
28084862	control	C2587213
28084862	Visual acuity	C0042812
28084862	impairment	C0221099
28084862	patients	C0030705
28084862	visual field defects	C3887875
28084862	patients	C0030705
28084862	FSRT	C4289264
28084862	patient	C0030705
28084862	radiation-induced optic neuropathy	C4302401
28084862	years	C0439234
28084862	FSRT	C4289264
28084862	patients	C0030705
28084862	pituitary deficiency	C0020635
28084862	FSRT	C4289264
28084862	pituitary deficiency	C0020635
28084862	FSRT	C4289264
28084862	Mean	C0444504
28084862	tumor volume	C0475276
28084862	FSRT	C4289264
28084862	range	C1514721
28084862	FSRT	C4289264
28084862	range	C1514721
28084862	Tumor	C0027651
28084862	control	C2587213
28084862	rate	C1521828
28084862	years	C0439234
28084862	FSRT	C4289264
28084862	FSRT	C4289264
28084862	cohort	C0599755
28084862	craniopharyngiomas	C0010276
28084862	case	C1706256
28084862	radiation-induced optic neuropathy	C4302401
28084862	case	C1706256
28084862	endocrinopathy	C0014130
28084862	Tumor	C0027651
28084862	control	C2587213
28084862	rate	C1521828
28086772	Scutellaria barbata D. Don extract	C1999758
28086772	inhibits	C3463820
28086772	tumor growth	C0598934
28086772	down-regulating	C0013081
28086772	Treg cells	C0039198
28086772	manipulating	C2584326
28086772	Th1	C1155080
28086772	Th17 immune response	C3156592
28086772	hepatoma H22	C0677626
28086772	mice	C0025929
28086772	Scutellaria barbata D. Don extract	C1999758
28086772	SBE	C1999758
28086772	inhibitor	C0018282
28086772	hepatoma	C0023903
28086772	immune function	C1817756
28086772	hepatoma H22	C0677626
28086772	mice	C0025929
28086772	immunomodulatory function	C1148560
28086772	SBE	C1999758
28086772	tumor growth	C0598934
28086772	hepatoma	C0023903
28086772	unclear	C3845108
28086772	study	C2603343
28086772	investigate	C1292732
28086772	anti-tumor	C2986475
28086772	effects	C1280500
28086772	SBE	C1999758
28086772	hepatoma H22	C0677626
28086772	mice	C0025929
28086772	immunomodulatory function	C1148560
28086772	hepatoma H22	C0677626
28086772	mice	C0025929
28086772	treated	C1522326
28086772	SBE	C1999758
28086772	days	C0439228
28086772	effect of	C1704420
28086772	SBE	C1999758
28086772	proliferation	C0596290
28086772	HepG2 cells	C2717940
28086772	in vitro	C1533691
28086772	growth of transplanted tumor	C0598934
28086772	cytotoxicity of natural killer (NK) cells	C1159807
28086772	spleen	C0037993
28086772	amount	C1265611
28086772	CD4(+)CD25(+)Foxp3(+) Treg cells	C3830403
28086772	Th17 cells	C2936411
28086772	tumor tissue	C0475358
28086772	levels	C0441889
28086772	IL-10	C3179724
28086772	TGF-β	C0076930
28086772	IL-17A	C1705947
28086772	IL-2	C0021756
28086772	IFN-γ	C0211279
28086772	serum	C0229671
28086772	hepatoma H22	C0677626
28086772	mice	C0025929
28086772	IL-17A	C1705947
28086772	injected	C0449894
28086772	SBE	C1999758
28086772	treated	C1522326
28086772	mice	C0025929
28086772	day	C0439228
28086772	post	C0687676
28086772	H22	C0677626
28086772	inoculation	C2987620
28086772	effect	C1280500
28086772	tumor growth	C0598934
28086772	SBE	C1999758
28086772	treatment	C1522326
28086772	inhibited	C0311403
28086772	proliferation	C0596290
28086772	HepG2 cells	C2717940
28086772	in vitro	C1533691
28086772	dose-dependent manner	C0205245
28086772	suppressed	C1260953
28086772	tumor growth	C0598934
28086772	hepatoma H22	C0677626
28086772	mice	C0025929
28086772	increased	C0205217
28086772	NK cells' cytotoxicity	C1159807
28086772	spleen	C0037993
28086772	down-regulated	C0013081
28086772	amount	C1265611
28086772	CD4(+)CD25(+)Foxp3(+) Treg cells	C3830403
28086772	Th17 cells	C2936411
28086772	tumor tissue	C0475358
28086772	decreased	C0205216
28086772	IL-10	C3179724
28086772	TGF-β	C0076930
28086772	IL-17A	C1705947
28086772	levels	C0441889
28086772	increased	C0205217
28086772	IL-2	C0021756
28086772	IFN-γ	C0211279
28086772	levels	C0441889
28086772	serum	C0229671
28086772	hepatoma H22	C0677626
28086772	mice	C0025929
28086772	administration	C0001555
28086772	recombinant mouse	C0025929
28086772	IL-17A	C1705947
28086772	reversed	C1555029
28086772	anti-tumor	C2986475
28086772	effects	C1280500
28086772	SBE	C1999758
28086772	SBE	C1999758
28086772	inhibit	C3463820
28086772	proliferation	C0596290
28086772	HepG2 cells	C2717940
28086772	in vitro	C1533691
28086772	SBE	C1999758
28086772	inhibit	C3463820
28086772	growth	C0007595
28086772	H22	C0677626
28086772	implanted tumor	C0027651
28086772	hepatoma H22	C0677626
28086772	mice	C0025929
28086772	function	C0542341
28086772	associated with	C0332281
28086772	immunomodulatory activity	C1148560
28086772	down-regulating	C0013081
28086772	Treg cells	C0039198
28086772	manipulating	C2584326
28086772	Th1	C1155080
28086772	Th17 immune response	C3156592
28086838	Clinical characteristics	C0683325
28086838	genital chlamydia infection	C0847922
28086838	pelvic inflammatory disease	C0242172
28086838	Chlamydia infection	C0008149
28086838	acute pelvic inflammatory disease	C0149959
28086838	PID	C0242172
28086838	complications	C0009566
28086838	ectopic pregnancy	C0032987
28086838	tubal infertility	C0156415
28086838	Fitz-Hugh-Curtis syndrome	C0549148
28086838	tubo-ovarian abscess	C0041343
28086838	TOA	C0041343
28086838	study	C2603343
28086838	clinical	C1516606
28086838	laboratory data	C1517709
28086838	PID	C0242172
28086838	chlamydia infection	C0008149
28086838	medical records	C0025102
28086838	women	C0043210
28086838	PID	C0242172
28086838	patients	C0030705
28086838	groups	C1257890
28086838	PID	C0242172
28086838	chlamydia infection	C0008149
28086838	patients' characteristics	C0815172
28086838	clinical presentation	C2708283
28086838	laboratory findings	C0587081
28086838	inflammatory	C0333348
28086838	markers	C0005516
28086838	chlamydia	C1257890
28086838	non-chlamydia groups	C1257890
28086838	women	C0043210
28086838	patients	C0030705
28086838	chlamydia group	C1257890
28086838	younger	C0332239
28086838	TOA	C0041343
28086838	mean	C0444504
28086838	hospital stay	C3489408
28086838	surgeries	C0543467
28086838	patients	C0030705
28086838	non- chlamydia group	C1257890
28086838	erythrocyte sedimentation rate	C1619634
28086838	ESR	C1619634
28086838	C-reactive protein	C0006560
28086838	CRP	C0006560
28086838	CA-125	C0006610
28086838	level	C0441889
28086838	chlamydia group	C1257890
28086838	non-chlamydia group	C1257890
28086838	significant	C0750502
28086838	white blood cell count	C2186576
28086838	groups	C1257890
28086838	CA-125	C0006610
28086838	level	C0441889
28086838	predictor	C2698872
28086838	chlamydia infection	C0008149
28086838	ESR	C1619634
28086838	CRP	C0006560
28086838	level	C0441889
28086838	area	C0205146
28086838	receiving operating curve	C0035787
28086838	CA-125	C0006610
28086838	ESR	C1619634
28086838	CRP	C0006560
28086838	Chlamydia infection	C0008149
28086838	acute PID	C0149959
28086838	level	C0441889
28086838	inflammatory	C0333348
28086838	markers	C0005516
28086838	CA-125	C0006610
28086838	ESR	C1619634
28086838	CRP	C0006560
28086838	TOA	C0041343
28086838	operation	C0543467
28086838	risk	C0035647
28086838	hospitalization	C0019993
28087131	Incidence	C0021149
28087131	effect of	C1704420
28087131	variant	C0205419
28087131	histology	C0019638
28087131	oncological outcomes	C0085415
28087131	patients	C0030705
28087131	bladder cancer	C0005684
28087131	treated	C1522326
28087131	radical cystectomy	C0194401
28087131	incidence	C0021149
28087131	histological	C0205462
28087131	variants	C0205419
28087131	radical cystectomy	C0194401
28087131	RC	C0194401
28087131	bladder cancer	C0005684
28087131	BCa	C0005684
28087131	survival	C0220921
28087131	outcomes	C0085415
28087131	retrospectively	C1514923
28087131	evaluated	C0220825
28087131	data	C1511726
28087131	patients	C0030705
28087131	BCa	C0005684
28087131	treated	C1522326
28087131	RC	C0194401
28087131	single tertiary care referral center	C0587437
28087131	specimen	C0370003
28087131	evaluated	C0220825
28087131	uropathologists	C1522486
28087131	Univariable and multivariable Cox regression analyses	C0034980
28087131	effect of	C1704420
28087131	histopathological	C0243140
28087131	variant	C0205419
28087131	recurrence	C0034897
28087131	cancer-specific mortality	C1516192
28087131	CSM	C1516192
28087131	overall mortality	C0205848
28087131	OM	C0205848
28087131	confounders	C0009673
28087131	patients	C0030705
28087131	pure urothelial BCa	C0751571
28087131	variant	C0205419
28087131	variants	C0205419
28087131	sarcomatoid	C0205697
28087131	lymphoepitelial	C0334254
28087131	small cell	C0262584
28087131	squamous	C0007137
28087131	micropapillary	C3472608
28087131	glandular	C0205854
28087131	variants	C0205419
28087131	variants	C0205419
28087131	median	C0876920
28087131	follow-up	C1522577
28087131	years	C0439234
28087131	recurrence	C0034897
28087131	CSM	C1516192
28087131	OM	C0205848
28087131	multivariable Cox regression analyses	C0034980
28087131	small cell variant	C0262584
28087131	associated with	C0332281
28087131	recurrence	C0034897
28087131	hazard ratio	C2985465
28087131	HR	C2985465
28087131	CSM	C1516192
28087131	HR	C2985465
28087131	OM	C0205848
28087131	HR	C2985465
28087131	urothelial cancer	C0751571
28087131	no survival differences	C3842396
28087131	histological	C0205462
28087131	variants	C0205419
28087131	study	C1706256
28087131	histological	C0205462
28087131	variant	C0205419
28087131	RC	C0194401
28087131	specimen	C0370003
28087131	single-center series	C1708333
28087131	patients	C0030705
28087131	small cell variant	C0262584
28087131	associated with	C0332281
28087131	negative	C0205160
28087131	effect	C1280500
28087131	survival	C0220921
28087131	RC	C0194401
28087217	Psychometric	C0033920
28087217	properties	C0871161
28087217	Japanese	C0376247
28087217	version	C0333052
28087217	short forms	C2964478
28087217	Pain Catastrophizing Scale	C4273905
28087217	participants	C0679646
28087217	musculoskeletal pain	C0026858
28087217	cross-sectional study	C0010362
28087217	Pain Catastrophizing Scale	C4273905
28087217	PCS	C4273905
28087217	measure	C0079809
28087217	pain catastrophizing	C3178745
28087217	scale	C4273905
28087217	items	C0871509
28087217	magnification	C0430022
28087217	rumination	C0232604
28087217	helplessness	C0150063
28087217	screening	C1710032
28087217	reduce	C0392756
28087217	participant's	C0679646
28087217	burden	C2828008
28087217	item	C0871509
28087217	item	C0871509
28087217	short forms	C2964478
28087217	English	C0376245
28087217	version	C0333052
28087217	PCS	C4273905
28087217	study	C2603343
28087217	evaluate	C0220825
28087217	psychometric	C0033920
28087217	properties	C0871161
28087217	Japanese	C0376247
28087217	version	C0333052
28087217	short forms	C2964478
28087217	PCS	C4273905
28087217	approach	C1292724
28087217	Rasch analysis	C0242481
28087217	patients	C0030705
28087217	musculoskeletal disorders	C0026857
28087217	study	C2603343
28087217	Participants	C0679646
28087217	study	C2603343
28087217	measures	C0079809
28087217	pain intensity	C1320357
28087217	Pain Catastrophizing Scale	C4273905
28087217	PCS	C4273905
28087217	Tampa Scale of Kinesiophobia	C0349674
28087217	TSK	C0349674
28087217	item	C0871509
28087217	items	C0871509
28087217	item	C0871509
28087217	items	C0871509
28087217	short forms	C2964478
28087217	Japanese	C0376247
28087217	version	C0333052
28087217	PCS	C4273905
28087217	Rasch analysis	C0242481
28087217	analyze	C1524024
28087217	psychometric	C0033920
28087217	properties	C0871161
28087217	item	C0871509
28087217	item	C0871509
28087217	short forms	C2964478
28087217	PCS	C4273905
28087217	Rasch analysis	C0242481
28087217	short forms	C2964478
28087217	PCS	C4273905
28087217	consistency	C0332529
28087217	unidimensionality	C1707753
28087217	functional	C0205245
28087217	category rating scale	C0349674
28087217	item	C0871509
28087217	short form	C2964478
28087217	PCS	C4273905
28087217	items	C0871509
28087217	item	C0871509
28087217	short form	C2964478
28087217	PCS	C4273905
28087217	psychometric	C0033920
28087217	properties	C0871161
28087217	participants	C0679646
28087217	musculoskeletal pain	C0026858
28087217	item	C0871509
28087217	instruments	C0348000
28087217	evaluate	C0220825
28087217	pain catastrophizing	C3178745
28088177	quantitative PCR	C1709846
28088177	Babesia	C0004572
28088177	infection	C3714514
28088177	patients	C0030705
28088177	non-nucleic acid amplification tests	C1441475
28088177	Ticks	C0040203
28088177	transmit	C1444006
28088177	Babesia microti	C0004574
28088177	causative agents	C0449411
28088177	babesiosis	C0004576
28088177	North America	C0028405
28088177	Europe	C0015176
28088177	Babesiosis	C0004576
28088177	endemic	C0277550
28088177	Northeastern	C0017446
28088177	USA	C0041703
28088177	people	C0027361
28088177	ages	C0001779
28088177	Babesia species	C0004572
28088177	erythrocytes	C0014792
28088177	transmitted	C0242781
28088177	blood transfusion	C0005841
28088177	Whole blood	C0370231
28088177	blood products	C0456388
28088177	Babesia	C0004572
28088177	transfusion	C0005841
28088177	transmitted	C0242781
28088177	babesiosis	C0004576
28088177	TTB	C0004576
28088177	severe	C0205082
28088177	consequences	C0686907
28088177	immuno-compromised	C0085393
28088177	patients	C0030705
28088177	study	C2603343
28088177	epidemiological evaluation	C0002783
28088177	babesiosis	C0004576
28088177	tick-infested state	C0040196
28088177	examined	C0332128
28088177	blood samples	C0178913
28088177	patients	C0030705
28088177	clinics	C0442592
28088177	tick-borne diseases	C0040196
28088177	season	C0036497
28088177	qPCR assay	C1709846
28088177	molecular beacon probe	C0028630
28088177	absence	C0332197
28088177	symptomology	C1457887
28088177	clinical laboratories	C1882331
28088177	samples	C0178913
28088177	IFA	C0282647
28088177	FISH	C0162789
28088177	microscopic examination	C0026018
28088177	Giemsa-stained	C0017542
28088177	blood smears	C2238079
28088177	Babesia	C0004572
28088177	infection	C3714514
28088177	age groups	C0027362
28088177	FISH	C0162789
28088177	microscopy	C0026018
28088177	patients	C0030705
28088177	years	C0439234
28088177	age	C0001779
28088177	samples	C0178913
28088177	younger	C0332239
28088177	patients	C0030705
28088177	samples	C0178913
28088177	qPCR	C1709846
28088177	positive	C1446409
28088177	Babesia	C0004572
28088177	samples	C0178913
28088177	positive	C1446409
28088177	FISH	C0162789
28088177	positive	C1446409
28088177	qPCR	C1709846
28088177	nucleic acid based tests	C0200932
28088177	asymptomatic	C0231221
28088177	samples	C0178913
28088177	FISH	C0162789
28088177	positive	C1446409
28088177	qPCR	C1709846
28088177	detection	C1511790
28088177	Babesia	C0004572
28088177	microscopic examination	C0026018
28088177	patient	C0030705
28088177	blood smears	C2238079
28088177	clinical laboratory	C1882331
28088177	examined	C0332128
28088177	blood samples	C0178913
28088177	counties	C0454664
28088177	microscopy	C0026018
28088177	individuals	C0237401
28088177	positive	C1446409
28088177	Babesia	C0004572
28088177	infection	C3714514
28088177	microscopy	C0026018
28088177	FISH	C0162789
28088177	serological tests	C0036743
28088177	positive	C1446409
28088177	qPCR	C1709846
28088177	sensitive	C0332324
28088177	specificity	C0037791
28088177	Babesia	C0004572
28088177	qPCR	C1709846
28088177	probes	C0026381
28088177	diagnosis	C1704656
28088177	babesiosis	C0004576
28088177	patients	C0030705
28088177	diagnostics	C1511890
28088177	blood screening	C1511226
28088177	nucleic acid amplification test	C0200932
28088177	screening of blood	C1511226
28088177	blood products	C0456388
28088177	TTB	C0004576
28088402	Historical relationships	C0019659
28088402	enigmatic	C0205556
28088402	phasianid genera	C0325635
28088402	Aves	C0005595
28088402	Galliformes	C0325589
28088402	phylogenomic and mitogenomic data	C2346460
28088402	phylogeny	C0031797
28088402	Phasianidae	C0325635
28088402	pheasants	C0999292
28088402	partridges	C1828284
28088402	allies	C3973343
28088402	enigmatic genera	C0205556
28088402	scarce	C0231180
28088402	DNA	C0012854
28088402	source material	C0449416
28088402	phylogenetic data	C0872179
28088402	blood pheasants	C1035898
28088402	Ithaginis	C1035898
28088402	snow partridges	C3684199
28088402	Lerwa	C3684199
28088402	long-billed partridges	C2291854
28088402	Rhizothera	C2291854
28088402	phylogenetic positions	C0314647
28088402	phylogeny	C0031797
28088402	data	C1511726
28088402	Lerwa	C3684199
28088402	Ithaginis	C1035898
28088402	overlapping data	C1948020
28088402	relationship	C0439849
28088402	Rhizothera	C2291854
28088402	Perdix	C0999297
28088402	true partridges	C0999297
28088402	cytochrome b	C0010744
28088402	CYB	C0010744
28088402	sister	C1546515
28088402	Pucrasia	C0999301
28088402	koklass pheasant	C0999301
28088402	relationships	C0439849
28088402	Ithaginis	C1035898
28088402	Lerwa	C3684199
28088402	Rhizothera	C2291854
28088402	phasianid relatives	C0325635
28088402	ultra-conserved element (UCE) loci	C0678933
28088402	mitogenomes	C0017428
28088402	species	C1705920
28088402	hypothesized	C1512571
28088402	relatives	C0439849
28088402	phasianid clades	C0325635
28088402	DNA extracted	C0012854
28088402	specimen toepads	C1848515
28088402	lacked fresh tissue	C2711421
28088402	museum collections	C0200345
28088402	multispecies coalescent UCE analyses	C0026757
28088402	Lerwa	C3684199
28088402	sister	C1546515
28088402	large clade	C0325635
28088402	Ithaginis	C1035898
28088402	turkey	C3669390
28088402	grouse	C0325618
28088402	pheasants	C0999292
28088402	tragopans	C0325686
28088402	Pucrasia	C0999301
28088402	Perdix	C0999297
28088402	Rhizothera	C2291854
28088402	clade	C0325635
28088402	sister	C1546515
28088402	Perdix	C0999297
28088402	pheasants	C0999292
28088402	Pucrasia	C0999301
28088402	turkey	C3669390
28088402	grouse	C0325618
28088402	Mitogenomic genealogies	C0017298
28088402	UCEs topologies	C0205245
28088402	sister relationship	C1546515
28088402	Ithaginis	C1035898
28088402	Lerwa	C3684199
28088402	Rhizothera	C2291854
28088402	mitogenomes	C0017428
28088402	analytical choices	C0936012
28088402	codon-based analyses	C0162802
28088402	Rhizothera	C2291854
28088402	sister	C1546515
28088402	tragopan clade	C0325635
28088402	DNA model	C0026343
28088402	mitogenome	C0017428
28088402	congruent	C0439853
28088402	UCE results	C0243095
28088402	mitogenome analyses	C3854164
28088402	Pucrasia	C0999301
28088402	sister	C1546515
28088402	clade	C0325635
28088402	Perdix	C0999297
28088402	pheasants	C0999292
28088402	published nuclear intron data	C0993637
28088402	topology	C0178476
28088402	UCE analyses	C0178476
28088402	phylogenetic	C0031797
28088402	relationships	C0439849
28088402	enigmatic	C0205556
28088402	phasianid taxa	C0325635
28091848	novel	C0205314
28091848	treatment	C1522326
28091848	stimulate	C1292856
28091848	bone healing	C1321023
28091848	regeneration	C0005972
28091848	hypoxic conditions	C0242184
28091848	photobiomodulation	C4019433
28091848	melatonin	C0025219
28091848	Melatonin	C0025219
28091848	anabolic effects	C3179309
28091848	bone	C0391978
28091848	hypoxia	C0242184
28091848	laser irradiation	C0871799
28091848	osteoblastic differentiation	C1159974
28091848	aim	C1947946
28091848	study	C2603343
28091848	investigate	C1292732
28091848	laser irradiation	C0871799
28091848	melatonin	C0025219
28091848	synergistic	C2986495
28091848	effects	C1280500
28091848	osteoblastic differentiation	C1159974
28091848	mineralization	C2350989
28091848	hypoxic conditions	C0242184
28091848	MC3T3-E1 cells	C0007634
28091848	oxygen tension	C0860755
28091848	hypoxia condition	C0242184
28091848	cells	C0007634
28091848	groups	C0441833
28091848	G1	C0441833
28091848	osteoblast differentiation	C1159974
28091848	medium	C0010454
28091848	hypoxic condition	C0242184
28091848	G2	C0441833
28091848	treatment	C1522326
28091848	melatonin	C0025219
28091848	G3	C0441833
28091848	laser irradiation	C0871799
28091848	GaAlAs diode	C0392255
28091848	G4	C0441833
28091848	treatment	C1522326
28091848	melatonin	C0025219
28091848	laser irradiation	C0871799
28091848	GaAlAs diode	C0392255
28091848	Immunoblotting	C0020985
28091848	osterix	C1312518
28091848	expression	C1171362
28091848	increased	C0205217
28091848	melatonin	C0025219
28091848	treated	C1522326
28091848	laser-irradiated	C0871799
28091848	cells	C0007634
28091848	alkaline phosphatase	C0002059
28091848	activity	C0441655
28091848	increased	C0205217
28091848	continued	C0549178
28091848	experiment	C0681814
28091848	Alizarin Red staining	C1318906
28091848	increased	C0205217
28091848	mineralized	C2350989
28091848	nodules	C0035441
28091848	melatonin	C0025219
28091848	treated	C1522326
28091848	laser-irradiated	C0871799
28091848	cells	C0007634
28091848	increased	C0205217
28091848	melatonin	C0025219
28091848	treated	C1522326
28091848	cells	C0007634
28091848	laser-irradiated	C0871799
28091848	differentiation	C0007589
28091848	mineralization	C2350989
28091848	cells	C0007634
28091848	p38 MAPK	C1120843
28091848	PRKD1	C2987025
28091848	signaling mechanisms	C0037083
28091848	enhanced	C2349975
28091848	effects of	C1704420
28091848	laser irradiation	C0871799
28091848	melatonin	C0025219
28091848	inhibited	C0311403
28091848	cells	C0007634
28091848	treated	C1522326
28091848	luzindole	C0065275
28091848	melatonin receptor antagonist	C2917356
28091848	laser irradiation	C0871799
28091848	effect of	C1704420
28091848	melatonin	C0025219
28091848	differentiation	C0007589
28091848	mineralization	C2350989
28091848	MC3T3-E1 cells	C0007634
28091848	hypoxic conditions	C0242184
28091848	melatonin 1/2 receptors	C0065911
28091848	PKRD	C2987025
28091848	p38	C1120843
28091848	signaling pathways	C0037080
28092112	Aquaporin-2	C0213238
28092112	excretion	C1373187
28092112	hospitalized patients	C0870668
28092112	cirrhosis	C1623038
28092112	development	C1527148
28092112	renal insufficiency	C1565489
28092112	mortality	C0205848
28092112	Urinary	C1524119
28092112	aquaporin-2	C0213238
28092112	AQP2	C0213238
28092112	water transport	C1159571
28092112	principal cells	C0007634
28092112	distal part	C0005898
28092112	nephron	C0027713
28092112	water retention	C2584327
28092112	cirrhosis	C1623038
28092112	marker	C0005516
28092112	renal function	C0232804
28092112	aim	C1947946
28092112	study	C2603343
28092112	AQP2	C0213238
28092112	predictor	C0683956
28092112	renal insufficiency	C1565489
28092112	death	C0011065
28092112	patients	C0030705
28092112	cirrhosis	C1623038
28092112	Urine samples	C1610733
28092112	patients	C0030705
28092112	patients	C0030705
28092112	organ failure	C0349410
28092112	Group 1	C0681860
28092112	patients	C0030705
28092112	organ failure	C0349410
28092112	renal failure	C0035078
28092112	Group 2	C0681860
28092112	patients	C0030705
28092112	organ failure	C0349410
28092112	renal failure	C0035078
28092112	Group 3	C0681860
28092112	CANONIC study	C2603343
28092112	urine	C0042036
28092112	AQP2	C0213238
28092112	urine osmolality	C0086741
28092112	no difference	C3842396
28092112	AQP2	C0213238
28092112	groups	C0681860
28092112	Urine osmolality	C0086741
28092112	significantly lower	C4055638
28092112	patients	C0030705
28092112	Group 3	C0681860
28092112	Group 1	C0681860
28092112	Group 2	C0681860
28092112	No relation	C1513916
28092112	AQP2	C0213238
28092112	glomerular filtration rate	C0017654
28092112	creatinine	C0010294
28092112	AQP2	C0213238
28092112	predictor	C0683956
28092112	development	C1527148
28092112	renal insufficiency	C1565489
28092112	univariate analysis	C0683962
28092112	AQP2	C0213238
28092112	predictor	C0683956
28092112	survival	C0220921
28092112	multivariate analysis	C0026777
28092112	Aquaporin-2	C0213238
28092112	disease severity	C0521117
28092112	markers	C0008963
28092112	renal function	C0232804
28092112	predictor	C0683956
28092112	development	C1527148
28092112	renal insufficiency	C1565489
28092112	death	C0011065
28092112	marker	C0005516
28092112	renal insufficiency	C1565489
28092112	research	C0035168
28092112	clinical	C0205210
28092340	Decompression Surgery	C0408670
28092340	Decompression	C0408670
28092340	Fusion	C0919636
28092340	Symptomatic	C0231220
28092340	Lumbar Spinal Stenosis	C0158288
28092340	Swiss	C0241315
28092340	Prospective Multi-center Cohort Study	C1709709
28092340	Years	C0439234
28092340	Follow-up	C0016441
28092340	Retrospective analysis	C0035363
28092340	prospective, multicenter cohort study	C1709709
28092340	effect	C1280500
28092340	surgical fusion	C0919636
28092340	decompression surgery	C0408670
28092340	symptomatic	C0231220
28092340	lumbar spinal stenosis	C0158288
28092340	patients	C0030705
28092340	spondylolisthesis	C0038016
28092340	optimal surgical management	C1515089
28092340	lumbar spinal stenosis	C0158288
28092340	patients	C0030705
28092340	spondylolisthesis	C0038016
28092340	Patients	C0030705
28092340	LSOS	C0543472
28092340	DLSS	C0410636
28092340	spondylolisthesis	C0038016
28092340	study	C1706256
28092340	outcomes	C0086750
28092340	study	C1706256
28092340	Spinal Stenosis	C0037944
28092340	Spinal Stenosis Measure	C0392762
28092340	SSM	C0392762
28092340	symptoms	C1457887
28092340	score range	C0449820
28092340	function	C0542341
28092340	over time	C0040223
28092340	measured	C0444706
28092340	baseline	C1442488
28092340	months	C0439231
28092340	follow-up	C0016441
28092340	quantify	C1709793
28092340	effect	C1280500
28092340	fusion surgery	C0919636
28092340	decompression	C0408670
28092340	number of decompressed levels	C0243095
28092340	effects	C1280500
28092340	models	C0026336
28092340	repeated observations	C0302523
28092340	outcomes	C0086750
28092340	SSM	C0392762
28092340	symptoms	C1457887
28092340	SSM	C0392762
28092340	function	C0542341
28092340	over time	C0040223
28092340	patients	C0030705
28092340	random effects	C1280500
28092340	fitted random slopes	C0807955
28092340	follow-up	C0589120
28092340	time points	C0439547
28092340	approaches	C1292724
28092340	Akaike's Information Criterion	C0282574
28092340	AIC	C0282574
28092340	chi-squared test	C0237913
28092340	Confounders	C0009673
28092340	fixed effects	C1280500
28092340	age	C0001779
28092340	gender	C0079399
28092340	BMI	C1305855
28092340	diabetes	C0011847
28092340	CIRS	C0681889
28092340	musculoskeletal disorders	C0026857
28092340	duration	C2926735
28092340	symptoms	C1457887
28092340	patients	C0030705
28092340	decompression surgery	C0408670
28092340	decompression	C0408670
28092340	fusion surgery	C0919636
28092340	study	C1706256
28092340	multiple mixed effects	C1280500
28092340	model	C0026336
28092340	effect	C1280500
28092340	fusion	C0919636
28092340	decompression alone surgery	C0408670
28092340	SSM	C0392762
28092340	symptoms	C1457887
28092340	confidence interval	C0009667
28092340	CI	C0009667
28092340	CI	C0009667
28092340	SSM	C0392762
28092340	function	C0542341
28092340	patients	C0030705
28092340	degenerative lumbar spinal stenosis	C0410636
28092340	spondylolisthesis	C0038016
28092340	study	C1706256
28092340	groups	C0441833
28092340	decompression	C0408670
28092340	decompression	C0408670
28092340	fusion	C0919636
28092340	patients	C0030705
28092340	surgical treatment	C0543467
28092340	confounders	C0009673
28092340	fusion surgery	C0919636
28092340	associated with	C0332281
28092340	outcome	C0086750
28092340	SSM scores	C0392762
28092340	decompression alone surgery	C0408670
28097208	Muscle	C0026845
28097208	synergies	C1704675
28097208	stroke	C0038454
28097208	perilesional	C1254362
28097208	high gamma	C0392762
28097208	Movements	C0517907
28097208	modules	C1709061
28097208	muscle	C0026845
28097208	synergies	C1704675
28097208	stroke	C0038454
28097208	abnormal	C0205161
28097208	synergies	C1704675
28097208	impaired	C0221099
28097208	movements	C0517907
28097208	neural	C0027882
28097208	basis	C1527178
28097208	electrocorticography signals	C0430797
28097208	perilesional	C1254362
28097208	cortex	C3499125
28097208	synergies	C1704675
28097208	synergies	C1704675
28097208	contained	C0332256
28097208	normal	C0205307
28097208	abnormal	C0205161
28097208	patterns	C0449774
28097208	normal	C0205307
28097208	abnormal	C0205161
28097208	synergies	C1704675
28097208	perilesional	C1254362
28097208	high gamma	C0392762
28097208	high gamma	C0392762
28097208	cortical spiking	C0243095
28097208	perilesional spiking	C0243095
28097208	synergies	C1704675
28097208	stroke	C0038454
28097611	Assessing	C0184514
28097611	nitrous oxide	C0028215
28097611	effect	C1280500
28097611	electroencephalographically	C0013819
28097611	depth of anesthesia	C0474710
28097611	measures	C0079809
28097611	cortical	C0007776
28097611	state	C0918012
28097611	cortical	C0007776
28097611	input	C0918012
28097611	electroencephalography	C0013819
28097611	EEG	C0013819
28097611	depth of anesthesia	C0474710
28097611	monitors	C0184514
28097611	sedative	C0036557
28097611	anesthetic	C0002932
28097611	states	C0348080
28097611	n-methyl-D-aspartate (NMDA) receptor antagonist	C3536824
28097611	anesthesia	C0002903
28097611	ketamine	C0022614
28097611	nitrous oxide	C0028215
28097611	N2O	C0028215
28097611	physiologically	C0205463
28097611	depth of anesthesia	C0474710
28097611	monitoring	C1283169
28097611	algorithm	C0002045
28097611	autoregressive-moving-average (ARMA) modeling	C3161035
28097611	Cortical	C0007776
28097611	State	C0918012
28097611	CS	C0918012
28097611	Cortical	C0007776
28097611	Input	C0918012
28097611	CI	C0918012
28097611	retrospectively	C0035363
28097611	exploratory	C1292732
28097611	NMDA receptor antagonist	C3536824
28097611	N2O	C0028215
28097611	adjuvant anesthetic gas	C0002904
28097611	clinical practice	C0205245
28097611	Composite Cortical State	C0918012
28097611	CCS	C0918012
28097611	Composite Cortical State distance	C0918012
28097611	CCSd	C0918012
28097611	modifications	C3840684
28097611	CS	C0918012
28097611	CS	C0918012
28097611	CI	C0918012
28097611	evaluated	C0220825
28097611	electroencephalographic	C0013819
28097611	EEG	C0013819
28097611	data	C1511726
28097611	healthy control individuals	C2986479
28097611	N2O	C0028215
28097611	inhalation	C0004048
28097611	equilibrated	C1547026
28097611	peak gas concentrations	C0457929
28097611	N2O	C0028215
28097611	O2	C0030054
28097611	CCSd	C0918012
28097611	increasing	C0205217
28097611	levels	C0441889
28097611	anesthetic concentration	C0474704
28097611	independent of	C0332291
28097611	anesthetic's	C0002932
28097611	microscopic	C0205288
28097611	mode of action	C1524059
28097611	N2O	C0028215
28097611	propofol	C0033487
28097611	effects	C1280500
28097611	peak gas concentration	C0457929
28097611	group	C1257890
28097611	peak gas levels	C0441889
28097611	individuals	C0237401
28097611	statistically significant	C0237881
28097611	reductions	C0441610
28097611	responsiveness	C3261286
28097611	compared	C1707455
28097611	rest	C0035253
28097611	group	C1257890
28097611	CS	C0918012
28097611	CCS	C0918012
28097611	increased	C0205217
28097611	CCSd	C0918012
28097611	decrease	C0547047
28097611	conclusion	C1707478
28097611	CI	C0918012
28097611	results	C1274040
28097611	contrary	C1521805
28097611	depth of anesthesia	C0474710
28097611	monitoring	C1283169
28097611	measures	C0079809
28097611	CS	C0918012
28097611	CCS	C0918012
28097611	CCSd	C0918012
28097611	measures	C0079809
28097611	derived	C1441547
28097611	frontal	C0205123
28097611	EEG	C0013819
28097611	potentially	C3245505
28097611	gas concentration	C0457929
28097611	responsiveness levels	C3261286
28097611	people	C0027361
28097611	N2O	C0028215
28097611	utility	C0457083
28097611	CI	C0918012
28097611	larger	C0549177
28097611	sample sizes	C0242618
28097611	potentially	C3245505
28097611	higher	C0205250
28097611	gas concentrations	C0457929
28097611	assess	C0184514
28097611	sensitivity	C0036667
28097611	CS	C0918012
28097611	CI	C0918012
28097611	measures	C0079809
28097611	anesthetics	C0002932
28097611	utility	C0457083
28097611	clinical	C0442592
28097611	environment	C0014406
28098510	DT MRI	C3163713
28098510	microstructural	C0205556
28098510	cortical	C0007776
28098510	lesion	C0221505
28098510	damage	C1883709
28098510	cognitive impairment	C0338656
28098510	MS	C0026769
28098510	double inversion recovery	C0430022
28098510	DIR	C0430022
28098510	diffusion tensor (DT) magnetic resonance imaging (MRI)	C3163713
28098510	quantify	C1709793
28098510	severity	C0439793
28098510	cortical	C0007776
28098510	lesion	C0221505
28098510	CL	C0221505
28098510	microstructural	C0205556
28098510	tissue	C0040300
28098510	abnormalities	C0221430
28098510	large	C0549177
28098510	cohort	C0599755
28098510	relapse	C0035020
28098510	onset	C0332162
28098510	multiple sclerosis	C0026769
28098510	MS	C0026769
28098510	patients	C0030705
28098510	contribution	C1880177
28098510	cognitive dysfunction	C0338656
28098510	DIR	C0430022
28098510	DT	C1537007
28098510	dual-echo	C0011923
28098510	three-dimensional	C0450363
28098510	3D	C0450363
28098510	T1-weighted scans	C0011923
28098510	MS	C0026769
28098510	patients	C0030705
28098510	controls	C0009932
28098510	Cognitively impaired	C0338656
28098510	CI	C0338656
28098510	patients	C0030705
28098510	abnormal	C0205161
28098510	neuropsychological tests	C0027902
28098510	Diffusivity values	C3899378
28098510	CLs	C0221505
28098510	cortex	C0007776
28098510	white matter (WM) lesions	C2752009
28098510	normal-appearing (NA) WM	C0682708
28098510	assessed	C1516048
28098510	Predictors	C2698872
28098510	cognitive impairment	C0338656
28098510	identified	C0205396
28098510	random forest analysis	C0936012
28098510	controls	C0009932
28098510	MS	C0026769
28098510	patients	C0030705
28098510	lower	C0205251
28098510	normalized brain volume	C1113695
28098510	NBV	C1113695
28098510	gray matter volume	C0392762
28098510	GMV	C0392762
28098510	WM volume	C3278845
28098510	lower	C0205251
28098510	fractional anisotropy	C0392762
28098510	FA	C0392762
28098510	higher	C0205250
28098510	mean diffusivity	C3899378
28098510	cortex	C0007776
28098510	normal-appearing white matter	C0682708
28098510	NAWM	C0682708
28098510	patients	C0030705
28098510	CI	C0338656
28098510	cognitively preserved	C0030705
28098510	CP	C0030705
28098510	CI	C0338656
28098510	patients	C0030705
28098510	higher	C0205250
28098510	T2 WM lesion volume	C0392762
28098510	LV	C0392762
28098510	lower	C0205251
28098510	NBV	C1113695
28098510	GMV	C0392762
28098510	severe	C0205082
28098510	diffusivity	C3899378
28098510	abnormalities	C0221430
28098510	WM lesions	C2752009
28098510	cortex	C0007776
28098510	NAWM	C0682708
28098510	CL	C0221505
28098510	measures	C0079809
28098510	not differ	C0243095
28098510	CI	C0030705
28098510	CP patients	C0030705
28098510	Cortex	C0007776
28098510	FA	C0392762
28098510	age	C0001779
28098510	disease duration	C0872146
28098510	T2 WM LV	C0392762
28098510	GMV	C0392762
28098510	MS	C0026769
28098510	cognitive impairment	C0338656
28098510	Diffuse	C0205219
28098510	GM	C0018220
28098510	NAWM	C0682708
28098510	damage	C1883709
28098510	WM lesions	C2752009
28098510	intrinsic	C0205102
28098510	CL	C0221505
28098510	damage	C1883709
28098510	cognitive impairment	C0338656
28098510	MS	C0026769
28099597	Correlation	C1707520
28099597	histopathology	C0243140
28099597	chronic urticaria	C0263338
28099597	clinical picture	C0683325
28099597	Chronic urticaria	C0263338
28099597	transient	C0205374
28099597	pruritic lesions	C0748813
28099597	sizes	C0456389
28099597	central	C0205099
28099597	pallor	C0030232
28099597	disease	C0012634
28099597	weeks	C0439230
28099597	cellular infiltrate	C1692321
28099597	neutrophils	C0027950
28099597	lymphocytes	C0024264
28099597	eosinophils	C0014467
28099597	patients	C0030705
28099597	eosinophilic	C0014467
28099597	neutrophilic urticaria	C1304205
28099597	treatment	C0087111
28099597	antihistamines	C0003360
28099597	antihistamine	C0003360
28099597	drugs	C0013227
28099597	infiltration	C0332448
28099597	chronic urticaria	C0263338
28099597	biopsies	C0005558
28099597	clinical disease activity	C0544450
28099597	response to treatment	C0521982
28099597	patients	C0030705
28099597	chronic urticaria	C0263338
28099597	score of severity	C0457451
28099597	disease	C0012634
28099597	response to treatment	C0521982
28099597	perivascular infiltrate	C1692321
28099597	Inflammatory infiltrates	C0541629
28099597	eosinophilic	C0014467
28099597	neutrophilic	C0027950
28099597	association	C0439849
28099597	eosinophilic infiltrate	C0541629
28099597	clinical scores	C0457451
28099597	severity	C0439793
28099597	association	C0439849
28099597	eosinophilic inflammatory infiltrates	C0541629
28099597	clinical activity	C0037088
28099597	severe	C0205082
28099597	clinical pictures	C0683325
28099597	disease	C0012634
28100136	Barriers	C0679881
28100136	access and uptake	C0018748
28100136	antiretroviral therapy	C1963724
28100136	HIV-positive	C0019699
28100136	men who have sex with men	C2827413
28100136	Hanoi	C0681784
28100136	Vietnam	C0042658
28100136	HIV testing	C1321876
28100136	treatment	C0087111
28100136	experiences	C0596545
28100136	Vietnamese	C1561452
28100136	men who have sex with men	C2827413
28100136	accessing	C0444454
28100136	HIV testing	C1321876
28100136	treatment	C0087111
28100136	barriers	C0679881
28100136	access and uptake	C0018748
28100136	antiretroviral therapy	C1963724
28100136	ART	C1963724
28100136	HIV-positive	C0019699
28100136	men who have sex with men	C2827413
28100136	Hanoi	C0681784
28100136	qualitative	C0205556
28100136	interviews	C0021822
28100136	participants	C0679646
28100136	snowball sampling	C2348215
28100136	research	C0035168
28100136	social networks	C0150775
28100136	ART	C1963724
28100136	inadequate	C0205412
28100136	preparation	C1521827
28100136	positive	C1446409
28100136	diagnosis	C0011900
28100136	stigmatisation	C0038330
28100136	homosexuality	C0019900
28100136	HIV	C0019682
28100136	consequences	C1511482
28100136	fear	C0015726
28100136	disclosure	C0012625
28100136	HIV status	C0458074
28100136	Health system	C0018696
28100136	barriers	C0679881
28100136	consistency	C0332529
28100136	access	C0018748
28100136	ART	C1963724
28100136	patient	C0030705
28100136	confidentiality	C0009669
28100136	providers	C1138603
28100136	sexual identity	C0017249
28100136	same-sex issues	C0019900
28100136	HIV testing	C1321876
28100136	Hanoi	C0681784
28100136	counselling	C0010210
28100136	peer support	C0679740
28100136	clear referral	C0034927
28100136	barriers	C0679881
28100136	men who have sex with men	C2827413
28100136	benefits	C0814225
28100136	routine testing	C2188403
28100136	improving	C1272745
28100136	access	C0018748
28100136	diagnostic services	C0011929
28100136	confidential	C3846676
28100136	treatment	C0087111
28100136	environment	C0014406
28100136	HIV-positive	C0019699
28100136	men	C0025266
28100136	access	C0018748
28100136	receive and remain in care	C1947933
28100698	Cdc45	C0755538
28100698	induced	C0205263
28100698	loading	C1708715
28100698	human RPA	C0122446
28100698	single-stranded DNA	C0012935
28100698	Cell division cycle protein 45	C0755538
28100698	Cdc45	C0755538
28100698	eukaryotic	C0684063
28100698	replicative	C1883725
28100698	DNA helicase	C0920283
28100698	human Cdc45	C0755538
28100698	complex	C1704241
28100698	single-stranded DNA (ssDNA) binding protein RPA	C0165675
28100698	loads	C1708715
28100698	RPA	C0165675
28100698	ssDNA	C0012935
28100698	Pull-down assays	C0022885
28100698	surface plasmon resonance studies	C0597731
28100698	Cdc45	C0755538
28100698	bound	C1167622
28100698	RPA	C0165675
28100698	complexed	C1704241
28100698	ssDNA	C0012935
28100698	nucleotide binding	C1148916
28100698	dissociated	C1148560
28100698	RPA	C0165675
28100698	30-mer	C0004793
28100698	Real-time analysis	C0022885
28100698	RPA	C0165675
28100698	ssDNA	C0012935
28100698	binding	C1167622
28100698	Cdc45	C0755538
28100698	loaded	C1708715
28100698	RPA	C0165675
28100698	ssDNA	C0012935
28100698	placement	C1524072
28100698	reaction	C0443286
28100698	physical contacts	C0392367
28100698	Cdc45	C0755538
28100698	RPA70A subdomain	C1514562
28100698	Cdc45	C0755538
28100698	stabilization	C1293130
28100698	nt	C0028630
28100698	RPA	C0165675
28100698	binding	C1167622
28100698	RPA	C0165675
28100698	30-mer	C0004793
28100698	mode	C1513371
28100698	binding	C1167622
28100698	ssDNA	C0012935
28100698	Cdc45	C0755538
28100698	loading	C1708715
28100698	deposition	C0333562
28100698	RPA	C0165675
28100698	ssDNA	C0012935
28100698	replication fork	C1167117
28101782	antineoplastic drug	C0003392
28101782	trastuzumab	C0728747
28101782	dysregulates	C0243095
28101782	metabolism	C0025519
28101782	iPSC	C2717959
28101782	cardiomyocytes	C0225828
28101782	targeted ERBB2 therapy	C2985566
28101782	trastuzumab	C0728747
28101782	impact	C4049986
28101782	management	C0376636
28101782	patients	C0030705
28101782	HER2+ breast cancer	C1960398
28101782	development	C1527148
28101782	increased	C0205217
28101782	HER2	C0069515
28101782	targeted therapies	C2985566
28101782	clinical	C0205210
28101782	side effect	C0879626
28101782	cardiotoxicity	C0876994
28101782	mechanism	C0441712
28101782	gene expression	C0017262
28101782	altered	C0392747
28101782	multiple	C0439064
28101782	models	C0026343
28101782	heart failure	C0018801
28101782	differential gene expression	C1519516
28101782	iPSC	C2717959
28101782	cardiomyocytes	C0225828
28101782	treated	C1522326
28101782	day	C0439228
28101782	ERBB2	C1702024
28101782	monoclonal antibody	C0003250
28101782	trastuzumab	C0728747
28101782	small molecule tyrosine kinase inhibitor	C1268567
28101782	EGFR	C0034802
28101782	ERBB2	C1702024
28101782	Transcriptome sequencing	C4086963
28101782	performed	C0884358
28101782	replicates	C1883725
28101782	group	C0441833
28101782	trastuzumab	C0728747
28101782	lapatinib	C1506770
28101782	differential gene expression	C1519516
28101782	analyses	C0936012
28101782	performed	C0884358
28101782	treatment	C1522326
28101782	group	C0441833
28101782	cardiomyocytes	C0225828
28101782	genes	C0017337
28101782	differentially expressed	C0017262
28101782	cardiomyocytes	C0225828
28101782	treated	C1522326
28101782	trastuzumab	C0728747
28101782	lapatinib	C1506770
28101782	Gene ontology	C1138831
28101782	analyses	C0936012
28101782	cardiomyocytes	C0225828
28101782	treated	C1522326
28101782	trastuzumab	C0728747
28101782	significant	C0750502
28101782	down-regulation	C0013081
28101782	genes	C0017337
28101782	small molecule metabolism	C2752534
28101782	cholesterol	C0008377
28101782	sterol	C0038323
28101782	measured	C0444706
28101782	glucose uptake	C1159527
28101782	lactate	C0376261
28101782	production	C0205245
28101782	iPSC	C2717959
28101782	cardiomyocytes	C0225828
28101782	days	C0439228
28101782	treated	C1522326
28101782	trastuzumab	C0728747
28101782	observed	C1441672
28101782	significantly	C0237881
28101782	decreased	C0205216
28101782	glucose uptake	C1159527
28101782	media	C0010454
28101782	iPSC	C2717959
28101782	cardiomyocytes	C0225828
28101782	treated	C1522326
28101782	trastuzumab	C0728747
28101782	consistently	C0332529
28101782	study	C2603343
28101782	dysregulation	C0243095
28101782	cardiac	C0018787
28101782	gene expression	C0017262
28101782	metabolism	C0025519
28101782	ERBB2	C0242957
28101782	signaling	C0037080
28101782	potentially	C3245505
28101782	biomarkers	C0005516
28101782	cardiotoxicity	C0876994
28102508	Simvastatin	C0074554
28102508	Hematoma	C0018944
28102508	Absorption	C0000854
28102508	Hydrocephalus	C0020255
28102508	Intraventricular Hemorrhage	C0240059
28102508	Upregulating	C0041904
28102508	CD36	C1366645
28102508	hematoma	C0018944
28102508	worsens	C1457868
28102508	hydrocephalus	C0020255
28102508	intraventricular hemorrhage	C0240059
28102508	IVH	C0240059
28102508	increasing	C0442808
28102508	iron deposition	C0333596
28102508	ependymal	C0014472
28102508	cilia	C0008778
28102508	injury	C3263723
28102508	hematoma	C0018944
28102508	absorption	C0000854
28102508	IVH	C0240059
28102508	simvastatin	C0074554
28102508	hematoma	C0018944
28102508	absorption	C0000854
28102508	efficacy	C1280519
28102508	simvastatin	C0074554
28102508	IVH	C0240059
28102508	rats	C0086893
28102508	Intracerebral hemorrhage	C0475526
28102508	adult male	C0086582
28102508	Sprague-Dawley rats	C0034715
28102508	autologous blood injection	C0849679
28102508	Simvastatin	C0074554
28102508	vehicle	C0042444
28102508	administered orally	C0001563
28102508	IVH	C0240059
28102508	MRI studies	C3515983
28102508	measure	C0242485
28102508	volumes	C2700258
28102508	intracranial	C0524466
28102508	hematoma	C0018944
28102508	lateral ventricle	C0152279
28102508	IVH	C0240059
28102508	Motor	C0234130
28102508	neurocognitive functions	C3714634
28102508	assessed	C1516048
28102508	Iron deposition	C0333596
28102508	iron	C0302583
28102508	protein expression	C1171362
28102508	ependymal damage	C3686783
28102508	histology	C4048239
28102508	detected	C0442726
28102508	Expression	C0017262
28102508	CD36	C1366645
28102508	scavenger receptor	C0074129
28102508	phagocytosis	C0031308
28102508	examined	C0332128
28102508	IVH	C0240059
28102508	western blotting	C0005863
28102508	immunofluorescence	C0079603
28102508	Simvastatin	C0074554
28102508	increased	C0205217
28102508	hematoma	C0018944
28102508	absorption	C0000854
28102508	ratio	C0456603
28102508	reduced	C0392756
28102508	ventricular volume	C1511726
28102508	attenuated neurological dysfunction	C1709219
28102508	IVH	C0240059
28102508	less iron accumulation	C4021076
28102508	cilia	C0008778
28102508	survival	C1709301
28102508	simvastatin	C0074554
28102508	control	C0009932
28102508	higher	C0205250
28102508	expression	C0017262
28102508	CD36	C1366645
28102508	detected	C0442726
28102508	hematoma	C0018944
28102508	simvastatin	C0074554
28102508	administration	C1533734
28102508	Simvastatin	C0074554
28102508	brain	C0006104
28102508	hematoma	C0018944
28102508	absorption	C0000854
28102508	alleviated hydrocephalus	C0020255
28102508	improved	C0184511
28102508	neurological	C0205494
28102508	recovery	C2004454
28102508	experimental	C1517586
28102508	IVH	C0240059
28102508	upregulating	C0041904
28102508	CD36	C1366645
28102508	expression	C0017262
28102508	data	C1511726
28102508	simvastatin	C0074554
28102508	novel	C0205314
28102508	therapy	C0087111
28102508	IVH	C0240059
28102508	patients	C0030705
28103582	AMPK	C2350345
28103582	autophagy	C0004391
28103582	inhibition	C3463820
28103582	icaritin	C1567768
28103582	induced	C0205263
28103582	anti-colorectal cancer	C0243095
28103582	cell activity	C0007613
28103582	current	C0521116
28103582	research	C0035168
28103582	potential effect	C1280500
28103582	autophagy	C0004391
28103582	icaritin	C1567768
28103582	induced	C0205263
28103582	anti-colorectal cancer	C0243095
28103582	CRC	C1527249
28103582	cell activity	C0007613
28103582	Treatment	C1522326
28103582	icaritin	C1567768
28103582	primary	C0205225
28103582	established	C0443211
28103582	HT-29	C0282639
28103582	CRC	C1527249
28103582	cells	C0007634
28103582	induced	C0205263
28103582	feedback activation	C1879547
28103582	autophagy	C0004391
28103582	p62	C1420393
28103582	degradation	C0314674
28103582	Beclin-1	C1412785
28103582	autophagy-related gene-5	C1825497
28103582	ATG-5	C1825497
28103582	upregulation	C0041904
28103582	light chain 3B	C1311384
28103582	LC3B	C1311384
28103582	GFP	C0120285
28103582	formation	C1522492
28103582	Pharmacological	C0205464
28103582	inhibiting	C3463820
28103582	autophagy	C0004391
28103582	icaritin	C1567768
28103582	induced	C0205263
28103582	CRC	C1527249
28103582	cell death	C0007587
28103582	apoptosis	C0162638
28103582	shRNA	C2930586
28103582	knockdown	C2350567
28103582	Beclin-1	C1412785
28103582	ATG-5	C1825497
28103582	icaritin	C1567768
28103582	induced	C0205263
28103582	CRC	C1527249
28103582	cell death	C0007587
28103582	apoptosis	C0162638
28103582	Icaritin	C1567768
28103582	activated	C1879547
28103582	AMP-activated protein kinase	C2350345
28103582	AMPK	C2350345
28103582	signaling	C0037083
28103582	CRC	C1527249
28103582	cells	C0007634
28103582	functioning	C0542341
28103582	signaling	C0037083
28103582	autophagy	C0004391
28103582	activation	C1879547
28103582	shRNA	C2930586
28103582	siRNA	C1099354
28103582	knockdown	C2350567
28103582	AMPKα1	C1418897
28103582	inhibited	C0311403
28103582	icaritin	C1567768
28103582	induced	C0205263
28103582	autophagy	C0004391
28103582	activation	C1879547
28103582	exacerbated	C1444749
28103582	CRC	C1527249
28103582	cell death	C0007587
28103582	AMPK	C2350345
28103582	compound 13	C1254351
28103582	C13	C1254351
28103582	autophagy	C0004391
28103582	MHY1485	C3661263
28103582	attenuated	C0599946
28103582	icaritin	C1567768
28103582	induced	C0205263
28103582	cytotoxicity	C0596402
28103582	nude mice	C0025932
28103582	icaritin	C1567768
28103582	oral administration	C0001563
28103582	induced	C0205263
28103582	HT-29	C0282639
28103582	tumor growth	C0598934
28103582	inhibition	C3463820
28103582	AMPKα1	C1418897
28103582	shRNA	C2930586
28103582	knockdown	C2350567
28103582	tumors	C0027651
28103582	feedback activation	C1879547
28103582	AMPK	C2350345
28103582	autophagy	C0004391
28103582	pathway	C0037080
28103582	resistance	C4281815
28103582	factor	C1521761
28103582	icaritin	C1567768
28105970	Classification	C0008902
28105970	Edible Oils	C1517288
28105970	ATR-FTIR	C0206055
28105970	Spectral Information	C1533716
28105970	Long Heating Treatment	C1254366
28105970	Identification	C0205396
28105970	oil	C1517288
28105970	type	C0332307
28105970	QC	C0034378
28105970	food	C0016452
28105970	food control laboratories	C0022877
28105970	Classifying	C0008902
28105970	edible oils	C1517288
28105970	unheated	C0205245
28105970	vibrational spectroscopy	C0037812
28105970	classification	C0008902
28105970	heat-treated	C0205245
28105970	oils	C1517288
28105970	effect	C1280500
28105970	long heating times	C0040223
28105970	classification	C0008902
28105970	edible oils	C1517288
28105970	canola	C0054599
28105970	corn	C0010029
28105970	frying	C1517288
28105970	sunflower	C0075639
28105970	attenuated total reflectance (ATR)-FTIR spectra	C0206055
28105970	surveyed	C0683942
28105970	sampling	C0870078
28105970	oils	C1517288
28105970	heating process	C1254366
28105970	ATR-FTIR spectra	C0206055
28105970	samples	C0370003
28105970	collected	C1516698
28105970	Interval extended canonical variates analysis	C0026777
28105970	ECVA	C0026777
28105970	variable selection	C0205556
28105970	classification	C0008902
28105970	intervals	C1272706
28105970	heating procedure	C1254366
28105970	classification	C0008902
28105970	Principal component analysis	C0429865
28105970	discriminate analysis	C0392762
28105970	partial least-squares discriminate analysis	C0392762
28105970	ECVA	C0026777
28105970	intervals	C1272706
28105970	total heating time	C0040223
28105970	autoscaling	C0243095
28105970	mean-centering	C0243095
28105970	data preprocessing methods	C0025663
28105970	investigated	C1292732
28105970	ECVA method	C0026777
28105970	classification	C0008902
28105970	cross-validated nonerror rate	C0392762
28105970	heating process	C1254366
28105970	times	C0040223
28106239	Intravitreal	C1517572
28106239	chemotherapy	C3665472
28106239	management	C0376636
28106239	vitreous disease	C0155365
28106239	retinoblastoma	C0035335
28106239	therapeutic outcome	C0085415
28106239	intravitreal	C1517572
28106239	melphalan	C0025241
28106239	injection	C1272883
28106239	management	C0376636
28106239	vitreous disease	C0155365
28106239	patients	C0030705
28106239	retinoblastoma	C0035335
28106239	higher	C0205250
28106239	melphalan	C0025241
28106239	dose	C0178602
28106239	lower	C0205251
28106239	number	C0237753
28106239	injections	C1272883
28106239	effective	C1704419
28106239	associated with	C0332281
28106239	fewer	C0205388
28106239	side effects	C0879626
28106239	retrospective	C0035363
28106239	interventional	C3274035
28106239	noncomparative	C2603343
28106239	nonrandomized study	C2603343
28106239	eyes	C0015392
28106239	patients	C0030705
28106239	Vitreous seeds	C1719830
28106239	classified	C0008902
28106239	dust	C0027651
28106239	sphere	C0027651
28106239	cloud types	C0027651
28106239	Intravitreal	C1517572
28106239	injections	C1272883
28106239	performed	C0884358
28106239	through	C0332273
28106239	pars plana	C0229167
28106239	visible	C0205379
28106239	tumor	C0027651
28106239	using	C1524063
28106239	30-G needle	C0027551
28106239	Response of the seeds	C1817727
28106239	disappearance	C0243095
28106239	conversion	C0439836
28106239	inactive debris	C1720491
28106239	progression	C0178874
28106239	enucleation	C0014392
28106239	rate	C1521828
28106239	outcome	C0085415
28106239	measures	C0079809
28106239	patients	C0030705
28106239	received	C1514756
28106239	systemic	C1883256
28106239	intra-arterial chemotherapy	C0842399
28106239	Vitreous seeding	C1719830
28106239	primary	C0205225
28106239	eyes	C0015392
28106239	secondary	C0175668
28106239	eyes	C0015392
28106239	Vitreous seeds	C1719830
28106239	classified	C0008902
28106239	dust	C0027651
28106239	eyes	C0015392
28106239	sphere	C0027651
28106239	eyes	C0015392
28106239	cloud	C0027651
28106239	eyes	C0015392
28106239	Melphalan	C0025241
28106239	dose	C0178602
28106239	eyes	C0015392
28106239	received	C1514756
28106239	total number	C4288115
28106239	injections	C1272883
28106239	mean	C0444504
28106239	eye	C0015392
28106239	Various	C0439064
28106239	types	C0332307
28106239	regression	C0684320
28106239	obtained	C1301820
28106239	eyes	C0015392
28106239	Sphere-type seeds	C0027651
28106239	most	C0205393
28106239	responsive	C0205342
28106239	melphalan	C0025241
28106239	Nonresponse	C3844724
28106239	disease progression	C0242656
28106239	noted	C4288581
28106239	eyes	C0015392
28106239	mean	C0444504
28106239	follow-up	C1522577
28106239	months	C0439231
28106239	eyes	C0015392
28106239	enucleated	C1396718
28106239	Vitreous hemorrhage	C0042909
28106239	retinal pigment epithelial	C0035322
28106239	alterations	C1515926
28106239	most	C0205393
28106239	common	C0205214
28106239	side effects	C0879626
28106239	Intravitreal	C1517572
28106239	melphalan	C0025241
28106239	injections	C1272883
28106239	effective	C1704419
28106239	eyes	C0015392
28106239	vitreous disease	C0155365
28108399	Fine structure	C0678594
28108399	anterior median eyes	C0015392
28108399	funnel	C0332495
28108399	web spider	C0037913
28108399	Agelena labyrinthica	C1905695
28108399	Araneae	C0037913
28108399	Agelenidae	C0998353
28108399	electron microscopic studies	C0026019
28108399	structure	C0678594
28108399	eyes	C0015392
28108399	anterior median eyes	C0015392
28108399	AME	C0015392
28108399	web spiders	C0037913
28108399	anatomy	C0700276
28108399	AME	C0015392
28108399	spider	C0037913
28108399	Agelena labyrinthica	C1905695
28108399	retina	C0035298
28108399	regions	C0205147
28108399	photoreceptor cells	C0031760
28108399	central part	C0205099
28108399	sensory cells	C0034837
28108399	rhabdomeres	C1167266
28108399	ventral	C1704448
28108399	retina	C0035298
28108399	rhabdomeres	C1167266
28108399	rhabdomeres	C1167266
28108399	ventral	C1704448
28108399	retina	C0035298
28108399	ventral	C1704448
28108399	long tangential rows	C0454236
28108399	center	C0205099
28108399	sensory cells	C0034837
28108399	unpigmented	C0243095
28108399	pigment cell	C1179009
28108399	processes	C0007613
28108399	agelenid	C0998353
28108399	spiders	C0037913
28108399	axons	C0004461
28108399	sensory cells	C0034837
28108399	cell body	C2752549
28108399	fine structure	C0678594
28108399	eye cup	C0180233
28108399	central part	C0205099
28108399	retina	C0035298
28108399	nerve fibres	C0027749
28108399	synapses	C0039062
28108399	distal region	C0205147
28108399	receptor cells	C0034837
28108399	muscle	C0026845
28108399	eye cup	C0180233
28108399	rotational	C0445237
28108399	movements	C0015413
28108399	eyes	C0015392
28108399	optical performance	C0029141
28108399	image resolution	C2699488
28108399	eyes	C0015392
28108399	visual cells	C0007634
28111379	Knocking down	C2350567
28111379	TCF8	C1420645
28111379	high glucose	C0860803
28111379	angiotensin II	C0003009
28111379	induced	C0205263
28111379	epithelial to mesenchymal transition	C1523298
28111379	podocytes	C1328818
28111379	Epithelial to mesenchymal transition	C1523298
28111379	EMT	C1523298
28111379	physiological phenomenon	C2350828
28111379	mammalian	C0024660
28111379	embryogenesis	C0013936
28111379	epithelial cells	C0014597
28111379	mesenchymal stem cells	C1257975
28111379	EMT	C1523298
28111379	pathogenic	C3816499
28111379	processes	C1522240
28111379	embryonic development	C0013936
28111379	tumor metastasis	C0027627
28111379	EMT	C1523298
28111379	renal fibrosis	C0151650
28111379	glucose	C0017725
28111379	angiotensin II	C0003009
28111379	EMT	C1523298
28111379	podocytes	C1328818
28111379	cellular morphology	C1521816
28111379	podocytes	C1328818
28111379	high	C0205250
28111379	concentration	C1446561
28111379	glucose	C0017725
28111379	angiotensin II	C0003009
28111379	podocyte	C1328818
28111379	movement	C1621968
28111379	migration	C1622501
28111379	high	C0205250
28111379	concentration	C1446561
28111379	glucose	C0017725
28111379	angiotensin II	C0003009
28111379	TCF8	C1420645
28111379	expression	C0017262
28111379	Inhibiting	C3463820
28111379	TCF8	C1420645
28111379	expression	C0017262
28111379	siRNA	C1099354
28111379	EMT	C1523298
28111379	podocytes	C1328818
28111379	high	C0205250
28111379	concentration	C1446561
28111379	glucose	C0017725
28111379	angiotensin	C0003018
28111379	Inhibiting	C3463820
28111379	TCF8	C1420645
28111379	expression	C0017262
28111379	cellular morphology	C1521816
28111379	podocyte	C1328818
28111379	movement	C1621968
28111379	migration	C1622501
28111379	glucose	C0017725
28111379	angiotensin II	C0003009
28111379	EMT	C1523298
28111379	podocytes	C1328818
28111379	TCF8	C1420645
28113047	upregulation	C0041904
28113047	host surface receptors	C0034800
28113047	bacterial adhesion	C0004614
28113047	disease	C0004623
28113047	Host surface receptors	C0034800
28113047	bacteria	C0004611
28113047	attach	C3714578
28113047	tissue	C0040300
28113047	human	C0086418
28113047	disease	C0012634
28113047	host receptors	C0034800
28113047	cognate adhesins	C0699040
28113047	bacterial	C0004611
28113047	pathogenesis	C0699748
28113047	elevated	C3163633
28113047	expression	C0597360
28113047	host surface receptors	C0034800
28113047	CEACAM-1	C3540477
28113047	CEACAM-6	C0376900
28113047	ICAM-1	C0063695
28113047	PAFR	C0071234
28113047	response to specific stimuli	C0542478
28113047	upregulated receptors	C0949479
28113047	host	C1167395
28113047	bacterial infections	C0004623
28113047	respiratory tract	C0035237
28113047	receptor	C0597357
28113047	induction	C0205263
28113047	bacterial adherence	C0004614
28113047	body system	C0460002
28113047	central nervous	C3714787
28113047	gastrointestinal	C0012240
28113047	urogenital systems	C0042066
28113047	Prokaryotic	C0686817
28113047	pathogens	C0699748
28113047	infectivity	C3714514
28113047	Streptococcus pneumoniae	C0038410
28113047	Haemophilus influenzae	C0018483
28113047	Neisseria meningitidis	C0027575
28113047	Escherichia coli	C0014834
28113047	in vitro	C1515654
28113047	in vivo experimental models	C1515657
28113047	bacterial attachment	C0004614
28113047	expressed	C0597360
28113047	host receptors	C0034800
28113047	targeted	C1521840
28113047	interventions	C1273869
28113047	prevention	C0199176
28113047	treatment	C0087111
28113047	bacterial disease	C0004623
28115057	Optogenetic	C3494301
28115057	Demonstration	C0441655
28115057	Functional	C0205245
28115057	Innervation	C0021516
28115057	Mouse	C0025929
28115057	Colon	C0009368
28115057	Neurons	C0027882
28115057	Transplanted	C0700106
28115057	Neural Cells	C0027882
28115057	Cell therapy	C0302189
28115057	treat	C1522326
28115057	gastrointestinal motility disorders	C0854121
28115057	diseased	C0027882
28115057	absent	C0332197
28115057	enteric	C1304890
28115057	neurons	C0027882
28115057	neurons	C0027882
28115057	transplanted	C0700106
28115057	enteric	C1304890
28115057	neural cells	C0027882
28115057	functional	C0205245
28115057	innervation	C0021516
28115057	bowel	C0021853
28115057	smooth muscle	C1267092
28115057	mice	C0025929
28115057	Enteric	C1304890
28115057	neural cells	C0027882
28115057	light-sensitive ion channel	C0022009
28115057	channelrhodopsin	C0033684
28115057	isolated	C0205409
28115057	fetal	C0521457
28115057	postnatal	C0443281
28115057	mouse	C0025929
28115057	bowel	C0021853
28115057	transplanted	C0700106
28115057	distal colon	C1517729
28115057	week	C0439230
28115057	wild-type	C1883559
28115057	recipient mice	C0025929
28115057	Intracellular	C0178719
28115057	electrophysiological recordings	C0022885
28115057	responses	C0205245
28115057	light stimulation	C0240188
28115057	transplanted	C0700106
28115057	cells	C0027882
28115057	colonic	C0009368
28115057	smooth muscle cells	C1135918
28115057	recipient mice	C0025929
28115057	Electrical stimulation	C1254366
28115057	endogenous	C0205227
28115057	enteric	C1304890
28115057	neurons	C0027882
28115057	control	C0009932
28115057	axons	C0004461
28115057	graft	C0332835
28115057	neurons	C0027882
28115057	plexus	C1184808
28115057	circular muscle layer	C0734812
28115057	Selective stimulation	C1254366
28115057	graft	C0332835
28115057	cells	C0027882
28115057	light	C0023693
28115057	excitatory	C0234121
28115057	inhibitory junction potentials	C0234122
28115057	electrical	C0442828
28115057	events	C0441471
28115057	contraction	C0026820
28115057	relaxation	C0026836
28115057	colonic	C0009368
28115057	muscle cells	C1135918
28115057	Graft	C0332835
28115057	excitatory	C0026609
28115057	inhibitory motor neurons	C0026609
28115057	neurotransmitters	C0027908
28115057	endogenous	C0205227
28115057	motor neurons	C0026609
28115057	acetylcholine	C0001041
28115057	adenosine triphosphate	C0001480
28115057	nitric oxide	C0028128
28115057	Graft	C0332835
28115057	neurons	C0027882
28115057	interneurons	C0021792
28115057	neurons	C0027882
28115057	pharmacologic properties	C0871161
28115057	interneurons	C0021792
28115057	age	C0001779
28115057	donors	C0013018
28115057	enteric	C1304890
28115057	neural cells	C0027882
28115057	Enteric	C1304890
28115057	neural cells	C0027882
28115057	transplanted	C0700106
28115057	bowel	C0021853
28115057	multiple	C0439064
28115057	functional	C0205245
28115057	types	C0332307
28115057	neurons	C0027882
28115057	functional	C0205245
28115057	innervation	C0021516
28115057	smooth muscle	C1267092
28115057	bowel wall	C1283694
28115057	Circuits	C0814033
28115057	motor neurons	C0026609
28115057	interneurons	C0021792
28115057	age	C0001779
28115057	cells	C0027882
28115057	neurotransmitter	C0027908
28115057	phenotype	C0031437
28115057	interneurons	C0021792
28117211	Assessment	C0220825
28117211	Vascular Stent	C0183521
28117211	Heating	C0018837
28117211	Repetitive Transcranial Magnetic Stimulation	C0872259
28117211	patients	C0030705
28117211	stroke	C0038454
28117211	repetitive transcranial magnetic stimulation	C0872259
28117211	rTMS	C0872259
28117211	clinical studies	C0008972
28117211	metallic stents	C0441290
28117211	metal	C0025552
28117211	heated	C0018837
28117211	eddy currents	C0013790
28117211	clinical safety data	C3899555
28117211	risk	C0035647
28117211	metallic stents	C0441290
28117211	heating	C0018837
28117211	rTMS	C0872259
28117211	tested	C0039593
28117211	safety	C1705187
28117211	rTMS	C0872259
28117211	protocols	C0442711
28117211	stents	C0183521
28117211	stroke	C0038454
28117211	nitinol	C0068790
28117211	elgiloy	C0002154
28117211	stents	C0183521
28117211	tested	C0392366
28117211	gelled	C1382104
28117211	saline	C0036082
28117211	locations	C0450429
28117211	at the center	C0205099
28117211	lobe	C0796494
28117211	coil	C1705946
28117211	location	C0450429
28117211	stent	C0441290
28117211	heating	C0018837
28117211	evaluated	C0220825
28117211	orientations	C1704322
28117211	parallel	C1254362
28117211	long axis	C0522487
28117211	coil	C1705946
28117211	parallel	C1254362
28117211	short axis	C0522488
28117211	coil	C1705946
28117211	perpendicular	C1295725
28117211	coil	C1705946
28117211	stents	C0183521
28117211	heat	C0018837
28117211	rTMS	C0872259
28117211	rTMS	C0872259
28117211	orientation	C1704322
28117211	Heating	C0018837
28117211	greater	C1704243
28117211	lobe	C0796494
28117211	stent	C0183521
28117211	oriented	C1704322
28117211	perpendicularly	C1295725
28117211	ex vivo	C2348480
28117211	quantification	C1709793
28117211	stent	C0441290
28117211	heating	C0018837
28117211	heating	C0018837
28117211	stents	C0183521
28117211	Food and Drug Administration	C1708333
28117211	standards	C0038137
28117211	in vivo	C1515655
28117211	testing	C0039593
28117211	rTMS	C0872259
28117211	implanted	C0021102
28117211	magnetic resonance imaging	C0024485
28117211	compatible	C1524057
28117211	stents	C0183521
28117211	animal studies	C0683949
28117211	human	C0086418
28117211	safety studies	C1705187
28117211	geometry	C0449829
28117211	orientation	C1704322
28117211	location	C0450429
28117211	coil	C1705946
28118200	Clinical Observation	C3889687
28118200	Treatment	C1522326
28118200	Chronic Subdural Hematoma	C0749095
28118200	Novel Double Needle Minimally Invasive Aspiration Technology	C0025080
28118200	aim	C1947946
28118200	study	C2603343
28118200	clinical effects	C3850123
28118200	complications	C0009566
28118200	treatment	C1522326
28118200	chronic subdural hematoma	C0749095
28118200	double needle aspiration	C0025080
28118200	clinical data	C1516606
28118200	patients	C0030705
28118200	chronic subdural hematoma	C0749095
28118200	treated	C1522326
28118200	double YL-1 needle	C0025080
28118200	skull drilling	C0185154
28118200	treated	C1522326
28118200	drilling	C0185154
28118200	drainage	C0013103
28118200	YL-1 needle	C0025080
28118200	group	C0441833
28118200	patient	C0030705
28118200	hematoma	C0018944
28118200	recurrence	C2825055
28118200	patient	C0030705
28118200	intracranial pneumocephalus	C0238376
28118200	patients	C0030705
28118200	months	C0439231
28118200	clinical cure	C3640840
28118200	traditional drilling	C0185154
28118200	drainage	C0013103
28118200	group	C0441833
28118200	patients	C0030705
28118200	hematoma	C0018944
28118200	recurrence	C2825055
28118200	months	C0439231
28118200	operation	C0543467
28118200	patients	C0030705
28118200	postoperative	C0032790
28118200	intracranial pneumocephalus	C0238376
28118200	method	C0025663
28118200	double YL-1 needle	C0025080
28118200	traditional drilling	C0185154
28118200	drainage method	C0013103
28118200	treatment	C1522326
28118200	chronic subdural hematoma	C0749095
28118200	postoperative	C0032790
28118200	recurrence	C2825055
28118200	complications	C0009566
28118752	impact	C4049986
28118752	adjunctive	C0677850
28118752	guanfacine	C0079466
28118752	extended release	C1707968
28118752	stimulant	C0304402
28118752	adherence	C1510802
28118752	children	C0008059
28118752	adolescents	C0205653
28118752	attention-deficit	C0041671
28118752	hyperactivity disorder	C1263846
28118752	stimulant	C0304402
28118752	adherence	C1510802
28118752	children	C0008059
28118752	adolescents	C0205653
28118752	attention-deficit	C0041671
28118752	hyperactivity disorder	C1263846
28118752	ADHD	C1263846
28118752	augmenting stimulants	C0449986
28118752	stimulants	C0304402
28118752	guanfacine extended-release	C1707968
28118752	GXR	C1707968
28118752	Inclusion criteria	C0243161
28118752	years	C0439234
28118752	ADHD	C1263846
28118752	diagnosis	C0011900
28118752	long-acting	C0304402
28118752	short-acting stimulant	C0304402
28118752	GXR	C1707968
28118752	augmentation	C1293122
28118752	Modified medication possession ratio	C0456603
28118752	mMPR	C0456603
28118752	days	C0439228
28118752	medication	C2081612
28118752	available	C0470187
28118752	days	C0439228
28118752	period	C1948053
28118752	excluding	C0332196
28118752	medication	C2081612
28118752	holidays	C0019843
28118752	mMPR	C0456603
28118752	nonadherent	C3845923
28118752	Regression	C0034980
28118752	models	C3161035
28118752	assessed	C0184514
28118752	change	C0392747
28118752	mMPR	C0456603
28118752	adjusting	C0456081
28118752	demographic	C0683970
28118752	clinical characteristics	C0683325
28118752	patients	C0030705
28118752	nonadherent	C3845923
28118752	stimulants	C0304402
28118752	pre	C0332152
28118752	augmentation	C1293122
28118752	unadjusted	C1439367
28118752	SD	C0871420
28118752	pre	C0332152
28118752	post	C0687676
28118752	stimulant	C0304402
28118752	mMPRs	C0456603
28118752	Adjusted	C0456081
28118752	change	C0392747
28118752	mMPR	C0456603
28118752	long-acting	C0304402
28118752	short-acting stimulants	C0304402
28118752	patients	C0030705
28118752	nonadherent	C3845923
28118752	stimulants	C0304402
28118752	GXR	C1707968
28118752	augmentation	C1293122
28118752	associated with	C0332281
28118752	increased	C0205217
28118752	stimulant	C0304402
28118752	adherence	C1510802
28118814	Bxb1 phage	C1071338
28118814	recombinase	C0073020
28118814	genome engineering	C0017387
28118814	Drosophila melanogaster	C0013139
28118814	Rapid	C0456962
28118814	reliable	C0205556
28118814	genome modifications	C4277689
28118814	in vivo	C1515655
28118814	functional analysis	C0558024
28118814	genomic entity	C1708234
28118814	gene	C0017337
28118814	regulatory DNA	C2329837
28118814	non-coding RNA	C0887909
28118814	CRISPR	C3658200
28118814	Cas9 genome editing technology	C4279981
28118814	manipulation	C0178659
28118814	genomic locus	C0678933
28118814	model organisms	C0029235
28118814	fruit fly Drosophila melanogaster	C0013139
28118814	genome engineering	C0017387
28118814	phage	C1071338
28118814	recombinase Bxb1	C0073020
28118814	D. melanogaster	C0013139
28118814	Bxb1	C1071338
28118814	recombinase activity	C1148744
28118814	recombinases	C0073020
28118814	targeted loci	C0678933
28119222	Tailor-made drug carrier	C0013161
28119222	Comparison	C1707455
28119222	physicochemical properties	C0871161
28119222	self-assembled	C0872376
28119222	aggregates	C0205418
28119222	optimal	C2698651
28119222	drug carrier	C0013161
28119222	Self-assembled	C0872376
28119222	surfactant	C0038888
28119222	aggregates	C0205418
28119222	micelles	C0025938
28119222	vesicles	C1254350
28119222	application	C1524063
28119222	drug carriers	C0013161
28119222	treatment	C0087111
28119222	diseases	C0012634
28119222	characteristics	C1521970
28119222	aggregate	C0205418
28119222	best	C1522427
28119222	drug carrier	C0013161
28119222	disease	C0012634
28119222	design	C1707689
28119222	optimal	C2698651
28119222	drug carrier	C0013161
28119222	disease	C0012634
28119222	self-assembled	C0872376
28119222	aggregates	C0205418
28119222	spherical micelles	C0025938
28119222	lens-like vesicles	C1254350
28119222	tube-like vesicles	C1254350
28119222	multiple techniques	C0449851
28119222	dynamic light scattering	C1882368
28119222	differential scanning calorimetry	C0006780
28119222	nuclear magnetic resonance spectroscopy	C0877853
28119222	fluorescence measurement	C0037802
28119222	Laurdan	C0083196
28119222	probe	C0182400
28119222	studies	C2603343
28119222	database	C0242356
28119222	self-assembled	C0872376
28119222	aggregates	C0205418
28119222	relationship	C0439849
28119222	physicochemical properties	C0871161
28119222	self-assembled	C0872376
28119222	aggregates	C0205418
28119222	functions	C0542341
28119222	drug carriers	C0013161
28119222	database	C0242356
28119222	optimal	C2698651
28119222	drug carrier	C0013161
28119222	tailor-made drug carrier	C0013161
28122499	Uridine	C0041984
28122499	laxative	C0282090
28122499	effect	C1280500
28122499	loperamide	C0023992
28122499	induced	C0205263
28122499	constipation	C0009806
28122499	SD rats	C2699239
28122499	regulation	C1327386
28122499	mAChRs	C0034826
28122499	signaling pathway	C0037080
28122499	mucin	C0026682
28122499	secretion	C0036536
28122499	Uridine	C0041984
28122499	Urd	C0041984
28122499	reported	C0700287
28122499	major	C0205164
28122499	RNA	C0035668
28122499	important	C3898777
28122499	role	C1705810
28122499	biological process	C3714634
28122499	neuroprotection	C0598958
28122499	biochemical modulation	C0678672
28122499	glycolysis	C0017952
28122499	role	C1705810
28122499	constipation	C0009806
28122499	established	C0443211
28122499	study	C2603343
28122499	investigated	C1292732
28122499	laxative	C0282090
28122499	effects	C1280500
28122499	Urd	C0041984
28122499	chronic	C0205191
28122499	constipation	C0009806
28122499	constipation	C0009806
28122499	phenotypes	C0031437
28122499	mechanisms	C0441712
28122499	investigated	C1292732
28122499	transverse colons	C0227386
28122499	SD rats	C2699239
28122499	loperamide	C0023992
28122499	Lop	C0023992
28122499	induced	C0205263
28122499	constipation	C0009806
28122499	treatment	C0087111
28122499	Urd	C0041984
28122499	number	C0237753
28122499	weight	C0043100
28122499	water	C0043047
28122499	contents	C0456205
28122499	stools	C0015733
28122499	significantly	C0750502
28122499	higher	C0205250
28122499	Lop	C0023992
28122499	Urd	C0041984
28122499	treated	C0332154
28122499	group	C0441833
28122499	Lop	C0023992
28122499	Vehicle	C0042444
28122499	treated	C0332154
28122499	group	C0441833
28122499	food intake	C0013470
28122499	water consumption	C0013123
28122499	group	C0441833
28122499	constant	C1948059
28122499	level	C0441889
28122499	thickness	C1280412
28122499	mucosa layer	C0026724
28122499	muscle	C0026845
28122499	flat luminal surface	C1180160
28122499	number	C0237753
28122499	goblet cells	C0506994
28122499	paneth cells	C0227276
28122499	lipid droplets	C0230704
28122499	enhanced	C2349975
28122499	Lop	C0023992
28122499	Urd	C0041984
28122499	treated	C0332154
28122499	group	C0441833
28122499	expression	C1171362
28122499	muscarinic acetylcholine receptors M2	C0384752
28122499	M3	C0289799
28122499	mAChR M2	C0384752
28122499	M3	C0289799
28122499	transcriptional	C1158770
28122499	translational	C3537096
28122499	level	C0441889
28122499	recovered	C0521108
28122499	Lop	C0023992
28122499	Urd	C0041984
28122499	treated	C0332154
28122499	group	C0441833
28122499	markers	C0005516
28122499	Gα	C0887847
28122499	inositol triphosphate	C0815032
28122499	IP3	C0815032
28122499	downstream	C0522506
28122499	signaling pathway	C0037080
28122499	recovered	C0521108
28122499	Urd	C0041984
28122499	treatment	C0087111
28122499	mucin	C0026682
28122499	secretion	C0036536
28122499	expression	C1171362
28122499	membrane water channel	C0599635
28122499	aquaporine 8	C1743716
28122499	AQP8	C1743716
28122499	increased	C0205217
28122499	significantly	C0750502
28122499	Lop	C0023992
28122499	Urd	C0041984
28122499	treated	C0332154
28122499	group	C0441833
28122499	compared	C1707455
28122499	Lop	C0023992
28122499	Vehicle	C0042444
28122499	treated	C0332154
28122499	group	C0441833
28122499	activity	C0441655
28122499	Urd	C0041984
28122499	primary smooth muscle	C1267092
28122499	rat	C0086893
28122499	intestine cells	C0814997
28122499	pRISMC	C1135918
28122499	Gα	C0887847
28122499	expression	C1171362
28122499	IP3	C0815032
28122499	concentration	C1446561
28122499	results	C0683954
28122499	study	C2603343
28122499	strong	C0442821
28122499	evidence	C3887511
28122499	Urd	C0041984
28122499	important	C3898777
28122499	improving	C1272745
28122499	chronic	C0205191
28122499	constipation	C0009806
28122499	induced	C0205263
28122499	Lop	C0023992
28122499	treatment	C0087111
28122499	animal models	C0599779
28123107	Characterization	C1880022
28123107	Phytochrome Interacting Factors	C0574031
28123107	Moss	C0282635
28123107	Physcomitrella patens	C0996529
28123107	Conservation	C2347858
28123107	Phytochrome Signaling Modules	C0574031
28123107	Land Plants	C1562025
28123107	plant kingdom	C0032098
28123107	phytochrome	C0031857
28123107	PHY	C0031857
28123107	photoreceptors	C0031760
28123107	adaptive	C0231193
28123107	responses to light	C2945741
28123107	Arabidopsis thaliana	C0162740
28123107	PHYs	C0031857
28123107	nucleus	C0007610
28123107	downstream signaling components	C1519315
28123107	phytochrome interacting factors	C0574031
28123107	PIFs	C0574031
28123107	PIFs	C0574031
28123107	transcription factors	C0040648
28123107	repressors	C1336789
28123107	photomorphogenesis	C1154971
28123107	inhibition	C2265391
28123107	PHYs	C0031857
28123107	gene expression	C0017262
28123107	nuclear function	C0007613
28123107	PHYs	C0031857
28123107	non-seed plants	C0032098
28123107	genes	C0017337
28123107	PHY	C0031857
28123107	signaling	C3537152
28123107	moss	C0282635
28123107	Physcomitrella patens	C0996529
28123107	light-regulated genes	C0017337
28123107	orthologs	C1335144
28123107	PIF-controlled genes	C0017337
28123107	Arabidopsis	C0162741
28123107	Phylogenetic analyses	C1519068
28123107	PIF-like gene	C0017337
28123107	streptophyte algae	C0002028
28123107	water-to-land transition	C2700061
28123107	plants	C0032098
28123107	PIF homologs	C0574031
28123107	genome	C0017428
28123107	P. patens	C0996529
28123107	Arabidopsis	C0162741
28123107	PIFs	C0574031
28123107	protein domain structure	C1510464
28123107	molecular properties	C1521991
28123107	physiological effects	C1254359
28123107	PHY	C0031857
28123107	interaction	C0596788
28123107	P. patens	C0996529
28123107	PIFs	C0574031
28123107	PHY	C0031857
28123107	signaling	C3537152
28123107	PHY-PIF signaling node	C0037080
28123107	light signals	C1710082
28123107	genes	C0017337
28123107	land plant	C1562025
28123107	evolution	C0015219
28123107	lineage-specific diversification	C1254372
28125105	Conditional reprogramming	C4042857
28125105	long-term	C0443252
28125105	expansion	C0007595
28125105	normal	C1268443
28125105	tumor cells	C0431085
28125105	human	C0086418
28125105	biospecimens	C2347026
28125105	propagate	C3146294
28125105	cells	C0007634
28125105	in vitro	C1533691
28125105	human	C0086418
28125105	tumors	C0027651
28125105	healthy tissue	C0040300
28125105	in vitro	C1533691
28125105	preclinical models	C1514292
28125105	study of basic cancer biology	C1516164
28125105	translational research	C3494163
28125105	drug discovery	C0920472
28125105	drug target identification	C0085104
28125105	protocol	C4042857
28125105	conditional reprogramming	C3850096
28125105	CR	C3850096
28125105	coculture	C0282547
28125105	mouse	C0025929
28125105	fibroblast feeder cells	C3179110
28125105	normal	C1268443
28125105	tumor	C0027651
28125105	human	C0086418
28125105	epithelial cells	C0014597
28125105	Rho kinase	C0389995
28125105	inhibitor	C0014432
28125105	Y-27632	C0667301
28125105	CR	C4042857
28125105	cells	C0007634
28125105	regenerative medicine	C1257974
28125105	drug sensitivity testing	C0013207
28125105	gene expression profiling	C0752248
28125105	xenograft studies	C0520484
28125105	method	C4042857
28125105	pathologist	C0334866
28125105	healthy tissue	C0040300
28125105	tumor tissue	C0475358
28125105	basic tissue culture	C0040284
28125105	protocol	C4042857
28125105	cells	C0007634
28125105	fresh	C1519521
28125105	cryopreserved tissue samples	C1511549
28125105	cells	C0007634
28125105	generated	C3146294
28125105	technique	C4042857
28125105	diagnostic	C0358514
28125105	predictive	C0681890
28125105	medicine	C0013227
28125105	epithelial cells	C0014597
28125105	propagated	C3146294
28125105	in vitro	C1533691
28125105	capacity	C1516240
28125105	differentiated	C0007589
28125105	conditions	C0014406
28125105	natural environment	C0557745
28125454	internal facilitation	C0018704
28125454	activities	C0441655
28125454	hospitals	C0019994
28125454	implementing evidence-based interventions	C0557981
28125454	Implementation	C1708476
28125454	models	C3161035
28125454	frameworks	C1709697
28125454	theories	C0871935
28125454	activities	C0441655
28125454	implementation	C1708476
28125454	success	C0597535
28125454	internal facilitation	C0018704
28125454	activities	C0441655
28125454	hospital personnel	C0031228
28125454	engage	C1314939
28125454	implementation efforts	C1708476
28125454	study	C2603343
28125454	internal facilitation	C0018704
28125454	activities	C0441655
28125454	critical access hospitals	C1552526
28125454	rural Iowa	C0022037
28125454	implementation	C1708476
28125454	TeamSTEPPS	C0080268
28125454	patient safety	C1113679
28125454	intervention	C0184661
28125454	characteristics	C1521970
28125454	facilitation	C0018704
28125454	activities	C0441655
28125454	critical access hospitals	C1552526
28125454	years	C0439234
28125454	onset of	C0332162
28125454	implementation	C1708476
28125454	quarterly	C0332179
28125454	interviews	C0021822
28125454	key informants	C0870704
28125454	transcripts	C0034869
28125454	quarters	C2825406
28125454	coding template	C1705542
28125454	inductive analyses	C0936012
28125454	template	C1705542
28125454	deductively	C0205556
28125454	interview	C0021822
28125454	transcripts	C0034869
28125454	comparative analysis	C0683941
28125454	characteristics	C1521970
28125454	facilitation	C0018704
28125454	facilitation	C0018704
28125454	activities	C0441655
28125454	Leadership	C0023181
28125454	Customization	C1880202
28125454	Accountability	C0078889
28125454	Individuals	C0237401
28125454	teams	C0871489
28125454	engaged	C1314939
28125454	facilitation	C0018704
28125454	activities	C0441655
28125454	ad hoc manner	C0243095
28125454	activities	C0441655
28125454	people	C0027361
28125454	practices	C0237607
28125454	temporal patterns	C4021204
28125454	start	C1301880
28125454	peak time	C1254367
28125454	facilitation	C0018704
28125454	activities	C0441655
28125454	hospitals	C0019994
28125454	engage	C1314939
28125454	implementing	C1708476
28125454	evidence-based practices	C4042762
28125454	parsimonious	C0205556
28125454	facilitation	C0018704
28125454	activities	C0441655
28125454	theoretical	C0871935
28125454	empirical	C0376367
28125454	research opportunities	C0683937
28125454	facilitation	C0018704
28125454	activities	C0441655
28125454	characteristics	C1521970
28125454	managers	C0335141
28125454	planning	C1301732
28125454	executing	C1705848
28125454	implementations	C1708476
28125454	evidence-based interventions	C4042762
28129043	Directing traffic on DNA	C0314627
28129043	transcription factors	C0040648
28129043	relieve	C1301676
28129043	induce	C0205263
28129043	transcriptional interference	C0598496
28129043	Transcriptional interference	C0598496
28129043	TI	C0598496
28129043	widespread	C0205391
28129043	gene control	C0017263
28129043	pervasive nature	C0220900
28129043	transcription	C0040649
28129043	sense	C1883001
28129043	antisense	C0079249
28129043	kingdoms	C1708611
28129043	transcription factor	C0040648
28129043	binding kinetics	C0598135
28129043	influence	C4054723
28129043	ability	C0085732
28129043	transcription factor	C0040648
28129043	relieve	C1301676
28129043	induce	C0205263
28129043	TI	C0598496
28131759	Acoustic startle response	C0038186
28131759	rats	C0034693
28131759	inter-individual	C0237401
28131759	variation	C1705242
28131759	fear	C0015726
28131759	extinction	C0015347
28131759	population	C1257890
28131759	traumatic	C0332663
28131759	event	C0441471
28131759	percentage	C0439165
28131759	population	C1257890
28131759	post-traumatic stress disorder	C0038436
28131759	PTSD	C0038436
28131759	predisposing factors	C0032946
28131759	Abnormal	C0205161
28131759	acoustic startle response	C0038186
28131759	ASR	C0038186
28131759	PTSD	C0038436
28131759	potential	C3245505
28131759	predictor	C2698872
28131759	development	C0243107
28131759	PTSD	C0038436
28131759	behavior	C0004927
28131759	extinction	C0015347
28131759	extinction learning	C0237613
28131759	PTSD	C0038436
28131759	patients	C0030705
28131759	abnormal	C0205161
28131759	ASR	C0038186
28131759	development	C0243107
28131759	deficits	C2987487
28131759	baseline	C1442488
28131759	ASR	C0038186
28131759	development	C0243107
28131759	PTSD	C0038436
28131759	behavior	C0004927
28131759	baseline	C1442488
28131759	ASR	C0038186
28131759	freezing behavior	C0004927
28131759	Pavlovian fear conditioning	C0681797
28131759	adult	C0001675
28131759	male	C0086582
28131759	Sprague-Dawley rats	C0034715
28131759	Baseline	C1442488
28131759	acoustic startle response	C0038186
28131759	ASR	C0038186
28131759	Pavlovian fear conditioning paradigm	C0681797
28131759	freezing behavior	C0004927
28131759	fear conditioning	C0681797
28131759	extinction	C0015347
28131759	training	C0220931
28131759	extinction	C0015347
28131759	testing	C0039593
28131759	baseline	C1442488
28131759	ASR	C0038186
28131759	fear	C0015726
28131759	memory	C0025260
28131759	conditioning	C0681797
28131759	rats	C0034715
28131759	baseline	C1442488
28131759	ASR	C0038186
28131759	retention	C0035280
28131759	extinction	C0015347
28131759	memory	C0025260
28131759	rats	C0034715
28131759	baseline	C1442488
28131759	ASR	C0038186
28131759	baseline	C1442488
28131759	ASR	C0038186
28131759	predictive	C0681890
28131759	index	C0918012
28131759	development	C0243107
28131759	PTSD	C0038436
28131759	phenotype	C0031437
28132082	tacrolimus	C0085149
28132082	blood concentrations	C0699870
28132082	lung transplantation	C0024128
28132082	risk	C0035647
28132082	kidney injury	C0160420
28132082	Lung	C0024109
28132082	transplant recipients	C0376387
28132082	acute kidney injury	C2609414
28132082	AKI	C2609414
28132082	chronic kidney disease	C1561643
28132082	CKD	C1561643
28132082	immunosuppressant	C0021081
28132082	tacrolimus	C0085149
28132082	associated with	C0332281
28132082	AKI	C2609414
28132082	development	C1527148
28132082	recovery	C2004454
28132082	kidney injury	C0160420
28132082	lung transplantation	C0024128
28132082	AKI	C2609414
28132082	whole-blood	C0370231
28132082	tacrolimus	C0085149
28132082	trough concentrations	C3640757
28132082	kidney injury	C0160420
28132082	retrospectively studied	C0035363
28132082	kidney injury	C0160420
28132082	lung-transplantation	C0024128
28132082	patients	C0030705
28132082	UMC Utrecht	C1708333
28132082	Kidney function	C0232804
28132082	whole-blood	C0370231
28132082	tacrolimus	C0085149
28132082	trough concentrations	C3640757
28132082	day	C0439228
28132082	months	C0439231
28132082	postoperative	C0032790
28132082	Systemic inflammatory response syndrome	C0242966
28132082	SIRS	C0242966
28132082	septic shock	C0036983
28132082	nephrotoxic	C1514118
28132082	medications	C4284232
28132082	covariates	C0814913
28132082	AKI	C2609414
28132082	liver injury	C0160390
28132082	drug-drug interactions	C0687133
28132082	AKI	C2609414
28132082	present	C0150312
28132082	patients	C0030705
28132082	Tacrolimus	C0085149
28132082	concentrations	C0699870
28132082	supra-therapeutic	C4049341
28132082	patients	C0030705
28132082	AKI	C2609414
28132082	week	C0439230
28132082	transplantation	C0024128
28132082	supra-therapeutic	C4049341
28132082	tacrolimus	C0085149
28132082	concentrations	C0699870
28132082	OR	C0028873
28132082	CI	C0009667
28132082	nephrotoxic drugs	C3687832
28132082	OR	C0028873
28132082	CI	C0009667
28132082	infection	C3714514
28132082	OR	C0028873
28132082	CI	C0009667
28132082	cystic fibrosis	C0010674
28132082	OR	C0028873
28132082	CI	C0009667
28132082	Recovery rate	C1521828
28132082	AKI	C2609414
28132082	incidence	C0220856
28132082	CKD	C1561643
28132082	year	C0439234
28132082	lung transplantation	C0024128
28132082	AKI	C2609414
28132082	severe	C0205082
28132082	CKD	C1561643
28132082	morbidity	C0026538
28132082	mortality	C0205848
28132082	Supra-therapeutic	C4049341
28132082	whole-blood	C0370231
28132082	tacrolimus	C0085149
28132082	trough concentrations	C3640757
28132082	AKI	C2609414
28132082	Conscientious	C0580939
28132082	targeting	C1521840
28132082	tacrolimus	C0085149
28132082	blood concentrations	C0699870
28132082	vital	C0442732
28132082	early phase	C0814494
28132082	lung transplantation	C0024128
28132082	Lung	C0024109
28132082	transplant recipients	C0376387
28132082	acute kidney injury	C2609414
28132082	chronic kidney disease	C1561643
28132082	morbidity	C0026538
28132082	mortality	C0026566
28132082	pathophysiology	C0031847
28132082	kidney injury	C0160420
28132082	lung transplantation	C0024128
28132082	immunosuppressant	C0021081
28132082	tacrolimus	C0085149
28132082	dose	C0678766
28132082	unstable	C0443343
28132082	clinical setting	C3176918
28132082	nephrotoxic	C1514118
28132082	supra-therapeutic	C4049341
28132082	whole-blood	C0370231
28132082	tacrolimus	C0085149
28132082	trough concentrations	C3640757
28132082	acute kidney injury	C2609414
28132082	days	C0439228
28132082	lung transplantation	C0024128
28132082	Supra-therapeutic	C4049341
28132082	whole-blood	C0370231
28132082	tacrolimus	C0085149
28132082	trough concentrations	C3640757
28132082	lung transplantation	C0024128
28132082	AKI	C2609414
28132082	lung transplantation	C0024128
28132082	low	C0205251
28132082	recovery	C2004454
28132082	rates	C1521828
28132765	Zebrafish	C0043457
28132765	akt2	C0812230
28132765	essential	C0205224
28132765	survival	C0038952
28132765	growth	C0018270
28132765	bone development	C0005939
28132765	glucose homeostasis	C1326961
28132765	akt	C0166559
28132765	isoforms	C0597298
28132765	akt2	C1312419
28132765	role	C1705810
28132765	regulation	C1327622
28132765	cellular processes	C1325880
28132765	mammals	C0024660
28132765	role	C1705810
28132765	mechanisms	C0441712
28132765	zebrafish	C0043457
28132765	unknown	C0439673
28132765	function	C0542341
28132765	akt2	C0812230
28132765	zebrafish	C0043457
28132765	generated	C2346631
28132765	zebrafish	C0043457
28132765	lacking	C0332268
28132765	akt2 gene	C0812230
28132765	CRISPR/Cas9	C3658355
28132765	technology	C0039421
28132765	Akt2	C0812230
28132765	null	C0456148
28132765	zebrafish	C0043457
28132765	lethality	C3151529
28132765	severe	C0205082
28132765	growth	C0018270
28132765	deficiency	C0011155
28132765	akt2	C0812230
28132765	null	C0456148
28132765	mice	C0025929
28132765	akt2	C0812230
28132765	null	C0456148
28132765	zebrafish	C0043457
28132765	display	C0870432
28132765	deficiency	C0011155
28132765	fin ray development	C2246747
28132765	cartilage	C0007301
28132765	not affected	C2986417
28132765	observations	C0302523
28132765	akt2	C0812230
28132765	null	C0456148
28132765	mice	C0025929
28132765	akt2	C0812230
28132765	null	C0456148
28132765	zebrafish	C0043457
28132765	display	C0870432
28132765	impaired	C0221099
28132765	glucose homeostasis	C1326961
28132765	akt2	C0812230
28132765	null	C0456148
28132765	mice	C0025929
28132765	insulin level	C0202098
28132765	lower	C0205251
28132765	akt2	C0812230
28132765	null	C0456148
28132765	zebrafish	C0043457
28132765	symptoms	C1457887
28132765	type I diabetes	C0011854
28132765	akt2	C0812230
28132765	null	C0456148
28132765	zebrafish	C0043457
28132765	transcriptome analysis	C0752248
28132765	reveals	C0443289
28132765	genes	C0017337
28132765	metabolism	C0025519
28132765	osteogenesis	C0029433
28132765	akt2	C0812230
28132765	null	C0456148
28132765	zebrafish	C0043457
28132765	data	C1511726
28132765	role	C1705810
28132765	akt2	C0812230
28132765	zebrafish	C0043457
28132765	survival	C0038952
28132765	growth	C0018270
28132765	bone development	C0005939
28132765	glucose homeostasis	C1326961
28132765	akt2	C0812230
28132765	functions	C0542341
28132765	mice	C0025929
28132765	zebrafish	C0043457
28132765	evolutionarily	C0015219
28132765	conserved	C0969701
28132824	Physiological	C0205463
28132824	Properties	C0871161
28132824	Behavioral	C0004927
28132824	Correlates	C1707520
28132824	Hippocampal	C0019564
28132824	Granule Cells	C0007634
28132824	Mossy Cells	C0007634
28132824	hippocampal	C0019564
28132824	dentate gyrus	C0152314
28132824	segregator	C0205245
28132824	upstream information	C1254358
28132824	Physiological support	C0031843
28132824	function	C0542341
28132824	lack	C0332268
28132824	well-defined	C0442825
28132824	characteristics	C1521970
28132824	granule cells	C0007634
28132824	mossy cells	C0007634
28132824	electrophysiology	C0678837
28132824	classification	C0008902
28132824	dentate	C0152314
28132824	granule cells	C0007634
28132824	mossy cells	C0007634
28132824	mice	C0025929
28132824	optogenetic tagging	C3494301
28132824	mossy cells	C0007634
28132824	Granule cells	C0007634
28132824	firing	C0007613
28132824	single	C0205171
28132824	place field	C1254362
28132824	changes	C0392747
28132824	mouse	C0025929
28132824	tested	C0039593
28132824	mazes	C0870866
28132824	room	C1547703
28132824	mossy cells	C0007634
28132824	active	C0205177
28132824	multiple	C0439064
28132824	place fields	C1254362
28132824	place fields	C1254362
28132824	conditions	C0348080
28132824	granule cell	C0007634
28132824	mossy cell	C0007634
28132824	synapse	C0039062
28132824	mossy cells	C0007634
28132824	place fields	C1254362
28132824	single	C0205171
28132824	granule cells	C0007634
28132824	findings	C2607943
28132824	granule cells	C0007634
28132824	mossy cells	C0007634
28132824	modulated	C0443264
28132824	action	C3266814
28132824	pattern separation	C0205245
28134415	intraosseous access	C0595613
28134415	History	C2004062
28134415	clinical considerations	C0427350
28134415	current devices	C0025080
28134415	Intraosseous (IO) access	C0595613
28134415	method	C0025663
28134415	American Heart Association	C0002458
28134415	European Resuscitation Council	C1708333
28134415	administer	C1621583
28134415	resuscitative drugs	C1254351
28134415	fluids	C1704353
28134415	intravenous (IV) access	C0013125
28134415	clinicians	C0871685
28134415	limited knowledge	C0376554
28134415	experience	C0596545
28134415	IO route	C0595613
28134415	review	C0282443
28134415	succinct review	C0282443
28134415	history	C2004062
28134415	clinical considerations	C0427350
28134415	devices	C0025080
28134415	associated with	C0332281
28134415	IO access	C0595613
28134415	IO access	C0595613
28134415	IO access	C0595613
28134415	lifesaving bridge	C1254370
28134415	definitive vascular access	C0750138
28134415	IV	C0348016
28134415	patient's outcome	C1547647
28134415	negatively affected	C0233467
28134415	prompt circulatory access	C0444454
28134415	IO route	C0595613
28134415	contraindications	C0522473
28134415	serious complications	C0009566
28134415	manual	C0175674
28134415	powered devices	C0025080
28134415	several anatomic sites	C1513749
28134415	clinicians	C0871685
28134415	acute care	C0679878
28134415	cardiovascular	C3887460
28134415	emergencies	C2745965
28134415	training	C0220931
28134415	proficiency	C0205556
28134415	IO	C0595613
28134415	devices	C0025080
28134415	IO route	C0595613
28134415	resuscitation organizations	C1708333
28134415	preferred route of infusion	C1827465
28134415	IV access	C0013125
28135569	C-5a-substituted validamine type	C0084937
28135569	glycosidase inhibitors	C1960098
28135569	N-alkyl derivatives	C1254351
28135569	D-galactosidase	C0005220
28135569	inhibitor	C0014432
28135569	1,4-di-epi-validamine	C1254351
28135569	lipophilic	C0598631
28135569	substituents at position C-5a	C1254350
28135569	screened	C0373483
28135569	glycosidase	C0017976
28135569	inhibitory properties	C1524081
28135569	Products	C1514468
28135569	β-galactosidases	C0005220
28135569	β-glucosidases	C1260223
28135997	Exposure to suicidal behaviors	C1760428
28135997	suicide	C0038661
28135997	risk factor	C0035648
28135997	personal	C1519021
28135997	negative life event	C1822593
28135997	Numerous	C0439064
28135997	suicide	C0038661
28135997	risk factors	C0035648
28135997	validated for epidemiology	C0042283
28135997	treatment	C0087111
28135997	prevention efforts	C2700409
28135997	Exposures to suicidal behaviors	C1760428
28135997	ESB	C1760428
28135997	family	C0015576
28135997	friend	C0079382
28135997	suicide attempts	C0038663
28135997	completions	C0038661
28135997	validity	C0042283
28135997	suicidal	C0038661
28135997	risk factor	C0035648
28135997	measurement	C0242485
28135997	adequacy	C0814633
28135997	anonymous	C2346787
28135997	online	C0029038
28135997	survey	C0038951
28135997	participants	C0679646
28135997	aged	C0001779
28135997	ESB	C1760428
28135997	Suicidal Affect-Behavior-Cognition Scale	C0282574
28135997	SABCS	C0282574
28135997	variables	C0439828
28135997	Tests	C0392366
28135997	dimensionality	C1707753
28135997	internal consistency	C0870731
28135997	ESB	C1760428
28135997	variables	C0439828
28135997	attempts	C0038663
28135997	completions	C0038661
28135997	family	C0015576
28135997	friends	C0079382
28135997	independent	C0332291
28135997	ESB	C1760428
28135997	latent	C0205275
28135997	trait	C0599883
28135997	ESB	C1760428
28135997	variables	C0439828
28135997	demographic	C0578829
28135997	psychiatric histories	C0748059
28135997	tests	C0392366
28135997	associations	C0439849
28135997	ESB	C1760428
28135997	suicidality	C3166387
28135997	suicide	C0038661
28135997	risk factors	C0035648
28135997	social support	C0037438
28135997	depression	C0011570
28135997	anxiety	C0003467
28135997	stress	C0038435
28135997	satisfaction with life	C0392352
28135997	emotional stability	C0237105
28135997	reports	C0684224
28135997	young adults	C0238598
28135997	aged	C0001779
28135997	increased	C0205217
28135997	suicidality	C3166387
28135997	ESB	C1760428
28135997	Results	C1274040
28135997	validity	C0042283
28135997	ESB	C1760428
28135997	risk factor	C0035648
28135997	suicidality	C3166387
28135997	psychopathology	C0544667
28135997	latent	C0205275
28135997	trait	C0599883
28135997	ESB	C1760428
28135997	evidence	C3887511
28135997	personal	C1519021
28135997	negative life event	C1822593
28135997	individual	C0237401
28135997	effects	C1280500
28135997	interpretations	C0459471
28137262	Direct anterior approach	C0205511
28137262	total hip arthroplasty	C0040508
28137262	mobile traction table	C0183817
28137262	prospective cohort study	C1709709
28137262	prospective cohort study	C1709709
28137262	total hip arthroplasty	C0040508
28137262	direct anterior approach	C0205511
28137262	supine position	C0038846
28137262	mobile traction table	C0183817
28137262	consecutive surgeries	C0035110
28137262	single surgeon	C0582175
28137262	direct anterior approach	C0205511
28137262	traction table	C0183817
28137262	follow-up	C1522577
28137262	patients	C0030705
28137262	patients	C0030705
28137262	previous hip surgeries	C3266738
28137262	severe deformity	C0302142
28137262	cemented implants	C0441496
28137262	groups	C0441833
28137262	patients	C0030705
28137262	patients	C0030705
28137262	implant survival rate	C0038954
28137262	follow-up	C1522577
28137262	Revision surgery	C0035110
28137262	periprosthetic	C2609162
28137262	femoral fracture	C0015802
28137262	patient	C0030705
28137262	complication	C0009566
28137262	rate	C1521828
28137262	traction table	C0183817
28137262	patients	C0030705
28137262	anterior dislocations	C1265658
28137262	periprosthetic	C2609162
28137262	femoral fracture	C0015802
28137262	intraoperative perforation	C0034117
28137262	femoral rasping	C0015802
28137262	complication	C0009566
28137262	rate	C1521828
28137262	decrease	C0547047
28137262	group	C0441833
28137262	Mean surgical time	C3494201
28137262	rate	C1521828
28137262	allogeneic blood transfusion	C0005841
28137262	cup alignment	C1821889
28137262	safe zone	C1254362
28137262	group	C0441833
28137262	group	C0441833
28137262	direct anterior approach	C0205511
28137262	mobile traction table	C0183817
28137262	positive learning curve	C0243095
28137262	surgical time	C3494201
28137262	rate	C1521828
28137262	allogeneic blood transfusion	C0005841
28137262	cup alignment	C1821889
28137262	safe zone	C1254362
28137449	binding	C0597358
28137449	orientations	C1704322
28137449	structurally	C0678594
28137449	ligands	C0023688
28137449	differ	C1705242
28137449	Crystal structures	C0444626
28137449	ligand-receptor interactions	C0597358
28137449	therapeutics	C0087111
28137449	experimental	C1517586
28137449	homologous proteins	C1512488
28137449	Tropisetron	C0063322
28137449	orthosteric ligand	C0023688
28137449	5-HT3	C0295352
28137449	α7 nACh receptors	C0051334
28137449	binding	C0597358
28137449	orientation	C1704322
28137449	structural homologue	C1449549
28137449	AChBP	C1254349
28137449	Co-crystallisation	C0010423
28137449	structurally	C0678594
28137449	ligand	C0023688
28137449	granisetron	C0061863
28137449	identical	C0205280
28137449	orientation	C1704322
28137449	difference	C1705242
28137449	affinity	C1510827
28137449	tropisetron	C0063322
28137449	5-HT3	C0295352
28137449	α7 nACh receptors	C0051334
28137449	α7 nACh receptors	C0051334
28137449	not	C1518422
28137449	bind	C0597358
28137449	granisetron	C0061863
28137449	pharmacological	C0205464
28137449	differences	C1705242
28137449	receptor	C0597357
28137449	crystal structures	C0444626
28137449	ligand	C0023688
28137449	orientations	C1704322
28137449	binding	C0597358
28137449	orientation	C1704322
28137449	tropisetron	C0063322
28137449	granisetron	C0061863
28137449	5-HT3 receptors	C0295352
28137449	in silico	C3489666
28137449	modelling	C0013193
28137449	docking	C1522290
28137449	radioligand binding	C1517880
28137449	cysteine	C0010654
28137449	substituted	C0525038
28137449	5-HT3 receptor	C0295352
28137449	mutants	C0596988
28137449	expressed	C0017262
28137449	HEK 293 cells	C2936239
28137449	synthetic modification	C0598331
28137449	ligands	C0023688
28137449	cysteine	C0010654
28137449	substitutions	C0525038
28137449	effects	C1280500
28137449	tropisetron	C0063322
28137449	granisetron	C0061863
28137449	Structure-activity relationships	C0038477
28137449	ligands	C0023688
28137449	orientations	C1704322
28137449	revealing	C0443289
28137449	crystallographic	C0010424
28137449	evidence	C3887511
28137449	AChBP	C1254349
28137449	ligands	C0023688
28137449	different	C1705242
28137449	orientations	C1704322
28137449	5-HT3 receptor	C0295352
28137449	binding site	C0005456
28137449	structurally	C0678594
28137449	molecules	C0567416
28137449	orientations	C1704322
28137449	binding site	C0005456
28137449	homologous proteins	C1512488
28137449	ligand binding	C1517880
28138631	Pancreatic	C0030274
28138631	neuroendocrine cancer	C0746852
28138631	liver metastases	C0494165
28138631	multiple peritoneal metastases	C0346989
28138631	Pancreatic	C0030274
28138631	neuroendocrine tumor	C0746852
28138631	pNET	C0746852
28138631	pancreatic tumor	C0030297
28138631	distant metastases	C4297205
28138631	found	C0150312
28138631	liver	C0023884
28138631	male patient	C0150904
28138631	pNET	C0746852
28138631	liver metastasis	C0494165
28138631	multiple abdominal metastases	C0854198
28138631	management	C0376636
28138631	tumor	C0027651
28138631	advanced stage	C1254367
28139296	Lignans	C0064971
28139296	fruits	C0016767
28139296	Schisandra chinensis (Turcz.) Baill	C0696946
28139296	inhibit	C3463820
28139296	proprotein convertase subtilisin/kexin type 9	C1426592
28139296	expression	C0017262
28139296	Bioactivity-guided fractionation	C0016640
28139296	fruits	C0016767
28139296	Schisandra chinensis	C0696946
28139296	proprotein convertase subtilisin-kexin type 9	C1426592
28139296	PCSK9	C1426592
28139296	mRNA expression	C1515670
28139296	screening assay	C1510438
28139296	isolation	C0205409
28139296	two	C0205448
28139296	previously unknown	C0439673
28139296	lignans	C0064971
28139296	14-tigloylschinlignan D	C0064971
28139296	rel-(7R, 8R, 7'R, 8'R)-manglisin E	C0064971
28139296	structures	C0220807
28139296	established	C0443211
28139296	NMR spectroscopic	C0877853
28139296	data	C1511726
28139296	CD	C0008813
28139296	MS	C0037813
28139296	analysis	C0936012
28139296	tested	C0039593
28139296	inhibitory	C3463820
28139296	activities	C0441655
28139296	mRNA expression	C1515670
28139296	PCSK9	C1426592
28139296	tested	C0039593
28139296	four	C0205450
28139296	rel-(7R, 8R, 7'R, 8'R)-manglisin E	C0064971
28139296	(-)-schisandrin C	C0074176
28139296	schinlignan D	C0064971
28139296	(+)-schisandrol B	C0074177
28139296	inhibited	C0311403
28139296	PCSK9	C1426592
28139296	mRNA expression	C1515670
28139296	IC50	C0600495
28139296	(+)-schisandrol B	C0074177
28139296	suppress	C1260953
28139296	PCSK9	C4255394
28139296	protein expressions	C1171362
28139296	schinlignan D	C0064971
28139296	low density lipoprotein receptor	C0034821
28139296	expression	C0597360
28139371	outcomes	C0085415
28139371	morbidly obese	C0028756
28139371	obese	C0028754
28139371	non-obese	C0005910
28139371	patients	C0030705
28139371	primary total knee	C0086511
28139371	total hip arthroplasty	C0040508
28139371	Obesity	C0028754
28139371	public	C0678367
28139371	health issue	C1398682
28139371	prevalence	C0220900
28139371	morbid obesity, (Body Mass Index (BMI) ≥ 40 kg/m(2))	C1319441
28139371	increasing	C0442808
28139371	evidence	C3887511
28139371	patients	C0030705
28139371	peri- and post-operative complications	C0280955
28139371	poorer outcomes	C0085415
28139371	arthroplasty procedures	C0003893
28139371	outcomes	C0085415
28139371	non-obese	C0005910
28139371	obese	C0028754
28139371	morbidly obese	C0028756
28139371	patients	C0030705
28139371	arthroplasty	C0003893
28139371	institution	C2607850
28139371	retrospective audit	C0184821
28139371	patients	C0030705
28139371	institution	C2607850
28139371	total knee	C0086511
28139371	TKA	C0086511
28139371	total hip arthroplasty	C0040508
28139371	THA	C0040508
28139371	Data	C1511726
28139371	collected	C1516695
28139371	age	C0001779
28139371	gender	C0079399
28139371	BMI	C1305855
28139371	length of stay	C0023303
28139371	LOS	C0023303
28139371	Oxford knee	C1997265
28139371	hip score	C1998079
28139371	OKS	C1997265
28139371	OHS	C1998079
28139371	satisfaction	C3476649
28139371	complications	C0274311
28139371	years	C0439234
28139371	post operation	C0543467
28139371	Patients	C0030705
28139371	groups	C0441833
28139371	BMI < 30	C0850114
28139371	BMI 30-40	C1305855
28139371	BMI > 40	C1561729
28139371	Outcomes	C0085415
28139371	BMI	C1305855
28139371	group	C0441833
28139371	TKA	C0086511
28139371	THA	C0040508
28139371	operations	C0543467
28139371	obese	C0028754
28139371	non-obese	C0005910
28139371	patients	C0030705
28139371	morbidly obese	C0028756
28139371	patients	C0030705
28139371	TKA	C0086511
28139371	LOS	C0023303
28139371	day	C0439228
28139371	mean OKS	C1997265
28139371	postoperative problems	C0032787
28139371	THA	C0040508
28139371	patients	C0030705
28139371	no difference	C3842396
28139371	LOS	C0023303
28139371	OHS score	C1998079
28139371	increasing	C0442808
28139371	BMI	C1305855
28139371	category	C0683312
28139371	postoperative problems	C0032787
28139371	increase	C0442805
28139371	non-obese	C0005910
28139371	obese	C0028754
28139371	morbidly obese	C0028756
28139371	patients	C0030705
28139371	obese	C0028754
28139371	patients	C0030705
28139371	outcomes	C0085415
28139371	TKA	C0086511
28139371	THA	C0040508
28139371	patients	C0030705
28139371	arthroplasty	C0003893
28139665	Vitamin D Receptor Activator	C0574031
28139665	Cause-specific Death	C1707318
28139665	dialysis	C0011946
28139665	Patients	C0030705
28139665	Nationwide Cohort Study	C0009247
28139665	Coarsened Exact Matching	C0026348
28139665	Vitamin D receptor activators	C0574031
28139665	VDRA	C0574031
28139665	pleiotropic effects	C2936488
28139665	cardiovascular disease	C0007222
28139665	malignancy	C4282132
28139665	infections	C3714514
28139665	dialysis	C0011946
28139665	patients	C0030705
28139665	cardiovascular outcomes	C0679250
28139665	patients	C0030705
28139665	dialysis	C0011946
28139665	who survived	C0038954
28139665	Renal Data Registry	C0920631
28139665	Japanese Society	C1708333
28139665	Dialysis Therapy	C0011946
28139665	VDRA	C0574031
28139665	clinically relevant variables	C0205563
28139665	coarsened exact matching procedure	C0026348
28139665	deaths	C0205848
28139665	cardiovascular deaths	C0376297
28139665	infection-related deaths	C1306577
28139665	malignancy-related deaths	C1516192
28139665	Multivariable survival analyses	C0038953
28139665	intra-region correlation	C1707520
28139665	VDRA	C0574031
28139665	lower rates	C1521828
28139665	infection	C3714514
28139665	malignancy	C4282132
28139665	deaths	C0205848
28139665	subhazard ratio	C2985465
28139665	CI	C0009667
28139665	CI	C0009667
28139665	cardiovascular death	C0376297
28139665	subhazard ratio	C2985465
28139665	CI	C0009667
28139665	randomized clinical trials	C0206034
28139665	sample size	C0242618
28139665	follow-up	C1522577
28139665	clinical effectiveness	C3850123
28139665	VDRA	C0574031
28139665	infection	C3714514
28139665	malignancy	C4282132
28139665	cardiovascular disease	C0007222
28139665	dialysis	C0011946
28139665	patients	C0030705
28144096	Burden	C2828008
28144096	cervical cancer	C4048328
28144096	screening	C1710032
28144096	India	C0021201
28144096	Cervical cancer	C4048328
28144096	cancer mortality	C1516192
28144096	women	C0043210
28144096	quarter	C2825406
28144096	global	C2348867
28144096	burden	C2828008
28144096	contributed	C1880177
28144096	developing countries	C0011750
28144096	India	C0021201
28144096	government-sponsored screening program	C0018109
28144096	study	C2603343
28144096	conducted	C0205245
28144096	assess	C1516048
28144096	burden	C2828008
28144096	cervical cancer	C4048328
28144096	India	C0021201
28144096	review	C0699752
28144096	performance	C1882330
28144096	characteristics	C1521970
28144096	cervical cancer	C4048328
28144096	screening	C1710032
28144096	provide	C1999230
28144096	evidence	C3887511
28144096	recommendations	C0034866
28144096	screening test	C2717746
28144096	resource	C0035201
28144096	MEDLINE	C0025141
28144096	Web of Science electronic database	C3841595
28144096	searched	C1706202
28144096	January	C3829466
28144096	December	C3830550
28144096	keywords	C1708608
28144096	cervical cancer	C4048328
28144096	screening	C2717746
28144096	early detection	C0596473
28144096	cervical cytology	C0856201
28144096	visual inspection	C3669138
28144096	MeSH terms	C1135584
28144096	combination	C0205195
28144096	Boolean operators	C1881439
28144096	authors	C3812881
28144096	selected	C1707391
28144096	studies	C2603343
28144096	published	C1704324
28144096	English	C0376245
28144096	conducted	C0205245
28144096	India	C0021201
28144096	total	C0439810
28144096	studies	C2603343
28144096	found	C0150312
28144096	relevant	C2347946
28144096	eligible	C1548635
28144096	included	C0332257
28144096	present	C0150312
28144096	study	C2603343
28144096	India	C0021201
28144096	cervical cancer	C4048328
28144096	contributes	C1880177
28144096	approximately	C0332232
28144096	cancers	C0006826
28144096	women	C0043210
28144096	age-adjusted incidence rate	C1706747
28144096	cervical cancer	C4048328
28144096	registries	C0034975
28144096	highest	C1522410
28144096	Mizoram state	C0681784
28144096	lowest	C1708760
28144096	Dibrugarh district	C0681784
28144096	estimates	C0750572
28144096	sensitivity	C0036667
28144096	specificity	C0037791
28144096	visual inspection with acetic acid	C0430022
28144096	VIA	C0430022
28144096	magnified VIA	C0430022
28144096	visual inspection with Lugol's iodine	C1519194
28144096	VILI	C1519194
28144096	cytology	C1305671
28144096	Pap smear	C0079104
28144096	human papillomavirus DNA	C2985459
28144096	developing countries	C0011750
28144096	lack	C0332268
28144096	infrastructure	C1998546
28144096	quality control	C0034378
28144096	high-quality	C0332306
28144096	cytology screening	C0199230
28144096	implementation	C1708476
28144096	cervical cancer	C4048328
28144096	screening	C1710032
28144096	program	C3484370
28144096	visual screening test	C2717746
28144096	VIA	C0430022
28144096	VILI	C1519194
28144096	health-care setup	C0086388
28144096	resource	C0035201
28144096	poor	C2700379
28144096	countries	C0454664
28144096	India	C0021201
28144564	Structural and tribometric characterization	C1880022
28144564	insect	C0021585
28144564	adhesives	C0001516
28144564	chemical analyses	C3495389
28144564	insect	C0021585
28144564	tarsal	C1550316
28144564	adhesives	C0001516
28144564	heterogeneous	C0019409
28144564	synthetic	C1883254
28144564	emulsions	C0014020
28144564	polar/non-polar principle	C0243095
28144564	microscopical structure	C0678594
28144564	adhesive	C0871161
28144564	frictional	C0871161
28144564	rheological properties	C0871161
28144564	prepared	C4082130
28144564	emulsions	C0014020
28144564	consistency	C0332529
28144564	solid	C0205208
28144564	rubber-like	C0035918
28144564	soft	C0205358
28144564	elastic	C0450146
28144564	fluid	C1704353
28144564	watery	C0443350
28144564	oily	C0205556
28144564	droplet sizes	C0456389
28144564	emulsions	C0014020
28144564	macroemulsions	C0014020
28144564	emulsions	C0014020
28144564	first generation	C0079411
28144564	droplet-size	C0456389
28144564	second generation	C0079411
28144564	components	C1254370
28144564	petrolatum	C0031262
28144564	waxes	C0043076
28144564	lipophilic	C0598631
28144564	fraction	C1264633
28144564	first generation	C0079411
28144564	emulsions	C0014020
28144564	prepared	C4082130
28144564	emulsions	C0014020
28144564	yield point	C0243095
28144564	Bingham fluids	C1254355
28144564	Tribometric adhesion	C0022885
28144564	probe tack tests	C0022885
28144564	second generation	C0079411
28144564	viscous	C0311419
28144564	components	C0439861
28144564	first generation	C0079411
28144564	emulsions	C0014020
28144564	more adhesive	C0243095
28144564	viscous	C0311419
28144564	components	C0439861
28144564	wax	C0043076
28144564	petrolatum	C0031262
28144564	gelatin	C0017237
28144564	poly(vinyl alcohol)	C0029224
28144564	second generation	C0079411
28144564	emulsions	C0014020
28144564	adhesivenesses	C0001515
28144564	adhesive	C0001516
28144564	performance	C1882330
28144564	reduced	C0392756
28144564	emulsions	C0014020
28144564	albumin	C0001924
28144564	protein component	C0033684
28144564	protein	C0033684
28144564	Tribometric shear tests	C0022885
28144564	normal loads	C0205556
28144564	friction forces	C0162691
28144564	second generation	C0079411
28144564	emulsions	C0014020
28144564	Differences	C1705241
28144564	shear	C3825679
28144564	performance	C1882330
28144564	chemical composition	C0243176
28144564	emulsion	C0014020
28144564	structure	C0678594
28144564	chemical composition	C0243176
28144564	heterogeneous	C0019409
28144564	adhesive	C0001516
28144564	emulsions	C0014020
28144564	consistencies	C0332529
28144564	rheological	C0871161
28144564	tribological properties	C0871161
28144564	natural	C0205296
28144564	tarsal	C1550316
28144564	insect	C0021585
28144564	adhesives	C0001516
28149973	Opioids	C0242402
28149973	chronic pain	C0150055
28149973	CDC's	C0007670
28149973	recommendations	C0034866
28149973	Centers for Disease Control and Prevention	C0007670
28149973	recommendations	C0034866
28149973	clinicians	C0871685
28149973	prescribe	C0033080
28149973	optimal	C2698651
28149973	treatment	C0087111
28149973	patients	C0030705
28150322	Three-Dimensional	C0450363
28150322	HyCoSy	C0412553
28150322	Perfluoropropane-Albumin Microspheres	C0389602
28150322	Contrast Agents	C0009924
28150322	Saline	C0036082
28150322	Injections	C1533685
28150322	Pelvic Cavity	C0559769
28150322	Morphological	C0332437
28150322	Assessment	C0220825
28150322	Fallopian Tube	C0015560
28150322	Infertile	C0021359
28150322	Women	C0043210
28150322	three-dimensional	C0450363
28150322	3D	C0450363
28150322	hysterosalpingo-contrast sonography	C0412553
28150322	HyCoSy	C0412553
28150322	perfluoropropane-albumin microspheres	C0389602
28150322	contrast agents	C0009924
28150322	saline	C0036082
28150322	injections	C1533685
28150322	pelvic cavity	C0559769
28150322	assessment of the tubal patency	C0015559
28150322	adhesions of fimbrial parts	C4303544
28150322	infertile	C0021359
28150322	female	C0086287
28150322	patients	C0030705
28150322	3D	C0450363
28150322	HyCoSy	C0412553
28150322	saline	C0036082
28150322	injected	C1533685
28150322	pelvic cavity	C0559769
28150322	contrast agents	C0009924
28150322	fimbriae	C0227912
28150322	fimbrial adhesion	C4303544
28150322	finger-like projections	C0348018
28150322	fimbriae	C0227912
28150322	floating	C0443223
28150322	moving status	C1561509
28150322	patients	C0030705
28150322	bilateral tubal patency	C0243095
28150322	unilateral tubal patency	C0243095
28150322	partial occlusion	C1997620
28150322	unilateral	C0205092
28150322	partial occlusion	C1997620
28150322	complete occlusion	C0028778
28150322	bilateral	C0238767
28150322	complete occlusion	C0028778
28150322	fimbrial parts	C0227912
28150322	fallopian tubes	C0015560
28150322	finger-like	C1254362
28150322	fimbriae	C0227912
28150322	floated	C0443223
28150322	moved	C1561509
28150322	pelvic cavity	C0559769
28150322	adhesion	C4303544
28150322	pelvic cavity	C0559769
28150322	ovary	C0029939
28150322	intestine	C0021853
28150322	finger-like projection	C0348018
28150322	patent	C0175566
28150322	fimbrial parts	C0227912
28150322	fewer	C0205388
28150322	flat	C0205324
28150322	finger-like projection	C0348018
28150322	adhesive tubes	C4303544
28150322	complications	C0009566
28150322	procedure	C0430022
28150322	Combination	C0205195
28150322	3D	C0450363
28150322	HyCoSy	C0412553
28150322	saline	C0036082
28150322	injected	C1533685
28150322	pelvic cavity	C0559769
28150322	procedure	C0430022
28150322	adhesions of the fimbrial parts	C4303544
28150378	Challenging	C0805586
28150378	empathy	C0013989
28150378	New Zealand	C0027978
28150378	nursing	C0013636
28150378	medical curricula	C0013631
28150378	time	C0040223
28150378	enhancement	C2349975
28150378	empathy	C0013989
28150378	empathic	C0564547
28150378	important	C3898777
28150378	patient care	C0017313
28150378	students	C0038492
28150378	students	C0038492
28150378	practicum	C0032929
28150378	experienced	C0237607
28150378	clinicians	C0871685
28150378	study	C2603343
28150378	compare	C1707455
28150378	self-reported	C2700446
28150378	empathy	C0013989
28150378	groups	C1257890
28150378	medical students	C0038495
28150378	cohort	C0599755
28150378	nursing students	C0038496
28150378	empathy	C0013989
28150378	training	C0220931
28150378	learning	C0023185
28150378	clinical settings	C3176918
28150378	patients	C0030705
28150378	Jefferson Scale of Physician Empathy	C0034375
28150378	JSPE	C0034375
28150378	medical	C0038495
28150378	nursing students	C0038496
28150378	extended	C0439590
28150378	periods	C1948053
28150378	practicum	C0032929
28150378	medical student	C0038495
28150378	cohorts	C0599755
28150378	brief	C1879313
28150378	empathy	C0013989
28150378	training	C0220931
28150378	training	C0220931
28150378	nursing student	C0038496
28150378	cohort	C0599755
28150378	no formal	C0557286
28150378	empathy	C0013989
28150378	training	C0220931
28150378	profession	C0028811
28150378	length	C0023980
28150378	practicum	C0032929
28150378	empathy	C0013989
28150378	training	C0220931
28150378	no significant differences	C3842396
28150378	self-reported	C2700446
28150378	JSPE scores	C0034375
28150378	cohorts	C0599755
28150378	students	C0038492
28150378	Empathy	C0013989
28150378	quality	C0332306
28150378	present	C0150312
28150378	students	C0038492
28150378	learned by	C0023185
28150378	students	C0038492
28150378	practicum	C0032929
28150378	DISCUSSION	C2584313
28150378	empathy	C0013989
28150378	caught	C0679140
28150378	taught	C0348054
28150378	enhance	C2349975
28150378	empathy	C0013989
28150378	futile	C3840836
28150378	inherent empathic qualities	C0564547
28150378	health professionals	C1704312
28150378	consideration	C0518609
28150378	empathy	C0013989
28150378	influenced	C4054723
28150378	practicum	C0032929
28150378	experience	C0237607
28155918	Surface	C0205148
28155918	interactions of drugs	C0687133
28155918	enhance	C2349975
28155918	mechanical forces	C0563538
28155918	antibiotic	C0003232
28155918	action	C3266814
28155918	alarming increase	C0442805
28155918	pathogenic bacteria	C0450254
28155918	resistant to multiple antibiotics	C0860044
28155918	major health issue	C4060919
28155918	demand	C0441516
28155918	drugs	C1254351
28155918	Bacterial resistance	C0151521
28155918	molecular changes	C0262496
28155918	bacterial surface	C0201029
28155918	drug-target interactions	C0687133
28155918	mechanism	C0441712
28155918	drug-target interactions	C0687133
28155918	resistant bacteria	C1444090
28155918	enhanced	C2349975
28155918	surface	C0205148
28155918	surface	C0205148
28155918	forces	C0441722
28155918	antibiotics	C0003232
28155918	vancomycin	C0042313
28155918	ristomycin	C0917879
28155918	chloroeremomycin	C0674648
28155918	oritavancin	C1144403
28155918	drug-susceptible	C0231204
28155918	drug-resistant targets	C4076168
28155918	significant	C0750502
28155918	mechanical	C0443254
28155918	response	C0871261
28155918	drug-resistant targets	C4076168
28155918	antibiotics	C0003232
28155918	observed	C1441672
28155918	susceptible targets	C0231204
28155918	binding affinity	C0678749
28155918	oritavancin	C1144403
28155918	drug-resistant targets	C4076168
28155918	vancomycin	C0042313
28155918	antibiotic	C0003232
28155918	resort treatment	C0087111
28155918	streptococcal	C0038402
28155918	staphylococcal bacteria	C0038170
28155918	methicillin-resistant Staphylococcus aureus	C1265292
28155918	MRSA	C1265292
28155918	exactly solvable model	C0282574
28155918	solvent	C0037638
28155918	membrane	C0596901
28155918	effects	C1280500
28155918	drug-target interactions	C0687133
28155918	pronounced polyvalent interactions	C0687133
28155918	catalyzed	C0007382
28155918	surface	C0205148
28155918	enhance	C2349975
28155918	understanding	C0162340
28155918	antibiotic mode of action	C1524059
28155918	development	C1527148
28155918	therapies	C0087111
28162781	Intra-articular	C0442108
28162781	corticosteroids	C3536709
28162781	intra-articular	C0442108
28162781	corticosteroids	C3536709
28162781	plus	C0332287
28162781	methotrexate	C0025677
28162781	oligoarticular juvenile idiopathic arthritis	C3898105
28162781	multicentre	C0206012
28162781	prospective	C0033522
28162781	randomised	C0206034
28162781	open-label trial	C0008976
28162781	guide	C2825826
28162781	treatment	C0087111
28162781	oligoarticular juvenile idiopathic arthritis	C3898105
28162781	investigate	C1292732
28162781	oral methotrexate	C1246896
28162781	increases	C0442805
28162781	efficacy	C1280519
28162781	intra-articular corticosteroid therapy	C4054701
28162781	prospective	C0033522
28162781	open-label	C0008976
28162781	randomised trial	C0206034
28162781	hospitals	C0019994
28162781	Italy	C0022277
28162781	concealed	C0443189
28162781	computer-generated list	C0745732
28162781	children	C0008059
28162781	younger than	C2237067
28162781	years	C1510829
28162781	oligoarticular	C0439754
28162781	onset disease	C0277793
28162781	randomly	C0439605
28162781	assigned	C1516050
28162781	intra-articular	C0442108
28162781	corticosteroids	C3536709
28162781	alone	C0205171
28162781	in combination with	C0205195
28162781	oral methotrexate	C1246896
28162781	maximum	C0806909
28162781	Corticosteroids	C3536709
28162781	triamcinolone hexacetonide	C0077004
28162781	shoulder	C0037009
28162781	elbow	C0013770
28162781	wrist	C1322271
28162781	knee	C0022745
28162781	tibiotalar joints	C0003087
28162781	methylprednisolone acetate	C0600901
28162781	subtalar	C0038593
28162781	tarsal joints	C1527245
28162781	patients	C0030705
28162781	investigators	C0008961
28162781	treatment	C0087111
28162781	assignments	C1516050
28162781	primary outcome	C1274040
28162781	proportion	C1709707
28162781	patients	C0030705
28162781	intention-to-treat	C2718028
28162781	population	C1257890
28162781	remission	C0544452
28162781	arthritis	C0003864
28162781	injected	C0021485
28162781	joints	C0022417
28162781	months	C0439231
28162781	trial	C0008976
28162781	registered	C1514821
28162781	European Union Clinical Trials Register	C1254363
28162781	EudraCT number	C0282574
28162781	July	C3829447
28162781	March	C3829202
28162781	screened	C2348582
28162781	participants	C0679646
28162781	randomly	C0439605
28162781	assigned	C1516050
28162781	intra-articular	C0442108
28162781	corticosteroids	C3536709
28162781	alone	C0205171
28162781	intra-articular	C0442108
28162781	corticosteroids	C3536709
28162781	plus	C0332287
28162781	methotrexate	C0025677
28162781	patients	C0030705
28162781	assigned	C1516050
28162781	intra-articular	C0442108
28162781	corticosteroids	C3536709
28162781	alone	C0205171
28162781	assigned	C1516050
28162781	intra-articular	C0442108
28162781	corticosteroids	C3536709
28162781	methotrexate	C0025677
28162781	therapy	C0087111
28162781	remission	C0544452
28162781	arthritis	C0003864
28162781	injected	C0021485
28162781	joints	C0022417
28162781	Adverse events	C0877248
28162781	patients	C0030705
28162781	methotrexate	C0025677
28162781	permanent	C0205355
28162781	treatment	C0087111
28162781	discontinuation	C1444662
28162781	patients	C0030705
28162781	increased liver transaminases	C1848701
28162781	gastrointestinal discomfort	C1096250
28162781	No	C1513916
28162781	patient	C0030705
28162781	serious	C0205404
28162781	adverse event	C0877248
28162781	Concomitant administration	C2826730
28162781	methotrexate	C0025677
28162781	augment	C0442805
28162781	effectiveness	C1280519
28162781	intra-articular corticosteroid therapy	C4054701
28162781	Future studies	C2603343
28162781	optimal	C2698651
28162781	therapeutic strategies	C0087111
28162781	oligoarticular juvenile idiopathic arthritis	C3898105
28162781	Italian Agency of Drug Evaluation	C1561598
28164568	Methylation Analysis	C1880239
28164568	BRCA1	C0376571
28164568	APC	C0162832
28164568	Breast Cancer	C0006142
28164568	Relationship	C0439849
28164568	Clinicopathological	C1521733
28164568	Features	C2348519
28164568	Promoter methylation	C0376452
28164568	tumor suppressor genes	C0079427
28164568	epigenetic alteration	C1516924
28164568	primary	C0205225
28164568	stages	C1306673
28164568	human	C0086418
28164568	tumors	C0027651
28164568	breast cancer	C0006142
28164568	methylated genes	C0017337
28164568	relationship	C0439849
28164568	clinical	C0205210
28164568	features	C2348519
28164568	prognosis	C0033325
28164568	early detection	C0596473
28164568	tumors	C0027651
28164568	study	C2603343
28164568	methylation	C0376452
28164568	status	C0449438
28164568	APC	C0162832
28164568	BRCA1 genes	C0376571
28164568	relationship	C0439849
28164568	clinical	C0205210
28164568	factors	C1521761
28164568	breast cancer	C0006142
28164568	patients	C0030705
28164568	BRCA1	C0376571
28164568	APC	C0162832
28164568	promoter methylation	C0376452
28164568	methylation	C0025723
28164568	specific multiplex ligation-dependent probe amplification	C3494189
28164568	MS-MLPA	C3494189
28164568	assay	C1510438
28164568	formalin-fixed paraffin embedded (FFPE) breast tissue	C2711483
28164568	patients	C0030705
28164568	APC	C0162832
28164568	promoter methylation	C0376452
28164568	detected	C0442726
28164568	breast cancer	C0006142
28164568	tissues	C0040300
28164568	BRCA1	C0376571
28164568	methylated	C0376452
28164568	breast tumors	C1458155
28164568	Methylation	C0376452
28164568	APC	C0162832
28164568	associated with	C0332281
28164568	histological grade	C0456201
28164568	methylation	C0376452
28164568	BRCA1	C0376571
28164568	lymph node	C0024204
28164568	metastasis	C4255448
28164568	findings	C0243095
28164568	methylation	C0376452
28164568	status	C0449438
28164568	APC	C0162832
28164568	BRCA1	C0376571
28164568	predictive marker	C0005516
28164568	early detection	C0596473
28164568	management	C0376636
28164568	breast cancer	C0006142
28164568	patients	C0030705
28166607	Recombinant	C0034861
28166607	fibrinogen	C0016006
28166607	differential	C1705242
28166607	α-	C0033684
28166607	γ-chain	C0033684
28166607	cross-linking	C0314675
28166607	molecular	C1521991
28166607	heterogeneity	C0019409
28166607	fibrin clot	C3156338
28166607	strain-stiffening	C0013764
28166607	Fibrinogen	C0016006
28166607	circulates	C0175630
28166607	human	C0086418
28166607	plasma	C0032105
28166607	complex	C1704241
28166607	mixture	C0439962
28166607	heterogeneous	C0019409
28166607	molecular	C1521991
28166607	variants	C0205419
28166607	measured	C0444706
28166607	strain-stiffening	C0013764
28166607	recombinantly	C0034865
28166607	fibrinogen	C0016006
28166607	clotting	C0005778
28166607	Factor XIII	C0015528
28166607	molecular	C1521991
28166607	heterogeneity	C0019409
28166607	clot	C3156338
28166607	elasticity	C0013764
28166607	protofibril	C0015982
28166607	fiber	C1304649
28166607	molecular	C1521991
28166607	composition	C0205198
28166607	fibrin clot	C3156338
28166607	mechanics	C0376706
28166607	Fibrin	C0015982
28166607	haemostasis	C0019116
28166607	wound healing	C0043240
28166607	strain-stiffening	C0013764
28166607	fibrous networks	C0243092
28166607	blood clots	C0302148
28166607	molecular	C1521991
28166607	fibrin's	C0015982
28166607	strain-stiffening	C0013764
28166607	plasma	C0032105
28166607	fibrinogen	C0016006
28166607	complex	C1704241
28166607	mixture	C0439962
28166607	heterogeneous	C0019409
28166607	molecular	C1521991
28166607	variants	C0205419
28166607	plasma factors	C0033684
28166607	clot	C3156338
28166607	properties	C0871161
28166607	mechanistic dissection	C0205245
28166607	fibrin	C0015982
28166607	nonlinear elasticity	C0013764
28166607	homogeneous	C1881065
28166607	recombinant	C0034861
28166607	fibrinogen	C0016006
28166607	variant	C0205419
28166607	human	C0086418
28166607	plasma	C0032105
28166607	rFib610	C0016006
28166607	structure	C0678594
28166607	rFib610	C0016006
28166607	clots	C3156338
28166607	turbidimetry	C0041394
28166607	microscopy	C0026018
28166607	X-ray scattering	C0043301
28166607	rheology	C0599706
28166607	measure	C0079809
28166607	strain-stiffening	C0013764
28166607	clots	C3156338
28166607	fiber	C1304649
28166607	properties	C0871161
28166607	modeling	C0870071
28166607	clots	C3156338
28166607	semi-flexible polymer networks	C1882071
28166607	FXIII	C0015528
28166607	rFib610	C0016006
28166607	clots	C3156338
28166607	dose-dependent stiffness	C0018599
28166607	deformations	C0333067
28166607	strain-stiffening	C0013764
28166607	γ-chain	C0033684
28166607	cross-linking	C0314675
28166607	clot	C3156338
28166607	elasticity	C0013764
28166607	force-extension behavior	C0205245
28166607	protofibrils	C0015982
28166607	α-chain	C0033684
28166607	cross-linking	C0314675
28166607	fibers	C1304649
28166607	tighter coupling	C1948027
28166607	protofibrils	C0015982
28166607	rFib610	C0016006
28166607	protofibrils	C0015982
28166607	bending rigidity	C0018599
28166607	plasma	C0032105
28166607	fibrin	C0015982
28166607	protofibrils	C0015982
28166607	strain-stiffening	C0013764
28166607	molecular	C1521991
28166607	heterogeneity	C0019409
28166607	influences	C4054723
28166607	clot	C3156338
28166607	mechanics	C0376706
28166607	protofibril scale	C0015982
28166607	Fibrinogen	C0016006
28166607	molecular	C1521991
28166607	heterogeneity	C0019409
28166607	FXIII	C0015528
28166607	mechanical function	C0542341
28166607	fibrin clots	C3156338
28166607	nonlinear viscoelastic properties	C0871161
28166607	protofibril	C0230898
28166607	fiber scale	C1304649
28166607	investigate	C1292732
28166607	molecular	C1521991
28166607	heterogeneity	C0019409
28166607	plasma	C0032105
28166607	fibrinogen	C0016006
28166607	fibrin clot	C3156338
28166607	mechanics	C0376706
28166607	haemostasis	C0019116
28166877	display	C0870432
28166877	curvature	C0205134
28166877	display	C0870432
28166877	zone	C1710706
28166877	task	C0679599
28166877	duration	C0449238
28166877	legibility	C0870803
28166877	visual fatigue	C0004095
28166877	visual search task	C0679599
28166877	display	C0870432
28166877	curvature	C0205134
28166877	flat	C0205324
28166877	display	C0870432
28166877	zone	C1710706
28166877	zones	C1710706
28166877	task	C0679599
28166877	duration	C0449238
28166877	legibility	C0870803
28166877	visual fatigue	C0004095
28166877	participant	C0679646
28166877	visual search task	C0679599
28166877	curvature	C0205134
28166877	setting	C0442307
28166877	settings	C0442307
28166877	flat	C0205324
28166877	setting	C0442307
28166877	legibility	C0870803
28166877	visual fatigue	C0004095
28166877	centre	C0205099
28166877	zone	C1710706
28166877	zones	C1710706
28166877	flat	C0205324
28166877	settings	C0442307
28166877	legibility	C0870803
28166877	flat	C0205324
28166877	setting	C0442307
28166877	increase	C0442805
28166877	perceived	C0030971
28166877	visual fatigue	C0004095
28166877	curvature	C0205134
28166877	legibility	C0870803
28166877	decreased	C0205216
28166877	perceived	C0030971
28166877	visual fatigue	C0004095
28166877	increased	C0442805
28166877	task set	C0679599
28166877	task sets	C0679599
28166877	increase	C0442805
28166877	eye complaint score	C0449820
28166877	critical fusion frequency	C0234697
28166877	increase	C0442805
28166877	visual fatigue	C0004095
28166877	curvature	C0205134
28166877	central	C0205099
28166877	display	C0870432
28166877	zones	C1710706
28166877	breaks	C0449647
28166877	improve	C0184511
28166877	legibility	C0870803
28166877	visual fatigue	C0004095
28171696	adaptive	C0231193
28171696	functioning	C0542341
28171696	behavioral	C0004927
28171696	adjustment	C0456081
28171696	treatment	C0087111
28171696	pediatric brain tumor	C0220603
28171696	report	C4255046
28171696	Brain	C0006104
28171696	Radiation Investigative Study Consortium	C1880171
28171696	Children	C0008059
28171696	risk	C0035647
28171696	behavioral	C0004927
28171696	adaptive	C0231193
28171696	difficulties	C0332218
28171696	pediatric brain tumor	C0220603
28171696	study	C2603343
28171696	familial	C0241888
28171696	demographic	C0011298
28171696	developmental	C0458003
28171696	diagnostic	C0348026
28171696	treatment	C0087111
28171696	variables	C0439828
28171696	posttreatment	C2709088
28171696	behavioral	C0004927
28171696	adaptive	C0231193
28171696	functioning	C0542341
28171696	Participants	C0679646
28171696	children	C0008059
28171696	mean	C0444504
28171696	age	C0001779
28171696	SD	C0871420
28171696	posttreatment	C2709088
28171696	mean	C0444504
28171696	time	C0040223
28171696	diagnosis	C0011900
28171696	SD	C0871420
28171696	pediatric brain tumor	C0220603
28171696	Parents	C0030551
28171696	children	C0008059
28171696	behavioral	C0004927
28171696	adjustment	C0456081
28171696	adaptive	C0231193
28171696	functioning	C0542341
28171696	demographic	C0011298
28171696	developmental	C0458003
28171696	histories	C0262926
28171696	Diagnostic	C0011900
28171696	treatment	C0087111
28171696	information	C1533716
28171696	medical records	C0025102
28171696	Ratings	C0871208
28171696	adaptive	C0231193
28171696	behavioral	C0004927
28171696	functioning	C0542341
28171696	postdiagnosis	C0011900
28171696	average	C1510992
28171696	range	C1514721
28171696	percentage	C0439165
28171696	children	C0008059
28171696	clinical	C0205210
28171696	cutoffs	C1442160
28171696	impairment	C0221099
28171696	adaptive	C0231193
28171696	skills	C0678856
28171696	expectation	C0679138
28171696	skills	C0678856
28171696	Premorbid behavior	C4062485
28171696	problems	C1546466
28171696	tumor size	C0475440
28171696	posttreatment	C2709088
28171696	adaptive	C0231193
28171696	functioning	C0542341
28171696	adaptive	C0231193
28171696	functioning	C0542341
28171696	diagnosis	C0011900
28171696	premorbid behavior	C4062485
28171696	problems	C1546466
28171696	adaptive	C0231193
28171696	functioning	C0542341
28171696	postdiagnosis	C0011900
28171696	adjustment	C0456081
28171696	diagnosis	C0011900
28171696	variables	C0439828
28171696	behavioral	C0004927
28171696	adjustment	C0456081
28171696	Children	C0008059
28171696	vulnerable	C0231204
28171696	adaptive	C0231193
28171696	functioning	C0542341
28171696	pediatric brain tumor	C0220603
28171696	treatment	C0087111
28171696	prediagnosis	C0011900
28171696	functioning	C0542341
28171696	diagnostic	C0011900
28171696	treatment	C0087111
28171696	variables	C0439828
28171696	improve	C0184511
28171696	ability	C0085732
28171696	risk	C0035647
28171696	factors	C1521761
28171696	helpful	C3898897
28171696	identifying	C0205396
28171696	children	C0008059
28171696	behavioral	C0004927
28171696	difficulties	C0332218
28171696	Screening	C1710032
28171696	factors	C1521761
28171696	tertiary care	C3494403
28171696	long-term	C0443252
28171696	follow-up	C1522577
28171696	improve	C0184511
28171696	identification	C0205396
28171696	need	C0027552
28171696	support services	C0679879
28175980	Spine fracture	C0080179
28175980	prevalence	C0033105
28175980	nationally representative	C0681788
28175980	US	C0041703
28175980	women	C0043210
28175980	men	C0025266
28175980	aged	C0001779
28175980	National Health and Nutrition Examination Survey	C0376344
28175980	NHANES	C0376344
28175980	Spine fracture	C0080179
28175980	prevalence	C0033105
28175980	men	C0025266
28175980	women	C0043210
28175980	Prevalence	C0033105
28175980	higher	C0205250
28175980	age	C0001779
28175980	age	C0001779
28175980	lower	C0205251
28175980	bone mineral density	C0005938
28175980	BMD	C0005938
28175980	criteria	C0242801
28175980	spine imaging	C1532547
28175980	subjects	C0178693
28175980	spine fractures	C0080179
28175980	unaware	C0589402
28175980	Spine fractures	C0080179
28175980	medical	C0205476
28175980	seldom	C0522498
28175980	nationally representative	C0681788
28175980	spine fracture	C0080179
28175980	prevalence	C0033105
28175980	Cross-sectional analysis	C0010362
28175980	US	C0041703
28175980	adults	C0001675
28175980	aged	C0001779
28175980	NHANES	C0376344
28175980	Vertebral Fracture	C0080179
28175980	VFA	C0185141
28175980	VFA	C0185141
28175980	BMD	C0005938
28175980	osteoporosis	C0029456
28175980	questionnaire	C0034394
28175980	spine fracture	C0080179
28175980	prevalence	C0033105
28175980	men	C0025266
28175980	women	C0043210
28175980	Prevalence	C0033105
28175980	age	C0001779
28175980	Fractures	C0016658
28175980	non-Hispanic whites	C1257890
28175980	lower	C0205251
28175980	body mass index	C1305855
28175980	BMD	C0005938
28175980	subjects	C0178693
28175980	spine fracture	C0080179
28175980	BMD	C0005938
28175980	criteria	C0242801
28175980	osteoporosis	C0029456
28175980	Prevalence	C0033105
28175980	higher	C0205250
28175980	subjects	C0178693
28175980	National Osteoporosis Foundation	C0679938
28175980	NOF	C0679938
28175980	criteria	C0242801
28175980	spine imaging	C1532547
28175980	spine fracture	C0080179
28175980	diagnosed	C0011900
28175980	VFA	C0185141
28175980	self-reported	C0681906
28175980	fracture	C0016658
28175980	self-reported	C0681906
28175980	spine fracture	C0080179
28175980	diagnosed	C0011900
28175980	fracture	C0016658
28175980	VFA	C0185141
28175980	Spine fracture	C0080179
28175980	prevalence	C0033105
28175980	women	C0043210
28175980	men	C0025266
28175980	age	C0001779
28175980	lower	C0205251
28175980	BMD	C0005938
28175980	subjects	C0178693
28175980	spine fracture	C0080179
28175980	BMD	C0005938
28175980	osteoporosis	C0029456
28175980	individuals	C0237401
28175980	unaware	C0589402
28175980	spine fractures	C0080179
28175980	lateral	C0205093
28175980	spine imaging	C1532547
28175980	women	C0043210
28175980	men	C0025266
28175980	Spine fracture	C0080179
28175980	prevalence	C0033105
28175980	higher	C0205250
28175980	individuals	C0237401
28175980	NOF	C0679938
28175980	criteria	C0242801
28175980	spine imaging	C1532547
28175980	VFA	C0185141
28175980	spine fractures	C0080179
28175980	comprehensive	C1880156
28175980	risk assessment	C0086930
28175980	improve	C0184511
28175980	clinical decision making	C4042877
28179308	Renieramycin M	C1435644
28179308	Cancer Stem Cell	C1956422
28179308	Phenotypes	C0031437
28179308	H460	C0597032
28179308	Lung	C0024109
28179308	Cancer Cells	C0597032
28179308	Cancer stem cells	C1956422
28179308	CSCs	C1956422
28179308	cancer cells	C0597032
28179308	self-renewal	C1155711
28179308	differentiation	C0007589
28179308	CSCs	C1956422
28179308	drug-resistance	C0013203
28179308	cancer recurrence	C0920420
28179308	metastasis	C4255448
28179308	development	C1527148
28179308	CSC	C1956422
28179308	therapeutic strategies	C0087111
28179308	cancer research	C1516225
28179308	study	C2603343
28179308	efficacy	C1280519
28179308	renieramycin M	C1435644
28179308	RM	C1435644
28179308	sponge	C0032699
28179308	Xestospongia species	C1204055
28179308	examined	C0332128
28179308	lung	C0024109
28179308	CSCs	C1956422
28179308	Colony and spheroid formation assays	C0005507
28179308	western blotting analysis	C0005863
28179308	lung	C0024109
28179308	CSC	C1956422
28179308	protein	C0033684
28179308	markers	C0041365
28179308	CSC	C1956422
28179308	phenotypes	C0031437
28179308	H460	C0597032
28179308	lung	C0024109
28179308	cancer cells	C0597032
28179308	treatment	C0087111
28179308	RM	C1435644
28179308	non-toxic concentrations	C0678563
28179308	RM	C1435644
28179308	treatment	C0087111
28179308	colony and spheroid formation	C0005507
28179308	H460 cells	C0597032
28179308	CSC	C1956422
28179308	markers	C0041365
28179308	CD133	C0673026
28179308	CD44	C1097299
28179308	ALDH1A1	C1721673
28179308	CSC	C1956422
28179308	H460 cells	C0597032
28179308	RM	C1435644
28179308	treatment	C0087111
28179308	RM	C1435644
28179308	anti-metastatic agent	C1516021
28179308	lung	C0024109
28179308	CSC	C1956422
28179308	phenotypes	C0031437
28179308	H460 cells	C0597032
28181464	chitosan	C0162969
28181464	hyaluronan	C0813622
28181464	lipid nanoparticles	C1709148
28181464	delivery	C0565867
28181464	paclitaxel	C0144576
28181464	proof-of-concept study	C2603343
28181464	breast cancer cells	C1512505
28181464	solid lipid nanoparticles	C1709148
28181464	SLN	C1709148
28181464	paclitaxel	C0144576
28181464	PAX	C0144576
28181464	SLN loaded with PAX	C3898158
28181464	high-pressure hot homogenization	C3828864
28181464	Formulation parameters	C0524527
28181464	high-quality delivery system	C0085104
28181464	SLN	C1709148
28181464	coated, layer-by-layer	C1522408
28181464	chitosan	C0162969
28181464	hyaluronan	C0813622
28181464	HA	C0813622
28181464	HA	C0813622
28181464	receptors	C0597357
28181464	breast cancer cell line	C1512505
28181464	MCF-7	C0596890
28181464	Stable and reproducible	C0205556
28181464	nano-sized	C0205556
28181464	negatively charged nanoparticles	C1450054
28181464	chitosan	C0162969
28181464	HA	C0813622
28181464	SLN	C1709148
28181464	targeting	C1521840
28181464	cellular uptake	C3888108
28181464	time-/dose-controlled delivery and release	C1616334
28181464	PAX	C0144576
28181464	intrinsic chemotherapeutic activities	C0870057
28181464	SLN	C1709148
28181464	carrier candidates	C1706209
28181464	nano-oncology	C0278627
28181464	cytotoxic potential	C0304497
28181464	overcoming	C0243095
28181464	multidrug-resistant cancer cells	C0282588
28181538	Epigenetic Editing	C4277689
28181538	Ascl1 Gene	C1332009
28181538	Neural Stem Cells	C1113654
28181538	Optogenetics	C3494301
28181538	Enzymes	C0014442
28181538	epigenetic processes	C1516924
28181538	methyltransferases	C0025831
28181538	demethylases	C0014442
28181538	highly	C0205250
28181538	utilized	C0457083
28181538	persistent DNA	C0012854
28181538	histone modifying	C1156199
28181538	efficacy	C1280519
28181538	optogenetic	C3494301
28181538	toolbox	C0282574
28181538	catalytic domain	C0600499
28181538	CD	C0600499
28181538	DNA-methyltransferase3A	C2348048
28181538	DNMT3A	C2348048
28181538	CD	C0600499
28181538	Ten-Eleven Dioxygenase-1	C2987138
28181538	TET1	C2987138
28181538	CD	C0600499
28181538	loci	C1708726
28181538	specific	C0205369
28181538	alteration	C0026882
28181538	methylation	C0376452
28181538	state	C1442792
28181538	promoter	C0086860
28181538	Ascl1	C1332009
28181538	Mash1	C1332009
28181538	candidate proneuron gene	C0017337
28181538	Optogenetical protein pairs	C0033684
28181538	CRY2	C3813555
28181538	DNMT3A	C2348048
28181538	CD	C0600499
28181538	TET1	C2987138
28181538	CD	C0600499
28181538	CIB1	C1447592
28181538	fused	C0699952
28181538	Transcription Activator-Like Element	C0033684
28181538	TALE	C0033684
28181538	Ascl1	C1332009
28181538	promoter region	C0033413
28181538	site specific	C0449604
28181538	epigenetic editing	C4277689
28181538	differentially	C0443199
28181538	methylated region	C1254362
28181538	Ascl1	C1332009
28181538	promoter	C0086860
28181538	isolated	C0205409
28181538	murine	C0035804
28181538	dorsal root ganglion	C0017070
28181538	hypermethylated	C0376452
28181538	striated	C0205364
28181538	cells	C0007634
28181538	hypomethylated	C0376452
28181538	targeted	C1521840
28181538	optogenetic-epigenetic constructs	C0033684
28181538	blue-light	C0303896
28181538	illumination	C0684292
28181538	triggered	C1444748
28181538	co-localization	C1254366
28181538	TALE constructs	C0033684
28181538	DNMT3A	C2348048
28181538	CD	C0600499
28181538	TET1	C2987138
28181538	CD	C0600499
28181538	fusion proteins	C0162768
28181538	targeted site	C1254362
28181538	Ascl1	C1332009
28181538	promoter	C0086860
28181538	spatiotemporal	C0205556
28181538	fusion proteins	C0162768
28181538	alters	C0392747
28181538	methylation	C0376452
28181538	state	C1442792
28181538	regulates	C0017263
28181538	gene activity	C0017255
28181538	concept	C0178566
28181538	immense	C1704243
28181538	promise	C1555307
28181538	regulate	C1148560
28181538	gene activity	C0017255
28181538	epigenetic modulation	C4277689
28181538	spatiotemporal	C0205556
28181538	precision	C1706245
28182076	Vaginal Infections	C0404521
28182076	Albanian	C0001909
28182076	women	C0043210
28182076	Infected	C3714514
28182076	HPV	C0021344
28182076	intraepithelial cervical lesions	C0206708
28182076	Pap test	C3516630
28182076	Cervical cytology	C0856201
28182076	screening	C1710031
28182076	precancerous lesions	C0940937
28182076	uterine cervix	C0007874
28182076	human papillomavirus (HPV) positivity	C4288937
28182076	Albanian	C0001909
28182076	women	C0043210
28182076	prevalence	C0220900
28182076	vaginal coinfections	C0404521
28182076	coinfections	C0275524
28182076	HPV	C0021344
28182076	metaplasia	C0025568
28182076	cervical intraepithelial lesions	C0206708
28182076	CIN	C0206708
28182076	retrospective study	C0035363
28182076	vaginal smears	C0079104
28182076	Papanicolaou stain	C3888892
28182076	New Bethesda System	C2121268
28182076	interpretations of the smears	C3526121
28182076	Statistical Package for the Social Sciences version	C0010998
28182076	Prevalence	C0220900
28182076	HPV positivity	C4288937
28182076	Candida coinfection	C0006840
28182076	HPV positive	C4288937
28182076	women	C0043210
28182076	Gardnerella coinfection	C1622505
28182076	mixed flora	C1400606
28182076	Trichomonas vaginalis	C0040923
28182076	HPV positive	C4288937
28182076	woman	C0043210
28182076	women	C0043210
28182076	positive HPV	C4288937
28182076	CIN	C0206708
28182076	metaplasia	C0025568
28182076	metaplasia	C0025568
28182076	CIN	C0206708
28182076	women	C0043210
28182076	HPV	C0021344
28182076	CIN1	C0349458
28182076	coinfections	C0275524
28182076	CIN1	C0349458
28182076	HPV positivity	C4288937
28182076	CIN1	C0349458
28182076	coinfections	C0275524
28182076	HPV infection	C0343641
28182076	metaplasia	C0025568
28182076	bacterial coinfections	C0004623
28182076	HPV positive	C4288937
28182076	women	C0043210
28182076	statistically significant	C0237881
28182076	metaplasia	C0025568
28182129	Acute	C0205178
28182129	Hepatitis E Infection	C2063407
28182129	Patient	C0030705
28182129	Non-Hodgkin Lymphoma	C0024305
28182129	Treated	C0332293
28182129	Ribavirin	C0035525
28182129	man	C0025266
28182129	immunosuppressive treatment	C0021079
28182129	non-Hodgkin lymphoma	C0024305
28182129	infected	C0439663
28182129	viral hepatitis E	C0085293
28182129	Acute	C0205178
28182129	hepatitis E virus infection	C2063407
28182129	patients	C0030705
28182129	deranged	C0205556
28182129	liver function	C0232741
28182129	haematological malignancies	C0376545
28182129	immunosuppression	C4048329
28182129	endemic regions	C0017446
28182129	immune	C0439662
28182129	competent	C0086035
28182129	individuals	C0237401
28182129	at-risk groups	C0684030
28182129	protracted disease course	C1864936
28182129	treatment	C0087111
28182129	ribavirin	C0035525
28182129	pegylated interferon	C0907160
28182129	eradication	C3178994
28183806	Commissioning	C0027363
28183806	competition	C0679932
28183806	cooperation	C0392337
28183806	English	C1556083
28183806	NHS	C0027462
28183806	Health and Social Care Act 2012	C1254363
28183806	qualitative study	C0949415
28183806	clinical commissioning groups	C0027363
28183806	Health and Social Care Act 2012	C1254363
28183806	HSCA 2012	C1254363
28183806	regulation	C0851285
28183806	competition	C0679932
28183806	National Health Service	C0027462
28183806	NHS	C0027462
28183806	cooperation	C0392337
28183806	NHS	C0027462
28183806	England's policy document	C0282574
28183806	Five Year Forward View	C0282574
28183806	5YFV	C0282574
28183806	competition	C0679932
28183806	legislation	C0600657
28183806	commissioners	C0949415
28183806	providers	C1138603
28183806	complex	C0439855
28183806	regulatory framework	C0220905
28183806	competition	C0679932
28183806	cooperation	C0392337
28183806	case studies	C0085973
28183806	clinical commissioning groups	C0027363
28183806	interviews	C0021822
28183806	documentary analysis	C0936012
28183806	commissioners	C0949415
28183806	providers	C1138603
28183806	competition	C0679932
28183806	cooperation	C0392337
28183806	interviews	C0021822
28183806	senior managers	C0335141
28183806	commissioning	C0027363
28183806	organisations	C0033282
28183806	senior managers	C0335141
28183806	NHS	C0027462
28183806	independent provider organisations	C1273814
28183806	acute and community services	C0009482
28183806	commissioners	C0949415
28183806	providers	C1138603
28183806	regulatory regime	C0220905
28183806	competition	C0679932
28183806	NHS	C0027462
28183806	regulatory authorities	C0220905
28183806	guidance	C0237645
28183806	HSCA 2012	C1254363
28183806	promoting	C0033414
28183806	competition	C0679932
28183806	commissioners	C0949415
28183806	collaborative strategies	C0681804
28183806	service	C0557854
28183806	providers	C1138603
28183806	commissioners	C0949415
28183806	competitive	C0679932
28183806	peripheral services	C0557854
28183806	quality of care	C0034379
28183806	value for money	C1548312
28183806	Commissioners	C0949415
28183806	competition	C0679932
28183806	cooperation	C0392337
28183806	NHS	C0027462
28183806	collaborative strategies	C0681804
28183806	large-scale changes	C0814860
28183806	regulatory framework	C0220905
28183806	HSCA 2012	C1254363
28183806	publication	C0034036
28183806	5YFV	C0282574
28183806	guidance	C0237645
28183806	regulatory authorities	C0220905
28187247	Prevalence	C0033105
28187247	correlates	C1707520
28187247	antibiotic	C0003232
28187247	sharing	C0237876
28187247	Philippines	C0031529
28187247	antibiotic	C0003232
28187247	misconceptions	C2717766
28187247	community	C0009462
28187247	level	C0441889
28187247	non-medical	C0598464
28187247	sources	C0449416
28187247	antibiotics	C0003232
28187247	sociodemographic	C0011292
28187247	knowledge	C0376554
28187247	attitudinal	C0004271
28187247	correlates	C1707520
28187247	antibiotic	C0003232
28187247	sharing	C0237876
28187247	community-based sample	C1709598
28187247	adults	C0001675
28187247	low-income setting	C1331016
28187247	Philippines	C0031529
28187247	community	C0009462
28187247	level	C0441889
28187247	data	C1511726
28187247	informal	C0243095
28187247	antibiotic	C0003232
28187247	distribution	C0024826
28187247	roadside stands	C1254362
28187247	sari-sari stands	C1254362
28187247	Participants	C0679646
28187247	completed	C0205197
28187247	self-administered	C1519231
28187247	surveys	C0038951
28187247	Correlates	C1707520
28187247	antibiotic	C0003232
28187247	sharing	C0237876
28187247	assessed	C1516048
28187247	logistic regression	C0206031
28187247	Firth's bias-adjusted estimate	C0282574
28187247	staff	C0851286
28187247	roadside stands	C1254362
28187247	collected data	C4019276
28187247	availability	C0470187
28187247	antibiotics	C0003232
28187247	stands	C1254362
28187247	shared	C0237876
28187247	antibiotics	C0003232
28187247	lifetime	C4071830
28187247	often	C0332183
28187247	family members	C0086282
28187247	multivariable analysis	C0026777
28187247	agreement	C0680240
28187247	belief	C0004951
28187247	prematurely	C1254367
28187247	stop	C1947925
28187247	antibiotic	C0003232
28187247	course	C0750729
28187247	OR	C0028873
28187247	concerns	C2699424
28187247	antibiotic side effects	C0850107
28187247	OR	C0028873
28187247	associated with	C0332281
28187247	increased	C0205217
28187247	antibiotic	C0003232
28187247	sharing	C0237876
28187247	Antibiotic	C0003232
28187247	sharing	C0237876
28187247	associated with	C0332281
28187247	sociodemographic characteristics	C0683970
28187247	antibiotic	C0003232
28187247	knowledge	C0376554
28187247	Antibiotics	C0003232
28187247	available	C0470187
28187247	sari-sari stands	C1254362
28187247	antibiotics	C0003232
28187247	missing expiration dates	C2609381
28187247	Amoxicillin	C0002645
28187247	cephalexin	C0007716
28187247	commonly	C0205214
28187247	available	C0470187
28187247	antibiotics	C0003232
28187247	stands	C1254362
28187247	Antibiotic	C0003232
28187247	sharing	C0237876
28187247	common	C0205214
28187247	associated with	C0332281
28187247	misconceptions	C2717766
28187247	antibiotic	C0003232
28187247	Antibiotics	C0003232
28187247	available	C0470187
28187247	sari-sari stands	C1254362
28187247	without	C0332288
28187247	expiration information	C3669020
28187247	curbing	C2587213
28187247	informal	C0243095
28187247	antibiotic	C0003232
28187247	Philippines	C0031529
28187247	Southeast-Asian countries	C0454709
28187885	Automated	C0205554
28187885	characterization	C1880022
28187885	counting	C0750480
28187885	Ki-67 protein	C0033684
28187885	breast cancer	C0006142
28187885	prognosis	C0033325
28187885	quantitative	C0392762
28187885	immunohistochemistry	C0021044
28187885	approach	C0449445
28187885	Ki-67 protein	C0033684
28187885	expression	C1171362
28187885	proliferative status	C1514489
28187885	tumour cell	C0431085
28187885	future	C0016884
28187885	course	C0750729
28187885	therapy	C0087111
28187885	breast cancer	C0006142
28187885	Immunohistochemical (IHC) determination	C0021044
28187885	Ki-67 score	C4049944
28187885	labelling index	C0022885
28187885	fraction of	C1264633
28187885	Ki67	C0033684
28187885	positively	C1446409
28187885	stained	C2986582
28187885	tumour cells	C0431085
28187885	method	C0430022
28187885	assess	C0184514
28187885	tumour	C0027651
28187885	proliferation	C1514485
28187885	Accurate	C0443131
28187885	manual counting	C1441639
28187885	cells	C0007634
28187885	specifically	C0205369
28187885	nuclei	C0007610
28187885	complex	C0439855
28187885	dense	C0439794
28187885	distribution	C1704711
28187885	cells	C0007634
28187885	critical	C1511545
28187885	presents	C0449450
28187885	major	C0205164
28187885	pathologists	C0334866
28187885	hybrid clustering algorithm	C0002045
28187885	quantify	C1709793
28187885	proliferative index	C1514489
28187885	breast cancer cells	C1512505
28187885	automated counting	C1441489
28187885	Ki-67	C0033684
28187885	nuclei	C0007610
28187885	methodology	C0430022
28187885	initially	C0205265
28187885	pre-processes	C1522240
28187885	IHC	C0021044
28187885	images	C1704254
28187885	Ki-67	C0033684
28187885	stained	C2986582
28187885	slides	C0444330
28187885	breast cancer	C0006142
28187885	grey	C1269776
28187885	colour space	C0876936
28187885	stained	C2986582
28187885	cells	C0007634
28187885	characterized	C1880022
28187885	two stage segmentation process	C0200768
28187885	Fuzzy C-means	C0002045
28187885	quantifies	C1709793
28187885	stained	C2986582
28187885	cells	C0007634
28187885	cluster	C1704332
28187885	blue	C1260957
28187885	channel	C1706095
28187885	first stage	C0441766
28187885	output	C1709366
28187885	k-means algorithm	C0009085
28187885	separate	C0443299
28187885	cluster	C1704332
28187885	Ki-67	C0033684
28187885	positive and negative	C3842923
28187885	cells	C0007634
28187885	count	C0750480
28187885	positive and negative	C3842923
28187885	nuclei	C0007610
28187885	calculate	C1443182
28187885	F-measure	C0079809
28187885	colour space	C0876936
28187885	comparative study	C1579762
28187885	expert opinion	C0600219
28187885	error	C0743559
28187885	rate	C1521828
28187885	positive and negative	C3842923
28187885	nuclei	C0007610
28187885	detection	C0442726
28187885	results	C1274040
28187885	colour space	C0876936
28187885	compared	C1707455
28187885	F-measure	C0079809
28187885	calculated	C1443182
28187885	F-measure	C0079809
28187885	colour space	C0876936
28187885	statistical	C2828391
28187885	result	C1274040
28187885	compared	C1707455
28187885	grey	C1269776
28187885	colour space	C0876936
28187885	study	C2603343
28187885	count	C0750480
28187885	nuclei	C0007610
28187885	manually	C1441639
28187885	automatically	C1441489
28187885	algorithm	C0002045
28187885	average	C1510992
28187885	error	C0743559
28187885	rate	C1521828
28187885	significant	C0750502
28187885	study	C2603343
28187885	automated	C0205554
28187885	count	C0750480
28187885	positive and negative	C3842923
28187885	nuclei	C0007610
28187885	colour space	C0876936
28187885	hybrid segmentation technique	C2697664
28187885	Computerized evaluation	C1441489
28187885	proliferation index	C1514489
28187885	pathologist	C0334866
28187885	breast cancer	C0006142
28187885	severity	C0439793
28187885	methodology	C0430022
28187885	potential	C3245505
28187885	assisting	C0557034
28187885	manual procedure	C1441639
28187885	pathological	C1521733
28187885	decision support system	C0023678
28189069	Multitarget	C1521840
28189069	sensing of glucose	C0337438
28189069	cholesterol	C0201950
28189069	Janus hydrogel microparticles	C0063083
28189069	visualized	C0234621
28189069	sensing method for glucose	C0337438
28189069	cholesterol	C0201950
28189069	Janus hydrogel microparticles	C0063083
28189069	Janus hydrogel microparticles	C0063083
28189069	centrifugal	C1301962
28189069	microfluidic chip	C1449582
28189069	glucose sensing	C0337438
28189069	concanavalin A	C0009630
28189069	fluorescein labeled dextran	C0060538
28189069	competitive binding assay	C0005507
28189069	encapsulated	C0205223
28189069	alginate	C0002040
28189069	microparticles	C0597177
28189069	fluorescence	C0016315
28189069	microparticles	C0597177
28189069	positively	C1446409
28189069	correlated	C1707520
28189069	glucose	C0017725
28189069	concentration	C1446561
28189069	cholesterol sensing	C0201950
28189069	microparticles	C0597177
28189069	γ-Fe2O3 nanoparticles	C3652446
28189069	catalyst	C0175921
28189069	oxidation	C0030011
28189069	3,3',5,5'-Tetramethylbenzidine	C0046880
28189069	H2O2	C0020281
28189069	enzymatic	C0014442
28189069	hydrolysis	C0020291
28189069	product	C1514468
28189069	cholesterol	C0008377
28189069	color	C0009393
28189069	transition	C2700061
28189069	sensitive	C0332324
28189069	microparticles	C0597177
28189069	solutions	C0037633
28189069	microparticles	C0597177
28189069	applicable	C1706839
28189069	visualized	C0234621
28189069	determination	C1148554
28189069	Janus microparticles	C0597177
28189069	employed	C0557351
28189069	multitarget	C1521840
28189069	sensing	C0205396
28189069	glucose	C0017725
28189069	cholesterol	C0008377
28189069	detected	C0442726
28189069	microparticles	C0597177
28189069	interference	C0521102
28189069	particles	C0597177
28189069	external	C0205101
28189069	magnetic field	C0563533
28189069	glucose	C0428548
28189069	cholesterol levels	C0428466
28189069	measured	C0444706
28189069	human	C0086418
28189069	serum	C0229671
28189069	microparticles	C0597177
28189069	confirmed	C0750484
28189069	potential	C3245505
28189069	microparticles	C0597177
28189069	sample	C0370003
28189069	detection	C1511790
28190392	PI3K	C0044602
28190392	Akt	C0164786
28190392	pathway	C0037080
28190392	therapeutic	C0302350
28190392	target	C1521840
28190392	chronic pain	C0150055
28190392	Chronic pain	C0150055
28190392	disabling	C0596452
28190392	disorders	C0012634
28190392	prevalence	C0683921
28190392	ranging	C1514721
28190392	therapeutic	C0302350
28190392	chronic pain	C0150055
28190392	unsatisfactory	C0439856
28190392	poor	C0542537
28190392	understanding	C0162340
28190392	mechanisms	C0441712
28190392	therapeutic	C0302350
28190392	targets	C1521840
28190392	improve	C0184511
28190392	patients'	C0030705
28190392	quality of life	C0034380
28190392	PI3K	C0044602
28190392	downstream	C0522506
28190392	Akt	C0164786
28190392	expressed	C1171362
28190392	spinal cord	C0037925
28190392	laminae I-IV	C2340386
28190392	dorsal horn	C0228575
28190392	nociceptive C	C0501409
28190392	Aδ fibers	C0027750
28190392	primary	C0205225
28190392	afferents	C0206309
28190392	terminate	C2746065
28190392	studies	C0008972
28190392	critical	C1511545
28190392	roles	C1705810
28190392	development	C1527148
28190392	maintenance	C0024501
28190392	chronic pain	C0150055
28190392	review	C0282443
28190392	roles	C1705810
28190392	mechanisms	C0441712
28190392	PI3K	C0044602
28190392	Akt	C0164786
28190392	pathway	C0037080
28190392	progression	C0242656
28190392	chronic pain	C0150055
28190392	sciatic nerve injury	C0161467
28190392	diabetic neuropathy	C0011882
28190392	spinal cord injury	C0037929
28190392	bone cancer	C0279530
28190392	opioid tolerance	C0240601
28190392	opioid	C0242402
28190392	induced	C0205263
28190392	hyperalgesia	C0020429
28190791	free bed	C0004916
28190791	ventilator	C0087153
28190791	public health specialist	C0334894
28190791	author	C3812881
28190791	poor	C0032854
28190791	elderly father	C0015671
28190791	gravely injured	C0332664
28190791	young	C0332239
28190791	son	C0037683
28190791	government hospital	C0337960
28190791	intensive care	C0085559
28190791	friends	C0079382
28190791	globe	C1254362
28190791	euthanasia	C0015187
28190791	social media	C3179065
28190791	marginalised	C3494319
28190791	groups of people	C1257890
28190791	access	C0015472
28190791	care	C1947933
28190791	India	C0021201
28190791	friends	C0079382
28190791	developed parts of the world	C0282613
28190791	choice	C1707391
28190791	live	C1548795
28190791	die	C0011065
28190791	poor	C0032854
28190791	father	C0015671
28190791	battling	C1407863
28190791	save	C1254370
28190791	son	C0037683
28190791	people	C0027361
28190791	help	C1269765
28190791	save	C1254370
28190791	Early treatment	C0814494
28190791	helped	C1269765
28190791	young	C0332239
28190791	boy	C0870221
28190791	incident	C1551358
28190791	author	C3812881
28190791	poor	C0032854
28190791	denied	C2700401
28190791	care	C1947933
28190791	debate	C0870392
28190791	pull the plug	C1254370
28190791	patient	C0030705
28190791	families	C0015576
28190791	care	C1947933
28190791	India	C0021201
28190791	people	C0027361
28190791	paying out of pocket	C3815933
28190791	healthcare	C0086388
28190791	below the poverty line	C0860094
28190791	every year	C0332181
28190791	think	C0039869
28190791	universal health coverage	C0376640
28190791	health	C0018684
28190791	fancy term	C1705313
28190791	conferences and meetings	C0586182
28190791	ground reality	C0871222
28190791	completely different	C1705242
28192718	Quantitative	C0392762
28192718	determination	C1148554
28192718	metabolites	C0870883
28192718	aspirin	C0004057
28192718	UHPLC-MS	C4053724
28192718	MS	C0037813
28192718	coupled	C1948027
28192718	enzymatic reaction	C1511131
28192718	effects	C1280500
28192718	aspirin	C0004057
28192718	dosage	C0178602
28192718	metabolic profile	C3853758
28192718	Acetylsalicylic acid	C0004057
28192718	Aspirin	C0004057
28192718	ASA	C0004057
28192718	drug	C0013227
28192718	cardiovascular diseases	C0007222
28192718	years	C0439234
28192718	ASA	C0004057
28192718	dosage	C0178602
28192718	metabolic profile	C3853758
28192718	study	C2603343
28192718	rapid	C0456962
28192718	reliable	C3858758
28192718	method	C0022885
28192718	quantify	C1709793
28192718	ASA	C0004057
28192718	metabolites	C0870883
28192718	biological matrices	C1706515
28192718	glucuronide	C0812407
28192718	metabolites	C0870883
28192718	method	C0022885
28192718	ASA	C0004057
28192718	dosage	C0178602
28192718	metabolic	C3853758
28192718	excretion	C0221102
28192718	profile	C0237801
28192718	ASA	C0004057
28192718	metabolites	C0870883
28192718	rat	C0034721
28192718	urine	C0042036
28192718	Salicylic acid	C0036079
28192718	SA	C0036079
28192718	gentisic acid	C0045555
28192718	GA	C0045555
28192718	salicyluric acid	C0073984
28192718	SUA	C0073984
28192718	UHPLC-MS	C4053724
28192718	MS	C0037813
28192718	salicyl phenolic glucuronide	C0044622
28192718	SAPG	C0044622
28192718	salicyluric acid phenolic glucuronide	C0752086
28192718	SUAPG	C0752086
28192718	quantified	C1709793
28192718	SA	C0036079
28192718	SUA	C0073984
28192718	SAPG	C0044622
28192718	SUAPG	C0752086
28192718	β-glucuronidase	C0017776
28192718	digestion	C0012238
28192718	SUA	C0073984
28192718	SUAPG	C0752086
28192718	metabolites	C0870883
28192718	ASA	C0004057
28192718	rat	C0034721
28192718	urine	C0042036
28192718	h	C0439227
28192718	ASA	C0004057
28192718	administration	C0001555
28192718	SUA	C0073984
28192718	SUAPG	C0752086
28192718	ASA	C0004057
28192718	dosage	C0178602
28192718	increased	C0205217
28192718	excretion	C0221102
28192718	metabolites	C0870883
28192718	GA	C0045555
28192718	SA	C0036079
28192718	SAPG	C0044622
28192718	SUA	C0073984
28192718	SUAPG	C0752086
28192718	excreted	C0221102
28192718	time period	C1948053
28192718	h	C0439227
28192718	GA	C0045555
28192718	excreted	C0221102
28192718	time periods	C1948053
28192718	h	C0439227
28192718	h	C0439227
28192718	SA	C0036079
28192718	excreted	C0221102
28192718	time period	C1948053
28192718	h	C0439227
28192718	h	C0439227
28192718	excretion	C0221102
28192718	SAPG	C0044622
28192718	time periods	C1948053
28192718	excretion	C0221102
28192718	metabolites	C0870883
28192718	rat	C0034721
28192718	urine	C0042036
28192718	ASA	C0004057
28192718	dosage	C0178602
28192718	increased	C0205217
28192718	rapid	C0456962
28192718	sensitive	C0205342
28192718	method	C0022885
28192718	ASA	C0004057
28192718	metabolites	C0870883
28192718	SA	C0036079
28192718	GA	C0045555
28192718	SUA	C0073984
28192718	SAPG	C0044622
28192718	SUAPG	C0752086
28192718	rat	C0034721
28192718	urine	C0042036
28192718	ASA	C0004057
28192718	dosage	C0178602
28192718	influence	C4054723
28192718	metabolic	C3853758
28192718	excretion	C0221102
28192718	profile	C0237801
28192718	ASA	C0004057
28192718	metabolites	C0870883
28192718	rat	C0034721
28192718	urine	C0042036
28193730	Mismatch Repair	C1155661
28193730	Incompatibilities	C0679426
28193730	Diverse	C1880371
28193730	Yeast	C0036025
28193730	Populations	C0017404
28193730	elevated	C3163633
28193730	mutation rate	C3178846
28193730	cells	C0007634
28193730	source	C0449416
28193730	mutations	C0026882
28193730	changing	C0392747
28193730	environments	C0014406
28193730	identified	C0205396
28193730	negative	C0205160
28193730	epistatic interaction	C0014589
28193730	involving	C1314939
28193730	variants	C0205419
28193730	MLH1	C0879389
28193730	PMS1	C0879390
28193730	mismatch repair	C1155661
28193730	MMR	C1155661
28193730	genes	C0017337
28193730	Saccharomyces cerevisiae	C0036025
28193730	MMR	C1155661
28193730	incompatibility	C0679426
28193730	mating	C1260875
28193730	S. cerevisiae	C0036025
28193730	progeny	C0680063
28193730	rapidly	C0456962
28193730	environmental stress	C0871732
28193730	analyzed	C0936012
28193730	MLH1	C0879389
28193730	PMS1 genes	C0879390
28193730	S. cerevisiae	C0036025
28193730	natural	C0205296
28193730	isolates	C1764827
28193730	range	C1514721
28193730	ecological	C0162358
28193730	sources	C0449416
28193730	tree	C0040811
28193730	exudates	C0015388
28193730	Drosophila	C0013138
28193730	fruits	C0016767
28193730	fermentation	C0015852
28193730	clinical	C0205210
28193730	isolates	C1764827
28193730	geographical	C0565935
28193730	sources	C0449416
28193730	Europe	C0015176
28193730	America	C0002454
28193730	Africa	C0001737
28193730	Asia	C0003980
28193730	identified	C0205396
28193730	homozygous	C0019904
28193730	clinical	C0205210
28193730	isolate	C1764827
28193730	heterozygous	C0019425
28193730	isolates	C1764827
28193730	containing	C0332256
28193730	MMR	C1155661
28193730	genotype	C0017431
28193730	MLH1	C0879389
28193730	PMS1 gene	C0879390
28193730	combination	C0205195
28193730	isolated	C0205409
28193730	homozygous	C0019904
28193730	clinical	C0205210
28193730	isolate	C1764827
28193730	phenotype	C0031437
28193730	expressed	C0017262
28193730	laboratory	C0022877
28193730	background	C1706907
28193730	reporter	C1522485
28193730	measure	C0079809
28193730	mutation rates	C3178846
28193730	overall	C1561607
28193730	mutation rate	C3178846
28193730	homozygous	C0019904
28193730	background	C1706907
28193730	compatible	C1524057
28193730	strains	C1518614
28193730	suppressor mutations	C0038859
28193730	clinical	C0205210
28193730	isolate	C1764827
28193730	mutation rate	C3178846
28193730	observation	C0302523
28193730	identification	C0205396
28193730	heterozygous	C0019425
28193730	isolates	C1764827
28193730	isolates	C1764827
28193730	MMR	C1155661
28193730	genotypes	C0017431
28193730	offspring	C0680063
28193730	consistent with	C0332290
28193730	elevated	C3163633
28193730	mutation rate	C3178846
28193730	adaptation	C0392673
28193730	long-term	C0443252
28193730	fitness	C2717776
28193730	costs	C0010186
28193730	incompatibility	C0679426
28193730	buffered	C0006353
28193730	mating	C1260875
28193730	suppressors	C0038859
28193730	observations	C0302523
28193730	effective	C1704419
28193730	eukaryotes	C0684063
28193730	long-term	C0443252
28193730	fitness	C2717776
28193730	costs	C0010186
28193730	associated with	C0332281
28193730	elevated	C3163633
28193730	mutation rates	C3178846
28203094	Mapping	C1283195
28203094	circulating	C0175630
28203094	serum	C0229671
28203094	miRNAs	C1101610
28203094	immune	C0439662
28203094	related	C0332281
28203094	target	C1521840
28203094	mRNAs	C0035696
28203094	Evidence	C3887511
28203094	suggests	C1705535
28203094	circulating	C0175630
28203094	serum	C0229671
28203094	microRNAs	C1101610
28203094	miRNAs	C1101610
28203094	target	C1521840
28203094	immune	C0439662
28203094	related	C0332281
28203094	mRNAs	C0035696
28203094	immune	C0439662
28203094	related	C0332281
28203094	mRNAs	C0035696
28203094	predicted	C0681842
28203094	serum	C0229671
28203094	miRNA binding	C1523647
28203094	sites	C0205145
28203094	mRNAs	C0035696
28203094	reciprocally	C1882911
28203094	serum	C0229671
28203094	miRNAs	C1101610
28203094	immune	C0439662
28203094	related	C0332281
28203094	mRNA	C0035696
28203094	targets	C1521840
28203094	non	C1518422
28203094	serum	C0229671
28203094	miRNAs	C1101610
28203094	developed	C1527148
28203094	target	C1521840
28203094	random forest framework	C0205245
28203094	calculated	C0444686
28203094	predicted	C0681842
28203094	miRNA	C1101610
28203094	mRNA	C0035696
28203094	interactions	C2753463
28203094	subsets	C1515021
28203094	miRNAs	C1101610
28203094	serum	C0229671
28203094	non	C1518422
28203094	serum	C0229671
28203094	mRNAs	C0035696
28203094	immune	C0439662
28203094	related	C0332281
28203094	nonimmune related	C0332281
28203094	Immune	C0439662
28203094	related	C0332281
28203094	mRNAs	C0035696
28203094	predicted	C0681842
28203094	targeted	C1521840
28203094	serum	C0229671
28203094	miRNA	C1101610
28203094	mRNAs	C0035696
28203094	serum	C0229671
28203094	miRNAs	C1101610
28203094	predicted	C0681842
28203094	target	C1521840
28203094	immune	C0439662
28203094	related	C0332281
28203094	mRNA	C0035696
28203094	targets	C1521840
28203094	non	C1518422
28203094	serum	C0229671
28203094	miRNAs	C1101610
28203094	biases	C0242568
28203094	immune	C0439662
28203094	related	C0332281
28203094	mRNAs	C0035696
28203094	serum	C0229671
28203094	miRNAs	C1101610
28203094	completely	C0205197
28203094	independent	C0085862
28203094	Immune	C0439662
28203094	related	C0332281
28203094	mRNAs	C0035696
28203094	miRNA binding	C1523647
28203094	sites	C0205145
28203094	serum	C0229671
28203094	miRNAs	C1101610
28203094	serum	C0229671
28203094	miRNAs	C1101610
28203094	target	C1521840
28203094	mRNAs	C0035696
28203094	non	C1518422
28203094	serum	C0229671
28203094	miRNAs	C1101610
28203094	regardless	C3641650
28203094	immune	C0439662
28203094	related	C0332281
28203094	independent	C0085862
28203094	phenomena	C1882365
28203094	result	C1274040
28203094	predicted	C0681842
28203094	serum	C0229671
28203094	miRNA	C1101610
28203094	immune	C0439662
28203094	mRNA	C0035696
28203094	interactions	C2753463
28205317	Oxidative stress	C0242606
28205317	immunosenescence	C0596761
28205317	spleen	C0037993
28205317	obese mice	C0025933
28205317	2-hydroxyoleic acid	C1436659
28205317	obesity	C0028754
28205317	oxidative stress	C0242606
28205317	leukocyte	C0023516
28205317	function	C0007613
28205317	spleen	C0037993
28205317	mice	C0025929
28205317	supplementation	C0242297
28205317	2-hydroxyoleic acid	C1436659
28205317	2-OHOA	C1436659
28205317	n-3 polyunsaturated fatty acids	C0015689
28205317	PUFA	C0015689
28205317	Female	C0086287
28205317	ICR/CD1 mice	C2697641
28205317	weeks	C0439230
28205317	obesogenic diet	C0012155
28205317	fat	C0012171
28205317	weeks	C0439230
28205317	fat	C0012171
28205317	weeks	C0439230
28205317	weeks	C0439230
28205317	mice	C0025929
28205317	groups	C0681860
28205317	group	C0681860
28205317	no supplementation	C0681860
28205317	2-OHOA supplementation	C0681860
28205317	n-3 PUFA supplementation	C0681860
28205317	EPA	C0000545
28205317	DHA	C0556150
28205317	mice	C0025929
28205317	diet	C0012155
28205317	duration	C0449238
28205317	study	C2603343
28205317	control group	C0009932
28205317	experiment	C0681814
28205317	variables	C0439828
28205317	assessed	C1516048
28205317	spleens	C0037993
28205317	levels	C0441889
28205317	reduced	C0017817
28205317	GSH	C0017817
28205317	oxidized (GSSG) glutathione	C0061516
28205317	GSH	C0017817
28205317	GSSG	C0061516
28205317	xanthine oxidase (XO) activity	C1151293
28205317	lipid peroxidation	C0023775
28205317	lymphocyte chemotaxis	C0312862
28205317	natural killer (NK) activity	C1317556
28205317	mitogen	C0026249
28205317	ConA	C0009630
28205317	LPS	C0023810
28205317	lymphocyte proliferation	C0596873
28205317	Obese	C0424612
28205317	animals	C0003062
28205317	higher	C0205250
28205317	GSSG	C0061516
28205317	levels	C0441889
28205317	GSSG	C0061516
28205317	GSH	C0017817
28205317	ratio	C0456603
28205317	lipid peroxidation	C0023775
28205317	XO activity	C1151293
28205317	lymphocyte chemotaxis	C0312862
28205317	NK activity	C1317556
28205317	proliferation	C1514485
28205317	ConA	C0009630
28205317	controls	C0009932
28205317	2-OHOA	C1436659
28205317	changes	C0443172
28205317	body weight	C0005910
28205317	GSSG	C0061516
28205317	levels	C0441889
28205317	GSH	C0017817
28205317	GSSG	C0061516
28205317	lipid peroxidation	C0023775
28205317	chemotaxis	C0008018
28205317	proliferation	C0596290
28205317	n-3 PUFA	C0015689
28205317	increase	C0442805
28205317	XO activity	C1151293
28205317	2-OHOA	C1436659
28205317	n-3 PUFA	C0015689
28205317	oxidative stress	C0242606
28205317	alteration	C1515926
28205317	leukocyte	C0023516
28205317	function	C0007613
28205317	spleen	C0037993
28205317	obese mice	C0025933
28205317	findings	C0243095
28205317	obesity	C0028754
28205317	immunosenescence	C0596761
28205317	therapeutic tool	C0302350
28205317	obesity	C0028754
28205317	immune dysfunction	C0021053
28207180	Assembly of the outermost spore layer	C2611271
28207180	endospore-forming soil dwelling bacteria	C0014248
28207180	human	C0086418
28207180	animal	C0003062
28207180	insect	C0021585
28207180	pathogens	C0450254
28207180	organisms	C0450254
28207180	spores	C0038027
28207180	outer layer	C0243092
28207180	exosporium	C1623474
28207180	exosporium	C1623474
28207180	site of	C2945843
28207180	interactions	C1704675
28207180	spore	C0038027
28207180	soil	C0037592
28207180	environment	C0014406
28207180	spore	C0038027
28207180	infected	C0439663
28207180	host	C1167395
28207180	initial	C0205265
28207180	stages	C1306673
28207180	infection	C3714514
28207180	composition	C0486616
28207180	assembly process of the exosporium	C2611271
28207180	stability	C0205360
28207180	exosporium	C1623474
28207180	methods	C0025664
28207180	intact	C0205266
28207180	structure	C0678594
28207180	component	C1705248
28207180	parts	C0449719
28207180	proteins	C0004627
28207180	identified	C0205396
28207180	exosporium	C1623474
28207180	associated	C0332281
28207180	abundance	C2346714
28207180	relationship	C0439849
28207180	proteins	C0033684
28207180	processes	C1522240
28207180	assembled to create the exosporium	C2611271
28207180	Molecular Microbiology	C0025952
28207180	laboratory	C0022877
28207180	ExsY protein	C0033684
28207180	structural protein	C0582263
28207180	exosporium basal layer	C1623474
28207180	B. cereus family	C0004590
28207180	spores	C0038027
28207180	self-assemble	C1706853
28207180	complex	C0439855
28207180	structures	C0678594
28207180	structural	C0678594
28207180	features	C2348519
28207180	characteristic	C1521970
28207180	exosporium basal layer	C1623474
28207180	authors	C3812881
28207180	model	C3161035
28207180	exosporium assembly	C2611271
28207180	findings	C0243095
28207180	exosporium	C1623474
28207180	formation	C1522492
28207180	spore forming bacteria	C0014248
28207180	Clostridium species	C1264830
28207880	Skeletal muscle	C0242692
28207880	adaptations	C0392673
28207880	endurance	C0031808
28207880	exercise training	C4279936
28207880	attainable	C0599946
28207880	mice	C0025929
28207880	simvastatin	C0074554
28207880	treatment	C0087111
28207880	hypothesis	C1512571
28207880	regimen	C0040808
28207880	simvastatin	C0074554
28207880	attenuate	C0599946
28207880	skeletal muscle	C0242692
28207880	adaptation	C0392673
28207880	low-intensity exercise	C0015259
28207880	Male	C0086582
28207880	C57BL/6J wildtype mice	C0025929
28207880	voluntary wheel running	C0035953
28207880	cage	C0179512
28207880	activities	C0441655
28207880	simvastatin	C0074554
28207880	treatment	C0087111
28207880	Adaptations	C0392673
28207880	in vivo	C0681829
28207880	fatigue	C0015672
28207880	resistance	C4281815
28207880	treadmill running test	C0087110
28207880	ankle plantarflexor	C0581542
28207880	contractile	C0026820
28207880	tibialis anterior	C0242690
28207880	gastrocnemius	C0242691
28207880	plantaris muscles	C0242693
28207880	evaluated	C0220825
28207880	exercised	C0015259
28207880	mitochondrial	C0026237
28207880	adaptations	C0392673
28207880	biogenesis	C0005495
28207880	function	C0542341
28207880	autophagy	C0004391
28207880	no difference	C3842396
28207880	wheel running distance	C0441655
28207880	simvastatin	C0074554
28207880	treated	C1522326
28207880	mice	C0025929
28207880	Trained	C0220931
28207880	mice	C0025929
28207880	treadmill running	C2712999
28207880	distance	C0012751
28207880	ankle plantarflexor	C0581542
28207880	contractile	C0026820
28207880	fatigue	C0015672
28207880	resistance	C4281815
28207880	mice	C0025929
28207880	simvastatin	C0074554
28207880	treatment	C0087111
28207880	cellular level	C0007634
28207880	trained	C0220931
28207880	mice	C0025929
28207880	mitochondrial biogenesis	C3494456
28207880	PGC1α	C1570275
28207880	expression	C1171362
28207880	mitochondrial	C0026237
28207880	citrate synthase	C0008855
28207880	activity	C0243102
28207880	simvastatin	C0074554
28207880	treatment	C0087111
28207880	Mitochondrial	C0026237
28207880	autophagy	C0004391
28207880	protein	C0033684
28207880	trained	C0220931
28207880	mice	C0025929
28207880	Bnip3	C1699488
28207880	simvastatin	C0074554
28207880	treatment	C0087111
28207880	Drp1	C1957127
28207880	marker	C0005516
28207880	mitochondrial fission	C0230871
28207880	simvastatin	C0074554
28207880	treated	C1522326
28207880	mice	C0025929
28207880	exercise training	C4279936
28207880	interaction	C1704675
28207880	training	C0220931
28207880	treatment	C0087111
28207880	LC3-II protein	C3711208
28207880	content	C1446561
28207880	marker	C0005516
28207880	autophagy	C0004391
28207880	whole body	C0444584
28207880	skeletal muscle	C0242692
28207880	adaptations	C0392673
28207880	endurance	C0031808
28207880	exercise training	C4279936
28207880	attainable	C0599946
28207880	simvastatin	C0074554
28207880	treatment	C0087111
28207880	simvastatin	C0074554
28207880	side effects	C0879626
28207880	muscle	C0026845
28207880	mitochondrial	C0026237
28207880	autophagy	C0004391
28207880	long-term	C0443252
28207880	muscle	C0026845
28207880	health	C0018684
28210010	Evaluation	C0220825
28210010	Treatment	C0039798
28210010	Anemia	C0002871
28210010	Premature Infants	C0021294
28210010	Anemia	C0002871
28210010	preterm infants	C4048294
28210010	pathophysiological	C0031847
28210010	process	C1522240
28210010	decline	C0282251
28210010	hemoglobin	C0019046
28210010	compared	C1707455
28210010	physiological	C0205463
28210010	anemia	C0002871
28210010	infants	C0021270
28210010	transfusions	C0005841
28210010	administration	C1533734
28210010	human recombinant erythropoietin	C0376541
28210010	determine	C0205258
28210010	frequency	C0439603
28210010	anemia	C0002871
28210010	premature infants	C0021294
28210010	Pediatric Clinic, University Clinical Center Sarajevo	C3839701
28210010	parameter values	C0549193
28210010	blood count	C0005771
28210010	premature infants	C0021294
28210010	relationship	C0439849
28210010	blood transfusions	C0005841
28210010	intraventricular hemorrhage	C0240059
28210010	determine	C0205258
28210010	treatment	C0039798
28210010	preterm infants	C4048294
28210010	Research	C0035168
28210010	retrospective study	C0035363
28210010	period	C0439531
28210010	months	C0439231
28210010	year	C0439234
28210010	Research	C0035168
28210010	patients	C0030705
28210010	gestational age	C0017504
28210010	weeks	C0439230
28210010	premature infants	C0021294
28210010	Data	C1511726
28210010	collected	C1516695
28210010	examining	C0332128
28210010	medical records	C0025102
28210010	patients	C0030705
28210010	Pediatric Clinic, UCCS	C3839701
28210010	first	C0205435
28210010	group	C0441833
28210010	patients	C0030705
28210010	premature infants	C0021294
28210010	gestational age	C0017504
28210010	weeks	C0439230
28210010	second	C0205436
28210010	group	C0441833
28210010	premature infants	C0021294
28210010	gestational age	C0017504
28210010	weeks	C0439230
28210010	patients	C0030705
28210010	boys	C0870221
28210010	girls	C0870604
28210010	significant difference	C1705241
28210010	birth weight	C0005612
28210010	APGAR score	C0003533
28210010	groups	C0441833
28210010	first	C0205435
28210010	group	C0441833
28210010	deaths	C1306577
28210010	second	C0205436
28210010	group	C0441833
28210010	deaths	C1306577
28210010	significant difference	C1705241
28210010	treatment	C0039798
28210010	statistically significant	C0237881
28210010	difference	C1705241
28210010	transfusion	C0005841
28210010	groups	C0441833
28210010	patients	C0030705
28210010	first	C0205435
28210010	group	C0441833
28210010	transfusion	C0005841
28210010	second	C0205436
28210010	group	C0441833
28210010	patients	C0030705
28210010	Preterm infants	C4048294
28210010	gestational age	C0017504
28210010	weeks	C0439230
28210010	candidates	C0030705
28210010	blood transfusion	C0005841
28210010	treatment	C0039798
28210010	Preterm infants	C4048294
28210010	gestational age	C0017504
28210010	weeks	C0439230
28210010	risk	C0035647
28210010	intracranial bleeding	C0151699
28210010	associated with	C0332281
28210010	application	C0185125
28210010	blood transfusion	C0005841
28210010	week	C0439230
28210010	life	C0376558
28210659	Medial Patellofemoral Ligament	C4254914
28210659	Reconstruction	C0547071
28210659	Femoral	C0015811
28210659	Tunnel	C1254362
28210659	Accuracy	C0443131
28210659	Disease	C0012634
28210659	Specific	C0205369
28210659	Quality of Life	C0034380
28210659	Medial patellofemoral ligament	C4254914
28210659	MPFL	C4254914
28210659	reconstruction	C0547071
28210659	lateral patellar translation	C0559397
28210659	patients	C0030705
28210659	symptomatic patellofemoral instability	C0856775
28210659	femoral	C0015811
28210659	tunnel	C1254362
28210659	position	C0733755
28210659	MPFL	C4254914
28210659	reconstruction	C0547071
28210659	accuracy	C0443131
28210659	patient outcomes	C0030698
28210659	accuracy	C0443131
28210659	femoral	C0015811
28210659	tunnel	C1254362
28210659	placement	C1533810
28210659	MPFL	C4254914
28210659	reconstruction	C0547071
28210659	cohort	C0599755
28210659	correlation	C1707520
28210659	tunnel	C1254362
28210659	accuracy	C0443131
28210659	validated	C1519941
28210659	disease	C0012634
28210659	specific	C0205369
28210659	patient	C0030705
28210659	quality-of-life	C0034380
28210659	outcome measure	C0086749
28210659	June	C3829443
28210659	February	C3830166
28210659	subjects	C0080105
28210659	MPFL	C4254914
28210659	reconstruction	C0547071
28210659	Lateral	C0205093
28210659	radiographs	C1306645
28210659	accuracy	C0443131
28210659	femoral	C0015811
28210659	tunnel	C1254362
28210659	femoral	C0015811
28210659	tunnel	C1254362
28210659	Schöttle point	C1254362
28210659	Banff Patella Instability Instrument (BPII) scores	C0086749
28210659	mean	C0444504
28210659	months	C0439231
28210659	postoperatively	C0032790
28210659	postoperative	C0032790
28210659	lateral	C0205093
28210659	radiographs	C1306645
28210659	BPII scores	C0086749
28210659	mean	C0444504
28210659	duration	C0449238
28210659	follow-up	C1522577
28210659	SD	C0871420
28210659	months	C0439231
28210659	months	C0439231
28210659	Measurement	C0242485
28210659	center	C0205099
28210659	femoral	C0015811
28210659	tunnel	C1254362
28210659	Schöttle point	C1254362
28210659	tunnel	C1254362
28210659	good	C0205170
28210659	ideal	C1512612
28210659	failures	C1262018
28210659	cohort	C0599755
28210659	malpositioned	C0333042
28210659	tunnels	C1254362
28210659	mean	C0444504
28210659	center	C0205099
28210659	MPFL	C4254914
28210659	tunnel	C1254362
28210659	center	C0205099
28210659	Schöttle point	C1254362
28210659	mean	C0444504
28210659	postoperative	C0032790
28210659	BPII score	C0086749
28210659	Pearson r correlation	C1709490
28210659	no statistically significant	C1273937
28210659	relationship	C0439849
28210659	accuracy	C0443131
28210659	femoral	C0015811
28210659	tunnel	C1254362
28210659	position	C0733755
28210659	BPII score	C0086749
28210659	no evidence of	C0332125
28210659	correlation	C1707520
28210659	accuracy	C0443131
28210659	MPFL	C4254914
28210659	reconstruction	C0547071
28210659	femoral	C0015811
28210659	tunnel	C1254362
28210659	Schöttle point	C1254362
28210659	disease	C0012634
28210659	specific	C0205369
28210659	quality-of-life scores	C3476431
28210659	Graft failure	C1262018
28210659	femoral	C0015811
28210659	tunnel	C1254362
28210659	placement	C1533810
28210659	patellofemoral instability	C0856775
28210659	patients	C0030705
28210659	risk factors	C0035648
28210659	accuracy	C0443131
28210659	tunnel	C1254362
28210659	position	C0733755
28210659	quality of life	C0034380
28210659	investigation	C0220825
28210819	instructions	C0039401
28210819	task-set representations	C0039333
28210819	informed	C1522154
28210819	fadeout effect	C0237614
28210819	cognitive system	C0392335
28210819	performance	C0039333
28210819	cognitive tasks	C0392335
28210819	task	C3540678
28210819	switching	C0392747
28210819	task	C3540678
28210819	level	C0441889
28210819	task	C3540678
28210819	performance	C0039333
28210819	research	C0035168
28210819	fadeout effect	C0237614
28210819	performance	C0039333
28210819	improvement	C0039333
28210819	task	C3540678
28210819	switching	C0392747
28210819	single-task	C2371306
28210819	passive	C3686820
28210819	learning	C0023185
28210819	intentional	C1283828
28210819	control	C0243148
28210819	informed	C1522154
28210819	fadeout	C0033897
28210819	paradigm	C0681797
28210819	tasks	C3540678
28210819	trials	C0681815
28210819	participants	C0679646
28210819	informed	C1522154
28210819	uninformed	C0562357
28210819	task	C3540678
28210819	cancelation	C0205544
28210819	informed	C1522154
28210819	fadeout effect	C0237614
28210819	performance	C0039333
28210819	informed	C1522154
28210819	uninformed	C0562357
28210819	fadeout	C0237614
28210819	informed	C1522154
28210819	trial	C0681815
28210819	executed	C1705848
28210819	trial	C0681815
28210819	mechanisms	C0441712
28217198	Metacarpophalangeal Joint Arthrodesis	C0187606
28217198	Thumb	C0040067
28217198	Months	C0439231
28217198	Follow-up	C1522577
28217198	Disorders	C0012634
28217198	thumb metacarpophalangeal (MCP) joint	C0224627
28217198	loss	C1517945
28217198	function	C1254359
28217198	pain	C0030193
28217198	Thumb MCP	C0224627
28217198	arthrodesis	C0003881
28217198	traumatic injuries	C3263723
28217198	described	C1552738
28217198	studies	C2603343
28217198	outcome	C1274040
28217198	treatment	C0087111
28217198	study	C2603343
28217198	report	C0700287
28217198	outcome	C1274040
28217198	disability	C0231170
28217198	thumb MCP joint	C0224627
28217198	arthrodesis	C0003881
28217198	treatment	C0087111
28217198	chronic instability	C0409364
28217198	traumatic injuries	C3263723
28217198	retrospective	C1514923
28217198	review	C0451610
28217198	patients	C0030705
28217198	operated	C0543467
28217198	MCP joint	C0224627
28217198	arthrodesis	C0003881
28217198	follow-up	C1522577
28217198	months	C0439231
28217198	months	C0439231
28217198	outcome	C1274040
28217198	assessed	C1516048
28217198	disabilities of the Arm, Shoulder, and Hand-questionnaire	C4295796
28217198	DASH	C4295796
28217198	patient satisfaction	C0030702
28217198	pain	C0030193
28217198	stiffness	C0427008
28217198	impairment	C0221099
28217198	activities of daily living	C0001288
28217198	assessed	C1516048
28217198	Visual Analogue Scale	C3536884
28217198	VAS	C3536884
28217198	procedure	C2700391
28217198	patients	C0030705
28217198	re-operation	C0035110
28217198	nonunion	C3897107
28217198	patients	C0030705
28217198	hardware removal	C1096445
28217198	Median	C0876920
28217198	DASH	C4295796
28217198	score	C0449820
28217198	range	C1514721
28217198	DASH	C4295796
28217198	score s	C0449820
28217198	Score s	C0449820
28217198	gender	C0079399
28217198	age	C0001779
28217198	individuals	C0237401
28217198	Median	C0876920
28217198	VAS	C3536884
28217198	pain	C0030193
28217198	range	C1514721
28217198	patients	C0030705
28217198	mild	C0278138
28217198	moderate	C0278139
28217198	severe pain	C0278140
28217198	patients	C0030705
28217198	procedure	C2700391
28217198	data	C1511726
28217198	patients	C0030705
28217198	post-traumatic	C1254367
28217198	thumb injuries	C0262649
28217198	thumb MCP joint	C0224627
28217198	arthrodesis	C0003881
28217198	gender	C0079399
28217198	age	C0001779
28217198	individuals	C0237401
28217198	pain	C0030193
28217198	procedure	C2700391
28217198	disability scale	C0451125
28217198	National Board of Industrial Injuries	C1948070
28217198	patients	C0030705
28217198	operated	C0543467
28217198	thumb MCP	C0224627
28217198	arthrodesis	C0003881
28217611	Pyoderma gangrenosum	C0085652
28217611	clinician's	C0871685
28217611	nightmare	C0028084
28217611	Pyoderma gangrenosum	C0085652
28217611	PG	C0085652
28217611	rare disease	C0678236
28217611	sole of the foot	C0230463
28217611	report	C0684224
28217611	old	C0580836
28217611	female	C0086287
28217611	admitted	C0184666
28217611	painful	C0030193
28217611	ulcer	C0041582
28217611	sole of the right foot	C0230463
28217611	treated with	C0332293
28217611	antibiotics	C0003232
28217611	debridement	C0011079
28217611	disease	C0012634
28217611	rapidly	C0456962
28217611	debridement	C0011079
28217611	culture reports	C2061903
28217611	negative	C0205160
28217611	rheumatology	C0035452
28217611	workup	C0750430
28217611	Doppler study	C0554756
28217611	normal limits	C0442816
28217611	clinical	C0205210
28217611	suspicion	C0750491
28217611	PG	C0085652
28217611	tissue biopsy	C3864006
28217611	started on oral steroids	C0419839
28217611	improved	C0184511
28217611	patient	C0030705
28217611	rapidly	C0456962
28217611	painful	C0030193
28217611	ulcer	C0041582
28217611	vascular limb	C0015385
28217611	refractory	C0205269
28217611	antibiotic treatment	C0338237
28217611	exacerbating	C1444749
28217611	debridement	C0011079
28217611	PG	C0085652
28217766	Visualization	C0178707
28217766	Uncertainty	C0087130
28217766	Activation	C1879547
28217766	Volumes	C0449468
28217766	Deep Brain Stimulation	C0394162
28217766	Neurostimulation Uncertainty Viewer (nuView or νView) tool	C0282574
28217766	data	C1511726
28217766	deep brain stimulation	C0394162
28217766	DBS	C0394162
28217766	Simulated	C0679083
28217766	volume of tissue activated	C0392762
28217766	VTA	C0392762
28217766	clinical electrode placements	C0430022
28217766	recorded	C0441655
28217766	patient	C0030705
28217766	outcomes	C0085415
28217766	Unified Parkinson's disease rating scale	C3639721
28217766	UPDRS	C3639721
28217766	data	C1511726
28217766	volumetric	C0205556
28217766	sparse	C0205556
28217766	multi-value	C0205556
28217766	patient	C0030705
28217766	results	C1274040
28217766	activated	C1879547
28217766	voxel	C2700259
28217766	simulation	C0679083
28217766	νView	C1254372
28217766	collection	C1516698
28217766	visual methods	C0025663
28217766	activated	C1879547
28217766	tissue	C0040300
28217766	electrode	C0013812
28217766	usage	C0457083
28217766	therapy	C0087111
28217766	DBS	C0394162
28217770	conversion	C0439836
28217770	5-pivaloyloxymethyluridine	C0073347
28217770	present	C0150312
28217770	RNA	C0035668
28217770	oligomer	C0599219
28217770	biologically	C0205460
28217770	relevant	C2347946
28217770	derivatives	C0243072
28217770	5-methyluridine	C0073347
28217770	reaction	C0443286
28217770	5-pivaloyloxymethyluridine	C0073347
28217770	present	C0150312
28217770	RNA	C0035668
28217770	oligomer	C0599219
28217770	nucleophilic reagents	C0034760
28217770	products	C1514468
28217770	tRNA wobble	C1817367
28217770	5-methyluridines	C0073347
28217770	mnm(5)U	C0073347
28217770	cmnm(5)U	C0073347
28217770	τm(5)U	C0073347
28217770	nm(5)U	C0073347
28217770	inm(5)U	C0073347
28217770	cnm(5)U	C0073347
28217770	syntheses	C1883254
28217770	oligoribonucleotides	C0028956
28217770	modified	C0392747
28217770	inm(5)U	C0073347
28217770	cnm(5)U	C0073347
28219657	Non-pharmacological	C0205245
28219657	treatments	C0087111
28219657	pain relief	C0451615
28219657	TENS	C0040654
28219657	acupuncture	C0394664
28219657	Acupuncture	C0394664
28219657	transcutaneous electrical nerve stimulation	C0040654
28219657	TENS	C0040654
28219657	non-pharmacological	C0205245
28219657	methods	C0449851
28219657	millennia	C1948053
28219657	relieve pain	C0451615
28219657	complementary treatments	C0936077
28219657	efficacy	C1280519
28219657	evaluations	C0220825
28219657	double-blinding	C0013072
28219657	optimal control population	C0029145
28219657	treatment	C0087111
28219657	good	C0205170
28219657	methodological quality	C0815254
28219657	benefits	C0814225
28219657	pain	C0030193
28219657	conventional	C0439858
28219657	treatment	C0087111
28219657	mechanisms of action	C0441712
28219657	acupuncture	C0394664
28219657	TENS	C0040654
28219657	increasingly	C0442808
28219657	endogenous	C0205227
28219657	pain control systems	C1304888
28219657	cerebral plasticity	C0027880
28219657	effects	C1280500
28219657	expectations	C0679138
28219657	placebo effect	C0032041
28219657	adverse effects	C0879626
28219657	data	C1511726
28219657	non-pharmacological	C0205245
28219657	pain management	C0002766
28219657	patients	C0030705
28219657	chronic pain	C0150055
28219657	relieved by	C0332303
28219657	medications	C0013227
28220082	Synaptic	C0039062
28220082	Neuronal	C0027882
28220082	Autoantibody	C0004358
28220082	Associated	C0332281
28220082	Psychiatric Syndromes	C0004936
28220082	Controversies	C0680243
28220082	Hypotheses	C1512571
28220082	Autoimmune encephalitis	C0393639
28220082	AE	C0393639
28220082	antibodies	C0003241
28220082	synaptic	C0039062
28220082	neuronal	C0027882
28220082	surface	C0205148
28220082	targets	C1521840
28220082	frequently	C0332183
28220082	presents	C0150312
28220082	psychiatric syndrome	C0004936
28220082	patients	C0030705
28220082	removal of	C0015252
28220082	autoantibodies	C0004358
28220082	treats	C1522326
28220082	disease	C0012634
28220082	outcomes	C0085415
28220082	intervention	C0184661
28220082	discovery	C1880355
28220082	autoantibodies	C0004358
28220082	isolated	C0205409
28220082	psychiatric syndromes	C0004936
28220082	raised	C0442818
28220082	patients	C0030705
28220082	benefits	C0814225
28220082	immunotherapy	C0021083
28220082	potentially	C3245505
28220082	approach	C0449445
28220082	treatment	C0039798
28220082	mental illness	C0004936
28220082	open-label case series	C3640652
28220082	therapeutic outcomes	C0085415
28220082	pathological	C1521733
28220082	relevance	C2347946
28220082	autoantibodies	C0004358
28220082	canonical presentations	C0870245
28220082	diagnostic criteria	C0679228
28220082	AE	C0393639
28220082	attempts	C1516084
28220082	identification	C0205396
28220082	risks	C0035647
28220082	potential	C3245505
28220082	scientific	C0036397
28220082	clinical significance	C2826293
28220082	isolated	C0205409
28220082	syndromes	C0039082
28220082	syndrome	C0039082
28220082	level	C0441889
28220082	taxonomy	C0087066
28220082	occasional	C0521114
28220082	overlap	C1948020
28220082	AE	C0393639
28220082	synaptic	C0039062
28220082	neuronal	C0027882
28220082	autoantibody	C0004358
28220082	associated	C0332281
28220082	psychiatric syndromes	C0004936
28220082	SNAps	C0004936
28220082	prevent	C1292733
28220082	AE	C0393639
28220082	act heuristically	C0597916
28220082	promote	C0033414
28220082	active	C0205177
28220082	investigation	C0220825
28220082	rare	C0522498
28220082	example	C1707959
28220082	psychopathology	C0033927
28220082	defined	C1704788
28220082	molecular level	C0596958
28220082	concept	C0178566
28220082	autoantibody	C0004358
28220082	associated	C0332281
28220082	syndromes	C0039082
28220082	including	C0332257
28220082	seizure	C0036572
28220082	cognitive	C1516691
28220082	movement disorders	C0026650
28220082	similar	C2348205
28220082	issues	C0033213
28220082	review	C0699752
28220082	direct	C1947931
28220082	indirect	C0439852
28220082	mechanisms	C0441712
28220082	experimentally	C1517586
28220082	hypotheses	C1512571
28220082	prospectively	C0033522
28220082	autoantibody	C0004358
28220082	detection	C1511790
28220082	relevant	C2347946
28220082	important	C3898777
28220082	pragmatic	C0871858
28220082	autoantibody	C0004358
28220082	testing	C0039593
28220082	management	C0376636
28220082	severe	C0205082
28220082	mental illness	C0004936
28220082	diagnose	C0011900
28220082	AE	C0393639
28220082	research	C0035168
28220082	orientated	C0424013
28220082	experimental	C1517586
28220082	medicine	C0013227
28220082	paradigm	C0681797
28220082	SNAps	C0004936
28220082	greater	C1704243
28220082	equipoise	C0702057
28220082	SNAps	C0004936
28220082	clinical	C0205210
28220082	neuroscience	C0027910
28220082	potential	C3245505
28220082	ongoing	C0549178
28220082	need	C0027552
28220082	psychiatry	C0033873
28220082	clinical research	C0008972
28220122	NF-κB	C0079904
28220122	TLR2	C0754728
28220122	PAR1	C4048327
28220122	Soluble	C1948047
28220122	Immunomodulator Factor	C1527392
28220122	Secretion	C0036536
28220122	Human	C0086418
28220122	Platelets	C0005821
28220122	primary	C0205225
28220122	toll-like receptor	C0670896
28220122	TLR	C0670896
28220122	immune cell response pathway	C1511003
28220122	TLRs	C0670896
28220122	MyD88	C0286648
28220122	activation	C0599177
28220122	NF-κB	C0079904
28220122	seminal	C0036628
28220122	transcription factor	C0040648
28220122	chemokines	C0282554
28220122	cytokines	C0079189
28220122	anucleate platelets	C0005821
28220122	NF-κB	C0079904
28220122	platelets	C0005821
28220122	investigated	C1292732
28220122	contribution	C1880177
28220122	NF-κB	C0079904
28220122	release	C0391871
28220122	cytokines	C0079189
28220122	serotonin	C0036751
28220122	human	C0086418
28220122	platelets	C0005821
28220122	following	C0332282
28220122	TLR2	C0754728
28220122	protease activated receptor 1	C4048327
28220122	PAR1	C4048327
28220122	pattern-recognition receptor	C1564907
28220122	innate immune system	C0020969
28220122	platelet	C0005821
28220122	PAR1	C4048327
28220122	activation	C0599177
28220122	NF-κB	C0079904
28220122	phosphorylation	C0031715
28220122	TLR2	C0754728
28220122	activation	C1514758
28220122	induces	C0205263
28220122	phosphorylation process	C0031715
28220122	platelet	C0005821
28220122	PAR1	C4048327
28220122	TLR2	C0754728
28220122	activation	C1879547
28220122	induces	C0205263
28220122	ERK1/2	C2611094
28220122	p38	C1120843
28220122	AKT	C0164786
28220122	phosphorylation	C0031715
28220122	platelet	C0005821
28220122	TLR2	C0754728
28220122	ligand	C0023688
28220122	Pam3CSK4	C1698795
28220122	significantly increases	C4055637
28220122	release	C0391871
28220122	sCD62P	C0134835
28220122	RANTES	C0072978
28220122	sCD40L	C0167627
28220122	effect	C1280500
28220122	attenuated by	C0332161
28220122	incubating	C1439852
28220122	platelets	C0005821
28220122	blocking	C0332206
28220122	anti-TLR2 antibody	C3712029
28220122	effect appeared	C2348382
28220122	modulation	C0443264
28220122	serotonin secretion	C1325900
28220122	observed	C1441672
28220122	following	C0332282
28220122	platelet	C0005821
28220122	TLR2	C0754728
28220122	activation	C1514758
28220122	Platelet	C0005821
28220122	release	C0391871
28220122	sCD62P	C0134835
28220122	RANTES	C0072978
28220122	sCD40L	C0167627
28220122	following	C0332282
28220122	TLR2	C0754728
28220122	PAR1	C4048327
28220122	presence	C0150312
28220122	NF-κB	C0079904
28220122	inhibitor	C0243077
28220122	Bay11-7082	C0969281
28220122	serotonin release	C1979804
28220122	following	C0332282
28220122	PAR1	C4048327
28220122	activation	C1514758
28220122	significantly decreased	C4055638
28220122	new	C0205314
28220122	findings	C2607943
28220122	NF-κB	C0079904
28220122	platelet	C0005821
28220122	immunoregulations	C0678889
28220122	functions	C1817756
28222010	Optical tweezers	C1883721
28222010	studies	C2603343
28222010	transcription	C0040649
28222010	eukaryotic	C0015161
28222010	RNA polymerases	C0035681
28222010	Transcription	C0040649
28222010	first step	C1261552
28222010	expression	C0017262
28222010	genetic	C0314603
28222010	information	C1533716
28222010	carried	C0206243
28222010	macromolecular	C1449655
28222010	enzymes	C0014442
28222010	RNA polymerases	C0035681
28222010	Transcription	C0040649
28222010	studied	C2603343
28222010	myriad	C1881938
28222010	experimental	C1517586
28222010	techniques	C0449851
28222010	ranging	C1514721
28222010	studies	C2603343
28222010	high-resolution transcript sequencing	C0917793
28222010	review	C0282443
28222010	single-molecule	C0872367
28222010	techniques	C0449851
28222010	optical tweezers	C1883721
28222010	study	C2603343
28222010	transcription	C0040649
28222010	dynamics	C3826426
28222010	overview	C0814812
28222010	results	C1274040
28222010	single-molecule	C0872367
28222010	transcription	C0040649
28222010	field	C1521738
28222010	transcription	C0040649
28222010	eukaryotic	C0015161
28222010	RNA polymerases	C0035681
28222010	quantitative	C0392762
28222010	models	C0026336
28222010	describe	C1552738
28222010	biophysics	C0005553
28222010	RNA polymerase	C0035681
28222010	translocation	C0599893
28222010	dynamics	C3826426
28222462	Decreased Frequencies	C1561548
28222462	Peripheral Blood	C0229664
28222462	CD4+CD25+CD127-Foxp3+	C0039198
28222462	Patients	C0030705
28222462	Graves' Disease	C0018213
28222462	Graves' Orbitopathy	C0339143
28222462	Enhancing Effect	C1280500
28222462	Insulin Growth Factor-1	C0021665
28222462	Treg Cells	C0039198
28222462	Graves' orbitopathy	C0339143
28222462	GO	C0339143
28222462	characterized	C1880022
28222462	orbital T cell	C0039194
28222462	infiltration	C0332448
28222462	evaluated	C0220825
28222462	regulatory T (Treg) cell	C0039198
28222462	fractions	C1264633
28222462	induced	C0205263
28222462	IGF-1	C0021665
28222462	Graves' disease	C0018213
28222462	GD	C0018213
28222462	GO	C0339143
28222462	Peripheral blood mononuclear cells	C1321301
28222462	PBMCs	C1321301
28222462	patients	C0030705
28222462	GD	C0018213
28222462	eye manifestations	C0015411
28222462	patients	C0030705
28222462	active	C0205177
28222462	GO	C0339143
28222462	patients	C0030705
28222462	nodular goiter	C0018023
28222462	NG	C0018023
28222462	patients	C0030705
28222462	GD	C0018213
28222462	GO	C0339143
28222462	NG	C0018023
28222462	subclinical hyperthyroid	C0745142
28222462	analyzed	C0936012
28222462	expression of Treg cell markers	C0600223
28222462	CD4	C0003323
28222462	CD25	C0007507
28222462	CD127(-)	C0083032
28222462	Foxp3	C4282118
28222462	T cells	C0039194
28222462	respond to	C1553423
28222462	IGF-1	C0021665
28222462	stimulation	C1948023
28222462	patients	C0030705
28222462	GD	C0018213
28222462	GO	C0339143
28222462	lowered percentages	C0439165
28222462	CD4(+) Foxp3(+) cells	C0039198
28222462	nodular goiter	C0018023
28222462	significantly reduced frequencies	C1561548
28222462	CD4(+)CD25(+)CD127(-)Foxp3(+)	C0039198
28222462	CD4(+)CD25(+)CD127(-) cells	C0039198
28222462	observed	C1441672
28222462	GD	C0018213
28222462	patients	C0030705
28222462	nodular goiter	C0018023
28222462	patients	C0030705
28222462	hyperthyreosis	C0020550
28222462	GO	C0339143
28222462	active	C0205177
28222462	GO	C0339143
28222462	percentage	C0439165
28222462	CD4(+)CD25(+)CD127(-) cells	C0039198
28222462	decreased	C0205216
28222462	nodular goiter	C0018023
28222462	Stimulation	C1948023
28222462	PBMC	C1321301
28222462	GO	C0339143
28222462	patients	C0030705
28222462	IGF-1	C0021665
28222462	significant increase of frequency	C1561548
28222462	CD4(+) Foxp3(+)	C0039198
28222462	CD4(+)CD25(+)CD127(-) Foxp3 cells	C0039198
28222462	Decreased frequencies	C1561548
28222462	peripheral blood	C0229664
28222462	CD4(+)CD25(+)CD127(-)Foxp3(+)	C0039198
28222462	patients	C0030705
28222462	GD	C0018213
28222462	GO	C0339143
28222462	useful marker	C0005516
28222462	autoimmune process	C0443146
28222462	future therapies	C0039798
28222462	study	C2603343
28222462	Treg	C0039198
28222462	enhancing effects	C1280500
28222462	IGF-1	C0021665
28222462	IGF-1	C0021665
28222462	modulating	C0443264
28222462	Treg cell	C0039198
28222462	action	C3266814
28222462	GO	C0339143
28228227	γ-Butenolide	C0574031
28228227	furanone derivatives	C0574031
28228227	soil	C0037592
28228227	fungus	C0016832
28228227	Aspergillus sclerotiorum	C0446101
28228227	PSU-RSPG178	C0446101
28228227	Chromatographic separation	C0008550
28228227	broth	C2919900
28228227	extract	C2828366
28228227	soil	C0037592
28228227	fungus	C0016832
28228227	Aspergillus sclerotiorum	C0446101
28228227	PSU-RSPG178	C0446101
28228227	isolation	C0205409
28228227	γ-butenolide-furanone dimers	C0574031
28228227	aspersclerotiorones A-D	C0574031
28228227	furanone derivative	C0574031
28228227	aspersclerotiorone E	C0574031
28228227	γ-butenolide derivatives	C0574031
28228227	aspersclerotiorones F	C0574031
28228227	G	C0574031
28228227	penicillic acid	C0030821
28228227	dihydropenicillic acid	C0574031
28228227	5,6-dihydro-6-hydroxypenicillic acid	C0574031
28228227	6-methoxy-5,6-dihydropenicillic acid	C0574031
28228227	coculnol	C0574031
28228227	(4R,5R)-4,5-dihydroxy-3-methoxy-5-methylcyclohex-2-en-1-one	C0574031
28228227	structures	C0220807
28228227	spectroscopic evidence	C0037812
28228227	aspersclerotiorones A	C0574031
28228227	B	C0574031
28228227	structures	C0220807
28228227	single-crystal X-ray diffraction crystallography	C0206755
28228227	antibacterial activity	C1271650
28228227	Staphylococcus aureus	C0038172
28228227	Escherichia coli	C0014834
28228227	MIC values	C1304747
28228227	noncytotoxic	C0205556
28228227	African green monkey	C0026438
28228227	kidney	C0022646
28228227	fibroblast cells	C0016030
28228265	E3 Ligase	C0077678
28228265	RNF126	C3657865
28228265	Ubiquitinates	C1519751
28228265	Frataxin	C0387678
28228265	Promoting	C0033414
28228265	Degradation	C0243125
28228265	Identification	C0205396
28228265	Therapeutic	C0302350
28228265	Target	C1521840
28228265	Friedreich Ataxia	C0016719
28228265	Friedreich ataxia	C0016719
28228265	FRDA	C0016719
28228265	genetic	C0314603
28228265	neurodegenerative disease	C0524851
28228265	expression	C1171362
28228265	mitochondrial protein	C0949610
28228265	frataxin	C0387678
28228265	therapy	C0039798
28228265	treat	C0087111
28228265	condition	C0348080
28228265	residual	C1609982
28228265	frataxin	C0387678
28228265	severity	C0439793
28228265	disease	C0012634
28228265	physiological	C0205463
28228265	frataxin	C0387678
28228265	levels	C0441889
28228265	therapeutically	C0302350
28228265	relevant	C2347946
28228265	Frataxin	C0387678
28228265	levels	C0441889
28228265	controlled by	C0332298
28228265	ubiquitin-proteasome system	C1523807
28228265	inhibition	C3463820
28228265	frataxin	C0387678
28228265	E3 ligase	C0077678
28228265	strategy	C0035171
28228265	frataxin	C0387678
28228265	levels	C0441889
28228265	identification	C0205396
28228265	RING E3 ligase	C0077678
28228265	RNF126	C3657865
28228265	enzyme	C0014442
28228265	frataxin	C0387678
28228265	ubiquitination	C1519751
28228265	degradation	C0243125
28228265	RNF126	C3657865
28228265	interacts	C1704675
28228265	frataxin	C0387678
28228265	promotes	C0033414
28228265	ubiquitination	C1519751
28228265	catalytic activity	C1264638
28228265	dependent	C0851827
28228265	in vivo	C1515655
28228265	in vitro	C1533691
28228265	RNF126	C3657865
28228265	depletion	C0333668
28228265	frataxin	C0387678
28228265	accumulation	C4055506
28228265	cells	C0007634
28228265	FRDA	C0016719
28228265	patients	C0030705
28228265	relevance	C2347946
28228265	RNF126	C3657865
28228265	therapeutic	C0302350
28228265	target	C1521840
28228265	Friedreich ataxia	C0016719
28228370	Doctors'	C0031831
28228370	Competencies	C0008956
28228370	Communication	C0009452
28228370	Activation	C1879547
28228370	Older	C1999167
28228370	Patients	C0030705
28228370	Promoting	C0033414
28228370	Active	C0205177
28228370	Aging	C0001811
28228370	PRACTA	C3898714
28228370	Computer-Based Intervention Study	C3898714
28228370	Demographic	C0011298
28228370	changes	C0392747
28228370	decades	C2981279
28228370	promotion of health and disease prevention	C0677273
28228370	older	C1999167
28228370	patients	C0030705
28228370	independence	C0085862
28228370	productivity	C0033269
28228370	quality of life	C0034380
28228370	computer-based educational intervention	C0281163
28228370	general practitioners	C0017319
28228370	GPs	C0017319
28228370	active	C0205177
28228370	aging	C0001811
28228370	Promoting	C0033414
28228370	Aging	C0001811
28228370	PRACTA	C3898714
28228370	baseline questionnaire	C0034394
28228370	implementation	C1708476
28228370	intervention	C0184661
28228370	follow-up questionnaire	C4054939
28228370	administered	C1621583
28228370	intervention	C3898714
28228370	primary care facilities	C1552443
28228370	response rate	C0237629
28228370	GPs	C0017319
28228370	response rate	C0237629
28228370	participate	C0679823
28228370	baseline assessment	C0282121
28228370	follow-up	C0016441
28228370	GPs	C0017319
28228370	questionnaires	C0034394
28228370	response rate	C0237629
28228370	intervention	C0184661
28228370	study group	C0681860
28228370	GPs	C0017319
28228370	e-learning	C0009597
28228370	knowledge	C0162340
28228370	skills	C0678856
28228370	modelling	C3161035
28228370	pdf article	C1706852
28228370	knowledge	C0162340
28228370	control	C0009932
28228370	no	C0332288
28228370	intervention	C3898714
28228370	scores	C0449820
28228370	Patients	C0030705
28228370	Expectations Scale	C0282574
28228370	Communication Scale	C0282574
28228370	Attitude Toward Treatment and Health Scale	C0282574
28228370	Self-Efficacy Scale	C0282574
28228370	GPs	C0017319
28228370	e-learning	C0009597
28228370	significant	C0750502
28228370	perception	C0030971
28228370	older	C1999167
28228370	patients	C0030705
28228370	expectations	C0679138
28228370	disease explanation	C0681841
28228370	perception	C0030971
28228370	motivational	C0026605
28228370	older	C1999167
28228370	patients	C0030705
28228370	treatment	C0039798
28228370	health	C0018684
28228370	control	C0009932
28228370	pdf article groups	C0681860
28228370	group	C0681860
28228370	level	C0441889
28228370	statistical	C0038215
28228370	GPs	C0017319
28228370	pdf article	C1706852
28228370	intervention	C0184661
28228370	communication	C0009452
28228370	level	C0441889
28228370	global scoring	C0449820
28228370	level	C0441889
28228370	specific behaviors	C0679160
28228370	effects of	C1704420
28228370	intervention	C0184661
28228370	patients	C0030705
28228370	GP	C0017319
28228370	organizational structure	C0687114
28228370	areas	C0205146
28228370	conditions	C0348080
28228370	pdf article	C1706852
28228370	intervention	C0184661
28228370	doctors	C0031831
28228370	limitations	C0449295
28228370	communication skills	C0870313
28228370	e-learning	C0009597
28228370	effective	C1704419
28228370	older	C1999167
28228370	patients	C0030705
28228370	GPs	C0017319
28228370	privately owned facilities	C0033173
28228370	assigned	C1516050
28228370	patients	C0030705
28228370	effects of	C1704420
28228370	PRACTA intervention	C3898714
28228370	competencies	C0008956
28228370	doctors	C0031831
28228370	communication	C0009452
28228370	older	C1999167
28228370	patients	C0030705
28229178	consummatory	C0009829
28229178	motivational	C0026605
28229178	behaviors	C0004927
28229178	natural	C0205296
28229178	rewards	C0035397
28229178	withdrawal	C1707825
28229178	morphine	C0026549
28229178	anhedonia	C0178417
28229178	maladaptive behaviors	C0562443
28229178	rewards	C0035397
28229178	anhedonia	C0178417
28229178	abstinence	C3843422
28229178	abused drugs	C0086190
28229178	motivational	C0026605
28229178	processes	C1522240
28229178	drug craving	C0556446
28229178	relapse	C0035020
28229178	anhedonia	C0178417
28229178	drug abstinence	C0237443
28229178	anhedonia	C0178417
28229178	withdrawal	C1707825
28229178	behavioral	C0004927
28229178	responses	C0871261
28229178	natural	C0205296
28229178	rewards	C0035397
28229178	weeks	C0439230
28229178	withdrawal	C1707825
28229178	morphine	C0026549
28229178	Male	C0086582
28229178	rats	C0034693
28229178	morphine	C0026549
28229178	paradigm	C0681797
28229178	daily	C0332173
28229178	saline injection	C0199797
28229178	days	C0439228
28229178	consummatory	C0009829
28229178	motivational	C0026605
28229178	behaviors	C0004927
28229178	natural	C0205296
28229178	rewards	C0035397
28229178	sucrose solutions	C0038636
28229178	social	C0728831
28229178	stimulus	C0234402
28229178	male	C0086582
28229178	rat	C0034693
28229178	sexual	C0036865
28229178	stimulus	C0234402
28229178	estrous	C0014948
28229178	female	C0086287
28229178	rat	C0034693
28229178	testing conditions	C0449910
28229178	morphine	C0026549
28229178	withdrawn	C1707825
28229178	rats	C0034693
28229178	sucrose solution	C0038636
28229178	consumption test	C0683443
28229178	operant responding	C0009651
28229178	sucrose solution	C0038636
28229178	progressive ratio (PR) schedule of reinforcement	C0871209
28229178	reinforcer	C0178826
28229178	foot	C0016504
28229178	shock	C0013870
28229178	PR-punishment schedule	C0035008
28229178	morphine	C0026549
28229178	withdrawn	C1707825
28229178	rats	C0034693
28229178	sucrose solution	C0038636
28229178	morphine	C0026549
28229178	withdrawn	C1707825
28229178	rats	C0034693
28229178	motivation	C0026605
28229178	sexual	C0036865
28229178	stimulus	C0234402
28229178	free-approach test	C0683443
28229178	behaviors	C0004927
28229178	sexual	C0036865
28229178	stimulus	C0234402
28229178	conflict-based approach test	C0683444
28229178	reward	C0035397
28229178	aversive stimulus	C1510994
28229178	No	C1513916
28229178	anhedonia	C0178417
28229178	behavior	C0004927
28229178	sensitized	C0332324
28229178	behaviors	C0004927
28229178	natural	C0205296
28229178	rewards	C0035397
28229178	morphine	C0026549
28229178	withdrawal	C1707825
28229178	morphine	C0026549
28229178	withdrawn	C1707825
28229178	rats	C0034693
28229178	motivated	C0026605
28229178	behaviors	C0004927
28229178	rewards	C0035397
28229178	sucrose	C0038636
28229178	sexual	C0036865
28229178	stimulus	C0234402
28229178	conflict tests	C0683443
28229178	morphine	C0026549
28229178	treated	C1522326
28229178	rats	C0034693
28230977	Extracellular	C0521119
28230977	Self-Assembly	C0872376
28230977	Functional	C0205245
28230977	Tunable Protein Conjugates	C0033684
28230977	Bacillus subtilis	C0004595
28230977	stably	C0205360
28230977	conjugate	C1160466
28230977	recombinant proteins	C0034861
28230977	engineering	C0017387
28230977	multifunctional	C0205245
28230977	enzymes	C0014442
28230977	protein therapeutics	C0872285
28230977	novel	C0205314
28230977	biological materials	C0005479
28230977	applications	C0869019
28230977	in vitro	C1533691
28230977	in vivo	C1515655
28230977	intracellular	C0178719
28230977	protein conjugation	C1160466
28230977	extracellular	C0521119
28230977	self-assembly	C0872376
28230977	protein conjugates	C0033684
28230977	purification	C0597301
28230977	reducing	C0392756
28230977	toxicity	C0600688
28230977	burden	C2828008
28230977	tunability	C0205556
28230977	SpyTag-SpyCatcher system	C0022885
28230977	enzymes	C0014442
28230977	structural proteins	C0582263
28230977	genetically encoded	C0314627
28230977	covalently	C1511539
28230977	conjugate	C1160466
28230977	culture media	C0010454
28230977	programmable secretion	C1327616
28230977	Bacillus subtilis	C0004595
28230977	self-conjugation	C1160466
28230977	secreted	C1327616
28230977	enzyme	C0014442
28230977	XynA	C0149034
28230977	increases	C0205217
28230977	resilience	C1821534
28230977	boiling	C0018851
28230977	cellular consortia	C0007634
28230977	engineered	C0017387
28230977	self-assemble	C0872376
28230977	functional	C0205245
28230977	protein-protein conjugates	C0033684
28230977	novel	C0205314
28230977	genetically encoded	C0314627
28230977	modular system	C0449913
28230977	flexible strategy	C0443220
28230977	protein conjugation	C1160466
28230977	extracellular	C0521119
28230977	self-assembly	C0872376
28234672	Vascular smooth muscle cell	C4082861
28234672	peroxisome proliferator-activated receptor γ	C0166417
28234672	endothelin-1	C0079281
28234672	induced	C0205263
28234672	oxidative stress	C0242606
28234672	inflammation	C0021368
28234672	Peroxisome proliferator-activated receptor γ	C0166417
28234672	PPARγ	C0166417
28234672	agonists	C0243192
28234672	reduce	C0392756
28234672	blood pressure	C0005823
28234672	vascular injury	C0178324
28234672	hypertensive	C0857121
28234672	rodents	C0035804
28234672	Pparγ	C0166417
28234672	inactivation	C0314679
28234672	vascular smooth muscle cells	C4082861
28234672	VSMC	C4082861
28234672	enhances	C2349975
28234672	vascular injury	C0178324
28234672	Transgenic mice	C0025936
28234672	overexpressing	C1171362
28234672	endothelin (ET)-1	C0079281
28234672	endothelium	C0014257
28234672	(eET-1)	C0079281
28234672	endothelial dysfunction	C0856169
28234672	increased	C0205217
28234672	oxidative stress	C0242606
28234672	inflammation	C0021368
28234672	hypothesized	C1512571
28234672	inactivation	C0314679
28234672	Pparγ gene	C1335238
28234672	VSMC	C4082861
28234672	smPparγ	C1335238
28234672	exaggerate	C0442801
28234672	ET-1	C0079281
28234672	induced	C0205263
28234672	vascular injury	C0178324
28234672	eET-1	C0079281
28234672	smPparγ	C0166417
28234672	eET-1	C0079281
28234672	smPparγ	C0166417
28234672	mice	C0025929
28234672	treated	C0332154
28234672	tamoxifen	C0039286
28234672	studied	C2603343
28234672	SBP	C0871470
28234672	higher	C0205250
28234672	eET-1	C0079281
28234672	unaffected	C2986417
28234672	smPparγ	C0166417
28234672	inactivation	C0314679
28234672	Mesenteric artery	C0025465
28234672	vasodilatory	C0042401
28234672	responses	C0871261
28234672	acetylcholine	C0001041
28234672	impaired	C0221099
28234672	smPparγ	C0166417
28234672	N-Nitro-L-arginine methyl ester	C0083536
28234672	abrogated	C3242341
28234672	relaxation	C0035028
28234672	responses	C0871261
28234672	Ednra	C1414262
28234672	Ednrb	C1414263
28234672	mRNA	C0035696
28234672	ratio	C0456603
28234672	decreased	C0205216
28234672	eET-1	C0079281
28234672	smPparγ	C0166417
28234672	indicate	C3146298
28234672	nitric oxide	C0028128
28234672	production	C1883254
28234672	enhanced	C2349975
28234672	ET-1	C0079281
28234672	stimulation	C0599177
28234672	endothelin type B receptors	C0218584
28234672	Mesenteric artery	C0025465
28234672	media	C1705217
28234672	lumen	C1301906
28234672	greater	C1704243
28234672	eET-1	C0079281
28234672	smPparγ	C0166417
28234672	Mesenteric artery	C0025465
28234672	reactive oxygen species	C0162772
28234672	increased	C0205217
28234672	smPparγ	C0166417
28234672	enhanced	C2349975
28234672	eET-1	C0079281
28234672	smPparγ	C0166417
28234672	Perivascular	C0442165
28234672	fat monocyte	C0206131
28234672	macrophage	C0024432
28234672	infiltration	C0332448
28234672	higher	C0205250
28234672	eET-1	C0079281
28234672	smPparγ	C0166417
28234672	increased	C0205217
28234672	eET-1	C0079281
28234672	smPparγ	C0166417
28234672	Spleen	C0037993
28234672	CD11b cells	C1983879
28234672	increased	C0205217
28234672	smPparγ	C0166417
28234672	enhance	C2349975
28234672	eET-1	C0079281
28234672	smPparγ	C0166417
28234672	Ly-6C monocytes	C0440752
28234672	increased	C0205217
28234672	eET-1	C0079281
28234672	smPparγ	C0166417
28234672	eET-1	C0079281
28234672	smPparγ	C0166417
28234672	Spleen	C0037993
28234672	T regulatory lymphocytes	C0039198
28234672	increased	C0205217
28234672	smPparγ	C0166417
28234672	decreased	C0205216
28234672	eET-1	C0079281
28234672	decreased	C0205216
28234672	eET-1	C0079281
28234672	smPparγ	C0166417
28234672	VSMC	C4082861
28234672	Pparγ	C0166417
28234672	inactivation	C0314679
28234672	exaggerates	C0442801
28234672	ET-1	C0079281
28234672	induced	C0205263
28234672	vascular injury	C0178324
28234672	role	C1705810
28234672	PPARγ	C0166417
28234672	hypertension	C0020538
28234672	modulation	C0443264
28234672	pro-oxidant	C0162772
28234672	proinflammatory	C0333348
28234672	pathways	C1704259
28234672	ET-1	C0079281
28234672	overexpression	C1171362
28234672	endothelial	C0014257
28234672	function	C0542341
28234672	smPparγ	C0166417
28234672	mice	C0025929
28234672	enhancing	C2349975
28234672	nitric oxide	C0028128
28234672	stimulation	C0599177
28234672	endothelin type B receptors	C0218584
28235120	Evaluation	C0220825
28235120	Opioid Consumption	C0240602
28235120	Distal Radius Fracture	C0435585
28235120	Repair Surgery	C0543467
28235120	Pain management	C0002766
28235120	opioid consumption	C0240602
28235120	distal radius fracture	C0435585
28235120	DRF	C0435585
28235120	open reduction and internal fixation (ORIF)	C0747060
28235120	optimize	C1273380
28235120	postoperative	C0032790
28235120	opioid	C0002772
28235120	dosage	C0178602
28235120	opioid consumption	C0240602
28235120	DRF	C0435585
28235120	ORIF	C0747060
28235120	prospective study	C0033522
28235120	hypothesis	C1512571
28235120	opioid consumption	C0240602
28235120	increase	C0442805
28235120	worsening	C0332271
28235120	fracture	C0016658
28235120	classification	C0008902
28235120	patient demographics	C1548106
28235120	patients	C0030705
28235120	DRF	C0435585
28235120	ORIF	C0747060
28235120	6-month period	C0439231
28235120	patient demographics	C1548106
28235120	fracture type	C0457357
28235120	anesthesia type	C1305863
28235120	amount	C0178602
28235120	type	C0332307
28235120	opioid	C0002772
28235120	prescribed	C0278329
28235120	number	C0237753
28235120	pills	C0002772
28235120	taken	C1883727
28235120	reason	C1550000
28235120	stopping	C0850893
28235120	adverse events	C0877248
28235120	Statistical analysis	C0871424
28235120	patients	C0030705
28235120	female	C0043210
28235120	male	C0025266
28235120	patients	C0030705
28235120	general anesthesia	C0002915
28235120	regional anesthesia	C1304876
28235120	peripheral nerve block	C0198807
28235120	opioid consumption	C0240602
28235120	morphine	C0026549
28235120	equivalence	C0205163
28235120	postoperative days	C0032790
28235120	no significant	C1273937
28235120	opioid consumption	C0240602
28235120	general	C0002915
28235120	regional anesthesia	C1304876
28235120	opioid consumption	C0240602
28235120	fracture-type	C0457357
28235120	AO/OTA [Arbeitsgemeinschaft für Osteosynthesefragen/Orthopaedic Trauma Association] classification	C0559822
28235120	class A	C0008902
28235120	class B	C0008902
28235120	class C	C0008902
28235120	Demographic analysis	C0011289
28235120	inverse	C0439850
28235120	relationship	C0439849
28235120	age	C0001779
28235120	opioid use	C0240602
28235120	opioid consumption	C0240602
28235120	self-pay	C3530213
28235120	Medicaid	C0025071
28235120	patients	C0030705
28235120	Opioid consumption	C0240602
28235120	DRF	C0435585
28235120	ORIF	C0747060
28235120	equivalent	C0205163
28235120	general	C0002915
28235120	regional anesthesia	C1304876
28235120	relationship	C0439849
28235120	increasing age	C3550265
28235120	decreasing	C0442797
28235120	opioid consumption	C0240602
28235120	Worsening	C0332271
28235120	fracture classification	C0559822
28235120	self-payment	C3530213
28235120	Medicaid payment	C0025071
28235120	increasing	C0442808
28235120	opioid consumption	C0240602
28235120	opioid consumption	C0240602
28235120	morphine	C0026549
28235120	equivalence	C0205163
28235120	pills	C0994475
28235120	oxycodone/acetaminophen	C0717368
28235120	Surgeons	C0582175
28235120	optimizing	C1273380
28235120	opioid	C0002772
28235120	DRF	C0435585
28235120	repair	C0543467
28236130	Entrapment	C0917811
28236130	posterior femoral cutaneous nerve	C0228931
28236130	inferior cluneal branches	C0229962
28236130	anatomical basis	C0277809
28236130	surgery	C1274039
28236130	inferior cluneal neuralgia	C0027796
28236130	pudendal nerve	C0228959
28236130	surgery	C1274039
28236130	patients	C0030705
28236130	entrapment	C0917811
28236130	adjacent nerve structures	C0027740
28236130	inferior cluneal neuralgia	C0027796
28236130	collateral branches	C0229962
28236130	posterior femoral cutaneous nerve	C0228931
28236130	posterior surface of the thigh	C0230422
28236130	infragluteal fold	C0229962
28236130	skin	C1123023
28236130	ischial tuberosity	C0223656
28236130	lateral anal region	C0005898
28236130	scrotum	C0036471
28236130	labium majus	C0227760
28236130	perineal branch	C0739940
28236130	pathophysiological	C0031847
28236130	features	C1521970
28236130	cluneal neuralgia	C0027796
28236130	surgical technique	C0011918
28236130	preliminary results	C1548161
28236130	transmuscular approach	C1997294
28236130	fat	C0015665
28236130	gluteal region	C0282082
28236130	Exploration	C1280903
28236130	piriformis	C0224429
28236130	entrapments	C0917811
28236130	posterior femoral cutaneous nerve	C0228931
28236130	sciatic nerve	C0036394
28236130	Nerve decompression	C0196571
28236130	lateral surface	C0230424
28236130	ischial tuberosity	C0223656
28236130	anatomical finding	C0277809
28236130	lateral fibrous	C0225331
28236130	expansion	C0196940
28236130	ischium	C0223653
28236130	nerves	C0027740
28236130	vessels	C0005847
28236130	posterior femoral cutaneous nerve	C0228931
28236130	perineal branches	C0739941
28236130	patients	C0030705
28236130	expansion	C0196940
28236130	decompression	C0196571
28236130	nerve trapped	C0917811
28236130	expansion	C0196940
28236130	Cluneal neuralgia	C0027796
28236130	perineal pain	C0240717
28236130	pudendal neuralgia	C1997249
28236130	Surgery	C1274039
28236130	transgluteal approach	C0444462
28236130	lateral ischial	C0223653
28236130	investigated	C1292732
28236130	fibrous	C0225331
28236130	expansion	C0196940
28236130	retinaculum	C0224996
28236130	nerve entrapment	C0917811
28237116	Methods	C0025663
28237116	Study	C2603343
28237116	Autophagy	C0004391
28237116	Zebrafish	C0043457
28237116	Autophagy	C0004391
28237116	cellular self-eating	C0004391
28237116	degradation process	C0314674
28237116	eukaryotic cell	C0015161
28237116	cytoplasm	C0010834
28237116	delivered	C1705822
28237116	broken down	C0443161
28237116	lysosomal compartment	C0521450
28237116	elimination	C0221102
28237116	cellular constituents	C0243092
28237116	macromolecular	C1148560
28237116	organellar turnover	C1254358
28237116	cellular homeostasis	C2244223
28237116	autophagy	C0004391
28237116	cellular	C1325880
28237116	developmental processes	C0678723
28237116	degrading	C0314674
28237116	regulatory proteins	C0815047
28237116	intracellular	C0178719
28237116	pathogens	C0450254
28237116	physiological roles	C0205463
28237116	pathological	C1521733
28237116	autophagy	C0004391
28237116	eukaryotic	C0684063
28237116	model systems	C0026339
28237116	yeast	C0043393
28237116	mice	C0026809
28237116	animal model	C0599779
28237116	autophagy	C0004391
28237116	zebrafish	C0043457
28237116	Danio rerio	C0043457
28237116	analysis	C0936012
28237116	biological processes	C3714634
28237116	tissue regeneration	C1623047
28237116	methods and tools	C0025664
28237116	autophagic structures	C0243092
28237116	assay	C0005507
28237116	autophagic responses	C0007613
28237116	vertebrate organism	C0042567
28237116	genetic (functional) approaches	C0017395
28237116	cellular	C1325880
28237116	developmental roles	C0678723
28237116	autophagic process	C0004391
28237961	Healthcare	C0086388
28237961	usage	C0457083
28237961	economic impact	C0681024
28237961	non-treated	C0332155
28237961	obesity	C0028754
28237961	Italy	C0022277
28237961	findings	C2607943
28237961	retrospective	C1514923
28237961	administrative	C3845829
28237961	clinical database	C1516642
28237961	analysis	C0936012
28237961	Investigate	C1292732
28237961	prevalence	C0683921
28237961	obesity	C0028754
28237961	Italy	C0022277
28237961	resource	C0035201
28237961	consumption	C0243095
28237961	economic impact	C0681024
28237961	Italian	C0022277
28237961	national healthcare system	C0282574
28237961	NHS	C0282574
28237961	Retrospective	C1514923
28237961	observational	C1518527
28237961	real-life study	C2603343
28237961	Data	C1511726
28237961	health units	C1708333
28237961	Northern	C1709269
28237961	Bergamo	C0017446
28237961	Lombardy	C0017446
28237961	Central	C0205099
28237961	Grosseto	C0017446
28237961	Tuscany	C0017446
28237961	Southern	C1710133
28237961	Naples	C0017446
28237961	Campania	C0017446
28237961	Italy	C0022277
28237961	patients	C0030705
28237961	aged	C0001779
28237961	≥18 years	C0439234
28237961	body mass index	C1305855
28237961	BMI	C1305855
28237961	measurement	C0242485
28237961	Information	C1533716
28237961	databases	C0242356
28237961	primary care data	C1511726
28237961	medical prescriptions	C1521941
28237961	specialist consultations	C2090905
28237961	hospital discharge records	C0743221
28237961	Costs	C0010186
28237961	associated with	C0332281
28237961	data	C1511726
28237961	calculated	C1441506
28237961	Data	C1511726
28237961	time periods	C1948053
28237961	1 year	C0439234
28237961	BMI	C1305855
28237961	measurement	C0242485
28237961	Primary	C0205225
28237961	estimate	C0750572
28237961	health resources	C0018741
28237961	consumption	C0243095
28237961	economic impact	C0681024
28237961	Italian	C0022277
28237961	NHS	C0282574
28237961	Secondary	C0205436
28237961	prevalence	C0683921
28237961	characteristics	C1521970
28237961	subjects	C0080105
28237961	BMI	C1305855
28237961	category	C0683312
28237961	adult	C0001675
28237961	subjects	C0080105
28237961	documented BMI	C2724372
28237961	measurement	C0242485
28237961	Subjects	C0080105
28237961	BMI	C1305855
28237961	obese	C0028754
28237961	prevalence	C0683921
28237961	obesity	C0028754
28237961	increased	C0205217
28237961	age	C0001779
28237961	1-year	C0439234
28237961	observation	C0302523
28237961	period	C1948053
28237961	obese	C0028754
28237961	subjects	C0080105
28237961	treatment	C0087111
28237961	obesity	C0028754
28237961	longer durations	C0449238
28237961	hospitalisation	C0019993
28237961	5 days	C0439228
28237961	3 days	C0439228
28237961	prescription drugs	C0304227
28237961	specialised	C1704211
28237961	outpatient	C0029921
28237961	healthcare	C0086388
28237961	mean number	C0392762
28237961	associated with	C0332281
28237961	greater costs	C0010186
28237961	prescription drugs	C0304227
28237961	hospital admissions	C0184666
28237961	mean annual cost	C0010186
28237961	year	C0439234
28237961	patient	C0030705
28237961	drug prescriptions	C0033081
28237961	hospitalisations	C0019993
28237961	outpatient care	C0002423
28237961	normal weight	C2712185
28237961	subjects	C0080105
28237961	findings	C2607943
28237961	period	C1948053
28237961	data	C1511726
28237961	follow-up	C1522577
28237961	Untreated	C0332155
28237961	obesity	C0028754
28237961	economic impact	C0681024
28237961	Italian	C0022277
28237961	healthcare system	C0282574
28237961	awareness	C0004448
28237961	treat	C0087111
28237961	subjects	C0080105
28239032	Effects of	C1704420
28239032	heat	C0018837
28239032	treatment	C1522326
28239032	conformation	C0033625
28239032	cell growth	C0007595
28239032	alpha- lactalbumin	C0002287
28239032	beta-lactoglobulin	C0005248
28239032	market	C1318228
28239032	milk	C2825079
28239032	Heat	C0018837
28239032	processes	C1522240
28239032	low	C0205251
28239032	temperature	C0039476
28239032	long	C0205166
28239032	time	C0040223
28239032	LTLT	C3825956
28239032	pasteurization	C3825956
28239032	ultra-heat treatment (UHT) sterilization	C3179136
28239032	market	C1318228
28239032	milk	C2825079
28239032	shelf life	C4279909
28239032	raw milk	C1442323
28239032	milk	C2825079
28239032	microbial	C0599840
28239032	safety	C0036043
28239032	effects of	C1704420
28239032	heat	C0018837
28239032	molecular	C1521991
28239032	properties	C0871161
28239032	α-lactalbumin	C0002287
28239032	α-LA	C0002287
28239032	β-lactoglobulin	C0005248
28239032	β-LG	C0005248
28239032	market	C1318228
28239032	milk	C2825079
28239032	LTLT-A	C3825956
28239032	LTLT-B	C3825956
28239032	UHT-I	C3179136
28239032	indirect	C0439852
28239032	heating	C0018837
28239032	UHT-D	C3179136
28239032	direct	C1947931
28239032	heating	C0018837
28239032	molecular conformations	C0026377
28239032	circular dichroism spectrum measurement	C0008813
28239032	cell growth	C0007595
28239032	WST-1 method	C2986858
28239032	proteins	C0033684
28239032	α-LA	C0002287
28239032	market	C1318228
28239032	milk	C2825079
28239032	no significant	C1273937
28239032	structural	C1510464
28239032	difference	C1705242
28239032	raw milk	C1442323
28239032	α-LA	C0002287
28239032	α-LA	C0002287
28239032	UHT-I	C3179136
28239032	inhibited	C0311403
28239032	cell growth	C0007595
28239032	intestinal	C0021853
28239032	epithelial cell line	C0014597
28239032	raw milk	C1442323
28239032	α-LA	C0002287
28239032	β-LG	C0005248
28239032	UHT-I	C3179136
28239032	change	C0392747
28239032	structure	C1510464
28239032	did not exhibit	C1513916
28239032	cytotoxicity	C0596402
28239032	cell viability	C0007620
28239032	effects of	C1704420
28239032	α-LA	C0002287
28239032	β-LG	C0005248
28239032	UHT	C3179136
28239032	indirect	C0439852
28239032	direct	C1947931
28239032	findings	C0243095
28239032	effect of	C1704420
28239032	heat	C0018837
28239032	treatment	C1522326
28239032	whey proteins	C0078479
28239032	investigated	C1292732
28240640	Comparison	C1707455
28240640	270	C0977876
28240640	320 mg I/mL of Iodixanol	C0977877
28240640	Image Assessment	C4076410
28240640	Renal Arteries	C0035065
28240640	Veins	C0042449
28240640	Dual-Energy Spectral CT Imaging	C0729619
28240640	Late Arterial Phase	C0205390
28240640	Influence	C4054723
28240640	Renal Function	C0232804
28240640	study	C2603343
28240640	compare	C1707455
28240640	image quality	C0806487
28240640	renal arteries	C0035065
28240640	veins	C0042449
28240640	dual-energy spectral computed tomography (CT) imaging	C0729619
28240640	late arterial phase	C0205390
28240640	270	C0977876
28240640	320 mg I/mL of iodixanol	C0977877
28240640	influence	C4054723
28240640	renal function	C0232804
28240640	patients	C0030705
28240640	renal CT angiography	C1637292
28240640	270	C0977876
28240640	320 mg I/mL of iodixanol	C0977877
28240640	dual-energy spectral CT imaging	C0729619
28240640	late arterial phase	C0205390
28240640	Image quality	C0806487
28240640	influence	C4054723
28240640	renal function	C0232804
28240640	compared	C1707455
28240640	CT value	C1522609
28240640	signal-to-noise ratio	C2986823
28240640	contrast-to-noise ratio	C0456603
28240640	score	C0449820
28240640	renal vessels	C0580863
28240640	incidence	C0021149
28240640	contrast-induced nephropathy	C4055183
28240640	patients	C0030705
28240640	abnormal renal function	C0151746
28240640	320 mg I/mL of iodixanol	C0977877
28240640	270 mg I/mL of iodixanol	C0977876
28240640	renal arteries	C0035065
28240640	veins	C0042449
28240640	late arterial phase	C0205390
28240640	270 mg I/mL of iodixanol	C0977876
28240640	dual-energy spectral CT scan	C0177779
28240640	renal function	C0232804
28241991	magnesium supplementation	C1096534
28241991	depression	C0011570
28241991	status	C0449437
28241991	depressed	C0011570
28241991	patients	C0030705
28241991	magnesium deficiency	C0024473
28241991	randomized	C0034656
28241991	double-blind	C0013072
28241991	placebo-controlled trial	C1706408
28241991	effect	C0728866
28241991	magnesium supplementation	C1096534
28241991	depression	C0011570
28241991	status	C0449437
28241991	depressed	C0011570
28241991	patients	C0030705
28241991	suffering	C0231303
28241991	magnesium deficiency	C0024473
28241991	Sixty depressed people	C0243095
28241991	suffering	C0231303
28241991	hypomagnesemia	C0151723
28241991	this trial	C0008976
28241991	individuals	C0237401
28241991	randomly categorized	C0034656
28241991	groups	C0441833
28241991	tablets of magnesium oxide	C0024477
28241991	MG	C0024477
28241991	placebo	C1696465
28241991	PG	C1696465
28241991	Beck Depression Inventory-II	C4273959
28241991	serum magnesium was measured	C0202125
28241991	MG	C0024477
28241991	PG	C1696465
28241991	normal level of magnesium	C1442943
28241991	changes of serum magnesium	C1826990
28241991	groups	C0441833
28241991	mean Beck score	C2960571
28241991	significantly declined	C4055638
28241991	MG	C0024477
28241991	more significant	C1299395
28241991	PG	C1696465
28241991	group	C0441833
28241991	PG	C1696465
28241991	Daily consumption	C0678263
28241991	magnesium oxide tablets	C0024477
28241991	depressed	C0011570
28241991	patients	C0030705
28241991	suffering	C0231303
28241991	magnesium deficiency	C0024473
28241991	depression	C0011570
28241991	status	C0449437
28241991	magnesium levels	C1442943
28241991	assessment of the magnesium serum	C0202125
28241991	deficiency	C0024473
28241991	treatment	C0087111
28241991	depressed	C0011570
28241991	patients	C0030705
28243780	influence	C4054723
28243780	cognitive load	C0870301
28243780	metabolic	C0025519
28243780	cost	C0015316
28243780	transport	C1554194
28243780	overground walking	C0080331
28243780	healthy	C3898900
28243780	young adults	C0238598
28243780	cognitive processing	C0025361
28243780	walking	C0080331
28243780	increases	C0442805
28243780	metabolic	C0025519
28243780	cost	C0015316
28243780	transport	C1554194
28243780	healthy	C3898900
28243780	young adults	C0238598
28243780	healthy	C3898900
28243780	young adults	C0238598
28243780	conditions	C0348080
28243780	walking	C0080331
28243780	self	C0036588
28243780	selected	C1707391
28243780	speed	C0678536
28243780	spontaneous	C0205359
28243780	single-task	C0441655
28243780	seated	C4042775
28243780	resting	C0035253
28243780	baseline	C1442488
28243780	cognitive	C0009240
28243780	task	C0441655
28243780	seated	C4042775
28243780	cognitive	C0009240
28243780	single-task	C0441655
28243780	walking	C0080331
28243780	simultaneously	C0521115
28243780	performing	C0884358
28243780	cognitive	C0009240
28243780	task	C0441655
28243780	dual-task	C0441655
28243780	single-task	C0441655
28243780	walking	C0080331
28243780	speed	C0678536
28243780	matched	C1708943
28243780	participant's	C0679646
28243780	dual-task	C0441655
28243780	gait speed	C2009910
28243780	matched	C1708943
28243780	single-task	C0441655
28243780	Rate of oxygen consumption	C1521828
28243780	V̇O2	C1521828
28243780	conditions	C0348080
28243780	Gait speed	C2009910
28243780	cost	C0015316
28243780	walking	C0080331
28243780	Cw	C0015316
28243780	oxygen consumed per distance traveled	C0030055
28243780	walking	C0080331
28243780	conditions	C0348080
28243780	Reaction time	C0034746
28243780	accuracy	C0443131
28243780	responses	C0871261
28243780	cognitive	C0009240
28243780	task	C0441655
28243780	cognitive	C0009240
28243780	task	C0441655
28243780	conditions	C0348080
28243780	Data	C1511726
28243780	minute	C0439232
28243780	min	C0439232
28243780	condition	C0348080
28243780	analyzed	C0936012
28243780	V̇O2	C1521828
28243780	dual-task	C0441655
28243780	matched	C1708943
28243780	single-task	C0441655
28243780	walking	C0080331
28243780	conditions	C0348080
28243780	V̇O2	C1521828
28243780	seated	C4042775
28243780	cognitive	C0009240
28243780	condition	C0348080
28243780	walking	C0080331
28243780	conditions	C0348080
28243780	Cw	C0015316
28243780	matched	C1708943
28243780	single-task	C0441655
28243780	walking	C0080331
28243780	condition	C0348080
28243780	dual-task	C0441655
28243780	walking	C0080331
28243780	condition	C0348080
28243780	Cw	C0015316
28243780	clinically	C0205210
28243780	significant	C0750502
28243780	Cognitive processing	C0025361
28243780	walking	C0080331
28243780	increase	C0442805
28243780	energy	C1442080
28243780	walking	C0080331
28243780	healthy	C3898900
28243780	young adults	C0238598
28243780	gait speed	C2009910
28243780	matched	C1708943
28243780	speed	C0678536
28243780	min	C0439232
28243780	attentional	C0004268
28243780	resources	C0035201
28243780	increase	C0442805
28243780	metabolic	C0025519
28243780	costs	C0015316
28243780	walking	C0080331
28243780	habitual	C0205353
28243780	speed	C0678536
28245193	Problem-based learning	C0243013
28245193	patient	C0030705
28245193	patient -simulated videos	C3463807
28245193	daily	C0332173
28245193	life	C0376558
28245193	comprehensive	C1880156
28245193	clinical	C0205210
28245193	approach	C0205245
28245193	problem-based learning	C0243013
28245193	tutorials	C0282574
28245193	patient	C0030705
28245193	patient -simulated videos	C3463807
28245193	daily	C0332173
28245193	life	C0376558
28245193	clinical	C0205210
28245193	learning	C0023185
28245193	paper-based problem-based learning	C0243013
28245193	rate of psychosocial issues	C0243095
28245193	recall rate	C0243095
28245193	experienced learning	C0023185
28245193	groups	C0441833
28245193	year	C0439234
28245193	students	C0038492
28245193	paper-based problem-based learning	C0243013
28245193	video	C3463807
28245193	video -based problem-based learning	C0243013
28245193	patient	C0030705
28245193	patient -simulated videos	C3463807
28245193	target	C1521840
28245193	achievement rates	C0243095
28245193	questionnaires	C0034394
28245193	Wilcoxon signed-rank test	C0871608
28245193	discussion	C2584313
28245193	contents	C0456205
28245193	diversity	C1880371
28245193	Mann-Whitney U test	C0242927
28245193	follow-up	C0016441
28245193	survey	C0038951
28245193	chi-square test	C0008041
28245193	students	C0038492
28245193	categories	C0683312
28245193	video	C3463807
28245193	paper	C0030351
28245193	non-experienced	C1254370
28245193	Video	C3463807
28245193	Video -based problem-based learning	C0243013
28245193	achievement rates	C0243095
28245193	authentic patients	C0030705
28245193	comprehensive	C1880156
28245193	approach	C0205245
28245193	psychosocial aspects	C0243156
28245193	sessions	C1883017
28245193	No significant differences	C3842396
28245193	discussion	C2584313
28245193	contents	C0456205
28245193	diversity	C1880371
28245193	International Classification of Primary Care Second Edition codes and chapter types	C3242518
28245193	rate of psychological codes	C0243095
28245193	follow-up	C0016441
28245193	survey	C0038951
28245193	video	C3463807
28245193	paper	C0030351
28245193	groups	C0441833
28245193	non-experienced groups	C0441833
28245193	rates	C1521828
28245193	video	C3463807
28245193	paper	C0030351
28245193	video	C3463807
28245193	rate	C1521828
28245193	paper	C0030351
28245193	rate	C1521828
28245193	no significant difference	C3842396
28245193	Patient	C0030705
28245193	Patient -simulated videos	C3463807
28245193	daily	C0332173
28245193	life	C0376558
28245193	patients	C0030705
28245193	comprehensive	C1880156
28245193	approach	C0205245
28245193	fosters	C0242298
28245193	memory	C0025260
28245193	clinical	C0205210
28245193	patient	C0030705
28245193	patient -simulated video	C3463807
28245193	method	C0449851
28245193	clinical	C0205210
28245193	problem-based tutorials	C0282574
28245193	patient	C0030705
28245193	patient -simulated videos	C3463807
28245193	symptom	C1457887
28245193	teaching materials	C0039402
28246934	Forensic characteristics	C0681831
28246934	phylogenetic analyses	C1519068
28246934	Chinese	C0152035
28246934	Yi population	C1257890
28246934	X-chromosomal	C0043292
28246934	STR	C0598994
28246934	loci	C0678933
28246934	demographic characteristics	C0683970
28246934	genetic polymorphism	C0032529
28246934	data	C1511726
28246934	Chinese	C0152035
28246934	nationalities	C0027473
28246934	administrative divisions	C2919030
28246934	Chinese mainland	C0008115
28246934	genetic research	C0243064
28246934	hotspots	C0205146
28246934	genetic studies	C2827447
28246934	Chinese	C0152035
28246934	populations	C1257890
28246934	autosomal	C0596142
28246934	Y-chromosomal	C0043381
28246934	genetic markers	C0017393
28246934	forensic characteristics	C0681831
28246934	phylogenetic analyses	C1519068
28246934	Chinese	C0152035
28246934	population	C1257890
28246934	Yi ethnicity	C0015031
28246934	X-chromosomal	C0043292
28246934	genetic markers	C0017393
28246934	allele frequencies	C0017270
28246934	forensic statistical parameters	C0449381
28246934	X-chromosomal	C0043292
28246934	short tandem repeat	C0598994
28246934	loci	C0678933
28246934	DXS7424-DXS101	C0678933
28246934	DXS6789-DXS6809	C0678933
28246934	DXS7423-DXS10134	C0678933
28246934	DXS10103-HPRTB-DXS10101	C0678933
28246934	DXS10159-DXS10162-DXS10164	C0678933
28246934	DXS10148-DXS10135-DXS8378	C0678933
28246934	DXS7132-DXS10079-DXS10074-DXS10075	C0678933
28246934	Chinese	C0152035
28246934	Yi individuals	C0237401
28246934	X-chromosomal	C0043292
28246934	short tandem repeat	C0598994
28246934	STR	C0598994
28246934	loci	C0678933
28246934	females	C0043210
28246934	alleles	C0002085
28246934	identified	C0205396
28246934	allele frequencies	C0017270
28246934	PE	C0392762
28246934	PDF	C0392762
28246934	PDM	C0392762
28246934	MECKrüger	C0392762
28246934	MECKishida	C0392762
28246934	MECDesmarais	C0392762
28246934	MECDesmarais Duo	C0392762
28246934	findings	C0243095
28246934	panel	C0441833
28246934	X-STR	C0598994
28246934	loci	C0678933
28246934	polymorphic	C1882417
28246934	informative	C2986490
28246934	Yi ethnic population	C0015031
28246934	tool	C0336791
28246934	forensic complex kinship identification	C0870773
28246934	Population differentiation analyses	C0242481
28246934	populations	C1257890
28246934	differences	C1705242
28246934	genetic structure	C1136352
28246934	Yi ethnicity	C0015031
28246934	Chinese	C0152035
28246934	Uyghur	C1257890
28246934	Kazakh	C1257890
28246934	genetic homogeneity	C1881065
28246934	ethno-origin	C0015031
28246934	geographic origin populations	C0032659
28249160	Loss	C1517945
28249160	Snf5	C0812273
28249160	Induces	C0205263
28249160	Formation	C1522492
28249160	Aberrant	C0443127
28249160	SWI/SNF Complex	C1167093
28249160	SWI/SNF	C1167093
28249160	chromatin remodeling complex	C1167087
28249160	yeast	C0043393
28249160	human	C0086418
28249160	aberrant	C0443127
28249160	SWI/SNF complexes	C1167093
28249160	human	C0086418
28249160	disease	C0012634
28249160	Snf5/SMARCB1/INI1	C0812273
28249160	subunit	C1711351
28249160	SWI/SNF	C1167093
28249160	tumor suppressor	C0079427
28249160	lost	C0745777
28249160	pediatric	C1521725
28249160	rhabdoid cancers	C0206743
28249160	effects of	C1704420
28249160	Snf5	C0812273
28249160	loss	C1517945
28249160	composition	C0243095
28249160	nucleosome binding	C1623159
28249160	yeast	C0043393
28249160	SWI/SNF	C1167093
28249160	Snf5	C0812273
28249160	subunit	C1711351
28249160	crosslinking-mass spectrometry	C0037813
28249160	CX-MS	C0037813
28249160	subunit	C1711351
28249160	deletion analysis	C1294202
28249160	ATPase domain	C1510701
28249160	Snf2	C0246454
28249160	submodule	C1959595
28249160	Snf5	C0812273
28249160	Swp82	C0017337
28249160	Taf14	C0017337
28249160	Snf5	C0812273
28249160	binding	C1623159
28249160	Snf2	C0246454
28249160	ATPase domain	C1510701
28249160	nucleosomal DNA	C1623161
28249160	SWI/SNF	C1167093
28249160	Snf5	C0812273
28249160	SWI/SNF	C1167093
28249160	acidic transcription factors	C0040648
28249160	RNA-seq analysis	C0162803
28249160	Snf5	C0812273
28249160	in vivo	C1515655
28249160	SWI/SNF	C1167093
28249160	regulation of gene expression	C0017263
28249160	loss	C1517945
28249160	SNF5	C0812273
28249160	structure	C0678594
28249160	function	C0542341
28249160	SWI/SNF	C1167093
28249785	presence	C0150312
28249785	Parkinson's disease	C0030567
28249785	low-frequency	C0205213
28249785	fluctuations	C0231239
28249785	BOLD signals	C1705491
28249785	Parkinson's disease	C0030567
28249785	PD	C0030567
28249785	chronic	C0205191
28249785	progressive	C0205329
28249785	degenerative	C1880269
28249785	neurological disorder	C0027765
28249785	characterized	C1880022
28249785	degeneration	C1880269
28249785	dopamine neurons	C1512035
28249785	substantia nigra	C0038590
28249785	formation	C1522492
28249785	intracellular	C0178719
28249785	Lewy inclusion bodies	C0085200
28249785	Resting-state functional magnetic resonance imaging	C4288291
28249785	RS-fMRI	C4288291
28249785	evidence	C3887511
28249785	metabolic	C0311400
28249785	patterns	C0449774
28249785	individuals	C0237401
28249785	PD	C0030567
28249785	purpose	C1285529
28249785	study	C2603343
28249785	presence	C0150312
28249785	PD	C0030567
28249785	predicted	C0681842
28249785	fluctuations	C0231239
28249785	blood oxygenation level dependent signal	C1655730
28249785	RS-fMRI	C4288291
28249785	amplitude	C2346753
28249785	low-frequency	C0205213
28249785	fluctuation	C0231239
28249785	ALFF	C0231239
28249785	ALFF	C0231239
28249785	fALFF	C0231239
28249785	patients	C0030705
28249785	PD	C0030567
28249785	age	C0001779
28249785	sex	C1522384
28249785	healthy controls	C2986479
28249785	healthy controls	C2986479
28249785	individuals	C0237401
28249785	PD	C0030567
28249785	ALFFs	C0231239
28249785	bilateral	C0238767
28249785	lingual gyrus	C0152308
28249785	left putamen	C2334169
28249785	fALFF	C0231239
28249785	right cerebellum posterior lobe	C2953249
28249785	Support vector machines	C2699740
28249785	SVMs	C2699740
28249785	pattern recognition	C1518918
28249785	method	C0025663
28249785	predictions	C0681842
28249785	individual	C0237401
28249785	level	C0441889
28249785	individuals	C0237401
28249785	PD	C0030567
28249785	healthy controls	C2986479
28249785	ALFF	C0231239
28249785	fALFF	C0231239
28249785	cross-validation method	C0681935
28249785	analyze	C0936012
28249785	sample	C0370003
28249785	participants	C0679646
28249785	PD	C0030567
28249785	controls	C0009932
28249785	sensitivity	C2349185
28249785	specificity	C0037791
28249785	findings	C2607943
28249785	SVM	C2699740
28249785	neuroimaging	C0679575
28249785	clinical	C0205210
28249785	PD	C0030567
28249785	individual	C0237401
28249785	level	C0441889
28249785	RS-fMRI	C4288291
28249785	development	C1527148
28249785	biomarker	C0005516
28249785	evaluation	C0220825
28249785	PD	C0030567
28250235	Methylation	C0376452
28250235	dynamics	C3826426
28250235	folliculogenesis	C1160267
28250235	early	C1279919
28250235	embryo development	C0013936
28250235	sheep	C0036945
28250235	Genome	C0017428
28250235	DNA methylation	C0376452
28250235	mammalian	C0024660
28250235	gametogenesis	C0017001
28250235	early	C1279919
28250235	embryogenesis	C0013936
28250235	Post	C0687676
28250235	fertilization	C0015914
28250235	demethylation	C2755352
28250235	paternal	C0337493
28250235	maternal	C1858460
28250235	genomes	C0017428
28250235	mammals	C0024660
28250235	sheep	C0036945
28250235	methylation	C0025723
28250235	pronucleus	C1167158
28250235	Post	C0687676
28250235	fertilization	C0015914
28250235	methylating	C0014442
28250235	demethylating enzymes	C0014442
28250235	oocyte growth	C1155900
28250235	re-methylation	C0376452
28250235	oocyte	C0029045
28250235	oocyte	C0029045
28250235	reproduction technologies	C0035157
28250235	environmental changes	C4060636
28250235	methylation	C0025723
28250235	dynamics	C3826426
28250235	folliculogenesis	C1160267
28250235	early	C1279919
28250235	embryo development	C0013936
28250235	sheep	C0036945
28250235	DNA methylation	C0376452
28250235	hydroxymethylation	C3830412
28250235	immunofluorescence	C0016318
28250235	expression	C1171362
28250235	enzymes	C0014442
28250235	DNA methyltransferases	C0012873
28250235	DNMTs	C0012873
28250235	ten-eleven translocation (TET) proteins	C0033684
28250235	methyl-CpG-binding domain	C4277657
28250235	MBD	C4277657
28250235	proteins	C0033684
28250235	hydroxymethylation	C3830412
28250235	oocyte growth	C1155900
28250235	methylation	C0376452
28250235	hydroxymethylation	C3830412
28250235	parental pronuclei	C1167158
28250235	male pronucleus	C1622926
28250235	demethylation	C2755352
28250235	sheep	C0036945
28250235	gene	C0017337
28250235	dynamics	C3826426
28250235	methylating	C0014442
28250235	demethylating enzymes	C0014442
28250235	oocyte growth	C1155900
28250235	expression	C1171362
28250235	developmental	C0458003
28250235	competence	C0086035
28250235	oocyte	C0029045
28250235	methylation	C0025723
28250235	dynamics	C3826426
28250235	folliculogenesis	C1160267
28250235	early	C1279919
28250235	embryo development	C0013936
28250235	early	C1279919
28250235	embryo	C0013935
28250235	epigenome	C0017428
28250430	Network	C1882071
28250430	analysis	C0936012
28250430	reveals	C0443289
28250430	Xylella fastidiosa	C0995982
28250430	Europe	C0015176
28250430	insect vector	C0021573
28250430	bacterium	C0004611
28250430	Xylella fastidiosa	C0995982
28250430	olive trees	C0996956
28250430	Southern Italy	C0022277
28250430	olive quick decline syndrome	C0012634
28250430	disease	C0012634
28250430	Italy's	C0022277
28250430	olive oil	C0069449
28250430	region	C0017446
28250430	epidemiology	C0002783
28250430	outbreak	C0012652
28250430	X. fastidiosa	C0995982
28250430	hosts	C1167395
28250430	vectors	C0021573
28250430	Europe	C0015176
28250430	humans	C0086418
28250430	dispersal	C0332261
28250430	unknown	C0439673
28250430	knowledge	C0376554
28250430	gaps	C3887622
28250430	management strategies	C1273870
28250430	vector control	C0031249
28250430	areas	C0681784
28250430	destruction	C1948029
28250430	infected plants	C0032098
28250430	healthy	C3898900
28250430	eradicate	C1883720
28250430	halt	C2746065
28250430	spreading	C0332261
28250430	pest	C0032064
28250430	epidemiological	C0014508
28250430	uncertainties	C0087130
28250430	olive	C0996956
28250430	olive orchards	C0681784
28250430	Southern Italy	C0022277
28250430	eradicating	C1883720
28250430	X. fastidiosa	C0995982
28250430	region	C0017446
28250430	results	C1274040
28250430	Southern Italy	C0022277
28250430	reservoir	C0442537
28250430	X. fastidiosa	C0995982
28250430	management strategies	C1273870
28250430	prevalence	C0220900
28250430	X. fastidiosa	C0995982
28250430	region	C0017446
28250430	vector control	C0031249
28250430	lest	C1292733
28250430	pathogen	C0450254
28250430	southern France	C0016674
28250430	island of Mallorca	C0454825
28250430	Spain	C0037747
28250430	spreading	C0332261
28250430	Italy	C0022277
28250430	Europe	C0015176
28251086	biomarkers	C0005516
28251086	patients	C0030705
28251086	idiopathic	C0332240
28251086	acute anterior uveitis	C0701807
28251086	neutrophil	C0027950
28251086	lymphocyte	C0024264
28251086	ratio	C0456603
28251086	platelet	C0005821
28251086	lymphocyte	C0024264
28251086	ratio	C0456603
28251086	assess	C1516048
28251086	levels	C0441889
28251086	neutrophil	C0027950
28251086	lymphocyte	C0024264
28251086	ratio	C0456603
28251086	N	C0027950
28251086	L	C0024264
28251086	platelet	C0005821
28251086	lymphocyte	C0024264
28251086	ratio	C0456603
28251086	P	C0005821
28251086	L	C0024264
28251086	patients	C0030705
28251086	idiopathic	C0332240
28251086	acute anterior uveitis	C0701807
28251086	AAU	C0701807
28251086	compare	C1707455
28251086	healthy controls	C2986479
28251086	male	C0025266
28251086	patients	C0030705
28251086	idiopathic	C0332240
28251086	AAU	C0701807
28251086	male	C0025266
28251086	healthy	C3898900
28251086	subjects	C2349001
28251086	retrospective study	C0035363
28251086	Complete	C0205197
28251086	ophthalmological examination	C0200149
28251086	blood count measurements	C1879889
28251086	results	C0683954
28251086	subjects	C2349001
28251086	evaluated	C0220825
28251086	significant	C0750502
28251086	N	C0027950
28251086	L	C0024264
28251086	P	C0005821
28251086	L	C0024264
28251086	idiopathic	C0332240
28251086	AAU	C0701807
28251086	control groups	C0009932
28251086	correlation analysis	C0010101
28251086	significant	C0750502
28251086	correlation	C1707520
28251086	C-reactive protein	C0006560
28251086	CRP	C0006560
28251086	N	C0027950
28251086	L	C0024264
28251086	study	C0008972
28251086	evidence of	C0332120
28251086	N	C0027950
28251086	L	C0024264
28251086	P	C0005821
28251086	L	C0024264
28251086	useful	C3827682
28251086	biomarkers	C0005516
28251086	patients	C0030705
28251086	idiopathic	C0332240
28251086	AAU	C0701807
28251086	N	C0027950
28251086	L	C0024264
28251086	correlated	C1707520
28251086	CRP	C0006560
28251086	useful	C3827682
28251086	biomarker	C0005516
28251086	prognosis	C0033325
28251086	idiopathic	C0332240
28251086	AAU	C0701807
28251780	Comparison	C1707455
28251780	magnetic resonance imaging	C0024485
28251780	B-mode ultrasound	C1302166
28251780	detecting	C0442726
28251780	estimating	C0750572
28251780	extent	C0439792
28251780	human	C0086418
28251780	carotid atherosclerosis	C0577631
28251780	MRI studies	C3515983
28251780	carotid plaques	C0751633
28251780	ultrasound	C1302166
28251780	find	C0243095
28251780	plaques	C0332461
28251780	imaged	C1704254
28251780	MRI	C0024485
28251780	performance	C1882330
28251780	plaque	C0332461
28251780	detection	C0442726
28251780	compared	C1707455
28251780	modalities	C1275506
28251780	study	C2603343
28251780	compare	C1707455
28251780	performance	C1882330
28251780	MRI	C0024485
28251780	ultrasound	C1302166
28251780	detecting	C0442726
28251780	carotid artery plaques	C0751633
28251780	measuring	C0444706
28251780	extent	C0439792
28251780	atherosclerosis	C0004153
28251780	Subjects	C0681850
28251780	plaque	C0332461
28251780	height	C0392762
28251780	ultrasound	C1302166
28251780	imaged	C1704254
28251780	MRI	C0024485
28251780	number	C0237753
28251780	plaques	C0332461
28251780	height	C0392762
28251780	measured	C0444706
28251780	modalities	C1275506
28251780	plaque	C0332461
28251780	area	C0205146
28251780	volume	C0449468
28251780	analysed	C0936012
28251780	ultrasound	C1302166
28251780	MRI	C0024485
28251780	Thirty-eight	C0392762
28251780	subjects	C0681850
28251780	included	C0332257
28251780	MRI	C0024485
28251780	detected	C0442726
28251780	plaques	C0332461
28251780	carotid arteries	C0007272
28251780	plaque	C0332461
28251780	height	C0392762
28251780	ultrasound	C1302166
28251780	carotid arteries	C0007272
28251780	plaque	C0332461
28251780	MRI	C0024485
28251780	detected	C0442726
28251780	plaques	C0332461
28251780	height	C0392762
28251780	plaque	C0332461
28251780	height	C0392762
28251780	measured	C0444706
28251780	techniques	C0449851
28251780	correlated	C1707520
28251780	Ultrasound	C1302166
28251780	plaque	C0332461
28251780	height	C0392762
28251780	plaque	C0332461
28251780	area	C0205146
28251780	correlated	C1707520
28251780	similarly	C2348205
28251780	MRI	C0024485
28251780	plaque	C0332461
28251780	volume	C0449468
28251780	MRI	C0024485
28251780	similar	C2348205
28251780	sensitivity	C1511883
28251780	ultrasound	C1302166
28251780	finding	C0243095
28251780	carotid artery plaques	C0751633
28251780	higher	C0205250
28251780	smaller	C0547044
28251780	plaques	C0332461
28251780	MRI	C0024485
28251780	detects	C0442726
28251780	fewer	C0205388
28251780	plaques	C0332461
28251780	Multiple carotid plaques	C0751633
28251780	ultrasound	C1302166
28251780	anatomy	C1384516
28251780	single plaque	C0332461
28251780	Plaque	C0332461
28251780	height	C0392762
28251780	ultrasound	C1302166
28251780	plaque	C0332461
28251780	height	C0392762
28251780	MRI	C0024485
28251780	correlates	C1707520
28251780	plaque	C0332461
28251780	volume	C0449468
28251780	MRI	C0024485
28251780	plaque	C0332461
28251780	burden	C2828008
28252933	Open-Cell Scaffolds	C0243092
28252933	Sea Urchin	C0036488
28252933	Spines	C0005479
28252933	Material	C0520510
28252933	Properties	C0871161
28252933	Bone Defect Repair	C0185364
28252933	Sea urchin	C0036488
28252933	spines	C0005479
28252933	Heterocentrotus mammillatus	C1003462
28252933	open-cell structure	C0243092
28252933	human	C0086418
28252933	trabecular bone	C0222660
28252933	mechanical property	C0871161
28252933	compressive strength	C0376507
28252933	suitable	C3900053
28252933	machining	C0441655
28252933	shape	C0348078
28252933	potential	C3245505
28252933	applications	C0205245
28252933	bone defect repair	C0185364
28252933	Finite element analyses	C0600552
28252933	stress	C0038435
28252933	concentrates	C2003864
28252933	dense	C0439794
28252933	growth rings	C0971859
28252933	dissipates	C0439742
28252933	structures of the stereoms	C0700276
28252933	mesostructures	C0678594
28252933	important	C3898777
28252933	strength	C0205556
28252933	weight	C0043100
28252933	ratios	C0456603
28252933	fracture	C0016658
28252933	strength	C0205556
28252933	magnesium	C0024467
28252933	substituted tricalcium phosphate	C0106141
28252933	(β-TCMP) scaffolds	C0005479
28252933	hydrothermal	C1254366
28252933	conversion	C0439836
28252933	urchin	C0036488
28252933	spines	C0005479
28252933	comparable	C1707455
28252933	human	C0086418
28252933	trabecular bone	C0222660
28252933	bone	C0262950
28252933	forms	C1522492
28252933	surfaces	C0205148
28252933	β-TCMP scaffolds	C0005479
28252933	implantation	C0021107
28252933	rabbit	C3887509
28252933	femoral defects	C0015802
28252933	month	C0439231
28252933	grows	C0971859
28252933	open-cell spaces	C1179886
28252933	postoperation	C1882428
28252933	month	C0439231
28252933	tight interface	C0920352
28252933	scaffold	C0005479
28252933	regenerative bone tissue	C0005972
28252933	Fusion	C1293131
28252933	beagle	C0324306
28252933	lumbar facet joints	C0507372
28252933	Ti-6Al-4V cage	C0076732
28252933	β-TCMP scaffold	C0005479
28252933	completed	C0205197
28252933	months	C0439231
28252933	biodegradation	C0005482
28252933	β-TCMP scaffold	C0005479
28252933	completely	C0205197
28252933	degraded	C0005482
28252933	replaced by	C1299987
28252933	formed	C0205431
28252933	bone	C0262950
28252933	months	C0439231
28252933	implantation	C0021107
28252933	sea urchin	C0036488
28252933	spines	C0005479
28252933	machining	C0441655
28252933	shape	C0348078
28252933	biodegradable	C0005482
28252933	artificial grafts	C0440261
28252933	bone defect repair	C0185364
28254544	Melatonin	C0025219
28254544	nitric oxide	C0028128
28254544	regulate	C3269637
28254544	sunflower	C0947381
28254544	seedling growth	C3156975
28254544	salt stress	C1154956
28254544	expression	C1171362
28254544	Cu/Zn SOD	C0010461
28254544	Mn SOD	C0024708
28254544	Salinity results	C1154956
28254544	significant reduction	C0392756
28254544	sunflower	C0947381
28254544	Helianthus annuus L.	C0947381
28254544	seedling growth	C3156975
28254544	reactive oxygen species	C0162772
28254544	ROS	C0162772
28254544	melatonin	C0025219
28254544	antioxidant	C0003402
28254544	nitric oxide	C0028128
28254544	NO	C0028128
28254544	NaCl-stress	C1154956
28254544	signaling molecule	C1519315
28254544	seedling	C0242437
28254544	cotyledons	C0242769
28254544	Exogenous	C0205228
28254544	melatonin	C0025219
28254544	NaCl	C0037494
28254544	inhibit	C3463820
28254544	seedling growth	C3156975
28254544	NO	C0028128
28254544	potential superoxide anion	C0038836
28254544	O2(•-)	C0038836
28254544	peroxynitrite anion	C0136157
28254544	ONOO(-)	C0136157
28254544	tyrosine-nitration	C4050156
28254544	proteins	C0033684
28254544	spatial localization	C0475264
28254544	activity of superoxide dismutase	C1151619
28254544	SOD	C0038838
28254544	isoforms	C0597298
28254544	NO	C0028128
28254544	melatonin	C0025219
28254544	seedling	C0242437
28254544	cotyledons	C0242769
28254544	long-distance signaling response	C1514991
28254544	Modulation of superoxide anion	C2246284
28254544	peroxynitrite anion	C0136157
28254544	melatonin	C0025219
28254544	ROS	C0162772
28254544	reactive nitrogen species	C0969698
28254544	melatonin	C0025219
28254544	NO	C0028128
28254544	seedling growth	C3156975
28254544	salt stress accompanying	C1154956
28254544	SOD	C0038838
28254544	isoforms	C0597298
28254544	Cu/Zn SOD	C0010461
28254544	Mn SOD	C0024708
28258572	Physiological	C0205463
28258572	Regulation	C1327622
28258572	Aquaporins	C0599635
28258572	Teleost	C0599050
28258572	Germ Cells	C0017471
28258572	germ cells	C0017471
28258572	gametes	C2718310
28258572	oviparous	C1568405
28258572	teleosts	C0599050
28258572	osmoregulatory	C1510659
28258572	organs	C0178784
28258572	juveniles	C3146221
28258572	adults	C0001675
28258572	development	C0243107
28258572	spawning	C2826216
28258572	osmotic	C0311417
28258572	challenges	C0033213
28258572	external	C0205101
28258572	aquatic environment	C0563034
28258572	transmembrane water channels	C0599635
28258572	aquaporins	C0599635
28258572	mitigate	C1553901
28258572	osmotic	C3661513
28258572	oxidative stress	C0242606
28258572	problems	C0033213
28258572	developing	C0243107
28258572	oocytes	C0029045
28258572	embryos	C0013935
28258572	spermatozoa	C0037868
28258572	diversity	C1880371
28258572	aquaporin	C0599635
28258572	teleosts	C0599050
28258572	molecular regulation	C1817179
28258572	aquaporins	C0599635
28258572	oogenesis	C0029047
28258572	spermatogenesis	C0037864
28258572	channels	C0599635
28258572	egg	C0029974
28258572	buoyancy	C1622066
28258572	activation	C1879547
28258572	detoxification	C0150543
28258572	spermatozoa	C0037868
28258572	marine	C0036493
28258572	environment	C0014406
28261447	Caribbean	C0206155
28261447	massive corals	C0324034
28261447	not recovering from	C0521109
28261447	thermal stress	C0871732
28261447	events	C0441471
28261447	Massive coral	C0324034
28261447	bleaching	C1254365
28261447	events	C0441471
28261447	sea	C0036493
28261447	surface	C0205148
28261447	temperatures	C0039476
28261447	frequent	C0332183
28261447	severe	C0205082
28261447	climate change	C2718051
28261447	Monitoring	C0302523
28261447	colony	C0596092
28261447	recovery	C0237820
28261447	bleaching	C1254365
28261447	multiyear time frames	C0332168
28261447	coral	C0324034
28261447	community	C0009462
28261447	changes	C0392747
28261447	multiyear studies	C2603343
28261447	long-term	C0443252
28261447	outcomes	C1274040
28261447	coral	C1063194
28261447	colonies	C0596092
28261447	acute bleaching	C1254365
28261447	events	C0441471
28261447	colony	C0596092
28261447	pigmentation	C0031911
28261447	size	C0456389
28261447	bleached	C0441833
28261447	unbleached groups	C0441833
28261447	reef-building scleractinian	C0997908
28261447	corals	C0324034
28261447	Orbicella franksi	C1013977
28261447	Siderastrea siderea	C1063194
28261447	Stephanocoenia michelini	C1062911
28261447	Bocas del Toro	C0681784
28261447	Panama	C0030266
28261447	bleaching	C1254365
28261447	event	C0441471
28261447	monitored	C0302523
28261447	pigmentation	C0031911
28261447	status	C0449438
28261447	live tissue	C0040300
28261447	colony	C0596092
28261447	size	C0456389
28261447	years	C0439234
28261447	Corals	C0324034
28261447	bleached	C1254365
28261447	colony	C0596092
28261447	groups	C0441833
28261447	live tissue	C0040300
28261447	loss	C1517945
28261447	bleached	C1254365
28261447	corals	C0324034
28261447	species	C1705920
28261447	bleaching	C1254365
28261447	live tissue	C0040300
28261447	losses	C1517945
28261447	colony	C0596092
28261447	months	C0439231
28261447	postbleaching	C1254367
28261447	O. franksi	C1013977
28261447	S. michelini	C1062911
28261447	S. siderea	C1063194
28261447	species	C1705920
28261447	O. franksi	C1013977
28261447	S. michelini	C1062911
28261447	positive	C1446409
28261447	growth	C0018270
28261447	thermal stress	C0871732
28261447	event	C0441471
28261447	event	C0441471
28261447	species	C1705920
28261447	lost	C0745777
28261447	tissue	C0040300
28261447	colony	C0596092
28261447	species	C1705920
28261447	groups	C0441833
28261447	groups	C0441833
28261447	bleached	C1254365
28261447	acclimative response	C0237446
28261447	bleached	C1254365
28261447	corals	C0324034
28261447	groups	C0441833
28261447	tissue	C0040300
28261447	loss	C1517945
28261447	Caribbean	C0206155
28261447	reef-building corals	C0324034
28261447	tissue	C0040300
28261447	loss	C1517945
28261447	benthic coverage	C1254362
28261447	thermal stress	C0871732
28261447	region	C0017446
28261447	bleaching	C1254365
28261447	acclimation	C0237446
28263833	Preparation	C1521827
28263833	characterization	C1880022
28263833	gastrointestinal	C0521362
28263833	wafer	C0991560
28263833	formulations	C1707824
28263833	active pharmaceutical ingredients	C1254351
28263833	API	C1254351
28263833	variable	C0439828
28263833	bioavailability	C0005508
28263833	oral administration	C0001563
28263833	overcome	C2983310
28263833	mucoadhesive dosage forms	C0013058
28263833	gastrointestinal	C0521362
28263833	wafers	C0991560
28263833	currently	C0521116
28263833	unsolved	C1710576
28263833	control	C0243148
28263833	adhesion	C0175633
28263833	wafer	C0991560
28263833	intestinal mucus	C0026727
28263833	combination	C0205195
28263833	gastrointestinal	C0521362
28263833	wafers	C0991560
28263833	expanding systems	C0205245
28263833	combination	C0205195
28263833	thin and elastic wafers	C0991560
28263833	characterized	C1880022
28263833	unidirectional drug release	C3850077
28263833	study	C2603343
28263833	gastrointestinal	C0521362
28263833	twolayered wafers	C0991560
28263833	water-insoluble backing layer	C0205556
28263833	drug-loaded	C0392762
28263833	mucoadhesive layer	C0205556
28263833	casting solvent technique	C0449851
28263833	backing layer	C0205556
28263833	Ethocel™ Standard 10 Premium	C1254351
28263833	mucoadhesive layer	C0205556
28263833	mixture	C0439962
28263833	Methocel™ E15 Premium LV	C3886467
28263833	polyvinyl alcohol	C0032623
28263833	Macrogol 400	C4076208
28263833	wafers	C0991560
28263833	characterized	C1880022
28263833	appearance	C0700364
28263833	mechanical properties	C0205556
28263833	dissolution profiles	C3850077
28263833	influence	C4054723
28263833	backing layer	C0205556
28263833	thickness	C1280412
28263833	drug transfer	C0441655
28263833	unidirectional drug release	C3850077
28263833	wafers	C0991560
28263833	backing layer	C0205556
28263833	thickness	C1280412
28263833	500μg Ethocel	C0059756
28263833	adequate	C0205411
28263833	mechanical properties	C0205556
28263833	drug transfer	C0441655
28263833	unidirectional drug release	C3850077
28264394	Discovery	C1880355
28264394	<i>Neopanorpa chillcotti</i> Byers	C4005338
28264394	Mecoptera	C1001487
28264394	Panorpidae	C1015340
28264394	Tibet	C0040182
28264394	China	C0008115
28264394	generic status	C1254370
28264394	Neopanorpa chillcotti Byers	C4005338
28264394	Kathmandu	C0681784
28264394	Nepal	C0027689
28264394	Gyirong	C0681784
28264394	Tibet	C0040182
28264394	China	C0008115
28264394	new material	C0439861
28264394	China	C0008115
28264394	Nepal	C0027689
28264394	generic status	C1254370
28264394	species	C1705920
28264394	discussed	C2584313
28264678	Passive case detection	C4288441
28264678	malaria	C0024530
28264678	Ratanakiri Province	C0681784
28264678	Cambodia	C0681784
28264678	detect	C0442726
28264678	villages	C0562518
28264678	at higher risk	C3843761
28264678	malaria	C0024530
28264678	Cambodia	C0681784
28264678	reduced	C0392756
28264678	malaria	C0024530
28264678	incidence	C0021149
28264678	target	C1521840
28264678	Millennium Development Goal 6	C0018017
28264678	Cambodian	C0681784
28264678	Government	C0018104
28264678	aims	C1947946
28264678	eliminate	C0849355
28264678	malaria	C0024530
28264678	country's	C0454664
28264678	malaria	C0024530
28264678	incidence	C0021149
28264678	highly	C0205250
28264678	variable	C0439828
28264678	provincial	C0681784
28264678	level	C0441889
28264678	village	C0562518
28264678	level	C0441889
28264678	study	C2603343
28264678	passive case detection	C4288441
28264678	PCD	C4288441
28264678	village	C0562518
28264678	level	C0441889
28264678	Ratanakiri Province	C0681784
28264678	incidence	C0021149
28264678	trends	C1521798
28264678	identify	C0205396
28264678	high-risk areas of	C0332167
28264678	malaria	C0024530
28264678	primarily	C0205225
28264678	targeted	C1521840
28264678	malaria	C0024530
28264678	elimination	C0849355
28264678	Cambodian	C0681784
28264678	malaria	C0024530
28264678	programme	C0376691
28264678	Malaria Information System	C0021428
28264678	MIS	C0021428
28264678	malaria	C0024530
28264678	information	C1533716
28264678	village	C0562518
28264678	level	C0441889
28264678	PCD	C4288441
28264678	village	C0562518
28264678	malaria workers	C0018724
28264678	health facilities	C0018704
28264678	MIS	C0021428
28264678	data	C1511726
28264678	Ratanakiri Province	C0681784
28264678	calculate	C1441506
28264678	annual	C0332181
28264678	incidence rates	C1708485
28264678	Plasmodium species	C0032148
28264678	province	C0681784
28264678	commune	C0598781
28264678	levels	C0441889
28264678	estimating	C0750572
28264678	trend	C1521798
28264678	provincial	C0681784
28264678	level	C0441889
28264678	villages	C0562518
28264678	reporting	C0700287
28264678	year	C0439234
28264678	communal	C0009462
28264678	incidences	C0021149
28264678	cases	C0868928
28264678	per	C3887962
28264678	village	C0562518
28264678	map	C0024779
28264678	Plasmodium species	C0032148
28264678	per year	C0439508
28264678	Analysis of spatial clustering	C0814928
28264678	village	C0562518
28264678	malaria	C0024530
28264678	cases	C0868928
28264678	Plasmodium species	C0032148
28264678	performed	C0884358
28264678	year	C0439234
28264678	malaria	C0024530
28264678	annual	C0332181
28264678	incidence rates	C1708485
28264678	inhabitants	C0030705
28264678	decreased	C0392756
28264678	Falciparum	C0032150
28264678	incidence	C0021149
28264678	decreased	C0392756
28264678	compared	C1707455
28264678	CI	C0009667
28264678	rapidly	C0456962
28264678	vivax	C0032154
28264678	incidence	C0021149
28264678	compared	C1707455
28264678	CI	C0009667
28264678	significant	C0750502
28264678	spatial clusters	C0012641
28264678	year	C0439234
28264678	Big clusters	C0012641
28264678	extend	C0439792
28264678	Cambodian-Vietnamese border	C0681784
28264678	Sesan River	C0337050
28264678	clusters	C0012641
28264678	years	C0439234
28264678	villages	C0562518
28264678	year	C0439234
28264678	shrunk	C0547047
28264678	progressively	C0205329
28264678	split	C1534709
28264678	clusters	C0012641
28264678	decline	C0868945
28264678	malaria	C0024530
28264678	burden	C2828008
28264678	intensive	C0521110
28264678	malaria control activities	C0441655
28264678	implemented	C1708476
28264678	areas	C0205146
28264678	distribution	C0520511
28264678	long-lasting	C0549178
28264678	insecticidal net	C2717999
28264678	person	C0027361
28264678	early diagnosis	C0596473
28264678	prompt	C0871157
28264678	treatment	C1522326
28264678	Dihydro-artemisinin	C0058108
28264678	piperaquine	C0071105
28264678	first-line treatment	C1708063
28264678	malaria	C0024530
28264678	cases	C0868928
28264678	radical	C0439807
28264678	treatment	C1522326
28264678	primaquine	C0071105
28264678	Plasmodium vivax	C0032154
28264678	cases	C0868928
28264678	slow	C0439834
28264678	decrease	C0547047
28264678	P. vivax	C0032154
28264678	relapses	C0035020
28264678	achieve	C0205197
28264678	malaria	C0024530
28264678	elimination	C0849355
28264678	priority	C0549179
28264678	stable	C0205360
28264678	malaria clusters	C0012641
28266114	Interaction of lifestyle	C0851537
28266114	behaviour	C0004927
28266114	systemic diseases	C0442893
28266114	dental caries	C0011334
28266114	periodontal diseases	C0031090
28266114	consensus report of group 2 of the joint EFP/ORCA workshop	C0086050
28266114	caries	C0011334
28266114	periodontal diseases	C0031090
28266114	Periodontal diseases	C0031090
28266114	dental caries	C0011334
28266114	common diseases	C0012634
28266114	tooth loss	C0080233
28266114	diseases	C0012634
28266114	nutritional compromise	C0012160
28266114	self-esteem	C0036597
28266114	quality of life	C0034380
28266114	complex chronic diseases	C0008679
28266114	common risk factors	C0035648
28266114	pathogenic plaque biofilm	C0599030
28266114	distinct pathophysiologies	C0277785
28266114	Multiple exposures	C0332157
28266114	susceptibility involves	C0012655
28266114	risk factors	C0035648
28266114	inherited	C0439660
28266114	genetic variants	C0042333
28266114	socio-economic factors	C0086996
28266114	biofilm	C0081786
28266114	smoking	C0037369
28266114	carbohydrate intake	C0489461
28266114	prevention of both diseases	C0679698
28266114	their management	C0376636
28266114	scientific literature	C0023866
28266114	potential risk factors	C0035648
28266114	caries	C0011334
28266114	periodontal diseases	C0031090
28266114	systematic review	C1955832
28266114	genetic risk factors	C0814299
28266114	narrative review	C0815257
28266114	role of diet and nutrition	C1511900
28266114	reference documentation	C0586393
28266114	modifiable acquired risk factors	C0035648
28266114	genetic contribution	C0243095
28266114	periodontal diseases	C0031090
28266114	caries susceptibility	C0011336
28266114	attributable risk	C0814766
28266114	genetics literature	C0017399
28266114	periodontal disease	C0031090
28266114	caries	C0011334
28266114	genes	C0017337
28266114	associated with	C0332281
28266114	chronic periodontitis	C0266929
28266114	vitamin D receptor	C0919430
28266114	VDR	C0919430
28266114	Fc gamma receptor IIA	C1414553
28266114	Fc-γRIIA	C1414553
28266114	Interleukin 10 (IL10) genes	C1334098
28266114	IL10	C1334098
28266114	caries	C0011334
28266114	genes	C0017337
28266114	enamel formation	C1333380
28266114	AMELX	C1412382
28266114	AMBN	C1412375
28266114	ENAM	C1414397
28266114	TUFT	C0059090
28266114	MMP20	C1417208
28266114	KLK4	C1416675
28266114	salivary characteristics	C2219488
28266114	AQP5	C1412495
28266114	immune regulation	C1327458
28266114	dietary preferences	C0016483
28266114	largest impact	C4049986
28266114	Fermentable carbohydrates	C0012170
28266114	sugars and starches	C0684177
28266114	risk factor for both diseases	C0850664
28266114	caries	C0011334
28266114	fermentation process	C0015852
28266114	generation of biofilm	C1325881
28266114	Glucans	C0017696
28266114	periodontitis	C0031099
28266114	glycaemia drives	C1320980
28266114	oxidative stress	C0242606
28266114	advanced glycation	C0598528
28266114	hyper inflammatory	C0021368
28266114	Micronutrient deficiencies	C0342917
28266114	vitamin C	C0003968
28266114	vitamin D	C0042866
28266114	vitamin B12	C0042845
28266114	onset	C0277793
28266114	progression of both diseases	C0242656
28266114	Functional foods	C2717755
28266114	probiotics	C0525033
28266114	caries prevention	C1960644
28266114	periodontal disease	C0031090
28266114	management	C0376636
28266114	biological mechanisms	C0678659
28266114	Hyposalivation	C0043352
28266114	rheumatoid arthritis	C0003873
28266114	smoking/tobacco use	C0425291
28266114	undiagnosed	C1408353
28266114	sub-optimally controlled	C2911690
28266114	diabetes	C0011847
28266114	obesity	C0028754
28266114	risk factors	C0035648
28266114	caries	C0011334
28266114	periodontal diseases	C0031090
28266884	Intestinal	C0021853
28266884	micropatches	C0991556
28266884	oral	C0442027
28266884	insulin delivery	C3165280
28266884	Diabetes mellitus	C0011849
28266884	public health issue	C1554189
28266884	epidemic proportions	C0220823
28266884	Injectable insulin	C0544377
28266884	management	C0376636
28266884	chronic disease	C0008679
28266884	lack of patient compliance	C0376405
28266884	injectable	C0086466
28266884	formulations	C1705957
28266884	oral	C0442027
28266884	insulin	C0021641
28266884	formulations	C1705957
28266884	delivery	C1533734
28266884	challenges	C0805586
28266884	mucoadhesive	C0001516
28266884	intestinal	C0021853
28266884	patches	C0991556
28266884	micrometers	C0439201
28266884	dimension	C0439534
28266884	micropatches	C0991556
28266884	challenges	C0805586
28266884	oral	C0442027
28266884	insulin delivery	C3165280
28266884	micropatches	C0991556
28266884	adhere	C3714578
28266884	intestinal mucosa	C0021839
28266884	drug	C1254351
28266884	rapidly	C0456962
28266884	effective	C1704419
28266884	lowering blood glucose levels	C0595883
28266884	in vivo	C1515655
28266884	insulin	C0021641
28266884	micropatches	C0991556
28266884	administered	C1533734
28266884	permeation enhancer	C1254351
28266884	protease inhibitor	C0033607
28266884	peak	C0444505
28266884	efficacy	C1280519
28266884	drop in blood glucose levels	C0595883
28266884	Efficacy	C1280519
28266884	micropatches	C0991556
28266884	administered	C1533734
28266884	multiple doses	C1960418
28266884	micropatches	C0991556
28266884	oral	C0442027
28266884	insulin	C0021641
28266884	formulation	C1705957
28266884	in vivo	C1515655
28266884	efficacy	C1280519
28269523	Hybrid automata models	C0026339
28269523	cardiac ventricular	C0018827
28269523	electrophysiology	C0430467
28269523	real-time	C1550177
28269523	computational applications	C0205245
28269523	heart models	C0026339
28269523	closed loop	C0443183
28269523	validation	C1519941
28269523	safety	C0036043
28269523	critical	C1511545
28269523	medical devices	C0025080
28269523	pacemakers	C0810633
28269523	models	C0026339
28269523	real-time	C1550177
28269523	medical devices	C0025080
28269523	Real-time	C1550177
28269523	performance	C1882330
28269523	obtained	C1301820
28269523	models	C0026339
28269523	computer hardware	C0009602
28269523	methods	C0025664
28269523	Hybrid Automata	C0026339
28269523	HA	C0026339
28269523	FPGA	C0025080
28269523	Models	C0026339
28269523	ventricular cardiac cell	C2339371
28269523	electrophysiology	C0430467
28269523	described	C1552738
28269523	HA	C0026339
28269523	capture	C1254366
28269523	behavior	C1521970
28269523	biological systems	C0449913
28269523	models	C0026339
28269523	closed-loop	C0443183
28269523	validation	C1519941
28269523	pacemakers	C0810633
28269523	abstract	C1552863
28269523	capture	C1254366
28269523	important	C3898777
28269523	characteristics	C1521970
28269523	dynamic	C0729333
28269523	rate response	C0237629
28269523	HA model	C0026339
28269523	cardiac cells	C0225828
28269523	captures	C1254366
28269523	dynamic	C0729333
28269523	behavior	C1521970
28269523	model	C0026339
28269523	hardware	C0009602
28269523	potentially	C3245505
28269523	modeling	C0870071
28269523	heart	C0018787
28269523	million	C1881839
28269523	dynamic	C0729333
28269523	cells	C0007634
28269523	ideal	C1512612
28269523	closed loop	C0443183
28269523	testing	C0039593
28269523	medical devices	C0025080
28269731	Comparison	C1707455
28269731	pulse wave velocity	C3494431
28269731	accelerometer	C0178951
28269731	reflective photo-plethysmography signals	C0203341
28269731	carotid	C0007272
28269731	femoral artery	C0015801
28269731	Carotid	C0007272
28269731	femoral	C0015801
28269731	pulse wave velocity	C3494431
28269731	established measure	C0079809
28269731	assess	C0184514
28269731	cardiovascular risk	C1113685
28269731	surrogate parameter	C0549193
28269731	non-invasive continuous blood pressure inference	C4301970
28269731	progress	C1280477
28269731	wearable wrist worn sensors	C0183210
28269731	photo-plethysmography	C0162599
28269731	high fidelity accelerometer s	C0178951
28269731	pulse information	C0034107
28269731	larger arteries	C0003842
28269731	blood volume	C0005850
28269731	superficial tissue	C0040300
28269731	pulse wave velocities	C3494431
28269731	accelerometer	C0178951
28269731	reflective photo-plethysmography signals	C0203341
28269731	carotid	C0007272
28269731	femoral artery	C0015801
28269731	physiological processes	C0031845
28269731	sensing principles	C1254370
28269731	experimental results	C2825142
28269731	study	C2603343
28269731	healthy subjects	C1708335
28270328	Constructive and Unproductive Processing	C0243095
28270328	Traumatic Experiences	C3203533
28270328	Trauma-Focused Cognitive-Behavioral Therapy	C0579049
28270328	Youth	C0087178
28270328	evidence	C3887511
28270328	efficacy	C1280519
28270328	cognitive-behavioral treatments	C0579049
28270328	CBT	C0579049
28270328	posttraumatic stress disorder	C0038436
28270328	PTSD	C0038436
28270328	treatments	C0087111
28270328	learning theory	C0870794
28270328	cognitive and emotional processing theories	C0282574
28270328	avoidance	C0870186
28270328	constructive processing of feared experiences	C0517168
28270328	inhibitory learning	C0679066
28270328	unproductive and constructive processing	C0243095
28270328	traumatic experiences	C3203533
28270328	PTSD	C0038436
28270328	symptoms	C1457887
28270328	Trauma-Focused Cognitive Behavioral Therapy	C0579049
28270328	TF-CBT	C0579049
28270328	abuse	C0237206
28270328	traumatic	C3203533
28270328	interpersonal loss	C0679461
28270328	Sessions	C1883017
28270328	trauma narrative phase	C3494322
28270328	TF-CBT	C0579049
28270328	unproductive processing	C0243095
28270328	overgeneralization	C0563151
28270328	rumination	C0154575
28270328	avoidance	C0870186
28270328	constructive processing	C0243095
28270328	decentering	C0243095
28270328	accommodation of corrective information	C1832072
28270328	levels of negative emotion	C3165349
28270328	previous	C0205156
28270328	overgeneralization	C0563151
28270328	narrative phase	C3494322
28270328	internalizing symptoms	C0237088
28270328	posttreatment	C0679865
28270328	worsening	C0332271
28270328	externalizing symptoms	C0237088
28270328	follow-up	C1522577
28270328	accommodation predicted improvement	C1832072
28270328	internalizing symptoms	C0237088
28270328	moderated	C1881878
28270328	negative	C0205160
28270328	effects of	C1704420
28270328	overgeneralization	C0563151
28270328	internalizing and externalizing symptoms	C0237088
28270328	overgeneralization	C0563151
28270328	accommodation	C1832072
28270328	Overgeneralization	C0563151
28270328	associated with	C0332281
28270328	rumination	C0154575
28270328	negative emotion	C3165349
28270328	suggesting	C0038659
28270328	immersion	C3714592
28270328	trauma	C3203533
28270328	Accommodation	C1832072
28270328	associated with	C0332281
28270328	avoidance	C0870186
28270328	decentering	C0243095
28270328	healthy	C3898900
28270328	trauma	C3203533
28270328	cognitive change	C1392786
28270328	predicted	C0681842
28270328	improvement	C2986411
28270328	externalizing symptoms	C0237088
28270328	posttreatment	C0679865
28270328	Rumination	C0154575
28270328	avoidance	C0870186
28270328	overgeneralization	C0563151
28270328	accommodation	C1832072
28270328	treatment outcomes	C0085415
28270328	overgeneralization	C0563151
28270328	accommodation	C1832072
28270328	unproductive and constructive processing	C0243095
28270328	traumatic experiences	C3203533
28273985	Giant	C0017526
28273985	Antrochoanal Polyp	C0008298
28273985	Rare	C0522498
28273985	Presentation	C0449450
28273985	Antrochoanal polyp	C0008298
28273985	ACP	C0008298
28273985	Killian polyp	C0008298
28273985	benign lesion	C0221198
28273985	maxillary	C0024947
28273985	patients	C0030705
28273985	antrochoanal polyp	C0008298
28273985	anatomical	C0220784
28273985	lateral nasal wall	C0456482
28273985	middle meatus	C0225401
28273985	antrum	C1549092
28273985	dumbbell	C0686912
28273985	problem	C0033213
28273985	unusual	C2700116
28273985	presentation	C0449450
28274612	Effects	C1280500
28274612	obesity	C0028754
28274612	IL-33	C2976122
28274612	ST2	C3849696
28274612	system	C0449913
28274612	heart	C0018787
28274612	adipose tissue	C0001527
28274612	liver	C0023884
28274612	study	C0008972
28274612	experimental model	C0086272
28274612	Zucker rats	C0034719
28274612	Suppression of tumorigenicity 2	C3849696
28274612	ST2	C3849696
28274612	effect	C1280500
28274612	Interleukin-33	C2976122
28274612	IL-33	C2976122
28274612	relationship	C0439849
28274612	IL-33	C2976122
28274612	ST2	C3849696
28274612	obesity	C0028754
28274612	effects	C1280500
28274612	obesity	C0028754
28274612	IL-33	C2976122
28274612	ST2	C3849696
28274612	system	C0449913
28274612	heart	C0018787
28274612	adipose tissue	C0001527
28274612	liver	C0023884
28274612	rodent model	C1519106
28274612	obesity	C0028754
28274612	relationship	C0439849
28274612	cardiac	C1272575
28274612	expression	C1171362
28274612	IL-33	C2976122
28274612	ST2	C3849696
28274612	system	C0449913
28274612	natriuretic peptides	C1144709
28274612	NPs	C1144709
28274612	system	C0449913
28274612	inflammatory mediators	C3155540
28274612	mRNA expression	C1515670
28274612	IL-33	C1825595
28274612	ST2	C1420442
28274612	system	C0449913
28274612	cardiac	C0189784
28274612	adipose	C0001527
28274612	hepatic biopsies	C0193388
28274612	obese Zucker rats	C0034719
28274612	O	C0034719
28274612	controls	C0009932
28274612	CO	C0009932
28274612	Expression	C1171362
28274612	sST2	C3852857
28274612	O rats	C0034719
28274612	CO	C0009932
28274612	tissues	C0040300
28274612	mRNA	C0035696
28274612	IL-33	C1825595
28274612	O	C0034719
28274612	CO	C0009932
28274612	expression	C0017262
28274612	ST2L	C1416400
28274612	liver	C0023884
28274612	CO	C0009932
28274612	O	C0034719
28274612	relationship	C0439849
28274612	IL-33	C2976122
28274612	ST2	C3849696
28274612	NPs	C1144709
28274612	inflammatory mediators	C3155540
28274612	cardiac tissue	C1272575
28274612	Expression	C1171362
28274612	sST2	C3852857
28274612	cardiac	C1272575
28274612	adipose	C0001527
28274612	liver tissue	C0023884
28274612	O	C0034719
28274612	controls	C0009932
28274612	IL-33	C2976122
28274612	ST2	C3849696
28274612	system	C0449913
28274612	molecular mechanisms	C1148560
28274612	obesity	C0028754
28274612	relationships	C0439849
28274612	NP	C1144709
28274612	systems	C0449913
28274612	inflammatory mediators	C3155540
28274612	IL-33	C2976122
28274612	ST2	C3849696
28274612	molecular pathways	C1704259
28274612	cardiac dysfunction	C3277906
28274612	inflammation	C0021368
28274612	obesity	C0028754
28277316	CXCL14	C1335988
28277316	CXCR4	C2352110
28277316	CXCL12	C1528383
28277316	CXCR4	C2352110
28277316	Invasion	C1269955
28277316	Process	C1522240
28277316	Endometrioid Carcinoma	C0206687
28277316	MELF-Pattern	C0449774
28277316	Myoinvasion	C1269955
28277316	MELF-pattern	C0449774
28277316	myometrial	C0521387
28277316	invasion	C1269955
28277316	MELF pattern	C0449774
28277316	unusual	C2700116
28277316	morphology	C0332437
28277316	myometrial	C0521387
28277316	invasion	C1269955
28277316	endometrioid carcinomas	C0206687
28277316	associated with	C0332281
28277316	lymphovascular invasion	C1708790
28277316	lymph node metastasis	C0024232
28277316	tumor cells	C0334227
28277316	collected	C1516695
28277316	MELF pattern	C0449774
28277316	laser microdissection	C1113652
28277316	Comprehensive	C1880156
28277316	microarray analysis	C1449575
28277316	genes	C0017337
28277316	expression	C1171362
28277316	metastasis progression gene, CXCR4	C2352110
28277316	ligands	C1749457
28277316	CXCL14	C1335988
28277316	CXCL12	C1528383
28277316	investigated	C1292732
28277316	In vitro studies	C0681828
28277316	endometrioid carcinoma	C0206687
28277316	cell lines	C0085983
28277316	elevated	C3163633
28277316	invasion	C1269955
28277316	activity	C0441655
28277316	CXCL14	C1335988
28277316	CXCR4	C2352110
28277316	CXCL12	C1528383
28277316	CXCR4	C2352110
28277316	Immunohistochemical analysis	C1441616
28277316	MELF group	C0441833
28277316	non-MELF group	C0441833
28277316	CXCR4	C2352110
28277316	expressed	C1171362
28277316	endometrioid carcinomas	C0206687
28277316	CXCL14	C1335988
28277316	CXCL12	C1528383
28277316	expression	C1171362
28277316	score	C0449820
28277316	high proportions	C1709707
28277316	cells	C0007634
28277316	positive	C1446409
28277316	sites	C0205145
28277316	MELF pattern	C0449774
28277316	no significant difference	C0243095
28277316	progression-free survival	C0242792
28277316	overall survival	C4086681
28277316	MELF group	C0441833
28277316	non-MELF group	C0441833
28277316	Kaplan-Meier analysis	C1720943
28277316	cells	C0007634
28277316	sites	C0205145
28277316	MELF pattern	C0449774
28277316	increased	C0205217
28277316	invasiveness	C0027626
28277316	function	C0031843
28277316	CXCL14	C1335988
28277316	CXCR4	C2352110
28277316	CXCL12	C1528383
28277316	CXCR4	C2352110
28277879	Crude	C1709843
28277879	4-methylcyclohexanemethanol	C4277102
28277879	MCHM	C4277102
28277879	cause	C0015127
28277879	skin irritation	C0152030
28277879	humans	C0086418
28277879	48-h	C0439586
28277879	patch test	C0030646
28277879	Crude	C1709843
28277879	4-methylcyclohexanemethanol	C4277102
28277879	MCHM	C4277102
28277879	industrial	C0021267
28277879	chemical	C0220806
28277879	wash	C0441648
28277879	clean	C1947930
28277879	coal	C0009131
28277879	10,000 gallons	C0560013
28277879	mixture	C0439962
28277879	crude	C1709843
28277879	MCHM	C4277102
28277879	Elk River	C0337050
28277879	Charleston	C0017446
28277879	West Virginia	C0043127
28277879	contaminating	C0205279
28277879	local	C0205276
28277879	water supply	C0043062
28277879	spill	C0392355
28277879	residents	C2347958
28277879	reported	C0700287
28277879	numerous	C0439064
28277879	health complaints	C0871764
28277879	medical attention	C0496675
28277879	ailments	C0221423
28277879	rashes	C0015230
28277879	itching	C0033774
28277879	relationship	C0439849
28277879	complaints	C0871764
28277879	spill	C0392355
28277879	symptoms	C1457887
28277879	reported	C0700287
28277879	frequently	C0332183
28277879	study	C2603343
28277879	primary	C0205225
28277879	irritation	C0152030
28277879	potential	C3245505
28277879	crude	C1709843
28277879	MCHM	C4277102
28277879	evaluated	C1292732
28277879	individuals	C0237401
28277879	48 hour	C0439586
28277879	semi-occluded	C1947917
28277879	patch testing	C0030646
28277879	MCHM	C4277102
28277879	concentrations	C1446561
28277879	study	C2603343
28277879	skin reactions	C0221743
28277879	individuals	C0237401
28277879	concentration	C1446561
28277879	concentrations	C1446561
28277879	evaluated	C1292732
28277879	measured concentration	C1446561
28277879	MCHM	C4277102
28277879	tap water	C2919405
28277879	residents	C2347958
28277879	West Virginia	C0043127
28277879	results	C1274040
28277879	study	C2603343
28277879	crude	C1709843
28277879	MCHM	C4277102
28277879	dermal	C0221928
28277879	irritant	C0022108
28277879	persons	C0027361
28277879	concentrations	C1446561
28277879	water	C2919405
28277879	reported	C0700287
28277879	spill	C0392355
28278674	New	C0205314
28278674	metabolites	C0870883
28278674	sponge	C0032699
28278674	fungus	C0016832
28278674	Aspergillus sydowii J05B-7F-4	C1085656
28278674	new	C0205314
28278674	metabolites	C0870883
28278674	diorcinolic acid	C0870883
28278674	β-d-glucopyranosyl aspergillusene A	C3253665
28278674	diphenylethers	C0870883
28278674	diketopiperazine	C0058171
28278674	chromone	C0008594
28278674	xanthone	C0078604
28278674	isolated	C0205409
28278674	fungus	C0016832
28278674	Aspergillus sydowii	C1085656
28278674	marine sponge	C0032699
28278674	Stelletta sp	C2800556
28278674	configurations	C0026377
28278674	1D, 2D NMR	C0028580
28278674	HRESIMS	C0201742
28278674	data	C1511726
28278674	Compound	C1706082
28278674	glycoside	C0017977
28278674	phenolic	C0359916
28278674	bisabolane sesquiterpenes	C0036847
28278674	Compounds 1 and 8	C1254351
28278674	mild	C2945599
28278674	cytotoxicity	C0596402
28278674	KB	C0022539
28278674	human nasopharyngeal carcinoma cells	C0022539
28278674	HepG2	C2717940
28278674	human liver cancer cells	C2717940
28278674	HCT 116	C1258005
28278674	human colon cancer cells	C1258005
28278674	compounds	C1254351
28278674	evaluated	C0220825
28278674	antibacterial activity	C0441655
28278674	suppress	C1260953
28278674	LPS	C0023810
28278674	nitric oxide	C0028128
28278674	NO	C0028128
28278674	Compounds 2 and 4-7	C1254351
28278674	mild	C2945599
28278674	antibacterial activity	C0243095
28278674	human	C0086418
28278674	pathogen	C0450254
28278674	Staphylococcus aureus	C0038172
28278674	fish	C0016163
28278674	pathogens	C0450254
28278674	Streptococcus iniae	C0318186
28278674	Vibrio ichthyoenteri	C1265314
28278674	compounds 4 and 7	C1706082
28278674	suppressed	C1260953
28278674	NO	C0028128
28279706	neural	C3714606
28279706	legacy	C0242538
28279706	concussion	C0006107
28279706	hypothesized	C1512571
28279706	concussions	C0006107
28279706	impart	C0332261
28279706	lasting	C0443252
28279706	brain damage	C0270611
28279706	patient	C0030705
28279706	recovered	C0521108
28279706	hypothesis	C1512571
28279706	largely	C0549177
28279706	neuropathological	C1521733
28279706	studies	C2603343
28279706	deceased	C0011065
28279706	athletes	C0238703
28279706	detected	C1511790
28279706	in vivo	C0681829
28279706	measured	C0444706
28279706	neural	C3714606
28279706	responses	C0871261
28279706	speech	C0037817
28279706	collegiate student	C0682177
28279706	athletes	C0238703
28279706	history	C0683519
28279706	concussion	C0006107
28279706	recovered	C0521108
28279706	student	C0038492
28279706	athletes	C0238703
28279706	weaker	C1762617
28279706	responses	C0871261
28279706	speech	C0037817
28279706	age	C0001779
28279706	position	C0733755
28279706	matched	C1708943
28279706	peers	C0679739
28279706	group	C0681860
28279706	difference	C1705242
28279706	suggests	C1705535
28279706	concussions	C0006107
28279706	engender	C0015127
28279706	small	C0700321
28279706	detectable	C3830527
28279706	changes	C0392747
28279706	brain function	C0678908
28279706	prior	C0332152
28279706	emergence	C0175673
28279706	frank	C1947931
28279706	behavioral indications	C2706099
28281265	Performance	C1882330
28281265	Colorimetric	C0009407
28281265	Biosensing	C0005567
28281265	Paper	C0030351
28281265	Microfluidic Platforms	C1449576
28281265	Chemical Modification	C0205245
28281265	Incorporation	C0243126
28281265	Nanoparticles	C1450054
28281265	methodologies	C0015194
28281265	analytical performance	C1882330
28281265	colorimetric	C0009407
28281265	paper	C0030351
28281265	biosensors	C0600364
28281265	Microfluidic paper-based analytical devices	C1449582
28281265	μPADs	C1449582
28281265	stamping process	C1254366
28281265	CO2	C0007012
28281265	laser ablation	C0348007
28281265	modified	C0205349
28281265	oxidation	C1254366
28281265	step	C1261552
28281265	silica	C0037098
28281265	nanoparticles	C1450054
28281265	paper structure	C0030351
28281265	methods	C0025663
28281265	problem	C0033213
28281265	associated with	C0332281
28281265	colorimetric detection	C0009407
28281265	heterogeneity	C0019409
28281265	color	C0009393
28281265	distribution	C1704711
28281265	detection zones	C1710706
28281265	modification	C0205245
28281265	steps	C1261552
28281265	interaction	C1704675
28281265	paper	C0030351
28281265	surface	C0205148
28281265	enzymes	C0014442
28281265	performance	C1882330
28281265	reliability	C2347947
28281265	quantitative	C0392762
28281265	analysis	C0936012
28281265	clinically	C0205210
28281265	compounds	C1706082
28282510	CXCR4	C2352110
28282510	CD184	C2352110
28282510	expression	C1171362
28282510	stem cell harvest	C0411265
28282510	CD34(+)	C0054953
28282510	cells	C0007634
28282510	post-transplant	C1254367
28282510	CXCR4	C2352110
28282510	receptor	C0597357
28282510	stromal-derived factor-1	C0218504
28282510	SDF-1	C0218504
28282510	molecule	C0567416
28282510	chemotactic	C0008018
28282510	activity	C0441655
28282510	lymphocytes	C0024264
28282510	homing	C0007613
28282510	hematopoietic stem cells	C0018956
28282510	adult marrow	C0005953
28282510	evaluated	C0220825
28282510	CXCR4	C2352110
28282510	CD184	C2352110
28282510	expression	C1171362
28282510	harvest cells	C0038250
28282510	post-transplant	C1254367
28282510	bone marrow	C0005953
28282510	BM	C0005953
28282510	relation	C0439849
28282510	engraftment	C0301944
28282510	consensus criteria	C0935549
28282510	chimerism	C0333678
28282510	prospective study	C0033522
28282510	patients	C0030705
28282510	hematopoietic stem cell transplantation	C0472699
28282510	patients	C0030705
28282510	received	C1514756
28282510	autograft	C0040736
28282510	patients	C0030705
28282510	received	C1514756
28282510	allograft	C0040739
28282510	assessed	C1516048
28282510	CD184	C2352110
28282510	CXCR4	C2352110
28282510	flow cytometry	C0016263
28282510	harvest cells	C0038250
28282510	post-transplant	C1254367
28282510	BM	C0005953
28282510	assessment	C0220825
28282510	complete	C0205197
28282510	morphologic	C0543482
28282510	molecular studies	C2236970
28282510	detection	C1511790
28282510	CD184	C2352110
28282510	expression	C1171362
28282510	CD34(+)	C0054953
28282510	cells	C0007634
28282510	chimerism	C0333678
28282510	total	C0439810
28282510	peripheral blood mononuclear cells	C1321301
28282510	Diagnoses	C0011900
28282510	patients	C0030705
28282510	acute myeloid leukemia	C0023467
28282510	multiple myeloma	C0026764
28282510	acute lymphoblastic leukemia	C0023449
28282510	non-Hodgkin lymphoma	C0024305
28282510	myelodysplastic syndromes	C3463824
28282510	aplastic anemia	C0002874
28282510	chronic myeloid leukemia	C0023473
28282510	Hodgkin lymphoma	C0019829
28282510	plasmacytomas	C0032131
28282510	patient	C0030705
28282510	died	C1546956
28282510	excluded	C2828389
28282510	study	C0008972
28282510	engraftment	C0301944
28282510	no	C1513916
28282510	statistical significance	C0237881
28282510	level	C0428479
28282510	CD184	C2352110
28282510	stem cell harvest	C0411265
28282510	prediction	C0681842
28282510	successful	C1272703
28282510	engraftment	C0301944
28282510	BM sample	C0438737
28282510	statistical significance	C0237881
28282510	level	C0428479
28282510	CD184	C2352110
28282510	BM sample	C0438737
28282510	occurrence	C2745955
28282510	successful	C1272703
28282510	engraftment	C0301944
28282510	SDF-1	C0218504
28282510	CXCR4	C2352110
28282510	engraftment	C0301944
28282510	assess	C1516048
28282510	expression	C1171362
28282510	post-transplant	C1254367
28282510	chemokine	C0282554
28282510	SDF-1	C0218504
28282510	receptor	C0597357
28282510	CXCR4	C2352110
28282510	potential	C3245505
28282510	surrogate markers	C0086589
28282510	assessment	C0220825
28282510	engraftment	C0301944
28284223	Genetic diversity	C0042333
28284223	Taenia saginata	C0221085
28284223	Cestoda	C1706526
28284223	Cyclophyllidea	C0322145
28284223	Lao People's Democratic Republic	C0023034
28284223	northeastern	C0017446
28284223	Thailand	C0039725
28284223	mitochondrial DNA	C0012929
28284223	Taenia saginata	C0221085
28284223	tapeworm	C1706526
28284223	cattle	C0007452
28284223	Analysis	C0936012
28284223	genetic diversity	C0042333
28284223	geographical populations	C0032659
28284223	T. saginata	C0221085
28284223	origin	C0439659
28284223	transmission	C1521797
28284223	spread	C0332261
28284223	organism	C0029235
28284223	T. saginata	C0221085
28284223	genetic variability	C0042333
28284223	T. saginata populations	C0221085
28284223	regions	C0017446
28284223	world	C2700280
28284223	Lao PDR	C0023034
28284223	Thailand	C0039725
28284223	genetic diversity	C0012929
28284223	T. saginata populations	C0221085
28284223	Lao PDR	C0023034
28284223	northeastern	C0017446
28284223	Thailand	C0039725
28284223	sequences	C0162326
28284223	T. saginata	C0221085
28284223	countries	C0454664
28284223	GenBank	C0598211
28284223	Mitochondrial cox1	C1537985
28284223	sequence analysis	C0162802
28284223	haplotypes	C0018591
28284223	T. saginata	C0221085
28284223	Lao PDR	C0023034
28284223	northeastern	C0017446
28284223	Thailand	C0039725
28284223	haplotypes	C0018591
28284223	sequences	C0162326
28284223	Phylogenetic tree	C1519068
28284223	haplotype network analyses	C0242481
28284223	global	C2348867
28284223	T. saginata	C0221085
28284223	groups	C0441833
28284223	A	C0441833
28284223	B	C0441833
28284223	C1	C0441833
28284223	C2	C0441833
28284223	D	C0441833
28284223	Taenia saginata	C0221085
28284223	Lao PDR	C0023034
28284223	northeastern	C0017446
28284223	Thailand	C0039725
28284223	Group A	C0441833
28284223	B	C0441833
28284223	Taenia saginata	C0221085
28284223	western	C0017446
28284223	Thailand	C0039725
28284223	groups C1	C0441833
28284223	C2	C0441833
28284223	D	C0441833
28284223	populations	C0684063
28284223	northeast	C0017446
28284223	western	C0017446
28284223	Thailand	C0039725
28284223	Taenia saginata	C0221085
28284223	Lao PDR	C0023034
28284223	Thailand	C0039725
28284223	genetically diverse	C0042333
28284223	genetic differentiation	C0917892
28284223	Taenia saginata populations	C0221085
28284223	Lao PDR	C0023034
28284223	northeastern	C0017446
28284223	Thailand	C0039725
28284223	population	C0684063
28284223	western	C0017446
28284223	Thailand	C0039725
28284223	T. saginata	C0221085
28284223	transmission routes	C1521797
28284223	Southeast Asia	C0003983
28284864	novel	C0205314
28284864	near-infrared	C1289901
28284864	fluorescent	C0016315
28284864	theranostic	C4046052
28284864	combretastain A-4	C0056154
28284864	analogue	C0002776
28284864	YK-5-252	C1254351
28284864	triple negative breast cancer	C3539878
28284864	treatment	C0087111
28284864	triple negative breast cancer	C3539878
28284864	TNBC	C3539878
28284864	cancer research	C1516225
28284864	hormone receptors	C0019929
28284864	treatment	C0087111
28284864	patients	C0030705
28284864	diagnosis	C0011900
28284864	radiation	C1522449
28284864	chemotherapy	C3665472
28284864	Anti-angiogenesis	C0281318
28284864	vasculature	C3714653
28284864	tumors	C0027651
28284864	Combretastatin A-4	C0056154
28284864	CA-4	C0056154
28284864	vasculature	C3714653
28284864	cancers	C0006826
28284864	inhibition	C3463820
28284864	tubulin	C0041348
28284864	polymerization	C0314672
28284864	toxicity	C0600688
28284864	analogues	C0002776
28284864	CA-4	C0056154
28284864	novel	C0205314
28284864	CA-4	C0056154
28284864	prodrug	C0033262
28284864	YK-5-252	C1254351
28284864	drug	C1254351
28284864	disulfide bond	C0813982
28284864	cleavage	C0596311
28284864	mechanism	C0441712
28284864	near-infrared	C1289901
28284864	NIR	C1289901
28284864	fluorophore	C0598447
28284864	fluorescence	C0016315
28284864	cleavage	C0596311
28284864	disulfide linkage	C0813982
28284864	CA-4	C0056154
28284864	glutathione	C0017817
28284864	GSH	C0017817
28284864	toxicity	C0600688
28284864	drug	C1254351
28284864	NIR	C1289901
28284864	fluorophore	C0598447
28284864	prodrug	C0033262
28284864	YK-5-252	C1254351
28284864	novel	C0205314
28284864	CA-4	C0056154
28284864	analogue	C0002776
28284864	toxicity	C0600688
28284864	theranostics	C4046052
28284864	imaging	C0079595
28288758	Epidemiological	C0014508
28288758	patterns	C0449774
28288758	bovine	C0007452
28288758	besnoitiosis	C0005146
28288758	endemic	C0302891
28288758	beef cattle	C0175923
28288758	herd	C1690528
28288758	reared	C3687023
28288758	Bovine	C0007452
28288758	besnoitiosis	C0005146
28288758	parasitic disease	C0030499
28288758	protozoan	C0033739
28288758	Besnoitia besnoiti	C0320701
28288758	epidemiological studies	C0002783
28288758	Europe	C0015176
28288758	years	C0439234
28288758	epidemiological	C0014508
28288758	aspects	C1879746
28288758	transmission	C0242781
28288758	incidence rates	C1708485
28288758	risk factors	C0035648
28288758	lacking	C0332268
28288758	appropriate disease control	C0009449
28288758	programmes	C0009457
28288758	study	C2603343
28288758	epidemiological	C0014508
28288758	pattern	C0449774
28288758	disease	C0012634
28288758	endemic	C0302891
28288758	herd	C1690528
28288758	reared	C3687023
28288758	Spanish	C0037747
28288758	Pyrenees	C0442533
28288758	associated with	C0332281
28288758	infection	C3714514
28288758	clinical disease	C0012634
28288758	dynamics	C3826426
28288758	study population	C0681876
28288758	Brown Swiss	C0324052
28288758	Pirenaica	C0007452
28288758	adult animals	C0596888
28288758	calves	C3668829
28288758	born	C0005615
28288758	weaned	C0420986
28288758	farm	C0557759
28288758	study	C2603343
28288758	sampling	C0870078
28288758	time frames	C0332168
28288758	periods	C0010339
28288758	mountain	C0442533
28288758	valley	C0563004
28288758	periods	C0010339
28288758	data	C1511726
28288758	animals	C0003062
28288758	breed	C1704650
28288758	sex	C0079399
28288758	age	C0001779
28288758	herd	C1690528
28288758	management	C1273870
28288758	animal grouping	C1642385
28288758	time	C0040223
28288758	housing	C0020057
28288758	data collection	C0010995
28288758	methodology	C3266812
28288758	clinical examinations	C1456356
28288758	serological	C0205473
28288758	status	C0449438
28288758	bovine	C0007452
28288758	besnoitiosis	C0005146
28288758	immunofluorescent antibody testing	C0016318
28288758	blood samples	C0178913
28288758	prevalence	C0033105
28288758	adult animals	C0596888
28288758	CI	C0009667
28288758	seropositive	C0521143
28288758	animals	C0003062
28288758	cumulative incidence	C0021149
28288758	new	C0205314
28288758	infections	C3714514
28288758	detected	C0442726
28288758	mountain	C0442533
28288758	period	C0010339
28288758	valley	C0563004
28288758	period	C0010339
28288758	incidence density	C1708485
28288758	new	C0205314
28288758	infections	C3714514
28288758	animal	C0003062
28288758	month	C0439231
28288758	mountain	C0442533
28288758	valley	C0563004
28288758	periods	C0010339
28288758	seroepidemiological study	C0036744
28288758	seroconversion	C4042908
28288758	probability	C0033204
28288758	B. besnoiti	C0320701
28288758	infection	C3714514
28288758	associated with	C0332281
28288758	number	C0237753
28288758	seropositive	C0521143
28288758	cows	C0007452
28288758	animal	C0003062
28288758	housing	C0020057
28288758	period	C0010339
28288758	duration	C0449238
28288758	horizontal transmission	C4288956
28288758	disease	C0012634
28288758	spread	C0332261
28288758	risk	C0035647
28288758	clinical course	C0449259
28288758	increased	C0205217
28288758	age	C0001779
28288758	presence	C0150312
28288758	clinical signs	C3540840
28288758	higher	C0205250
28288758	antibody responses	C0003261
28288758	calves	C3668829
28288758	months	C0439231
28288758	old	C0580836
28288758	weaning	C0043084
28288758	seroprevalence	C0600367
28288758	CI	C0009667
28288758	chronic	C0205191
28288758	stage	C1306673
28288758	animals	C0003062
28288758	B. besnoiti	C0320701
28288758	infect	C3714514
28288758	cause	C0015127
28288758	disease	C0012634
28288758	animals	C0003062
28288758	months	C0439231
28288758	old	C0580836
28288758	risk	C0035647
28288758	calf	C3668829
28288758	seroconversion	C4042908
28288758	serological	C0205473
28288758	status	C0449438
28288758	cows	C0007452
28288758	postnatal	C0443281
28288758	transmission	C0242781
28288758	dams	C0007452
28288758	offspring	C3668829
28288758	suckling	C0003068
28288758	period	C0010339
28295177	fast small-sample kernel independence test	C0237913
28295177	microbiome	C1956108
28295177	community	C0009462
28295177	level association analysis	C0242481
28295177	role	C1705810
28295177	microbiome	C1956108
28295177	human	C0086418
28295177	health	C0018684
28295177	diseases	C0012634
28295177	researchers	C0035173
28295177	assessing	C1516048
28295177	relationship	C0439849
28295177	microbiome composition	C1956108
28295177	host	C1167395
28295177	genomic	C0017428
28295177	data	C1511726
28295177	dimensionality	C1707753
28295177	data	C1511726
28295177	complex	C0439855
28295177	relationships	C0439849
28295177	microbiota	C3887843
28295177	host	C1167395
28295177	genomics	C0017428
28295177	challenges	C0805586
28295177	analysis	C0936012
28295177	kernel RV coefficient (KRV) test	C0237913
28295177	overall	C1561607
28295177	association	C0439849
28295177	host	C1167395
28295177	gene expression	C0017262
28295177	microbiome composition	C1956108
28295177	KRV statistic	C0237913
28295177	nonlinear correlations	C1707520
28295177	complex	C0439855
28295177	relationships	C0439849
28295177	data types	C1609081
28295177	gene expression	C0017262
28295177	microbiome composition	C1956108
28295177	dependency	C1254370
28295177	Testing	C0039593
28295177	tests	C0392366
28295177	RV coefficients	C1707429
28295177	p-value	C1709380
28295177	calculation	C1441506
28295177	Strategies	C0205245
28295177	confounding effects	C0009673
28295177	results	C1274040
28295177	problem	C0033213
28295177	kernel	C1881303
28295177	Simulation studies	C0679083
28295177	KRV	C1707429
28295177	testing	C0039593
28295177	statistical independence	C0085862
28295177	kernels	C1881303
28295177	associations	C0439849
28295177	microbiome composition	C1956108
28295177	host	C1167395
28295177	genomic	C0017428
28295177	data	C1511726
28295177	type I	C0441729
28295177	error	C0743559
28295177	KRV	C1707429
28295177	microbiome	C1956108
28295177	study	C2603343
28295177	relationship	C0439849
28295177	host	C1167395
28295177	transcriptome	C3178810
28295177	microbiome composition	C1956108
28295177	context	C0449255
28295177	inflammatory bowel disease	C0021390
28295177	qualitative observations	C0449576
28295357	Analysis	C0936012
28295357	Systematic	C0220922
28295357	Elemental	C0013879
28295357	Changes	C0443172
28295357	Decomposing Bone	C0262950
28295357	aim	C1947946
28295357	pilot study	C0031928
28295357	investigate	C1292732
28295357	compositional	C0486616
28295357	changes	C0443172
28295357	bone	C0262950
28295357	decomposition	C2700592
28295357	Elemental	C0013879
28295357	concentrations	C1446561
28295357	barium	C0004749
28295357	calcium	C0006675
28295357	iron	C0302583
28295357	potassium	C0032821
28295357	magnesium	C0024467
28295357	zinc	C0043481
28295357	phosphorus	C0031705
28295357	porcine	C0039005
28295357	bone	C0262950
28295357	experimental	C1517586
28295357	analog	C0243071
28295357	human	C0086418
28295357	bone	C0262950
28295357	analyzed	C0936012
28295357	inductively coupled plasma optical emission spectroscopy	C0260252
28295357	ICP-OES	C0260252
28295357	samples	C0444227
28295357	porcine	C0039005
28295357	bone	C0262950
28295357	subjected	C1550501
28295357	shallow burial	C0006407
28295357	surface	C0825429
28295357	depositions	C0333562
28295357	day	C0439228
28295357	intervals	C1272706
28295357	period	C1948053
28295357	days	C0439228
28295357	Results	C0683954
28295357	indicated	C1444656
28295357	ICP-OES	C0260252
28295357	elemental	C0013879
28295357	profiling	C2003903
28295357	potential	C3245505
28295357	developed	C0205556
28295357	forensic test	C0022885
28295357	determining	C0205556
28295357	bone sample	C0444227
28295357	early	C1279919
28295357	stages	C1306673
28295357	soft tissue	C0225317
28295357	putrefaction	C0333532
28295357	Significant changes	C0443172
28295357	iron	C0302583
28295357	sodium	C0037473
28295357	potassium	C0032821
28295357	concentrations	C1446561
28295357	found	C0150312
28295357	over	C0347984
28295357	days	C0439228
28295357	elements	C0013879
28295357	known	C0205309
28295357	primarily	C0205225
28295357	associated with	C0332281
28295357	proteins	C0033684
28295357	tissue fluids	C0162367
28295357	bone	C0262950
28295357	Changes	C0443172
28295357	concentrations	C1446561
28295357	dehydration	C1963090
28295357	time	C0040223
28295357	time	C0040223
28295357	since	C1711239
28295357	deposition	C0333562
28295838	Oxyria sinensis	C1066614
28295838	Polygonaceae	C0524882
28295838	diploid	C0012568
28295838	congener	C0678518
28295838	ancestor	C0870134
28295838	origin	C0005495
28295838	polyploid	C0032578
28295838	species	C1705920
28295838	ancestor	C0870134
28295838	extinct	C1720991
28295838	extinct	C1720991
28295838	genome	C0017428
28295838	polyploid	C0032578
28295838	species	C1705920
28295838	existence	C1547035
28295838	presence	C3854307
28295838	genome	C0017428
28295838	polyploid	C0032578
28295838	polyploid	C0032578
28295838	origin	C0005495
28295838	Oxyria sinensis	C1066614
28295838	congeneric	C0678518
28295838	species	C1705920
28295838	diploid	C0012568
28295838	O. digyna	C1481306
28295838	Genomic in situ hybridization	C0162788
28295838	GISH	C0162788
28295838	transcriptome	C0752248
28295838	phylogenetic	C1519068
28295838	demographic analyses	C0011289
28295838	ecological niche modelling	C0282574
28295838	GISH	C0162788
28295838	O. sinensis	C1066614
28295838	chromosomes	C1135923
28295838	O. digyna	C1481306
28295838	chromosomes	C1135923
28295838	ancestor	C0870134
28295838	Transcriptome analysis	C0752248
28295838	divergence	C0443204
28295838	O. digyna	C1481306
28295838	genome duplication	C0017261
28295838	genome duplication	C0017261
28295838	O. sinensis	C1066614
28295838	Oxyria sinensis	C1066614
28295838	homologous gene sequences	C0162774
28295838	divergent	C0443204
28295838	O. digyna	C1481306
28295838	clustered	C0017258
28295838	O. digyna	C1481306
28295838	Coalescent simulations	C0876936
28295838	O. sinensis	C1066614
28295838	distribution	C3494413
28295838	polyploidization event	C0032578
28295838	O. digyna	C1481306
28295838	distributions	C3494413
28295838	species	C1705920
28295838	contracted and re-expanded	C0205245
28295838	Pleistocene climatic oscillations	C3826560
28295838	Ecological niche modelling	C0282574
28295838	species	C1705920
28295838	distributional	C3494413
28295838	Quaternary climatic changes	C3826560
28295838	extinction	C1720991
28295838	tetraploid	C0333694
28295838	species	C1705920
28295838	origin	C0005495
28295838	O. sinensis	C1066614
28295838	adaptation	C0000934
28295838	O. sinensis	C1066614
28295838	repeated climatic changes	C3826560
28296680	Primitive Neuroectodermal Tumors	C0206663
28296680	Female Genital Tract	C0017421
28296680	Morphologic	C0332437
28296680	Immunohistochemical	C1441616
28296680	Molecular	C1521991
28296680	Study	C2603343
28296680	Cases	C1706256
28296680	Primary primitive neuroectodermal tumor	C0206663
28296680	PNET	C0206663
28296680	female genital tract	C0017421
28296680	classification	C0008902
28296680	clinical	C0205210
28296680	histologic	C0205462
28296680	immunophenotypic	C0079611
28296680	features	C2348519
28296680	EWSR1	C0808901
28296680	rearrangement	C0017287
28296680	gynecologic	C0205480
28296680	PNETs	C0206663
28296680	ovarian	C0205065
28296680	uterine	C0042149
28296680	vulvar	C0042993
28296680	tumors	C0027651
28296680	reported	C0684224
28296680	Patient	C0030705
28296680	age	C0001779
28296680	ranged	C1514721
28296680	years	C0439234
28296680	age	C0001779
28296680	years	C0439234
28296680	ovarian	C0205065
28296680	uterine	C0042149
28296680	PNETs	C0206663
28296680	Morphologic	C0332437
28296680	features	C2348519
28296680	central nervous system	C3714787
28296680	CNS	C3714787
28296680	tumors	C0027651
28296680	PNETs	C0206663
28296680	medulloblastomas	C0025149
28296680	ependymomas	C0014474
28296680	medulloepitheliomas	C0334596
28296680	glioblastoma	C0017636
28296680	central PNET	C0206663
28296680	PNETs	C0206663
28296680	undifferentiated	C0205618
28296680	small round blue cells	C0007634
28296680	Ewing sarcoma/peripheral PNET	C0684337
28296680	PNETs	C0206663
28296680	tumor	C0027651
28296680	ovarian	C0205065
28296680	mature cystic teratomas	C1368910
28296680	endometrial low-grade	C1282907
28296680	endometrioid carcinomas	C0206687
28296680	uterine carcinosarcoma	C0280630
28296680	immunohistochemistry	C0021044
28296680	PNETs	C0206663
28296680	marker	C0041366
28296680	neuronal differentiation	C1518294
28296680	synaptophysin	C0085255
28296680	NSE	C1880904
28296680	CD56	C0108754
28296680	S100	C0027758
28296680	chromogranin	C0008586
28296680	tumors	C0027651
28296680	GFAP	C0017626
28296680	PNETs	C0206663
28296680	Membranous	C0025255
28296680	CD99	C0058889
28296680	nuclear	C0521447
28296680	Fli-1	C1437505
28296680	staining	C0487602
28296680	tumors	C0027651
28296680	expression	C1171362
28296680	markers	C0041366
28296680	central	C0206663
28296680	Ewing sarcoma/peripheral PNET	C0684337
28296680	tumors	C0027651
28296680	expressed	C1171362
28296680	vimentin	C0042666
28296680	keratin	C0022564
28296680	CAM5.2	C0910360
28296680	AE1/AE3	C1545476
28296680	staining	C0487602
28296680	PNETs	C0206663
28296680	Fluorescence in situ hybridization	C0162789
28296680	cases	C1706256
28296680	EWSR1	C0808901
28296680	rearrangement	C0017287
28296680	tumors	C0027651
28296680	morphologic	C0332437
28296680	features	C2348519
28296680	Ewing sarcoma/peripheral PNET	C0684337
28296680	CD99	C0058889
28296680	Fli-1	C1437505
28296680	expression	C1171362
28296680	central	C0206663
28296680	Ewing sarcoma/peripheral PNETs	C0684337
28296680	female genital tract	C0017421
28296680	central PNETs	C0206663
28296680	Central PNETs	C0206663
28296680	spectrum	C2827424
28296680	morphologic	C0332437
28296680	features	C2348519
28296680	CNS	C3714787
28296680	tumors	C0027651
28296680	EWSR1	C0808901
28296680	rearrangement	C0017287
28296680	GFAP	C0017626
28296680	expression	C1171362
28296680	morphologic	C0332437
28296680	central PNET	C0206663
28296680	sarcoma/peripheral PNET	C0684337
28296680	Ewing sarcoma/peripheral PNETs	C0684337
28296680	morphologic	C0332437
28296680	features	C2348519
28296680	CNS	C3714787
28296680	tumors	C0027651
28297577	Surgical Excision	C0728940
28297577	Heterotopic Ossification	C0029396
28297577	Re-Emergence	C1254367
28297577	Mesenchymal Stem Cell Populations	C1257975
28297577	Recurrence	C0034897
28297577	heterotopic ossification	C0029396
28297577	HO	C0029396
28297577	severe	C0205082
28297577	musculoskeletal injuries	C0272448
28297577	burns	C0562038
28297577	significant	C0750502
28297577	patient	C0030705
28297577	rehabilitation	C0034991
28297577	incidence	C0021149
28297577	HO	C0029396
28297577	increases	C0205217
28297577	repeated operations	C0035110
28297577	resection	C0728940
28297577	HO	C0029396
28297577	Treatment	C0087111
28297577	heterotopic ossification	C0029396
28297577	surgical excision	C0728940
28297577	incomplete	C0205257
28297577	evidence of	C0332120
28297577	persistent	C0205322
28297577	heterotopic bone	C4061353
28297577	patients	C0030705
28297577	continue	C0549178
28297577	signs or symptoms	C3540840
28297577	HO	C0029396
28297577	chronic pain	C0150055
28297577	nonhealing	C3845448
28297577	wounds	C0043250
28297577	joint restriction	C0231589
28297577	study	C0008972
28297577	model	C2986594
28297577	recurrent	C2945760
28297577	HO	C0029396
28297577	surgical excision	C0728940
28297577	mature	C0205286
28297577	HO	C0029396
28297577	mouse model	C2986594
28297577	hind-limb Achilles' tendon	C0001074
28297577	transection	C0152060
28297577	dorsal	C0205095
28297577	burn injury	C0006434
28297577	key	C3898777
28297577	signaling	C0037080
28297577	mediators	C0033684
28297577	HO	C0029396
28297577	bone morphogenetic protein signaling	C1155364
28297577	mature bone	C0682560
28297577	surgical excision	C0728940
28297577	upregulation	C0041904
28297577	downstream	C0522506
28297577	mediators	C0033684
28297577	osteogenic	C0599660
28297577	differentiation	C2945687
28297577	pSMAD 1	C1566789
28297577	5	C0529859
28297577	surgical excision	C0728940
28297577	re-emergence	C1254367
28297577	mesenchymal cell population	C1257975
28297577	expression	C0597360
28297577	platelet-derived growth factor receptor-α	C0290067
28297577	PDGFRα	C0290067
28297577	present	C0150312
28297577	initial	C0205265
28297577	HO	C0029396
28297577	lesion	C0221198
28297577	absent	C0332197
28297577	mature	C0205286
28297577	HO	C0029396
28297577	recurrent	C2945760
28297577	lesion	C0221198
28297577	PDGFRα	C0290067
28297577	mesenchymal cells	C1257975
28297577	proliferative	C0334094
28297577	initial	C0205265
28297577	HO	C0029396
28297577	lesion	C0221198
28297577	surgical excision	C0728940
28297577	HO	C0029396
28297577	results	C0683954
28297577	recurrence	C0034897
28297577	mesenchymal cell populations	C1257975
28297577	signaling	C0037080
28297577	mechanisms	C0441712
28297577	present	C0150312
28297577	initial	C0205265
28297577	HO	C0029396
28297577	lesion	C0221198
28297577	results	C0683954
28297577	consistent with	C0332290
28297577	findings	C0243095
28297577	patients	C0030705
28297577	foci	C0205234
28297577	ectopic bone	C1384482
28297577	excision	C0728940
28297577	sites	C1515974
28297577	de novo	C1515568
28297577	formation	C1522492
28297577	extension	C0231448
28297577	unresected	C2986425
28297577	bone	C1384482
28298171	Extended release	C0868939
28298171	flurbiprofen	C0016377
28298171	tromethamine	C0041175
28298171	buffered	C0006353
28298171	HPMC	C0063242
28298171	hydrophilic	C0475370
28298171	matrix tablets	C0039225
28298171	pH	C0020283
28298171	dependent	C3244310
28298171	solubility	C0037628
28298171	drug	C1254351
28298171	pH	C0020283
28298171	dependent	C3244310
28298171	drug release	C3850077
28298171	hydrophilic	C0475370
28298171	matrix tablets	C0039225
28298171	buffer salts	C1659042
28298171	formulation	C0013058
28298171	attempt	C1516084
28298171	mitigate	C1553901
28298171	impair	C0221099
28298171	matrix hydration	C0596317
28298171	negatively	C0205160
28298171	impact	C4049986
28298171	drug release	C3850077
28298171	evaluation	C0220825
28298171	buffering	C0006353
28298171	hydrophilic	C0475370
28298171	matrix tablets	C0039225
28298171	pH	C0020283
28298171	dependent	C3244310
28298171	solubility	C0037628
28298171	weak acid drug	C1254351
28298171	flurbiprofen	C0016377
28298171	identified	C0205396
28298171	possessing	C3154893
28298171	deleterious effect	C1280500
28298171	hydroxypropyl methylcellulose	C0063242
28298171	HPMC	C0063242
28298171	solubility	C0037628
28298171	swelling	C1522240
28298171	gelation	C1522240
28298171	drug dissolution	C3850077
28298171	characteristics	C1521970
28298171	hydrophilic	C0475370
28298171	matrix gel layer	C0017243
28298171	presence	C0332443
28298171	tromethamine	C0041175
28298171	buffer	C0006353
28298171	inclusion	C1512693
28298171	tromethamine	C0041175
28298171	alkalizing agent	C0304463
28298171	pH	C0020283
28298171	independent	C0332291
28298171	flurbiprofen	C0016377
28298171	release	C0868939
28298171	matrices	C0439861
28298171	HPMC 2910 (E series)	C0063242
28298171	2208 (K series)	C0063242
28298171	concomitantly	C0521115
28298171	decreasing	C0442797
28298171	critical effect	C1280500
28298171	dissolution	C3850077
28298171	mediated	C0086597
28298171	drug	C1254351
28298171	pseudo-gel layer formation	C1522492
28298171	functionality	C0205245
28298171	Drug release profiles	C1707824
28298171	unaffected	C2986417
28298171	matrix	C0439861
28298171	pH-changes	C0243095
28298171	loss	C1517945
28298171	tromethamine	C0041175
28298171	over time	C1254367
28298171	HPMC	C0063242
28298171	inhibited	C0311403
28298171	precipitation	C0032931
28298171	drug	C1254351
28298171	supersaturated solution	C0037633
28298171	hydrated matrix	C0596317
28298171	facilitation	C0234112
28298171	diffusion-based	C0012222
28298171	release	C0868939
28298171	deleterious drugs	C1254351
28298171	hydrophilic	C0475370
28298171	matrices	C0439861
28298171	buffering species	C0006353
28299515	influence	C4054723
28299515	slope	C1254362
28299515	Spartium junceum	C1014924
28299515	root system	C0242726
28299515	morphological	C0332437
28299515	anatomical	C0220784
28299515	biomechanical	C0205556
28299515	adaptation	C0392673
28299515	Root systems	C0242726
28299515	role	C1705810
28299515	plant	C0032098
28299515	anchorage	C2825961
28299515	mechanical interactions	C1704675
28299515	soil	C0037592
28299515	soil	C0037592
28299515	reinforcement	C0205245
28299515	stabilization	C0205360
28299515	slide-prone slopes	C1254362
28299515	responses	C0871261
28299515	root system	C0242726
28299515	mechanical stress	C0038442
28299515	induced	C0205263
28299515	slope	C1254362
28299515	samples	C0370003
28299515	Spartium junceum L.	C1014924
28299515	growing	C0205245
28299515	slope	C1254362
28299515	plane	C1254362
28299515	natural conditions	C0205296
28299515	morphology	C0332437
28299515	biomechanical properties	C0871161
28299515	anatomical features	C0502371
28299515	Soils	C0037592
28299515	sampled	C0870078
28299515	slope	C1254362
28299515	plane	C1254362
28299515	characteristics	C1521970
28299515	exception	C1705847
28299515	organic matter	C0439861
28299515	content	C0456205
28299515	penetrometer resistance	C4281815
28299515	slope	C1254362
28299515	Slope	C1254362
28299515	influenced	C4054723
28299515	root	C0242726
28299515	morphology	C0332437
28299515	distribution	C1704711
28299515	lateral	C0205093
28299515	roots	C0242726
28299515	soil	C0037592
28299515	depth	C0205125
28299515	first-order	C1373201
28299515	lateral	C0205093
28299515	roots	C0242726
28299515	plants	C0032098
28299515	growing	C0205245
28299515	slope	C1254362
28299515	condition	C0348080
28299515	asymmetric	C0332514
28299515	distribution	C1704711
28299515	up-	C1254362
28299515	down-slope	C1254362
28299515	asymmetric	C0332514
28299515	distribution	C1704711
28299515	plants	C0032098
28299515	growing	C0205245
28299515	plane	C1254362
28299515	tensile strength	C0039526
28299515	lateral	C0205093
28299515	roots	C0242726
28299515	growing	C0205245
28299515	up-slope	C1254362
28299515	plane	C1254362
28299515	conditions	C0348080
28299515	growing	C0205245
28299515	down-slope	C1254362
28299515	Anatomical investigations	C0242481
28299515	roots	C0242726
28299515	up-slope	C1254362
28299515	area	C0205146
28299515	xylem fibers	C1720877
28299515	ratio	C0456603
28299515	xylem	C1720877
28299515	phloem fibers	C1720878
28299515	root	C0242726
28299515	diameter	C1301886
28299515	conditions	C0348080
28299515	no differences	C3842396
28299515	xylem fiber	C1720877
28299515	cell wall	C0007623
28299515	thickness	C1280412
28299515	Roots	C0242726
28299515	growing	C0205245
28299515	up-slope	C1254362
28299515	anchorage	C2825961
28299515	properties	C0871161
28299515	strength	C0039526
28299515	fibers	C1260603
28299515	xylematic	C1720877
28299515	tissues	C1514137
28299515	root	C0242726
28299515	specific	C0205369
28299515	morphological	C0332437
28299515	anatomical	C0220784
28299515	biomechanical	C0205556
28299515	traits	C0599883
28299515	anchorage	C2825961
28299515	functions	C0542341
28299515	slope	C1254362
28299515	conditions	C0348080
28299817	expression	C0017262
28299817	Olr59	C1418155
28299817	Ethe1	C1428025
28299817	Slc10a2 genes	C1420087
28299817	liver	C1882726
28299817	F344 rats	C0034703
28299817	neonatal	C0021289
28299817	thyroid hormone disruption	C0347610
28299817	thyroid hormone-disrupting	C0347610
28299817	chemicals	C0018624
28299817	environment	C0014406
28299817	disruption of thyroid hormones	C0347610
28299817	neonatal period	C0935562
28299817	permanent effects	C1280500
28299817	thyroid hormone	C0040135
28299817	homeostasis	C0019868
28299817	developmental disorders	C0008073
28299817	thyroid hormones	C0040135
28299817	regulating the growth	C1160191
28299817	differentiation of many tissues	C1519519
28299817	gene expressions	C0017262
28299817	neonatal	C0021289
28299817	administration of thyroid hormone	C0199780
28299817	genes whose expression	C0017262
28299817	altered	C0392747
28299817	liver	C1882726
28299817	thyroid hormone	C0040135
28299817	neonatal	C0021289
28299817	exposure to	C0332157
28299817	triiodothyronine	C0041014
28299817	T3	C0041014
28299817	T3	C0041014
28299817	administered	C0199780
28299817	male F344 rats	C0034703
28299817	postnatal days	C0443281
28299817	cDNA microarray analysis	C1609488
28299817	hepatic	C0205054
28299817	genes	C0017337
28299817	expression	C0017262
28299817	neonatal	C0021289
28299817	exposure to	C0332157
28299817	T3	C0041014
28299817	up-regulated genes	C0041904
28299817	expression	C0017262
28299817	Olr59	C1418155
28299817	Ethe1	C1428025
28299817	Slc10a2	C1420087
28299817	rats	C0034721
28299817	neonatally	C0021289
28299817	exposed to	C0332157
28299817	T3	C0041014
28299817	hepatic	C0205054
28299817	expression of these genes	C0017262
28299817	hydroxylated polybrominated diphenyl ether	C4086502
28299817	PBDE	C4086502
28299817	OH-BDE42	C4086502
28299817	binding to the TR	C1323384
28299817	neonatally	C0021289
28299817	neonatal	C0021289
28299817	thyroid hormones	C0040135
28299817	expression of the genes	C0017262
28299817	neonatal effects	C0856669
28299817	thyroid hormone	C0040135
28299817	disrupting chemicals	C0018624
28300431	Psychometric Costs	C0033920
28300431	Applicants	C0696628
28300431	Faking	C0871743
28300431	Measurement	C0242485
28300431	Retest Correlations	C0237828
28300431	Response Conditions	C0009647
28300431	examines the stability	C0205360
28300431	response process	C0009647
28300431	rank-order	C0871206
28300431	respondents	C0282122
28300431	responding	C0009647
28300431	personality scales	C0582654
28300431	response conditions	C0009647
28300431	Applicants	C0696628
28300431	University College of Teacher Education	C0041740
28300431	Styria	C0017446
28300431	personality scales	C0582654
28300431	college admission process	C0009352
28300431	personality scales	C0582654
28300431	randomly assigned	C0814868
28300431	response conditions	C0009647
28300431	honest	C0870663
28300431	faking-good	C0871743
28300431	Longitudinal means	C0023981
28300431	covariance structure analyses	C0814908
28300431	applicants	C0696628
28300431	response processes	C0009647
28300431	respondents	C0282122
28300431	honest	C0870663
28300431	response behavior	C0009647
28300431	frame of reference	C1711364
28300431	applicants	C0696628
28300431	faking behavior	C0871743
28300431	faking	C0871743
28300431	faking-good	C0871743
28300431	latent	C0205275
28300431	retest correlations	C0237828
28300431	measurement	C0242485
28300431	latent	C0205275
28300431	retest correlations	C0237828
28300431	indicated	C1444656
28300431	faking	C0871743
28300431	distort	C0700135
28300431	respondents	C0282122
28300431	rank-order	C0871206
28300431	fairness	C2911689
28300431	selection decisions	C0011109
28300431	faking behavior	C0871743
28300431	faking	C0871743
28300431	faking-good	C0871743
28300431	measurement	C0242485
28300431	applicants	C0696628
28300431	faking behavior	C0871743
28300431	correlations	C1707520
28300431	personality scales	C0582654
28300431	predictive validity	C0681898
28300431	interpreted	C1285553
28300431	applicants	C0696628
28300431	Faking behavior	C0871743
28300431	uniform bias	C0242568
28300431	mean raw score	C0392762
28300431	interpreted	C1285553
28303067	Intraspinal meningioma	C1334264
28303067	malignant transformation	C1608408
28303067	distant metastasis	C1269798
28303067	Meningioma	C0025286
28303067	benign tumor	C0086692
28303067	Malignant transformation	C1608408
28303067	metastasis	C0027627
28303067	meningiomas	C0025286
28303067	rare	C0522498
28303067	meningiomas	C0025286
28303067	intracranial	C0524466
28303067	reports	C0684224
28303067	intraspinal meningiomas	C1334264
28303067	report	C0684224
28303067	clinical features	C0683325
28303067	pathological	C1521733
28303067	findings	C0243095
28303067	case	C1706256
28303067	malignant transformation	C1608408
28303067	distant metastasis	C1269798
28303067	intraspinal meningioma	C1334264
28303067	review of	C0699752
28303067	literature	C0023866
28303067	man	C0025266
28303067	bilateral	C0238767
28303067	lower limb paresis	C1836296
28303067	diagnosed	C0011900
28303067	intradural extramedullary tumor of the thoracic spine	C1334255
28303067	Primary	C0205225
28303067	tumor resection	C0472422
28303067	performed	C0884358
28303067	histological findings	C0449575
28303067	atypical meningioma	C0431122
28303067	meningioma	C0025286
28303067	recurred	C0034897
28303067	years	C0439234
28303067	primary	C0205225
28303067	surgery	C0543467
28303067	second	C0205436
28303067	resection	C0728940
28303067	performed	C0884358
28303067	partial	C0728938
28303067	resection	C0728940
28303067	decreased	C0205216
28303067	motor evoked potential	C0282617
28303067	age	C0001779
28303067	patient's	C0030705
28303067	lower limb weakness	C1836296
28303067	returned	C0034897
28303067	third	C0205437
28303067	resection	C0728940
28303067	performed	C0884358
28303067	histological finding	C0449575
28303067	atypical meningioma	C0431122
28303067	age	C0001779
28303067	tumor	C0027651
28303067	increased	C0205217
28303067	stereotactic irradiation	C0085203
28303067	performed	C0884358
28303067	age	C0001779
28303067	patient	C0030705
28303067	diagnosed	C0011900
28303067	metastatic tumors	C0027627
28303067	rib	C0035561
28303067	lumbar vertebra	C0024091
28303067	cervical spine	C0728985
28303067	sacrum	C0036037
28303067	Biopsy	C0005558
28303067	rib	C0035561
28303067	metastatic tumor	C2939420
28303067	performed	C0884358
28303067	histological findings	C0449575
28303067	anaplastic meningioma	C0259785
28303067	case	C1706256
28303067	report	C0684224
28303067	intraspinal meningioma	C1334264
28303067	transformed	C1608408
28303067	atypical	C0431122
28303067	anaplastic meningioma	C0259785
28303067	distant hematogenous metastasis	C1269798
28303067	hematogenous	C0796572
28303341	Epidemiology	C0014507
28303341	risk factors	C0035648
28303341	associated with	C0332281
28303341	surgical site infection	C0038941
28303341	types	C0332307
28303341	hepatobiliary and pancreatic surgery	C1319408
28303341	Surgical site infection	C0038941
28303341	SSI	C0038941
28303341	healthcare-associated infections	C0010356
28303341	HAIs	C0010356
28303341	SSI	C0038941
28303341	hepatobiliary and pancreatic surgery	C1319408
28303341	HBPS	C1319408
28303341	investigated	C1292732
28303341	large	C0549177
28303341	cohort	C0599755
28303341	patients	C0030705
28303341	factors	C1521761
28303341	associated with	C0332281
28303341	SSI	C0038941
28303341	HBPS	C1319408
28303341	Japan	C0022341
28303341	Japanese national database	C0242356
28303341	Data	C1511726
28303341	HBPS	C1319408
28303341	performed	C0884358
28303341	extracted	C1707635
28303341	national monitoring system	C0282574
28303341	HAI	C0010356
28303341	Japan Nosocomial Infections Surveillance	C0419786
28303341	multivariate logistic regression	C0206031
28303341	assessed	C1516048
28303341	factors	C1521761
28303341	associated with	C0332281
28303341	SSI	C0038941
28303341	cumulative	C1511559
28303341	incidence	C0021149
28303341	SSI	C0038941
28303341	HBPS	C1319408
28303341	incidence	C0021149
28303341	SSI	C0038941
28303341	pancreatoduodenectomy	C0085162
28303341	significantly higher	C4055637
28303341	liver resection	C0019144
28303341	types	C0332307
28303341	HBPS	C1319408
28303341	traditional	C0443324
28303341	risk factors	C0035648
28303341	American Society of Anesthesiologists	C2346733
28303341	score	C0449820
28303341	ineffective	C3242229
28303341	predicting	C0681842
28303341	SSI	C0038941
28303341	model	C3161035
28303341	types	C0332307
28303341	surgery	C0543467
28303341	risk factors	C0035648
28303341	identified	C0205396
28303341	age	C0001779
28303341	male gender	C0086582
28303341	incidence	C0021149
28303341	factors	C1521761
28303341	associated with	C0332281
28303341	SSI	C0038941
28303341	types	C0332307
28303341	HBPS	C1319408
28303341	accurately	C0443131
28303341	compare	C1707455
28303341	hospital	C0019994
28303341	performance	C0871017
28303341	relation	C0439849
28303341	SSI	C0038941
28303341	HBPS	C1319408
28303341	operative procedure	C0543467
28303341	category	C0683312
28303341	surveillance system	C1254363
28303341	divided	C0332849
28303341	types	C0332307
28303942	Signature	C1514562
28303942	aggregation	C0332621
28303942	prone	C0033422
28303942	tau	C0085401
28303942	self-assembly	C0872376
28303942	microtubule	C0026046
28303942	associated	C0332281
28303942	tau protein	C0085401
28303942	fibrillar cell inclusions	C0230674
28303942	linked	C0449379
28303942	number	C0237753
28303942	neurodegenerative disorders	C0524851
28303942	tauopathies	C0949664
28303942	mechanism	C0441712
28303942	tau	C0085401
28303942	self-assembles	C0872376
28303942	pathological	C1521733
28303942	entities	C1551338
28303942	debate	C0870392
28303942	largely	C0549177
28303942	due to	C0678226
28303942	direct	C1947931
28303942	experimental	C1517586
28303942	insights	C0233820
28303942	earliest stages	C2363430
28303942	aggregation	C0332621
28303942	pulsed double electron-electron resonance	C0022885
28303942	measurements	C0242485
28303942	fibril	C0225328
28303942	forming	C1522492
28303942	regions	C0205147
28303942	tau	C0085401
28303942	PHF6	C1608562
28303942	PHF6*	C0033684
28303942	transient	C0205374
28303942	aggregation	C0332621
28303942	end-to-end distance	C0012751
28303942	distribution	C1704711
28303942	function	C0542341
28303942	aggregation	C0332621
28303942	time	C0040223
28303942	PHF6((*))	C0033684
28303942	regions	C0205147
28303942	extend	C0231448
28303942	distances	C0012751
28303942	commensurate	C0205163
28303942	extended	C0231449
28303942	β-strand structures	C0600383
28303942	earliest stages	C2363430
28303942	aggregation	C0332621
28303942	fibril	C0225328
28303942	formation	C1522492
28303942	Combined	C0205195
28303942	simulations	C0679083
28303942	experiments	C0681814
28303942	extended	C0231449
28303942	β-strand conformational	C0600383
28303942	state	C1442792
28303942	PHF6((*))	C0033684
28303942	aggregating	C0332621
28303942	conditions	C0348080
28303942	signature	C1514562
28303942	aggregation	C0332621
28303942	prone	C0033422
28303942	tau	C0085401
28303942	target	C1521840
28303942	therapeutic interventions	C0808232
28304102	Design	C1707689
28304102	Synthesis	C0007987
28304102	Cytotoxic	C0596402
28304102	Evaluation	C0220825
28304102	7-Chloro-4-(piperazin-1-yl)quinoline	C0034424
28304102	Derivatives	C0243072
28304102	VEGFR-II	C0378796
28304102	Inhibitors	C0243077
28304102	Signaling pathway	C0037080
28304102	inhibition	C3463820
28304102	VEGFR-II	C0378796
28304102	cancer	C0006826
28304102	management	C0376636
28304102	current study	C2603343
28304102	synthesis	C0007987
28304102	novel	C0205314
28304102	1-4-(7-chloroquinolin-4-yl)piperazin-1-yl)-2-(N-substituted-amino)-ethanone	C0034424
28304102	derivatives	C0243072
28304102	4a-t	C0034424
28304102	amination	C0002505
28304102	2-chloro-1-(4-(7-chloroquinolin-4-yl)piperazin-1-yl)ethanone (3)	C0034424
28304102	secondary amines.	C0002508
28304102	structures	C0026383
28304102	target	C1521840
28304102	compounds	C1706082
28304102	confirmed by	C0521093
28304102	IR	C0037807
28304102	(1) H-NMR	C3850001
28304102	(13) C-NMR	C3850003
28304102	HRMS	C0037813
28304102	microanalysis	C0013844
28304102	Compounds	C1706082
28304102	4a-t	C0034424
28304102	in vitro	C1533691
28304102	anticancer	C0920425
28304102	screening	C1710032
28304102	human breast cancer	C0678222
28304102	MCF-7	C0596890
28304102	prostate cancer	C0600139
28304102	PC3	C0007634
28304102	cell lines	C0007600
28304102	cytotoxicty	C0596402
28304102	cell lines	C0007600
28304102	2-(4-(4-bromobenzyl)piperazin-1-yl)-1-(4-(7-chloroquinolin-4-yl)piperazin-1-yl)ethanone (4q)	C0034424
28304102	IC50 values	C0600495
28304102	MCF-7	C0596890
28304102	PC3 cells	C0007634
28304102	compared	C1707455
28304102	standard drug	C0920479
28304102	doxorubicin	C0013089
28304102	MCF-7	C0596890
28304102	PC3	C0007634
28304102	activity	C0441655
28304102	MCF-7 cells	C0596890
28304102	4q	C0034424
28304102	VEGFR-II	C0378796
28304102	inhibitor	C0243077
28304102	IC50	C0600495
28304102	sorafenib	C1516119
28304102	docking	C1522290
28304102	4q	C0034424
28304102	binding mode	C1167622
28304102	VEGFR-II	C0378796
28304102	inhibitors	C0243077
28304405	ErbB3 receptor tyrosine kinase	C0072460
28304405	regulates	C1327622
28304405	Paneth cells	C0227276
28304405	PI3K	C0044602
28304405	dependent	C3244310
28304405	suppression	C0038855
28304405	Atoh1	C1412626
28304405	Paneth cells	C0227276
28304405	PCs	C0227276
28304405	secretory population	C1519221
28304405	intestinal crypt	C3686613
28304405	intestinal	C0021853
28304405	stem cells	C0038250
28304405	ISC	C0038250
28304405	growth factors	C0018284
28304405	innate immunity	C0020969
28304405	antimicrobial peptides	C4084937
28304405	lysozyme	C3541379
28304405	defensins	C0057256
28304405	PC	C0227276
28304405	dysfunction	C3887504
28304405	disorders	C0012634
28304405	Crohn's disease	C0010346
28304405	necrotizing enterocolitis	C0520459
28304405	pathways	C1148560
28304405	regulating	C1327622
28304405	PC	C0227276
28304405	development	C0815089
28304405	function	C0007613
28304405	neuregulin receptor ErbB3	C0072460
28304405	PC	C0227276
28304405	differentiation	C0007589
28304405	ISC niche	C2350292
28304405	Intestinal	C0021853
28304405	epithelial	C0221908
28304405	ErbB3	C0812265
28304405	knockout	C0599772
28304405	precocious	C1279930
28304405	appearance	C0700364
28304405	PCs	C0227276
28304405	postnatal	C0443281
28304405	day 7	C3842672
28304405	increased	C0205217
28304405	mature	C0205286
28304405	PCs	C0227276
28304405	adult mouse	C0025929
28304405	ileum	C0020885
28304405	ErbB3	C0072460
28304405	secretory lineages	C0282637
28304405	increased	C0205217
28304405	expression	C1171362
28304405	ISC	C0038250
28304405	Lgr5	C0762578
28304405	ErbB3	C0072460
28304405	intestines	C0021853
28304405	Atoh1	C1412626
28304405	transcription factor	C0040648
28304405	Atoh1(+)	C1567779
28304405	cells	C0007634
28304405	ErbB3	C0812265
28304405	reciprocal	C1882911
28304405	negative	C0205160
28304405	regulation	C1327622
28304405	ErbB3	C0072460
28304405	intestinal progenitor cells	C0814997
28304405	reduced	C0392756
28304405	activation	C1879547
28304405	PI3K-Akt	C2984369
28304405	ERK MAPK pathways	C1148560
28304405	pathways	C1148560
28304405	HT29 cells	C0007634
28304405	increased	C0205217
28304405	ATOH1	C1412626
28304405	PC	C0227276
28304405	LYZ	C1416945
28304405	ErbB3	C0072460
28304405	suppressed	C0038855
28304405	LYZ	C1416945
28304405	ATOH1	C1412626
28304405	PI3K	C0044602
28304405	dependent	C3244310
28304405	PC	C0227276
28304405	ErbB3	C0072460
28304405	intestines	C0021853
28304405	ER stress	C3178870
28304405	inflammation	C0021368
28304405	markers	C0005516
28304405	negative	C0205160
28304405	regulation	C1327622
28304405	PCs	C0227276
28304405	ErbB3	C0072460
28304405	homeostasis	C0019868
28304405	data	C1511726
28304405	ErbB3	C0072460
28304405	PC	C0227276
28304405	PI3K	C0044602
28304405	suppression	C0038855
28304405	Atoh1	C1412626
28304405	PC	C0227276
28304405	differentiation	C0007589
28304405	regulation	C0007613
28304405	ISC niche	C2350292
28306155	CDF	C3826440
28306155	quantile	C1709792
28306155	distributions	C0038205
28306155	modelling	C3161035
28306155	random variables	C1705098
28306155	unit interval	C1552654
28306155	two-parameter	C0549193
28306155	distributions	C0038205
28306155	modelling	C3161035
28306155	random variables	C1705098
28306155	interval	C1552654
28306155	cumulative distribution function	C3826440
28306155	parent' distribution	C3826440
28306155	quantile	C1709792
28306155	function	C1705273
28306155	probability density	C2986804
28306155	functions	C1705273
28306155	cumulative distribution functions	C3826440
28306155	quantile	C1709792
28306155	location	C0450429
28306155	parameter	C0549193
28306155	dispersion	C0332624
28306155	parameter	C0549193
28306155	variety	C2346866
28306155	shapes	C0332479
28306155	beta	C1552649
28306155	Kumaraswamy distributions	C3826440
28306155	cannot	C0243095
28306155	amenable	C3900053
28306155	likelihood inference	C0023707
28306155	variety	C2346866
28306155	quantile	C1709792
28306155	regression models	C0034980
28306155	predictors	C2698872
28306155	location	C0450429
28306155	dispersion	C0332624
28306155	parameters	C0549193
28306155	psychological	C0033909
28306155	research problems	C0242481
28306155	utility	C0457083
28306155	modelling	C3161035
28306155	real data	C3272377
28314676	First	C0205435
28314676	second	C0205436
28314676	generation	C0079411
28314676	DESs	C1322815
28314676	reduce	C0392756
28314676	diabetes	C0011847
28314676	adverse effect	C0879626
28314676	mortality	C0205848
28314676	re-intervention	C0184661
28314676	multivessel	C0005847
28314676	coronary disease	C0010054
28314676	Year	C0439234
28314676	analysis	C0936012
28314676	Diabetes	C0011847
28314676	portends	C0205245
28314676	increased	C0205217
28314676	risk	C0035647
28314676	adverse	C0879626
28314676	early	C1279919
28314676	late	C0205087
28314676	outcomes	C1274040
28314676	patients	C0030705
28314676	PCI	C1532338
28314676	study	C2603343
28314676	investigate	C1292732
28314676	adverse effect	C0879626
28314676	diabetes mellitus	C0011849
28314676	DM	C0011849
28314676	early	C1279919
28314676	late	C0205087
28314676	PCI	C1532338
28314676	outcomes	C1274040
28314676	reduced	C0392756
28314676	drug-eluting	C1322815
28314676	DES	C1322815
28314676	bare-metal (BMS) stents	C2825200
28314676	reviewed	C1552617
28314676	Mount Sinai Beth Israel Hospital	C0019994
28314676	first	C0205435
28314676	PCI	C1532338
28314676	multivessel	C0005847
28314676	coronary artery disease	C0010054
28314676	CAD	C0010054
28314676	Patients	C0030705
28314676	excluded	C2828389
28314676	single-vessel CAD	C0581374
28314676	emergency	C1561583
28314676	no	C1513916
28314676	stent	C0038257
28314676	prior	C0332152
28314676	bypass graft	C0185098
28314676	myocardial infarction	C0027051
28314676	Diabetes	C0011847
28314676	effect	C1280500
28314676	year	C0439234
28314676	mortality	C0205848
28314676	re-intervention	C0184661
28314676	risk-adjusted hazard ratios	C2985465
28314676	AHR	C2985465
28314676	confidence intervals	C0009667
28314676	DES	C1322815
28314676	three-vessel	C3272265
28314676	DM	C0011849
28314676	BMS	C2825200
28314676	three-vessel	C3272265
28314676	DM	C0011849
28314676	stent	C0038257
28314676	DES	C1322815
28314676	BMS	C2825200
28314676	vessel disease	C0042373
28314676	two	C0581375
28314676	three	C3272265
28314676	Diabetes	C0011847
28314676	effect	C1280500
28314676	mortality	C0205848
28314676	lower	C0205556
28314676	DES	C1322815
28314676	AHRDM/NoDM	C2985465
28314676	BMS	C2825200
28314676	AHRDM/NoDM	C2985465
28314676	predominantly	C1542147
28314676	two-vessel	C0581375
28314676	patients	C0030705
28314676	diabetes	C0011847
28314676	effect	C1280500
28314676	first	C0205435
28314676	DES1	C1322815
28314676	AHRDM/NoDM	C2985465
28314676	second	C0205436
28314676	DES2	C1322815
28314676	AHRDM/NoDM	C2985465
28314676	generation	C0079411
28314676	DES	C1322815
28314676	Re-intervention	C0184661
28314676	comparisons	C1707455
28314676	increased	C0205217
28314676	diabetes	C0011847
28314676	sub-cohorts	C0599755
28314676	analysis	C0936012
28314676	PCI	C1532338
28314676	diabetes	C0011847
28314676	associated with	C0332281
28314676	worse	C1457868
28314676	year	C0439234
28314676	mortality	C0205848
28314676	irrespective	C1254372
28314676	stent	C0038257
28314676	type	C0332307
28314676	DES	C1322815
28314676	DES2	C1322815
28314676	2-vessel disease	C0581375
28314676	complementary	C1254372
28314676	stent	C0038257
28314676	effect	C1280500
28314676	analysis	C0936012
28314676	confirmed	C0750484
28314676	DES	C1322815
28314676	BMS	C2825200
28314676	DES2	C1322815
28314676	DES1	C1322815
28314676	superiority	C0205556
28314676	diabetics	C0241863
28314676	non-diabetics	C0243095
28318092	Lycopene	C0065331
28318092	risk	C0035647
28318092	cardiovascular diseases	C0007222
28318092	meta-analysis	C0920317
28318092	observational studies	C0552617
28318092	meta-analysis	C0920317
28318092	investigate	C1292732
28318092	lycopene	C0065331
28318092	risk	C0035647
28318092	cardiovascular diseases	C0007222
28318092	CVD	C0007222
28318092	Studies	C2603343
28318092	lycopene	C0065331
28318092	risk	C0035647
28318092	CVD	C0007222
28318092	Pubmed	C1138432
28318092	Embase	C0282574
28318092	Web of Science	C0282574
28318092	eligible studies	C2603343
28318092	identified	C0205396
28318092	inverse association	C1708567
28318092	risk ratio	C0242492
28318092	RR	C0242492
28318092	CI	C0009667
28318092	lycopene	C0065331
28318092	exposure	C0332157
28318092	risk	C0035647
28318092	CVD	C0007222
28318092	Findings	C0243095
28318092	dietary	C0012155
28318092	studies	C2603343
28318092	RR	C0242492
28318092	CI	C0009667
28318092	biomarker	C0005516
28318092	studies	C2603343
28318092	RR	C0242492
28318092	CI	C0009667
28318092	Dietary	C0012155
28318092	lycopene	C0065331
28318092	intake	C1512806
28318092	statistically significant	C0237881
28318092	coronary heart disease	C0010068
28318092	CHD	C0010068
28318092	RR	C0242492
28318092	CI	C0009667
28318092	stroke	C0038454
28318092	RR	C0242492
28318092	CI	C0009667
28318092	risk estimate	C1519101
28318092	lycopene	C0065331
28318092	biomarker	C0005516
28318092	statistically significant	C0237881
28318092	stroke	C0038454
28318092	RR	C0242492
28318092	CI	C0009667
28318092	Subgroup	C1515021
28318092	analyses	C0936012
28318092	retrospective	C0035363
28318092	studies	C2603343
28318092	statistically significant	C0237881
28318092	heterogeneity	C0019409
28318092	lycopene	C0065331
28318092	exposure	C0332157
28318092	inversely associated	C1708567
28318092	risk	C0035647
28318092	CVD	C0007222
28318092	randomized clinical trials	C0206034
28318092	lycopene	C0065331
28318092	CVD	C0007222
28318300	Bacteria	C0004611
28318300	Wheat	C1123020
28318300	Cucurbit	C0446254
28318300	Plant Roots	C0242726
28318300	Metabolize	C0025519
28318300	PAHs	C0032458
28318300	Aromatic	C0020245
28318300	Root	C0242726
28318300	Exudates	C1720935
28318300	Implications	C0392360
28318300	Rhizodegradation	C1720751
28318300	chemical interaction	C1537001
28318300	plants	C0032098
28318300	bacteria	C0004611
28318300	root	C0242726
28318300	zone	C1710706
28318300	soil	C0037592
28318300	decontamination	C0205245
28318300	Bacteria	C0004611
28318300	degrade	C0243125
28318300	PAHs	C0032458
28318300	isolated	C0205409
28318300	rhizospheres	C2936389
28318300	plant	C0032098
28318300	species	C1705920
28318300	biological	C0205460
28318300	traits	C0599883
28318300	phytochemicals	C0577749
28318300	contaminant	C2827365
28318300	degradation	C0243125
28318300	monocot	C0032098
28318300	dicotyledon plants	C0032098
28318300	grown	C0597252
28318300	PAH	C0032458
28318300	contaminated	C0205279
28318300	soil	C0037592
28318300	manufactured gas plant	C3273359
28318300	MGP	C3273359
28318300	site	C0205145
28318300	phytotoxicity assay	C0005507
28318300	soil	C0037592
28318300	decontamination	C0205245
28318300	rhizospheres	C2936389
28318300	compared	C1707455
28318300	soil	C0037592
28318300	controls	C2587213
28318300	Bacteria	C0004611
28318300	isolated	C0205409
28318300	plant roots	C0242726
28318300	rhizobacteria	C0004611
28318300	selected	C1707391
28318300	growth	C0018270
28318300	anthracene	C0003162
28318300	chrysene	C0055655
28318300	PAH	C0032458
28318300	amended	C1691222
28318300	plates	C1139067
28318300	Rhizosphere	C2936389
28318300	isolates	C1764827
28318300	metabolized	C0025519
28318300	PAHs	C0032458
28318300	PAH	C0032458
28318300	catabolic	C0311402
28318300	liquid incubations	C1439852
28318300	Aromatic	C0020245
28318300	root	C0242726
28318300	exudate compounds	C1720935
28318300	flavonoids	C0596577
28318300	simple phenols	C0031428
28318300	substrates	C3891814
28318300	isolated	C0205409
28318300	rhizobacteria	C0004611
28318300	phenolic compounds	C0031428
28318300	morin	C0066801
28318300	caffeic acid	C0054433
28318300	protocatechuic acid	C0072489
28318300	bacterial	C0004611
28318300	degradation	C0243125
28318300	PAHs	C0032458
28318300	rhizosphere	C2936389
28319455	Joint model imputation	C2825511
28319455	estimate	C0750572
28319455	treatment effect	C1518681
28319455	long-term	C0443252
28319455	survival	C0038952
28319455	auxiliary events	C0441471
28319455	Clinical trial	C0008976
28319455	duration	C0449238
28319455	clinical research	C0008972
28319455	cancer trials	C1516640
28319455	endpoint	C2347784
28319455	overall survival	C4086681
28319455	surrogate endpoint	C0162488
28319455	auxiliary variable	C0439828
28319455	analyze	C0936012
28319455	treatment effect	C1518681
28319455	censored	C3889994
28319455	observations	C0302523
28319455	compensated	C0205432
28319455	imputation	C2825511
28319455	unobserved	C0243095
28319455	deaths	C1306577
28319455	predictions	C0681842
28319455	risk	C0035647
28319455	death	C0011065
28319455	joint model	C2825511
28319455	recurrent	C2945760
28319455	event	C0441471
28319455	terminal	C0205088
28319455	event	C0441471
28319455	disease relapse	C0277556
28319455	information	C1533716
28319455	imputation methods	C2825511
28319455	compared	C1707455
28319455	sampling	C0036150
28319455	estimated parametric distribution	C0392762
28319455	survival time	C2919552
28319455	sampling	C0036150
28319455	nonparametric estimation	C0242932
28319455	treatment effect	C1518681
28319455	standard error	C1710181
28319455	estimated	C0750572
28319455	multiple imputations	C2825511
28319455	performances	C1882330
28319455	methods	C0025663
28319455	compared	C1707455
28319455	bias	C0242568
28319455	estimates	C0750572
28319455	standard errors	C1710181
28319455	coverage	C2700387
28319455	probability	C0033204
28319455	methods	C0025663
28319455	retrospectively	C1514923
28319455	applied	C4048755
28319455	randomized clinical trials	C0206034
28319455	effect	C1280500
28319455	adjuvant	C1522673
28319455	chemotherapy	C3665472
28319455	breast cancer	C0006142
28319455	patients	C0030705
28319640	Corneal Epithelial	C1182610
28319640	Barrier	C1704511
28319640	Developmental	C0458003
28319640	Isolating	C0205409
28319640	Corneal Epithelial	C1182610
28319640	Conjunctival Cells	C1182611
28319640	development	C1527148
28319640	corneal epithelium	C0459875
28319640	CE	C0459875
28319640	conjunctiva	C0009758
28319640	surface ectoderm	C1515087
28319640	examined	C0332128
28319640	development	C1527148
28319640	cells	C0007634
28319640	isolated	C0205409
28319640	Epithelia	C0014609
28319640	anterior eyes	C0003151
28319640	chicken embryos	C0008046
28319640	labeled	C1522485
28319640	fluorescent	C0016320
28319640	lipophilic dye	C0013343
28319640	1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate	C2350183
28319640	DiI	C2350183
28319640	DiI	C2350183
28319640	epithelial surface	C2327105
28319640	anterior eye	C0003151
28319640	diffusion	C0012222
28319640	fluorescence microscopy	C0026022
28319640	morphologic	C0332437
28319640	changes	C0392747
28319640	surface cells of these epithelial	C2327105
28319640	examined	C0332128
28319640	scanning electron microscopy	C0026020
28319640	Immunofluorescence	C0079604
28319640	expression	C1171362
28319640	cytokeratin K3	C1313613
28319640	ZO-1	C3503764
28319640	N-cadherin	C0027215
28319640	Connexin-43	C0110613
28319640	function	C0031843
28319640	gap junctions	C0206117
28319640	analyzed	C0936012
28319640	cut-loading	C0392762
28319640	fluorescent dye	C0016320
28319640	rhodamine-dextran	C0073196
28319640	embryonic	C0013936
28319640	day	C0439228
28319640	E	C0013936
28319640	DiI	C2350183
28319640	surface	C0205148
28319640	CE	C0459875
28319640	spreads	C0332261
28319640	epithelial cells	C0014597
28319640	anterior eye	C0003151
28319640	older eyes	C0015392
28319640	labeled	C1522485
28319640	dye	C0013343
28319640	diffusion	C0012222
28319640	restricted	C0443288
28319640	CE	C0459875
28319640	diffusion	C0012222
28319640	DiI	C2350183
28319640	conjunctival	C0009758
28319640	surface	C0205148
28319640	E	C0013936
28319640	restricted	C0443288
28319640	conjunctiva	C0009758
28319640	Scanning electron microscopy	C0026020
28319640	developmentally	C1527148
28319640	physical separations	C4060664
28319640	progressively	C0205329
28319640	cells	C1182610
28319640	CE	C0459875
28319640	conjunctiva	C0009758
28319640	E	C0013936
28319640	separations	C0205245
28319640	ring	C0229119
28319640	cornea	C0010031
28319640	functional	C0205245
28319640	restriction	C0443288
28319640	gap junctions	C0206117
28319640	tissues	C0014609
28319640	occur	C1709305
28319640	E	C0013936
28319640	ocular development	C1517080
28319640	barrier	C1704511
28319640	diffusion	C0012222
28319640	DiI	C2350183
28319640	contiguous	C0205283
28319640	CE	C0459875
28319640	conjunctiva	C0009758
28319640	differential	C1705242
28319640	expression	C1171362
28319640	gap junctions	C0206117
28319640	tissues	C0014609
28321789	Longitudinal study	C0023981
28321789	bovine	C0007452
28321789	rotavirus group A	C1002306
28321789	newborn	C0003065
28321789	calves	C3668829
28321789	vaccinated	C1519885
28321789	unvaccinated	C0243095
28321789	dairy herds	C0175925
28321789	rotavirus	C0035870
28321789	excretion	C0504085
28321789	calves	C3668829
28321789	cross-sectional studies	C0010362
28321789	protection	C0150259
28321789	calves	C3668829
28321789	born	C0005615
28321789	vaccinated	C1519885
28321789	dams	C0007452
28321789	diarrhea	C0011991
28321789	rotavirus	C0035870
28321789	excretion	C0504085
28321789	dairy calves	C3668829
28321789	vaccinated	C1519885
28321789	unvaccinated	C0243095
28321789	dams	C0007452
28321789	genotypes	C0017431
28321789	bovine	C0007452
28321789	rotavirus group A	C1002306
28321789	RVA	C1002306
28321789	strains	C1518614
28321789	animals	C3668829
28321789	disease	C0012634
28321789	naturally	C0205296
28321789	occurring	C1709305
28321789	first month of life	C3278912
28321789	fecal samples	C0475362
28321789	calves	C3668829
28321789	farm	C0557759
28321789	vaccinated	C1519885
28321789	herd	C0175925
28321789	samples	C0475362
28321789	calves	C3668829
28321789	tested positive	C1514241
28321789	RVA	C1002306
28321789	unvaccinated	C0243095
28321789	samples	C0475362
28321789	calves	C3668829
28321789	tested positive	C1514241
28321789	genotyping	C2368152
28321789	VP7 genes	C0017337
28321789	nucleotide sequence	C0004793
28321789	G6 genotype	C0017431
28321789	NCDV strain	C1518614
28321789	VP4 gene	C0017337
28321789	strains	C1518614
28321789	vaccinated	C1519885
28321789	B223 strain	C1518614
28321789	strains	C1518614
28321789	unvaccinated	C0243095
28321789	herd	C0175925
28321789	P[5] genotype	C0017431
28321789	UK strain	C1518614
28321789	Genotypes	C0017431
28321789	G6P[11]	C0017431
28321789	vaccinated	C1519885
28321789	herd	C0175925
28321789	G6P[5]	C0017431
28321789	unvaccinated	C0243095
28321789	herd	C0175925
28321789	calves	C3668829
28321789	infected	C0439663
28321789	rotavirus	C0035870
28321789	diarrhea	C0011991
28321789	genotypes	C0017431
28321789	commercial vaccine	C0042210
28321789	G6P[1]	C0017431
28321789	G10P[11]	C0017431
28321789	rotavirus	C0035870
28321789	strains	C1518614
28321789	vaccinated	C1519885
28321789	unvaccinated	C0243095
28321789	herds	C0175925
28321789	constant	C1948059
28321789	surveillance	C0038842
28321789	potential	C3245505
28321789	causes	C0015127
28321789	vaccination	C0042196
28321789	failure	C0162643
28322352	Gene	C0017337
28322352	genome-wide association study	C2350277
28322352	identified	C0205396
28322352	19p13.3	C1520850
28322352	lean body mass	C0424678
28322352	Lean body mass	C0424678
28322352	LBM	C0424678
28322352	trait	C0599883
28322352	human	C0086418
28322352	health	C0018684
28322352	genomic loci	C0678933
28322352	LBM	C0424678
28322352	gene	C0017337
28322352	genome-wide association study	C2350277
28322352	lean mass index	C0392762
28322352	LMI	C0392762
28322352	unrelated	C0445356
28322352	Caucasian	C0043157
28322352	subjects	C0080105
28322352	replicated	C0205173
28322352	unrelated	C0445356
28322352	Caucasians	C0043157
28322352	subjects	C0080105
28322352	Gene	C0017337
28322352	association analyses	C2350277
28322352	associations	C0439849
28322352	genes	C0017337
28322352	UQCR	C1540163
28322352	TCF3	C1336596
28322352	MBD3	C1417051
28322352	single	C0205171
28322352	locus	C0678933
28322352	19p13.3	C1520850
28322352	discovery	C0205556
28322352	replication	C1883725
28322352	functional	C0205245
28322352	relevance	C2347946
28322352	genes	C0017337
28322352	LMI	C0392762
28322352	19p13.3	C1520850
28322352	region	C0205147
28322352	UQCR	C1540163
28322352	TCF3	C1336596
28322352	MBD3 genes	C1417051
28322352	locus	C0678933
28322352	lean mass	C0424678
28322352	variation	C0042333
28322744	Basal	C0205112
28322744	ryanodine receptor activity	C1753335
28322744	suppresses	C1260953
28322744	autophagic	C0333781
28322744	flux	C2348693
28322744	inositol 1,4,5-trisphosphate receptors	C0063592
28322744	IP3Rs	C0063592
28322744	intracellular Ca(2+) signaling	C3158759
28322744	critically	C1511545
28322744	involved	C1314939
28322744	regulating	C1327622
28322744	different	C1705242
28322744	steps	C1261552
28322744	autophagy	C0004391
28322744	lysosomal	C0024369
28322744	degradation pathway	C1511758
28322744	ryanodine receptors	C0917729
28322744	RyR	C0917729
28322744	intracellular Ca(2+)-release channels	C1153434
28322744	expressed	C1171362
28322744	excitable	C1562285
28322744	cell types	C0449475
28322744	including	C0332257
28322744	muscle	C0026845
28322744	neurons	C0027882
28322744	extensively	C0205231
28322744	studied	C2603343
28322744	autophagy	C0004391
28322744	aberrant	C0443127
28322744	expression	C1171362
28322744	excessive	C0442802
28322744	activity	C1537044
28322744	RyRs	C0917729
28322744	tissues	C0040300
28322744	implicated	C2945640
28322744	onset of	C0332162
28322744	several	C0443302
28322744	diseases	C0012634
28322744	including	C0332257
28322744	Alzheimer's disease	C0002395
28322744	impaired	C0221099
28322744	autophagy	C0004391
28322744	regulation	C1327622
28322744	contributes	C1880177
28322744	pathology	C0205469
28322744	study	C2603343
28322744	determined	C1148554
28322744	pharmacological	C0007992
28322744	RyR	C0917729
28322744	inhibition	C3463820
28322744	modulate	C0443264
28322744	autophagic	C0333781
28322744	flux	C2348693
28322744	ectopic	C0574895
28322744	RyR	C0917729
28322744	expressing	C1171362
28322744	models	C3161035
28322744	HEK293 cells	C2936239
28322744	cell types	C0449475
28322744	endogenously	C0205227
28322744	express	C1171362
28322744	RyR	C0917729
28322744	C2C12 myoblasts	C0596995
28322744	primary	C0205225
28322744	hippocampal	C0019564
28322744	neurons	C0027882
28322744	Importantly	C3898777
28322744	RyR3	C0524964
28322744	overexpression	C1171362
28322744	HEK293 cells	C2936239
28322744	impaired	C0221099
28322744	autophagic	C0333781
28322744	flux	C2348693
28322744	cell	C0007634
28322744	models	C3161035
28322744	tested	C0039593
28322744	pharmacological	C0007992
28322744	inhibition	C3463820
28322744	endogenous	C0205227
28322744	ectopically	C0574895
28322744	expressed	C1171362
28322744	RyRs	C0917729
28322744	dantrolene	C0010976
28322744	ryanodine	C0035983
28322744	augmented	C0205217
28322744	autophagic	C0333781
28322744	flux	C2348693
28322744	increasing	C0442808
28322744	lysosomal	C0024369
28322744	turn-over	C0597297
28322744	number	C0237753
28322744	autophagosomes	C3887595
28322744	autolysosomes	C0230822
28322744	measured	C0444706
28322744	mCherry	C3489546
28322744	LC3 punctae	C3540600
28322744	cell	C0007634
28322744	increased	C0205217
28322744	control	C0009932
28322744	HEK RyR3 cells	C0007634
28322744	dantrolene	C0010976
28322744	ryanodine	C0035983
28322744	treatments	C1533734
28322744	differentiated	C1159966
28322744	C2C12 cells	C0596995
28322744	transmission electron microscopy	C0678118
28322744	demonstrated	C0443289
28322744	dantrolene	C0010976
28322744	treatment	C1533734
28322744	decreased	C0205216
28322744	number	C0237753
28322744	autophagic	C0333781
28322744	vacuoles	C0042219
28322744	cellular	C0007634
28322744	cross section	C0552389
28322744	modulation	C0678672
28322744	autophagic	C0333781
28322744	flux	C2348693
28322744	functional	C0205245
28322744	inhibition	C3463820
28322744	RyR channels	C0054493
28322744	RyR	C0917729
28322744	inhibitors	C0243077
28322744	efficiently	C0442799
28322744	number	C0237753
28322744	cells	C0007634
28322744	spontaneous	C0205359
28322744	RyR3	C0524964
28322744	activity	C1537044
28322744	HEK293 cell	C2936239
28322744	model	C3161035
28322744	control	C0009932
28322744	cells	C0007634
28322744	dantrolene	C0010976
28322744	ryanodine	C0035983
28322744	treatments	C1533734
28322744	conclusion	C1707478
28322744	basal	C0205112
28322744	RyR	C0917729
28322744	Ca(2+)-release events	C1820193
28322744	suppress	C1260953
28322744	autophagic	C0333781
28322744	flux	C2348693
28322744	level	C0441889
28322744	lysosomes	C0024369
28322885	Fluoride	C0016327
28322885	concentration	C1446561
28322885	saliva	C0036087
28322885	biofilm fluid	C0081786
28322885	application	C0185125
28322885	fluoride varnishes	C0016326
28322885	fluoride varnishes	C0016326
28322885	FV	C0016326
28322885	evaluated	C0220825
28322885	cariostatic properties	C3179394
28322885	Consequently	C3845876
28322885	aim	C1947946
28322885	in vivo	C1515655
28322885	study	C2603343
28322885	investigate	C0220825
28322885	intra	C0442107
28322885	oral	C0442027
28322885	fluoride	C0016327
28322885	retention	C0333117
28322885	clearance patterns	C0231360
28322885	FV	C0016326
28322885	subjects	C0080105
28322885	years	C1510829
28322885	laboratory	C0022877
28322885	analyst	C0870132
28322885	blinded	C0150108
28322885	randomized	C0034656
28322885	crossover study	C0150097
28322885	comparing	C1707455
28322885	ability	C0085732
28322885	sodium fluoride varnishes	C0016326
28322885	CavityShield-CS	C0016326
28322885	Enamel Pro-EP	C0016326
28322885	Vanish-V	C0016326
28322885	enhance	C2349975
28322885	fluoride	C0016327
28322885	concentrations	C1446561
28322885	biofilm fluid	C0081786
28322885	centrifuged	C3897072
28322885	whole	C0444667
28322885	saliva	C0036087
28322885	period	C1948053
28322885	FV	C0016326
28322885	fluoride	C0016327
28322885	concentration	C1446561
28322885	time patterns	C0439545
28322885	noted	C1317574
28322885	investigated	C0449433
28322885	FV	C0016326
28322885	studied	C2603343
28322885	variables	C0439828
28322885	highest	C1522410
28322885	fluoride	C0016327
28322885	concentrations	C1446561
28322885	observed	C1441672
28322885	biological sample	C2347026
28322885	collected	C1516698
28322885	FV	C0016326
28322885	Mean±SE	C2348148
28322885	area under fluoride clearance curve	C0376690
28322885	values	C0042295
28322885	biofilm fluid	C0081786
28322885	CS	C0016326
28322885	EP	C0016326
28322885	V	C0016326
28322885	centrifuged	C3897072
28322885	saliva	C0036087
28322885	CS	C0016326
28322885	EP	C0016326
28322885	V	C0016326
28322885	whole	C0444667
28322885	saliva	C0036087
28322885	CS	C0016326
28322885	EP	C0016326
28322885	V	C0016326
28322885	V	C0016326
28322885	fluoride	C0016327
28322885	biofilm fluid	C0081786
28322885	CS	C0016326
28322885	EP	C0016326
28322885	centrifuged	C3897072
28322885	saliva	C0036087
28322885	CS	C0016326
28322885	V	C0016326
28322885	significantly	C0750502
28322885	resulted	C1274040
28322885	higher	C1522410
28322885	fluoride	C0016327
28322885	retention	C0333117
28322885	EP	C0016326
28322885	significant	C0750502
28322885	FV	C0016326
28322885	observed	C1441672
28322885	whole	C0444667
28322885	saliva	C0036087
28322885	present	C0150312
28322885	study	C2603343
28322885	FV	C0016326
28322885	ability	C0085732
28322885	fluoride	C0016327
28322885	intra	C0442107
28322885	orally	C0442027
28322885	potentially	C3245505
28322885	related	C0439849
28322885	differences	C1705242
28322885	extent	C0439792
28322885	present	C0150312
28322885	findings	C0243095
28322885	relate	C0439849
28322885	clinical efficacy	C3850123
28322885	determined	C1148554
28322885	Clinical research	C0008972
28322885	investigates	C0220825
28322885	fluoride	C0016327
28322885	release	C0205556
28322885	patterns	C0449774
28322885	saliva	C0036087
28322885	biofilm fluid	C0081786
28322885	FV products	C0016326
28322885	insufficient	C0231180
28322885	research	C0242481
28322885	investigate	C0220825
28322885	FV formulations	C0016326
28322885	efficacy	C1280519
28322885	clinicians	C0871685
28322885	better	C0332272
28322885	evidence	C3887511
28322885	treatment	C1522326
28323338	prognostic value	C1514474
28323338	extranodal extension	C3899187
28323338	human papillomavirus	C0021344
28323338	oropharyngeal squamous cell carcinoma	C0280313
28323338	Extranodal (or extracapsular) extension	C3899187
28323338	ENE	C3899187
28323338	adverse prognostic factor	C1514474
28323338	patients	C0030705
28323338	head and neck cancers	C0278996
28323338	primary surgery	C2081627
28323338	ENE	C3899187
28323338	human papillomavirus (HPV)-positive oropharyngeal squamous cell carcinoma (OPSCC)	C2828150
28323338	single-institution	C2607850
28323338	studies	C2603343
28323338	not established	C0443211
28323338	ENE	C3899187
28323338	predicts	C0681842
28323338	inferior	C0542339
28323338	outcome	C1274040
28323338	prognostic value	C1514474
28323338	ENE	C3899187
28323338	HPV	C0021344
28323338	positive	C1446409
28323338	patients	C0030705
28323338	primary surgery	C2081627
28323338	adjuvant chemoradiation	C3178761
28323338	overall survival	C4086681
28323338	OS	C4086681
28323338	compared	C1707455
28323338	radiation alone	C0851346
28323338	ENE	C3899187
28323338	positive	C1446409
28323338	patients	C0030705
28323338	Patients	C0030705
28323338	primary surgery	C2081627
28323338	pathologic T1	C1521733
28323338	pT1	C1521733
28323338	pT4 tumors	C0027651
28323338	pathologic N1	C1521733
28323338	pN1	C1521733
28323338	pN3 lymph node	C0024204
28323338	status	C0449438
28323338	HPV-positive OPSCC	C2828150
28323338	identified	C0205396
28323338	National Cancer Data Base	C3826808
28323338	Features	C1521970
28323338	associated with	C0332281
28323338	ENE	C3899187
28323338	analyzed	C0936012
28323338	Univariable and multivariable Cox regression analyses	C0034980
28323338	identified	C0205396
28323338	predictors	C2698872
28323338	OS	C4086681
28323338	effect	C1280500
28323338	adjuvant treatment	C3162256
28323338	OS	C4086681
28323338	ENE	C3899187
28323338	positive	C1446409
28323338	cohort	C0009247
28323338	evaluated	C0220825
28323338	patients	C0030705
28323338	inclusion criteria	C1512693
28323338	ENE	C3899187
28323338	positive	C1446409
28323338	ENE	C3899187
28323338	positive	C1446409
28323338	patients	C0030705
28323338	treatment	C0087111
28323338	received	C1514756
28323338	concurrent chemoradiotherapy	C3178775
28323338	received	C1514756
28323338	radiotherapy	C0038886
28323338	received	C1514756
28323338	no	C0332288
28323338	adjuvant treatment	C3162256
28323338	median	C0876920
28323338	follow-up	C1522577
28323338	months	C0439231
28323338	ENE	C3899187
28323338	associated with	C0332281
28323338	worse	C1457868
28323338	year	C0439234
28323338	OS	C4086681
28323338	multivariable analysis	C0034980
28323338	included	C0332257
28323338	lymph nodes	C0024204
28323338	ENE	C3899187
28323338	lymphovascular invasion	C1708790
28323338	pT3/pT4 tumors	C0027651
28323338	Charlson-Deyo score	C0449820
28323338	associated with	C0332281
28323338	worse	C1457868
28323338	OS	C4086681
28323338	ENE	C3899187
28323338	positive	C1446409
28323338	patients	C0030705
28323338	no difference	C3842396
28323338	year	C0439234
28323338	OS	C4086681
28323338	received	C1514756
28323338	adjuvant concurrent chemoradiotherapy	C3178761
28323338	radiotherapy alone	C0038886
28323338	Propensity score	C2718044
28323338	matched comparison	C0086766
28323338	revealed	C0443289
28323338	results	C1274040
28323338	ENE	C3899187
28323338	associated with	C0332281
28323338	inferior	C0542339
28323338	OS	C4086681
28323338	patients	C0030705
28323338	HPV-positive OPSCC	C2828150
28323338	OS	C4086681
28323338	not better	C4049139
28323338	adjuvant chemoradiotherapy	C3178761
28323338	compared	C1707455
28323338	radiotherapy alone	C0038886
28323338	ENE	C3899187
28323338	positive	C1446409
28323338	patients	C0030705
28323338	current findings support	C0035176
28323338	prospective studies	C0033522
28323338	adjuvant chemoradiation	C3178761
28323338	HPV	C0021344
28323338	positive	C1446409
28323338	patients	C0030705
28323338	ENE	C3899187
28323926	Psychological Distress	C0815107
28323926	Fertile	C0015895
28323926	Age	C0001779
28323926	Premenopausal	C0206158
28323926	Women	C0043210
28323926	PCOS	C0032460
28323926	Symptoms	C1457887
28323926	Follow-up	C1522577
28323926	Polycystic ovary syndrome	C0032460
28323926	PCOS	C0032460
28323926	psychological distress	C0815107
28323926	obesity	C0028754
28323926	hyperandrogenism	C0206081
28323926	promoters	C0033414
28323926	investigate	C1292732
28323926	prevalence	C0683921
28323926	anxiety	C0003469
28323926	depression	C0011581
28323926	women	C0043210
28323926	PCOS	C0032460
28323926	PCOS	C0032460
28323926	symptoms	C1457887
28323926	age	C0001779
28323926	obesity	C0028754
28323926	hyperandrogenism	C0206081
28323926	awareness	C0004448
28323926	PCOS	C0032460
28323926	psychological distress	C0815107
28323926	assessed	C1516048
28323926	Population based follow-up	C1709599
28323926	Northern Finland	C0016132
28323926	Birth Cohort	C1706962
28323926	year	C0439234
28323926	follow-up	C1522577
28323926	age	C0001779
28323926	questionnaire-based screening	C1134635
28323926	oligoamenorrhea	C0028949
28323926	OA	C0028949
28323926	hirsutism	C0271610
28323926	H	C0271610
28323926	asymptomatic	C0231221
28323926	controls	C0009932
28323926	OA	C0028949
28323926	H	C0271610
28323926	OA	C0028949
28323926	H	C0271610
28323926	PCOS	C0032460
28323926	year	C0439234
28323926	follow-up	C1522577
28323926	controls	C0009932
28323926	OA	C0028949
28323926	H	C0271610
28323926	PCOS	C0032460
28323926	Questionnaire-based screening	C1134635
28323926	anxiety	C0003469
28323926	depression symptoms	C0086132
28323926	Hopkins Symptom Checklist-25	C0451218
28323926	diagnosed	C0011900
28323926	treated	C0332154
28323926	depression	C0011581
28323926	age	C0001779
28323926	BMI	C1305855
28323926	serum testosterone	C4064092
28323926	free androgen index	C0428629
28323926	FAI	C0428629
28323926	awareness	C0004448
28323926	polycystic ovaries	C0032460
28323926	PCOS	C0032460
28323926	psychological distress	C0815107
28323926	assessed	C1516048
28323926	Population-based prevalence	C1709597
28323926	anxiety	C0003469
28323926	depression	C0011581
28323926	women	C0043210
28323926	PCOS	C0032460
28323926	PCOS	C0032460
28323926	symptoms	C1457887
28323926	age	C0001779
28323926	Anxiety	C0003469
28323926	depression symptoms	C0086132
28323926	depression	C0011581
28323926	age	C0001779
28323926	women	C0043210
28323926	PCOS	C0032460
28323926	H	C0271610
28323926	controls	C0009932
28323926	BMI	C1305855
28323926	hyperandrogenism	C0206081
28323926	anxiety	C0003469
28323926	depression symptoms	C0086132
28323926	awareness	C0004448
28323926	PCOS	C0032460
28323926	anxiety	C0003469
28323926	Women	C0043210
28323926	PCOS	C0032460
28323926	H	C0271610
28323926	anxiety	C0003469
28323926	depression symptoms	C0086132
28323926	controls	C0009932
28323926	BMI	C1305855
28323926	hyperandrogenism	C0206081
28323926	psychological distress	C0815107
28323926	PCOS	C0032460
28323926	awareness	C0004448
28323926	PCOS	C0032460
28323926	anxiety	C0003469
28323926	anxiety	C0003469
28323926	depression	C0011581
28327913	use of	C1524063
28327913	Oxford Nanopore	C1561598
28327913	native	C0302891
28327913	barcoding	C2936547
28327913	complete	C0205197
28327913	genome assembly	C2348746
28327913	Oxford Nanopore Technologies	C1561598
28327913	MinION(TM)	C0025080
28327913	mobile	C0231435
28327913	long read sequences	C0162326
28327913	turn-around time	C1254367
28327913	report	C0684224
28327913	single contig genome assembly	C2348746
28327913	using	C1524063
28327913	Oxford Nanopore	C1561598
28327913	native	C0302891
28327913	barcoding	C2936547
28327913	applied	C4048755
28327913	multiplexed library	C0017430
28327913	samples	C2347026
28327913	combined	C0205195
28327913	existing	C2987476
28327913	short-read data	C0950138
28327913	closure	C1521802
28327913	multiple	C0439064
28327913	bacterial genomes	C0085238
28327913	single	C0205171
28327913	MinION(TM)	C0025080
28327913	sequencing	C1328887
28327913	run	C1704688
28327913	availability of	C0470187
28327913	existing	C2987476
28327913	short-read data	C0950138
28327913	strain	C1518614
28327913	used	C1524063
28327913	MHO_001	C1518614
28327913	methicillin resistant	C0079830
28327913	Staphylococcus aureus	C0038172
28327913	USA300	C1518614
28327913	Using	C1524063
28327913	assembly	C2348746
28327913	existing	C2987476
28327913	short read	C0205556
28327913	barcoded long read sequences	C0162326
28327913	multiplexed data	C1547368
28327913	genome	C0017428
28327913	S. aureus	C0038172
28327913	USA300 strain MHO_001	C1518614
28327913	long-read data	C0950138
28327913	average	C1510992
28327913	MinION(TM)	C0025080
28327913	run	C1704688
28327913	genomic	C0017428
28327913	coverage	C1999244
28327913	using	C1524063
28327913	standard	C0034925
28327913	tools	C0037589
28327913	sufficient	C0205410
28327913	complete	C0205197
28327913	circular chromosome	C0035639
28327913	S. aureus	C0038172
28327913	strain MHO_001	C1518614
28327913	complete	C0205197
28327913	plasmids	C0032136
28327913	Minor	C0205165
28327913	differences	C1705242
28327913	noted	C4288581
28327913	compared	C1707455
28327913	USA300	C1518614
28327913	genome	C0017428
28327913	USA300_FPR3757	C0085238
28327913	including	C0332257
28327913	translocation	C0282583
28327913	loss	C1517945
28327913	gain	C1517378
28327913	mobile genetic elements	C1257903
28327913	MinION(TM)	C0025080
28327913	reads	C1704688
28327913	multiplexed	C0205245
28327913	using	C1524063
28327913	native	C0302891
28327913	barcoding	C2936547
28327913	used	C1524063
28327913	combination	C0205195
28327913	short-read data	C0950138
28327913	complete	C0205197
28327913	bacterial genome	C0085238
28327913	complete	C0205197
28327913	multiple	C0439064
28327913	genomes	C0017428
28327913	short-read data	C0950138
28327913	available	C0243095
28327913	single	C0205171
28327913	MinION(TM)	C0025080
28327913	run	C1704688
28327913	impact	C4049986
28327913	understanding	C0162340
28327913	accessory	C1883702
28327913	genome content	C0017428
28327913	plasmid	C0032136
28327913	diversity	C1880371
28327913	genome	C0017428
28327913	rearrangements	C0017287
28329872	Doxorubicin	C0013089
28329872	Dose-Dependent	C1512045
28329872	Toxicity	C0600688
28329872	Mouse	C0025929
28329872	Ovarian Follicle	C0018120
28329872	Development	C0243107
28329872	Hormone Secretion	C0312431
28329872	Oocyte Maturation	C1160520
28329872	Doxorubicin	C0013089
28329872	DOX	C0013089
28329872	commonly	C0205214
28329872	anticancer medications	C0003392
28329872	fertility	C0015895
28329872	damaging	C1883709
28329872	ovarian follicles	C0018120
28329872	dose-dependent	C1512045
28329872	toxicity	C0600688
28329872	DOX	C0013089
28329872	dynamic	C0729333
28329872	follicle	C0018120
28329872	development	C0243107
28329872	oocyte maturation	C1160520
28329872	objective	C0018017
28329872	effects of	C1704420
28329872	human	C0086418
28329872	relevant	C2347946
28329872	exposure	C0332157
28329872	levels	C0441889
28329872	DOX	C0013089
28329872	follicular	C0018120
28329872	functions	C0542341
28329872	developmental	C0243107
28329872	time	C0040223
28329872	In vitro	C1533691
28329872	cultured	C0430400
28329872	multilayered secondary mouse follicles	C0737234
28329872	treated	C1522326
28329872	DOX	C0013089
28329872	follicle	C0018120
28329872	development	C0243107
28329872	hormone secretion	C0312431
28329872	oocyte maturation	C1160520
28329872	DOX	C0013089
28329872	dose-dependent	C1512045
28329872	toxicity	C0600688
28329872	follicle growth	C1155902
28329872	survival	C0220921
28329872	secretion	C0312431
28329872	17β-estradiol	C0014912
28329872	E2	C0014912
28329872	DOX	C0013089
28329872	induced	C0205263
28329872	DNA damage	C0012860
28329872	apoptosis	C0162638
28329872	follicle	C0018120
28329872	somatic cells	C1257909
28329872	oocytes	C0029045
28329872	uptake	C0243144
28329872	DOX	C0013089
28329872	somatic cells	C1257909
28329872	germ cells	C0017471
28329872	Follicles	C0018120
28329872	treated	C1522326
28329872	DOX	C0013089
28329872	oocyte	C0029045
28329872	metaphase II	C1155832
28329872	MII	C1155832
28329872	percentages	C0439165
28329872	in vitro	C1533691
28329872	oocyte maturation	C1160520
28329872	DOX	C0013089
28329872	increased	C0205217
28329872	MII	C1155832
28329872	oocytes	C0029045
28329872	abnormal	C0205161
28329872	spindle	C1166795
28329872	morphology	C0332437
28329872	chromosome	C0008633
28329872	misalignment	C1275957
28329872	in vitro study	C0681828
28329872	in vivo	C1515655
28329872	treatment	C1522326
28329872	dose-dependent	C1512045
28329872	toxicity	C0600688
28329872	oocyte meiotic maturation	C1160520
28329872	CD-1 mice	C0025929
28329872	treated	C1522326
28329872	DOX	C0013089
28329872	consistent with	C0332290
28329872	in vitro	C1533691
28329872	oocyte maturation	C1160520
28329872	outcomes	C1274040
28329872	study	C2603343
28329872	DOX	C0013089
28329872	dose-dependent	C1512045
28329872	toxicity	C0600688
28329872	ovarian follicle	C0018120
28329872	development	C0243107
28329872	hormone secretion	C0312431
28329872	oocyte maturation	C1160520
28329872	factors	C1521761
28329872	female reproductive	C0278049
28329872	endocrine functions	C0678896
28330470	apoptotic pathways	C3269135
28330470	docosahexaenoic acid	C0556150
28330470	prostate cancer	C0376358
28330470	gene expression analysis	C1880945
28330470	RT(2) Profile PCR Array System	C3179034
28330470	apoptotic pathways	C3269135
28330470	docosahexaenoic acid	C0556150
28330470	DHA	C0556150
28330470	apoptosis	C0162638
28330470	prostate cancer	C0376358
28330470	cells	C0334227
28330470	Human	C0086418
28330470	prostate cancer	C0376358
28330470	DU145 cells	C0334227
28330470	fish oil	C0016157
28330470	omega-3 PUFA	C0015689
28330470	DHA	C0556150
28330470	Eicosapentaenoic acid	C0000545
28330470	EPA	C0000545
28330470	omega-6 PUFA	C0133860
28330470	Arachidonic acid	C0003695
28330470	AA	C0003695
28330470	Cell viability	C0007620
28330470	apoptosis	C0162638
28330470	MTT assay	C2986858
28330470	Hoechst staining	C1441607
28330470	gene expression profiling	C0752248
28330470	DU145 cells	C0334227
28330470	real time quantitative polymerase chain reaction	C3179034
28330470	RT-qPCR	C3179034
28330470	AA	C0003695
28330470	viability	C0007620
28330470	DU145 cells	C0334227
28330470	fish oil	C0016157
28330470	EPA	C0000545
28330470	DHA	C0556150
28330470	cell viability	C0007620
28330470	growth inhibition	C1512773
28330470	DHA	C0556150
28330470	EPA	C0000545
28330470	DHA	C0556150
28330470	apoptotic	C1516044
28330470	genes	C0017337
28330470	genes	C0017337
28330470	DHA	C0556150
28330470	RT-qPCR	C3179034
28330470	DHA	C0556150
28330470	genes	C0017337
28330470	DHA	C0556150
28330470	apoptosis	C0162638
28330470	cancer cells	C0334227
28330470	P53	C2984306
28330470	MAPK	C2611831
28330470	TNF	C1519684
28330470	PI3K/AKT	C2984369
28330470	NF-κB signaling pathways	C1513838
28330470	DHA	C0556150
28330470	human	C0086418
28330470	prostate carcinoma	C0376358
28330470	cell line DU145	C0334227
28330470	DHA	C0556150
28330470	DU145 cells	C0334227
28330470	pathways	C0037080
28330470	P53	C2984306
28330470	MAPK	C2611831
28330470	TNF	C1519684
28330470	PI3K/AKT	C2984369
28330470	NF-κB signaling pathways	C1513838
28330470	Molecular mechanisms	C1258062
28330470	DHA	C0556150
28330470	apoptosis	C0162638
28330470	cancer cells	C0334227
28333697	Medication Reconciliation	C2317067
28333697	Hospitalization	C0019993
28333697	Hospital-Home Interface	C1254363
28333697	Observational Retrospective Study	C0035363
28333697	Medication errors	C0025115
28333697	patient harms	C3658342
28333697	Medication reconciliation	C2317067
28333697	care transition	C4019071
28333697	investigate	C1292732
28333697	medication reconciliation	C2317067
28333697	Fondazione Toscana Gabriele Monasterio hospitals	C0019994
28333697	assess the quality	C0332306
28333697	medication reconciliation	C2317067
28333697	inpatient	C0021562
28333697	outpatient	C0029921
28333697	care	C1947933
28333697	analyzing	C0936012
28333697	medication patterns	C1254363
28333697	months	C0439231
28333697	admission	C0184666
28333697	hospitalization	C0019993
28333697	months	C0439231
28333697	discharge	C0030685
28333697	patients	C0030705
28333697	cardiovascular diseases	C0007222
28333697	retrospective observational study	C0035363
28333697	Cardiothoracic Department	C0587505
28333697	Fondazione Toscana Gabriele Monasterio hospitals	C0019994
28333697	Medication history	C1553893
28333697	reviewed	C1709940
28333697	patients	C0030705
28333697	admitted	C0184666
28333697	discharged	C0030685
28333697	community	C0009462
28333697	Patients	C0030705
28333697	drugs	C3687832
28333697	drugs	C3687832
28333697	cardiovascular system	C0007226
28333697	prescription list	C3533331
28333697	admission	C0184666
28333697	died	C4264514
28333697	follow-up	C1522577
28333697	patients	C0030705
28333697	clinical charts	C0025102
28333697	drug prescriptions	C0033081
28333697	patients	C0030705
28333697	hospitalization	C0019993
28333697	electronic clinical recording system	C1737029
28333697	analyzed	C0936012
28333697	list of prescriptions	C3533331
28333697	patients	C0030705
28333697	months	C0439231
28333697	admission	C0184666
28333697	months	C0439231
28333697	discharge	C0030685
28333697	regional prescription registry	C0282574
28333697	prescriptions	C0033081
28333697	analyzed	C0936012
28333697	unintentional	C1283932
28333697	discrepancies	C1290905
28333697	study	C2603343
28333697	patients	C0030705
28333697	age	C0001779
28333697	years	C0439234
28333697	inclusion and exclusion criteria	C0243161
28333697	prescriptions	C0033081
28333697	analyzed	C0936012
28333697	discrepancies	C1290905
28333697	discrepancies	C1290905
28333697	patient	C0030705
28333697	discrepancies	C1290905
28333697	unintentional	C1283932
28333697	discrepancies	C1290905
28333697	patient	C0030705
28333697	unintentional	C1283932
28333697	discrepancies	C1290905
28333697	hospitalization	C0019993
28333697	hospital-home interface	C1254363
28333697	unintentional	C1283932
28333697	discrepancies	C1290905
28333697	comparison	C1707455
28333697	patients	C0030705
28333697	therapy	C0039798
28333697	medication consumption	C1254363
28333697	comparison	C1707455
28333697	prescription	C0033081
28333697	discharge	C0030685
28333697	medication pattern	C1254363
28333697	home	C0442519
28333697	Medication errors	C0025115
28333697	patient safety	C1113679
28333697	clinical practice	C1254363
28333697	comparison	C1707455
28333697	medication patterns	C1254363
28333697	regional prescription registry	C0282574
28333697	hospitalization	C0019993
28333697	medication reconciliation	C2317067
28333697	medication reconciliation	C2317067
28333697	hospitals	C0019994
28333697	primary care services	C0018747
28333697	medication discrepancies	C0025115
28333697	patient safety	C1113679
28334327	Autologous	C0181074
28334327	Irradiated Homologous Costal Cartilage	C0181074
28334327	Graft Material	C0181074
28334327	Rhinoplasty	C0035467
28334327	rhinoplasty	C0035467
28334327	autologous costal cartilage	C0181074
28334327	ACC	C0181074
28334327	irradiated homologous costal cartilage	C0181074
28334327	IHCC	C0181074
28334327	clinical results	C0456984
28334327	augmentation rhinoplasty	C0176371
28334327	ACC	C0181074
28334327	IHCC	C0181074
28334327	histologic properties	C4048239
28334327	cartilage	C0007301
28334327	retrospective clinical study	C0008972
28334327	patients	C0030705
28334327	rhinoseptoplasty	C0189054
28334327	ACC	C0181074
28334327	IHCC	C0181074
28334327	Patients	C0030705
28334327	followed up	C1522577
28334327	surgery	C0543467
28334327	histologic characteristics	C4048239
28334327	ACC	C0181074
28334327	IHCC	C0181074
28334327	compared	C1707455
28334327	surgical procedures	C0543467
28334327	complications	C0221082
28334327	warping	C0221082
28334327	infection	C3714514
28334327	resorption	C2985494
28334327	donor-site	C1444716
28334327	morbidity	C0026538
28334327	evaluated	C0220825
28334327	medical records	C0025102
28334327	facial photographs	C0441468
28334327	Patients	C0030705
28334327	subjective	C0439655
28334327	satisfaction	C0242428
28334327	aesthetic	C0870111
28334327	functional	C0205245
28334327	results	C1274040
28334327	evaluated	C0220825
28334327	questionnaire	C0034394
28334327	surgical procedures	C0543467
28334327	complications	C0221082
28334327	warping	C0221082
28334327	infection	C3714514
28334327	resorption	C2985494
28334327	donor-site	C1444716
28334327	morbidity	C0026538
28334327	patients	C0030705
28334327	subjective	C0439655
28334327	satisfaction	C0242428
28334327	aesthetic	C0870111
28334327	functional	C0205245
28334327	results	C1274040
28334327	objective	C1571702
28334327	evaluation	C1261322
28334327	surgical	C0543467
28334327	outcomes	C1274040
28334327	symmetry	C2825575
28334327	dorsal	C0205095
28334327	height	C0489786
28334327	dorsal	C0205095
28334327	length	C1444754
28334327	dorsal	C0205095
28334327	width	C0487742
28334327	tip projection	C0243095
28334327	tip rotation	C0243095
28334327	tip width	C0243095
28334327	overall	C1561607
28334327	result	C1274040
28334327	histologic	C0205462
28334327	structures	C0678594
28334327	Objective	C1571702
28334327	evaluation	C0220825
28334327	surgical	C0543467
28334327	outcomes	C1274040
28334327	Objective	C1571702
28334327	Rhinoplasty	C0035467
28334327	Outcome Score	C4274403
28334327	symmetry	C2825575
28334327	dorsal	C0205095
28334327	height	C0489786
28334327	dorsal	C0205095
28334327	length	C1444754
28334327	dorsal	C0205095
28334327	width	C0487742
28334327	tip projection	C0243095
28334327	tip rotation	C0243095
28334327	tip width	C0243095
28334327	overall	C1561607
28334327	result	C1274040
28334327	Histologic structures	C4048239
28334327	evaluated	C0220825
28334327	hematoxylin and eosin	C0523207
28334327	Masson trichrome	C1294297
28334327	Alcian blue	C1293946
28334327	Verhoeff elastic stains	C1294321
28334327	patients	C0030705
28334327	males	C0086582
28334327	females	C0086287
28334327	rhinoseptoplasty	C0189054
28334327	ACC	C0181074
28334327	males	C0086582
28334327	females	C0086287
28334327	rhinoseptoplasty	C0189054
28334327	IHCC	C0181074
28334327	observed	C1441672
28334327	complications	C0221082
28334327	notable	C4288581
28334327	resorption	C2985494
28334327	occurred	C1709305
28334327	frequently	C0332183
28334327	patients	C0030705
28334327	IHCC	C0181074
28334327	ACC	C0181074
28334327	subjective	C0439655
28334327	evaluations	C0220825
28334327	aesthetic	C0870111
28334327	satisfaction	C0242428
28334327	patients	C0030705
28334327	received	C1514756
28334327	ACC	C0181074
28334327	significantly	C0750502
28334327	greater	C1704243
28334327	satisfaction	C0242428
28334327	patients	C0030705
28334327	very satisfied	C3840671
28334327	received	C1514756
28334327	IHCC	C0181074
28334327	subjective	C0439655
28334327	functional	C0205245
28334327	outcomes	C1274040
28334327	patients	C0030705
28334327	receiving	C1514756
28334327	ACC	C0181074
28334327	receiving	C1514756
28334327	IHCC	C0181074
28334327	satisfied	C0242428
28334327	receiving	C1514756
28334327	ACC	C0181074
28334327	receiving	C1514756
28334327	IHCC	C0181074
28334327	very satisfied	C3840671
28334327	objective	C1571702
28334327	aesthetic	C0870111
28334327	outcomes	C1274040
28334327	scores	C0449820
28334327	ACC	C0181074
28334327	IHCC	C0181074
28334327	good	C0205170
28334327	excellent	C1961136
28334327	Histologic analyses	C0344441
28334327	larger	C0549177
28334327	uniform	C0205375
28334327	chondrocytes	C0225369
28334327	collagens	C0009325
28334327	proteoglycan	C0033692
28334327	contents	C1550605
28334327	ACC	C0181074
28334327	IHCC	C0181074
28334327	Compared	C1707455
28334327	patients	C0030705
28334327	receiving	C1514756
28334327	IHCC	C0181074
28334327	receiving	C1514756
28334327	ACC	C0181074
28334327	rhinoseptoplasty	C0189054
28334327	superior	C0205250
28334327	aesthetic	C0870111
28334327	satisfaction	C0242428
28334327	ACC	C0181074
28334327	less	C0547044
28334327	frequent	C0332183
28334327	notable	C4288581
28334327	resorption	C2985494
28334327	Autologous costal cartilage	C0181074
28334327	better	C0332272
28334327	histologic properties	C4048239
28334327	IHCC	C0181074
28334327	ideal	C1512612
28334327	graft material	C0181074
28334327	less	C0547044
28334327	chance	C0237506
28334327	long-term	C0443252
28334327	resorption	C2985494
28334784	Ret	C0694890
28334784	Sema3d	C1419945
28334784	genetic interaction	C0596610
28334784	mouse	C0025929
28334784	enteric nervous system development	C1522995
28334784	multigenic disorders	C0567439
28334784	clinical manifestation	C1280464
28334784	penetrance	C0524899
28334784	presentation	C0449450
28334784	expressivity	C0449450
28334784	outcome	C1274040
28334784	genetic interaction	C0596610
28334784	susceptibility genes	C0919542
28334784	gene knockouts	C0814039
28334784	mice	C0025929
28334784	genetic interaction	C0596610
28334784	Ret	C0694890
28334784	Sema3d	C1419945
28334784	Hirschsprung disease	C0019569
28334784	susceptibility genes	C0919542
28334784	Ret	C0694890
28334784	Sema3d	C1419945
28334784	generate mice	C0205245
28334784	genotypes	C0017431
28334784	assessed survival	C1516048
28334784	counting various genotypes	C1285573
28334784	myenteric plexus	C0027028
28334784	acetylcholinesterase staining	C0201829
28334784	embryonic day 12.5	C0815083
28334784	E12.5	C0815083
28334784	intestine transcriptome	C3178810
28334784	RNA-sequencing	C0162327
28334784	Survival rates	C0038954
28334784	Ret	C0694890
28334784	wildtype	C0694890
28334784	mice	C0025929
28334784	E12.5	C0815083
28334784	birth	C0005615
28334784	weaning	C0043084
28334784	genotypes	C0017431
28334784	Sema3d	C1419945
28334784	locus	C1708726
28334784	myenteric plexus	C0027028
28334784	Ret	C0694890
28334784	genotypes	C0017431
28334784	Sema3d	C1419945
28334784	locus	C1708726
28334784	Sema3d	C1419945
28334784	heterozygote	C0019425
28334784	homozygote mice	C0019904
28334784	intestinal innervation	C1619351
28334784	wildtype mice intestinal	C1883559
28334784	gene expression	C0017262
28334784	Ret	C0694890
28334784	expression of ∼300 genes,	C0017262
28334784	Sema3d	C1419945
28334784	no evidence	C0332125
28334784	interaction between the two genes	C0596610
28334784	intestine transcriptome	C3178810
28334784	null alleles	C2985437
28334784	phenotypic assays	C1285572
28334784	not find evidence	C0332125
28334784	genetic interaction	C0596610
28334784	Ret	C0694890
28334784	Sema3d	C1419945
28334784	myenteric plexus	C0027028
28334784	intestine transcriptome	C3178810
28338376	Pembrolizumab	C3658706
28338376	treatment	C0087111
28338376	non-small cell lung cancer	C0007131
28338376	development	C1527148
28338376	immunotherapeutic agents	C0876248
28338376	PD-1	C2986635
28338376	PD-L1	C4300350
28338376	development	C1527148
28338376	checkpoint inhibitors	C0243077
28338376	treatment	C0087111
28338376	lung cancer	C0242379
28338376	first	C1708063
28338376	second line	C1710038
28338376	limited	C0439801
28338376	toxicity	C0013221
28338376	treat	C0087111
28338376	prolonged	C0439590
28338376	periods	C1948053
28338376	smokers	C0337664
28338376	oncologist	C0259990
28338376	review	C0282443
28338376	results	C1274040
28338376	clinical trials	C0008976
28338376	pembrolizumab	C3658706
28338376	treatment	C0087111
28338376	non-small cell lung cancer	C0007131
28338376	authors	C3812881
28338376	first	C1708063
28338376	second line treatment	C1710038
28338376	pembrolizumab	C3658706
28338376	monotherapy	C0087111
28338376	combination therapies	C0013218
28338376	PD-L1	C4300350
28338376	immunohistochemistry assay	C0020980
28338376	22C3 antibody	C0003241
28338376	use	C0457083
28338376	clinical practice	C0008967
28338376	trials	C0008976
28338376	higher	C0205250
28338376	overall response	C3272903
28338376	overall survival	C4086681
28338376	moderate	C0205081
28338376	toxicity	C0013221
28338376	use	C0457083
28338376	pembrolizumab	C3658706
28338376	chemotherapy	C3665472
28338376	first	C1708063
28338376	second line	C1710038
28338376	results	C1274040
28338376	registration	C1514821
28338376	pembrolizumab	C3658706
28338376	first	C1708063
28338376	second line	C1710038
28338376	patients	C0030705
28338376	high	C0205250
28338376	expression	C1171362
28338376	PD-L1	C4300350
28338376	PD-L1	C4300350
28338376	staining	C0487602
28338376	responders	C0919876
28338376	non-responders	C0919875
28338376	checkpoint inhibitors	C0243077
28338376	predictive	C0681890
28338376	biomarker	C0005516
28338976	Synchronisms	C0439580
28338976	bud	C2700462
28338976	cambium	C2339480
28338976	phenology	C0205556
28338976	black spruce	C0996604
28338976	early	C1279919
28338976	flushing	C1882955
28338976	provenances	C1709753
28338976	early	C1279919
28338976	xylem	C1720877
28338976	formation	C1522492
28338976	Bud	C2700462
28338976	cambial	C2339480
28338976	phenology	C0205556
28338976	represent	C1882932
28338976	adaptation	C0392673
28338976	species	C1705920
28338976	local	C0205276
28338976	environment	C0014406
28338976	growing season	C0036497
28338976	maximized	C0442805
28338976	minimizing	C0392756
28338976	risk	C0035647
28338976	frost	C0020746
28338976	developing	C1527148
28338976	tissues	C1514137
28338976	temporal	C2362314
28338976	relationship	C0439849
28338976	apical	C0205111
28338976	radial	C0442038
28338976	meristems	C0242728
28338976	tree	C0040811
28338976	growth	C0018270
28338976	growth	C0018270
28338976	whole	C0444667
28338976	process	C1522240
28338976	aim	C1947946
28338976	study	C2603343
28338976	compare	C1707455
28338976	cambial	C2339480
28338976	phenology	C0205556
28338976	black spruce	C0996604
28338976	Picea mariana	C0996604
28338976	provenances	C1709753
28338976	classified	C0008902
28338976	early	C1279919
28338976	late	C0205087
28338976	bud	C2700462
28338976	flushing	C1882955
28338976	different	C1705242
28338976	phases	C0205390
28338976	cambial	C2339480
28338976	phenology	C0205556
28338976	assessed	C1516048
28338976	wood	C0043217
28338976	microcores	C0444669
28338976	sampled	C0870078
28338976	weekly	C0332174
28338976	trees	C0040811
28338976	growing	C0018270
28338976	provenance trial	C0868962
28338976	Quebec	C0034390
28338976	Canada	C0006823
28338976	Trees	C0040811
28338976	early	C1279919
28338976	bud	C2700462
28338976	flush	C1882955
28338976	early	C1279919
28338976	reactivation	C4086768
28338976	xylem	C1720877
28338976	differentiation	C0007589
28338976	average	C1510992
28338976	difference	C1705241
28338976	days	C0439228
28338976	buds	C2700462
28338976	small	C0700321
28338976	significant	C0237881
28338976	differences	C1705241
28338976	days	C0439228
28338976	xylem	C1720877
28338976	Provenances	C1709753
28338976	early	C1279919
28338976	bud	C2700462
28338976	flush	C1882955
28338976	early	C1279919
28338976	bud	C2700462
28338976	completed	C0205197
28338976	xylem	C1720877
28338976	formation	C1522492
28338976	earlier	C1279919
28338976	late	C0205087
28338976	bud	C2700462
28338976	flush	C1882955
28338976	provenances	C1709753
28338976	No significant	C1273937
28338976	difference	C1705241
28338976	period	C1948053
28338976	xylem	C1720877
28338976	formation	C1522492
28338976	total	C0439810
28338976	growth	C0018270
28338976	growth	C0018270
28338976	observed	C1441672
28338976	flushing	C1882955
28338976	results	C2825142
28338976	ecotype	C3178911
28338976	differentiation	C0007589
28338976	black spruce	C0996604
28338976	provenances	C1709753
28338976	phenological	C0205556
28338976	adaptation	C0392673
28338976	buds	C2700462
28338976	local	C0205276
28338976	climate	C0008946
28338976	specific	C0205369
28338976	growth	C0018270
28338976	dynamics	C3826426
28338976	xylem	C1720877
28340485	liposome	C0023828
28340485	immobilization	C0020944
28340485	sterically stabilized	C0205556
28340485	micelles	C0025938
28340485	SSMs	C0025938
28340485	precursor	C1709634
28340485	bio-layer interferometry	C0021730
28340485	based	C1527178
28340485	interaction	C1704675
28340485	studies	C2603343
28340485	Non-fluidic	C0205556
28340485	bio-layer interferometry	C0021730
28340485	BLI	C0021730
28340485	rapidly	C0456962
28340485	standard	C1442989
28340485	monitoring	C0005517
28340485	biomolecular	C0205556
28340485	interactions	C1704675
28340485	label-free	C0205556
28340485	real-time	C1550177
28340485	high-throughput	C0205556
28340485	High	C0205250
28340485	efficiency	C0013682
28340485	screening methods	C0022885
28340485	measure	C0079809
28340485	kinetics	C0022702
28340485	liposomes	C0023828
28340485	variety	C2346866
28340485	compounds	C1706082
28340485	immobilization	C0020944
28340485	liposomes	C0023828
28340485	method	C0449851
28340485	described	C1552738
28340485	immobilizing	C0020944
28340485	liposomes	C0023828
28340485	interaction	C1704675
28340485	studies	C2603343
28340485	based	C1527178
28340485	biophysical principles	C2350452
28340485	biosensor	C0600364
28340485	platform	C1710360
28340485	immobilization	C0020944
28340485	includes	C0332257
28340485	loading	C1708715
28340485	DSPE-PEG(2000)	C0664515
28340485	biotin	C0005575
28340485	sterically stabilized	C0205556
28340485	micelles	C0025938
28340485	SSMs	C0025938
28340485	restructured	C0205556
28340485	buffer change	C0205556
28340485	resulting in	C0332294
28340485	substrate	C3891814
28340485	liposome	C0023828
28340485	immobilization	C0020944
28340485	Liposomes	C0023828
28340485	concentration	C1446561
28340485	composition	C0486616
28340485	fluidity	C0596579
28340485	immobilized	C0020944
28340485	sensor	C0600364
28340485	surface	C0205148
28340485	hydrophobic	C0598629
28340485	residues	C1709915
28340485	former	C0205156
28340485	SSMs	C0025938
28340485	Cytochrome C	C0010749
28340485	membrane-interacting	C0205556
28340485	protein	C0033684
28340485	binding	C0033618
28340485	Cytochrome C	C0010749
28340485	immobilized	C0020944
28340485	liposomes	C0023828
28340485	kinetic	C0022702
28340485	affinity	C1510827
28340485	constants	C1547014
28340485	similar	C2348205
28340485	values	C0042295
28340485	literature	C0023866
28340485	detailed	C1522508
28340485	understanding	C0162340
28340485	surface	C0205148
28340485	integrity	C1947912
28340485	liposomes	C0023828
28340485	confocal fluorescence microscopy	C0026022
28340485	immobilized	C0020944
28340485	liposomes	C0023828
28340485	containing	C0332256
28340485	calcein	C0060549
28340485	aqueous	C0599956
28340485	core	C0444669
28340485	indicated	C1444656
28340485	intact	C0205266
28340485	vesicles	C1622418
28340485	combination	C0205195
28340485	liposome	C0023828
28340485	immobilization	C0020944
28340485	automation	C0004376
28340485	BLI	C0021730
28340485	systems	C0449913
28340485	high throughput	C0205556
28340485	acceptable	C1879533
28340485	excellent	C1961136
28340485	reproducibility	C1514863
28340485	assay	C0005507
28340485	suitable	C3900053
28340485	research	C0035168
28340485	industrial	C0868973
28340485	regulatory applications	C2347934
28341903	Exercise	C0015259
28341903	increases	C0205217
28341903	lactoferrin	C0022942
28341903	decreases	C0547047
28341903	lysozyme	C0026794
28341903	salivary	C0442040
28341903	granulocytes	C0018183
28341903	Intracellular lactoferrin	C0022942
28341903	Lac	C0022942
28341903	lysozyme	C0026794
28341903	Lys	C0026794
28341903	inflammation	C0021368
28341903	promoting	C0033414
28341903	host protection	C0524828
28341903	exercise	C0015259
28341903	increase	C0205217
28341903	Lac	C0022942
28341903	Lys	C0026794
28341903	concentration	C1446561
28341903	exocrine solutions	C0504082
28341903	intracellular concentration changes	C1446561
28341903	exercise	C0015259
28341903	quantify	C1709793
28341903	Lac	C0022942
28341903	Lys	C0026794
28341903	concentration	C1446561
28341903	exercise	C0015259
28341903	salivary	C0442040
28341903	CD45(+)CD15(+) cells	C0018183
28341903	males	C0086582
28341903	years	C0439234
28341903	V̇O2pk	C0392762
28341903	body fat	C0344335
28341903	ran	C0035953
28341903	min	C0439232
28341903	VO2pk	C0392762
28341903	stimulated saliva	C0036087
28341903	collected	C1516698
28341903	pre	C1439922
28341903	post exercise	C1979962
28341903	Saliva	C0036087
28341903	leukocytes	C0023516
28341903	CD45(+)	C0023516
28341903	granulocytes	C0018183
28341903	CD45(+)CD15(+)	C0018183
28341903	flow cytometry	C0016263
28341903	Median fluorescent intensity	C0392762
28341903	MFI	C0392762
28341903	Lac	C0022942
28341903	increased	C0205217
28341903	pre	C1439922
28341903	MFI	C0392762
28341903	post	C1979962
28341903	MFI	C0392762
28341903	exercise	C0015259
28341903	Lys	C0026794
28341903	MFI	C0392762
28341903	decreased	C0205216
28341903	exercise	C0015259
28341903	pre	C1439922
28341903	post	C1439922
28341903	Acute running	C0035953
28341903	increased	C0205217
28341903	Lac	C0022942
28341903	concentration	C1446561
28341903	decrease	C0205216
28341903	inflammation	C0021368
28341903	anti-inflammatory effects	C1515999
28341903	exercise	C0015259
28341903	exercise	C0015259
28341903	decrease	C0547047
28341903	intracellular Lys	C0026794
28341903	cause	C0015127
28341903	increased	C0205217
28341903	Lys	C0026794
28341903	exocrine solutions	C0504082
28345005	Chronic Enzyme Replacement	C0598391
28345005	Brain	C0006104
28345005	Late Infantile Neuronal Ceroid Lipofuscinosis	C0022340
28345005	Mouse	C0025929
28345005	Effects	C1280500
28345005	Phenotypes	C0031437
28345005	Disease	C0012634
28345005	Late infantile neuronal ceroid lipofuscinosis	C0022340
28345005	LINCL	C0022340
28345005	fatal	C1302234
28345005	neurodegenerative disease	C0524851
28345005	lysosomal protease tripeptidyl peptidase 1	C1430948
28345005	TPP1	C1430948
28345005	effects	C1280500
28345005	chronic intrathecal (IT) administration	C0677897
28345005	enzyme replacement therapy	C0598391
28345005	ERT	C0598391
28345005	brain	C0006104
28345005	LINCL	C0022340
28345005	mouse model	C2986594
28345005	locomotor function	C0234130
28345005	early death	C1836407
28345005	lifespan	C0870809
28345005	days	C0439228
28345005	days	C0439228
28345005	chronic IT treatment	C1831734
28345005	onset	C0449244
28345005	disease	C0012634
28345005	animals	C0003062
28345005	locomotor dysfunction	C0521654
28345005	died	C0011065
28345005	cerebrospinal fluid	C0007806
28345005	CSF	C0007806
28345005	delivery	C1705822
28345005	deliver	C1705822
28345005	TPP1	C1530775
28345005	brain regions	C1273723
28345005	Morphological	C0543482
28345005	studies	C2603343
28345005	delivery	C1705822
28345005	TPP1	C1530775
28345005	ventral	C1273723
28345005	dorsal regions	C1273723
28345005	IT treatment	C1831734
28345005	severely	C0205082
28345005	affected	C0392760
28345005	LINCL	C0022340
28345005	mice	C0025929
28345005	lifespan	C0870809
28345005	cohort	C0599755
28345005	Treatment	C1522326
28345005	locomotor function	C0234130
28345005	animals	C0003062
28345005	animals	C0003062
28345005	die	C0011065
28345005	pathology	C0677042
28345005	LINCL	C0022340
28345005	reversible	C0205343
28345005	neuronal death	C2754100
28346872	5-Bromo-2-aryl benzimidazole derivatives	C0005050
28346872	non-cytotoxic	C2827065
28346872	potential	C3245505
28346872	inhibitors	C0014432
28346872	α-glucosidase	C0002272
28346872	urease enzymes	C0041945
28346872	report	C0684224
28346872	α-glucosidase	C0002272
28346872	inhibitory activity	C1152555
28346872	5-bromo-2-aryl benzimidazole derivatives	C0005050
28346872	screened	C0373483
28346872	urease	C0041945
28346872	inhibitory	C1152555
28346872	cytotoxicity activity	C0201622
28346872	more potent	C3245505
28346872	non-cytotoxic	C2827065
28346872	potential	C3245505
28346872	inhibitor	C0014432
28346872	patients	C0030705
28346872	diabetes	C0011847
28346872	peptic ulcer	C0030920
28346872	study	C2603343
28346872	compounds	C1254351
28346872	degree of potency	C0678792
28346872	IC50	C0600495
28346872	standard	C0034925
28346872	thiourea	C0039958
28346872	IC50	C0600495
28346872	derivatives 7	C1254351
28346872	IC50	C0600495
28346872	8	C1254351
28346872	IC50	C0600495
28346872	11	C1254351
28346872	IC50	C0600495
28346872	14	C1254351
28346872	IC50	C0600495
28346872	22	C1254351
28346872	IC50	C0600495
28346872	potent inhibitors	C0014432
28346872	standard	C0034925
28346872	compounds	C1254351
28346872	cytotoxicity	C0201622
28346872	3T3	C0085087
28346872	mouse fibroblast cell line	C1513528
28346872	non-toxic	C0243095
28346872	benzimidazole 1-25	C0005050
28346872	α-glucosidase	C0002272
28346872	inhibitory potential	C1152555
28346872	In silico	C3489666
28346872	studies	C2603343
28346872	lead molecules	C1254351
28346872	2	C1254351
28346872	7	C1254351
28346872	8	C1254351
28346872	11	C1254351
28346872	14	C1254351
28346872	22	C1254351
28346872	binding interaction	C0687133
28346872	compounds	C1254351
28346872	active site	C0205681
28346872	urease enzyme	C0041945
28347978	Intra-articular	C0442108
28347978	implantation	C0021107
28347978	collagen	C0009325
28347978	scaffold	C0337143
28347978	carriers	C0025080
28347978	safe	C0557723
28347978	native	C0302891
28347978	arthrofibrotic	C1142253
28347978	rabbit	C3887509
28347978	knee joints	C0022745
28347978	Sustained	C0443318
28347978	intra-articular	C0442108
28347978	delivery of pharmacological agents	C3850077
28347978	attractive	C2346874
28347978	modality	C0695347
28347978	use	C0457083
28347978	safe	C0557723
28347978	carrier	C0025080
28347978	induce	C0205263
28347978	cartilage damage	C0549421
28347978	fibrosis	C0016059
28347978	Collagen	C0009325
28347978	scaffolds	C0337143
28347978	available	C0470187
28347978	intra-articularly	C0442108
28347978	investigation	C0220825
28347978	safety	C0036043
28347978	collagen	C0009325
28347978	scaffolds	C0337143
28347978	synovial joints	C0224507
28347978	aim	C1947946
28347978	study	C2603343
28347978	determine	C0205258
28347978	safety	C0036043
28347978	collagen	C0009325
28347978	scaffold	C0337143
28347978	implantation	C0021107
28347978	validated	C1519941
28347978	in vivo	C1515655
28347978	animal	C0003062
28347978	knee arthrofibrosis	C1142253
28347978	rabbits	C3887509
28347978	randomly	C0439605
28347978	equally	C0205163
28347978	assigned	C1516050
28347978	different	C1705242
28347978	groups	C0441833
28347978	arthrotomy	C0185160
28347978	arthrotomy	C0185160
28347978	collagen	C0009325
28347978	scaffold	C0337143
28347978	placement	C0441587
28347978	contracture	C0009918
28347978	surgery	C0543467
28347978	contracture	C0009918
28347978	surgery	C0543467
28347978	collagen	C0009325
28347978	scaffold	C0337143
28347978	placement	C0441587
28347978	Animals	C0003062
28347978	killed	C0162388
28347978	equal	C0205163
28347978	hours	C0439227
28347978	weeks	C0439230
28347978	weeks	C0439230
28347978	weeks	C0439230
28347978	Joint contracture	C0009918
28347978	measured	C0444706
28347978	cartilage	C0007301
28347978	synovial	C1550315
28347978	samples	C0370003
28347978	histological analysis	C0002778
28347978	Animals	C0003062
28347978	arthrotomy	C0185160
28347978	equivalent	C0205163
28347978	joint contractures	C0009918
28347978	scaffold	C0337143
28347978	implantation	C0021107
28347978	Animals	C0003062
28347978	surgery	C0543467
28347978	induce	C0205263
28347978	contracture	C0009918
28347978	equivalent	C0205163
28347978	joint contracture	C0009918
28347978	joint contracture s	C0009918
28347978	collagen	C0009325
28347978	scaffold	C0337143
28347978	implantation	C0021107
28347978	Chondral	C0442012
28347978	damage	C1883709
28347978	damage	C1883709
28347978	occurred	C1709305
28347978	rates	C1521828
28347978	scaffold	C0337143
28347978	implantation	C0021107
28347978	significant difference	C1705241
28347978	synovitis	C0039103
28347978	groups	C0441833
28347978	Absorption	C0000854
28347978	collagen	C0009325
28347978	scaffold	C0337143
28347978	occurred	C1709305
28347978	weeks	C0439230
28347978	animals	C0003062
28347978	data	C1511726
28347978	intra-articular	C0442108
28347978	implantation	C0021107
28347978	collagen	C0009325
28347978	sponge	C0337143
28347978	induce	C0205263
28347978	synovitis	C0039103
28347978	cartilage damage	C0549421
28347978	Implantation	C0021107
28347978	native	C0302891
28347978	joint	C0022745
28347978	induce	C0205263
28347978	contracture	C0009918
28347978	Implantation	C0021107
28347978	collagen	C0009325
28347978	sponge	C0337143
28347978	rabbit	C3887509
28347978	contracture	C0009918
28347978	decrease	C0547047
28347978	severity	C0439793
28347978	contracture	C0009918
28348057	HOST	C1167395
28348057	IMMUNE RECOGNITION	C0301872
28348057	EPIDEMIC	C0014499
28348057	CYSTIC FIBROSIS	C0010674
28348057	PATHOGEN	C0450254
28348057	BURKHOLDERIA DOLOSA	C1482113
28348057	Burkholderia dolosa	C1482113
28348057	cystic fibrosis	C0010674
28348057	CF	C0010674
28348057	Boston Children's Hospital	C0020017
28348057	infection	C3714514
28348057	patients	C0030705
28348057	died	C0011065
28348057	complications	C0009566
28348057	infection	C3714514
28348057	organism	C1482113
28348057	B. dolosa	C1482113
28348057	disease	C0012634
28348057	host	C1167395
28348057	immune response	C0301872
28348057	mice	C0026809
28348057	infected	C0439663
28348057	B. dolosa strain	C1482113
28348057	AU0158	C1482113
28348057	responses	C0871261
28348057	CF	C0010674
28348057	pathogen	C0450254
28348057	Pseudomonas aeruginosa	C0033809
28348057	mice	C0026809
28348057	infected	C0439663
28348057	flagellin	C0016192
28348057	mutant	C0596988
28348057	B. dolosa	C1482113
28348057	flagella	C0016192
28348057	B. dolosa	C1482113
28348057	lung	C0024109
28348057	colonization	C4289767
28348057	higher	C0205250
28348057	persistence	C0546816
28348057	host	C1167395
28348057	B. dolosa strains	C1482113
28348057	neutrophil	C0027950
28348057	cytokine	C0079189
28348057	production	C0005572
28348057	P. aeruginosa	C0033809
28348057	host	C1167395
28348057	immune cells	C0007634
28348057	B. dolosa	C1482113
28348057	B. dolosa	C1482113
28348057	cytokine	C0079189
28348057	cultured cells	C0007635
28348057	flagella	C0016192
28348057	bacteria	C0004611
28348057	dead	C0011065
28348057	B. dolosa	C1482113
28348057	host cells	C1819995
28348057	in vitro	C1533691
28348057	suppress	C1260953
28348057	host	C1167395
28348057	immune response	C0301872
28348057	in vivo	C1515655
28348057	B. dolosa	C1482113
28348057	Burkholderia species	C1264855
28348057	cytokine	C0079189
28348057	production	C0005572
28348057	macrophages	C0024432
28348057	B. cenocepacia strains	C1187839
28348057	data	C1511726
28348057	B. dolosa AU0158	C1482113
28348057	host cells	C1819995
28348057	immune systems	C0020962
28348057	Burkholderia strains	C0282676
28348057	species	C1705920
28355176	Visualization	C0243095
28355176	targeting	C1521840
28355176	LGR5(+)	C1537570
28355176	human	C0086418
28355176	colon	C0009368
28355176	cancer stem cells	C1956422
28355176	cancer stem cell	C1956422
28355176	CSC	C1956422
28355176	theory	C0871935
28355176	self-renewing	C4042950
28355176	subpopulation	C0449560
28355176	cancer cells	C0334227
28355176	tumour growth.	C0598934
28355176	existence	C1547035
28355176	human	C0086418
28355176	CSCs	C1956422
28355176	xenotransplantation	C0520484
28355176	isolated cells	C3829491
28355176	clonal	C1522642
28355176	dynamics	C3826426
28355176	plasticity	C0678558
28355176	human	C0086418
28355176	LGR5(+)	C1537570
28355176	colorectal cancer cells	C0334227
28355176	CSCs	C1956422
28355176	cancer	C0006826
28355176	tissues	C0040300
28355176	Lineage	C1881379
28355176	tracing experiments	C0022885
28355176	tamoxifen	C0039286
28355176	Cre	C1744318
28355176	knock-in	C2350597
28355176	allele	C0002085
28355176	LGR5	C3640115
28355176	self-renewal	C4042950
28355176	differentiation	C0007589
28355176	capacity	C1516240
28355176	LGR5(+)	C1537570
28355176	tumour cells	C0334227
28355176	ablation	C0547070
28355176	LGR5(+)	C1537570
28355176	CSCs	C1956422
28355176	LGR5	C1537570
28355176	Caspase9	C1332668
28355176	knock-in	C2350597
28355176	organoids	C0029250
28355176	tumour regression	C1718423
28355176	tumour regrowth	C0598934
28355176	LGR5(+)	C1537570
28355176	CSCs	C1956422
28355176	KRT20	C1426926
28355176	knock-in	C2350597
28355176	reporter	C0206414
28355176	differentiated	C0007589
28355176	cancer cells	C0334227
28355176	tumour tissues	C0475358
28355176	LGR5(+)	C1537570
28355176	CSCs	C1956422
28355176	tumour regrowth	C0598934
28355176	LGR5(+)	C1537570
28355176	CSC	C1956422
28355176	ablation	C0547070
28355176	chemotherapy	C3665472
28355176	targeting	C1521840
28355176	LGR5(+)	C1537570
28355176	CSCs	C1956422
28355176	data	C1511726
28355176	plasticity	C0678558
28355176	CSCs	C1956422
28355176	potential	C3245505
28355176	therapeutic	C0302350
28355176	target	C1521840
28355176	human	C0086418
28355176	colorectal cancer	C1527249
28355605	Software	C0037585
28355605	Assisted	C1269765
28355605	Method	C0025663
28355605	Estimate	C0750572
28355605	Fetal Weight	C0751992
28355605	Term	C0232991
28355605	Magnetic Resonance Imaging	C0024485
28355605	study	C2603343
28355605	semi-automated	C0205554
28355605	calculation	C1441506
28355605	method	C0025663
28355605	fetal	C0015965
28355605	body volume	C0178521
28355605	magnetic resonance-estimated fetal weight	C0751992
28355605	MR-EFW	C0751992
28355605	planned	C1301732
28355605	delivery	C0005615
28355605	evaluate	C0220825
28355605	technique	C0449851
28355605	measurement	C0242485
28355605	simplified	C0205352
28355605	remaining	C1527428
28355605	accurate	C0443131
28355605	MR-EFW	C0751992
28355605	calculated	C0444686
28355605	semi-automated	C0205554
28355605	method	C0025663
28355605	weeks	C0439230
28355605	gestation	C0032961
28355605	patients	C0030705
28355605	picture archiving and communication system	C0182281
28355605	PACS	C0182281
28355605	patient	C0030705
28355605	sequences	C1519249
28355605	acquired	C0439661
28355605	slice thickness	C3829566
28355605	intersection gap	C3887622
28355605	median	C2939193
28355605	absolute	C0205344
28355605	relative errors	C0743559
28355605	MR-EFW	C0751992
28355605	time	C0040223
28355605	planimetric measurements	C0242485
28355605	calculated	C0444686
28355605	sequences	C1519249
28355605	method	C0025663
28355605	assisted	C3204107
28355605	PACS	C0182281
28355605	methods	C0025663
28355605	calculated	C0444686
28355605	median	C2939193
28355605	median	C2939193
28355605	relative error	C0743559
28355605	MR-EFW	C0751992
28355605	calculations	C1441506
28355605	semi-automated	C0205554
28355605	method	C0025663
28355605	PACS	C0182281
28355605	method	C0025663
28355605	Measurements	C0242485
28355605	sequences	C1519249
28355605	assisted	C3204107
28355605	method	C0025663
28355605	PACS	C0182281
28355605	time	C0040223
28355605	planimetric measurement	C0242485
28355605	decreased	C0205216
28355605	gap	C3887622
28355605	assisted	C3204107
28355605	method	C0025663
28355605	PACS	C0182281
28355605	method	C0025663
28355605	simplified	C0205352
28355605	MR-EFW	C0751992
28355605	measurement	C0242485
28355605	dramatic decrease	C0547047
28355605	time	C0040223
28355605	planimetric measurement	C0242485
28355605	decrease	C0547047
28355605	accuracy	C0598285
28355605	weight	C0751992
28355605	estimates	C0681916
28355968	Abiraterone	C0754011
28355968	induced	C0458082
28355968	rhabdomyolysis	C0035410
28355968	acute kidney injury	C2609414
28355968	case report	C0007320
28355968	review of the literature	C0282441
28355968	Abiraterone	C0754011
28355968	CYP17 inhibitor	C3160096
28355968	androgen biosynthesis	C1157302
28355968	tissue	C0040300
28355968	prednisone	C0032952
28355968	first-line treatment	C1708063
28355968	metastatic	C2939420
28355968	castration-resistant prostate cancer	C1328504
28355968	case	C1706256
28355968	rhabdomyolysis	C0035410
28355968	abiraterone	C0754011
28355968	therapy	C0087111
28355968	acute	C2609414
28355968	chronic	C0205191
28355968	kidney injury	C0160420
28355968	patient	C0030705
28355968	metastatic	C2939420
28355968	castration-resistant prostate cancer	C1328504
28355968	monitoring	C1516647
28355968	patients	C0030705
28355968	abiraterone	C0754011
28355968	risk factors	C0035648
28355968	rhabdomyolysis	C0035410
28356949	Association	C0439849
28356949	XRCC1	C1366475
28356949	ERCC1	C1333355
28356949	single-nucleotide polymorphisms	C0752046
28356949	efficacy	C1280519
28356949	concurrent radiochemotherapy	C3178775
28356949	patients	C0030705
28356949	esophageal squamous cell carcinoma	C0279626
28356949	investigate	C1292732
28356949	association	C0439849
28356949	single-nucleotide polymorphisms	C0752046
28356949	SNPs	C0752046
28356949	X-ray repair cross-complementing 1-399	C1366475
28356949	XRCC1-399	C1366475
28356949	excision repair cross-complementation group 1-118	C1333355
28356949	ERCC1-118	C1333355
28356949	short-term	C0443303
28356949	efficacy	C1280519
28356949	radiochemotherapy	C0436307
28356949	tumor metastasis	C0027627
28356949	relapse	C0035020
28356949	survival time	C2919552
28356949	patients	C0030705
28356949	esophageal squamous cell carcinoma	C0279626
28356949	ESCC	C0279626
28356949	TaqMan probe-based quantitative polymerase chain reaction	C3179034
28356949	qPCR	C3179034
28356949	examine	C0332128
28356949	levels	C0441889
28356949	XRCC1-399	C1366475
28356949	ERCC1-118	C1333355
28356949	SNPs	C0752046
28356949	peripheral blood	C0229664
28356949	patients	C0030705
28356949	pathologically	C1521733
28356949	confirmed	C0750484
28356949	ESCC	C0279626
28356949	associations	C0439849
28356949	different	C1705242
28356949	genotypes	C0017431
28356949	short-term	C0443303
28356949	therapeutic efficacy	C2348767
28356949	complete remission	C0677874
28356949	CR	C0677874
28356949	rate	C1521828
28356949	tumor metastasis	C0027627
28356949	relapse	C0035020
28356949	survival time	C2919552
28356949	concurrent radiochemotherapy	C3178775
28356949	determined	C0521095
28356949	ESCC	C0279626
28356949	patients	C0030705
28356949	concurrent radiochemotherapy	C3178775
28356949	short-term	C0443303
28356949	therapeutic efficacy	C2348767
28356949	CR	C0677874
28356949	rate	C1521828
28356949	group	C0441833
28356949	patients	C0030705
28356949	homozygous mutation	C0026882
28356949	XRCC1-399	C1366475
28356949	A	C0001443
28356949	A	C0001443
28356949	genotype	C0017431
28356949	group	C0441833
28356949	patients	C0030705
28356949	XRCC1-399	C1366475
28356949	mutation	C0026882
28356949	G	C0018330
28356949	G	C0018330
28356949	genotype	C0017431
28356949	CR	C0677874
28356949	rate	C1521828
28356949	significantly increased	C4055637
28356949	patients	C0030705
28356949	ERCC1-118	C1333355
28356949	alleles	C0002085
28356949	C	C0010715
28356949	C	C0010715
28356949	C	C0010715
28356949	T	C0040077
28356949	genotype	C0017431
28356949	compared	C1707455
28356949	patients	C0030705
28356949	C	C0010715
28356949	allele	C0002085
28356949	T	C0040077
28356949	T	C0040077
28356949	genotype	C0017431
28356949	statistically significant	C0237881
28356949	A	C0001443
28356949	A	C0001443
28356949	G	C0018330
28356949	G	C0018330
28356949	T	C0040077
28356949	T	C0040077
28356949	C	C0010715
28356949	T	C0040077
28356949	C	C0010715
28356949	C	C0010715
28356949	follow-up period	C0589120
28356949	group	C0441833
28356949	patients	C0030705
28356949	homozygous mutation	C0026882
28356949	XRCC1-399	C1366475
28356949	A	C0001443
28356949	A	C0001443
28356949	genotype	C0017431
28356949	markedly reduced	C0392756
28356949	risk	C0035647
28356949	metastasis	C4255448
28356949	relapse	C0035020
28356949	compared	C1707455
28356949	group	C0441833
28356949	patients	C0030705
28356949	XRCC1-399	C1366475
28356949	G	C0018330
28356949	G	C0018330
28356949	genotype	C0017431
28356949	ERCC1-118	C1333355
28356949	SNP	C0752046
28356949	associated with	C0332281
28356949	risk	C0035647
28356949	metastasis	C4255448
28356949	recurrence	C0034897
28356949	univariate	C0683962
28356949	multivariate Cox regression analysis	C0034980
28356949	SNP	C0752046
28356949	ERCC1-118	C1333355
28356949	associated with	C0332281
28356949	survival time	C2919552
28356949	mean survival time	C0086595
28356949	significantly	C0750502
28356949	prolonged	C0439590
28356949	patients	C0030705
28356949	C	C0010715
28356949	alleles	C0002085
28356949	C	C0010715
28356949	C	C0010715
28356949	C	C0010715
28356949	T	C0040077
28356949	genotype	C0017431
28356949	compared	C1707455
28356949	patients	C0030705
28356949	C	C0010715
28356949	allele	C0002085
28356949	T	C0040077
28356949	T	C0040077
28356949	genotype	C0017431
28356949	T	C0040077
28356949	T	C0040077
28356949	C	C0010715
28356949	C	C0010715
28356949	HR	C2985465
28356949	confidence interval	C0009667
28356949	CI	C0009667
28356949	T	C0040077
28356949	T	C0040077
28356949	C	C0010715
28356949	T	C0040077
28356949	C	C0010715
28356949	C	C0010715
28356949	HR	C2985465
28356949	CI	C0009667
28356949	XRCC1-399	C1366475
28356949	SNP	C0752046
28356949	no effect	C1301751
28356949	survival time	C2919552
28356949	XRCCl-399	C1366475
28356949	SNP	C0752046
28356949	associated with	C0332281
28356949	short-term	C0443303
28356949	therapeutic efficacy	C2348767
28356949	CR	C0677874
28356949	rate	C1521828
28356949	tumor metastasis	C0027627
28356949	relapse	C0035020
28356949	ESCC	C0279626
28356949	patients	C0030705
28356949	docetaxel plus cisplatin (TP) regimen	C1880380
28356949	concurrent radiochemotherapy	C3178775
28356949	ERCC1-118	C1333355
28356949	SNP	C0752046
28356949	significantly	C0750502
28356949	associated with	C0332281
28356949	short-term	C0443303
28356949	therapeutic efficacy	C2348767
28356949	CR	C0677874
28356949	rate	C1521828
28356949	survival time	C2919552
28356949	ESCC	C0279626
28356949	patients	C0030705
28356949	TP regimen	C1880380
28356949	concurrent radiochemotherapy	C3178775
28357725	Ventricular pacing	C0199648
28357725	site separation	C1254362
28357725	cardiac	C1522601
28357725	computed tomography	C0040405
28357725	validation	C1519941
28357725	prediction	C0681842
28357725	clinical response	C4055223
28357725	cardiac resynchronization therapy	C1167956
28357725	Cardiac Resynchronization Therapy	C1167956
28357725	CRT	C1167956
28357725	provide	C1999230
28357725	benefit	C0814225
28357725	patients	C0030705
28357725	geographic separation	C1254362
28357725	right	C1254362
28357725	left	C1254362
28357725	ventricular pacing	C0199648
28357725	lead sites	C0442031
28357725	suggested	C1705535
28357725	improve	C0184511
28357725	response	C0871261
28357725	Cardiac CT	C0202850
28357725	provides	C1999230
28357725	opportunity	C0683937
28357725	3-dimensional	C0450363
28357725	inter-lead distance	C1254362
28357725	ILD	C1254362
28357725	measures	C0079809
28357725	prediction	C0681842
28357725	CRT	C1167956
28357725	response	C0871261
28357725	objective	C0018017
28357725	study	C2603343
28357725	investigate	C1292732
28357725	associations	C0439849
28357725	standardized	C1442989
28357725	measures	C0079809
28357725	ILD	C1254362
28357725	cardiac CT	C0202850
28357725	echocardiographic	C0013516
28357725	response	C0871261
28357725	CRT	C1167956
28357725	consecutive	C1707491
28357725	patients	C0030705
28357725	CRT	C1167956
28357725	clinical	C4084924
28357725	echocardiographic	C0013516
28357725	evaluations	C0220825
28357725	performed	C0884358
28357725	in addition to	C0332287
28357725	post-procedural	C3272301
28357725	cardiac	C1522601
28357725	CT	C0040405
28357725	blinded	C0150108
28357725	measurement	C0242485
28357725	direct	C1947931
28357725	circumferential	C0205113
28357725	myocardium	C0027061
28357725	ILD	C1254362
28357725	measures	C0079809
28357725	Clinical response	C4055223
28357725	CRT	C1167956
28357725	primary clinical outcome	C0456984
28357725	reduction	C0392756
28357725	LVESV	C0080308
28357725	echocardiography	C0013516
28357725	mean age	C0001779
28357725	ejection fraction	C2700378
28357725	primary outcome	C3274433
28357725	occurred	C1709305
28357725	patients	C0030705
28357725	direct	C1947931
28357725	circumferential	C0205113
28357725	CT	C0040405
28357725	ILD	C1254362
28357725	measures	C0079809
28357725	associated with	C0332281
28357725	primary outcome	C3274433
28357725	univariate analysis	C0683962
28357725	Receiver Operator Characteristic	C0034772
28357725	analysis	C0936012
28357725	Circumferential	C0205113
28357725	ILD	C1254362
28357725	predictive	C0681890
28357725	accuracy	C0443131
28357725	Inter-	C0021713
28357725	intra-observer	C0021861
28357725	reproducibility	C1514863
28357725	CT	C0040405
28357725	ILD	C1254362
28357725	measures	C0079809
28357725	excellent	C1961136
28357725	Circumferential	C0205113
28357725	ILD	C1254362
28357725	measures	C0079809
28357725	cardiac CT	C0202850
28357725	predictive	C0681890
28357725	clinical response	C4055223
28357725	CRT	C1167956
28357725	Incorporation	C0243126
28357725	measures	C0079809
28357725	selection	C1707391
28357725	optimal	C2698651
28357725	pacing	C0199640
28357725	targets	C1521840
28357725	pre-procedural	C3272300
28357725	CT	C0040405
28357725	coronary vein	C3495141
28357725	imaging	C0011923
28357725	therapeutic	C0302350
28357725	benefit	C0814225
28357725	investigation	C0220825
28358234	Iodine Storage	C2348268
28358234	Metabolism	C0025519
28358234	Mild to Moderate	C1299392
28358234	Iodine-Deficient	C0342927
28358234	Pregnant	C0032961
28358234	Rats	C0034693
28358234	Severe iodine deficiency	C0342927
28358234	during pregnancy results	C0585037
28358234	neurodevelopmental disorders	C1535926
28358234	children	C0008059
28358234	consequences of	C0686907
28358234	mild to moderate iodine deficiency	C0342927
28358234	MMID	C0342927
28358234	uncertain	C0087130
28358234	concentration of iodine	C0523726
28358234	thyroid	C0040132
28358234	iodine nutrition	C2348268
28358234	iodine stores	C2348268
28358234	thyroid cover	C0040132
28358234	mother and the fetus	C0545509
28358234	iodine	C0021968
28358234	sufficient	C0205410
28358234	MMID	C0342927
28358234	inductively coupled plasma-mass spectrometry	C1553183
28358234	female Wistar rats	C0034716
28358234	MMID	C0342927
28358234	low iodine intake	C3714384
28358234	normal	C3840145
28358234	normal iodine intake	C3840145
28358234	groups	C0441833
28358234	rats	C0034693
28358234	fed for the next three months	C2987508
28358234	after pregnancy	C0086839
28358234	divided into two subgroups	C1515021
28358234	low iodine	C2745994
28358234	pregnancy	C0032961
28358234	LP	C2745994
28358234	low iodine	C2745994
28358234	pregnancy	C0032961
28358234	iodine supplement	C3661599
28358234	LP+	C3661599
28358234	normal iodine intake	C3840145
28358234	pregnancy	C0032961
28358234	NP	C0032961
28358234	normal iodine intake	C3840145
28358234	pregnancy	C0032961
28358234	iodine supplement	C3661599
28358234	NP+	C3661599
28358234	iodine intake	C4263590
28358234	pregnant	C0032961
28358234	rats	C0034693
28358234	NP+	C3661599
28358234	LP+ groups	C3661599
28358234	NP	C3840145
28358234	LP groups	C2745994
28358234	rats	C0034693
28358234	gestational day	C0439671
28358234	postnatal day	C0443281
28358234	iodine concentration	C0523726
28358234	thyroid	C0040132
28358234	maternal	C1858460
28358234	newborn	C2239178
28358234	rats	C0034693
28358234	maternal serum	C4064645
28358234	placenta	C0032043
28358234	amniotic fluid	C0002638
28358234	inductively coupled plasma-mass spectrometry	C1553183
28358234	concentration of iodine	C0523726
28358234	thyroid	C0040132
28358234	N group	C3840145
28358234	significantly higher	C4055637
28358234	L group	C2745994
28358234	before pregnancy	C3840692
28358234	concentration of iodine	C0523726
28358234	maternal thyroids	C2228489
28358234	LP group	C2745994
28358234	during pregnancy	C0585037
28358234	NP group	C3840145
28358234	iodine concentration	C0523726
28358234	thyroid	C0040132
28358234	mothers	C0026591
28358234	offspring	C0680063
28358234	NP	C3840145
28358234	NP+ groups	C3661599
28358234	LP	C0032961
28358234	LP+ groups	C3661599
28358234	concentration of iodine	C0523726
28358234	amniotic fluid	C0002638
28358234	groups	C0441833
28358234	iodine storage	C2348268
28358234	thyroid	C0040132
28358234	maternal	C1858460
28358234	rats	C0034693
28358234	normal iodine intake	C4263590
28358234	during pregnancy	C0585037
28358234	iodine supplementation	C3661575
28358234	iodine stores	C2348268
28358234	rats	C0034693
28358234	MMID	C0342927
28358234	Iodine supplementation	C3661575
28358234	iodine concentration	C0523726
28358234	thyroid	C0040132
28358234	maternal	C1858460
28358234	rats	C0034693
28358234	MMID	C0342927
28358234	offspring	C0680063
28358234	amniotic fluid	C0002638
28358234	during pregnancy	C0585037
28359664	Omega 3 Fatty Acids	C0015689
28359664	Reduce	C0392756
28359664	Bone Resorption	C0005974
28359664	Promoting Bone Generation	C1371285
28359664	Rat	C0034721
28359664	Apical Periodontitis	C0031030
28359664	evaluated	C0220825
28359664	effects of	C1704420
28359664	dietary supplement	C0242295
28359664	omega 3 polyunsaturated fatty acids	C0015689
28359664	ω-3 PUFAs	C0015689
28359664	pulp exposure	C0011406
28359664	apical periodontitis	C0031030
28359664	AP	C0031030
28359664	rats	C0034721
28359664	male	C0086582
28359664	rats	C0034721
28359664	groups	C1257890
28359664	untreated	C0332155
28359664	rats	C0034721
28359664	rats	C0034721
28359664	treated with	C1522326
28359664	ω-3 PUFAs	C0015689
28359664	rats	C0034721
28359664	pulp exposure	C0011406
28359664	AP	C0031030
28359664	rats	C0034721
28359664	pulp exposure	C0011406
28359664	AP	C0031030
28359664	treated with	C1522326
28359664	ω-3 PUFAs	C0015689
28359664	AP	C0031030
28359664	ω-3 PUFAs	C0015689
28359664	administered orally	C0001563
28359664	pulp exposure	C0011406
28359664	pulp exposure	C0011406
28359664	Rats	C0034721
28359664	killed	C0162388
28359664	pulp exposure	C0011406
28359664	jaws	C0022359
28359664	histologic	C0681853
28359664	immunohistochemical	C1441616
28359664	analyses	C0936012
28359664	Immunohistochemical	C1441616
28359664	analyses	C0936012
28359664	tartrate-resistant acid phosphatase	C0297331
28359664	positive	C1446409
28359664	osteoclasts	C0029431
28359664	osteocalcin	C0029419
28359664	positive	C1446409
28359664	osteoblasts	C0029418
28359664	bone surface	C0825429
28359664	periapical area	C0729269
28359664	evaluated	C0220825
28359664	analysis of variance	C0002780
28359664	Tukey honestly significant difference	C0392762
28359664	statistically significant	C0237881
28359664	bone resorption	C0005974
28359664	lesion	C0221198
28359664	significantly larger	C4055637
28359664	AP	C0031030
28359664	AP	C0031030
28359664	groups	C1257890
28359664	level	C0441889
28359664	inflammatory cell infiltration	C0302158
28359664	tartrate-resistant acid phosphatase	C0297331
28359664	positive	C1446409
28359664	osteoclasts	C0029431
28359664	significantly higher	C4055637
28359664	periapical	C0729269
28359664	lesions	C0221198
28359664	AP	C0031030
28359664	AP	C0031030
28359664	groups	C1257890
28359664	osteocalcin	C0029419
28359664	positive	C1446409
28359664	osteoblasts	C0029418
28359664	increased	C0205217
28359664	AP	C0031030
28359664	AP	C0031030
28359664	Supplementation	C0242297
28359664	ω-3 PUFAs	C0015689
28359664	suppresses	C1260953
28359664	bone resorption	C0005974
28359664	promotes new bone formation	C1371285
28359664	periapical area	C0729269
28359664	rats	C0034721
28359664	AP	C0031030
28359664	conjunction	C2699427
28359664	downregulation	C0013081
28359664	inflammatory cell infiltration	C0302158
28359664	lesion	C0221198
28360843	MagR	C0033684
28360843	Insufficient	C0231180
28360843	Cellular Calcium Responses	C2754478
28360843	Magnetic	C0563532
28360843	Stimulation	C1292856
28360843	Magnetic	C0563532
28360843	manipulation	C0947647
28360843	cell activity	C0007613
28360843	advantages	C0814225
28360843	optical manipulation	C0947647
28360843	MagR protein	C0033684
28360843	interaction	C0872079
28360843	cryptochrome	C2717939
28360843	Cry	C2717939
28360843	protein	C0033684
28360843	solution	C0037633
28360843	respond	C0871261
28360843	magnetic	C0563532
28360843	stimulation	C1292856
28360843	MS	C1292856
28360843	investigation	C0220825
28360843	role	C1705810
28360843	MagR	C0033684
28360843	cellular response	C2754478
28360843	MS	C1292856
28360843	study	C2603343
28360843	MagR	C0033684
28360843	expression	C1171362
28360843	cellular activation	C1326120
28360843	MS	C1292856
28360843	systematically	C0220922
28360843	testing	C0039593
28360843	measuring	C0444706
28360843	intracellular	C0178719
28360843	calcium	C0006675
28360843	MS	C1292856
28360843	protocols	C0442711
28360843	detect	C0442726
28360843	cellular	C0007634
28360843	neuronal	C0027882
28360843	responses	C0871261
28360843	MS	C1292856
28360843	MagR	C0033684
28360843	expressing	C1171362
28360843	HEK cells	C2936239
28360843	primary	C0205225
28360843	neurons	C0027882
28360843	dorsal	C0205095
28360843	root ganglion	C0017070
28360843	hippocampus	C0019564
28360843	neurons	C0027882
28360843	co-expressing	C1171362
28360843	MagR	C0033684
28360843	channelrhodopin	C3253054
28360843	optical	C1292856
28360843	MS	C1292856
28360843	increased	C0205217
28360843	calcium influx	C3158761
28360843	hippocampal	C0019564
28360843	neurons	C0027882
28360843	MagR	C0033684
28360843	not sufficient	C0231180
28360843	cellular	C0007634
28360843	magnetic responses	C2754103
28361230	Acute kidney injury	C2609414
28361230	fluid overload	C0546817
28361230	infants	C0021270
28361230	children	C0008059
28361230	cardiac surgery	C0018821
28361230	Acute kidney injury	C2609414
28361230	serious	C0205404
28361230	complication	C0009566
28361230	congenital heart surgery	C2037615
28361230	infants	C0021270
28361230	comorbidity	C0009488
28361230	associated with	C0332281
28361230	adverse outcomes	C0879626
28361230	increase	C0442805
28361230	mortality	C0178686
28361230	Postoperative	C0032790
28361230	acute kidney injury	C2609414
28361230	pathophysiology	C0031847
28361230	risk factors	C0035648
28361230	no single medication	C0746919
28361230	therapy	C0746919
28361230	effective	C1704419
28361230	treatment	C0087111
28361230	prevention	C2700409
28361230	fluid overload	C0546817
28361230	determinants	C1521761
28361230	morbidity	C0026538
28361230	infants	C0021270
28361230	cardiac surgery	C0018821
28361230	absence	C0332197
28361230	intervention	C0184661
28361230	acute kidney injury	C2609414
28361230	improve	C1272747
28361230	outcomes	C0085415
28361230	treating	C0039798
28361230	preventing	C2700409
28361230	fluid overload	C0546817
28361230	Early	C1279919
28361230	renal replacement therapy	C0206074
28361230	peritoneal dialysis	C0031139
28361230	safe	C0036043
28361230	beneficial	C0814225
28361230	infants	C0021270
28361230	oliguria	C0028961
28361230	heart surgery	C0018821
28361230	pathophysiology	C0031847
28361230	acute kidney injury	C2609414
28361230	diagnose	C0011900
28361230	preventative	C2700409
28361230	therapeutic interventions	C0808232
28362102	Systems	C0449913
28362102	Toxicology	C0040541
28362102	World	C2700280
28362102	Applications	C0205245
28362102	Opportunities	C1254370
28362102	Systems	C0449913
28362102	Toxicology	C0040541
28362102	adverse biological effects	C0001688
28362102	xenobiotics	C0043335
28362102	characterized	C1880022
28362102	empirical	C1880496
28362102	end points	C2349179
28362102	modes	C1513371
28362102	action	C3266814
28362102	adverse	C0001688
28362102	outcome	C1274040
28362102	pathways	C1705987
28362102	perturbed networks	C1882071
28362102	Systems	C0449913
28362102	Toxicology	C0040541
28362102	integration	C1705422
28362102	in vitro	C1533691
28362102	in vivo	C1515655
28362102	toxicity	C0600688
28362102	data	C1511726
28362102	computational modeling	C0009609
28362102	approach	C1292724
28362102	data	C1511726
28362102	reliability	C2347947
28362102	relevance	C2347946
28362102	quality	C0332306
28362102	experimental models	C0086272
28362102	bioanalysis techniques	C0242481
28362102	toxicological	C0205472
28362102	data	C1511726
28362102	Systems	C0449913
28362102	Toxicology	C0040541
28362102	data streams	C0150098
28362102	data	C1511726
28362102	omics measurements	C0242481
28362102	computational	C1880157
28362102	informative	C2986490
28362102	results	C1274040
28362102	integrative analysis	C0936012
28362102	multiple	C0439064
28362102	molecular measurements	C0242485
28362102	omics strategies	C0022885
28362102	approach	C1292724
28362102	Systems	C0449913
28362102	Toxicology	C0040541
28362102	in vitro	C1533691
28362102	bioanalytical strategies	C0022885
28362102	linking	C0205245
28362102	network	C1882071
28362102	perturbations	C0332453
28362102	phenotypes	C0031437
28362102	pathways	C1705987
28362102	networks	C1882071
28362102	adverse responses	C0001688
28362102	summary	C1552616
28362102	Systems	C0449913
28362102	Toxicology	C0040541
28362102	meeting	C0556656
28362102	international conference	C0086047
28362102	Alps	C0017446
28362102	Switzerland	C0039021
28362102	limitations	C0449295
28362102	opportunities	C1254370
28362102	applications	C0205245
28362102	Systems	C0449913
28362102	Toxicology	C0040541
28362102	adverse biological effects	C0001688
28362102	xenobiotics	C0043335
28362102	characterized	C1880022
28362102	empirical	C1880496
28362102	end points	C2349179
28362102	pathways	C1705987
28362102	toxicity	C0600688
28362102	integration	C1705422
28362102	in vitro	C1533691
28362102	in vivo	C1515655
28362102	data	C1511726
28362102	computational modeling	C0009609
28362102	bioanalytical technologies	C0022885
28362102	data	C1511726
28362102	reliability	C2347947
28362102	relevance	C2347946
28362102	pathway	C1705987
28362102	approach	C1292724
28362102	link	C0205245
28362102	network	C1882071
28362102	perturbations	C0332453
28362102	phenotypic	C0031437
28362102	toxicity	C0600688
28363626	Validating	C1519941
28363626	Signs and Symptoms	C0037088
28363626	Mass Casualty Incident	C1955957
28363626	Characterize	C1880022
28363626	Irritant Gas Syndrome Agent	C1254354
28363626	IGSA	C1254354
28363626	Development	C1527148
28363626	Novel	C0205314
28363626	IGSA	C1254354
28363626	Triage	C0040861
28363626	Algorithm	C0002045
28363626	Chemical exposures	C0678803
28363626	significant	C0750502
28363626	threat	C0749385
28363626	life	C0376558
28363626	assessment	C0220825
28363626	first responders	C3824749
28363626	emergency nurses	C0557519
28363626	required	C1514873
28363626	reduce	C0392756
28363626	death	C0011065
28363626	disability	C0231170
28363626	no	C1518422
28363626	informatics tools	C0037589
28363626	irritant gas syndrome agent	C1254354
28363626	IGSA	C1254354
28363626	exposures	C0332157
28363626	exist	C2987476
28363626	process	C1522240
28363626	victims	C0680681
28363626	efficiently	C0442799
28363626	continuously	C0549178
28363626	monitor	C1283169
28363626	latent	C0205275
28363626	signs/symptoms	C0037088
28363626	triage	C0040861
28363626	recommendations	C0034866
28363626	study	C2603343
28363626	ED	C0562508
28363626	informatics tools	C0037589
28363626	chemical incidents	C2350599
28363626	validation	C1519941
28363626	signs/symptoms	C0037088
28363626	characterize	C1880022
28363626	IGSA	C1254354
28363626	syndrome	C0039082
28363626	Data abstracted	C3259344
28363626	patients	C0030705
28363626	treated	C0087111
28363626	chlorine exposure	C0239049
28363626	emergency department	C0562508
28363626	during	C0347984
28363626	train derailment	C0337199
28363626	patients	C0030705
28363626	not	C1518422
28363626	exposed to chlorine	C0239049
28363626	comparison group	C0009932
28363626	mapped	C3858752
28363626	signs/symptoms	C0037088
28363626	tools	C0037589
28363626	WISER	C0037589
28363626	CHEMM-IST	C0037589
28363626	designed	C1707689
28363626	assist	C1269765
28363626	emergency responders	C3178988
28363626	emergency nurses	C0557519
28363626	hazardous material	C0018626
28363626	exposures	C0332157
28363626	Inferential statistics	C0032685
28363626	Fisher's exact test	C0237913
28363626	diagnostics tests	C0086143
28363626	used	C1524063
28363626	mapped	C3858752
28363626	signs/symptoms	C0037088
28363626	persons	C0027361
28363626	exposed to chlorine	C0239049
28363626	clusters	C1704332
28363626	signs/symptoms	C0037088
28363626	statistically	C2828391
28363626	associated with	C0332281
28363626	IGSA	C1254354
28363626	syndrome	C0039082
28363626	respiratory	C0521346
28363626	shortness of breath	C0013404
28363626	wheezing	C0043144
28363626	coughing	C0010200
28363626	choking	C0008301
28363626	chest discomfort	C0235710
28363626	tightness	C0232292
28363626	pain	C0008031
28363626	burning	C0740396
28363626	eye	C0015392
28363626	nose	C0028429
28363626	throat	C3665375
28363626	pain	C0030193
28363626	irritation	C0441723
28363626	burning	C0085624
28363626	syndrome	C0039082
28363626	presence	C0150312
28363626	signs/symptoms	C0037088
28363626	clusters	C1704332
28363626	latency period	C0023103
28363626	considered	C0750591
28363626	exposed	C1998203
28363626	potentially	C3245505
28363626	exposed persons	C1998203
28363626	study	C2603343
28363626	uses	C1524063
28363626	patient data	C2707520
28363626	chemical incident	C2350599
28363626	characterize	C1880022
28363626	validate	C1519941
28363626	signs/symptoms	C0037088
28363626	IGSA	C1254354
28363626	syndrome	C0039082
28363626	Validating	C1519941
28363626	signs/symptoms	C0037088
28363626	new	C0205314
28363626	ED	C0562508
28363626	informatics tools	C0037589
28363626	potential	C3245505
28363626	process	C1522240
28363626	emergency nurses	C0557519
28363626	triage	C0040861
28363626	victims	C0680681
28363626	chemical incidents	C2350599
28363782	Fyn	C1442788
28363782	multipolar	C1254362
28363782	bipolar	C0443156
28363782	transition	C2700061
28363782	neurite morphogenesis	C1753129
28363782	migrating neurons	C1326504
28363782	developing neocortex	C1818475
28363782	Fyn	C1442788
28363782	non-receptor	C0243095
28363782	protein tyrosine kinase	C0033681
28363782	Src family kinases	C0282625
28363782	Fyn	C1442788
28363782	neuronal migration	C1326504
28363782	mechanism	C0441712
28363782	unclear	C3845108
28363782	suppression	C0038855
28363782	Fyn	C1442788
28363782	expression	C1171362
28363782	mouse cerebral cortex	C1522579
28363782	migration defects	C2750249
28363782	early-born	C1279919
28363782	late-born	C0205087
28363782	neurons	C0027882
28363782	Morphological	C0543482
28363782	analysis	C0936012
28363782	Fyn	C1442788
28363782	multipolar	C1254362
28363782	bipolar	C0443156
28363782	transition	C2700061
28363782	generated	C3146294
28363782	neurons	C0027882
28363782	neurite formation	C1753129
28363782	phase	C0205390
28363782	migration	C1326504
28363782	Fyn	C1442788
28363782	inhibition	C1519619
28363782	leading process	C0007613
28363782	branching	C0205384
28363782	migrating cortical neurons	C1326504
28363782	Fyn	C1442788
28363782	controls	C2587213
28363782	neuronal migration	C1326504
28363782	regulating	C1327622
28363782	cytoskeletal	C0010853
28363782	dynamics	C3826426
28363782	multipolar	C1254362
28363782	bipolar	C0443156
28363782	transition	C2700061
28363782	newly	C0750546
28363782	generated	C3146294
28363782	neurons	C0027882
28363782	cortical development	C1818475
28367636	Closing the Loop	C0443183
28367636	Adults	C0001675
28367636	Children	C0008059
28367636	Adolescents	C0205653
28367636	Suboptimally Controlled Type 1 Diabetes	C2732401
28367636	Free	C0870587
28367636	Living Conditions	C0337645
28367636	Psychosocial	C0542298
28367636	Substudy	C2603343
28367636	psychosocial experiences	C1458132
28367636	closed loop technology	C0181334
28367636	adults	C0001675
28367636	children	C0008059
28367636	adolescents	C0205653
28367636	type 1 diabetes	C0011854
28367636	parents	C0030551
28367636	multicenter	C1096776
28367636	free	C0870587
28367636	living	C0337645
28367636	randomized	C0034656
28367636	crossover home studies	C0150097
28367636	Participants	C0679646
28367636	insulin pump	C1140609
28367636	therapy	C0087111
28367636	randomized	C0034656
28367636	weeks	C0439230
28367636	automated	C0205554
28367636	closed-loop	C0443183
28367636	glucose control	C0726398
28367636	weeks	C0439230
28367636	sensor	C0183210
28367636	augmented	C0205217
28367636	insulin pump	C1140609
28367636	therapy	C0087111
28367636	open loop	C0559530
28367636	Closed loop	C0443183
28367636	hours	C0439227
28367636	adults	C0001675
28367636	overnight	C0439583
28367636	children	C0008059
28367636	adolescents	C0205653
28367636	Participants	C0679646
28367636	Diabetes Technology Questionnaire	C0034394
28367636	DTQ	C0034394
28367636	periodically	C0332182
28367636	views	C0449911
28367636	semistructured interviews	C0681913
28367636	analysis	C0936012
28367636	characterizes	C3875152
28367636	impact	C4049986
28367636	technology	C0039421
28367636	positive	C1446409
28367636	negative	C3853545
28367636	living	C0337645
28367636	device	C0025080
28367636	participants	C0679646
28367636	expectations	C0679138
28367636	hopes	C0392347
28367636	anxieties	C0003467
28367636	Participants	C0679646
28367636	adults	C0001675
28367636	years	C0439234
28367636	male	C0086582
28367636	children	C0008059
28367636	age	C0001779
28367636	years	C0439234
28367636	years	C0439234
28367636	male	C0086582
28367636	DTQ	C0034394
28367636	results	C1274040
28367636	moderately favorable impact	C4049986
28367636	open	C0559530
28367636	closed loop	C0443183
28367636	interventions	C0184661
28367636	evidence	C3887511
28367636	comparative advantage	C0681074
28367636	positive themes	C1446409
28367636	improved blood glucose control	C1873605
28367636	improved general well-being	C2939150
28367636	waking	C0442696
28367636	improved sleep	C0037313
28367636	reduced	C0392756
28367636	burden	C2828008
28367636	diabetes	C0011847
28367636	visibility	C0205556
28367636	data	C1511726
28367636	negative themes	C3853545
28367636	equipment	C0014672
28367636	dislike	C0870431
28367636	pump	C1140609
28367636	cannula	C0520453
28367636	sensor	C0183210
28367636	participants	C0679646
28367636	positive	C1446409
28367636	experience	C0683573
28367636	closed loop technology	C0181334
28367636	Results	C1274040
28367636	consistent with	C0332290
28367636	size	C0456389
28367636	equipment	C0014672
28367636	problem	C0033213
28367636	usability	C0457083
28367636	closed-loop system	C0181334
28370352	Serum	C0229671
28370352	levels	C0441889
28370352	genomic DNA	C3272453
28370352	α1(I) collagen	C1332772
28370352	elevated	C3163633
28370352	scleroderma	C0011644
28370352	patients	C0030705
28370352	nucleic acids	C0028606
28370352	human	C0086418
28370352	sera	C0229671
28370352	disease markers	C1511983
28370352	human	C0086418
28370352	diseases	C0012634
28370352	DNA	C0012854
28370352	RNA	C0035668
28370352	collagens	C1333079
28370352	human	C0086418
28370352	sera	C0229671
28370352	serum	C0229671
28370352	levels	C0441889
28370352	biomarkers	C0005516
28370352	scleroderma	C0011644
28370352	patients	C0030705
28370352	RNA	C0035668
28370352	DNA	C0012854
28370352	collagens	C1333079
28370352	purified	C1998793
28370352	sera	C0229671
28370352	detected	C0442726
28370352	polymerase chain reaction	C0032520
28370352	quantitated	C1709793
28370352	real-time polymerase chain reaction	C1709846
28370352	360 bases of full-length α1(I) collagen	C1332772
28370352	DNA	C0012854
28370352	regions	C0017337
28370352	detected	C0442726
28370352	polymerase chain reaction	C0032520
28370352	human	C0086418
28370352	sera	C0229671
28370352	α2(I) collagen	C1332773
28370352	DNA	C0012854
28370352	α1(I) collagen	C1332772
28370352	RNA	C0035668
28370352	α2(I) collagen	C1332773
28370352	RNA	C0035668
28370352	not detectable	C0243095
28370352	α1(I) Collagen	C1332772
28370352	DNA	C0012854
28370352	sera	C0229671
28370352	quantitative	C0392762
28370352	levels	C0441889
28370352	serum	C0229671
28370352	α1(I) collagen	C1332772
28370352	DNA	C0012854
28370352	increased	C0205217
28370352	scleroderma	C0011644
28370352	patients	C0030705
28370352	healthy control	C2986479
28370352	subjects	C0080105
28370352	systemic lupus erythematosus	C0024141
28370352	patients	C0030705
28370352	receiver-operator curve analysis	C0035787
28370352	serum	C0229671
28370352	α1(I) collagen	C1332772
28370352	DNA	C0012854
28370352	levels	C0441889
28370352	diagnostic marker	C1511876
28370352	scleroderma	C0011644
28370352	association	C0439849
28370352	serum	C0229671
28370352	α1(I) collagen	C1332772
28370352	DNA	C0012854
28370352	levels	C0441889
28370352	clinical	C0205210
28370352	laboratory	C0022877
28370352	features	C1521970
28370352	scleroderma	C0011644
28370352	patients	C0030705
28370352	elevated	C3163633
28370352	α1(I) collagen	C1332772
28370352	DNA	C0012854
28370352	levels	C0441889
28370352	prevalence	C0220900
28370352	pitting scars	C0012634
28370352	ulcers	C0041582
28370352	elevation	C3163633
28370352	serum	C0229671
28370352	α1(I) collagen	C1332772
28370352	DNA	C0012854
28370352	levels	C0441889
28370352	scleroderma	C0011644
28370352	patients	C0030705
28370352	diagnostic marker	C1511876
28370352	vasculopathy	C0042373
28370352	rna	C0035668
28370605	Metabolite	C0870883
28370605	mapping	C1283195
28370605	nanostructure	C1450053
28370605	silver-assisted mass spectrometry imaging	C0037813
28370605	tissue sections	C2316368
28370605	Nanostructure-based mass spectrometry imaging	C0037813
28370605	MSI	C0037813
28370605	molecular imaging	C1537028
28370605	small molecules	C1328819
28370605	matrix-assisted molecular imaging	C1537028
28370605	surfaces	C0205148
28370605	silver	C0037125
28370605	Ag	C0037125
28370605	MSI data	C0282574
28370605	MSI data	C0282574
28370605	application	C4048755
28370605	laser desorption/ionization mass spectrometry	C0282597
28370605	biological samples	C0444062
28370605	desorption/ionization on silicon	C1254366
28370605	DIOS	C1254366
28370605	substrates	C3891814
28370605	analysis	C0936012
28370605	ultra-thin Ag layers	C1522408
28370605	MSI analysis	C0037813
28370605	Ag-DIOS MSI	C0282597
28370605	small molecules	C1328819
28370605	environmental	C0014406
28370605	contaminants	C2827365
28370605	sebum	C0036511
28370605	lipids	C0023779
28370605	metabolites	C0870883
28370605	fore-stomach sections	C1517295
28370605	6-bromoisatin	C3493005
28370605	chemopreventative	C3273128
28370605	murine mouse model	C2986594
28370605	DIOS MSI	C0037813
28370605	mapping	C1283195
28370605	ions	C0022023
28370605	6-bromoisatin	C3493005
28370605	metabolites	C0870883
28370605	lipids	C0023779
28370605	murine fore-stomach	C1517295
28370605	DIOS MSI	C0037813
28370605	Ag-DIOS MSI	C0282597
28370605	Ag-adductable lipids	C0023779
28370605	wax esters	C0014898
28370605	cholesterol	C0008377
28370605	murine fore-stomach	C1517295
28370605	Gastrointestinal acid	C0017119
28370605	condensation	C0596312
28370605	products	C0566267
28370605	6-bromoisatin	C3493005
28370605	6,6'-dibromoindirubin	C0574031
28370605	isolate	C0220862
28370605	characterize	C1880022
28370605	tissue	C0040300
28370605	metabolite	C0870883
28370605	DIOS	C1254366
28370605	tissue-specific spatial context	C1955394
28370605	lipid distributions	C0007613
28370605	Ag-DIOS MSI	C0282597
28370605	metabolite	C0870883
28370605	lipid	C0023779
28370605	tissue-specific	C1955394
28370605	MSI analyses	C0037813
28370605	small molecules	C1328819
28370605	metabolites	C0870883
28370605	undetectable	C3827727
28370728	culturally competent paediatric oncology care	C3850087
28370728	qualitative study	C0949415
28370728	perspective	C1711364
28370728	care providers	C0018724
28370728	influence	C4054723
28370728	ethnic	C0680174
28370728	diversity	C1880371
28370728	paediatric	C0030755
28370728	cancer care	C0920687
28370728	perspectives	C1711364
28370728	care providers	C0018724
28370728	Semi-structured interviews	C0683518
28370728	paediatric oncologists	C0279158
28370728	nurses	C0028661
28370728	paediatric oncology wards	C0587485
28370728	analysed	C0936012
28370728	framework method	C0025663
28370728	care providers	C0018724
28370728	Turkish	C0549217
28370728	Moroccan	C1257890
28370728	parents	C0030551
28370728	language barriers	C0237167
28370728	care provider	C0018724
28370728	parents	C0030551
28370728	hindered	C0205245
28370728	exchange of information	C0870706
28370728	cultural barriers	C0810880
28370728	care provider	C0018724
28370728	parents	C0030551
28370728	diagnosis	C0011900
28370728	palliative	C1285530
28370728	perspective	C1711364
28370728	hindered	C0205245
28370728	communication	C0009452
28370728	Care providers	C0018724
28370728	solutions	C2699488
28370728	barriers	C0009454
28370728	interpreter	C0150646
28370728	cultural knowledge	C0376554
28370728	patients	C0030705
28370728	interpreters	C0150646
28370728	eliciting	C0474408
28370728	parents	C0030551
28370728	perspectives	C1711364
28370728	Communication	C0009452
28370728	techniques	C0449851
28370728	dilemmas	C1510640
28370728	parents	C0030551
28370728	care providers	C0018724
28370728	care providers	C0018724
28370728	stereotypes	C3825635
28370728	prejudice	C0033023
28370728	Care providers	C0018724
28370728	cultural barriers	C0810880
28370728	Training	C0220931
28370728	cultural competence	C0679748
28370728	manifest	C0205319
28370728	barriers	C0009454
28371313	Obesogenic	C0028754
28371313	eating behaviors	C0015745
28371313	relationships	C0439849
28371313	psychological problems	C0848067
28371313	BMI	C1305855
28371313	children	C0008059
28371313	association	C0439849
28371313	psychological problems	C0848067
28371313	weight	C0005910
28371313	status	C0449438
28371313	children	C0008059
28371313	aged	C0001779
28371313	years	C0439234
28371313	obesogenic	C0028754
28371313	eating behaviors	C0015745
28371313	relationship	C0439849
28371313	cross-sectional secondary analysis	C0010362
28371313	data	C1511726
28371313	first-time mothers	C0026591
28371313	NOURISH randomized controlled trial	C0206035
28371313	child	C0008059
28371313	child	C0008059
28371313	maternal	C0026591
28371313	child	C0008059
28371313	eating behaviors	C0015745
28371313	psychological problems	C0848067
28371313	child	C0008059
28371313	weight	C0005910
28371313	height	C0005890
28371313	data were collected	C0010995
28371313	staff	C1552084
28371313	Pearson's correlations	C1709490
28371313	linear regressions	C0023733
28371313	associations	C0439849
28371313	eating behaviors	C0015745
28371313	psychological problems	C0848067
28371313	BMI	C1305855
28371313	z score	C0871421
28371313	Multiple mediation models	C0814912
28371313	tested	C0039593
28371313	indirect	C0439852
28371313	effects	C1280500
28371313	psychological problems	C0848067
28371313	BMI	C1305855
28371313	z score	C0871421
28371313	obesogenic	C0028754
28371313	eating behaviors	C0015745
28371313	Peer	C0679739
28371313	problems	C0848067
28371313	associated with	C0332281
28371313	higher	C0205250
28371313	food	C0016452
28371313	responsiveness	C0205342
28371313	emotional overeating	C0556019
28371313	directly	C1947931
28371313	higher	C0205250
28371313	BMI	C1305855
28371313	z score	C0871421
28371313	relationship	C0439849
28371313	emotional overeating	C0556019
28371313	emotional overeating	C0556019
28371313	food	C0016452
28371313	responsiveness	C0205342
28371313	association	C0439849
28371313	emotional problems	C0677660
28371313	BMI	C1305855
28371313	z score	C0871421
28371313	food	C0016452
28371313	responsiveness	C0205342
28371313	association	C0439849
28371313	conduct problems	C0149654
28371313	BMI	C1305855
28371313	z score	C0871421
28371313	children	C0008059
28371313	psychological problems	C0848067
28371313	obesogenic	C0028754
28371313	eating behaviors	C0015745
28371313	higher	C0205250
28371313	BMI	C1305855
28371313	clinical management	C1516615
28371313	pediatric	C1521725
28371313	overweight	C0497406
28371313	obesity	C0028754
28371313	psychological problems	C0848067
28371745	Homocysteine	C0019878
28371745	peripheral	C0205100
28371745	biomarker	C0005516
28371745	bipolar disorder	C0005586
28371745	meta-analysis	C0920317
28371745	Bipolar disorder	C0005586
28371745	BD	C0005586
28371745	psychiatric disorder	C0004936
28371745	uncertain	C0087130
28371745	aetiology	C1314792
28371745	homocysteine	C0019878
28371745	Hcy	C0019878
28371745	alterations	C1515926
28371745	1-carbon metabolism	C1158831
28371745	psychiatric disorders	C0004936
28371745	uncertainty	C0087130
28371745	alterations	C1515926
28371745	peripheral	C0205100
28371745	Hcy	C0019878
28371745	BD	C0005586
28371745	meta-analysis	C0920317
28371745	serum	C1278080
28371745	plasma Hcy levels	C1278165
28371745	persons	C0027361
28371745	BD	C0005586
28371745	healthy controls	C2986479
28371745	systematic	C0220922
28371745	search	C1706202
28371745	eligible	C1548635
28371745	peer-reviewed articles	C2985503
28371745	cross-sectional studies	C0010362
28371745	included	C0332257
28371745	meta-analyses	C0920317
28371745	providing	C1999230
28371745	data	C1511726
28371745	participants	C0679646
28371745	Random-effects	C1280500
28371745	meta-analysis	C0920317
28371745	serum	C1278080
28371745	plasma levels of Hcy	C1278165
28371745	increased	C0205217
28371745	subjects	C0681850
28371745	BD	C0005586
28371745	mania	C0338831
28371745	euthymia	C0948853
28371745	compared	C1707455
28371745	healthy controls	C2986479
28371745	effect size	C0814843
28371745	mania	C0338831
28371745	group	C1257890
28371745	CI	C0009667
28371745	effect	C1280500
28371745	euthymia	C0948853
28371745	group	C1257890
28371745	CI	C0009667
28371745	meta-analysis	C0920317
28371745	Hcy levels are elevated	C0920051
28371745	persons	C0027361
28371745	BD	C0005586
28371745	mania	C0338831
28371745	euthymia	C0948853
28371745	Peripheral	C0205100
28371745	Hcy	C0019878
28371745	considered	C0750591
28371745	potential	C3245505
28371745	biomarker	C0005516
28371745	BD	C0005586
28371745	trait	C0599883
28371745	increased	C0205217
28371745	euthymia	C0948853
28371745	state	C1442792
28371745	increase	C0442805
28371745	accentuated	C1997416
28371745	mania	C0338831
28371745	Longitudinal studies	C0023981
28371745	relationship	C0439849
28371745	bipolar disorder	C0005586
28371745	Hcy	C0019878
28371745	usefulness	C3827682
28371745	peripheral	C0205100
28371745	Hcy	C0019878
28371745	trait	C0599883
28371745	state	C1442792
28371745	biomarker	C0005516
28371745	BD	C0005586
28373195	Structural Modification	C0581602
28373195	Lipopolysaccharide	C0023810
28373195	mcr-1	C0017337
28373195	Gram-Negative ESKAPE	C0018150
28373195	Pathogens	C0450254
28373195	mcr-1	C0017337
28373195	plasmid	C0032136
28373195	colistin	C0009316
28373195	resistance gene	C2945710
28373195	clinical isolates	C1764827
28373195	Escherichia coli	C0014834
28373195	Klebsiella pneumoniae	C0001699
28373195	China	C0008115
28373195	species	C1705920
28373195	family Enterobacteriaceae	C0014346
28373195	mcr-1	C0017337
28373195	phosphoethanolamine transferase	C2248757
28373195	expression	C0017262
28373195	phosphoethanolamine	C0070939
28373195	bis-phosphorylated hexa-acylated lipid A	C0023767
28373195	E. coli	C0014834
28373195	effects of	C1704420
28373195	mcr-1	C0017337
28373195	colistin	C0009316
28373195	susceptibility	C0427965
28373195	lipopolysaccharide	C0023810
28373195	structures	C0678594
28373195	laboratory	C0022877
28373195	clinical	C0205210
28373195	strains	C0456178
28373195	Gram-negative ESKAPE	C0018150
28373195	Enterococcus faecium	C0085495
28373195	Staphylococcus aureus	C0038172
28373195	K. pneumoniae	C0001699
28373195	K. pneumoniae	C0001699
28373195	Acinetobacter baumannii	C0314787
28373195	Pseudomonas aeruginosa	C0033809
28373195	Enterobacter species	C1295792
28373195	pathogens	C0450254
28373195	treated	C1522326
28373195	clinically	C0205210
28373195	colistin	C0009316
28373195	effects of	C1704420
28373195	mcr-1	C0017337
28373195	colistin	C0009316
28373195	resistance	C0949285
28373195	MIC assays	C0427978
28373195	laboratory	C0022877
28373195	clinical	C0205210
28373195	strains	C0456178
28373195	E. coli	C0014834
28373195	K. pneumoniae	C0001699
28373195	A. baumannii	C0314787
28373195	P. aeruginosa	C0033809
28373195	Lipid A	C0023767
28373195	structural	C0678594
28373195	MCR-1	C4308704
28373195	mass spectrometry	C0037813
28373195	mcr-1	C0017337
28373195	colistin	C0009316
28373195	resistance	C0949285
28373195	E. coli	C0014834
28373195	K. pneumoniae	C0001699
28373195	A. baumannii	C0314787
28373195	reduced	C0392756
28373195	susceptibility	C0427965
28373195	P. aeruginosa	C0033809
28373195	Phosphoethanolamine	C0070939
28373195	modification	C3840684
28373195	lipid A	C0023767
28373195	species	C1705920
28373195	findings	C2607943
28373195	risk	C0035647
28373195	colistin	C0009316
28373195	resistance	C0949285
28373195	consequence of	C0686907
28373195	mcr-1	C0017337
28373195	expression	C0017262
28373195	ESKAPE	C0018150
28373195	pathogens	C0450254
28373195	K. pneumoniae	C0001699
28373195	A. baumannii	C0314787
28373195	lipid A	C0023767
28373195	structures	C0678594
28373195	increases	C0442805
28373195	colistin	C0009316
28373195	MICs	C0427978
28373195	surveillance methods	C1515093
28373195	dissemination	C0205221
28373195	mcr-1	C0017337
28373195	plasmid	C0032136
28373195	plasmid	C0032136
28373195	phosphoethanolamine transferases	C2248757
28373627	Effects	C1280500
28373627	Transplanted	C0935850
28373627	Human	C0086418
28373627	Cord Blood	C0162371
28373627	Mononuclear Cells	C0806987
28373627	Pulmonary Hypertension	C0020542
28373627	Immunodeficient Mice	C0599920
28373627	Distribution	C1704711
28373627	investigate	C0220825
28373627	effects	C1280500
28373627	human	C0086418
28373627	umbilical cord blood	C0162371
28373627	mononuclear cell	C0806987
28373627	hUCB	C0162371
28373627	MNC	C0806987
28373627	transplantation	C0935850
28373627	pulmonary hypertension	C0020542
28373627	PH	C0020542
28373627	induced	C0205263
28373627	monocrotaline	C0085241
28373627	MCT	C0085241
28373627	immunodeficient mice	C0599920
28373627	distribution	C1704711
28373627	MCT	C0085241
28373627	administered	C1521801
28373627	BALB/c Slc-nu/nu mice	C0025919
28373627	PH	C0020542
28373627	induced	C0205263
28373627	mice	C0025919
28373627	Fresh	C0443224
28373627	hUCB	C0162371
28373627	MNCs	C0806987
28373627	harvested	C0411265
28373627	human	C0086418
28373627	donor	C0013018
28373627	delivery	C1705822
28373627	injected intravenously	C0021494
28373627	PH	C0020542
28373627	mice	C0025919
28373627	medial	C0205098
28373627	thickness	C1280412
28373627	pulmonary arterioles	C4243802
28373627	ratio	C0456603
28373627	right ventricular	C0225883
28373627	septum	C0018819
28373627	plus	C0332287
28373627	left ventricular	C0225897
28373627	weight	C0043100
28373627	RV	C0225883
28373627	S	C0018819
28373627	LV	C0225897
28373627	ratio	C0456603
28373627	acceleration time	C3655682
28373627	ejection time	C0812388
28373627	pulmonary blood flow	C4071554
28373627	waveform	C0450448
28373627	AT	C3655682
28373627	ET	C0812388
28373627	determined	C0521095
28373627	hUCB	C0162371
28373627	MNC	C0806987
28373627	transplantation	C0935850
28373627	reveal	C0443289
28373627	incorporation	C0243126
28373627	lung	C0024109
28373627	CMTMR	C0761898
28373627	labeled	C1522485
28373627	hUCB	C0162371
28373627	MNCs	C0806987
28373627	observed	C1441672
28373627	lung	C0024109
28373627	fluorescent microscopy	C0026022
28373627	DiR-labeled	C0034551
28373627	hUCB	C0162371
28373627	MNCs	C0806987
28373627	detected	C0442726
28373627	lung	C0024109
28373627	organs	C0178784
28373627	bioluminescence images	C2955764
28373627	Medial	C0205098
28373627	thickness	C1280412
28373627	RV	C0225883
28373627	S	C0018819
28373627	LV	C0225897
28373627	AT	C3655682
28373627	ET	C0812388
28373627	significantly	C0750502
28373627	improved	C0184511
28373627	hUCB	C0162371
28373627	MNC	C0806987
28373627	transplantation	C0935850
28373627	compared	C1707455
28373627	mice	C0025919
28373627	hUCB	C0162371
28373627	MNC	C0806987
28373627	transplantation	C0935850
28373627	CMTMR	C0761898
28373627	positive	C1446409
28373627	hUCB	C0162371
28373627	MNCs	C0806987
28373627	observed	C1441672
28373627	lung	C0024109
28373627	transplantation	C0935850
28373627	Bioluminescence	C0162404
28373627	signals	C1710082
28373627	detected	C0442726
28373627	strongly	C0442821
28373627	lung	C0024109
28373627	organs	C0178784
28373627	transplantation	C0935850
28373627	results	C0683954
28373627	indicate	C1444656
28373627	hUCB	C0162371
28373627	MNCs	C0806987
28373627	incorporated	C0243126
28373627	lung	C0024109
28373627	early	C1279919
28373627	hUCB	C0162371
28373627	MNC	C0806987
28373627	transplantation	C0935850
28373627	improve	C0184511
28373627	MCT	C0085241
28373627	induced	C0205263
28373627	PH	C0020542
28375952	Interprofessional Barriers	C0243095
28375952	Quality Improvement Work	C2936612
28375952	Nurses	C0028661
28375952	Physicians	C0031831
28375952	interprofessional barriers	C0243095
28375952	nurses	C0028661
28375952	physicians	C0031831
28375952	context	C0449255
28375952	quality improvement work	C2936612
28375952	nurses	C0028661
28375952	physicians	C0031831
28375952	interviewed	C0018260
28375952	hospitals	C0019994
28375952	Sweden	C0038995
28375952	study uncovered	C0439845
28375952	number of barriers	C4296486
28375952	each group	C0441833
28375952	areas of responsibility	C0678341
28376287	Recovery	C0237820
28376287	alcohol dependence	C0001973
28376287	smoking	C0037369
28376287	indicators	C1522602
28376287	abstinence	C3843422
28376287	inconsistent	C0442809
28376287	evidence	C3887511
28376287	potential	C3245505
28376287	influence	C4054723
28376287	smoking	C0037369
28376287	recovery	C0237820
28376287	alcohol dependence	C0001973
28376287	study	C0947630
28376287	assessing	C0184514
28376287	impact	C4049986
28376287	smoking-behavior	C1519383
28376287	relapse	C0035020
28376287	months	C0439231
28376287	follow-up	C1522577
28376287	period	C1948053
28376287	detoxification	C0150543
28376287	patients	C0030705
28376287	Alcohol Use Disorder	C0001956
28376287	AUD	C0001956
28376287	Patients	C0030705
28376287	AUD	C0001956
28376287	smoking	C0037369
28376287	inpatient	C0021562
28376287	detoxification units	C1708333
28376287	psychiatric hospitals	C0020021
28376287	Germany	C0017480
28376287	alcohol consumption	C0001948
28376287	year	C0439234
28376287	Data	C1511726
28376287	indicators	C1522602
28376287	smoking behavior	C1519383
28376287	Cox regression model	C0033489
28376287	evaluate	C0220825
28376287	potential	C3245505
28376287	risk factors	C0035648
28376287	relapse	C0035020
28376287	alcohol consumption	C0001948
28376287	participants	C0679646
28376287	final	C3853528
28376287	analysis	C0936012
28376287	Smoking	C0037369
28376287	increased	C0205217
28376287	risk	C0035647
28376287	alcohol relapse	C0035020
28376287	hazard ratio	C2985465
28376287	CI	C0009667
28376287	increased	C0205217
28376287	risk	C0035647
28376287	reduced	C0392756
28376287	daily	C0332173
28376287	consumed cigarettes	C0459840
28376287	hazard ratio	C2985465
28376287	per	C3887962
28376287	cigarette	C0459840
28376287	CI	C0009667
28376287	Smoking reduced	C1276355
28376287	probability	C0033204
28376287	maintaining	C0024501
28376287	alcohol abstinence	C3843422
28376287	significantly	C0750502
28376287	higher	C0205250
28376287	cigarettes smoked	C0459840
28376287	daily	C0332173
28376287	diminished	C0205216
28376287	increased	C0205217
28376287	risk	C0035647
28376287	alcohol relapse	C0035020
28376287	alcohol-dependent	C0001973
28376287	patients	C0030705
28376287	Coordinated	C0700114
28376287	psychiatric	C0205487
28376287	substance abuse	C0740858
28376287	interventions	C0184661
28376287	subgroups	C1515021
28376287	patients	C0030705
28376287	AUD	C0001956
28376287	post-acute treatment phase	C0814495
28376287	Individualized	C1881197
28376287	treatment	C1522326
28376287	smoking	C0037369
28376287	patients	C0030705
28376287	AUD	C0001956
28376287	relapse to alcohol drinking	C0035020
28376287	somatic	C2986476
28376287	complications	C0009566
28376287	findings	C0243095
28376287	individualized	C1881197
28376287	treatment plans	C0599880
28377210	patterns	C0449774
28377210	neural activity	C1254358
28377210	memory function	C0025260
28377210	encoding	C0679058
28377210	retrieval	C0679061
28377210	Neural networks	C0242406
28377210	span	C2700613
28377210	medial temporal lobe	C0039485
28377210	MTL	C0039485
28377210	prefrontal cortex	C0162783
28377210	posterior cortical regions	C4252868
28377210	episodic memory function	C0561843
28377210	humans	C0086418
28377210	Encoding	C0679058
28377210	retrieval	C0679061
28377210	neural pathways	C0027792
28377210	cortex	C0007776
28377210	structures	C0678594
28377210	medial temporal lobes	C0039485
28377210	memory performance	C1285654
28377210	neural processing	C0597043
28377210	encoding	C0679058
28377210	retrieval	C0679061
28377210	neural signatures	C1704864
28377210	memory function	C0025260
28377210	free-recall task	C3540678
28377210	neurosurgical	C0524850
28377210	patients	C0030705
28377210	implanted	C0021107
28377210	subdural	C0038541
28377210	intraparenchymal	C0933845
28377210	depth electrodes	C0491577
28377210	multivariate classifiers	C0282574
28377210	patterns	C0449774
28377210	brain	C0006104
28377210	episodic encoding	C0679058
28377210	retrieval	C0679061
28377210	encoding	C0679058
28377210	retrieval	C0679061
28377210	patterns	C0449774
28377210	high frequency	C0205212
28377210	activity	C1254358
28377210	prefrontal	C0162783
28377210	MTL	C0039485
28377210	inferior parietal cortices	C0030560
28377210	low frequency	C0205213
28377210	brain	C0006104
28377210	memory function	C0025260
28377210	cross-decoding approach	C0026777
28377210	memory function	C0025260
28377210	free-recall task	C3540678
28377210	classifiers	C0282574
28377210	encoding	C0679058
28377210	retrieval states	C0679061
28377210	task-independent models	C3161035
28377210	memory network	C0025260
28377210	encoding	C0679058
28377210	retrieval	C0679061
28377210	shapes	C0332479
28377210	ability to remember the past	C4303539
28377210	neural interactions	C1254358
28377210	encoding	C0679058
28377210	retrieval	C0679061
28378668	Trump's	C0086418
28378668	right idea	C1254370
28378668	US	C0041703
28378668	nursing student	C0038496
28378668	feel	C0013987
28378668	Obamacare	C2936611
28378668	bad idea	C1254370
28378668	disappointed	C0870427
28378668	President	C1527114
28378668	Trump	C0086418
28378668	not able to get rid of	C0243095
28378668	last month	C0439231
28379026	Bilirubin	C0005437
28379026	atherosclerotic	C0004153
28379026	diseases	C0012634
28379026	Bilirubin	C0005437
28379026	product	C1514468
28379026	heme catabolism	C1157876
28379026	systemic circulation	C0678860
28379026	decades	C2981279
28379026	increased	C0205217
28379026	serum	C0229671
28379026	plasma	C0032105
28379026	bilirubin	C0005437
28379026	levels	C0441889
28379026	sign	C0311392
28379026	liver disease	C0023895
28379026	data	C1511726
28379026	years	C0439234
28379026	elevated	C3163633
28379026	bilirubin	C0005437
28379026	concentrations	C1446561
28379026	associated	C0439849
28379026	protection	C1545588
28379026	oxidative stress	C0242606
28379026	diseases	C0012634
28379026	diseases	C0012634
28379026	atherosclerotic	C0004153
28379026	clinically	C0205210
28379026	relevant	C2347946
28379026	data	C1511726
28379026	beneficial	C0086387
28379026	effects	C1280500
28379026	bilirubin	C0005437
28379026	published	C0034037
28379026	clinical study	C0008972
28379026	increased	C0205217
28379026	risk	C0035647
28379026	coronary heart disease	C0010068
28379026	low	C0205251
28379026	serum	C0229671
28379026	bilirubin	C0005437
28379026	levels	C0441889
28379026	bilirubin	C0005437
28379026	risk factor	C0035648
28379026	atherosclerotic	C0004153
28379026	diseases	C0012634
28379026	risk factors	C0035648
28379026	results	C1274040
28379026	studies	C2603343
28379026	mild elevation of serum levels of unconjugated bilirubin	C0241024
28379026	benign	C0205183
28379026	hyperbilirubinemia	C0020433
28379026	Gilbert syndrome	C0017551
28379026	prevalence	C0033105
28379026	incidence	C0021149
28379026	coronary heart	C0010068
28379026	peripheral vascular disease	C0085096
28379026	association	C0439849
28379026	serum	C0229671
28379026	bilirubin	C0005437
28379026	biomarker	C0005516
28379026	diseases	C0012634
28379026	diseases	C0012634
28379026	associated	C0439849
28379026	increased	C0205217
28379026	risk	C0035647
28379026	atherosclerosis	C0004153
28379026	data	C1511726
28379026	biological pathways	C1704259
28379026	bilirubin	C0005437
28379026	clinical	C0205210
28379026	associations	C0439849
28379326	Automated	C0205554
28379326	Pharmacist	C0031323
28379326	Initiative	C0424093
28379326	Improves	C0184511
28379326	Quality of Care	C0034379
28379326	Staphylococcus aureus Bacteremia	C1142423
28379326	Infectious diseases	C0009450
28379326	ID	C0009450
28379326	consultation	C0009818
28379326	antimicrobial stewardship intervention	C0086388
28379326	improve	C0184511
28379326	management	C0376636
28379326	Staphylococcus aureus bacteremia	C1142423
28379326	SAB	C1142423
28379326	workload	C0085122
28379326	antimicrobial stewardship programs	C0086388
28379326	ASPs	C0086388
28379326	ASPs	C0086388
28379326	efficiency of the program	C0033335
28379326	patient	C0030705
28379326	outcomes	C1274040
28379326	study	C2603343
28379326	evaluate	C0220825
28379326	impact	C4049986
28379326	health informatics	C0008960
28379326	management	C0376636
28379326	SAB	C1142423
28379326	pharmacist	C0031323
28379326	initiative	C0424093
28379326	Retrospective	C1514923
28379326	quasi-experimental	C1510570
28379326	study	C2603343
28379326	hospitalized patients	C0030705
28379326	SAB	C1142423
28379326	intervention	C0184661
28379326	period	C1948053
28379326	pharmacists	C0031323
28379326	patients	C0030705
28379326	SAB	C1142423
28379326	patient	C0030705
28379326	scoring tool	C0025080
28379326	electronic medical record	C2362543
28379326	Pharmacists	C0031323
28379326	scoring tool	C0025080
28379326	institution's	C2607850
28379326	evidence-based practice	C1510541
28379326	guideline	C0162791
28379326	standardized recommendations	C0034866
28379326	adherence	C1510802
28379326	SAB	C1142423
28379326	quality-of-care	C0034379
28379326	measures	C0079809
28379326	ID	C0009450
28379326	consultation	C0009818
28379326	primary	C0205225
28379326	outcome	C1274040
28379326	compliance	C3714738
28379326	adherence	C1510802
28379326	individual	C0237401
28379326	quality-of-care	C0034379
28379326	components	C1705248
28379326	Secondary	C0175668
28379326	outcomes	C1274040
28379326	analyzed	C0936012
28379326	patients	C0030705
28379326	study	C2603343
28379326	inclusion	C1512693
28379326	intervention	C0184661
28379326	intervention	C0184661
28379326	group	C0441833
28379326	quality-of-care	C0034379
28379326	components	C1705248
28379326	management	C0376636
28379326	SAB	C1142423
28379326	significantly	C0750502
28379326	intervention	C0184661
28379326	group	C0441833
28379326	incidence	C0021149
28379326	ID	C0009450
28379326	consult	C0009818
28379326	improved	C0184511
28379326	significantly	C0750502
28379326	intervention	C0184661
28379326	group	C0441833
28379326	statistically significant	C0237881
28379326	differences	C1705242
28379326	bacteremia	C0004610
28379326	length-of-stay	C0023303
28379326	infection	C3714514
28379326	length-of-stay	C0023303
28379326	readmission	C0030700
28379326	groups	C0441833
28379326	incidence	C0021149
28379326	mortality	C0026565
28379326	intervention	C0184661
28379326	group	C0441833
28379326	intervention	C0184661
28379326	group	C0441833
28379326	automated	C0205554
28379326	pharmacist	C0031323
28379326	intervention	C0184661
28379326	management	C0376636
28379326	patients	C0030705
28379326	SAB	C1142423
28379326	significant	C0750502
28379326	improvement	C2986411
28379326	patients	C0030705
28379326	ID	C0009450
28379326	consult	C0009818
28379326	targeted	C1521840
28379326	antimicrobial therapy	C0443071
28379326	adherence	C1510802
28379326	SAB	C1142423
28379326	quality-of-care	C0034379
28379326	measures	C0079809
28379326	antimicrobial stewardship	C0086388
28379326	mandatory	C1514873
28379326	healthcare	C0086388
28379326	hospitals	C0019994
28379326	U.S.	C0041703
28379326	ASPs	C0086388
28379326	forced	C0443221
28379326	find	C0243095
28379326	efficient	C0442799
28379326	impactful	C4049986
28379326	disease	C0012634
28379326	patient care	C0017313
28379326	study	C2603343
28379326	data	C1511726
28379326	intervention	C0184661
28379326	clinically important	C0443178
28379326	infectious diseases	C0009450
28380662	intracellular	C0175996
28380662	Zn(2+)	C0043481
28380662	signaling	C4236609
28380662	LTP	C0206249
28380662	perforant pathway	C0524810
28380662	CA1 pyramidal cell synapse	C2717851
28380662	Physiological	C0205463
28380662	synaptic Zn(2+) signaling	C4236609
28380662	perforant pathway	C0524810
28380662	CA1 pyramidal cell synapses	C2717851
28380662	In vivo	C1515655
28380662	long-term potentiation	C0206249
28380662	LTP	C0206249
28380662	perforant pathway	C0524810
28380662	CA1 pyramidal cell synapses	C2717851
28380662	electrode	C0013812
28380662	microdialysis	C0206056
28380662	probe	C0182400
28380662	perfused	C0031001
28380662	artificial cerebrospinal fluid	C0220806
28380662	ACSF	C0220806
28380662	microdialysis	C0206056
28380662	probe	C0182400
28380662	Perforant pathway	C0524810
28380662	LTP	C0206249
28380662	perfusion	C0031001
28380662	CaEDTA	C0021212
28380662	extracellular	C0521119
28380662	Zn(2+)	C0043481
28380662	perfusion	C0031001
28380662	ZnAF-2DA	C0021212
28380662	intracellular	C0175996
28380662	Zn(2+)	C0043481
28380662	intracellular	C0175996
28380662	Zn(2+)	C0043481
28380662	signaling	C4236609
28380662	perforant pathway	C0524810
28380662	LTP	C0206249
28380662	rat brain slices	C1882598
28380662	CaEDTA	C0021212
28380662	ACSF	C0220806
28380662	intracellular	C0175996
28380662	Zn(2+)	C0043481
28380662	intracellular	C0175996
28380662	ZnAF-2	C0021212
28380662	stratum lacunosum-moleculare	C3498968
28380662	perforant pathway	C0524810
28380662	CA1 pyramidal cell synapses	C2717851
28380662	tetanic stimulation	C1292856
28380662	intracellular	C0175996
28380662	Zn(2+)	C0043481
28380662	signaling	C4236609
28380662	proteins	C0033684
28380662	LTP	C0206249
28380662	perforant pathway	C0524810
28380662	CA1 pyramidal cell synapses	C2717851
28380662	influx	C0007613
28380662	extracellular	C0521119
28380662	Zn(2+)	C0043481
28380662	presynaptic Zn(2+) release	C0007613
28380662	LTP	C0206249
28380662	Schaffer collateral	C3544403
28380662	CA1 pyramidal cell synapses	C2717851
28380662	synapse	C0039062
28380662	Zn(2+)	C0043481
28380662	plasticity	C4042875
28380662	postsynaptic	C0682686
28380662	CA1 pyramidal cells	C0206441
28381880	20S immunoproteasomes	C0014442
28381880	formaldehyde	C0016564
28381880	damaged	C1883709
28381880	cytoplasmic proteins	C1333198
28381880	suppressing	C1260953
28381880	caspase-independent cell death	C3820502
28381880	Immunoproteasomes	C0014442
28381880	involvement	C1314939
28381880	antigen presentation	C0206431
28381880	broad	C0332464
28381880	tissue	C0040300
28381880	presence	C0150312
28381880	evidence	C0332120
28381880	indicative of	C0392360
28381880	nonimmune functions	C0031843
28381880	immunoproteasomes	C0014442
28381880	cellular responses	C1817908
28381880	endogenous	C0205227
28381880	environmental carcinogen	C0007091
28381880	formaldehyde	C0016564
28381880	FA	C0016564
28381880	cytosolic	C1383501
28381880	nuclear proteins	C0028589
28381880	proteotoxic stress	C0449430
28381880	genotoxic	C0598309
28381880	DNA	C0012854
28381880	histone	C0019652
28381880	crosslinks	C0178576
28381880	immunoproteasomes	C0014442
28381880	important	C3898777
28381880	suppression	C1260953
28381880	caspase-independent cell death	C3820502
28381880	long-term	C0443252
28381880	survival	C0220921
28381880	FA-treated cells	C0007634
28381880	genotoxic	C0598309
28381880	responses	C0871261
28381880	FA	C0016564
28381880	replication inhibition	C1511692
28381880	activation	C1879547
28381880	transcription factor p53	C0080055
28381880	apical	C0205111
28381880	ATM	C3711796
28381880	ATR kinases	C3711837
28381880	unaffected	C2986417
28381880	immunoproteasome	C0014442
28381880	inactivity	C3244312
28381880	inhibition	C3463820
28381880	enhanced	C2349975
28381880	activation	C1879547
28381880	cytosolic	C1383501
28381880	protein	C0033684
28381880	damage	C1883709
28381880	sensor HSF1	C0121235
28381880	elevated levels	C0441889
28381880	K48-polyubiquitinated	C3820607
28381880	cytoplasmic proteins	C1333198
28381880	increased	C0205217
28381880	depletion	C0333668
28381880	unconjugated	C0522530
28381880	ubiquitin	C0041538
28381880	FA	C0016564
28381880	induced	C0205263
28381880	disassembly	C1707798
28381880	26S immunoproteasomes	C0014442
28381880	26S proteasomes	C0286330
28381880	20S catalytic immunoproteasome	C0014442
28381880	FA-treated cells	C0007634
28381880	higher amounts	C1265611
28381880	activators PA28αβ	C0753808
28381880	PA28γ	C0893173
28381880	20S particles	C0014442
28381880	significance	C0750502
28381880	nonnuclear damage	C1883709
28381880	FA	C0016564
28381880	immunoproteasomes	C0014442
28381880	FA-damaged	C1883709
28381880	cytoplasmic proteins	C1333198
28381880	ubiquitin	C0041538
28381880	independent	C0085862
28381880	proteolysis	C0597304
28383311	Musculoskeletal pain	C0026858
28383311	profile	C1518848
28383311	obese	C0028754
28383311	individuals	C0027361
28383311	attending	C1999232
28383311	multidisciplinary weight management service	C0596660
28383311	Obesity	C0028754
28383311	associated with	C0332281
28383311	numerous	C0439064
28383311	chronic diseases	C0008679
28383311	including	C0332257
28383311	musculoskeletal (MSK) pain	C0026858
28383311	impacts	C4049986
28383311	quality of life	C0034380
28383311	QoL	C0034380
28383311	comprehensive	C1880156
28383311	MSK pain	C0026858
28383311	profile	C1518848
28383311	obese	C0028754
28383311	cohort	C0599755
28383311	retrospective study	C2985505
28383311	patient	C0030705
28383311	database	C0242356
28383311	national weight management service	C0596660
28383311	WMS	C0596660
28383311	ethical	C1136353
28383311	approval	C2346845
28383311	anonymized	C3858751
28383311	patient data	C2707520
28383311	statistically analyzed	C0871424
28383311	pain	C0030193
28383311	profile	C1518848
28383311	investigate	C1292732
28383311	relationships	C0439849
28383311	pain	C0030193
28383311	sleep	C0037313
28383311	function	C0516981
28383311	variables	C0439828
28383311	associated with	C0332281
28383311	low back pain	C0024031
28383311	LBP	C0024031
28383311	knee pain	C0231749
28383311	individuals	C0027361
28383311	WMS	C0596660
28383311	male	C0025266
28383311	CI	C0009667
28383311	female	C0043210
28383311	CI	C0009667
28383311	mean	C0444504
28383311	age	C0001779
28383311	Mean	C0444504
28383311	BMI	C1305855
28383311	obese	C0028754
28383311	BMI	C1305855
28383311	CI	C0009667
28383311	Approximately	C0332232
28383311	MSK pain	C0026858
28383311	LBP	C0024031
28383311	CI	C0009667
28383311	mean	C0444504
28383311	knee pain	C0231749
28383311	CI	C0009667
28383311	mean	C0444504
28383311	obese	C0028754
28383311	multi-site	C1254362
28383311	pain	C0030193
28383311	patients	C0030705
28383311	lower	C2003888
28383311	QoL	C0034380
28383311	physical activity	C0026606
28383311	levels	C0441889
28383311	reduced	C0392756
28383311	sleep	C0037313
28383311	poorer	C2700379
28383311	physical function	C0516981
28383311	less	C0547044
28383311	obese	C0028754
28383311	patients	C0030705
28383311	without	C0332288
28383311	pain	C0030193
28383311	Relationships	C0439849
28383311	demographic	C0011298
28383311	pain	C0030193
28383311	self-report	C0681906
28383311	psychological	C0205486
28383311	functional	C0205245
28383311	measures	C0079809
28383311	Patients	C0030705
28383311	slept fewer hours	C0243095
28383311	poorer	C2700379
28383311	functional outcomes	C0243095
28383311	LBP	C0024031
28383311	patients	C0030705
28383311	divorced	C0086170
28383311	lower	C2003888
28383311	QoL	C0034380
28383311	frequent	C0332183
28383311	nocturia	C0028734
28383311	knee pain	C0231749
28383311	Multi-site	C1254362
28383311	MSK pain	C0026858
28383311	prevalent	C0220900
28383311	severe	C0205082
28383311	obese	C0028754
28383311	patients	C0030705
28383311	negatively	C1513916
28383311	associated with	C0332281
28383311	functional outcomes	C0243095
28383311	prevalence	C0220900
28383311	pain management	C0002766
28383311	treating	C0087111
28383311	obesity	C0028754
28384898	Primary	C0205225
28384898	Management	C0376636
28384898	Outcome	C1274040
28384898	Open Laryngotracheal Trauma	C0339881
28384898	Acute	C0205178
28384898	external injury	C0443212
28384898	larynx	C0023078
28384898	life threatening	C2826244
28384898	long term	C0443252
28384898	management	C0680830
28384898	Otorhinolaryngologist	C0334893
28384898	patients	C0030705
28384898	patients	C0030705
28384898	open laryngeal traumas	C0339881
28384898	primary closure	C0441503
28384898	patients	C0030705
28384898	nature of injury	C0449499
28384898	patients	C0030705
28384898	nature of injury	C0449499
28384898	primary closure	C0441503
28384898	patients	C0030705
28384898	injury	C3263723
28384898	survived	C0038952
28384898	patients	C0030705
28384898	injury	C3263723
28384898	died	C0011065
28384898	experience	C0557355
28384898	primary closure	C0441503
28384898	nature of injury	C0449499
28384898	outcome	C1274040
28384898	favourable	C0278250
28385001	kinematic gait analysis	C0558820
28385001	young	C0332239
28385001	old	C0580836
28385001	Beagle dogs	C1296765
28385001	Age-related	C0851454
28385001	involution	C0333953
28385001	dogs	C1296765
28385001	loss of muscle mass	C1837108
28385001	connective tissue	C0009780
28385001	articular cartilage	C0007303
28385001	examine	C0332128
28385001	age-related	C0851454
28385001	joint mobility	C1820723
28385001	detected	C0442726
28385001	absence	C0332197
28385001	diseases	C0012634
28385001	young	C0332239
28385001	years	C0439234
28385001	old	C0580836
28385001	years	C0439234
28385001	healthy	C3898900
28385001	sound Beagle dogs	C1296765
28385001	measured	C0444706
28385001	locomotion	C0023946
28385001	treadmill	C0184069
28385001	computer-assisted	C2362103
28385001	gait analysis	C0558820
28385001	Angles	C0205143
28385001	shoulder	C0037009
28385001	elbow	C0013770
28385001	carpal	C1262468
28385001	hip	C0019558
28385001	stifle	C1456798
28385001	tarsal joints	C1527245
28385001	analyzed	C0936012
28385001	joint angle progression curves	C0392762
28385001	minimum	C1524031
28385001	maximum	C0806909
28385001	joint	C0022417
28385001	angles	C0205143
28385001	range of motion	C2607871
28385001	ROM	C2607871
28385001	old	C0580836
28385001	group	C0681850
28385001	joint	C0022417
28385001	angle	C0205143
28385001	ROM	C2607871
28385001	carpal joint	C1262468
28385001	shoulder	C0037009
28385001	elbow	C0013770
28385001	carpal joint	C1262468
28385001	descriptive analysis	C0678257
28385001	progression curves	C0392762
28385001	less flexion	C0231455
28385001	extension	C0231448
28385001	joints	C0022417
28385001	forelimb	C0016555
28385001	restricted	C0443288
28385001	joint mobility	C1820723
28385001	forelimb	C0016555
28385001	carpal joint	C1262468
28385001	Findings	C2607943
28385001	joints	C0022417
28385001	hindlimb	C1522391
28385001	consistent	C0332290
28385001	alterations	C1515926
28385001	compensatory	C0231186
28385001	mechanism	C0441712
28385001	alterations	C1515926
28385001	found	C0150312
28385001	distal joints	C0224640
28385001	particular attention	C0589098
28385001	elderly dogs	C1296765
28385075	Propensity Score	C2718044
28385075	Comparison	C1707455
28385075	Partial	C0728938
28385075	Whole	C0444667
28385075	Gland	C0033572
28385075	Cryotherapy	C3544233
28385075	Intermediate-Risk	C3640764
28385075	Prostate Cancer	C0376358
28385075	analysis	C0936012
28385075	COLD registry data	C0282574
28385075	oncological	C0027651
28385075	functional	C0205245
28385075	outcomes	C0085415
28385075	partial	C0728938
28385075	whole	C0444667
28385075	gland	C0033572
28385075	cryotherapy	C3544233
28385075	men	C0025266
28385075	intermediate-risk	C3640764
28385075	prostate cancer	C0376358
28385075	Men	C0025266
28385075	intermediate-risk	C3640764
28385075	prostate cancer	C0376358
28385075	treated with	C0332293
28385075	primary	C0205225
28385075	prostate cryotherapy	C3544233
28385075	Cryo On-Line Data Registry	C0282574
28385075	matched	C0150103
28385075	comparison	C1707455
28385075	whole	C0444667
28385075	gland	C0033572
28385075	partial	C0728938
28385075	prostate cryotherapy	C3544233
28385075	targeted-ablation	C0547070
28385075	unilateral/bilateral nerve-sparing ablations	C0547070
28385075	propensity score	C2718044
28385075	age	C0001779
28385075	pre-biopsy serum	C0229671
28385075	PSA	C0138741
28385075	biopsy Gleason score	C2123503
28385075	clinical stage	C0205563
28385075	prostate volume	C1441416
28385075	neoadjuvant androgen deprivation	C1515985
28385075	status	C0449438
28385075	year	C0439234
28385075	surgery	C0543467
28385075	pre-treatment	C2709094
28385075	Outcomes	C0085415
28385075	biochemical	C3897727
28385075	progression-free survival	C0242792
28385075	BPFS	C0242792
28385075	ASTRO	C0935549
28385075	Phoenix criteria	C0935549
28385075	continence	C0542565
28385075	sexual function	C0278092
28385075	sufficient	C0205410
28385075	sexual intercourse	C0009253
28385075	propensity score	C2718044
28385075	matching	C0150103
28385075	BPFS	C0242792
28385075	compared	C1707455
28385075	Kaplan-Meier analysis	C1720943
28385075	functional	C0205245
28385075	outcomes	C0085415
28385075	chi-square tests	C0008041
28385075	men	C0025266
28385075	identified	C0205396
28385075	whole	C0444667
28385075	gland	C0033572
28385075	partial	C0728938
28385075	Post-matching	C1254367
28385075	men	C0025266
28385075	analysed	C0936012
28385075	follow-up	C1522577
28385075	BPFS	C0242792
28385075	rate	C1521828
28385075	whole	C0444667
28385075	gland	C0033572
28385075	partial	C0728938
28385075	ablation	C0547070
28385075	Phoenix	C0935549
28385075	whole	C0444667
28385075	gland	C0033572
28385075	partial	C0728938
28385075	ablation	C0547070
28385075	ASTRO	C0935549
28385075	continence	C0542565
28385075	rate	C1521828
28385075	similar	C2348205
28385075	successful	C1272703
28385075	intercourse	C0009253
28385075	whole	C0444667
28385075	gland	C0033572
28385075	partial	C0728938
28385075	ablation	C0547070
28385075	incidence	C0021149
28385075	post-treatment	C2709088
28385075	urinary retention	C0080274
28385075	whole	C0444667
28385075	gland	C0033572
28385075	partial	C0728938
28385075	ablation	C0547070
28385075	rectourethral fistula	C0268875
28385075	Partial	C0728938
28385075	ablation	C0547070
28385075	results	C0808233
28385075	better	C0332272
28385075	post-treatment	C2709088
28385075	sexual function	C0278092
28385075	compared	C1707455
28385075	whole	C0444667
28385075	gland	C0033572
28385075	ablation	C0547070
28385075	men	C0025266
28385075	intermediate-risk	C3640764
28385075	prostate cancer	C0376358
28385075	early	C1279919
28385075	BPFS	C0242792
28385075	groups	C0441833
28386687	Abnormal	C0205161
28386687	metabolic	C0311400
28386687	brain	C0006104
28386687	network	C0598941
28386687	Parkinson's disease	C0030567
28386687	replication	C1883725
28386687	European	C0239307
28386687	sample	C2347026
28386687	study	C2603343
28386687	identify	C0205396
28386687	metabolic	C0311400
28386687	brain	C0006104
28386687	pattern	C0449774
28386687	characteristic	C1521970
28386687	Parkinson's disease	C0030567
28386687	PD	C0030567
28386687	Parkinson's disease-related pattern	C0449782
28386687	PDRP	C0449782
28386687	network	C0598941
28386687	[18F]-fluorodeoxyglucose positron emission tomography	C0872169
28386687	FDG-PET	C0872169
28386687	brain	C0006104
28386687	images	C1704254
28386687	cohort	C0599755
28386687	Slovenian	C0037334
28386687	PD	C0030567
28386687	patients	C0030705
28386687	PD	C0030567
28386687	patients	C0030705
28386687	age	C0001779
28386687	years	C0439234
28386687	Movement Disorder Society Unified Parkinson's Disease Motor Rating Scale	C3639714
28386687	MDS-UPDRS-III	C3639714
28386687	disease duration	C0872146
28386687	years	C0439234
28386687	age	C0001779
28386687	matched	C1708943
28386687	normal controls	C0009932
28386687	NCs	C0009932
28386687	FDG-PET	C0872169
28386687	brain imaging	C0203860
28386687	automatic voxel-based scaled subprofile model	C0026336
28386687	principal component analysis	C0429865
28386687	SSM	C0026336
28386687	PCA	C0429865
28386687	scans	C0441633
28386687	PDRP	C0449782
28386687	Slovenia	C0037334
28386687	identification	C0205396
28386687	pattern	C0449782
28386687	characterized	C1880022
28386687	hypermetabolism	C0342952
28386687	pallidum	C0017651
28386687	putamen	C0034169
28386687	thalamus	C0039729
28386687	brain stem	C0006121
28386687	cerebellum	C0007765
28386687	hypometabolism	C0347938
28386687	sensorimotor cortex	C3499125
28386687	posterior parietal	C3853037
28386687	occipital	C1184145
28386687	frontal cortices	C0016733
28386687	expression	C1254370
28386687	PDRP	C0449782
28386687	Slovenia	C0037334
28386687	PD	C0030567
28386687	patients	C0030705
28386687	NCs	C0009932
28386687	correlated	C1707520
28386687	patients	C0030705
28386687	clinical	C0205210
28386687	score	C0449820
28386687	MDS-UPDRS-III	C3639714
28386687	topography	C0392918
28386687	PDRP	C0449782
28386687	identified	C0205396
28386687	American	C0596070
28386687	cohort	C0599755
28386687	PD	C0030567
28386687	patients	C0030705
28386687	PDRP	C0449782
28386687	Slovenia	C0037334
28386687	expression	C1254370
28386687	FDG-PET	C0872169
28386687	scans	C0441633
28386687	PD	C0030567
28386687	patients	C0030705
28386687	NCs	C0009932
28386687	patients	C0030705
28386687	atypical parkinsonism	C4302185
28386687	AP	C4302185
28386687	expression	C1254370
28386687	PDRP	C0449782
28386687	Slovenia	C0037334
28386687	diagnostic accuracy	C0598285
28386687	specificity	C1511884
28386687	sensitivity	C1511883
28386687	pattern	C0449782
28386687	expression	C1254370
28386687	PD	C0030567
28386687	patients	C0030705
28386687	NCs	C0009932
28386687	AP	C4302185
28386687	PDRP	C0449782
28386687	Slovenia	C0037334
28386687	functional imaging	C1517324
28386687	biomarker	C0005516
28386687	patient	C0030705
28386687	population	C1257890
28386687	PD	C0030567
28386687	patients	C0030705
28386687	NCs	C0009932
28386687	AP	C4302185
28386687	clinical	C0205210
28386687	measure	C0079809
28386687	PD	C0030567
28386687	progression	C0242656
28386942	effects of	C1704420
28386942	gestational	C0439671
28386942	use of	C1524063
28386942	antidepressants	C0003289
28386942	antipsychotics	C0040615
28386942	neonatal	C0021289
28386942	outcomes	C1274040
28386942	women	C0043210
28386942	severe	C0205082
28386942	mental illness	C0004936
28386942	Psychotropic medication	C0033978
28386942	use	C1524063
28386942	occurs	C2745955
28386942	pregnancies	C0032961
28386942	rates	C2359857
28386942	increasing	C0442808
28386942	often	C0332183
28386942	multiple	C0439064
28386942	medications	C0013227
28386942	prescribed	C0278329
28386942	study	C2603343
28386942	use of	C1524063
28386942	psychotropic medication	C0033978
28386942	cohort	C0599755
28386942	women	C0043210
28386942	severe	C0205082
28386942	mental illness	C0004936
28386942	increases	C0442805
28386942	rates	C0032975
28386942	special care nursery	C0204795
28386942	admission	C0184666
28386942	reports	C0025102
28386942	differences	C1705242
28386942	antidepressant	C0003289
28386942	antipsychotic medication	C0040615
28386942	use	C1524063
28386942	alone	C0205171
28386942	combination	C0013162
28386942	retrospective database analysis from a cohort	C2985505
28386942	severe	C0205082
28386942	mental illness	C0004936
28386942	pregnancy	C0032961
28386942	identified	C0205396
28386942	pregnant women	C0033011
28386942	grouped	C0008902
28386942	medication	C0013227
28386942	type	C0332307
28386942	Demographic	C0681668
28386942	obstetric	C0205484
28386942	neonatal	C0021289
28386942	variables	C0439828
28386942	analysed	C0936012
28386942	using	C1524063
28386942	t-tests	C0871472
28386942	analysis	C0936012
28386942	variance	C1711260
28386942	logistic regression analysis	C0681925
28386942	special care nursery	C0204795
28386942	admission	C0184666
28386942	medication groups	C0030705
28386942	women	C0043210
28386942	taking no psychotropic medications	C0030705
28386942	those taking antipsychotics	C0030705
28386942	those taking antidepressants	C0030705
28386942	those taking and a combination of antidepressants/antipsychotics	C0030705
28386942	Rates	C2359857
28386942	special care nursery	C0204795
28386942	admission	C0184666
28386942	women	C0043210
28386942	psychotropic medication	C0033978
28386942	compared	C1707455
28386942	those who did not	C0030705
28386942	significantly	C0750502
28386942	raised	C0442818
28386942	compared	C1707455
28386942	general population	C0683971
28386942	No significant difference	C3842396
28386942	medication groups	C0030705
28386942	significant	C0750502
28386942	odds ratio	C0028873
28386942	found	C0150312
28386942	special care nursery	C0204795
28386942	psychiatric admission	C0237457
28386942	during	C0347984
28386942	pregnancy	C0032961
28386942	psychotropic medication	C0033978
28386942	Rates	C0032975
28386942	special care nursery	C0204795
28386942	admission	C0184666
28386942	neonates	C0021289
28386942	women	C0043210
28386942	severe	C0205082
28386942	mental illness	C0004936
28386942	psychotropic medication	C0033978
28386942	monotherapy	C3846440
28386942	polytherapy	C0013218
28386942	prescribing	C0278329
28386942	antidepressants	C0003289
28386942	antipsychotic medication	C0040615
28386942	vulnerability	C1821973
28386942	occurs	C2745955
28386942	neonates	C0021289
28386942	women	C0043210
28386942	mental illness	C0004936
28386942	paediatric	C0237433
28386942	delivery	C0005615
28386942	recommended	C0034866
28387851	Intrawound Vancomycin	C0042313
28387851	Application	C4048755
28387851	Spine Surgery	C2608059
28387851	Vancomycin-Resistant	C0752078
28387851	Organism	C0029235
28387851	Surgical site infection	C0038941
28387851	SSI	C0038941
28387851	spine surgery	C2608059
28387851	morbid	C0205556
28387851	expensive complication	C1171258
28387851	intrawound vancomycin	C0042313
28387851	SSI	C0038941
28387851	vancomycin-resistant	C0752078
28387851	pathogens	C0450254
28387851	occurrence	C2745955
28387851	vancomycin-resistant	C0752078
28387851	SSI	C0038941
28387851	patients	C0030705
28387851	intrawound vancomycin	C0042313
28387851	Patients	C0030705
28387851	Patients	C0030705
28387851	spine surgery	C2608059
28387851	dichotomized	C0443299
28387851	intrawound vancomycin	C0042313
28387851	occurrence	C2745955
28387851	SSI	C0038941
28387851	operating room	C0029064
28387851	postoperative 90 days	C0032790
28387851	intrawound culture	C0596932
28387851	vancomycin	C0042313
28387851	minimal inhibitory concentrations	C0427978
28387851	MIC	C0427978
28387851	pathogen profile	C0450254
28387851	MIC	C0427978
28387851	vancomycin	C0042313
28387851	patients	C0030705
28387851	vancomycin	C0042313
28387851	patients	C0030705
28387851	intrawound vancomycin	C0042313
28387851	during the index surgery	C1254367
28387851	vancomycin	C0042313
28387851	significantly lower	C4055638
28387851	SSI	C0038941
28387851	rates	C0037993
28387851	occurrence	C2745955
28387851	Staphylococcus aureus	C0038172
28387851	SSI	C0038941
28387851	significantly lower	C4055638
28387851	patients	C0030705
28387851	application	C4048755
28387851	intrawound vancomycin	C0042313
28387851	patients	C0030705
28387851	application	C4048755
28387851	intrawound vancomycin powder	C0042313
28387851	S aureus	C0038172
28387851	SSI	C0038941
28387851	pathogens	C0450254
28387851	resistance to vancomycin	C3265908
28387851	patients	C0030705
28387851	MIC	C0427978
28387851	vancomycin	C0042313
28387851	occurrence	C2745955
28387851	gram-negative	C0085423
28387851	SSI	C0038941
28387851	culture negative fluid collection	C0429652
28387851	higher	C0205250
28387851	vancomycin	C0042313
28387851	cohort	C0599755
28387851	intrawound vancomycin	C0042313
28387851	spine surgery	C2608059
28387851	SSI	C0038941
28387851	spine surgery	C2608059
28387851	application	C4048755
28387851	intrawound vancomycin	C0042313
28387851	during index surgery	C1254367
28387851	vancomycin-resistant	C0752078
28387851	organisms	C0029235
28387851	SSI	C0038941
28388017	Adequacy	C0808073
28388017	criteria	C0243161
28388017	thyroid FNA	C0193787
28388017	evaluated	C0220825
28388017	ThinPrep slides	C0430022
28388017	Adequacy	C0808073
28388017	criteria	C0243161
28388017	thyroid fine-needle aspiration	C0193787
28388017	FNA	C0193787
28388017	recommended	C0034866
28388017	Bethesda System for Reporting Thyroid Cytopathology	C0022885
28388017	TBS	C0022885
28388017	smears	C0444186
28388017	applied	C4048755
28388017	ThinPreps	C0430022
28388017	TPs	C0430022
28388017	evaluated	C0220825
28388017	adequacy	C0808073
28388017	TPs	C0430022
28388017	diagnostic	C0348026
28388017	thresholds	C0449864
28388017	FNA procedures	C0193787
28388017	performed	C0884358
28388017	matched	C1708943
28388017	surgical specimens	C0370003
28388017	analyzed	C0936012
28388017	Cell counts	C0007584
28388017	cytological	C0205471
28388017	features	C2348519
28388017	evaluated	C0220825
28388017	nondiagnostic	C0686919
28388017	ND	C0686919
28388017	cases	C0681850
28388017	ND	C0686919
28388017	cases	C0681850
28388017	reclassified	C0205542
28388017	TBS	C0022885
28388017	categories	C0683312
28388017	pathologists	C0334866
28388017	results	C1274040
28388017	compared	C1707455
28388017	surgical outcomes	C1274040
28388017	hundred forty-six	C0392762
28388017	cases	C0681850
28388017	classified	C0008902
28388017	ND	C0686919
28388017	available	C0470187
28388017	review	C0699752
28388017	mean	C0444504
28388017	cell count	C0007584
28388017	standard deviation	C0871420
28388017	Interobserver agreement	C0680240
28388017	reclassification	C0008902
28388017	ND	C0686919
28388017	cases	C0681850
28388017	moderate	C0205081
28388017	consensus	C0376298
28388017	yielded	C0392762
28388017	ND	C0686919
28388017	cases	C0681850
28388017	benign	C0205183
28388017	cases	C0681850
28388017	cases	C0681850
28388017	atypia	C0741302
28388017	undetermined significance	C1272585
28388017	cases	C0681850
28388017	suspicious for malignancy	C4050405
28388017	Lowering	C2003888
28388017	diagnostic	C0348026
28388017	threshold	C0449864
28388017	follicular	C1571705
28388017	cells	C0007634
28388017	yielded	C0392762
28388017	sensitivity	C0036667
28388017	specificity	C0037791
28388017	positive predictive value	C1514243
28388017	negative predictive value	C1513918
28388017	false-negative	C0205558
28388017	rate	C1521828
28388017	diagnostic	C0348026
28388017	cases	C0681850
28388017	cases	C0681850
28388017	cells	C0007634
28388017	lacking	C0332268
28388017	groups	C0681860
28388017	containing	C2700400
28388017	cells	C0007634
28388017	test performance	C0871060
28388017	Nuclear enlargement	C0333902
28388017	pallor	C0030232
28388017	grooves	C1184482
28388017	presence	C0150312
28388017	histiocytoid cells	C1516945
28388017	ND	C0686919
28388017	FNA	C0193787
28388017	correlated	C1707520
28388017	malignancy	C4282132
28388017	thyroid FNA	C0193787
28388017	examined	C0332128
28388017	TP	C0430022
28388017	lowering	C2003888
28388017	adequacy	C0808073
28388017	threshold	C0449864
28388017	requirement	C1514873
28388017	groups	C0681860
28388017	cells	C0007634
28388017	significantly	C0750502
28388017	test performance	C0871060
28388017	cytological	C0205471
28388017	features	C2348519
28388017	associated with	C0332281
28388017	malignancy	C4282132
28388017	absent	C0332197
28389368	Silk I	C0074529
28389368	Silk II	C0074529
28389368	studied	C2603343
28389368	fast scanning calorimetry	C0006780
28389368	fast scanning calorimetry	C0006780
28389368	FSC	C0006780
28389368	investigated	C1292732
28389368	glass transition	C2700061
28389368	crystal	C0444626
28389368	melting	C0599882
28389368	samples	C0370003
28389368	B. mori	C0323309
28389368	silk fibroin	C1449666
28389368	Silk I	C0074529
28389368	Silk II	C0074529
28389368	crystal	C0444626
28389368	short	C1806781
28389368	residence	C0237096
28389368	times	C0040223
28389368	high	C0205250
28389368	temperatures	C0039476
28389368	measurements	C0242485
28389368	thermal	C0018837
28389368	decomposition	C2700592
28389368	silk protein	C0074529
28389368	significantly	C0750502
28389368	suppressed	C0443189
28389368	FSC	C0006780
28389368	performed	C0884358
28389368	Mettler Flash DSC1	C0006780
28389368	fibroin	C0016042
28389368	films	C1561572
28389368	masses	C1306372
28389368	Films	C1561572
28389368	different	C1705242
28389368	crystalline	C0444626
28389368	fractions	C1264633
28389368	different	C1705242
28389368	crystal structures	C0444626
28389368	Silk I	C0074529
28389368	Silk II	C0074529
28389368	processing	C1709694
28389368	conditions	C0348080
28389368	water	C0043047
28389368	annealing	C0150247
28389368	different	C1705242
28389368	temperatures	C0039476
28389368	exposure to	C0332157
28389368	MeOH	C0001963
28389368	water	C0043047
28389368	autoclaving	C0179177
28389368	resulting	C1274040
28389368	crystal structure	C0444626
28389368	wide angle	C0205143
28389368	X-ray scattering	C1306645
28389368	Degree	C0449286
28389368	crystallinity	C0444626
28389368	evaluated	C0332128
28389368	Fourier transform infrared (FTIR) spectroscopy	C0206055
28389368	analysis	C0936012
28389368	heat capacity	C2349063
28389368	increment	C1705117
28389368	glass transition temperature	C1257885
28389368	Silk fibroin	C1449666
28389368	films	C1561572
28389368	water	C0043047
28389368	annealing	C0150247
28389368	crystalline	C0444626
28389368	Silk I	C0074529
28389368	structure	C1510464
28389368	FTIR	C0206055
28389368	FSC	C0006780
28389368	studies	C2603343
28389368	films	C1561572
28389368	autoclaving	C0179177
28389368	MeOH	C0001963
28389368	exposure	C0332157
28389368	crystalline	C0444626
28389368	Silk II	C0074529
28389368	structure	C1510464
28389368	Intermediate	C0205103
28389368	crystalline	C0444626
28389368	fraction	C1264633
28389368	Silk I	C0074529
28389368	Silk II	C0074529
28389368	structure	C1510464
28389368	films	C1561572
28389368	water	C0043047
28389368	annealing	C0150247
28389368	FSC	C0006780
28389368	results	C0683954
28389368	Silk I	C0074529
28389368	Silk I I	C0074529
28389368	crystals	C0444626
28389368	endotherms	C0205556
28389368	narrower width	C0333164
28389368	higher	C0205250
28389368	mean	C0444504
28389368	melting temperature	C1456458
28389368	compared	C1707455
28389368	Silk I	C0074529
28389368	crystals	C0444626
28389368	melt	C0599882
28389368	Films	C1561572
28389368	Silk I	C0074529
28389368	Silk II	C0074529
28389368	structure	C1510464
28389368	clearly	C2963144
28389368	separated	C0443299
28389368	endothermic	C0205556
28389368	peaks	C0444505
28389368	Evidence	C3887511
28389368	crystal	C0444626
28389368	melt	C0599882
28389368	separately	C0443299
28389368	thermal	C0018837
28389368	interconvert	C0439836
28389368	extremely	C0205403
28389368	short	C1806781
28389368	time scale	C0040223
28389368	melting	C0599882
28389368	FSC experiment	C0006780
28389368	Silkworm	C0037119
28389368	silk	C0074529
28389368	naturally	C0205296
28389368	biomaterial	C1704781
28389368	fibroin component	C0016042
28389368	silk forms	C0074529
28389368	crystals	C0444626
28389368	Silk	C0074529
28389368	properties	C0871161
28389368	amount	C1265611
28389368	crystals	C0444626
28389368	stability	C0205360
28389368	measure	C0079809
28389368	stability	C0205360
28389368	crystal	C0444626
28389368	melting temperature	C1456458
28389368	Crystal	C0444626
28389368	stable	C0205360
28389368	higher	C0205250
28389368	melting temperature	C1456458
28389368	study	C2603343
28389368	thermal	C0018837
28389368	behavior	C0004927
28389368	silk	C0074529
28389368	crystal	C0444626
28389368	degrade	C1880269
28389368	high	C0205250
28389368	temperature	C0039476
28389368	degradation	C0243125
28389368	study	C2603343
28389368	melting	C0599882
28389368	properties	C0871161
28389368	silk	C0074529
28389368	biomaterial	C1704781
28389368	heated	C1522240
28389368	silk	C0074529
28389368	special calorimeter	C0175896
28389368	crystal	C0444626
28389368	different	C1705242
28389368	melting temperature	C1456458
28389368	crystal	C0444626
28389368	type	C0332307
28389368	stable	C0205360
28389633	Leonurine	C0064761
28389633	Attenuates	C0599946
28389633	Hyperalgesia	C0020429
28389633	Mice	C0026809
28389633	Induced	C0205263
28389633	Adenomyosis	C0341858
28389633	Adenomyosis	C0341858
28389633	invasion	C2699153
28389633	endometrial glands	C0227848
28389633	stroma	C0927195
28389633	myometrium	C0027088
28389633	common	C0205214
28389633	gynecological disorder	C0017411
28389633	report	C0684224
28389633	effect	C1280500
28389633	leonurine	C0064761
28389633	ICR mice	C0025925
28389633	adenomyosis	C0341858
28389633	induced	C0205263
28389633	neonatal	C2939425
28389633	tamoxifen	C0039286
28389633	treated	C1522326
28389633	tamoxifen	C0039286
28389633	assessed	C1516048
28389633	body weight	C0005910
28389633	pain	C0030193
28389633	mice	C0026809
28389633	hotplate	C0182315
28389633	tests	C0022885
28389633	mice	C0026809
28389633	divided	C0332849
28389633	groups	C0441833
28389633	low-dose	C0445550
28389633	leonurine	C0064761
28389633	treatment	C0087111
28389633	group	C0441833
28389633	high-dose	C0444956
28389633	leonurine	C0064761
28389633	treatment	C0087111
28389633	group	C0441833
28389633	valproic acid	C0042291
28389633	VPA	C0042291
28389633	treatment	C0087111
28389633	group	C0441833
28389633	vehicle	C0042444
28389633	only	C0205171
28389633	treatment	C0087111
28389633	group	C0441833
28389633	blank	C0750479
28389633	control group	C0009932
28389633	evaluated	C0220825
28389633	body weight	C0005910
28389633	hotplate	C0182315
28389633	tests	C0022885
28389633	depth	C0205125
28389633	myometrial	C0521387
28389633	infiltration	C0332448
28389633	Immunoreactivity	C0597879
28389633	staining	C0487602
28389633	progesterone receptor	C0034833
28389633	PR	C0034833
28389633	nuclear factor-κB phosphorylated-p65	C1567061
28389633	p-p65	C1567061
28389633	cyclooxygenase-2	C1447194
28389633	COX-2	C1447194
28389633	oxytocin receptor	C3849099
28389633	OTR	C3849099
28389633	evaluated	C0220825
28389633	immunohistochemistry	C0021044
28389633	measurement	C0242485
28389633	body weight	C0005910
28389633	myometrial	C0521387
28389633	infiltration	C0332448
28389633	neonatal	C2939425
28389633	tamoxifen	C0039286
28389633	treatment	C0087111
28389633	adenomyosis	C0341858
28389633	Leonurine	C0064761
28389633	treatment	C0087111
28389633	decrease	C0547047
28389633	hyperalgesia	C0020429
28389633	myometrial	C0521387
28389633	infiltration	C0332448
28389633	Immunoreactivity	C0597879
28389633	staining	C0487602
28389633	decreased	C0205216
28389633	p-p65	C1567061
28389633	COX-2	C1447194
28389633	OTR	C3849099
28389633	protein expressions	C1171362
28389633	leonurine	C0064761
28389633	attenuates	C0599946
28389633	hyperalgesia	C0020429
28389633	mice	C0026809
28389633	induced	C0205263
28389633	adenomyosis	C0341858
28389633	down-regulating	C0013081
28389633	expressions	C1171362
28389633	p-P65	C1567061
28389633	COX-2	C1447194
28389633	OTR	C3849099
28389633	treating	C1522326
28389633	adenomyosis	C0341858
28394217	Randomized	C0034656
28394217	Head-to-Head	C0205556
28394217	Study	C2603343
28394217	Virtual Reality Exposure Therapy	C3494470
28394217	Posttraumatic Stress Disorder	C0038436
28394217	Virtual reality exposure therapy	C3494470
28394217	VRET	C3494470
28394217	interventions	C1273869
28394217	supported	C1521721
28394217	randomized controlled trials	C0282440
28394217	treatment	C0087111
28394217	combat-related posttraumatic stress disorder	C0038436
28394217	PTSD	C0038436
28394217	active duty service	C2135638
28394217	members	C0680022
28394217	comparative effectiveness study	C1579762
28394217	virtual reality	C0871582
28394217	technology	C0039421
28394217	improved	C0184511
28394217	outcomes	C0085415
28394217	similar	C2348205
28394217	results	C1274040
28394217	achieved	C0001072
28394217	control exposure therapy	C0870527
28394217	CET	C0870527
28394217	condition	C0348080
28394217	Service	C0557854
28394217	members	C0680022
28394217	combat-related PTSD	C0038436
28394217	randomly	C0439605
28394217	selected	C1707391
28394217	receive	C1514756
28394217	weeks	C0439230
28394217	VRET	C3494470
28394217	CET	C0870527
28394217	Assessors	C0401803
28394217	therapists	C0871525
28394217	blinded	C0150108
28394217	PTSD	C0038436
28394217	symptom	C1457887
28394217	improvement	C2986411
28394217	assessed	C1516048
28394217	week	C0439230
28394217	months	C0439231
28394217	conclusion	C1707478
28394217	treatment	C0087111
28394217	clinician-administered PTSD scale	C0349674
28394217	CAPS	C0349674
28394217	small	C0700321
28394217	included	C0332257
28394217	Results	C1274040
28394217	PTSD	C0038436
28394217	symptoms	C1457887
28394217	improved	C0184511
28394217	treatments	C0087111
28394217	statistically significant	C0237881
28394217	differences	C3842396
28394217	groups	C0441833
28394217	Dropout	C0030686
28394217	rates	C1521828
28394217	higher	C0205250
28394217	VRET	C3494470
28394217	received	C1514756
28394217	VRET	C3494470
28394217	improvement	C2986411
28394217	CAPS	C0349674
28394217	received	C1514756
28394217	CET	C0870527
28394217	months	C0439231
28394217	treatment	C0087111
28394217	improvement	C2986411
28394217	VRET	C3494470
28394217	participants	C0679646
28394217	CET	C0870527
28394217	Participants	C0679646
28394217	crossed over	C0243095
28394217	statistically significant	C0237881
28394217	improvements	C2986411
28394217	second	C0205436
28394217	treatment	C0087111
28394217	regardless	C3641650
28394217	condition	C0348080
28394217	study	C2603343
28394217	supported	C1521721
28394217	utility	C3669222
28394217	exposure therapy	C0870527
28394217	PTSD	C0038436
28394217	support	C1521721
28394217	additional	C1524062
28394217	benefit	C0814225
28394217	inclusion	C1512693
28394217	virtual reality	C0871582
28394503	Accounting	C0680857
28394503	linkage disequilibrium	C0023746
28394503	genome scans	C2349866
28394503	selection	C0036576
28394503	without	C0332288
28394503	individual	C0443299
28394503	genotypes	C0017431
28394503	local score approach	C0036449
28394503	Detecting genomic footprints	C0282579
28394503	selection	C0036576
28394503	evolution	C0015219
28394503	linkage disequilibrium	C0023746
28394503	genome scans	C2349866
28394503	detection	C1511790
28394503	power	C3854080
28394503	haplotype	C0018591
28394503	individual	C0443299
28394503	genotypes	C0017431
28394503	pool-sequenced samples	C1509144
28394503	local score approach	C0036449
28394503	linkage disequilibrium	C0023746
28394503	genome scans	C2349866
28394503	selection	C0036576
28394503	cumulating	C1516698
28394503	signals	C0037080
28394503	markers	C0017393
28394503	genomic segment	C1517520
28394503	selection	C0036576
28394503	signal	C0037080
28394503	computer simulations	C0009609
28394503	detects	C0442726
28394503	selection	C0036576
28394503	state-of-the-art	C0700033
28394503	single-marker	C0017393
28394503	haplotype	C0018591
28394503	benchmark	C0525063
28394503	data sets	C0150098
28394503	individual	C0443299
28394503	genotypes	C0017431
28394503	local score	C0036449
28394503	haplotype	C0018591
28394503	local score approach	C0036449
28394503	Pool-Seq data	C0282574
28394503	divergent	C1705242
28394503	selection	C0036576
28394503	experiment	C0681814
28394503	behaviour	C0004927
28394503	quail	C0034374
28394503	biologically	C0205460
28394503	coherent	C4068804
28394503	selection	C0036576
28394503	signals	C0037080
28394503	selection	C0036576
28394503	detects	C0442726
28394503	genes	C0017337
28394503	social	C0728831
28394503	responsiveness	C0205342
28394503	autistic traits	C4314654
28394503	detection	C0442726
28394503	positive	C1446409
28394503	selection	C0036576
28394503	multiple population data	C0282574
28394503	local score approach	C0036449
28394503	genome scans	C2349866
28394503	selection	C0036576
28394503	genomewide analyses	C2350277
28394503	GWAS	C2350277
28394602	UV	C0041625
28394602	Induced	C0205263
28394602	Electron-Driven Proton Transfer	C1254365
28394602	Active	C0205177
28394602	Chemically Modified	C0205556
28394602	A	C0001407
28394602	T	C0040087
28394602	DNA	C0012854
28394602	Base Pair	C0600436
28394602	Transient electronic and vibrational absorption spectroscopies	C0037806
28394602	investigate	C1292732
28394602	UV	C0041625
28394602	induced	C0205263
28394602	electron-driven proton transfer	C1254365
28394602	EDPT	C1254365
28394602	mechanisms	C0441712
28394602	active	C0205177
28394602	chemically modified	C0205556
28394602	adenine	C0001407
28394602	thymine	C0040087
28394602	A	C0001407
28394602	T	C0040087
28394602	DNA	C0012854
28394602	base pair	C0600436
28394602	fraction of	C1264633
28394602	biologically relevant	C2347946
28394602	Watson-Crick (WC) hydrogen-bonding	C0020276
28394602	motifs	C3178796
28394602	Hoogsteen structures	C1254350
28394602	chemically modified	C0205556
28394602	derivative of A	C1527240
28394602	A	C0001407
28394602	synthesized	C1883254
28394602	8-(tert-butyl)-9-ethyladenine	C0029224
28394602	8tBA	C0029224
28394602	Equimolar solutions	C0037633
28394602	8tBA	C0029224
28394602	silyl-protected T	C0040087
28394602	nucleosides	C0028621
28394602	chloroform	C0008238
28394602	yield	C0392762
28394602	mixture	C0439962
28394602	WC pairs	C0600436
28394602	reverse WC pairs	C0600436
28394602	residual monomers	C0596973
28394602	transient absorption studies	C0037806
28394602	guanine	C0018321
28394602	cytosin	C0010843
28394602	G	C0018321
28394602	C	C0010843
28394602	pairs	C0600436
28394602	spectroscopic or kinetic evidence	C3887511
28394602	identified	C0205396
28394602	participation	C0679823
28394602	EDPT	C1254365
28394602	excited-state relaxation dynamics	C1254365
28394602	8tBA	C0029224
28394602	T	C0040087
28394602	pairs	C0600436
28394602	ultrafast	C0456962
28394602	EDPT	C1254365
28394602	Monomer-like dynamics	C3826426
28394602	8tBA	C0029224
28394602	T	C0040087
28395554	Monitoring	C1283169
28395554	proteolytic processing	C1514570
28395554	events	C0441471
28395554	quantitative mass spectrometry	C3525763
28395554	Protease activity	C1150095
28395554	role	C3871154
28395554	biological processes	C3714634
28395554	including	C0332257
28395554	gene expression	C0017262
28395554	protein turnover	C0597297
28395554	development	C0678723
28395554	misregulation	C0243095
28395554	proteins	C0033684
28395554	associated with	C0332281
28395554	cancer types	C0872066
28395554	prostate	C0376358
28395554	breast	C0006142
28395554	skin cancer	C0007114
28395554	identification	C0205396
28395554	protease	C0030940
28395554	substrates	C3891814
28395554	provide	C1999230
28395554	information	C1533716
28395554	understand	C0162340
28395554	proteolysis	C0597304
28395554	pathologies	C0030664
28395554	covered	C0439844
28395554	Proteomics	C0872252
28395554	methods	C0025663
28395554	investigate	C1292732
28395554	proteolysis activity,	C0597304
28395554	substrate	C3891814
28395554	identification	C0205396
28395554	protease	C0030940
28395554	specificity	C0678612
28395554	applications	C0441485
28395554	systems biology	C1450477
28395554	reviewed	C1709940
28395554	quantification	C1709793
28395554	challenges	C0805586
28395554	pitfalls	C0205556
28395554	biological	C0205460
28395554	protease	C0030940
28395554	malfunction	C0231174
28395554	Expert commentary	C0600219
28395554	Dysregulated	C0243095
28395554	protease activity	C1150095
28395554	hallmark	C0205556
28395554	disease	C0012634
28395554	pathologies	C0030664
28395554	cancer	C0006826
28395554	Current	C0521116
28395554	biochemical	C0205474
28395554	approaches	C1292724
28395554	low	C0205251
28395554	throughput	C0392762
28395554	limited	C0439801
28395554	amount	C1265611
28395554	sample	C2347026
28395554	required	C1514873
28395554	obtain	C1301820
28395554	results	C0456984
28395554	Mass spectrometry	C0037813
28395554	proteomics	C0872252
28395554	provides	C1999230
28395554	suitable	C3900053
28395554	platform	C1710360
28395554	investigate	C1292732
28395554	protease activity	C1150095
28395554	providing	C1999230
28395554	information	C1533716
28395554	substrate specificity	C0038592
28395554	mapping	C0030944
28395554	cleavage sites	C0002518
28396744	Diabetic nephropathy	C0011881
28396744	cause	C1314792
28396744	end-stage kidney disease	C0022661
28396744	medical evidence form	C3261387
28396744	CMS2728	C3261387
28396744	center	C0475309
28396744	End-stage renal disease	C0022661
28396744	ESRD	C0022661
28396744	incidence	C0021149
28396744	Type 2	C0441730
28396744	diabetic nephropathy	C0011881
28396744	DN	C0011881
28396744	United States Renal Data System	C1622900
28396744	center	C0475309
28396744	retrospective cohort study	C2985505
28396744	incidence	C0021149
28396744	diagnostic accuracy	C0598285
28396744	Type 2	C0441730
28396744	DN	C0011881
28396744	primary	C0205225
28396744	cause	C1314792
28396744	ESRD	C0022661
28396744	Center for Medicare & Medicaid	C0041718
28396744	CMS	C0041718
28396744	Medical Evidence Report form	C3261387
28396744	CMS2728	C3261387
28396744	submitted	C1515023
28396744	renal replacement therapy	C0206074
28396744	patients	C0030705
28396744	years	C0439234
28396744	age	C0001779
28396744	CMS2728	C3261387
28396744	submitted	C1515023
28396744	academic military medical center	C1552471
28396744	ESRD	C0022661
28396744	Medical records	C0025102
28396744	diagnosis	C0011900
28396744	reviewed	C1709940
28396744	Kidney Disease Outcomes Quality Initiative	C1708333
28396744	KDOQI	C1708333
28396744	criteria	C0679228
28396744	DN	C0011881
28396744	ESRD	C0022661
28396744	incidence	C0021149
28396744	Type 2	C0441730
28396744	DN	C0011881
28396744	individual	C0027361
28396744	CMS2728	C3261387
28396744	submissions	C1515022
28396744	KDOQI criteria	C0679228
28396744	Type 2	C0441730
28396744	DN	C0011881
28396744	diabetes	C0011847
28396744	not meeting criteria	C3828770
28396744	disease duration	C0872031
28396744	active	C0205177
28396744	urine sediment	C1261248
28396744	macroalbuminuria	C1654921
28396744	retinopathy	C0035309
28396744	ESRD	C0022661
28396744	logistic regression	C0206031
28396744	retinopathy	C0035309
28396744	associated with	C0332281
28396744	KDOQI	C1708333
28396744	DN	C0011881
28396744	odds ratio	C0028873
28396744	confidence interval	C0009667
28396744	Conclusions	C1707478
28396744	center	C0475309
28396744	cohort	C2985505
28396744	identified	C0205396
28396744	Type 2	C0441730
28396744	DN	C0011881
28396744	primary	C0205225
28396744	cause	C1314792
28396744	ESRD	C0022661
28396744	assigned	C1516050
28396744	KDOQI	C1708333
28396744	clinical	C0205210
28396744	criteria	C0679228
28396744	replicated	C0205173
28396744	larger	C0549177
28396744	populations	C1257890
28396744	epidemiology	C0014507
28396744	ESRD	C0022661
28396744	USA	C0041703
28397533	Socioeconomic	C0748878
28397533	Predictors	C2698872
28397533	Adherence Behavior	C0516638
28397533	HIV-Positive	C0019699
28397533	Patients	C0030705
28397533	Receiving	C1514756
28397533	Antiretroviral Therapy	C1963724
28397533	Selangor	C0017446
28397533	Malaysia	C0024552
28397533	Medication adherence	C2364172
28397533	critical	C1511545
28397533	prescribed	C0278329
28397533	ART	C1963724
28397533	regimen	C0040808
28397533	treatment outcome	C0085415
28397533	Several	C0443302
28397533	factors	C1521761
28397533	influence	C4054723
28397533	adherence behavior	C0516638
28397533	cross-sectional study	C0010362
28397533	aimed	C1947946
28397533	socioeconomic	C0748878
28397533	predictors	C2698872
28397533	adherence behavior	C0516638
28397533	cohort	C0599755
28397533	adult	C0001675
28397533	Malaysian	C0240293
28397533	patients	C0030705
28397533	receiving	C1514756
28397533	antiretroviral therapy	C1963724
28397533	Hospital Sungai Buloh	C0019994
28397533	Malaysia	C0024552
28397533	single-blinded	C0242570
28397533	randomized controlled trial	C0206035
28397533	January	C3829466
28397533	December	C3830550
28397533	Statistical analysis	C0871424
28397533	secondary data	C0683944
28397533	adherence behavior	C0516638
28397533	sociodemographic characteristics	C0683970
28397533	patients	C0030705
28397533	revealed	C0443289
28397533	mean age	C0243095
28397533	years	C0439234
28397533	ranged	C1514721
28397533	years	C0439234
28397533	males	C0086582
28397533	patients	C0030705
28397533	adherence assessment	C1254363
28397533	included	C0332257
28397533	achieved	C0432600
28397533	optimal	C2698651
28397533	adherence	C1510802
28397533	Multivariate binary logistic regression analysis	C0034980
28397533	revealed	C0443289
28397533	patient's	C0030705
28397533	income	C0021162
28397533	ethnicity	C0243103
28397533	significant	C0750502
28397533	predictors	C2698872
28397533	adherence behavior	C0516638
28397533	targeted	C1521840
28397533	programmatic interventions	C0184661
28397533	enhance	C2349975
28397533	successful treatment	C0521982
28397533	outcomes	C1274040
28397533	target population	C0039309
28399372	Tobramycin Vector	C0040341
28399372	Enhances	C2349975
28399372	Synergy	C1318081
28399372	Efficacy	C0598333
28399372	Efflux Pump Inhibitors	C1254351
28399372	against	C0521124
28399372	Multidrug-Resistant	C0242640
28399372	Gram-Negative Bacteria	C0018150
28399372	Drug efflux	C1512072
28399372	mechanisms	C0441712
28399372	interact	C0687133
28399372	synergistically	C2986495
28399372	outer membrane	C1167331
28399372	permeability	C0007605
28399372	barrier	C0028778
28399372	Gram-negative bacteria	C0018150
28399372	leading	C1522538
28399372	intrinsic	C0205102
28399372	resistance	C4281815
28399372	major	C0205164
28399372	challenge	C0805586
28399372	antibiotic	C0003232
28399372	drug development	C1512068
28399372	Efflux pump inhibitors	C1254351
28399372	EPIs	C1254351
28399372	block	C0332206
28399372	efflux	C1512072
28399372	antibiotics	C0003232
28399372	synergize	C0205195
28399372	antibiotics	C0003232
28399372	clinical development	C1512068
28399372	EPI	C1254351
28399372	antibiotic	C0003232
28399372	combination therapy	C0013218
28399372	treat	C0087111
28399372	multidrug-resistant	C0242640
28399372	MDR	C0242640
28399372	Gram-negative infections	C0085423
28399372	challenging	C0805586
28399372	caused	C0015127
28399372	inefficiency	C0231184
28399372	current	C0521116
28399372	EPIs	C1254351
28399372	penetrate	C0205321
28399372	outer membrane	C1167331
28399372	resist	C4281815
28399372	efflux	C1512072
28399372	conjugation	C1160466
28399372	tobramycin	C0040341
28399372	TOB	C0040341
28399372	EPIs	C1254351
28399372	NMP	C0044097
28399372	paroxetine	C0070122
28399372	DBP	C0428883
28399372	enhances	C2349975
28399372	synergy	C1318081
28399372	efficacy	C0598333
28399372	EPIs	C1254351
28399372	combination	C0205195
28399372	tetracycline antibiotics	C1744619
28399372	MDR	C0242640
28399372	Gram-negative bacteria	C0018150
28399372	Pseudomonas aeruginosa	C0033809
28399372	potentiating	C2242637
28399372	tetracycline antibiotics	C1744619
28399372	TOB	C0040341
28399372	EPI	C1254351
28399372	conjugates	C0596313
28399372	suppress	C1260953
28399372	resistance	C4281815
28399372	development	C1527148
28399372	tetracycline antibiotic	C1744619
28399372	minocycline	C0026187
28399372	providing	C1999230
28399372	strategy	C0679199
28399372	develop	C1527148
28399372	effective	C1704419
28399372	adjuvants	C0001552
28399372	tetracycline antibiotics	C1744619
28399372	resistance	C4281815
28399372	MDR	C0242640
28399372	Gram-negative bacteria	C0018150
28400582	Detection	C1511790
28400582	AMA-M2	C0312621
28400582	human	C0086418
28400582	saliva	C0036087
28400582	Potentials	C3245505
28400582	diagnosis	C0011900
28400582	monitoring	C1283169
28400582	primary biliary cholangitis	C0008312
28400582	Serum	C0229671
28400582	anti-mitochondrial antibody type 2	C0312621
28400582	AMA-M2	C0312621
28400582	biomarker	C0005516
28400582	diagnosis	C0011900
28400582	primary biliary cholangitis	C0008312
28400582	PBC	C0008312
28400582	serological tests	C0036743
28400582	limitations	C0449295
28400582	inconvenience	C4062984
28400582	invasiveness	C1301757
28400582	infection risks	C0582147
28400582	less	C0547044
28400582	invasive	C0205281
28400582	approach	C0449445
28400582	detect	C0442726
28400582	AMA-M2 titer	C1446191
28400582	salivary	C0036087
28400582	AMA-M2	C0312621
28400582	potential	C3245505
28400582	PBC	C0008312
28400582	patients	C0030705
28400582	AMA-M2	C0312621
28400582	detected	C0442726
28400582	saliva	C0036087
28400582	serum	C0229671
28400582	AMA-M2-positive	C4021051
28400582	PBC	C0008312
28400582	patients	C0030705
28400582	saliva	C0036087
28400582	serum	C0229671
28400582	AMA-M2-negative	C0853205
28400582	PBC	C0008312
28400582	patients	C0030705
28400582	oral lichen planus	C0206139
28400582	patients	C0030705
28400582	OLP	C0206139
28400582	patients	C0030705
28400582	healthy controls	C2986479
28400582	concentration	C1446561
28400582	salivary	C0036087
28400582	AMA-M2	C0312621
28400582	positively correlated	C1707520
28400582	amount	C1265611
28400582	serum	C0229671
28400582	AMA-M2	C0312621
28400582	patients	C0030705
28400582	salivary	C0036087
28400582	inflammatory cytokines	C0079189
28400582	increased	C0205217
28400582	PBC	C0008312
28400582	consistent with	C0332290
28400582	results	C1274040
28400582	serum	C0229671
28400582	test	C0022885
28400582	saliva	C0036087
28400582	less	C0547044
28400582	invasive	C0205281
28400582	cost-effective	C1511536
28400582	medium	C1705217
28400582	test	C0039593
28400582	AMA-M2 levels	C2825862
28400582	development	C1527148
28400582	diagnosis	C0011900
28400582	monitoring	C1283169
28400582	PBC	C0008312
28402002	Mental health	C0025353
28402002	associated	C0332281
28402002	factors	C1521761
28402002	young	C0332239
28402002	offenders	C0699726
28402002	Chile	C0008107
28402002	cross-sectional study	C0010362
28402002	Latin America	C0023122
28402002	mental disorder	C0004936
28402002	young	C0332239
28402002	offenders	C0699726
28402002	variables	C0439828
28402002	associated with	C0332281
28402002	associations	C0439849
28402002	childhood	C0231335
28402002	adversity	C3900081
28402002	substance misuse	C4061432
28402002	psychiatric disorders	C0004936
28402002	young	C0332239
28402002	offenders	C0699726
28402002	Sentenced	C0860081
28402002	adolescent	C0205653
28402002	offenders	C0699726
28402002	recruited	C2949735
28402002	young	C0332239
28402002	offenders'	C0699726
28402002	institutions	C0442681
28402002	community centres	C3162245
28402002	Chilean National Service for Minors	C0680773
28402002	Psychiatric disorders	C0004936
28402002	assessed	C1516048
28402002	Mini International Neuropsychiatric Interview	C0021819
28402002	trained psychologists	C0033908
28402002	trained sociologist	C0037467
28402002	ad hoc interview	C0021822
28402002	information	C1533716
28402002	childhood experiences	C4298416
28402002	parenting	C3836557
28402002	trauma	C3714660
28402002	education	C0013622
28402002	substance misuse	C4061432
28402002	Multivariable logistic regressions	C0206031
28402002	analyse data	C0010998
28402002	psychiatric disorders	C0004936
28402002	participants	C0679646
28402002	marijuana dependence disorder	C0006870
28402002	major depressive disorder	C1269683
28402002	anxiety disorders	C0003469
28402002	Substance use disorders	C0038586
28402002	young	C0332239
28402002	offenders	C0699726
28402002	sentence	C0392751
28402002	young	C0332239
28402002	offenders'	C0699726
28402002	institutions	C0442681
28402002	community centres	C3162245
28402002	frequent	C0332183
28402002	started	C1272689
28402002	use marijuana	C0024809
28402002	earlier age	C0001779
28402002	variables	C1705098
28402002	childhood maltreatment	C0008060
28402002	major depressive disorder	C1269683
28402002	maternal death	C3494405
28402002	anxiety disorders	C0003469
28402002	educational status	C0013658
28402002	lower frequency	C0205213
28402002	depressive	C0011581
28402002	anxiety disorders	C0003469
28402002	findings	C0243095
28402002	suggest	C1705535
28402002	identify	C0205396
28402002	vulnerable	C0231204
28402002	young	C0332239
28402002	people	C0027361
28402002	earlier	C1279919
28402002	Few	C0205388
28402002	young	C0332239
28402002	offenders	C0699726
28402002	mental health	C0025353
28402002	problems	C0033213
28402002	adjusted	C0456081
28402002	health	C0018684
28402002	education	C0013622
28402002	socially	C0037397
28402002	period	C1948053
28402002	detention	C0237567
28402055	Effects of	C1704420
28402055	regular	C0205272
28402055	water	C2712391
28402055	land-based exercise	C0015259
28402055	physical function	C0516981
28402055	years	C0439234
28402055	long-term study	C0023981
28402055	older Japanese	C1556094
28402055	adults	C0001792
28402055	investigate	C1292732
28402055	effects	C1280500
28402055	years	C0439234
28402055	physical exercise	C0015259
28402055	functional	C0205245
28402055	parameters	C0549193
28402055	older Japanese	C1556094
28402055	adults	C0001792
28402055	water	C2712391
28402055	land-based exercise	C0015259
28402055	retrospectively	C1514923
28402055	investigated	C1292732
28402055	data	C1511726
28402055	medical examinations	C0582103
28402055	enrolled	C1516879
28402055	older adults	C0001792
28402055	study	C2603343
28402055	participants	C0679646
28402055	aged	C0001779
28402055	years	C0439234
28402055	water-based exercise	C2712391
28402055	combination	C0205195
28402055	water	C2712391
28402055	land-based exercise	C0015259
28402055	total exercise time	C0429931
28402055	years	C0439234
28402055	fitness center	C0600623
28402055	statistical analysis	C0871424
28402055	two-way repeated-measures analysis of variance	C1710497
28402055	examine	C0332128
28402055	effects	C1280500
28402055	time	C0040223
28402055	exercise type	C2708664
28402055	changes	C0392747
28402055	parameter	C0549193
28402055	years	C0439234
28402055	compared	C1707455
28402055	groups	C0441833
28402055	found	C0243095
28402055	significant	C0750502
28402055	main	C1542147
28402055	effects	C1280500
28402055	interaction	C1704675
28402055	time	C0040223
28402055	exercise type	C2708664
28402055	gait speed	C2009910
28402055	early decline	C0547047
28402055	combined	C0205195
28402055	exercise group	C0441833
28402055	significant	C0750502
28402055	main	C1542147
28402055	effects of	C1704420
28402055	time	C0040223
28402055	functional decline	C4304688
28402055	grip strength	C0429271
28402055	one-leg standing	C0231472
28402055	time	C0040223
28402055	step/height	C0427127
28402055	ratio	C0456603
28402055	exercise types	C2708664
28402055	year	C0439234
28402055	follow up	C1522577
28402055	year	C0439234
28402055	changes	C0392747
28402055	parameter	C0549193
28402055	groups	C0441833
28402055	frequency of exercise	C0556455
28402055	found	C0243095
28402055	negative	C0205160
28402055	correlation	C1707520
28402055	changes	C0392747
28402055	one-leg standing	C0231472
28402055	time	C0040223
28402055	total	C0439810
28402055	amount	C1265611
28402055	water-based exercise	C2712391
28402055	expectations	C0679138
28402055	results	C1274040
28402055	suggest	C1705535
28402055	regular	C0205272
28402055	water-based exercise	C2712391
28402055	combined	C0205195
28402055	land-based exercise	C0015259
28402055	long-term	C0443252
28402055	benefits	C0814225
28402055	maintaining	C1314677
28402055	physical performance	C2607857
28402055	older adults	C0001792
28402232	Combined	C0205195
28402232	exposures	C0028798
28402232	whole-body vibration	C4060689
28402232	awkward posture	C2112849
28402232	cross sectional investigation	C0010362
28402232	occupational	C0028811
28402232	drivers	C0684312
28402232	simultaneous	C0521115
28402232	field measurements	C0242485
28402232	Multifactorial	C1837655
28402232	workloads	C0085122
28402232	whole-body vibration	C4060689
28402232	WBV	C4060689
28402232	awkward posture	C2112849
28402232	lifting	C0206244
28402232	potential	C3245505
28402232	predictors	C0035648
28402232	low back pain	C0024031
28402232	LBP	C0024031
28402232	study	C2603343
28402232	investigate	C1292732
28402232	association	C0439849
28402232	LBP	C0024031
28402232	exposures	C0028798
28402232	professional	C0028811
28402232	drivers	C0684312
28402232	combined	C0205195
28402232	exposures	C0028798
28402232	WBV	C4060689
28402232	measured	C0444706
28402232	different	C1705242
28402232	workplaces	C0162579
28402232	Health	C0018684
28402232	data	C1511726
28402232	information	C1533716
28402232	lifting	C0206244
28402232	tasks	C3540678
28402232	collected	C1516698
28402232	questionnaire	C0034394
28402232	daily	C0332173
28402232	vibration exposure	C0677519
28402232	value	C1522609
28402232	odds ratio	C0028873
28402232	index	C1881192
28402232	awkward posture	C2112849
28402232	odds ratio	C0028873
28402232	significant	C0750502
28402232	association	C0439849
28402232	occurence	C2745955
28402232	LBP	C0024031
28402232	Awkward posture	C2112849
28402232	lifting	C0206244
28402232	appear	C0700364
28402232	associated with	C0332281
28402232	sick leave	C0242807
28402232	WBV	C4060689
28402232	exposure	C0028798
28402232	combination	C0205195
28402232	measurement	C0242485
28402232	results	C1274040
28402232	WBV	C4060689
28402232	awkward posture	C2112849
28402232	quantity	C1265611
28402232	significant	C0750502
28402232	correlation	C1707520
28402232	LBP	C0024031
28402232	combined	C0205195
28402232	exposure	C0028798
28402232	WBV	C4060689
28402232	awkward posture	C2112849
28402232	described	C1552738
28402232	daily	C0332173
28402232	vibration exposure	C0677519
28402232	index	C1881192
28402232	awkward posture	C2112849
28402232	work place	C0162579
28402232	assessments	C1516048
28402232	future	C0016884
28402232	research	C0035168
28402232	area	C0205146
28402232	quantitative	C0392762
28402232	measures	C0079809
28402232	whole-body vibration	C4060689
28402232	awkward posture	C2112849
28402232	exposures	C0028798
28402232	correlate	C1707520
28402232	occurrence	C2745955
28402232	low back pain	C0024031
28402232	quantities	C1265611
28402232	measurement	C0242485
28402232	methods	C0025664
28402232	workplace	C0162579
28402232	assessments	C1516048
28402232	assist	C1269765
28402232	design	C1707689
28402232	further	C0016884
28402232	studies	C2603343
28402232	establish	C0443211
28402232	causal exposure	C0274281
28402232	response	C0871261
28402232	relationship	C0439849
28402261	Association	C0439849
28402261	CKIP-1 P21A	C1826600
28402261	polymorphism	C0752046
28402261	risk	C0035647
28402261	chronic heart failure	C0264716
28402261	Chinese population	C0152035
28402261	Pathological	C1521733
28402261	cardiac hypertrophy	C1383860
28402261	risk factor	C0035648
28402261	chronic heart failure	C0264716
28402261	Casein kinase-2 interacting protein-1	C1309499
28402261	CKIP-1	C1309499
28402261	pathological	C1521733
28402261	cardiac hypertrophy	C1383860
28402261	investigated	C1292732
28402261	CKIP-1	C1826600
28402261	nonsynonymous polymorphism rs2306235	C0752046
28402261	Pro21Ala	C0026882
28402261	risk	C0035647
28402261	prognosis	C0033325
28402261	chronic heart failure	C0264716
28402261	Chinese population	C0152035
28402261	adult	C0001675
28402261	patients	C0030705
28402261	chronic heart failure	C0264716
28402261	age	C0001779
28402261	gender	C0079399
28402261	healthy controls	C2986479
28402261	CKIP-1 rs2306235	C1826600
28402261	polymorphism	C0752046
28402261	genotyped	C1285573
28402261	PCR	C0032520
28402261	restriction fragment length polymorphism	C3714764
28402261	follow-up	C1522577
28402261	data	C1511726
28402261	chronic heart failure	C0264716
28402261	patients	C0030705
28402261	evaluated	C0220825
28402261	rs2306235	C1826600
28402261	G allele	C0002085
28402261	increased	C0205217
28402261	risk	C0035647
28402261	chronic heart failure	C0264716
28402261	OR	C0028873
28402261	CI	C0009667
28402261	p	C1709380
28402261	patients	C0030705
28402261	hypertension	C0020538
28402261	OR	C0028873
28402261	CI	C0009667
28402261	coronary heart disease	C0010068
28402261	OR	C0028873
28402261	CI	C0009667
28402261	p	C1709380
28402261	multiple cardiovascular	C1979763
28402261	risk factors	C0035648
28402261	rs2306235	C1826600
28402261	polymorphism	C0752046
28402261	cardiovascular mortality	C0205848
28402261	chronic heart failure	C0264716
28402261	CKIP-1 rs2306235	C1826600
28402261	polymorphism	C0752046
28402261	risk factor	C0035648
28402261	chronic heart failure	C0264716
28402261	Chinese Han population	C0814942
28403152	phenological events	C0023675
28403152	migratory passerines	C0600537
28403152	changing climate	C2718051
28403152	years	C0439234
28403152	Laurel Highlands of Pennsylvania	C0030853
28403152	Advanced timing	C0449243
28403152	seasonal	C0036497
28403152	reproduction	C0232896
28403152	birds	C0005595
28403152	associated with	C0332281
28403152	warming climate	C0178683
28403152	bird	C0005595
28403152	species	C1705920
28403152	Phenological responses	C0023675
28403152	climate	C0008946
28403152	stages	C1306673
28403152	impact	C4049986
28403152	fitness	C2349186
28403152	analyzed	C0936012
28403152	decades	C2981279
28403152	banding data	C1511726
28403152	migratory bird	C0600537
28403152	species	C1705920
28403152	spring	C0241232
28403152	arrival	C1706079
28403152	timing	C0449243
28403152	breeding	C0178477
28403152	interval	C1272706
28403152	arrival	C1706079
28403152	breeding	C0178477
28403152	increasing	C0442808
28403152	spring	C0241232
28403152	temperatures	C0039476
28403152	arrival	C1706079
28403152	timing	C0449243
28403152	breeding	C0178477
28403152	timing	C0449243
28403152	local productivity	C2015882
28403152	species	C1705920
28403152	mid- to long-distance migrants	C0600537
28403152	hatched	C0598016
28403152	years	C0439234
28403152	migrants	C0026093
28403152	arrived	C1706079
28403152	earlier	C1279919
28403152	breeding grounds	C1254362
28403152	day advancement	C0439228
28403152	interval	C1272706
28403152	arrival	C1706079
28403152	breeding grounds	C1254362
28403152	appearance	C0700364
28403152	juveniles	C3146221
28403152	shortened	C1282927
28403152	spring	C0241232
28403152	temperatures	C0039476
28403152	species	C1705920
28403152	days	C0439228
28403152	increase	C0442805
28403152	species	C1705920
28403152	decade	C2981279
28403152	migratory passerines	C0600537
28403152	climate change	C2718051
28403152	laying	C1622979
28403152	more quickly	C4036056
28403152	arrival	C0574839
28403152	reducing	C0392756
28403152	time	C0040223
28403152	laying	C1622979
28403152	former	C0750523
28403152	rate	C1521828
28403152	reproductive advancement	C0035150
28403152	higher	C0205250
28403152	arrival	C0574839
28403152	warm years	C0178683
28403152	Timing	C0449243
28403152	spring	C0241232
28403152	arrival	C1706079
28403152	breeding	C0178477
28403152	poor	C0542537
28403152	predictors	C2698872
28403152	avian	C0005595
28403152	productivity	C0033269
28403152	migrants	C0600537
28403152	analyzed	C0936012
28403152	evidence	C3887511
28403152	fitness	C2717777
28403152	shifts	C2347509
28403152	spring	C0241232
28403152	arrival	C1706079
28403152	multi-brooded Song Sparrow	C0326953
28403152	results	C1274040
28403152	avian	C0005595
28403152	species	C1705920
28403152	phenologically plastic	C0023675
28403152	response	C0871261
28403152	climate change	C2718051
28403152	breeding grounds	C1254362
28403152	migrants	C0026093
28403152	weaker	C1762617
28403152	response	C0871261
28403152	temperatures	C0039476
28403152	breeding	C0178477
28403152	window	C1272706
28403152	arrival	C1706079
28403152	optimal breeding	C0178477
28403152	shortens	C1282927
28403152	plasticity	C0678558
28403152	ability	C0085732
28403152	species	C1705920
28403152	future warming	C0687712
28404634	Mucosal	C0026724
28404634	IgM Antibody	C1292066
28404634	d-Mannose	C0024742
28404634	Affinity	C1510827
28404634	Fugu Takifugu rubripes	C0949586
28404634	Monogenean	C0322374
28404634	Parasite	C0030498
28404634	Heterobothrium okamotoi	C1499594
28404634	Host Recognition	C1658611
28404634	parasites	C0030498
28404634	recognize	C0524637
28404634	definitive	C0443196
28404634	hosts	C1167395
28404634	parasitism	C0677482
28404634	recognition	C0524637
28404634	molecules	C0567416
28404634	host surfaces	C2752522
28404634	Fish	C0016163
28404634	ectoparasites	C0562634
28404634	initial contact	C1320656
28404634	hosts	C1167395
28404634	body surfaces	C0489451
28404634	skin	C1123023
28404634	gills	C0017558
28404634	covered	C0439844
28404634	mucosa	C0026724
28404634	mammalian guts	C0699819
28404634	Fish	C0016163
28404634	primitive vertebrates	C0042567
28404634	immune systems	C0020962
28404634	mammals	C0024660
28404634	secrete	C0036536
28404634	IgM	C0020861
28404634	mucus	C0026727
28404634	monogenean	C0322374
28404634	parasite	C0030498
28404634	Heterobothrium okamotoi	C1499594
28404634	IgM	C0020861
28404634	recognize	C0678894
28404634	host	C1167395
28404634	fugu Takifugu rubripes Oncomiracidia	C0949586
28404634	infective larvae	C0686891
28404634	H. okamotoi	C1499594
28404634	cilia	C0008778
28404634	metamorphose	C0025558
28404634	juveniles	C3146221
28404634	purified	C1998793
28404634	d-mannose	C0024742
28404634	binding	C1145667
28404634	fractions	C1264633
28404634	fugu	C0949586
28404634	fugu	C0949586
28404634	mucus	C0026727
28404634	liquid chromatography-tandem mass spectrometry analysis	C4049918
28404634	proteins	C0033684
28404634	fraction	C1264633
28404634	identified	C0205396
28404634	d-mannose	C0024742
28404634	IgM	C0020861
28404634	d-mannose	C0024742
28404634	d-mannose -binding	C1145667
28404634	lectins	C0023206
28404634	deciliation	C0031843
28404634	induced	C0205263
28404634	IgM	C0020861
28404634	inhibited	C0311403
28404634	d-mannose	C0024742
28404634	Ab	C0003241
28404634	fugu	C0949586
28404634	IgM	C0020861
28404634	lectins	C0023206
28404634	no effect	C1301751
28404634	IgM	C0020861
28404634	d-mannose	C0024742
28404634	affinity	C1510827
28404634	induced	C0205263
28404634	deciliation	C0031843
28404634	immunofluorescent staining experiments	C1318793
28404634	fugu	C0949586
28404634	d-mannose	C0024742
28404634	IgM	C0020861
28404634	binds	C1145667
28404634	ciliated epidermal cells	C1179149
28404634	oncomiracidium	C0949586
28404634	observations	C1554188
28404634	deciliation	C0031843
28404634	triggered by	C1444748
28404634	binding	C1145667
28404634	fugu	C0949586
28404634	IgM	C0020861
28404634	cell surface Ags	C0003339
28404634	Ag binding sites	C0221114
28404634	concentrations	C1446561
28404634	d-mannose	C0024742
28404634	binding	C1145667
28404634	IgM	C0020861
28404634	gill mucus	C0026727
28404634	induce	C0205263
28404634	deciliation	C0031843
28404634	in vitro	C1533691
28404634	indicating	C3146298
28404634	H. okamotoi parasites	C1499594
28404634	use	C0457083
28404634	host	C1167395
28404634	Abs	C0003241
28404634	colonize	C4289767
28404634	host	C1167395
28404634	gills	C0017558
28404899	BALB/c mice	C0025919
28404899	immunized	C0020971
28404899	virus-like particles	C0333785
28404899	Kaposi sarcoma-associated herpesvirus	C0376526
28404899	KSHV	C0376526
28404899	glycoproteins gpK8.1	C0767120
28404899	gB	C0761135
28404899	gH	C1142879
28404899	gL	C2606403
28404899	serum	C0229671
28404899	neutralizing antibody	C0475463
28404899	activity	C1621287
28404899	UV	C0041625
28404899	inactivated	C0544461
28404899	KSHV	C0376526
28404899	Kaposi sarcoma-associated herpesvirus	C0376526
28404899	KSHV	C0376526
28404899	Kaposi sarcoma	C0036220
28404899	Africa	C0001737
28404899	virus	C0376526
28404899	prophylactic vaccine	C0042210
28404899	KSHV	C0376526
28404899	KSHV	C0376526
28404899	gpK8.1	C0767120
28404899	gB	C0761135
28404899	gH	C1142879
28404899	gL glycoproteins	C2606403
28404899	virus	C0376526
28404899	host cells	C1819995
28404899	vaccine	C0042210
28404899	targets	C1521840
28404899	neutralizing antibodies	C0475463
28404899	nAbs	C0475463
28404899	virus infection	C0042769
28404899	gpK8.1	C0767120
28404899	gB	C0761135
28404899	gB	C0761135
28404899	gH	C1142879
28404899	gL	C2606403
28404899	virus-like particles	C0333785
28404899	VLPs	C0333785
28404899	VLPs	C0333785
28404899	viral glycoprotein(s)	C1325834
28404899	serum	C0229671
28404899	nAbs	C0475463
28404899	immunized	C0020971
28404899	BALB/c mice	C0025919
28404899	gpK8.1	C0767120
28404899	gB	C0761135
28404899	gH	C1142879
28404899	gL	C2606403
28404899	VLPs	C0333785
28404899	Neutralizing antibody	C0475463
28404899	mice	C0025919
28404899	immunized	C0020971
28404899	VLPs	C0333785
28404899	KSHV	C0376526
28404899	infection	C0042769
28404899	HEK-293 cells	C2936239
28404899	dose-dependent	C1512045
28404899	immunogen	C0003320
28404899	gpK8.1	C0767120
28404899	VLPs	C0333785
28404899	nAb	C0475463
28404899	UV	C0041625
28404899	inactivated	C0544461
28404899	KSHV	C0376526
28404899	UV-KSHV	C0376526
28404899	UV-KSHV	C0376526
28404899	gB	C0761135
28404899	gH	C1142879
28404899	gL	C2606403
28404899	Mice	C0025919
28404899	immunized	C0020971
28404899	gB	C0761135
28404899	gH	C1142879
28404899	gL	C2606403
28404899	VLPs	C0333785
28404899	immunized	C0020971
28404899	gB	C0761135
28404899	gH	C1142879
28404899	VLP	C1325725
28404899	immunogens	C0003320
28404899	Immunization	C0020971
28404899	VLP	C1325725
28404899	nAb	C0475463
28404899	UV-KSHV	C0376526
28404899	serum	C0229671
28404899	KSHV	C0376526
28404899	gpK8.1	C0767120
28404899	gB	C0761135
28404899	gH	C1142879
28404899	gL glycoproteins	C2606403
28404899	VLPs	C0333785
28404899	prophylactic vaccine	C0042210
28404899	KSHV	C0376526
28404899	infection	C0042769
28405013	missense	C0599155
28405013	variant	C0205419
28405013	rs373863828-A (p.Arg457Gln), of CREBRF	C3469921
28405013	body mass index	C1305855
28405013	Oceanic populations	C0682094
28405013	genotype	C0017431
28405013	hypothesis	C1512571
28405013	high prevalence	C1512456
28405013	obesity	C0028754
28405013	island	C0022130
28405013	populations	C1257890
28405013	Oceania	C0282279
28405013	genome-wide association study	C2350277
28405013	missense	C0599155
28405013	variant	C0205419
28405013	rs373863828-A (p.Arg457Gln), of the CREBRF gene	C3469921
28405013	CREB3 regulatory factor	C1447550
28405013	associated with	C0332281
28405013	excessive	C0442802
28405013	increase	C0442805
28405013	body mass index	C1305855
28405013	BMI	C1305855
28405013	Samoans	C1556103
28405013	rs373863828-A	C3469921
28405013	increase	C0442805
28405013	BMI	C1305855
28405013	examined	C0332128
28405013	Austronesian	C0682410
28405013	AN	C0682410
28405013	speaking	C0234856
28405013	populations	C1257890
28405013	Oceania	C0282279
28405013	rs373863828-A	C3469921
28405013	Tongans	C0337933
28405013	Polynesians	C0240790
28405013	associated with	C0332281
28405013	BMI	C1305855
28405013	rs373863828-A	C3469921
28405013	allele	C0002085
28405013	increased	C0205217
28405013	BMI	C1305855
28405013	age	C0001779
28405013	sex	C1522384
28405013	No significant	C1273937
28405013	association	C0439849
28405013	detected	C1511790
28405013	AN	C0682410
28405013	speaking	C0234856
28405013	populations	C1257890
28405013	Melanesians	C0337924
28405013	Micronesians	C1556099
28405013	living	C0376558
28405013	Solomon Islands	C0037623
28405013	low	C0205251
28405013	allele frequency	C0017270
28405013	rs373863828-A	C3469921
28405013	sample size	C0242618
28405013	rs373863828-A	C3469921
28405013	allele	C0002085
28405013	AN	C0682410
28405013	speaking	C0234856
28405013	AN	C0682410
28405013	speaking	C0234856
28405013	Melanesians	C0337924
28405013	Papua New Guinea	C0030375
28405013	rs373863828-A of CREBRF	C3469921
28405013	variant	C0205419
28405013	ancestors	C0870134
28405013	AN	C0682410
28405013	speaking	C0234856
28405013	Polynesians	C0240790
28405450	Vaccination	C0042196
28405450	piglets	C0039005
28405450	Ingelvac PRRSFLEX® EU	C1516086
28405450	protection	C1545588
28405450	heterologous	C0439860
28405450	homologous	C0301883
28405450	maternally derived antibodies	C0729663
28405450	eradicating	C3178994
28405450	porcine reproductive and respiratory syndrome	C0376538
28405450	PRRS	C0376538
28405450	transmission of the virus	C1160716
28405450	efficient	C0442799
28405450	DIVA vaccines	C0887908
28405450	successful	C1272703
28405450	control	C0243148
28405450	PRRS	C0376538
28405450	management measures	C0376636
28405450	vaccination	C0042196
28405450	sows	C0684075
28405450	piglets	C0039005
28405450	study	C2603343
28405450	assess	C0184514
28405450	efficacy	C1280519
28405450	MLV vaccine	C1516086
28405450	Ingelvac PRRSFLEX® EU	C1516086
28405450	piglets	C0039005
28405450	presence	C0150312
28405450	homologous	C0301883
28405450	maternally derived antibodies	C0729663
28405450	vaccinated	C0042196
28405450	vaccine strain	C0042210
28405450	ReproCyc® PRRS EU	C1516086
28405450	study	C2603343
28405450	Hungarian farrow	C1296656
28405450	farm	C0557759
28405450	naturally infected	C0439663
28405450	PRRSv	C0376536
28405450	study	C2603343
28405450	blind	C2347038
28405450	placebo controlled	C1706408
28405450	ORF5	C0758157
28405450	sequence similarity	C1710052
28405450	vaccine strain	C0042210
28405450	resident field strain	C1257890
28405450	PRRS	C0376538
28405450	real-time quantitative PCR	C3179034
28405450	serum samples	C1550100
28405450	measure	C0079809
28405450	viral load	C1261478
28405450	virus positive	C1167762
28405450	animals	C0003062
28405450	natural infection	C3714514
28405450	observed	C1441672
28405450	control group	C0009932
28405450	viraemic	C0243095
28405450	animals	C0003062
28405450	vaccinated	C0042196
28405450	infection	C3714514
28405450	dynamics	C3826426
28405450	positive	C1446409
28405450	PCR	C0032520
28405450	samples	C0370003
28405450	ORF5	C0758157
28405450	data analysis	C0010992
28405450	indicated	C1444656
28405450	circulation	C0237318
28405450	virus	C0042776
28405450	data	C1511726
28405450	piglets	C0039005
28405450	vaccinated	C0042196
28405450	Ingelvac PRRSFLEX® EU	C1516086
28405450	proportion	C1709707
28405450	viraemic	C0243095
28405450	animals	C0003062
28405450	viraemia	C0042749
28405450	piglets	C0039005
28405450	homologous	C0301883
28405450	maternally derived antibodies	C0729663
28405450	MDA	C0729663
28405450	vaccination	C0042196
28406413	Lung nodule	C0034079
28406413	French Guiana	C0016703
28406413	immunocompetent	C1512656
28406413	patient	C0030705
28406413	case	C1706256
28406413	immunocompetent	C1512656
28406413	French	C1556084
28406413	soldier	C0524647
28406413	French Guiana	C0016703
28406413	symptomatic	C0231220
28406413	pulmonary histoplasmosis	C1306038
28407625	Comparison	C1707455
28407625	Occlusive	C1947917
28407625	Open	C0175566
28407625	Application	C4048755
28407625	Psoriasis Plaque Test Design	C0008976
28407625	Investigations	C1292732
28407625	Mapracorat	C3252363
28407625	Ointment	C0028912
28407625	Vehicle	C0042444
28407625	Reference	C1706462
28407625	Drugs	C0013227
28407625	Psoriasis plaque tests	C0008976
28407625	PPTs	C0008976
28407625	antipsoriatic	C1874314
28407625	drug development	C0872152
28407625	PPT design	C0008976
28407625	open	C0013153
28407625	occluded drug application	C0013153
28407625	antipsoriatic	C1874314
28407625	mapracorat	C3252363
28407625	ointment	C0028912
28407625	reference	C1706462
28407625	drugs	C0013227
28407625	studies	C2603343
28407625	open	C0008976
28407625	occluded PPT designs	C0008976
28407625	drug effect	C0728866
28407625	sonography	C0041618
28407625	thickness	C1280412
28407625	chromametry	C0022885
28407625	clinical assessment	C3845884
28407625	Antipsoriatic	C1874314
28407625	effects	C0728866
28407625	study	C2603343
28407625	drugs	C0013227
28407625	occluded	C0008976
28407625	open PPTs	C0008976
28407625	potency	C0678792
28407625	antipsoriatic drugs	C1874314
28407625	vehicle	C0042444
28407625	antipsoriatic	C1874314
28407625	effect	C0728866
28407625	occluded PPT	C0008976
28407625	open PPT	C0008976
28407625	treatment duration	C0444921
28407625	weeks	C0439230
28407625	Effect	C0728866
28407625	dynamics	C3826426
28407625	time	C0040223
28407625	study	C2603343
28407625	drugs	C0013227
28407625	open PPT	C0008976
28407625	occluded PPT	C0008976
28407625	technical challenges	C1710348
28407625	open PPT	C0008976
28407625	occluded PPT	C0008976
28407625	screening	C0013206
28407625	early	C1279919
28407625	drug development	C0872152
28407625	drug	C0013227
28407625	aspects	C1879746
28407625	study	C2603343
28407625	open PPT	C0008976
28407625	PPT	C0008976
28407625	classification	C0008902
28407625	phase I studies	C0920321
28407625	study	C2603343
28407625	duration	C0449238
28407625	compounds	C1706082
28407625	concentrations	C1264643
28407625	measurement	C0242485
28407625	treatment response	C0521982
28407625	early	C1279919
28407625	clinical development	C1512068
28407650	Insurance Coverage	C0376629
28407650	Utilization	C0042153
28407650	Sexually Transmitted Disease Clinic	C0338053
28407650	Medicaid	C0025071
28407650	State	C1301808
28407650	Rhode Island	C0035487
28407650	Patient Protection and Affordable Care Act	C2936611
28407650	state's	C1301808
28407650	population	C0032659
28407650	insured	C1548605
28407650	evaluated	C0220825
28407650	insurance coverage	C0376629
28407650	barriers	C0243095
28407650	insurance	C0021682
28407650	patients	C0030705
28407650	services	C1704289
28407650	Rhode Island	C0035487
28407650	sexually transmitted disease (STD) clinic	C0338053
28407650	analyzed	C0936012
28407650	factors	C1521761
28407650	associated with	C0332281
28407650	insurance coverage	C0376629
28407650	utilization	C0042153
28407650	patients	C0030705
28407650	STD	C0036916
28407650	services	C1704289
28407650	July	C3829447
28407650	December	C3830550
28407650	patients	C0030705
28407650	insurance information	C1548070
28407650	available	C1511733
28407650	uninsured	C0087134
28407650	Patients	C0030705
28407650	without insurance	C0087134
28407650	insurance	C0021682
28407650	uninsured	C0087134
28407650	insured	C1548605
28407650	Hispanic	C0086409
28407650	Latino/a	C0086528
28407650	men	C0025266
28407650	sex	C0009253
28407650	men	C0025266
28407650	health insurance	C0021682
28407650	coverage	C0376629
28407650	result	C1274040
28407650	Affordable Care Act	C2936611
28407650	uninsured	C0087134
28407650	uninsured individuals	C0087134
28407650	barriers	C0243095
28407650	health insurance	C0021682
28407650	cost	C0087112
28407650	unemployment	C0041674
28407650	with insurance	C1548605
28407650	willingness	C0600109
28407650	insurance	C0021682
28407650	STD	C0036916
28407650	services	C1704289
28407650	Barriers	C0243095
28407650	insurance	C0021682
28407650	anonymity	C0871649
28407650	out-of-pocket costs	C3815933
28407650	insurance	C0021682
28407650	access	C0015472
28407650	individuals	C0237401
28407650	Rhode Island	C0035487
28407650	STD Clinic	C0338053
28407650	uninsured	C0087134
28407650	insured	C1548605
28407650	barriers	C0243095
28407650	insurance	C0021682
28407650	STD clinics	C0338053
28407650	safety-net	C3658319
28407650	STD	C0036916
28407650	services	C1704289
28407650	states	C1301808
28407650	uninsured	C0087134
28407650	rates	C1521828
28407650	public	C0678367
28407650	private	C0679727
28407650	insurers	C0021675
28407650	financial barriers	C4062976
28407650	optimize	C2698650
28407650	payment	C0680264
28407650	structures	C0678594
28407650	services	C1704289
28410389	Molecular subtyping	C1294399
28410389	Treponema pallidum	C0040840
28410389	associated factors	C1521761
28410389	serofast	C3841011
28410389	status	C0449438
28410389	early syphilis	C0348148
28410389	patients	C0030705
28410389	Identified	C0205396
28410389	genotype	C0017431
28410389	cytokine	C0079189
28410389	marker	C0005516
28410389	Serofast	C3841011
28410389	persistent	C0205322
28410389	nontreponemal serological	C0205473
28410389	response	C0521982
28410389	observed	C1441672
28410389	early syphilis	C0348148
28410389	patients	C0030705
28410389	conventional treatment	C2945704
28410389	concern	C2699424
28410389	clinicians	C0871685
28410389	syphilis	C0348148
28410389	patients	C0030705
28410389	effective	C1704419
28410389	treatment strategy	C0040808
28410389	clarifies	C2986669
28410389	pathogenesis	C0699748
28410389	study	C2603343
28410389	patients	C0030705
28410389	early syphilis	C0348148
28410389	enrolled	C1516879
28410389	treated	C1522326
28410389	months	C0439231
28410389	treatment	C0087111
28410389	patients	C0030705
28410389	serological	C0205473
28410389	cure	C1880198
28410389	serofast	C3841011
28410389	serological	C0205473
28410389	failures	C0231174
28410389	Multivariate analysis	C0026777
28410389	older age	C1999167
28410389	years	C0439234
28410389	baseline	C1442488
28410389	RPR titer	C3835799
28410389	associated with	C0332281
28410389	serofast	C3841011
28410389	status	C0449438
28410389	T. pallidum	C0040840
28410389	molecular subtypes	C0449560
28410389	early syphilis	C0348148
28410389	patients	C0030705
28410389	subtype, 14i/a	C0449560
28410389	14i/a type	C0449560
28410389	serofast	C3841011
28410389	patients	C0030705
28410389	patients	C0030705
28410389	serological	C0205473
28410389	cure	C1880198
28410389	increasing	C0442808
28410389	risk	C0035647
28410389	serofast	C3841011
28410389	status	C0449438
28410389	status	C0449438
28410389	Levels	C0441889
28410389	chemerin	C1312957
28410389	higher	C0205250
28410389	serum	C0229671
28410389	serofast	C3841011
28410389	serological	C0205473
28410389	cure	C1880198
28410389	cytokine	C0079189
28410389	marker	C0005516
28410389	serofast	C3841011
28410389	early syphilis	C0348148
28410389	patients	C0030705
28410389	therapy	C0087111
28410389	results	C1274040
28410389	contribute	C1880177
28410389	improve	C0184511
28410389	guidelines	C0162791
28410389	management	C0376636
28410389	syphilis	C0348148
28410389	patients	C0030705
28410389	serofast	C3841011
28411311	Fluorescence	C0016315
28411311	Fingerprinting	C0016126
28411311	Pesticides	C0031253
28411311	Continuous	C0549178
28411311	Monitoring of Soils and Waters	C0014416
28411311	creation	C1706214
28411311	extension	C0231448
28411311	database	C0242356
28411311	Total Excitation-Emission and Total Synchronous Fluorescence Matrices	C0037802
28411311	TEEMs and TSFMs	C0037802
28411311	optimal Synchronous Fluorescence Spectra	C0037802
28411311	SFS	C0037802
28411311	fingerprint	C0016126
28411311	pesticides	C0031253
28411311	Morocco	C0026544
28411311	spectrometric multi-component fingerprinting	C0436196
28411311	detection of pesticides	C0430417
28411311	persisting in soil	C0037594
28411311	water	C0043053
28411311	detect four pesticide	C0430417
28411311	agricultural soils	C0562975
28411311	spectrometric fingerprinting	C0037802
28411311	insecticide Axlera 5G	C0021578
28411311	carbamate	C0021578
28411311	fungicide Orsalis 5% SC	C0392419
28411311	triazole	C0392419
28411311	insecticide Force 0,5 G	C0597329
28411311	pyrethrinoid	C0597329
28411311	insecticide Proclaim 05 SG	C0021576
28411311	agricultural plantations monitored	C0001827
28411311	great agricultural Doukkala region	C0017446
28411311	western Atlantic side	C0017446
28411311	Morocco	C0026544
28411311	chemicals	C0220806
28412969	cellular prion protein	C0074202
28412969	co-chaperone	C0243041
28412969	Hsp70	C0243043
28412969	Hsp70 / 90 organizing protein	C0018850
28412969	90	C0243044
28412969	proliferation	C0596290
28412969	glioblastoma	C0017636
28412969	glioblastoma stem-like cells	C0007634
28412969	Glioblastoma	C0017636
28412969	GBM	C0017636
28412969	brain tumor	C0006118
28412969	glioblastoma	C0017636
28412969	glioblastoma stem-like cells	C0007634
28412969	GSCs	C0007634
28412969	tumor	C0027651
28412969	maintenance	C0024501
28412969	invasion	C0027626
28412969	therapeutic resistance	C0013203
28412969	GSCs	C0007634
28412969	target	C1521840
28412969	GBM	C0017636
28412969	treatment	C1522326
28412969	cellular prion protein	C0074202
28412969	PrP(C)	C0074202
28412969	co-chaperone	C0243041
28412969	Hsp70	C0243043
28412969	Hsp70 / 90 organizing protein	C0018850
28412969	90	C0243044
28412969	HOP	C0018850
28412969	target	C1521840
28412969	GBM	C0017636
28412969	tumorigenesis	C0596263
28412969	neural stem cell	C1113654
28412969	GSCs	C0007634
28412969	PrP(C)	C0074202
28412969	cultured	C0007585
28412969	neurospheres	C0007634
28412969	growth factors	C0018284
28412969	stem cells	C0038250
28412969	markers	C0012872
28412969	adhesion molecules markers	C0012872
28412969	immunofluorescence	C0079603
28412969	flow cytometry	C0016263
28412969	GSC	C0007634
28412969	self-renewal	C4042950
28412969	proliferation	C0596290
28412969	clonal density assays	C0005507
28412969	BrdU	C0006233
28412969	BrdU incorporation	C0022885
28412969	HOP	C0018850
28412969	treatment	C1522326
28412969	HOP	C0018850
28412969	peptide	C0030956
28412969	PrP(C)	C0074202
28412969	binding site	C0005456
28412969	silencing	C0598496
28412969	HOP	C0018850
28412969	PrP(C)	C0074202
28412969	cell populations	C0007634
28412969	proliferation	C0596290
28412969	in vitro	C1533691
28412969	tumor growth	C0598934
28412969	in vivo	C1515655
28412969	Migration assays	C1513300
28412969	laminin-1	C0908936
28412969	laminin-1 pre-coated glass	C0017596
28412969	GBM	C0017636
28412969	cells	C0007634
28412969	cultured	C0007585
28412969	neurospheres	C0007634
28412969	stemness markers	C0012872
28412969	CD133	C0673026
28412969	CD15	C0080188
28412969	Oct4	C0069304
28412969	SOX2	C0300483
28412969	PrP(C)	C0074202
28412969	monolayer culture	C1510803
28412969	CD133	C0673026
28412969	PrP(C)	C0074202
28412969	silencing	C0598496
28412969	expression of molecules	C0017262
28412969	cancer stem cells	C1956422
28412969	markers	C0012872
28412969	cell differentiation	C0007589
28412969	GSC	C0007634
28412969	self-renewal	C4042950
28412969	PrP(C)	C0074202
28412969	GSCs	C0007634
28412969	HOP	C0018850
28412969	treatment	C1522326
28412969	proliferation	C0596290
28412969	self-renewal	C4042950
28412969	GSCs	C0007634
28412969	PrP(C)	C0074202
28412969	HOP	C0018850
28412969	proliferation process	C0596290
28412969	In vivo	C1515655
28412969	PrP(C)	C0074202
28412969	HOP	C0018850
28412969	inhibits	C3463820
28412969	growth	C0007595
28412969	glioblastoma	C0017636
28412969	cells	C0007634
28412969	PrP(C)	C0074202
28412969	PrP(C) - HOP complex	C1180347
28412969	HOP	C0018850
28412969	HOP	C0018850
28412969	peptide	C0030956
28412969	PrP(C)	C0074202
28412969	binding site	C0005456
28412969	GSC	C0007634
28412969	self-renewal	C4042950
28412969	proliferation	C0596290
28412969	HOP	C0018850
28412969	HOP - PrP(C) complex	C1180347
28412969	PrP(C)	C0074202
28412969	GSC	C0007634
28412969	stemness	C0205556
28412969	PrP(C)	C0074202
28412969	GSCs	C0007634
28412969	cell	C0007634
28412969	adhesion-related proteins	C0033684
28412969	cell migration	C1622501
28412969	PrP(C)	C0074202
28412969	cell surface stability	C0243095
28412969	cell adhesion molecules	C0007578
28412969	GBM	C0017636
28412969	invasiveness	C0027626
28412969	HOP	C0018850
28412969	PrP(C)	C0074202
28412969	PrP(C)	C0074202
28412969	HOP	C0018850
28412969	expression	C0017262
28412969	therapeutic intervention	C0808232
28412969	GBM	C0017636
28412969	glioblastoma	C0017636
28412969	glioblastoma stem-like cell	C0007634
28412969	self-renewal	C4042950
28412969	proliferation	C0596290
28412969	migration	C1622501
28413179	Cyclic thrombocytopenia	C0272282
28413179	synchronizing	C0439580
28413179	menstrual cycle	C0025329
28413179	periodic	C0332182
28413179	phases	C0205390
28413179	thrombocytopenia	C0040034
28413179	rebound	C0034897
28413179	thrombocytosis	C0836924
28413179	year	C1510829
28413179	woman	C0043210
28413179	admitted	C0184666
28413179	hospital	C0019994
28413179	purpura	C0034150
28413179	extremities	C0278454
28413179	thrombocytopenia	C0040034
28413179	Prednisolone	C0032950
28413179	PSL	C0032950
28413179	administered	C1521801
28413179	diagnosis	C0011900
28413179	idiopathic thrombocytopenic purpura	C0398650
28413179	ITP	C0398650
28413179	not effective	C1301751
28413179	maintaining	C0024501
28413179	platelet count	C0032181
28413179	normal range	C0086715
28413179	cyclic fluctuation	C0681684
28413179	menstrual cycle	C0025329
28413179	discontinued	C1444662
28413179	PSL	C0032950
28413179	cyclic thrombocytopenia	C0272282
28413179	CTP	C0272282
28413179	diagnosed	C0011900
28413179	CTP	C0272282
28413179	rare disease	C0678236
28413179	treated	C1522326
28413179	ITP	C0398650
28413179	no response	C4282382
28413179	cause	C0085978
28413179	CTP	C0272282
28413179	uncertain	C0087130
28413179	case	C1706256
28413179	hormonal mechanism	C0920552
28413179	fluctuating	C0231241
28413179	platelet count	C0032181
28413794	Comparative evaluation	C1261322
28413794	iodine-131 metaiodobenzylguanidine	C0879568
28413794	18-fluorodeoxyglucose	C0046056
28413794	positron emission tomography	C0032743
28413794	neural crest tumors	C2931189
28413794	18-Fluorodeoxyglucose	C0046056
28413794	positron emission tomography	C0032743
28413794	FDG-PET	C0032743
28413794	malignancies	C0006826
28413794	clinical role	C2347795
28413794	neural crest cell tumors	C2931189
28413794	iodine-131 metaiodobenzylguanidine	C0879568
28413794	(131)I-MIBG	C0879568
28413794	FDG-PET	C0032743
28413794	patients	C0030705
28413794	neural crest tumors	C2931189
28413794	qualitatively	C0034375
28413794	semiquantitatively	C2986822
28413794	clinical utility	C0422813
28413794	disease status evaluation	C0243095
28413794	further management	C0376636
28413794	patients	C0030705
28413794	(131)I-MIBG	C0879568
28413794	FDG-PET	C0032743
28413794	clinicopathologically	C0205469
28413794	neuroblastoma	C0027819
28413794	pheochromocytoma	C0031511
28413794	medullary carcinoma thyroid	C0238462
28413794	patients	C0030705
28413794	neuroblastoma	C0027819
28413794	FDG PET	C0032743
28413794	(131)I-MIBG	C0879568
28413794	patient-specific sensitivity	C4304945
28413794	maximum standardized uptake value	C2986846
28413794	SUVmax	C2986846
28413794	primary lesions	C1402294
28413794	patients	C0030705
28413794	unfavorable histology	C4048239
28413794	favorable histology	C4048239
28413794	SUVmax	C2986846
28413794	posterior superior iliac spine	C0223646
28413794	PSIS	C0223646
28413794	greater trochanter	C0223865
28413794	patients	C0030705
28413794	marrow	C0376152
28413794	SUVmax	C2986846
28413794	contralateral normal sites	C0441988
28413794	equivocal	C0332241
28413794	bone marrow results	C0427694
28413794	SUV	C2348529
28413794	metastatic involvement	C1522484
28413794	biopsy site	C1301128
28413794	patients	C0030705
28413794	pheochromocytoma	C0031511
28413794	FDG-PET	C0032743
28413794	patient-specific sensitivity	C4304945
28413794	FDG-PET	C0032743
28413794	metastatic foci	C0205234
28413794	(131)I-MIBG	C0879568
28413794	patients	C0030705
28413794	medullary carcinoma thyroid	C0238462
28413794	FDG-PET	C0032743
28413794	recurrent	C0277556
28413794	metastatic disease	C0027627
28413794	metastatic foci	C0205234
28413794	patient specific sensitivity	C4304945
28413794	(131)I-MIBG	C0879568
28413794	higher serum calcitonin levels	C0863135
28413794	FDG-PET	C0032743
28413794	complementary modality	C0695347
28413794	neural crest cell tumors	C2931189
28413794	(131)I-MIBG	C0879568
28413794	nonavid tumors	C0027651
28416410	Progressive Occlusion	C0441597
28416410	Recanalization	C0034771
28416410	Endovascular Treatment	C0087111
28416410	Unruptured Small Aneurysms	C0002940
28416410	Single-Center	C1274109
28416410	6-Year	C0439234
28416410	Experience	C0596545
28416410	effect	C1280500
28416410	coiling	C0444764
28416410	unruptured intracranial aneurysms	C0007766
28416410	UIAs	C0007766
28416410	progressive occlusio	C0441597
28416410	recanalization	C0034771
28416410	progressive occlusion	C0441597
28416410	recanalization	C0034771
28416410	UIAs	C0007766
28416410	occlusion	C0441597
28416410	patients	C0030705
28416410	UIAs	C0007766
28416410	institute	C0021622
28416410	UIAs	C0007766
28416410	group	C0441833
28416410	UIAs	C0007766
28416410	occlusion	C0441597
28416410	progressive	C0205329
28416410	stable	C0205360
28416410	recanalization	C0034771
28416410	groups	C0441833
28416410	Baseline	C1442488
28416410	characteristics	C1521970
28416410	procedure	C0087111
28416410	complications	C0009566
28416410	angiographic	C0002978
28416410	follow-up results	C1522577
28416410	clinical outcomes	C0085415
28416410	statistically analyzed	C0871424
28416410	aneurysms	C0002940
28416410	aneurysms	C0002940
28416410	intraoperative	C0456904
28416410	ruptures	C3203359
28416410	perioperative	C1518988
28416410	thromboembolic events	C0040038
28416410	Angiographic	C0002978
28416410	follow-up	C1522577
28416410	patients	C0030705
28416410	incidence	C0021149
28416410	recanalization	C0034771
28416410	aneurysms	C0002940
28416410	occlusion	C0441597
28416410	progressive occlusion	C0441597
28416410	recanalization	C0034771
28416410	Anatomic results	C0243095
28416410	follow-up	C1522577
28416410	groups	C0441833
28416410	groups	C0441833
28416410	logistic regression analysis	C0681925
28416410	size	C0456389
28416410	occlusion	C0441597
28416410	recanalization	C0034771
28416410	study	C2603343
28416410	coil embolization	C0013931
28416410	UIAs	C0007766
28416410	progressive occlusion	C0441597
28416410	recanalization	C0034771
28416410	follow-up	C1522577
28416410	Anatomic results	C0243095
28416410	follow-up	C1522577
28416410	groups	C0441833
28416410	groups	C0441833
28416410	occlusion	C0441597
28416410	recanalization	C0034771
28417422	Selection	C1707391
28417422	Artificial	C2004457
28417422	Diet	C0012155
28417422	Laboratory	C0022877
28417422	Rearing	C1441721
28417422	Opogona sacchari	C3002762
28417422	Lepidoptera	C0023338
28417422	Tineidae	C1009208
28417422	banana moth Opogona sacchari	C3002762
28417422	Bojer	C3002762
28417422	Lepidoptera	C0023338
28417422	Tineidae	C1009208
28417422	polyphagous pest	C0684063
28417422	serious	C0205404
28417422	damage	C1883709
28417422	banana	C0004722
28417422	crops	C0242775
28417422	southern	C1710133
28417422	Brazil	C0006137
28417422	insect	C0021585
28417422	pest	C0684063
28417422	countries	C0454664
28417422	Argentina	C0003761
28417422	consumer	C1707496
28417422	market	C1318228
28417422	bananas	C0004722
28417422	southern	C1710133
28417422	Brazil	C0006137
28417422	information	C1533716
28417422	biology	C0005532
28417422	ecology	C0013546
28417422	moth	C0026593
28417422	diet	C0012155
28417422	laboratory	C0022877
28417422	rearing	C1441721
28417422	pest management	C0031249
28417422	pest	C0684063
28417422	study	C2603343
28417422	data	C1511726
28417422	diets	C0012155
28417422	laboratory	C0022877
28417422	rearing	C1441721
28417422	O. sacchari	C3002762
28417422	dried	C1512080
28417422	beans	C0004896
28417422	wheat germ	C0016452
28417422	soy bran	C0016452
28417422	brewer's yeast	C0036025
28417422	casein	C0007332
28417422	diet	C0012155
28417422	wheat germ	C0016452
28417422	casein	C0007332
28417422	protein	C0033684
28417422	sources	C0449416
28417422	diets	C0012155
28417422	viability	C0443348
28417422	egg	C0029974
28417422	adult	C0001675
28417422	period	C1948053
28417422	fertility	C0015895
28417422	eggs	C0029974
28417422	female	C0043210
28417422	biotic	C1253910
28417422	potential	C3245505
28417422	analysis	C0936012
28417422	values	C0042295
28417422	diets	C0012155
28420538	impact	C4049986
28420538	productivity	C0033269
28420538	hypothetical tax	C0039371
28420538	sugar-sweetened beverages	C0005329
28420538	potential	C3245505
28420538	impact	C4049986
28420538	additional	C1524062
28420538	tax	C0039371
28420538	sugar-sweetened beverages	C0005329
28420538	SSBs	C0005329
28420538	productivity	C0033269
28420538	Australia	C0004340
28420538	multi-state lifetable Markov model	C0023682
28420538	examine	C0332128
28420538	potential	C3245505
28420538	impact	C4049986
28420538	additional	C1524062
28420538	tax	C0039371
28420538	SSBs	C0005329
28420538	total lifetime	C4071830
28420538	productivity	C0033269
28420538	paid and unpaid sectors	C0009433
28420538	economy	C0870462
28420538	study population	C2348561
28420538	Australians	C0238711
28420538	aged	C0001779
28420538	years	C0439234
28420538	older	C0001792
28420538	health	C1550208
28420538	relevant	C2347946
28420538	outcomes	C1274040
28420538	modelled	C0870071
28420538	remaining	C1527428
28420538	lifetime	C4071830
28420538	SSBs	C0005329
28420538	tax	C0039371
28420538	estimated	C0750572
28420538	reduce	C0392756
28420538	number	C0237753
28420538	people	C0027361
28420538	obesity	C0028754
28420538	population	C1257890
28420538	persons	C0027361
28420538	obesity	C0028754
28420538	reduce	C0392756
28420538	number	C0237753
28420538	employees	C0599987
28420538	obesity	C0028754
28420538	persons	C0027361
28420538	effects	C1280500
28420538	productivity	C0033269
28420538	gains	C1517378
28420538	paid sector	C0009433
28420538	million	C1881839
28420538	working	C0043227
28420538	age	C0001779
28420538	population	C1257890
28420538	confidence interval	C0009667
28420538	million	C1881839
28420538	million	C1881839
28420538	human capital	C0700103
28420538	approach	C0449445
28420538	unpaid sector	C0009433
28420538	potential	C3245505
28420538	productivity	C0033269
28420538	gains	C1517378
28420538	amounted	C1265611
28420538	million	C1881839
28420538	million	C1881839
28420538	million	C1881839
28420538	replacement cost method	C0025663
28420538	productivity	C0033269
28420538	benefits	C0814225
28420538	health benefits	C0086387
28420538	life years	C0080071
28420538	gained	C1517378
28420538	reduction	C0392756
28420538	healthcare costs	C0085552
28420538	million	C1881839
28420538	additional	C1524062
28420538	tax	C0039371
28420538	SSBs	C0005329
28420538	improves	C0184511
28420538	health outcomes	C1550208
28420538	reduces	C0392756
28420538	healthcare costs	C0085552
28420538	productivity	C0033269
28420538	gains	C1517378
28420538	paid and unpaid sectors	C0009433
28420538	economy	C0870462
28421026	Effect	C1280500
28421026	Teachers'	C0221457
28421026	Parents'	C0030551
28421026	Emotional Support	C0600015
28421026	Children's	C0008059
28421026	Working Memory	C0025265
28421026	Performance	C1285654
28421026	Working memory	C0025265
28421026	temporarily store	C0025265
28421026	information	C1533716
28421026	children's	C0008059
28421026	learning	C0023185
28421026	factors	C1521761
28421026	promote	C0033414
28421026	hinder	C3463820
28421026	working memory	C0025265
28421026	performance	C1285654
28421026	research	C0035168
28421026	positive	C1446409
28421026	associations	C0439849
28421026	positive	C1446409
28421026	parent-child	C0030542
28421026	teacher-student interactions	C0871486
28421026	working memory	C0025265
28421026	performance	C1285654
28421026	development	C1527148
28421026	study	C2603343
28421026	experimentally investigated	C1292732
28421026	parents	C0030551
28421026	teachers	C0221457
28421026	working memory	C0025265
28421026	performance	C1285654
28421026	attachment theory	C0871935
28421026	study	C2603343
28421026	investigated	C1292732
28421026	parent	C0030551
28421026	teacher	C0221457
28421026	emotional support	C0600015
28421026	promoting	C0033414
28421026	working memory	C0025265
28421026	performance	C1285654
28421026	negative	C0205160
28421026	effect	C1280500
28421026	social stress	C0871388
28421026	Questionnaires	C0034394
28421026	experimental session	C0242481
28421026	children	C0008059
28421026	years	C0439234
28421026	months	C0439231
28421026	months	C0439231
28421026	Questionnaires	C0034394
28421026	children's	C0008059
28421026	perceptions	C0030971
28421026	teacher-student	C0871486
28421026	parent-child relationship	C0030542
28421026	experimental session	C0242481
28421026	working memory	C0025265
28421026	Corsi task backward	C0681907
28421026	pre-	C1707689
28421026	post-test design	C1707689
28421026	tests	C0392366
28421026	stress	C0038435
28421026	induced	C0205263
28421026	children	C0008059
28421026	Cyberball paradigm	C0681797
28421026	Emotional support	C0600015
28421026	manipulated	C0018578
28421026	audio	C3273156
28421026	message	C0470166
28421026	weather	C0043085
28421026	report	C0684224
28421026	supportive	C0600015
28421026	message	C0470166
28421026	stranger	C1257890
28421026	supportive	C0600015
28421026	message	C0470166
28421026	parent	C0030551
28421026	supportive	C0600015
28421026	message	C0470166
28421026	teacher	C0221457
28421026	Results	C1274040
28421026	repeated measures	C0871881
28421026	ANOVA	C0002780
28421026	effect	C1280500
28421026	stress	C0038435
28421026	induction	C0205263
28421026	effect	C1280500
28421026	parent	C0030551
28421026	teacher	C0221457
28421026	support	C0600015
28421026	quality	C0332306
28421026	parent-child relationship	C0030542
28421026	children	C0008059
28421026	positive	C1446409
28421026	relationship	C0439849
28421026	parent	C0030551
28421026	support	C0600015
28421026	parents	C0030551
28421026	teachers	C0221457
28421026	effect	C1280500
28421026	working memory	C0025265
28421026	performance	C1285654
28421026	children	C0008059
28421026	negative	C0205160
28421026	relationship	C0439849
28421026	parent	C0030551
28421026	supportive	C0600015
28421026	message	C0470166
28421026	parent	C0030551
28421026	working memory	C0025265
28421026	performance	C1285654
28421026	supportive	C0600015
28421026	message	C0470166
28421026	teacher	C0221457
28421026	performance	C1285654
28421026	study	C2603343
28421026	parents	C0030551
28421026	teachers	C0221457
28421026	support	C0600015
28421026	working memory	C0025265
28421026	performance	C1285654
28421026	supportive	C0600015
28421026	child	C0008059
28421026	Teacher	C0221457
28421026	support	C0600015
28421026	effective	C1704419
28421026	child	C0008059
28421026	negative	C0205160
28421026	relationship	C0439849
28421026	parent	C0030551
28421026	preventing	C1292733
28421026	resolving	C3714811
28421026	working memory	C0025265
28421026	problems	C0033213
28421026	issues	C0033213
28424445	Management	C1273870
28424445	tachyarrhythmia	C0080203
28424445	pregnancy	C0032961
28424445	Maternal	C1858460
28424445	tachyarrhythmia	C0080203
28424445	common	C0205214
28424445	complication	C0009566
28424445	pregnancy	C0032961
28424445	hormonal changes	C1134488
28424445	enhance	C2349975
28424445	pre-existing	C2347662
28424445	arrhythmias	C0080203
28424445	induce	C0205263
28424445	arrhythmias	C0080203
28424445	presence	C0150312
28424445	congenital heart defects	C0018798
28424445	pregnant females	C0033011
28424445	Presence	C0150312
28424445	tachyarrhythmia	C0080203
28424445	pregnancy	C0032961
28424445	risk	C0035647
28424445	mother	C0026591
28424445	fetus	C0015965
28424445	calling	C0679006
28424445	proper treatment	C0087111
28424445	medications	C0013227
28424445	antiarrhythmic drugs	C0003195
28424445	maternal	C1858460
28424445	tachyarrhythmia	C0080203
28424445	consideration	C0750591
28424445	potential	C3245505
28424445	teratogenic side effects	C0232910
28424445	Utilization	C0042153
28424445	antiarrhythmic drugs	C0003195
28424445	pregnancy	C0032961
28424445	studied	C2603343
28424445	result	C1274040
28424445	minimal	C0547040
28424445	fetal	C0015965
28424445	harm	C0005604
28424445	techniques	C0449851
28424445	cardiac ablation	C0162563
28424445	implemented	C1708476
28424445	minimal	C0547040
28424445	radiation exposure	C0015333
28424445	fetus	C0015965
28424445	mother	C0026591
28424445	Pregnant women	C0033011
28424445	tachyarrhythmia	C0080203
28424445	successfully	C1272703
28424445	treated	C0332154
28424445	little	C0700321
28424445	impact	C4049986
28424445	developing fetus	C3824789
28424445	result	C1274040
28424445	increasing	C0442808
28424445	experience	C0596545
28424445	antiarrhythmic drugs	C0003195
28424445	progress	C1280477
28424445	procedural	C2700391
28424445	techniques	C0449851
28424584	Hif-1α	C0965644
28424584	Overexpression	C1514559
28424584	Improves	C0184511
28424584	Transplanted Bone Mesenchymal Stem Cells	C1257990
28424584	Survival	C0007620
28424584	Rat MCAO Stroke Model	C0012644
28424584	Bone mesenchymal stem cells	C1257975
28424584	BMSCs	C1257975
28424584	death	C0007587
28424584	transplantation	C1257990
28424584	cell therapy	C0302189
28424584	cerebral infarction	C0007785
28424584	study	C0008972
28424584	aimed	C1947946
28424584	investigate	C1292732
28424584	modification	C0392747
28424584	BMSCs	C1257975
28424584	hypoxia-inducible factor 1α	C0965644
28424584	Hif-1α	C0965644
28424584	enhance	C2349975
28424584	survival	C0007620
28424584	implanted BMSCs	C1257990
28424584	BMSCs	C1257975
28424584	isolated	C3827940
28424584	Wistar rats	C0034716
28424584	infected	C3714514
28424584	Hif-1α-GFP lentiviral vector	C1520007
28424584	Hif-1α siRNA	C1099354
28424584	modified	C0392747
28424584	BMSCs	C1257975
28424584	oxygen-glucose deprivation (OGD) condition	C4236781
28424584	cellular viability	C0007620
28424584	apoptosis	C0162638
28424584	assessed	C1516048
28424584	inhibitor	C1254351
28424584	AMPK	C2350345
28424584	compound C	C1254351
28424584	detect	C1511790
28424584	AMPK	C2350345
28424584	mTOR	C1447315
28424584	Hif-1α	C0965644
28424584	BMSCs survival	C0007620
28424584	BMSCs	C1257975
28424584	expression of autophagy markers	C1171362
28424584	modified	C0392747
28424584	BMSCs	C1257975
28424584	transplanted	C1257990
28424584	middle cerebral artery occlusion	C0740391
28424584	MCAO	C0740391
28424584	model of rats	C0012644
28424584	cerebral infarction	C0007785
28424584	volume	C0449468
28424584	neurological function	C0027767
28424584	assessed	C1516048
28424584	Hif-1α overexpression	C1514559
28424584	OGD	C4236781
28424584	induced	C0205263
28424584	injury	C3263723
28424584	cellular viability	C0007620
28424584	inhibiting	C0021469
28424584	apoptosis	C0162638
28424584	AMPK	C2350345
28424584	mTOR	C1447315
28424584	inactivated	C0544461
28424584	Hif-1α overexpression	C1514559
28424584	Hif-1α	C0965644
28424584	BMSCs survival	C0007620
28424584	Hif-1α overexpression	C1514559
28424584	autophagy	C0004391
28424584	compound C	C1254351
28424584	induction of Hif-1α	C0014431
28424584	autophagy	C0004391
28424584	Transplantation of the overexpressed Hif-1α of BMSCs	C1257990
28424584	MCAO rats	C0012644
28424584	brain infarct	C0007785
28424584	volume	C0449468
28424584	improved	C0184511
28424584	neurobehavioral outcome	C2986478
28424584	pro-inflammatory cytokines	C0079189
28424584	neurotrophin	C0132298
28424584	secretion	C1159339
28424584	Hif-1α	C0965644
28424584	survival of BMSCs	C0007620
28424584	activation of AMPK and mTOR	C0014429
28424584	autophagy	C0004391
28425183	Associations	C0439849
28425183	major life events	C0557155
28425183	adherence	C1510802
28425183	glycemic control,	C3267174
28425183	psychosocial characteristics	C0033963
28425183	teens	C1521910
28425183	type 1 diabetes	C0011854
28425183	cross-sectional study	C0010362
28425183	assessed	C1516048
28425183	major life events	C0557155
28425183	teens	C1521910
28425183	type 1 diabetes	C0011854
28425183	association	C0439849
28425183	event frequency	C0441471
28425183	demographic	C0011292
28425183	diabetes management	C0948092
28425183	psychosocial characteristics	C0033963
28425183	Parents	C0030551
28425183	teens	C1521910
28425183	Life Events	C0557155
28425183	Checklist	C1707357
28425183	events	C0441471
28425183	teens	C1521910
28425183	experienced	C0023672
28425183	year	C0439234
28425183	experienced	C0023672
28425183	event	C0441471
28425183	experienced	C0023672
28425183	events	C0441471
28425183	experienced	C0023672
28425183	events	C0441471
28425183	Teens	C1521910
28425183	parents	C0030551
28425183	measures	C0079809
28425183	treatment adherence	C0516958
28425183	diabetes	C0011847
28425183	self-efficacy	C0600564
28425183	quality of life	C0034380
28425183	diabetes	C0011847
28425183	family conflict	C0233542
28425183	Parent-youth interview	C0021822
28425183	chart review	C0541653
28425183	demographics	C0011287
28425183	diabetes management	C0948092
28425183	events	C0441471
28425183	teen	C1521910
28425183	events	C0441471
28425183	Hospitalization	C0019993
28425183	family member	C0086282
28425183	Getting a bad report card	C0243095
28425183	arguments	C0680226
28425183	parents	C0030551
28425183	Serious illness	C0221423
28425183	injury	C3263722
28425183	family member	C0086282
28425183	teens	C1521910
28425183	event	C0441471
28425183	teens	C1521910
28425183	events	C0441471
28425183	parents	C0030551
28425183	parent	C0030551
28425183	college degree	C0542560
28425183	Teen	C1521910
28425183	events	C0441471
28425183	adherence	C1510802
28425183	teen	C1521910
28425183	parent	C0030551
28425183	self-efficacy	C0600564
28425183	teen	C1521910
28425183	parent	C0030551
28425183	quality of life	C0034380
28425183	teen	C1521910
28425183	parent	C0030551
28425183	conflict	C0233542
28425183	teen	C1521910
28425183	parent	C0030551
28425183	teens	C1521910
28425183	events	C0441471
28425183	multivariate model	C3161035
28425183	demographic	C0011292
28425183	diabetes management	C0948092
28425183	events	C0441471
28425183	A1c	C0019018
28425183	major life events	C0557155
28425183	associated with	C0332281
28425183	diabetes care	C3274787
28425183	A1c	C0019018
28425183	psychosocial qualities	C0243156
28425183	teens	C1521910
28425183	type 1 diabetes	C0011854
28427537	Metabolomics	C1328813
28427537	Nutrition	C0392209
28427537	Potential	C3245505
28427537	Biomarkers	C0005516
28427537	Food Quality	C0920525
28427537	Intake	C1512806
28427537	Health Status	C0018759
28427537	Diet	C0012155
28427537	dietary patterns	C1517289
28427537	environmental factors	C0686732
28427537	exposure to	C0332157
28427537	toxins	C0040549
28427537	role	C1705810
28427537	prevention	C2700409
28427537	development	C1527148
28427537	diseases	C0012634
28427537	obesity	C0028754
28427537	type 2 diabetes	C0011860
28427537	health status	C0018759
28427537	individuals	C0237401
28427537	identify	C0205396
28427537	novel	C0205314
28427537	biomarkers	C0005516
28427537	detect	C0442726
28427537	early	C1279919
28427537	metabolic	C0311400
28427537	dysfunction	C3887504
28427537	predict	C0681842
28427537	evolution	C0205245
28427537	health status	C0018759
28427537	nutritional advices	C0850410
28427537	population groups	C1257890
28427537	Omics technologies	C0039421
28427537	genomics	C0887950
28427537	proteomics	C0872252
28427537	metabolomics	C1328813
28427537	coupled	C1948027
28427537	statistical	C0037589
28427537	bioinformatics tools	C0037589
28427537	potential	C3245505
28427537	research field	C0683945
28427537	biomarkers	C0005516
28427537	decades	C2981279
28427537	analytical techniques	C0022885
28427537	developed	C0205245
28427537	detect	C0442726
28427537	metabolites	C0870883
28427537	human	C0086418
28427537	biofluids	C0005889
28427537	urine	C0042036
28427537	blood	C0005767
28427537	saliva	C0036087
28427537	food science	C0920526
28427537	nutrition	C0028707
28427537	studies	C2603343
28427537	food	C0016452
28427537	authenticity	C0205556
28427537	quality	C0332306
28427537	safety	C0036043
28427537	food processing	C0016487
28427537	metabolomic	C1328813
28427537	investigations	C1292732
28427537	discover	C1880355
28427537	early	C1279919
28427537	biomarkers	C0005516
28427537	metabolic	C0311400
28427537	dysfunction	C3887504
28427537	predictive	C0681890
28427537	biomarkers	C0005516
28427537	pathologies	C0030664
28427537	obesity	C0028754
28427537	metabolic syndrome	C0039082
28427537	type-2 diabetes	C0011860
28427537	development	C1527148
28427537	methodologies	C0086912
28427537	identify	C0205396
28427537	biomarkers	C0005516
28427537	nutrients	C0678695
28427537	exposure	C0332157
28428293	Draft Genome Sequence	C0162326
28428293	Bacillus cereus LA2007	C0004590
28428293	Human-Pathogenic Isolate	C3494793
28428293	Anthrax	C1254288
28428293	Anthrax -Like Plasmids	C0032136
28428293	genome sequence	C0162326
28428293	Bacillus cereus LA2007	C0004590
28428293	strain	C1518614
28428293	isolated	C0205409
28428293	fatal pneumonia	C0004626
28428293	case	C0085973
28428293	Louisiana	C0024024
28428293	Sequence-based genome analysis	C3854164
28428293	revealed	C0443289
28428293	LA2007	C0004590
28428293	carries	C0699809
28428293	plasmid	C0032136
28428293	Bacillus anthracis pXO1	C0004589
28428293	genes	C0017337
28428293	production	C0444622
28428293	regulation	C1327622
28428293	anthrax toxin	C0051962
28429154	elite	C1522427
28429154	Neurospora crassa	C0027923
28429154	strains	C1518614
28429154	cellulosic	C0007648
28429154	ethanol production	C0678710
28429154	fungal	C0521033
28429154	breeding	C1260875
28429154	renewable	C3178762
28429154	sustainable energy	C3178763
28429154	generated	C3146294
28429154	interest	C0543488
28429154	conversion	C0439836
28429154	cellulosic	C0007648
28429154	biomass	C0005535
28429154	liquid	C0302908
28429154	fuels	C0556991
28429154	ethanol	C0001962
28429154	filamentous fungus	C0016832
28429154	attempts	C1516084
28429154	study	C2603343
28429154	cellulose metabolism	C1157836
28429154	use of	C1524063
28429154	knock-out	C1522225
28429154	mutants	C0596988
28429154	systematic	C0220922
28429154	characterize	C1880022
28429154	natural	C0205296
28429154	variation	C0042333
28429154	cellulose metabolism	C1157836
28429154	ecotypes	C3178911
28429154	adapted	C0001398
28429154	different	C1705242
28429154	habitats	C0871648
28429154	characterized	C1880022
28429154	natural	C0205296
28429154	variation	C0042333
28429154	saccharification	C1254366
28429154	cellulose	C0007648
28429154	fermentation	C0015852
28429154	ecotypes	C3178911
28429154	laboratory	C0022877
28429154	strains	C1518614
28429154	model	C3161035
28429154	fungus	C0016832
28429154	Neurospora crassa	C0027923
28429154	observed	C1441672
28429154	significant	C0750502
28429154	variation	C0042333
28429154	traits	C0599883
28429154	natural	C0205296
28429154	laboratory generated	C2346631
28429154	populations	C0016832
28429154	elite	C1522427
28429154	strains	C1518614
28429154	performing	C0884358
28429154	better	C0332272
28429154	reference	C0034925
28429154	strain	C1518614
28429154	F1 population N345	C0314650
28429154	population	C0016832
28429154	parents	C0016832
28429154	performing	C0884358
28429154	strain	C1518614
28429154	improvement	C2986411
28429154	ethanol production	C0678710
28429154	results	C1254595
28429154	natural	C0205296
28429154	alleles	C0002085
28429154	fungal	C0521033
28429154	breeding	C1260875
28429154	elite	C1522427
28429154	industrial	C0021267
28429154	strains	C1518614
28429154	bioethanol production	C0678710
28429354	hippocampus	C0019564
28429354	calcitonin gene-related peptide	C0006669
28429354	traumatic brain injury	C0876926
28429354	fracture-healing	C0162542
28429354	hippocampus	C0019564
28429354	fracture-healing	C0162542
28429354	traumatic brain injury	C0876926
28429354	calcitonin gene-related peptide	C0006669
28429354	CGRP	C0006669
28429354	Sprague-Dawley rats	C0034715
28429354	groups	C0441833
28429354	TBI	C0876926
28429354	fracture	C0016658
28429354	group	C0441833
28429354	fracture	C0016658
28429354	only	C0205171
28429354	group	C0441833
28429354	TBI	C0876926
28429354	only	C0205171
28429354	group	C0441833
28429354	control group	C0009932
28429354	blood specimen	C0178913
28429354	rats	C0034715
28429354	groups	C0441833
28429354	control group	C0009932
28429354	post	C0687676
28429354	damage	C0270611
28429354	rats	C0034715
28429354	neurological	C0205494
28429354	brain injury	C0270611
28429354	Blood samples	C1277698
28429354	control group	C0009932
28429354	injury	C0270611
28429354	brain tissues	C0459385
28429354	injured	C0332664
28429354	groups	C0441833
28429354	harvested	C0185110
28429354	post	C0687676
28429354	injury	C0270611
28429354	serum	C0229671
28429354	CGRP	C0006669
28429354	concentration	C1446561
28429354	CGRP	C0006669
28429354	CGRP	C0006669
28429354	expression	C1171362
28429354	expression	C1171362
28429354	CGRP	C0006669
28429354	hippocampus	C0019564
28429354	expression	C1171362
28429354	CGRP	C0006669
28429354	hippocampus	C0019564
28429354	expression	C1171362
28429354	CGRP	C0006669
28429354	hippocampus	C0019564
28429354	expression	C1171362
28429354	CGRP	C0006669
28429354	brain	C0006104
28429354	immunohistochemistry	C0021044
28429354	Western blotting	C0949466
28429354	RT	C0035380
28429354	CGRP	C0017337
28429354	RNA expression	C1515670
28429354	Neurological examinations	C0027853
28429354	cerebral cortex	C0007776
28429354	cerebellum	C0007765
28429354	brain stem	C0006121
28429354	pre	C0332152
28429354	post	C0687676
28429354	injury	C0270611
28429354	ELISA analysis	C0014441
28429354	CGRP	C0006669
28429354	TBI	C0876926
28429354	fracture	C0016658
28429354	group	C0441833
28429354	TBI	C0876926
28429354	fracture	C0016658
28429354	group	C0441833
28429354	CGRP	C0006669
28429354	hippocampus	C0019564
28429354	whole brain	C1269537
28429354	RT-PCR	C0599161
28429354	western blot analysis	C0949466
28429354	post	C0687676
28429354	injury	C0270611
28429354	only	C0205171
28429354	immunohistochemistry analysis	C0021044
28429354	CGRP	C0006669
28429354	hippocampus	C0019564
28429354	post	C0687676
28429354	injury	C0270611
28429354	hippocampus	C0019564
28429354	CGRP	C0006669
28429354	bone-healing	C3687232
28429354	hippocampus	C0019564
28429354	fracture healing	C0162542
28429354	CGRP	C0006669
28429354	expression	C1171362
28429354	IHC	C0021044
28429354	groups	C0441833
28429354	hippocampus	C0019564
28429354	brain	C0006104
28429354	big stress	C0449430
28429412	Bone	C0391978
28429412	extracellular matrix	C0015350
28429412	hydrogel	C0600484
28429412	osteogenic differentiation	C0007589
28429412	C2C12 myoblasts	C0596995
28429412	mouse	C0025929
28429412	calvarial	C0205950
28429412	cells	C0007634
28429412	Hydrogel scaffolds	C0600484
28429412	extracellular matrix	C0015350
28429412	ECM	C0015350
28429412	mammalian tissues	C0040300
28429412	tissue repair	C0043240
28429412	in vitro	C1533691
28429412	in vivo	C1515655
28429412	study	C2603343
28429412	osteogenic potential	C0029433
28429412	ECM	C0015350
28429412	hydrogels	C0600484
28429412	demineralized	C1832069
28429412	decellularized bovine bone	C0005479
28429412	osteogenic medium	C0010454
28429412	Culture	C0430400
28429412	C2C12	C0596995
28429412	mouse	C0025929
28429412	calvarial	C0205950
28429412	cells	C0007634
28429412	mPCs	C0007634
28429412	decellularized bone ECM	C0005479
28429412	bECM	C0005479
28429412	demineralized bone matrix	C1832069
28429412	DBM	C1832069
28429412	gels	C0600484
28429412	expression	C0600223
28429412	osteogenic gene markers	C0017393
28429412	osteopontin	C0069676
28429412	osteocalcin	C0029419
28429412	mPCs	C0007634
28429412	cultured	C0430400
28429412	bECM	C0005479
28429412	basal	C0010454
28429412	osteogenic media	C0010454
28429412	bECM	C0005479
28429412	hydrogels	C0600484
28429412	osteogenic differentiation	C0007589
28429412	C2C12	C0596995
28429412	mPCs	C0007634
28429412	osteogenic medium	C0010454
28429412	bECM	C0005479
28429412	hydrogel scaffolds	C0600484
28429412	clinical	C0205210
28429412	applications	C4048755
28429412	bone	C0391978
28429412	tissue engineering	C0596171
28430341	Prostate-specific antigen	C0138741
28430341	increase	C0442805
28430341	dutasteride	C0754659
28430341	prostate biopsy	C0194804
28430341	prostatic inflammation	C0033581
28430341	analyze	C0936012
28430341	increase	C0442805
28430341	total prostate-specific antigen (PSA) serum levels	C2123607
28430341	dutasteride	C0754659
28430341	treatment	C0087111
28430341	predictor	C2698872
28430341	prostate cancer	C0376358
28430341	PC	C0376358
28430341	biopsy	C0005558
28430341	rate	C1521828
28430341	PSA	C0138741
28430341	PSA	C0138741
28430341	increase	C0442805
28430341	prostatic inflammation	C0033581
28430341	men	C0025266
28430341	prostate biopsy	C0194804
28430341	elevated	C3163633
28430341	PSA	C0138741
28430341	PSA levels	C2123607
28430341	dutasteride	C0754659
28430341	treatment	C0087111
28430341	population	C1257890
28430341	PSA	C0138741
28430341	increase	C0442805
28430341	follow-up	C1522577
28430341	prostate biopsy	C0194804
28430341	PSA	C0138741
28430341	increase	C0442805
28430341	associated with	C0332281
28430341	PC	C0376358
28430341	re-biopsy	C0005558
28430341	PSA reduction	C1096147
28430341	treatment	C0087111
28430341	indicator	C0005516
28430341	PC	C0376358
28430341	inflammatory infiltrates	C3887644
28430341	prostate biopsies	C0194804
28430341	PC	C0376358
28430341	biopsy	C0005558
28430341	increase	C0442805
28430341	PSA	C0138741
28430341	PSA level	C2123607
28430341	dutasteride	C0754659
28430341	Treatment	C0087111
28430341	dutasteride	C0754659
28430341	analyze	C0936012
28430341	PSA	C0138741
28430341	kinetic	C0022702
28430341	prostatic inflammation	C0033581
28430341	PSA	C0138741
28430341	kinetic	C0022702
28430341	dutasteride	C0754659
28430341	treatment	C0087111
28433844	Neurological Decline	C4314692
28433844	Elderly	C0001792
28433844	Repaired	C0205340
28433844	Myelomeningocele	C0025312
28433844	Complicated	C0231242
28433844	Lumbar Canal Stenosis	C0158288
28433844	case report	C0085973
28433844	Tethered cord syndrome	C0080218
28433844	complication	C0009566
28433844	myelomeningocele	C0025312
28433844	MMC	C0025312
28433844	repair	C1705181
28433844	childhood	C0231335
28433844	complications	C0009566
28433844	adults	C0001675
28433844	repaired	C0205340
28433844	MMC	C0025312
28433844	influence	C4054723
28433844	degenerative spinal deformity	C0575157
28433844	sustained	C0443318
28433844	tethered cord	C1842369
28433844	63-year-old	C0001675
28433844	man	C0086582
28433844	repaired	C0205340
28433844	MMC	C0025312
28433844	progressive gait disturbance	C0243095
28433844	numbness	C0028643
28433844	lower limbs	C0023216
28433844	Magnetic resonance images	C1704922
28433844	tethered spinal cord	C1842369
28433844	compressed	C0332260
28433844	severe	C0205082
28433844	canal stenosis	C0158288
28433844	entire lumbar spine	C1269871
28433844	multi-level lumbar decompression	C0578803
28433844	surgery	C0543467
28433844	patient recovered	C1115804
28433844	baseline	C1442488
28433844	neurological	C0205494
28433844	adults	C0001675
28433844	repaired	C0205340
28433844	MMC	C0025312
28433844	lumbar canal stenosis	C0158288
28433844	investigated	C1292732
28433844	neurological decline	C4314692
28433844	complicated	C0231242
28433844	neurological disorders	C0027765
28433844	disorders	C0012634
28433844	compressive myelopathy	C0037926
28433844	surgical decompression	C0376530
28433844	spinal cord dysfunction	C0012634
28434897	Epidemiology	C0014507
28434897	polyomavirus BK	C0005670
28434897	BKV	C0005670
28434897	emergent	C0750573
28434897	African	C0001737
28434897	variant	C0205419
28434897	kidney	C0022646
28434897	bone marrow	C0005953
28434897	transplant recipients	C0376387
28434897	Fundacion Valle del Lili in Cali	C1708333
28434897	Colombia	C3245499
28434897	epidemiology	C0014507
28434897	BKV	C0005670
28434897	assess	C1516048
28434897	presence	C0150312
28434897	African	C0001737
28434897	variant	C0205419
28434897	bone marrow	C0005953
28434897	kidney transplant patients	C4304779
28434897	suspected	C0332147
28434897	BKV	C0005670
28434897	reactivation	C4086768
28434897	descriptive study	C0002783
28434897	conducted	C3844519
28434897	institutional records	C0034869
28434897	Fundación Valle del Lili, Cali	C1708333
28434897	Colombia	C3245499
28434897	overall prevalence	C0033106
28434897	BKV	C0005670
28434897	African	C0001737
28434897	variant	C0205419
28434897	identified	C0205396
28434897	samples	C0370003
28434897	positive	C1446409
28434897	BKV	C0005670
28434897	samples	C0370003
28434897	wild	C1883559
28434897	strain	C0456178
28434897	BKV	C0005670
28434897	BKV	C0005670
28434897	positive	C1446409
28434897	patients	C0030705
28434897	kidney transplant recipients	C4304779
28434897	bone marrow	C0005953
28434897	transplant recipients	C0376387
28434897	epidemiological study	C0002783
28434897	African	C0001737
28434897	variant	C0205419
28434897	BKV	C0005670
28434897	Colombia	C3245499
28434980	Thaw	C1710378
28434980	target cells	C0221284
28434980	pre-labeled	C1708632
28434980	calcein AM	C0016320
28434980	antibody-dependent cell-mediated cytotoxicity assays	C0201624
28434980	In vitro	C1533691
28434980	antibody-dependent cell-mediated cytotoxicity (ADCC) assays	C0201624
28434980	therapeutic antibodies	C0003241
28434980	ADCC assays	C0201624
28434980	target cells	C0221284
28434980	antibodies	C0003241
28434980	lysed	C0024348
28434980	activated	C1879547
28434980	effector cells	C0312740
28434980	Fc region	C0021032
28434980	antibody	C0003241
28434980	Fcγ receptors	C0034805
28434980	effector cells	C0312740
28434980	Target cell	C0221284
28434980	lysis	C0024348
28434980	quantification	C1709793
28434980	endogenous	C0205227
28434980	enzymes	C0014442
28434980	lactate dehydrogenase	C0022917
28434980	exogenous	C0205228
28434980	labels	C1522485
28434980	(51)Cr	C0303212
28434980	europium	C0015180
28434980	calcein	C0060549
28434980	ADCC assays	C0201624
28434980	exogenous	C0205228
28434980	labels	C1522485
28434980	lysed	C0024348
28434980	target cells	C0221284
28434980	incubation times	C1320226
28434980	target cells	C0221284
28434980	labeled	C1708632
28434980	assay	C1510438
28434980	assay	C1510438
28434980	variations	C0205419
28434980	target cell	C0221284
28434980	labeling	C2347885
28434980	handling processes	C0037793
28434980	thaw	C1710378
28434980	pre-labeled	C1708632
28434980	target cells	C0221284
28434980	ADCC assays	C0201624
28434980	Thaw	C1710378
28434980	target cells	C0221284
28434980	pre-labeled	C1708632
28434980	fluorescent dye calcein AM	C0016320
28434980	cryopreserved	C0010405
28434980	assays	C1510438
28434980	thawing	C2025613
28434980	thaw	C1710378
28434980	pre-labeled	C1708632
28434980	cells	C0007634
28434980	viability	C0007620
28434980	label	C1522485
28434980	retention	C0333118
28434980	labeled	C1708632
28434980	cells	C0007634
28434980	ADCC	C0003272
28434980	peripheral blood mononuclear cells	C1321301
28434980	engineered natural killer cells	C0022688
28434980	ADCC assays	C0201624
28434980	thaw	C1710378
28434980	pre-labeled	C1708632
28434980	target cells	C0221284
28434980	ADCC assays	C0201624
28434980	cell culture	C0007585
28434980	dye labeling	C0886517
28434980	assay	C1510438
28434980	assay consistency	C0332529
28434980	robustness	C2986815
28436433	Pathways	C1704259
28436433	Genes	C0017337
28436433	Associated with	C0332281
28436433	Immune	C0020962
28436433	Dysfunction	C0277785
28436433	Sheep	C0036945
28436433	Paratuberculosis	C0030524
28436433	Multibacillary	C0243095
28436433	paucibacillary	C0243095
28436433	paratuberculosis	C0030524
28436433	Mycobacterium avium subspecies paratuberculosis	C0085442
28436433	Multibacillary	C0243095
28436433	lesions	C0221198
28436433	infected	C0439663
28436433	epithelioid macrophages	C0014603
28436433	paucibacillary	C0243095
28436433	lesions	C0221198
28436433	T cells	C0039194
28436433	bacteria	C0004611
28436433	Multibacillary	C0243095
28436433	disease	C0012634
28436433	lepromatous leprosy	C0023348
28436433	antibody	C0003241
28436433	dysfunctional	C0031847
28436433	immune response	C0301872
28436433	Animals	C0003062
28436433	paucibacillary	C0243095
28436433	disease	C0012634
28436433	cell-mediated immunity	C0020966
28436433	variable levels	C0441889
28436433	antibody	C0003241
28436433	immunological dysfunction	C1532237
28436433	TruSeq	C0282574
28436433	analysis	C0936012
28436433	ileocaecal	C0700426
28436433	lymph node	C0024204
28436433	disease	C0012634
28436433	lesions	C0221198
28436433	Immune	C0020962
28436433	dysfunction	C0277785
28436433	repression	C0920533
28436433	TCR	C0524889
28436433	CD3 genes	C0017337
28436433	T cell co-receptors	C0034790
28436433	co-stimulators	C3203085
28436433	T cell activation	C1155065
28436433	signal-transduction	C0037083
28436433	genes	C0017337
28436433	Inflammation	C0021368
28436433	acute phase response	C0001349
28436433	chronic inflammation	C0021376
28436433	acute inflammation	C0333361
28436433	immunoglobulin	C0021027
28436433	plasma cell	C0032112
28436433	transcripts	C1519595
28436433	anti-MAP antibody responses	C0003261
28436433	paratuberculosis	C0030524
28436433	sheep	C0036945
28436433	reduction	C0392756
28436433	mast cell	C0024880
28436433	transcripts	C1519595
28436433	affecting	C0392760
28436433	DC activation of the immune response	C1817431
28436433	gene expression	C0017262
28436433	multibacillary	C0243095
28436433	paucibacillary	C0243095
28436433	disease	C0012634
28436433	T cell	C0039194
28436433	genes	C0017337
28436433	Th1	C0242632
28436433	Th2	C0242633
28436433	incremental	C1705117
28436433	immune	C0020962
28436433	dysfunction	C0277785
28436433	multibacillary	C0243095
28436433	pathology	C0012634
28437582	Modified	C0392747
28437582	frailty index	C4075886
28437582	predicts	C0681842
28437582	postoperative	C0231287
28437582	outcomes	C0086749
28437582	older	C3826770
28437582	gastrointestinal cancer	C0685938
28437582	patients	C0030705
28437582	Frailty	C0424594
28437582	disproportionately	C0205556
28437582	impacts	C4049986
28437582	older	C3826770
28437582	patients	C0030705
28437582	gastrointestinal cancer	C0685938
28437582	rendering	C0205245
28437582	increased risk for poor outcomes	C3553618
28437582	frailty index	C4075886
28437582	preoperative	C0445204
28437582	risk	C0035647
28437582	stratification	C1514983
28437582	hypothesized	C1512571
28437582	modified frailty index (mFI) scores	C4075885
28437582	associated with	C0332281
28437582	adverse outcomes	C1705586
28437582	tumor	C0027651
28437582	resection	C0015252
28437582	older	C3826770
28437582	gastrointestinal cancer	C0685938
28437582	patients	C0030705
28437582	Patients	C0030705
28437582	60-90 years old	C3826770
28437582	underwent	C0205245
28437582	gastrointestinal tumor resection	C0744337
28437582	identified	C0205396
28437582	NSQIP	C1532051
28437582	Participant	C0679646
28437582	mFI	C4075885
28437582	previously	C0205156
28437582	described	C1552738
28437582	preoperative	C0445204
28437582	variables	C0439828
28437582	Frailty	C0424594
28437582	mFI score	C4075885
28437582	postoperative course	C0032786
28437582	evaluated	C0220825
28437582	univariate	C0683962
28437582	multivariate analysis	C0026777
28437582	patients	C0030705
28437582	female	C0086287
28437582	identified	C0205396
28437582	prevalent form	C0205391
28437582	cancer	C0006826
28437582	colorectal	C1527249
28437582	patients	C0030705
28437582	frail	C0871754
28437582	Frail	C0871754
28437582	patients	C0030705
28437582	significantly	C0750502
28437582	more likely	C0750501
28437582	increased length of stay	C3840528
28437582	major	C0205164
28437582	complications	C0009566
28437582	mortality	C0026565
28437582	Multivariate analysis	C0026777
28437582	identified	C0205396
28437582	mFI	C4075885
28437582	independent	C0085862
28437582	predictor	C2698872
28437582	major	C0205164
28437582	complications	C0009566
28437582	mortality	C0026565
28437582	mFI	C4075885
28437582	associated with	C0332281
28437582	incidence	C0021149
28437582	postoperative	C0231287
28437582	complications	C0009566
28437582	mortality	C0026565
28437582	older	C3826770
28437582	surgical patients	C0871463
28437582	gastrointestinal cancer	C0685938
28440090	Spermatocytic Tumor	C0334517
28440090	Sarcoma	C1261473
28440090	Rare	C0522498
28440090	Testicular Neoplasm	C0039590
28440090	Spermatocytic tumor	C0334517
28440090	spermatocytic seminoma	C0334517
28440090	uncommon	C0522498
28440090	testicular neoplasm	C0039590
28440090	clinicopathologic entity	C0205469
28440090	seminoma	C0036631
28440090	tumors	C0027651
28440090	germ cell neoplasia	C4021985
28440090	germ cell tumors	C0205851
28440090	isochromosome 12p	C1515647
28440090	tumors	C0027651
28440090	excellent	C1961136
28440090	prognosis	C0033325
28440090	occasional cases	C0868928
28440090	associated with	C0332281
28440090	sarcoma	C1261473
28440090	very poor prognosis	C0278252
28440090	case	C1706256
28440090	spermatocytic tumor	C0334517
28440090	sarcoma	C1261473
28440090	chondrosarcomatous component	C0008479
28440090	pathologic findings	C1317598
28440090	differential diagnosis	C0011906
28440090	follow-up	C1522577
28440090	information	C1533716
28443376	Remote	C0205157
28443376	Ischemic Conditioning	C0376466
28443376	Renal	C0022646
28443376	Protection	C1545588
28443376	remote	C0205157
28443376	ischemic conditioning	C0376466
28443376	RIC	C0376466
28443376	research	C0035168
28443376	interest	C0543488
28443376	RIC	C0376466
28443376	protecting	C1545588
28443376	tissues	C0040300
28443376	ischemic	C0475224
28443376	damage	C0010957
28443376	medical	C0205476
28443376	conditions	C0348080
28443376	procedures	C0199171
28443376	Acute kidney injury	C2609414
28443376	AKI	C2609414
28443376	side effect	C0001688
28443376	medical procedures	C0199171
28443376	RIC	C0376466
28443376	Outcomes	C1274040
28443376	kidney function	C0232804
28443376	studies	C0079816
28443376	effects of	C1704420
28443376	RIC	C0376466
28443376	cardiac surgery	C0018821
28443376	interventions	C0184661
28443376	intravenous administration	C0013125
28443376	contrast media	C0009924
28443376	studies	C0079816
28443376	effect of	C1704420
28443376	RIC	C0376466
28443376	kidney function	C0232804
28443376	randomized controlled trials	C0206035
28443376	patients	C0030705
28443376	Effect of	C1704420
28443376	Remote Ischemic Preconditioning	C0376442
28443376	Cardiac Surgery	C0018821
28443376	Remote Ischaemic Preconditioning	C0376442
28443376	Heart Surgery	C0018821
28443376	E RIC CA	C0010055
28443376	RIC	C0376466
28443376	negative	C1513916
28443376	AKI	C2609414
28443376	renal function	C0232804
28443376	trials	C0008976
28443376	meta-analyses	C0920317
28443376	participants	C0679646
28443376	results	C1274040
28443376	RIC	C0376466
28443376	published	C1704324
28443376	studies	C0079816
28443376	adversely affecting	C0001688
28443376	quality	C0332306
28443376	available data	C0150098
28443376	review	C0282443
28443376	research	C0035168
28443376	authors	C3812881
28443376	review	C0282443
28443376	clinical trial	C0008976
28443376	ischemic conditioning	C0376466
28443376	studies	C0079816
28443376	definitions	C1704788
28443376	procedures	C0025664
28443376	outcomes	C1274040
28443376	goals persists	C0679840
28443376	ischemic conditioning	C0376466
28443376	clinical utility	C0008971
28446912	Temporal	C2362314
28446912	Spatial	C1254362
28446912	Variability	C2827666
28446912	Fungal Structures	C2717804
28446912	Host Responses	C0301872
28446912	Incompatible Rust-Wheat Interaction	C1155325
28446912	Information	C1533716
28446912	temporal	C2362314
28446912	spatial	C1254362
28446912	variability	C2827666
28446912	fungal structures	C2717804
28446912	host responses	C0301872
28446912	scarce	C0231180
28446912	comparison	C1707455
28446912	amount	C1265611
28446912	genetic	C0314603
28446912	biochemical	C0205474
28446912	physiological	C0205463
28446912	studies	C2603343
28446912	host-pathogen interactions	C1752856
28446912	study	C2603343
28446912	used	C0457083
28446912	avirulent	C0205556
28446912	wild type	C1883559
28446912	virulent	C1520022
28446912	mutant	C0678941
28446912	isolates	C1764827
28446912	Puccinia striiformis	C1001443
28446912	characterize	C1880022
28446912	interactions	C1704675
28446912	wheat	C0043137
28446912	carrying	C0206243
28446912	yellow rust	C1001443
28446912	Yr2	C1001443
28446912	resistance	C4087433
28446912	conventional	C1442989
28446912	advanced	C0205179
28446912	microscopic	C0205288
28446912	techniques	C0449851
28446912	used	C0457083
28446912	detailed	C1522508
28446912	study	C2603343
28446912	morphology	C0332437
28446912	growth	C0018270
28446912	fungal	C0521033
28446912	colonies	C1947989
28446912	associated	C0332281
28446912	host cell responses	C0301872
28446912	growth	C0018270
28446912	wild type	C1883559
28446912	isolates	C1764827
28446912	highly	C0205250
28446912	restricted	C0443288
28446912	hypersensitive response	C0020517
28446912	HR	C0020517
28446912	plant	C0032098
28446912	cell death	C0007587
28446912	indicated	C1444656
28446912	autofluorescence	C0544711
28446912	change	C0392747
28446912	shape	C0332479
28446912	affected	C0392760
28446912	plant cells	C3178867
28446912	host response	C0301872
28446912	appeared	C0700364
28446912	post	C0687676
28446912	haustorial	C2717804
28446912	large	C0549177
28446912	variation	C0205419
28446912	time	C0040223
28446912	stage	C0205390
28446912	arrest	C0333951
28446912	observed	C1441672
28446912	individual	C0237401
28446912	fungal	C0521033
28446912	colonies	C1947989
28446912	probably	C0750492
28446912	delay	C0205421
28446912	between	C0205103
28446912	detection	C1511790
28446912	response	C0871261
28446912	colonies	C1947989
28446912	stopped	C2746065
28446912	right after	C0205253
28446912	formation	C1522492
28446912	primary infection	C0948192
28446912	hyphae	C0521057
28446912	formed	C0205431
28446912	highly	C0205250
28446912	branched	C2700384
28446912	mycelia	C0949695
28446912	HR	C0020517
28446912	observed	C1441672
28446912	host cells	C1819995
28446912	direct	C1947931
28446912	contact	C0392367
28446912	fungal structures	C2717804
28446912	defense responses	C1154988
28446912	spread	C0332261
28446912	adjacent	C0205117
28446912	host cells	C1819995
28446912	encasement	C1254362
28446912	fungal	C0521033
28446912	colony	C1947989
28446912	Several	C0443302
28446912	cells	C0007634
28446912	HR	C0020517
28446912	contained	C2700400
28446912	haustoria	C2717804
28446912	small	C0700321
28446912	underdeveloped	C0205252
28446912	some	C0205392
28446912	cells	C0007634
28446912	contained	C2700400
28446912	normal	C0205307
28446912	sized	C0456389
28446912	haustoria	C2717804
28446912	signs	C0037088
28446912	hypersensitivity	C0020517
28446912	growth	C0018270
28446912	virulent	C1520022
28446912	mutants	C0678941
28446912	resistant	C0332325
28446912	plants	C0032098
28446912	similar	C2348205
28446912	growth	C0018270
28446912	plants	C0032098
28446912	Yr2	C1001443
28446912	resistance	C4087433
28446912	strong	C0442821
28446912	indication	C3146298
28446912	incompatible	C1881865
28446912	phenotype	C0031437
28446912	associated	C0332281
28446912	Yr2	C1001443
28446912	interaction	C1704675
28446912	between	C0205103
28446912	P. striiformis	C1001443
28446912	wheat	C0043137
28446912	Yr2	C1001443
28446912	resistance	C4087433
28446912	highly	C0205250
28446912	variable	C0439828
28446912	time	C0040223
28446912	space	C1254362
28446912	demonstrate	C0443289
28446912	histological	C0019638
28446912	studies	C2603343
28446912	important	C3898777
28446912	deeper understanding	C0162340
28446912	host-pathogen interactions	C1752856
28446912	plant	C0032098
28446912	defense	C0520990
28446912	mechanisms	C0441712
28446912	general	C0205246
28447924	Effects of	C1704420
28447924	Messages	C0470166
28447924	Causes	C0015127
28447924	Obesity	C0028754
28447924	Disciplinary Action	C1552598
28447924	Decisions	C0679006
28447924	Overweight	C1561826
28447924	Employees	C0599987
28447924	investigated	C1292732
28447924	impact	C4049986
28447924	messages	C0470166
28447924	causes	C0015127
28447924	obesity	C0028754
28447924	controllable	C2911690
28447924	uncontrollable	C0205318
28447924	disciplinary action	C1552598
28447924	consequences	C0686907
28447924	obese	C0028754
28447924	employees	C0599987
28447924	response	C0871261
28447924	work-related	C1698590
28447924	mistake	C0743559
28447924	Participants	C0679646
28447924	controllable	C2911690
28447924	uncontrollable	C0205318
28447924	causes	C0015127
28447924	obesity	C0028754
28447924	reviewing	C1704362
28447924	ostensible	C0750489
28447924	employee	C0599987
28447924	file	C0016094
28447924	employee	C0599987
28447924	mistake	C0743559
28447924	file	C0016094
28447924	photo	C0441468
28447924	employee	C0599987
28447924	obese	C0028754
28447924	average	C1510992
28447924	weight	C0005910
28447924	Participants	C0679646
28447924	withhold	C1705116
28447924	promotion	C0681129
28447924	obese	C0028754
28447924	employee	C0599987
28447924	average	C1510992
28447924	weight	C0005910
28447924	employee	C0599987
28447924	evidence	C3887511
28447924	messages	C0470166
28447924	causes	C0015127
28447924	obesity	C0028754
28447924	affected	C0392760
28447924	participants	C0679646
28447924	perceived control	C0517445
28447924	self-efficacy	C0600564
28447924	healthy	C3898900
28447924	behaviors	C0004927
28447984	Experience	C0596545
28447984	Instrumental	C1704339
28447984	Tuning	C0006751
28447984	Link	C2986575
28447984	Language	C0023008
28447984	Cognition	C0009240
28447984	Evidence	C3887511
28447984	6- to 7- Month-Old	C0001779
28447984	Infants	C0021270
28447984	Categorization	C0008902
28447984	At birth	C1744681
28447984	infants	C0021270
28447984	listening	C2584303
28447984	human	C0086418
28447984	vocalizations	C0009452
28447984	begun	C0439659
28447984	link	C2986575
28447984	vocalizations	C0009452
28447984	cognition	C0009240
28447984	infants	C0021270
28447984	young	C0332239
28447984	three months	C1442461
28447984	age	C0001779
28447984	listening	C2584303
28447984	human	C0086418
28447984	language	C0023008
28447984	categorization	C0008902
28447984	core	C0444669
28447984	cognitive	C1516691
28447984	capacity	C1516240
28447984	precocious	C1279930
28447984	link	C0449379
28447984	initially	C0205265
28447984	broad	C0332464
28447984	vocalizations	C0009452
28447984	both	C1706086
28447984	humans	C0086418
28447984	nonhuman primates	C0237798
28447984	categorization	C0008902
28447984	6 months	C4082120
28447984	infants	C0021270
28447984	narrowed	C0333164
28447984	link	C2986575
28447984	human	C0086418
28447984	vocalizations	C0009452
28447984	categorization	C0008902
28447984	infants	C0021270
28447984	tune	C0006751
28447984	initially	C0205265
28447984	broad	C0332464
28447984	link	C2986575
28447984	precise	C2828393
28447984	vocalizations	C0009452
28447984	species	C1705920
28447984	studies	C2603343
28447984	novel	C0205314
28447984	exposure	C0332157
28447984	paradigm	C0681797
28447984	effects	C1280500
28447984	experience	C0596545
28447984	exposing	C0332157
28447984	infants	C0021270
28447984	nonhuman primate	C0237798
28447984	vocalizations	C0009452
28447984	enables	C1171285
28447984	infants	C0021270
28447984	early	C1279919
28447984	established	C0443211
28447984	link	C2986575
28447984	signal	C1710082
28447984	categorization	C0008902
28447984	exposing	C0332157
28447984	infants	C0021270
28447984	backward	C1555029
28447984	speech	C0037817
28447984	signal	C1710082
28447984	fails	C0231175
28447984	support	C1521721
28447984	categorization	C0008902
28447984	age	C0001779
28447984	findings	C0243095
28447984	reveal	C0443289
28447984	power	C3854080
28447984	early	C1279919
28447984	experience	C0596545
28447984	infants	C0021270
28447984	signals	C1710082
28447984	initially	C0205265
28447984	broad	C0332464
28447984	continue	C0549178
28447984	link	C2986575
28447984	cognition	C0009240
28448089	Bone Degeneration	C1390464
28448089	SMP30/GNL	C1419366
28448089	Knockout Mice	C0206745
28448089	Senescence marker protein-30	C1451963
28448089	SMP30	C1451963
28448089	androgen	C0002844
28448089	aging	C0001811
28448089	lactone	C0022947
28448089	hydrolyzing enzyme	C0014442
28448089	gluconolactonase	C0051129
28448089	GNL	C0051129
28448089	vitamin C	C0003968
28448089	biosynthesis	C0005572
28448089	study	C2603343
28448089	bone	C0262950
28448089	SMP30/GNL	C1419366
28448089	knockout (KO) mice	C0206745
28448089	deficiency	C0011155
28448089	vitamin C	C0003968
28448089	synthesis	C0005572
28448089	SMP30/GNL	C1451963
28448089	exogenous	C0205228
28448089	vitamin C	C0003968
28448089	supplementation	C0302837
28448089	bone formation	C0029433
28448089	Mineral content	C0005963
28448089	BMC	C0005963
28448089	mineral density	C0005938
28448089	BMD	C0005938
28448089	mandible	C0024687
28448089	femur	C0015811
28448089	SMP30/GNL	C1419366
28448089	KO	C0206745
28448089	wild-type mice	C1520150
28448089	months	C0439231
28448089	age	C0001779
28448089	vitamin C	C0003968
28448089	supplementation	C0302837
28448089	dual-energy X-ray absorptiometry	C1510486
28448089	Body	C0005910
28448089	bone	C0262950
28448089	weight	C0043100
28448089	age groups	C0596090
28448089	wild-type mice	C1520150
28448089	bones	C0262950
28448089	SMP30/GNL	C1419366
28448089	KO mice	C0206745
28448089	BMC	C0005963
28448089	BMD	C0005938
28448089	wild-type	C1520150
28448089	Oral	C0226896
28448089	supplementation	C0302837
28448089	vitamin C	C0003968
28448089	body weight	C0005910
28448089	bone	C0262950
28448089	BMC	C0005963
28448089	BMD	C0005938
28448089	SMP30/GNL	C1419366
28448089	KO	C0206745
28448089	wild-type mice	C1520150
28448089	age	C0001779
28448089	bone degeneration	C1390464
28448089	SMP30/GNL	C1419366
28448089	KO mice	C0206745
28448089	vitamin C	C0003968
28448089	mouse strain	C0025930
28448089	model	C0599779
28448089	bone metabolism	C0596204
28448089	humans	C0086418
28448089	synthesize	C0005572
28448089	vitamin C	C0003968
28449774	Post-Mortem	C0004398
28449774	Genetic Testing	C1517514
28449774	Sudden Arrhythmic Death Syndrome	C2721586
28449774	Sudden arrhythmic death syndrome	C2721586
28449774	SADS	C2721586
28449774	sudden death	C0011071
28449774	autopsy	C0004398
28449774	toxicological	C0205472
28449774	analysis	C0936012
28449774	Cardiac genetic disease	C0019247
28449774	etiology	C1314792
28449774	study	C2603343
28449774	investigated	C1292732
28449774	clinical utility	C0205210
28449774	post-mortem	C0004398
28449774	genetic testing	C1517514
28449774	molecular autopsy	C0004398
28449774	SADS	C2721586
28449774	comprehensive	C1880156
28449774	clinical evaluation	C4084924
28449774	surviving	C0038952
28449774	relatives	C0080103
28449774	evaluated	C0220825
28449774	SADS	C2721586
28449774	DNA	C0012854
28449774	age	C0001779
28449774	males	C0086582
28449774	next-generation	C3274765
28449774	sequencing	C1294197
28449774	panel	C0441833
28449774	primary electrical disorder	C0017337
28449774	cardiomyopathy genes	C0017337
28449774	Pathogenic	C3816499
28449774	pathogenic variants	C0205419
28449774	American College of Medical Genetics	C1708333
28449774	ACMG	C1708333
28449774	consensus guidelines	C0162791
28449774	molecular autopsy	C0004398
28449774	clinical evaluation	C4084924
28449774	surviving families	C0015576
28449774	evaluated	C0220825
28449774	gene-level rare variant association analysis	C2350277
28449774	SADS	C2721586
28449774	controls	C0009932
28449774	clinically actionable	C0205556
28449774	pathogenic	C3816499
28449774	pathogenic variant	C0205419
28449774	etiologies	C1314792
28449774	catecholaminergic polymorphic ventricular tachycardia	C4053736
28449774	long QT syndrome	C0023976
28449774	Gene-based rare variants association analysis	C2350277
28449774	deleterious variants	C0205419
28449774	RYR2	C1419779
28449774	molecular autopsy	C0004398
28449774	clinical evaluation	C4084924
28449774	surviving families	C0015576
28449774	diagnostic yield	C0205556
28449774	Molecular autopsy	C0004398
28449774	electrical disorder	C0017337
28449774	cardiomyopathy genes	C0017337
28449774	ACMG	C1708333
28449774	guidelines	C0162791
28449774	variant classification	C0008902
28449774	SADS	C2721586
28449774	catecholaminergic polymorphic ventricular tachycardia	C4053736
28449774	long QT syndrome	C0023976
28449774	RYR2 gene	C1419779
28449774	genes	C0017337
28449774	clinical	C4084924
28449774	genetic evaluation	C0846617
28450395	Binding	C1145667
28450395	DEAD-box helicase	C0072382
28450395	Dhh1	C1100944
28450395	5'UTR	C0600493
28450395	ASH1	C1426004
28450395	mRNA	C0035696
28450395	represses	C1519619
28450395	translation	C1519614
28450395	ASH1	C1426004
28450395	yeast	C0043393
28450395	cells	C0007634
28450395	Local translation	C1519614
28450395	specific	C0205369
28450395	mRNAs	C0035696
28450395	regulated	C1326447
28450395	subcellular	C0729605
28450395	localization	C0475264
28450395	changes	C0392747
28450395	complex	C0439855
28450395	mechanisms	C0441712
28450395	controlling	C2239193
28450395	cytoplasmic	C0521449
28450395	mRNA transport	C1523053
28450395	budding yeast	C0014181
28450395	Saccharomyces cerevisiae	C0036025
28450395	mechanisms	C0441712
28450395	transcripts	C1519595
28450395	transported	C1519628
28450395	mother cell	C0007634
28450395	budding	C1155616
28450395	daughter cell	C0007634
28450395	investigated	C1292732
28450395	translational control	C1157519
28450395	ASH1	C1426004
28450395	mRNA	C0035696
28450395	transport	C1519628
28450395	localization	C0475264
28450395	ASH1	C1426004
28450395	ASH1	C1426004
28450395	transcripts	C1519595
28450395	translated	C1519614
28450395	bud-tip	C2263090
28450395	mRNAs	C0035696
28450395	RNA-binding protein	C0085177
28450395	Puf6	C1453996
28450395	non-polysomal	C0243095
28450395	DEAD-box helicase	C0072382
28450395	Dhh1	C1100944
28450395	complexed	C0439855
28450395	untranslated	C0600680
28450395	ASH1	C1426004
28450395	mRNA	C0035696
28450395	Puf6	C1453996
28450395	Dhh1	C1100944
28450395	local translation	C1519614
28450395	ASH1	C1426004
28450395	mRNA	C0035696
28450395	delocalization	C0475264
28450395	ASH1	C1426004
28450395	transcript	C1519595
28450395	bud	C2700462
28450395	non-polysomal	C0243095
28450395	ASH1	C1426004
28450395	mRNA	C0035696
28450395	polysomes	C0032592
28450395	Dhh1	C1100944
28450395	dissociation	C0086168
28450395	Dhh1	C1100944
28450395	ASH1	C1426004
28450395	mRNA	C0035696
28450395	co-transcriptionally	C0040649
28450395	suggesting	C1705535
28450395	ASH1	C1426004
28450395	mRNA	C0035696
28450395	cytoplasm	C0010834
28450395	Dhh1	C1100944
28450395	5 UTR	C0600493
28450395	ASH1	C1426004
28450395	mRNA	C0035696
28450395	inhibited	C0311403
28450395	translation	C1519614
28450395	in vitro	C1533691
28450395	suggest	C1705535
28450395	localization	C0475264
28450395	bud tip,	C2263090
28450395	portion	C0449719
28450395	localized	C0392752
28450395	ASH1	C1426004
28450395	mRNA	C0035696
28450395	translationally	C1519614
28450395	inactive	C3244312
28450395	binding	C1145667
28450395	Dhh1	C1100944
28450395	Puf6	C1453996
28450395	5' and 3' UTRs	C0600493
28450395	ASH1	C1426004
28450395	mRNA	C0035696
28450855	Abundance	C2346714
28450855	Endofungal Bacterium	C0004611
28450855	Rhizobium radiobacter	C0085472
28450855	Agrobacterium tumefaciens	C0085472
28450855	Increases	C0442805
28450855	Fungal	C0521033
28450855	Host	C1167395
28450855	Piriformospora indica	C1025512
28450855	Sebacinalean	C1665458
28450855	Symbiosis	C0039029
28450855	Higher Plants	C1562025
28450855	Rhizobium radiobacter	C0085472
28450855	Agrobacterium tumefaciens	C0085472
28450855	Agrobacterium fabrum	C3560206
28450855	endofungal bacterium	C0004611
28450855	fungal	C0521033
28450855	mutualist	C0599514
28450855	Piriformospora	C1025512
28450855	Serendipita	C1916017
28450855	indica	C1025512
28450855	Basidiomycota	C0004810
28450855	Sebacinalean	C1665458
28450855	symbiosis	C0039029
28450855	plants	C0032098
28450855	R. radiobacter	C0085472
28450855	strain F4	C1518614
28450855	RrF4	C1518614
28450855	P. indica DSM 11827	C1025512
28450855	induces	C0205263
28450855	growth	C0018270
28450855	promotion	C0033414
28450855	systemic resistance	C1155264
28450855	cereal	C0007757
28450855	crops	C0242775
28450855	barley	C0004755
28450855	wheat	C0087114
28450855	R. radiobacter	C0085472
28450855	symbiosis	C0039029
28450855	impact	C4049986
28450855	endobacteria	C0004611
28450855	morphology	C0332437
28450855	P. indica	C1025512
28450855	interactions	C1704675
28450855	plants	C0032098
28450855	endobacteria	C0004611
28450855	detected	C0442726
28450855	axenically grown	C0598869
28450855	P. indica	C1025512
28450855	long term	C0443252
28450855	lab-cultured	C0430400
28450855	lcPiri	C1025512
28450855	mycelia	C0949695
28450855	colonizing	C4289767
28450855	plant root	C0242726
28450855	increased	C0205217
28450855	bacteria	C0004611
28450855	endobacteria	C0004611
28450855	axenic cultures	C0598869
28450855	P. indica	C1025512
28450855	re-isolated	C0205409
28450855	riPiri	C1025512
28450855	plant roots	C0242726
28450855	axenic re-cultivation	C0598869
28450855	Prolonged	C0439590
28450855	treatments	C0087111
28450855	P. indica	C1025512
28450855	cultures	C0200954
28450855	antibiotics	C0003232
28450855	bacterium	C0004611
28450855	detectable	C3830527
28450855	endobacteria	C0004611
28450855	decreased	C0205216
28450855	significantly	C0750502
28450855	partial-cured	C0243095
28450855	P. indica	C1025512
28450855	pcPiri	C1025512
28450855	pcPiri	C1025512
28450855	reduced	C0392756
28450855	growth	C0018270
28450855	axenic cultures	C0598869
28450855	poor	C0542537
28450855	sporulation	C2613267
28450855	Consistent with	C0332290
28450855	pcPiri	C1025512
28450855	reduced	C0392756
28450855	plant growth	C0597252
28450855	promotion	C0033414
28450855	reduced	C0392756
28450855	systemic resistanc	C1155264
28450855	powdery mildew	C0319635
28450855	infection	C3714514
28450855	riPiri	C1025512
28450855	lcPiri	C1025512
28450855	results	C1274040
28450855	consistent with	C0332290
28450855	endobacterium	C0004611
28450855	R. radiobacter	C0085472
28450855	improves	C0184511
28450855	P. indica's	C1025512
28450855	fitness	C4305181
28450855	Sebacinalean	C1665458
28450855	symbiosis	C0039029
28451446	Stem cell	C0038250
28451446	registry	C0920695
28451446	programme	C3484370
28451446	patients	C0030705
28451446	ischemic cardiomyopathy	C0349782
28451446	coronary artery bypass grafting	C0010055
28451446	benefits	C0814225
28451446	Standardization	C0038136
28451446	stem cell therapy	C0872278
28451446	methods	C2911685
28451446	evaluate	C0220825
28451446	safety and efficac	C0511730
28451446	long-term	C0443252
28451446	pharmacovigilance	C3178990
28451446	objective	C0018017
28451446	long-term	C0443252
28451446	registry programme	C0037585
28451446	patients	C0030705
28451446	ischemic cardiomyopathy	C0349782
28451446	received	C1514756
28451446	intramyocardial	C0027061
28451446	CD133+ bone marrow mononuclear stem cell	C1511246
28451446	treatment	C0087111
28451446	combined	C0205195
28451446	coronary artery bypass grafting	C0010055
28451446	CABG	C0010055
28451446	CABG	C0010055
28451446	alone	C0205171
28451446	mortality rate	C0026565
28451446	major	C0205164
28451446	adverse cerebral	C0243095
28451446	cardiac events	C1556247
28451446	evaluated	C0220825
28451446	time period	C1948053
28451446	follow-up	C1522577
28451446	stratified	C0205363
28451446	patient	C0030705
28451446	population	C1257890
28451446	patients	C0030705
28451446	responders	C0919876
28451446	non-responders	C0919875
28451446	analysis	C0936012
28451446	relevant	C2347946
28451446	predictors	C2698872
28451446	good response	C0184785
28451446	CD133+ bone marrow mononuclear stem cell	C1511246
28451446	treatment	C0087111
28451446	performed	C0884358
28451446	Several	C0443302
28451446	stem cells transplantation	C1504389
28451446	no significant	C0243095
28451446	difference	C1705242
28451446	major	C0205164
28451446	adverse cardiovascular	C0243095
28451446	cerebral events	C0243095
28451446	observed	C1441672
28451446	stem cell	C0038250
28451446	control group	C0009932
28451446	follow-up	C1522577
28451446	improvement	C2986411
28451446	left ventricle ejection fraction	C0428772
28451446	LVEF	C0428772
28451446	stem cell	C0038250
28451446	group	C0441833
28451446	retained	C0333118
28451446	contrast	C1979874
28451446	CABG	C0010055
28451446	only	C0205171
28451446	group	C0441833
28451446	LVEF	C0428772
28451446	LVEF	C0428772
28451446	left ventricle end diastolic diameter	C0919652
28451446	predictors	C2698872
28451446	functional	C0205245
28451446	CD133+ cell	C0007634
28451446	therapy	C0302189
28451446	Participants	C0679646
28451446	overt heart failure	C0018801
28451446	benefit	C0814225
28451446	most	C0205393
28451446	CABG	C0010055
28451446	combined	C0205195
28451446	intramyocardial	C0027061
28451446	injection	C1533685
28451446	CD133+ bone marrow mononuclear cell	C1511246
28451446	group	C0441833
28451446	improvement	C2986411
28451446	LVEF	C0428772
28451446	stem cell	C0038250
28451446	group	C0441833
28451446	contrast	C1979874
28451446	CABG	C0010055
28451446	only	C0205171
28451446	group	C0441833
28451446	patients	C0030705
28451446	improvement	C2986411
28451446	LVEF	C0428772
28451446	LVED	C0919652
28451446	observed	C1441672
28451446	increased	C0205217
28451446	life expectancy	C0023671
28454482	Effects	C1280500
28454482	Environmental	C0014406
28454482	Factors	C1521761
28454482	Metallic	C0025552
28454482	Electrodes	C0013812
28454482	AC	C0442830
28454482	Electrical Conduction	C0013777
28454482	DNA Molecule	C0012854
28454482	Deoxyribonucleic acid (DNA)	C0012854
28454482	device	C0699733
28454482	applications	C4048755
28454482	electrodes	C0013812
28454482	rechargeable batteries	C0337088
28454482	biosensors	C0600364
28454482	molecular electronics	C0025080
28454482	medical	C0025080
28454482	biomedical	C0025080
28454482	applications	C4048755
28454482	charge transport	C0563548
28454482	DNA molecule	C0012854
28454482	DNA	C0012854
28454482	molecular	C1521991
28454482	conducting	C0457405
28454482	material	C0520510
28454482	wire	C1705105
28454482	semiconductor	C0036623
28454482	insulator	C3273359
28454482	DNA	C0012854
28454482	electric charges	C0563548
28454482	ions	C0022023
28454482	dipoles	C0813981
28454482	charges	C0563548
28454482	electric barrier(s)	C3273359
28454482	metallic	C0025552
28454482	electrodes	C0013812
28454482	environmental	C0014406
28454482	factors	C1521761
28454482	EFs	C1521761
28454482	measuring	C0444706
28454482	measuring	C0444706
28454482	electrical conductivity	C0013777
28454482	λ-double helix (DNA) molecule	C0012854
28454482	metallic	C0025552
28454482	electrodes	C0013812
28454482	strong	C0442821
28454482	frequency	C0439603
28454482	AC	C0442830
28454482	complex	C0439855
28454482	conductivity	C0013777
28454482	electrical conduction	C2747877
28454482	EFs	C1521761
28454482	experimental	C0681814
28454482	measured	C0444706
28454482	experiment	C0681814
28454482	electrical conductivity	C0013777
28454482	DNA molecule	C0012854
28454482	electrical conduction	C0013777
28454482	ions	C0022023
28454482	experiment	C0681814
28454482	environmental	C0014406
28454482	charges	C0563548
28454482	DNA molecule	C0012854
28454482	experiment	C0681814
28454482	measure	C0079809
28454482	electrical conductivity	C0013777
28454482	EFs	C1521761
28454482	electrical conductivity	C0013777
28454482	DNA molecule	C0012854
28454482	σ DNA	C0012854
28454482	measurements	C0242485
28454482	DNA	C0012854
28454482	lengths	C1444754
28454482	measurements	C0242485
28454482	frequency (f)	C0376249
28454482	temperature (T)	C0039476
28454482	measured	C0444706
28454482	conductivity	C0013777
28454482	metal	C0025552
28454482	high frequencies	C0205212
28454482	σ DNA	C0012854
28454482	conduction	C0457405
28454482	EFs	C1521761
28454482	σ DNA	C0012854
28454482	low frequencies	C0205213
28454482	measuring	C0444706
28454482	electrical conductivity	C0013777
28454482	lengths	C1444754
28454482	electrical conduction	C2747877
28454482	DNA molecule	C0012854
28454482	EFs	C1521761
28454482	molecule	C0012854
28454482	σ DNA	C0012854
28454482	dielectric constant	C0813980
28454482	ε'DNA	C0012854
28454482	electrical conduction	C2747877
28454482	DNA molecule	C0012854
28454482	DNA	C0012854
28454482	semiconductor	C0036623
28454482	charges	C0563548
28454482	dipoles	C0813981
28454482	ions	C0022023
28454482	localized	C0475264
28454482	energy	C1442080
28454482	states	C1442792
28454482	energy gap	C0013790
28454482	DNA molecule	C0012854
28454482	charge transfer mechanism	C1254365
28454482	DNA	C0012854
28454482	charge transfer	C1254365
28454482	DNA	C0012854
28454482	insulating	C0457405
28454482	semiconducting	C0457405
28454482	metallic	C0025552
28454482	charges	C0563548
28454482	DNA	C0012854
28454482	electric field	C0337037
28454482	potential wells/hills	C1254362
28454482	Localization	C0475264
28454482	charges	C0563548
28454482	DNA	C0012854
28454482	intrinsic	C0439674
28454482	structural	C0678594
28454482	property	C0871161
28454482	thermal	C0018837
28454482	induced	C0205263
28454482	charge	C0563548
28454482	delocalization of holes	C1254365
28454482	electrons	C0013852
28454482	potential hills	C1254362
28454482	potential wells)	C1254362
28454482	electric	C0392762
28454482	dielectric behavior	C0596437
28454482	DNA molecule	C0012854
28454482	experiment	C0681814
28454482	potential hills/wells	C1254362
28454482	energy	C1442080
28456987	Next-Generation Sequencing	C2936622
28456987	Approaches	C1292724
28456987	Role	C1705810
28456987	Autophagy Lysosomal Pathway	C0007613
28456987	Human	C0086418
28456987	Disease	C0012634
28456987	Example	C1707959
28456987	LysoPlex	C0442711
28456987	Next-Generation Sequencing (NGS) technologies	C2936622
28456987	throughput	C2986816
28456987	genetic testing	C0679560
28456987	DNA fragments	C0684192
28456987	parallel	C0205556
28456987	application	C0205245
28456987	genetically	C0314603
28456987	heterogeneous	C1858576
28456987	complex diseases	C0012634
28456987	genes	C0017337
28456987	control	C0243148
28456987	pathways	C1704259
28456987	disorders	C0012634
28456987	traditional	C0443324
28456987	approaches	C1292724
28456987	gene-by-gene Sanger sequencing	C1511897
28456987	NGS	C2936622
28456987	protocol	C0442711
28456987	selection	C1707391
28456987	DNA regions	C0012854
28456987	genes	C0017337
28456987	autophagy-lysosomal (ALP) pathway	C0007613
28456987	technical steps	C1261552
28456987	challenges	C0805586
28456987	protocol	C0442711
28456987	LysoPlex	C0442711
28456987	high-coverage sequencing	C0687728
28456987	ALP genes	C0017337
28456987	LysoPlex	C0442711
28456987	NGS	C2936622
28456987	applications	C0205245
28456987	sensitivity and specificity	C0036668
28456987	variations	C0042333
28456987	ALP genes	C0017337
28457143	Skin Injuries	C0281980
28457143	Children	C0008059
28457143	Autism Spectrum Disorder	C1510586
28457143	Pediatric	C1521725
28457143	skin injuries	C0281980
28457143	developing children	C0008059
28457143	objectives	C0018017
28457143	prevalence	C0683921
28457143	pattern	C0449774
28457143	skin injuries	C0281980
28457143	children	C0008059
28457143	autism spectrum disorder	C1510586
28457143	ASD	C1510586
28457143	skin injury	C0281980
28457143	locations	C0552513
28457143	developing children	C0008059
28457143	differences	C1705242
28457143	skin injury	C0281980
28457143	frequency	C0439603
28457143	locations	C0552513
28457143	autistic children	C0175842
28457143	self-injurious behaviors	C0085271
28457143	SIBs	C0085271
28457143	Children	C0008059
28457143	ASD	C1510586
28457143	September	C3828193
28457143	September	C3828193
28457143	Demographic information	C0011292
28457143	caregiver	C0085537
28457143	skin injuries	C0281980
28457143	locations	C0552513
28457143	documented	C1301725
28457143	children	C0008059
28457143	SIBs	C0085271
28457143	skin injury	C0281980
28457143	locations	C0552513
28457143	legs	C1140621
28457143	knees	C0022742
28457143	back	C0004600
28457143	Children	C0008059
28457143	autism	C0004352
28457143	skin injuries	C0281980
28457143	locations	C0552513
28457143	developing children	C0008059
28457143	skin injuries	C0281980
28457143	locations	C0552513
28457143	accidental injuries	C0151736
28457143	SIBs	C0085271
28459420	Total Elbow Arthroplasty	C0186781
28459420	Safe	C0036043
28459420	Outpatient Procedure	C1299353
28459420	Ambulatory surgery centers	C1321139
28459420	preferred setting	C0815184
28459420	procedures	C2700391
28459420	performed	C0884358
28459420	hospital	C0019994
28459420	setting	C0815184
28459420	study	C2603343
28459420	outpatient	C0029921
28459420	total elbow arthroplasty	C0186781
28459420	TEA	C0186781
28459420	safe	C0036043
28459420	inpatient	C0021562
28459420	TEA	C0186781
28459420	retrospective analysis	C0035363
28459420	performed	C0884358
28459420	inpatient	C0021562
28459420	IP	C0021562
28459420	outpatient	C0029921
28459420	OP	C0029921
28459420	TEA	C0186781
28459420	single	C0205171
28459420	surgeon	C0582175
28459420	years	C0439234
28459420	Demographic	C0011289
28459420	social	C0699806
28459420	comorbidity measures	C1516737
28459420	complication	C0009566
28459420	rates	C1521828
28459420	analyzed	C0936012
28459420	stratified	C0205363
28459420	IP	C0021562
28459420	OP	C0029921
28459420	status	C0449438
28459420	Bivariate comparison	C0681927
28459420	increased	C0205217
28459420	prevalence	C0033105
28459420	coronary artery disease	C1956346
28459420	OP	C0029921
28459420	group	C1257890
28459420	increased	C0205217
28459420	age	C0001779
28459420	IP	C0021562
28459420	group	C1257890
28459420	years	C0439234
28459420	years	C0439234
28459420	demographic	C0011289
28459420	social	C0699806
28459420	comorbidity factors	C1516737
28459420	comparable	C1707455
28459420	IP	C0021562
28459420	OP	C0029921
28459420	groups	C1257890
28459420	more	C0205172
28459420	infections	C3714514
28459420	seen	C0205397
28459420	IP	C0021562
28459420	group	C1257890
28459420	surgeons'	C0582175
28459420	initial learning curve	C2936637
28459420	occurred	C1709305
28459420	IP	C0021562
28459420	group	C1257890
28459420	no difference	C3842396
28459420	complication	C0009566
28459420	rate	C1521828
28459420	observed	C1441672
28459420	IP	C0021562
28459420	OP	C0029921
28459420	groups	C1257890
28459654	Developmental	C0458003
28459654	Hypoxia	C0242184
28459654	Negligible	C0332269
28459654	Effects	C1280500
28459654	Long-Term	C0443252
28459654	Hypoxia	C0242184
28459654	Tolerance	C1704410
28459654	Aerobic Metabolism	C0282636
28459654	Atlantic Salmon	C0327949
28459654	Salmo salar	C0327949
28459654	Exposure to	C0332157
28459654	developmental	C0458003
28459654	hypoxia	C0242184
28459654	long-term	C0443252
28459654	impacts	C4049986
28459654	physiological	C0031845
28459654	performance	C1882330
28459654	fish	C0016163
28459654	irreversible	C0205245
28459654	plasticity	C0678558
28459654	Wild	C0445392
28459654	captive-reared	C0243095
28459654	Atlantic salmon	C0327949
28459654	Salmo salar	C0327949
28459654	exposed to	C0332157
28459654	hypoxic	C0242184
28459654	conditions	C0348080
28459654	development	C1527148
28459654	continue	C0549178
28459654	fluctuating	C0231241
28459654	oxygen	C0030054
28459654	levels	C0441889
28459654	juveniles	C3146221
28459654	adults	C0001675
28459654	examine	C0332128
28459654	developmental	C0458003
28459654	hypoxia	C0242184
28459654	impacts	C4049986
28459654	subsequent	C0332282
28459654	hypoxia	C0242184
28459654	tolerance	C1704410
28459654	aerobic	C1510824
28459654	performance	C1882330
28459654	Atlantic salmon	C0327949
28459654	Individuals	C0016163
28459654	exposed to	C0332157
28459654	hypoxia	C0242184
28459654	normoxia	C0311411
28459654	dissolved oxygen (DO) saturation	C0369768
28459654	air saturation	C0522534
28459654	fertilization	C3826354
28459654	raised	C0442818
28459654	normoxic	C0311411
28459654	conditions	C0348080
28459654	fertilization	C3826354
28459654	aerobic	C1510824
28459654	scope	C1710028
28459654	calculated	C1441506
28459654	normoxia	C0311411
28459654	DO	C0030054
28459654	acute	C0205178
28459654	hypoxia	C0242184
28459654	DO	C0030054
28459654	difference	C1705242
28459654	minimum	C1524031
28459654	maximum	C0806909
28459654	oxygen consumption	C0030055
28459654	rates	C1521828
28459654	Hypoxia	C0242184
28459654	tolerance	C1704410
28459654	determined	C0521095
28459654	DO	C0030054
28459654	loss of equilibrium	C0278126
28459654	LOE	C0278126
28459654	occurred	C1709305
28459654	decreasing	C0442797
28459654	DO	C0030054
28459654	no difference	C3842396
28459654	aerobic	C1510824
28459654	scope	C1710028
28459654	fish	C0016163
28459654	raised	C0442818
28459654	hypoxia	C0242184
28459654	normoxia	C0311411
28459654	evidence	C3887511
28459654	hypoxia	C0242184
28459654	tolerance	C1704410
28459654	lower	C2003888
28459654	DO	C0030054
28459654	LOE	C0278126
28459654	hypoxia	C0242184
28459654	raised	C0442818
28459654	fish	C0016163
28459654	raised	C0442818
28459654	normoxia	C0311411
28459654	magnitude	C1704240
28459654	effect	C1280500
28459654	small	C0700321
28459654	DO	C0030054
28459654	DO	C0030054
28459654	LOE	C0278126
28459654	Acute	C0205178
28459654	hypoxia	C0242184
28459654	reduced	C0392756
28459654	aerobic	C1510824
28459654	scope	C1710028
28459654	reducing	C0392756
28459654	unchanged	C0442739
28459654	acute	C0205178
28459654	hypoxia	C0242184
28459654	individual	C0016163
28459654	relationships	C0439849
28459654	DO	C0030054
28459654	LOE	C0278126
28459654	aerobic	C1510824
28459654	scope	C1710028
28459654	findings	C2607943
28459654	developmental	C0458003
28459654	aerobic	C1510824
28459654	performance	C1882330
28459654	hypoxia	C0242184
28459654	tolerance	C1704410
28460374	LDL	C0023823
28460374	particle number	C0392762
28460374	size	C0030608
28460374	cardiovascular	C3887460
28460374	risk	C0035647
28460374	potential	C3245505
28460374	use	C0457083
28460374	LDL	C0023823
28460374	particle number	C0392762
28460374	size	C0030608
28460374	risk factors	C0035648
28460374	cardiovascular disease	C0007222
28460374	CVD	C0007222
28460374	risk	C0035647
28460374	clinical	C0205210
28460374	Studies	C0008972
28460374	significant	C0750502
28460374	proportion	C1709707
28460374	population	C1257890
28460374	discordant	C3639994
28460374	LDL	C0023823
28460374	particle number	C0392762
28460374	cholesterol	C0008377
28460374	indices	C0918012
28460374	non-HDL cholesterol	C0729627
28460374	HDL-C	C0023822
28460374	information	C1533716
28460374	LDL	C0023823
28460374	particle number	C0392762
28460374	patients	C0030705
28460374	discordant	C3639994
28460374	particle number	C0392762
28460374	cholesterol	C0008377
28460374	CVD	C0007222
28460374	guidelines	C0282451
28460374	LDL	C0023823
28460374	particle number	C0392762
28460374	cholesterol	C0008377
28460374	indices	C0918012
28460374	non-HDL-C	C0729627
28460374	concentrations	C1446561
28460374	CVD	C0007222
28460374	risk	C0035647
28460374	LDL	C0023823
28460374	particle size	C0030608
28460374	associated with	C0332281
28460374	CVD	C0007222
28460374	risk	C0035647
28460374	adjustment	C0456081
28460374	risk factors	C0035648
28460374	LDL cholesterol	C0023824
28460374	triglycerides	C0041004
28460374	HDL-C	C0023822
28460374	information	C1533716
28460374	particle size	C0030608
28460374	patients'	C0030705
28460374	risk	C0035647
28460374	Additional	C1524062
28460374	studies	C0008972
28460374	debate	C0870392
28460374	cholesterol	C0008377
28460374	indices	C0918012
28460374	LDL	C0023823
28460374	particle number	C0392762
28460374	CVD	C0007222
28460374	risk	C0035647
28460374	measures	C0079809
28460374	clinical practice	C0087111
28462032	emerging contribution	C1880177
28462032	social wasps	C0043041
28462032	grape rot disease	C0032080
28462032	ecology	C0013546
28462032	Grape sour (bunch) rot	C0032080
28462032	polymicrobial disease	C0598196
28462032	vineyards	C4279988
28462032	millions	C1881839
28462032	dollars	C0562019
28462032	lost revenue	C0681042
28462032	per year	C0439508
28462032	decreased	C0205216
28462032	quality	C0332306
28462032	grapes	C0018208
28462032	resultant wine	C0043188
28462032	disease	C0012634
28462032	associated with	C0332281
28462032	damaged	C1883709
28462032	berries	C0005135
28462032	infected	C0439663
28462032	community	C0009462
28462032	acetic acid bacteria	C0018150
28462032	yeasts	C0043393
28462032	filamentous fungi	C0369241
28462032	rotting	C2700592
28462032	berries	C0005135
28462032	high	C0205250
28462032	amounts	C1265611
28462032	volatile	C1963547
28462032	acidity	C0001128
28462032	insect	C0021585
28462032	species	C1705920
28462032	initial	C0205265
28462032	grape	C0018208
28462032	berry	C0005135
28462032	damage	C1883709
28462032	disease	C0012634
28462032	studies	C0681814
28462032	focused	C1285542
28462032	role	C1705810
28462032	fruit flies	C0013138
28462032	symptoms	C1457887
28462032	vectoring	C0021573
28462032	microorganisms	C0445623
28462032	disease	C0012634
28462032	complex	C0439855
28462032	fruit flies	C0013138
28462032	social wasps	C0043041
28462032	abundant	C2346714
28462032	vineyards	C4279988
28462032	ripe berries	C0005135
28462032	significant	C0750502
28462032	damage	C1883709
28462032	dispersing	C0332624
28462032	yeasts	C0043393
28462032	involved	C1314939
28462032	wine	C0043188
28462032	fermentation	C0015852
28462032	role	C1705810
28462032	disease	C0012634
28462032	dispersal of grape rots	C0012634
28462032	tested	C0039593
28462032	hypothesis	C1512571
28462032	paper wasp	C0446349
28462032	Polistes dominulus	C1005260
28462032	grape sour rot	C0012634
28462032	absence	C0332197
28462032	insect vectors	C0021573
28462032	marker gene sequencing	C1294197
28462032	characterized	C1880022
28462032	bacterial	C0004611
28462032	fungal	C0016832
28462032	community	C0009462
28462032	wild-caught adults	C0001675
28462032	foraging arena	C0205146
28462032	wasps	C0043041
28462032	viable	C0443348
28462032	microorganisms	C0445623
28462032	foraging	C2752984
28462032	tested	C0039593
28462032	wasps	C0043041
28462032	native	C0079891
28462032	microbial	C0599840
28462032	community	C0009462
28462032	inoculated	C2987620
28462032	sour rot	C0012634
28462032	effect	C1280500
28462032	grape sour rot	C0012634
28462032	incidence	C0021149
28462032	severity	C0439793
28462032	laboratory foraging arena	C0017446
28462032	wasps	C0043041
28462032	sour rot	C0012634
28462032	microbial	C0599840
28462032	community	C0009462
28462032	ability	C0085732
28462032	viable	C0443348
28462032	microorganisms	C0445623
28462032	foraging	C2752984
28462032	Foraging	C2752984
28462032	inoculated	C2987620
28462032	uninoculated wasps	C0043041
28462032	increase	C0442805
28462032	berry rot disease	C0032080
28462032	symptom	C1457887
28462032	severity	C0439793
28462032	incidence	C0021149
28462032	results	C0459422
28462032	paper wasps	C0446349
28462032	sour rot diseases	C0032080
28462032	absence	C0332197
28462032	other vectors	C0021573
28462032	mechanism	C0441712
28462032	increasing	C0442808
28462032	host	C1167395
28462032	susceptibility	C0012655
28462032	transmitting	C0332289
28462032	microbial	C0599840
28462032	communities	C0009462
28462032	grapes	C0018208
28462032	Social wasps	C0043041
28462032	relevant players	C2347946
28462032	sour rot	C0012634
28462032	ecology	C0013546
28462032	vineyards	C4279988
28463085	Low-intensity pulsed ultrasound	C4042796
28463085	periodontal atrophy	C2350270
28463085	occlusal	C0011382
28463085	hypofunctional	C0679221
28463085	teeth	C0040426
28463085	low-intensity pulsed ultrasound	C4042796
28463085	LIPUS	C4042796
28463085	hypofunctional	C0679221
28463085	periodontal ligament	C0031093
28463085	PDL	C0031093
28463085	interradicular alveolar bone	C0932533
28463085	IRAB	C0932533
28463085	week	C0439230
28463085	male	C0086582
28463085	Sprague-Dawley rats	C0034715
28463085	groups	C1257890
28463085	normal occlusion	C0011382
28463085	group	C1257890
28463085	occlusal	C0011382
28463085	hypofunction	C0679221
28463085	group	C1257890
28463085	occlusal hypofunction group	C1257890
28463085	LIPUS	C4042796
28463085	treatment	C0087111
28463085	Hypofunctional	C0679221
28463085	occlusion	C0011382
28463085	maxillary first molar	C4082817
28463085	M1	C4082817
28463085	H	C1257890
28463085	HL groups	C1257890
28463085	bite-raising technique	C0376583
28463085	HL group	C1257890
28463085	LIPUS	C4042796
28463085	days	C0439228
28463085	IRAB	C0932533
28463085	PDL	C0031093
28463085	M1	C4082817
28463085	microcomputed tomography	C2350281
28463085	micro-CT	C2350281
28463085	analysis	C0936012
28463085	mRNA	C0035696
28463085	expression	C1171362
28463085	cytokines	C0079189
28463085	PDL	C0031093
28463085	proliferation	C1514485
28463085	development	C1527148
28463085	real-time reverse transcription quantitative PCR	C0599161
28463085	qRT-PCR	C0599161
28463085	twist family bHLH transcription factor 1	C1421244
28463085	Twist1	C1421244
28463085	periostin	C1424662
28463085	connective tissue growth factor	C1413791
28463085	CTGF	C1413791
28463085	PDL	C0031093
28463085	samples	C0370003
28463085	Micro-CT	C2350281
28463085	analysis	C0936012
28463085	PDL	C0031093
28463085	volume	C0449468
28463085	H group	C1257890
28463085	C	C1257890
28463085	HL groups	C1257890
28463085	bone volume	C1317149
28463085	tissue volume	C0449468
28463085	BV	C1317149
28463085	TV	C0449468
28463085	IRAB	C0932533
28463085	H group	C1257890
28463085	C group	C1257890
28463085	LIPUS	C4042796
28463085	BV	C1317149
28463085	TV	C0449468
28463085	IRAB	C0932533
28463085	HL group	C1257890
28463085	qRT-PCR	C0599161
28463085	analysis	C0936012
28463085	Twist1	C1421244
28463085	periostin	C1424662
28463085	CTGF	C1413791
28463085	mRNA	C0035696
28463085	levels	C0441889
28463085	H group	C1257890
28463085	HL group	C1257890
28463085	LIPUS	C4042796
28463085	atrophic	C0333641
28463085	changes	C0392747
28463085	alveolar bone	C0932533
28463085	inducing	C0205263
28463085	upregulation	C0041904
28463085	periostin	C1424662
28463085	CTGF	C1413791
28463085	expression	C1171362
28463085	PDL	C0031093
28463085	healing	C0043240
28463085	induction	C0857127
28463085	occlusal	C0011382
28463085	hypofunction	C0679221
28464019	Radiologic assessment	C0043299
28464019	root canal fillings	C0035848
28464019	periapical status	C0729269
28464019	Austrian	C0337795
28464019	subpopulation	C1257890
28464019	observational study	C1518527
28464019	Progress	C1280477
28464019	endodontic techniques	C0700632
28464019	root canal therapy	C0035849
28464019	periodical	C0031082
28464019	documentation	C0920316
28464019	observational study	C1518527
28464019	prevalence	C0220900
28464019	endodontic treatments,	C0700632
28464019	investigated	C1292732
28464019	periapical status	C0729269
28464019	Austrian	C0337795
28464019	subpopulation	C1257890
28464019	orthopantomograms	C0034579
28464019	university	C0020028
28464019	patients	C0030705
28464019	radiographed	C1306645
28464019	outpatient clinic	C0029916
28464019	evaluated	C0220825
28464019	tooth	C0040426
28464019	presence	C0150312
28464019	periradicular pathosis	C0031028
28464019	endodontic treatment	C0700632
28464019	endodontic treatment	C0700632
28464019	homogeneity	C1881065
28464019	root canal fillings	C0035848
28464019	preparation failures	C2938896
28464019	posts	C0183062
28464019	screws	C0301559
28464019	apicoectomies	C0003571
28464019	coronal restorations	C0204297
28464019	evaluators	C1707957
28464019	blinded	C0150108
28464019	scored	C0449820
28464019	teeth	C0040426
28464019	score	C0449820
28464019	teeth were counted	C0449772
28464019	teeth	C0040426
28464019	periapical pathosis	C0031028
28464019	teeth	C0040426
28464019	root canal treatment	C0035849
28464019	endodontically treated teeth	C0376699
28464019	radiographic	C0444708
28464019	apical periodontitis	C4082298
28464019	apical lesions	C1402310
28464019	widened periodontal ligament space	C1290664
28464019	root canal fillings	C0035848
28464019	presence	C0150312
28464019	apical	C0524789
28464019	pathosis	C0012634
28464019	significantly correlated	C1707520
28464019	odds ratio	C0028873
28464019	OR	C0028873
28464019	confidence interval	C0009667
28464019	CI	C0009667
28464019	root canal fillings	C0035848
28464019	homogeneity	C1881065
28464019	Posts	C0183062
28464019	screws	C0301559
28464019	periapical status	C0729269
28464019	OR	C0028873
28464019	endodontically treated posterior teeth	C0376699
28464019	restored	C0565067
28464019	posts	C0183062
28464019	screws	C0301559
28464019	teeth	C0040426
28464019	endodontic treatment	C0700632
28464019	coronal restoration	C0204297
28464019	high prevalence	C1512456
28464019	periradicular radiolucencies	C1852169
28464019	root canal filled teeth	C0040426
28464019	treatment	C0087111
28464019	Periapical	C0729269
28464019	health	C0018684
28464019	associated with	C0332281
28464019	root canal obturation	C0035848
28464019	postendodontic restorations	C2368673
28464019	periapical	C0729269
28464019	health	C0018684
28464071	Chemical composition	C0243176
28464071	amino acid	C0002520
28464071	digestibility	C0392762
28464071	soybean meal	C0037733
28464071	United States	C0041703
28464071	China	C0008115
28464071	Argentina	C0003761
28464071	Brazil	C0006137
28464071	India	C0021201
28464071	nutritional	C1521739
28464071	composition	C0243176
28464071	soybean meal	C0037733
28464071	SBM	C0037733
28464071	China	C0008115
28464071	Argentina	C0003761
28464071	Brazil	C0006137
28464071	U.S	C0041703
28464071	India	C0021201
28464071	apparent ileal digestibility	C0392762
28464071	AID	C0392762
28464071	standardized ileal digestibility	C0392762
28464071	SID	C0392762
28464071	CP	C0033684
28464071	AA	C0002520
28464071	SBM	C0037733
28464071	pigs	C0039005
28464071	SBM	C0037733
28464071	China	C0008115
28464071	Argentina	C0003761
28464071	Brazil	C0006137
28464071	U.S	C0041703
28464071	India	C0021201
28464071	SBM	C0037733
28464071	energy	C1442080
28464071	DM	C1720884
28464071	nutrients	C0678695
28464071	cornstarch based diet	C1384515
28464071	SBM	C0037733
28464071	AA	C0002520
28464071	ingredient	C1550600
28464071	N-free diet	C0012155
28464071	distal ileum	C0227327
28464071	Youden square design	C0035171
28464071	diets	C0012155
28464071	periods	C1948053
28464071	concentration	C0457929
28464071	CP	C0033684
28464071	SBM	C0037733
28464071	Brazil	C0006137
28464071	India	C0021201
28464071	SBM	C0037733
28464071	China	C0008115
28464071	Argentina	C0003761
28464071	U.S	C0041703
28464071	concentration	C0457929
28464071	AA	C0002520
28464071	CP	C0033684
28464071	SBM	C0037733
28464071	U.S	C0041703
28464071	AA	C0002520
28464071	SBM	C0037733
28464071	China	C0008115
28464071	Argentina	C0003761
28464071	SBM	C0037733
28464071	India	C0021201
28464071	trypsin inhibitors	C0041242
28464071	SBM	C0037733
28464071	countries	C0454664
28464071	AID	C0392762
28464071	SID	C0392762
28464071	CP	C0033684
28464071	AA	C0002520
28464071	SBM	C0037733
28464071	U.S	C0041703
28464071	SBM	C0037733
28464071	Brazil	C0006137
28464071	Argentina	C0003761
28464071	India	C0021201
28464071	SBM	C0037733
28464071	U.S	C0041703
28464071	SBM	C0037733
28464071	China	C0008115
28464071	concentration	C0457929
28464071	AA	C0002520
28464071	SBM	C0037733
28464071	China	C0008115
28464071	concentration	C0457929
28464071	standardized ileal digestible	C0392762
28464071	AA	C0002520
28464071	SBM	C0037733
28464071	China	C0008115
28464071	SBM	C0037733
28464071	U.S	C0041703
28464071	U.S	C0041703
28464071	Brazil	C0006137
28464071	SID	C0392762
28464071	SBM	C0037733
28464071	Argentina	C0003761
28464071	China	C0008115
28464071	India	C0021201
28464071	SID	C0392762
28464071	CP	C0033684
28464071	AA	C0002520
28464071	country	C0454664
28464071	SBM	C0037733
28464071	country	C0454664
28464071	formulating diets	C0012164
28464071	pigs	C0039005
28464291	Developing	C1527148
28464291	understanding	C0162340
28464291	object	C0347997
28464291	fall	C0085639
28464291	inhibitory	C3463820
28464291	processes	C1522240
28464291	study	C2603343
28464291	reported	C0684224
28464291	participants	C0679646
28464291	aged	C0001779
28464291	early	C1279919
28464291	trajectories	C0750729
28464291	expected	C1517001
28464291	objects	C0347997
28464291	follow	C4281991
28464291	fell	C0085639
28464291	younger	C0332239
28464291	participants	C0679646
28464291	typically	C3538928
28464291	anticipated	C3840775
28464291	backward	C0439781
28464291	trajectories	C0750729
28464291	fall	C0085639
28464291	moving	C0560560
28464291	carriers	C3888060
28464291	forward	C0439780
28464291	non-parabolic trajectories	C0750729
28464291	relatively	C0205345
28464291	more	C0205172
28464291	frequent	C0332183
28464291	older participants	C0001792
28464291	patterns	C0449774
28464291	suggest	C1705535
28464291	strong	C0442821
28464291	sociocultural	C0680352
28464291	influences	C4054723
28464291	implications	C3146298
28464291	models	C3161035
28464291	development	C1527148
28464291	area	C0178566
28464291	purely	C2963144
28464291	inhibition	C3463820
28464291	principles	C0678989
28464291	established	C0443211
28464291	infancy	C0231330
28464291	Statement	C1710187
28464291	contribution	C1880177
28464291	known	C0205309
28464291	subject	C0681850
28464291	Research	C0035168
28464291	infants	C0021270
28464291	demonstrates	C0443289
28464291	early	C1279919
28464291	established	C0443211
28464291	belief	C0004951
28464291	dropped	C1705648
28464291	objects	C0347997
28464291	fall	C0085639
28464291	straight	C0445291
28464291	down	C0205104
28464291	erroneous	C1547323
28464291	expectations	C0679138
28464291	pre-schoolers	C0008100
28464291	hold	C1948035
28464291	object	C0347997
28464291	fall	C0085639
28464291	consistent with	C0332290
28464291	failure	C0680095
28464291	inhibit	C3463820
28464291	presumption	C1254370
28464291	straight	C0445291
28464291	down	C0205104
28464291	fall	C0085639
28464291	contexts	C0449255
28464291	inappropriate	C1548788
28464291	study	C2603343
28464291	research	C0035168
28464291	replicates	C0205173
28464291	extends	C0231448
28464291	research	C0035168
28464291	older participants	C0001792
28464291	indicates	C3146298
28464291	errors	C0743559
28464291	explained	C3526595
28464291	failed	C0231175
28464291	inhibition	C3463820
28464291	straight	C0445291
28464291	down	C0205104
28464291	fall	C0085639
28464291	study	C2603343
28464291	patterns	C0449774
28464291	errors	C0743559
28464291	late	C0205087
28464291	childhood	C0231335
28464291	adolescence	C0001578
28464291	early	C1279919
28464291	adulthood	C0700597
28464291	consequence of	C0686907
28464291	findings	C0243095
28464291	adequate	C0205411
28464291	modelling	C3714583
28464291	developmental psychology	C1511810
28464291	consider	C0750591
28464291	multilayered	C1254372
28464291	interactions	C1704675
28464291	prior	C0332152
28464291	representations	C1882932
28464291	sociocultural	C0680352
28464291	experiences	C0596545
28464602	Attenuation	C0599946
28464602	High Glucose	C0017725
28464602	Induced	C0205263
28464602	Rat	C0034693
28464602	Cardiomyocyte	C0225828
28464602	Apoptosis	C0162638
28464602	Exendin-4	C0167117
28464602	Intervention	C0184661
28464602	HO-1	C0538674
28464602	Nrf-2	C0289507
28464602	PI3K/AKT Signaling Pathway	C2984369
28464602	Exendin-4	C0167117
28464602	glucagon-like peptide-1 receptor agonist	C2917359
28464602	cytoprotective actions	C0524828
28464602	glycemic control	C0522082
28464602	aims	C1947946
28464602	study	C2603343
28464602	investigate	C1292732
28464602	effects of	C1704420
28464602	exendin-4	C0167117
28464602	high glucose	C0017725
28464602	HG	C0017725
28464602	induced	C0205263
28464602	cardiomyocyte	C0225828
28464602	apoptosis	C0162638
28464602	mechanisms	C0441712
28464602	Rat	C0034693
28464602	cardiomyocytes	C0225828
28464602	groups	C0681860
28464602	normal glucose	C0017725
28464602	group	C0681860
28464602	NG	C0017725
28464602	group	C0681860
28464602	HG	C0017725
28464602	group	C0681860
28464602	HG	C0017725
28464602	exendin-4	C0167117
28464602	group	C0681860
28464602	HG	C0017725
28464602	Ex	C0167117
28464602	Group	C0681860
28464602	Cardiomyocyte	C0225828
28464602	apoptosis	C0162638
28464602	double-staining	C0022885
28464602	annexin V-fluorescein isothiocyanate	C0085216
28464602	FITC	C0085216
28464602	propidium iodide	C0033470
28464602	PI	C0033470
28464602	flow cytometry	C0016263
28464602	Intracellular	C0178719
28464602	reactive oxygen species (ROS)	C1537052
28464602	production	C0542341
28464602	detected	C0442726
28464602	2’,7’-dichlorodihydrofluorescein diacetate	C0670829
28464602	DCHF-DA	C0670829
28464602	incubation	C1439852
28464602	fluorescence microscopy	C0026022
28464602	LY294002	C0251991
28464602	LY	C0251991
28464602	phosphoinositide 3-kinase	C0044602
28464602	PI3K	C0044602
28464602	pathway	C1704259
28464602	inhibitor	C1999216
28464602	medium	C0010454
28464602	HG	C0017725
28464602	Ex	C0167117
28464602	LY	C0251991
28464602	Group	C0681860
28464602	western blot analysis	C0949466
28464602	proteins	C0033684
28464602	analyzed	C0936012
28464602	oxidative stress	C0242606
28464602	associated proteins	C0033684
28464602	heme oxygenase-1	C0538674
28464602	HO-1	C0538674
28464602	nuclear factor E2-related factor 2	C0289507
28464602	Nrf-2	C0289507
28464602	apoptosis	C0162638
28464602	associated proteins	C0033684
28464602	caspase-3	C0291573
28464602	Bax/B-cell lymphoma 2	C0219474
28464602	Bcl-2	C0219474
28464602	p-AKT	C0164786
28464602	AKT	C0164786
28464602	HG	C0017725
28464602	treatment	C1522326
28464602	induced	C0205263
28464602	cardiomyocyte	C0225828
28464602	apoptosis	C0162638
28464602	upregulated	C0041904
28464602	ROS	C0162772
28464602	production	C0542341
28464602	exendin-4	C0167117
28464602	co-incubation	C1439852
28464602	cardiomyocyte	C0225828
28464602	apoptosis	C0162638
28464602	decreased	C0205216
28464602	ROS	C0162772
28464602	level	C0441889
28464602	significantly	C0750502
28464602	HO-1	C0538674
28464602	Nrf-2	C0289507
28464602	protein expression	C1171362
28464602	levels	C0441889
28464602	decreased	C0205216
28464602	significantly	C0750502
28464602	HG	C0017725
28464602	group	C0681860
28464602	levels	C0441889
28464602	elevated	C3163633
28464602	exendin-4	C0167117
28464602	intervention	C0184661
28464602	exendin-4	C0167117
28464602	attenuated	C0599946
28464602	HG	C0017725
28464602	induced	C0205263
28464602	protein expression	C1171362
28464602	caspase-3	C0291573
28464602	Bax	C0219474
28464602	increased	C0205217
28464602	expression	C1171362
28464602	Bcl-2 protein	C4042483
28464602	impacts	C4049986
28464602	exendin-4	C0167117
28464602	significantly	C0750502
28464602	co-incubation	C1439852
28464602	LY294002	C0251991
28464602	exendin-4	C0167117
28464602	HG	C0017725
28464602	induced	C0205263
28464602	p-AKT	C0164786
28464602	AKT	C0164786
28464602	lower expression	C1171362
28464602	impact	C4049986
28464602	suppressed	C1260953
28464602	LY294002	C0251991
28464602	Exendin-4	C0167117
28464602	HG	C0017725
28464602	induced	C0205263
28464602	cardiomyocyte	C0225828
28464602	apoptosis	C0162638
28464602	mechanisms	C0441712
28464602	anti-oxidative stress	C1148560
28464602	HO-1	C0538674
28464602	Nrf-2	C0289507
28464602	intervention	C0184661
28464602	PI3K/AKT signaling pathway	C2984369
28465793	KMAP-O framework	C0679897
28465793	care management	C2735310
28465793	research	C0035168
28465793	patients	C0030705
28465793	type 2 diabetes	C0011860
28465793	review	C1704362
28465793	impacts	C4049986
28465793	interventions	C1273869
28465793	self-management education	C3698325
28465793	health coaching	C4255176
28465793	motivational interviewing	C0683474
28465793	type 2 diabetes	C0011860
28465793	review	C1552617
28465793	scientific literature	C0023866
28465793	diabetes	C0011847
28465793	care and management	C2735310
28465793	research	C0035168
28465793	team	C0871489
28465793	article	C1706852
28465793	findings	C2607943
28465793	validity	C2349101
28465793	developing	C0205245
28465793	comprehensive	C1880156
28465793	behavioral system	C1254370
28465793	framework	C0679897
28465793	empirical	C1880496
28465793	investigation	C0220825
28465793	behavioral system	C1254370
28465793	framework	C0679897
28465793	patients	C0030705
28465793	knowledge	C0518904
28465793	K	C0518904
28465793	motivation	C0026605
28465793	M	C0026605
28465793	attitude	C0004271
28465793	A	C0004271
28465793	practice	C0237607
28465793	P	C0237607
28465793	predictor	C2698872
28465793	variables	C0439828
28465793	diabetes	C0011847
28465793	care outcomes	C0518889
28465793	O	C0518889
28465793	Care management	C2735310
28465793	health education programs	C0679897
28465793	intervention	C1273869
28465793	variable	C0439828
28465793	influences	C4054723
28465793	K	C0518904
28465793	M	C0026605
28465793	A	C0004271
28465793	P	C0237607
28465793	variability	C2827666
28465793	patient	C0030705
28465793	care outcomes	C0518889
28465793	patients	C0030705
28465793	type 2 diabetes	C0011860
28465793	review	C0282443
28465793	KMAP-O framework	C0679897
28465793	guide	C0681467
28465793	care management	C2735310
28465793	patients	C0030705
28465793	type 2 diabetes	C0011860
28465793	interventions	C1273869
28465793	knowledge	C0518904
28465793	enhancement	C2349975
28465793	increased motivation	C0520939
28465793	attitudinal	C0004271
28465793	changes	C0392747
28465793	improved	C0184511
28465793	preventive practice	C1516623
28465793	reduce	C0392756
28465793	progression	C0242656
28465793	type 2 diabetes	C0011860
28465793	comorbidities	C0009488
28465793	use of	C1524063
28465793	health information technology	C2936756
28465793	enhancing	C2349975
28465793	changes	C0392747
28465793	KMAP	C0679897
28465793	communications	C0009452
28465793	health promotion	C0018738
28465793	development	C1527148
28466379	Bayesian	C0242196
28466379	Phylogenic Approaches	C1519068
28466379	Relationships	C0439849
28466379	Table Olive Cultivars	C0996956
28466379	table olive tree	C0996956
28466379	authentication	C0205556
28466379	relationship	C0439849
28466379	productivity	C0033269
28466379	analysis	C0936012
28466379	table olive cultivars	C0996956
28466379	Olea europaea L.	C0996956
28466379	morphological	C0332437
28466379	biological	C0205460
28466379	physicochemical markers	C0017393
28466379	bioinformatic	C0037589
28466379	biostatistic tools	C0037589
28466379	relationships	C0439849
28466379	varieties	C0205419
28466379	productivity	C0033269
28466379	quantitative	C0392762
28466379	parameter	C0549193
28466379	bioinformatic	C0037589
28466379	analysis	C0936012
28466379	graphical representation	C0870616
28466379	matrix of Euclidean distances	C1880593
28466379	principal components analysis	C0429865
28466379	unweighted pair group method	C1881045
28466379	arithmetic mean	C0444504
28466379	principal coordinate analysis	C0936012
28466379	PCoA	C0936012
28466379	clusters	C1704332
28466379	geographic	C1517526
28466379	origin	C0584985
28466379	statistical analysis	C0871424
28466379	Spearman correlation coefficients	C0242929
28466379	associations	C0439849
28466379	fruit	C0016767
28466379	color	C0009393
28466379	pollinization	C1522786
28466379	productivity	C0033269
28466379	results	C1274040
28466379	multiple linear regression prediction models	C0023733
28466379	coefficient of determination	C2827748
28466379	R (2)	C2827748
28466379	model	C3161035
28466379	power	C3854080
28466379	pollinization	C1522786
28466379	productivity	C0033269
28466379	R (2)	C2827748
28466379	directed acyclic graph	C1706232
28466379	influences	C4054723
28466379	detected	C0442726
28466379	effect	C1280500
28466379	tolerance	C1704410
28466379	fruit	C0016767
28466379	stone symmetry	C0205556
28466379	effect	C1280500
28466379	tolerance	C1704410
28466379	stone form	C0205556
28466379	oil	C0028908
28466379	content	C0456205
28466379	diversity	C1880371
28466379	table olive cultivars	C0996956
28466379	olive	C0996956
28466379	breeding	C0006159
28466379	authenticity	C0205556
28468175	Wiedemann-Rautenstrauch Syndrome	C0406586
28468175	Bilateral	C0238767
28468175	Tarsal Kink	C1303000
28468175	Sutures	C0038968
28468175	Correction	C1947976
28468175	month-old	C0580836
28468175	male	C0086582
28468175	infant	C0021270
28468175	Wiedemann-Rautenstrauch syndrome	C0406586
28468175	rare	C0522498
28468175	condition	C0012634
28468175	tarsal kink	C1303000
28468175	upper eyelids	C0585636
28468175	both eyes	C0229118
28468175	treated	C1522326
28468175	bilateral	C0238767
28468175	tarsal kink	C1303000
28468175	everting	C0455231
28468175	suture	C0038968
28468175	transconjunctival approach	C0442347
28468175	local anesthesia	C0002921
28468714	Indications	C0392360
28468714	Laparoscopic Pancreatectomy	C0030279
28468714	Laparoscopic pancreatectomy	C0030279
28468714	routine procedure	C1298805
28468714	Germany	C0017480
28468714	countries	C0454664
28468714	data	C1511726
28468714	short- and long-term outcomes	C0085415
28468714	working group	C1883562
28468714	centers	C0475309
28468714	centers	C0475309
28468714	data	C1511726
28468714	cases	C0868928
28468714	laparoscopic pancreatectomy	C0030279
28468714	Procedures	C0087111
28468714	laparoscopy	C1883297
28468714	open surgery	C4283938
28468714	registry	C0034975
28468714	data	C1511726
28468714	cases	C0868928
28468714	benign disease	C0086692
28468714	malignancies	C0006826
28468714	borderline tumors	C0027651
28468714	procedure	C0087111
28468714	laparoscopic left pancreatectomy	C0030279
28468714	resection	C0015252
28468714	head of the pancreas	C0227579
28468714	tumor	C0027651
28468714	enucleation	C1283063
28468714	intraoperative complication	C0021890
28468714	hemorrhage	C0019080
28468714	rate	C1521828
28468714	conversion	C0439836
28468714	open surgery	C4283938
28468714	minilaparotomies	C0026168
28468714	conversion	C0439836
28468714	rate	C1521828
28468714	patients	C0030705
28468714	pancreatic fistula	C0030290
28468714	surgery	C0543467
28468714	reoperation	C0035110
28468714	postoperative hemorrhage	C0032788
28468714	procedure-related mortality	C0277599
28468714	patients	C0030705
28468714	postoperative pain	C0030201
28468714	diabetes mellitus	C0011849
28468714	procedure	C0087111
28468714	patient	C0030705
28468714	cohort	C0599755
28468714	registry	C0034975
28468714	persons	C0027361
28468714	laparoscopic pancreatectomy	C0030279
28468714	hospital	C0019994
28468714	teams	C0871489
28468714	data	C1511726
28468714	selection bias	C0036577
28468714	operative procedures	C0543467
28468714	laparoscopic pancreatectomy	C0030279
28468714	Germany	C0017480
28468714	complication	C0009566
28468714	rates	C1521828
28468714	open surgery	C4283938
28468714	Selection bias	C0036577
28468714	randomized trial	C0206034
28470106	NEUROD2	C1417684
28470106	polymorphisms	C0678951
28470106	change	C0392747
28470106	cognitive dysfunctions	C0338656
28470106	schizophrenia	C0036341
28470106	schizoaffective disorder	C0036337
28470106	weeks	C0439230
28470106	antipsychotic	C0040615
28470106	treatment	C0087111
28470106	NEUROD2	C1417684
28470106	neurospecific helix-loop-helix	C0206678
28470106	transcription factor	C0040648
28470106	impact	C4049986
28470106	regulation	C0017263
28470106	glutamatergic	C0220839
28470106	GABAergic	C0016904
28470106	genes	C0017337
28470106	investigated	C1292732
28470106	NEUROD2	C1417684
28470106	neurocognitive dysfunctions	C0338656
28470106	schizophrenia	C0036341
28470106	schizoaffective disorder	C0036337
28470106	patients	C0030705
28470106	treatment	C0087111
28470106	second-generation antipsychotics	C0040615
28470106	Patients	C0030705
28470106	genotyped	C0017431
28470106	polymorphisms	C0678951
28470106	NEUROD2	C1417684
28470106	gene	C0017337
28470106	rs9889354(A/G	C0678951
28470106	rs1877032(C/T)	C0678951
28470106	rs12453682(C/T)	C0678951
28470106	rs11078918(C/G)	C0678951
28470106	Cognitive function	C0392335
28470106	assessed	C1516048
28470106	baseline	C1442488
28470106	week	C0439230
28470106	Results	C1274040
28470106	neuropsychological tests	C0027902
28470106	cognitive domains	C4050130
28470106	(reaction time	C0034746
28470106	quality	C0332306
28470106	executive function	C0935584
28470106	working	C1563351
28470106	verbal	C0561770
28470106	visual memory	C0542316
28470106	cognitive	C1516691
28470106	index	C0918012
28470106	patients	C0030705
28470106	study	C2603343
28470106	NEUROD2	C1417684
28470106	exonic polymorphism rs11078918	C0678951
28470106	verbal memory	C0561770
28470106	executive functions	C0935584
28470106	NEUROD2	C1417684
28470106	polymorphism rs12453682	C0678951
28470106	working	C1563351
28470106	verbal memory	C0561770
28470106	executive functions	C0935584
28470106	cognitive	C1516691
28470106	index	C0918012
28470106	baseline	C1442488
28470106	weeks	C0439230
28470106	change	C0392747
28470106	neuropsychological test	C0027902
28470106	results	C1274040
28470106	antipsychotic	C0040615
28470106	treatment	C0087111
28470106	NEUROD2	C1417684
28470106	polymorphisms	C0678951
28470106	rs11078918	C0678951
28470106	rs12453682	C0678951
28470106	NEUROD2 gene	C1417684
28470106	pathophysiology	C0031847
28470106	neurocognitive dysfunctions	C0338656
28470106	change	C0392747
28470106	cognitive symptoms	C0525041
28470106	antipsychotic	C0040615
28470106	treatment	C0087111
28470106	schizophrenia	C0036341
28470106	schizoaffective disorder	C0036337
28470482	New	C0205314
28470482	Diterpenoids	C0012780
28470482	Clerodendranthus spicatus	C2311252
28470482	new	C0205314
28470482	diterpenoids	C0012780
28470482	neoorthosiphonones B	C0012780
28470482	C	C0012780
28470482	1	C0012780
28470482	2	C0012780
28470482	diterpenoid	C0012780
28470482	isolated	C0205409
28470482	aerial parts	C1136056
28470482	Clerodendranthus spicatus	C2311252
28470482	structures	C0678594
28470482	absolute	C0205344
28470482	configurations	C0449830
28470482	determined by	C0521095
28470482	spectroscopic analyses	C0022885
28470482	X-ray crystallographic methods	C0206755
28470482	compound	C0205198
28470482	inhibit	C0521111
28470482	fibronectin	C0016055
28470482	production	C0033268
28470482	concentration	C1446561
28470753	Stalk	C1947953
28470753	base	C0700276
28470753	invasion	C1269955
28470753	pT1	C0332391
28470753	papillary cancers of the bladder	C0699885
28470753	risk	C0035647
28470753	progression	C0242656
28470753	Pathologic stage T1	C0332391
28470753	pT1	C0332391
28470753	bladder cancers	C0699885
28470753	clinically	C0205210
28470753	heterogeneous group	C0019409
28470753	staging	C0178759
28470753	superficially	C0205124
28470753	invasive cancers	C0677898
28470753	variability	C2827666
28470753	lamina propria invasion	C1269980
28470753	papillary urothelial carcinomas	C1368911
28470753	PUC	C1368911
28470753	inter-observer variation	C0021713
28470753	limited value	C0439801
28470753	patient outcomes	C0030698
28470753	reappraise	C0184514
28470753	pT1	C0332391
28470753	PUC	C1368911
28470753	aiming	C1947946
28470753	identify	C0205396
28470753	novel	C0205314
28470753	scheme	C1519193
28470753	reproducible	C1524057
28470753	prognostically	C0220901
28470753	Stage pT1	C0332391
28470753	PUC	C1368911
28470753	diagnosed	C0011900
28470753	years	C0439234
28470753	retrospectively reviewed	C0035363
28470753	characterized	C1880022
28470753	focal	C0205234
28470753	invasion	C2699153
28470753	papillary stalk	C1947953
28470753	focal	C0205234
28470753	invasion	C1269955
28470753	tumor	C0027651
28470753	base	C0700276
28470753	invasion	C1269955
28470753	tumor	C0027651
28470753	base	C0700276
28470753	Cases	C0868928
28470753	concurrent	C0205420
28470753	flat carcinoma in-situ	C1300924
28470753	angiolymphatic invasion	C1708790
28470753	absent	C0332197
28470753	muscularis propria	C0225358
28470753	clinically	C0205210
28470753	advanced disease	C0679246
28470753	excluded	C0332196
28470753	cumulative	C1511559
28470753	incidence	C0021149
28470753	recurrence	C0679254
28470753	progression	C0242656
28470753	death	C0011065
28470753	tumor subtype	C1519691
28470753	evaluated	C0220825
28470753	differential risks	C0035648
28470753	log-rank tests	C0237913
28470753	Kaplan-Meier curves	C1720944
28470753	stratified	C0205363
28470753	type	C0332307
28470753	extent of invasion	C1269793
28470753	patients	C0030705
28470753	inclusion	C1512693
28470753	criteria	C0243161
28470753	patients	C0030705
28470753	base	C0700276
28470753	extensive	C0205231
28470753	invasion	C1269955
28470753	progressed	C1280477
28470753	base	C0700276
28470753	focal	C0205234
28470753	stalk	C1947953
28470753	invasion	C1269955
28470753	progressed	C1280477
28470753	base	C0700276
28470753	patients	C0030705
28470753	risk	C0035647
28470753	progression	C0242656
28470753	death	C0011065
28470753	bladder cancer	C0699885
28470753	base	C0700276
28470753	focal	C0205234
28470753	stalk	C1947953
28470753	tumor subtype	C1519691
28470753	risk	C0035647
28470753	recurrence	C0679254
28470753	lamina propria invasion	C1269980
28470753	patients	C0030705
28470753	pT1	C0332391
28470753	PUC	C1368911
28470753	patient	C0030705
28470753	stratification	C0205363
28470753	risk	C0035647
28470753	progression	C0242656
28471941	Basic science	C0681833
28471941	pathogenesis	C0699748
28471941	ageing	C0001811
28471941	HIV	C0019693
28471941	mechanisms	C0441712
28471941	biomarkers	C0005516
28471941	prevalence	C0220900
28471941	age	C0001779
28471941	comorbidities	C0009488
28471941	mortality	C0178686
28471941	worrisome	C0233481
28471941	ageing	C0001811
28471941	HIV-infected	C0019693
28471941	patients	C0030705
28471941	aim	C1947946
28471941	analyse	C0936012
28471941	ageing	C0001811
28471941	mechanisms	C0441712
28471941	HIV infection	C0019693
28471941	Ageing	C0001811
28471941	time	C0040223
28471941	dependent	C3244310
28471941	accumulation	C4055506
28471941	cellular damage	C0599732
28471941	Epigenetic modifications	C1516924
28471941	mitochondrial DNA	C0012929
28471941	haplogroups	C0018591
28471941	modulate	C0443264
28471941	ageing	C0001811
28471941	antiretroviral treatment	C1963724
28471941	patients	C0030705
28471941	epigenetic clock	C0085759
28471941	haplogroups	C0018591
28471941	HIV infection	C0019693
28471941	severity	C0439793
28471941	Telomere shortening	C1515263
28471941	HIV-infected	C0019693
28471941	patients	C0030705
28471941	HIV	C0019682
28471941	nucleoside analogue	C1579410
28471941	reverse transcriptase inhibitors	C0282519
28471941	Mitochondria	C0026237
28471941	oxidative stress	C0242606
28471941	mitochondrial DNA	C0012929
28471941	mutations	C0026882
28471941	ageing	C0001811
28471941	nucleoside analogue	C1579410
28471941	reverse transcriptase inhibitors	C0282519
28471941	inflammation	C0021368
28471941	inflammageing	C0021368
28471941	ageing	C0001811
28471941	cell senescence	C0007581
28471941	proinflammatory mediators	C0243042
28471941	gut microbiota	C2985398
28471941	coinfections	C0275524
28471941	HIV-infected	C0019693
28471941	patients	C0030705
28471941	level	C0441889
28471941	inflammation	C0021368
28471941	innate immunity	C0020969
28471941	activation	C1879547
28471941	comorbidities	C0009488
28471941	mortality	C0178686
28471941	age	C0001779
28471941	virus	C0042776
28471941	viral protein	C0042736
28471941	reservoirs	C0012653
28471941	HIV	C0019682
28471941	gut	C0699819
28471941	permeability	C0031164
28471941	dysbiosis	C3658208
28471941	antiretroviral treatment	C1963724
28471941	cytomegalovirus	C0010825
28471941	hepatitis C virus	C0220847
28471941	coinfections	C0275524
28471941	environmental factors	C1516998
28471941	fat accumulation	C0333574
28471941	smoking	C0037369
28471941	Adaptive immune	C0678209
28471941	activation	C1879547
28471941	immunosenescence	C0596761
28471941	comorbidities	C0009488
28471941	mortality	C0178686
28471941	general population	C0683971
28471941	predictive	C0681890
28471941	HIV-infected	C0019693
28471941	patients	C0030705
28471941	Biomarkers	C0005516
28471941	evaluate	C0220825
28471941	ageing	C0001811
28471941	HIV-infected	C0019693
28471941	patients	C0030705
28471941	systemic	C0205373
28471941	cellular inflammatory	C0440752
28471941	immune	C0439662
28471941	activation	C1879547
28471941	oxidative stress	C0242606
28471941	markers	C0005516
28471941	tested	C0039593
28471941	serum	C0229671
28471941	peripheral blood mononuclear cells	C1321301
28471941	European	C0015176
28471941	Study	C2603343
28471941	Biomarkers	C0005516
28471941	Human Ageing MARK-AGE algorithm	C0002045
28471941	evaluating	C0220825
28471941	biological	C0205460
28471941	age	C0001779
28471941	HIV-infected	C0019693
28471941	patients	C0030705
28471941	biological	C0205460
28471941	age	C0001779
28471941	inflammatory	C0333348
28471941	innate immune	C0020969
28471941	activation	C1879547
28471941	markers	C0005516
28471941	patient's	C0030705
28471941	follow-up	C1522577
28471941	patients	C0030705
28471941	biological	C0205460
28471941	age	C0001779
28471941	healthspan	C0018684
28473015	MESOTHELIAL CELL	C0225335
28473015	ADHERENCE	C0334154
28473015	VASCULAR PROSTHESES	C0005846
28473015	SUBSEQUENT	C0332282
28473015	GROWTH	C0018270
28473015	IN VITRO	C1533691
28473015	Cell	C0007634
28473015	seeding	C1705192
28473015	decrease	C0547047
28473015	thrombogenicity	C0040053
28473015	implanted	C0021102
28473015	vascular grafts	C0879126
28473015	availability of	C0470187
28473015	autologous	C0439859
28473015	endothelial cells	C0225336
28473015	Human	C0086418
28473015	peritoneal	C0442034
28473015	mesothelial cells	C0225335
28473015	blood flow	C0232338
28473015	supporting qualities	C0332306
28473015	readily available	C0470187
28473015	investigated	C1292732
28473015	adherence	C0334154
28473015	mesothelial cells	C0225335
28473015	vascular prostheses	C0005846
28473015	subsequent	C0332282
28473015	growth	C0018270
28473015	in vitro	C1533691
28473015	Circular	C1282913
28473015	pieces	C2982836
28473015	vascular	C1801960
28473015	prosthetic materials	C0444752
28473015	seeded	C1705192
28473015	51Chromium-labeled	C0303212
28473015	mesothelial	C0225335
28473015	endothelial cells	C0225336
28473015	minutes	C0439232
28473015	unattached	C3841381
28473015	cells	C0007634
28473015	removed	C0849355
28473015	degree	C0449286
28473015	cell	C0007634
28473015	attachment	C1947904
28473015	measured	C0444706
28473015	number	C0237753
28473015	mesothelial cells	C0225335
28473015	Dacron	C0947693
28473015	increased	C0205217
28473015	min	C0439232
28473015	seeded	C1705192
28473015	inoculum	C0439861
28473015	plateau	C2964353
28473015	reached	C0243095
28473015	Scanning electron microscopy	C0026020
28473015	spreaded	C0332261
28473015	mesothelial cells	C0225335
28473015	adherent	C0334154
28473015	Dacron fibers	C0947693
28473015	significant	C0750502
28473015	increase	C0442805
28473015	adherence	C0334154
28473015	observed	C1441672
28473015	preincubation	C0022885
28473015	Dacron	C0947693
28473015	fibronectin	C0016055
28473015	no improvement	C3844714
28473015	found	C0150312
28473015	preincubation	C0022885
28473015	human	C0086418
28473015	serum albumin	C0036773
28473015	gelatin	C0017237
28473015	Mesothelial cells	C0225335
28473015	adhered	C3714578
28473015	Gelcoated	C1522408
28473015	Gelsealed	C0205556
28473015	plain Dacron	C0947693
28473015	adherence	C0334154
28473015	mesothelial cells	C0225335
28473015	ePTFE	C0015312
28473015	Teflon	C0699518
28473015	significantly	C0750502
28473015	poorer	C2700379
28473015	No significant	C1273937
28473015	differences	C1705242
28473015	adherence	C0334154
28473015	found	C0150312
28473015	mesothelial	C0225335
28473015	endothelial cells	C0225336
28473015	Mesothelial cell	C0225335
28473015	growth	C0018270
28473015	Dacron	C0947693
28473015	resulted	C1274040
28473015	modest increase	C0442805
28473015	number	C0237753
28473015	viable cells	C1441322
28473015	days	C0439228
28473015	biocompatibility	C0596177
28473015	Dacron	C0947693
28473015	mesothelial cells	C0225335
28473015	in vitro	C1533691
28473640	Anterolateral	C0332194
28473640	entorhinal cortex	C0175196
28473640	volume	C0449468
28473640	intra-item configural processing	C0449335
28473640	imaging studies	C1881134
28473640	human	C0086418
28473640	entorhinal cortex	C0175196
28473640	anterolateral	C0332194
28473640	alERC	C0175196
28473640	posteromedial	C1179848
28473640	pmERC	C0175196
28473640	subregions	C0005898
28473640	alERC	C0175196
28473640	Alzheimer's disease	C0002395
28473640	pathology	C0677042
28473640	cognitive function	C0392335
28473640	human	C0086418
28473640	fMRI studies	C0376335
28473640	object	C0347997
28473640	memory	C0025260
28473640	rodent	C0035804
28473640	studies	C0683949
28473640	entorhinal cortex	C0175196
28473640	spatial properties	C0012727
28473640	objects	C0347997
28473640	cognitive effects	C0935657
28473640	human	C0086418
28473640	alERC	C0175196
28473640	volume	C0449468
28473640	evaluate	C0220825
28473640	intra-item configural processing	C0449335
28473640	processing	C1709694
28473640	arrangement	C0449830
28473640	object's	C0347997
28473640	manual segmentation	C0700381
28473640	developed protocol	C2348563
28473640	alERC	C0175196
28473640	pmERC	C0175196
28473640	medial temporal lobe	C0039485
28473640	MTL	C0039485
28473640	subregions	C0005898
28473640	adult	C0001675
28473640	men	C0025266
28473640	women	C0043210
28473640	stages	C1306673
28473640	brain atrophy	C0235946
28473640	cognitive decline	C0234985
28473640	intra-item configural processing	C0449335
28473640	object's	C0347997
28473640	alERC	C0175196
28473640	volume	C0449468
28473640	volume	C0449468
28473640	MTL subregion	C0039485
28473640	human	C0086418
28473640	alERC	C0175196
28473640	object	C0347997
28473640	processing	C1709694
28473640	arrangement	C0449830
28473640	object's	C0347997
28473640	Alzheimer's disease	C0002395
28473640	pathology	C0677042
28473640	brain regions	C1273723
28473640	anterolateral	C0332194
28473640	entorhinal cortex	C0175196
28473640	alERC	C0175196
28473640	cognitive role	C0009240
28473640	alERC	C0175196
28473640	human studies	C0178693
28473640	treat	C0087111
28473640	alERC	C0175196
28473640	perirhinal cortex	C2326929
28473640	object	C0347997
28473640	memory	C0025260
28473640	Animal studies	C0683949
28473640	alERC	C0175196
28473640	spatial properties	C0012727
28473640	objects	C0347997
28473640	adult	C0001675
28473640	humans	C0086418
28473640	earliest stages	C2363430
28473640	cognitive decline	C0234985
28473640	alERC	C0175196
28473640	volume	C0449468
28473640	configural processing	C0449335
28473640	attention	C0004268
28473640	spatial arrangement	C0449830
28473640	object's	C0347997
28473640	cognitive role	C0009240
28473640	alERC	C0175196
28473640	volume	C0449468
28473640	humans	C0086418
28473640	early detection method	C0449335
28473640	Alzheimer's disease	C0002395
28473640	pathology	C0677042
28476271	Alcohol brief intervention	C3494740
28476271	primary care	C0033137
28476271	Blood pressure	C0005823
28476271	outcomes	C2015879
28476271	hypertensive	C0020538
28476271	patients	C0030705
28476271	clinical trials	C0008976
28476271	alcohol brief intervention	C3494740
28476271	BI	C3494740
28476271	adult	C0001675
28476271	primary care	C0033137
28476271	efficacious	C1704419
28476271	reducing	C0392756
28476271	alcohol consumption	C0001948
28476271	impact	C4049986
28476271	health outcomes	C0085415
28476271	Hypertension	C0020538
28476271	chronic condition	C4315615
28476271	U.S.	C0041703
28476271	worldwide	C2348867
28476271	alcohol use	C0001948
28476271	hypertension	C0020538
28476271	risk factor	C0035648
28476271	effect	C1280500
28476271	BI	C3494740
28476271	unhealthy drinking	C4303858
28476271	blood pressure (BP) control	C1753303
28476271	adult	C0001675
28476271	hypertensive	C0020538
28476271	patients	C0030705
28476271	analyzing secondary data	C0683944
28476271	clustered	C0009085
28476271	randomized controlled trial	C0206035
28476271	alcohol screening	C0420032
28476271	brief intervention	C0814459
28476271	referral to treatment	C0814457
28476271	SBIRT	C1254363
28476271	implementation	C1708476
28476271	primary care physicians	C0033131
28476271	PCP intervention arm	C0033131
28476271	non-physician providers	C0027363
28476271	medical assistants	C0334914
28476271	NPP	C0027363
28476271	MA intervention arm	C0334914
28476271	integrated health care delivery system	C0282599
28476271	Observational	C1518527
28476271	prospective cohort study	C1709709
28476271	adult	C0001675
28476271	hypertensive	C0020538
28476271	primary care patients	C0030705
28476271	screening	C1710032
28476271	past-year	C4086728
28476271	heavy drinking	C0687132
28476271	baseline	C1442488
28476271	electronic health record	C2362543
28476271	BP	C0005823
28476271	baseline	C1442488
28476271	18-month	C0439231
28476271	follow-up	C1522577
28476271	Change in BP	C1268766
28476271	controlled BP	C1753303
28476271	systolic/diastolic BP	C2704328
28476271	mmHg	C0439475
28476271	associations	C0439849
28476271	alcohol BI	C3494740
28476271	BP change	C1268766
28476271	18-month	C0439231
28476271	follow-up	C1522577
28476271	subjects	C0080105
28476271	intervention arms	C0027363
28476271	BI	C3494740
28476271	past-year	C4086728
28476271	unhealthy drinking	C4303858
28476271	associated with	C0332281
28476271	BP control	C1753303
28476271	18months	C0439231
28476271	PCP intervention arm	C0033131
28476271	heavy drinking	C0687132
28476271	frequency	C0439603
28476271	BP control	C1753303
28476271	index screening	C1710032
28476271	hypertensive	C0020538
28476271	patients	C0030705
28476271	benefit	C0814225
28476271	physician	C0031831
28476271	brief intervention	C0814459
28476271	unhealthy alcohol use	C4303858
28476271	primary care	C0033137
28476271	population-level benefits	C0814225
28476271	alcohol BI	C3494740
28476271	SBIRT delivery	C1254363
28476271	primary care	C0033137
28476381	Unusual	C2700116
28476381	asymptomatic presentation	C0275522
28476381	bladder cancer	C0005695
28476381	metastatic to the penis	C0347002
28476381	Penile metastasis	C0347002
28476381	extremely rare event	C0678236
28476381	pelvic	C0030797
28476381	tumor sites	C0475445
28476381	urinary bladder	C0005682
28476381	gastro-intestinal tract	C0017189
28476381	prostate	C0033572
28476381	respiratory system	C0035237
28476381	bone tumors	C0005967
28476381	melanoma	C0025202
28476381	unusual	C2700116
28476381	presentation	C0449450
28476381	bladder urothelial cancer	C0751571
28476381	metastatic to	C0036525
28476381	penis	C0030851
28476381	no relevant clinical symptoms	C0231221
28476381	lesions	C0221198
28476381	foreskin and the glans	C0545925
28476381	condylomata	C0302180
28476381	histological	C0019637
28476381	immunohistochemical analysis	C1441616
28476381	bladder urothelial carcinoma	C2145472
28476381	reddish	C1260956
28476381	skin lesion of the glans	C2168434
28476381	history of bladder	C0567322
28476381	urethral carcinoma	C2145472
28476381	histological pagetoid spread	C1335292
28476381	urothelial cancer	C2145472
28476381	to the glans	C0227948
28476381	Recurrent bladder urothelial carcinoma	C0278827
28476381	visceral	C0042779
28476381	disease	C0012634
28476381	asymptomatic	C0231221
28476381	skin lesion	C0037284
28476381	cases were asymptomatic	C0231221
28476381	superficial penis metastases	C0347002
28476381	fairy good prognosis	C0278250
28476381	conservative surgical approach	C0449446
28476381	clinical examination of the penis is mandatory for males	C0242803
28476381	history of bladder cancer	C0567322
28478321	Female	C0086287
28478321	Siamese fighting fish	C0599049
28478321	avoid	C0443288
28478321	males	C0086582
28478321	exposed to	C0332157
28478321	estrogen	C0014939
28478321	mimic	C0205245
28478321	improper	C3827420
28478321	disposal	C1707797
28478321	lack	C0332268
28478321	removal	C1883720
28478321	wastewater	C3494254
28478321	treatment process	C1522326
28478321	endocrine	C0521425
28478321	disrupting	C0332454
28478321	chemicals	C0220806
28478321	aquatic ecosystems	C0563034
28478321	effects	C1280500
28478321	fish	C0016163
28478321	behavior	C0004927
28478321	physiology	C0031843
28478321	prevalent	C0220900
28478321	EDC	C0220806
28478321	17α-ethinylestradiol	C0015011
28478321	EE2	C0015011
28478321	ingredient	C1550600
28478321	oral contraceptives	C0009905
28478321	reductions	C0392756
28478321	male	C0086582
28478321	behaviors	C0004927
28478321	alterations	C1515926
28478321	male	C0086582
28478321	courtship	C0237548
28478321	behavior	C0004927
28478321	decrease	C0547047
28478321	reproductive fitness	C2717777
28478321	EE2	C0015011
28478321	exposure	C0332157
28478321	reduces	C0392756
28478321	male	C0086582
28478321	attractiveness	C0871078
28478321	female	C0086287
28478321	Siamese fighting fish	C0599049
28478321	Betta splendens	C0599049
28478321	investigated	C1292732
28478321	females	C0086287
28478321	video	C3463807
28478321	images	C1704922
28478321	exposed	C2348484
28478321	unexposed	C2349018
28478321	males	C0086582
28478321	Females	C0086287
28478321	exposure	C0332157
28478321	conditions	C0348080
28478321	exposed to	C0332157
28478321	EE2	C0015011
28478321	control	C0009932
28478321	subject	C0681850
28478321	four	C0205450
28478321	different	C1705242
28478321	video	C3463807
28478321	combinations	C0205195
28478321	male	C0086582
28478321	conspecifics	C1510537
28478321	courting	C0237548
28478321	exposed	C2348484
28478321	exposed	C2348484
28478321	courting	C0237548
28478321	unexposed	C2349018
28478321	unexposed	C2349018
28478321	courting	C0237548
28478321	unexposed	C2349018
28478321	exposed	C2348484
28478321	swimming	C0039003
28478321	unexposed	C2349018
28478321	exposed	C2348484
28478321	Females	C0086287
28478321	exposed to	C0332157
28478321	EE2	C0015011
28478321	behavior	C0004927
28478321	exposed	C2348484
28478321	males	C0086582
28478321	exposed	C2348484
28478321	male	C0086582
28478321	unexposed	C2349018
28478321	male	C0086582
28478321	simultaneously	C0521115
28478321	EE2	C0015011
28478321	significant	C0750502
28478321	individual	C0205171
28478321	population-level	C1257890
28478321	consequences	C0686907
28478321	fitness	C0031812
28478321	disrupting	C0332454
28478321	sexual selection	C0024909
28478321	success	C0597535
28478321	exposed	C2348484
28478321	males	C0086582
28478321	males	C0086582
28478867	Targeting	C1521840
28478867	accuracy	C0443131
28478867	single-isocenter	C1881275
28478867	intensity-modulated	C1512814
28478867	radiosurgery	C0085203
28478867	lesions	C0221198
28478867	investigate	C1292732
28478867	targeting	C1521840
28478867	accuracy	C0443131
28478867	intensity-modulated	C1512814
28478867	SRS	C0085203
28478867	IMRS	C0085203
28478867	plans	C0599880
28478867	brain	C0006104
28478867	metastases	C4255448
28478867	single isocenter	C1881275
28478867	home-made acrylic	C0001222
28478867	phantom	C0282611
28478867	film	C1561572
28478867	EBT3	C1561572
28478867	coronal plane	C0205123
28478867	phantom	C0282611
28478867	CT scanned	C0040405
28478867	targets	C1521840
28478867	central	C0205099
28478867	peripheral	C0205100
28478867	Eclipse system	C2363849
28478867	Peripheral	C0205100
28478867	targets	C1521840
28478867	central	C0205099
28478867	IMRS	C0085203
28478867	plan	C0599880
28478867	targets	C1521840
28478867	single isocenter	C1881275
28478867	central	C0205099
28478867	target	C1521840
28478867	positioning	C1550045
28478867	phantom	C0282611
28478867	linac	C0023730
28478867	room	C1547703
28478867	lasers	C0023089
28478867	CBCT scan	C0040405
28478867	plan	C0599880
28478867	mapped	C1283195
28478867	isocenter	C1881275
28478867	intersection	C1555443
28478867	film	C1561572
28478867	linac	C0023730
28478867	isocenter	C1881275
28478867	mapped	C1283195
28478867	plan	C0599880
28478867	recalculated	C1441506
28478867	delivered	C1705822
28478867	film	C1561572
28478867	dose distribution	C0087111
28478867	cloud computing application	C3873720
28478867	www.radiochromic.com	C3873720
28478867	dosimetry	C0016103
28478867	algorithm	C0002045
28478867	dose distributions	C0087111
28478867	gamma index	C1708185
28478867	target	C1521840
28478867	2D shifts	C0333051
28478867	gamma	C0017011
28478867	peripheral	C0205100
28478867	target	C1521840
28478867	central	C0205099
28478867	target	C1521840
28478867	experiment	C0681814
28478867	sessions	C0481503
28478867	2D shifts	C0333051
28478867	gamma	C0017011
28478867	central	C0205099
28478867	peripheral	C0205100
28478867	targets	C1521840
28478867	targeting	C1521840
28478867	accuracy	C0443131
28478867	central	C0205099
28478867	peripheral	C0205100
28478867	targets	C1521840
28478867	study	C2603343
28478867	targeting	C1521840
28478867	accuracy	C0443131
28478867	isocenter	C1881275
28478867	targets	C1521840
28478867	linac	C0023730
28478867	isocenter	C1881275
28478867	single-isocenter	C1881275
28478867	IMRS	C0085203
28478867	plan	C0599880
28479259	Physical activity	C0026606
28479259	limits	C0439801
28479259	effects of	C1704420
28479259	age	C0001779
28479259	Alzheimer's disease	C0002395
28479259	postural control	C0683212
28479259	aim	C1947946
28479259	influence	C4054723
28479259	physical activity	C0026606
28479259	postural	C0205278
28479259	performance	C1882330
28479259	subjects	C2349001
28479259	Alzheimer's disease	C0002395
28479259	AD	C0002395
28479259	postural	C0205278
28479259	performance	C1882330
28479259	surface area	C4263416
28479259	center of foot pressure displacement	C0012727
28479259	groups	C0441833
28479259	compared	C1707455
28479259	Alzheimer active group	C0441833
28479259	AA	C0441833
28479259	Alzheimer non-active group	C0441833
28479259	ANA	C0441833
28479259	healthy non-active group	C0441833
28479259	HNA	C0441833
28479259	AA group's	C1257890
28479259	postural	C0205278
28479259	performance	C1882330
28479259	superior	C1282910
28479259	ANA	C0441833
28479259	HNA groups	C0441833
28479259	AD	C0002395
28479259	postural	C0205278
28479259	performance	C1882330
28479259	participation	C0679823
28479259	regular	C0205272
28479259	physical activity	C0026606
28479259	limit	C0439801
28479259	disturbing effects	C1280500
28479259	AD	C0002395
28479259	postural	C0205278
28479259	performance	C1882330
28479259	active AD subjects	C0080105
28479259	superior	C1282910
28479259	healthy subjects	C1708335
28483530	LAMP-2	C1563373
28483530	oxidative stress	C0242606
28483530	cell death	C0007587
28483530	Zn(2+)	C2346521
28483530	treated	C0087111
28483530	lung	C0024109
28483530	epithelium cells	C0014597
28483530	Zinc	C0043481
28483530	element	C0013879
28483530	biological system	C0460002
28483530	exogenous	C0205228
28483530	Zn(2+)	C2346521
28483530	cellular Zn(2+) homeostasis	C2263139
28483530	cause toxicity	C0600688
28483530	Zinc salts	C0351669
28483530	ZnO	C0043491
28483530	nanoparticles	C1450054
28483530	respiratory injury	C0560313
28483530	organelle	C0029219
28483530	damage	C0599732
28483530	mitochondria	C0026237
28483530	lysosomes	C0024369
28483530	reactive oxygen species	C0162772
28483530	ROS	C0162772
28483530	Zn(2+)	C2346521
28483530	toxicity	C0600688
28483530	mitochondria	C0026237
28483530	lysosomes	C0024369
28483530	damage	C0599732
28483530	ROS	C0162772
28483530	Zn(2+)	C2346521
28483530	deglycosylation	C1157972
28483530	lysosome-associated membrane protein 1	C3539735
28483530	2	C1563373
28483530	LAMP-1	C3539735
28483530	LAMP-2	C1563373
28483530	endosomes	C0034850
28483530	lysosomes	C0024369
28483530	A549 lung epithelium cells	C0014597
28483530	LAMP-2	C1416790
28483530	knockdown	C2350567
28483530	aggravated	C1444749
28483530	Zn(2+)	C2346521
28483530	ROS	C0162772
28483530	cell death	C0007587
28483530	LAMP-2	C1563373
28483530	LAMP-1	C3539735
28483530	Zn(2+)	C2346521
28483530	toxicity	C0600688
28483530	LAMP-2	C1563373
28483530	ROS	C0162772
28483530	cell death	C0007587
28483530	Zn(2+)	C2346521
28483530	treatment	C0087111
28483530	Zn(2+)	C2346521
28483530	toxicity	C0600688
28483530	respiratory system	C0035237
28485130	Fluorescence hyperspectral imaging	C0430022
28485130	fHSI	C0430022
28485130	spectrally	C0205556
28485130	resolved	C3714811
28485130	detector array	C0025080
28485130	resolve	C2699488
28485130	multiple	C0439064
28485130	fluorescent emissions	C1522240
28485130	different	C1705242
28485130	biological	C0205460
28485130	targets	C1521840
28485130	video rate applications	C0869019
28485130	endoscopy	C0014245
28485130	intraoperative imaging	C3898703
28485130	limited	C0439801
28485130	filter-based	C0205556
28485130	imaging systems.	C0025080
28485130	Hyperspectral imaging	C0430022
28485130	HSI	C0430022
28485130	detection	C1511790
28485130	spatial	C0037775
28485130	spectral	C1883073
28485130	information	C1533716
28485130	single data acquisition	C0441655
28485130	instrumentation	C0021632
28485130	HSI	C0430022
28485130	complex	C0439855
28485130	bulky	C0392762
28485130	expensive	C0205556
28485130	overcome	C2983310
28485130	limitations	C0449295
28485130	novel	C0205314
28485130	robust	C2986815
28485130	low cost	C0392762
28485130	HSI	C0430022
28485130	camera	C0179533
28485130	spectrally resolved detector array	C0025080
28485130	SRDA	C0025080
28485130	integrated	C1705422
28485130	HSI	C0430022
28485130	camera	C0179533
28485130	wide-field	C0243095
28485130	reflectance-based	C1514813
28485130	imaging system	C2697665
28485130	operating	C0205245
28485130	near-infrared	C1532326
28485130	range	C1514721
28485130	assess	C0184514
28485130	in vivo imaging	C1708481
28485130	exogenous	C0205228
28485130	fluorescent contrast agents	C0009924
28485130	fluorescence HSI	C0430022
28485130	fHSI	C0430022
28485130	system	C0449913
28485130	accurately	C0443131
28485130	resolve	C2699488
28485130	presence	C3854307
28485130	concentration	C1446561
28485130	fluorescent dyes	C0016320
28485130	solution	C0037633
28485130	high	C0205250
28485130	spectral unmixing	C2827423
28485130	precision	C1706245
28485130	signal	C1710082
28485130	linearity	C0205556
28485130	dye	C0013343
28485130	concentration	C1446561
28485130	depth	C0205125
28485130	tissue	C0040300
28485130	mimicking	C4042849
28485130	phantoms	C0282611
28485130	delineate	C0243095
28485130	fluorescent dyes	C0016320
28485130	in vivo	C1515655
28485130	including	C0332257
28485130	statistical	C0205556
28485130	background	C1706907
28485130	directly	C1947931
28485130	generalised	C0205246
28485130	broader spectral	C1138667
28485130	ranges	C1514721
28485130	resolve	C2699488
28485130	tissue	C0040300
28485130	reflectance	C1514813
28485130	autofluorescence	C0544711
28485130	future	C0016884
28485130	video rate applications	C0869019
28485130	HSI	C0430022
28485130	data acquisition	C0441655
28485268	Biochemical	C0205474
28485268	studies	C2603343
28485268	amylase	C0002712
28485268	lipase	C0023764
28485268	protease	C0030940
28485268	Callosobruchus maculatus	C1024702
28485268	Coleoptera	C0009276
28485268	Chrysomelidae	C1001499
28485268	populations	C1257890
28485268	Vigna unguiculata	C0996865
28485268	grain	C0007757
28485268	cultivated	C0242481
28485268	diazotrophic bacteria strains	C0004611
28485268	study	C2603343
28485268	enzymatic activity	C0243102
28485268	homogenates	C3829671
28485268	insects	C0021585
28485268	grain	C0007757
28485268	cowpea	C0996865
28485268	Vigna unguiculata (L.)	C0996865
28485268	cultivars	C0032098
28485268	nitrogen	C0028158
28485268	homogenate	C3829671
28485268	adult	C0001675
28485268	insects	C0021585
28485268	grain	C0007757
28485268	cowpea	C0996865
28485268	cultivars	C0032098
28485268	BRS Acauã	C0032098
28485268	BRS Carijó	C0032098
28485268	BRS Pujante	C0032098
28485268	BRS Tapaihum	C0032098
28485268	nitrogen	C0028158
28485268	mineral	C0026162
28485268	fertilizer	C0015919
28485268	inoculation	C0022885
28485268	strains of diazotrophs	C0004611
28485268	BR 3267	C3917457
28485268	BR 3262	C3917456
28485268	BR 3299	C0004611
28485268	INPA 03-11B	C0004611
28485268	03-84 UFLA	C0004611
28485268	control	C0009932
28485268	soil	C0037592
28485268	nitrogen	C0028158
28485268	enzymatic activities	C0243102
28485268	insect	C0021585
28485268	protease	C0030940
28485268	amylase	C0002712
28485268	lipase	C0023764
28485268	starch	C0038179
28485268	grains	C0007757
28485268	enzymatic activity	C0243102
28485268	amylase	C0002712
28485268	lipase	C0023764
28485268	protease	C0030940
28485268	insect	C0021585
28485268	homogenate	C3829671
28485268	food	C0016452
28485268	activity of the enzyme	C0243102
28485268	amylase	C0002712
28485268	C. maculatus	C1024702
28485268	homogenate	C3829671
28485268	insects	C0021585
28485268	grain	C0007757
28485268	cultivar BRS Carijó	C0032098
28485268	activity of lipase enzyme	C1149836
28485268	C. maculatus	C1024702
28485268	homogenate	C3829671
28485268	insects	C0021585
28485268	grain	C0007757
28485268	cultivar Tapaihum	C0032098
28485268	BR 3262 diazotrophs	C3917456
28485268	proteolytic activity	C0597304
28485268	homogenate	C3829671
28485268	insects	C0021585
28485268	BRS Carijó	C0032098
28485268	BR 3262 diazotroph	C3917456
28485268	Starch	C0038179
28485268	amylase activity	C1150038
28485268	C. maculatus	C1024702
28485268	homogenate	C3829671
28485268	cultivar BRS Carijó	C0032098
28485268	cultivars	C0032098
28485268	cluster analysis	C0009085
28485296	correlation of the results	C0010100
28485296	survey SNOT-20	C0038951
28485296	objective studies	C2985627
28485296	nasal obstruction	C0027429
28485296	nasal cavities	C0027423
28485296	correlation between the results	C0010100
28485296	survey SNOT-20	C0038951
28485296	results of the objective tests	C0243095
28485296	nasal obstruction	C0027429
28485296	rhinomanometry	C0430615
28485296	acoustic rhinometry	C0430619
28485296	surgical treatment	C0543467
28485296	septoplasty	C0844334
28485296	septoconchoplasty	C0430022
28485296	ethmoidectomy	C0189149
28485296	septoethmoidectomy	C0430022
28485296	patients	C0030705
28485296	diagnosed	C0011900
28485296	Rhinomanometry	C0430615
28485296	Laboratory	C0022877
28485296	Department of Otolaryngology	C4047590
28485296	Medical University	C0000872
28485296	Warsaw	C0681784
28485296	rhinological problems	C0029896
28485296	Data	C1511726
28485296	women	C0043210
28485296	men	C0025266
28485296	RhinoMetrics SRE 2100	C0025080
28485296	Rhinomanometer	C0183043
28485296	RhinoStream	C0183043
28485296	Acoustic Rhinometer	C3881541
28485296	RhinoScan	C3881541
28485296	Interacoustics AS	C0025080
28485296	Denmark	C0011318
28485296	Survey SNOT-20	C0038951
28485296	Sino-Nasal Outcome Test-20	C0038951
28485296	Polish	C0681784
28485296	patients	C0030705
28485296	before surgery	C1254367
28485296	during the postoperative control visits	C0032790
28485296	objective parameter	C0449381
28485296	resistance	C4281815
28485296	flow of air through the nasal cavity	C0429203
28485296	subjective feelings of respondents	C0243095
28485296	survey SNOT-20	C0038951
28485296	generally weak	C1762617
28485296	statistical significance	C0237881
28485296	first question survey	C0038949
28485296	severity of the nose obstruction	C0027429
28485296	resistance flow	C4281815
28485296	nasal obstruction	C0027429
28485296	patient	C0030705
28485296	rhinological problems	C0029896
28486935	Emergency department	C0562508
28486935	use	C0457083
28486935	barriers	C0679881
28486935	wellness	C0018684
28486935	survey	C0038951
28486935	emergency department	C0562508
28486935	frequent	C0332183
28486935	users	C1706077
28486935	needs	C0027552
28486935	emergency department	C0562508
28486935	ED	C0562508
28486935	frequent	C0332183
28486935	users	C1706077
28486935	patients	C0030705
28486935	study	C2603343
28486935	population	C1257890
28486935	Examinations	C0582103
28486935	ED	C0562508
28486935	frequent	C0332183
28486935	users	C1706077
28486935	present	C0150312
28486935	ED	C0562508
28486935	barriers	C0679881
28486935	care	C0017313
28486935	exist	C2987476
28486935	service	C0557854
28486935	patients	C0030705
28486935	optimal	C2698651
28486935	level	C0441889
28486935	health	C0018684
28486935	prospective study	C0033522
28486935	frequent	C0332183
28486935	ED	C0562508
28486935	users	C1706077
28486935	adult	C0001675
28486935	level 1 trauma center	C0040786
28486935	approximately	C0332232
28486935	visits	C1512346
28486935	per year	C0439508
28486935	Frequent	C0332183
28486935	ED	C0562508
28486935	users	C1706077
28486935	ED visits	C0586082
28486935	month	C0439231
28486935	period	C1948053
28486935	Participants	C0679646
28486935	administered	C1521801
28486935	piloted structured interview	C0681913
28486935	trained researcher	C0035173
28486935	querying	C1522634
28486935	demographics	C0011298
28486935	ED	C0562508
28486935	usage	C0457083
28486935	perceived barriers	C0205556
28486935	care	C0017313
28486935	aids	C0205556
28486935	maintaining health	C2371475
28486935	screened	C1710032
28486935	patients	C0030705
28486935	identified	C0205396
28486935	frequent	C0332183
28486935	ED	C0562508
28486935	users	C1706077
28486935	frequent	C0332183
28486935	ED	C0562508
28486935	users	C1706077
28486935	mean age	C0001779
28486935	years	C1510829
28486935	CI	C0009667
28486935	subjects	C0080105
28486935	female	C0043210
28486935	CI	C0009667
28486935	white	C1257890
28486935	CI	C0009667
28486935	insured	C1548605
28486935	Medicaid	C0025071
28486935	CI	C0009667
28486935	Medicare	C0018717
28486935	CI	C0009667
28486935	Subjects	C0080105
28486935	median	C0439536
28486935	ED visits	C0586082
28486935	inpatient admissions	C0420512
28486935	past	C1444637
28486935	months	C0439231
28486935	hospital	C0019994
28486935	frequent	C0332183
28486935	ED	C0562508
28486935	users	C1706077
28486935	CI	C0009667
28486935	primary reason	C1549995
28486935	visit	C1512346
28486935	health problem	C1398682
28486935	treated	C1522326
28486935	ED	C0562508
28486935	Transportation	C1554194
28486935	major	C0205164
28486935	barrier	C0205556
28486935	few	C0205388
28486935	patients	C0030705
28486935	CI	C0009667
28486935	Subjects	C0080105
28486935	after-hours options	C1136313
28486935	ED	C0562508
28486935	minor	C0205165
28486935	health issues	C2362508
28486935	CI	C0009667
28486935	nurse	C0028661
28486935	work	C0043227
28486935	one-on-one	C0557987
28486935	manage	C0184516
28486935	health care	C0086388
28486935	needs	C0027552
28486935	CI	C0009667
28486935	optimal	C2698651
28486935	health	C0018684
28486935	study	C2603343
28486935	characterized	C1880022
28486935	ED	C0562508
28486935	frequent	C0332183
28486935	users	C1706077
28486935	identified	C0205396
28486935	several	C0443302
28486935	opportunities	C0683937
28486935	population	C1257890
28486935	barriers	C0205556
28486935	care	C0017313
28486935	patient	C0030705
28486935	health systems	C1456613
28486935	needs	C0027552
28486935	prevent	C2700409
28486935	wellness	C0018684
28486935	population	C1257890
28490164	Contralateral	C0441988
28490164	Superior Cerebellar Artery Syndrome	C1384733
28490164	Consequence of	C0686907
28490164	Brain Herniation	C0553686
28490164	Vascular	C0005847
28490164	compromise	C2945640
28490164	consequence of	C0686907
28490164	brain herniation	C0553686
28490164	syndromes	C0039082
28490164	Transtentorial	C0522519
28490164	brain herniation	C0553686
28490164	posterior cerebral arteries	C0149576
28490164	isolated	C0205409
28490164	involvement	C1314939
28490164	contralateral	C0441988
28490164	superior cerebellar artery	C0149575
28490164	SCA	C0149575
28490164	unilateral	C0205092
28490164	impending	C0332190
28490164	brain herniation	C0553686
28490164	reported	C0700287
28490164	rare	C0522498
28490164	entity	C1551338
28490164	man	C0025266
28490164	impending	C0332190
28490164	herniation	C0019270
28490164	multiloculated	C0205293
28490164	hydrocephalus	C0020255
28490164	course of illness	C0242656
28490164	isolated	C0205409
28490164	SCA	C0149575
28490164	ischemia	C0022116
28490164	dilated	C0700124
28490164	horn	C0019939
28490164	article	C1706852
28490164	pathophysiologic	C0031847
28490164	mechanisms	C0441712
28490164	phenomenon	C1882365
28490164	inclusive	C0332257
28490164	brain	C0006104
28490164	suspected	C0750491
28490164	Kernohan-Woltman notch phenomenon	C0030660
28490164	unilateral	C0205092
28490164	brain herniation	C0553686
28490164	rationale	C2699007
28490164	commentary	C0282411
28490164	contralateral	C0441988
28490164	SCA	C0149575
28490164	transient ischemia	C0022118
28490164	infarct	C0021308
28490164	underdiagnosed	C0243095
28490164	pathomechanism	C0030660
28490164	ipsilateral	C0441989
28490164	hemiparesis	C0018989
28490164	vague	C0205408
28490164	phenomenon	C1882365
28490376	effects of	C1704420
28490376	clinical supervision	C0870294
28490376	supervisees	C1257890
28490376	patients	C0030705
28490376	cognitive-behavioral therapy	C0009244
28490376	study protocol	C2348563
28490376	systematic review	C1955832
28490376	Clinical supervision	C0870294
28490376	senior therapist	C0871525
28490376	practice	C0032893
28490376	psychotherapist	C0557555
28490376	training	C0220931
28490376	psychiatric care	C0597312
28490376	clinical supervision	C0870294
28490376	educational and governing institutions	C0681325
28490376	clinical supervision	C0870294
28490376	supervisees	C1257890
28490376	competence	C0086035
28490376	attitudes	C0004271
28490376	behaviors	C0004927
28490376	skills	C0678856
28490376	treatment outcomes	C0085415
28490376	patient	C0030705
28490376	Evidence-based practice	C1510541
28490376	clinical settings	C3176918
28490376	systematic review	C1955832
28490376	empirical literature	C0023866
28490376	clinical supervision	C0870294
28490376	cognitive-behavioral therapy	C0009244
28490376	systematic review	C1955832
28490376	literature	C0023866
28490376	supervised psychotherapists	C0557555
28490376	patients	C0030705
28490376	indexed	C0918012
28490376	MEDLINE	C0025141
28490376	EMBASE	C0282574
28490376	PsycINFO	C1140129
28490376	Cochrane Library databases	C0282574
28490376	Data	C1511726
28490376	psychotherapists	C0557555
28490376	patients	C0030705
28490376	reported	C0684224
28490376	systematic review	C1955832
28490376	guidelines	C0162791
28490376	systematic reviews	C1955832
28490376	clinical supervision	C0870294
28490376	cognitive-behavioral therapy	C0009244
28490376	research	C0035168
28492106	Higher risk of	C0332167
28492106	revision	C0439617
28492106	infection	C3714514
28492106	systemic	C0205373
28492106	clindamycin	C0008947
28492106	prophylaxis	C0282638
28492106	cloxacillin	C0009077
28492106	Clindamycin	C0008947
28492106	antibiotics	C0003232
28492106	prophylaxis	C0282638
28492106	arthroplasty	C0003893
28492106	Swedish Knee Arthroplasty Register	C0034975
28492106	Knee Arthroplasty	C0086511
28492106	SKAR	C0034975
28492106	collecting	C1516698
28492106	information	C1533716
28492106	prophylactic antibiotic regime	C0282638
28492106	individual	C0237401
28492106	operation	C0038895
28492106	Sweden	C0038995
28492106	allergy	C0020517
28492106	penicillin	C0220892
28492106	clindamycin	C0008947
28492106	recommended	C0034866
28492106	alternative	C1523987
28492106	revision	C0439617
28492106	infection	C3714514
28492106	antibiotic	C0003232
28492106	systemic	C0205373
28492106	prophylaxis	C0282638
28492106	Patients	C0030705
28492106	Patients	C0030705
28492106	total knee arthroplasty	C0086511
28492106	TKA	C0086511
28492106	osteoarthritis	C0029408
28492106	OA	C0029408
28492106	antibiotic	C0003232
28492106	operations	C0038895
28492106	patients	C0030705
28492106	Survival statistics	C0600673
28492106	revision	C0439617
28492106	infection	C3714514
28492106	patients	C0030705
28492106	cloxacillin	C0009077
28492106	clindamycin	C0008947
28492106	systemic	C0205373
28492106	prophylaxis	C0282638
28492106	Cloxacillin	C0009077
28492106	clindamycin	C0008947
28492106	cephalosporins	C3536856
28492106	infection	C3714514
28492106	clindamycin	C0008947
28492106	cloxacillin	C0009077
28492106	revision	C0439617
28492106	causes	C0015127
28492106	Interpretation	C0459471
28492106	patients	C0030705
28492106	allergic reaction	C1527304
28492106	penicillin	C0220892
28492106	allergic history	C2106654
28492106	history	C2106654
28492106	type-I allergic reaction	C1527304
28492106	urticaria	C0042109
28492106	anaphylaxis	C0850803
28492106	bronchospasm	C0006266
28492106	third-generation cephalosporin	C0304320
28492106	clindamycin	C0008947
28492106	perioperative	C1518988
28492106	prophylaxis	C0282638
28492106	TKR	C0086511
28492106	recommendation	C0034866
28492106	patients	C0030705
28492106	type-1 allergy	C0020517
28492483	PCVMZM	C1516769
28492483	Probabilistic Classification Vector Machines Model Combined with a Zernike Moments	C1516769
28492483	Predict	C0681842
28492483	Protein-Protein Interactions	C0872079
28492483	Protein Sequences	C0002518
28492483	Protein-protein interactions	C0872079
28492483	PPIs	C0872079
28492483	living organisms	C0029235
28492483	PPIs	C0872079
28492483	molecular	C1521991
28492483	mechanisms	C0441712
28492483	biological systems	C0449913
28492483	PPIs	C0872079
28492483	high-throughput technologies	C0872047
28492483	organisms	C0029235
28492483	high-throughput technologies	C0872047
28492483	PPIs	C0872079
28492483	unavoidable defects	C1457869
28492483	time consumption	C0040223
28492483	cost	C0010186
28492483	error rate	C0392762
28492483	machine learning	C0376284
28492483	computational methods	C1516769
28492483	PPIs	C0872079
28492483	prediction	C0681842
28492483	PCVMZM	C1516769
28492483	computational method	C1516769
28492483	Probabilistic Classification Vector Machines (PCVM) model	C2699740
28492483	Zernike moments (ZM) descriptor	C0026346
28492483	predicting	C0681842
28492483	PPIs	C0872079
28492483	protein	C0033684
28492483	amino acids sequences	C0002518
28492483	Zernike moments (ZM) descriptor	C0026346
28492483	protein	C0033684
28492483	information	C1533716
28492483	Position-Specific Scoring Matrix	C2717845
28492483	PSSM	C2717845
28492483	Position-Specific Iterated Basic Local Alignment Search Tool (PSI-BLAST)	C2698333
28492483	PCVM classifier	C2699740
28492483	interactions	C0872079
28492483	protein	C0033684
28492483	PPIs	C0872079
28492483	Yeast	C0043393
28492483	H. Pylori	C0079488
28492483	prediction	C0681842
28492483	accuracy	C0443131
28492483	state-of-the-art	C0038199
28492483	support vector machines	C2699740
28492483	SVM) classifier	C2699740
28492483	PCVM model	C2699740
28492483	Experimental results	C2825142
28492483	Yeast	C0043393
28492483	PCVM classifier	C2699740
28492483	SVM classifier	C2699740
28492483	experimental results	C2825142
28492483	proteomics research	C0035168
28493125	Conditional	C1701901
28493125	Knockdown	C2350567
28493125	Endogenous	C0205227
28493125	MicroRNAs	C1101610
28493125	CHO Cells	C0085080
28493125	TET-ON-SanDI Sponge Vectors	C0017397
28493125	MicroRNAs	C1101610
28493125	miRNAs	C1101610
28493125	noncoding RNAs	C0887909
28493125	nucleotides	C0028630
28493125	targets	C1521840
28493125	genetic modifications	C4277689
28493125	phenotype	C0031437
28493125	biotech	C0005574
28493125	industry	C0021267
28493125	miRNA sponge" vectors	C0017397
28493125	tandem miRNA	C1101610
28493125	binding sites	C0005456
28493125	transcripts	C1519595
28493125	transcriptionally regulated	C1158770
28493125	promoter	C0086860
28493125	down regulating	C0013081
28493125	endogenous	C0205227
28493125	microRNAs	C1101610
28493125	Chinese hamster ovary (CHO) cells	C0085080
28493125	antisense oligonucleotides	C0079925
28493125	miRNA sponges	C0599566
28493125	biotechnological	C0005574
28493125	processes	C1522240
28493125	effective	C1704419
28493125	expression	C0017262
28493125	miRNA sponges	C0599566
28493125	CHO cell lines	C0085080
28493125	expressing	C0017262
28493125	TET-ON-SanDI-miRNA-sponge	C0599566
28493125	inducer	C3898767
28494421	Forest	C0086312
28494421	protected areas	C0017446
28494421	governance	C0243148
28494421	Zimbabwe	C0043476
28494421	Shift	C2347509
28494421	long history	C3714536
28494421	local	C0205276
28494421	community	C0009462
28494421	exclusion	C2828389
28494421	concept	C0178566
28494421	exclusion	C2828389
28494421	local	C0205276
28494421	communities	C0009462
28494421	accessing	C0015472
28494421	resources	C0027492
28494421	forest	C0086312
28494421	protected areas	C0017446
28494421	FPAs	C0017446
28494421	Zimbabwe	C0043476
28494421	colonial	C0870077
28494421	post	C0687676
28494421	colonial forms	C0870077
28494421	mechanisms	C0441712
28494421	exclusion	C2828389
28494421	social	C0037403
28494421	economic	C0013551
28494421	ecological outcomes	C0870460
28494421	examined	C0332128
28494421	range	C1514721
28494421	powers	C0037430
28494421	processes	C1522240
28494421	social relations	C0037397
28494421	impact	C4049986
28494421	local	C0205276
28494421	communities	C0009462
28494421	access	C0015472
28494421	FPA	C0017446
28494421	resources	C0027492
28494421	benefits	C0814225
28494421	historical	C0681698
28494421	trajectory	C0392747
28494421	forest	C0086312
28494421	governance	C0243148
28494421	Zimbabwe	C0043476
28494421	forms	C0348078
28494421	extent	C0439792
28494421	exclusion	C2828389
28494421	changed	C0443172
28494421	over	C0347984
28494421	time	C0040223
28494421	shifting	C0333051
28494421	political	C0032381
28494421	economic landscape	C0282159
28494421	colonial period	C1254367
28494421	exclusion	C2828389
28494421	people	C0027361
28494421	evicted	C2828389
28494421	forest	C0086312
28494421	land	C0557668
28494421	denied	C0332319
28494421	access	C0015472
28494421	basic	C1527178
28494421	resources	C0027492
28494421	Local	C0205276
28494421	communities	C0009462
28494421	access	C0015472
28494421	low	C0205251
28494421	value	C1522609
28494421	FPA	C0017446
28494421	resources	C0027492
28494421	improved	C0184511
28494421	post-colonial period	C1254367
28494421	access	C0015472
28494421	high	C0205250
28494421	value	C1522609
28494421	resources	C0027492
28494421	commercial timber	C0043217
28494421	sharing	C0237876
28494421	income	C0021162
28494421	benefits	C0814225
28494421	derived	C1441547
28494421	FPA	C0017446
28494421	commercial activities	C0441655
28494421	pipe dream	C1254372
28494421	Regulation	C0851285
28494421	legitimation	C0023637
28494421	FPA	C0017446
28494421	governing	C0243148
28494421	authorities	C0599437
28494421	exclude	C2828389
28494421	local	C0205276
28494421	communities	C0009462
28494421	intact	C0205266
28494421	collaborative	C0282116
28494421	governance	C0243148
28494421	local	C0205276
28494421	communities	C0009462
28494421	expressed	C0455212
28494421	dissatisfaction	C0870433
28494421	centralised exclusionary governance system	C0034982
28494421	FPAs	C0017446
28494421	ungovernable	C0243095
28494421	policy	C0242456
28494421	reform	C0392747
28494421	FPA	C0017446
28494421	sector	C1708237
28494421	improve	C0184511
28494421	current	C0521116
28494421	dire situation	C0013956
28495504	Renal arterial mycotic aneurysm	C0085808
28495504	kidney transplantation	C0022671
28495504	Mycotic aneurysm	C0085808
28495504	attributable	C0449234
28495504	Candida	C0006836
28495504	Aspergillus species	C0004034
28495504	Candida	C0006836
28495504	arteritis	C0003860
28495504	kidney transplant	C0022671
28495504	patients	C0030705
28495504	report	C0684224
28495504	kidney	C0022646
28495504	donor	C0013018
28495504	accidental	C0521129
28495504	digestive wound	C0850041
28495504	organ retrieval	C0162438
28495504	anuria	C0003460
28495504	renal transplantation	C0022671
28495504	mycotic aneurysm	C0085808
28495504	kidney graft	C1720289
28495504	renal artery	C0035065
28495504	Organs	C0178784
28495504	donors	C0013018
28495504	digestive breach	C0850041
28495504	used with caution	C1710588
28496002	Risk of cancer	C0596244
28496002	patients	C0030705
28496002	heart failure	C0018801
28496002	digoxin	C0012265
28496002	follow-up study	C0016441
28496002	cell	C0007634
28496002	verification	C1711411
28496002	Heart failure	C0018801
28496002	HF	C0018801
28496002	cause of death	C0007465
28496002	world	C2700280
28496002	digoxin	C0012265
28496002	therapies	C0087111
28496002	HF	C0018801
28496002	safety	C0036043
28496002	efficacy	C1280519
28496002	use	C0457083
28496002	uncertainty	C0087130
28496002	long-term	C0443252
28496002	efficacy	C1280519
28496002	safety	C0036043
28496002	repositioning	C0556030
28496002	cardiac glycosides	C0007158
28496002	function	C0542341
28496002	anti-tumor activity	C0920425
28496002	multiple	C0439064
28496002	working pathways	C1705987
28496002	compare	C1707455
28496002	potential	C3245505
28496002	effects	C1280500
28496002	digoxin	C0012265
28496002	clinical	C0205210
28496002	patients	C0030705
28496002	cell lines	C0085983
28496002	patient information	C1955348
28496002	National Health Insurance Research database	C0242356
28496002	Taiwan	C0039260
28496002	retrospective study	C0035363
28496002	cohort	C0599755
28496002	patients	C0030705
28496002	comparison	C1707455
28496002	cohort	C0599755
28496002	analytical data	C1511726
28496002	patients	C0030705
28496002	digoxin	C0012265
28496002	increased	C0205217
28496002	risk of cancers	C0596244
28496002	breast	C0006142
28496002	liver	C0345904
28496002	lung cancers	C0684249
28496002	follow-up period	C1522577
28496002	anti-tumor function	C0920425
28496002	digoxin	C0012265
28496002	potential	C3245505
28496002	pathway	C1291081
28496002	digoxin	C0012265
28496002	cell	C0007634
28496002	strategy	C0679199
28496002	breast cancer	C0678222
28496002	cell lines	C0085983
28496002	MCF-7	C0596890
28496002	BT-474	C0085983
28496002	MAD-MB-231	C0085983
28496002	ZR-75-1	C0085983
28496002	Digoxin	C0012265
28496002	cytotoxicity	C0596402
28496002	cell lines	C0085983
28496002	concentration	C1446561
28496002	proliferation	C1514485
28496002	ZR-75-1 cells	C0085983
28496002	cell lines	C0085983
28496002	digoxin	C0012265
28496002	suppressed	C1260953
28496002	digoxin	C0012265
28496002	responsiveness	C0205342
28496002	SRSF3	C1419994
28496002	digoxin	C0012265
28496002	cell-type	C0449475
28496002	differences	C1705242
28496002	cohort study	C0009247
28496002	digoxin	C0012265
28496002	treatment	C0087111
28496002	HF	C0018801
28496002	patients	C0030705
28496002	cell	C0007634
28496002	strategy	C0679199
28496002	complexity	C0439855
28496002	personalized medicine	C2718059
28496419	Analysis of Patients	C0679830
28496419	Takotsubo Cardiomyopathy	C1739395
28496419	Triggered by	C1444748
28496419	Emotional Stress	C0086209
28496419	Physical Stress	C0231302
28496419	takotsubo cardiomyopathy	C1739395
28496419	TTC	C1739395
28496419	triggered by	C1444748
28496419	physical	C0231302
28496419	emotional stresses	C0086209
28496419	short-	C0443303
28496419	long-term	C0443252
28496419	emotional-	C0086209
28496419	physical stress	C0231302
28496419	associated with	C0332281
28496419	TTC	C1739395
28496419	institutional database	C0242356
28496419	patients	C0030705
28496419	diagnosed	C0011900
28496419	TTC	C1739395
28496419	patients	C0030705
28496419	groups	C0441833
28496419	emotional stress	C0086209
28496419	physical stress	C0231302
28496419	endpoint	C2349179
28496419	composite	C0205199
28496419	in-hospital events	C0243095
28496419	thromboembolic events	C0040038
28496419	life-threatening	C2826244
28496419	arrhythmias	C0003811
28496419	myocardial infarction	C0027051
28496419	cause of mortality	C1408525
28496419	re-hospitalization	C1254363
28496419	heart failure	C0018801
28496419	stroke	C0038454
28496419	recurrence	C0034897
28496419	TTC	C1739395
28496419	Kaplan-Meier analysis	C1720943
28496419	survival rate	C0038954
28496419	follow-up	C1522577
28496419	emotional	C0086209
28496419	group	C0441833
28496419	physical stress	C0231302
28496419	group	C0441833
28496419	Multivariate Cox regression analysis	C0034980
28496419	emotional stress	C0086209
28496419	negative independent predictor	C0243095
28496419	endpoint	C2349179
28496419	in-hospital events	C0243095
28496419	short-	C0443303
28496419	long-term	C0443252
28496419	TTC	C1739395
28496419	patients	C0030705
28496419	suffering	C0683278
28496419	emotional stress	C0086209
28496419	patients	C0030705
28496419	physical stress	C0231302
28497887	Surviving	C0220921
28497887	moment	C0040223
28497887	moment	C0040223
28497887	experience	C0596545
28497887	living	C0376558
28497887	state	C0278060
28497887	ambivalence	C0233495
28497887	recurrent	C2945760
28497887	suicide attempts	C0038663
28497887	qualitative study	C0949415
28497887	experience	C0596545
28497887	living	C0376558
28497887	ambivalent space	C0233495
28497887	life	C0376558
28497887	death	C1546949
28497887	adults	C0001675
28497887	recurrent	C2945760
28497887	suicide attempts	C0038663
28497887	RSA	C0038663
28497887	expand	C0205229
28497887	study	C2603343
28497887	processes	C0025361
28497887	involved	C1314939
28497887	transitioning	C2700061
28497887	RSA	C0038663
28497887	adults	C0001675
28497887	revealed	C0443289
28497887	ambivalent space	C0233495
28497887	process	C1522240
28497887	Interpretive phenomenological analysis	C0936012
28497887	IPA	C0936012
28497887	methodology	C3266812
28497887	designed	C1707689
28497887	lived experiences	C0596545
28497887	meaning making	C0025361
28497887	interpretation	C0871180
28497887	multidimensional	C2347299
28497887	subjective	C0439655
28497887	experiences	C0596545
28497887	RSA	C0038663
28497887	participants	C0679646
28497887	semi-structured interviews	C0681913
28497887	conducted	C0441655
28497887	adult women	C0043210
28497887	history	C0019665
28497887	RSA	C0038663
28497887	participated	C0679823
28497887	therapeutic intervention	C0808232
28497887	research	C0035168
28497887	site	C0205145
28497887	Skills	C0678856
28497887	Safer Living	C0376558
28497887	Psychosocial	C0542298
28497887	Psychoeducational Intervention	C0871175
28497887	People	C0027361
28497887	Recurrent	C2945760
28497887	Suicide Attempts	C0038663
28497887	SfSL	C0376558
28497887	PISA	C0038663
28497887	stages	C1306673
28497887	IPA	C0936012
28497887	analyse	C0936012
28497887	interview	C0683518
28497887	data	C1511726
28497887	Analysis	C0936012
28497887	revealed	C0443289
28497887	superordinate theme	C0869035
28497887	surviving	C0220921
28497887	moment	C0040223
28497887	moment	C0040223
28497887	precarious state	C0278060
28497887	making decisions	C0011109
28497887	life	C0376558
28497887	destiny	C0016884
28497887	moment	C0040223
28497887	moment	C0040223
28497887	commitment	C0870312
28497887	life	C0376558
28497887	death	C1546949
28497887	subordinate themes	C0869035
28497887	identified	C0205396
28497887	deciding	C0205556
28497887	die	C4061184
28497887	moment	C0040223
28497887	participants	C0679646
28497887	invested	C0205245
28497887	dying	C4061184
28497887	living	C0376558
28497887	deciding	C0205556
28497887	live	C0376558
28497887	moment	C0040223
28497887	invested	C0205245
28497887	living	C0376558
28497887	dying	C4061184
28497887	study	C2603343
28497887	complex	C0439855
28497887	process	C1522240
28497887	making decisions	C0011109
28497887	destiny	C0016884
28497887	moment	C0040223
28497887	moment	C0040223
28497887	revealed	C0443289
28497887	experienced	C0596545
28497887	state	C0278060
28497887	paradoxically	C0205310
28497887	indecision	C0423908
28497887	life	C0376558
28497887	death	C1546949
28497887	provided	C1999230
28497887	lifeline	C0376558
28497887	opportunity	C0205556
28497887	RSA	C0038663
28497887	Clinicians	C0871685
28497887	associated with	C0332281
28497887	state	C0278060
28497887	interventions	C0184661
28497887	Surviving	C0220921
28497887	moment	C0040223
28497887	moment	C0040223
28497887	characterized	C1880022
28497887	state	C0278060
28497887	emotional flux	C0849912
28497887	uncertainty	C0087130
28497887	destiny	C0016884
28497887	person	C0027361
28497887	life	C0376558
28497887	death	C1546949
28497887	state	C0278060
28497887	interlinked subprocesses	C0025361
28497887	person	C0027361
28497887	leaning	C0558295
28497887	death	C1546949
28497887	life	C0376558
28497887	feature	C2348519
28497887	working	C0043227
28497887	client group	C0008942
28497887	ambiguity	C2346729
28497887	fragility	C3553489
28497887	temporality	C0040226
28497887	decisions	C0679006
28497887	destiny	C0016884
28497887	practitioner	C1709627
28497887	opportunity	C0205556
28497887	life	C0376558
28497887	understanding	C0162340
28497887	survival	C0220921
28497887	struggle	C0243095
28497887	tailoring intervention	C0184661
28497887	nuanced processes	C0025361
28497887	state	C0278060
28500997	policy	C0242456
28500997	earlier induction	C3710446
28500997	labour	C0022864
28500997	outcomes	C1274040
28500997	women	C0033011
28500997	induced	C0205263
28500997	postmaturity	C0221007
28500997	retrospective	C1514923
28500997	analysis	C0936012
28500997	tertiary hospital	C0337954
28500997	North	C1709269
28500997	England	C0014282
28500997	investigate	C1292732
28500997	change	C0392747
28500997	management	C1273870
28500997	postmature pregnancy	C0032993
28500997	earlier induction	C3710446
28500997	length of labour	C0566679
28500997	induction process	C0259787
28500997	assess	C1516048
28500997	feasibility	C0015730
28500997	research process	C0242481
28500997	future	C0016884
28500997	larger study	C2603343
28500997	change	C0392747
28500997	management	C1273870
28500997	postmature pregnancy	C0032993
28500997	NHS	C0027462
28500997	hospital	C0019994
28500997	October	C3828732
28500997	induction	C0259787
28500997	weeks	C0439230
28500997	gestation	C0032961
28500997	induction	C0259787
28500997	weeks	C0439230
28500997	provided	C1999230
28500997	opportunity	C0683937
28500997	retrospective	C1514923
28500997	analysis	C0936012
28500997	Pre-existing	C2347662
28500997	data	C1511726
28500997	maternity	C0681108
28500997	database	C0242356
28500997	casenotes	C3842891
28500997	collected	C1516698
28500997	primary outcomes	C0086750
28500997	analysed	C0936012
28500997	Mann-Whitney test	C1708930
28500997	Hodges-Lehman confidence interval	C0009667
28500997	differences	C1705242
28500997	medians	C0876920
28500997	large city	C0008848
28500997	tertiary referral hospital	C0587437
28500997	North	C1709269
28500997	England	C0014282
28500997	women	C0033011
28500997	induced	C0205263
28500997	change	C0392747
28500997	policy	C0242456
28500997	compared	C1707455
28500997	women	C0033011
28500997	induced	C0205263
28500997	change	C0392747
28500997	primary outcomes	C0086750
28500997	length	C1444754
28500997	1st	C0022871
28500997	2nd stage of labour	C0022872
28500997	length of labour	C0566679
28500997	length	C1444754
28500997	induction	C0259787
28500997	established	C0443211
28500997	labour	C0022864
28500997	length	C1444754
28500997	induction	C0259787
28500997	birth	C0005615
28500997	median	C0876920
28500997	length of labour	C0566679
28500997	women	C0033011
28500997	induced	C0205263
28500997	weeks	C0439230
28500997	hours	C0439227
28500997	women	C0033011
28500997	induced	C0205263
28500997	weeks	C0439230
28500997	hours	C0439227
28500997	difference	C1705242
28500997	statistically significant	C0237881
28500997	CI	C0009667
28500997	median	C0876920
28500997	difference	C1705242
28500997	hours	C0439227
28500997	small effect size	C0814843
28500997	Pearson's	C0871052
28500997	median	C0876920
28500997	length	C1444754
28500997	induction	C0259787
28500997	birth	C0005615
28500997	hours	C0439227
28500997	women	C0033011
28500997	induced	C0205263
28500997	weeks	C0439230
28500997	hours	C0439227
28500997	women	C0033011
28500997	induced	C0205263
28500997	weeks	C0439230
28500997	difference	C1705242
28500997	statistically significant	C0237881
28500997	CI	C0009667
28500997	median	C0876920
28500997	difference	C1705242
28500997	hours	C0439227
28500997	small effect size	C0814843
28500997	Pearson's	C0871052
28500997	study	C2603343
28500997	statistically significant	C0237881
28500997	difference	C1705242
28500997	length of labour	C0566679
28500997	induction	C0259787
28500997	change	C0392747
28500997	management	C1273870
28500997	postmature pregnancy	C0032993
28500997	earlier induction	C3710446
28500997	large study	C2603343
28500997	establish	C0443211
28500997	effects of	C1704420
28500997	earlier induction	C3710446
28500997	labour	C0022864
28500997	outcomes	C1274040
28501006	Liquid chromatography-mass spectrometry	C0872318
28501006	quantitative proteomics analysis	C0022885
28501006	proteomics	C0872252
28501006	chondroprotective effects	C0243095
28501006	astragaloside IV	C0378018
28501006	interleukin-1β	C0021753
28501006	induced	C0205263
28501006	SW1353 chondrocyte-like cells	C1516497
28501006	Chondrocyte	C0225369
28501006	apoptosis	C0162638
28501006	progression	C0242656
28501006	Osteoarthritis	C0029408
28501006	OA	C0029408
28501006	drugs	C3687832
28501006	treatment	C1522326
28501006	OA	C0029408
28501006	study	C1706256
28501006	Astragaloside IV	C0378018
28501006	ASG-IV	C0378018
28501006	protective effect	C0678771
28501006	articular cartilage degeneration	C1394964
28501006	proliferation	C1514485
28501006	chondrocyte	C0225369
28501006	study	C1706256
28501006	effects	C0728866
28501006	mechanisms	C0441712
28501006	ASG-IV	C0378018
28501006	chondrocyte	C0225369
28501006	apoptosis	C0162638
28501006	Isobaric Tags For Relative And Absolute Quantitation (iTRAQ)-based quantitative proteomics	C0022885
28501006	proteomics	C0872252
28501006	detect	C0442726
28501006	map	C1283195
28501006	proteins	C0033684
28501006	SW1353 chondrocyte-like cells	C1516497
28501006	pre-treated	C1522326
28501006	ASG-IV	C0378018
28501006	interleukin-1β	C0021753
28501006	IL-1β	C0021753
28501006	ASG-IV	C0378018
28501006	IL-1β	C0021753
28501006	iTRAQ-labeled peptides	C0030956
28501006	fractionated	C1979893
28501006	high-accuracy liquid chromatography-mass spectrometry	C0872318
28501006	LC-MS	C0872318
28501006	Cell apoptosis	C0162638
28501006	differentially expressed proteins	C0033684
28501006	detected	C0442726
28501006	flow cytometry	C0016263
28501006	FCM	C0016263
28501006	quantitative real-time polymerase chain reaction	C3179034
28501006	qRT-PCR	C3179034
28501006	western blotting	C0005863
28501006	apoptosis	C0162638
28501006	IL-1β	C0021753
28501006	induced	C0205263
28501006	SW1353 cells	C1516497
28501006	treated	C1522326
28501006	ASG-IV	C0378018
28501006	inhibited	C0311403
28501006	Bioinformatics	C1140694
28501006	Bioinformatics analysis	C0022885
28501006	gamma actin 1	C3884655
28501006	ACTG1	C3884655
28501006	Yes Associated Protein 1	C1318127
28501006	YAP1	C1318127
28501006	Hippo signaling pathway	C3158583
28501006	Vitronectin	C4281807
28501006	VTN	C4281807
28501006	Collagen Type I Alpha 1 Chain	C0972255
28501006	COL1A1	C0972255
28501006	extracellular matrix (ECM)-receptor interaction signaling pathway	C2984324
28501006	up-regulated	C0041904
28501006	IL-1β	C0021753
28501006	induced	C0205263
28501006	SW1353 cells	C1516497
28501006	treatment	C1522326
28501006	ASG-IV	C0378018
28501006	qRT-PCR	C3179034
28501006	Western blotting	C0005863
28501006	up-regulation	C0041904
28501006	genes	C0017337
28501006	ASG-IV	C0378018
28501006	positive role	C1446409
28501006	human	C0086418
28501006	osteoarthritic chondrocyte apoptosis	C0162638
28501006	chondrocyte	C0225369
28501006	modulation	C0544633
28501006	Hippo signaling pathway	C3158583
28501006	up-regulating	C0041904
28501006	YAP1	C1318127
28501006	ACTG1	C3884655
28501006	expression	C0017262
28501006	up-regulating	C0041904
28501006	VTN	C4281807
28501006	COL1A1	C0972255
28501006	ECM-receptor interaction pathway	C2984324
28501006	ASG-IV	C0378018
28501006	therapeutic	C0302350
28501006	potential	C3245505
28501006	treatment	C1522326
28501006	OA	C0029408
28501764	Open-label, multicentre safety study	C1709323
28501764	vemurafenib	C3192263
28501764	patients	C0030705
28501764	BRAF(V600) mutation	C3811884
28501764	positive	C1514241
28501764	metastatic melanoma	C0278883
28501764	follow-up	C1522577
28501764	data	C1511726
28501764	long-term	C0443252
28501764	responders' analysis	C0936012
28501764	orally	C0442027
28501764	BRAF kinase inhibitor	C3838813
28501764	vemurafenib	C3192263
28501764	effective	C1704419
28501764	tolerable	C4053931
28501764	treatment option	C0683525
28501764	patients	C0030705
28501764	metastatic melanoma	C0278883
28501764	BRAF(V600) mutations	C3811884
28501764	assessed	C1516048
28501764	safety	C0678800
28501764	vemurafenib	C3192263
28501764	large	C0549177
28501764	population	C1257890
28501764	patients	C0030705
28501764	alternative	C1523987
28501764	treatment options	C0683525
28501764	safety	C0678800
28501764	open-label, multicentre study	C1709323
28501764	vemurafenib	C3192263
28501764	patients	C0030705
28501764	treated	C1522326
28501764	untreated	C0332155
28501764	BRAF mutation	C3811884
28501764	positive	C1514241
28501764	metastatic melanoma	C0278883
28501764	cobas(®) 4800	C0025080
28501764	BRAF V600 Mutation Test	C1504359
28501764	primary	C0205225
28501764	end-point	C2349179
28501764	safety	C0678800
28501764	end-points	C2349179
28501764	secondary	C0175668
28501764	exploratory analysis	C0936012
28501764	assess	C0184514
28501764	safety	C0678800
28501764	outcomes	C0085415
28501764	patients	C0030705
28501764	long	C0205166
28501764	duration of response	C0237585
28501764	DOR	C0237585
28501764	months	C0439231
28501764	median	C0549183
28501764	follow-up	C1522577
28501764	months	C0439231
28501764	months	C0439231
28501764	patients	C0030705
28501764	discontinued treatment	C0558681
28501764	Adverse events	C0877248
28501764	AEs	C0877248
28501764	consistent with	C0332290
28501764	treatment	C0039798
28501764	AEs	C0877248
28501764	arthralgia	C0003862
28501764	alopecia	C0002170
28501764	hyperkeratosis	C0870082
28501764	treatment	C0039798
28501764	AEs	C0877248
28501764	squamous cell carcinoma of the skin	C0553723
28501764	keratoacanthoma	C0022572
28501764	exploratory analysis	C0936012
28501764	patients	C0030705
28501764	DOR	C0237585
28501764	months	C0439231
28501764	months	C0439231
28501764	AEs	C0877248
28501764	overall	C1561607
28501764	population	C1257890
28501764	specific	C0205369
28501764	safety signals	C0183301
28501764	vemurafenib	C3192263
28501764	vemurafenib exposure	C0743284
28501764	follow-up	C1522577
28501764	safety	C0678800
28501764	large group	C0679991
28501764	patients	C0030705
28501764	BRAF(V600) mutation	C3811884
28501764	positive	C1514241
28501764	metastatic melanoma	C0278883
28501764	clinical practice	C0205897
28501764	clinical trial	C0008976
28501764	populations	C1257890
28501764	long-term	C0443252
28501764	vemurafenib	C3192263
28501764	treatment	C0039798
28501764	effective	C1704419
28501764	tolerable	C4053931
28501764	safety signals	C0183301
28502812	Collecting	C0010995
28502812	Reporting Safety Data	C0011000
28502812	Monitoring Trial Conduct	C1516647
28502812	Pragmatic Trials	C3658215
28502812	Pragmatic trials	C3658215
28502812	opportunity	C0683937
28502812	real-life	C0376558
28502812	data	C1511726
28502812	effectiveness	C1280519
28502812	safety	C0036043
28502812	treatment	C0087111
28502812	market authorisation	C2981648
28502812	penultimate paper	C1547566
28502812	design	C0013171
28502812	choices	C1707391
28502812	implementation	C1708476
28502812	pragmatic trials	C3658215
28502812	paper	C1547566
28502812	collecting	C0010995
28502812	reporting safety data	C0011000
28502812	monitoring trial conduct	C1516647
28502812	clinical care practice	C0695275
28502812	ICH	C0282574
28502812	serious adverse events	C1519255
28502812	SAEs	C1519255
28502812	drug	C1254351
28502812	interventional	C0184661
28502812	trial	C0008976
28502812	risk	C0035647
28502812	approach	C0449445
28502812	collection	C0010995
28502812	non	C1513916
28502812	drug	C1254351
28502812	non-serious AEs	C1518404
28502812	serious events	C2826307
28502812	treatment	C0087111
28502812	risk	C0035647
28502812	profile	C2003903
28502812	medicine	C0013227
28502812	patient	C0030705
28502812	population	C1257890
28502812	collection	C0010995
28502812	reporting of safety data	C0011000
28502812	study	C2603343
28502812	follow-up visits	C0589121
28502812	risk	C0035647
28502812	approach	C0449445
28502812	monitoring trial conduct	C1516647
28502812	risks	C0035647
28502812	pragmatic trial	C3658215
28502812	clinical trials	C0008976
28502812	mitigation	C1553901
28502812	management of these risks	C0035649
28502812	care	C1947933
28503431	pilot study	C0031928
28503431	intraocular lens explantation	C1096279
28503431	eyes	C0015392
28503431	Chinese patients	C0030705
28503431	intraocular lens (IOL) explantation	C1096279
28503431	demographic characteristics	C0683970
28503431	Retrospective	C1514923
28503431	non-comparative case series	C0150093
28503431	Clinical data	C1516606
28503431	patient charts	C1268547
28503431	demographic	C0683970
28503431	preoperative	C0205908
28503431	postoperative	C0032790
28503431	characteristics	C1521970
28503431	complications	C0009566
28503431	surgical methods	C0683469
28503431	visual acuity	C0200150
28503431	eyes	C0015392
28503431	Chinese	C0152035
28503431	patients	C0030705
28503431	IOL explants	C1096279
28503431	patients	C0030705
28503431	age	C0001779
28503431	time of explantation	C1254367
28503431	patients were female	C0150905
28503431	employment	C0014003
28503431	farmers	C0221460
28503431	retired	C4076599
28503431	students	C0038492
28503431	unemployed	C0041674
28503431	workers	C1527116
28503431	staff members	C1552089
28503431	teachers	C0221457
28503431	officers	C1549461
28503431	explantation	C0561946
28503431	dislocation	C0012691
28503431	decentration	C2609312
28503431	retinal detachment	C0035305
28503431	prevalent cause	C0015127
28503431	incorrect lens power	C1627355
28503431	eyes	C0015392
28503431	endophthalmitis	C0014236
28503431	posterior capsular opacity	C1444680
28503431	eyes	C0015392
28503431	impacting	C4049986
28503431	retinal surgery operation	C0197770
28503431	comorbidities	C0009488
28503431	high myopia	C0271183
28503431	eyes	C0015392
28503431	trauma	C3714660
28503431	eyes	C0015392
28503431	retinal detachment	C0035305
28503431	eyes	C0015392
28503431	congenital cataracts	C0009691
28503431	eyes	C0015392
28503431	Marfan's syndrome	C0024796
28503431	eyes	C0015392
28503431	mean time from implantation to explantation	C1254367
28503431	Treatment after explantation	C0032786
28503431	posterior chamber IOL implantation	C1298763
28503431	eyes	C0015392
28503431	aphakia	C0003534
28503431	eyes	C0015392
28503431	After surgery	C0241311
28503431	best corrected visual ability	C1690532
28503431	BCVA	C1690532
28503431	patients	C0030705
28503431	visual ability	C0042812
28503431	Dislocation	C0012691
28503431	decentration	C2609312
28503431	main cause	C0015127
28503431	explantation	C0561946
28503431	high myopia	C0271183
28503431	main risk factor	C0035648
28503431	Posterior chamber IOL implantation	C1298763
28503431	treatment after explantation	C0032786
28505472	Improvement	C2986411
28505472	older	C0001792
28505472	person	C0027361
28505472	specific	C0205369
28505472	QOL	C0034380
28505472	hearing aid	C0018768
28505472	fitting	C0185023
28505472	relation	C0439849
28505472	social interaction	C0037420
28505472	study	C2603343
28505472	aimed	C1947946
28505472	investigate	C1292732
28505472	hearing aids	C0018768
28505472	associated with	C0332281
28505472	improvement	C2986411
28505472	older	C0001792
28505472	person	C0027361
28505472	specific	C0205369
28505472	QOL	C0034380
28505472	social interactions	C0037420
28505472	modify	C0392747
28505472	association	C0439849
28505472	WHOQOL-OLD questionnaire	C0034394
28505472	answered	C1706817
28505472	older adults	C0001792
28505472	aged	C0001779
28505472	newly	C0750546
28505472	fitted	C0185023
28505472	hearing aids	C0018768
28505472	fitting	C0185023
28505472	afterward	C0205087
28505472	associations	C0439849
28505472	hearing aid	C0018768
28505472	usage	C0457083
28505472	social relations	C0683633
28505472	changes	C0392747
28505472	WHOQOL-OLD	C0034394
28505472	total score	C2964552
28505472	hearing aids	C0018768
28505472	fitting	C0185023
28505472	estimated	C0750572
28505472	adjusting	C0849719
28505472	possible	C0332149
28505472	confounders	C0009673
28505472	Older	C0001792
28505472	persons	C0027361
28505472	hearing loss	C3887873
28505472	experienced	C1709305
28505472	significant	C0750502
28505472	increases	C0442805
28505472	WHOQOL-OLD	C0034394
28505472	total score	C2964552
28505472	hearing aid	C0018768
28505472	fitting	C0185023
28505472	Regular	C0205272
28505472	use of	C1524063
28505472	hearing aid	C0018768
28505472	associated with	C0332281
28505472	greater	C1704243
28505472	increase	C0442805
28505472	total score	C2964552
28505472	combined	C0205195
28505472	categorical	C0683312
28505472	variable	C0439828
28505472	social relations	C0683633
28505472	hearing aid	C0018768
28505472	usage	C0457083
28505472	revealed	C0443289
28505472	separate	C0443299
28505472	effects	C1280500
28505472	variables	C0439828
28505472	combined	C0205195
28505472	effect	C1280500
28505472	frequent	C0332183
28505472	social interactions	C0037420
28505472	hearing aid	C0018768
28505472	regularly	C0205272
28505472	significantly	C0750502
28505472	greater	C1704243
28505472	increase	C0442805
28505472	WHOQOL-OLD	C0034394
28505472	total score	C2964552
28505472	study's	C2603343
28505472	findings	C2607943
28505472	indicate	C1521902
28505472	hearing aid	C0018768
28505472	fitting	C0185023
28505472	associated with	C0332281
28505472	subsequent	C0332282
28505472	improvement	C2986411
28505472	older	C0001792
28505472	person	C0027361
28505472	specific	C0205369
28505472	QOL	C0034380
28505472	improvements	C2986411
28505472	hearing	C0018767
28505472	hearing aid	C0018768
28505472	possibly	C0332149
28505472	enhanced	C2349975
28505472	communication	C0009452
28505472	opportunities	C0237506
28506958	Comparative Effectiveness Research	C2718022
28506958	Automated	C0205554
28506958	Pediatric	C1521725
28506958	Pneumonia	C0032285
28506958	Detection	C1511790
28506958	Multi-Institutional	C0026738
28506958	Clinical	C0205210
28506958	Repository	C3847505
28506958	PHIS	C0679918
28506958	Pilot Study	C0031928
28506958	Community-acquired pneumonia	C0694549
28506958	pediatric	C1521725
28506958	morbidity	C0026538
28506958	Administrative	C1292785
28506958	data	C1511726
28506958	comparative effectiveness research	C2718022
28506958	CER	C2718022
28506958	sample sizes	C0242618
28506958	detection	C0442726
28506958	important	C3898777
28506958	outcomes	C1274040
28506958	misclassification errors	C0743559
28506958	variable	C0439828
28506958	accuracy	C0443131
28506958	discharge diagnosis	C1555319
28506958	codes	C0805701
28506958	automated	C0205554
28506958	scalable	C1513040
28506958	accurate	C0443131
28506958	method	C0025663
28506958	determine	C0521095
28506958	presence	C0150312
28506958	absence	C0332197
28506958	pneumonia	C0032285
28506958	children	C0008059
28506958	chest imaging	C1531652
28506958	reports	C4274373
28506958	multi-institutional	C0026738
28506958	PHIS	C0679918
28506958	clinical	C0205210
28506958	repository	C3847505
28506958	pediatric	C1521725
28506958	CER	C2718022
28506958	administrative	C1292785
28506958	database	C0242356
28506958	children's hospitals	C0020017
28506958	clinical	C0205210
28506958	data	C1511726
28506958	scalable	C1513040
28506958	find	C0243095
28506958	patients	C0030705
28506958	bacterial pneumonia	C0004626
28506958	Natural Language Processing	C0027489
28506958	NLP	C0027489
28506958	application	C0205556
28506958	relevant	C2347946
28506958	information	C1533716
28506958	chest diagnostic imaging	C1531652
28506958	reports	C4274373
28506958	Domain	C1880389
28506958	experts	C0009817
28506958	established	C0443211
28506958	reference standard	C0034925
28506958	manually	C3842330
28506958	annotating	C0205245
28506958	reports	C4274373
28506958	NLP	C0027489
28506958	application	C0205556
28506958	pleural effusion	C0032227
28506958	pulmonary infiltrate	C0235896
28506958	pneumonia	C0032285
28506958	automatically	C3842331
28506958	reports	C4274373
28506958	automatically	C3842331
28506958	classify	C0008902
28506958	report	C4274373
28506958	consistent with	C0332290
28506958	bacterial pneumonia	C0004626
28506958	Compared	C1707455
28506958	diagnostic imaging	C0011923
28506958	reports	C4274373
28506958	reference standard	C0034925
28506958	accurate	C0443131
28506958	implementation	C1708476
28506958	machine learning	C0376284
28506958	algorithms	C0002045
28506958	NLP	C0027489
28506958	application	C0205556
28506958	relevant	C2347946
28506958	findings	C2607943
28506958	sensitivity	C0036667
28506958	positive	C1446409
28506958	predictive value	C1514307
28506958	classifying	C0008902
28506958	reports	C4274373
28506958	sensitivity	C0036667
28506958	positive	C1446409
28506958	predictive value	C1514307
28506958	specificity	C0037791
28506958	compared	C1707455
28506958	domain	C1880389
28506958	experts	C0009817
28506958	manually	C3842330
28506958	annotating	C0205245
28506958	reports	C0025102
28506958	NLP	C0027489
28506958	application	C0205556
28506958	significantly higher	C4055637
28506958	sensitivity	C0036667
28506958	positive	C1446409
28506958	predictive value	C1514307
28506958	specificity	C0037791
28506958	NLP	C0027489
28506958	pneumonia	C0032285
28506958	information	C1533716
28506958	pediatric	C1521725
28506958	diagnostic imaging	C0011923
28506958	reports	C4274373
28506958	performed	C0884358
28506958	domain	C1880389
28506958	experts	C0009817
28506958	pilot study	C0031928
28506958	NLP	C0027489
28506958	information	C1533716
28506958	collection	C1516698
28506958	imaging reports	C4274373
28506958	CER	C2718022
28507202	Determination	C1254363
28507202	volatile organic compounds	C2350439
28507202	exhaled	C0231800
28507202	cell lines	C0682523
28507202	derived	C1441547
28507202	hematological malignancies	C0376545
28507202	gas	C0017110
28507202	human	C0086418
28507202	exhaled	C0231800
28507202	volatile organic compounds	C2350439
28507202	VOCs	C2350439
28507202	health status	C0018759
28507202	body	C0242821
28507202	Analysis	C0936012
28507202	VOCs	C2350439
28507202	noninvasive	C2986496
28507202	diagnostic tool	C0430022
28507202	cancers	C0027651
28507202	VOCs	C2350439
28507202	gas	C0017110
28507202	exhaled	C0231800
28507202	cell	C0007634
28507202	cell type	C0449475
28507202	metabolites	C0870883
28507202	cancer markers	C0041366
28507202	clinical practice	C0205897
28507202	Solid phase microextraction	C1720881
28507202	gas chromatography	C0008555
28507202	mass spectrometry	C0037813
28507202	VOCs	C2350439
28507202	tissue culture flask	C0492793
28507202	non-Hodgkin's lymphoma	C0024305
28507202	cell line JEKO	C0085983
28507202	acute mononuclear leukemia	C0085669
28507202	cell line SHI-1	C0085983
28507202	gaseous	C0017110
28507202	biomarkers	C0041366
28507202	hematological malignancies	C0376545
28507202	macrophage cells	C0024432
28507202	lymphocytic cells	C0024264
28507202	control	C0009932
28507202	blank group	C0441833
28507202	RPMI 1640 medium	C0010454
28507202	fetal calf serum	C3812213
28507202	cells	C0007634
28507202	control group	C0009932
28507202	concentration	C1446561
28507202	dimethyl sulphide	C0574031
28507202	2,4-dimethyl-heptane	C0574031
28507202	methylbenzene	C0040383
28507202	o-xylene	C0046596
28507202	dodecane	C0067942
28507202	1,3-ditert-butylbenzene	C0574031
28507202	JEKO cells	C0085983
28507202	ethanol	C0001962
28507202	hexanal	C0068007
28507202	benzaldehyde	C0005023
28507202	SHI-1 cells	C0085983
28507202	2,4-dimethyl-heptane	C0574031
28507202	benzene	C0005036
28507202	4-methyldecane	C0574031
28507202	chloroform	C0008238
28507202	3,7-dimethyl dodecane	C0574031
28507202	hexadecane	C0068005
28507202	hexanol	C0001978
28507202	cyclohexanol	C0010569
28507202	pilot study	C0031928
28507202	malignant hematological	C0376545
28507202	cells	C0007634
28507202	VOCs	C2350439
28507202	cell culture flask	C3830103
28507202	cell type	C0449475
28507202	VOCs	C2350439
28507202	hematological malignancies	C0376545
28507202	biomarkers	C0041366
28507202	diagnosis	C0011900
28507202	malignant	C0205282
28507202	hematological diseases	C0018939
28511890	Intratympanic steroid delivery	C1517566
28511890	steroid	C0038317
28511890	indwelling catheter	C0007439
28511890	refractory severe sudden sensorineural hearing loss	C4275242
28511890	decade	C2981279
28511890	outcomes	C0085415
28511890	intratympanic	C1517566
28511890	IT	C1517566
28511890	steroid	C0038317
28511890	steroid treatment	C0149783
28511890	salvage treatment	C0085405
28511890	systemic therapy	C1515119
28511890	ST	C1515119
28511890	sensorineural hearing loss	C4275242
28511890	resistant	C0332325
28511890	ST	C1515119
28511890	infusion mode	C0574032
28511890	type	C0332307
28511890	concentration	C0392762
28511890	solution	C0037633
28511890	drug	C1254351
28511890	total amount	C1265611
28511890	duration	C0444921
28511890	fractionation	C0524811
28511890	treatment	C0087111
28511890	investigate	C1292732
28511890	outcomes	C0085415
28511890	direct and constant IT delivery	C1517566
28511890	dexamethasone	C0011777
28511890	DEX	C0011777
28511890	indwelling catheter	C0007439
28511890	prospective case-control study	C0007328
28511890	tertiary referral university hospital	C0020028
28511890	subjects	C0080105
28511890	treated	C1522326
28511890	ST	C1515119
28511890	IT	C1517566
28511890	DEX	C0011777
28511890	4 Fr catheter	C0085590
28511890	inserted	C0441587
28511890	sub-annular fashion	C0205556
28511890	postero-inferior	C1179852
28511890	tympanotomy	C0087123
28511890	endocanalar approach	C0444470
28511890	local anesthesia	C0002921
28511890	DEX	C0011777
28511890	days	C0439228
28511890	bone and air-conducted pure tone	C0200273
28511890	speech audiometry	C0004293
28511890	months	C0439231
28511890	treatment	C0087111
28511890	patients	C0030705
28511890	refractory	C0205269
28511890	ST	C1515119
28511890	HL	C0175841
28511890	IT	C1517566
28511890	DEX	C0011777
28511890	HL	C0175841
28511890	ST	C1515119
28511890	side effects	C0879626
28511890	sudden deafness	C1148477
28511890	refractory	C0205269
28511890	ST	C1515119
28511890	perfusion	C0031001
28511890	DEX	C0011777
28511890	intratympanic	C1517566
28511890	catheter	C0085590
28511890	patients	C0030705
28511890	drug	C1254351
28511890	middle ear	C0013455
28511890	repeatable	C0087111
28511890	sustained form	C1710261
28511890	discomfort and a partial rescue	C3661486
28511890	speech recognition	C0597498
28511906	Design	C1707689
28511906	synthesis	C1883254
28511906	anti-tumor activity	C1148560
28511906	study	C2603343
28511906	histone deacetylase inhibitors	C1512474
28511906	isatin	C0022115
28511906	caps	C1254350
28511906	o-phenylenediamine	C0043796
28511906	zinc binding groups	C1254350
28511906	epigenetic studies	C1655731
28511906	histone deacetylases	C0019643
28511906	HDACs	C0019643
28511906	diseases	C0012634
28511906	cancer	C0027651
28511906	researches	C0035168
28511906	different	C1705242
28511906	HDAC isoforms	C0019643
28511906	roles	C1705810
28511906	tumor types	C4263544
28511906	series	C0205549
28511906	HDAC inhibitors	C1512474
28511906	isatin	C0022115
28511906	caps	C1254350
28511906	o-phenylenediamine	C0043796
28511906	zinc binding groups	C1254350
28511906	designed	C1707689
28511906	synthesized	C1883254
28511906	through	C0332273
28511906	scaffold hopping strategy	C0022885
28511906	compounds	C1706082
28511906	compound 9n	C1706082
28511906	better	C0332272
28511906	HDAC	C0019643
28511906	inhibition	C1524081
28511906	antiproliferative activities	C1148560
28511906	multiple	C0439064
28511906	tumor cell lines	C0085983
28511906	compared	C1707455
28511906	positive control	C1883676
28511906	entinostat	C2743752
28511906	MS-275	C1510480
28511906	compared	C1707455
28511906	MS-275	C1510480
28511906	IC50	C0600495
28511906	values	C1522609
28511906	HDAC1	C2718309
28511906	2	C0768528
28511906	3	C1098658
28511906	compound 9n	C1706082
28511906	IC50	C0600495
28511906	values	C1522609
28511906	HDAC1	C2718309
28511906	2	C0768528
28511906	3	C1098658
28511906	HDAC1	C2718309
28511906	selectivity	C0205556
28514486	Efficacy	C1280519
28514486	Pharmacologic	C1254351
28514486	Cotreatment	C0087111
28514486	Antipsychotic	C0040615
28514486	Monotherapy	C0087111
28514486	Schizophrenia	C0036341
28514486	Quality	C0332306
28514486	Meta-analytic	C0920317
28514486	Evidence	C3887511
28514486	treatment	C0087111
28514486	responses	C0871261
28514486	schizophrenia	C0036341
28514486	antipsychotic drug	C0040615
28514486	treatment	C0087111
28514486	psychotropic	C0033978
28514486	medication	C0013227
28514486	evaluation	C0220825
28514486	efficacy	C1280519
28514486	medication	C0013227
28514486	combinations	C0013162
28514486	meta-analytically	C0920317
28514486	efficacy	C1280519
28514486	pharmacologic	C1254351
28514486	combination	C0013162
28514486	antipsychotic drugs	C0040615
28514486	adults	C0001675
28514486	schizophrenia	C0036341
28514486	PubMed	C1138432
28514486	PsycInfo	C1140129
28514486	Meta-analyses	C0920317
28514486	randomized clinical trials	C0206034
28514486	efficacy	C1280519
28514486	antipsychotic drugs	C0040615
28514486	antipsychotic	C0040615
28514486	nonantipsychotic medications	C0013227
28514486	placebos	C1696465
28514486	antipsychotic	C0040615
28514486	monotherapy	C0087111
28514486	adults	C0001675
28514486	schizophrenia	C0036341
28514486	reviewers	C1882950
28514486	data	C1511726
28514486	quality	C0332306
28514486	methods	C0025663
28514486	meta-analyses	C0920317
28514486	Measurement Tool to Assess Systematic Reviews	C1955832
28514486	AMSTAR	C1955832
28514486	quality	C0332306
28514486	Effect sizes	C0814843
28514486	standardized mean difference	C1828170
28514486	risk ratio	C0028873
28514486	combinations	C0013162
28514486	antipsychotic drug	C0040615
28514486	combinations	C0013162
28514486	clozapine	C0009079
28514486	symptom	C1457887
28514486	reduction	C0392756
28514486	positive	C1446409
28514486	negative	C0205160
28514486	symptoms	C1457887
28514486	treatment recommendations	C0582427
28514486	inefficacies	C0231184
28514486	cognitive	C1516691
28514486	depressive symptoms	C0086132
28514486	discontinuation	C0457454
28514486	treatment	C0087111
28514486	inefficacies	C0231184
28514486	meta-analyses	C0920317
28514486	combination	C0013162
28514486	individual	C0237401
28514486	participants	C0679646
28514486	symptom	C1457887
28514486	reductions	C0441610
28514486	antipsychotic drug	C0040615
28514486	clozapine	C0009079
28514486	combination	C0013162
28514486	treatments	C0087111
28514486	standard mean difference	C1828170
28514486	CI	C0009667
28514486	CI	C0009667
28514486	combination	C0013162
28514486	clozapine	C0009079
28514486	quality	C0332306
28514486	methods	C0025663
28514486	meta-analyses	C0920317
28514486	high	C0205250
28514486	mean score	C3533236
28514486	maximum score	C0449820
28514486	quality	C0332306
28514486	meta-analyzed studies	C0920317
28514486	low	C0205251
28514486	mean score	C3533236
28514486	maximum score	C0449820
28514486	Treatment recommendations	C0582427
28514486	effect size	C0814843
28514486	correlation coefficient	C0392762
28514486	CI	C0009667
28514486	effect sizes	C0814843
28514486	quality	C0332306
28514486	correlation coefficient	C0392762
28514486	CI	C0009667
28514486	Meta-analyses	C0920317
28514486	recommendations	C0034866
28514486	positively	C1446409
28514486	effect sizes	C0814843
28514486	effect sizes	C0814843
28514486	meta-analyzed study	C0920317
28514486	quality	C0332306
28514486	reducing	C0392756
28514486	confidence	C1704726
28514486	recommendations	C0034866
28514486	Higher	C0205250
28514486	quality	C0332306
28514486	patient	C0030705
28514486	meta-analyses	C0920317
28514486	subpopulations	C1257890
28514486	combination	C0013162
28514486	treatment	C0087111
28514486	patients	C0030705
28514486	schizophrenia	C0036341
28514486	meta-analytic	C0920317
28514486	literature	C0023866
28515448	Involvement	C1314939
28515448	Vascular	C0005847
28515448	Aldosterone Synthase	C0075233
28515448	Phosphate	C1601799
28515448	Induced	C0205263
28515448	Osteogenic Transformation	C0243095
28515448	Vascular	C0005847
28515448	Smooth Muscle Cells	C1135918
28515448	Vascular calcification	C0342649
28515448	hyperphosphatemia	C0085681
28515448	mortality	C0178686
28515448	chronic kidney disease	C1561643
28515448	CKD	C1561643
28515448	Vascular calcification	C0342649
28515448	aldosterone	C0002006
28515448	osteogenic transformation	C0243095
28515448	vascular	C0005847
28515448	smooth muscle cells	C1135918
28515448	VSMCs	C1135918
28515448	absence	C0332197
28515448	exogenous	C0205228
28515448	aldosterone	C0002006
28515448	silencing	C1148560
28515448	pharmacological inhibition	C1148560
28515448	spironolactone	C0037982
28515448	eplerenone	C0961485
28515448	mineralocorticoid receptor	C0066563
28515448	MR	C0066563
28515448	phosphate	C1601799
28515448	induced	C0205263
28515448	osteo-	C0243095
28515448	chondrogenic transformation	C0243095
28515448	primary	C0205225
28515448	human	C0086418
28515448	aortic	C0003483
28515448	smooth muscle cells	C1135918
28515448	HAoSMCs	C1135918
28515448	phosphate	C1601799
28515448	concentrations	C0392762
28515448	up-regulated	C0041904
28515448	aldosterone synthase	C0075233
28515448	CYP11B2	C1527416
28515448	expression	C1171362
28515448	HAoSMCs	C1135918
28515448	Silencing	C1148560
28515448	deficiency	C0033626
28515448	CYP11B2	C1527416
28515448	VSMCs	C1135918
28515448	phosphate	C1601799
28515448	induced	C0205263
28515448	osteogenic reprogramming	C1254358
28515448	calcification	C1533591
28515448	Phosphate	C1601799
28515448	treatment	C1522326
28515448	nuclear export	C0887840
28515448	APEX1	C0140145
28515448	CYP11B2	C1413857
28515448	transcriptional repressor	C1336789
28515448	APEX1	C0140145
28515448	silencing	C1148560
28515448	up-regulated	C0041904
28515448	CYP11B2	C1413857
28515448	expression	C0017262
28515448	osteo-	C0243095
28515448	chondrogenic transformation	C0243095
28515448	APEX1	C0140145
28515448	overexpression	C1514559
28515448	phosphate	C1601799
28515448	induced	C0205263
28515448	osteo-	C0243095
28515448	chondrogenic transformation	C0243095
28515448	calcification	C1533591
28515448	HAoSMCs	C1135918
28515448	Cyp11b2	C1413857
28515448	expression	C0017262
28515448	aortic	C0003483
28515448	tissue	C0040300
28515448	hyperphosphatemic	C0085681
28515448	klotho-hypomorphic (kl/kl) mice	C0025929
28515448	wild-type	C1883559
28515448	mice	C0025929
28515448	adrenalectomized kl/kl mice	C0025929
28515448	spironolactone	C0037982
28515448	treatment	C1522326
28515448	aortic	C0003483
28515448	osteoinductive reprogramming	C1254358
28515448	findings	C2607943
28515448	VSMCs	C1135918
28515448	aldosterone synthase	C0075233
28515448	up-regulated	C0041904
28515448	phosphate	C1601799
28515448	induced	C0205263
28515448	disruption	C0332453
28515448	APEX1	C0140145
28515448	gene suppression	C0038855
28515448	Vascular	C0005847
28515448	CYP11B2	C1527416
28515448	VSMCs	C1135918
28515448	osteo-	C0243095
28515448	chondrogenic transformation	C0243095
28515448	hyperphosphatemia	C0085681
28516341	Fairness	C2911689
28516341	challenge	C0805586
28516341	competency-based postgraduate medical education programs	C0150562
28516341	Competency-based medical education systems	C0681326
28516341	institutions	C0681325
28516341	individualize	C0205245
28516341	teaching practices	C0039403
28516341	meet	C1550543
28516341	needs	C0027552
28516341	diverse learners	C0038492
28516341	improvement	C2986411
28516341	individualization	C0205245
28516341	curricula	C0010478
28516341	programs	C3484370
28516341	learners	C0038492
28516341	fair manner	C0243095
28516341	learners	C0038492
28516341	competencies	C0086035
28516341	probation	C0687758
28516341	dismissed	C2348301
28516341	training programs	C0040607
28516341	issues	C0033213
28516341	fairness	C2911689
28516341	legal claims	C0282574
28516341	examination	C0033336
28516341	fairness	C2911689
28516341	examine	C0332128
28516341	fairness	C2911689
28516341	postgraduate medical education	C0013633
28516341	contexts	C0449255
28516341	educational opportunities	C0243095
28516341	assessment practices	C0220825
28516341	decision-making processes	C0011111
28516341	fairness	C2911689
28516341	legal standpoint	C1301860
28516341	fairness	C2911689
28516341	context	C0449255
28516341	learning environment	C1510556
28516341	fairness	C2911689
28516341	issues	C0033213
28516341	US	C0041703
28516341	training programs	C0040607
28516341	fairness	C2911689
28516341	medical education system	C0681326
28516341	competency-based education framework	C1254370
28516341	Assessment	C0033336
28516341	committees	C1522486
28516341	annual programmatic evaluations	C0033336
28516341	fairness	C2911689
28516341	postgraduate medical education programs	C0150562
28516341	fairness	C2911689
28516341	training experiences	C0220931
28516341	assessment practices	C0220825
28516341	examined	C0332128
28516341	committees	C1522486
28516341	programs	C3484370
28516341	fairness	C2911689
28516341	educational program	C0150562
28516341	conversations	C0871703
28516341	issues	C0033213
28516841	Us3	C0033684
28516841	Us9	C2001544
28516841	proteins	C0033684
28516841	stromal invasion	C1336515
28516841	bovine herpesvirus 1	C0021335
28516841	respiratory mucosa	C0751974
28516841	Bovine herpesvirus 1 (BHV-1) infection	C3687301
28516841	conjunctivitis	C0009763
28516841	upper respiratory tract	C0458578
28516841	problems	C0033213
28516841	pneumonia	C0032285
28516841	genital disorders	C0178829
28516841	abortion	C0156543
28516841	BHV-1	C0021335
28516841	spread	C0332261
28516841	plaque	C0332461
28516841	manner	C0205245
28516841	invade	C0205245
28516841	breaching	C3203359
28516841	basement membrane	C0004799
28516841	(BM)	C0004799
28516841	barrier	C0682585
28516841	respiratory mucosa	C0751974
28516841	BHV-1	C0021335
28516841	Us3	C0033684
28516841	serine/threonine kinase	C0072402
28516841	induces	C0205263
28516841	cytoskeletal reorganization	C1511632
28516841	BHV-1	C0021335
28516841	Us9	C2001544
28516841	tail-anchored membrane protein	C0025252
28516841	axonal transport	C0004462
28516841	viruses	C0042776
28516841	neurons	C0027882
28516841	study	C2603343
28516841	investigated	C1292732
28516841	role	C1705810
28516841	Us3	C0033684
28516841	Us9	C2001544
28516841	BHV-1 infection	C3687301
28516841	respiratory mucosa	C0751974
28516841	characterized	C1880022
28516841	BHV-1	C0021335
28516841	Us3	C0017337
28516841	null	C0042776
28516841	Us9	C0017337
28516841	null	C0042776
28516841	revertant viruses	C0042776
28516841	analysed	C0936012
28516841	viral replication	C0042774
28516841	plaque	C0332461
28516841	size	C0456389
28516841	Madin-Darby bovine kidney	C0598829
28516841	MDBK	C0598829
28516841	cells	C0598829
28516841	respiratory mucosa	C0751974
28516841	viral penetration	C1656555
28516841	BM	C0004799
28516841	respiratory mucosa	C0751974
28516841	inoculated	C2987620
28516841	recombinant viruses	C0085391
28516841	Knockout	C1522225
28516841	Us3	C0017337
28516841	reduction	C0392756
28516841	viral titre	C2713348
28516841	plaque	C0332461
28516841	size	C0456389
28516841	latitude	C1627936
28516841	MDBK cells	C0598829
28516841	trachea mucosa	C0225584
28516841	no	C1513916
28516841	defects	C1457869
28516841	cell-to-cell spread	C1160712
28516841	observed	C1441672
28516841	BHV-1	C0021335
28516841	Us9	C0017337
28516841	null virus	C0042776
28516841	BHV-1	C0021335
28516841	Us3	C0017337
28516841	null	C0042776
28516841	Us9	C0017337
28516841	null viruses	C0042776
28516841	significant	C0750502
28516841	reduction	C0392756
28516841	plaque	C0332461
28516841	penetration	C0205321
28516841	BM	C0004799
28516841	penetration	C0205321
28516841	inhibited	C3463820
28516841	conclusion	C1707478
28516841	findings	C0035168
28516841	Us3	C0017337
28516841	Us9	C0017337
28516841	role	C1705810
28516841	invasion	C1336515
28516841	BHV-1	C0021335
28516841	BM	C0004799
28516841	respiratory mucosa	C0751974
28516841	research	C0035168
28516841	attenuation	C0599946
28516841	viruses	C0042776
28516841	better	C0332272
28516841	performing	C0884358
28516841	vaccines	C0042210
28520661	Traumatic Brain Injury	C0876926
28520661	Depression	C0011570
28520661	Community	C0009462
28520661	Based	C1527178
28520661	Cohort Study	C0009247
28520661	Adult	C0001675
28520661	Life Span	C0870809
28520661	traumatic brain injuries	C0876926
28520661	TBIs	C0876926
28520661	associated with	C0332281
28520661	cases	C1706256
28520661	clinically significant	C2826293
28520661	depression	C0011570
28520661	general community	C0009462
28520661	interactions	C1704675
28520661	variables	C1705098
28520661	depression	C0011570
28520661	TBI	C0876926
28520661	Population	C1257890
28520661	community	C0009462
28520661	study	C2603343
28520661	Canberra	C0454764
28520661	Queanbeyan	C0681784
28520661	Australia	C0004340
28520661	Three	C0205449
28520661	age cohorts	C2348001
28520661	young	C0332239
28520661	middle-aged	C0205847
28520661	older	C0001792
28520661	adults	C0001675
28520661	aged	C0001779
28520661	60-64 years	C4035747
28520661	baseline	C1442488
28520661	randomly	C0439605
28520661	selected	C1707391
28520661	followed	C0332283
28520661	years apart	C0439234
28520661	people	C0027361
28520661	TBI	C0876926
28520661	Lifetime	C4071830
28520661	sustained	C0443318
28520661	time	C0040223
28520661	since	C1711239
28520661	birth	C0005615
28520661	recent	C0332185
28520661	preceding	C0332152
28520661	years	C0439234
28520661	multiple	C0439064
28520661	TBIs	C0876926
28520661	current	C0521116
28520661	depression	C0011570
28520661	risk factors	C0035648
28520661	depression	C0011570
28520661	age	C0001779
28520661	sex	C0079399
28520661	marital	C0024819
28520661	employment status	C0242271
28520661	prior history	C2133631
28520661	depression	C0011570
28520661	medical conditions	C0243095
28520661	life events	C0441471
28520661	alcohol consumption	C0001948
28520661	social support	C0037438
28520661	physical activity	C0026606
28520661	equations	C0552449
28520661	association	C0439849
28520661	TBI	C0876926
28520661	clinically significant	C2826293
28520661	depression	C0011570
28520661	cases	C1706256
28520661	controlling	C2239193
28520661	multiple	C0439064
28520661	demographic	C0011292
28520661	health	C0018684
28520661	lifestyle	C0023676
28520661	factors	C1521761
28520661	association	C0439849
28520661	depression	C0011570
28520661	TBI	C0876926
28520661	TBI	C0876926
28520661	individuals	C0237401
28520661	monitored	C1521743
28520661	long-term	C0443252
28520661	psychological health	C0025353
28521254	CS	C0162969
28521254	PEG	C0032483
28521254	PLGA nano-prototype	C0071599
28521254	delivery	C3850077
28521254	bioactive compounds	C0574031
28521254	novel	C0205314
28521254	approach	C0449445
28521254	induction	C0205263
28521254	apoptosis	C0162638
28521254	HepG2 cell line	C2717940
28521254	Polymer	C0032521
28521254	based	C1527178
28521254	nanoparticles	C1450054
28521254	used	C1524063
28521254	vectors	C0442335
28521254	cancer	C0007097
28521254	drug delivery	C0039798
28521254	bioactive compounds	C0574031
28521254	quercetin	C0034392
28521254	ellagic acid	C0013900
28521254	gallic acid	C0016979
28521254	antioxidants	C0003402
28521254	chemopreventive candidates	C1516463
28521254	against	C0521124
28521254	various	C0439064
28521254	types	C0332307
28521254	cancers	C0007097
28521254	low	C0205251
28521254	bioavailability	C0005508
28521254	short	C1806781
28521254	half-life	C0018517
28521254	time	C0040223
28521254	obstacles	C0332206
28521254	novel	C0205314
28521254	PLGA nano-platform	C0071599
28521254	functionalized	C0205245
28521254	CS	C0162969
28521254	PEG	C0032483
28521254	encapsulate	C0205223
28521254	phytochemicals	C0577749
28521254	encapsulation	C2348438
28521254	protect	C1545588
28521254	compounds	C1254351
28521254	phagocytic uptake	C3888108
28521254	deliver	C3850077
28521254	PLGA-CS-PEG nano-prototype	C1254351
28521254	biodegradability	C0205556
28521254	biosafety	C0205556
28521254	types	C0332307
28521254	PLGA-based nanocomposites	C1254351
28521254	prepared	C1521827
28521254	characterized	C1880022
28521254	investigated	C1292732
28521254	synthesized	C1883254
28521254	nano-formulations	C1707824
28521254	against	C0521124
28521254	human	C0086418
28521254	hepatocellular carcinoma	C2239176
28521254	HepG2	C2717940
28521254	colorectal cancer	C1527249
28521254	HCT 116	C1258005
28521254	cell lines	C0682523
28521254	using	C1524063
28521254	cell growth inhibition	C1512773
28521254	assays	C1510438
28521254	followed by	C0332283
28521254	apoptosis	C0162638
28521254	necrosis	C0027540
28521254	assays	C1510438
28521254	using	C1524063
28521254	flow cytometry	C0016263
28521254	detect	C0022885
28521254	mechanism	C0441712
28521254	HepG2	C2717940
28521254	cell death	C0007587
28521254	average	C1510992
28521254	diameters	C1301886
28521254	nano-prototypes	C1450054
28521254	cytotoxic activity	C1551412
28521254	quercetin	C0034392
28521254	ellagic acid	C0013900
28521254	gallic acid	C0016979
28521254	encapsulated	C0205223
28521254	PLGA	C0071599
28521254	PLGA-CS	C1254351
28521254	PLGA-CS-PEG nano-prototypes	C1254351
28521254	found	C0150312
28521254	reduce	C0392756
28521254	IC50s	C0600495
28521254	HepG2 cells	C2717940
28521254	values	C1522609
28521254	folds	C1880833
28521254	folds	C1880833
28521254	folds	C1880833
28521254	quercetin	C0034392
28521254	dependent	C0851827
28521254	apoptosis	C0162638
28521254	necrosis	C0027540
28521254	ellagic acid	C0013900
28521254	gallic acid	C0016979
28521254	dependent	C0851827
28521254	apoptosis	C0162638
28521254	CS	C0162969
28521254	PEG	C0032483
28521254	PLGA	C0071599
28521254	nano-delivery system	C0449914
28521254	quercetin	C0034392
28521254	ellagic acid	C0013900
28521254	gallic acid	C0016979
28521254	potentiate	C2349975
28521254	apoptosis-mediated	C0162638
28521254	cell death	C0007587
28521254	HepG2 cell line	C2717940
28521617	Fingerprint	C0016126
28521617	background checks	C0243095
28521617	personal care workers	C1522486
28521617	Stakeholder	C0027361
28521617	views	C1254370
28521617	policy	C0242456
28521617	criteria	C0243161
28521617	Decision makers	C1257890
28521617	implementing	C1708476
28521617	mechanisms	C0441712
28521617	protecting	C0516529
28521617	elderly	C0001792
28521617	vulnerable adults	C1562367
28521617	abuse	C1546935
28521617	pilot project	C0031928
28521617	fingerprint	C0016126
28521617	criminal	C2607966
28521617	background checks	C0243095
28521617	personal care workers	C1522486
28521617	Michigan	C1548669
28521617	opportunity	C0683937
28521617	mechanism	C0441712
28521617	conjunction	C2699427
28521617	pilot project	C0031928
28521617	stakeholder	C1522486
28521617	analysis	C0936012
28521617	decision makers	C1257890
28521617	stakeholder	C0027361
28521617	perceptions	C0030971
28521617	standard	C3244099
28521617	policy	C0242456
28521617	criteria	C0243161
28521617	effectiveness	C1280519
28521617	efficiency	C0013682
28521617	equity	C0237597
28521617	focus groups	C0681860
28521617	web-based survey	C0038951
28521617	collect	C0010995
28521617	data	C1511726
28521617	stakeholders	C0027361
28521617	stakeholders	C0027361
28521617	fingerprint	C0016126
28521617	background checks	C0243095
28521617	personal care workers	C1522486
28521617	effective	C1704419
28521617	net benefit	C0814225
28521617	contingencies	C0441471
28521617	difficulties	C0425101
28521617	constraints	C0443288
28521617	government	C0018104
28521617	involvement	C1314939
28521617	preliminary analysis	C0936012
28521617	foundational information	C1533716
28521617	decision makers	C1257890
28521617	benefit-cost analysis	C0010174
28523090	Penetrating	C0205321
28523090	Craniomaxillofacial Injury	C0024961
28523090	Craniomaxillofacial Injury Caused by a Pneumatic Nail Gun	C0418073
28523090	Pneumatic Nail Gun	C3273359
28523090	treatment	C1522326
28523090	penetrating	C0205321
28523090	oral	C0226896
28523090	nasal cavities	C0027423
28523090	treatment	C1522326
28523090	enhanced	C2349975
28523090	lingual nerve	C0394805
28523090	inferior alveolar nerve blocks	C0394801
28523090	maintain	C0024501
28523090	spontaneous respiration	C0412771
28523090	tongue	C0040408
28523090	distracted	C0243095
28523090	palate	C0700374
28523090	upper airway	C0458827
28523722	vibrational signal	C1710082
28523722	mating	C1260875
28523722	disruption	C0332453
28523722	glassy-winged sharpshooter	C0600235
28523722	Homalodisca vitripennis	C1218186
28523722	glassy-winged sharpshooter	C0600235
28523722	GWSS	C0600235
28523722	Homalodisca vitripennis	C1218186
28523722	pest	C0021585
28523722	grapevines	C0682492
28523722	transmit	C0332289
28523722	Xylella fastidiosa	C0995982
28523722	causal agent	C0314732
28523722	Pierce's disease	C0032080
28523722	GWSS	C0600235
28523722	mating	C1260875
28523722	communication	C0003046
28523722	vibrational signals	C1710082
28523722	vibrational	C0205556
28523722	mating	C1260875
28523722	disruption	C0332453
28523722	alternative	C1523987
28523722	insecticides	C0021576
28523722	suppression	C0678671
28523722	GWSS	C0600235
28523722	population	C1257890
28523722	objectives	C0018017
28523722	spectral	C1883073
28523722	features	C2348519
28523722	female	C0086287
28523722	signal	C1710082
28523722	male	C0086582
28523722	signaling	C3158821
28523722	disruptive	C0332454
28523722	signals	C1710082
28523722	alter	C0392747
28523722	male	C0086582
28523722	perception	C0030971
28523722	acceptance	C0000899
28523722	female	C0086287
28523722	signal intensity	C0871362
28523722	Results	C0683954
28523722	male	C0086582
28523722	responses	C0871261
28523722	playback	C0441655
28523722	modified	C0392747
28523722	female	C0086287
28523722	signals	C1710082
28523722	significantly	C0750502
28523722	reduced	C0392756
28523722	female	C0086287
28523722	signal spectral components	C1705248
28523722	Playback	C0441655
28523722	bioassays	C0005507
28523722	transmission	C1521797
28523722	frequency tone	C0237917
28523722	plants	C0032098
28523722	suppressed	C1260953
28523722	male	C0086582
28523722	signaling	C3158821
28523722	female	C0086287
28523722	signal playback	C0441655
28523722	disruptive	C0332454
28523722	signal amplitude	C3828024
28523722	female	C0086287
28523722	signal playback	C0441655
28523722	mechanism	C0441712
28523722	cessation	C1880019
28523722	male	C0086582
28523722	signaling	C3158821
28523722	presence	C0150312
28523722	disruption	C0332453
28523722	results	C0683954
28523722	vibrational signal	C1710082
28523722	laboratory	C0022877
28523722	field experiments	C0868962
28523722	assess	C1516048
28523722	efficacy	C1280519
28523722	mating	C1260875
28523722	GWSS	C0600235
28526000	Barriers	C0205556
28526000	facilitators	C0205556
28526000	smoking cessation	C0085134
28526000	cancer	C0006826
28526000	context	C0449255
28526000	qualitative study	C0949415
28526000	patient	C0030705
28526000	family	C0015576
28526000	professional	C0679924
28526000	views	C0205556
28526000	Continued	C0549178
28526000	smoking	C0037369
28526000	cancer	C0006826
28526000	adversely affects	C0879626
28526000	quality of life	C0518214
28526000	survival	C0220921
28526000	cancer	C0006826
28526000	survivors	C0206194
28526000	smoke	C0037369
28526000	cancer	C0006826
28526000	positive	C1446409
28526000	behaviour change	C0542299
28526000	Smoking	C0037369
28526000	social groups	C0687744
28526000	interventions	C0184661
28526000	target	C1521840
28526000	families	C0015576
28526000	individuals	C0027361
28526000	successful	C1272703
28526000	qualitative study	C0949415
28526000	patients	C0030705
28526000	family members	C0086282
28526000	health professionals	C1704312
28526000	views	C0205556
28526000	experiences	C0596545
28526000	smoking	C0037369
28526000	smoking cessation	C0085134
28526000	cancer	C0006826
28526000	interventions	C0184661
28526000	In-depth qualitative interviews	C0683518
28526000	patients	C0030705
28526000	family members	C0086282
28526000	health professionals	C1704312
28526000	Data	C1511726
28526000	'Framework' method	C0449851
28526000	patient	C0030705
28526000	family members	C0086282
28526000	National Health Service	C0027462
28526000	NHS	C0027462
28526000	smoking cessation	C0085134
28526000	services	C0018747
28526000	smoked	C0037369
28526000	smoking	C0037369
28526000	discussion	C0557050
28526000	clinicians	C0871685
28526000	Clinicians	C0871685
28526000	barriers	C0205556
28526000	discussion	C0557050
28526000	Participants	C0679646
28526000	continued	C0549178
28526000	smoking	C0037369
28526000	stress	C0038435
28526000	diagnosis	C0920688
28526000	personal	C1519021
28526000	control	C0243148
28526000	lack	C0332268
28526000	smoking	C0037369
28526000	cancer	C0006826
28526000	health	C0018684
28526000	barriers	C0205556
28526000	smoking cessation	C0085134
28526000	patients	C0030705
28526000	family members	C0086282
28526000	insufficiently	C0231180
28526000	assessed	C1516048
28526000	clinicians	C0871685
28526000	Interventions	C0184661
28526485	Improving	C1272745
28526485	Sexual Health	C2362326
28526485	Young People	C0087178
28526485	Mobility Impairments	C0518456
28526485	Challenges	C0805586
28526485	Recommendations	C0034866
28526485	mixed-method study	C0681814
28526485	challenges	C0805586
28526485	providing	C1999230
28526485	sexual health	C2362326
28526485	services	C0018747
28526485	youth	C0087178
28526485	mobility impairments	C0518456
28526485	perspective	C0449911
28526485	health care providers	C0018724
28526485	experts	C0009817
28526485	compares	C1707455
28526485	sexual health	C2362326
28526485	experiences	C0596545
28526485	youth	C0087178
28526485	mobility impairments	C0518456
28526485	Secondary data analysis of My Path	C0683944
28526485	study	C0681814
28526485	focused	C1285542
28526485	transition	C2700061
28526485	adulthood	C0700597
28526485	youth	C0087178
28526485	mobility impairments	C0518456
28526485	exploratory sequential design	C0035171
28526485	qualitative data	C0681942
28526485	analyzed	C0936012
28526485	systematic	C0220922
28526485	content analysis	C0681915
28526485	quantitative analysis of survey data	C0681919
28526485	Challenges	C0805586
28526485	included	C0332257
28526485	not talking	C0205556
28526485	sex	C1522384
28526485	sexual development	C0233896
28526485	adaptation	C0000934
28526485	instruction	C1442085
28526485	parent roles	C0680075
28526485	safety	C0036043
28526485	Survey	C0038951
28526485	data	C1511726
28526485	youth	C0087178
28526485	mobility impairments	C0518456
28526485	diverse	C1880371
28526485	experiences	C0596545
28526485	sexual behavior	C0036864
28526485	sources	C0449416
28526485	sexual health	C2362326
28526485	information	C1533716
28526485	connected	C2986575
28526485	primary care providers	C0018724
28526485	received	C1514756
28526485	information	C1533716
28526485	sexual health	C2362326
28526485	Interventions	C1273869
28526485	improve	C0184511
28526485	youths	C0087178
28526485	well-being	C0018684
28526485	include	C2700399
28526485	comprehensive care	C0009586
28526485	education	C0018701
28526485	promotes	C0033414
28526485	supports	C1521721
28526485	healthy	C3898900
28526485	sexual development	C0233896
28526692	Understanding	C0162340
28526692	interrelationship	C0439849
28526692	synthesis	C0220781
28526692	urea	C0041942
28526692	gluconeogenesis	C0017715
28526692	overall	C1561607
28526692	balanced equation	C0552449
28526692	metabolic	C0311400
28526692	interrelationship	C0439849
28526692	ureagenesis	C0597619
28526692	gluconeogenesis	C0017715
28526692	overall	C1561607
28526692	equation	C0552449
28526692	metabolic	C0311400
28526692	link	C0449379
28526692	ureagenesis	C0597619
28526692	gluconeogenesis	C0017715
28526692	guided approach	C0449445
28526692	students	C0038492
28526692	problem	C0033213
28526692	obtaining	C1706701
28526692	overall	C1561607
28526692	equation	C0552449
28526692	metabolic pathway	C1291081
28526692	atoms	C0567415
28526692	charges	C1706211
28526692	reactions	C0443286
28526692	cellular localizations	C1660642
28526692	substrates	C3891814
28526692	transport	C1519628
28526692	systems	C0449913
28526692	balanced	C0205415
28526692	overall	C1561607
28526692	equation	C0552449
28526692	metabolic pathway	C1291081
28526692	physiological	C0205463
28526692	textbooks	C0039712
28526692	report	C0684224
28526692	overall	C1561607
28526692	equations	C0552449
28526692	metabolic pathways	C1291081
28526692	ureagenesis	C0597619
28526692	gluconeogenesis	C0017715
28526692	metabolism	C0025519
28526692	enzymology	C0014445
28526692	molecular biology	C0026376
28526692	molecular genetics	C0086345
28526692	paper	C1706852
28526692	students	C0038492
28526692	overall	C1561607
28526692	reaction	C0443286
28526692	metabolic pathway	C1291081
28526692	reactions	C0443286
28526692	balanced	C0205415
28526692	atoms	C0567415
28526692	charges	C1706211
28526692	suggestion	C1705535
28526692	overall	C1561607
28526692	equation	C0552449
28526692	metabolic	C0311400
28526692	interrelationship	C0439849
28526692	ureagenesis	C0597619
28526692	gluconeogenesis	C0017715
28526692	urea	C0041942
28526692	glucose	C0017725
28526692	final	C3853528
28526692	products	C1514468
28526692	rationalize	C1552821
28526692	topic	C1706203
28526692	students	C0038492
28526692	teachers	C0221457
28526692	metabolism	C0025519
28526692	chapter	C1552857
28526692	human physiology	C3826168
28526816	B-cell	C0004561
28526816	Epitopes	C0003316
28526816	Salmonella enterica serovar Typhi	C0036125
28526816	Hemolysin E	C2603981
28526816	Potential	C3245505
28526816	antibody	C0003241
28526816	therapeutic	C0087111
28526816	target	C1521840
28526816	Hemolysin E	C2603981
28526816	HlyE	C2603981
28526816	immunogenic	C0872192
28526816	novel	C0205314
28526816	pore	C1325742
28526816	toxin	C0073997
28526816	pathogenesis	C0699748
28526816	typhoid fever	C0041466
28526816	mapping	C1283195
28526816	B-cell	C0004561
28526816	epitopes	C0003316
28526816	Salmonella enterica serovar Typhi	C0036125
28526816	S. Typhi	C0036125
28526816	critical	C1511545
28526816	immunogenic regions	C1254362
28526816	HlyE	C2603981
28526816	peptide library	C0376436
28526816	anti-HlyE polyclonal antibodies	C0312586
28526816	typhoid	C0041466
28526816	patient	C0030705
28526816	sera	C0229671
28526816	Bioinformatic	C1140694
28526816	tools	C0037589
28526816	analyze	C0936012
28526816	map	C1283195
28526816	peptide sequences	C0920679
28526816	protein	C0033684
28526816	epitopes	C0003316
28526816	analysis	C0936012
28526816	linear	C0205132
28526816	conformational	C1254362
28526816	epitopes	C0003316
28526816	HlyE protein	C2603981
28526816	predicted	C0681842
28526816	linear	C0205132
28526816	GAAAGIVAG	C0002518
28526816	conformational	C1254362
28526816	epitope	C0003316
28526816	PYSQESVLSADSQNQK	C0002518
28526816	sera	C0229671
28526816	epitopes	C0003316
28526816	isolate	C0204727
28526816	epitope	C0003316
28526816	monoclonal antibodies	C0003250
28526816	antibody	C0003241
28526816	phage display	C1519025
28526816	Monoclonal scFv	C1432679
28526816	antibodies	C0003241
28526816	linear	C0205132
28526816	conformational	C1254362
28526816	epitopes	C0003316
28526816	Molecular docking	C3494274
28526816	antigen-antibody interaction	C1268869
28526816	monoclonal antibodies	C0003250
28526816	epitopes	C0003316
28526816	HlyE	C2603981
28526816	monomer	C0312811
28526816	oligomer structure	C0599219
28526816	positional	C0240795
28526816	characteristics	C1521970
28526816	antibodies	C0003241
28526816	epitope	C0003316
28526816	HlyE	C2603981
28526816	combination	C0205195
28526816	phage display	C1519025
28526816	bioinformatic	C1140694
28526816	analysis	C0936012
28526816	predicted	C0681842
28526816	function	C0542341
28526816	structure	C0678594
28526816	antibodies	C0003241
28526816	antibodies	C0003241
28526816	neutralizing agents	C1254351
28526816	typhoid fever	C0041466
28532107	Comparison	C1707455
28532107	electrospun	C1254366
28532107	solvent cast	C1254366
28532107	polylactic acid	C0071443
28532107	PLA	C0071443
28532107	poly(vinyl alcohol)	C0032623
28532107	PVA	C0032623
28532107	inserts	C0005479
28532107	ocular	C0015392
28532107	drug delivery vehicles	C0042444
28532107	electrospun nanofiber	C1881960
28532107	inserts	C0005479
28532107	ENIs	C1881960
28532107	solvent cast	C1254366
28532107	polymeric	C0032521
28532107	inserts	C0005479
28532107	SCIs	C0032521
28532107	ocular	C0015392
28532107	drug delivery	C0085104
28532107	ENI	C1881960
28532107	SCI	C0032521
28532107	dexamethasone	C0011777
28532107	fabricated	C1254366
28532107	blend	C0678946
28532107	poly-lactic acid	C0071443
28532107	PLA	C0071443
28532107	poly-vinyl alcohol	C0032623
28532107	PVA	C0032623
28532107	Inserts	C0005479
28532107	morphology	C0332437
28532107	thickness	C1280412
28532107	pH	C0020283
28532107	drug content	C0456205
28532107	drug crystallinity	C0205556
28532107	in vitro	C1533691
28532107	drug release	C3850077
28532107	sterility	C0232920
28532107	dimethylformamide	C0012426
28532107	DMF	C0012426
28532107	chloroform	C0008238
28532107	content	C0456205
28532107	cytotoxicity	C0596402
28532107	thickness	C1280412
28532107	dexamethasone	C0011777
28532107	ENIs	C1881960
28532107	folding endurance	C0518031
28532107	SCIs	C0032521
28532107	brittle	C3810845
28532107	thickness	C1280412
28532107	Drug release	C3850077
28532107	rates	C1521828
28532107	ENIs	C1881960
28532107	SCIs	C0032521
28532107	DMF	C0012426
28532107	content	C0456205
28532107	ENIs	C1881960
28532107	SCIs	C0032521
28532107	chloroform	C0008238
28532107	not detected	C0442737
28532107	No	C1513916
28532107	cytotoxicity	C0596402
28532107	ENIs	C1881960
28532107	cultured	C0007635
28532107	bovine	C3667982
28532107	corneal endothelial cells	C0225336
28532107	ENIs	C1881960
28532107	SCIs	C0032521
28532107	delivery system	C0085104
28532107	treating	C1522326
28532107	anterior segment	C0348014
28532107	ocular diseases	C0015397
28532323	Quantitative	C0392762
28532323	regulation	C1327622
28532323	histone variant H2A.Z	C4284633
28532323	during	C0347984
28532323	cell cycle	C0007586
28532323	ubiquitin proteasome system	C1523807
28532323	SUMO-targeted ubiquitin ligases	C2247240
28532323	Quantitative	C0392762
28532323	control	C2587213
28532323	histones	C0019652
28532323	histone variants	C1529369
28532323	during	C0347984
28532323	cell cycle	C0007586
28532323	relevant	C2347946
28532323	epigenetic functions	C1160465
28532323	level	C0441889
28532323	yeast histone variant H2A.Z	C4284633
28532323	G2/M-phase	C3824600
28532323	actively	C0205177
28532323	ubiquitin proteasome system	C1523807
28532323	SUMO-targeted ubiquitin ligases	C2247240
28532323	Overexpression	C1514559
28532323	H2A.Z	C4284633
28532323	induced defects in mitotic progression	C1155864
28532323	suggesting	C1705535
28532323	functional	C0205245
28532323	importance	C3898777
28532323	quantitative	C0392762
28532323	control	C2587213
28532624	Tyrphostin AG-related compounds	C1254351
28532624	H2O2	C0020281
28532624	induced	C0205263
28532624	TRPM2	C1505166
28532624	dependent	C0851827
28532624	independent	C0332291
28532624	cellular	C0007634
28532624	responses	C0871261
28532624	TRPM2	C1505166
28532624	Ca(2+)-permeable channel	C0006685
28532624	activated	C1879547
28532624	H2O2	C0020281
28532624	TRPM2	C1505166
28532624	Ca(2+) signaling	C0600431
28532624	aggravation	C0541889
28532624	inflammatory diseases	C1290884
28532624	development	C1527148
28532624	TRPM2	C1505166
28532624	inhibitors	C0033671
28532624	aggravation	C0541889
28532624	diseases	C0012634
28532624	Tyrphostin AG-related compounds	C1254351
28532624	inhibited	C0311403
28532624	H2O2	C0020281
28532624	induced	C0205263
28532624	activation	C1879547
28532624	TRPM2	C1505166
28532624	scavenging the intracellular hydroxyl radical	C3537124
28532624	effects of	C1704420
28532624	AG-related compounds	C1254351
28532624	H2O2	C0020281
28532624	induced	C0205263
28532624	cellular	C0007634
28532624	responses	C0871261
28532624	human	C0086418
28532624	monocytic	C0026473
28532624	U937 cells	C0600531
28532624	functionally	C0205245
28532624	express	C1171362
28532624	TRPM2	C1505166
28532624	effects of	C1704420
28532624	AG-related compounds	C1254351
28532624	H2O2	C0020281
28532624	induced	C0205263
28532624	changes	C0392747
28532624	intracellular	C0178719
28532624	Ca(2+)	C0596235
28532624	concentrations	C1446561
28532624	extracellular signal-regulated kinase	C0600388
28532624	ERK	C0600388
28532624	activation	C1879547
28532624	CXCL8	C1698756
28532624	secretion	C1159339
28532624	U937 cells	C0600531
28532624	Ca(2+) influxes	C3158761
28532624	TRPM2	C1505166
28532624	H2O2	C0020281
28532624	blocked	C0028778
28532624	AG-related compounds	C1254351
28532624	AG-related compounds	C1254351
28532624	inhibited	C0311403
28532624	H2O2	C0020281
28532624	induced	C0205263
28532624	activation	C1879547
28532624	ERK	C0600388
28532624	secretion	C1159339
28532624	CXCL8	C1698756
28532624	TRPM2	C1505166
28532624	dependent	C0851827
28532624	independent	C0332291
28532624	mechanisms	C0441712
28532624	AG-related compounds	C1254351
28532624	inhibit	C0311403
28532624	H2O2	C0020281
28532624	induced	C0205263
28532624	CXCL8	C1698756
28532624	secretion	C1159339
28532624	ERK	C0600388
28532624	activation	C1879547
28532624	TRPM2	C1505166
28532624	dependent	C0851827
28532624	independent	C0332291
28532624	mechanisms	C0441712
28532624	U937 cells	C0600531
28532624	AG-related compounds	C1254351
28532624	blocked	C0028778
28532624	H2O2	C0020281
28532624	induced	C0205263
28532624	TRPM2	C1505166
28532624	activation	C1879547
28532624	scavenging the hydroxyl radical	C3537124
28532624	inhibitory	C3463820
28532624	effects	C1280500
28532624	AG-related compounds	C1254351
28532624	TRPM2	C1505166
28532624	independent	C0332291
28532624	responses	C0871261
28532624	scavenging of the hydroxyl radical	C3537124
28532629	Shared decision making	C3179495
28532629	UK	C0041700
28532629	Shared decision making	C3179495
28532629	SDM	C3179495
28532629	policy	C0242456
28532629	agenda	C0681473
28532629	UK	C0041700
28532629	legal	C1301860
28532629	ruling	C0022424
28532629	Policymakers	C0242170
28532629	ethicists	C0086267
28532629	professional regulators	C1522486
28532629	societies	C0037455
28532629	patient organisations	C1561598
28532629	courts	C0178572
28532629	SDM	C3179495
28532629	norm	C0205307
28532629	NHS	C0027462
28532629	economic climate	C0683773
28532629	progress	C1280477
28532629	years	C0439234
28532629	learning	C0023185
28532629	demonstration	C0237560
28532629	sites	C0205145
28532629	initiatives	C0424093
28532629	capacity building	C2718026
28532629	training	C0220931
28532629	patient	C0030705
28532629	decision aids	C0086104
28532629	leadership	C0023181
28532629	initiatives	C0424093
28532629	Enthusiasm	C0424090
28532629	working	C0043227
28532629	clinicians	C0871685
28532629	patients	C0030705
28532629	managers	C0335141
28532629	SDM	C3179495
28532629	means	C1704970
28532629	cost control	C0010176
28536031	Lactate	C0022924
28536031	osteoblast differentiation	C1159974
28536031	stabilization	C1152620
28536031	HIF1α	C0965644
28536031	Aerobic glycolysis	C0598754
28536031	osteoblast differentiation	C1159974
28536031	Wnt signaling	C1520113
28536031	PTH	C0030520
28536031	treatment	C1522326
28536031	lactate	C0022924
28536031	aerobic glycolysis	C0598754
28536031	osteoblast differentiation	C1159974
28536031	cultures	C0007585
28536031	osteoblast-lineage cells	C0029418
28536031	lactate	C0022924
28536031	alkaline phosphatase	C0002059
28536031	cell formation	C0007613
28536031	activity	C0243102
28536031	alkaline phosphatase	C0002059
28536031	expression	C1171362
28536031	osteocalcin	C0029419
28536031	osteoblast differentiation	C1159974
28536031	lactate	C0022924
28536031	inhibited	C0311403
28536031	blocking	C0332206
28536031	cells	C0007634
28536031	MCT1	C3812715
28536031	siRNA	C1099354
28536031	inhibitors	C0033671
28536031	metabolism	C0025519
28536031	siRNAs	C1099354
28536031	LDHB	C0022918
28536031	PDH	C0034343
28536031	lactate	C0022924
28536031	HIF1α	C0965644
28536031	expression	C1171362
28536031	inhibited	C0311403
28536031	HIF1α	C0965644
28536031	activity	C1537044
28536031	BAY87-2243	C0033671
28536031	osteoblast differentiation	C1159974
28536031	lactate	C0022924
28536031	findings	C0243095
28536031	aerobic glycolysis	C0598754
28536031	osteoblast differentiation	C1159974
28536031	lactate	C0022924
28538491	Committee	C2699414
28538491	Route	C0449444
28538491	Hysterectomy	C0020699
28538491	Benign	C0205183
28538491	Disease	C0012634
28538491	Hysterectomy	C0020699
28538491	surgical procedures	C0543467
28538491	United States	C0041703
28538491	Selection	C1707391
28538491	route	C0449444
28538491	hysterectomy	C0020699
28538491	benign	C0205183
28538491	size	C0456389
28538491	shape	C0332479
28538491	vagina	C0042232
28538491	uterus	C0042149
28538491	uterus	C0042149
28538491	extrauterine disease	C0012634
28538491	surgeon	C0582175
28538491	training	C0220931
28538491	experience	C0596545
28538491	case volume	C0392762
28538491	hospital	C0019994
28538491	technology	C0752189
28538491	devices	C0025080
28538491	patient	C0030705
28538491	Vaginal	C0195117
28538491	laparoscopic procedures	C0751429
28538491	minimally invasive	C2711297
28538491	surgical approaches	C0449446
28538491	abdominal incision	C0198488
28538491	hospitalization	C0019993
28538491	postoperative recovery times	C4061108
28538491	abdominal hysterectomy	C0404077
28538491	Minimally invasive approaches	C2711297
28538491	hysterectomy	C0020699
28538491	abdominal hysterectomy	C0404077
28538491	vaginal approach	C0175672
28538491	minimally invasive approaches	C2711297
28538491	Laparoscopic hysterectomy	C0404089
28538491	abdominal hysterectomy	C0404077
28538491	patients	C0030705
28538491	vaginal hysterectomy	C0020700
28538491	minimally invasive approaches	C2711297
28538491	hysterectomy	C0020699
28538491	route	C0449444
28538491	open	C4283938
28538491	abdominal hysterectomy	C0404077
28538491	patients	C0030705
28538491	obstetrician	C0334897
28538491	gynecologist	C0237419
28538491	patients	C0030705
28538491	route	C0449444
28538491	hysterectomy	C0020699
28538491	benefits	C0814225
28538491	risks	C0035647
28538491	approaches	C1292724
28538491	hysterectomy	C0020699
28538491	patient	C0030705
28538491	preferences	C0376409
28538491	patient	C0030705
28538491	health care provider	C0018724
28538990	Measuring	C0444706
28538990	nonlinear	C0205556
28538990	signal	C1710082
28538990	combination	C0205195
28538990	EEG	C0013819
28538990	Relatively	C0205345
28538990	processes	C1522240
28538990	linear	C0205132
28538990	nonlinear	C0205556
28538990	signals	C1710082
28538990	combined	C0205195
28538990	V1	C0038446
28538990	stimulus	C0234402
28538990	components	C1705248
28538990	simultaneously	C0521115
28538990	flickering	C0243095
28538990	different	C1705242
28538990	temporal frequencies	C0871500
28538990	frequency	C0871396
28538990	tagging	C0183825
28538990	measuring	C0444706
28538990	steady-state	C0678587
28538990	visual evoked potentials	C0015217
28538990	assess	C0184514
28538990	responses	C0871261
28538990	components	C1705248
28538990	direct	C1947931
28538990	measurements	C0242485
28538990	suppression	C0221103
28538990	nonlinear	C0205556
28538990	responses	C0871261
28538990	combination	C0205195
28538990	intermodulation	C0205556
28538990	frequencies	C0871396
28538990	result	C0456984
28538990	dataset	C0150098
28538990	frequencies	C0871396
28538990	responses	C0871261
28538990	pairs	C1709450
28538990	sinusoidal gratings	C1254362
28538990	different	C1705242
28538990	temporal frequencies	C0871500
28538990	plaid patterns	C0243095
28538990	coherent	C4068804
28538990	looking like a checkerboar	C0456340
28538990	noncoherent	C0243095
28538990	pair	C1709450
28538990	transparently	C0522503
28538990	overlaid gratings	C0456341
28538990	intermodulation	C0205556
28538990	responses	C0871261
28538990	compound	C0205198
28538990	stimuli	C0234402
28538990	nonlinear	C0205556
28538990	summation	C0234109
28538990	cross-orientation	C1704322
28538990	suppression	C0221103
28538990	pattern	C0449774
28538990	intermodulation	C0205556
28538990	responses	C0871261
28538990	differed	C0205556
28538990	coherent	C4068804
28538990	noncoherent	C0243095
28538990	patterns	C0449774
28538990	effects of	C1704420
28538990	suppression	C0221103
28538990	component	C1705248
28538990	frequencies	C0871396
28538990	two-stage model	C3161035
28538990	nonlinear	C0205556
28538990	summation	C0234109
28538990	conjunction	C2699427
28538990	detection	C1511790
28538990	logical	C1705253
28538990	AND gate	C0282574
28538990	data	C1511726
28538990	difference	C1705241
28538990	coherent	C4068804
28538990	noncoherent	C0243095
28538990	plaids	C1254362
28538990	array	C1510941
28538990	possible	C0332149
28538990	response frequencies	C0237629
28538990	Multistimulus	C0205556
28538990	frequency	C0871396
28538990	EEG	C0013819
28538990	combination	C0205195
28538990	computational modeling	C3850009
28538990	conjunction	C2699427
28538990	signals	C1710082
28538990	study	C2603343
28538990	results	C0456984
28538990	second-order mechanism	C0597439
28538990	selectively	C0205556
28538990	coherent	C4068804
28538990	plaid patterns	C0243095
28539349	Sleep Loss	C0235161
28539349	Promotes	C0033414
28539349	Astrocytic	C0521395
28539349	Phagocytosis	C0031308
28539349	Microglial Activation	C1326169
28539349	Mouse Cerebral Cortex	C1522579
28539349	Mertk	C1259418
28539349	ligand Gas6	C1567829
28539349	astrocytic	C0521395
28539349	genes	C0017337
28539349	phagocytosis	C0031308
28539349	upregulated	C0041904
28539349	after	C0687676
28539349	acute	C0205178
28539349	sleep deprivation	C0037316
28539349	astrocytes	C0004112
28539349	phagocytic activity	C0031308
28539349	during	C0347984
28539349	extended	C0231449
28539349	wake	C0442696
28539349	direct	C1947931
28539349	evidence	C3887511
28539349	lacking	C0332268
28539349	Studies	C2603343
28539349	humans	C0086418
28539349	rodents	C0035804
28539349	found	C0150312
28539349	sleep loss	C0235161
28539349	increases	C0442805
28539349	peripheral	C0205100
28539349	markers	C0005516
28539349	inflammation	C0021368
28539349	changes	C0392747
28539349	associated with	C0332281
28539349	neuroinflammation	C0683396
28539349	activation	C1326120
28539349	microglia	C0206116
28539349	brain's	C0006104
28539349	innate immune cells	C0312740
28539349	unknown	C0439673
28539349	used	C1524063
28539349	serial block-face scanning electron microscopy	C0026020
28539349	volume	C0449468
28539349	measurements	C0242485
28539349	synapses	C0039062
28539349	surrounding	C1282914
28539349	astrocytic	C0521395
28539349	processes	C3714634
28539349	mouse	C0025929
28539349	frontal cortex	C0016733
28539349	after	C0687676
28539349	sleep	C0037313
28539349	spontaneous	C0205359
28539349	wake	C0442696
28539349	sleep deprivation	C0037316
28539349	SD	C0037316
28539349	after	C0687676
28539349	chronic (∼5 d) sleep restriction	C0443288
28539349	CSR	C0443288
28539349	Astrocytic	C0521395
28539349	phagocytosis	C0031308
28539349	presynaptic components of large synapses	C1179895
28539349	increased	C0205217
28539349	after	C0687676
28539349	both	C1706086
28539349	acute	C0205178
28539349	chronic	C0205191
28539349	sleep loss	C0235161
28539349	relative	C0205345
28539349	sleep	C0037313
28539349	wake	C0442696
28539349	MERTK	C1259417
28539349	expression	C1171362
28539349	lipid peroxidation	C0023775
28539349	synaptoneurosomes	C0039067
28539349	increased	C0205217
28539349	similar	C2348205
28539349	extent	C0439792
28539349	after	C0687676
28539349	short	C1806781
28539349	long	C0205166
28539349	sleep loss	C0235161
28539349	astrocytic	C0521395
28539349	phagocytosis	C0031308
28539349	represent	C1882932
28539349	brain's	C0006104
28539349	response	C0871261
28539349	increase	C0442805
28539349	synaptic activity	C0027793
28539349	associated with	C0332281
28539349	prolonged	C0439590
28539349	wake	C0442696
28539349	clearing	C2963144
28539349	used	C1524063
28539349	synapses	C0039062
28539349	Using	C1524063
28539349	confocal microscopy	C0242842
28539349	found	C0150312
28539349	CSR	C0443288
28539349	not	C1518422
28539349	SD	C0037316
28539349	mice	C0025929
28539349	morphological	C0543482
28539349	signs	C0037088
28539349	microglial activation	C1326169
28539349	enhanced	C2349975
28539349	microglial	C0521398
28539349	phagocytosis	C0031308
28539349	synaptic elements	C3893360
28539349	without	C0332288
28539349	signs	C0037088
28539349	neuroinflammation	C0683396
28539349	CSF	C0007806
28539349	low	C0205251
28539349	level	C0441889
28539349	sustained	C0443318
28539349	microglia activation	C1326169
28539349	abnormal	C0205161
28539349	responses	C0871261
28539349	secondary	C0175668
28539349	insult	C0598698
28539349	results	C1274040
28539349	suggest	C1705535
28539349	chronic	C0205191
28539349	sleep loss	C0235161
28539349	through	C0332273
28539349	microglia	C0206116
28539349	priming	C0007613
28539349	brain	C0006104
28539349	further	C1517331
28539349	damage	C1883709
28539349	find	C0243095
28539349	astrocytic	C0521395
28539349	phagocytosis	C0031308
28539349	synaptic elements	C3893360
28539349	presynaptic origin	C3893360
28539349	large	C0549177
28539349	synapses	C0039062
28539349	upregulated	C0041904
28539349	after	C0687676
28539349	few	C0205388
28539349	hours	C0439227
28539349	sleep deprivation	C0037316
28539349	further	C1517331
28539349	significant	C0750502
28539349	increase	C0442805
28539349	after	C0687676
28539349	prolonged	C0439590
28539349	severe	C0205082
28539349	sleep loss	C0235161
28539349	promote	C0033414
28539349	housekeeping	C0020053
28539349	used	C1524063
28539349	strong	C0442821
28539349	synapses	C0039062
28539349	response	C0871261
28539349	increased	C0205217
28539349	neuronal	C0027882
28539349	activity	C0007613
28539349	extended	C0231449
28539349	wake	C0442696
28539349	contrast	C1979874
28539349	chronic sleep restriction	C0443288
28539349	not	C1518422
28539349	acute	C0205178
28539349	sleep loss	C0235161
28539349	activates	C1326120
28539349	microglia	C0206116
28539349	promotes	C0033414
28539349	phagocytic activity	C0031308
28539349	absence	C0332197
28539349	signs	C0037088
28539349	neuroinflammation	C0683396
28539349	other	C0205394
28539349	stressors	C0597530
28539349	extended	C0231449
28539349	sleep disruption	C1821308
28539349	state	C1442792
28539349	sustained	C0443318
28539349	microglia activation	C1326169
28539349	increasing	C0442808
28539349	brain's	C0006104
28539349	susceptibility	C1264642
28539349	other	C0205394
28539349	forms	C1522492
28539349	damage	C1883709
28540341	Reflections	C2603343
28540341	Hip Fracture Recovery	C0744924
28540341	Older Adults	C0001792
28540341	Clinical Trial	C0008976
28540341	study	C2603343
28540341	patients'	C0030705
28540341	perspectives	C0678958
28540341	recovery	C0237820
28540341	participation	C0679823
28540341	randomized controlled trial	C0206035
28540341	tested	C0392366
28540341	postoperative	C0032790
28540341	hip fracture	C0019557
28540341	management program	C0039798
28540341	B4 Clinic	C0442592
28540341	compared	C1707455
28540341	usual care	C0511425
28540341	mobility	C0449580
28540341	Semistructured	C0678594
28540341	qualitative	C0205556
28540341	interviews	C0021822
28540341	older adults	C0001792
28540341	hip fracture	C0019557
28540341	groups	C1257890
28540341	total	C0439810
28540341	women	C0043210
28540341	men	C0025266
28540341	participated	C0679823
28540341	study	C2603343
28540341	mean	C0444504
28540341	age	C0001779
28540341	baseline	C1442488
28540341	range	C1514721
28540341	total	C0439810
28540341	participants	C0679646
28540341	reported	C0700287
28540341	recovery	C0237820
28540341	goals	C0018017
28540341	recovery	C0237820
28540341	hip fracture	C0019557
28540341	participants	C0679646
28540341	realized	C4304473
28540341	goals	C0018017
28540341	Recovering	C2004454
28540341	mobility	C0449580
28540341	returning	C0332156
28540341	prefracture activities	C0441655
28540341	obtaining	C1301820
28540341	stable	C0205360
28540341	health	C0018684
28540341	most	C0205393
28540341	commonly	C0205214
28540341	reported	C0700287
28540341	goals	C0018017
28540341	Participants	C0679646
28540341	good	C0205170
28540341	social support	C1540833
28540341	access	C0444454
28540341	physiotherapy	C0949766
28540341	positive	C1446409
28540341	perspective	C0678958
28540341	most	C0205393
28540341	important	C3898777
28540341	recovery	C0237820
28540341	factors	C1521761
28540341	influenced	C4054723
28540341	participants	C0679646
28540341	knowledge	C0376554
28540341	resources	C0035201
28540341	contact	C1705415
28540341	study	C2603343
28540341	staff	C0851286
28540341	perceived	C0030971
28540341	social support	C1540833
28540341	most	C0205393
28540341	frequently	C0332183
28540341	reported	C0700287
28540341	barriers	C0679881
28540341	participants	C0679646
28540341	recovery	C0237820
28540341	onset of	C0332162
28540341	complications	C0009566
28540341	pain	C0030193
28540341	limited access	C1948144
28540341	physiotherapy	C0949766
28540341	Potential	C3245505
28540341	implications	C0392360
28540341	findings	C0243095
28540341	include	C2700399
28540341	design	C1707689
28540341	modification	C3840684
28540341	preexisting	C2347662
28540341	fracture	C0016658
28540341	programs	C3484370
28540341	prioritizing	C0549179
28540341	patient engagement	C0030675
28540341	enhanced	C2349975
28540341	knowledge	C0376554
28540341	future	C0016884
28540341	clinical research	C0008972
28540341	hip fracture recovery	C0744924
28542333	learn	C0023185
28542333	Physical activity	C0026606
28542333	improves	C0184511
28542333	learning	C0023185
28542333	second language	C0557074
28542333	studies	C2603343
28542333	concurrent	C0205420
28542333	physical activity	C0026606
28542333	enhances	C2349975
28542333	learning	C0023185
28542333	L2	C0557074
28542333	vocabulary	C0042926
28542333	learning	C0023185
28542333	static	C0441463
28542333	condition	C0348080
28542333	study	C2603343
28542333	possible	C0332149
28542333	positive	C1446409
28542333	effects of	C1704420
28542333	physical activity	C0026606
28542333	L2	C0557074
28542333	learning	C0023185
28542333	level	C0441889
28542333	proficiency	C0678997
28542333	better	C0332272
28542333	performance	C1882330
28542333	physical activity	C0026606
28542333	linguistic	C0023741
28542333	level	C0441889
28542333	training	C2673163
28542333	L2	C0557074
28542333	vocabulary	C0042926
28542333	tested	C0039593
28542333	Word-Picture Verification task	C0242481
28542333	sentence	C0876929
28542333	level	C0441889
28542333	tested	C0039593
28542333	Sentence Semantic Judgment Task	C0242481
28542333	Chinese speakers	C0152035
28542333	basic knowledge	C4036283
28542333	English	C0376245
28542333	benefited	C0814225
28542333	physical activity	C0026606
28542333	learning	C0023185
28542333	words	C0042926
28542333	better	C0332272
28542333	performance	C1882330
28542333	sentential	C0876929
28542333	level,	C0441889
28542333	performance	C1882330
28542333	Semantic Judgment task	C0242481
28542333	lexical	C1705313
28542333	sentential	C0876929
28542333	level	C0441889
28542333	experimental	C0441833
28542333	control group	C0009932
28542333	testing session	C1883016
28542333	lexical	C1705313
28542333	level	C0441889
28542333	sentential	C0876929
28542333	level	C0441889
28543041	added	C1524062
28543041	value	C1522609
28543041	cardiac index	C0428776
28543041	pulse pressure	C0949236
28543041	variation	C0205419
28543041	monitoring	C1283169
28543041	mean arterial pressure	C0428886
28543041	guided volume therapy	C0087111
28543041	moderate-risk abdominal surgery	C2066139
28543041	COGUIDE	C0087111
28543041	pragmatic	C3658312
28543041	multicentre	C0206012
28543041	randomised controlled trial	C0206035
28543041	disagreement	C0681800
28543041	benefits	C0814225
28543041	goal-directed therapy	C1271494
28543041	moderate-risk abdominal surgery	C2066139
28543041	tested	C0392366
28543041	hypothesis	C1512571
28543041	addition	C0332287
28543041	non-invasive	C0205303
28543041	cardiac index	C0428776
28543041	pulse pressure	C0949236
28543041	variation	C0205419
28543041	monitoring	C1283169
28543041	mean arterial pressure	C0428886
28543041	goal-directed therapy	C1271494
28543041	reduce	C0392756
28543041	incidence	C0021149
28543041	postoperative complications	C0032787
28543041	patients	C0030705
28543041	moderate-risk abdominal surgery	C2066139
28543041	pragmatic	C3658312
28543041	multicentre	C0206012
28543041	randomised controlled trial	C0206035
28543041	randomly allocated	C0034656
28543041	patients	C0030705
28543041	envelope drawing	C0013113
28543041	stratified	C0205363
28543041	patients	C0030705
28543041	mean arterial pressure	C0428886
28543041	cardiac index	C0428776
28543041	pulse pressure	C0949236
28543041	variation	C0205419
28543041	measured	C0444706
28543041	continuously	C0549178
28543041	group	C0441833
28543041	healthcare professionals	C0018724
28543041	blinded	C0150108
28543041	cardiac index	C0428776
28543041	pulse pressure	C0949236
28543041	variation	C0205419
28543041	values	C1522609
28543041	haemodynamic therapy	C0087111
28543041	mean arterial pressure	C0428886
28543041	control group	C0009932
28543041	group	C0441833
28543041	cardiac index	C0428776
28543041	pulse pressure	C0949236
28543041	variation	C0205419
28543041	values	C1522609
28543041	displayed	C0870432
28543041	target	C1521840
28543041	ranges	C1514721
28543041	pre-defined algorithm	C0002045
28543041	CI-PPV group	C0441833
28543041	primary endpoint	C2986535
28543041	incidence	C0021149
28543041	postoperative complications	C0032787
28543041	within 30 days	C3845590
28543041	patients	C0030705
28543041	eligible	C1548635
28543041	final	C3853528
28543041	analysis	C0936012
28543041	Overall	C1561607
28543041	complication rates	C0009566
28543041	control	C0009932
28543041	CI-PPV groups	C0441833
28543041	CI-PPV group	C0441833
28543041	lower	C0205251
28543041	mean	C0444504
28543041	SD	C0871420
28543041	pulse pressure	C0949236
28543041	variation	C0205419
28543041	values	C1522609
28543041	higher	C0205250
28543041	mean	C0444504
28543041	SD	C0871420
28543041	cardiac indices	C0428776
28543041	control group	C0009932
28543041	moderate-risk abdominal surgery	C2066139
28543041	observed	C1441672
28543041	additional value	C0439062
28543041	cardiac index	C0428776
28543041	pulse pressure	C0949236
28543041	variation	C0205419
28543041	guided haemodynamic therapy	C0087111
28543041	mean arterial pressure	C0428886
28543041	guided volume therapy	C0087111
28543041	postoperative complications	C0032787
28544215	Anterior single implants	C0376511
28544215	neck	C1254362
28544215	designs	C1707689
28544215	Year	C0439234
28544215	randomized clinical trial	C0206034
28544215	design	C1707689
28544215	implant neck	C0376511
28544215	preservation	C1514402
28544215	marginal	C0205284
28544215	bone	C0005931
28544215	5-year	C0439234
28544215	radiographic	C0444708
28544215	clinical	C0205210
28544215	outcome	C1274040
28544215	single anterior implants	C0376511
28544215	smooth	C0205357
28544215	smooth neck	C1254362
28544215	rough neck	C1254362
28544215	rough neck	C1254362
28544215	Patients	C0030705
28544215	anterior	C0205094
28544215	tooth	C0040426
28544215	maxilla	C0024947
28544215	patients	C0030705
28544215	implant	C0376511
28544215	smooth	C0205357
28544215	neck	C1254362
28544215	smooth group	C0441833
28544215	rough neck	C1254362
28544215	rough group	C0441833
28544215	rough neck	C1254362
28544215	scalloped group	C0441833
28544215	Implants	C0376511
28544215	healed sites	C1515974
28544215	Follow-up visits	C0589121
28544215	crown delivery	C1705822
28544215	year	C0439234
28544215	years	C0439234
28544215	implants	C0376511
28544215	marginal	C0205284
28544215	bone resorption	C0005974
28544215	bone loss	C0005974
28544215	smooth group	C0441833
28544215	rough group	C0441833
28544215	scalloped group	C0441833
28544215	Survival rates	C0038954
28544215	smooth	C0441833
28544215	scalloped group	C0441833
28544215	rough group	C0441833
28544215	implants	C0376511
28544215	deeper pocket depths	C0205125
28544215	bleeding	C0019080
28544215	complications	C2362589
28544215	esthetic outcome	C1274040
28544215	patient satisfaction	C0030702
28544215	anterior	C0205094
28544215	tooth replacements	C3893426
28544215	implants	C0376511
28544215	radiographic	C0444708
28544215	clinical	C0205210
28544215	outcome	C1274040
28544215	implants	C0376511
28544215	smooth	C0205357
28544215	neck	C1254362
28544215	rough neck	C1254362
28544275	Recessive mutations	C0026882
28544275	MSTO1	C1957185
28544275	mitochondrial dynamics	C3494415
28544275	impairment	C0221099
28544275	myopathy	C0026848
28544275	ataxia	C0004134
28544275	families	C0015576
28544275	variants	C0205419
28544275	MSTO1 gene	C1826310
28544275	compound heterozygous	C4264438
28544275	mutations	C0026882
28544275	mutations	C0026882
28544275	identified	C0205396
28544275	sisters	C0337514
28544275	unrelated	C0445356
28544275	singleton	C1313913
28544275	presented	C0449450
28544275	complex	C0439855
28544275	phenotype	C0031437
28544275	characterized	C1880022
28544275	myopathy	C0026848
28544275	cerebellar ataxia	C0007758
28544275	Human MSTO1	C1957185
28544275	suggested	C1705535
28544275	mitochondrial localization	C1657244
28544275	regulate	C1327622
28544275	morphology	C0332437
28544275	distribution of mitochondria	C1522855
28544275	mutations	C0026882
28544275	affecting	C0392760
28544275	genes	C0017337
28544275	mitochondrial dynamics	C3494415
28544275	biochemical	C0205474
28544275	defects	C0243067
28544275	mitochondrial disorders	C0751651
28544275	reported	C0700287
28544275	patients	C0030705
28544275	fibroblasts	C0016030
28544275	revealed	C0443289
28544275	MSTO1 protein	C1957185
28544275	levels	C0441889
28544275	reduced	C0392756
28544275	mitochondrial network was fragmented	C3809602
28544275	fusion	C0332466
28544275	mitochondria	C0026237
28544275	decreased	C0205216
28544275	deleterious effect	C2985436
28544275	identified	C0205396
28544275	variants	C0205419
28544275	MSTO1	C1957185
28544275	modulating	C0443264
28544275	mitochondrial dynamics	C3494415
28544275	cytosolic protein	C0033684
28544275	recessive mutations	C0026882
28544275	MSTO1	C1957185
28544275	inherited	C0439660
28544275	neuromuscular disorders	C0027868
28545217	bird	C0005595
28545217	passive air sampler	C0178984
28545217	monitoring	C1283169
28545217	halogenated flame retardants	C0016198
28545217	Birds	C0005595
28545217	biomonitors	C0025080
28545217	halogenated flame retardants	C0016198
28545217	HFRs	C0016198
28545217	studies	C2603343
28545217	tissue	C0040300
28545217	concentrations	C1446561
28545217	individual	C0237401
28545217	variability	C2827666
28545217	contaminants	C2827365
28545217	diet	C0012155
28545217	exposure	C0332157
28545217	pathway	C1705987
28545217	HFRs	C0016198
28545217	birds	C0005595
28545217	suggested	C1705535
28545217	exposure	C0332157
28545217	air	C0001861
28545217	represent	C1882932
28545217	source	C0449416
28545217	HFRs	C0016198
28545217	species	C1705920
28545217	method	C0025663
28545217	not available	C0686905
28545217	measuring	C0444706
28545217	atmospheric	C0004178
28545217	exposure	C0332157
28545217	individual	C0237401
28545217	birds	C0005595
28545217	HFRs	C0016198
28545217	semi-volatile	C1963547
28545217	contaminants	C2827365
28545217	goal	C0018017
28545217	study	C2603343
28545217	bird	C0005595
28545217	passive air sampler	C0178984
28545217	PAS	C0178984
28545217	determination	C1148554
28545217	individual	C0237401
28545217	atmospheric	C0004178
28545217	exposure	C0332157
28545217	gas	C0017110
28545217	particle-phase	C0597177
28545217	HFRs	C0016198
28545217	ring-billed gull	C1061035
28545217	Larus delawarensis	C1061035
28545217	nesting	C0870949
28545217	Montreal area	C0681784
28545217	QC	C0034390
28545217	Canada	C0006823
28545217	elliptical-shaped	C1947977
28545217	PAS	C0178984
28545217	mean weight	C0043100
28545217	tested	C0039593
28545217	two sorbent types	C0022885
28545217	exposure periods	C2826764
28545217	Results	C1274040
28545217	PAS	C0178984
28545217	polyurethane foam	C0071696
28545217	PUF	C0071696
28545217	glass fiber	C0060317
28545217	filter collected	C0545227
28545217	polybrominated diphenyl ethers	C2350562
28545217	PBDEs	C2350562
28545217	better performance	C1882330
28545217	collecting	C1516698
28545217	highly hydrophobic	C0598629
28545217	DecaBDE	C2350562
28545217	mixture	C0439962
28545217	congeners	C0678518
28545217	compared to	C1707455
28545217	PAS	C0178984
28545217	polydimethylsiloxane	C0137758
28545217	PDMS	C0137758
28545217	HFRs	C0016198
28545217	hexabromobenzene	C0062598
28545217	Dechlorane 604 Component B	C3180256
28545217	Dechlorane plus	C2351195
28545217	DP	C2351195
28545217	isomers	C0022203
28545217	sampled	C0441621
28545217	PUF	C0071696
28545217	PAS	C0178984
28545217	Sampling	C0441621
28545217	rates	C1521828
28545217	HFRs	C0016198
28545217	comparable	C1707455
28545217	exposure periods	C2826764
28545217	bird	C0005595
28545217	PAS	C0178984
28545217	valuable information	C1533716
28545217	non-dietary exposure	C0332157
28545217	free-ranging	C3845292
28545217	birds	C0005595
28545217	HFRs	C0016198
28545437	Post	C0032790
28545437	endodontic pain	C0030193
28545437	root canal preparation	C0282543
28545437	rotary	C0011377
28545437	reciprocating instruments	C0011377
28545437	meta-analysis	C0920317
28545437	randomized clinical trials	C0206034
28545437	endodontic therapy	C0035849
28545437	rotary instrumentation	C0587378
28545437	debris	C0440266
28545437	reciprocal instrumentation	C0587378
28545437	incidence	C0021149
28545437	post-endodontic pain	C0030193
28545437	PP	C0030193
28545437	study	C2603343
28545437	PP	C0030193
28545437	incidence	C0021149
28545437	rotary	C0011377
28545437	reciprocal instruments	C0011377
28545437	meta-analysis	C0920317
28545437	Pubmed	C1138432
28545437	EM databases	C0242356
28545437	clinical randomized trials	C0206034
28545437	root canal preparation	C0282543
28545437	instrumentation	C0587378
28545437	treatment	C0087111
28545437	therapy	C0087111
28545437	post-operative	C0032790
28545437	endodontic pain	C0030193
28545437	reciprocal	C0011377
28545437	rotary instruments	C0011377
28545437	studies	C2603343
28545437	patients	C0030705
28545437	reciprocating instruments	C0011377
28545437	rotary instruments	C0011377
28545437	PP	C0030193
28545437	patients	C0030705
28545437	reciprocating group	C1257890
28545437	rotary group	C1257890
28545437	PP	C0030193
28545437	incidence	C0021149
28545437	confidence interval	C0009667
28545437	CI	C0009667
28545437	rotary instruments	C0011377
28545437	mild	C2945599
28545437	moderate	C0205081
28545437	severe	C0205082
28545437	PP	C0030193
28545437	Rotary instrument	C0011377
28545437	endodontic therapy	C0035849
28545437	associated with	C0332281
28545437	incidence	C0021149
28545437	PP	C0030193
28545437	reciprocating instruments	C0011377
28545437	reciprocating instruments	C0011377
28545437	associated with	C0332281
28545437	PP	C0030193
28545437	incidence	C0021149
28546554	resistance	C1514892
28546554	profiling	C2003903
28546554	Plasmodium falciparum	C0032150
28546554	Plasmodium falciparum infections	C3714514
28546554	custom dual indexing	C0017395
28546554	Illumina next generation sequencing-technology	C0017395
28546554	Genetic polymorphisms	C0032529
28546554	P. falciparum	C0032150
28546554	parasite's	C0030498
28546554	susceptibility	C0243095
28546554	antimalarial drugs	C0003374
28546554	geographical origin	C0565935
28546554	monitoring	C1283169
28546554	development	C1527148
28546554	spread	C0332261
28546554	antimalarial	C0003374
28546554	antimalarial drug resistance	C0013203
28546554	multiplex PCR	C2732533
28546554	custom designed dual indexing	C0017395
28546554	Miseq	C3898361
28546554	sequencing	C1294197
28546554	SNP	C0752046
28546554	profiling	C2003903
28546554	malaria	C0024530
28546554	infections	C3714514
28546554	Guinea-Bissau	C0018387
28546554	cost	C0010186
28546554	amplifying	C0017256
28546554	sequencing	C1294197
28546554	genetic	C0314603
28546554	fragments	C1708096
28546554	resistance	C1514892
28546554	SNPs	C0752046
28546554	pfcrt	C0017337
28546554	pfmdr1	C0017337
28546554	pfdhfr	C0017337
28546554	pfdhps	C0017337
28546554	length	C1444754
28546554	pfK13	C0017337
28546554	mitochondrial	C0026237
28546554	barcode	C0004738
28546554	parasite	C0030498
28546554	origin	C0584985
28546554	SNPs	C0752046
28546554	average	C1510992
28546554	SNP	C0752046
28546554	positions	C0733755
28546554	SNP	C0752046
28546554	artemisinin	C0052430
28546554	artemisinin resistance	C0013203
28546554	SNPs	C0752046
28546554	pfK13	C0017337
28546554	absent	C0332197
28546554	Guinea-Bissau	C0018387
28546554	pfmdr1	C0017337
28546554	prevalence	C0220900
28546554	mitochondrial	C0026237
28546554	barcodes	C0004738
28546554	West African	C0238606
28546554	West African origin	C0584985
28546554	parasites	C0030498
28546554	method	C0025663
28546554	reliable	C3858758
28546554	surveillance	C0038842
28546554	antimalarial	C0003374
28546554	antimalarial drug resistance	C0013203
28549399	systematic review	C1955832
28549399	investigating	C1292732
28549399	psychosocial aspects	C0243156
28549399	egg sharing	C4053456
28549399	United Kingdom	C0041700
28549399	potential	C3245505
28549399	effects	C1280500
28549399	egg donation	C4053456
28549399	numbers	C0237753
28549399	review	C0282443
28549399	knowledge	C0376554
28549399	psychosocial aspects	C0243156
28549399	egg donation	C4053456
28549399	egg share donor	C0029975
28549399	recipient	C1709854
28549399	motives	C0869035
28549399	experiences	C0596545
28549399	attitudes	C0004271
28549399	egg sharers	C0029975
28549399	donor	C0029975
28549399	anonymity	C0871649
28549399	disclosure	C0012625
28549399	Conclusions	C1707478
28549399	findings	C0243095
28549399	guide clinical practice	C0282451
28549399	egg sharing	C4053456
28549399	numbers	C0237753
28549399	systematic	C0220922
28549399	search	C1706202
28549399	peer-reviewed journals	C2985503
28549399	computerized databases	C0871696
28549399	studies	C2603343
28549399	review	C0282443
28549399	Psychosocial aspects	C0243156
28549399	donation	C4053456
28549399	positive	C1446409
28549399	egg share donor	C0029975
28549399	recipient	C1709854
28549399	Concerns	C2699424
28549399	raised	C0442818
28549399	participating	C0679823
28549399	egg sharing	C4053456
28549399	scheme	C1519193
28549399	impact	C4049986
28549399	success	C0679864
28549399	rates	C1521828
28549399	frustration	C0016770
28549399	expressed	C1551042
28549399	minority	C0026192
28549399	lack of knowledge	C1998986
28549399	egg sharing	C4053456
28549399	fertility	C0015895
28549399	clinics	C0442592
28549399	legislative	C2937257
28549399	changes	C0392747
28549399	UK	C0041700
28549399	decrease	C0547047
28549399	egg donation	C4053456
28549399	oocyte donation	C0242813
28549399	demand	C0441516
28549399	Egg sharing	C4053456
28549399	practical option	C1518601
28549399	patients	C0030705
28549399	access	C1554204
28549399	IVF	C0015915
28549399	donor oocytes	C3267027
28549399	information provision	C0681319
28549399	result	C1274040
28549399	awareness	C0004448
28549399	egg sharing	C4053456
28549399	potential	C3245505
28549399	recruit	C2949735
28549399	meet	C1550543
28549399	recipients	C1709854
28549399	currently	C0521116
28549399	waiting lists	C0043010
28550348	Medication regimen	C0237125
28550348	complexity	C0237522
28550348	prevalence	C0033105
28550348	potentially inappropriate medicines	C4042848
28550348	older	C0001792
28550348	patients	C0030705
28550348	hospitalisation	C0019993
28550348	relative	C0205345
28550348	information	C1533716
28550348	potential	C3245505
28550348	changes	C0392747
28550348	medication regimen	C0237125
28550348	complexity	C0237522
28550348	prevalence	C0033105
28550348	prescribing	C2239117
28550348	potentially inappropriate medications	C4042848
28550348	hospitalisation	C0019993
28550348	Australia	C0004340
28550348	Objective	C0018017
28550348	evaluate	C0220825
28550348	medication regimen	C0237125
28550348	complexity	C0237522
28550348	prevalence	C0033105
28550348	potentially inappropriate medications	C4042848
28550348	before	C0332152
28550348	admission to hospital	C0184666
28550348	General medical units	C1708333
28550348	tertiary care hospital	C0337954
28550348	Australia	C0004340
28550348	Retrospective cohort study	C2985505
28550348	patients	C0030705
28550348	aged	C0001779
28550348	Medication	C2081612
28550348	complexity	C0237522
28550348	measured	C0444706
28550348	Medication Regimen Complexity Index	C0282574
28550348	MRCI	C0282574
28550348	Main outcome measure	C3274433
28550348	primary outcome	C3274433
28550348	change	C0392747
28550348	Medication Regimen Complexity Index	C0282574
28550348	prescribed medications	C3166216
28550348	hospitalization	C0019993
28550348	Results	C0456984
28550348	convenience sample	C0150095
28550348	patients	C0030705
28550348	included	C0332257
28550348	study	C2603343
28550348	significant	C0750502
28550348	change	C0392747
28550348	mean	C0444504
28550348	medication	C2081612
28550348	complexity	C0237522
28550348	score	C0449820
28550348	measured	C0444706
28550348	MRCI	C0282574
28550348	increasing	C0205217
28550348	time of admission	C3854259
28550348	time of discharge	C3864299
28550348	Factors	C1521761
28550348	baseline	C1442488
28550348	medication regimen	C0237125
28550348	complexity	C0237522
28550348	pre-admission	C0559269
28550348	MRCI	C0282574
28550348	length of stay in the hospitals	C0023303
28550348	appear	C0700364
28550348	influence	C4054723
28550348	change	C0392747
28550348	medication	C2081612
28550348	complexity	C0237522
28550348	proportion	C1709707
28550348	patients	C0030705
28550348	prescribed	C0278329
28550348	potentially inappropriate medicine	C4042848
28550348	PIM	C4042848
28550348	decreased significantly	C4055638
28550348	pre-hospitalization	C0019993
28550348	at discharge	C3871203
28550348	Relative	C0205345
28550348	time of admission	C3854259
28550348	overall	C1561607
28550348	medication	C2081612
28550348	complexity	C0237522
28550348	increased	C0205217
28550348	proportion	C1709707
28550348	patients	C0030705
28550348	prescribed	C0278329
28550348	PIMs	C4042848
28550348	decreased	C0205216
28550348	hospitalisation	C0019993
